PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ebadi, A; Schiffauerova, A				Ebadi, Ashkan; Schiffauerova, Andrea			How to Receive More Funding for Your Research? Get Connected to the Right People!	PLOS ONE			English	Article							RESEARCH COLLABORATION; IMPACT; UNIVERSITIES; PERFORMANCE; GROWTH	Funding has been viewed in the literature as one of the main determinants of scientific activities. Also, at an individual level, securing funding is one of the most important factors for a researcher, enabling him/her to carry out research projects. However, not everyone is successful in obtaining the necessary funds. The main objective of this work is to measure the effect of several important factors such as past productivity, scientific collaboration or career age of researchers, on the amount of funding that is allocated to them. For this purpose, the paper estimates a temporal non-linear multiple regression model. According to the results, although past productivity of researchers positively affects the funding level, our findings highlight the significant role of networking and collaboration. It was observed that being a member of large scientific teams and getting connected to productive researchers who have also a good control over the collaboration network and the flow of information can increase the chances for securing more money. In fact, our results show that in the quest for the research money it is more important how researchers build their collaboration network than what publications they produce and whether they are cited.	[Ebadi, Ashkan; Schiffauerova, Andrea] Concordia Univ, CIISE, Montreal, PQ, Canada; [Schiffauerova, Andrea] Masdar Inst Sci & Technol, Dept Engn Syst & Management, Abu Dhabi, U Arab Emirates	Concordia University - Canada; Khalifa University of Science & Technology	Ebadi, A (corresponding author), Concordia Univ, CIISE, Montreal, PQ, Canada.	a_ebad@encs.concordia.ca	Ebadi, Ashkan/GWZ-9018-2022; Ebadi, Ashkan/AAI-5123-2020	Ebadi, Ashkan/0000-0002-4542-9105				Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; [Anonymous], [No title captured]; Arora A, 2000, ECONOMICS AND ECONOMETRICS OF INNOVATION, P141; Beaudry C, 2012, RES POLICY, V41, P1589, DOI 10.1016/j.respol.2012.03.022; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Borr&aacute;s S., 2000, 0001 UN POL COMP CSI; Braun D., 2003, SCI PUBL POLICY, V30, P309, DOI [10.3152/147154303781780353, DOI 10.3152/147154303781780353]; Burt D. R., 2001, NETWORKS MARKETS CON; De Solla Price D, 1963, BIG SCI LITTLE SCI, P119; Defazio D, 2009, RES POLICY, V38, P293, DOI 10.1016/j.respol.2008.11.008; Elzinga A., 1995, HDB SCI TECHNOLOGY S; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; Gambardella A., 1998, ANN EC STAT, P91; Geuna A, 2001, J ECON ISSUES, V35, P607, DOI 10.1080/00213624.2001.11506393; Gladwell Malcolm, 2008, OUTLIERS; Griffith R, 2004, REV ECON STAT, V86, P883, DOI 10.1162/0034653043125194; Gulati R., 1999, AM J SOCIOL, V104, P177; Hanneman R. A., 2011, SAGE HDB SOCIAL NETW, P340, DOI 10.4135/9781446294413.n24; HEFFNER AG, 1981, SCIENTOMETRICS, V3, P5, DOI 10.1007/BF02021860; Industry Canada, 2002, ACH EXC INV PEOPL KN; Irvine J., 1984, FORESIGHT SCI PICKIN; Jacob BA, 2011, J PUBLIC ECON, V95, P1168, DOI 10.1016/j.jpubeco.2011.05.005; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Kortum S., 2002, INNOVATING FIRMS AGG; Kyvik S, 2008, SCIENTOMETRICS, V76, P439, DOI 10.1007/s11192-007-1767-z; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Leydesdorff L, 2009, J INFORMETR, V3, P353, DOI 10.1016/j.joi.2009.05.005; Martin B., 2003, SCI INNOVATION RETHI, P7, DOI DOI 10.4337/9781781950241.00011; MERTON Robert King., 1973, THEORETICAL SOCIOLOG; Moed HF, 1996, SCIENTOMETRICS, V37, P105, DOI 10.1007/BF02093487; Okubo Y., 1997, OECD SCI TECHNOLOGY, V5, P150; Oyo B., 2008, P 24 INT C SYST DYN; Payne A.A., 2003, ADV EC ANAL POLICY, V3, P1, DOI [10.2202/1538-0637.1018, DOI 10.2202/1538-0637.1018]; Polster C, 2007, HIGH EDUC, V53, P599, DOI 10.1007/s10734-005-1118-z; RIP A, 1994, HIGH EDUC, V28, P3, DOI 10.1007/BF01383569; Schiffauerova A., 2015, J INFORM UNPUB; Schilling MA, 2007, MANAGE SCI, V53, P1113, DOI 10.1287/mnsc.1060.0624; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Seglen PO, 1997, BRIT MED J, V314, P498; Shapira P, 2010, NATURE, V468, P627, DOI 10.1038/468627a; Stuart TE, 2000, STRATEGIC MANAGE J, V21, P791, DOI 10.1002/1097-0266(200008)21:8<791::AID-SMJ121>3.0.CO;2-K; Tijssen RJW, 2004, RES POLICY, V33, P709, DOI 10.1016/j.respol.2003.11.002; Ubfal D, 2011, RES POLICY, V40, P1269, DOI 10.1016/j.respol.2011.05.023; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	47	54	54	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133061	10.1371/journal.pone.0133061	http://dx.doi.org/10.1371/journal.pone.0133061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222598	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800038
J	Kolan, SS; Lejon, K; Holm, CK; Sulniute, R; Lundberg, P; Matozaki, T; Oldenborg, PA				Kolan, Shrikant Shantilal; Lejon, Kristina; Holm, Cecilia Koskinen; Sulniute, Rima; Lundberg, Pernilla; Matozaki, Takashi; Oldenborg, Per-Arne			Non-Hematopoietic and Hematopoietic SIRP alpha Signaling Differently Regulates Murine B Cell Maturation in Bone Marrow and Spleen	PLOS ONE			English	Article							HOMEOSTASIS; RESPONSES; RECEPTOR; NICHES; CD47; SELF	B lymphocyte development occurs in the bone marrow, while final differentiation and maturation can occur in both the bone marrow and the spleen. Here we provide evidence that signal regulatory protein a (SIRP alpha), an Ig-superfamily ITIM-receptor expressed by myeloid but not by lymphoid cells, is involved in regulating B cell maturation. Lack of SIRP alpha signaling in adult SIRP alpha-mutant mice resulted in a reduced maturation of B cells in the bone marrow, evident by reduced numbers of semi-mature IgD(+)vertical bar IgM(hi) follicular type-II (F-II) and mature IgD(+)vertical bar IgM(lo) follicular type-I (F-I) B cells, as well as reduced blood B cell numbers. In addition, lack of SIRP alpha signaling also impaired follicular B cell maturation in the spleen. Maturing BM or splenic B cells of SIRP alpha-mutant mice were found to express higher levels of the pro-apoptotic protein BIM and apoptosis was increased among these B cells. Bone marrow reconstitution experiments revealed that the B cell maturation defect in bone marrow and blood was due to lack of SIRP alpha signaling in non-hematopoietic cells, while hematopoietic SIRP alpha signaling was important for follicular B cell maturation in the spleen. Adding on to our previous findings of a stromal cell defect in SIRP alpha-mutant mice was the finding that gene expression of receptor activator of nuclear factor-kappa B ligand (RANKL) was significantly lower in cultured bone marrow stromal cells of SIRP alpha mutant mice. These data suggest a novel and opposite contribution of SIRP alpha signaling within non-hematopoietic and hematopoietic cells, respectively, to maintain B cell maturation and to prevent apoptosis in the bone marrow and spleen of adult mice.	[Kolan, Shrikant Shantilal; Oldenborg, Per-Arne] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Lejon, Kristina] Umea Univ, Immunol Sect, Dept Clin Microbiol, Umea, Sweden; [Holm, Cecilia Koskinen; Sulniute, Rima; Lundberg, Pernilla] Umea Univ, Dept Odontol, Umea, Sweden; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan	Umea University; Umea University; Umea University; Kobe University	Oldenborg, PA (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	per-arne.oldenborg@umu.se			Swedish Research Council [20122702]; King Gustaf V 80-Year Foundation [FAI2013-0090]; Grants-in-Aid for Scientific Research [26291022] Funding Source: KAKEN	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V 80-Year Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Swedish Research Council (20122702; PAO) http://www.vr.se; The King Gustaf V 80-Year Foundation (FAI2013-0090; PAO) http://www.kungahuset.se/monarkinhovstaterna/kungligastiftelser/forskning/konunggustafvs80arsfond. 4.11deaee4147afe3f46050da.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Ceredig R, 2012, SEMIN IMMUNOL, V24, P159, DOI 10.1016/j.smim.2012.02.004; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; den Haan JM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00201; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Gaudin E, 2004, IMMUNOL REV, V197, P102, DOI 10.1111/j.0105-2896.2004.0095.x; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jorgensen TN, 2007, J IMMUNOL, V179, P3417, DOI 10.4049/jimmunol.179.6.3417; Koskinen C, 2013, J BIOL CHEM, V288, P29333, DOI 10.1074/jbc.M113.494591; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Lindsley RC, 2007, BLOOD, V109, P2521, DOI 10.1182/blood-2006-04-018085; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Patton DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088771; Perlot T, 2012, J IMMUNOL, V188, P1201, DOI 10.4049/jimmunol.1102063; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2009, IMMUNOL CELL BIOL, V87, P16, DOI 10.1038/icb.2008.89; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Sato-Hashimoto M, 2011, J IMMUNOL, V187, P291, DOI 10.4049/jimmunol.1100528; Stenberg A, 2014, J INNATE IMMUN, V6, P553, DOI 10.1159/000357820; Tischner D, 2010, Cell Death Dis, V1, pe48, DOI 10.1038/cddis.2010.27; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Yun TJ, 1998, J IMMUNOL, V161, P6113; Zen K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3436	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134113	10.1371/journal.pone.0134113	http://dx.doi.org/10.1371/journal.pone.0134113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222253	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800105
J	Mogen, AB; Chen, F; Ahn, SJ; Burne, RA; Wang, D; Rice, KC				Mogen, Austin B.; Chen, Fu; Ahn, Sang-Joon; Burne, Robert A.; Wang, Dong; Rice, Kelly C.			Pluronics-Formulated Farnesol Promotes Efficient Killing and Demonstrates Novel Interactions with Streptococcus mutans Biofilms	PLOS ONE			English	Article							SALIVA-COATED HYDROXYAPATITE; QUORUM-SENSING MOLECULE; DENTAL-CARIES; CANDIDA-ALBICANS; STAPHYLOCOCCUS-AUREUS; TARGETED DELIVERY; DRUG-DELIVERY; GLUCOSYLTRANSFERASE ACTIVITY; TT-FARNESOL; IN-VITRO	Streptococcus mutans is the primary causative agent of dental caries, one of the most prevalent diseases in the United States. Previously published studies have shown that Pluronic-based tooth-binding micelles carrying hydrophobic antimicrobials are extremely effective at inhibiting S. mutans biofilm growth on hydroxyapatite (HA). Interestingly, these studies also demonstrated that non-binding micelles (NBM) carrying antimicrobial also had an inhibitory effect, leading to the hypothesis that the Pluronic micelles themselves may interact with the biofilm. To explore this potential interaction, three different S. mutans strains were each grown as biofilm in tissue culture plates, either untreated or supplemented with NBM alone (P85), NBM containing farnesol (P85F), or farnesol alone (F). In each tested S. mutans strain, biomass was significantly decreased (SNK test, p < 0.05) in the P85F and F biofilms relative to untreated biofilms. Furthermore, the P85F biofilms formed large towers containing dead cells that were not observed in the other treatment conditions. Tower formation appeared to be specific to formulated farnesol, as this phenomenon was not observed in S. mutans biofilms grown with NBM containing triclosan. Parallel CFU/ml determinations revealed that biofilm growth in the presence of P85F resulted in a 3-log reduction in viability, whereas F decreased viability by less than 1-log. Wild-type biofilms grown in the absence of sucrose or gtfBC mutant biofilms grown in the presence of sucrose did not form towers. However, increased cell killing with P85F was still observed, suggesting that cell killing is independent of tower formation. Finally, repeated treatment of pre-formed biofilms with P85F was able to elicit a 2-log reduction in viability, whereas parallel treatment with F alone only reduced viability by 0.5-log. Collectively, these results suggest that Pluronics-formulated farnesol induces alterations in biofilm architecture, presumably via interaction with the sucrose-dependent biofilm matrix, and may be a viable treatment option in the prevention and treatment of pathogenic plaque biofilms.	[Mogen, Austin B.; Rice, Kelly C.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Chen, Fu; Wang, Dong] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Ahn, Sang-Joon; Burne, Robert A.] Univ Florida, Dept Oral Biol, Coll Dent, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Medical Center; State University System of Florida; University of Florida	Rice, KC (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	kcrice@ufl.edu		Burne, Robert/0000-0002-4234-0316	University of Florida-University Scholars undergraduate research fellowship; National Institutes of Health [R03 DE019179, R01 DE13239]; "Proof of Concept" grant award from University of Nebraska Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019179] Funding Source: NIH RePORTER	University of Florida-University Scholars undergraduate research fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Proof of Concept" grant award from University of Nebraska Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by University of Florida-University Scholars undergraduate research fellowship (http://scholars.ufl.edu/) to ABM, and in part by National Institutes of Health grants R03 DE019179 (KCR), R01 DE13239 (RAB), and a "Proof of Concept" grant award from University of Nebraska Foundation (https://nufoundation.org/unmc) (DW).	AOKI H, 1986, INFECT IMMUN, V53, P587, DOI 10.1128/IAI.53.3.587-594.1986; ARENDS J, 1986, J DENT RES, V65, P2, DOI 10.1177/00220345860650010201; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; Cerca Nuno, 2012, BMC Res Notes, V5, P244, DOI 10.1186/1756-0500-5-244; Chen F, 2013, PHARM RES-DORDR, V30, P2808, DOI 10.1007/s11095-013-1105-5; Chen F, 2010, PHARM RES-DORDR, V27, P2356, DOI 10.1007/s11095-010-0119-5; Chen F, 2009, ANTIMICROB AGENTS CH, V53, P4898, DOI 10.1128/AAC.00387-09; Cross SE, 2007, MICROBIOL-SGM, V153, P3124, DOI 10.1099/mic.0.2007/007625-0; Decanis Nadege, 2011, Open Microbiol J, V5, P119, DOI 10.2174/1874285801105010119; Edwards BJ, 2008, LANCET ONCOL, V9, P1166, DOI 10.1016/S1470-2045(08)70305-X; Edwards BJ, 2008, J AM DENT ASSOC, V139, P1674, DOI 10.14219/jada.archive.2008.0110; EMILSON CG, 1994, J DENT RES, V73, P682, DOI 10.1177/00220345940730031401; FITZGERALD R J, 1960, J Am Dent Assoc, V61, P9; Gomes F, 2011, CURR MICROBIOL, V63, P354, DOI 10.1007/s00284-011-9984-3; Gomes F, 2011, AM J MED SCI, V341, P191, DOI 10.1097/MAJ.0b013e3181fcf138; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; HAMADA S, 1984, J DENT RES, V63, P407, DOI 10.1177/00220345840630031001; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Horev B, 2015, ACS NANO, V9, P2390, DOI 10.1021/nn507170s; Horn T, 2004, TOXICOLOGIST, V78, P15; Horn TL, 2005, CHEM-BIOL INTERACT, V152, P79, DOI 10.1016/j.cbi.2005.02.006; Housley L, 2009, FEMS MICROBIOL LETT, V293, P148, DOI 10.1111/j.1574-6968.2009.01528.x; Hu ZY, 2008, J BIOMED MATER RES A, V85A, P797, DOI 10.1002/jbm.a.31615; Inoue Y, 2004, FEMS MICROBIOL LETT, V237, P325, DOI 10.1016/j.femsle.2004.06.049; Jabra-Rizk MA, 2006, ANTIMICROB AGENTS CH, V50, P1463, DOI 10.1128/AAC.50.4.1463-1469.2006; Jabra-Rizk MA, 2006, FEMS YEAST RES, V6, P1063, DOI 10.1111/j.1567-1364.2006.00121.x; Jagdale SC, 2014, J DRUG DELIV, V2014, DOI 10.1155/2014/804616; Jeon JG, 2011, INT J ORAL SCI, V3, P98, DOI 10.4248/IJOS11038; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Kim JY, 2013, BIOMATERIALS, V34, P1170, DOI 10.1016/j.biomaterials.2012.09.047; Klapper I, 2002, BIOTECHNOL BIOENG, V80, P289, DOI 10.1002/bit.10376; Koo H, 2002, ANTIMICROB AGENTS CH, V46, P1302, DOI 10.1128/AAC.46.5.1302-1309.2002; Koo H, 2005, J DENT RES, V84, P1016, DOI 10.1177/154405910508401109; Koo H, 2002, ORAL MICROBIOL IMMUN, V17, P337, DOI 10.1034/j.1399-302X.2002.170602.x; Korstgens V, 2001, J MICROBIOL METH, V46, P9, DOI 10.1016/S0167-7012(01)00248-2; Kozlov MY, 2000, MACROMOLECULES, V33, P3305, DOI 10.1021/ma991634x; Langford ML, 2009, FUTURE MICROBIOL, V4, P1353, DOI [10.2217/fmb.09.98, 10.2217/FMB.09.98]; Lapczynski A, 2008, FOOD CHEM TOXICOL, V46, pS149, DOI 10.1016/j.fct.2008.06.046; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; Li XR, 2009, J DRUG TARGET, V17, P739, DOI 10.3109/10611860903062062; LI YH, 1994, J DENT RES, V73, P1615, DOI 10.1177/00220345940730100601; LITTLE WA, 1979, ANTIMICROB AGENTS CH, V15, P440, DOI 10.1128/AAC.15.3.440; Liu J, 2013, FEMS MICROBIOL LETT, V340, P11, DOI 10.1111/1574-6968.12066; Liu JS, 2014, INT J NANOMED, V9, P3923, DOI 10.2147/IJN.S62263; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; MURCHISON HH, 1986, INFECT IMMUN, V54, P273, DOI 10.1128/IAI.54.2.273-282.1986; Nguyen PTM, 2005, ORAL MICROBIOL IMMUN, V20, P93, DOI 10.1111/j.1399-302X.2004.00197.x; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Olson ME, 2002, CAN J VET RES, V66, P86; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; PUCCI MJ, 1987, INFECT IMMUN, V55, P2176, DOI 10.1128/IAI.55.9.2176-2182.1987; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; SHAW JH, 1987, NEW ENGL J MED, V317, P996, DOI 10.1056/NEJM198710153171605; Shen S, 2004, J DENT, V32, P667, DOI 10.1016/j.jdent.2004.07.002; Shirtliff ME, 2009, ANTIMICROB AGENTS CH, V53, P2392, DOI 10.1128/AAC.01551-08; Tang Zi-sheng, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P266; TANZER JM, 1995, J DENT RES, V74, P1536, DOI 10.1177/00220345950740090601; Tatman D, 2002, CANCER LETT, V175, P129, DOI 10.1016/S0304-3835(01)00723-6; Tavano L, 2013, LANGMUIR, V29, P12638, DOI 10.1021/la4021383; Twetman S, 2004, CARIES RES, V38, P223, DOI 10.1159/000077758; Unnanuntana A, 2009, J BONE JOINT SURG AM, V91A, P2683, DOI 10.2106/JBJS.H.01699; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; VaccaSmith AM, 1996, ARCH ORAL BIOL, V41, P291, DOI 10.1016/0003-9969(95)00129-8; Wang YZ, 2007, INT J PHARM, V337, P63, DOI 10.1016/j.ijpharm.2006.12.033; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; Zhou Q, 2011, J PHYS CHEM B, V115, P12662, DOI 10.1021/jp207951e; Zhu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028830	73	16	16	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133886	10.1371/journal.pone.0133886	http://dx.doi.org/10.1371/journal.pone.0133886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222384	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800076
J	Sahu, BD; Kumar, JM; Sistla, R				Sahu, Bidya Dhar; Kumar, Jerald Mahesh; Sistla, Ramakrishna			Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-kappa B Pathways	PLOS ONE			English	Article							INDUCED RENAL INJURY; INDUCED NEPHROTOXICITY; SCUTELLARIA-BAICALENSIS; OXIDATIVE STRESS; PROTEIN-KINASE; CELL-DEATH; INHIBITION; PROTECTION; NRF2; INFLAMMATION	Acute renal failure is a serious complication of the anticancer drug cisplatin. The potential role of baicalein, a naturally occurring bioflavonoid on cisplatin-induced renal injury is unknown. Here, we assessed the effect of baicalein against a murine model of cisplatin-induced acute renal failure and investigated the underlying possible mechanisms. Renal function, kidney histology, inflammation, oxidative stress, renal mitochondrial function, proteins involved in apoptosis, nuclear translocation of Nrf2 and effects on intracellular signaling pathways such as MAPKs, and NF-kappa B were assessed. Pretreatment with baicalein ameliorated the cisplatin-induced renal oxidative stress, apoptosis and inflammation and improved kidney injury and function. Baicalein inhibited the cisplatin-induced expression of iNOS, TNF-alpha, IL-6 and mononuclear cell infiltration and concealed redox-sensitive transcription factor NF-kappa B activation via reduced DNA-binding activity, I kappa B alpha phosphorylation and p65 nuclear translocation in kidneys. Further studies demonstrated baicalein markedly attenuated cisplatin-induced p38 MAPK, ERK1/2 and JNK phosphorylation in kidneys. Baicalein also restored the renal antioxidants and increased the amount of total and nuclear accumulation of Nrf2 and downstream target protein, HO-1 in kidneys. Moreover, baicalein preserved mitochondrial respiratory enzyme activities and inhibited cisplatin-induced apoptosis by suppressing p53 expression, Bax/Bcl-2 imbalance, cytochrome c release and activation of caspase-9, caspase-3 and PARP. Our findings suggest that baicalein ameliorates cisplatin-induced renal damage through up-regulation of antioxidant defense mechanisms and down regulation of the MAPKs and NF-kappa B signaling pathways.	[Sahu, Bidya Dhar; Sistla, Ramakrishna] CSIR Indian Inst Chem Technol IICT, Med Chem & Pharmacol Div, Hyderabad 500007, Andhra Pradesh, India; [Kumar, Jerald Mahesh] CSIR Ctr Cellular & Mol Biol CCMB, Anim House Facil, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sistla, R (corresponding author), CSIR Indian Inst Chem Technol IICT, Med Chem & Pharmacol Div, Hyderabad 500007, Andhra Pradesh, India.	sistla@iict.res.in			CSIR project 'SMiLE' [CSC 0111]; CSIR, India	CSIR project 'SMiLE'; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was partly supported by a research grant from CSIR project 'SMiLE' (CSC 0111). Senior Research Fellowship to BDS from CSIR, India, is gratefully acknowledged.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; Ahad A, 2014, BIOCHIMIE, V106, P101, DOI 10.1016/j.biochi.2014.08.006; Akmal Y, 2011, J AM COLL SURGEONS, pS136; Aleksunes LM, 2010, J PHARMACOL EXP THER, V335, P2, DOI 10.1124/jpet.110.170084; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Chang WT, 2011, J CELL BIOCHEM, V112, P2873, DOI 10.1002/jcb.23201; Chao JI, 2007, MOL CANCER THER, V6, P3039, DOI 10.1158/1535-7163.MCT-07-0281; Chen HJ, 2014, CANCER LETT, V354, P5, DOI 10.1016/j.canlet.2014.08.003; Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Guerrero-Beltran CE, 2012, J NUTR BIOCHEM, V23, P494, DOI 10.1016/j.jnutbio.2011.02.004; Francescato HDC, 2007, NEPHROL DIAL TRANSPL, V22, P2138, DOI 10.1093/ndt/gfm144; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kang KP, 2011, NEPHROL DIAL TRANSPL, V26, P814, DOI 10.1093/ndt/gfq528; Khan MAH, 2013, FASEB J, V27, P2946, DOI 10.1096/fj.12-218040; King T.E., 1967, METHOD ENZYMOL, V10, P322, DOI DOI 10.1016/0076-6879(67)10061-X; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; Lee EK, 2011, FREE RADICAL RES, V45, P507, DOI 10.3109/10715762.2011.555479; Liu AD, 2015, INT IMMUNOPHARMACOL, V24, P72, DOI 10.1016/j.intimp.2014.11.014; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Maimaitiyiming H, 2013, AM J PHYSIOL-RENAL, V305, pF881, DOI 10.1152/ajprenal.00192.2013; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Moon JH, 2013, FOOD CHEM TOXICOL, V62, P159, DOI 10.1016/j.fct.2013.08.039; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Nozaki Y, 2011, AM J PHYSIOL-RENAL, V301, pF1098, DOI 10.1152/ajprenal.00193.2011; Oh GS, 2014, KIDNEY INT, V85, P547, DOI 10.1038/ki.2013.330; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; Pan H, 2009, AM J PHYSIOL-RENAL, V296, pF496, DOI 10.1152/ajprenal.90443.2008; Park HM, 2008, BIOCHEM PHARMACOL, V76, P597, DOI 10.1016/j.bcp.2008.06.021; Piao XL, 2008, FOOD CHEM TOXICOL, V46, P1576, DOI 10.1016/j.fct.2007.12.023; Qin S, 2014, ARCH BIOCHEM BIOPHYS, V559, P53, DOI 10.1016/j.abb.2014.03.011; Rajasundari A, 2011, LAB INVEST, V91, P1717, DOI 10.1038/labinvest.2011.126; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Sahu BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105070; Sahu BD, 2013, PHYTOMEDICINE, V20, P453, DOI 10.1016/j.phymed.2012.12.001; Sahu BD, 2011, FOOD CHEM TOXICOL, V49, P3090, DOI 10.1016/j.fct.2011.08.018; Shelton LM, 2013, KIDNEY INT, V84, P1090, DOI 10.1038/ki.2013.248; Sung MJ, 2008, KIDNEY INT, V74, P1538, DOI 10.1038/ki.2008.409; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; Tsai CL, 2014, J ETHNOPHARMACOL, V153, P197, DOI 10.1016/j.jep.2014.02.010; Wang YW, 2014, MOL MED REP, V10, P515, DOI 10.3892/mmr.2014.2157; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Xin WY, 2014, CURR OPIN COMPLEMENT, V1; Xing J, 2006, ASIAN J PHARMACODYN, V6, P29, DOI DOI 10.1016/J.LFS.2005.04.072; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yeh JH, 2010, INT J PHARMACOL, V6, P81; Zhang ZJ, 2012, J AGR FOOD CHEM, V60, P8171, DOI 10.1021/jf301511m; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; Zirak MR, 2014, EUR J PHARMACOL, V738, P222, DOI 10.1016/j.ejphar.2014.05.050	55	105	113	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134139	10.1371/journal.pone.0134139	http://dx.doi.org/10.1371/journal.pone.0134139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222683	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800109
J	Sanchez-Diaz, I; Rosales-Bravo, F; Reyes-Taboada, JL; Covarrubias, AA; Narvaez-Padilla, V; Reynaud, E				Sanchez-Diaz, Ivan; Rosales-Bravo, Fernando; Luis Reyes-Taboada, Jose; Covarrubias, Alejandra A.; Narvaez-Padilla, Veronica; Reynaud, Enrique			The Esg Gene Is Involved in Nicotine Sensitivity in Drosophila melanogaster	PLOS ONE			English	Article							EXPRESSION; RECEPTOR; COCAINE; FAMILY; CELLS; GERM	In humans, there is a strong correlation between sensitivity to substances of abuse and addiction risk. This differential tolerance to drugs has a strong genetic component. The identification of human genetic factors that alter drug tolerance has been a difficult task. For this reason and taking advantage of the fact that Drosophila responds similarly to humans to many drugs, and that genetically it has a high degree of homology (sharing at least 70% of genes known to be involved in human genetic diseases), we looked for genes in Drosophila that altered their nicotine sensitivity. We developed an instantaneous nicotine vaporization technique that exposed flies in a reproducible way. The amount of nicotine sufficient to "knock out" half of control flies for 30 minutes was determined and this parameter was defined as Half Recovery Time (HRT). Two fly lines, L4 and L70, whose HRT was significantly longer than control's were identified. The L4 insertion is a loss of function allele of the transcriptional factor escargot (esg), whereas L70 insertion causes miss-expression of the microRNA cluster miR-310-311-312-313 (miR-310(c)). In this work, we demonstrate that esg loss of function induces nicotine sensitivity possibly by altering development of sensory organs and neurons in the medial section of the thoracoabdominal ganglion. The ectopic expression of the miR-310(c) also induces nicotine sensitivity by lowering Esg levels thus disrupting sensory organs and possibly to the modulation of other miR-310(c) targets.	[Sanchez-Diaz, Ivan; Reynaud, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico; [Rosales-Bravo, Fernando; Narvaez-Padilla, Veronica] Univ Autonoma Estado Morelos, Ctr Invest Dinam Celular, Cuernavaca 62209, Morelos, Mexico; [Luis Reyes-Taboada, Jose; Covarrubias, Alejandra A.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62210, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Reynaud, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Ave Univ 2001,Apartado Postal 510-3, Cuernavaca 62210, Morelos, Mexico.	enrique@ibt.unam.mx	Reyes, Jose/D-7331-2013	Narvaez Padilla, Veronica/0000-0002-3484-1612	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [131685, 481914, 255052]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN203611, IN204214]	Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico), (http://www.conacyt.mx/), (grant no. 131685 to ER), scholarship no. 481914 to Fernando Rosales, and scholarship no. 255052 to Ivan Sanchez. Universidad Nacional Autonoma de Mexico; Direccion General de asuntos del Personal Academico. Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (http://dgapa.unam.mx/html/papiit/papit.html), grant no. IN203611 and IN204214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; FUSE N, 1994, GENE DEV, V8, P2270, DOI 10.1101/gad.8.19.2270; Hartl M, 2011, J NEUROSCI, V31, P15660, DOI 10.1523/JNEUROSCI.2592-11.2011; HAYASHI S, 1993, DEVELOPMENT, V118, P105; Heberlein U, 2009, NEUROPHARMACOLOGY, V56, P97, DOI 10.1016/j.neuropharm.2008.07.023; Hersberger M, 1996, MUTAT RES-ENVIR MUTA, V361, P165, DOI 10.1016/S0165-1161(96)90251-4; Huang AM, 2009, COLD SPRING HARB PRO, V2009; Korzelius J, 2014, EMBO J, V289, P29261; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; Lai SL, 2012, DEV CELL, V23, P849, DOI 10.1016/j.devcel.2012.09.007; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Mandke P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042034; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morel C, 2014, MOL PSYCHIATR, V19, P930, DOI 10.1038/mp.2013.158; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Pancratov R, 2013, DEVELOPMENT, V140, P2904, DOI 10.1242/dev.092817; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Streit A, 2002, INT J DEV BIOL, V46, P159; TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697; Tang TA, 2010, P NATL ACAD SCI USA, V107, P12935, DOI 10.1073/pnas.1007591107; Tarazona S., 2011, EMBNET J, V17, P18, DOI [10.14806/ej.17.B.265, DOI 10.14806/EJ.17.B.265]; Tsurudome K, 2010, NEURON, V68, P879, DOI 10.1016/j.neuron.2010.11.016; Velazquez-Marrero C, 2014, J BIOL CHEM, V289, P29261, DOI 10.1074/jbc.M114.604306; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; WHITELEY M, 1992, MECH DEVELOP, V36, P117, DOI 10.1016/0925-4773(92)90063-P; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525	35	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133956	10.1371/journal.pone.0133956	http://dx.doi.org/10.1371/journal.pone.0133956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222315	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800085
J	Thangamani, S; Younis, W; Seleem, MN				Thangamani, Shankar; Younis, Waleed; Seleem, Mohamed N.			Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens	PLOS ONE			English	Article							INTRACELLULAR STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; INHIBITION; VANCOMYCIN; MECHANISM; GENES; ANTIMICROBIALS; COMBINATION; EXPRESSION; BACTERIA	Without a doubt, our current antimicrobials are losing the battle in the fight against newly-emerged multidrug-resistant pathogens. There is a pressing, unmet need for novel antimicrobials and novel approaches to develop them; however, it is becoming increasingly difficult and costly to develop new antimicrobials. One strategy to reduce the time and cost associated with antimicrobial innovation is drug repurposing, which is to find new applications outside the scope of the original medical indication of the drug. Ebselen, an organoselenium clinical molecule, possesses potent antimicrobial activity against clinical multidrug-resistant Gram-positive pathogens, including Staphylococcus, Streptococcus, and Enterococcus, but not against Gram-negative pathogens. Moreover, the activity of ebselen against Gram-positive pathogens exceeded those activities determined for vancomycin and linezolid, drugs of choice for treatment of Enterococcus and Staphylococcus infections. The minimum inhibitory concentrations of ebselen at which 90% of clinical isolates of Enterococcus and Staphylococcus were inhibited (MIC90) were found to be 0.5 and 0.25 mg/L, respectively. Ebselen showed significant clearance of intracellular methicillin-resistant S. aureus (MRSA) in comparison to vancomycin and linezolid. We demonstrated that ebselen inhibits the bacterial translation process without affecting mitochondrial biogenesis. Additionally, ebselen was found to exhibit excellent activity in vivo in a Caenorhabditis elegans MRSA-infected whole animal model. Finally, ebselen showed synergistic activities with conventional antimicrobials against MRSA. Taken together, our results demonstrate that ebselen, with its potent antimicrobial activity and safety profiles, can be potentially used to treat multidrug resistant Gram-positive bacterial infections alone or in combination with other antibiotics and should be further clinically evaluated.	[Thangamani, Shankar; Younis, Waleed; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018; Younis, Wlaeed/AAA-1743-2022	Seleem, Mohamed/0000-0003-0939-0458; Younis, Wlaeed/0000-0001-5572-0142	NIAID/NIH [HHSN272200700055C]	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank the Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program supported under NIAID/NIH Contract #HHSN272200700055C and BEI resources, NIAID, NIH for providing bacterial strains used in this study.	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Alajlouni RA, 2013, NUCLEIC ACID THER, V23, P363, DOI 10.1089/nat.2013.0426; Appelbaum PC, 2007, CLIN INFECT DIS, V45, pS165, DOI 10.1086/519474; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; Chan G, 2007, J BIOCHEM MOL TOXIC, V21, P252, DOI 10.1002/jbt.20189; CLSI, 2007, M7A7 CLSI; Cohen DJ, 2012, ANN SURG ONCOL, V19, P478, DOI 10.1245/s10434-011-1940-8; Cruciani M, 1996, J ANTIMICROB CHEMOTH, V38, P865; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Deresinski S, 2009, CLIN INFECT DIS, V49, P1072, DOI 10.1086/605572; Diep BA, 2013, J INFECT DIS, V208, P75, DOI 10.1093/infdis/jit129; Diep BA, 2012, CURR THER RES CLIN E, V73, P86, DOI 10.1016/j.curtheres.2012.04.002; Drago L, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-111; Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003; Ellington JK, 2003, J BONE JOINT SURG BR, V85B, P918, DOI 10.1302/0301-620X.85B6.13509; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Gerson SL, 2002, ANTIMICROB AGENTS CH, V46, P2723, DOI 10.1128/AAC.46.8.2723-2726.2002; Huang VH, 2005, ANTIMICROB AGENTS CH, V49, P302, DOI 10.1128/AAC.49.1.302-308.2005; Karau MJ, 2012, ANTIMICROB AGENTS CH, V56, P5401, DOI 10.1128/AAC.01080-12; Kuter DJ, 2001, PHARMACOTHERAPY, V21, P1010, DOI 10.1592/phco.21.11.1010.34517; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; MANYAN DR, 1972, J LAB CLIN MED, V79, P137; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Mohammad H, 2014, J ANTIBIOTICS; Nakae T, 1991, Kitasato Arch Exp Med, V64, P115; Nau R, 2002, CLIN MICROBIOL REV, V15, P95, DOI 10.1128/CMR.15.1.95-110.2002; NOZAWA R, 1989, ANTIMICROB AGENTS CH, V33, P1388, DOI 10.1128/AAC.33.8.1388; Otto MP, 2013, J ANTIMICROB CHEMOTH, V68, P1524, DOI 10.1093/jac/dkt073; Parashar S, 1972, J Postgrad Med, V18, P90; Peltola H, 2009, CLIN INFECT DIS, V49, P993, DOI 10.1086/605541; Rajamuthiah R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124595; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Seleem MN, 2009, ANTIMICROB AGENTS CH, V53, P4270, DOI 10.1128/AAC.00815-09; Seleem MN, 2009, FEMS MICROBIOL LETT, V294, P24, DOI 10.1111/j.1574-6968.2009.01530.x; Seral C, 2003, ANTIMICROB AGENTS CH, V47, P2283, DOI 10.1128/AAC.47.7.2283-2292.2003; Skripkin E, 2008, ANTIMICROB AGENTS CH, V52, P3550, DOI 10.1128/AAC.01193-07; Soofi MA, 2012, ANTIMICROB AGENTS CH, V56, P6407, DOI 10.1128/AAC.01437-12; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Thangamani S, 2015, CURRENT PHARM DESIGN; Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11596; Yan K, 2006, ANTIMICROB AGENTS CH, V50, P3875, DOI 10.1128/AAC.00184-06; Younis W, 2015, CURRENT PHARM DESIGN; YUNIS AA, 1973, SEMIN HEMATOL, V10, P225	48	45	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133877	10.1371/journal.pone.0133877	http://dx.doi.org/10.1371/journal.pone.0133877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222252	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800075
J	Zhu, W; Castro, NJ; Cheng, XQ; Keidar, M; Zhang, LG				Zhu, Wei; Castro, Nathan J.; Cheng, Xiaoqian; Keidar, Michael; Zhang, Lijie Grace			Cold Atmospheric Plasma Modified Electrospun Scaffolds with Embedded Microspheres for Improved Cartilage Regeneration	PLOS ONE			English	Article							SURFACE MODIFICATION; TISSUE; BONE; DIFFERENTIATION; NANOFIBERS; BLENDS	Articular cartilage is prone to degeneration and possesses extremely poor self-healing capacity due to inherent low cell density and the absence of a vasculature network. Tissue engineered cartilage scaffolds show promise for cartilage repair. However, there still remains a lack of ideal biomimetic tissue scaffolds which effectively stimulate cartilage regeneration with appropriate functional properties. Therefore, the objective of this study is to develop a novel biomimetic and bioactive electrospun cartilage substitute by integrating cold atmospheric plasma (CAP) treatment with sustained growth factor delivery microspheres. Specifically, CAP was applied to a poly(e-caprolactone) electrospun scaffold with homogeneously distributed bioactive factors (transforming growth factor-beta 1 and bovine serum albumin) loaded poly(lactic-co-glycolic) acid microspheres. We have shown that CAP treatment renders electrospun scaffolds more hydrophilic thus facilitating vitronectin adsorption. More importantly, our results demonstrate, for the first time, CAP and microspheres can synergistically enhance stem cell growth as well as improve chondrogenic differentiation of human marrow-derived mesenchymal stem cells (such as increased glycosaminoglycan, type II collagen, and total collagen production). Furthermore, CAP can substantially enhance 3D cell infiltration (over two-fold increase in infiltration depth after 1 day of culture) in the scaffolds. By integrating CAP, sustained bioactive factor loaded microspheres, and electrospinning, we have fabricated a promising bioactive scaffold for cartilage regeneration.	[Zhu, Wei; Castro, Nathan J.; Cheng, Xiaoqian; Keidar, Michael; Zhang, Lijie Grace] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA; [Zhang, Lijie Grace] George Washington Univ, Dept Med, Washington, DC USA	George Washington University; George Washington University	Zhang, LG (corresponding author), George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.	lgzhang@gwu.edu	Castro, Nathan/F-9421-2015	Castro, Nathan/0000-0002-2526-3849; Zhang, Lijie Grace/0000-0003-3009-045X; Cheng, Xiaoqian/0000-0002-2544-4260	NIH National Center for Advancing Translational Sciences [UL1TR000075]; NIH Director's New Innovator Award [DP2EB020549]; George Washington Institute for Biomedical Engineering	NIH National Center for Advancing Translational Sciences; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Washington Institute for Biomedical Engineering	This work was supported by Award Number UL1TR000075 from the NIH National Center for Advancing Translational Sciences, NIH Director's New Innovator Award DP2EB020549, and the George Washington Institute for Biomedical Engineering.	Adam C, 1998, CLIN BIOMECH, V13, P1, DOI 10.1016/S0268-0033(97)85881-0; Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0; Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017; Chan CM, 1996, SURF SCI REP, V24, P3; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071265; Cheng XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098652; Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805; Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s; Dolci LS, 2014, PLASMA PROCESS POLYM, V11, P203, DOI 10.1002/ppap.201300104; Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031; Ghasemi-Mobarakeh L, 2007, TISSUE ENG, V13, P916; Holmes B, 2016, CARBON, V97, P1, DOI 10.1016/j.carbon.2014.12.035; Holmes B, 2012, TISSUE ENG PART B-RE, V18, P478, DOI [10.1089/ten.teb.2012.0096, 10.1089/ten.TEB.2012.0096]; Holmes B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/36/365102; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484; Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101; Li YF, 2012, PLASMA PROCESS POLYM, V9, P585, DOI 10.1002/ppap.201100090; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Matsiko A, 2013, MATERIALS, V6, P637, DOI 10.3390/ma6020637; Moffa M, 2013, SOFT MATTER, V9, P5529, DOI 10.1039/c3sm50328c; Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073; Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k; Ratovitski EA, 2014, PLASMA PROCESS POLYM, V11, P1128, DOI 10.1002/ppap.201400071; Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223; Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304; Toh WS, 2014, STEM CELL REV REP, V10, P686, DOI 10.1007/s12015-014-9526-z; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wang MA, 2014, TISSUE ENG PT A, V20, P1060, DOI [10.1089/ten.tea.2013.0235, 10.1089/ten.TEA.2013.0235]; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1, DOI 10.1615/CritRevBiomedEng.v37.i1-2.10; Zheng R, 2014, BIOMATERIALS, V35, P152, DOI 10.1016/j.biomaterials.2013.09.082; Zhu W, 2015, NANOMED-NANOTECHNOL, DOI [10.1016/j.nano.2014.12.001, DOI 10.1016/J.NAN0.2014.12.001]; Zhu W, 2014, NANOMEDICINE-UK, V9, P859, DOI [10.2217/NNM.14.36, 10.2217/nnm.14.36]	43	25	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134729	10.1371/journal.pone.0134729	http://dx.doi.org/10.1371/journal.pone.0134729			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222527	Green Published, gold			2022-12-27	WOS:000358836800157
J	Asejczyk-Widlicka, M; Krzyzanowska-Berkowska, P; Sander, BP; Iskander, DR				Asejczyk-Widlicka, Magdalena; Krzyzanowska-Berkowska, Patrycja; Sander, Beata P.; Iskander, D. Robert			Age-Related Changes in Ocular Blood Velocity in Suspects with Glaucomatous Optic Disc Appearance. Comparison with Healthy Subjects and Glaucoma Patients	PLOS ONE			English	Article							CENTRAL RETINAL ARTERY; OPEN-ANGLE GLAUCOMA; DYNAMIC CONTOUR TONOMETRY; FLOW VELOCITIES; RETROBULBAR CIRCULATION; PERFUSION-PRESSURE; OPHTHALMIC ARTERY; PREDICTIVE-VALUE; RESISTIVE INDEX; PROGRESSION	Purpose To evaluate retrobulbar blood flow characteristics of glaucoma suspects with glaucomatous optic disc appearance (GODA) in comparison to healthy control group (CG) and primary open angle glaucoma patients (POAG) and assess the effect of age. Methods 145 patients from a single glaucoma clinic were enrolled and classified into two diagnostic groups (GODA and POAG). Third group of subjects consisted of 67 age matched individuals (CG). Retrobulbar blood velocity measurement in central retinal artery was performed using color Doppler imaging (CDI). CDI images were processed in custom software leading a range of parameter estimates from a continuous waveform signal. The effect of age on the estimated parameters was evaluated with the stepwise forward regression and ANCOVA in which age was used as a continuous factor. One-way ANOVA was used to test for the differences in the CDI parameters between the three considered groups. Correlation between restive index (RI) and pulsatility index (PI) was assessed with a bilinear fitting guaranteeing no discontinuities in RI intercept estimate. Fisher test was used to assess the applicability of a bilinear PI/RI relationship, while the statistics of the RI intercept estimate were evaluated using the bootstrap. Results ANCOVA showed significant interaction between age and group (p<0.05) for five out of nine considered CDI parameters. The RI intercept for CG and GODA groups was 0.602 +/- 0.047, and 0.574 +/- 0.044 respectively, while the RI intercept of 0.934 +/- 0.066 was found for the POAG. Conclusions The observed similarity of CG and GODA group and dissimilarity between GODA and POAG groups in terms of PI/RI relationship is remarkable. Age may play some role in the different mechanisms occurring in blood velocity dynamics in GODA and POAG subjects but it is not a strongly determining factor.	[Asejczyk-Widlicka, Magdalena] Wroclaw Univ Technol, Dept Opt & Photon, PL-50370 Wroclaw, Poland; [Krzyzanowska-Berkowska, Patrycja] Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland; [Sander, Beata P.] Queensland Univ Technol, Sch Optometry, Brisbane, Qld 4001, Australia; [Iskander, D. Robert] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University; Queensland University of Technology (QUT); Wroclaw University of Science & Technology	Asejczyk-Widlicka, M (corresponding author), Wroclaw Univ Technol, Dept Opt & Photon, PL-50370 Wroclaw, Poland.	magdalena.widlicka@pwr.edu.pl	Asejczyk-Widlicka, Magdalena/M-1414-2017; Iskander, D Robert/E-3576-2017; Asejczyk-Widlicka, Magdalena/AAA-1187-2020; Sander, Beata/B-4916-2017	Iskander, D Robert/0000-0002-5962-6206; Asejczyk-Widlicka, Magdalena/0000-0002-7448-9684; Sander, Beata/0000-0002-8220-7616; Krzyzanowska-Berkowska, Patrycja/0000-0001-8034-2534	Polish National Centre for Research and Development [NR13-0012-10]; Internal Research Funds of the Department of Biomedical Engineering, Wroclaw University of Technology	Polish National Centre for Research and Development; Internal Research Funds of the Department of Biomedical Engineering, Wroclaw University of Technology	Supported by the grant from the Polish National Centre for Research and Development, grant number, NR13-0012-10 (http://www.ncbir.pl/en/) and by the Internal Research Funds of the Department of Biomedical Engineering, Wroclaw University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asejczyk-Widlicka M, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-30; Ben Zion I, 2007, BRIT J OPHTHALMOL, V91, P882, DOI 10.1136/bjo.2006.108340; Berisha F, 2008, AM J OPHTHALMOL, V146, P466, DOI 10.1016/j.ajo.2008.04.034; Boehm AG, 2005, INVEST OPHTH VIS SCI, V46, P1291, DOI 10.1167/iovs.04-0987; Bude RO, 1999, RADIOLOGY, V211, P411, DOI 10.1148/radiology.211.2.r99ma48411; Butt Z, 1997, INVEST OPHTH VIS SCI, V38, P690; Calvo P, 2012, INVEST OPHTH VIS SCI, V53, P3875, DOI 10.1167/iovs.11-8817; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Ceruti P, 2009, EYE, V23, P262, DOI 10.1038/sj.eye.6703102; Chrisholm IA, 1989, GRAEFES ARCH CLIN EX, V227, P110; Danielewska ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102814; DENNIS KJ, 1995, J ULTRAS MED, V14, P463; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Galassi F, 2003, ARCH OPHTHALMOL-CHIC, V121, P1711, DOI 10.1001/archopht.121.12.1711; GALASSI F, 1992, INT OPHTHALMOL, V16, P273, DOI 10.1007/BF00917974; Galassi F, 2011, INVEST OPHTH VIS SCI, V52, P4467, DOI 10.1167/iovs.10-6710; Garhofer G, 2010, INVEST OPHTH VIS SCI, V51, P6652, DOI 10.1167/iovs.10-5490; Groh MJM, 1996, OPHTHALMOLOGY, V103, P529; Harris A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1076, DOI 10.1001/archopht.118.8.1076; Harris A, 1995, J Glaucoma, V4, P281; Harris A, 1996, BRIT J OPHTHALMOL, V80, P1055, DOI 10.1136/bjo.80.12.1055; HARRIS A, 1994, AM J OPHTHALMOL, V118, P642, DOI 10.1016/S0002-9394(14)76579-1; HILL DW, 1976, T OPHTHAL SOC UK, V96, P199; Kaiser HJ, 1997, AM J OPHTHALMOL, V123, P320, DOI 10.1016/S0002-9394(14)70127-8; Kolodjaschna J, 2005, INVEST OPHTH VIS SCI, V46, P636, DOI 10.1167/iovs.04-0717; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P4229, DOI 10.1167/iovs.08-2955; Lam AKC, 2003, OPTOMETRY VISION SCI, V80, P305, DOI 10.1097/00006324-200304000-00008; Levy BI, 2001, CIRCULATION, V104, P735, DOI 10.1161/hc3101.091158; Martinez A, 2005, ACTA OPHTHALMOL SCAN, V83, P716, DOI 10.1111/j.1600-0420.2005.00567.x; Memarzadeh F, 2010, INVEST OPHTH VIS SCI, V51, P2872, DOI 10.1167/iovs.08-2956; Nicolela MT, 1996, J GLAUCOMA, V5, P308; Nicolela MT, 1996, AM J OPHTHALMOL, V121, P502, DOI 10.1016/S0002-9394(14)75424-8; Park JB, 2001, J HYPERTENS, V19, P921, DOI 10.1097/00004872-200105000-00013; Pinto LA, 2014, ACTA OPHTHALMOL, V92, pe286, DOI 10.1111/aos.12314; Pinto LA, 2012, INVEST OPHTH VIS SCI, V53, P2448, DOI 10.1167/iovs.11-9388; Pinto LA, 2012, ACTA OPHTHALMOL, V90, pe214, DOI 10.1111/j.1755-3768.2011.02335.x; Plange N, 2006, BRIT J OPHTHALMOL, V90, P1501, DOI 10.1136/bjo.2006.099853; PLATT JF, 1990, AM J ROENTGENOL, V154, P1223, DOI 10.2214/ajr.154.6.2110732; Polska E, 2001, AM J PHYSIOL-HEART C, V280, pH1442, DOI 10.1152/ajpheart.2001.280.4.H1442; Ravalico G, 1996, INVEST OPHTH VIS SCI, V37, P2645; Realini T, 2009, J GLAUCOMA, V18, P119, DOI 10.1097/IJG.0b013e31817d23c7; Riddle DR, 2003, AGEING RES REV, V2, P149, DOI 10.1016/S1568-1637(02)00064-8; Rosengarten B, 2001, ULTRASOUND MED BIOL, V27, P1499, DOI 10.1016/S0301-5629(01)00464-1; SAHA M, 1993, STROKE, V24, P1686, DOI 10.1161/01.STR.24.11.1686; Satilmis M, 2003, AM J OPHTHALMOL, V135, P664, DOI 10.1016/S0002-9394(02)02156-6; Schmetterer L, 2001, PROG RETIN EYE RES, V20, P823, DOI 10.1016/S1350-9462(01)00014-3; Siesky B, 2009, AAO M; Smulyan H, 2001, J AM COLL CARDIOL, V37, P1374, DOI 10.1016/S0735-1097(01)01166-4; Stalmans I, 2011, ACTA OPHTHALMOL, V89, pe609, DOI 10.1111/j.1755-3768.2011.02178.x; Stalmans I, 2009, GRAEF ARCH CLIN EXP, V247, P1531, DOI 10.1007/s00417-009-1178-3; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Yamazaki Y, 1997, AM J OPHTHALMOL, V124, P287, DOI 10.1016/S0002-9394(14)70820-7; Zeitz O, 2006, BRIT J OPHTHALMOL, V90, P1245, DOI 10.1136/bjo.2006.093633	53	10	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134357	10.1371/journal.pone.0134357	http://dx.doi.org/10.1371/journal.pone.0134357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218249	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900113
J	Futro, A; Maslowska, K; Dwyer, CM				Futro, Agnieszka; Maslowska, Katarzyna; Dwyer, Cathy M.			Ewes Direct Most Maternal Attention towards Lambs that Show the Greatest Pain-Related Behavioural Responses	PLOS ONE			English	Article							REPEATED NEONATAL PAIN; RUBBER RING METHOD; TAIL DOCKING; INFANT RATS; CASTRATION; SENSITIVITY; EXPRESSION; ANALGESIA; DISTRESS; STRESS	Although neonatal farm animals are frequently subjected to painful management procedures, the role of maternal behaviour in pain coping, has not been much studied. We investigated whether ewes were able to distinguish between lambs in pain and those that were not, and whether their behaviour altered depending on the severity of lamb pain. Eighty male lambs were allocated to one of 4 pain treatments within 24 hours of birth. Lambs were either handled only (C), bilaterally castrated with tight rubber rings (RR), as for RR but with the application of a Burdizzo clamp immediately proximal to the ring (Combined) or subjected to short scrotum castration (SSC) where the testicles were retained within the abdomen and only the scrotum removed. The behaviour of the ewe, treated lamb and untreated sibling where present (n = 54) were recorded for 30 minutes after treatment. Castration treatment increased the expression of abnormal standing and lying postures, specific pain-related behaviours (head-turning, stamping/kicking, easing quarters, tail wagging) and composite pain scores (P<0.001 for all). The greatest expression of pain-related behaviours was shown by lambs in the RR group, which were the only group to show rolling responses indicative of severe pain, followed by the SSC group. Ewes expressed more licking/sniffing responses to the RR and SSC lambs than towards the Combined and C lambs (P<0.05), and oriented most to RR lambs and least to C lambs (P<0.001). Ewes with two lambs also directed more attention towards the treated than the untreated lamb (P<0.001). The quantity of maternal care directed towards the lamb was positively correlated with the expression of active pain behaviours. The data demonstrate that ewes are able to discriminate between lambs in pain and those that are not, and that their response is increased with a greater severity of pain.	[Futro, Agnieszka; Maslowska, Katarzyna] Univ Edinburgh, Royal Dick Sch Vet Med, Edinburgh, Midlothian, Scotland; [Futro, Agnieszka; Maslowska, Katarzyna; Dwyer, Cathy M.] SRUC, Edinburgh, Midlothian, Scotland	University of Edinburgh	Dwyer, CM (corresponding author), SRUC, Edinburgh, Midlothian, Scotland.	cathy.dwyer@sruc.ac.uk		Dwyer, Cathy/0000-0001-7511-2056	Scottish Government	Scottish Government	Animals and experimental materials and CD were supported by the Scottish Government as part of a Strategic Programme grant 2011-2016 to SRUC. AF and KM are postgradaute students at University of Edinburgh who worked on the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anseloni V, 2004, PAIN, V109, P507, DOI 10.1016/j.pain.2004.02.031; Archer N, 2004, ANIM WELFARE, V13, P135; BLASS EM, 1995, BEHAV NEUROSCI, V109, P342, DOI 10.1037/0735-7044.109.2.342; Blass EM, 1999, PAIN, V83, P611, DOI 10.1016/S0304-3959(99)00166-9; Chung EKY, 2007, BRAIN RES, V1153, P68, DOI 10.1016/j.brainres.2007.03.047; Clark C, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0273; Colditz IG, 2012, APPL ANIM BEHAV SCI, V136, P136, DOI 10.1016/j.applanim.2011.12.011; de Medeiros CB, 2009, PEDIATR RES, V66, P272, DOI 10.1203/PDR.0b013e3181b1be06; Dwyer CM, 2014, ANIMAL, V8, P102, DOI 10.1017/S1751731113001614; Farm Animal Welfare Council, 2008, FAWC REP IMOL CASTR; Gray L, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e14; Guesgen MJ, 2014, APPL ANIM BEHAV SCI, V159, P41, DOI 10.1016/j.applanim.2014.07.008; Hild S, 2011, APPL ANIM BEHAV SCI, V132, P114, DOI 10.1016/j.applanim.2011.04.003; Hild S, 2010, SMALL RUMINANT RES, V90, P142, DOI 10.1016/j.smallrumres.2009.12.008; Jewell PA, 1997, J ZOOL, V243, P623, DOI 10.1111/j.1469-7998.1997.tb02806.x; Johnston C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008435.pub2; KEMP JD, 1970, J ANIM SCI, V30, P348, DOI 10.2527/jas1970.303348x; Kent JE, 2001, VET J, V162, P250, DOI 10.1053/tvjl.2001.0598; Landa L, 2003, ACTA VET BRNO, V72, P175, DOI 10.2754/avb200372020175; Melches S, 2007, VET J, V173, P554, DOI 10.1016/j.tvjl.2006.01.006; Mellema SC, 2006, VET J, V172, P274, DOI 10.1016/j.tvjl.2005.06.002; MOLONY V, 1993, RES VET SCI, V55, P236, DOI 10.1016/0034-5288(93)90087-V; Molony V, 2002, APPL ANIM BEHAV SCI, V76, P215, DOI 10.1016/S0168-1591(02)00014-X; Molony V, 1997, J ANIM SCI, V75, P266; MOLONY V., 2007, DIS SHEEP, P27; Molony V, 2012, VET J, V193, P81, DOI 10.1016/j.tvjl.2011.09.030; Pickup HE, 2011, APPL ANIM BEHAV SCI, V132, P33, DOI 10.1016/j.applanim.2011.03.010; PORTER RH, 1995, APPL ANIM BEHAV SCI, V45, P239, DOI 10.1016/0168-1591(95)00630-B; Price J, 2001, VET REC, V149, P321, DOI 10.1136/vr.149.11.321; Rand JS, 2002, ANIM WELFARE, V11, P395; Ren K, 1997, P NATL ACAD SCI USA, V94, P1471, DOI 10.1073/pnas.94.4.1471; Walker CD, 2003, DEV BRAIN RES, V140, P253, DOI 10.1016/S0165-3806(02)00611-9; Walker CD, 2008, PAIN, V140, P167, DOI 10.1016/j.pain.2008.08.004; Walker CD, 2010, DEV PSYCHOBIOL, V52, P638, DOI 10.1002/dev.20492; Weaver SA, 2007, J PAIN, V8, P962, DOI 10.1016/j.jpain.2007.07.001	35	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134024	10.1371/journal.pone.0134024	http://dx.doi.org/10.1371/journal.pone.0134024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217942	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900066
J	Aoudjehane, L; Bisch, G; Scatton, O; Granier, C; Gaston, J; Housset, C; Roingeard, P; Cosset, FL; Perdigao, F; Balladur, P; Wakita, T; Calmus, Y; Conti, F				Aoudjehane, Lynda; Bisch, Gregoire; Scatton, Olivier; Granier, Christelle; Gaston, Jesintha; Housset, Chantal; Roingeard, Philippe; Cosset, Francois-Loic; Perdigao, Fabiano; Balladur, Pierre; Wakita, Takaji; Calmus, Yvon; Conti, Filomena			Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C	PLOS ONE			English	Article							STELLATE CELLS; PERIPHERAL-BLOOD; IN-VITRO; REPLICATION; PROTEIN; CD81; HCV; HEPATOCYTES; FIBROBLASTS; CORE	Background Chronic hepatitis C is a major cause of liver fibrosis and cirrhosis. It is generally accepted that inflammation that occurs in response to hepatocyte infection by the hepatitis C virus (HCV) is the main mechanism that triggers myofibroblast differentiation and stimulation in chronic hepatitis C. The aim of this study was to determine if HCV might infect human liver myofibroblasts (HLMF) and directly stimulate their fibrogenic activities. Methods We evaluated the expression of the viral entry receptors, levels of HCV-RNA and HCV-protein and the expression of fibrosis markers in HLMF by using quantitative PCR, western blot and immunofluorescence analyses. Pseudoparticles (HCVpp) and cell culture-derived HCV (HCVcc) were used to study the ability of HLMF to support viral entry, replication and fibrosis induction. Results We showed that HLMF expressed all known molecules of the HCV receptor complex, i.e. CD81, LDL-R, scavenger receptor-BI, claudin-1 and occludin. These cells were also permissive to HCVpp entry. Inoculation with HCVcc caused short-term infection of these cells, as shown by their content in positive-and negative-strand HCV RNA, in core and NS3 viral proteins, and by their release of core protein levels in the culture supernatants. HCV infection stimulated myofibroblastic differentiation, proliferation and collagen production in these cells. In addition, evidence of in vivo infection was provided by the detection of positive- and negative-strand HCV RNA in preparations of HLMF obtained from HCV-infected patients. Conclusion These findings indicate that HCV infection of HLMF can occur and trigger extracellular matrix overproduction, thereby contributing to the development of HCV-related liver fibrosis.	[Aoudjehane, Lynda; Scatton, Olivier; Housset, Chantal; Balladur, Pierre; Calmus, Yvon; Conti, Filomena] Univ Paris 06, Univ Paris 04, CDR St Antoine, UMR S 938, F-75005 Paris, France; [Aoudjehane, Lynda; Scatton, Olivier; Housset, Chantal; Balladur, Pierre; Calmus, Yvon; Conti, Filomena] INSERM, CDR St Antoine, UMR S 938, F-75012 Paris, France; [Aoudjehane, Lynda; Bisch, Gregoire] Hop St Antoine, Human HepCell, F-75012 Paris, France; [Scatton, Olivier; Perdigao, Fabiano; Calmus, Yvon; Conti, Filomena] Hop La Pitie Salpetriere, AP HP, Unite Transplantat Hepat, F-75013 Paris, France; [Granier, Christelle; Cosset, Francois-Loic] Univ Lyon, Team EVIR, CIRI, Int Ctr Infectiol Res, Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] INSERM, U1111, F-69008 Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] Univ Lyon 1, Ctr Int Rech Infect, F-69365 Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] CNRS, UMR5308, Lyon, France; [Granier, Christelle; Cosset, Francois-Loic] Univ Lyon, LabEx Ecofect, Lyon, France; [Gaston, Jesintha] Univ Paris 05, Inst Cochin, INSERM U1016, CNRS UMR 8104, Paris, France; [Roingeard, Philippe] Univ Tours, INSERM U966, F-37041 Tours, France; [Roingeard, Philippe] CHRU, Tours, France; [Balladur, Pierre] Hop St Antoine, AP HP, Dept Chirurg Digest, F-75012 Paris, France; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; National Institute of Infectious Diseases (NIID)	Aoudjehane, L (corresponding author), Univ Paris 06, Univ Paris 04, CDR St Antoine, UMR S 938, F-75005 Paris, France.	lynda.aoudjehane@inserm.fr	Cosset, François-Loïc/M-5862-2019	Cosset, François-Loïc/0000-0001-8842-3726; Christelle, GRANIER/0000-0001-8987-0632; Housset, Chantal/0000-0001-6469-0651; Aoudjehane, lynda/0000-0003-4191-0564				Aoudjehane L, 2008, LAB INVEST, V88, P973, DOI 10.1038/labinvest.2008.61; Arrieta JJ, 2001, AM J PATHOL, V158, P259, DOI 10.1016/S0002-9440(10)63964-8; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Boisvert J, 2001, J INFECT DIS, V184, P827, DOI 10.1086/323391; Bosselut N, 2010, PROTEOMICS, V10, P1017, DOI 10.1002/pmic.200900257; BRILLANTI S, 1993, LANCET, V341, P464, DOI 10.1016/0140-6736(93)90210-8; Brown PMJ, 2001, CLIN BIOCHEM, V34, P167, DOI 10.1016/S0009-9120(01)00210-7; Burgel B, 2011, J VIRAL HEPATITIS, V18, P562, DOI 10.1111/j.1365-2893.2010.01339.x; Carriere M, 2007, J MED VIROL, V79, P155, DOI 10.1002/jmv.20773; Caussin-Schwemling C, 2001, J MED VIROL, V65, P14, DOI 10.1002/jmv.1095; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Demetris AJ, 2009, LIVER TRANSPLANT, V15, pS35, DOI 10.1002/lt.21890; Florimond A, 2014, GUT; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jiang ZT, 2010, MED SCI MONITOR, V16, pBR107; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; Mederacke I, 2009, J CLIN VIROL, V46, P210, DOI 10.1016/j.jcv.2009.08.014; Molina S, 2008, J VIROL, V82, P569, DOI 10.1128/JVI.01443-07; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40; Tan K, 2003, J VIRAL HEPATITIS, V10, P427, DOI 10.1046/j.1365-2893.2003.00460.x; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watanabe N, 2011, BIOCHEM BIOPH RES CO, V407, P135, DOI 10.1016/j.bbrc.2011.02.125; Wong DKH, 2001, J VIROL, V75, P1229, DOI 10.1128/JVI.75.3.1229-1235.2001; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134141	10.1371/journal.pone.0134141	http://dx.doi.org/10.1371/journal.pone.0134141			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214688	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300052
J	Dukers-Muijrers, NHTM; Somers, C; de Graaf, H; Meijer, S; Hoebe, CJPA				Dukers-Muijrers, Nicole H. T. M.; Somers, Carlijn; de Graaf, Hanneke; Meijer, Suzanne; Hoebe, Christian J. P. A.			Prevalence of Non-Volitional Sex Types and Associated Factors: A National Sample of Young People	PLOS ONE			English	Article							RISK BEHAVIORS; VIOLENCE; ASSAULT; GENDER; HEALTH; ABUSE; WOMEN; VICTIMIZATION; POPULATION; EXPERIENCE	Background Non-volitional sex (NVS) in young people continues to be a major public health problem with long-term negative health outcomes. For the first time, the prevalence of different types of NVS and associated factors are compared between young people with same-sex sexual activities and those who have not. Methods We obtained data from 10,401 young women and men (aged 12 to 25 years) who participated in a population study on sexual health, the Netherlands. We calculated and compared the prevalence of six types of NVS between women who had sex with men (yWSM) or women (yWSW), and men who had sex with women (yMSW) or men (yMSM). In sexually experienced participants (n = 5986) logistic regression analyses were applied to assess associations with NVS by assault or penetration. Analyses were weighted to represent the Dutch population. Results The prevalence of NVS ranged from 1% to 61%, depending on type. Prevalence was higher for young women (any: 40.6%) than men (any: 20.4%), and highest for yMSM and yWSW. Prevalence of NVS by assault or penetration was related to a range of socio-demographic, behavioral and social factors, which were largely similar regardless of sex or same-sex-experiences. The NVS perpetrators were in over 70% of cases known to the victim; 1 in 4 cases of NVS by penetration were accompanied by violence. Conclusion A substantial proportion of young people in the Netherlands have experienced NVS. Medical professionals, educators and caregivers should integrate services to continue to address NVS by targeting young people's multifaceted risk profiles and evidenced based interventions for doing so are needed.	[Dukers-Muijrers, Nicole H. T. M.; Somers, Carlijn; Hoebe, Christian J. P. A.] South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.] Maastricht Univ Med Ctr, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [de Graaf, Hanneke] Rutgers WPF, Res Dept, Utrecht, Netherlands; [Meijer, Suzanne] STI AIDS Netherlands, Youth Dept, Amsterdam, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Dukers-Muijrers, NHTM (corresponding author), South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands.	nicole.dukers@ggdzl.nl	Dukers-Muijrers, Nicole/M-7178-2014	De Graaf, Hanneke/0000-0002-2350-0230; Dukers-Muijrers, Nicole/0000-0003-4896-758X; Hoebe, Christian/0000-0003-1815-0974	Netherlands Organization for Health Research and Development (ZonMw) [124280002]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Funding was obtained from the Netherlands Organization for Health Research and Development (ZonMw No: 124280002).	Agardh A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-527; Aggleton P, 2014, NEW OUTCOMES SEXUAL; Akre C, 2012, J WOMENS HLTH LARCHM, V21, P1222, DOI [10.1089/jwh.2012.4058, DOI 10.1089/JWH.2012.4058]; Allsworth JE, 2009, J WOMENS HEALTH, V18, P529, DOI 10.1089/jwh.2007.0757; Bartholemew L. K., 2011, PLANNING HLTH PROMOT; Basile Kathleen C, 2006, J Adolesc Health, V39, DOI 10.1016/j.jadohealth.2006.06.001; Black M.C., 2011, NATL INTIMATE PARTNE; Brener ND, 1999, J CONSULT CLIN PSYCH, V67, P252, DOI 10.1037/0022-006X.67.2.252; Choudhary E, 2008, AM J MENS HEALTH, V2, P254, DOI 10.1177/1557988307313819; Cybulska B, 2007, J ROY SOC MED, V100, P321, DOI 10.1258/jrsm.100.7.321; Danielson CK, 2004, CURR OPIN OBSTET GYN, V16, P383, DOI 10.1097/00001703-200410000-00005; Deliramich AN, 2008, BEHAV MODIF, V32, P611, DOI 10.1177/0145445508314642; Dube SR, 2005, AM J PREV MED, V28, P430, DOI 10.1016/j.amepre.2005.01.015; Gunby C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-216; Hamby S, 2013, VIOLENCE VICTIMS, V28, P915, DOI 10.1891/0886-6708.VV-D-12-00067; Homma Y, 2012, J ADOLESCENT HEALTH, V51, P18, DOI 10.1016/j.jadohealth.2011.12.032; Howard DE, 2005, J ADOLESCENT HEALTH, V36, P372, DOI 10.1016/j.jadohealth.2004.07.007; Jozkowski KN, 2012, WOMEN HEALTH, V52, P101, DOI 10.1080/03630242.2011.649397; Kaufman M, 2008, PEDIATRICS, V122, P462, DOI 10.1542/peds.2008-1581; Kilpatrick DG, 2004, J INTERPERS VIOLENCE, V19, P1209, DOI 10.1177/0886260504269679; Knight RE, 2014, HEALTH EDUC RES, V29, P662, DOI 10.1093/her/cyt116; Macdowall W, 2013, LANCET, V382, P1845, DOI 10.1016/S0140-6736(13)62300-4; McFarlane M, 2002, J ADOLESCENT HEALTH, V31, P11, DOI 10.1016/S1054-139X(02)00373-7; McLean IA, 2013, BEST PRACT RES CL OB, V27, P39, DOI 10.1016/j.bpobgyn.2012.08.006; Noll J G, 2000, Child Maltreat, V5, P323, DOI 10.1177/1077559500005004004; Ollis D, 2014, HLTH ED RES IN PRESS; Raj A, 2000, Matern Child Health J, V4, P125, DOI 10.1023/A:1009526422148; Seto MC, 2010, CHILD MALTREATMENT, V15, P219, DOI 10.1177/1077559510367937; Shrier LA, 1998, ARCH PEDIAT ADOL MED, V152, P57; Speizer IS, 2009, AM J PUBLIC HEALTH, V99, pS425, DOI 10.2105/AJPH.2008.136606; Steel JL, 2005, CHILD ABUSE NEGLECT, V29, P1141, DOI 10.1016/j.chiabu.2004.10.015; Temkin J, 2004, CRIM LAW REV, P328; Truman JenniferL., 2014, CRIMINAL VICTIMIZATI; Wadsworth P, 2013, JOGNN-J OBST GYN NEO, V42, P249, DOI 10.1111/1552-6909.12041; World Health Organization, 2021, VIOL WOM PREV EST 20; Wu Z Helen, 2003, J Pediatr Adolesc Gynecol, V16, P207, DOI 10.1016/S1083-3188(03)00123-2; Yahner J, 2014, J INTERPERS VIOLENCE; Ybarra ML, 2013, JAMA PEDIATR, V167, P1125, DOI 10.1001/jamapediatrics.2013.2629; Young MED, 2011, J ADOLESCENT HEALTH, V49, P287, DOI 10.1016/j.jadohealth.2010.12.019	39	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132847	10.1371/journal.pone.0132847	http://dx.doi.org/10.1371/journal.pone.0132847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7DN	26214829	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300011
J	Gonese, E; Mapako, T; Dzangare, J; Rusakaniko, S; Kilmarx, PH; Postma, MJ; Ngwende, S; Mandisarisa, J; Nyika, P; Mvere, DA; Mugurungi, O; Tshimanga, M; van Hulst, M				Gonese, Elizabeth; Mapako, Tonderai; Dzangare, Janet; Rusakaniko, Simbarashe; Kilmarx, Peter H.; Postma, Maarten J.; Ngwende, Stella; Mandisarisa, John; Nyika, Ponesai; Mvere, David A.; Mugurungi, Owen; Tshimanga, Mufuta; van Hulst, Marinus			Within-Gender Changes in HIV Prevalence among Adults between 2005/6 and 2010/11 in Zimbabwe	PLOS ONE			English	Article							AFRICA; SPREAD; RISK; MEN	Introduction Zimbabwe has reported significant declines in HIV prevalence between 2005/06 and 2010/ 11 Demography and Health Surveys; a within-gender analysis to identify the magnitude and factors associated with this change, which can be masked, is critical for targeting interventions. Methods We analyzed change in HIV prevalence for 6,947 women and 5,848 men in the 2005/06 survey and 7,313 women and 6,250 men in 201011 surveys using 2005/06 as referent. The data was analyzed taking into consideration the survey design and therefore the svy, mean command in Stata was used in both linear and logistic regression. Results There were similar proportional declines in prevalence at national level for males (15% p=0.011) and females (16%, p=0.008). However, there were variations in decline by provincial setting, demographic variables of age, educational level and some sexual risk behaviours. In logistic regression analysis, statistically significant declines were observed among men in Manicaland, Mashonaland East and Harare (p<0.01) and for women in Manicaland, Mashonaland Central and Harare (p<0.01). Although not statistically significant, numerical increases were observed among men in Matebeleland North, Matebeleland South, Midlands and for both men and women in Bulawayo. Young women in the age range 15-34 experienced a decline in prevalence (p<0.01) while older men 30-44 had a statistically significant decline (p<0.01). Having a secondary and above education, regardless of employment status for both men and women recorded a significant decline. For sexual risk behaviours, currently in union for men and women and not in union for women there was a significant decline in prevalence. Conclusion Zimbabwe has reported a significant decline among both men and women but there are important differentials across provinces, demographic characteristics and sexual risk behaviours that suggest that the epidemic in Zimbabwe is heterogeneous and therefore interventions must be targeted in order to achieve epidemic control.	[Gonese, Elizabeth; Kilmarx, Peter H.; Mandisarisa, John] US Ctr Dis Control & Prevent CDC, Harare, Zimbabwe; [Mapako, Tonderai; Mvere, David A.] Natl Blood Serv Zimbabwe, Harare, Zimbabwe; [Mapako, Tonderai; Postma, Maarten J.; van Hulst, Marinus] Univ Groningen, Unit Pharmacoepidemiol & Pharmacoecon PE2, Dept Pharm, Groningen, Netherlands; [Dzangare, Janet; Nyika, Ponesai; Mugurungi, Owen] Minist Hlth & Child Welf, Harare, Zimbabwe; [Rusakaniko, Simbarashe; Tshimanga, Mufuta] Univ Zimbabwe, Dept Community Med, Harare, Zimbabwe; [Kilmarx, Peter H.] CDC, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Ngwende, Stella] Natl Microbiol Reference Lab, Harare, Zimbabwe; [van Hulst, Marinus] Martini Hosp, Dept Clin Pharm & Toxicol, Groningen, Netherlands	University of Groningen; University of Zimbabwe; Centers for Disease Control & Prevention - USA; Martini Hospital	Gonese, E (corresponding author), US Ctr Dis Control & Prevent CDC, Harare, Zimbabwe.	hol9@cdc.gov	Mapako, Tonderai/I-4664-2019	Mapako, Tonderai/0000-0003-2873-4420; Postma, Maarten/0000-0002-6306-3653; Kilmarx, Peter/0000-0001-6464-3345	United States Agency for International Development (USAID) through the MEASURE DHS project [GPO-C-00-08-00008-00]; Centers for Disease Control and Prevention (CDC); T-REC project - European Union [266194]	United States Agency for International Development (USAID) through the MEASURE DHS project(United States Agency for International Development (USAID)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); T-REC project - European Union	This research is carried out with support provided by the United States Agency for International Development (USAID) through the MEASURE DHS project (#GPO-C-00-08-00008-00) and the Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief. T. Mapako was supported by T-REC project funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 266194.	Adebajo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081981; Akwara P A, 2008, IN DEPTH ANAL HIV PR; [Anonymous], 2004, ANT CLIN SURV PREGN; [Anonymous], NAT CENS REP 2012; [Anonymous], 2009, ANT CLIN SURV PREGN; [Anonymous], 2002, ZIMB DEM HLTH SURV 2; [Anonymous], 2006, ANT CLIN SURV PREGN; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Dlodlo Riitta A, 2011, J Int AIDS Soc, V14 Suppl 1, pS2, DOI 10.1186/1758-2652-14-S1-S2; Fylkesnes K, 2001, AIDS, V15, P907, DOI 10.1097/00002030-200105040-00011; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hong R, 2008, FACTORS ASS PREVALEN; Kayeyi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033652; Mapako T, 2013, TRANSFUSION, V53, P2413, DOI 10.1111/trf.12311; Mishra V, DEMOGR HLTH RES, V207; Mmbanga E, 2013, CALVERTON MD US ICF, V85; Montana L., 2007, SPATIAL MODELLING HI; UNAIDS, 2010, GLOB REP UNAIDS REP; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2, P215; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2007, ZIMB DEM HLTH SURV 2, P219	25	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0129611	10.1371/journal.pone.0129611	http://dx.doi.org/10.1371/journal.pone.0129611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208134	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000005
J	Zhang, WY; Wang, LY; Zhang, XS; Han, ZH; Hu, WB; Qian, Q; Haque, U; Magalhaes, RJS; Li, SL; Tong, SL; Li, CY; Sun, HL; Sun, YS				Zhang, Wen-Yi; Wang, Li-Ya; Zhang, Xiu-Shan; Han, Zhi-Hai; Hu, Wen-Biao; Qian, Quan; Haque, Ubydul; Magalhaes, Ricardo J. Soares; Li, Shen-Long; Tong, Shi-Lu; Li, Cheng-Yi; Sun, Hai-Long; Sun, Yan-Song			Spatiotemporal Clustering Analysis and Risk Assessments of Human Cutaneous Anthrax in China, 2005-2012	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; INHALATIONAL ANTHRAX; SPATIAL-ANALYSIS; OUTBREAK; INFECTION; PROVINCE; AGENT; USERS	Objective To investigate the epidemic characteristics of human cutaneous anthrax ( CA) in China, detect the spatiotemporal clusters at the county level for preemptive public health interventions, and evaluate the differences in the epidemiological characteristics within and outside clusters. Methods CA cases reported during 2005-2012 from the national surveillance system were evaluated at the county level using space-time scan statistic. Comparative analysis of the epidemic characteristics within and outside identified clusters was performed using using the. 2 test or Kruskal-Wallis test. Results The group of 30-39 years had the highest incidence of CA, and the fatality rate increased with age, with persons >= 70 years showing a fatality rate of 4.04%. Seasonality analysis showed that most of CA cases occurred between May/June and September/October of each year. The primary spatiotemporal cluster contained 19 counties from June 2006 to May 2010, and it was mainly located straddling the borders of Sichuan, Gansu, and Qinghai provinces. In these high-risk areas, CA cases were predominantly found among younger, local, males, shepherds, who were living on agriculture and stockbreeding and characterized with high morbidity, low mortality and a shorter period from illness onset to diagnosis. Conclusion CA was geographically and persistently clustered in the Southwestern China during 20052012, with notable differences in the epidemic characteristics within and outside spatiotemporal clusters; this demonstrates the necessity for CA interventions such as enhanced surveillance, health education, mandatory and standard decontamination or disinfection procedures to be geographically targeted to the areas identified in this study.	[Zhang, Wen-Yi; Wang, Li-Ya; Zhang, Xiu-Shan; Li, Shen-Long; Li, Cheng-Yi; Sun, Hai-Long] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China; [Han, Zhi-Hai] Navy Gen Hosp PLA, Beijing, Peoples R China; [Hu, Wen-Biao] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Haque, Ubydul] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Haque, Ubydul] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Magalhaes, Ricardo J. Soares] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Magalhaes, Ricardo J. Soares] Univ Queensland, Queensland Childrens Med Res Inst, Childrens Hlth & Environm Program, Brisbane, Qld, Australia; [Sun, Yan-Song] Acad Mil Med Sci, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Sixth Medical Center of Chinese PLA General Hospital; Queensland University of Technology (QUT); State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Queensland; University of Queensland; Academy of Military Medical Sciences - China	Li, CY (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	licy_60@163.com; xxsunhl@163.com; sunys1964@hotmail.com	zhang, wenyi/AGO-3371-2022; Wang, Liya/ABH-4045-2020; Magalhaes, Ricardo J. Soares/A-5316-2010	Magalhaes, Ricardo J. Soares/0000-0001-9157-8470; Hu, Wenbiao/0000-0001-6422-9240; Wang, Liya/0000-0003-3496-6084	National Basic Research Program of China [2012CB955500-955504]; National Natural Science Foundation of China [81102169]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded in part by the grants from National Basic Research Program of China (2012CB955500-955504) and National Natural Science Foundation of China (81102169). The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	Ashkenazi-Hoffnung L, 2009, AM J INFECT CONTROL, V37, P495, DOI 10.1016/j.ajic.2008.08.008; Blackburn JK, 2007, AM J TROP MED HYG, V77, P1103, DOI 10.4269/ajtmh.2007.77.1103; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; Chikerema SM, 2012, TROP ANIM HEALTH PRO, V44, P63, DOI 10.1007/s11250-011-9888-z; China CDC, NAT ANTHR MON PROGR; Chirundu D, 2009, Cent Afr J Med, V55, P50; Clegg SB, 2007, VET REC, V160, P113, DOI 10.1136/vr.160.4.113; Demirdag K, 2003, INFECTION, V31, P327, DOI 10.1007/s15010-003-3169-3; Doganay Mehmet, 2010, J Infect Public Health, V3, P98, DOI 10.1016/j.jiph.2010.07.004; Epp T, 2010, CAN VET J, V51, P743; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Holzmann T, 2012, EUROSURVEILLANCE, V17, P2; Huang DeHui, 2005, China Tropical Medicine, V5, P456; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Joyner TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009596; Kracalik I, 2014, EMERG INFECT DIS, V20, P261, DOI 10.3201/eid2002.130522; Kracalik IT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002388; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, SATSCAN USER GUIDE V; Kyriacou DN, 2004, LANCET, V364, P449, DOI 10.1016/S0140-6736(04)16769-X; Li ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-132; Mwenye K. S., 1996, Central African Journal of Medicine, V42, P312; Ozkurt Z, 2005, EMERG INFECT DIS, V11, P1939; Palmateer NE, 2012, CLIN INFECT DIS, V55, P706, DOI 10.1093/cid/cis511; Ramsay CN, 2010, EUROSURVEILLANCE, V15, P2; Ray TK, 2009, EMERG INFECT DIS, V15, P497, DOI 10.3201/eid1503.080972; Ringertz SH, 2000, LANCET, V356, P1574, DOI 10.1016/S0140-6736(00)03133-0; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Siddiqui Muhammad Afsar, 2012, BMC Res Notes, V5, P464, DOI 10.1186/1756-0500-5-464; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Ting-Lu Z, 2012, WEST PAC SURVEILL RE, V3, P12, DOI [10.5365/wpsar.2012.3.4.005, 10.5365/WPSAR.2012.3.4.005]; Wang LY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002285; Wang LM, 2011, J PREV MED INF, V27, P792; Woods CW, 2004, AM J TROP MED HYG, V71, P48, DOI 10.4269/ajtmh.2004.71.48; World Health Organization, ANTHR HUM AN; Zhang WY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002493; Zhang WY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-206	38	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133736	10.1371/journal.pone.0133736	http://dx.doi.org/10.1371/journal.pone.0133736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208355	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000127
J	Licence, S; Smith, R; McGuigan, MP; Earnest, CP				Licence, Sammy; Smith, Robynne; McGuigan, Miranda P.; Earnest, Conrad P.			Gait Pattern Alterations during Walking, Texting and Walking and Texting during Cognitively Distractive Tasks while Negotiating Common Pedestrian Obstacles	PLOS ONE			English	Article							DUAL-TASK; INATTENTIONAL BLINDNESS; MOBILE TELEPHONES; HEALTHY-YOUNG; CELL PHONE; AVOIDANCE; ADULTS; ATTENTION; LOOKING; TALKING	Objectives Mobile phone texting is a common daily occurrence with a paucity of research examining corresponding gait characteristics. To date, most studies have participants walk in a straight line vs. overcoming barriers and obstacles that occur during regular walking. The aim of our study is to examine the effect of mobile phone texting during periods of cognitive distraction while walking and negotiating barriers synonymous with pedestrian traffic. Methods Thirty participants (18-50y) completed three randomized, counter-balanced walking tasks over a course during: (1) normal walking (control), (2) texting and walking, and (3) texting and walking whilst being cognitively distraction via a standard mathematical test performed while negotiating the obstacle course. We analyzed gait characteristics during course negotiation using a 3-dimensional motion analysis system and a general linear model and Dunnet-Hsu post-hoc procedure the normal walking condition to assess gait characteristic differences. Primary outcomes included the overall time to complete the course time and barrier contact. Secondary outcomes included obstacle clearance height, step frequency, step time, double support phase and lateral deviation. Results Participants took significantly longer (mean +/- SD) to complete the course while texting (24.96 +/- 4.20 sec) and during cognitive distraction COG (24.09 +/- 3.36 sec) vs. normal walking (19.32 +/- 2.28 sec; all, P<0.001). No significant differences were noted for barrier contacts (P = 0.28). Step frequency, step time, double support phase and lateral deviation all increased in duration during the texting and cognitive distraction trial. Texting and being cognitively distracted also increased obstacle clearance versus the walking condition (all, P<0.02). Conclusions Texting while walking and/or being cognitively distracted significantly affect gait characteristics concordant to mobile phone usage resulting in a more cautious gate pattern. Future research should also examine a similar study in older participants who may be at a greater risk of tripping with such walking deviations.	[Licence, Sammy; Smith, Robynne; McGuigan, Miranda P.] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Earnest, Conrad P.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	University of Bath; Texas A&M University System; Texas A&M University College Station	Earnest, CP (corresponding author), Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England.	conrad.earnest@hlkn.tamu.edu	Earnest, Conrad P./M-6849-2017	Earnest, Conrad P./0000-0002-6546-1268	Dept. of Health	Dept. of Health	Funding for this project was obtained from internal monies within the Dept. of Health	BECKLEN R, 1983, MEM COGNITION, V11, P601, DOI 10.3758/BF03198284; Burns PC., 2002, DANGEROUS IS DRIVING; Chapman GJ, 2007, GAIT POSTURE, V26, P59, DOI 10.1016/j.gaitpost.2006.07.010; CHEN HC, 1991, J GERONTOL, V46, pM196, DOI 10.1093/geronj/46.6.M196; Demura S, 2009, EUR J SPORT SCI, V9, P303, DOI 10.1080/17461390902853069; Di Fabio RP, 2003, J MOTOR BEHAV, V35, P383, DOI 10.1080/00222890309603158; EBERSBACH G, 1995, PERCEPT MOTOR SKILL, V81, P107, DOI 10.2466/pms.1995.81.1.107; Hosking SG, 2009, HUM FACTORS, V51, P582, DOI 10.1177/0018720809341575; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; Ishigami Y, 2009, J SAFETY RES, V40, P157, DOI 10.1016/j.jsr.2009.02.006; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Lowrey CR, 2007, EXP BRAIN RES, V182, P289, DOI 10.1007/s00221-007-0986-0; Mack A, 2003, CURR DIR PSYCHOL SCI, V12, P180, DOI 10.1111/1467-8721.01256; McFayden BJ, 2002, J GERONTOL A-BIOL, V57, pB166, DOI 10.1093/gerona/57.4.B166; McKenzie NC, 2004, GAIT POSTURE, V19, P226, DOI 10.1016/S0966-6362(03)00060-2; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; Nasar JL, 2013, ACCIDENT ANAL PREV, V57, P91, DOI 10.1016/j.aap.2013.03.021; Owen D H, 1985, Clin Geriatr Med, V1, P581; Patten CJD, 2004, ACCIDENT ANAL PREV, V36, P341, DOI 10.1016/S0001-4575(03)00014-9; Pijnappels M, 2008, J ELECTROMYOGR KINES, V18, P188, DOI 10.1016/j.jelekin.2007.06.004; Plummer P, 2015, GAIT POSTURE, V41, P46, DOI 10.1016/j.gaitpost.2014.08.007; Schabrun SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084312; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Thompson LL, 2013, INJURY PREV, V19, P232, DOI 10.1136/injuryprev-2012-040601; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	28	65	67	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133281	10.1371/journal.pone.0133281	http://dx.doi.org/10.1371/journal.pone.0133281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222430	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358836800046
J	Chantepie, S; Robert, A; Sorci, G; Hingrat, Y; Charmantier, A; Leveque, G; Lacroix, F; Teplitsky, C				Chantepie, Stephane; Robert, Alexandre; Sorci, Gabriele; Hingrat, Yves; Charmantier, Anne; Leveque, Gwenaelle; Lacroix, Frederic; Teplitsky, Celine			Quantitative Genetics of the Aging of Reproductive Traits in the Houbara Bustard	PLOS ONE			English	Article							AGE-SPECIFIC MORTALITY; NATURAL-POPULATIONS; DROSOPHILA-MELANOGASTER; INBREEDING DEPRESSION; EVOLUTIONARY-THEORIES; SEXUAL SELECTION; TRADE-OFFS; SENESCENCE; WILD; PATTERNS	Do all traits within an organism age for the same reason? Evolutionary theories of aging share a common assumption: the strength of natural selection declines with age. A corollary is that additive genetic variance should increase with age. However, not all senescent traits display such increases suggesting that other mechanisms may be at play. Using longitudinal data collected from more than 5400 houbara bustards (Chlamydotis undulata) with an exhaustive recorded pedigree, we investigated the genetics of aging in one female reproductive trait (egg production) and three male reproductive traits (courtship display rate, ejaculate size and sperm viability), that display senescence at the phenotypic level. Animal models revealed an increase in additive genetic variance with age for courtship display rate and egg production but an unexpected absence of increased additive genetic variance for ejaculate size and no additive genetic variance for sperm viability. Our results suggest that the mechanisms behind the senescence of some traits are linked with a change in genetic expression, whereas for some other traits, aging may result from the constraints associated with physiological wear and tear on the organism throughout the life of the individual.	[Chantepie, Stephane; Robert, Alexandre; Teplitsky, Celine] UPMC, Museum Natl Hist Nat, CNRS, Ctr Ecol & Sci Conservat,UMR 7204, Paris, France; [Sorci, Gabriele] Univ Bourgogne, UMR CNRS, UB Biogeosci 6282, Dijon, France; [Hingrat, Yves; Lacroix, Frederic] Reneco Wildlife Preservat, Abu Dhabi, U Arab Emirates; [Charmantier, Anne] CNRS, CEFE, UMR 5175, Montpellier, France; [Leveque, Gwenaelle] Emirates Ctr Wildlife Propagat, Missour, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Chantepie, S (corresponding author), UPMC, Museum Natl Hist Nat, CNRS, Ctr Ecol & Sci Conservat,UMR 7204, Paris, France.	stephane.chantepie@gmail.com	Hingrat, Yves/AAR-3275-2021; Teplitsky, Celine/H-3621-2019	Teplitsky, Celine/0000-0001-9458-709X; Sorci, Gabriele/0000-0002-0799-3995; Hingrat, Yves/0000-0003-2388-8826	Centre National de la Recherche Scientifique (National Center for Scientific Research); French ANR [ANR-12-ADAP-0006]	Centre National de la Recherche Scientifique (National Center for Scientific Research); French ANR(French National Research Agency (ANR))	Stephane Chantepie's work is funded by a Phd grant from the Centre National de la Recherche Scientifique (National Center for Scientific Research). SC, CT, AC and AR were funded by the French ANR (grant ANR-12-ADAP-0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Reneco Wildlife Preservation provided support in the form of a salary for author YH and data collection used in the manuscript but did not have any additional role in the analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Arnaud CM, 2013, BEHAV ECOL, V24, P683, DOI 10.1093/beheco/ars214; Bonduriansky R, 2005, J EVOLUTION BIOL, V18, P1332, DOI 10.1111/j.1420-9101.2005.00957.x; Brody S, 1923, J GEN PHYSIOL, V6, P41, DOI 10.1085/jgp.6.1.41; Brommer JE, 2010, HEREDITY, V104, P363, DOI 10.1038/hdy.2009.125; Brommer JE, 2007, AM NAT, V170, P643, DOI 10.1086/521241; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Burger JMS, 2006, EXP GERONTOL, V41, P1108, DOI 10.1016/j.exger.2006.08.008; Chantepie S, 2016, OIKOS, V125, P167, DOI 10.1111/oik.02216; Charge R, 2013, J ANIM ECOL, V82, P399, DOI 10.1111/1365-2656.12023; Charlesworth B, 1996, P NATL ACAD SCI USA, V93, P6140, DOI 10.1073/pnas.93.12.6140; Charlesworth B, 2001, J THEOR BIOL, V210, P47, DOI 10.1006/jtbi.2001.2296; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Charmantier A, 2006, P ROY SOC B-BIOL SCI, V273, P225, DOI 10.1098/rspb.2005.3294; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Combreau O, 2001, ANIM CONSERV, V4, P133, DOI 10.1017/S1367943001001160; Dean R, 2010, CURR BIOL, V20, P1192, DOI 10.1016/j.cub.2010.04.059; Flatt Thomas, 2012, Frontiers in Genetics, V3, P148, DOI 10.3389/fgene.2012.00148; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Gaucher P, 1996, IBIS, V138, P273, DOI 10.1111/j.1474-919X.1996.tb04339.x; Gavrilov L a, 2006, HDB BIOL AGING, P6; Gilmour A.R., 2009, ASREML USER GUIDE RE; Goriup Paul D., 1997, Bird Conservation International, V7, P373; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hayward AD, 2013, FUNCT ECOL, V27, P184, DOI 10.1111/1365-2435.12029; HOULE D, 1992, GENETICS, V130, P195; Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199; Jing HC, 2007, J EXP BOT, V58, P3885, DOI 10.1093/jxb/erm237; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Laird RA, 2009, J EVOLUTION BIOL, V22, P974, DOI 10.1111/j.1420-9101.2009.01709.x; LAKE PE, 1984, BRIT POULTRY SCI, V25, P145, DOI 10.1080/13632758408454852; Lesobre L, 2010, J AVIAN BIOL, V41, P117, DOI 10.1111/j.1600-048X.2009.04794.x; Lindsay C, 1999, J REPROD FERTIL, V117, P307; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; Lynch M, 1998, GENETICS AND ANALYSI; MARTIN K, 1995, AM ZOOL, V35, P340; Massot M, 2011, FUNCT ECOL, V25, P848, DOI 10.1111/j.1365-2435.2011.01837.x; Medawar P B., 1952, UNSOLVED PROBLEM BIO; Moller AP, 1999, J ANIM ECOL, V68, P163, DOI 10.1046/j.1365-2656.1999.00274.x; Moorad JA, 2009, P ROY SOC B-BIOL SCI, V276, P2271, DOI 10.1098/rspb.2009.0183; Moore PJ, 2004, EVOLUTION, V58, P1773, DOI 10.1111/j.0014-3820.2004.tb00460.x; Morrissey MB, 2014, QUANTITATIVE GENETICS IN THE WILD, P228; Morrissey MB, 2010, MOL ECOL RESOUR, V10, P711, DOI 10.1111/j.1755-0998.2009.02817.x; Mysterud A, 2001, P ROY SOC B-BIOL SCI, V268, P911, DOI 10.1098/rspb.2001.1585; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Nussey DH, 2008, P ROY SOC B-BIOL SCI, V275, P745, DOI 10.1098/rspb.2007.0986; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Nussey DH, 2009, AM NAT, V174, P342, DOI 10.1086/603615; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Pletcher SD, 1999, GENETICS, V153, P813; Pletcher SD, 1998, GENETICS, V148, P287; Preston BT, 2011, ECOL LETT, V14, P1017, DOI 10.1111/j.1461-0248.2011.01668.x; Promislow DEL, 1996, GENETICS, V143, P839; Pujol B, 2014, CURR BIOL, V24, P744, DOI 10.1016/j.cub.2014.02.012; R Core Team, 2021, R LANGUAGE ENV STAT; Reale D, 1999, HEREDITY, V83, P526, DOI 10.1038/sj.hdy.6885430; Reid JM, 2011, AM NAT, V177, P177, DOI 10.1086/657977; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; Rose Michael R., 2012, Frontiers in Genetics, V3, P134, DOI 10.3389/fgene.2012.00134; Saint Jalme M, 2003, THERIOGENOLOGY, V59, P875, DOI 10.1016/S0093-691X(02)01153-6; Shaw FH, 1999, GENETICS, V152, P553; Simmons L, 2008, SPERM EVOLUTION EVOL; Sloter E, 2006, HUM REPROD, V21, P2868, DOI 10.1093/humrep/del250; Snoke MS, 2003, HEREDITY, V91, P546, DOI 10.1038/sj.hdy.6800353; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008; Wilson AJ, 2008, FUNCT ECOL, V22, P431, DOI 10.1111/j.1365-2435.2008.01412.x; Wilson AJ, 2007, CURR BIOL, V17, P2136, DOI 10.1016/j.cub.2007.11.043	73	12	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133140	10.1371/journal.pone.0133140	http://dx.doi.org/10.1371/journal.pone.0133140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218735	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900019
J	De Paris, R; Quevedo, CV; Ruiz, DDA; de Souza, ON				De Paris, Renata; Quevedo, Christian V.; Ruiz, Duncan D. A.; de Souza, Osmar Norberto			An Effective Approach for Clustering InhA Molecular Dynamics Trajectory Using Substrate-Binding Cavity Features	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SIMULATIONS; ALGORITHMS; DOCKING; ZINC	Protein receptor conformations, obtained from molecular dynamics (MD) simulations, have become a promising treatment of its explicit flexibility in molecular docking experiments applied to drug discovery and development. However, incorporating the entire ensemble of MD conformations in docking experiments to screen large candidate compound libraries is currently an unfeasible task. Clustering algorithms have been widely used as a means to reduce such ensembles to a manageable size. Most studies investigate different algorithms using pairwise Root-Mean Square Deviation (RMSD) values for all, or part of the MD conformations. Nevertheless, the RMSD only may not be the most appropriate gauge to cluster conformations when the target receptor has a plastic active site, since they are influenced by changes that occur on other parts of the structure. Hence, we have applied two partitioning methods (k-means and k-medoids) and four agglomerative hierarchical methods (Complete linkage, Ward's, Unweighted Pair Group Method and Weighted Pair Group Method) to analyze and compare the quality of partitions between a data set composed of properties from an enzyme receptor substrate-binding cavity and two data sets created using different RMSD approaches. Ensembles of representative MD conformations were generated by selecting a medoid of each group from all partitions analyzed. We investigated the performance of our new method for evaluating binding conformation of drug candidates to the InhA enzyme, which were performed by cross-docking experiments between a 20 ns MD trajectory and 20 different ligands. Statistical analyses showed that the novel ensemble, which is represented by only 0.48% of the MD conformations, was able to reproduce 75% of all dynamic behaviors within the binding cavity for the docking experiments performed. Moreover, this new approach not only outperforms the other two RMSD-clustering solutions, but it also shows to be a promising strategy to distill biologically relevant information from MD trajectories, especially for docking purposes.	[De Paris, Renata; Quevedo, Christian V.; Ruiz, Duncan D. A.] Pontificia Univ Catolica Rio Grande do Sul, Fac Informat, GPIN, Porto Alegre, RS, Brazil; [de Souza, Osmar Norberto] Pontificia Univ Catolica Rio Grande do Sul, Fac Informat, Lab Bioinformat Modelagem & Simulacao Biossistema, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Ruiz, DDA (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Informat, GPIN, Av Ipiranga 6681-Predio 32,Sala 628, Porto Alegre, RS, Brazil.	duncan.ruiz@pucrs.br; osmar.norberto@pucrs.br	Ruiz, Duncan/J-7498-2012; de Souza, Osmar Norberto/B-7328-2013	Ruiz, Duncan/0000-0002-4071-3246; de Souza, Osmar Norberto/0000-0002-4602-1208	Hewlett Packard - PROFACC; Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS); National Council for Scientific and Technological Development (CNPq)	Hewlett Packard - PROFACC; Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Hewlett Packard - PROFACC, PhD Scholarship: RDP; the Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS) (http://www.fapergs.rs.gov.br/), PhD Scholarship: CVQ, Project Grant: DDAR, Project Grant: ONS; and the National Council for Scientific and Technological Development (CNPq) (http://www.cnpq.br/), Project Grant: ONS, CNPq Research Fellow: ONS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; Amaro RE, 2010, CURR TOP MED CHEM, V10, P3, DOI 10.2174/156802610790232279; [Anonymous], 2009, CLUSTER ANAL; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binkowski TA, 2006, NUCLEIC ACIDS RES, V31, P3352; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Case AC, 2009, AMBER 9; Case DA, 2014, AMBER 14; Chen JH, 2007, BIOINFORMATICS, V23, P2348, DOI 10.1093/bioinformatics/btm341; Chen JY, 1992, BIOL DATA MINING; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; De Paris R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/469363; Deng JX, 2005, J MED CHEM, V48, P1496, DOI 10.1021/jm049410e; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; DOANE D., 2012, APPL STAT BUSINESS E; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Gargano F., 2007, ANN 3 INT C BRAZ ASS; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Han J., 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hruschka ER, 2009, IEEE T SYST MAN CY C, V39, P133, DOI 10.1109/TSMCC.2008.2007252; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jain AK., 1988, TECHNOMETRICS; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Landon MR, 2008, CHEM BIOL DRUG DES, V71, P106, DOI 10.1111/j.1747-0285.2007.00614.x; Li Y, 2006, J CHEM INF MODEL, V46, P1742, DOI 10.1021/ci050463u; Liu Zhi-Ping, 2008, Int J Bioinform Res Appl, V4, P445, DOI 10.1504/IJBRA.2008.021179; Lyman E, 2006, BIOPHYS J, V91, P164, DOI 10.1529/biophysj.106.082941; Machado KS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S6; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pauli I, 2013, J CHEM INF MODEL, V53, P2390, DOI 10.1021/ci400202t; Phillips JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-445; Quevedo CV, 2014, EXPERT SYST APPL, V41, P7608, DOI 10.1016/j.eswa.2014.05.038; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; RYDE U, 1995, PROTEINS, V21, P40, DOI 10.1002/prot.340210106; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Tan P., 2006, INTRO DATA MINING; Team RC R, 2012, TECHNICAL REPORT; TORDA AE, 1994, J COMPUT CHEM, V15, P1331, DOI 10.1002/jcc.540151203; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; TROYER JM, 1995, PROTEINS, V23, P97, DOI 10.1002/prot.340230111; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhong S, 2008, J MED CHEM, V51, P4553, DOI 10.1021/jm8001668	55	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133172	10.1371/journal.pone.0133172	http://dx.doi.org/10.1371/journal.pone.0133172			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218832	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900020
J	Farrell, D; Shaughnessy, RG; Britton, L; MacHugh, DE; Markey, B; Gordon, SV				Farrell, Damien; Shaughnessy, Ronan G.; Britton, Louise; MacHugh, David E.; Markey, Bryan; Gordon, Stephen V.			The Identification of Circulating MiRNA in Bovine Serum and Their Potential as Novel Biomarkers of Early Mycobacterium avium subsp paratuberculosis Infection	PLOS ONE			English	Article							JOHNES-DISEASE; MICRORNA; CATTLE; RNAS; REVEALS; TARGETS; GENES; SEQUENCE; DATABASE; PROFILE	Mycobacterium avium subspecies paratuberculosis (MAP) is the aetiological agent of Johne's disease (JD), a chronic enteritis in ruminants that causes substantial economic loses to agriculture worldwide. Current diagnostic assays are hampered by low sensitivity and specificity that seriously complicate disease control; a new generation of diagnostic and prognostic assays are therefore urgently needed. Circulating microRNAs (miRNAs) have been shown to have significant potential as novel biomarkers for a range of human diseases, but their potential application in the veterinary sphere has been less well characterised. The aim of this study was therefore to apply RNA-sequencing approaches to serum from an experimental JD infection model as a route to identify novel diagnostic and prognostic miRNA biomarkers. Sera from experimental MAP-challenged calves (n = 6) and age-matched controls (n = 6) were used. We identified a subset of known miRNAs from bovine serum across all samples, with approximately 90 being at potentially functional abundance levels. The majority of known bovine miRNAs displayed multiple isomiRs that differed from the canonical sequences. Thirty novel miRNAs were identified after filtering and were found within sera from all animals tested. No significant differential miRNA expression was detected when comparing sera from MAP-challenged animals to their age-matched controls at six-month's post-infection. However, comparing sera from pre-infection bleeds to six-month's post-infection across all 12 animals did identify increased miR-205 (2-fold) and decreased miR-432 (2-fold) within both challenged and control groups, which suggests changes in circulating miRNA profiles due to ageing or development (P<0.00001). In conclusion our study has identified a range of novel miRNA in bovine serum, and shown the utility of small RNA sequencing approaches to explore the potential of miRNA as novel biomarkers for infectious disease in cattle.	[Farrell, Damien; Shaughnessy, Ronan G.; Britton, Louise; Markey, Bryan; Gordon, Stephen V.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [MacHugh, David E.] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Med, Dublin 2, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [MacHugh, David E.; Gordon, Stephen V.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	University College Dublin; University College Dublin; University College Dublin; University College Dublin; University College Dublin	Gordon, SV (corresponding author), Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland.	stephen.gordon@ucd.ie		Farrell, Damien/0000-0003-3020-7945; Gordon, Stephen/0000-0002-4833-5542; Shaughnessy, Ronan/0000-0002-9164-3583; MacHugh, David/0000-0002-8112-4704	Department of Agriculture Food and the Marine [RSF11/S/141, EMIDA ERA_NET 11/RD/EMIDA/1]	Department of Agriculture Food and the Marine	This work was supported by the Department of Agriculture Food and the Marine grants RSF11/S/141 (ICONMAP) and EMIDA ERA_NET 11/RD/EMIDA/1 (MycobactDiagnosis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bu D, 2011, NONCODE V3 0 INTEGRA; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Cho J, 2012, J DAIRY SCI, V95, P1855, DOI 10.3168/jds.2011-4787; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; Clark DL, 2008, J DAIRY SCI, V91, P2620, DOI 10.3168/jds.2007-0902; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; de Candia P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00043; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Geraghty T, 2014, PREV VET MED, V116, P1, DOI 10.1016/j.prevetmed.2014.06.003; Gilardoni LR, 2012, REV ARGENT MICROBIOL, V44, P201; Golby P, 2014, VACCINE, V32, P5839, DOI 10.1016/j.vaccine.2014.07.034; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guo DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091354; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Juan L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06277; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Krauskopf J, 2015, TOXICOL SCI, V143, P268, DOI 10.1093/toxsci/kfu232; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Mehta MD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00231; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Miotto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080149; Olsen I, 2002, VET QUART, V24, P12, DOI 10.1080/01652176.2002.9695120; Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; Qian NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068004; Rihani A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09027; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roussey JA, 2014, FRONTIERS IN VETERIN, V1; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Scott MC, 2010, FOODBORNE PATHOG DIS, V7, P1291, DOI 10.1089/fpd.2010.0541; Shin SJ, 2007, J CLIN MICROBIOL, V45, P1941, DOI 10.1128/JCM.02616-06; Sita-Lumsden A, 2013, BRIT J CANCER, V108, P1925, DOI 10.1038/bjc.2013.192; Timms VJ, 2011, J MICROBIOL METH, V85, P1, DOI 10.1016/j.mimet.2011.01.026; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vosgha H, 2014, CURR CANCER DRUG TAR, V14, P621, DOI 10.2174/156800961407140926105634; Wang WJ, 2015, FEBS LETT, V589, P555, DOI 10.1016/j.febslet.2015.01.012; Wells SJ, 2006, CLIN VACCINE IMMUNOL, V13, P1125, DOI 10.1128/CVI.00236-06; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Zhang HY, 2015, J GERONTOL A-BIOL, V70, P102, DOI 10.1093/gerona/glu145; Zhang HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088909; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076; Zhao C, 2015, HUM CELL	68	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134310	10.1371/journal.pone.0134310	http://dx.doi.org/10.1371/journal.pone.0134310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218736	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900108
J	Hancke, K; Dalsgaard, T; Sejr, MK; Markager, S; Glud, RN				Hancke, Kasper; Dalsgaard, Tage; Sejr, Mikael Kristian; Markager, Stiig; Glud, Ronnie Nohr			Phytoplankton Productivity in an Arctic Fjord (West Greenland): Estimating Electron Requirements for Carbon Fixation and Oxygen Production	PLOS ONE			English	Article							FLUORESCENCE EXCITATION-SPECTRA; AMPLITUDE-MODULATED FLUORESCENCE; IN-VIVO FLUORESCENCE; CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-II; MARINE-PHYTOPLANKTON; O-2 PRODUCTION; PHOTOSYNTHETIC PRODUCTION; CHARGE SEPARATION; LIGHT-ABSORPTION	Accurate quantification of pelagic primary production is essential for quantifying the marine carbon turnover and the energy supply to the food web. Knowing the electron requirement (K) for carbon (C) fixation (K-C) and oxygen (O-2) production (K-O2), variable fluorescence has the potential to quantify primary production in microalgae, and hereby increasing spatial and temporal resolution of measurements compared to traditional methods. Here we quantify K-C and K-O2 through measures of Pulse Amplitude Modulated (PAM) fluorometry, C fixation and O-2 production in an Arctic fjord (Godthabsfjorden, W Greenland). Through short- (2h) and long-term (24h) experiments, rates of electron transfer (ETRPSII), C fixation and/or O-2 production were quantified and compared. Absolute rates of ETR were derived by accounting for Photosystem II light absorption and spectral light composition. Two-hour incubations revealed a linear relationship between ETRPSII and gross C-14 fixation (R-2 = 0.81) during light-limited photosynthesis, giving a K-C of 7.6 +/- 0.6 (mean +/- S.E.) mole (mol C)(-1). Diel net rates also demonstrated a linear relationship between ETRPSII and C fixation giving a K-C of 11.2 +/- 1.3 mole (mol C)(-1) (R-2 = 0.86). For net O-2 production the electron requirement was lower than for net C fixation giving 6.5 +/- 0.9 mole (mol O-2)(-1) (R-2 = 0.94). This, however, still is an electron requirement 1.6 times higher than the theoretical minimum for O-2 production [i.e. 4 mole (mol O-2)(-1)]. The discrepancy is explained by respiratory activity and non-photochemical electron requirements and the variability is discussed. In conclusion, the bio-optical method and derived electron requirement support conversion of ETR to units of C or O-2, paving the road for improved spatial and temporal resolution of primary production estimates.	[Hancke, Kasper; Glud, Ronnie Nohr] Univ Southern Denmark, Dept Biol, Nord Ctr Earth Evolut NordCEE, Odense, Denmark; [Hancke, Kasper; Sejr, Mikael Kristian; Glud, Ronnie Nohr] Greenland Inst Nat Resources, Greenland Climate Res Ctr, Nuuk, Greenland; [Dalsgaard, Tage; Sejr, Mikael Kristian; Glud, Ronnie Nohr] Aarhus Univ, Arctic Res Ctr, Aarhus, Denmark; [Markager, Stiig] Aarhus Univ, Inst Biosci, Aarhus, Denmark; [Glud, Ronnie Nohr] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland	University of Southern Denmark; Greenland Institute of Natural Resources; Aarhus University; Aarhus University; UHI Millennium Institute	Hancke, K (corresponding author), Univ Southern Denmark, Dept Biol, Nord Ctr Earth Evolut NordCEE, Odense, Denmark.	khancke@biology.sdu.dk	Dalsgaard, Tage/J-6258-2014; Sejr, Mikael K./P-4235-2019; Markager, Stiig/I-7587-2013	Dalsgaard, Tage/0000-0003-2604-6499; Sejr, Mikael K./0000-0001-8370-5791; Glud, Ronnie N./0000-0002-7069-893X; Markager, Stiig/0000-0001-5427-2026	Nordic Center for Earth Evolution/Danish National Research Foundation (NordCEE, DNRF) [53]; Commission for Scientific Research in Greenland [GCRC6507]; Arctic Research Centre (ARC, Aarhus University); Canada Excellence Research Chair (CERC)	Nordic Center for Earth Evolution/Danish National Research Foundation (NordCEE, DNRF); Commission for Scientific Research in Greenland; Arctic Research Centre (ARC, Aarhus University); Canada Excellence Research Chair (CERC)	Funding is acknowledged to KH and RNG from the Nordic Center for Earth Evolution/Danish National Research Foundation (NordCEE, DNRF#53) and The Commission for Scientific Research in Greenland (GCRC6507). TD and MKS were supported by the Arctic Research Centre (ARC, Aarhus University) and the Canada Excellence Research Chair (CERC). This work is a part of the Greenland Institute of Natural Resources activities and a contribution to the Arctic Science Partnership (ASP) (asp-net.org).	Babin M, 1996, INT J REMOTE SENS, V17, P2417, DOI 10.1080/01431169608948781; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; BRICAUD A, 1990, LIMNOL OCEANOGR, V35, P562, DOI 10.4319/lo.1990.35.3.0562; CLEVELAND JS, 1993, LIMNOL OCEANOGR, V38, P1321, DOI 10.4319/lo.1993.38.6.1321; Cosgrove J, 2010, DEVEL APPL PHYCOL, V4, P1, DOI 10.1007/978-90-481-9268-7_1; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 1986, BIOCHIM BIOPHYS ACTA, V849, P183, DOI 10.1016/0005-2728(86)90024-1; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; Gaarder T., 1927, RAPP P VERB CONS INT, V42, P3; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert M, 2000, PHOTOSYNTHETICA, V38, P111, DOI 10.1023/A:1026708327185; Gilbert M, 2000, J PLANT PHYSIOL, V157, P307, DOI 10.1016/S0176-1617(00)80052-8; Grasshoff K, 1999, METHODS SEAWATER ANA; Halsey KH, 2010, PHOTOSYNTH RES, V103, P125, DOI 10.1007/s11120-009-9526-z; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; Hancke TB, 2008, J PHYCOL, V44, P803, DOI 10.1111/j.1529-8817.2008.00509.x; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Johnsen G, 1997, LIMNOL OCEANOGR, V42, P1166, DOI 10.4319/lo.1997.42.5_part_2.1166; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Johnson KS, 2008, LIMNOL OCEANOGR, V53, P2237, DOI 10.4319/lo.2008.53.5_part_2.2237; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kromkamp JC, 2008, EUR J PHYCOL, V43, P327, DOI 10.1080/09670260802080895; KROON B, 1993, J PHYCOL, V29, P453, DOI 10.1111/j.1529-8817.1993.tb00146.x; Kruskopf M, 2006, NEW PHYTOL, V169, P525, DOI 10.1111/j.1469-8137.2005.01601.x; Lagaria A, 2011, BIOGEOSCIENCES, V8, P2595, DOI 10.5194/bg-8-2595-2011; LANGDON C, 1995, J GEOPHYS RES-OCEANS, V100, P6645, DOI 10.1029/94JC02286; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lippemeier S, 1999, J PLANKTON RES, V21, P269, DOI 10.1093/plankt/21.2.269; Longstaff BJ, 2002, PHOTOSYNTH RES, V74, P281, DOI 10.1023/A:1021279627409; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; Maranon E, 2004, LIMNOL OCEANOGR, V49, P1652, DOI 10.4319/lo.2004.49.5.1652; Markager S, 2001, J PLANKTON RES, V23, P1373, DOI 10.1093/plankt/23.12.1373; MARRA J, 1988, J EXP MAR BIOL ECOL, V115, P263, DOI 10.1016/0022-0981(88)90159-1; Marra J, 2007, PHYTOPLANKTON PRODUC, P78; Marra J, 2009, AQUAT MICROB ECOL, V56, P123, DOI 10.3354/ame01306; Masojidek J, 2001, J PLANKTON RES, V23, P57, DOI 10.1093/plankt/23.1.57; MITCHELL BG, 1988, DEEP-SEA RES, V35, P639, DOI 10.1016/0198-0149(88)90024-6; Morris EP, 2003, EUR J PHYCOL, V38, P133, DOI 10.1080/0967026031000085832; Napoleon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066423; Napoleon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040284; NEORI A, 1988, MAR ECOL PROG SER, V44, P297, DOI 10.3354/meps044297; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pei S, 2013, DEEP-SEA RES PT I, V82, P1, DOI 10.1016/j.dsr.2013.07.011; PETERSON BJ, 1980, ANNU REV ECOL SYST, V11, P359, DOI 10.1146/annurev.es.11.110180.002043; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rysgaard S, 2012, MAR CHEM, V128, P26, DOI 10.1016/j.marchem.2011.11.002; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Staehr PA, 2004, INT J REMOTE SENS, V25, P5117, DOI 10.1080/01431160410001716932; Steeman-Nielsen E., 1952, J CONSEIL INT EXPLOR, V18, P177; Suggett D, 2001, LIMNOL OCEANOGR, V46, P802, DOI 10.4319/lo.2001.46.4.0802; Suggett D, 2011, DEV APPL PHYCOLOGY, V4, DOI [10.1007/978-90-481-9268-7_6, DOI 10.1007/978-90-481-9268-7_]; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; WEBB WL, 1974, OECOLOGIA, V17, P281, DOI 10.1007/BF00345747; Williams PJL, 1996, J PLANKTON RES, V18, P1961, DOI 10.1093/plankt/18.10.1961; Yun MS, 2014, CONT SHELF RES, V76, P1, DOI 10.1016/j.csr.2014.01.001	66	17	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133275	10.1371/journal.pone.0133275	http://dx.doi.org/10.1371/journal.pone.0133275			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218096	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900024
J	Sawada, H; Oeda, T; Umemura, A; Tomita, S; Kohsaka, M; Park, K; Yamamoto, K; Sugiyama, H				Sawada, Hideyuki; Oeda, Tomoko; Umemura, Atsushi; Tomita, Satoshi; Kohsaka, Masayuki; Park, Kwiyoung; Yamamoto, Kenji; Sugiyama, Hiroshi			Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALPHA-SYNUCLEIN; SYSTEMIC INFLAMMATION; CHRONIC NEURODEGENERATION; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; MICROGLIA; BRAIN; RISK	Background C-reactive protein (CRP) is a biomarker of inflammation, and high levels of CRP correlate with vascular death. Chronic inflammation is considered to be involved in neurodegeneration, although there is no evidence linking it with the process of neurodegenerative diseases. Objective To determine the role of baseline CRP levels in the prognosis of patients with Parkinson disease (PD). Methods A cohort of 313 patients with a mean age of 69.1 and mean PD duration of 7.9 years was retrospectively followed for a mean observation time of 1,753 days. CRP was measured when patients were not diagnosed with any infections, and levels were repetitively measured to investigate a tendency of "regression to mean." The primary outcome measure was a survival time from study enrollment to death. Results During the observation period 56 patients died. Baseline CRP was log-linearly associated with a risk of death in PD. Mean survival time was 3,149 (95% confidence interval; 3,0093,289) days in patients with CRP <= 0.8mg/L (lower two thirds) and 2,620 (2,343-2,897) days in those with CRP >0.8 mg/L (top third, p<0.001, log-rank test). The adjusted hazard ratio (HR) per two-fold higher CRP concentration for all deaths was 1.29 (1.10-1.52), and after excluding PD-unrelated deaths, such as cancer or stroke, HR was 1.23 (1.01-1.49) (adjusted for age, sex, PD duration, modified Hohen-Yahr stages, MMSE scores, and serum albumin). Conclusions Baseline CRP concentrations were associated with the risk of death and predicted life prognosis of patients with PD. The associations were independent from PD duration, PD severity, cognitive function, ages, and nutritional conditions, suggesting the possibility that subclinical chronic inflammation is associated with a neurodegenerative process in PD.	[Sawada, Hideyuki] Natl Hosp Org, Natl Utano Hosp, Dept Neurol, Kyoto, Japan; Natl Hosp Org, Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan		Sawada, H (corresponding author), Natl Hosp Org, Natl Utano Hosp, Dept Neurol, Kyoto, Japan.	sawada@unh.hosp.go.jp	Yamamoto, Kenji/AAD-8766-2019; Umemura, Atsushi/ABC-4716-2021	Yamamoto, Kenji/0000-0003-1240-6369; Umemura, Atsushi/0000-0001-8557-6014; Sawada, Hideyuki/0000-0002-5909-3366; Tomita, Satoshi/0000-0003-4410-6539	National Hospital Organization in Japan; Grants-in-Aid for Scientific Research [26461287] Funding Source: KAKEN	National Hospital Organization in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by Grants-in-Aid from the National Hospital Organization in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima H, 2008, ARTERIOSCL THROM VAS, V28, P1385, DOI 10.1161/ATVBAHA.107.157164; BENSHLOMO Y, 1995, J NEUROL NEUROSUR PS, V58, P293, DOI 10.1136/jnnp.58.3.293; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cao SW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-259; Cerejeira J, 2010, ACTA NEUROPATHOL, V119, P737, DOI 10.1007/s00401-010-0674-1; Closhen D, 2010, CYTOKINE, V50, P117, DOI 10.1016/j.cyto.2010.02.011; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Driver JA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d198; Ebadi M, 2003, ANTIOXID REDOX SIGN, V5, P319, DOI 10.1089/152308603322110896; Emberson JR, 2004, EUR J CARDIOV PREV R, V11, P125, DOI 10.1097/01.hjr.0000114967.39211.e5; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Gao XA, 2011, NEUROLOGY, V76, P863, DOI 10.1212/WNL.0b013e31820f2d79; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hristova K, 2014, NUTRITION, V30, P1085, DOI [10.1016/j.nut.2013.12.013, 10.1016/j.nut.2014.01.007]; Ibi M, 1999, J NEUROCHEM, V73, P1696, DOI 10.1046/j.1471-4159.1999.731696.x; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kuhlmann CRW, 2009, STROKE, V40, P1458, DOI 10.1161/STROKEAHA.108.535930; Levy G, 2002, NEUROLOGY, V59, P1708, DOI 10.1212/01.WNL.0000036610.36834.E0; Li YN, 2008, J NEUROSCI RES, V86, P3556, DOI 10.1002/jnr.21810; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Matsumoto H, 2014, J NEUROL SCI, V343, P149, DOI 10.1016/j.jns.2014.05.060; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Morgante L, 2000, ARCH NEUROL-CHICAGO, V57, P507, DOI 10.1001/archneur.57.4.507; Mortensen RF, 2000, J LEUKOCYTE BIOL, V67, P495, DOI 10.1002/jlb.67.4.495; Nakanishi S, 2003, DIABETES CARE, V26, P2754, DOI 10.2337/diacare.26.10.2754; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Sawada H, 1996, J NEUROSCI RES, V43, P503, DOI 10.1002/(SICI)1097-4547(19960215)43:4<503::AID-JNR12>3.0.CO;2-2; Sawada H, 1996, J NEUROSCI RES, V43, P55, DOI 10.1002/jnr.490430107; Sawada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085886; Sharma SK, 2003, ANTIOXID REDOX SIGN, V5, P251, DOI 10.1089/152308603322110832; Umemura A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094944; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X	45	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134118	10.1371/journal.pone.0134118	http://dx.doi.org/10.1371/journal.pone.0134118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218286	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900081
J	Vashishta, M; Khan, N; Mehto, S; Sehgal, D; Natarajan, K				Vashishta, Mohit; Khan, Naeem; Mehto, Subhash; Sehgal, Devinder; Natarajan, Krishnamurthy			Pneumococal Surface Protein A (PspA) Regulates Programmed Death Ligand 1 Expression on Dendritic Cells in a Toll-Like Receptor 2 and Calcium Dependent Manner	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; IMMUNE-RESPONSE; PROTECTIVE IMMUNITY; ANTIBODIES; IMMUNIZATION; ACTIVATION; COMPLEMENT; INFECTION; RELEASE; ADULTS	Pneumonia leads to high mortality in children under the age of five years worldwide, resulting in close to 20 percent of all deaths in this age group. Therefore, investigations into host-pathogen interactions during Streptococcus pneumoniae infection are key in devising strategies towards the development of better vaccines and drugs. To that end, in this study we investigated the role of S. pneumoniae and its surface antigen Pneumococcal surface protein A (PspA) in modulating the expression of co-stimulatory molecule Programmed Death Ligand 1 (PD-L1) expression on dendritic cells (DCs) and the subsequent effects of increased PD-L1 on key defence responses. Our data indicate that stimulation of DCs with PspA increases the surface expression of PD-L1 in a time and dose dependent manner. Characterization of mechanisms involved in PspA induced expression of PD-L1 indicate the involvement of Toll-Like Receptor 2 (TLR2) and calcium homeostasis. While calcium release from intracellular stores positively regulated PD-L1 expression, calcium influx from external milieu negatively regulated PD-L1 expression. Increase in PD-L1 expression, when costimulated with PspA and through TLR2 was higher than when stimulated with PspA or through TLR2. Further, knockdown of TLR2 and the intermediates in the TLR signaling machinery pointed towards the involvement of a MyD88 dependent pathway in PspA induced PD-L1 expression. Incubation of DCs with S. pneumoniae resulted in the up-regulation of PD-L1 expression, while infection with a strain lacking surface PspA failed to do so. Our data also suggests the role of PspA in ROS generation. These results suggest a novel and specific role for PspA in modulating immune responses against S. pneumoniae by regulating PD-L1 expression.	[Vashishta, Mohit; Mehto, Subhash; Natarajan, Krishnamurthy] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India; [Khan, Naeem; Sehgal, Devinder] Natl Inst Immunol, Mol Immunol Lab, New Delhi 110067, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Vashishta, M (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India.	mohitp.biotech@gmail.com; devinder@nii.ac.in; knatarajan@acbr.du.ac.in	Khan, Naeem/ABB-4214-2021	Mehto, Subhash/0000-0002-5351-7850	University of Delhi; National Institute of Immunology	University of Delhi(University of Delhi); National Institute of Immunology	This work was funded by grants from the University of Delhi to KN and the intramural research programme of the National Institute of Immunology to DS. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Asmat TM, 2011, J BIOL CHEM, V286, P17861, DOI 10.1074/jbc.M110.212225; Bowers NL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003993; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Brown KE, 2010, CURR OPIN IMMUNOL, V22, P397, DOI 10.1016/j.coi.2010.03.007; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Buddhisa S, 2015, J IMMUNOL, V194, P4413, DOI 10.4049/jimmunol.1402417; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Cao J, 2013, J LEUKOCYTE BIOL, V93, P737, DOI 10.1189/jlb.0812428; Choi YW, 2005, VIROLOGY, V332, P454, DOI 10.1016/j.virol.2004.11.019; Colino J, 2003, J IMMUNOL, V171, P2354, DOI 10.4049/jimmunol.171.5.2354; CRAIN MJ, 1990, INFECT IMMUN, V58, P3293, DOI 10.1128/IAI.58.10.3293-3299.1990; Daniels CC, 2010, INFECT IMMUN, V78, P2163, DOI 10.1128/IAI.01199-09; Ginsburg AS, 2012, EXPERT REV VACCINES, V11, P279, DOI [10.1586/ERV.12.5, 10.1586/erv.12.5]; Goulart C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059605; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hollingshead SK, 2006, J MED MICROBIOL, V55, P215, DOI 10.1099/jmm.0.46268-0; Hotomi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058124; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Khan N, 2015, CLINICAL VAC IMM, V1, P99; Koedel U, 2003, J IMMUNOL, V170, P438, DOI 10.4049/jimmunol.170.1.438; Krishnappa LG, 2014, ACTA MICROBIOL IMM H, V61, P173, DOI 10.1556/AMicr.61.2014.2.7; Littmann M, 2009, EMBO MOL MED, V1, P211, DOI 10.1002/emmm.200900025; Mckay JT, 2015, J IMMUNOL, V194, P2289, DOI 10.4049/jimmunol.1401673; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Noske N, 2009, J IMMUNOL, V183, P1952, DOI 10.4049/jimmunol.0804383; Oma K, 2009, VACCINE, V27, P3181, DOI 10.1016/j.vaccine.2009.03.055; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Piao ZY, 2014, VACCINE, V32, P5607, DOI 10.1016/j.vaccine.2014.07.108; Rabe H, 2014, IMMUNOLOGY, V141, P467, DOI 10.1111/imm.12209; Rada B, 2014, INFLAMM RES, V63, P821, DOI 10.1007/s00011-014-0756-y; Ren B, 2004, INFECT IMMUN, V72, P114, DOI 10.1128/IAI.72.1.114-122.2004; Richard AL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004339; Rohatgi S, 2009, J IMMUNOL, V182, P5570, DOI 10.4049/jimmunol.0803254; Rosendahl A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00021; Selvakumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096427; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Singhal J, 2012, J BIOL CHEM, V287, P11108, DOI 10.1074/jbc.M111.300319; Tan TQ, 2012, CLIN MICROBIOL REV, V25, P409, DOI 10.1128/CMR.00018-12; Tart RC, 1996, J INFECT DIS, V173, P380, DOI 10.1093/infdis/173.2.380; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Haasteren G, 1999, J RECEPT SIGNAL TR R, V19, P481, DOI 10.3109/10799899909036666; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wang JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00606; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; Zdrenghea MT, 2012, MICROBES INFECT, V14, P495, DOI 10.1016/j.micinf.2012.01.002; Zhang JY, 2008, J IMMUNOL, V181, P3741, DOI 10.4049/jimmunol.181.6.3741	56	3	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133601	10.1371/journal.pone.0133601	http://dx.doi.org/10.1371/journal.pone.0133601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214513	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300023
J	Montano, S; Maggioni, D; Arrigoni, R; Seveso, D; Puce, S; Galli, P				Montano, Simone; Maggioni, Davide; Arrigoni, Roberto; Seveso, Davide; Puce, Stefania; Galli, Paolo			The Hidden Diversity of Zanclea Associated with Scleractinians Revealed by Molecular Data	PLOS ONE			English	Article							CNIDARIA HYDROZOA; TAXONOMIC CLASSIFICATION; HYDROIDS CNIDARIA; SULAWESI SEA; MITOCHONDRIAL; PHYLOGENY; EVOLUTION; CAPITATA; CORALS; HYDROIDOMEDUSAE	Scleractinian reef corals have recently been acknowledged as the most numerous host group found in association with hydroids belonging to the Zanclea genus. However, knowledge of the molecular phylogenetic relationships among Zanclea species associated with scleractinians is just beginning. This study, using the nuclear 28S rDNA region and the fast-evolving mitochondrial 16S rRNA and COI genes, provides the most comprehensive phylogenetic reconstruction of the genus Zanclea with a particular focus on the genetic diversity among Zanclea specimens associated with 13 scleractinian genera. The monophyly of Zanclea associated with scleractinians was strongly supported in all nuclear and mitochondrial phylogenetic reconstructions. Furthermore, a combined mitochondrial 16S and COI phylogenetic tree revealed a multitude of hidden molecular lineages within this group (Clades I, II, III, V, VI, VII, and VIII), suggesting the existence of both host-generalist and genus-specific lineages of Zanclea associated with scleractinians. In addition to Z. gallii living in association with the genus Acropora, we discovered four well-supported lineages (Clades I, II, III, and VII), each one forming a strict association with a single scleractinian genus, including sequences of Zanclea associated with Montipora from two geographically separated areas (Maldives and Taiwan). Two host-generalist Zanclea lineages were also observed, and one of them was formed by Zanclea specimens symbiotic with seven scleractinian genera (Clade VIII). We also found that the COI gene allows the recognition of separated hidden lineages in agreement with the commonly recommended mitochondrial 16S as a DNA barcoding gene for Hydrozoa and shows reasonable potential for phylogenetic and evolutionary analyses in the genus Zanclea. Finally, as no DNA sequences are available for the majority of the nominal Zanclea species known, we note that they will be necessary to elucidate the diversity of the Zanclea-scleractinian association.	[Montano, Simone; Maggioni, Davide; Arrigoni, Roberto; Seveso, Davide; Galli, Paolo] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Montano, Simone; Maggioni, Davide; Seveso, Davide; Galli, Paolo] Marine Res & High Educ Ctr, MaRHE Ctr, Magoodhoo Isl, Faafu Atoll, Maldives; [Arrigoni, Roberto] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia; [Puce, Stefania] Polytech Univ Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy	University of Milano-Bicocca; King Abdullah University of Science & Technology; Marche Polytechnic University	Montano, S (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Piazza Sci 2, I-20126 Milan, Italy.	simone.montano@unimib.it	Maggioni, Davide/K-1272-2019; seveso, davide/C-9507-2011	Maggioni, Davide/0000-0003-0508-3987; Arrigoni, Roberto/0000-0002-6825-6331; Galli, Paolo/0000-0002-6065-8192				Arrigoni R, 2014, ZOOL SCR, V43, P661, DOI 10.1111/zsc.12072; Arrigoni R, 2014, MOL PHYLOGENET EVOL, V73, P60, DOI 10.1016/j.ympev.2014.01.010; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boero F, 2000, ITAL J ZOOL, V67, P93, DOI 10.1080/11250000009356301; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Bouillon J, 2000, SCI MAR, V64, P87, DOI 10.3989/scimar.2000.64s187; Bouillon J, 2006, AN INTRODUCTION TO H; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Cairns Stephen D., 2001, Smithsonian Contributions to Zoology, V615, P1; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Collins AG, 2005, ZOOL SCR, V34, P91, DOI 10.1111/j.1463-6409.2005.00172.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evans NM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-139; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontana S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050130; Gershwin LA, 2003, T ROY SOC SOUTH AUST, V127, P205; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; Gravier-Bonnet Nicole, 2012, Atoll Research Bulletin, P85; Gravili C, 1996, SCI MAR, V60, P99; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haeckel EHPA, 1879, MONOGRAPHIE DER MEDU; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hirohito ES, 1988, THE HYDROIDS OF SAGA; Hirose M, 2012, J MAR BIOL ASSOC UK, V92, P877, DOI 10.1017/S0025315411001238; Hoeksema BW, 2012, J MAR BIOL ASSOC UK, V92, P647, DOI 10.1017/S0025315411001445; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Huang DW, 2014, ZOOL SCR, V43, P531, DOI 10.1111/zsc.12061; Huang DW, 2014, ZOOL J LINN SOC-LOND, V171, P277, DOI 10.1111/zoj12140; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kitano YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098406; Kramp P. L., 1968, Sections 2 and 3 Dana Rep, VNo. 72, P1; Lindner A, 2011, ZOOTAXA, P23; Martinez DE, 2010, MOL PHYLOGENET EVOL, V57, P403, DOI 10.1016/j.ympev.2010.06.016; McKinney F, 2009, ICHNOS, V16, P193, DOI 10.1080/10420940802686160; Miglietta MP, 2007, J ZOOL SYST EVOL RES, V45, P11, DOI 10.1111/j.1439-0469.2006.00379.x; Miglietta MP, 2009, ZOOL SCR, V38, P403, DOI 10.1111/j.1463-6409.2008.00376.x; Migotto A.E., 1996, Zoologische Verhandelingen (Leiden), V306, P1; MILLARD N A H, 1974, Annals of the South African Museum, V65, P1; Millard NAH, 1975, ANN S AFR MUS, V68, P1; Montano S, 2013, CORAL REEFS, V32, P701, DOI 10.1007/s00338-013-1023-3; Montano S, 2015, MAR BIOL RES, V11, P773, DOI 10.1080/17451000.2015.1009467; Montano S, 2014, MAR BIODIVERS, V44, P581, DOI 10.1007/s12526-014-0207-6; Montano S, 2015, ZOOL SCR, V44, P92, DOI 10.1111/zsc.12081; Moura CJ, 2008, ZOOL SCR, V37, P93, DOI 10.1111/j.1463-6409.2007.00312.x; Moura CJ, 2011, INVERTEBR SYST, V25, P454, DOI 10.1071/IS11045; Moura CJ, 2012, ZOOL SCR, V41, P79, DOI 10.1111/j.1463-6409.2011.00503.x; Moura CJ, 2011, ZOOL SCR, V40, P520, DOI 10.1111/j.1463-6409.2011.00489.x; Nawrocki AM, 2013, MOL PHYLOGENET EVOL, V67, P60, DOI 10.1016/j.ympev.2012.12.016; Nawrocki AM, 2010, ZOOL SCR, V39, P290, DOI 10.1111/j.1463-6409.2009.00419.x; Nylander J, 2004, MRMODELTEST V2 SOFTW; Ortman BD, 2010, DEEP-SEA RES PT II, V57, P2148, DOI 10.1016/j.dsr2.2010.09.017; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Pantos O, 2010, CORAL REEFS, V29, P761, DOI 10.1007/s00338-010-0622-5; Pantos O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020946; Puce S, 2002, J MAR BIOL ASSOC UK, V82, P943, DOI 10.1017/S0025315402006434; Puce S, 2007, SYMBIOSIS, V44, P137; Puce S, 2008, J MAR BIOL ASSOC UK, V88, P1715, DOI 10.1017/S0025315408002233; Puce S, 2008, J MAR BIOL ASSOC UK, V88, P1643, DOI 10.1017/S0025315408001094; RISTEDT H, 1985, Marine Ecology, V6, P167, DOI 10.1111/j.1439-0485.1985.tb00136.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schuchert P, 2006, CAN J ZOOL, V84, P564, DOI 10.1139/Z06-031; Schuchert P, 2005, MOL PHYLOGENET EVOL, V36, P194, DOI 10.1016/j.ympev.2005.03.021; Schuchert P, 2014, MOL PHYLOGENET EVOL, V76, P1, DOI 10.1016/j.ympev.2014.02.020; Schuchert P, 2010, REV SUISSE ZOOL, V117, P337; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Stepanjants S. D., 1972, ISSLEDOVANIYA FAUNY, V11, P56; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UCHIDA T, 1976, P JPN ACAD, V52, P141, DOI 10.2183/pjab1945.52.141; Veron J.E.N, 2000, CORALS WORLD; Wallace CC, 2007, CORAL REEFS, V26, P231, DOI 10.1007/s00338-007-0203-4; Wallace Carden C., 2012, Memoirs of the Queensland Museum, V57, P1; Xu Z, 1991, MINNAN TAIWAN BANK F, V469, P486; Xu Z.Z., 2008, S OCEANOGRAPHY BEIBU, P209; Zietara MS, 2000, J PARASITOL, V86, P1368, DOI 10.1645/0022-3395(2000)086[1368:TNRROG]2.0.CO;2	84	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133084	10.1371/journal.pone.0133084	http://dx.doi.org/10.1371/journal.pone.0133084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207903	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000062
J	Mortimer, M; Visser, K; de Beer, D; Joubert, E; Louw, A				Mortimer, M.; Visser, K.; de Beer, D.; Joubert, E.; Louw, A.			Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met	PLOS ONE			English	Article							ROOIBOS ASPALATHUS-LINEARIS; CAMELLIA-SINENSIS TEAS; HUMAN BREAST-CANCER; RANDOMIZED CONTROLLED-TRIAL; AFRICAN HERBAL TEAS; RECEPTOR-BETA; POSTMENOPAUSAL WOMEN; DRUG DISCOVERY; ALTERNATIVE MEDICINE; PHENOLIC COMPOSITION	The genus Cyclopia, an indigenous South African fynbos plant used to prepare honeybush tea, contains phytoestrogenic compounds. An extract from C. subternata, SM6Met, displays three desirable estrogenic attributes for future development of a phytoestrogenic nutraceutical, namely, ER alpha antagonism, ER beta agonism, and also antagonism of E-2-induced breast cancer cell proliferation. Activity-guided fractionation of SM6Met was used in an attempt to isolate and identify compounds conferring the desirable estrogenic profile to SM6Met. Initial liquid-liquid fractionation of SM6Met yielded a polar fraction (PF) and a non-polar fraction (NPF), with the desirable estrogenic attributes retained in the NPF. Subsequent high performance counter-current chromatography (HPCCC) fractionation of the NPF yielded three fractions (F1-F3). Interestingly, the fractions revealed separation of the previously demonstrated positive estrogenic attributes of the NPF into separate fractions, with F1 and F2 acting as ERa antagonists, only F2 inducing antagonism of E-2-induced breast cancer cell proliferation and only F3 retaining robust ER beta agonist activity. In terms of major polyphenols, quantitative HPLC and liquid chromatography tandem mass spectrometry (LC-MS/MS) indicated that HPCCC fractionation resulted in a divergence of polyphenolic classes, with F1 emerging as the dihydrochalcone-rich fraction and F2 as the flavanone- and benzophenone-rich fraction, while the xanthones, flavones and phenolic acids were retained in F3. F3 was re-engineered into F3R by reassembling the major polyphenols identified in the fraction. F3R could, however, not replicate the effect of F3. In conclusion, although activity-guided fractionation results suggest that retention of all the desirable estrogenic attributes of the original SM6Met in one fraction is not an attainable goal, fractionation is a useful tool to enhance specific desirable estrogenic attributes.	[Mortimer, M.; Visser, K.; Louw, A.] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, Western Cape, South Africa; [de Beer, D.; Joubert, E.] Agr Res Council South Africa Infruitec Nietvoorbi, Postharvest & Wine Technol Div, Stellenbosch, Western Cape, South Africa; [Joubert, E.] Univ Stellenbosch, Dept Food Sci, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University; Agricultural Research Council of South Africa; Stellenbosch University	Louw, A (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, Western Cape, South Africa.	al@sun.ac.za	De Beer, Dalene/E-8831-2010; Louw, Ann/A-7620-2012	De Beer, Dalene/0000-0002-3680-142X; Louw, Ann/0000-0002-1021-6732; Joubert, Elizabeth/0000-0002-9717-9769	Medical Research Council; Cancer Association of South Africa; National Research Foundation; Harry Crossley Foundation; National Research Foundation IFRR grant [85277]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Association of South Africa; National Research Foundation; Harry Crossley Foundation; National Research Foundation IFRR grant	The authors would like to thank the Medical Research Council (http://www.mrc.ac.za/) and the Cancer Association of South Africa (http://www.cansa.org.za/) for financial support to AL (grant for projects entitled "Cyclopia Phytoestrogens" and "Cyclopia and breast cancer") and for financial support to KV and MM the National Research Foundation (http://www.nrf.ac.za/) and the Harry Crossley Foundation (http://www.educationinnovations.org/funder/harry-crossley-foundation) is acknowledged. The National Research Foundation IFRR grant 85277 to EJ is also acknowledged. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and therefore the funders do not accept any liability in regard thereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bader S, 2009, NAT BIOTECHNOL, V27, P427, DOI 10.1038/nbt0509-427; Al-Janabi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082576; Ali S, 2000, J MAMMARY GLAND BIOL, V5, P271, DOI 10.1023/A:1009594727358; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Anderson LN, 2013, INT J CANCER, V132, P1683, DOI 10.1002/ijc.27788; Andlauer W, 2004, CLIN NUTR, V23, P989, DOI 10.1016/j.clnu.2003.11.009; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bartoszewski R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092128; Basu S. K., 2007, Australian Journal of Basic and Applied Sciences, V1, P637; Bedell S, 2014, J STEROID BIOCHEM, V139, P225, DOI 10.1016/j.jsbmb.2012.12.004; Beelders T, 2014, J NAT PROD, V77, P2694, DOI 10.1021/np5007247; Bhutani K., 2003, INDIAN J NATURAL PRO, V19, P3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carusi, 2000, Prim Care Update Ob Gyns, V7, P253, DOI 10.1016/S1068-607X(00)00055-X; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chawla R, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-35; Chen MF, 2011, APPETITE, V57, P253, DOI 10.1016/j.appet.2011.05.305; Collins-Burow BM, 2000, NUTR CANCER, V38, P229, DOI 10.1207/S15327914NC382_13; Das L, 2012, J FOOD SCI TECH MYS, V49, P173, DOI 10.1007/s13197-011-0269-4; de Beer D, 2012, MOLECULES, V17, P14602, DOI 10.3390/molecules171214602; de Kleijn MJJ, 2002, J NUTR, V132, P276, DOI 10.1093/jn/132.2.276; Dillard CJ, 2000, J SCI FOOD AGR, V80, P1744, DOI [10.1002/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W, 10.1002/1097-0010(20000915)80:12&lt;1744::AID-JSFA725&gt;3.0.CO;2-W]; Efferth T, 2011, CURR DRUG TARGETS, V12, P122, DOI 10.2174/138945011793591626; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904; Ghorbani A, 2012, EUR J NUTR, V51, P39, DOI 10.1007/s00394-011-0187-2; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Hardy G, 2002, CURR OPIN CLIN NUTR, V5, P671, DOI 10.1097/00075197-200211000-00010; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hostettmann K, 1999, IUPAC, V70, P1; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Joubert E, 2008, J ETHNOPHARMACOL, V119, P376, DOI 10.1016/j.jep.2008.06.014; Joubert E, 2011, S AFR J BOT, V77, P887, DOI 10.1016/j.sajb.2011.05.014; Joubert E, 2008, J AGR FOOD CHEM, V56, P954, DOI 10.1021/jf072904a; Katiyar Chandrakant, 2012, Ayu, V33, P10, DOI 10.4103/0974-8520.100295; Kitalong C, 2012, REC NAT PROD, V6, P296; Kokate C, 1990, PHARMACOGNOSY, P105; Kokotkiewicz A, 2012, FOOD CHEM, V133, P1373, DOI 10.1016/j.foodchem.2012.01.114; Kong DX, 2009, DRUG DISCOV TODAY, V14, P115, DOI 10.1016/j.drudis.2008.07.002; Kronenberg F, 2002, ANN INTERN MED, V137, P805, DOI 10.7326/0003-4819-137-10-200211190-00009; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee CJ, 2010, PHYTOTHER RES, V24, pS15, DOI 10.1002/ptr.2856; Li AP, 2001, DRUG DISCOV TODAY, V6, P357, DOI 10.1016/S1359-6446(01)01712-3; Louw A, 2013, PLANTA MED, V79, P580, DOI 10.1055/s-0032-1328463; Marnewick J, 2005, CANCER LETT, V224, P193, DOI 10.1016/j.canlet.2004.11.014; Marnewick JL, 2009, FOOD CHEM TOXICOL, V47, P220, DOI 10.1016/j.fct.2008.11.004; Marnewick JL, 2003, J AGR FOOD CHEM, V51, P8113, DOI 10.1021/jf0344643; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 1999, J MED CHEM, V42, P2456, DOI 10.1021/jm990101b; Mfenyana C, 2008, J STEROID BIOCHEM, V112, P74, DOI 10.1016/j.jsbmb.2008.08.005; Natarajan N., 2011, BIOMEDICINE PREVENTI, V1, P207, DOI DOI 10.1016/j.bionut.2011.07.001; Nikander E, 2004, J CLIN ENDOCR METAB, V89, P1207, DOI 10.1210/jc.2003-031166; Palmieri C, 2002, ENDOCR-RELAT CANCER, V9, P1, DOI 10.1677/erc.0.0090001; Park HJ, 2008, PHYTOMEDICINE, V15, P147, DOI 10.1016/j.phymed.2007.07.061; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Paruthiyil S, 2011, BREAST CANCER RES TR, V129, P777, DOI 10.1007/s10549-010-1273-5; Pasquet V, 2011, MAR DRUGS, V9, P819, DOI 10.3390/md9050819; Patwardhan B, 2009, DRUG DISCOV TODAY, V14, P804, DOI 10.1016/j.drudis.2009.05.009; Piersen Colleen E, 2003, Integr Cancer Ther, V2, P120, DOI 10.1177/1534735403002002004; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Rezaie R, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-18; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Shaaban AM, 2003, AM J SURG PATHOL, V27, P1502, DOI 10.1097/00000478-200312000-00002; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Sissing L, 2011, NUTR CANCER, V63, P600, DOI 10.1080/01635581.2011.539313; Soto AM, 2006, BEST PRACT RES CL EN, V20, P15, DOI 10.1016/j.beem.2005.09.001; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Sun J, 1999, ENDOCRINOLOGY, V140, P800, DOI 10.1210/en.140.2.800; Tsuboy MS, 2014, J MED FOOD, V17, P218, DOI 10.1089/jmf.2013.0067; van de Weijer PHM, 2002, MATURITAS, V42, P187, DOI 10.1016/S0378-5122(02)00080-4; van der Merwe JD, 2006, MUTAT RES-GEN TOX EN, V611, P42, DOI 10.1016/j.mrgentox.2006.06.030; Verhoog NJD, 2007, S AFR J SCI, V103, P13; Verhoog NJD, 2007, J AGR FOOD CHEM, V55, P4371, DOI 10.1021/jf063588n; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Wagner H, 2011, FITOTERAPIA, V82, P34, DOI 10.1016/j.fitote.2010.11.016; Zhu JTT, 2007, J AGR FOOD CHEM, V55, P2438, DOI 10.1021/jf063299z; Zych M, 2009, ACTA BIOCHIM POL, V56, P503	79	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132950	10.1371/journal.pone.0132950	http://dx.doi.org/10.1371/journal.pone.0132950			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208351	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000047
J	Scheelings, TF; Frith, SE				Scheelings, Titus Franciscus; Frith, Sarah Elizabeth			Anthropogenic Factors Are the Major Cause of Hospital Admission of a Threatened Species, the Grey-Headed Flying Fox (Pteropus poliocephalus), in Victoria, Australia	PLOS ONE			English	Article							PTEROPODIDAE; CHIROPTERA	To determine the reasons for presentation and outcomes of hospitalised grey-headed flying foxes (Pteropus poliocephalus) in Victoria, Australia, a retrospective analysis was performed on 532 records from two wildlife hospitals. Cases were categorised based on presenting signs and outcomes determined. Anthropogenic factors (63.7%) were a major cause of flying fox admissions with entanglement in fruit netting the most significant risk for bats (36.8%). Overall the mortality rate for flying fox admissions was 59.3%. This study highlights the effects of urbanisation on wild animal populations and a need for continued public education in order to reduce morbidity and mortality of wildlife, especially threatened species.	[Scheelings, Titus Franciscus] Healesville Sanctuary, Australian Wildlife Hlth Ctr, Healesville, Vic, Australia; [Frith, Sarah Elizabeth] Royal Melbourne Zool Gardens, Parkville, Vic, Australia		Scheelings, TF (corresponding author), Healesville Sanctuary, Australian Wildlife Hlth Ctr, Healesville, Vic, Australia.	fscheelings@zoo.org.au	Scheelings, Franciscus/GQH-4874-2022					Acevedo-Whitehouse K, 2009, PHILOS T R SOC B, V364, P3429, DOI 10.1098/rstb.2009.0128; Bradshaw CJA, 2012, J PLANT ECOL, V5, P109, DOI 10.1093/jpe/rtr038; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Duncan A, 1999, ACTION PLAN AUSTR BA, P85; EBY P, 1991, WILDLIFE RES, V18, P547, DOI 10.1071/WR9910547; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Hall L.S., 2000, FLYING FOXES FRUIT B; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Ng JHJ, 2013, AUST J ZOOL, V61, P48, DOI 10.1071/ZO12126; Parris KM, 2005, BIOL CONSERV, V124, P267, DOI 10.1016/j.biocon.2005.01.035; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Saunders L, 2004, AUSTRALASIAN BAT SOC, V23, P18; Schenk AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093517; Schrader GM, 2010, J WILDLIFE DIS, V46, P1079, DOI 10.7589/0090-3558-46.4.1079; van der Ree R, 2006, J ZOOL, V268, P177, DOI 10.1111/j.1469-7998.2005.00005.x	15	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133638	10.1371/journal.pone.0133638	http://dx.doi.org/10.1371/journal.pone.0133638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207984	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000113
J	Simoes, RV; Munoz-Moreno, E; Carbajo, RJ; Gonzalez-Tendero, A; Illa, M; Sanz-Cortes, M; Pineda-Lucena, A; Gratacos, E				Simoes, Rui V.; Munoz-Moreno, Emma; Carbajo, Rodrigo J.; Gonzalez-Tendero, Anna; Illa, Miriam; Sanz-Cortes, Magdalena; Pineda-Lucena, Antonio; Gratacos, Eduard			In Vivo Detection of Perinatal Brain Metabolite Changes in a Rabbit Model of Intrauterine Growth Restriction (IUGR)	PLOS ONE			English	Article							H-1-NMR SPECTROSCOPY; GESTATIONAL-AGE; FETAL; TEMPERATURE; INFANTS; GLYCINE; INJURY; QUANTIFICATION; PERTURBATION; ASSOCIATION	Background Intrauterine growth restriction (IUGR) is a risk factor for abnormal neurodevelopment. We studied a rabbit model of IUGR by magnetic resonance imaging (MRI) and spectroscopy (MRS), to assess in vivo brain structural and metabolic consequences, and identify potential metabolic biomarkers for clinical translation. Methods IUGR was induced in 3 pregnant rabbits at gestational day 25, by 40-50% uteroplacental vessel ligation in one horn; the contralateral horn was used as control. Fetuses were delivered at day 30 and weighted. A total of 6 controls and 5 IUGR pups underwent T2-w MRI and localized proton MRS within the first 8 hours of life, at 7T. Changes in brain tissue volumes and respective contributions to each MRS voxel were estimated by semi-automated registration of MRI images with a digital atlas of the rabbit brain. MRS data were used for: (i) absolute metabolite quantifications, using linear fitting; (ii) local temperature estimations, based on the water chemical shift; and (iii) classification, using spectral pattern analysis. Results Lower birth weight was associated with (i) smaller brain sizes, (ii) slightly lower brain temperatures, and (iii) differential metabolite profile changes in specific regions of the brain parenchyma. Specifically, we found estimated lower levels of aspartate and N-acetylaspartate (NAA) in the cerebral cortex and hippocampus (suggesting neuronal impairment), and higher glycine levels in the striatum (possible marker of brain injury). Our results also suggest that the metabolic changes in cortical regions are more prevalent than those detected in hippocampus and striatum. Conclusions IUGR was associated with brain metabolic changes in vivo, which correlate well with the neurostructural changes and neurodevelopment problems described in IUGR. Metabolic parameters could constitute non invasive biomarkers for the diagnosis and abnormal neurodevelopment of perinatal origin.	[Simoes, Rui V.; Munoz-Moreno, Emma; Gonzalez-Tendero, Anna; Illa, Miriam; Sanz-Cortes, Magdalena; Gratacos, Eduard] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Simoes, Rui V.; Munoz-Moreno, Emma; Gonzalez-Tendero, Anna; Illa, Miriam; Sanz-Cortes, Magdalena; Gratacos, Eduard] Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Hosp St Joan de Deu, Fetal i D Fetal Med Res Ctr,IDIBAPS, Barcelona, Spain; [Carbajo, Rodrigo J.; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Struct Biochem Lab, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Prince Felipe Research Center	Gratacos, E (corresponding author), Univ Barcelona, Ctr Biomed Res Rare Dis CIBER ER, Hosp Clin, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain.	gratacos@clinic.ub.es	Simoes, Rui Vasco/AAB-3303-2020; Muñoz-Moreno, Emma/ABD-6424-2021; Muñoz-Moreno, Emma/A-2363-2016; Gratacos, Eduard/AAR-4939-2020; Pineda-Lucena, Antonio/B-1320-2014	Simoes, Rui Vasco/0000-0001-7574-4723; Muñoz-Moreno, Emma/0000-0003-2104-7265; Muñoz-Moreno, Emma/0000-0003-2104-7265; Gratacos, Eduard/0000-0002-7405-7224; Pineda-Lucena, Antonio/0000-0002-3532-8781; Illa, Miriam/0000-0002-8366-830X; Sanz-Cortes, Magda/0000-0002-0265-9859	Obra Social "La Caixa" (Barcelona, Spain); Fundacion Dexeus (Barcelona, Spain); AGAUR SGR [928]; Ministerio de Ciencia e Innovacion [SAF2011-28350]	Obra Social "La Caixa" (Barcelona, Spain)(La Caixa Foundation); Fundacion Dexeus (Barcelona, Spain); AGAUR SGR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work funded by grants from Obra Social "La Caixa" (Barcelona, Spain), Fundacion Dexeus (Barcelona, Spain), AGAUR 2014 SGR (grant no 928), and Ministerio de Ciencia e Innovacion (SAF2011-28350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als H, 2011, J PERINATOL, V31, P130, DOI 10.1038/jp.2010.81; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Bassan H, 2000, PEDIATR NEPHROL, V15, P192, DOI 10.1007/s004670000457; Batalle D, 2014, NEUROIMAGE, V100, P24, DOI 10.1016/j.neuroimage.2014.05.065; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Bishop C. M, 2006, PATTERN RECOGNITION; BOTTOMLEY PA, 1984, Patent No. 4480228; Cerdan S, 2006, NEUROCHEM INT, V48, P523, DOI 10.1016/j.neuint.2005.12.036; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Corbett RJT, 1999, AM J NEURORADIOL, V20, P1851; Cruz-Lemini M, 2012, FETAL DIAGN THER, V32, P116, DOI 10.1159/000333001; Derrick M, 2004, J NEUROSCI, V24, P24, DOI 10.1523/JNEUROSCI.2816-03.2004; Dezortova M, 2008, EUR J RADIOL, V67, P240, DOI 10.1016/j.ejrad.2008.02.035; Duda R.O., 2006, PATTERN CLASSIFICATI; Egana-Ugrinovic G, 2014, PRENATAL DIAG, V34, P843, DOI 10.1002/pd.4381; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Erickson KM, 2003, ANESTH ANALG, V96, P1460, DOI 10.1213/01.ANE.0000061221.23197.CE; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Haber S, 2001, BRAIN RES, V896, P102, DOI 10.1016/S0006-8993(01)02065-0; Hall M.A, 1999, CORRELATION BASED FE; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hernandez-Andrade E, 2014, NEUROSCI LETT; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Illa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076453; Kiyatkin EA, 2005, PHYSIOL BEHAV, V84, P563, DOI 10.1016/j.physbeh.2005.02.002; Knobel R, 2007, JOGNN-J OBST GYN NEO, V36, P280, DOI 10.1111/j.1552-6909.2007.00149.x; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Lu Y, 2012, NEUROCHEM INT, V61, P649, DOI 10.1016/j.neuint.2012.07.005; Masoller N, 2014, ULTRASOUND OBST GYN, V44, P2; Munoz-Moreno E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067418; Narendran V, 1999, J PEDIATR-US, V134, P529, DOI 10.1016/S0022-3476(99)70232-5; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; NEWELL DW, 1995, BRAIN RES, V675, P38, DOI 10.1016/0006-8993(95)00039-S; Ortega-Martorell S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-106; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Pardo B, 2011, J CEREBR BLOOD F MET, V31, P90, DOI 10.1038/jcbfm.2010.146; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Sanz-Cortes M, 2014, FETAL DIAGN THER; Simoes RV, 2010, NMR BIOMED, V23, P23, DOI 10.1002/nbm.1421; Story L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.032; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tristan-Vega A, 2007, FAST B SPLINE PSEUDO, P768; van Vliet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064545; Simoes RV, 2012, INTEGR BIOL-UK, V4, P183, DOI 10.1039/c2ib00079b; Warfield SK, 2002, ADV NONRIGID REGISTR, P661; WEINBERG JM, 1987, J CLIN INVEST, V80, P1446, DOI 10.1172/JCI113224; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	51	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131310	10.1371/journal.pone.0131310	http://dx.doi.org/10.1371/journal.pone.0131310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208165	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000015
J	Beasley, DE; Koltz, AM; Lambert, JE; Fierer, N; Dunn, RR				Beasley, DeAnna E.; Koltz, Amanda M.; Lambert, Joanna E.; Fierer, Noah; Dunn, Rob R.			The Evolution of Stomach Acidity and Its Relevance to the Human Microbiome	PLOS ONE			English	Article							GASTRIC RESIDENCE TIME; GASTROINTESTINAL-TRACT; FERMENTATIVE DIGESTION; SMALL-INTESTINE; BEAGLE DOGS; PH; HEALTHY; MONKEY; PRIMATES; MAMMALS	Gastric acidity is likely a key factor shaping the diversity and composition of microbial communities found in the vertebrate gut. We conducted a systematic review to test the hypothesis that a key role of the vertebrate stomach is to maintain the gut microbial community by filtering out novel microbial taxa before they pass into the intestines. We propose that species feeding either on carrion or on organisms that are close phylogenetic relatives should require the most restrictive filter (measured as high stomach acidity) as protection from foreign microbes. Conversely, species feeding on a lower trophic level or on food that is distantly related to them (e.g. herbivores) should require the least restrictive filter, as the risk of pathogen exposure is lower. Comparisons of stomach acidity across trophic groups in mammal and bird taxa show that scavengers and carnivores have significantly higher stomach acidities compared to herbivores or carnivores feeding on phylogenetically distant prey such as insects or fish. In addition, we find when stomach acidity varies within species either naturally (with age) or in treatments such as bariatric surgery, the effects on gut bacterial pathogens and communities are in line with our hypothesis that the stomach acts as an ecological filter. Together these results highlight the importance of including measurements of gastric pH when investigating gut microbial dynamics within and across species.	[Beasley, DeAnna E.; Dunn, Rob R.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Koltz, Amanda M.] Duke Univ, Dept Biol, Durham, NC USA; [Lambert, Joanna E.] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	University of North Carolina; North Carolina State University; Duke University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Beasley, DE (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	debeasl2@ncsu.edu		Beasley, DeAnna/0000-0001-9250-7244; Dunn, Robert/0000-0002-6030-4837; FIERER, NOAH/0000-0002-6432-4261	Division Of Research On Learning [1319293] Funding Source: National Science Foundation	Division Of Research On Learning(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))		ADIBI SA, 1976, AM J CLIN NUTR, V29, P205, DOI 10.1093/ajcn/29.2.205; Akimoto M, 2000, EUR J PHARM BIOPHARM, V49, P99, DOI 10.1016/S0939-6411(99)00070-3; Amir I, 2013, ENV MICROBOL, V16, P2905; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1035, DOI 10.1152/ajplegacy.1974.226.5.1035; ARGENZIO RA, 1975, AM J PHYSIOL, V228, P454, DOI 10.1152/ajplegacy.1975.228.2.454; Aviles-Jimenez F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04202; BANTA CA, 1979, J NUTR, V109, P1592, DOI 10.1093/jn/109.9.1592; Barrett L, 2008, CURR BIOL, V18, pR404, DOI 10.1016/j.cub.2008.02.074; BAUCHOP T, 1968, SCIENCE, V161, P698, DOI 10.1126/science.161.3842.698; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Blaser Martin, 2014, MISSING MICROBES; BODMER RE, 1989, J ZOOL, V219, P457, DOI 10.1111/j.1469-7998.1989.tb02593.x; BROIDO PW, 1973, ARCH SURG-CHICAGO, V106, P90; Brosey BP, 2000, AM J VET RES, V61, P359, DOI 10.2460/ajvr.2000.61.359; CARRION V, 1990, J PEDIATR GASTR NUTR, V11, P317, DOI 10.1097/00005176-199010000-00006; CARTMILL M, 1981, Z ZOOL SYST EVOL, V19, P73; Carvalho Machado JD, 2008, OBES SURG, V18, P139, DOI 10.1007/s11695-007-9365-y; Chen EP, 2008, PHARM RES, V25, P123, DOI 10.1007/s11095-007-9358-5; Cherian G, 2013, POULTRY SCI, V92, P1085, DOI 10.3382/ps.2012-02752; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; CLEMENS E, 1980, COMP BIOCHEM PHYS A, V66, P529, DOI 10.1016/0300-9629(80)90204-2; CLEMENS ET, 1982, J ZOOL, V198, P141, DOI 10.1111/j.1469-7998.1982.tb02066.x; COOK GC, 1985, SCAND J GASTROENTERO, V20, P17, DOI 10.3109/00365528509093751; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; CREGAN J, 1953, BRIT MED J, V1, P1356, DOI 10.1136/bmj.1.4824.1356; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; Dehority Burk A., 1997, P39; Dellow DW, 1979, THESIS U NEW ENGLAND; DEMEYER DI, 1981, AGR ENVIRON, V6, P295, DOI 10.1016/0304-1131(81)90020-5; Denbow D. Michael, 2000, P299, DOI 10.1016/B978-012747605-6/50013-4; DIXON JMS, 1960, J PATHOL BACTERIOL, V79, P131, DOI 10.1002/path.1700790116; DOGLIONI C, 1992, J CLIN PATHOL, V45, P964, DOI 10.1136/jcp.45.11.964; DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309; DUKE GE, 1975, COMP BIOCHEM PHYS A, V50, P649, DOI 10.1016/0300-9629(75)90121-8; Eden A, 1940, NATURE, V145, P36, DOI 10.1038/145036a0; FOX JG, 1991, INFECT IMMUN, V59, P1875, DOI 10.1128/IAI.59.6.1875-1880.1991; FREELAND WJ, 1980, ECOLOGY, V61, P1297, DOI 10.2307/1939037; Gooden BA, 2006, MUSSER ECHIDNA EXTRA; GRAJAL A, 1989, SCIENCE, V245, P1236, DOI 10.1126/science.245.4923.1236; Gremillet D, 2000, CAN J ZOOL, V78, P1567, DOI 10.1139/cjz-78-9-1567; Gremillet D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037834; GRIFFITHS M, 1963, J NUTR, V80, P171, DOI 10.1093/jn/80.2.171; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; HOUSTON D C, 1975, Journal of Wildlife Diseases, V11, P306; HOWDEN CW, 1987, GUT, V28, P96, DOI 10.1136/gut.28.1.96; Hu Y, 2012, WORLD J GASTROENTERO, V18, P1257, DOI 10.3748/wjg.v18.i11.1257; Hume ID, 1982, DIGESTIVE PHYSL NUTR, P69; HUNT RH, 1988, SCAND J GASTROENTERO, V23, P34, DOI 10.3109/00365528809099128; HUSEBYE E, 1992, GUT, V33, P1331, DOI 10.1136/gut.33.10.1331; KAY RNB, 1976, EXPERIENTIA, V32, P485, DOI 10.1007/BF01920812; KINNEAR JE, 1979, COMP BIOCHEM PHYS A, V64, P357, DOI 10.1016/0300-9629(79)90455-9; KITTS W. D., 1957, CANADIAN JOUR ZOOL, V35, P449, DOI 10.1139/z57-036; KOELZ HR, 1992, SCAND J GASTROENTERO, V27, P2, DOI 10.3109/00365529209095998; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; Lambert JE, 2012, INT J PRIMATOL, V33, P263, DOI 10.1007/s10764-011-9559-y; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Martinsen TC, 2005, BASIC CLIN PHARMACOL, V96, P94, DOI 10.1111/j.1742-7843.2005.pto960202.x; McCord AI, 2014, AM J PRIMATOL, V76, P347, DOI 10.1002/ajp.22238; MILTON K, 1983, COMP BIOCHEM PHYS A, V74, P29, DOI 10.1016/0300-9629(83)90706-5; Mitchell MA, 2008, AM J VET RES, V69, P900, DOI 10.2460/ajvr.69.7.900; Moir RJ, 1955, AUST J BIOL SCI, V9, P293; NAUMOVA EI, 1984, DOKL AKAD NAUK SSSR+, V275, P1256; OLSEN MA, 1994, J ZOOL, V234, P55, DOI 10.1111/j.1469-7998.1994.tb06056.x; ORLAJENSEN S, 1949, J GERONTOL, V4, P5; PALMIERI JR, 1984, J AM VET MED ASSOC, V185, P1374; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Parra R., 1978, P205; Ragir S, 2000, J ANTHROPOL RES, V56, P477, DOI 10.1086/jar.56.4.3630928; RHOADES DD, 1975, AUK, V92, P786; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; RUSSELL TL, 1993, PHARMACEUT RES, V10, P187, DOI 10.1023/A:1018970323716; Sagawa K, 2009, J PHARM SCI-US, V98, P2494, DOI 10.1002/jps.21602; Sangild P. T., 2001, P3, DOI 10.1079/9780851995175.0003; Schwenk K, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P1; Skinner MA, 2005, RES VET SCI, V78, P231, DOI 10.1016/j.rvsc.2004.07.007; SMITH CR, 1972, WILSON BULL, V84, P179; SMITH HW, 1965, J PATHOL BACTERIOL, V89, P95, DOI 10.1002/path.1700890112; Smith JL, 2003, J FOOD PROTECT, V66, P1292, DOI 10.4315/0362-028X-66.7.1292; Stevens CE., 1995, COMP PHYSL VERTEBRAT, DOI 10.1086/416640; Strobel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072770; Thouzeau C, 2004, J EXP BIOL, V207, P2715, DOI 10.1242/jeb.01074; USAI P, 1995, GASTROENTEROLOGY, V108, pA702, DOI 10.1016/0016-5085(95)27122-8; VALLENAS AP, 1971, AM J PHYSIOL, V220, P275, DOI 10.1152/ajplegacy.1971.220.1.275; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; VISPO C, 1995, CAN J ZOOL, V73, P967, DOI 10.1139/z95-113; WILLIAMS VJ, 1963, NATURE, V197, P1221, DOI 10.1038/1971221a0; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; YOUNGBERG CA, 1985, AM J VET RES, V46, P1516; Ziswiler V., 1972, P343	91	167	172	10	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134116	10.1371/journal.pone.0134116	http://dx.doi.org/10.1371/journal.pone.0134116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222383	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800106
J	Choudhury, D; Das Talukdar, A; Choudhury, MD; Maurya, AP; Paul, D; Chanda, DD; Chakravorty, A; Bhattacharjee, A				Choudhury, Debarati; Das Talukdar, Anupam; Choudhury, Manabendra Dutta; Maurya, Anand Prakash; Paul, Deepjyoti; Chanda, Debadatta Dhar; Chakravorty, Atanu; Bhattacharjee, Amitabha			Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; EXPRESSION; MECHANISMS; EMERGENCE; OPERON	Carbapenem resistance presents severe threat to the treatment of multidrug resistant Pseudomonas aeruginosa infections. The study was undertaken to investigate the role of efflux pumps in conferring meropenem resistance and effect of single dose exposure of meropenem on transcription level of mexA gene in clinical isolates of P. aeruginosa from a tertiary referral hospital of India. Further, in this investigation an effort was made to assess whether different components of MexAB-OprM operon expresses in the same manner and the extent of contributions of those components in meropenem resistance in its natural host (P. aeruginosa) and in a heterologous host (E. coli). Out of 83 meropenem nonsusceptible isolates, 22 isolates were found to possess efflux pump activity phenotypically. Modified hodge test and multiplex PCR confirmed the absence of carbapenemase genes in those isolates. All of them were of multidrug resistant phenotype and were resistant to all the carbepenem drug tested. MexAB-OprM efflux pump was found to be overexpressed in all the study isolates. It could be observed that single dose exposure meropenem could give rise to trivial increase in transcription of mexA gene. Different constructs of MexAB-OprM (mexR-mexA-mexB-OprM; mexA-mexB-OprM; mexA-mexB) could be expressed in both its natural (P. aeruginosa PAO1) and heterologous host (E. coli JM107) but transcription level of mexA gene varied in both the hosts before and after single dose exposure of meropenem. Different components of the operon failed to enhance meropenem resistance in E. coli JM107 and P. aeruginosa PAO1. This study could prove that MexAB-OprM efflux pump can significantly contribute to meropenem resistance in hospital isolates of P. aeruginosa where an acquired resistant mechanism is absent. Thus, equal importance should be given for diagnosis of intrinsic resistance mechanism so as to minimize treatment failure. As meropenem could not enhance mexA transcriptions significantly, there might be a possibility that the increase in expression of efflux pump genes does not mediated by single antibiotic but rather by a combination of antipseudomonal drugs which are used during treatments. Early detection of efflux genes will help in selection of proper therapeutic options.	[Choudhury, Debarati; Das Talukdar, Anupam; Choudhury, Manabendra Dutta] Assam Univ, Dept Life Sci & Bioinformat, Silchar, Assam, India; [Maurya, Anand Prakash; Paul, Deepjyoti; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar, Assam, India; [Chanda, Debadatta Dhar; Chakravorty, Atanu] Silchar Med Coll & Hosp, Dept Microbiol, Silchar, Assam, India	Assam University; Assam University	Bhattacharjee, A (corresponding author), Assam Univ, Dept Microbiol, Silchar, Assam, India.	ab0404@gmail.com	Choudhury, Manabendra/AAP-1817-2021	Paul, Deepjyoti/0000-0002-6078-9408; Dutta Choudhury, Manabendra/0000-0002-9472-0572; Talukdar, Anupam Das/0000-0001-8916-2791; Maurya, Anand Prakash/0000-0001-5231-8174	DBT-NER twining Department of Biotechnology (DBT) government of India [BCIL/NER-BPMC/2014-203]; Assam University Institutional Biotech Hub Department of Biotechnology (DBT) government of India [BT/04/NE/2009]; University Grants Commission Basic Scientific Research (UGC-BSR) scheme	DBT-NER twining Department of Biotechnology (DBT) government of India; Assam University Institutional Biotech Hub Department of Biotechnology (DBT) government of India; University Grants Commission Basic Scientific Research (UGC-BSR) scheme	This research was funded by DBT-NER twining (BCIL/NER-BPMC/2014-203) Department of Biotechnology (DBT) government of India (www.dbtindia.gov.in): AB Assam University Institutional Biotech Hub (BT/04/NE/2009) Department of Biotechnology (DBT) government of India (www.dbtindia.gov.in): MDC. Debarati Choudhury received a junior research fellowship under University Grants Commission Basic Scientific Research (UGC-BSR) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrain L, 2013, RND EFFLUX PUMPS P A, P26; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Jh Y., 2002, J ANTIMICROB CHEMOTH, V49, P837; Kolayli F, 2004, J MED MICROBIOL, V53, P915, DOI 10.1099/jmm.0.45692-0; Kriengkauykiat J, 2005, ANTIMICROB AGENTS CH, V49, P565, DOI 10.1128/AAC.49.2.565-570.2005; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V47, P247, DOI 10.1093/jac/47.3.247; Meletis G, 2012, HIPPOKRATIA, V16, P303; Mendes RE, 2009, J ANTIMICROB CHEMOTH, V63, P55, DOI 10.1093/jac/dkn434; Mesaros N, 2007, J ANTIMICROB CHEMOTH, V59, P378, DOI 10.1093/jac/dkl504; Pai H, 2001, ANTIMICROB AGENTS CH, V45, P480, DOI 10.1128/AAC.45.2.480-484.2001; Poole K, 1996, ANTIMICROB AGENTS CH, V40, P2021, DOI 10.1128/AAC.40.9.2021; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Quale J, 2003, CLIN INFECT DIS, V37, P214, DOI 10.1086/375821; Riou M, 2010, ECCMID 10 13 APR VIE, pP780; Saito K, 2001, FEMS MICROBIOL LETT, V195, P23, DOI 10.1016/S0378-1097(00)00539-5; Shibl A, 2013, INT J INFECT DIS, V17, pE1130, DOI 10.1016/j.ijid.2013.06.016; Srikumar R, 1998, ANTIMICROB AGENTS CH, V42, P65, DOI 10.1128/AAC.42.1.65; Tomas M, 2010, ANTIMICROB AGENTS CH, V54, P2219, DOI 10.1128/AAC.00816-09; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Xavier DE, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-217; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	23	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133842	10.1371/journal.pone.0133842	http://dx.doi.org/10.1371/journal.pone.0133842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221722	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800071
J	Dominguez-Martinez, E; Parise, E; Strandvall, T; Reid, VM				Dominguez-Martinez, Estefania; Parise, Eugenio; Strandvall, Tommy; Reid, Vincent M.			The Fixation Distance to the Stimulus Influences ERP Quality: An EEG and Eye Tracking N400 Study	PLOS ONE			English	Article							AVERAGE REFERENCE; MODULATION; ACTIVATION; ATTENTION; COMPONENT; INFANT; FOVEAL	In a typical visual Event Related Potential (ERP) study, the stimulus is presented centrally on the screen. Normally an ERP response will be measured provided that the participant directs their gaze towards the stimulus. The aim of this study was to assess how the N400 component of an ERP was affected when the stimulus was presented in the foveal, parafoveal or peripheral vision of the participant's visual field. Utilizing stimuli that have previously produced an N400 response to action incongruities, the same stimuli sequences were presented at 0 degrees, 4 degrees, 8 degrees and 12 degrees of visual angle from a fixation location. In addition to the EEG data, eye tracking data were recorded to act as a fixation control method and to allow for eye artifact detection. The results show a significant N400 effect in the right parietotemporal electrodes within the 0 degrees visual angle condition. For the other conditions, the N400 effect was reduced (4 degrees) or not present (8 degrees and 12 degrees). Our results suggest that the disappearance of the N400 effect with eccentricity is due to the fixation distance to the stimulus. However, variables like attentional allocation could have also had an impact on the results. This study highlights the importance of presenting a stimulus within the foveal vision of the participant in order to maximize ERP effects related to higher order cognitive processes.	[Dominguez-Martinez, Estefania; Parise, Eugenio; Reid, Vincent M.] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Dominguez-Martinez, Estefania; Strandvall, Tommy] Tobii AB, Danderyd, Sweden	Lancaster University	Dominguez-Martinez, E (corresponding author), Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England.	e.dominguezmartinez@lancaster.ac.uk	Parise, Eugenio/ABC-3974-2021; Parise, Eugenio/ABD-9940-2021	Parise, Eugenio/0000-0003-4836-6370; Parise, Eugenio/0000-0003-4836-6370; Reid, Vincent/0000-0002-2774-6975	Marie Curie FP7-PEOPLE / Initial Training Network of the European Union [ACT 289404]; Economic and Social Research Council [ES/L008955/1]; Tobii Technology AB; ESRC [ES/L008955/1] Funding Source: UKRI	Marie Curie FP7-PEOPLE / Initial Training Network of the European Union; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Tobii Technology AB; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Marie Curie FP7-PEOPLE / Initial Training Network of the European Union (ACT 289404) and the Economic and Social Research Council [ES/L008955/1]. Tobii Technology AB also provided support in the form of salaries for authors EDM and TS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amoruso L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00057; ANTES JR, 1981, PSYCHOL RES-PSYCH FO, V43, P277, DOI 10.1007/BF00308452; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; BIEDERMAN I, 1992, J EXP PSYCHOL HUMAN, V18, P121, DOI 10.1037/0096-1523.18.1.121; Bonifacci P, 2008, COGN PROCESS, V9, P127, DOI 10.1007/s10339-007-0198-3; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brouwer GJ, 2005, J NEUROSCI, V25, P10403, DOI 10.1523/JNEUROSCI.2408-05.2005; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Cristescu TC, 2008, J COGNITIVE NEUROSCI, V20, P787, DOI 10.1162/jocn.2008.20503; DeHaan M., 2007, INFANT EEG EVENT REL; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; Duchowski A., 2007, EYE TRACKING METHODO; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P230, DOI 10.1162/jocn.2008.21025; HIRSCH J, 1989, VISION RES, V29, P1095, DOI 10.1016/0042-6989(89)90058-8; Hoehl S, 2008, DEVELOPMENTAL SCI, V11, P10, DOI 10.1111/j.1467-7687.2007.00643.x; Hoehl S, 2012, DEV NEUROPSYCHOL, V37, P187, DOI 10.1080/87565641.2011.627958; Holmqvist K., 2011, EYE TRACKING COMPREH; Hoormann J, 1998, BEHAV RES METH INS C, V30, P103, DOI 10.3758/BF03209420; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Karatekin C, 2007, J EXP CHILD PSYCHOL, V96, P107, DOI 10.1016/j.jecp.2006.05.005; Kleiner M, 2007, PERC 36 ECVP S14; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Luck SJ, 1995, INTRO EVENT RELATED; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; MCCARTHY G, 1993, ELECTROEN CLIN NEURO, V88, P210, DOI 10.1016/0168-5597(93)90005-A; Olsen A, 2012, P S EYE TRACKING RES, P317, DOI [DOI 10.1145/2168556.2168625, 10.1145/2168556.2168625]; Olsen A., 2012, TOBII I VT FIXATION, V21, P4; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1981, J EXP PSYCHOL HUMAN, V7, P167, DOI 10.1037/0096-1523.7.1.167; Reid VM, 2009, DEV PSYCHOL, V45, P620, DOI 10.1037/a0015209; Rugg M., 1995, ELECTROPHYSIOLOGY MI; Sanocki T, 1997, PSYCHOL SCI, V8, P374, DOI 10.1111/j.1467-9280.1997.tb00428.x; Shibata H, 2009, NEUROSCI LETT, V452, P189, DOI 10.1016/j.neulet.2009.01.042; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003	43	7	7	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134339	10.1371/journal.pone.0134339	http://dx.doi.org/10.1371/journal.pone.0134339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222059	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000358836800133
J	Nakiyingi, L; Nonyane, BAS; Ssengooba, W; Kirenga, BJ; Nakanjako, D; Lubega, G; Byakika-Kibwika, P; Joloba, ML; Ellner, JJ; Dorman, SE; Mayanja-Kizza, H; Manabe, YC				Nakiyingi, Lydia; Nonyane, Bareng A. S.; Ssengooba, Willy; Kirenga, Bruce J.; Nakanjako, Damalie; Lubega, Gloria; Byakika-Kibwika, Pauline; Joloba, Moses L.; Ellner, Jerry J.; Dorman, Susan E.; Mayanja-Kizza, Harriet; Manabe, Yukari C.			Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ALGORITHM; SETTINGS; PREVALENCE; MORTALITY; PERFORMANCE; COUNTRIES; ACCURACY; AREA	Background The existing World Health Organization diagnostic algorithms for smear-negative TB perform poorly in HIV-infected individuals. New TB diagnostics such as urine TB lipoarabinomannan (LAM) could improve the accuracy and reduce delays in TB diagnosis in HIV-infected smear-negative presumptive TB. We sought to determine predictors for MTB culture-positivity among these patients. Methods This study was nested into a prospective evaluation of HIV-infected outpatients and inpatients clinically suspected to have TB who were screened by smear-microscopy on two spot sputum samples. Data on socio-demographics, clinical symptoms, antiretroviral therapy, CXR, CD4 count, mycobacterial sputum and blood cultures and TB-LAM were collected. Logistic regression and conditional inference tree analysis were used to determine the most predictive indicators for MTB culture-positivity. Results Of the 418 smear-negative participants [female, 64%; median age (IQR) 32 (28-39) years, median CD4 106 (IQR 22-298) cells/mm(3)], 96/418 (23%) were sputum and/or blood culture-positive for Mycobacterium tuberculosis (MTB) complex. Abnormal CXR (aOR 3.68, 95% CI 1.76-7.71, p=0.001) and positive urine TB-LAM (aOR 6.21, 95% CI 3.14-12.27, p<0.001) were significantly associated with MTB culture-positivity. Previous TB treatment (aOR 0.41, 95% CI 0.17-0.99, p=0.049) reduced the likelihood of a positive MTB culture. A conditional inference tree analysis showed that positive urine TB-LAM and abnormal CXR were the most predictive indicators of MTB culture-positivity. A combination of urine TB-LAM test and CXR had sensitivity and specificity of 50% and 86.1% respectively overall, and 70.8% and 84.1% respectively among those with CD4<100 cells/mm(3). Conclusions A positive urine TB-LAM test and an abnormal CXR significantly predict MTB culture-positivity among smear-negative HIV-infected presumptive TB patients while previous TB treatment reduces the likelihood of a positive MTB culture. Validation studies to assess the performance of diagnostic algorithms that include urine TB-LAM in the diagnosis of smear-negative TB in HIV-infected individuals are warranted.	[Nakiyingi, Lydia; Nakanjako, Damalie; Lubega, Gloria; Byakika-Kibwika, Pauline; Manabe, Yukari C.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Nakiyingi, Lydia; Nakanjako, Damalie; Byakika-Kibwika, Pauline; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda; [Nonyane, Bareng A. S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Ssengooba, Willy; Joloba, Moses L.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Dorman, Susan E.; Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Ellner, Jerry J.] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02215 USA	Makerere University; Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University; Johns Hopkins University; Boston Medical Center; Boston University	Nakiyingi, L (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	lydikiyingi@yahoo.com	Ssengooba, Willy/AAG-1202-2020; Mayanja-Kizza, Harriet/AAM-5372-2020; Ssengooba, Willy/ABE-2168-2020; Nonyane, Bareng A.S./AAC-8118-2020; Nakiyingi, Lydia/ABG-7669-2020	Ssengooba, Willy/0000-0002-1643-110X; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Ssengooba, Willy/0000-0002-1643-110X; Nonyane, Bareng A.S./0000-0001-5633-7487; Nakiyingi, Lydia/0000-0001-7263-3198; Joloba, Moses/0000-0002-0334-9983; Nakanjako, Damalie/0000-0002-0935-2112; Kirenga, Bruce/0000-0002-2023-2840	Medical Education for Equitable Services to All Ugandans (MESAU); Medical Education Partnership Initiative (MEPI) grant from the Office of Global AIDS Coordinator [5R24TW008886]; U. S. Department of Health and Human Services, Health Resources and Services Administration; National Institutes of Health; federal funds from the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under "TB Clinical Diagnostics Research Consortium" [HHSN2722000900050C]; Johns Hopkins University Center for AIDS Research (National Institute of Allergy and Infectious Diseases) [1P30AI094189]; FOGARTY INTERNATIONAL CENTER [R24TW008886, D43TW009771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, K24AI104830] Funding Source: NIH RePORTER	Medical Education for Equitable Services to All Ugandans (MESAU); Medical Education Partnership Initiative (MEPI) grant from the Office of Global AIDS Coordinator; U. S. Department of Health and Human Services, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); federal funds from the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under "TB Clinical Diagnostics Research Consortium"; Johns Hopkins University Center for AIDS Research (National Institute of Allergy and Infectious Diseases); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	LN is a PhD candidate funded by Medical Education for Equitable Services to All Ugandans (MESAU), a Medical Education Partnership Initiative (MEPI) grant number 5R24TW008886 from the Office of Global AIDS Coordinator and the U. S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health. The study project was funded with federal funds from the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract #HHSN2722000900050C, "TB Clinical Diagnostics Research Consortium." Additional support to YCM was by the Johns Hopkins University Center for AIDS Research (Grant Number 1P30AI094189 from the National Institute of Allergy and Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamo ST, 2012, TROP MED INT HEALTH, V17, P884, DOI 10.1111/j.1365-3156.2012.03003.x; [Anonymous], 2012, INFECTIOUS DISEASES; Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Bah B, 2002, INT J TUBERC LUNG D, V6, P592; Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Banda H, 2000, INT J TUBERC LUNG D, V4, P968; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Henegar C, 2012, INT J TUBERC LUNG D, V16, P1199, DOI 10.5588/ijtld.11.0613; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Huerga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051336; Kanaya AM, 2001, CHEST, V120, P349, DOI 10.1378/chest.120.2.349; Kirwan DE, 2012, AM J TROP MED HYG, V87, P197, DOI 10.4269/ajtmh.2012.12-0107; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Li XX, 2013, CHINESE MED J-PEKING, V126, P3662, DOI 10.3760/cma.j.issn.0366-6999.20122778; MacPherson P, 2011, INT J TUBERC LUNG D, V15, P1390, DOI 10.5588/ijtld.11.0056; Nakiyingi L, 2013, AFR HEALTH SCI, V13, P522, DOI 10.4314/ahs.v13i2.46; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Nakiyingi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074023; Nakiyingi Lydia, 2012, BMC Res Notes, V5, P487, DOI 10.1186/1756-0500-5-487; NUNN PP, 1994, THORAX, V49, P511, DOI 10.1136/thx.49.5.511; Orikiriza P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118191; Padmapriyadarsini C, 2013, JAIDS-J ACQ IMM DEF, V63, P331, DOI 10.1097/QAI.0b013e31829341af; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Shah M, 2014, AIDS, V28, P1307, DOI 10.1097/QAD.0000000000000264; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Swai Hedwiga F, 2011, BMC Res Notes, V4, P475, DOI 10.1186/1756-0500-4-475; Tafuma TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088654; Tamhane A, 2009, INT J TUBERC LUNG D, V13, P347; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Trauner A, 2014, DRUGS, V74, P1063, DOI 10.1007/s40265-014-0248-y; van't Hoog AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082786; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Walley J, 2011, JAIDS-J ACQ IMM DEF, V57, pE93, DOI 10.1097/QAI.0b013e3182243a8c; Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440; World Health Organisation, 2007, WHO HTM HIV 2007 01	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133756	10.1371/journal.pone.0133756	http://dx.doi.org/10.1371/journal.pone.0133756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222142	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800064
J	Wolf, RM; Steele, KE; Peterson, LA; Magnuson, TH; Schweitzer, MA; Wong, GW				Wolf, Risa M.; Steele, Kimberley E.; Peterson, Leigh A.; Magnuson, Thomas H.; Schweitzer, Michael A.; Wong, G. William			Lower Circulating C1q/TNF-Related Protein-3 (CTRP3) Levels Are Associated with Obesity: A Cross-Sectional Study	PLOS ONE			English	Article							ADIPOSE-SPECIFIC PROTEIN; UNITED-STATES; ADIPONECTIN; ADIPOKINE; TISSUE; GLUCOSE; PATTERNS; FAMILY; MICE	Purpose C1q/TNF-related protein-3 (CTRP3) is a novel adipokine that lowers blood glucose levels, reduces liver triglyceride synthesis, and is protective against hepatic steatosis in diet-induced obese mouse models. We hypothesized that higher circulating serum levels of CTRP3 would be associated with a lean body mass index (BMI) and a more favorable metabolic profile in humans. The aim of this study was to investigate CTRP3 levels in lean individuals compared to obese individuals. Methods This was a cross-sectional study of obese (n=44) and lean control patients (n=60). Fasting metabolic parameters were measured in all patients and serum CTRP3 levels were measured by ELISA. Results BMI of the lean group was 21.9 +/- 0.2 kg/m(2) and obese group was 45.2 +/- 1.1 kg/m(2). We found significantly lower circulating levels of CTRP3 in obese individuals (405 +/- 8.3 vs. 436 +/- 6.7ng/mL, p=0.004) compared to the lean group. Serum CTRP3 levels were inversely correlated with BMI (p=0.001), and triglycerides (p<0.001), and significantly associated with gender (p<0.01), ethnicity (p=0.05), HDL-cholesterol (p<0.01), and adiponectin (p<0.01). We found BMI (p<0.01), gender (p< 0.01), and ethnicity (p<0.05) to be significant predictors of CTRP3 levels when controlling for age in multiple regression analysis. Conclusions CTRP3 is a beneficial adipokine whose circulating levels are significantly lower in obese individuals. Obesity causes dysregulation in adipokine production, including the down-regulation of CTRP3. Lower CTRP3 levels may contribute to the pathophysiology of metabolic disorders associated with obesity. Optimizing CTRP3 levels through novel therapies may improve obesity and its comorbidities.	[Wolf, Risa M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Steele, Kimberley E.; Peterson, Leigh A.; Magnuson, Thomas H.; Schweitzer, Michael A.] Johns Hopkins Ctr Bariatr Surg, Dept Surg, Baltimore, MD 21205 USA; [Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Wolf, Risa M.; Wong, G. William] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wolf, RM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	RWolf@jhu.edu	Frame, Leigh A./L-3104-2016	Frame, Leigh A./0000-0002-1475-2778; Wong, G. William/0000-0002-5286-6506	NIDDK [DK007751]; Pediatric Endocrine Society Research Fellowship Award; Endocrine Society Endocrine Scholars Award; NIH [DK084171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, T32DK007751] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Pediatric Endocrine Society Research Fellowship Award; Endocrine Society Endocrine Scholars Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	R. M. W. was supported by a T32 training grant from NIDDK (DK007751), the Pediatric Endocrine Society Research Fellowship Award, and the Endocrine Society Endocrine Scholars Award. G. W. W. was supported by an NIH RO1 grant (DK084171). These funding sources played no role in the study design, collection, analysis, and interpretation of data, the writing of the manuscript and the decision to submit the manuscript for publication.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Azrad M, 2013, ENDOCRINE, V43, P586, DOI 10.1007/s12020-012-9797-6; Ban B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112931; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Choi KM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-14; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Cossrow N, 2004, J CLIN ENDOCR METAB, V89, P2590, DOI 10.1210/jc.2004-0339; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hulver MW, 2004, METABOLISM, V53, P1, DOI 10.1016/j.metabol.2003.07.002; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Li XB, 2015, FOOD AGR IMMUNOL, V26, P109, DOI 10.1080/09540105.2013.873390; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Tan BK, 2013, J CLIN ENDOCR METAB, V98, pE1891, DOI 10.1210/jc.2013-2227; Wei Z, 2014, AM J PHYSL IN PRESS; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Ye RS, 2014, ELIFE, V3, DOI 10.7554/eLife.03851; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744	40	59	65	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133955	10.1371/journal.pone.0133955	http://dx.doi.org/10.1371/journal.pone.0133955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222183	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800084
J	Chao, J; Lee, T; Ward, ES; Ober, RJ				Chao, Jerry; Lee, Taiyoon; Ward, E. Sally; Ober, Raimund J.			Fluorescent Microspheres as Point Sources: A Localization Study	PLOS ONE			English	Article							MICROSCOPY; COLOCALIZATION; RESOLUTION; ACCURACY	The localization of fluorescent microspheres is often employed for drift correction and image registration in single molecule microscopy, and is commonly carried out by fitting a point spread function to the image of the given microsphere. The mismatch between the point spread function and the image of the microsphere, however, calls into question the suitability of this localization approach. To investigate this issue, we subject both simulated and experimental microsphere image data to a maximum likelihood estimator that localizes a microsphere by fitting an Airy pattern to its image, and assess the suitability of the approach by evaluating the ability of the estimator to recover the true location of the microsphere with the best possible accuracy as determined based on the Cramer - Rao lower bound. Assessing against criteria based on the standard errors of the mean and the variance for an ideal estimator of the microsphere's location, we find that microspheres up to 100 nm in diameter can in general be localized using a fixed width Airy pattern, and that microspheres as large as 1 mu m in diameter can in general be localized using a floated width Airy pattern.	[Chao, Jerry; Ober, Raimund J.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA; [Chao, Jerry; Ward, E. Sally; Ober, Raimund J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA; [Lee, Taiyoon] Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75083 USA; [Ward, E. Sally] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Dallas; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Ober, RJ (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	raimund.ober@tamu.edu		Ober, Raimund/0000-0002-1290-7430; Ward, E. Sally/0000-0003-3232-7238	National Institutes of Health [R01 GM085575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM085575 to RJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Casella G., 2002, STAT INFERENCE, V2nd; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Erdelyi M, 2013, OPT EXPRESS, V21, P10978, DOI 10.1364/OE.21.010978; GIBSON SF, 1991, J OPT SOC AM A, V8, P1601, DOI 10.1364/JOSAA.8.001601; Goodman J. W., 1996, INTRO FOURIER OPTICS; Janesick J.R., 2001, SCI CHARGE COUPLED D; Malkusch S, 2012, HISTOCHEM CELL BIOL, V137, P1, DOI 10.1007/s00418-011-0880-5; Metcalf DJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50579; Newberry M., 1998, PIXEL RESPONSE EFFEC; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; PREZA C, 1992, MICRON MICROSC ACTA, V23, P501, DOI 10.1016/0739-6260(92)90024-8; Ram S, 2006, MULTIDIM SYST SIGN P, V17, P27, DOI 10.1007/s11045-005-6237-2; Ram S, 2009, OPT EXPRESS, V17, P6881, DOI 10.1364/OE.17.006881; Rao C.R., 1965, LINEAR STAT INFERENC, V2nd; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SNYDER DL, 1995, J OPT SOC AM A, V12, P272, DOI 10.1364/JOSAA.12.000272; Zessin PJM, 2013, OPT NANOSCOPY, V2, P4, DOI [10.1186/2192-2853-2-4, DOI 10.1186/2192-2853-2-4]	20	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134112	10.1371/journal.pone.0134112	http://dx.doi.org/10.1371/journal.pone.0134112			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218251	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000358595900080
J	de Sonneville-Koedoot, C; Stolk, E; Rietveld, T; Franken, MC				de Sonneville-Koedoot, Caroline; Stolk, Elly; Rietveld, Toni; Franken, Marie-Christine			Direct versus Indirect Treatment for Preschool Children who Stutter: The RESTART Randomized Trial	PLOS ONE			English	Article							LIDCOMBE PROGRAM; SPEECH; ADOLESCENTS; ETIOLOGY; ADULTS; MODEL; TWIN; AGE	Objective Stuttering is a common childhood disorder. There is limited high quality evidence regarding options for best treatment. The aim of the study was to compare the effectiveness of direct treatment with indirect treatment in preschool children who stutter. Methods In this multicenter randomized controlled trial with an 18 month follow-up, preschool children who stutter who were referred for treatment were randomized to direct treatment (Lidcombe Program; n = 99) or indirect treatment (RESTART-DCM treatment; n = 100). Main inclusion criteria were age 3-6 years, >= 3% syllables stuttered (%SS), and time since onset >= 6 months. The primary outcome was the percentage of non-stuttering children at 18 months. Secondary outcomes included stuttering frequency (%SS), stuttering severity ratings by the parents and therapist, severity rating by the child, health-related quality of life, emotional and behavioral problems, and speech attitude. Results Percentage of non-stuttering children for direct treatment was 76.5% (65/85) versus 71.4% (65/91) for indirect treatment (Odds Ratio (OR), 0.6; 95% CI, 0.1-2.4, p = .42). At 3 months, children treated by direct treatment showed a greater decline in % SS (significant interaction time x therapy: beta = -1.89; t(282.82) = -2.807, p = .005). At 18 months, stuttering frequency was 1.2% (SD 2.1) for direct treatment and 1.5% (SD 2.1) for indirect treatment. Direct treatment had slightly better scores on most other secondary outcome measures, but no differences between treatment approaches were significant. Conclusions Direct treatment decreased stuttering more quickly during the first three months of treatment. At 18 months, however, clinical outcomes for direct and indirect treatment were comparable. These results imply that at 18 months post treatment onset, both treatments are roughly equal in treating developmental stuttering in ways that surpass expectations of natural recovery. Follow-up data are needed to confirm these findings in the longer term.	[de Sonneville-Koedoot, Caroline; Stolk, Elly] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands; [de Sonneville-Koedoot, Caroline; Franken, Marie-Christine] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Speech & Hearing Ctr,Dept Otorhinolaryngol, Rotterdam, Netherlands; [Rietveld, Toni] Radboud Univ Nijmegen, Dept Linguist, NL-6525 ED Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Radboud University Nijmegen	de Sonneville-Koedoot, C (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands.	desonneville@bmg.eur.nl			Netherlands Organization for Health Research and Development (ZonMw) NWO-Health Care Efficiency Research Program [945-07-417]	Netherlands Organization for Health Research and Development (ZonMw) NWO-Health Care Efficiency Research Program	The RESTART-study was funded by The Netherlands Organization for Health Research and Development (ZonMw; http://www.zonmw.nl/en/) NWO-Health Care Efficiency Research Program (Grant number 945-07-417). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Altman DG, 1991, PRACTICAL STAT MED R, P396; Bernstein Ratner N., 2006, CURRENT ISSUES STUTT; BOBERG E, 1994, J SPEECH HEAR RES, V37, P1050, DOI 10.1044/jshr.3705.1050; Chang SE, 2013, BRAIN; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Clark CE, 2013, J FLUENCY DISORD, V38, P325, DOI 10.1016/j.jfludis.2013.09.004; Conture EG, 1996, J SPEECH HEAR RES, V39, pS18, DOI 10.1044/jshr.3905.s18; Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; Cykowski MD, 2010, NEUROIMAGE, V52, P1495, DOI 10.1016/j.neuroimage.2010.05.011; Donaghy M, 2015, INT J SPEECH-LANG PA, P1; EuroQol Group, 2009, EQ 5D US GUID BAS IN; Evans S, MINIM ALLOCATION MIN; Felsenfeld S, 2000, BEHAV GENET, V30, P359, DOI 10.1023/A:1002765620208; Franken MC, 2014, RESTART DCM METHOD T; Gore K., 2015, AUSTR BUDGET LIDCOMB; Guitar B, 2013, PUBLICATION STUTTERI, V0023; Hayes AF, 2013, SPSS MACRO CALCULATI; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Hayhow R, 2011, INT J LANG COMM DIS, V46, P155, DOI 10.3109/13682822.2010.490572; HOLM S, 1979, SCAND J STAT, V6, P65; Imel Z.E., 2008, HDB COUNSELING PSYCH, P249; Ingham JC, 1998, J SPEECH LANG HEAR R, V41, P753, DOI 10.1044/jslhr.4104.753; Ingham RJ, 1998, AM J SPEECH-LANG PAT, V7, P10, DOI 10.1044/1058-0360.0703.10; Jones M, 2005, BMJ-BRIT MED J, V331, P659, DOI 10.1136/bmj.38520.451840.E0; Jones M, 2008, INT J LANG COMM DIS, V43, P649, DOI 10.1080/13682820801895599; Kang C, 2010, NEW ENGL J MED, V362, P677, DOI 10.1056/NEJMoa0902630; Koedoot C, 2011, J COMMUN DISORD 0327; LUBORSKY L, 1975, ARCH GEN PSYCHIAT, V32, P995; Mansson H, 2000, J FLUENCY DISORD, V25, P47, DOI 10.1016/S0094-730X(99)00023-6; Menzies RG, 2009, J FLUENCY DISORD, V34, P187, DOI 10.1016/j.jfludis.2009.09.002; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nye C, 2013, J SPEECH LANG HEAR R, V56, P921, DOI 10.1044/1092-4388(2012/12-0036); O'Brian S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3742; O'Callaghan CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110761; Onslow M, 2001, BEHAV MODIF, V25, P116, DOI 10.1177/0145445501251007; Onslow M, 2003, LIDCOMBE PROGRAM EAR; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Ratner NB, 2005, J FLUENCY DISORD, V30, P163, DOI 10.1016/j.jfludis.2005.04.002; Rautakoski P, 2012, J FLUENCY DISORD, V37, P202, DOI 10.1016/j.jfludis.2011.12.003; Reilly S, 2013, PEDIATRICS, V132, P460, DOI 10.1542/peds.2012-3067; Riley G., 1994, STUTTERING SEVERITY; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; SANDER E K, 1961, J Speech Hear Disord, V(Suppl 7), P21; Sawyer J, 2006, AM J SPEECH-LANG PAT, V15, P36, DOI 10.1044/1058-0360(2006/005); Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Starkweather CW, 2002, J FLUENCY DISORD, V27, P269, DOI 10.1016/S0094-730X(02)00144-4; STARKWEATHER CW, 1990, J FLUENCY DISORD, V15, P143, DOI 10.1016/0094-730X(90)90015-K; Vanryckeghem M, 2005, J FLUENCY DISORD, V30, P307, DOI 10.1016/j.jfludis.2005.09.003; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yairi E, 1996, J COMMUN DISORD, V29, P51, DOI 10.1016/0021-9924(95)00051-8; Yairi E., 2005, EARLY CHILDHOOD STUT, V1st; Yairi E, 2013, J FLUENCY DISORD, V38, P66, DOI 10.1016/j.jfludis.2012.11.002; Yaruss JS, 2000, J FLUENCY DISORD, V25, P305, DOI 10.1016/S0094-730X(00)00088-7	54	67	67	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133758	10.1371/journal.pone.0133758	http://dx.doi.org/10.1371/journal.pone.0133758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218228	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900046
J	Liu, XR; Ren, JQ; Li, SG; Zhang, QW				Liu, Xing-ren; Ren, Jian-qiang; Li, Sheng-gong; Zhang, Qing-wen			Effects of Simulated Nitrogen Deposition on Soil Net Nitrogen Mineralization in the Meadow Steppe of Inner Mongolia, China	PLOS ONE			English	Article							N MINERALIZATION; IMMOBILIZATION TURNOVER; MICROBIAL BIOMASS; CONIFER FOREST; NITRIFICATION; GRASSLAND; CARBON; FERTILIZATION; TEMPERATURE; MOISTURE	Effects of simulated nitrogen (N) deposition on soil net nitrogen mineralization (NNM) were examined in situ during two growing seasons, using the resin-core technique in the semiarid meadow steppe in Inner Mongolia, China. The aim of this study is to clarify the effect of N levels (0, 10, and 20 kg N ha(-1)yr(-1)) and forms (NH4+ and NO3-) on soil mineral N and NNM. Our results showed that N levels had no significant differences on soil mineral N and NNM. In the first year, three N treatments ((NH4)(2)SO4, NH4Cl and KNO3) increased soil NH4+ concentrations but had no significant effects on soil NO3- concentrations. In the second year, (NH4)(2)SO4 treatment increased soil NO3- concentrations, NH4Cl and KNO3 treatments decreased them. Three N treatments significantly decreased soil NH4+ concentrations in the later stages of the second year. As for the soil NNM, three N treatments had no significant effects on the rates of soil NNM (R-m) and net nitrification (R-n) in the first year, but significantly decreased them in the second year. The contribution of N addition to Rm was higher from (NH4)(2)SO4 than from NH4Cl and KNO3. However, Soil Rm was mainly affected by soil water content (SWC), accumulated temperature (T-a), and soil total N (TN). These results suggest that the short-term atmospheric N deposition may inhibit soil NNM in the meadow steppe of Inner Mongolia.	[Liu, Xing-ren; Zhang, Qing-wen] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Agr Clear Watershed Grp, Beijing 100081, Peoples R China; [Liu, Xing-ren; Zhang, Qing-wen] Minist Agr, Key Lab Agr Environm, Beijing, Peoples R China; [Ren, Jian-qiang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100081, Peoples R China; [Li, Sheng-gong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, QW (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Agr Clear Watershed Grp, Beijing 100081, Peoples R China.	ellenzhqw@163.com	Li, Sheng-Gong/H-5101-2012	Li, Sheng-Gong/0000-0003-4889-9927	National Natural Science Foundation of China [31130009, 31300375]; National Key Project of Scientific and Technical Supporting Program [2013BAC03B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Scientific and Technical Supporting Program	This work was supported by the National Natural Science Foundation of China (Grant No. 31130009, 31300375) and the National Key Project of Scientific and Technical Supporting Program (Grant No. 2013BAC03B03).	Aber JD, 2004, FOREST ECOL MANAG, V196, P1, DOI 10.1016/j.foreco.2004.03.009; Bardgett RD, 1999, FUNCT ECOL, V13, P650, DOI 10.1046/j.1365-2435.1999.00362.x; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Bhogal A, 1999, PLANT SOIL, V207, P15, DOI 10.1023/A:1004420602776; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Chen YT, 2011, SOIL BIOL BIOCHEM, V43, P333, DOI 10.1016/j.soilbio.2010.10.020; Currey PM, 2010, GLOBAL CHANGE BIOL, V16, P2307, DOI 10.1111/j.1365-2486.2009.02082.x; Dalias P, 2002, SOIL BIOL BIOCHEM, V34, P691, DOI 10.1016/S0038-0717(01)00234-6; Emmett BA, 1998, ECOSYSTEMS, V1, P352, DOI 10.1007/s100219900029; Fang HJ, 2014, GEODERMA, V213, P444, DOI 10.1016/j.geoderma.2013.08.006; Fang HJ, 2012, PLANT SOIL, V351, P177, DOI 10.1007/s11104-011-0942-4; Fenn ME, 2005, CAN J FOREST RES, V35, P1464, DOI 10.1139/X05-068; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Ghani A, 2003, SOIL BIOL BIOCHEM, V35, P1231, DOI 10.1016/S0038-0717(03)00186-X; Gundersen P, 1998, FOREST ECOL MANAG, V101, P37, DOI 10.1016/S0378-1127(97)00124-2; Gundersen P, 1998, FOREST ECOL MANAG, V101, P251, DOI 10.1016/S0378-1127(97)00141-2; Guntias ME, 2011, EUROPEAN J SOIL BIOL, V48, P1; Hatch DJ, 2000, BIOL FERT SOILS, V30, P492, DOI 10.1007/s003740050028; Jiao Y, 2012, J ARID LAND, V4, P420, DOI 10.3724/SP.J.1227.2012.00420; Jussy JH, 2004, BIOGEOCHEMISTRY, V69, P241, DOI 10.1023/B:BIOG.0000031050.13663.82; Killham K., 1994, SOIL ECOLOGY, V4th ed.; Li HL, 2003, GEODERMA, V115, P161, DOI 10.1016/S0016-7061(02)00358-0; Li Y, 2014, J ARID LAND, V6, P571, DOI 10.1007/s40333-014-0025-5; Liu WX, 2007, BIOL FERT SOILS, V44, P259, DOI 10.1007/s00374-007-0198-6; Liu XR, 2010, NUTR CYCL AGROECOSYS, V87, P59, DOI 10.1007/s10705-009-9312-5; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; Luxhoi J, 2006, SOIL SCI SOC AM J, V70, P1121, DOI 10.2136/sssaj2005.0133; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; McNulty SG, 2005, FOREST ECOL MANAG, V219, P279, DOI 10.1016/j.foreco.2005.09.004; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; [秦子娴 Qin Zixian], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P3392; Sparrius LB, 2013, PLANT SOIL, V364, P219, DOI 10.1007/s11104-012-1351-z; Sun SH, 2013, PLANT SOIL, V372, P597, DOI 10.1007/s11104-013-1758-1; Throop HL, 2004, GLOBAL CHANGE BIOL, V10, P1092, DOI 10.1111/j.1529-8817.2003.00791.x; Tietema A, 1998, FOREST ECOL MANAG, V101, P19, DOI 10.1016/S0378-1127(97)00123-0; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Turner MM, 2010, OECOLOGIA, V162, P227, DOI 10.1007/s00442-009-1435-5; Vernimmen RRE, 2007, SOIL BIOL BIOCHEM, V39, P2992, DOI 10.1016/j.soilbio.2007.06.005; Vestgarden LS, 2003, FOREST ECOL MANAG, V176, P205, DOI 10.1016/S0378-1127(02)00275-X; Vor T, 2002, SOIL BIOL BIOCHEM, V34, P541, DOI 10.1016/S0038-0717(01)00190-0; Vourlitis GL, 2007, BIOL FERT SOILS, V43, P611, DOI 10.1007/s00374-006-0137-y; Wang CH, 2006, SOIL BIOL BIOCHEM, V38, P1101, DOI 10.1016/j.soilbio.2005.09.009; Xu XK, 2009, GEODERMA, V151, P370, DOI 10.1016/j.geoderma.2009.05.008; Yan ER, 2008, BIOGEOCHEMISTRY, V89, P239, DOI 10.1007/s10533-008-9216-5; Zaman M, 2004, BIOL FERT SOILS, V39, P269, DOI 10.1007/s00374-003-0716-0; Zhang Lu, 2009, Chinese Journal of Plant Ecology, V33, P563, DOI 10.3773/j.issn.1005-264x.2009.03.015; Zhang NL, 2008, PLANT SOIL, V311, P19, DOI 10.1007/s11104-008-9650-0; Zhang XL, 2008, ACTA OECOL, V34, P322, DOI 10.1016/j.actao.2008.06.004; Zhou PD, 2002, PLANT NUTR FERTIL SC, V7, P397; Zhu TB, 2013, BIOL FERT SOILS, V49, P323, DOI 10.1007/s00374-012-0725-y	52	11	17	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134039	10.1371/journal.pone.0134039	http://dx.doi.org/10.1371/journal.pone.0134039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218275	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900070
J	Massey, AJ				Massey, Andrew J.			Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC	PLOS ONE			English	Article							KI-67 PROTEIN; INHIBITOR; REPAIR	High-content imaging is a powerful tool for determining cell phenotypes at the single cell level. Characterising the effect of small molecules on cell cycle distribution is important for understanding their mechanism of action especially in oncology drug discovery but also for understanding potential toxicology liabilities. Here, a high-throughput phenotypic assay utilising the PerkinElmer Operetta high-content imager and Harmony software to determine cell cycle distribution is described. PhenoLOGIC, a machine learning algorithm within Harmony software was employed to robustly separate single cells from cell clumps. DNA content, EdU incorporation and pHH3 (S10) expression levels were subsequently utilised to separate cells into the various phases of the cell cycle. The assay is amenable to multiplexing with an additional pharmacodynamic marker to assess cell cycle changes within a specific cellular sub-population. Using this approach, the cell cycle distribution of gamma H2AX positive nuclei was determined following treatment with DNA damaging agents. Likewise, the assay can be multiplexed with Ki67 to determine the fraction of quiescent cells and with BrdU dual labelling to determine S-phase duration. This methodology therefore provides a relatively cheap, quick and high-throughput phenotypic method for determining accurate cell cycle distribution for small molecule mechanism of action and drug toxicity studies.	Vernalis Res, Cambridge CB21 6GB, England	Vernalis	Massey, AJ (corresponding author), Vernalis Res, Granta Pk, Cambridge CB21 6GB, England.	a.massey@vernalis.com	Massey, Andrew J./H-6954-2019	Massey, Andrew J./0000-0002-0276-2573	Vernalis Research	Vernalis Research	This work was funded by Vernalis Research who agreed to the publication of this manuscript. The funder provided support in the form of salaries for author AJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author are articulated in the 'author contributions' section.	Andreassen Paul R, 2004, Methods Mol Biol, V281, P213; Bradford JA., 2011, CURR PROTOC CYTOM, DOI 10.1002/0471142956.cy0738s55; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Chan GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063583; Gasparri F, 2007, ADV EXP MED BIOL, V604, P137, DOI 10.1007/978-0-387-69116-9_13; Gasparri F, 2006, J BIOMOL SCREEN, V11, P586, DOI 10.1177/1087057106289406; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; HANG HY, 2003, METH MOL B, V241, P23; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; KUWANO M, 1973, CANCER RES, V33, P2965; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Martin HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088338; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; Mouchet EH, 2008, IDRUGS, V11, P422; O'Brien PJ, 2014, BASIC CLIN PHARMACOL, V115, P4, DOI 10.1111/bcpt.12227; ORMEROD MG, 2000, FLOW CYTOMETRY; Persson M, 2014, BASIC CLIN PHARMACOL, V115, P18, DOI 10.1111/bcpt.12200; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; SHIBUI S, 1989, J HISTOCHEM CYTOCHEM, V37, P1007, DOI 10.1177/37.7.2659659; VANDIERENDONCK JH, 1989, CANCER RES, V49, P2999; Vignon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068425	27	28	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134306	10.1371/journal.pone.0134306	http://dx.doi.org/10.1371/journal.pone.0134306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218638	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900107
J	Skaar, K; Korza, HJ; Tarry, M; Sekyrova, P; Hogbom, M				Skaar, Karin; Korza, Henryk J.; Tarry, Michael; Sekyrova, Petra; Hogbom, Martin			Expression and Subcellular Distribution of GFP-Tagged Human Tetraspanin Proteins in Saccharomyces cerevisiae	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MEMBRANE-PROTEINS; EXTRACELLULAR DOMAIN; FREE PURIFICATION; QUALITY-CONTROL; FUSION PROTEIN; BINDING; RECONSTITUTION; COMPLEXES; ANTIGEN	Tetraspanins are integral membrane proteins that function as organizers of multimolecular complexes and modulate function of associated proteins. Mammalian genomes encode approximately 30 different members of this family and remotely related eukaryotic species also contain conserved tetraspanin homologs. Tetraspanins are involved in a number of fundamental processes such as regulation of cell migration, fusion, immunity and signaling. Moreover, they are implied in numerous pathological states including mental disorders, infectious diseases or cancer. Despite the great interest in tetraspanins, the structural and biochemical basis of their activity is still largely unknown. A major bottleneck lies in the difficulty of obtaining stable and homogeneous protein samples in large quantities. Here we report expression screening of 15 members of the human tetraspanin superfamily and successful protocols for the production in S. cerevisiae of a subset of tetraspanins involved in human cancer development. We have demonstrated the subcellular localization of overexpressed tetraspanin-green fluorescent protein fusion proteins in S. cerevisiae and found that despite being mislocalized, the fusion proteins are not degraded. The recombinantly produced tetraspanins are dispersed within the endoplasmic reticulum membranes or localized in granule-like structures in yeast cells. The recombinantly produced tetraspanins can be extracted from the membrane fraction and purified with detergents or the poly (styreneco-maleic acid) polymer technique for use in further biochemical or biophysical studies.	[Skaar, Karin; Korza, Henryk J.; Tarry, Michael; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Sekyrova, Petra] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Sekyrova, Petra] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Stockholm University; Karolinska Institutet; Masaryk University Brno	Hogbom, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	hogbom@dbb.su.se	Korza, Henryk/H-9331-2012	Korza, Henryk/0000-0003-4434-3972; Hogbom, Martin/0000-0001-5574-9383	Swedish Cancer Society [CAN 2012/571]; Swedish Foundation for Strategic Research [SSF FFL4]; Knut and Alice Wallenberg foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Cancer Society (CAN 2012/571), www.cancerfonden.se and the Swedish Foundation for Strategic Research (SSF FFL4), http://www.stratresearch.se. The confocal microscopy facility was supported by the Knut and Alice Wallenberg foundation, www.wallenberg.com/kaw/.	Ailane N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00364; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Bailey RL, 2011, BIOCHEM SOC T, V39, P1667, DOI 10.1042/BST20110745; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berthier-Vergnes O, 2011, BRIT J CANCER, V104, P155, DOI 10.1038/sj.bjc.6605994; Boavida LC, 2013, PLANT PHYSIOL, V163, P696, DOI 10.1104/pp.113.216598; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Damek-Poprawa M, 2005, J BIOL CHEM, V280, P9217, DOI 10.1074/jbc.M407166200; Detchokul S, 2014, BRIT J PHARMACOL, V171, P5462, DOI 10.1111/bph.12260; Dorr JM, 2014, P NATL ACAD SCI USA, V111, P18607, DOI 10.1073/pnas.1416205112; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; DUNCAN R, 1992, ANTI-CANCER DRUG, V3, P175, DOI 10.1097/00001813-199206000-00001; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fairchild CL, 2013, J CELL SCI, V126, P1464, DOI 10.1242/jcs.120915; Gesierich S, 2006, CANCER RES, V66, P7083, DOI 10.1158/0008-5472.CAN-06-0391; Goddard AD, 2015, METHOD ENZYMOL, V556, P405, DOI 10.1016/bs.mie.2015.01.004; Gulati S, 2014, BIOCHEM J, V461, P269, DOI 10.1042/BJ20131477; Guo QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038464; He Y, 2014, PROTEIN CELL, V5, P658, DOI 10.1007/s13238-014-0086-4; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Henry SM, 2006, BIOMACROMOLECULES, V7, P2407, DOI 10.1021/bm060143z; HIGASHIHARA M, 1990, FEBS LETT, V264, P270, DOI 10.1016/0014-5793(90)80265-K; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Ito E, 2003, AM J PATHOL, V163, P2165, DOI 10.1016/S0002-9440(10)63573-0; Jamshad M, 2008, PROTEIN EXPRES PURIF, V57, P206, DOI 10.1016/j.pep.2007.10.013; Jamshad M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140171; Jamshad M, 2011, BIOCHEM SOC T, V39, P813, DOI 10.1042/BST0390813; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kevany BM, 2013, J BIOL CHEM, V288, P36272, DOI 10.1074/jbc.M113.520700; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Knoblich K, 2014, CELL MOL LIFE SCI, V71, P1305, DOI 10.1007/s00018-013-1444-8; Knowles TJ, 2009, J AM CHEM SOC, V131, P7484, DOI 10.1021/ja810046q; Kwon MS, 2007, LUNG CANCER, V57, P46, DOI 10.1016/j.lungcan.2007.01.032; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Li D, 2015, PROTEIN CELL, V6, P229, DOI 10.1007/s13238-014-0129-x; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Long AR, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-41; MAEDA H, 1979, INT J PEPT PROT RES, V14, P81; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Mus-Veteau I, 2014, MEMBRANE PROTEINS PR, DOI [10.1007/978-1-4939-0662-8, DOI 10.1007/978-1-4939-0662-8]; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; Orwick MC, 2012, ANGEW CHEM INT EDIT, V51, P4653, DOI 10.1002/anie.201201355; Parker JL, 2014, PROTEIN SCI, V23, P1309, DOI 10.1002/pro.2507; Postis V, 2015, BBA-BIOMEMBRANES, V1848, P496, DOI 10.1016/j.bbamem.2014.10.018; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; RADFORD KJ, 1995, INT J CANCER, V62, P631, DOI 10.1002/ijc.2910620523; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Rath A, 2013, P NATL ACAD SCI USA, V110, P15668, DOI 10.1073/pnas.1311305110; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Sala-Valdes M, 2012, EXPERT OPIN THER TAR, V16, P985, DOI 10.1517/14728222.2012.712688; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Swainsbury DJK, 2014, ANGEW CHEM INT EDIT, V53, P11803, DOI 10.1002/anie.201406412; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; TAKAGI S, 1995, INT J CANCER, V61, P706, DOI 10.1002/ijc.2910610519; Takayama H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002314; Tarry M, 2012, PROTEIN EXPRES PURIF, V82, P373, DOI 10.1016/j.pep.2012.02.003; Thomas JA, 2014, J MOL BIOL, V426, P4139, DOI 10.1016/j.jmb.2014.10.012; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang HX, 2011, BIOCHEM SOC T, V39, P547, DOI 10.1042/BST0390547; Xia YF, 2012, NAT CELL BIOL, V14, P257, DOI 10.1038/ncb2428; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829	80	19	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134041	10.1371/journal.pone.0134041	http://dx.doi.org/10.1371/journal.pone.0134041			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218426	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900071
J	Verbeke, LPC; Van den Eynden, J; Fierro, AC; Demeester, P; Fostier, J; Marchal, K				Verbeke, Lieven P. C.; Van den Eynden, Jimmy; Fierro, Ana Carolina; Demeester, Piet; Fostier, Jan; Marchal, Kathleen			Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration	PLOS ONE			English	Article							OVARIAN-CANCER; BREAST; NOTCH; PRIORITIZATION; ARCHITECTURE; KERNELS	The study of cancer, a highly heterogeneous disease with different causes and clinical outcomes, requires a multi-angle approach and the collection of large multi-omics datasets that, ideally, should be analyzed simultaneously. We present a new pathway relevance ranking method that is able to prioritize pathways according to the information contained in any combination of tumor related omics datasets. Key to the method is the conversion of all available data into a single comprehensive network representation containing not only genes but also individual patient samples. Additionally, all data are linked through a network of previously identified molecular interactions. We demonstrate the performance of the new method by applying it to breast and ovarian cancer datasets from The Cancer Genome Atlas. By integrating gene expression, copy number, mutation and methylation data, the method's potential to identify key pathways involved in breast cancer development shared by different molecular subtypes is illustrated. Interestingly, certain pathways were ranked equally important for different subtypes, even when the underlying (epi)-genetic disturbances were diverse. Next to prioritizing universally high-scoring pathways, the pathway ranking method was able to identify subtype-specific pathways. Often the score of a pathway could not be motivated by a single mutation, copy number or methylation alteration, but rather by a combination of genetic and epi-genetic disturbances, stressing the need for a network-based data integration approach. The analysis of ovarian tumors, as a function of survival-based subtypes, demonstrated the method's ability to correctly identify key pathways, irrespective of tumor subtype. A differential analysis of survival-based subtypes revealed several pathways with higher importance for the bad-outcome patient group than for the good-outcome patient group. Many of the pathways exhibiting higher importance for the bad-outcome patient group could be related to ovarian tumor proliferation and survival.	[Verbeke, Lieven P. C.; Van den Eynden, Jimmy; Fierro, Ana Carolina; Demeester, Piet; Fostier, Jan; Marchal, Kathleen] Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium; [Van den Eynden, Jimmy; Fierro, Ana Carolina; Marchal, Kathleen] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium	Ghent University; IMEC; Ghent University	Verbeke, LPC (corresponding author), Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium.	lieven.verbeke@intec.ugent.be; jan.fostier@intec.ugent.be; kathleen.marchal@intec.ugent.be	Marchal, Kathleen/O-7936-2017; Van den Eynden, Jimmy/AAB-7221-2020; Marchal, Kathleen/B-5001-2013; Fostier, Jan/A-8275-2012	Marchal, Kathleen/0000-0002-2169-4588; Van den Eynden, Jimmy/0000-0003-0002-5614; Marchal, Kathleen/0000-0002-2169-4588; Fostier, Jan/0000-0002-9994-8269	Ghent University Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'; Fonds Wetenschappelijk Onderzoek-Vlaanderen [G.0329.09]; Agentschap voor Innovatie door Wetenschap en Technologie: NEMOA; KULeuven [NATAR PF/10/010]	Ghent University Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks'(Ghent University); Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); Agentschap voor Innovatie door Wetenschap en Technologie: NEMOA; KULeuven(KU Leuven)	This work was supported by the Ghent University Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks' (http://www.nucleotides2networks.be/), Fonds Wetenschappelijk Onderzoek-Vlaanderen G.0329.09 (http://www.fwo.be/), Agentschap voor Innovatie door Wetenschap en Technologie: NEMOA (http://www.nemoa.net/), and KULeuven NATAR PF/10/010 (http://www.kuleuven.be/kuleuven/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI 10.1016/j.ygyno.2013.09.034; Attisano Liliana, 2013, F1000Prime Rep, V5, P17, DOI 10.12703/P5-17; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhattacharya D, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/716564; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Dutta B, 2012, BRIT J CANCER, V106, P1107, DOI 10.1038/bjc.2011.584; Fouss F, 2012, NEURAL NETWORKS, V31, P53, DOI 10.1016/j.neunet.2012.03.001; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Groeneweg JW, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0095-1; Gubbay O, 2006, J ENDOCRINOL, V191, P275, DOI 10.1677/joe.1.06928; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hu W, 2014, CANCER RES, V74, P3282, DOI 10.1158/0008-5472.CAN-13-2066; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lavi O, 2012, J COMPUT BIOL, V19, P694, DOI 10.1089/cmb.2012.0065; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Ng S, 2012, BIOINFORMATICS, V28, pI640, DOI 10.1093/bioinformatics/bts402; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Pham Trang T, 2013, Genes Cancer, V4, P419, DOI 10.1177/1947601913513950; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Ribeiro JR, 2014, J STEROID BIOCHEM, V143, P160, DOI 10.1016/j.jsbmb.2014.02.010; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rose SL, 2010, GYNECOL ONCOL, V117, P130, DOI 10.1016/j.ygyno.2009.12.003; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Verbeke LPC, 2013, BIOINFORMATICS, V29, P1308, DOI 10.1093/bioinformatics/btt142; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]	43	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133503	10.1371/journal.pone.0133503	http://dx.doi.org/10.1371/journal.pone.0133503			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217958	Green Published, gold			2022-12-27	WOS:000358595900033
J	Chu, PY; Walder, K; Horlock, D; Williams, D; Nelson, E; Byrne, M; Jandeleit-Dahm, K; Zimmet, P; Kaye, DM				Chu, Po-Yin; Walder, Ken; Horlock, Duncan; Williams, David; Nelson, Erin; Byrne, Melissa; Jandeleit-Dahm, Karin; Zimmet, Paul; Kaye, David M.			CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; REGULATORY T-CELLS; MYOCARDIAL-INFARCTION; DIASTOLIC FUNCTION; MELLITUS; DYSFUNCTION; CARDIOMYOPATHY; IMPACT; SPIRONOLACTONE; EPIDEMIOLOGY	Heart failure (HF) is an increasingly recognized complication of diabetes. Cardiac fibrosis is an important causative mechanism of HF associated with diabetes. Recent data indicate that inflammation may be particularly important in the pathogenesis of cardiovascular fibrosis. We sought to determine the mechanism by which cardiac fibrosis develops and to specifically investigate the role of the CXCR4 axis in this process. Animals with type I diabetes (streptozotocin treated mice) or type II diabetes (Israeli Sand-rats) and controls were randomized to treatment with a CXCR4 antagonist, candesartan or vehicle control. Additional groups of mice also underwent bone marrow transplantation (GFP+ donor marrow) to investigate the potential role of bone marrow derived cell mobilization in the pathogenesis of cardiac fibrosis. Both type I and II models of diabetes were accompanied by the development of significant cardiac fibrosis. CXCR4 antagonism markedly reduced cardiac fibrosis in both models of diabetes, similar in magnitude to that seen with candesartan. In contrast to candesartan, the anti-fibrotic actions of CXCR4 antagonism occurred in a blood pressure independent manner. Whilst the induction of diabetes did not increase the overall myocardial burden of GFP+ cells, it was accompanied by an increase in GFP+ cells expressing the fibroblast marker alpha-smooth muscle actin and this was attenuated by CXCR4 antagonism. CXCR4 antagonism was also accompanied by increased levels of circulating regulatory T cells. Taken together the current data indicate that pharmacological inhibition of CXCR4 significantly reduces diabetes induced cardiac fibrosis, providing a potentially important therapeutic approach.	[Chu, Po-Yin; Horlock, Duncan; Williams, David; Nelson, Erin; Byrne, Melissa; Kaye, David M.] Baker IDI Heart & Diabet Res Inst, Heart Failure Res Grp, Melbourne, Vic, Australia; [Walder, Ken] Deakin Univ, Sch Med, Metab Res Unit, Waurn Ponds, Vic, Australia; [Jandeleit-Dahm, Karin] Baker IDI Heart & Diabet Res Inst, Diabet Complicat Div, Melbourne, Vic, Australia; [Zimmet, Paul] Baker IDI Heart & Diabet Res Inst, Clin Diabet & Epidemiol Dept, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Deakin University	Kaye, DM (corresponding author), Baker IDI Heart & Diabet Res Inst, Heart Failure Res Grp, Melbourne, Vic, Australia.	david.kaye@bakeridi.edu.au	Zimmet, Paul/O-8486-2019; Kaye, David/AAF-1202-2021	Zimmet, Paul/0000-0003-0627-0776; Kaye, David/0000-0003-4058-0372	National Health and Medical Research Council of Australia; National Heart Foundation; Victorian Government Operational Infrastructure Scheme (OIS)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia); Victorian Government Operational Infrastructure Scheme (OIS)	This study was performed with support from the National Health and Medical Research Council of Australia, National Heart Foundation, and the Victorian Government Operational Infrastructure Scheme (OIS).	Abe T, 2002, AM J PHYSIOL-HEART C, V282, pH138, DOI 10.1152/ajpheart.2002.282.1.H138; Alberti KGMM, 2013, NAT REV ENDOCRINOL, V9, P258, DOI 10.1038/nrendo.2013.54; Amador CA, 2014, HYPERTENSION, V63, P797, DOI 10.1161/HYPERTENSIONAHA.113.02883; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Aronow WS, 2001, AM J CARDIOL, V87, P224, DOI 10.1016/S0002-9149(00)01324-2; Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Bertoni AG, 2004, DIABETES CARE, V27, P699, DOI 10.2337/diacare.27.3.699; Bodart V, 2009, BIOCHEM PHARMACOL, V78, P993, DOI 10.1016/j.bcp.2009.06.010; Chu PY, 2011, CIRC-HEART FAIL, V4, P651, DOI 10.1161/CIRCHEARTFAILURE.110.960831; Chu PY, 2010, AM J PATHOL, V176, P1735, DOI 10.2353/ajpath.2010.090574; de Simone G, 2010, J HYPERTENS, V28, P353, DOI 10.1097/HJH.0b013e3283331169; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Dhingra R, 2012, HEART FAIL CLIN, V8, P125, DOI 10.1016/j.hfc.2011.08.008; From AM, 2006, AM J MED, V119, P591, DOI 10.1016/j.amjmed.2006.05.024; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iribarren C, 2001, CIRCULATION, V103, P2668; Jie W, 2010, INT J EXP PATHOL, V91, P436, DOI 10.1111/j.1365-2613.2010.00720.x; Kaiser Nurit, 2012, Methods Mol Biol, V933, P89, DOI 10.1007/978-1-62703-068-7_7; Kanellakis P, 2011, J HYPERTENS, V29, P1820, DOI 10.1097/HJH.0b013e328349c62d; Konig A, 2012, HEART FAIL CLIN, V8, P551, DOI 10.1016/j.hfc.2012.06.001; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lewis EF, 2003, J AM COLL CARDIOL, V42, P1446, DOI 10.1016/S0735-1097(03)01057-X; Lindman BR, 2011, CIRC-HEART FAIL, V4, P286, DOI 10.1161/CIRCHEARTFAILURE.110.960039; Matsushita K, 2010, DIABETES, V59, P2020, DOI 10.2337/db10-0165; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Miric G, 2001, BRIT J PHARMACOL, V133, P687, DOI 10.1038/sj.bjp.0704131; Murcia AM, 2004, ARCH INTERN MED, V164, P2273, DOI 10.1001/archinte.164.20.2273; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Rijzewijk LJ, 2009, J AM COLL CARDIOL, V54, P1524, DOI 10.1016/j.jacc.2009.04.074; SAVAGE MP, 1988, AM J CARDIOL, V62, P665, DOI 10.1016/0002-9149(88)91199-X; Schilling JD, 2012, HEART FAIL CLIN, V8, P619, DOI 10.1016/j.hfc.2012.06.007; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Shivalkar B, 2006, AM J CARDIOL, V97, P77, DOI 10.1016/j.amjcard.2005.07.111; Walder K R, 2000, Int J Exp Diabetes Res, V1, P177, DOI 10.1155/EDR.2000.177; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	39	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133616	10.1371/journal.pone.0133616	http://dx.doi.org/10.1371/journal.pone.0133616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214690	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300024
J	Ganu, RS; Ishida, Y; Koutmos, M; Kolokotronis, SO; Roca, AL; Garrow, TA; Schook, LB				Ganu, Radhika S.; Ishida, Yasuko; Koutmos, Markos; Kolokotronis, Sergios-Orestis; Roca, Alfred L.; Garrow, Timothy A.; Schook, Lawrence B.			Evolutionary Analyses and Natural Selection of Betaine-Homocysteine S-Methyltransferase (BHMT) and BHMT2 Genes	PLOS ONE			English	Article							RAT-LIVER; DNA-SEQUENCES; PHYLOGENETIC ANALYSIS; DIETARY METHIONINE; DUPLICATED GENES; ANALYSIS TOOLS; CDNA CLONING; EXPRESSION; CHOLINE; METABOLISM	Betaine-homocysteine S-methyltransferase (BHMT) and BHMT2 convert homocysteine to methionine using betaine and S-methylmethionine, respectively, as methyl donor substrates. Increased levels of homocysteine in blood are associated with cardiovascular disease. Given their role in human health and nutrition, we identified BHMT and BHMT2 genes and proteins from 38 species of deuterostomes including human and non-human primates. We aligned the genes to look for signatures of selection, to infer evolutionary rates and events across lineages, and to identify the evolutionary timing of a gene duplication event that gave rise to two genes, BHMT and BHMT2. We found that BHMT was present in the genomes of the sea urchin, amphibians, reptiles, birds and mammals; BHMT2 was present only across mammals. BHMT and BHMT2 were present in tandem in the genomes of all monotreme, marsupial and placental species examined. Evolutionary rates were accelerated for BHMT2 relative to BHMT. Selective pressure varied across lineages, with the highest dN/dS ratios for BHMT and BHMT2 occurring immediately following the gene duplication event, as determined using GA Branch analysis. Nine codons were found to display signatures suggestive of positive selection; these contribute to the enzymatic or oligomerization domains, suggesting involvement in enzyme function. Gene duplication likely occurred after the divergence of mammals from other vertebrates but prior to the divergence of extant mammalian subclasses, followed by two deletions in BHMT2 that affect oligomerization and methyl donor specificity. The faster evolutionary rate of BHMT2 overall suggests that selective constraints were reduced relative to BHMT. The dN/dS ratios in both BHMT and BHMT2 was highest following the gene duplication, suggesting that purifying selection played a lesser role as the two paralogs diverged in function.	[Ganu, Radhika S.; Schook, Lawrence B.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Ishida, Yasuko; Roca, Alfred L.; Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Kolokotronis, Sergios-Orestis] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; [Garrow, Timothy A.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Uniformed Services University of the Health Sciences - USA; Fordham University; University of Illinois System; University of Illinois Urbana-Champaign	Schook, LB (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	schook@illinois.edu	Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Roca, Alfred/0000-0001-9217-5593; Schook, Lawrence/0000-0002-6580-8364; Koutmos, Markos/0000-0003-0933-6312	USDA/Agricultural Research Service (ARS) [AG 58-5438-7-3171]; USDA/Cooperative State Research, Education and Extension Service (CSREES) [AG 2009-34480-19875]; USDA National Institute of Food and Agriculture [ILLU-538-395, 0232734]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK 52501]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK052501, R01DK052501] Funding Source: NIH RePORTER	USDA/Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA/Cooperative State Research, Education and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support of RG and LS was provided by the USDA/Agricultural Research Service (ARS) (AG 58-5438-7-3171) and USDA/Cooperative State Research, Education and Extension Service (CSREES) (AG 2009-34480-19875). Support for AR and YI was provided by the USDA National Institute of Food and Agriculture through Hatch project ILLU-538-395 (Accession Number 0232734). Support for TG was provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK 52501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ananth CV, 2007, MOL GENET METAB, V91, P104, DOI 10.1016/j.ymgme.2007.02.004; BERGLUND L, 1990, J PERINAT MED, V18, P89, DOI 10.1515/jpme.1990.18.2.89; Breksa AP, 1999, BIOCHEMISTRY-US, V38, P13991, DOI 10.1021/bi991003v; Chadwick LH, 2000, GENOMICS, V70, P66, DOI 10.1006/geno.2000.6319; Delgado-Reyes CV, 2005, AM J PHYSIOL-REG I, V288, pR182, DOI 10.1152/ajpregu.00406.2004; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DYKHUIZEN D, 1980, GENETICS, V96, P801; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Furness D, 2013, MATERN CHILD NUTR, V9, P155, DOI 10.1111/j.1740-8709.2011.00364.x; Ganu RS, 2011, GENE, V473, P133, DOI 10.1016/j.gene.2010.11.015; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Gonzalez B, 2004, J MOL BIOL, V338, P771, DOI 10.1016/j.jmb.2004.03.005; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hague WM, 2003, BEST PRACT RES CL OB, V17, P459, DOI 10.1016/S1521-6934(03)00009-9; Hughes AL, 1999, ADAPTIVE EVOLUTION O; Jordan IK, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-22; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan AA, 2011, EVOL BIOINFORM, V7, P7, DOI 10.4137/EBO.S6179; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; KOVATSCHEVA EG, 1977, NAHRUNG, V21, P465, DOI 10.1002/food.19770210602; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YN, 1996, HUM MOL GENET, V5, P1851, DOI 10.1093/hmg/5.12.1851; Liu HH, 2010, GENOME RES, V20, P28, DOI 10.1101/gr.097212.109; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Miller CM, 2005, BIOCHEM J, V392, P443, DOI 10.1042/BJ20050356; Mizrahi EH, 2002, ISR MED ASSOC J, V4, P187; Neece DJ, 2000, GENE, V250, P31, DOI 10.1016/S0378-1119(00)00191-8; Ohno S, 1970, EVOLUTION BY GENE DU; OHTA T, 1994, GENETICS, V138, P1331; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Park EI, 1999, J BIOL CHEM, V274, P7816, DOI 10.1074/jbc.274.12.7816; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Poon AFY, 2009, METHODS MOL BIOL, V537, P163, DOI 10.1007/978-1-59745-251-9_8; Rao PV, 1998, J BIOL CHEM, V273, P30669, DOI 10.1074/jbc.273.46.30669; Refsum H, 2001, BRIT J NUTR, V85, pS109, DOI 10.1079/BJN2000302; Roca AL, 2010, ENCYCLOPEDIA OF BIOT, V1, P320; Sakamoto A, 2002, PEDIATR INT, V44, P409, DOI 10.1046/j.1442-200X.2002.01591.x; Schafer C, 2007, AM J PHYSIOL-GASTR L, V292, pG1089, DOI 10.1152/ajpgi.00088.2006; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Schrodinger LLC, 2010, THE PYMOL MOLECULAR; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Sunden SLF, 1997, ARCH BIOCHEM BIOPHYS, V345, P171, DOI 10.1006/abbi.1997.0246; SWEIRY JH, 1986, J DEV PHYSIOL, V8, P435; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; Szegedi SS, 2004, ARCH BIOCHEM BIOPHYS, V426, P32, DOI 10.1016/j.abb.2004.03.040; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Ueland P M, 1989, Nord Med, V104, P293; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Woodside JV, 2004, FOLATE HOMOCYSTEINE; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; XUE GP, 1986, COMP BIOCHEM PHYS B, V83, P115, DOI 10.1016/0305-0491(86)90340-8; XUE GP, 1985, COMP BIOCHEM PHYS B, V80, P489, DOI 10.1016/0305-0491(85)90278-0; Zanton GI, 2014, J DAIRY SCI, V97, P7085, DOI 10.3168/jds.2014-8220; Zeisel SH, 2003, J NUTR, V133, P1302; ZEISEL SH, 1995, J NUTR, V125, P3049; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	70	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134084	10.1371/journal.pone.0134084	http://dx.doi.org/10.1371/journal.pone.0134084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213999	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300048
J	Geselbracht, LL; Freeman, K; Birch, AP; Brenner, J; Gordon, DR				Geselbracht, Laura L.; Freeman, Kathleen; Birch, Anne P.; Brenner, Jorge; Gordon, Doria R.			Modeled Sea Level Rise Impacts on Coastal Ecosystems at Six Major Estuaries on Florida's Gulf Coast: Implications for Adaptation Planning	PLOS ONE			English	Article								The Sea Level Affecting Marshes Model (SLAMM) was applied at six major estuaries along Florida's Gulf Coast (Pensacola Bay, St. Andrews/Choctawhatchee Bays, Apalachicola Bay, Southern Big Bend, Tampa Bay and Charlotte Harbor) to provide quantitative and spatial information on how coastal ecosystems may change with sea level rise (SLR) and to identify how this information can be used to inform adaption planning. High resolution LiDAR-derived elevation data was utilized under three SLR scenarios: 0.7 m, 1 m and 2 m through the year 2100 and uncertainty analyses were conducted on selected input parameters at three sites. Results indicate that the extent, spatial orientation and relative composition of coastal ecosystems at the study areas may substantially change with SLR. Under the 1 m SLR scenario, total predicted impacts for all study areas indicate that coastal forest (-69,308 ha; -18%), undeveloped dry land (-28,444 ha; -2%) and tidal flat (-25,556 ha; -47%) will likely face the greatest loss in cover by the year 2100. The largest potential gains in cover were predicted for saltmarsh (+32,922 ha; +88%), transitional saltmarsh (+23,645 ha; na) and mangrove forest (+12,583 ha; +40%). The Charlotte Harbor and Tampa Bay study areas were predicted to experience the greatest net loss in coastal wetlands The uncertainty analyses revealed low to moderate changes in results when some numerical SLAMM input parameters were varied highlighting the value of collecting long-term sedimentation, accretion and erosion data to improve SLAMM precision. The changes predicted by SLAMM will affect exposure of adjacent human communities to coastal hazards and ecosystem functions potentially resulting in impacts to property values, infrastructure investment and insurance rates. The results and process presented here can be used as a guide for communities vulnerable to SLR to identify and prioritize adaptation strategies that slow and/or accommodate the changes underway.	[Geselbracht, Laura L.; Freeman, Kathleen; Birch, Anne P.; Gordon, Doria R.] Nature Conservancy, Florida Chapter, Altamonte Springs, FL 32714 USA; [Brenner, Jorge] Nature Conservancy, Texas Chapter, Corpus Christi, TX USA; [Gordon, Doria R.] Univ Florida, Dept Biol, Gainesville, FL USA	Nature Conservancy; State University System of Florida; University of Florida	Geselbracht, LL (corresponding author), Nature Conservancy, Florida Chapter, Altamonte Springs, FL 32714 USA.	lgeselbracht@tnc.org		Brenner, Jorge/0000-0002-4962-4784	US Environmental Protection Agency, Gulf of Mexico Program [MX-95463410]; Florida Department of Environmental Protection, Coastal Management Program [CM112]; National Oceanic and Atmospheric Administration [NOAA-GOMA-1001]	US Environmental Protection Agency, Gulf of Mexico Program; Florida Department of Environmental Protection, Coastal Management Program; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding was provided by the US Environmental Protection Agency, Gulf of Mexico Program, Agreement No. MX-95463410, http://www.epa.gov/gmpo/, to LG; Florida Department of Environmental Protection, Coastal Management Program, Agreement #CM112, http://www.dep.state.fl.us/cmp/default.htm, to DG; and National Oceanic and Atmospheric Administration, Grant #NOAA-GOMA-1001, http://www.noaa.gov/, to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony A, 2009, ECOL SOC, V14; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Brooks SM, 2014, J COAST CONSERV, V18, P581, DOI 10.1007/s11852-013-0279-7; Camoin GF, 2012, GEOLOGY, V40, P643, DOI 10.1130/G32057.1; Castaneda H., 2007, Florida Scientist, V70, P166; Chatterjee N., 2013, BLOOMBERG       1120; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Church J.A., 2013, CLIMATE CHANGE 2013, P1137, DOI [10.1017/CBO9781107415324.026, DOI 10.1017/CBO9781107415324.026, DOI 10.1017/CB09781107415324.026]; Clough J, 2010, SLAMM 6 0 1 BETA USE; Clough J.S., 2012, SLAMM 6 2 TECHNICAL; Corbett Catherine A., 2006, Florida Scientist, V69, P7; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Costanza R, 2007, ECOL ECON, V63, P249, DOI 10.1016/j.ecolecon.2007.03.002; Creel L., 2003, RIPPLE EFFECTS POPUL; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Davis R.A., 1997, GEOLOGY FLORIDA, P155; Desantis LRG, 2007, GLOBAL CHANGE BIOL, V13, P2349, DOI 10.1111/j.1365-2486.2007.01440.x; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Florida Natural Areas Inventory, 2010, DEV COOP LAND COV MA; Florida Ocean Alliance, 2013, FLOR OC COASTS EC CL; Frazer TK, 2002, WATER QUALITY CHARAC; Fussel HM, 2007, SUSTAIN SCI, V2, P265, DOI 10.1007/s11625-007-0032-y; Geselbracht L, 2011, CLIMATIC CHANGE, DOI [10.1007/s10584-011-0084-y, DOI 10.1007/S10584-011-0084-YAVAILABLE]; Geselbracht L, 2009, AQUAT CONSERV, V19, P408, DOI 10.1002/aqc.992; GLICK P., 2006, UNFAVORABLE TIDE GLO; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Jackson AC, 2011, J EXP MAR BIOL ECOL, V400, P314, DOI 10.1016/j.jembe.2011.02.012; Jevrejeva S, 2012, GLOBAL PLANET CHANGE, V80-81, P14, DOI 10.1016/j.gloplacha.2011.09.006; Keppner E, 2001, 004 BAY ENG STUD TEA; LEONARD LA, 1995, J COASTAL RES, V11, P322; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; McIvor A., 2012, NATURAL COASTAL PROT; McKay MD, 1999, COMPUT PHYS COMMUN, V117, P44, DOI 10.1016/S0010-4655(98)00155-6; Moretzsohn F, 2013, GULFBASE RESOURCE DA; National Ocean Service NOAA, 2011, GULF MEX GLANC 2 GLA; National Oceanic and Atmospheric Administration, TID CURR WEBS SEA LE; New York State Homes and Community Renewal, 2013, STAT NEW YORK ACT PL; Osterman LE, 2009, GEO-MAR LETT, V29, P395, DOI 10.1007/s00367-009-0159-1; Park RA, 1986, SUPPL P 1986 E SIM C, P149; Parry ML, 2007, CLIMATE CHANGE 2007; Pendleton L., 2008, EC MARKET VALUE COAS; Pfeffer WT, 2008, KINEMATIC CONSTRAINT, DOI [10.1126/science.1159099, DOI 10.1126/SCIENCE.1159099]; Pilkey Orrin H., 2009, THE RISING SEA; Rahmstorf S, 2012, ENVIRON RES LETT, V7, DOI [10.1088/1748-9326/7/4/044035, 10.1088/1748-9326/7/2/021001]; Reece JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080658; Shepard CC, 2011, NAT HAZARDS, DOI [10.1007/s11069-011-0046-8, DOI 10.1007/S11069-011-0046-8]; Stewart MG, 2011, RISK ASSESSMENT CLIM; Stutz ML, 2011, J COASTAL RES, V27, P207, DOI 10.2112/09-1190.1; Swedeen P, 2008, EARTH EC; Tanaka N, 2006, LANDSC ECOL ENG, V7, P127; The Nature Conservancy, 2013, RED CLIM RISKS NAT I; Titus J. G., 2009, COASTAL SENSITIVITY, P141; United Nations Environmental Program-World Conservation Monitoring Centre, 2006, FRONT LIN SHOR PROT; United Nations University Institute for Environment and Human Security and The Nature Conservancy, 2012, FOC ENV DEGR DIS; US Geological Survey US Environmental Protection Agency (USEPA), 2004, 855R04001 USEPA US G; USEPA, 1999, 620R98004 USEPA NAT; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Whitney E. N., 2004, PRICELESS FLORIDA NA; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361	59	30	30	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132079	10.1371/journal.pone.0132079	http://dx.doi.org/10.1371/journal.pone.0132079			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207914	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000022
J	Wang, PL; Wang, Z; Wang, DN; Tian, Y; Li, F; Zhang, SY; Zhang, L; Guo, YY; Liu, WB; Wang, CH; Chen, SG; Guo, JH				Wang, Peiliang; Wang, Zheng; Wang, Dongni; Tian, Yu; Li, Fan; Zhang, Shaoyao; Zhang, Lin; Guo, Yaoyu; Liu, Weibo; Wang, Chunhui; Chen, Shanguang; Guo, Jinhu			Altered Gravity Simulated by Parabolic Flight and Water Immersion Leads to Decreased Trunk Motion	PLOS ONE			English	Article							HEART-RATE; US ASTRONAUTS; BED REST; MICROGRAVITY; WEIGHTLESSNESS; CENTRIFUGATION; ACTIHEART; RESPONSES	Gravity is one of the important environmental factors that influence the physiologies and behaviors of animals and humans, and changes in gravity elicit a variety of physiological and behavioral alterations that include impaired movement coordination, vertigo, spatial disorientation, and perceptual illusions. To elucidate the effects of gravity on human physiology and behavior, we examined changes in wrist and trunk activities and heart rate during parabolic flight and the activity of wrist and trunk in water immersion experiments. Data from 195 person-time parabolas performed by eight subjects revealed that the trunk motion counts decreased by approximately half during ascending legs (hypergravity), relative to the data acquired before the parabolic flights. In contrast, the wrist activity remained unchanged. The results from the water immersion experiments demonstrated that in the underwater condition, both the wrist and trunk activities were significantly decreased but the latter decreased to a much lower level. Together, these data suggest that gravitational alterations can result in differential influences on the motions of the wrist and the trunk. These findings might be important for understanding the degeneration of skeleton and muscular system and performance of astronauts in microgravity.	[Wang, Peiliang; Wang, Zheng; Wang, Dongni; Zhang, Lin; Guo, Jinhu] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Minist Educ,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Yu; Li, Fan; Zhang, Shaoyao; Guo, Yaoyu; Liu, Weibo; Wang, Chunhui; Chen, Shanguang] China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences	Guo, JH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Minist Educ,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.	guojinhu@mail.sysu.edu.cn	ZHANG, LIN/GYD-9123-2022; zhan, lin/AAP-5149-2020		National Basic Program of China [2011CB711000, 2012CB947600]; National Natural Science Foundation of China [31171119, 71201148]; New Century Training Program Foundation for the Talents by the State Education Commission [NCET-12-0566]	National Basic Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Training Program Foundation for the Talents by the State Education Commission	This work was supported by the National Basic Program of China (2011CB711000, 2012CB947600, http://most.gov.cn/), the National Natural Science Foundation of China (31171119, 71201148, http://www.nsfc.gov.cn/), the New Century Training Program Foundation for the Talents by the State Education Commission (NCET-12-0566, http://www.moe.edu.cn/).	Beckers F, 2003, EUR J APPL PHYSIOL, V90, P83, DOI 10.1007/s00421-003-0854-y; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; CLEMENT G, 1988, EXP BRAIN RES, V72, P381; Dalecki M, 2012, EXP BRAIN RES, V218, P41, DOI 10.1007/s00221-012-2999-6; De Witt JK, 2010, AVIAT SPACE ENVIR MD, V81, P1092, DOI 10.3357/ASEM.2413.2010; DIETZ V, 1992, EXP BRAIN RES, V89, P229; DUDDY JH, 1969, HUM FACTORS, V11, P507, DOI 10.1177/001872086901100509; Grabherr L, 2010, J VESTIBUL RES-EQUIL, V20, P53, DOI 10.3233/VES-2010-0364; GREENLEAF JE, 1989, J APPL PHYSIOL, V67, P2191, DOI 10.1152/jappl.1989.67.6.2191; Guo JH, 2014, MILITARY MED RES, V1, DOI 10.1186/2054-9369-1-23; Hecht H, 2001, J VESTIBUL RES-EQUIL, V11, P115; Hides JA, 2011, EUR SPINE J, V20, P808, DOI 10.1007/s00586-010-1491-x; Holley DC, 2003, J APPL PHYSIOL, V95, P1266, DOI 10.1152/japplphysiol.00707.2002; Johnston SL, 2010, AVIAT SPACE ENVIR MD, V81, P566, DOI 10.3357/ASEM.2427.2010; LATHERS CM, 1990, J CLIN PHARMACOL, V30, P494, DOI 10.1002/j.1552-4604.1990.tb03614.x; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; Liang XD, 2014, BIOL RHYTHM RES, V45, P591, DOI 10.1080/09291016.2014.882093; Liang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047984; Liu ZZ, 2015, LIFE SCI SPACE RES, V4, P62, DOI 10.1016/j.lssr.2015.01.001; Masumoto K, 2005, EUR J APPL PHYSIOL, V94, P54, DOI 10.1007/s00421-004-1288-x; McPhee J. C., 2009, HUMAN HLTH PERFORMAN; Melzer K., 2012, E SPEN J, V7, pe5, DOI [10.1016/j.eclnm.2011.12.008, DOI 10.1016/J.ECLNM.2011.12.008]; Mori S, 1995, Nagoya J Med Sci, V58, P71; Osborne JR, 2014, MICROGRAVITY SCI TEC, V26, P11, DOI 10.1007/s12217-014-9365-1; Pletser V, 2004, ACTA ASTRONAUT, V55, P829, DOI 10.1016/j.actaastro.2004.04.006; Putcha L, 1999, AVIAT SPACE ENVIR MD, V70, P705; Ruttkay-Nedecky I, 1977, Act Nerv Super (Praha), V19 Suppl 2, P391; Sayson JV, 2008, AVIAT SPACE ENVIR MD, V79, P365, DOI 10.3357/ASEM.1994.2008; Somody L, 1998, LIFE SCI, V63, P851, DOI 10.1016/S0024-3205(98)00342-7; Takken T, 2010, EUR J CLIN NUTR, V64, P1494, DOI 10.1038/ejcn.2010.196; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; TROUT OF, 1969, HUM FACTORS, V11, P473, DOI 10.1177/001872086901100507; Verheyden B, 2005, EUR J APPL PHYSIOL, V95, P557, DOI 10.1007/s00421-005-0016-5; Verheyden B, 2009, RESP PHYSIOL NEUROBI, V169, pS13, DOI 10.1016/j.resp.2009.03.008; Wang D, 2014, SCI HUMAN PERFORMA S, P15; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415	36	1	1	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133398	10.1371/journal.pone.0133398	http://dx.doi.org/10.1371/journal.pone.0133398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208253	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000086
J	Wu, Y; Sun, Y; Shen, K; Sun, S; Wang, J; Jiang, TT; Cao, S; Josiah, SM; Pang, JS; Lin, XY; Liu, B				Wu, Ying; Sun, Yue; Shen, Kun; Sun, Shuai; Wang, Jie; Jiang, Tingting; Cao, Shuai; Josiah, Samuel Manthi; Pang, Jinsong; Lin, Xiuyun; Liu, Bao			Immediate Genetic and Epigenetic Changes in F1 Hybrids Parented by Species with Divergent Genomes in the Rice Genus (Oryza)	PLOS ONE			English	Article							TERMINAL REPEAT ELEMENT; CYTOSINE METHYLATION; DNA METHYLATION; WIDE HYBRIDIZATION; RETROTRANSPOSON; WHEAT; ELIMINATION; ALLOPOLYPLOIDY; SATIVA; INTROGRESSION	Background Inter-specific hybridization occurs frequently in higher plants, and represents a driving force of evolution and speciation. Inter-specific hybridization often induces genetic and epigenetic instabilities in the resultant homoploid hybrids or allopolyploids, a phenomenon known as genome shock. Although genetic and epigenetic consequences of hybridizations between rice subspecies (e.g., japonica and indica) and closely related species sharing the same AA genome have been extensively investigated, those of inter-specific hybridizations between more remote species with different genomes in the rice genus, Oryza, remain largely unknown. Methodology/Principal Findings We investigated the immediate chromosomal and molecular genetic/epigenetic instability of three triploid F1 hybrids produced by inter-specific crossing between species with divergent genomes of Oryza by genomic in situ hybridization (GISH) and molecular marker analysis. Transcriptional and transpositional activity of several transposable elements (TEs) and methylation stability of their flanking regions were also assessed. We made the following principle findings: (i) all three triploid hybrids are stable in both chromosome number and gross structure; (ii) stochastic changes in both DNA sequence and methylation occurred in individual plants of all three triploid hybrids, but in general methylation changes occurred at lower frequencies than genetic changes; (iii) alteration in DNA methylation occurred to a greater extent in genomic loci flanking potentially active TEs than in randomly sampled loci; (iv) transcriptional activation of several TEs commonly occurred in all three hybrids but transpositional events were detected in a genetic context-dependent manner. Conclusions/Significance Artificially constructed inter-specific hybrids of remotely related species with divergent genomes in genus Oryza are chromosomally stable but show immediate and highly stochastic genetic and epigenetic instabilities at the molecular level. These novel hybrids might provide a rich resource of genetic and epigenetic diversities for potential utilization in rice genetic improvements.	[Wu, Ying; Sun, Yue; Shen, Kun; Sun, Shuai; Wang, Jie; Jiang, Tingting; Cao, Shuai; Josiah, Samuel Manthi; Pang, Jinsong; Lin, Xiuyun; Liu, Bao] NE Normal Univ, MOE, Key Lab Mol Epigenet, Changchun, Peoples R China; [Wu, Ying; Sun, Yue; Shen, Kun; Sun, Shuai; Wang, Jie; Jiang, Tingting; Cao, Shuai; Josiah, Samuel Manthi; Pang, Jinsong; Lin, Xiuyun; Liu, Bao] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Lin, Xiuyun] Jilin Acad Agr Sci, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Jilin Academy of Agricultural Sciences	Lin, XY (corresponding author), NE Normal Univ, MOE, Key Lab Mol Epigenet, Changchun, Peoples R China.	linxiuyun1965@163.com; baoliu@nenu.edu.cn		Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	National Natural Science Foundation of China [31290210, 11301064]; S & T Agency of Jilin Province [20140101014JC]; Program for Introducing Talents to Universities [B07017]; Graduate Student Innovation Fund of Northeast Normal University [12SSXT130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); S & T Agency of Jilin Province; Program for Introducing Talents to Universities; Graduate Student Innovation Fund of Northeast Normal University	This work was supported by the National Natural Science Foundation of China (31290210, 11301064), a project from the S & T Agency of Jilin Province (20140101014JC), the Program for Introducing Talents to Universities (B07017), and the Graduate Student Innovation Fund of Northeast Normal University (12SSXT130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Bimpong I. K., 2011, International Journal of Genetics and Molecular Biology, V3, P7; Chen LZ, 2008, GENOME, V51, P789, DOI 10.1139/G08-063; Chodavarapu RK, 2012, P NATL ACAD SCI USA, V109, P12040, DOI 10.1073/pnas.1209297109; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Feldman M, 1997, GENETICS, V147, P1381; Feldman M, 2009, J GENET GENOMICS, V36, P511, DOI 10.1016/S1673-8527(08)60142-3; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gao LH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-18; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Han FP, 2004, THEOR APPL GENET, V109, P1070, DOI 10.1007/s00122-004-1720-y; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hegarty MJ, 2011, MOL ECOL, V20, P105, DOI 10.1111/j.1365-294X.2010.04926.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jiang BA, 2011, PLANT MOL BIOL, V77, P225, DOI 10.1007/s11103-011-9804-y; Jiang N, 2002, PLANT PHYSIOL, V130, P1697, DOI 10.1104/pp.015412; Jiang N, 2002, GENETICS, V161, P1293; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Jin HJ, 2008, THEOR APPL GENET, V117, P1271, DOI 10.1007/s00122-008-0861-9; Kawakami T, 2011, GENOME BIOL EVOL, V3, P156, DOI 10.1093/gbe/evr005; Khasdan V, 2010, GENETICS, V185, P387, DOI 10.1534/genetics.110.116178; Kraitshtein Z, 2010, GENETICS, V186, P801, DOI 10.1534/genetics.110.120790; Li H, 2010, J GENET GENOMICS, V37, P703, DOI 10.1016/S1673-8527(09)60088-6; Lin XY, 2006, J EXP BOT, V57, P2313, DOI 10.1093/jxb/erj203; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Liu ZL, 2004, PLANT MOL BIOL, V54, P571, DOI 10.1023/B:PLAN.0000038270.48326.7a; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Parisod C, 2009, NEW PHYTOL, V184, P1003, DOI 10.1111/j.1469-8137.2009.03029.x; Picault N, 2009, PLANT J, V58, P754, DOI 10.1111/j.1365-313X.2009.03813.x; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Senerchia N, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2874; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Tan GX, 2005, THEOR APPL GENET, V111, P1585, DOI 10.1007/s00122-005-0090-4; Ungerer MC, 2006, CURR BIOL, V16, pR872, DOI 10.1016/j.cub.2006.09.020; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074479; Wu Y, 2016, J INTEGR PLANT BIOL, V58, P150, DOI 10.1111/jipb.12357; Xu Chunming, 2014, Mol Biol Evol, V31, P1066, DOI 10.1093/molbev/msu085; Yaakov B, 2012, PLANT MOL BIOL, V80, P419, DOI 10.1007/s11103-012-9957-3; Yang GJ, 2007, P NATL ACAD SCI USA, V104, P10962, DOI 10.1073/pnas.0702080104; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P3447, DOI 10.1073/pnas.1300153110; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao N, 2011, GENETICS, V188, P499, DOI 10.1534/genetics.111.127688	61	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132911	10.1371/journal.pone.0132911	http://dx.doi.org/10.1371/journal.pone.0132911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208215	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000045
J	Amaral, SV; Forte, T; Ramalho-Santos, J; da Cruz, MTG				Amaral, Sara Varela; Forte, Teresa; Ramalho-Santos, Joao; Teresa Girao da Cruz, M.			I Want More and Better Cells! - An Outreach Project about Stem Cells and Its Impact on the General Population	PLOS ONE			English	Article							SCIENCE COMMUNICATION; PUBLIC SUPPORT	Although science and technology impact every aspect of modern societies, there is still an extensive gap between science and society, which impairs the full exercise of citizenship. In the particular case of biomedical research increased investment should be accompanied by parallel efforts in terms of public information and engagement. We have carried out a project involving the production and evaluation of educational contents focused on stem cells - illustrated newspaper chronicles, radio interviews, a comic book, and animated videos - and monitored their impact on the Portuguese population. The study of the outreach materials in a heterogeneous sample of the population suggests that they are valuable tools to disseminate scientific messages, and that this is especially true for the comic-book format. Furthermore, the data showed that clear and stimulating outreach materials, that are able to teach new concepts and to promote critical thinking, increase engagement in science at different levels, depending on the depth of the concepts involved. Additionally, these materials can influence political, social and personal attitudes toward science. These results, together with the importance attributed to scientific research in stem cells by the population sampled, validates the diffusion of such materials as a significant contribution towards an overall public understanding and engagement in contemporary science, and this strategy should thus be considered in future projects. Regardless, stringent quality control must be implemented in order to efficiently communicate accurate scientific developments, and the public stimulated in terms of finding additional sources of reliable information.	[Amaral, Sara Varela; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Amaral, Sara Varela; Ramalho-Santos, Joao; Teresa Girao da Cruz, M.] Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, Coimbra, Portugal; [Forte, Teresa] Univ Coimbra, Fac Psychol & Educ Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	da Cruz, MTG (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, Coimbra, Portugal.	mtgirao@cnc.uc.pt	Amaral, Sara/AAX-8956-2021; da Cruz, Maria Teresa Girão/D-8576-2011; Ramalho-Santos, João/F-8641-2012; Santos, João/HHZ-5595-2022	da Cruz, Maria Teresa Girão/0000-0003-2625-2567; Ramalho-Santos, João/0000-0002-1172-4018; Forte, Teresa/0000-0003-3817-7410; Varela Amaral, Sara/0000-0001-9514-4696				Allen S, 2009, FRAMEWORK EVALUATING; [Anonymous], 2013, HOP HYP SCOTT STEM C; [Anonymous], 2013, WHAT ARE STEM CELLS; Barros A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096672; Bauer M.W., 2014, MODERN PORTUGAL ITS; Besley JC, 2015, J RES SCI TEACH, V52, P199, DOI 10.1002/tea.21186; Bodmer W., 1985, PUBLIC UNDERST SCI; Burns TW, 2003, PUBLIC UNDERST SCI, V12, P183, DOI 10.1177/09636625030122004; Cambridge Science Festival, 2014, CAMBR SCI FEST; Carvalho AS, 2013, EUR J HUM GENET, V21, P591, DOI 10.1038/ejhg.2012.232; Dench S, 2000, LEARNING LATER LIFE; Dire&ccedil;&atilde;ao-Geral de Estat&iacute;sticas de Educa&ccedil;&atilde;o eCi&ecirc;ncia, 2014, PROD CIENT PORT 1990; DURANT JR, 1989, NATURE, V340, P11, DOI 10.1038/340011a0; EC, 2002, SCI SOC ACT PLAN; European-Commission, 2007, PUBL ENG SCI REP SCI; European-Commission, 2008, FLASH EUR 239 YOUNG; European-Commission, 2009, MASIS REP CHALL FUT; European-Commission, 2010, SPEC EUR 340 SCI TEC; European-Commission, 2013, EUR 79 2 RESP RES IN; Fischhoff B, 2013, P NATL ACAD SCI USA, V110, P14033, DOI 10.1073/pnas.1213273110; Greco P, 2003, J SCI COMMUNICATION; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Irwin A, 2001, PUBLIC UNDERST SCI, V10, P1, DOI 10.1088/0963-6625/10/1/301; Kemp E, 2015, EMBO REP, V16, P7, DOI 10.15252/embr.201439398; Kim A, 2004, EDUC GERONTOL, V30, P441, DOI 10.1080/03601270490445069; Kouper I, 2010, JCOM-J SCI COMMUN, V9; Leao MJ, 2012, EMBO REP, V13, P954, DOI 10.1038/embor.2012.151; Lee O, 1997, J RES SCI TEACH, V34, P219; Liu H, 2009, PUBLIC UNDERST SCI, V18, P704, DOI 10.1177/0963662508097625; Macleod K, 2012, HOPE HYPE STORY STEM; NIH, 2001, STEM CELLS SCI PROGR; Nisbet MC, 2009, AM J BOT, V96, P1767, DOI 10.3732/ajb.0900041; Nisbet MC, 2005, INT J PUBLIC OPIN R, V17, P90, DOI 10.1093/ijpor/edh058; Obliger JL, 2008, ED NET GENERATION; Pestana M. H., 2014, ANALISE DADOS CIENCI, V6; Pinto B, 2013, PUBLIC UNDERST SCI, V0, P1; Ramalho-Santos J, 2013, CELULAS ESTAMINAIS Q; Ramalho-Santos J, 2013, UMA AVENTURA ESTAMIN; Redey S, 2006, SCI PUBLIC DIMENSION, P75; Semir V, 2012, TOOLKIT IMPACT ASSES; Sutton M, 2007, S AFR J SCI, V9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakeford T, 2004, DEMOCRATISING TECHNO	44	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133753	10.1371/journal.pone.0133753	http://dx.doi.org/10.1371/journal.pone.0133753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222053	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800063
J	Cerina, F; Zhu, Z; Chessa, A; Riccaboni, M				Cerina, Federica; Zhu, Zhen; Chessa, Alessandro; Riccaboni, Massimo			World Input-Output Network	PLOS ONE			English	Article							INTERNATIONAL-TRADE; GROWTH	Production systems, traditionally analyzed as almost independent national systems, are increasingly connected on a global scale. Only recently becoming available, the World Input-Output Database (WIOD) is one of the first efforts to construct the global multi-regional input-output (GMRIO) tables. By viewing the world input-output system as an interdependent network where the nodes are the individual industries in different economies and the edges are the monetary goods flows between industries, we analyze respectively the global, regional, and local network properties of the so-called world input-output network (WION) and document its evolution over time. At global level, we find that the industries are highly but asymmetrically connected, which implies that micro shocks can lead to macro fluctuations. At regional level, we find that the world production is still operated nationally or at most regionally as the communities detected are either individual economies or geographically well defined regions. Finally, at local level, for each industry we compare the network-based measures with the traditional methods of backward linkages. We find that the network-based measures such as PageRank centrality and community coreness measure can give valuable insights into identifying the key industries.	[Cerina, Federica; Chessa, Alessandro] Complex Syst Computat Lab, Linkalab, Cagliari, Italy; [Cerina, Federica] Univ Cagliari, Dept Phys, Cagliari, Italy; [Zhu, Zhen; Chessa, Alessandro; Riccaboni, Massimo] IMT Inst Adv Studies Lucca, Lucca, Italy; [Riccaboni, Massimo] Katholieke Univ Leuven, Dept Managerial Econ Strategy & Innovat, Leuven, Belgium	University of Cagliari; IMT School for Advanced Studies Lucca; KU Leuven	Zhu, Z (corresponding author), IMT Inst Adv Studies Lucca, Lucca, Italy.	zhen.zhu@imtlucca.it	Zhu, Zhen/AAN-9861-2020	Zhu, Zhen/0000-0003-0258-1454; RICCABONI, Massimo/0000-0003-4979-8933	Ministry of Education, Universities and Research (MIUR)-the Basic Research Investment Fund (FIRB) [RBFR12BA3Y]; "ViWaN: The Global Virtual Water Network" project; Future Emerging Technologies (FET) [317532, 610704]; National Research Project (PNR) project CRISIS Lab; Sardinia Regional Government; Linkalab	Ministry of Education, Universities and Research (MIUR)-the Basic Research Investment Fund (FIRB)(Ministry of Education, Universities and Research (MIUR)); "ViWaN: The Global Virtual Water Network" project; Future Emerging Technologies (FET); National Research Project (PNR) project CRISIS Lab; Sardinia Regional Government(Regione Sardegna); Linkalab	M.R. and Z.Z. acknowledge funding from the Ministry of Education, Universities and Research (MIUR)-the Basic Research Investment Fund (FIRB) project RBFR12BA3Y and from the "ViWaN: The Global Virtual Water Network" project. All authors acknowledge support from the Future Emerging Technologies (FET) projects MULTIPLEX 317532 and SIMPOL 610704 and the National Research Project (PNR) project CRISIS Lab. F.C. acknowledges Sardinia Regional Government for the financial support of her PhD scholarship (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013-Axis IV Human Resources, Objective l.3, Line of Activity l.3.1.). Linkalab provided support in the form of salaries for authors F.C. and A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], ARXIV14080443; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; Blochl F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046127; Buchanan M., 2010, NETWORKS CELL BIOL; Caldarelli G, 2013, NAT PHYS, V9, P125, DOI 10.1038/nphys2580; Carvalho VM, 2013, SURVEY PAPER RECENT; Chessa A, 2013, SCIENCE, V339, P650, DOI 10.1126/science.1227970; Contreras MGA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062812; De Benedictis L, 2011, WORLD ECON, V34, P1417, DOI 10.1111/j.1467-9701.2011.01360.x; De Leo V, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042810; DIETZENBACHER E, 1992, ECON MODEL, V9, P419, DOI 10.1016/0264-9993(92)90022-T; Emmerich T, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062806; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gabaix X, 2011, J BUS ECON STAT, V29, P24, DOI 10.1198/jbes.2009.06157; Gabaix X, 2009, ANNU REV ECON, V1, P255, DOI 10.1146/annurev.economics.050708.142940; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; GHOSH A, 1958, ECONOMICA, V25, P58, DOI 10.2307/2550694; Johnson RC, 2014, AM ECON J-MACROECON, V6, P39, DOI 10.1257/mac.6.4.39; Kitsak M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036117; Koopman R, 2014, AM ECON REV, V104, P459, DOI 10.1257/aer.104.2.459; KUZNETS S, 1973, AM ECON REV, V63, P247; Kuznets S, 1957, ECON DEV CULT CHANGE, V5, P1, DOI [10.1086/449740, DOI 10.1086/449740]; LAUMAS PS, 1976, Q J ECON, V90, P308, DOI 10.2307/1884632; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Lenzen M, 2013, ECOL ECON, V94, P78, DOI 10.1016/j.ecolecon.2013.06.018; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Lenzen M, 2012, ENVIRON SCI TECHNOL, V46, P8374, DOI 10.1021/es300171x; Leontief WW, 1936, REV ECON STATISTICS, V18, P105, DOI 10.2307/1927837; Lopez-Gonzalez J, 2013, SUPPLY CHAIN TRADE P; McNerney J, 2013, PHYSICA A, V392, P6427, DOI 10.1016/j.physa.2013.07.063; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Pammolli F, 2002, SMALL BUS ECON, V19, P205, DOI 10.1023/A:1019682612073; Rasmussen P, 1956, STUDIES INTERSECTORA; Riccaboni M, 2013, J ECON INTERACT COOR, V8, P33, DOI 10.1007/s11403-012-0101-x; Riccaboni M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/2/023003; Schiavo S, 2014, J COMPLEX N IN PRESS, DOI [10.1093/comnet/cnu025, DOI 10.1093/C0MNET/CNU025]; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Sufrauj S, 2015, EC POLITICA, P1; Timmer M., 2012, IIDE DISCUSSION PAPE; Timmer MP, 2013, ECON POLICY, V28, P613, DOI 10.1111/1468-0327.12018; Tukker A, 2013, ECON SYST RES, V25, P1, DOI 10.1080/09535314.2012.761179; Wiedmann T, 2011, ECOL ECON, V70, P1937, DOI 10.1016/j.ecolecon.2011.06.014; Wiedmann TO, 2013, SCIENCES; Zhu Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126699; Zhu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105496	50	93	94	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134025	10.1371/journal.pone.0134025	http://dx.doi.org/10.1371/journal.pone.0134025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222389	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000358836800096
J	Chiodini, RJ; Dowd, SE; Chamberlin, WM; Galandiuk, S; Davis, B; Glassing, A				Chiodini, Rodrick J.; Dowd, Scot E.; Chamberlin, William M.; Galandiuk, Susan; Davis, Brian; Glassing, Angela			Microbial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn's Disease of the Ileum	PLOS ONE			English	Article							BILOPHILA-WADSWORTHIA; RUMEN	Since Crohn's disease is a transmural disease, we hypothesized that examination of deep submucosal tissues directly involved in the inflammatory disease process may provide unique insights into bacterial populations transgressing intestinal barriers and bacterial populations more representative of the causes and agents of the disease. We performed deep 16s microbiota sequencing on isolated ilea mucosal and submucosal tissues on 20 patients with Crohn's disease and 15 non-inflammatory bowel disease controls with a depth of coverage averaging 81,500 sequences in each of the 70 DNA samples yielding an overall resolution down to 0.0001% of the bacterial population. Of the 4,802,328 total sequences generated, 98.9% or 4,749,183 sequences aligned with the Kingdom Bacteria that clustered into 8545 unique sequences with <3% divergence or operational taxonomic units enabling the identification of 401 genera and 698 tentative bacterial species. There were significant differences in all taxonomic levels between the submucosal microbiota in Crohn's disease compared to controls, including organisms of the Order Desulfovibrionales that were present within the submucosal tissues of most Crohn's disease patients but absent in the control group. A variety of organisms of the Phylum Firmicutes were increased in the subjacent submucosa as compared to the parallel mucosal tissue including Ruminococcus spp., Oscillospira spp., Pseudobutyrivibrio spp., and Tumebacillus spp. In addition, Propionibacterium spp. and Cloacibacterium spp. were increased as well as large increases in Proteobacteria including Parasutterella spp. and Methylobacterium spp. This is the first study to examine the microbial populations within submucosal tissues of patients with Crohn's disease and to compare microbial communities found deep within the submucosal tissues with those present on mucosal surfaces. Our data demonstrate the existence of a distinct submucosal microbiome and ecosystem that is not well reflected in the mucosa and/or downstream fecal material.	[Chiodini, Rodrick J.; Chamberlin, William M.] St Vincent Healthcare, Sisters Charity Leavenworth Hlth Syst, Billings, MT 59101 USA; [Chiodini, Rodrick J.; Glassing, Angela] Montana State Univ, Dept Biol & Phys Sci, Billings, MT USA; [Dowd, Scot E.] Mr DNA Mol Res Lab, Shallowater, TX USA; [Galandiuk, Susan] Univ Louisville, Dept Surg, Louisville, KY 40292 USA; [Davis, Brian] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, Paul L Foster Sch Med, El Paso, TX USA	Montana State University System; Montana State University Billings; Montana State University Bozeman; University of Louisville; Texas Tech University System; Texas Tech University	Chiodini, RJ (corresponding author), St Vincent Healthcare, Sisters Charity Leavenworth Hlth Syst, Billings, MT 59101 USA.	rodrick.chiodini@msubillings.edu	Davis, Brian/T-5148-2019; Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427	Broad Medical Research Program (BMRP-CCFA Proposal) [335929 IBD-0381]; State of Montana, Montana Department of Commerce Biomedical Research Grant [14-51-BMR-002]; St. Vincent Healthcare; Montana State University-Billings	Broad Medical Research Program (BMRP-CCFA Proposal); State of Montana, Montana Department of Commerce Biomedical Research Grant; St. Vincent Healthcare; Montana State University-Billings	Supported in part by grants from the Broad Medical Research Program (BMRP-CCFA Proposal No. 335929 IBD-0381) (http://www.ccfa.org/science-and-professionals/broad/); State of Montana, Montana Department of Commerce Biomedical Research Grant (14-51-BMR-002) (http://commerce.mt.gov/); St. Vincent Healthcare (http://www.svh-mt.org/); and Montana State University-Billings (http://www.msubillings.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Ballester JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062107; Baron EJ, 1997, ANAEROBE, V3, P83, DOI 10.1006/anae.1997.0075; BARON EJ, 1992, J CLIN MICROBIOL, V30, P1882, DOI 10.1128/JCM.30.7.1882-1884.1992; Burcelin R, 2013, DIABETES OBES METAB, V15, P61, DOI 10.1111/dom.12157; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Chiodini RJ, 2013, J CLIN GASTROENTEROL, V47, P612, DOI 10.1097/MCG.0b013e31827b4f94; D'Argenio V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/325340; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gutierrez A, 2014, GUT, V63, P272, DOI 10.1136/gutjnl-2012-303557; Haag LM, 2014, BEST PRACT RES CL GA, V28, P399, DOI 10.1016/j.bpg.2014.04.001; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Janowitz HD, 1998, INFLAMM BOWEL DIS, V4, P29, DOI 10.1097/00054725-199802000-00006; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Liu JZ, 2014, BEST PRACT RES CL GA, V28, P373, DOI 10.1016/j.bpg.2014.04.009; Martinez-Medina Margarita, 2014, World J Gastrointest Pathophysiol, V5, P213, DOI 10.4291/wjgp.v5.i3.213; McInnes P, 2010, HUMAN MICROBIOME PRO; McOrist AL, 2001, J CLIN MICROBIOL, V39, P1577, DOI 10.1128/JCM.39.4.1577-1579.2001; Nagalingam NA, 2012, INFLAMM BOWEL DIS, V18, P968, DOI 10.1002/ibd.21866; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Williams WL, 2010, J DAIRY SCI, V93, P4735, DOI 10.3168/jds.2009-2920; Winter SE, 2014, GUT MICROBES, V5, P71, DOI 10.4161/gmic.27129; Winter SE, 2014, CELL MICROBIOL, V16, P179, DOI 10.1111/cmi.12245	29	92	94	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134382	10.1371/journal.pone.0134382	http://dx.doi.org/10.1371/journal.pone.0134382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222621	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800138
J	Gariboldi, MC; Tunez, JI; Dejean, CB; Failla, M; Vitullo, AD; Negri, MF; Cappozzo, HL				Constanza Gariboldi, Maria; Ignacio Tunez, Juan; Beatriz Dejean, Cristina; Failla, Mauricio; Daniel Vitullo, Alfredo; Fernanda Negri, Maria; Luis Cappozzo, Humberto			Population Genetics of Franciscana Dolphins (Pontoporia blainvillei): Introducing a New Population from the Southern Edge of Their Distribution	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; TIME DEPENDENCY; NORTH-ATLANTIC; MITOCHONDRIAL; DIFFERENTIATION; CONSERVATION; WHALES; GROWTH; FLOW	Due to anthropogenic factors, the franciscana dolphin, Pontoporia blainvillei, is the most threatened small cetacean on the Atlantic coast of South America. Four Franciscana Management Areas have been proposed: Espiritu Santo to Rio de Janeiro (FMA I), Sao Paulo to Santa Catarina (FMA II), Rio Grande do Sul to Uruguay (FMA III), and Argentina (FMA IV). Further genetic studies distinguished additional populations within these FMAs. We analyzed the population structure, phylogeography, and demographic history in the southernmost portion of the species range. From the analysis of mitochondrial DNA control region sequences, 5 novel haplotypes were found, totalizing 60 haplotypes for the entire distribution range. The haplotype network did not show an apparent phylogeographical signal for the southern FMAs. Two populations were identified: Monte Hermoso (MH) and Necochea (NC)+Claromeco (CL)+Rio Negro (RN). The low levels of genetic variability, the relative constant size over time, and the low levels of gene flow may indicate that MH has been colonized by a few maternal lineages and became isolated from geographically close populations. The apparent increase in NC+CL+RN size would be consistent with the higher genetic variability found, since genetic diversity is generally higher in older and expanding populations. Additionally, RN may have experienced a recent split from CL and NC; current high levels of gene flow may be occurring between the latter ones. FMA IV would comprise four franciscana dolphin populations: Samborombon West+Samborombon South, Cabo San Antonio+Buenos Aires East, NC+CL+Buenos Aires Southwest+RN and MH. Results achieved in this study need to be taken into account in order to ensure the long-term survival of the species.	[Constanza Gariboldi, Maria; Beatriz Dejean, Cristina; Daniel Vitullo, Alfredo; Luis Cappozzo, Humberto] Univ Maimonides, CEBBAD, Buenos Aires, DF, Argentina; [Constanza Gariboldi, Maria; Ignacio Tunez, Juan; Daniel Vitullo, Alfredo; Fernanda Negri, Maria; Luis Cappozzo, Humberto] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Ignacio Tunez, Juan] Univ Nacl Lujan, Dept Ciencias Basicas, Grp Estud Ecol Mamiferos, Lujan, Argentina; [Beatriz Dejean, Cristina] Univ Buenos Aires, Fac Filosofia & Letras, ICA, Secc Antropol Biol, Buenos Aires, DF, Argentina; [Beatriz Dejean, Cristina; Luis Cappozzo, Humberto] Univ Maimonides, Fdn Azara, Buenos Aires, DF, Argentina; [Failla, Mauricio] Fdn Cethus, Buenos Aires, DF, Argentina; [Fernanda Negri, Maria; Luis Cappozzo, Humberto] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Ecol Comportamiento & Mamiferos Marinos, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Lujan; University of Buenos Aires; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Gariboldi, MC (corresponding author), Univ Maimonides, CEBBAD, Buenos Aires, DF, Argentina.	gariboldi.constanza@maimonides.edu	Vitullo, Alfredo/F-9744-2015; Dejean, Cristina/AAM-1408-2021	Vitullo, Alfredo/0000-0002-4833-5147; 	Fundacion Cientifica Felipe Fiorellino, Buenos Aires, Argentina; Fundacion Cethus, Buenos Aires, Argentina; Organization of the American States; Western Hemispheric Migratoty Species Initiative; Rufford Foundation; Whale and Dolphin Conservation	Fundacion Cientifica Felipe Fiorellino, Buenos Aires, Argentina; Fundacion Cethus, Buenos Aires, Argentina; Organization of the American States; Western Hemispheric Migratoty Species Initiative; Rufford Foundation; Whale and Dolphin Conservation	Funding was provided by Fundacion Cientifica Felipe Fiorellino, Buenos Aires, Argentina; Fundacion Cethus, Buenos Aires, Argentina; Organization of the American States; Western Hemispheric Migratoty Species Initiative; Rufford Foundation; and Whale and Dolphin Conservation.	Adams LD, 2006, MAR BIOL, V148, P671, DOI 10.1007/s00227-005-0094-2; [Anonymous], 2010, LATIN AM J AQUAT MAM, DOI DOI 10.5597/lajam00155; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berggren P, 2002, BIOL CONSERV, V103, P313, DOI 10.1016/S0006-3207(01)00142-2; Bordino P, 2013, ENDANGER SPECIES RES, V21, P1, DOI 10.3354/esr00503; Bordino P, 2002, MAR MAMMAL SCI, V18, P833, DOI 10.1111/j.1748-7692.2002.tb01076.x; Bordino P, 2008, INT WHAL COMM SCI CO; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Cappozzo Humberto L., 2007, Latin American Journal of Aquatic Mammals, V6, P127; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen L, 2010, MAR BIOL, V157, P1453, DOI 10.1007/s00227-010-1420-x; Costa-Urrutia P, 2012, J HERED, V103, P92, DOI 10.1093/jhered/esr103; Crespo EA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P466; Crespo EA, 2010, MAR MAMMAL SCI, V26, P17, DOI 10.1111/j.1748-7692.2009.00313.x; Crespo Enrique Alberto, 1994, Reports of the International Whaling Commission Special Issue, V15, P269; Cunha HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085633; Di Beneditto Ana Paula Madeira, 2003, Latin American Journal of Aquatic Mammals, V2, P79; DIZON AE, 1992, CONSERV BIOL, V6, P24, DOI 10.1046/j.1523-1739.1992.610024.x; Donovan GP, 1995, REPORT INT WHALING C, P378; Dornburg A, 2012, MOL BIOL EVOL, V29, P721, DOI 10.1093/molbev/msr228; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Failla M., 2004, 56 ANN M SCI COMM IN; Failla Mauricio, 2012, Marine Biodiversity Records, V5, pe102, DOI 10.1017/S1755267212000875; Negri MF, 2012, BRAZ J OCEANOGR, V60, P149, DOI 10.1590/S1679-87592012000200005; Frankham R, 2010, INTRO CONSERVATION G; Franklin I.R., 1980, CONSERVATION BIOL EV; Fu YX, 1997, GENETICS, V147, P915; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; HARPENDING HC, 1994, HUM BIOL, V66, P591; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; King TL, 1999, MOL ECOL, V8, pS1, DOI 10.1046/j.1365-294X.1999.00893.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KOCHER TD, 1993, MOL PHYLOGENET EVOL, V2, P158, DOI 10.1006/mpev.1993.1016; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazaro M, 2004, MAR MAMMAL SCI, V20, P201, DOI 10.1111/j.1748-7692.2004.tb01151.x; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mardulyn P, 2012, MOL ECOL, V21, P3385, DOI 10.1111/j.1365-294X.2012.05622.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Negri MF, 2011, THESIS U BUENOS AIRE; Nielsen R, 2001, GENETICS, V158, P885; OCorryCrowe GM, 1997, MOL ECOL, V6, P955, DOI 10.1046/j.1365-294X.1997.00267.x; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Parsons KM, 2006, MAR MAMMAL SCI, V22, P276, DOI 10.1111/j.1748-7692.2006.00019.x; Paso Viola MN, 2014, THESIS U BUENOS AIRE; Pinedo M.C., 1989, Biology and Conservation of the River Dolphins, VNo. 3, P46; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reeves R, 2012, DATABASE IUCN RED LI; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosel PE, 1999, MOL ECOL, V8, pS41, DOI 10.1046/j.1365-294X.1999.00758.x; Rousset F, 1997, GENETICS, V145, P1219; Sambrook J., 1989, MOLECULAR CLONING A; Schneider S, 1999, GENETICS, V152, P1079; Secchi Eduardo R., 2003, Journal of Cetacean Research and Management, V5, P61; Secchi ER, 2010, WILDL PROT DESTR EXT, P323; Secchi Eduardo R., 2001, Journal of Cetacean Research and Management, V3, P95; Secchi Eduardo R., 1997, Report of the International Whaling Commission, V47, P653; Secchi ER, 1998, CAN J ZOOL, V76, P1622, DOI 10.1139/cjz-76-9-1622; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; TAJIMA F, 1989, GENETICS, V123, P585; Valsecchi E., 2003, Journal of Cetacean Research and Management, V5, P69; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Wells RS, 2013, MAR MAMMAL SCI, V29, pE520, DOI 10.1111/mms.12010; Xu LJ, 2010, J HERED, V101, P562, DOI 10.1093/jhered/esq039	78	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132854	10.1371/journal.pone.0132854	http://dx.doi.org/10.1371/journal.pone.0132854			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221960	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800032
J	Grover, P; Shi, HB; Baumgartner, M; Camacho, CJ; Smithgall, TE				Grover, Prerna; Shi, Haibin; Baumgartner, Matthew; Camacho, Carlos J.; Smithgall, Thomas E.			Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function	PLOS ONE			English	Article							C-ABL; BCR-ABL; FAMILY KINASES; DYNAMIC REGULATION; AUTOINHIBITION; MECHANISMS; LIGAND; AMBER	The ABL protein-tyrosine kinase regulates intracellular signaling pathways controlling diverse cellular processes and contributes to several forms of cancer. The kinase activity of ABL is repressed by intramolecular interactions involving its regulatory Ncap, SH3 and SH2 domains. Small molecules that allosterically regulate ABL kinase activity through its noncatalytic domains may represent selective probes of ABL function. Here we report a screening assay for chemical modulators of ABL kinase activity that target the regulatory interaction of the SH3 domain with the SH2-kinase linker. This fluorescence polarization (FP) assay is based on a purified recombinant ABL protein consisting of the N-cap, SH3 and SH2 domains plus the SH2-kinase linker (N32L protein) and a short fluorescein-labeled probe peptide that binds to the SH3 domain. In assay development experiments, we found that the probe peptide binds to the recombinant ABL N32L protein in vitro, producing a robust FP signal that can be competed with an excess of unlabeled peptide. The FP signal is not observed with control N32L proteins bearing either an inactivating mutation in the SH3 domain or enhanced SH3: linker interaction. A pilot screen of 1200 FDA-approved drugs identified four compounds that specifically reduced the FP signal by at least three standard deviations from the untreated controls. Secondary assays showed that one of these hit compounds, the antithrombotic drug dipyridamole, enhances ABL kinase activity in vitro to a greater extent than the previously described ABL agonist, DPH. Docking studies predicted that this compound binds to a pocket formed at the interface of the SH3 domain and the linker, suggesting that it activates ABL by disrupting this regulatory interaction. These results show that screening assays based on the non-catalytic domains of ABL can identify allosteric small molecule regulators of kinase function, providing a new approach to selective drug discovery for this important kinase system.	[Grover, Prerna; Shi, Haibin; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Baumgartner, Matthew; Camacho, Carlos J.] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsmithga@pitt.edu		Baumgartner, Matthew/0000-0002-1279-9038	National Institutes of Health [CA185702, GM097082]; Commonwealth of Pennsylvania Department of Health Grant [SAP 4100062224]; National Science Foundation [CNS1229064]; NATIONAL CANCER INSTITUTE [R21CA185702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania Department of Health Grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA185702 (to T.E.S.) and GM097082 (C.J.C.) as well as Commonwealth of Pennsylvania Department of Health Grant SAP 4100062224 (C.J.C.). Computational resources were supported by National Science Foundation Grant CNS1229064 (C.J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Balakumar P, 2014, PHARMACOL RES, V87, P144, DOI 10.1016/j.phrs.2014.05.008; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Case DA, 2014, AMBER 14; Champ PC, 2007, NUCLEIC ACIDS RES, V35, pW556, DOI 10.1093/nar/gkm326; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; Chen SG, 2008, BIOCHEMISTRY-US, V47, P5795, DOI 10.1021/bi800446b; Chen SG, 2007, PROTEIN SCI, V16, P572, DOI 10.1110/ps.062631007; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Dragiev P, 2012, BIOINFORMATICS, V28, P1775, DOI 10.1093/bioinformatics/bts262; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Engen JR, 2013, INT REV PHYS CHEM, V32, P96, DOI 10.1080/0144235X.2012.751175; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Jason-Moller L., 2006, CURR PROTOC PROTEIN, P1, DOI [10.1002/0471140864.ps1913-45, DOI 10.1002/0471140864.PS1913-45, 10.1002/0471142301.ps1914s45]; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Maiani E, 2011, BIOCHEM PHARMACOL, V82, P1269, DOI 10.1016/j.bcp.2011.07.001; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Moroco JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105629; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Panjarian S, 2013, J BIOL CHEM, V288, P5443, DOI 10.1074/jbc.R112.438382; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Shun TY, 2011, J BIOMOL SCREEN, V16, P1, DOI 10.1177/1087057110389039; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	40	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133590	10.1371/journal.pone.0133590	http://dx.doi.org/10.1371/journal.pone.0133590			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222440	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000358836800056
J	Aspatwar, A; Tolvanen, MEE; Ojanen, MJT; Barker, HR; Saralahti, AK; Bauerlein, CA; Ortutay, C; Pan, P; Kuuslahti, M; Parikka, M; Ramet, M; Parkkila, S				Aspatwar, Ashok; Tolvanen, Martti E. E.; Ojanen, Markus J. T.; Barker, Harlan R.; Saralahti, Anni K.; Bauerlein, Carina A.; Ortutay, Csaba; Pan, Peiwen; Kuuslahti, Marianne; Parikka, Mataleena; Ramet, Mika; Parkkila, Seppo			Inactivation of ca10a and ca10b Genes Leads to Abnormal Embryonic Development and Alters Movement Pattern in Zebrafish	PLOS ONE			English	Article							ANHYDRASE-RELATED PROTEIN; CARBONIC-ANHYDRASES; HUMAN BRAIN; SEQUENCE ALIGNMENTS; CDNA SEQUENCE; I-TASSER; EXPRESSION; VIII; XI; GENERATION	Carbonic anhydrase related proteins (CARPs) X and XI are highly conserved across species and are predominantly expressed in neural tissues. The biological role of these proteins is still an enigma. Ray-finned fish have lost the CA11 gene, but instead possess two co-orthologs of CA10. We analyzed the expression pattern of zebrafish ca10a and ca10b genes during embryonic development and in different adult tissues, and studied 61 CARP X/XI-like sequences to evaluate their phylogenetic relationship. Sequence analysis of zebrafish ca10a and ca10b reveals strongly predicted signal peptides, N-glycosylation sites, and a potential disulfide, all of which are conserved, suggesting that all of CARP X and XI are secretory proteins and potentially dimeric. RT-qPCR showed that zebrafish ca10a and ca10b genes are expressed in the brain and several other tissues throughout the development of zebrafish. Antisense morpholino mediated knockdown of ca10a and ca10b showed developmental delay with a high rate of mortality in larvae. Zebrafish morphants showed curved body, pericardial edema, and abnormalities in the head and eye, and there was increased apoptotic cell death in the brain region. Swim pattern showed abnormal movement in morphant zebrafish larvae compared to the wild type larvae. The developmental phenotypes of the ca10a and ca10b morphants were confirmed by inactivating these genes with the CRISPR/Cas9 system. In conclusion, we introduce a novel zebrafish model to investigate the mechanisms of CARP Xa and CARP Xb functions. Our data indicate that CARP Xa and CARP Xb have important roles in zebrafish development and suppression of ca10a and ca10b expression in zebrafish larvae leads to a movement disorder.	[Aspatwar, Ashok; Tolvanen, Martti E. E.; Ojanen, Markus J. T.; Saralahti, Anni K.; Bauerlein, Carina A.; Ortutay, Csaba; Parikka, Mataleena; Ramet, Mika] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Aspatwar, Ashok; Barker, Harlan R.; Pan, Peiwen; Kuuslahti, Marianne; Parkkila, Seppo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Tolvanen, Martti E. E.] Univ Turku, Dept Informat Technol, Turku, Finland; [Ramet, Mika] Univ Oulu, PEDEGO Res Ctr, Oulu, Finland; [Ramet, Mika] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Parkkila, Seppo] Fimlab Ltd, Tampere, Finland; [Parkkila, Seppo] Tampere Univ, FIN-33101 Tampere, Finland	Tampere University; Tampere University; University of Turku; University of Oulu; University of Oulu; University of Oulu; Tampere University	Aspatwar, A (corresponding author), Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland.	ashok.aspatwar@staff.uta.fi	Ortutay, Csaba/H-2827-2012; Ojanen, Markus/AAI-8316-2021; Aspatwar, Ashok/I-4358-2019	Ortutay, Csaba/0000-0001-6306-6101; Ojanen, Markus/0000-0001-6623-844X; Aspatwar, Ashok/0000-0002-6938-7835; Barker, Harlan/0000-0003-4125-2522; Saralahti, Anni/0000-0002-6145-6875; Tolvanen, Martti/0000-0003-3434-7646; Parikka, Mataleena/0000-0001-5555-3815; Parkkila, Seppo/0000-0001-7323-8536	Tampere University Hospital; Jane and Aatos Erkko Foundation; Academy of Finland; Finnish Cultural Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Biocenter Finland	Tampere University Hospital; Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Biocenter Finland	This work was supported by the competitive Research Funding of the Tampere University Hospital and grants from the Jane and Aatos Erkko Foundation (SP, MR), Academy of Finland (SP, MR, MP), Finnish Cultural Foundation (HB), Sigrid Juselius Foundation (SP, MR), and Tampere Tuberculosis Foundation (SP, MR and MP). The zebrafish work was carried out at the Tampere Zebrafish Core Facility funded by the Biocenter Finland and Tampere Tuberculosis Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aspatwar A, 2014, SUBCELL BIOCHEM, V75, P135, DOI 10.1007/978-94-007-7359-2_8; Aspatwar A, 2013, HUM MOL GENET, V22, P417, DOI 10.1093/hmg/dds438; Aspatwar A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-25; Bellingham J, 1998, BIOCHEM BIOPH RES CO, V253, P364, DOI 10.1006/bbrc.1998.9449; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Chen X, 2008, J NEUROSCI, V28, P12713, DOI 10.1523/JNEUROSCI.3909-08.2008; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fujikawa-Adachi K, 1999, BBA-PROTEIN STRUCT M, V1431, P518, DOI 10.1016/S0167-4838(99)00067-9; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hruscha A, 2015, METHODS MOL BIOL, V1254, P341, DOI 10.1007/978-1-4939-2152-2_24; Hsieh M, 2013, CEREBELLUM; Huang M, 2014, BIOCHIMICA ET BIOPHY; Huang MS, 2014, BBA-GEN SUBJECTS, V1840, P2829, DOI 10.1016/j.bbagen.2014.04.017; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiao Y, 2005, GENETICS, V171, P1239, DOI 10.1534/genetics.105.044487; Kaya N, 2011, AM J MED GENET B, V156B, P826, DOI 10.1002/ajmg.b.31227; Kleiderlein JJ, 1998, HUM GENET, V103, P666, DOI 10.1007/s004390050889; Krebs J, 2014, CRISPR DESIGN TOOL A; Linser PJ, 2009, J EXP BIOL, V212, P1662, DOI 10.1242/jeb.028084; Lohi O, 2013, ACTA PAEDIATR, V102, P104, DOI 10.1111/j.1651-2227.2012.02835.x; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Morimoto K, 2005, VIRCHOWS ARCH, V447, P66, DOI 10.1007/s00428-005-1225-3; Nishimori Isao, 2003, Biomedical Research (Aligarh), V14, P70; Okamoto N, 2001, BBA-GENE STRUCT EXPR, V1518, P311, DOI 10.1016/S0167-4781(01)00193-2; Ortutay C, 2010, HAUPPAUGE, P145; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pastorekova S, 2004, J ENZYM INHIB MED CH, V19, P199, DOI 10.1080/14756360410001689540; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Taniuchi K, 2002, MOL BRAIN RES, V109, P207, DOI 10.1016/S0169-328X(02)00563-6; Taniuchi K, 2002, NEUROSCIENCE, V112, P93, DOI 10.1016/S0306-4522(02)00066-0; Tolvanen MEE, 2013, BIOORGAN MED CHEM, V21, P1503, DOI 10.1016/j.bmc.2012.08.060; Turkmen S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000487; Westerfield M., 2000, THE ZEBRAFISH BOOK A; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	52	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134263	10.1371/journal.pone.0134263	http://dx.doi.org/10.1371/journal.pone.0134263			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218428	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900104
J	Kansiime, C; Atuyambe, LM; Asiimwe, BB; Mugisha, A; Mugisha, S; Guma, V; Rwego, IB; Rutebemberwa, E				Kansiime, Catherine; Atuyambe, Lynn M.; Asiimwe, Benon B.; Mugisha, Anthony; Mugisha, Samuel; Guma, Victor; Rwego, Innocent B.; Rutebemberwa, Elizeus			Community Perceptions on Integrating Animal Vaccination and Health Education by Veterinary and Public Health Workers in the Prevention of Brucellosis among Pastoral Communities of South Western Uganda	PLOS ONE			English	Article							DISEASES	Background Brucellosis is a zoonotic disease of veterinary, public health, and economic significance in most developing countries, yet there are few studies that show integrated human and veterinary health care intervention focusing on integration at both activity and actors levels. The aim of our study, therefore, was to explore community perceptions on integration of animal vaccination and health education by veterinary and public health workers in the management of brucellosis in Uganda. Methods This study used a qualitative design where six Focus Group Discussions (FGDs) that were homogenous in nature were conducted, two from each sub-county, one with the local leaders, and another with pastoralists and farmers. Five Key Informant Interviews (KIIs) with two public health workers and three veterinary extension workers from three sub-counties in Kiruhura district, Uganda were conducted. All FGDs were conducted in the local language and tape recorded with consent from the participants. KIIs were in English and later transcribed and analyzed using latent content data analysis method. Results All the groups mentioned that they lacked awareness on brucellosis commonly known as Brucella and its vaccination in animals. Respondents perceived improvement in human resources in terms of training and recruiting more health personnel, facilitation of the necessary activities such as sensitization of the communities about brucellosis, and provision of vaccines and diagnostic tests as very important in the integration process in the communities. The FGD participants also believed that community participation was crucial for sustainability and ownership of the integration process. Conclusions The respondents reported limited knowledge of brucellosis and its vaccination in animals. The community members believed that mass animal vaccination in combination with health education about the disease is important and possible if it involves government and all other stakeholders such as wildlife authorities, community members, local to national political leaders, as well as the technical personnel from veterinary, medical and public health sectors since it affects both humans and animals.	[Kansiime, Catherine; Rutebemberwa, Elizeus] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Atuyambe, Lynn M.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Asiimwe, Benon B.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Mugisha, Anthony] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Dept Vet Med, Kampala, Uganda; [Mugisha, Samuel; Rwego, Innocent B.] Makerere Univ, Coll Nat Sci, Dept Biol Sci, Kampala, Uganda; [Guma, Victor] Makerere Univ, Coll Humanities & Social Sci, Dept Mental Hlth & Community Psychol, Kampala, Uganda; [Rwego, Innocent B.] Univ Minnesota, Coll Vet Med, Ecosyst Hlth Initiat, St Paul, MN 55108 USA	Makerere University; Makerere University; Makerere University; Makerere University; Makerere University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities	Kansiime, C (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda.	cathie.kansiime@gmail.com	Rwego, Innocent Bidason/I-5049-2013	Rwego, Innocent Bidason/0000-0003-1274-7788; Rutebemberwa, Elizeus/0000-0001-8363-7928	International Development Research Centre (IDRC), Canada	International Development Research Centre (IDRC), Canada	CK, SM, BBA, and IBR received funding from the International Development Research Centre (IDRC), Canada (http://www.idrc.ca/EN/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; BROWN M, 1992, HLTH CARE MANAGEMENT; Choudhary V, 2011, UGANDA DAIRY SUPPLY; Dawson S, 1992, MANUAL USE FOCUS GRO; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Garcia-Barbero M, 2001, INT J INTEGRATED CAR; Godfroid J, 2002, VET MICROBIOL, V90, P135, DOI 10.1016/S0378-1135(02)00217-1; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Goering PN, 1996, CAN J PSYCHIAT, V41, P491, DOI 10.1177/070674379604100804; Gul S. T., 2007, Pakistan Veterinary Journal, V27, P145; Holstein J. A., 1995, ACTIVE INTERVIEW; Ibironke Ademola A, 2008, Vet Ital, V44, P549; Jelastopulu E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-241; Kalema-Zikusoka G, 2005, ONDERSTEPOORT J VET, V72, P145; Kangethe EK, 2007, E AFR MED J, V84, P96; Kansiime C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-242; KHAN M E, 1991, World Health Statistics Quarterly, V44, P145; KHAN ME, 1992, HEALTH POLICY PLANN, V7, P56, DOI 10.1093/heapol/7.1.56; Kodner D, 2002, EQUITABLE EFFICIENT; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Lakshman M., 2000, Indian Journal of Pediatrics, V67, P358, DOI 10.1007/BF02820688; Lawrence P.R., 1967, ORG ENV MANAGING DIF; Magona JW, 2009, TROP ANIM HEALTH PRO, V41, P1765, DOI 10.1007/s11250-009-9375-y; Makita K, 2008, ANN NY ACAD SCI, V1149, P309, DOI 10.1196/annals.1428.015; Makita K, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-52; Makita K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014188; Marshall Catherine, 2006, DESIGNING QUALITATIV; Meslin F. X., 1996, Livestock production and diseases in the tropics: livestock production and human welfare. Proceedings of the 8th International Conference of Institutions of Tropical Medicine held from the 25 to 29 September, 1995 in Berlin, Germany Volume 1., P101; Mugabi R, 2012, THESIS MAKERERE U KA; Newman W.L., 2003, SOCIAL RES METHODS Q; NICHTER M, 1995, SOC SCI MED, V41, P617, DOI 10.1016/0277-9536(95)00034-5; Pfeffer J., 1982, ORG ORG THEORY; Program for Appropriate Technology in Health (PATH), 2011, INT HLTH SERV THEOR; Reviriego FJ, 2000, PREV VET MED, V44, P167, DOI 10.1016/S0167-5877(00)00108-2; Rhyan JC, 2000, EMERGING DISEASES OF ANIMALS, P161; Rice P., 1999, QUALITATIVE RES METH; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Schelling E, 2002, NOMADIC PASTORALISTS; Scott R, 1992, ORG RATIONAL NATURAL, V3, P199; Smits HL, 2004, AFRICAN J BIOTECHNOL, V12, P631; Thakur S. D., 2002, Journal of Communicable Diseases, V34, P287; Ward D. E., 1993, Nomadic Peoples, P55; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	43	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132206	10.1371/journal.pone.0132206	http://dx.doi.org/10.1371/journal.pone.0132206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218368	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900004
J	Mayordomo-Cava, J; Yajeya, J; Navarro-Lopez, JD; Jimenez-Diaz, L				Mayordomo-Cava, Jennifer; Yajeya, Javier; Navarro-Lopez, Juan D.; Jimenez-Diaz, Lydia			Amyloid-beta((25-35)) Modulates the Expression of GirK and KCNQ Channel Genes in the Hippocampus	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; ADULT-RAT BRAIN; REAL-TIME PCR; ALZHEIMERS-DISEASE; POTASSIUM CHANNEL; RNA INTEGRITY; PRION PROTEIN; DOWN-SYNDROME; FYN-KINASE; MECHANISMS	During early stages of Alzheimer's disease (AD), synaptic dysfunction induced by toxic amyloid-beta (A beta) is present before the accumulation of histopathological hallmarks of the disease. This scenario produces impaired functioning of neuronal networks, altered patterns of synchronous activity and severe functional deficits mainly due to hyperexcitability of hippocampal networks. The molecular mechanisms underlying these alterations remain unclear but functional evidence, shown by our laboratory and others, points to the involvement of receptors/channels which modulate neuronal excitability, playing a pivotal role in early A beta-induced AD pathogenesis. In particular, two potassium channels that control neuronal excitability, G protein-coupled activated inwardly-rectifying potassium channel (GirK), and voltage-gated K channel (KCNQ), have been recently linked to A beta pathophysiology in the hippocampus. Specifically, by using A beta 25-35, we previously found that GirK conductance is greatly decreased in the hippocampus, and similar effects have also been reported on KCNQ conductance. Thus, in the present study, our goal was to determine the effect of A beta on the transcriptional expression pattern of 17 genes encoding neurotransmitter receptors and associated channels which maintain excitatory-inhibitory neurotransmission balance in hippocampal circuits, with special focus in potassium channels. For this purpose, we designed a systematic and reliable procedure to analyze mRNA expression by reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) in hippocampal rat slices incubated with A beta(25-35). We found that: 1) A beta down-regulated mRNA expression of ionotropic GluN1 and metabotropic mGlu1 glutamate receptor subunits as previously reported in other AD models; 2) A beta also reduced gene expression levels of GirK2, 3, and 4 subunits, and KCNQ2 and 3 subunits, but did not change expression levels of its associated GABA(B) and M1 receptors, respectively. Our results provide evidence that A beta can modulate the expression of these channels which could affect the hippocampal activity balance underlying learning and memory processes impaired in AD.	[Mayordomo-Cava, Jennifer; Navarro-Lopez, Juan D.; Jimenez-Diaz, Lydia] Univ Castilla La Mancha, CRIB, Sch Med Ciudad Real, Neurophysiol & Behav Lab, E-13071 Ciudad Real, Spain; [Yajeya, Javier] Univ Salamanca, Dept Physiol & Pharmacol, E-37008 Salamanca, Spain	Universidad de Castilla-La Mancha; University of Salamanca	Navarro-Lopez, JD (corresponding author), Univ Castilla La Mancha, CRIB, Sch Med Ciudad Real, Neurophysiol & Behav Lab, E-13071 Ciudad Real, Spain.	Juan.Navarro@uclm.es; Lydia.Jimenez@uclm.es	Jiménez-Diaz, Lydia/R-8383-2019; Yajeya, Javier/B-4325-2017; de Dios Navarro López, Juan/Q-9318-2019; MC, Jennifer/U-1506-2017	Jiménez-Diaz, Lydia/0000-0001-9121-0334; de Dios Navarro López, Juan/0000-0002-1877-7833; MC, Jennifer/0000-0001-6476-1173; Yajeya, Javier/0000-0003-1617-4227	Spanish Ministry of Economy and Competitivity [BFU2009-07341, SAF2010-14878, BFU2011-22740, BFU2014-56164-P]; Fundacion Eugenio Rodriguez Pascual; Fundacion Tatiana Perez de Guzman el Bueno	Spanish Ministry of Economy and Competitivity(Spanish Government); Fundacion Eugenio Rodriguez Pascual; Fundacion Tatiana Perez de Guzman el Bueno	This work was supported by Spanish Ministry of Economy and Competitivity Grants (BFU2009-07341 to JY; SAF2010-14878 and BFU2011-22740 to JDNL; BFU2014-56164-P to LJD and JDNL); Fundacion Eugenio Rodriguez Pascual to JDNL; Fundacion Tatiana Perez de Guzman el Bueno to LJD. JDNL held a Ramon y Cajal Research Fellow (RYC-2009-03827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001; Amaral D., 2007, HIPPOCAMPAL NEUROANA; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersen P., 2007, HIPPOCAMPUS BOOK; Ashenafi S, 2005, NEUROBIOL AGING, V26, P419, DOI 10.1016/j.neurobiolaging.2004.05.008; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Caccamo A, 2009, CURR ALZHEIMER RES, V6, P112, DOI 10.2174/156720509787602915; Chang ZW, 2011, J PHYS CHEM B, V115, P1165, DOI 10.1021/jp107558e; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Colom LV, 2006, J NEUROCHEM, V96, P609, DOI 10.1111/j.1471-4159.2005.03630.x; Cooper A, 2012, P NATL ACAD SCI USA, V109, P2642, DOI 10.1073/pnas.1109099109; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Duran-Gonzalez J, 2013, NEUROBIOL AGING, V34, P2071, DOI 10.1016/j.neurobiolaging.2013.02.005; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fidzinski P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7254; Fisher A, 2012, J NEUROCHEM, V120, P22, DOI 10.1111/j.1471-4159.2011.07507.x; Fitzjohn SM, 2008, EUR J PHARMACOL, V585, P50, DOI 10.1016/j.ejphar.2008.02.077; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gaisler-Salomon I, 2014, NEUROBIOL AGING, V35, P1785, DOI 10.1016/j.neurobiolaging.2014.02.018; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Hynd MR, 2001, J NEUROCHEM, V78, P175, DOI 10.1046/j.1471-4159.2001.00409.x; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Janickova H, 2013, NEUROPHARMACOLOGY, V67, P272, DOI 10.1016/j.neuropharm.2012.11.014; Jimenez-Diaz Lydia, 2011, Front Neurol, V2, P59, DOI 10.3389/fneur.2011.00059; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaufmann K, 2013, ACS CHEM NEUROSCI, V4, P1278, DOI 10.1021/cn400062a; Kerrigan TL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00009; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kumar A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00215; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Leao RN, 2012, NEUROBIOL AGING, V33, P2046, DOI 10.1016/j.neurobiolaging.2011.07.013; Linley JE, 2012, J PHYSIOL-LONDON, V590, P793, DOI 10.1113/jphysiol.2011.223404; Lott IT, 2005, NEUROBIOL AGING, V26, P383, DOI 10.1016/j.neurobiolaging.2004.08.005; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Lujan R, 2014, TRENDS NEUROSCI, V37, P20, DOI 10.1016/j.tins.2013.10.006; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Millucci L, 2010, CURR PROTEIN PEPT SC, V11, P54, DOI 10.2174/138920310790274626; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Mishizen-Eberz AJ, 2004, NEUROBIOL DIS, V15, P80, DOI 10.1016/j.nbd.2003.09.016; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; Mota SI, 2014, NEUROPHARMACOLOGY, V76, P16, DOI 10.1016/j.neuropharm.2013.08.013; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Murer G, 1997, NEUROSCIENCE, V80, P345, DOI 10.1016/S0306-4522(97)00001-8; Nava-Mesa MO, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00167; Nava-Mesa MO, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00117; Navarro-Lopez JD, 2004, J NEUROSCI, V24, P5109, DOI 10.1523/JNEUROSCI.0235-04.2004; Navarro-Lopez J, 2009, J MOL NEUROSCI, V37, P263, DOI 10.1007/s12031-008-9130-2; Nistico R, 2012, MOL NEUROBIOL, V46, P572, DOI 10.1007/s12035-012-8324-3; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Parra-Damas A, 2014, J NEUROSCI, V34, P5776, DOI 10.1523/JNEUROSCI.5288-13.2014; Pena F, 2010, HIPPOCAMPUS, V20, P78, DOI 10.1002/hipo.20592; Perry CA, 2008, P NATL ACAD SCI USA, V105, P8148, DOI 10.1073/pnas.0803261105; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Rockwood K, 1997, CAN J NEUROL SCI, V24, P140, DOI 10.1017/S031716710002148X; Santos-Torres J, 2007, J NEUROSCI RES, V85, P634, DOI 10.1002/jnr.21150; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P1, DOI 10.1016/S0028-3908(98)00170-1; Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471; Seifert S., 2022, DANNY BOY THE STEVE; Spauschus A, 1996, J NEUROSCI, V16, P930; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Swanberg MM, 2004, ARCH NEUROL-CHICAGO, V61, P556, DOI 10.1001/archneur.61.4.556; Tsang SWY, 2006, NEUROBIOL AGING, V27, P1216, DOI 10.1016/j.neurobiolaging.2005.07.010; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Xi YD, 2015, CELL MOL NEUROBIOL, V35, P555, DOI 10.1007/s10571-014-0151-9	88	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134385	10.1371/journal.pone.0134385	http://dx.doi.org/10.1371/journal.pone.0134385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218288	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900114
J	Montezano, D; Meek, L; Gupta, R; Bermudez, LE; Bermudez, JCM				Montezano, Daniel; Meek, Laura; Gupta, Rashmi; Bermudez, Luiz E.; Bermudez, Jose C. M.			Flux Balance Analysis with Objective Function Defined by Proteomics Data-Metabolism of Mycobacterium tuberculosis Exposed to Mefloquine	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; MODELS; GROWTH; RESISTANCE; NETWORKS; DRUGS	We present a study of the metabolism of the Mycobacterium tuberculosis after exposure to antibiotics using proteomics data and flux balance analysis (FBA). The use of FBA to study prokaryotic organisms is well-established and allows insights into the metabolic pathways chosen by the organisms under different environmental conditions. To apply FBA a specific objective function must be selected that represents the metabolic goal of the organism. FBA estimates the metabolism of the cell by linear programming constrained by the stoichiometry of the reactions in an in silico metabolic model of the organism. It is assumed that the metabolism of the organism works towards the specified objective function. A common objective is the maximization of biomass. However, this goal is not suitable for situations when the bacterium is exposed to antibiotics, as the goal of organisms in these cases is survival and not necessarily optimal growth. In this paper we propose a new approach for defining the FBA objective function in studies when the bacterium is under stress. The function is defined based on protein expression data. The proposed methodology is applied to the case when the bacterium is exposed to the drug mefloquine, but can be easily extended to other organisms, conditions or drugs. We compare our method with an alternative method that uses experimental data for adjusting flux constraints. We perform comparisons in terms of essential enzymes and agreement using enzyme abundances. Results indicate that using proteomics data to define FBA objective functions yields less essential reactions with zero flux and lower error rates in prediction accuracy. With flux variability analysis we observe that overall variability due to alternate optima is reduced with the incorporation of proteomics data. We believe that incorporating proteomics data in the objective function used in FBA may help obtain metabolic flux representations that better support experimentally observed features.	[Montezano, Daniel; Bermudez, Jose C. M.] Univ Fed Santa Catarina, Lab Pesquisa Proc Digital Sinais LPDS, Florianopolis, SC, Brazil; [Meek, Laura; Bermudez, Luiz E.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Gupta, Rashmi] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA	Universidade Federal de Santa Catarina (UFSC); Oregon State University; State University System of Florida; University of Central Florida	Montezano, D (corresponding author), Univ Fed Santa Catarina, Lab Pesquisa Proc Digital Sinais LPDS, Florianopolis, SC, Brazil.	daniel@lpds.ufsc.br	Bermudez, Jose C M/A-3670-2008	Bermudez, Jose C M/0000-0002-6712-939X	Bill and Melinda Gates Foundation [OPP50277]; Foundation for Microbiology [10923SR]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for Microbiology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Bill and Melinda Gates Foundation, grant number OPP50277 (www.gatesfoundation.org, LEB), and by Foundation for Microbiology, grant number 10923SR (www.waksman-foundation.org, LEB).	Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Danelishvili L, 2005, ANTIMICROB AGENTS CH, V49, P3707, DOI 10.1128/AAC.49.9.3707-3714.2005; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Gevorgyan A, 2011, BIOINFORMATICS, V27, P433, DOI 10.1093/bioinformatics/btq679; Lakshmanan M, 2014, BRIEF BIOINFORM, V15, P108, DOI 10.1093/bib/bbs069; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; McNamara M, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-45; McNamara M, 2012, INFECT IMMUN, V80, P1868, DOI 10.1128/IAI.06151-11; Movahedzadeh F, 2004, MOL MICROBIOL, V51, P1003, DOI 10.1046/j.1365-2958.2003.03900.x; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Proteome Software, 2014, PROTEOME SOFTWARE WI; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Reed JL, 2004, GENOME RES, V14, P1797, DOI 10.1101/gr.2546004; Sanz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022178; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre Daniel, 2003, OMICS A Journal of Integrative Biology, V7, P301, DOI 10.1089/153623103322452413; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; van Berlo RJP, 2011, IEEE ACM T COMPUT BI, V8, P206, DOI 10.1109/TCBB.2009.55; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994	27	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134014	10.1371/journal.pone.0134014	http://dx.doi.org/10.1371/journal.pone.0134014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218987	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900065
J	Srutkova, D; Schwarzer, M; Hudcovic, T; Zakostelska, Z; Drab, V; Spanova, A; Rittich, B; Kozakova, H; Schabussova, I				Srutkova, Dagmar; Schwarzer, Martin; Hudcovic, Tomas; Zakostelska, Zuzana; Drab, Vladimir; Spanova, Alena; Rittich, Bohuslav; Kozakova, Hana; Schabussova, Irma			Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; TIGHT JUNCTION; IMMUNOMODULATORY PROPERTIES; DENDRITIC CELLS; DEXTRAN SULFATE; IN-VIVO; ANTIINFLAMMATORY CAPACITY; PROBIOTIC PREPARATION	Background Reduced microbial diversity has been associated with inflammatory bowel disease (IBD) and probiotic bacteria have been proposed for its prevention and/or treatment. Nevertheless, comparative studies of strains of the same subspecies for specific health benefits are scarce. Here we compared two Bifidobacterium longum ssp. longum strains for their capacity to prevent experimental colitis. Methods Immunomodulatory properties of nine probiotic bifidobacteria were assessed by stimulation of murine splenocytes. The immune responses to B. longum ssp. longum CCM 7952 (Bl 7952) and CCDM 372 (Bl 372) were further characterized by stimulation of bone marrow-derived dendritic cell, HEK293/TLR2 or HEK293/NOD2 cells. A mouse model of dextran sulphate sodium (DSS)-induced colitis was used to compare their beneficial effects in vivo. Results The nine bifidobacteria exhibited strain-specific abilities to induce cytokine production. Bl 372 induced higher levels of both pro-and anti-inflammatory cytokines in spleen and dendritic cell cultures compared to Bl 7952. Both strains engaged TLR2 and contain ligands for NOD2. In a mouse model of DSS-induced colitis, Bl 7952, but not Bl 372, reduced clinical symptoms and preserved expression of tight junction proteins. Importantly, Bl 7952 improved intestinal barrier function as demonstrated by reduced FITC-dextran levels in serum. Conclusions We have shown that Bl 7952, but not Bl 372, protected mice from the development of experimental colitis. Our data suggest that although some immunomodulatory properties might be widespread among the genus Bifidobacterium, others may be rare and characteristic only for a specific strain. Therefore, careful selection might be crucial in providing beneficial outcome in clinical trials with probiotics in IBD.	[Srutkova, Dagmar; Schwarzer, Martin; Hudcovic, Tomas; Kozakova, Hana] Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Gnotobiol, Novy Hradek, Czech Republic; [Zakostelska, Zuzana] Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Cellular & Mol Immunol, Prague, Czech Republic; [Drab, Vladimir] Dairy Res Inst Ltd, Prague, Czech Republic; [Spanova, Alena; Rittich, Bohuslav] Brno Univ Technol, Fac Chem, CS-61090 Brno, Czech Republic; [Schabussova, Irma] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Dairy Research Institute; Brno University of Technology; Medical University of Vienna	Kozakova, H (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Vvi, Lab Gnotobiol, Novy Hradek, Czech Republic.	kozakova@biomed.cas.cz	Zákostelská, Zuzana/ABB-9807-2021; Zakostelska, Zuzana/D-6518-2012; Hudcovic, Tomas/H-7917-2014; Kozakova, Hana/I-1153-2014; Schwarzer, Martin/P-9871-2017; Drab, Vladimir/E-3133-2010; Šrůtková, Dagmar/H-8511-2014	Hudcovic, Tomas/0000-0002-4761-5040; Kozakova, Hana/0000-0001-7352-5922; Schwarzer, Martin/0000-0002-1401-6578; Šrůtková, Dagmar/0000-0003-0054-5396; Rittich, Bohuslav/0000-0002-1167-4604; Schabussova, Irma/0000-0002-2109-2640; Zakostelska, Zuzana/0000-0002-6695-8188	Czech Science Foundation [303/09/0449, P303/12/0535]; OeAD-GmbH grant [CZ 15/2015]; Austrian Science Fund [SFB F46];  [CZ.3.22/2.1.00/09.01574];  [CZ.3.22/2.1.00/13.03892];  [FCH-S- 14-2325]	Czech Science Foundation(Grant Agency of the Czech Republic); OeAD-GmbH grant; Austrian Science Fund(Austrian Science Fund (FWF)); ; ; 	Supported by grants 303/09/0449 and P303/12/0535 of the Czech Science Foundation, grants CZ.3.22/2.1.00/09.01574 and CZ.3.22/2.1.00/13.03892, OeAD-GmbH grant CZ 15/2015 and grant SFB F46 from Austrian Science Fund. The financial support of internal grant FCH-S- 14-2325 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Biswas A, 2013, INT IMMUNOL, V25, P207, DOI 10.1093/intimm/dxs116; Boirivant M, 2012, ORAL DIS, V18, P1, DOI 10.1111/j.1601-0825.2011.01811.x; Buning C, 2012, INFLAMM BOWEL DIS, V18, P1932, DOI 10.1002/ibd.22909; Cinova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016169; COOPER HS, 1993, LAB INVEST, V69, P238; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Dong HL, 2012, BRIT J NUTR, V108, P459, DOI 10.1017/S0007114511005824; Favier C, 1997, DIGEST DIS SCI, V42, P817, DOI 10.1023/A:1018876400528; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Fujiwara M, 2003, DIGESTION, V67, P90, DOI 10.1159/000069704; Furrie E, 2005, GUT, V54, P242, DOI 10.1136/gut.2004.044834; Geier MS, 2007, INT J FOOD MICROBIOL, V115, P1, DOI 10.1016/j.ijfoodmicro.2006.10.006; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gyires K, 2014, CURR PHARM DESIGN, V20, P1063, DOI 10.2174/13816128113199990417; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kole A, 2014, CURR TOP MICROBIOL, V380, P19, DOI 10.1007/978-3-662-43492-5_2; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Krizova J, 2006, SYST APPL MICROBIOL, V29, P36, DOI 10.1016/j.syapm.2005.07.003; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Latvala S, 2008, WORLD J GASTROENTERO, V14, P5570, DOI 10.3748/wjg.14.5570; Lopez P, 2010, INT J FOOD MICROBIOL, V138, P157, DOI 10.1016/j.ijfoodmicro.2009.12.023; Makino H, 2011, APPL ENVIRON MICROB, V77, P6788, DOI 10.1128/AEM.05346-11; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Mann ER, 2013, IMMUNOL LETT, V150, P30, DOI 10.1016/j.imlet.2013.01.007; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Miele E, 2009, AM J GASTROENTEROL, V104, P437, DOI 10.1038/ajg.2008.118; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Neurath MF, 2012, DIGEST DIS, V30, P91, DOI 10.1159/000341131; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Prantera C, 2002, GUT, V51, P405, DOI 10.1136/gut.51.3.405; Preising J, 2010, APPL ENVIRON MICROB, V76, P3048, DOI 10.1128/AEM.03127-09; Rahimi R, 2008, DIGEST DIS SCI, V53, P2524, DOI 10.1007/s10620-007-0171-0; Repa A, 2003, VACCINE, V22, P87, DOI 10.1016/S0264-410X(03)00528-0; Rolfe VE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004826; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schabussova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040271; Schabussova I, 2011, VACCINE, V29, P1981, DOI 10.1016/j.vaccine.2010.12.101; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Schwarzer M, 2013, VACCINE, V31, P5405, DOI 10.1016/j.vaccine.2013.09.014; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Srutkova D, 2011, J MICROBIOL METH, V87, P10, DOI 10.1016/j.mimet.2011.06.014; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Steinbach EC, 2014, INFLAMM BOWEL DIS, V20, P166, DOI 10.1097/MIB.0b013e3182a69dca; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Ventura M, 2014, J SCI FOOD AGR, V94, P163, DOI 10.1002/jsfa.6356; Venturi A, 1999, ALIMENT PHARM THER, V13, P1103; Verbeke KA, 2014, P NUTR SOC, V73, P490, DOI 10.1017/S0029665114000639; Weinstock JV, 2013, INT J PARASITOL, V43, P245, DOI 10.1016/j.ijpara.2012.10.016; Wildt S, 2011, J CROHNS COLITIS, V5, P115, DOI 10.1016/j.crohns.2010.11.004; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; Zenlea T, 2014, WORLD J GASTROENTERO, V20, P3146, DOI 10.3748/wjg.v20.i12.3146; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	80	106	112	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134050	10.1371/journal.pone.0134050	http://dx.doi.org/10.1371/journal.pone.0134050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218526	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900072
J	Thibodeau, PH; Boroditsky, L				Thibodeau, Paul H.; Boroditsky, Lera			Measuring Effects of Metaphor in a Dynamic Opinion Landscape	PLOS ONE			English	Article							TELEVISION-NEWS	Metaphors pervade discussions of critical issues, making up as much as 10-20% of natural discourse. Recent work has suggested that these conventional and systematic metaphors influence the way people reason about the issues they describe. For instance, previous work has found that people were more likely to want to fight back against a crime beast by increasing the police force but more likely to want to diagnose and treat a crime virus through social reform. Here, we report the results of three norming tasks and two experiments that reveal a shift in the overall landscape of opinion on the topic of crime. Importantly, we find that the metaphors continue to have an influence on people's reasoning about crime. Our results and analyses highlight the importance of up-to-date opinion norms and carefully controlled materials in metaphor research.	[Thibodeau, Paul H.] Oberlin Coll, Dept Psychol, Oberlin, OH 44074 USA; [Boroditsky, Lera] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	Oberlin College; University of California System; University of California San Diego	Thibodeau, PH (corresponding author), Oberlin Coll, Dept Psychol, Oberlin, OH 44074 USA.	paul.thibodeau@oberlin.edu	Thibodeau, Paul/AAY-7259-2021		Division Of Behavioral and Cognitive Sci [1547901] Funding Source: National Science Foundation	Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Barak G, 1995, STUDIES NEWSMAKING C, V10; BEHR RL, 1985, PUBLIC OPIN QUART, V49, P38, DOI 10.1086/268900; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; Festinger L., 1962, THEORY COGNITIVE DIS, V2; Gilliam Jr F. D., 1996, HARV INT J PRESS/POL, V1, P6, DOI DOI 10.1177/1081180X96001003003; Hauser DJ, 2015, PERS SOC PSYCHOL B, V41, P66, DOI 10.1177/0146167214557006; IYENGAR S, 1982, AM POLIT SCI REV, V76, P848, DOI 10.2307/1962976; Iyengar S, 1994, IS ANYONE RESPONSIBL; Iyengar S., 1987, NEWS MATTERS TELEVIS; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Lakoff George, 2003, METAPHOR WE LIVE BY; Landau MJ, 2009, PSYCHOL SCI, V20, P1421, DOI 10.1111/j.1467-9280.2009.02462.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ripley B., 2014, PACKAGE MASS SUPPORT; Schlesinger Philip, 1994, REPORTING CRIME MEDI; Steen G, 2010, METHOD LINGUISTIC ME, DOI 10.1075/celcr.14; Steen GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113536; Thibodeau PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052961; Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Venables WN., 2002, MODERN APPL STAT S 4	21	32	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133939	10.1371/journal.pone.0133939	http://dx.doi.org/10.1371/journal.pone.0133939			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218229	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900057
J	Kawashima, A; Koide, K; Hasegawa, J; Arakaki, T; Takenaka, S; Maruyama, D; Matsuoka, R; Sekizawa, A				Kawashima, Akihiro; Koide, Keiko; Hasegawa, Junichi; Arakaki, Tatsuya; Takenaka, Shin; Maruyama, Daisuke; Matsuoka, Ryu; Sekizawa, Akihiko			Maternal Smoking History Enhances the Expression of Placental Growth Factor in Invasive Trophoblasts at Early Gestation Despite Cessation of Smoking	PLOS ONE			English	Article							CIGARETTE-SMOKING; ANGIOGENIC FACTORS; SOLUBLE ENDOGLIN; NORMAL-PREGNANCY; DNA METHYLATION; RECEPTOR SYSTEM; FETAL-GROWTH; RISK-FACTORS; PREECLAMPSIA; PLASMA	Maternal smoking during early pregnancy is associated with a reduced risk for preeclampsia even after smoking cessation during pregnancy. Although the pathophysiology of preeclampsia has not been established, placental growth factor (PlGF) is believed to be a key factor. The aim of this study was to assess the effect of maternal smoking on the PlGF expression in invasive trophoblasts at early gestation. We collected villous tissues from women requesting surgical termination due to non-medical reasons at 7-8 weeks of gestation. The maternal smoking status was evaluated by measuring the serum cotinine level and patients were divided into two groups: active smokers and non-smokers. After separating invasive trophoblasts from villous tissues cultured initially under 2% O-2 for 24 hours, the separated invasive trophoblasts were cultured under 2% or 8% O-2 for 48 hours. The expression levels of the PlGF gene in villous tissue specimens and in invasive trophoblasts cultured after the conditions were quantified using qRT-PCR. The levels of PlGF protein in the medium were quantified using an ELISA. The gene expression level of PlGF in the villi in the active-smokers was significantly higher than that of the non-smokers. In comparison of the invasive trophoblasts under normoxia and oxygenated conditions, the ratio of PlGF gene expression and protein expression under oxygenation (2% O-2+8% O-2 / 2% O-2+2% O-2) in the active-smokers were both significantly higher than in the non-smokers. Maternal smoking history appears to stimulate PlGF expression in invasive trophoblasts under oxygenated conditions. This may be one of several causes leading to the protective effect of maternal smoking on preeclampsia.	[Kawashima, Akihiro; Koide, Keiko; Hasegawa, Junichi; Arakaki, Tatsuya; Takenaka, Shin; Maruyama, Daisuke; Matsuoka, Ryu; Sekizawa, Akihiko] Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa, Japan	Showa University	Kawashima, A (corresponding author), Showa Univ, Sch Med, Dept Obstet & Gynecol, Shinagawa, Japan.	kurobei343@mac.com	Kawashima, Akihiro/AAK-8103-2020; Arakaki, Tatsuya/AAA-2108-2021; Hasegawa, Junichi/AAO-5291-2020	Kawashima, Akihiro/0000-0002-3501-4854; Arakaki, Tatsuya/0000-0001-5113-0110; Hasegawa, Junichi/0000-0002-5789-1022; takenaka, shin/0000-0002-4333-6271	Ministry of Education, Science, Sport and Culture of Japan [26462501]; Smoking Research Foundation; Ogyaa Foundation; Grants-in-Aid for Scientific Research [26462501] Funding Source: KAKEN	Ministry of Education, Science, Sport and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Ogyaa Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sport and Culture of Japan (#26462501) AS; Smoking Research Foundation, Ogyaa Foundation AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2001, AM J EPIDEMIOL, V153, P771, DOI 10.1093/aje/153.8.771; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Einarson A, 2009, EUR J CLIN PHARMACOL, V65, P325, DOI 10.1007/s00228-008-0609-0; England LJ, 2002, AM J OBSTET GYNECOL, V186, P1035, DOI 10.1067/mob.2002.122404; Hoyo C, 2012, CANCER CAUSE CONTROL, V23, P635, DOI 10.1007/s10552-012-9932-y; Huuskonen P, 2008, CLIN PHARMACOL THER, V83, P542, DOI 10.1038/sj.clpt.6100376; Jauniaux E, 2001, AM J OBSTET GYNECOL, V184, P998, DOI 10.1067/mob.2001.111935; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kawashima A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106140; Krauss T, 2004, HYPERTENS PREGNANCY, V23, P101, DOI 10.1081/PRG-120028286; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Lash GE, 2010, PLACENTA, V31, P545, DOI 10.1016/j.placenta.2010.02.020; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; Mimura K, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.037; MONGELLI M, 1995, ULTRASOUND OBST GYN, V6, P340, DOI 10.1046/j.1469-0705.1995.06050340.x; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Munaut C, 2008, HUM REPROD, V23, P1407, DOI 10.1093/humrep/den114; Naicker T, 2003, ACTA OBSTET GYN SCAN, V82, P722, DOI 10.1034/j.1600-0412.2003.00220.x; Naruse K, 2010, J REPROD IMMUNOL, V86, P148, DOI 10.1016/j.jri.2010.04.004; Newman M G, 2001, J Matern Fetal Med, V10, P166, DOI 10.1080/714904321; Ohkuchi A, 2007, HYPERTENS RES, V30, P151, DOI 10.1291/hypres.30.151; Onogi A, 2011, PLACENTA, V32, P665, DOI 10.1016/j.placenta.2011.06.023; Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Rosenberg TJ, 2005, AM J PUBLIC HEALTH, V95, P1545, DOI 10.2105/AJPH.2005.065680; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Votavova H, 2011, PLACENTA, V32, P763, DOI 10.1016/j.placenta.2011.06.022; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; Welch PC, 2006, AM J OBSTET GYNECOL, V194, P1625, DOI 10.1016/j.ajog.2006.01.012; Zhang J, 1999, AM J OBSTET GYNECOL, V181, P1407, DOI 10.1016/S0002-9378(99)70384-4; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	41	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134181	10.1371/journal.pone.0134181	http://dx.doi.org/10.1371/journal.pone.0134181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214510	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300058
J	Linhart, M; Sinning, JM; Ghanem, A; Kozhuppakalam, FJ; Fistera, R; Hammerstingl, C; Pizarro, C; Grube, E; Werner, N; Nickenig, G; Skowasch, D				Linhart, Markus; Sinning, Jan-Malte; Ghanem, Alexander; Kozhuppakalam, Finny J.; Fistera, Rebecca; Hammerstingl, Christoph; Pizarro, Carmen; Grube, Eberhard; Werner, Nikos; Nickenig, Georg; Skowasch, Dirk			Prevalence and Impact of Sleep Disordered Breathing in Patients with Severe Aortic Stenosis	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CHEYNE-STOKES RESPIRATION; POSITIVE AIRWAY PRESSURE; VALVE IMPLANTATION; APNEA; TRANSCATHETER; REPLACEMENT; DISEASE; RISK; METAANALYSIS	Background Unlike the well-established association between sleep disordered breathing (SDB) and chronic heart failure, the relationship between SDB and severe aortic stenosis (AS) is not well investigated. Given the increasing prevalence of AS, and the improving prognosis of high risk AS patients attributable to transcatheter aortic valve implantation (TAVI), the prevalence and impact of SDB needs to be better understood. Methods and Results In this study, 140 patients with severe AS underwent polygraphy prior to TAVI. Clinical and hemodynamic parameters were recorded. Patients were followed for 573 +/- 405 days. We found that 99/140 patients (71%) had SDB with a mean apnoea-hypopnoea-index of 24 +/- 17/h. SDB was mild in 27%, moderate in 23% and severe in 21% of patients. In addition, 35 patients (25%) had obstructive sleep apnoea (OSA), whereas 64 patients (46%) had central sleep apnoea (CSA). Patients with OSA had predominantly mild SDB (20/38 pts.), and patients with CSA mostly had severe SDB (24/29 pts.). The prevalence and distribution of OSA and CSA were independent of left ventricular function. Overall, 1 and 2 year survival rates (74% and 71%, resp.) did not differ significantly between patients without SDB or those with OSA and CSA (p=0.81). Conclusions SDB, with a preponderance of CSA, was found to be highly prevalent in patients with high-grade AS scheduled for TAVI. SDB prevalence was independent of left ventricular function. Mortality after TAVI was not influenced by the type or severity of SDB.	[Linhart, Markus; Sinning, Jan-Malte; Ghanem, Alexander; Kozhuppakalam, Finny J.; Fistera, Rebecca; Hammerstingl, Christoph; Pizarro, Carmen; Grube, Eberhard; Werner, Nikos; Nickenig, Georg; Skowasch, Dirk] Univ Klin Bonn, Med Klin & Poliklin 2, D-53127 Bonn, Germany	University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf	Linhart, M (corresponding author), Univ Klin Bonn, Med Klin & Poliklin 2, Sigmund Freud Str 25, D-53127 Bonn, Germany.	markus.linhart@ukb.uni-bonn.de	Hammerstingl, Christoph/GQQ-3316-2022					Abe H, 2009, CIRC J, V73, P2148, DOI 10.1253/circj.CJ-09-0307; Agmon Y, 2001, J AM COLL CARDIOL, V38, P827, DOI 10.1016/S0735-1097(01)01422-X; Bliwise DL, 2009, SLEEP MED CLIN, V4, P57, DOI 10.1016/j.jsmc.2008.11.004; Bliwise DL, 2010, J GERONTOL A-BIOL, V65, P997, DOI 10.1093/gerona/glq071; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Bradley TD, 2003, CIRCULATION, V107, P1671, DOI 10.1161/01.CIR.0000061757.12581.15; Bradley TD, 2003, CIRCULATION, V107, P1822, DOI 10.1161/01.CIR.0000061758.05044.64; Calvin AD, 2011, CHEST, V140, P1517, DOI 10.1378/chest.10-2472; Cowie MR, 2013, EUR J HEART FAIL, V15, P937, DOI 10.1093/eurjhf/hft051; Dai YMN, 2010, CIRCULATION, V121, P1598, DOI 10.1161/CIRCULATIONAHA.109.902452; Damy T, 2012, EUR J HEART FAIL, V14, P1009, DOI 10.1093/eurjhf/hfs085; Dimitriadis Z, 2013, CLIN RES CARDIOL, V102, P895, DOI 10.1007/s00392-013-0603-0; El Shayeb M, 2014, CAN MED ASSOC J, V186, pE25, DOI 10.1503/cmaj.130952; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Ghanem A, 2010, J AM COLL CARDIOL, V55, P1427, DOI 10.1016/j.jacc.2009.12.026; Green P, 2012, JACC-CARDIOVASC INTE, V5, P974, DOI 10.1016/j.jcin.2012.06.011; Iber C A-I S, 2008, DAS AASM MANUAL ZUM; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Kourouklis SP, 2013, INT J CARDIOL, V168, P157, DOI 10.1016/j.ijcard.2012.09.101; Linhart M, 2013, EUROINTERVENTION, V9, P923, DOI 10.4244/EIJV9I8A155; Oldenburg O, 2007, EUR J HEART FAIL, V9, P251, DOI 10.1016/j.ejheart.2006.08.003; Osnabrugge RLJ, 2013, J AM COLL CARDIOL, V62, P1002, DOI 10.1016/j.jacc.2013.05.015; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Prinz C, 2011, POSTGRAD MED J, V87, P458, DOI 10.1136/pgmj.2010.112052; Sinha AM, 2004, J AM COLL CARDIOL, V44, P68, DOI 10.1016/j.jacc.2004.03.040; Sinning JM, 2012, AM HEART J, V164, P102, DOI 10.1016/j.ahj.2012.04.016; Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048; Sinning JM, 2010, JACC-CARDIOVASC INTE, V3, P1141, DOI 10.1016/j.jcin.2010.09.009; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Solin P, 1999, CIRCULATION, V99, P1574, DOI 10.1161/01.CIR.99.12.1574; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Webb JG, 2012, J AM COLL CARDIOL, V60, P483, DOI 10.1016/j.jacc.2012.01.071; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yumino Dai, 2008, Proc Am Thorac Soc, V5, P226, DOI 10.1513/pats.200708-129MG	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133176	10.1371/journal.pone.0133176	http://dx.doi.org/10.1371/journal.pone.0133176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214183	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300014
J	Pratt, DR; Lohrer, AM; Thrush, SF; Hewitt, JE; Townsend, M; Cartner, K; Pilditch, CA; Harris, RJ; van Colen, C; Rodil, IF				Pratt, Daniel R.; Lohrer, Andrew M.; Thrush, Simon F.; Hewitt, Judi E.; Townsend, Michael; Cartner, Katie; Pilditch, Conrad A.; Harris, Rachel J.; van Colen, Carl; Rodil, Ivan F.			Detecting Subtle Shifts in Ecosystem Functioning in a Dynamic Estuarine Environment	PLOS ONE			English	Article							INTERTIDAL SANDFLATS; INTERACTION NETWORKS; MARINE; COASTAL; BIODIVERSITY; MACROFAUNA; SEDIMENTS; BIOTURBATION; DISTURBANCE; DENSITY	Identifying the effects of stressors before they impact ecosystem functioning can be challenging in dynamic, heterogeneous 'real-world' ecosystems. In aquatic systems, for example, reductions in water clarity can limit the light available for photosynthesis, with knock-on consequences for secondary consumers, though in naturally turbid wave-swept estuaries, detecting the effects of elevated turbidity can be difficult. The objective of this study was to investigate the effects of shading on ecosystem functions mediated by sandflat primary producers (microphytobenthos) and deep-dwelling surface-feeding macrofauna (Macomona liliana; Bivalvia, Veneroida, Tellinidae). Shade cloths (which reduced incident light intensity by similar to 80%) were deployed on an exposed, intertidal sandflat to experimentally stress the microphytobenthic community associated with the sediment surface. After 13 weeks, sediment properties, macrofauna and fluxes of oxygen and inorganic nutrients across the sediment-water interface were measured. A multivariate metric of ecosystem function (MF) was generated by combining flux-based response variables, and distance-based linear models were used to determine shifts in the drivers of ecosystem function between non-shaded and shaded plots. No significant differences in MF or in the constituent ecosystem function variables were detected between the shaded and non-shaded plots. However, shading reduced the total explained variation in MF (from 64% in non-shaded plots to 15% in shaded plots) and affected the relative influence of M. liliana and other explanatory variables on MF. This suggests that although shade stress may shift the drivers of ecosystem functioning (consistent with earlier investigations of shading effects on sandflat interaction networks), ecosystem functions appear to have a degree of resilience to those changes.	[Pratt, Daniel R.; Lohrer, Andrew M.; Thrush, Simon F.; Hewitt, Judi E.; Townsend, Michael; Cartner, Katie] Natl Inst Water & Atmospher Res, Hamilton, New Zealand; [Thrush, Simon F.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand; [Pilditch, Conrad A.; Harris, Rachel J.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [van Colen, Carl] Univ Ghent, Dept Biol, Marine Biol Grp, B-9000 Ghent, Belgium; [Rodil, Ivan F.] Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, P-4100 Oporto, Portugal	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland; University of Waikato; Ghent University; Universidade do Porto	Pratt, DR (corresponding author), Natl Inst Water & Atmospher Res, POB 11-115, Hamilton, New Zealand.	dan.prtt@gmail.com	Harris, Rachel Joy/R-5903-2019; Pratt, Dan/H-3919-2019; Rodil, Iván F./I-5305-2013	Harris, Rachel Joy/0000-0001-5117-7592; Pratt, Dan/0000-0003-1781-4468; Rodil, Iván F./0000-0001-6375-1598; Thrush, Simon/0000-0002-4005-3882	Ministry of Business, Innovation and Employment [CO 1X1005]; National Institute of Water and Atmospheric Research under the Coasts and Oceans Research Programme 3 [2012/13 SCI]; Flemish Fund for Scientific Research [FWO-1.2.380.11.N.00]; Xunta de Galicia, Spain	Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); National Institute of Water and Atmospheric Research under the Coasts and Oceans Research Programme 3; Flemish Fund for Scientific Research(FWO); Xunta de Galicia, Spain(Xunta de Galicia)	This work was funded by Ministry of Business, Innovation and Employment (CO 1X1005) and National Institute of Water and Atmospheric Research under the Coasts and Oceans Research Programme 3 (2012/13 SCI). C. Van Colen acknowledges a postdoctoral fellowship provided by the Flemish Fund for Scientific Research (FWO-1.2.380.11.N.00). Funding to I. F. Rodil was provided by a post-doctoral fellowship (Angeles Alvarino, Xunta de Galicia, Spain).	Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Anderson MJ, 1998, PERMANOVA PRIMER GUI; Asmus R., 1998, PRIMARY PRODUCTION M, P367; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CLAVERO V, 1992, HYDROBIOLOGIA, V235, P387, DOI 10.1007/BF00026228; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Friberg N, 2014, WIRES WATER, V1, P513, DOI 10.1002/wat2.1040; Harris RJ, 2015, MAR ECOL PROG SER, V523, P15, DOI 10.3354/meps11164; Hedman JE, 2011, J EXP MAR BIOL ECOL, V407, P294, DOI 10.1016/j.jembe.2011.06.026; Hewitt JE, 1997, J EXP MAR BIOL ECOL, V216, P77, DOI 10.1016/S0022-0981(97)00091-9; Kang CK, 2003, MAR ECOL PROG SER, V259, P79, DOI 10.3354/meps259079; Kristensen E, 2013, ESTUAR COAST SHELF S, V134, P80, DOI 10.1016/j.ecss.2013.09.020; Lelieveld SD, 2004, NEW ZEAL J MAR FRESH, V38, P115, DOI 10.1080/00288330.2004.9517223; Lohrer AM, 2010, J EXP MAR BIOL ECOL, V390, P6, DOI 10.1016/j.jembe.2010.04.035; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Lohrer AM, 2012, MAR POLLUT BULL, V64, P2761, DOI 10.1016/j.marpolbul.2012.09.012; Mccauley DJ, 2014, CONSERV BIOL, V28, P1312, DOI 10.1111/cobi.12314; Mermillod-Blondin F, 2006, AQUAT SCI, V68, P434, DOI 10.1007/s00027-006-0858-x; Michener WK, 2001, BIOSCIENCE, V51, P1018, DOI 10.1641/0006-3568(2001)051[1018:DAUB]2.0.CO;2; Needham HR, 2011, ECOSYSTEMS, V14, P1096, DOI 10.1007/s10021-011-9468-0; Norkko A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02646; Painting SJ, 2013, BIOGEOCHEMISTRY, V113, P237, DOI 10.1007/s10533-012-9774-4; Pillay D, 2007, MAR BIOL, V152, P611, DOI 10.1007/s00227-007-0715-z; Pratt DR, 2015, ESTUAR COAST, V38, P722, DOI 10.1007/s12237-014-9857-7; Pratt DR, 2014, J SEA RES, V92, P170, DOI 10.1016/j.seares.2013.07.009; PRIDMORE RD, 1990, NEW ZEAL J MAR FRESH, V24, P81, DOI 10.1080/00288330.1990.9516404; Rodil IF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081646; Rossi F, 2007, MAR BIOL, V151, P2077, DOI 10.1007/s00227-007-0641-0; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Thornton DCO, 1999, MAR ECOL PROG SER, V184, P11, DOI 10.3354/meps184011; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2014, ECOLOGY, V95, P1451, DOI 10.1890/13-1879.1; Townsend M, 2011, MAR ECOL PROG SER, V434, P291, DOI 10.3354/meps09118; Van Colen C, 2015, J SEA RES, V98, P42, DOI 10.1016/j.seares.2014.10.016; Van De Koppel J, 2001, ECOLOGY, V82, P3449, DOI 10.1890/0012-9658(2001)082[3449:DASSOI]2.0.CO;2; Villnas A, 2013, ECOLOGY, V94, P2275, DOI 10.1890/12-1716.1; Volkenborn N, 2012, J MAR RES, V70, P794, DOI 10.1357/002224012806770955; Welsh DT, 2003, CHEM ECOL, V19, P321, DOI 10.1080/0275754031000155474; Woodin SA, 2012, J EXP MAR BIOL ECOL, V413, P184, DOI 10.1016/j.jembe.2011.12.010; Woodin SA, 2010, INTEGR COMP BIOL, V50, P176, DOI 10.1093/icb/icq031; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005	51	23	23	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133914	10.1371/journal.pone.0133914	http://dx.doi.org/10.1371/journal.pone.0133914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214854	Green Published, gold			2022-12-27	WOS:000358594300040
J	Kazmi, SA; Yang, ZK; Hong, N; Wang, GP; Wang, YF				Kazmi, Syeda Amber; Yang, Zuokun; Hong, Ni; Wang, Guoping; Wang, Yanfen			Characterization by Small RNA Sequencing of Taro Bacilliform CH Virus (TaBCHV), a Novel Badnavirus	PLOS ONE			English	Article							COMPLETE GENOMIC SEQUENCE; MOTTLE VIRUS; COLOCASIA-ESCULENTA; MOSAIC-VIRUS; BANANA; DIVERSITY; DISCOVERY; CLONING	RNA silencing is an antiviral immunity that regulates gene expression through the production of small RNAs (sRNAs). In this study, deep sequencing of small RNAs was used to identify viruses infecting two taro plants. Blast searching identified five and nine contigs assembled from small RNAs of samples T1 and T2 matched onto the genome sequences of badnaviruses in the family Caulimoviridae. Complete genome sequences of two isolates of the badnavirus determined by sequence specific amplification comprised of 7,641 nucleotides and shared overall nucleotide similarities of 44.1%-55.8% with other badnaviruses. Six open reading frames (ORFs) were identified on the plus strand, showed amino acid similarities ranging from 59.8%(ORF3) to 10.2% (ORF6) to the corresponding proteins encoded by other badnaviruses. Phylogenetic analysis also supports that the virus is a new member in the genus Badnavirus. The virus is tentatively named as Taro bacilliform CH virus (TaBCHV), and it is the second badnavirus infecting taro plants, following Taro bacilliform virus (TaBV). In addition, analyzes of viral derived small RNAs (vsRNAs) from TaBCHV showed that almost equivalent number of vsRNAs were generated from both strands and the most abundant vsRNAs were 21 nt, with uracil bias at 5' terminal. Furthermore, TaBCHV vsRNAs were asymmetrically distributed on its entire circular genome at both orientations with the hotspots mainly generated in the ORF5 region.	[Kazmi, Syeda Amber; Hong, Ni; Wang, Guoping] Huazhong Agr Univ, State Key Lab Agromicrobiol, Wuhan, Hubei, Peoples R China; [Kazmi, Syeda Amber; Yang, Zuokun; Hong, Ni; Wang, Guoping; Wang, Yanfen] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Hong, N (corresponding author), Huazhong Agr Univ, State Key Lab Agromicrobiol, Wuhan, Hubei, Peoples R China.	whni@mail.hzau.edu.cn			 [nyhzx-200903017-08]		This work was financially supported by the agricultural project (nyhzx-200903017-08) administered by the Chinese Ministry of Agriculture. HN has received the funding. The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOEKE JD, 1989, ANNU REV MICROBIOL, V43, P403, DOI 10.1146/annurev.micro.43.1.403; BOUHIDA M, 1993, J GEN VIROL, V74, P15, DOI 10.1099/0022-1317-74-1-15; Brunt A, 1990, VIRUSES TROPICAL PLA; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Lara A, 2015, VIRUS GENES, V50, P104, DOI 10.1007/s11262-014-1149-6; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; HAGEN LS, 1993, VIROLOGY, V196, P619, DOI 10.1006/viro.1993.1518; Hany U, 2014, ARCH VIROL, V159, P385, DOI 10.1007/s00705-013-1824-2; Harper G, 1998, VIRUS GENES, V17, P271, DOI 10.1023/A:1008021921849; Harper G, 2005, ARCH VIROL, V150, P2407, DOI 10.1007/s00705-005-0610-1; Huang Q, 2001, J GEN VIROL, V82, P2549, DOI 10.1099/0022-1317-82-10-2549; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Kalischuka ML, 2013, VIRUS RES, V178, P306, DOI 10.1016/j.virusres.2013.09.026; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; King AMQ, 2012, VIRUS TAXONOMY 9 REP; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; LACO GS, 1995, VIROLOGY, V208, P207, DOI 10.1006/viro.1995.1144; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LOCKHART BEL, 1990, PHYTOPATHOLOGY, V80, P127, DOI 10.1094/Phyto-80-127; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marmey P, 1999, VIROLOGY, V253, P319, DOI 10.1006/viro.1998.9519; MEDBERRY SL, 1990, NUCLEIC ACIDS RES, V18, P5505, DOI 10.1093/nar/18.18.5505; MEDBERRY SL, 1993, PLANT J, V3, P619, DOI 10.1046/j.1365-313X.1993.03040619.x; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Pearson MN, 1999, AUSTRALAS PLANT PATH, V28, P248, DOI 10.1071/AP99040; Rajeswaran R, 2014, J VIROL, V88, P11516, DOI 10.1128/JVI.01496-14; Revill P, 2005, J GEN VIROL, V86, P491, DOI 10.1099/vir.0.80591-0; Revill PA, 2005, AUSTRALAS PLANT PATH, V34, P327, DOI 10.1071/AP05032; Rychlik Wojciech, 2007, V402, P35; Seguin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088513; Sether DM, 2012, PLANT DIS, V96, P1798, DOI 10.1094/PDIS-08-11-0718-RE; [施世明 Shi Shiming], 2013, [植物病理学报, Acta Phytopathologica Sinica], V43, P590; Su L, 2007, VIRUS GENES, V35, P423, DOI 10.1007/s11262-007-0102-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tzafrir I, 1997, VIROLOGY, V232, P359, DOI 10.1006/viro.1997.8569; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Wang YF, 2014, PLANT DIS, V98, P574, DOI 10.1094/PDIS-09-13-0916-PDN; Wang YL, 2014, VIRUS RES, V188, P103, DOI 10.1016/j.virusres.2014.04.006; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xu DL, 2011, VIRUS GENES, V43, P130, DOI 10.1007/s11262-011-0614-8; Yang IC, 2003, ARCH VIROL, V148, P1957, DOI 10.1007/s00705-003-0163-0; Yang IC, 2003, ARCH VIROL, V148, P937, DOI 10.1007/s00705-002-0969-1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	47	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134147	10.1371/journal.pone.0134147	http://dx.doi.org/10.1371/journal.pone.0134147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207896	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000212
J	Liang, ZF; He, XH; Ceritoglu, C; Tang, XY; Li, Y; Kutten, KS; Oishi, K; Miller, MI; Mori, S; Faria, AV				Liang, Zifei; He, Xiaohai; Ceritoglu, Can; Tang, Xiaoying; Li, Yue; Kutten, Kwame S.; Oishi, Kenichi; Miller, Michael I.; Mori, Susumu; Faria, Andreia V.			Evaluation of Cross-Protocol Stability of a Fully Automated Brain Multi-Atlas Parcellation Tool	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; IMAGE SEGMENTATION; MRI; PREDICTION; ATROPHY; CLASSIFICATION; HIPPOCAMPAL; MORPHOMETRY; STRATEGIES	Brain parcellation tools based on multiple-atlas algorithms have recently emerged as a promising method with which to accurately define brain structures. When dealing with data from various sources, it is crucial that these tools are robust for many different imaging protocols. In this study, we tested the robustness of a multiple-atlas, likelihood fusion algorithm using Alzheimer's Disease Neuroimaging Initiative (ADNI) data with six different protocols, comprising three manufacturers and two magnetic field strengths. The entire brain was parceled into five different levels of granularity. In each level, which defines a set of brain structures, ranging from eight to 286 regions, we evaluated the variability of brain volumes related to the protocol, age, and diagnosis (healthy or Alzheimer's disease). Our results indicated that, with proper pre-processing steps, the impact of different protocols is minor compared to biological effects, such as age and pathology. A precise knowledge of the sources of data variation enables sufficient statistical power and ensures the reliability of an anatomical analysis when using this automated brain parcellation tool on datasets from various imaging protocols, such as clinical databases.	[Liang, Zifei; He, Xiaohai] Sichuan Univ, Coll Elect & Informat Engn, Chengdu 610064, Peoples R China; [Kutten, Kwame S.; Miller, Michael I.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Liang, Zifei; Li, Yue; Oishi, Kenichi; Mori, Susumu; Faria, Andreia V.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Ceritoglu, Can; Tang, Xiaoying; Miller, Michael I.] Johns Hopkins Univ, Ctr Imaging Sci, Baltimore, MD USA	Sichuan University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Faria, AV (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	afaria1@jhmi.edu	Oishi, Kenichi/H-1371-2013	Oishi, Kenichi/0000-0002-1200-8611	American Heart Association [12SDG12080169]; National Institutes of Health [R03EB014367, R21AG033774, NS084957, EB017638, EB015909, NS058299]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017638, P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084957, R01NS058299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, R21AG033774] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by American Heart Association 12SDG12080169 (AVF) and National Institutes of Health: R03EB014367 (AVF), R21AG033774 (KO), NS084957 (SM), EB017638 (SM, MIM), EB015909 (SM, MIM), NS058299 (SM).	Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Beg MF, 2005, INT J COMPUT VISION, V61, P139, DOI 10.1023/B:VISI.0000043755.93987.aa; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Djamanakova A, 2014, NEUROIMAGE; Du AT, 2001, J NEUROL NEUROSUR PS, V71, P441, DOI 10.1136/jnnp.71.4.441; Eskildsen SF, 2013, NEUROIMAGE, V65, P511, DOI 10.1016/j.neuroimage.2012.09.058; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Hua X, 2009, NEUROIMAGE, V48, P668, DOI 10.1016/j.neuroimage.2009.07.011; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kovacevic S, 2009, ALZ DIS ASSOC DIS, V23, P139, DOI 10.1097/WAD.0b013e318192e745; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Mori S, 2013, ANNU REV BIOMED ENG, V15, P71, DOI 10.1146/annurev-bioeng-071812-152335; Morra JH, 2009, HUM BRAIN MAPP, V30, P2766, DOI 10.1002/hbm.20708; Pich EM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt276; Pitiot A, 2004, NEUROIMAGE, V23, pS85, DOI 10.1016/j.neuroimage.2004.07.040; Ridha BH, 2008, J NEUROL, V255, P567, DOI 10.1007/s00415-008-0750-9; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Schott JM, 2008, NEUROPSYCHOLOGIA, V46, P1732, DOI 10.1016/j.neuropsychologia.2008.02.015; Tang XY, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00061; Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065591; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang Hongzhi, 2013, Inf Process Med Imaging, V23, P548, DOI 10.1007/978-3-642-38868-2_46; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056	37	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133533	10.1371/journal.pone.0133533	http://dx.doi.org/10.1371/journal.pone.0133533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208327	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000097
J	Quaranta, N; Squeo, V; Sangineto, M; Graziano, G; Sabba, C				Quaranta, Nicola; Squeo, Valentina; Sangineto, Moris; Graziano, Giusi; Sabba, Carlo			High Total Cholesterol in Peripheral Blood Correlates with Poorer Hearing Recovery in Idiopathic Sudden Sensorineural Hearing Loss	PLOS ONE			English	Article							RISK-FACTORS; CARDIOVASCULAR RISK; CHINESE PATIENTS; DEAFNESS; DISTURBANCE; GUIDELINE; CORONARY; ADULTS	Idiopathic sudden sensorineural hearing loss (ISSHL) is a common otologic emergency whose cause is still unclear. The importance of blood lipids in the pathogenesis of ISSHL is widely reported in literature. In fact elevated levels of low density lipoprotein cholesterol (LDL), total cholesterol (TC) and apolipoprotein B (Apo-B) have been proposed as risk factors for this pathology. No correlation has been described between serum lipid parameters and the prognosis of ISSHL. Aim of the present study was to identify prognostic factors associated with hearing recovery in a group of patients affected by ISSHL. Ninety-four patients with the diagnosis of ISSHL hospitalized between March 2013 and October 2014 were included in this study. Patients' blood sampling and hearing assessments were carried out. Patients were divided into two groups as "recovered" and "unrecovered", according to their response to the treatment. We found a statistically significant higher level of total cholesterol in the unrecovered group compared to the recovered one (p=0.03). None of the other routine laboratory parameters have shown a statistically significant difference between the patients successfully treated and patients with poor outcomes. Total cholesterol concentrations may be a prognostic factor for recovery in ISSHL and should be assessed together with routine tests in patients with this condition. The other routine laboratory parameters seem to have no effect on the development and prognosis of this pathology.	[Quaranta, Nicola; Squeo, Valentina] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sensory Organs, Otolaryngol, I-70124 Bari, Italy; [Sangineto, Moris; Sabba, Carlo] Univ Bari Aldo Moro, Dept Interdisciplinary Med, Clin Med Cesare Frugoni, I-70124 Bari, Italy; [Graziano, Giusi] IRCCS Ist Tumori Giovanni Paolo II, I-70124 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II	Quaranta, N (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sensory Organs, Otolaryngol, I-70124 Bari, Italy.	nicolaantonioadolfo.quaranta@uniba.it	Graziano, Giusi/J-9083-2016; Sangineto, Moris/AAJ-8889-2021; Quaranta, Nicola/AAC-7494-2022	Graziano, Giusi/0000-0002-3347-8049; Sangineto, Moris/0000-0002-0936-8843; Quaranta, Nicola/0000-0001-6214-2336				Arruda-Olson AM, 2009, CIRC-CARDIOVASC QUAL, V2, P656, DOI 10.1161/CIRCOUTCOMES.108.831024; BYL FM, 1984, LARYNGOSCOPE, V94, P647; Cadoni G, 2010, ANN OTO RHINOL LARYN, V119, P82, DOI 10.1177/000348941011900203; Canis Martin, 2012, Clin Res Cardiol Suppl, V7, P36; Chang IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121025; Ciccone MM, 2012, ATHEROSCLEROSIS, V225, P511, DOI 10.1016/j.atherosclerosis.2012.10.024; CIUFFETTI G, 1991, LARYNGOSCOPE, V101, P65; Eisenman DJ, 2000, ARCH OTOLARYNGOL, V126, P1161, DOI 10.1001/archotol.126.9.1161; Guo YK, 2005, HEARING RES, V208, P54, DOI 10.1016/j.heares.2005.05.010; Kanzaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104680; Li J, 2014, J CLIN LAB ANAL; Lin RJ, 2012, LARYNGOSCOPE, V122, P624, DOI 10.1002/lary.22480; Lu YY, 2008, ACTA OTO-LARYNGOL, V128, P1168, DOI 10.1080/00016480801901626; Menotti A, 1997, EUR HEART J, V18, P566; Merchant SN, 2008, ORL-J OTO-RHIN-LARYN, V70, P52, DOI 10.1159/000111048; Mosnier I, 2011, AUDIOL NEURO-OTOL, V16, P55, DOI 10.1159/000312640; OHINATA Y, 1994, ACTA OTO-LARYNGOL, V114, P601, DOI 10.3109/00016489409126112; Owens AP, 2014, TRENDS CARDIOVAS MED, V24, P95, DOI 10.1016/j.tcm.2013.07.003; Quaranta N, 2008, OTOL NEUROTOL, V29, P470, DOI 10.1097/MAO.0b013e318170b650; Quaranta N, 2011, ACTA OTO-LARYNGOL, V131, P347, DOI 10.3109/00016489.2010.536990; Rudack C, 2006, THROMB HAEMOSTASIS, V95, P454, DOI 10.1160/TH05-08-0554; SHIRAISHI T, 1993, ACTA OTO-LARYNGOL, P46; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; Suzuki H, 2011, EUR ARCH OTO-RHINO-L, V268, P497, DOI 10.1007/s00405-010-1400-2; Ulu S, 2013, OTOL NEUROTOL, V34, P1400, DOI 10.1097/MAO.0b013e31829b57df; Weng TW, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-95	28	21	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133300	10.1371/journal.pone.0133300	http://dx.doi.org/10.1371/journal.pone.0133300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208311	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000076
J	Dan, XJ; King, BR; Doyon, JL; Chan, P				Dan, Xiaojuan; King, Bradley R.; Doyon, Julien; Chan, Piu			Motor Sequence Learning and Consolidation in Unilateral De Novo Patients with Parkinson's Disease	PLOS ONE			English	Article							REACTION-TIME-TASK; BASAL GANGLIA; MEMORY CONSOLIDATION; VISUOMOTOR SEQUENCE; FUNCTIONAL MRI; FRONTAL LOBES; OLDER-ADULTS; SLEEP; STRIATUM; SKILL	Previous research investigating motor sequence learning (MSL) and consolidation in patients with Parkinson's disease (PD) has predominantly included heterogeneous participant samples with early and advanced disease stages; thus, little is known about the onset of potential behavioral impairments. We employed a multisession MSL paradigm to investigate whether behavioral deficits in learning and consolidation appear immediately after or prior to the detection of clinical symptoms in the tested (left) hand. Specifically, our patient sample was limited to recently diagnosed patients with pure unilateral PD. The left hand symptomatic (LH-S) patients provided an assessment of performance following the onset of clinical symptoms in the tested hand. Conversely, right hand affected (left hand asymptomatic, LH-A) patients served to investigate whether MSL impairments appear before symptoms in the tested hand. LH-S patients demonstrated impaired learning during the initial training session and both LH-S and LH-A patients demonstrated decreased performance compared to controls during the next-day retest. Critically, the impairments in later learning stages in the LH-A patients were evident even before the appearance of traditional clinical symptoms in the tested hand. Results may be explained by the progression of disease-related alterations in relevant corticostriatal networks.	[Dan, Xiaojuan; Chan, Piu] Capital Med Univ, Dept Neurobiol & Neurol, Beijing Key Lab Parkinsons Dis, Xuanwu Hosp,Key Lab,Minist Educ Neurodegenerat Di, Beijing, Peoples R China; [King, Bradley R.; Doyon, Julien] Univ Montreal, Dept Psychol, Funct Neuroimaging Unit, Montreal, PQ H3C 3J7, Canada; [Chan, Piu] Parkinsons Dis Ctr, Beijing Inst Brain Disorders, Beijing, Peoples R China	Capital Medical University; Universite de Montreal	Chan, P (corresponding author), Capital Med Univ, Dept Neurobiol & Neurol, Beijing Key Lab Parkinsons Dis, Xuanwu Hosp,Key Lab,Minist Educ Neurodegenerat Di, Beijing, Peoples R China.	pbchan90@gmail.com	King, Bradley/U-1820-2018; Chan, Piu/I-4580-2016	King, Bradley/0000-0002-3010-8755; Chan, Piu/0000-0003-1346-881X	Ministry of Science and Technology of China [2012AA02A514]; National Basic Research Development Program of China [2011CB504101]; Ministry of Health [201002011]; Beijing High Standard Health Human Resource Cultural Program in Health System [2009e1e12]; European Commission - ERA Net Neuron [26659]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Basic Research Development Program of China(National Basic Research Program of China); Ministry of Health; Beijing High Standard Health Human Resource Cultural Program in Health System; European Commission - ERA Net Neuron(European CommissionEuropean Commission Joint Research Centre); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	The study was supported by grants from the Ministry of Science and Technology of China (2012AA02A514), the National Basic Research Development Program of China (2011CB504101), Ministry of Health (201002011), Beijing High Standard Health Human Resource Cultural Program in Health System (2009e1e12) awarded to P.C. as well as the European Commission - ERA Net Neuron (Identifying #26659) awarded to J.D. Postdoctoral fellowship support for author B.R.K. was provided by the Fonds de la Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino R, 2004, MOVEMENT DISORD, V19, P1285, DOI 10.1002/mds.20247; Albouy G, 2015, NEUROIMAGE, V108, P423, DOI 10.1016/j.neuroimage.2014.12.049; Albouy G, 2013, HIPPOCAMPUS, V23, P985, DOI 10.1002/hipo.22183; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Brown RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006683; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Debas K, 2010, P NATL ACAD SCI USA, V107, P17839, DOI 10.1073/pnas.1013176107; Deroost N, 2006, NEUROPSYCHOLOGIA, V44, P1653, DOI 10.1016/j.neuropsychologia.2006.03.021; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Doyon J, 1998, NEUROPSYCHOLOGIA, V36, P625, DOI 10.1016/S0028-3932(97)00168-1; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2008, CURR OPIN NEUROL, V21, P478, DOI 10.1097/WCO.0b013e328304b6a3; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fogel SM, 2014, HUM BRAIN MAPP, V35, P3625, DOI 10.1002/hbm.22426; Ghilardi MF, 2003, NEUROLOGY, V60, P1313, DOI 10.1212/01.WNL.0000059545.69089.EE; Helmuth LL, 2000, NEUROPSYCHOLOGIA, V38, P1443, DOI 10.1016/S0028-3932(00)00059-2; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kwak Y, 2013, J MOTOR BEHAV, V45, P423, DOI 10.1080/00222895.2013.817380; Kwak Y, 2012, BEHAV BRAIN RES, V230, P116, DOI 10.1016/j.bbr.2012.02.006; Kwak Y, 2010, J NEUROPHYSIOL, V103, P942, DOI 10.1152/jn.00197.2009; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Marek KL, 1996, NEUROLOGY, V46, P231, DOI 10.1212/WNL.46.1.231; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; MARSDEN CD, 1994, BRAIN, V117, P877, DOI 10.1093/brain/117.4.877; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Muslimovic D, 2007, BRAIN, V130, P2887, DOI 10.1093/brain/awm211; NAHMIAS C, 1985, J NEUROL SCI, V69, P223, DOI 10.1016/0022-510X(85)90135-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penhune VB, 2002, J NEUROSCI, V22, P1397, DOI 10.1523/JNEUROSCI.22-04-01397.2002; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Ruitenberg MFL, 2015, CORTEX, V65, P102, DOI 10.1016/j.cortex.2015.01.005; Schwarz J, 2000, ARCH NEUROL-CHICAGO, V57, P205, DOI 10.1001/archneur.57.2.205; Seidler RD, 2007, BRAIN RES, V1137, P104, DOI 10.1016/j.brainres.2006.12.057; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Siegert RJ, 2006, NEUROPSYCHOLOGY, V20, P490, DOI 10.1037/0894-4105.20.4.490; Smith J, 2001, BRAIN COGNITION, V45, P378, DOI 10.1006/brcg.2001.1286; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Stefanova ED, 2000, MOVEMENT DISORD, V15, P1095, DOI 10.1002/1531-8257(200011)15:6<1095::AID-MDS1006>3.0.CO;2-R; Stephan MA, 2011, BRAIN COGNITION, V75, P135, DOI 10.1016/j.bandc.2010.10.015; Terpening Z, 2013, J SLEEP RES, V22, P398, DOI 10.1111/jsr.12028; Tessa C, 2013, PARKINSONISM RELAT D, V19, P265, DOI 10.1016/j.parkreldis.2012.07.018; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Williams JR, 2012, NEUROLOGY, V78, P998, DOI 10.1212/WNL.0b013e31824d587f; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	56	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134291	10.1371/journal.pone.0134291	http://dx.doi.org/10.1371/journal.pone.0134291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222151	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800124
J	Drummond, H; Rodriguez, C				Drummond, Hugh; Rodriguez, Cristina			Viability of Booby Offspring is Maximized by Having One Young Parent and One Old Parent	PLOS ONE			English	Article							BLUE-FOOTED BOOBY; PATERNAL AGE; DIFFERENTIAL ALLOCATION; REPRODUCTIVE SUCCESS; BREEDING PERFORMANCE; MATERNAL AGE; GOOD GENES; FEMALE; SENESCENCE; QUALITY	It is widely expected that the quality of offspring will vary with the age of their parents and that this variation should influence animals' choice of mates. However, theoretical predictions for age effects are contradictory and, to our knowledge, we do not know for any wild animal how the quality of offspring is affected by both parents' ages across their lifespans, or whether mothers' and fathers' ages interact. We tackled this question using long-term data on a highly philopatric, insular population of the blue-footed booby (Sula nebouxii). In this species extra-pair paternity is most common in pairs of two young parents or two old parents, implying that these age combinations might prejudice offspring quality. Analysis of the viability of 3,361 offspring of parents up to 21 years old revealed that fledglings with two young parents or two old parents were least likely to become breeders, whereas fledglings with one young parent and one old parent were most likely to do so. For young parents of either sex, offspring viability increased with age of the other parent; for very old parents, it decreased. These effects could be mediated by parents flexibly modifying their investment in offspring in response to their own and their partners 'ages, but evidence for this was lacking. In 5,343 breeding attempts, although mothers' and fathers' ages independently affected four heavily care-dependent breeding traits at the clutch and nestling stages, their interaction did not affect any trait. The effects of parental age combinations on viability could also be mediated by genes: fledglings with one young parent and one old parent could benefit from greater heterozygosity or better genes.	[Drummond, Hugh; Rodriguez, Cristina] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolutiva, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Drummond, H (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolutiva, Mexico City 04510, DF, Mexico.	hugh@unam.mx			Consejo Nacional de Ciencia y Tecnologia [4722-N9407, C01-47599, D112-903581, PCCNCNA-031528, 31973-H, 34500V, 104313]; Universidad Nacional Autonoma de Mexico (PAPIIT) [IN211491, IN-200702-3, IN206610-3, IN205313]; National Geographic Society	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); National Geographic Society(National Geographic Society)	Finance was provided by the Consejo Nacional de Ciencia y Tecnologia (4722-N9407, C01-47599, D112-903581, PCCNCNA-031528, 31973-H, 34500V, 104313), the Universidad Nacional Autonoma de Mexico (PAPIIT, IN211491, IN-200702-3, IN206610-3, IN205313) and the National Geographic Society (1992, 1996).	Balbontin J, 2007, J ANIM ECOL, V76, P915, DOI 10.1111/j.1365-2656.2007.01269.x; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beamonte-Barrientos R, 2010, AM NAT, V175, P469, DOI 10.1086/650726; Beck CW, 2000, EVOL ECOL RES, V2, P107; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Bille C, 2005, EPIDEMIOLOGY, V16, P311, DOI 10.1097/01.ede.0000158745.84019.c2; Bluhm CK, 2004, ANIM BEHAV, V68, P985, DOI 10.1016/j.anbehav.2004.01.012; Bogdanova MI, 2006, FUNCT ECOL, V20, P132, DOI 10.1111/j.1365-2435.2006.01088.x; Bouwhuis S, 2010, J EVOLUTION BIOL, V23, P636, DOI 10.1111/j.1420-9101.2009.01929.x; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Carmichael AN, 2000, J MOL EVOL, V50, P443, DOI 10.1007/s002390010046; Cichon M, 2003, OECOLOGIA, V134, P78, DOI 10.1007/s00442-002-1099-x; Crawley M.J., 2007, R BOOK; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Descamps S, 2008, OIKOS, V117, P1406, DOI 10.1111/j.0030-1299.2008.16545.x; Drummond H, 2003, AM NAT, V161, P794, DOI 10.1086/375170; Ellegren H, 2007, P ROY SOC B-BIOL SCI, V274, P1, DOI 10.1098/rspb.2006.3720; ELLNER S, 1994, AM NAT, V143, P403, DOI 10.1086/285610; Ellner S, 1996, THEOR POPUL BIOL, V50, P31, DOI 10.1006/tpbi.1996.0022; Fisch H, 2003, J UROLOGY, V169, P2275, DOI 10.1097/01.ju.0000067958.36077.d8; Forstmeier W, 2014, TRENDS ECOL EVOL, V29, P456, DOI 10.1016/j.tree.2014.05.005; Fuerst-Waltl B, 2004, J DAIRY SCI, V87, P2293, DOI 10.3168/jds.S0022-0302(04)70050-8; Garcia-Palomares S, 2009, BIOL REPROD, V80, P337, DOI 10.1095/biolreprod.108.072066; Gonzalez-Solis J, 2004, J ORNITHOL, V145, P129, DOI 10.1007/s10336-004-0023-z; Green RF, 2010, ANN EPIDEMIOL, V20, P241, DOI 10.1016/j.annepidem.2009.10.009; Griffith SC, 2009, J AVIAN BIOL, V40, P97, DOI 10.1111/j.1600-048X.2009.04562.x; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Harris WE, 2009, PHILOS T R SOC B, V364, P1039, DOI 10.1098/rstb.2008.0299; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; Hegyi G, 2006, BEHAV ECOL SOCIOBIOL, V60, P672, DOI 10.1007/s00265-006-0211-3; Johnson SL, 2012, BIOESSAYS, V34, P609, DOI 10.1002/bies.201100157; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Jones TM, 2000, P ROY SOC B-BIOL SCI, V267, P681, DOI 10.1098/rspb.2000.1056; Kim SY, 2007, BEHAV ECOL, V18, P1132, DOI 10.1093/beheco/arm091; Kim SY, 2011, OECOLOGIA, V166, P615, DOI 10.1007/s00442-011-1914-3; Kokko H, 1998, EVOL ECOL, V12, P739, DOI 10.1023/A:1006541701002; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P1533, DOI 10.1098/rspb.1996.0224; Krishna MS, 2012, ZOOL STUD, V51, P72; Limmer B, 2009, ANIM BEHAV, V77, P1095, DOI 10.1016/j.anbehav.2009.01.015; Liu YS, 2011, AGEING RES REV, V10, P115, DOI 10.1016/j.arr.2010.09.004; MANNING JT, 1985, J THEOR BIOL, V116, P349, DOI 10.1016/S0022-5193(85)80273-3; McCleery RH, 2008, P R SOC B, V275, P963, DOI 10.1098/rspb.2007.1418; Michl G, 2005, BEHAV ECOL, V16, P383, DOI 10.1093/beheco/ari002; Moller AP, 2009, J EVOLUTION BIOL, V22, P334, DOI 10.1111/j.1420-9101.2008.01650.x; Moore PJ, 2003, P ROY SOC B-BIOL SCI, V270, pS192, DOI 10.1098/rsbl.2003.0051; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Nikola T, 2004, EVOL ECOL, V18, P187, DOI 10.1023/B:EVEC.0000021090.51851.bd; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; Osorio-Beristain M, 1998, BEHAV ECOL SOCIOBIOL, V43, P307, DOI 10.1007/s002650050496; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Postma M, 2013, POLAR BIOL, V36, P719, DOI 10.1007/s00300-013-1298-4; Preston BT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7146; Price DK, 1998, BEHAV GENET, V28, P395, DOI 10.1023/A:1021677804038; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramos AG, 2014, BEHAV ECOL SOCIOBIOL, V68, P1603, DOI 10.1007/s00265-014-1769-9; Ratikainen II, 2010, BEHAV ECOL, V21, P195, DOI 10.1093/beheco/arp168; Rebke M, 2010, P NATL ACAD SCI USA, V107, P7841, DOI 10.1073/pnas.1002645107; Richard M, 2005, MOL ECOL, V14, P3147, DOI 10.1111/j.1365-294X.2005.02662.x; Saino N, 2002, J ANIM ECOL, V71, P309, DOI 10.1046/j.1365-2656.2002.00600.x; Sanchez-Macouzet O, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2843; Sartorius GA, 2010, HUM REPROD UPDATE, V16, P65, DOI 10.1093/humupd/dmp027; Sayres MAW, 2011, BIOESSAYS, V33, P938, DOI 10.1002/bies.201100091; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Serre V, 1998, FERTIL STERIL, V70, P625, DOI 10.1016/S0015-0282(98)00259-3; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Skaug H, 2011, GEN LINEAR MIXED MOD, pr143; Torres R, 2003, BEHAV ECOL SOCIOBIOL, V55, P65, DOI 10.1007/s00265-003-0669-1; Torres R, 2011, PLOS ONE, V6, P11, DOI [10.1371/journal.pone.0027245, DOI 10.1371/J0URNAL.P0NE.0027245]; Torres R, 2007, J ANIM ECOL, V76, P1161, DOI 10.1111/j.1365-2656.2007.01282.x; Velando A, 2011, J EVOLUTION BIOL, V24, P693, DOI 10.1111/j.1420-9101.2010.02201.x; Velando A, 2008, BIOESSAYS, V30, P1212, DOI 10.1002/bies.20838; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; Wang MH, 2000, NATURE, V407, P469, DOI 10.1038/35035156; WILK MB, 1968, BIOMETRIKA, V55, P1	80	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133213	10.1371/journal.pone.0133213	http://dx.doi.org/10.1371/journal.pone.0133213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221951	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800042
J	Fellman, JB; Hood, E; Dryer, W; Pyare, S				Fellman, Jason B.; Hood, Eran; Dryer, William; Pyare, Sanjay			Stream Physical Characteristics Impact Habitat Quality for Pacific Salmon in Two Temperate Coastal Watersheds	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; GLACIER COVERAGE; CLIMATE-CHANGE; TEMPORAL VARIABILITY; BRITISH-COLUMBIA; THERMAL REGIME; OXYGEN; RIVER; TROUT; FLOW	Climate warming is likely to cause both indirect and direct impacts on the biophysical properties of stream ecosystems especially in regions that support societally important fish species such as Pacific salmon. We studied the seasonal variability and interaction between stream temperature and DO in a low-gradient, forested stream and a glacial-fed stream in coastal southeast Alaska to assess how these key physical parameters impact freshwater habitat quality for salmon. We also use multiple regression analysis to evaluate how discharge and air temperature influence the seasonal patterns in stream temperature and DO. Mean daily stream temperature ranged from 1.1 to 16.4 degrees C in non-glacial Peterson Creek but only 1.0 to 8.8 degrees C in glacial-fed Cowee Creek, reflecting the strong moderating influence glacier meltwater had on stream temperature. Peterson Creek had mean daily DO concentrations ranging from 3.8 to 14.1mg L-1 suggesting future climate changes could result in an even greater depletion in DO. Mean daily stream temperature strongly controlled mean daily DO in both Peterson ( R-2 = 0.82, P<0.01) and Cowee Creek ( R-2=0.93, P<0.01). However, DO in Peterson Creek was mildly related to stream temperature ( R-2=0.15, P<0.01) and strongly influenced by discharge ( R-2=0.46, P<0.01) on days when stream temperature exceeded 10 degrees C. Moreover, Peterson Creek had DO values that were particularly low (<5.0 mg L-1) on days when discharge was low but also when spawning salmon were abundant. Our results demonstrate the complexity of stream temperature and DO regimes in coastal temperate watersheds and highlight the need for watershed managers to move towards multi-factor risk assessment of potential habitat quality for salmon rather than single factor assessments alone.	[Fellman, Jason B.; Hood, Eran; Dryer, William; Pyare, Sanjay] Univ Alaska Southeast, Environm Sci & Geog Program, Juneau, AK 99801 USA	University of Alaska System; University of Alaska Southeastern	Fellman, JB (corresponding author), Univ Alaska Southeast, Environm Sci & Geog Program, Juneau, AK 99801 USA.	jbfellman@uas.alaska.edu			Department of Interior Alaska Climate Science Center; U. S. National Science Foundation [OIA-1208927]; Office of Integrative Activities [1208927] Funding Source: National Science Foundation	Department of Interior Alaska Climate Science Center; U. S. National Science Foundation(National Science Foundation (NSF)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by the Department of Interior Alaska Climate Science Center and the U. S. National Science Foundation (#OIA-1208927).	ALABASTER JS, 1989, J FISH BIOL, V34, P331, DOI 10.1111/j.1095-8649.1989.tb03315.x; Arendt A, 2009, J CLIMATE, V22, P4117, DOI 10.1175/2009JCLI2784.1; Armstrong JB, 2013, ECOSYSTEMS, V16, P1429, DOI 10.1007/s10021-013-9693-9; Armstrong JB, 2013, ECOLOGY, V94, P2066, DOI 10.1890/12-1200.1; Bacon PJ, 2005, J ANIM ECOL, V74, P1, DOI 10.1111/j.1365-2656.2004.00875.x; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Blaen PJ, 2013, HYDROL PROCESS, V27, P2958, DOI 10.1002/hyp.9431; Brabets T, 2001, 014109 US GEOL SURV, P24; Brett J. R., 1971, INTEGR COMP BIOL, V11, P99, DOI [DOI 10.1093/ICB/11.1.99, 10.1093/ICB/11.1.99]; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; Brown LE, 2007, GLOBAL CHANGE BIOL, V13, P958, DOI 10.1111/j.1365-2486.2007.01341.x; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Carter K., 2005, EFFECTS DISSOLVED OX; Connolly NM, 2004, J N AM BENTHOL SOC, V23, P251, DOI 10.1899/0887-3593(2004)023&lt;0251:EOLDOO&gt;2.0.CO;2; DAVIS GERALD E., 1963, TRANS AMER FISH SOC, V92, P111, DOI 10.1577/1548-8659(1963)92[111:TIOOCO]2.0.CO;2; Dewson ZS, 2007, J N AM BENTHOL SOC, V26, P401, DOI 10.1899/06-110.1; Dorava JM, 2000, HYDROL PROCESS, V14, P3149, DOI 10.1002/1099-1085(200011/12)14:16/17<3149::AID-HYP139>3.3.CO;2-P; Dugdale SJ, 2013, REMOTE SENS ENVIRON, V136, P358, DOI 10.1016/j.rse.2013.05.018; EATON JG, 1995, FISHERIES, V20, P10, DOI 10.1577/1548-8446(1995)020<0010:AFISFE>2.0.CO;2; Fellman JB, 2014, ECOSYSTEMS, V17, P1014, DOI 10.1007/s10021-014-9777-1; Fellman JB, 2014, HYDROL PROCESS, V28, P2062, DOI 10.1002/hyp.9742; Fleming SW, 2005, J HYDRAUL ENG-ASCE, V131, P615, DOI 10.1061/(ASCE)0733-9429(2005)131:7(615); FOUNTAIN AG, 1985, WATER RESOUR RES, V21, P579, DOI 10.1029/WR021i004p00579; Geist DR, 2006, T AM FISH SOC, V135, P1462, DOI 10.1577/T05-294.1; Graeber D, 2013, HYDROBIOLOGIA, V717, P147, DOI 10.1007/s10750-013-1570-1; HALUPKA KC, 2002, PNW468 USDA FOR SERV; Hannah DM, 2005, J HYDROL, V308, P18, DOI 10.1016/j.jhydrol.2004.10.018; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Holtgrieve GW, 2011, ECOLOGY, V92, P373, DOI 10.1890/09-1694.1; Hood E, 2007, LIMNOL OCEANOGR, V52, P1580, DOI 10.4319/lo.2007.52.4.1580; Hood E, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000971; Hrachowitz M, 2010, HYDROL PROCESS, V24, P3374, DOI 10.1002/hyp.7756; Imholt C, 2013, RIVER RES APPL, V29, P403, DOI 10.1002/rra.1608; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Kelleher C, 2012, HYDROL PROCESS, V26, P771, DOI 10.1002/hyp.8186; KNAPP G, 2007, GREAT SALMON RUN COM; Krider LA, 2013, J AM WATER RESOUR AS, V49, P896, DOI 10.1111/jawr.12046; Larsen CF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000586; Levi PS, 2013, ECOSYSTEMS, V16, P269, DOI 10.1007/s10021-012-9613-4; Lightfoot G, 2008, SCHO0808BOLVEP ENV A, P42; Lisi PJ, 2013, GEOMORPHOLOGY, V185, P78, DOI 10.1016/j.geomorph.2012.12.013; Lisi PJ, 2014, GEOPHYS RES IN PRESS; Mark BG, 2007, ENVIRON SCI TECHNOL, V41, P6955, DOI 10.1021/es071099d; Matthews KR, 1997, J FISH BIOL, V50, P50, DOI 10.1111/j.1095-8649.1997.tb01339.x; Mauger S, 2011, 1101 COOK INL; McAfee SA, 2014, HYDROL PROCESS, V28, P3930, DOI 10.1002/hyp.9934; Milner AM, 2009, HYDROL PROCESS, V23, P62, DOI 10.1002/hyp.7197; Mitchell NL, 2005, LIMNOL OCEANOGR, V50, P217, DOI 10.4319/lo.2005.50.1.0217; Moore R. D., 2006, Canadian Water Resources Journal, V31, P41; Moore RD, 2013, CAN WATER RESOUR J, V38, P135, DOI 10.1080/07011784.2013.794992; Neal EG, 2002, J HYDROL, V263, P188, DOI 10.1016/S0022-1694(02)00058-6; Nelitz MA, 2007, N AM J FISH MANAGE, V27, P405, DOI 10.1577/M05-146.1; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Radic V, 2011, NAT GEOSCI, V4, P91, DOI [10.1038/ngeo1052, 10.1038/NGEO1052]; REYNOLDS WW, 1974, COPEIA, P747; Richards J, 2012, HYDROL PROCESS, V26, P2687, DOI 10.1002/hyp.8360; Richards J, 2011, HYDROL PROCESS, V25, P4154, DOI 10.1002/hyp.8343; Rieman BE, 2007, T AM FISH SOC, V136, P1552, DOI 10.1577/T07-028.1; Rietti-Shati M, 2000, CHEM GEOL, V166, P341, DOI 10.1016/S0009-2541(99)00233-8; Ruggerone GT, 2000, J FISH BIOL, V56, P1013, DOI 10.1111/j.1095-8649.2000.tb00889.x; Sear DA, 2014, HYDROL PROCESS, V28, P86, DOI 10.1002/hyp.9565; Sergeant CJ, 2015, RIVER RES APPL, V31, P602, DOI 10.1002/rra.2767; Shanley C, 2015, CLIMATE CHA IN PRESS; Shanley CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104799; SPOOR WA, 1990, J FISH BIOL, V36, P363, DOI 10.1111/j.1095-8649.1990.tb05616.x; Stahl K, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR005956; Stahl K, 2006, WATER RESOUR RES, V42, DOI 10.1029/2006WR005022; Sullivan K., 2000, ANAL EFFECTS TEMPERA; Trepanier S, 1996, J FISH BIOL, V48, P925, DOI 10.1111/j.1095-8649.1996.tb01487.x; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Whited DC, 2007, ECOLOGY, V88, P940, DOI 10.1890/05-1149; WHITMORE CECIL M., 1960, TRANS AMER FISH SOC, V89, P17, DOI 10.1577/1548-8659(1960)89[17:AROSAC]2.0.CO;2	73	23	35	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132652	10.1371/journal.pone.0132652	http://dx.doi.org/10.1371/journal.pone.0132652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222506	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800027
J	Koehn, D; Meyer, KJ; Syed, NA; Anderson, MG				Koehn, Demelza; Meyer, Kacie J.; Syed, Nasreen A.; Anderson, Michael G.			Ketamine/Xylazine-Induced Corneal Damage in Mice	PLOS ONE			English	Article							BAND KERATOPATHY; MOUSE MODELS; KETAMINE; XYLAZINE; RATS; SUSCEPTIBILITY; ANESTHESIA; THICKNESS; CATARACT; GLAUCOMA	Purpose We have observed that the commonly used ketamine/xylazine anesthesia mix can induce a focally severe and permanent corneal opacity. The purpose of this study was to establish the clinical and histological features of this deleterious side effect, its sensitivity with respect to age and anesthesia protocol, and approaches for avoiding it. Methods Young C57BL/6J, C57BLKS/J, and SJL/J mice were treated with permutations of anesthesia protocols and compared using slit-lamp exams, optical coherence tomography, histologic analyses, and telemetric measurements of body temperature. Results Ketamine/xylazine induces corneal damage in mice with a variable frequency. Among 12 experimental cohorts, corneal damage associated with ketamine/xylazine was observed in 9 of them. Despite various treatments to avoid corneal dehydration during anesthesia, the frequency of corneas experiencing damage among responding cohorts was 42% (26% inclusive of all cohorts), which is significantly greater than the natural prevalence (5%). The damage was consistent with band keratopathy. It appeared as a white or gray horizontal band located proximal to the pupil and was positive for subepithelial calcium deposition with von Kossa stain. Conclusions The sum of our clinical and histological observations is consistent with ketamine/xylazine-induced band keratopathy in mice. This finding is relevant for mouse studies involving the eye and/or vision-dependent behavioral assays, which would both be prone to artifact without appreciation of the damage caused by ketamine/xylazine anesthesia. Use of yohimbine is suggested as a practical means of avoiding this complication.	[Koehn, Demelza; Meyer, Kacie J.; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Syed, Nasreen A.; Anderson, Michael G.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Syed, Nasreen A.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Anderson, Michael G.] Iowa City VA Hlth Care Syst, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Anderson, MG (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	michael-g-anderson@uiowa.edu	Anderson, Michael/B-4580-2009	Anderson, Michael/0000-0001-5730-6105; Syed, Nasreen/0000-0002-7192-0774	National Institutes of Health [EY021436, EY017673, EY018825]; NATIONAL EYE INSTITUTE [R01EY017673, R01EY018825, F32EY021436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the following: National Institutes of Health EY021436 (to DK) (http://www.nih.gov/) and National Institutes of Health EY017673 and EY018825 (to MGA) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Bartsch U, 2013, INVEST OPHTH VIS SCI, V54, P6952, DOI 10.1167/iovs.13-12945; Bergman S A, 1999, Anesth Prog, V46, P10; Bhutta AT, 2007, SEMIN PERINATOL, V31, P303, DOI 10.1053/j.semperi.2007.07.005; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Ding C, 2011, EXP EYE RES, V92, P512, DOI 10.1016/j.exer.2011.03.016; Dolansky G, 2008, PAED CHILD HEALT-CAN, V13, P307, DOI 10.1093/pch/13.4.307; Dursun I, 2011, ALCOHOL CLIN EXP RES, V35, P2063, DOI 10.1111/j.1530-0277.2011.01557.x; Eagle RC., 2011, EYE PATHOLOGY ATLAS; Fario QA, 2004, OPHTHALMOLOGY; Gaertner DJ, 2008, AM COLL LAB, P239, DOI 10.1016/B978-012373898-1.50014-0; Graw J, 2009, J GENET, V88, P469, DOI 10.1007/s12041-009-0066-2; GREENE SA, 1988, J VET PHARMACOL THER, V11, P295, DOI 10.1111/j.1365-2885.1988.tb00189.x; GUILLET R, 1988, INVEST OPHTH VIS SCI, V29, P949; HOFFMAN RW, 1983, ARTHRITIS RHEUM, V26, P645, DOI 10.1002/art.1780260511; Islam MS, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/149452; Jhanji V, 2011, CURR OPIN OPHTHALMOL, V22, P283, DOI 10.1097/ICU.0b013e3283477d36; Jones NP, 2013, UVEITIS; Lively GD, 2010, PHYSIOL GENOMICS, V42, P281, DOI 10.1152/physiolgenomics.00140.2009; Lively GD, 2010, INVEST OPHTH VIS SCI, V51, P160, DOI 10.1167/iovs.09-3429; Mao M, 2011, INVEST OPHTH VIS SCI, V52, P2679, DOI 10.1167/iovs.10-5993; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; O'Connor G R, 1972, Trans Am Ophthalmol Soc, V70, P58; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Qiu YG, 2014, CURR EYE RES, V39, P365, DOI 10.3109/02713683.2013.845224; Seo S, 2013, INVEST OPHTH VIS SCI, V54, P6118, DOI 10.1167/iovs.13-11673; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Son AI, 2013, MOL VIS, V19, P254; Song J, 2003, INVEST OPHTH VIS SCI, V44, P548, DOI 10.1167/iovs.02-0592; Starte JM, 2012, CORNEA, V31, P572, DOI 10.1097/ICO.0b013e31823f8af4; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Tita B, 2001, OPHTHALMIC RES, V33, P345, DOI 10.1159/000055692; Turner PV, 2005, COMPARATIVE MED, V55, P175; Wood D, 2011, BJU INT, V107, P1881, DOI 10.1111/j.1464-410X.2010.10031.x; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	37	26	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132804	10.1371/journal.pone.0132804	http://dx.doi.org/10.1371/journal.pone.0132804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222692	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800029
J	Paiva, RJO; Brites, RS; Machado, RB				Oliveira Paiva, Rodrigo Jose; Brites, Ricardo Seixas; Machado, Ricardo Bomfim			The Role of Protected Areas in the Avoidance of Anthropogenic Conversion in a High Pressure Region: A Matching Method Analysis in the Core Region of the Brazilian Cerrado	PLOS ONE			English	Article							LAND-USE; AVOIDED DEFORESTATION; CONSERVATION; BIODIVERSITY; LOCATION; HISTORY; RESERVE; IMPACT; GOVERNANCE; VEGETATION	Global efforts to avoid anthropogenic conversion of natural habitat rely heavily on the establishment of protected areas. Studies that evaluate the effectiveness of these areas with a focus on preserving the natural habitat define effectiveness as a measure of the influence of protected areas on total avoided conversion. Changes in the estimated effectiveness are related to local and regional differences, evaluation methods, restriction categories that include the protected areas, and other characteristics. The overall objective of this study was to evaluate the effectiveness of protected areas to prevent the advance of the conversion of natural areas in the core region of the Brazil's Cerrado Biome, taking into account the influence of the restriction degree, governmental sphere, time since the establishment of the protected area units, and the size of the area on the performance of protected areas. The evaluation was conducted using matching methods and took into account the following two fundamental issues: control of statistical biases caused by the influence of covariates on the likelihood of anthropogenic conversion and the non-randomness of the allocation of protected areas throughout the territory (spatial correlation effect) and the control of statistical bias caused by the influence of auto-correlation and leakage effect. Using a sample design that is not based on ways to control these biases may result in outcomes that underestimate or overestimate the effectiveness of those units. The matching method accounted for a bias reduction in 94-99% of the estimation of the average effect of protected areas on anthropogenic conversion and allowed us to obtain results with a reduced influence of the auto-correlation and leakage effects. Most protected areas had a positive influence on the maintenance of natural habitats, although wide variation in this effectiveness was dependent on the type, restriction, governmental sphere, size and age group of the unit.	[Oliveira Paiva, Rodrigo Jose; Brites, Ricardo Seixas] Univ Brasilia, Inst Geociencias, Programa Posgrad Geociencias Aplicadas, Brasilia, DF, Brazil; [Machado, Ricardo Bomfim] Univ Brasilia, Dept Zool, Programa Posgrad Zool, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia	Paiva, RJO (corresponding author), Univ Brasilia, Inst Geociencias, Programa Posgrad Geociencias Aplicadas, Brasilia, DF, Brazil.	drigojbio@gmail.com	Machado, Ricardo Bomfim/J-5894-2012; Machado, Ricardo/GXM-8198-2022	Machado, Ricardo Bomfim/0000-0002-6508-9005; Brites, Ricardo/0000-0002-8471-8823	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RBM received a research grant from CNPq (http://www.cnpq.br/).	Abbot JIO, 1999, J APPL ECOL, V36, P422, DOI 10.1046/j.1365-2664.1999.00413.x; Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Angelsen A., 2009, REALISING REDD NATL; Barber CP, 2012, BIOL CONSERV, V149, P6, DOI 10.1016/j.biocon.2011.08.024; Beltran J., 2000, BEST PRACT PROTECT A, V4; Bernard E, 2014, CONSERV BIOL, V28, P939, DOI 10.1111/cobi.12298; Brandon K., 1998, PARKS PERIL PEOPLE P; Brasil, 2007, INFORME NACL AREAS P; Bray D. B., 2008, Ecology and Society, V13, P56; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Carranza T, 2014, CONSERV LETT, V7, P216, DOI 10.1111/conl.12049; CBD, 2010, C PART CONV BIOL DIV; Chape S., 2009, BIOSCIENCE, V59, P623; Cropper M, 2001, LAND ECON, V77, P172, DOI 10.2307/3147088; CSR/IBAMA, 2013, PROJ MON DESM BIOM B; Diniz Filho J.A.F., 2009, OECOLOGIA BRAS, V13, P470, DOI DOI 10.4257/0EC0.2009.1303.05; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; Evans Sterling, 1999, GREEN REPUBLIC CONSE; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; FELFILI J. M., 2005, CERRADO ECOLOGIA BIO; Ferraro PJ, 2007, PROTECTED AREAS AVOI; Ferreira L.G, 2008, ENCRUZILHAD SOCIOAMB; Ferreira ME, 2009, REV BRASILEIRA CARTO, V61, P37; FUNAI, 2013, MAP TERR IND BRAS; Gangl M., 2004, RBOUNDS STATA MODULE; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; IBGE, 2013, IBGE SER HIST EST PO; INCRA, 2013, MAP TERR QUIL INCRA; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2004, MAP BIOM BRAS; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Klink C.A., 2002, CERRADOS BRAZIL ECOL, P69, DOI DOI 10.7312/0LIV12042; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Leverington F, 2010, MANAGEMENT EFFECTIVE; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Machado A. B. M., 2008, RED BOOK BRAZILIAN F; MARGULES CR, 1988, BIOL CONSERV, V43, P63, DOI 10.1016/0006-3207(88)90078-X; Martinelli G, 2013, LIVRO VERMALHO FLORA; Mas JF, 2005, ENVIRON MONIT ASSESS, V105, P69, DOI 10.1007/s10661-005-3156-5; Mistry J., 2000, WORLD SAVANNAS ECOLO; Mittermeier RA, 2005, CONSERV BIOL, V19, P601, DOI 10.1111/j.1523-1739.2005.00709.x; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; MMA, 2013, MAP UN CONS MMA; MMA, 2010, 4 MMA CONV BIOL DIV; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; NELSON A, 2009, PROTECTED AREA EFFEC; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nelson GC, 2013, LAND ECON, V77, P187; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Pauchard A, 2002, NAT AREA J, V22, P318; Pelkey NW, 2000, BIOL CONSERV, V94, P297, DOI 10.1016/S0006-3207(99)00195-0; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff A, 2012, OXFORD REV ECON POL, V28, P164, DOI 10.1093/oxrep/grs012; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; R Core Team, 2019, R LANG ENV STAT COMP; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Robalino JA, 2012, J DEV ECON, V97, P427, DOI 10.1016/j.jdeveco.2011.06.003; Rocha G.F., 2012, REV BRAS CARTOGR, V63, P341; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Rylands AB, 2005, CONSERV BIOL, V19, P612, DOI 10.1111/j.1523-1739.2005.00711.x; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Silva JF, 2006, J BIOGEOGR, V33, P536, DOI 10.1111/j.1365-2699.2005.01422.x; Siqueira Marinez Ferreira de, 2003, Biota Neotrop., V3, P1, DOI 10.1590/S1676-06032003000200005; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; UNEP, 2004, US EC INSTR ENV POL; UNEP/CBD, 1992, CONV BIOL DIV, P1; Walter BMT, 2008, CERRADO ECOLOGIA FLO, V1, P21; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wu JJ, 2000, AM J AGR ECON, V82, P979, DOI 10.1111/0002-9092.00096; Wunder S, 2008, MOVING AHEAD REDD IS; Yanai AM, 2012, FOREST ECOL MANAG, V282, P78, DOI 10.1016/j.foreco.2012.06.029; Yoshii K, 2000, ENV MONITORING PROCE	92	17	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132582	10.1371/journal.pone.0132582	http://dx.doi.org/10.1371/journal.pone.0132582			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222140	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800024
J	Papais-Alvarenga, RM; Vasconcelos, CCF; Carra, A; de Castillo, IS; Florentin, S; de Bedoya, FHD; Mandler, R; de Siervi, LC; Pimentel, MLV; Alvarenga, MP; Alvarenga, MP; Grzesiuk, AK; Pereira, ABCG; Neto, APG; Velasquez, C; Soublette, C; Fleitas, CV; Diniz, DS; Armas, E; Batista, E; Hernandez, F; Pereira, FFCD; Siqueira, HH; Cabea, H; Sanchez, J; Brooks, JBB; Brooks, B; Barroso, MCD; Ravelo, ME; Castillo, MC; Ferreira, MLB; Rocha, MSG; Parolin, MKF; Molina, O; Marinho, PBC; Christo, PP; de Souza, RB; Neto, SP; Camargo, SMD; Machado, SC; Neri, VC; Fragoso, YD; Alvarenga, H; Thuler, LCS				Papais-Alvarenga, Regina Maria; Ferreira Vasconcelos, Claudia Cristina; Carra, Adriana; Soto de Castillo, Ibis; Florentin, Sara; Diaz de Bedoya, Fernando Hamuy; Mandler, Raul; de Siervi, Luiza Campanella; Vellutini Pimentel, Maria Lucia; Alvarenga, Marina Papais; Alvarenga, Marcos Papais; Grzesiuk, Anderson Kuntz; Calmon Gama Pereira, Ana Beatriz; Gomes Neto, Antonio Pereira; Velasquez, Carolina; Soublette, Carlos; Fleitas, Cynthia Veronica; Diniz, Denise Sisteroli; Armas, Elizabeth; Batista, Elizabeth; Hernandez, Freda; Chaves da Costa Pereira, Fernanda Ferreira; Siqueira, Heloise Helena; Cabea, Hideraldo; Sanchez, Jose; Bidin Brooks, Joseph Bruno; Goncalves, Marcus Vinicius; Del Negro Barroso, Maria Cristina; Elena Ravelo, Maria; Carlota Castillo, Maria; Brito Ferreira, Maria Lucia; Guimaraes Rocha, Maria Sheila; Fiuza Parolin, Monica Koncke; Molina, Omaira; Christino Marinho, Patricia Beatriz; Christo, Paulo Pereira; de Souza, Renata Brant; Neto, Silvio Pessanha; das Gracas Camargo, Solange Maria; Machado, Suzana Costa; Neri, Vanderson Carvalho; Fragoso, Yara Dadalti; Alvarenga, Helcio; Santos Thuler, Luiz Claudio			Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study	PLOS ONE			English	Article							EXTENSIVE TRANSVERSE MYELITIS; DEVICS-NEUROMYELITIS-OPTICA; REVISED DIAGNOSTIC-CRITERIA; SPINAL MULTIPLE-SCLEROSIS; LONG-TERM DISABILITY; NATURAL-HISTORY; CLINICAL-COURSE; LATIN-AMERICA; AQUAPORIN-4 ANTIBODY; NMO-IGG	The idiopathic inflammatory demyelinating disease (IIDD) spectrum has been investigated among different populations, and the results have indicated a low relative frequency of neuromyelitis optica (NMO) among multiple sclerosis (MS) cases in whites (1.2%-1.5%), increasing in Mestizos (8%) and Africans (15.4%-27.5%) living in areas of low MS prevalence. South America (SA) was colonized by Europeans from the Iberian Peninsula, and their miscegenation with natives and Africans slaves resulted in significant racial mixing. The current study analyzed the IIDD spectrum in SA after accounting for the ethnic heterogeneity of its population. A cross-sectional multicenter study was performed. Only individuals followed in 2011 with a confirmed diagnosis of IIDD using new diagnostic criteria were considered eligible. Patients' demographic, clinical and laboratory data were collected. In all, 1,917 individuals from 22 MS centers were included (73.7% female, 63.0% white, 28.0% African, 7.0% Mestizo, and 0.2% Asian). The main disease categories and their associated frequencies were MS (76.9%), NMO (11.8%), other NMO syndromes (6.5%), CIS (3.5%), ADEM (1.0%), and acute encephalopathy (0.4%). Females predominated in all main categories. The white ethnicity also predominated, except in NMO. Except in ADEM, the disease onset occurred between 20 and 39 years old, early onset in 8.2% of all cases, and late onset occurred in 8.9%. The long-term morbidity after a mean disease time of 9.28 +/- 7.7 years was characterized by mild disability in all categories except in NMO, which was scored as moderate. Disease time among those with MS was positively correlated with the expanded disability status scale (EDSS) score (r=0.374; p=<0.001). This correlation was not observed in people with NMO or those with other NMO spectrum disorders (NMOSDs). Among patients with NMO, 83.2% showed a relapsing-remitting course, and 16.8% showed a monophasic course. The NMO-IgG antibody tested using indirect immunofluorescence (IIF) with a composite substrate of mouse tissues in 200 NMOSD cases was positive in people with NMO (95/162; 58.6%), longitudinally extensive transverse myelitis (10/30; 33.3%) and bilateral or recurrent optic neuritis (8/8; 100%). No association of NMO-IgG antibody positivity was found with gender, age at onset, ethnicity, early or late onset forms, disease course, or long-term severe disability. The relative frequency of NMO among relapsing-remitting MS (RRMS) + NMO cases in SA was 14.0%. Despite the high degree of miscegenation found in SA, MS affects three quarters of all patients with IIDD, mainly white young women who share similar clinical characteristics to those in Western populations in the northern hemisphere, with the exception of ethnicity; approximately one-third of all cases occur among non-white individuals. At the last assessment, the majority of RRMS patients showed mild disability, and the risk for secondary progression was significantly superior among those of African ethnicity. NMO comprises 11.8% of all IIDD cases in SA, affecting mostly young African-Brazilian women, evolving with a recurrent course and causing moderate or severe disability in both ethnic groups. The South-North gradient with increasing NMO and non-white individuals from Argentina, Paraguay, Brazil and Venezuela confirmed previous studies showing a higher frequency of NMO among non-white populations.	[Papais-Alvarenga, Regina Maria; Ferreira Vasconcelos, Claudia Cristina; de Siervi, Luiza Campanella; Alvarenga, Marina Papais; Alvarenga, Marcos Papais; Batista, Elizabeth; Neto, Silvio Pessanha; Neri, Vanderson Carvalho; Fragoso, Yara Dadalti; Alvarenga, Helcio; Santos Thuler, Luiz Claudio] Univ Fed Estado Rio De Janeiro, Dept Neurol, Rio De Janeiro, Brazil; [Papais-Alvarenga, Regina Maria; Ferreira Vasconcelos, Claudia Cristina; Alvarenga, Marina Papais; Alvarenga, Marcos Papais; Batista, Elizabeth] Hosp Fed Lagoa, Minist Saude, Dept Neurol, Rio De Janeiro, Brazil; [Papais-Alvarenga, Regina Maria; Ferreira Vasconcelos, Claudia Cristina; Alvarenga, Marcos Papais] Clin Neuroimunol, Rio De Janeiro, Brazil; [Carra, Adriana] Hosp Britanico, Dept Neurol, Buenos Aires, DF, Argentina; [Soto de Castillo, Ibis; Hernandez, Freda; Carlota Castillo, Maria; Molina, Omaira] Hosp Clin Maracaibo, Dept Neurol, Maracaibo, Venezuela; [Florentin, Sara; Velasquez, Carolina; Fleitas, Cynthia Veronica; Sanchez, Jose] Inst Previs Social, Dept Neurol, Asuncion, Paraguay; [Diaz de Bedoya, Fernando Hamuy] Univ Unida, Dept Neurol, Asuncion, Paraguay; [Mandler, Raul] Johns Hopkins Univ, Dept Neurol, Washington, DC USA; [Vellutini Pimentel, Maria Lucia] Santa Casa Misericordia, Dept Neurol, Rio De Janeiro, Brazil; [Alvarenga, Marina Papais; Del Negro Barroso, Maria Cristina; Christino Marinho, Patricia Beatriz] Rede Sarah Reabilitacao, Dept Neurol, Rio De Janeiro, Brazil; [Grzesiuk, Anderson Kuntz] Ctr Reabilitacao Integral Dom Aquino Correa, Dept Neurol, Mato Grosso, Brazil; [Calmon Gama Pereira, Ana Beatriz] Univ Severino Sombra, Dept Neurol, Rio De Janeiro, Brazil; [Gomes Neto, Antonio Pereira; Christo, Paulo Pereira; de Souza, Renata Brant] Santa Casa Misericordia, Dept Neurol, Belo Horizonte, MG, Brazil; [Soublette, Carlos; Armas, Elizabeth] Univ Hosp, Dept Neurol, Caracas, Venezuela; [Diniz, Denise Sisteroli] Univ Fed Goias, Hosp Clin, Dept Neurol, Goiania, Go, Brazil; [Chaves da Costa Pereira, Fernanda Ferreira] Neuroclin, Rio De Janeiro, Brazil; [Siqueira, Heloise Helena] Univ Fed Mato Grosso, Dept Neurol, Cuiaba, Brazil; [Cabea, Hideraldo] Hosp Ofir Loiola, Dept Neurol, Belem, Para, Brazil; [Bidin Brooks, Joseph Bruno; Fragoso, Yara Dadalti] Ctr Referencia Esclerose Multipla Litoral Paulist, Dept Neurol, Sao Paulo, Brazil; [Goncalves, Marcus Vinicius] Dept Neurol, Joinville, SC, Brazil; [Elena Ravelo, Maria] Hosp JM De Los Rios, Dept Neurol, Caracas, Venezuela; [Brito Ferreira, Maria Lucia] Hosp Restauracao, Dept Neurol, Recife, PE, Brazil; [Guimaraes Rocha, Maria Sheila] Hosp Santa Marcelina, Dept Neurol, Sao Paulo, Brazil; [Machado, Suzana Costa] Imperial Hosp Caridade, Dept Neurol, Florianopolis, SC, Brazil; [Santos Thuler, Luiz Claudio] Inst Nacl Canc, Div Clin Res, Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro; Hospital Britanico de Buenos Aires; Instituto de Prevision Social (IPS); Johns Hopkins University; Universidade Severino Sombra; Universidade Federal de Goias; Universidade Federal de Mato Grosso; National Cancer Institute (Inca)	Papais-Alvarenga, RM (corresponding author), Univ Fed Estado Rio De Janeiro, Dept Neurol, Rio De Janeiro, Brazil.	regina_alvarenga@hotmail.com	Christo, Paulo Pereira/AAK-9780-2020; ROCHA, MARIA SHEILA G/G-6645-2012; ROCHA, MARIA SHEILA GUIMARAES/AAK-7584-2020; de Siervi, Luiza/X-9429-2018; Papais-Alvarenga, Regina M/A-9385-2012	Christo, Paulo Pereira/0000-0003-1224-5243; ROCHA, MARIA SHEILA G/0000-0003-4312-3994; ROCHA, MARIA SHEILA GUIMARAES/0000-0003-4312-3994; de Siervi, Luiza/0000-0001-6564-9669; Siqueira, Heloise/0000-0002-5586-3933; Papais-Alvarenga, Regina Maria/0000-0002-1141-8619				Abad P, 2012, REV NEUROLOGIA, V55, P737, DOI 10.33588/rn.5512.2012306; Aboul-Enein F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079649; Adoni T, 2010, MULT SCLER J, V16, P81, DOI 10.1177/1352458509353651; Alvarenga MP, 2012, J SPINAL CORD MED, V35, P251, DOI 10.1179/2045772312Y.0000000019; Asgari N, 2011, NEUROLOGY, V76, P1589, DOI 10.1212/WNL.0b013e3182190f74; Bichuetti DB, 2009, MULT SCLER, V15, P613, DOI 10.1177/1352458508101935; Bichuetti DB, 2013, ARQ NEURO-PSIQUIAT, V71, P275, DOI 10.1590/0004-282X20130020; Bigi S, 2012, J CHILD NEUROL, V27, P1378, DOI 10.1177/0883073812452784; Bizzoco E, 2009, J NEUROL, V256, P1891, DOI 10.1007/s00415-009-5171-x; Brum DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058925; Cabre P, 2009, REV NEUROL-FRANCE, V165, P676, DOI 10.1016/j.neurol.2009.02.012; Cabre P, 2001, NEUROLOGY, V56, P507, DOI 10.1212/WNL.56.4.507; Cabrera-Gomez JA, 2009, MULT SCLER J, V15, P828, DOI 10.1177/1352458509104585; Collongues N, 2010, NEUROLOGY, V74, P736, DOI 10.1212/WNL.0b013e3181d31e35; Confavreux C, 2014, HAND CLINIC, V122, P343, DOI 10.1016/B978-0-444-52001-2.00014-5; Corona T, 2006, NEUROEPIDEMIOLOGY, V26, P1, DOI 10.1159/000089230; Cossburn M, 2012, EUR J NEUROL, V19, P655, DOI 10.1111/j.1468-1331.2011.03529.x; Cree BAC, 2009, ARCH NEUROL-CHICAGO, V66, P226, DOI 10.1001/archneurol.2008.541; Cristiano E, 2008, EUR J NEUROL, V15, P1273, DOI 10.1111/j.1468-1331.2008.02330.x; Damasceno A, 2013, J NEUROL SCI, V324, P29, DOI 10.1016/j.jns.2012.09.020; Fazio R, 2009, MULT SCLER J, V15, P1153, DOI 10.1177/1352458509106851; Ferreira Vasconcelos Claudia Cristina, 2012, ISRN Neurol, V2012, P410629, DOI 10.5402/2012/410629; Vasconcelos CCF, 2010, MULT SCLER J, V16, P597, DOI 10.1177/1352458509360987; Rivera JF, 2008, J NEUROL, V255, P710, DOI 10.1007/s00415-008-0781-2; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009; Herbert J, 2006, MULT SCLER, V12, pS21; IBGE, 2010, TITLE; Jacob A, 2013, J NEUROL, V260, P2134, DOI 10.1007/s00415-013-6926-y; Jarius S, 2007, NEUROLOGY, V68, P1076, DOI 10.1212/01.wnl.0000256822.01222.bd; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jiao YJ, 2013, NEUROLOGY, V81, P1197, DOI 10.1212/WNL.0b013e3182a6cb5c; Kantarci O, 2006, CURR OPIN NEUROL, V19, P248, DOI 10.1097/01.wco.0000227033.47458.82; Kantarci OH, 2008, SEMIN NEUROL, V28, P7, DOI 10.1055/s-2007-1019125; Kidd D, 2003, BRAIN, V126, P276, DOI 10.1093/brain/awg045; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Kira Jun-Ichi, 2011, Pathophysiology, V18, P69, DOI 10.1016/j.pathophys.2010.04.008; Krishnan C, 2004, FRONT BIOSCI-LANDMRK, V9, P1483, DOI 10.2741/1351; KURTZKE JF, 1980, NEUROLOGY, V30, P61, DOI 10.1212/WNL.30.7_Part_2.61; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; MANDLER RN, 1993, ANN NEUROL, V34, P162, DOI 10.1002/ana.410340211; Marignier R, 2008, MULT SCLER, V14, P440, DOI 10.1177/1352458507084595; Marignier R, 2013, NEUROLOGY, V80, P2194, DOI 10.1212/WNL.0b013e318296e917; Mealy MA, 2012, ARCH NEUROL-CHICAGO, V69, P1176, DOI 10.1001/archneurol.2012.314; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Papais-Alvarenga RM, 2014, MULT SCLER J, V20, P374, DOI 10.1177/1352458513495580; Paul F, 2007, PLOS MED, V4, P669, DOI 10.1371/journal.pmed.0040133; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Poser CM, 1998, AN ATLAS OF MULTIPLE; Risco J, 2011, MULT SCLER J, V17, P1055, DOI 10.1177/1352458511405562; Rivera VM, 2014, NEUROLOGY, V82, P1660, DOI 10.1212/WNL.0000000000000376; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sadovnick AD, 2009, J NEUROL SCI, V286, P1, DOI 10.1016/j.jns.2009.09.005; Saiz A, 2007, J NEUROL, V254, P1233, DOI 10.1007/s00415-007-0509-8; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Takahashi T, 2006, TOHOKU J EXP MED, V210, P307, DOI 10.1620/tjem.210.307; Tanaka M, 2007, J NEUROL NEUROSUR PS, V78, P990, DOI 10.1136/jnnp.2006.114165; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk D.W., 2008, MULTIPLE SCLEROSIS C, P24; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Wu JS, 2008, J NEUROL NEUROSUR PS, V79, P1022, DOI 10.1136/jnnp.2007.131177	69	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0127757	10.1371/journal.pone.0127757	http://dx.doi.org/10.1371/journal.pone.0127757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222205	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800004
J	Hii, HP; Liao, MH; Chen, SJ; Wu, CC; Shih, CC				Hii, Hiong-Ping; Liao, Mei-Hui; Chen, Shiu-Jen; Wu, Chin-Chen; Shih, Chih-Chin			Distinct Patterns of Wnt3a and Wnt5a Signaling Pathway in the Lung from Rats with Endotoxic Shock	PLOS ONE			English	Article							BETA-CATENIN; PROTEIN-KINASE; MECHANISMS; EXPRESSION; SEPSIS; MACROPHAGES; ACTIVATION; RECEPTORS; WINGLESS; OUTCOMES	Septic shock is a syndrome with severe hypotension and multiple organ dysfunction caused by an imbalance between pro-inflammatory and anti-inflammatory response. The most common risk factor of acute lung injury is severe sepsis. Patients with sepsis-related acute respiratory distress syndrome have higher mortality. Recent studies reveal regulatory roles of Wnt3a and Wnt5a signaling in inflammatory processes. Wnt3a signaling has been implicated in anti-inflammatory effects, whereas Wnt5a signaling has been postulated to have pro-inflammatory properties. However, the balance between Wnt3a and Wnt5a signaling pathway in the lung of rats with endotoxic shock has not been determined. Thus, we investigated the major components of Wnt3a and Wnt5a signaling pathway in the lung of endotoxemic rats. Male Wistar rats were intravenously infused with saline or lipopolysaccharide (LPS, 10 mg/kg). The changes of hemodynamics, biochemical variables, and arterial blood gas were examined during the experimental period. At 6 h after saline or LPS, animals were sacrificed, and lungs were obtained for analyzing superoxide production, water accumulation, histologic assessment, and protein expressions of Wnt3a and Wnt5a signaling pathway. Animals that received LPS showed circulatory failure, multiple organ dysfunction, metabolic acidosis, hyperventilation, lung edema, and high mortality. The lung from rats with endotoxic shock exhibited significant decreases in the levels of Wnt3a, Fzd1, Dsh1, phosphorylated GSK-3 beta at Ser9, and beta-catenin. In contrast, the expressions of Wnt5a, Fzd5, and CaMKII were up-regulated in the lung of endotoxemic rats. These findings indicate the major components of Wnt3a and Wnt5a signaling in the lung are disturbed under endotoxic insult.	[Hii, Hiong-Ping] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Liao, Mei-Hui; Wu, Chin-Chen; Shih, Chih-Chin] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Chen, Shiu-Jen] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Shih, Chih-Chin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Chi Mei Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Shih, CC (corresponding author), Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.	898010201@mail.ndmctsgh.edu.tw			National Defense Medical Center, R.O.C., Taiwan [MAB-102-52, 103-M025]	National Defense Medical Center, R.O.C., Taiwan	This research was supported by grants MAB-102-52 and 103-M025 from National Defense Medical Center, R.O.C., Taiwan.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bhatt PM, 2014, ATHEROSCLEROSIS, V237, P155, DOI 10.1016/j.atherosclerosis.2014.08.027; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guo Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.254; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malhotra S, 2009, EXP HEMATOL, V37, P19, DOI 10.1016/j.exphem.2008.08.008; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Neumann J, 2010, FASEB J, V24, P4599, DOI 10.1096/fj.10-160994; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sheu CC, 2010, CHEST, V138, P559, DOI 10.1378/chest.09-2933; Tanjore H, 2013, AM J RESP CRIT CARE, V187, P630, DOI 10.1164/rccm.201205-0972OC; Tickenbrock L, 2006, J LEUKOCYTE BIOL, V79, P1306, DOI 10.1189/jlb.0905539; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Villar J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0568-z	33	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134492	10.1371/journal.pone.0134492	http://dx.doi.org/10.1371/journal.pone.0134492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218875	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900120
J	Hoffmann, K; Peersman, W; George, A; Dorner, TE				Hoffmann, Kathryn; Peersman, Wim; George, Aaron; Dorner, Thomas Ernst			Associations and Synergistic Effects for Psychological Distress and Chronic Back Pain on the Utilization of Different Levels of Ambulatory Health Care. A Cross-Sectional Study from Austria	PLOS ONE			English	Article							DISABILITY PENSION; SICK LEAVE; DEPRESSION; SERVICES; INTERVENTION; COMORBIDITY; EUROPE; ACCESS; ADULTS; TIME	The aim of this analysis was to assess the impact of chronic back pain and psychological distress on the utilization of primary and secondary levels of care in the ambulatory health care sector in Austria - a country without a gatekeeping system. Additionally, we aimed to determine if the joint effect of chronic back pain and psychological distress was higher than the impact of the sum of the two single conditions. The database used for this analysis was the Austrian Health Interview Survey, with data from 15,474 individuals. Statistical methods used were descriptive tests, regression models and the calculation of synergistic effects. Both chronic back pain and psychological distress had a positive association with the utilization of the primary (OR for chronic back pain 1.53 and psychological distress 1.33) and secondary (OR for chronic back pain 1.32 and psychological distress 1.24) levels of the health care sector. In the fully adjusted model, the synergistic effect of chronic back pain and psychological distress was significant for the secondary level of care (S 1.99, PAF 0.20), but not for the primary level of care (S 1.16, PAF 0.07). Synergistic effects and associations for chronic back pain and psychological distress on the utilization of both the primary and secondary levels of the ambulatory health care sector were observed, particularly for the secondary level of care. Our results demonstrate the utilization of health care services settings by individuals with these conditions, and offer opportunities to consider reorganization and structuring of the Austrian health care system.	[Hoffmann, Kathryn] Med Univ Vienna, Ctr Publ Hlth, Dept Gen Practice, Vienna, Austria; [Peersman, Wim] Univ Ghent, Dept Family Med & Primary Care, B-9000 Ghent, Belgium; [George, Aaron] Duke Med Ctr, Dept Community & Family Med, Durham, NC USA; [Dorner, Thomas Ernst] Med Univ Vienna, Ctr Publ Hlth, Inst Social Med, Vienna, Austria	Medical University of Vienna; Ghent University; Duke University; Medical University of Vienna	Hoffmann, K (corresponding author), Med Univ Vienna, Ctr Publ Hlth, Dept Gen Practice, Vienna, Austria.	kathryn.hoffmann@meduniwien.ac.at	Hoffmann, Kathryn/AAK-9099-2021; Peersman, Wim/K-3576-2019	Peersman, Wim/0000-0002-4276-7408; Dorner, Thomas Ernst/0000-0002-5218-1160; Hoffmann, Kathryn/0000-0001-8760-4250				Alexanderson K, 2012, J EPIDEMIOL COMMUN H, V66, P155, DOI 10.1136/jech.2010.126789; Anderson Daren, 2012, Qual Prim Care, V20, P421; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], MED OUTC STUD 36 IT; [Anonymous], 2009, STROBE STAT CHECKL C; [Anonymous], 2012, PRIM CAR 21 CENT; Aromaa A, 2003, EUR J PUBLIC HEALTH, V13, P67, DOI 10.1093/eurpub/13.suppl_1.67; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bakker Ingrid M, 2007, PLoS Clin Trials, V2, pe26, DOI 10.1371/journal.pctr.0020026; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Chouinard MC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-49; De Maeseneer J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652553; Dorner TE, 2015, EUR J PAIN; Dorner TE, 2010, WIEN KLIN WOCHENSCHR, V122, P103, DOI 10.1007/s00508-010-1312-6; Eriksen J, 2004, EUR J PAIN, V8, P517, DOI 10.1016/j.ejpain.2003.12.001; Expert Panel on Effective Ways of Investing in Health, 2014, EXP PAN EFF WAYS INV; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Gleicher Y, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-147; Hoffmann K, 2013, EUR J PUBLIC HEALTH, V23, P933, DOI 10.1093/eurpub/ckt008; Hofmarcher M, 2013, AUSTRIA HLTH SYSTEM; Klimont J, 2007, AUSTRIAN HLTH SURVEY; Kringos D, 2013, BRIT J GEN PRACT, V63, pE742, DOI 10.3399/bjgp13X674422; Lazarus R. S., 1984, STRESS APPRAISAL COP; Overland S, 2012, EUR J PAIN, V16, P611, DOI 10.1016/j.ejpain.2011.08.005; Pearson WS, 2009, INT J PUBLIC HEALTH, V54, P23, DOI 10.1007/s00038-009-0003-4; Peersman W, 2014, EUR J PUBLIC HEALTH, V24, P91, DOI 10.1093/eurpub/ckt079; Pichlhofer O, 2015, EUR J PUBLIC HEALTH, V25, P401, DOI 10.1093/eurpub/cku189; Pieber K, 2012, J REHABIL MED, V44, P658, DOI 10.2340/16501977-1010; Rumball-Smith J, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-149; Saastamoinen P, 2012, PAIN, V153, P526, DOI 10.1016/j.pain.2011.11.005; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; Stein KV, 2010, SCHMERZ, V24, P468, DOI 10.1007/s00482-010-0962-7; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Stigler FL, 2013, FAM PRACT, V30, P185, DOI 10.1093/fampra/cms067; Stinson J, 2013, CLIN J PAIN, V29, P600, DOI 10.1097/AJP.0b013e31826dce65; Taloyan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044721; Terluin B, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-58; The European definition of General Practice / Family Medicine, 2011, EUR DEF GEN PRACT FA; Tripp D. A., 2006, PAIN RES MANAG, V11, P225, DOI DOI 10.1155/2006/720895; Ullrich PM, 2013, REHABIL PSYCHOL, V58, P158, DOI 10.1037/a0032047; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weimer MB, 2013, PAIN MED, V14, P1839, DOI 10.1111/pme.12177; WELLS JE, 1994, SOC PSYCH PSYCH EPID, V29, P155; WHO, 2008, WORLD HLTH REPORT 20	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134136	10.1371/journal.pone.0134136	http://dx.doi.org/10.1371/journal.pone.0134136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218661	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900085
J	Lin, GG; Yi, L; Zhang, K; Wang, LN; Zhang, R; Xie, JH; Li, JM				Lin, Guigao; Yi, Lang; Zhang, Kuo; Wang, Lunan; Zhang, Rui; Xie, Jiehong; Li, Jinming			Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach	PLOS ONE			English	Article							GENETIC-POLYMORPHISM; ASSOCIATION; POPULATIONS; GUIDELINES; VARIANT; EVENTS; UPDATE; CYP2D6	Laboratories are increasingly requested to perform CYP2C19 genetic testing when managing clopidogrel therapy, especially in patients with acute coronary syndrome undergoing percutaneous coronary intervention. To ensure high quality molecular testing and ascertain that the referring clinician has the correct information for CYP2C19 genotype-directed antiplatelet therapy, a proficiency testing scheme was set up to evaluate the laboratory performance for the entire testing process. Proficiency panels of 10 cell samples encompassing the common CYP2C19 genetic polymorphisms were distributed to 62 participating laboratories for routine molecular testing and the responses were analyzed for accuracy of genotyping and the reporting of results. Data including the number of samples tested, the accreditation/certification status, and test methodology of each individual laboratory were also reviewed. Fifty-seven of the 62 participants correctly identified the CYP2C19 variants in all samples. There were six genotyping errors, with a corresponding analytical sensitivity of 98.5%(333/338 challenges; 95% confidence interval: 96.5-99.5%) and an analytic specificity of 99.6% (281/282; 95% confidence interval: 98.0-99.9%). Reports of the CYP2C19 genotyping results often lacked essential information. In conclusion, clinical laboratories demonstrated good analytical sensitivity and specificity; however, the pharmacogenetic testing community requires additional education regarding the correct reporting of CYP2C19 genetic test results.	[Lin, Guigao; Yi, Lang; Zhang, Kuo; Wang, Lunan; Zhang, Rui; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing 100730, Peoples R China; [Yi, Lang] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JM (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing 100730, Peoples R China.	jmli@nccl.org.cn	Wang, Lunan/AAS-9785-2021	Wang, Lunan/0000-0003-3163-7891	Beijing Municipal Public Health Bureau [2011-4011-02]; Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China [201402018]	Beijing Municipal Public Health Bureau; Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China	This work was supported by the capital development fund from the Beijing Municipal Public Health Bureau (No. 2011-4011-02) (JL) and the Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China (No. 201402018) (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz N, 2014, ARCH PATHOL IN PRESS; Chen LL, 2008, PHARMACOGENOMICS, V9, P691, DOI 10.2217/14622416.9.6.691; Geisler T, 2008, PHARMACOGENOMICS, V9, P1251, DOI 10.2217/14622416.9.9.1251; International Organization for Standardization, 2007, 151892007 ISO; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Lewis JP, 2013, J THROMB HAEMOST, V11, P1640, DOI 10.1111/jth.12342; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Myrand SP, 2008, CLIN PHARMACOL THER, V84, P347, DOI 10.1038/sj.clpt.6100482; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Tiroch KA, 2010, AM HEART J, V160, P506, DOI 10.1016/j.ahj.2010.06.039; Wu AHB, 2013, ARCH PATHOL LAB MED, V137, P1232, DOI 10.5858/arpa.2012-0261-CP; Yamamoto K, 2011, J CARDIOL, V57, P194, DOI 10.1016/j.jjcc.2010.10.007; Zhou Q, 2009, PHARMACOGENOMICS J, V9, P380, DOI 10.1038/tpj.2009.31	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134174	10.1371/journal.pone.0134174	http://dx.doi.org/10.1371/journal.pone.0134174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218263	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900091
J	Zhang, Y; Berhane, K; Eckel, SP; Salam, MT; Linn, WS; Rappaport, EB; Bastain, TM; Gilliland, FD				Zhang, Yue; Berhane, Kiros; Eckel, Sandrah P.; Salam, Muhammad T.; Linn, William S.; Rappaport, Edward B.; Bastain, Theresa M.; Gilliland, Frank D.			Determinants of Children's Exhaled Nitric Oxide: New Insights from Quantile Regression	PLOS ONE			English	Article							ALLERGIC RHINITIS; ASTHMA; HEALTHY; ADOLESCENTS; MANAGEMENT	While the fractional concentration of exhaled nitric oxide (FeNO) has proven useful in asthma research, its exact role in clinical care remains unclear, in part due to unexplained inter-subject heterogeneity. In this study, we assessed the hypothesis that the effects of determinants of the fractional concentration of exhaled nitric oxide (FeNO) vary with differing levels of FeNO. In a population-based cohort of 1542 school children aged 12-15 from the Southern California Children's Health Study, we used quantile regression to investigate if the relationships of asthma, socio-demographic and clinical covariates with FeNO vary across its distribution. Differences in FeNO between children with and without asthma increased steeply as FeNO increased (Estimated asthma effects (in ppb) at selected 20th, 50th and 80th percentiles of FeNO are 2.4, 6.3 and 22.2, respectively) but the difference was steeper with increasing FeNO in boys and in children with active rhinitis (p-values<0.01). Active rhinitis also showed significantly larger effects on FeNO at higher concentrations of FeNO (Estimated active rhinitis effects (in ppb) at selected 20th, 50th and 80th percentiles of FeNO are 2.1, 5.7 and 14.3, respectively). Boys and children of Asian descent had higher FeNO than girls and non-Hispanic whites; these differences were significantly larger in those with higher FeNO (p-values<0.01). In summary, application of quantile regression techniques provides new insights into the determinants of FeNO showing substantially varying effects in those with high versus low concentrations.	[Zhang, Yue] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Zhang, Yue] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA; [Zhang, Yue] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Berhane, Kiros; Eckel, Sandrah P.; Salam, Muhammad T.; Linn, William S.; Rappaport, Edward B.; Bastain, Theresa M.; Gilliland, Frank D.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Salam, Muhammad T.] Kern Med Ctr, Dept Psychiat, Bakersfield, CA USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Southern California	Zhang, Y (corresponding author), Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.	zhang.yue@hsc.utah.edu		Bastain, Theresa/0000-0002-0029-5641	National Heart, Lung and Blood Institute [5R01HL61768, 5R01HL76647]; Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences [5P30ES007048]; Children's Environmental Health Center - National Institute of Environmental Health Sciences [5P01ES009581, R826708-01, RD831861-01]; Environmental Protection Agency; National Institute of Environmental Health Sciences [5P01ES011627, 1K22ES022987, R01ES023262]; James H. Zumberge Research and Innovation Fund; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076647, R01HL061768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, R01ES023262, K22ES022987, P01ES011627, P01ES009581] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences; Children's Environmental Health Center - National Institute of Environmental Health Sciences; Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); James H. Zumberge Research and Innovation Fund; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Heart, Lung and Blood Institute (grants 5R01HL61768 and 5R01HL76647); the Southern California Environmental Health Sciences Center (grant 5P30ES007048) funded by the National Institute of Environmental Health Sciences; the Children's Environmental Health Center (grants 5P01ES009581, R826708-01 and RD831861-01) funded by the National Institute of Environmental Health Sciences and the Environmental Protection Agency; the National Institute of Environmental Health Sciences (grants 5P01ES011627, 1K22ES022987 and R01ES023262); the James H. Zumberge Research and Innovation Fund, and the Hastings Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, ALLERGY, V64, P123, DOI 10.1111/j.1398-9995.2008.01884.x; ALVING K, 1993, EUR RESPIR J, V6, P1368; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090; Berhane K, 2014, OCCUP ENV MED; Bjermer L, 2014, RESP MED; de Groot EP, 2012, THORAX, V67, P582, DOI 10.1136/thoraxjnl-2011-201168; Kalpaklioglu AF, 2012, AM J RHINOL ALLERGY, V26, pE50, DOI 10.2500/ajra.2012.26.3717; Koch B, 2011, RESP MED, V105, P352, DOI 10.1016/j.rmed.2010.10.014; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Kovesi T, 2008, CHEST, V133, P169, DOI 10.1378/chest.07-1177; Levesque MC, 2008, J ALLERGY CLIN IMMUN, V121, P396, DOI 10.1016/j.jaci.2007.09.031; Linn WS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-28; Malinovschi A, 2012, CLIN EXP ALLERGY, V42, P433, DOI 10.1111/j.1365-2222.2011.03947.x; Malinovschi A, 2013, J ALLERGY CLIN IMMUN, V132, P821, DOI 10.1016/j.jaci.2013.06.007; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Olivieri M, 2007, CHEST, V132, P1410, DOI 10.1378/chest.07-0741; Pavord ID, 2008, J ASTHMA, V45, P523, DOI 10.1080/02770900801978557; Pedersen S, 2008, LANCET, V372, P1015, DOI 10.1016/S0140-6736(08)61420-8; Ricciardolo FLM, 2014, CURR OPIN PULM MED, V20, P53, DOI 10.1097/MCP.0000000000000006; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Taylor DR, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-82; Van der Valk RJ, 2013, J ALLERGY CLIN IMMUN; Van Sickle D, 2011, AM J RESP CRIT CARE, V184, P521, DOI 10.1164/rccm.201012-2095OC; Xu F, 2011, J ASTHMA, V48, P1001, DOI 10.3109/02770903.2011.627487; Yao TC, 2012, EUR RESPIR J, V39, P378, DOI 10.1183/09031936.00013911	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0130505	10.1371/journal.pone.0130505	http://dx.doi.org/10.1371/journal.pone.0130505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214692	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300003
J	Cao, BY; Wang, SW; Tian, ZY; Hu, PL; Feng, L; Wang, L				Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Hu, Pinliang; Feng, Lu; Wang, Lei			DNA Microarray Characterization of Pathogens Associated with Sexually Transmitted Diseases	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CHLAMYDIA-TRACHOMATIS; NEISSERIA-GONORRHOEAE; UREAPLASMA-UREALYTICUM; ANTIGEN-DETECTION; CLINICAL-SAMPLES; PCR; DIAGNOSIS; HERPES; INFECTIONS	This study established a multiplex PCR-based microarray to detect simultaneously a diverse panel of 17 sexually transmitted diseases (STDs)-associated pathogens including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma, Herpes simplex virus (HSV) types 1 and 2, and Human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 35, 39, 54 and 58. The target genes are 16S rRNA gene for N. gonorrhoeae, M. genitalium, M. hominism, and Ureaplasma, the major outer membrane protein gene (ompA) for C. trachomatis, the glycoprotein B gene (gB) for HSV; and the L1 gene for HPV. A total of 34 probes were selected for the microarray including 31 specific probes, one as positive control, one as negative control, and one as positional control probe for printing reference. The microarray is specific as the commensal and pathogenic microbes (and closely related organisms) in the genitourinary tract did not cross-react with the microarray probes. The microarray is 10 times more sensitive than that of the multiplex PCR. Among the 158 suspected HPV specimens examined, the microarray showed that 49 samples contained HPV, 21 samples contained Ureaplasma, 15 contained M. hominis, four contained C. trachomatis, and one contained N. gonorrhoeae. This work reports the development of the first high through-put detection system that identifies common pathogens associated with STDs from clinical samples, and paves the way for establishing a time-saving, accurate and high-throughput diagnostic tool for STDs.	[Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Inst Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Hu, Pinliang; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Res Ctr Funct Genom & Biochips, Tianjin 300071, Peoples R China; [Cao, Boyang; Wang, Suwei; Tian, Zhenyang; Hu, Pinliang; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Wang, L (corresponding author), Nankai Univ, TEDA Coll, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China.	leiwang@nankai.edu.cn	Wang, Lei/C-5176-2009; feng, lu/M-5113-2015	Wang, Lei/0000-0003-4427-0881; 	National program of China [2012AA020103]; National Natural Science Foundation of China (NSFC) Program [31170094]	National program of China; National Natural Science Foundation of China (NSFC) Program(National Natural Science Foundation of China (NSFC))	This work was supported by the National program of China (2012AA020103) and the National Natural Science Foundation of China (NSFC) Program (31170094). The authors thank the General Hospital of Tianjin Medical University, the Renmin Hospital of Tianjin, and the Changzheng Hospital of Tianjin for supplying the clinical specimens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boel CHE, 2005, J CLIN MICROBIOL, V43, P2231, DOI 10.1128/JCM.43.5.2231-2235.2005; Cao X, 2006, BIOSENS BIOELECTRON, V22, P393, DOI 10.1016/j.bios.2006.05.011; CLES LD, 1988, J CLIN MICROBIOL, V26, P1735, DOI 10.1128/JCM.26.9.1735-1737.1988; CONE RW, 1991, J INFECT DIS, V164, P757, DOI 10.1093/infdis/164.4.757; Corey L, 2005, J MED VIROL, V76, P350, DOI 10.1002/jmv.20365; Farrell DJ, 1999, J CLIN MICROBIOL, V37, P386, DOI 10.1128/JCM.37.2.386-390.1999; Geisler WM, 2003, INFECT MED, V20, P340; Gevelber MA, 1999, PEDIATR CLIN N AM, V46, P747, DOI 10.1016/S0031-3955(05)70150-4; HALLSWORTH PG, 1995, PATHOLOGY, V27, P168, DOI 10.1080/00313029500169812; JENKINS A, 1991, APMIS, V99, P667, DOI 10.1111/j.1699-0463.1991.tb01244.x; Jephcott AE, 1997, GENITOURIN MED, V73, P245; LAN J, 1995, J CLIN PATHOL, V48, P815, DOI 10.1136/jcp.48.9.815; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Li YY, 2006, J CLIN MICROBIOL, V44, P4376, DOI 10.1128/JCM.01389-06; MCELHINNEY LM, 1995, J VIROL METHODS, V53, P223, DOI 10.1016/0166-0934(95)00019-Q; Morshed MG, 2007, FEMS IMMUNOL MED MIC, V49, P184, DOI 10.1111/j.1574-695X.2006.00191.x; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Shi G, 2005, J MICROBIOL METH, V62, P245, DOI 10.1016/j.mimet.2005.02.017; Slomka MJ, 1998, J MED VIROL, V55, P177, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;177::AID-JMV15&gt;3.0.CO;2-F; Stothard DR, 2001, J CLIN MICROBIOL, V39, P2655, DOI 10.1128/JCM.39.7.2655-2659.2001; Tuuminen T, 2000, J MICROBIOL METH, V42, P265, DOI 10.1016/S0167-7012(00)00209-8; Van Dyck E, 2001, J CLIN MICROBIOL, V39, P1751, DOI 10.1128/JCM.39.5.1751-1756.2001; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Wallace J, 2005, J MOL DIAGN, V7, P72, DOI 10.1016/S1525-1578(10)60011-6; Wang Ying, 2008, Disease Surveillance, V23, P481; Yoshida T, 2002, J CLIN MICROBIOL, V40, P105, DOI 10.1128/JCM.40.1.105-110.2002; Zhou N, 2015, CHIN J AIDS STD, V21, P213	28	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133927	10.1371/journal.pone.0133927	http://dx.doi.org/10.1371/journal.pone.0133927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208181	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000175
J	Ferreira, A; Sagkriotis, A; Olson, M; Lu, JS; Makin, C; Milnes, F				Ferreira, Alberto; Sagkriotis, Alexandros; Olson, Melvin; Lu, Jingsong; Makin, Charles; Milnes, Fran			Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA	PLOS ONE			English	Article							VISUAL-ACUITY; DISEASE; EYE; VERTEPORFIN; PREVALENCE; MECHANISMS; SAFETY	Purpose To compare treatment patterns of intravitreal ranibizumab and aflibercept for the management of neovascular age-related macular degeneration (nAMD) in a real-world setting over the first 12 months of treatment. Methods A proprietary clinical database was used to identify treatment-naive patients with nAMD in the USA with claims for ranibizumab or aflibercept between November 1, 2011 and November 30, 2013 and with follow-up of at least 12 months. Patients were considered treatment-naive if they had no anti-VEGF treatment code for 6 months before the index date. Mean numbers of injections and of non-injection visits to a treating physician were compared between the two treatment cohorts (ranibizumab or aflibercept). In addition, the mean interval between doses was also investigated. Results Patient characteristics were similar for those receiving either ranibizumab (n = 5421) or aflibercept (n = 3506) at the index date. The mean (+/- standard deviation) numbers of injections received by patients treated with ranibizumab (4.9 +/- 3.3) or aflibercept (5.2 +/- 2.9) were not clinically different. The mean number of non-injection visits was 2.8 +/- 2.8 and 2.1 +/- 2.5 for ranibizumab and aflibercept, respectively. Mean dosing interval was 51.0 days (+/- 41.8 days) in patients receiving ranibizumab and 54.1 days (+/- 36.0 days) in those receiving aflibercept. Results were robust to sensitivity analyses for definition of treatment-naive, length of follow-up and treatment in the index eye only. Conclusions Limited data exist regarding real-world treatment patterns of aflibercept for the management of nAMD. Our results suggest that, in routine clinical practice, patients receive a comparable number of injections in the first year of treatment with ranibizumab or aflibercept.	[Ferreira, Alberto; Sagkriotis, Alexandros; Olson, Melvin; Milnes, Fran] Novartis Pharma AG, Basel, Switzerland; [Lu, Jingsong; Makin, Charles] IMS Hlth, Plymouth Meeting, PA USA	Novartis	Ferreira, A (corresponding author), Novartis Pharma AG, Basel, Switzerland.	alberto.ferreira@novartis.com			Novartis Pharma AG, Basel, Switzerland	Novartis Pharma AG, Basel, Switzerland	Novartis Pharma AG, Basel, Switzerland funded this study. AF, AS, MO and FM are employees of Novartis Pharma AG. JL and CM are employees of IMS Health, USA, which received funding from Novartis Pharma AG, Basel, Switzerland.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; American Society of Retina Specialists, 2013, PREF TRENDS PAT SURV; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Bandello F, 2008, DRUG AGING, V25, P255, DOI 10.2165/00002512-200825030-00007; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Busbee BG, 2013, OPHTHALMOLOGY, V120, P1046, DOI 10.1016/j.ophtha.2012.10.014; Cruess AF, 2008, PHARMACOECONOMICS, V26, P57, DOI 10.2165/00019053-200826010-00006; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; EMA, 2012, EYL SUMM PROD CHAR; EMA, 2013, LUC SUMM PROD CHAR; FDA, 2013, LUC PRESCR INF; FDA, 2013, EYL PRESCR INF; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Heier JS, 2012, INTRAVITREAL AFLIBER; Holekamp NM, 2014, AM J OPHTHALMOL, V157, P825, DOI 10.1016/j.ajo.2013.12.018; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P1161, DOI 10.1136/bjophthalmol-2013-303232; Hyman L, 1992, EPIDEMIOLOGY OF AMD; Johnston SS, 2013, ADV THER, V30, P1111, DOI 10.1007/s12325-013-0078-4; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Rakic JM, 2013, CLIN OPHTHALMOL, V7, P1849, DOI 10.2147/OPTH.S49385; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ross AH, 2013, EYE, V27, P56, DOI 10.1038/eye.2012.225; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Stewart MW, 2012, CLIN OPHTHALMOL, V6, P1175, DOI 10.2147/OPTH.S33372; Sunness J S, 1998, Geriatrics, V53, P70; Sunness JS., 1998, GERIATRICS, V53, P77	28	42	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133968	10.1371/journal.pone.0133968	http://dx.doi.org/10.1371/journal.pone.0133968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208030	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000183
J	Jeong, HS; Lee, HK				Jeong, Hii-Sun; Lee, Hye-Kyung			Correction of Inverted Nipple Using Subcutaneous Turn-Over Flaps to Create a Tent Suspension-Like Effect	PLOS ONE			English	Article							DERMAL FLAPS; SURGICAL-CORRECTION	Background Many techniques have been reported for the correction of inverted nipples. However, the conventional methods may be insufficient, especially for moderate to severe inversions. We propose a modification of Elsahy's method and report satisfactory results. Methods A single-institutional retrospective review was performed for all patients who received the modified operation. Patient charts were reviewed for demographic data, pertinent preoperative factors such as Han and Hong classification, and clinical outcomes including postoperative nipple height and sensation. Surgical details are described within the main text. Results The review identified 26 female patients amongst whom 47 inverted nipples were corrected using the modified method. The mean nipple height was 9 mm with an average follow-up period of 14 months. Brush stimulation elicited nipple contraction in all patients. There was no recurrence of nipple inversion, nor were there any surgical complications to report. Conclusion The suspension technique is a simple, reliable method for correcting grade II and III nipple inversions.	[Jeong, Hii-Sun] Hallym Univ, Coll Med, Dept Plast & Reconstruct Surg, Kangnam Sacred Heart Hosp,Hallym Univ Med Ctr, Seoul, South Korea; [Lee, Hye-Kyung] Eulji Univ, Sch Med, Dept Plast & Reconstruct Surg, Eulji Gen Hosp, Seoul, South Korea	Hallym University; Eulji University	Lee, HK (corresponding author), Eulji Univ, Sch Med, Dept Plast & Reconstruct Surg, Eulji Gen Hosp, Seoul, South Korea.	hklee240@gmail.com		JEONG, HII-SUN/0000-0001-9408-8207				BROADBENT TR, 1976, PLAST RECONSTR SURG, V58, P673, DOI 10.1097/00006534-197612000-00003; Burm JS, 2007, PLAST RECONSTR SURG, V120, P1483, DOI 10.1097/01.prs.0000282028.29647.ad; CRESTINU JM, 1987, PLAST RECONSTR SURG, V79, P127, DOI 10.1097/00006534-198701000-00024; Elsahy N, 2009, PLAST RECONSTR SURG, V123, P1131, DOI 10.1097/PRS.0b013e31819a3456; ELSAHY NI, 1976, PLAST RECONSTR SURG, V57, P438, DOI 10.1097/00006534-197604000-00004; HAESEKER B, 1984, BRIT J PLAST SURG, V37, P253, DOI 10.1016/0007-1226(84)90019-5; Han SH, 1999, PLAST RECONSTR SURG, V104, P389, DOI 10.1097/00006534-199908000-00010; HUGO NE, 1993, ANN PLAS SURG, V30, P510, DOI 10.1097/00000637-199306000-00006; Kim DY, 2003, ANN PLAS SURG, V51, P636, DOI 10.1097/01.sap.0000095722.82954.82; Kim JT, 2006, PLAST RECONSTR SURG, V118, P1526, DOI 10.1097/01.prs.0000233028.14581.3f; Kolker AR, 2009, ANN PLAS SURG, V62, P549, DOI 10.1097/SAP.0b013e31819fb190; Lee HB, 1998, PLAST RECONSTR SURG, V102, P1253, DOI 10.1097/00006534-199809040-00055; Lee KY, 2004, PLAST RECONSTR SURG, V113, P328, DOI 10.1097/01.PRS.0000097166.83987.C6; Longo B, 2013, PLAST RECONSTR SURG, V132, p735E, DOI 10.1097/PRS.0b013e3182a3bf05; Park HS, 1999, AESTHET PLAST SURG, V23, P144, DOI 10.1007/s002669900258; Schlenz I, 2000, PLAST RECONSTR SURG, V105, P905, DOI 10.1097/00006534-200003000-00012; SCHWAGER RG, 1974, PLAST RECONSTR SURG, V54, P564, DOI 10.1097/00006534-197411000-00007; Shiau JP, 2011, AESTHET PLAST SURG, V35, P1137, DOI 10.1007/s00266-011-9739-3; Taylor DM, 2011, J PLAST RECONSTR AES, V64, pE297, DOI 10.1016/j.bjps.2011.05.002; TEIMOURIAN B, 1980, PLAST RECONSTR SURG, V65, P504, DOI 10.1097/00006534-198004000-00020; Tezer M, 2012, J ANDROL, V33, P805, DOI 10.2164/jandrol.111.014951; TOWNSEND PL, 1974, BRIT J PLAST SURG, V27, P308, DOI 10.1016/0007-1226(74)90027-7	22	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133588	10.1371/journal.pone.0133588	http://dx.doi.org/10.1371/journal.pone.0133588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208118	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000104
J	Jonson, M; Pokrzywa, M; Starkenberg, A; Hammarstrom, P; Thor, S				Jonson, Maria; Pokrzywa, Malgorzata; Starkenberg, Annika; Hammarstrom, Per; Thor, Stefan			Systematic A beta Analysis in Drosophila Reveals High Toxicity for the 1-42, 3-42 and 11-42 Peptides, and Emphasizes N- and C-Terminal Residues	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID FIBRILS; IN-VITRO; COGNITIVE DECLINE; MODEL; PROTEIN; AGGREGATION; A-BETA-42; OLIGOMERIZATION; MELANOGASTER	Brain amyloid plaques are a hallmark of Alzheimer's disease (AD), and primarily consist of aggregated A beta peptides. While A beta 1-40 and A beta 1-42 are the most abundant, a number of other A beta peptides have also been identified. Studies have indicated differential toxicity for these various A beta peptides, but in vivo toxicity has not been systematically tested. To address this issue, we generated improved transgenic Drosophila UAS strains expressing 11 pertinent A beta peptides. UAS transgenic flies were generated by identical chromosomal insertion, hence removing any transgenic position effects, and crossed to a novel and robust Gal4 driver line. Using this improved Gal4/UAS set-up, survival and activity assays revealed that A beta 1-42 severely shortens lifespan and reduces activity. N-terminal truncated peptides were quite toxic, with 3-42 similar to 1-42, while 11-42 showed a pronounced but less severe phenotype. N-terminal mutations in 3-42 (E3A) or 11-42 (E11A) resulted in reduced toxicity for 11-42, and reduced aggregation for both variants. Strikingly, C-terminal truncation of A beta (1-41, -40, -39, -38, -37) were non-toxic. In contrast, C-terminal extension to 1-43 resulted in reduced lifespan and activity, but not to the same extent as 1-42. Mutating residue 42 in 1-42 (A42D, A42R and A42W) greatly reduced A beta accumulation and toxicity. Histological and biochemical analysis revealed strong correlation between in vivo toxicity and brain A beta aggregate load, as well as amount of insoluble A beta. This systematic Drosophila in vivo and in vitro analysis reveals crucial N- and C-terminal specificity for A beta neurotoxicity and aggregation, and underscores the importance of residues 1-10 and E11, as well as a pivotal role of A42.	[Pokrzywa, Malgorzata; Starkenberg, Annika; Thor, Stefan] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Jonson, Maria; Hammarstrom, Per] Linkoping Univ, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden	Linkoping University; Linkoping University	Thor, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	stefan.thor@liu.se	Thor, Stefan/Y-5804-2019; Pokrzywa, Małgorzata/GQA-6257-2022	Thor, Stefan/0000-0001-5095-541X; 	Swedish VINNOVA; King Gustaf V's and Queen Victoria's Freemasons' Foundation; AstraZeneca, Sodertalje; Swedish Research Council; VINNOVA grant, "Innovations for future health"	Swedish VINNOVA(Vinnova); King Gustaf V's and Queen Victoria's Freemasons' Foundation; AstraZeneca, Sodertalje(AstraZeneca); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA grant, "Innovations for future health"(Vinnova)	This work was supported by Swedish VINNOVA, by King Gustaf V's and Queen Victoria's Freemasons' Foundation, and by AstraZeneca, Sodertalje, to ST, and by the Swedish Research Council to PH. MJ was supported by a VINNOVA grant, "Innovations for future health". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1958, J AM STAT ASS; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Berg I, 2009, NEURODEGENER DIS, V6, P127, DOI 10.1159/000213761; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BURDICK D, 1992, J BIOL CHEM, V267, P546; Burnouf S, 2015, ACTA NEUROPATHOL, V130, P35, DOI 10.1007/s00401-015-1419-y; Caesar I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031424; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Crowther DC, 2004, CURR OPIN PHARMACOL, V4, P513, DOI 10.1016/j.coph.2004.07.001; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Davis S, 2003, MOL NEUROBIOL, V27, P249, DOI 10.1385/MN:27:3:249; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jahn TR, 2011, J NEUROSCI METH, V197, P186, DOI 10.1016/j.jneumeth.2011.01.026; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Parvathy S, 2001, ARCH NEUROL-CHICAGO, V58, P2025, DOI 10.1001/archneur.58.12.2025; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Philipson O, 2010, FEBS J, V277, P1389, DOI 10.1111/j.1742-4658.2010.07564.x; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2007, BIOCHEMISTRY-US, V46, P10921, DOI 10.1021/bi701043x; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Schoonenboom NS, 2005, ANN NEUROL, V58, P139, DOI 10.1002/ana.20508; Tekirian TL, 2001, J ALZHEIMERS DIS, V3, P241; Vandersteen A, 2012, J BIOL CHEM, V287, P36732, DOI 10.1074/jbc.M112.394635; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Wittnam JL, 2012, J BIOL CHEM, V287, P8154, DOI 10.1074/jbc.M111.308601	58	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133272	10.1371/journal.pone.0133272	http://dx.doi.org/10.1371/journal.pone.0133272			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208119	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000074
J	Takahashi, K; Takahashi, K; Washitani, I				Takahashi, Kazuaki; Takahashi, Kaori; Washitani, Izumi			Do Small Canopy Gaps Created by Japanese Black Bears Facilitate Fruiting of Fleshy-Fruited Plants?	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; ECOSYSTEM ENGINEERS; ECOLOGICAL COMMUNITIES; TREE DIVERSITY; LIGHT-GAP; GROWTH; SIZE; ARCHITECTURE; POPULATION; DYNAMICS	Japanese black bears often break branches when climbing trees and feeding on fruit in canopies, thereby creating small canopy gaps. However, the role of black bear-created canopy gaps has not been evaluated in the context of multiple forest dynamics. Our hypothesis was that small canopy gaps created by black bears improve light conditions, which facilitates fruiting of adult fleshy-fruited plants located beneath the gaps, and also that this chain interaction depends on interactions among the size of gaps, improved light conditions, forest layers, and life form of plants. The rPPFD, size of black bear-created canopy gaps, and fruiting/non-fruiting of fleshy-fruited plants were investigated in five forest layers beneath black-bear-created canopy gaps and closed canopies of Mongolian oak (Quercus crispula). We found that light conditions improved beneath black bear-disturbed trees with canopy gaps of large size, and the effect of improvement of light conditions was reduced with descending forest layers. Fruiting of fleshy-fruited plants, especially woody lianas and trees, was facilitated by the improvement of light conditions accompanied by an increase in the size of black-bear-created gaps. Data from this study revealed that canopy disturbance by black bears was key for improving light conditions and accelerating fruiting of fleshy-fruited trees and woody lianas in the canopy layers in particular. Therefore, our hypothesis was mostly supported. Our results provide evidence that Japanese black bears have high potential as ecosystem engineers that increase the availability of resources (light and fruit in this study) to other species by causing physical state changes in biotic materials (branches of Q. crispula in this study).	[Takahashi, Kazuaki] Nagano Univ, Fac Tourism & Environm Studies, Ueda, Nagano, Japan; [Takahashi, Kaori] Shinshu Univ, Res Ctr Human & Environm Sci, Dept Life Sci, Div Gene Res, Ueda, Nagano, Japan; [Washitani, Izumi] Univ Tokyo, Inst Agr & Life Sci, Biodivers & Ecosyst Restorat, Bunkyo Ku, Tokyo, Japan	Shinshu University; University of Tokyo	Takahashi, K (corresponding author), Nagano Univ, Fac Tourism & Environm Studies, Ueda, Nagano, Japan.	k-takahashi@nagano.ac.jp		Washitani, Izumi/0000-0002-5761-7947	Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [21780154, 26450203]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI (21780154, 26450203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; Berkenbusch K, 2003, NEW ZEAL J ECOL, V27, P67; Binkley D, 2013, FOREST ECOL MANAG, V288, P5, DOI 10.1016/j.foreco.2011.11.002; Boogert NJ, 2006, BIOSCIENCE, V56, P570, DOI 10.1641/0006-3568(2006)56[570:TIONCA]2.0.CO;2; Brokaw N, 2000, TRENDS ECOL EVOL, V15, P183, DOI 10.1016/S0169-5347(00)01822-X; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; DAHLEM TS, 1987, CAN J BOT, V65, P242, DOI 10.1139/b87-034; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Faegri K., 1979, PRINCIPLES POLLINATI; FEINSINGER P, 1991, ECOLOGY, V72, P1953, DOI 10.2307/1941550; FEINSINGER P, 1987, ECOLOGY, V68, P1294, DOI 10.2307/1939214; Fleming T.H., 1991, P119; Frazer GW, 1999, GAP LIGHT ANAL V2 0; Gribben PE, 2009, ECOL LETT, V12, P1127, DOI 10.1111/j.1461-0248.2009.01366.x; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; Hale SE, 2003, FOREST ECOL MANAG, V179, P341, DOI 10.1016/S0378-1127(02)00540-6; Harper J. L, 1977, POPULATION BIOL PLAN; Hashimoto Y, 2003, ECOL RES, V18, P485, DOI 10.1046/j.1440-1703.2003.00572.x; Hashimoto Y., 1997, MAMMALIAN SCI, V37, P1; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kikuzawa K, 1995, REPROD ECOLOGY PLANT, P146; Kishimoto Ryosuke, 2008, Honyurui Kagaku, V48, P73; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Koike S., 2008, Journal of the Japanese Forest Society, V90, P26, DOI 10.4005/jjfs.90.26; Koike S, 2008, ECOL RES, V23, P385, DOI 10.1007/s11284-007-0399-3; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; LEVEY DJ, 1988, ECOLOGY, V69, P1076, DOI 10.2307/1941263; NAKASHIZUKA T, 1989, ECOLOGY, V70, P1273, DOI 10.2307/1938186; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; R Development Core Team, 2014, R LANG ENV STAT COMP; Rathcke B., 1983, P305; Schliemann SA, 2011, FOREST ECOL MANAG, V261, P1143, DOI 10.1016/j.foreco.2011.01.011; Schnitzer SA, 2005, FOREST CLIMBING PLANTS OF WEST AFRICA: DIVERSITY, ECOLOGY AND MANAGEMENT, P59, DOI 10.1079/9780851999142.0059; Takahashi K, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-23; Takanose Yoichiro, 2003, Ornithological Science, V2, P25, DOI 10.2326/osj.2.25; VanderMeer PJ, 1996, J ECOL, V84, P19, DOI 10.2307/2261696; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Yamamoto S, 1999, PLANT ECOL, V140, P167, DOI 10.1023/A:1009713002039; Yamamoto S.I., 2000, J FORESTRY RES, V5, P223, DOI DOI 10.1007/BF02767114	44	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130956	10.1371/journal.pone.0130956	http://dx.doi.org/10.1371/journal.pone.0130956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207908	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000012
J	Beckenkamp, A; Willig, JB; Santana, DB; Nascimento, J; Paccez, JD; Zerbini, LF; Bruno, AN; Pilger, DA; Wink, MR; Buffon, A				Beckenkamp, Aline; Willig, Julia Biz; Santana, Danielle Bertodo; Nascimento, Jessica; Paccez, Juliano Domiraci; Zerbini, Luiz Fernando; Bruno, Alessandra Nejar; Pilger, Diogo Andre; Wink, Marcia Rosangela; Buffon, Andreia			Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; PROSTATE-CANCER CELLS; OVARIAN-CARCINOMA; MALIGNANT PHENOTYPE; HUMAN-LYMPHOCYTES; CD26; BINDING; ACTIVATION; SERUM; CHEMOKINE	Dipeptidyl peptidase IV (DPPIV/CD26) is a transmembrane glycoprotein that inactivates or degrades some bioactive peptides and chemokines. For this reason, it regulates cell proliferation, migration and adhesion, showing its role in cancer processes. This enzyme is found mainly anchored onto the cell membrane, although it also has a soluble form, an enzymatically active isoform. In the present study, we investigated DPPIV/CD26 activity and expression in cervical cancer cell lines (SiHa, HeLa and C33A) and non-tumorigenic HaCaT cells. The effect of the DPPIV/CD26 inhibitor (sitagliptin phosphate) on cell migration and adhesion was also evaluated. Cervical cancer cells and keratinocytes exhibited DPPIV/CD26 enzymatic activity both membrane-bound and in soluble form. DPPIV/CD26 expression was observed in HaCaT, SiHa and C33A, while in HeLa cells it was almost undetectable. We observed higher migratory capacity of HeLa, when compared to SiHa. But in the presence of sitagliptin SiHa showed an increase in migration, indicating that, at least in part, cell migration is regulated by DPPIV/CD26 activity. Furthermore, in the presence of sitagliptin phosphate, SiHa and HeLa cells exhibited a significant reduction in adhesion. However this mechanism seems to be mediated independent of DPPIV/CD26. This study demonstrates, for the first time, the activity and expression of DPPIV/CD26 in cervical cancer cells and the effect of sitagliptin phosphate on cell migration and adhesion.	[Beckenkamp, Aline; Willig, Julia Biz; Santana, Danielle Bertodo; Nascimento, Jessica; Pilger, Diogo Andre; Buffon, Andreia] Fed Univ Rio Grande do Sul UFRGS, Fac Pharm, Pharmaceut Sci Grad Program, Porto Alegre, RS, Brazil; [Paccez, Juliano Domiraci; Zerbini, Luiz Fernando] Canc Genom Grp, ICGEB, Cape Town, South Africa; [Bruno, Alessandra Nejar] Fed Inst Educ Sci & Technol, Porto Alegre, RS, Brazil; [Wink, Marcia Rosangela] Fed Univ Hlth Sci Porto Alegre, Cell Biol Lab, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; Instituto Federal do Rio Grande do Sul (IFRS)	Buffon, A (corresponding author), Fed Univ Rio Grande do Sul UFRGS, Fac Pharm, Pharmaceut Sci Grad Program, Porto Alegre, RS, Brazil.	andreia.buffon@ufrgs.br	Paccez, Juliano/K-8560-2012; Zerbini, Luiz/B-7720-2015; Pilger, Diogo/S-5299-2019; Beckenkamp, Aline/L-9540-2015	Paccez, Juliano/0000-0002-1086-4588; Zerbini, Luiz/0000-0003-0736-9508; Pilger, Diogo/0000-0002-6773-6480; Beckenkamp, Aline/0000-0003-4227-7844	Pharmaceutical Sciences Graduate Program (PPGCF/UFRGS), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [Auxilio Recem-Doutor 0902665]; Pro-Reitoria de Pesquisa-UFRGS (PROPESQ-UFRGS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Procad-CAPES) [071/2013 - 15819]; Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil); CAPES-Brazil; ICGEB	Pharmaceutical Sciences Graduate Program (PPGCF/UFRGS), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Pro-Reitoria de Pesquisa-UFRGS (PROPESQ-UFRGS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Procad-CAPES); Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ICGEB(Department of Biotechnology (DBT) India)	This work was supported by grants from Pharmaceutical Sciences Graduate Program (PPGCF/UFRGS), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, Auxilio Recem-Doutor 0902665), Pro-Reitoria de Pesquisa-UFRGS (PROPESQ-UFRGS) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Procad-CAPES, Edital no 071/2013 - 15819). A. Beckenkamp was a recipient of fellowships from Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq-Brasil) and CAPES-Brazil, and J. Paccez was a recipient of postdoctoral fellowship from ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arscott WT, 2009, ONCOGENE, V28, P479, DOI 10.1038/onc.2008.402; BAUVOIS B, 1988, BIOCHEM J, V252, P723, DOI 10.1042/bj2520723; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buffon A, 2007, LIFE SCI, V80, P950, DOI 10.1016/j.lfs.2006.11.024; Busek P, 2012, INT J BIOCHEM CELL B, V44, P738, DOI 10.1016/j.biocel.2012.01.011; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Cordero OJ, 2011, WORLD J CLIN ONCOL, V2, P245, DOI 10.5306/wjco.v2.i6.245; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Cro L, 2009, HEMATOL ONCOL, V27, P140, DOI 10.1002/hon.888; De Andrade CFCG, 2009, J ENZYM INHIB MED CH, V24, P708, DOI 10.1080/14756360802334800; De Chiara L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-333; de Cremoux P, 2009, INT J CANCER, V124, P778, DOI 10.1002/ijc.24075; De Meester I, 1999, IMMUNOL TODAY, V20, P367, DOI 10.1016/S0167-5699(99)01486-3; Dong RP, 1997, J IMMUNOL, V159, P6070; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Eric-Nikolic A, 2011, IMMUNOBIOLOGY, V216, P942, DOI 10.1016/j.imbio.2011.01.005; Gonzalez-Gronow M, 2001, BIOCHEM J, V355, P397, DOI 10.1042/0264-6021:3550397; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Goscinski MA, 2008, APMIS, V116, P823, DOI 10.1111/j.1600-0463.2008.01029.x; HANSKI C, 1988, EXP CELL RES, V178, P64, DOI 10.1016/0014-4827(88)90378-3; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Herrera C, 2001, J BIOL CHEM, V276, P19532, DOI 10.1074/jbc.M004586200; Hinke SA, 2000, J BIOL CHEM, V275, P3827, DOI 10.1074/jbc.275.6.3827; Iwaki-Egawa S, 1998, J BIOCHEM, V124, P428, DOI 10.1093/oxfordjournals.jbchem.a022130; Kajiyama H, 2003, CANCER RES, V63, P2278; Kajiyama H, 2002, CANCER RES, V62, P2753; Kajiyama H, 2006, ANN NY ACAD SCI, V1086, P233, DOI 10.1196/annals.1377.007; Kikkawa F, 2005, BBA-PROTEINS PROTEOM, V1751, P45, DOI 10.1016/j.bbapap.2004.09.028; Kirby M, 2010, CLIN SCI, V118, P31, DOI 10.1042/CS20090047; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Lambeir AM, 1997, BBA-PROTEIN STRUCT M, V1340, P215, DOI 10.1016/S0167-4838(97)00045-9; LOSTER K, 1995, BIOCHEM BIOPH RES CO, V217, P341, DOI 10.1006/bbrc.1995.2782; Maes MB, 2005, BIOCHEM J, V386, P315, DOI 10.1042/BJ20041156; Matic IZ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-48; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Proost P, 1999, J BIOL CHEM, V274, P3988, DOI 10.1074/jbc.274.7.3988; Rama CH, 2008, REV SAUDE PUBL, V42, P123, DOI 10.1590/S0034-89102008000100016; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Shioda T, 1998, P NATL ACAD SCI USA, V95, P6331, DOI 10.1073/pnas.95.11.6331; TORIMOTO Y, 1991, J IMMUNOL, V147, P2514; Wang Aiying, 2012, BMC Pharmacology, V12, P2, DOI 10.1186/1471-2210-12-2; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Wesley UV, 1999, J EXP MED, V190, P311, DOI 10.1084/jem.190.3.311; Wesley UV, 2004, INT J CANCER, V109, P855, DOI 10.1002/ijc.20091; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760; Zagouri F, 2012, GYNECOL ONCOL, V126, P291, DOI 10.1016/j.ygyno.2012.04.007; Zanoni TB, 2014, TOXICOL LETT, V227, P139, DOI 10.1016/j.toxlet.2014.03.007; Zerbini LF, 2003, CANCER RES, V63, P2206	51	28	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134305	10.1371/journal.pone.0134305	http://dx.doi.org/10.1371/journal.pone.0134305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222679	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800128
J	Jones, B; Till, K; Barlow, M; Lees, M; O'Hara, JP; Hind, K				Jones, Ben; Till, Kevin; Barlow, Matthew; Lees, Matthew; O'Hara, John Paul; Hind, Karen			Anthropometric and Three-Compartment Body Composition Differences between Super League and Championship Rugby League Players: Considerations for the 2015 Season and Beyond	PLOS ONE			English	Article							SKILL QUALITIES; STRENGTH; UNION; POWER; FAT; SELECTION; SPEED; TEAM; BONE; MASS	Super League (SL) and Championship (RLC) rugby league players will compete against each other in 2015 and beyond. To identify possible discrepancies, this study compared the anthropometric profile and body composition of current SL (full-time professional) and RLC (part-time semi-professional) players using dual-energy X-ray absorptiometry (DXA). A cross-sectional design involved DXA scans on 67 SL (n=29 backs, n=38 forwards) and 46 RLC (n=20 backs, n=26 forwards) players during preseason. A one-way ANOVA was used to compare age, stature, body mass, soft tissue fat percentage, bone mineral content (BMC), total and regional (i.e., arms, legs and trunk) fat and lean mass between SL forwards, SL backs, RLC forwards and RLC backs. No significant differences in age, stature or body mass were observed. SL forwards and backs had relatively less soft tissue fat (17.5 +/- 3.7 and 14.8 +/- 3.6 vs. 21.4 +/- 4.3 and 20.8 +/- 3.8%), greater BMC (4,528 +/- 443 and 4,230 +/- 447 vs. 4,302 +/- 393 and 3,971 +/- 280 g), greater trunk lean mass (37.3 +/- 3.0 and 35.3 +/- 3.8 vs. 34.9 +/- 32.3 and 32.3 +/- 2.6 kg) and less trunk fat mass (8.5 +/- 2.7 and 6.2 +/- 2.1 vs. 10.7 +/- 2.8 and 9.5 +/- 2.9 kg) than RLC forwards and backs. Observed differences may reflect selection based on favourable physical attributes, or training adaptations. To reduce this discrepancy, some RLC players should reduce fat mass and increase lean mass, which may be of benefit for the 2015 season and beyond.	[Jones, Ben; Till, Kevin; Barlow, Matthew; Lees, Matthew; O'Hara, John Paul; Hind, Karen] Leeds Beckett Univ, Res Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England	Leeds Beckett University	Jones, B (corresponding author), Leeds Beckett Univ, Res Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	b.jones@leedsbeckett.ac.uk	Hind, Karen/AAE-6433-2021; Till, Kevin/AAP-7379-2021; Hind, Karen/HII-7471-2022	Lees, Matthew/0000-0003-1422-0154; Jones, Ben/0000-0002-4274-6236; Barlow, Matthew/0000-0001-7291-9516; Hind, Karen/0000-0002-4546-5536				Baker D, 1999, J STRENGTH COND RES, V13, P230; Baker D, 2002, J STRENGTH COND RES, V16, P581; Baker DG, 2008, J STRENGTH COND RES, V22, P153, DOI 10.1519/JSC.0b013e31815f9519; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Cohen J.E., 1988, STAT POWER ANAL BEHA; Delahunt E, 2013, J STRENGTH COND RES, V27, P3252, DOI 10.1519/JSC.0b013e3182915ea6; Duthie GM, 2006, BRIT J SPORT MED, V40, P202, DOI 10.1136/bjsm.2005.019695; Gabbett TJ, 2009, J SPORT MED PHYS FIT, V49, P233; Gabbett T, 2011, J SPORT SCI, V29, P7, DOI 10.1080/02640414.2010.514280; Gabbett TJ, 2011, J SPORT SCI, V29, P1453, DOI 10.1080/02640414.2011.603348; Gabbett TJ, 2002, J SPORT SCI, V20, P399, DOI 10.1080/026404102317366654; Georgeson EC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001400; Harley JA, 2011, J STRENGTH COND RES, V25, P1024, DOI 10.1519/JSC.0b013e3181cc21fb; Higham DG, 2014, INT J SPORTS MED, V35, P575, DOI 10.1055/s-0033-1355419; Hind K, 2013, EUR J CLIN NUTR, V67, P1331, DOI 10.1038/ejcn.2013.210; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Hind K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097427; Johnston RD, 2014, SPORTS MED, V44, P1087, DOI 10.1007/s40279-014-0190-x; MILBURN PD, 1993, SPORTS MED, V16, P168, DOI 10.2165/00007256-199316030-00002; Nana A, 2012, MED SCI SPORT EXER, V44, P180, DOI 10.1249/MSS.0b013e318228b60e; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Schriefer JL, 2005, J BIOMECH, V38, P1838, DOI 10.1016/j.jbiomech.2004.08.017; Sedeaud A, 2012, BRIT J SPORT MED, V46, P580, DOI 10.1136/bjsports-2011-090506; Sykes D, 2009, INT J PERFORM ANAL S, V9, P47, DOI DOI 10.1080/24748668.2009.11868463; Till K., 2010, TALENT DEV EXCELLENC, V2, P193; Till K, 2015, J SCI MED SPORT, V18, P310, DOI 10.1016/j.jsams.2014.05.003; Till K, 2014, J STRENGTH COND RES, V28, P319, DOI 10.1519/JSC.0b013e3182a73c0e; Till K, 2011, J SCI MED SPORT, V14, P264, DOI 10.1016/j.jsams.2011.01.006; Twist C, 2014, INT J SPORT PHYSIOL, V9, P925, DOI 10.1123/ijspp.2013-0270; WITHERS RT, 1987, EUR J APPL PHYSIOL O, V56, P191, DOI 10.1007/BF00640643	31	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133188	10.1371/journal.pone.0133188	http://dx.doi.org/10.1371/journal.pone.0133188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221720	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358836800041
J	Mentzel, CMJ; Anthon, C; Jacobsen, MJ; Karlskov-Mortensen, P; Bruun, CS; Jorgensen, CB; Gorodkin, J; Cirera, S; Fredholm, M				Mentzel, Caroline M. Junker; Anthon, Christian; Jacobsen, Mette J.; Karlskov-Mortensen, Peter; Bruun, Camilla S.; Jorgensen, Claus B.; Gorodkin, Jan; Cirera, Susanna; Fredholm, Merete			Gender and Obesity Specific MicroRNA Expression in Adipose Tissue from Lean and Obese Pigs	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE; INSULIN-RESISTANCE; GENE-EXPRESSION; ACCUMULATION; FAT; INFORMATION; MUSCLE; MIRNA; PCR; MEN	Obesity is a complex condition that increases the risk of life threatening diseases such as cardiovascular disease and diabetes. Studying the gene regulation of obesity is important for understanding the molecular mechanisms behind the obesity derived diseases and may lead to better intervention and treatment plans. MicroRNAs (miRNAs) are short non-coding RNAs regulating target mRNA by binding to their 3'UTR. They are involved in numerous biological processes and diseases, including obesity. In this study we use a mixed breed pig model designed for obesity studies to investigate differentially expressed miRNAs in subcutaneous adipose tissue by RNA sequencing (RNAseq). Both male and female pigs are included to explore gender differences. The RNAseq study shows that the most highly expressed miRNAs are in accordance with comparable studies in pigs and humans. A total of six miRNAs are differentially expressed in subcutaneous adipose tissue between the lean and obese group of pigs, and in addition gender specific significant differential expression is observed for a number of miRNAs. The differentially expressed miRNAs have been verified using qPCR. The results of these studies in general confirm the trends found by RNAseq. Mir-9 and mir-124a are significantly differentially expressed with large fold changes in subcutaneous adipose tissue between lean and obese pigs. Mir-9 is more highly expressed in the obese pigs with a fold change of 10 and a p-value <0.001. Mir-124a is more highly expressed in the obese pigs with a fold change of 114 and a p-value <0.001. In addition, mir-124a is significantly higher expressed in abdominal adipose tissue in male pigs with a fold change of 119 and a p-value <0.05. Both miRNAs are also significantly higher expressed in the liver of obese male pigs where mir-124a has a fold change of 12 and mir-9 has a fold change of 1.6, both with p-values <0.05.	[Mentzel, Caroline M. Junker; Jacobsen, Mette J.; Karlskov-Mortensen, Peter; Bruun, Camilla S.; Jorgensen, Claus B.; Cirera, Susanna; Fredholm, Merete] Univ Copenhagen, Fac Hlth Sci, Dept Vet Clin & Anim Sci, Anim Genet, Frederiksberg, Denmark; [Mentzel, Caroline M. Junker; Anthon, Christian; Gorodkin, Jan; Fredholm, Merete] Univ Copenhagen, Fac Hlth Sci, Dept Vet Clin & Anim Sci, Ctr Non Coding RNA Technol & Hlth Computat Biol &, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen	Fredholm, M (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Vet Clin & Anim Sci, Anim Genet, Frederiksberg, Denmark.	mf@sund.ku.dk	Cirera, Susanna/K-8540-2017; Jorgensen, Claus B./GXH-7925-2022; Mentzel, Caroline/AAX-1577-2021; Karlskov-Mortensen, Peter/C-3030-2013	Jorgensen, Claus B./0000-0003-4749-5306; Mentzel, Caroline/0000-0003-4688-7367; Karlskov-Mortensen, Peter/0000-0002-2491-2763; Cirera, Susanna/0000-0001-8105-1579; Jacobsen, Mette Juul/0000-0001-9264-7554; Fredholm, Merete/0000-0002-3563-7648; Anthon, Christian/0000-0002-4336-1688; Gorodkin, Jan/0000-0001-5823-4000	Ministry for Science and Technology; Danish Independent Research Council [DFF - 1335-00127]; Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies)	Ministry for Science and Technology; Danish Independent Research Council(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies)	The project was supported by a grant from the Ministry for Science and Technology to the "UNIK Project for Food Fitness and Pharma for Health", by the Danish Independent Research Council (DFF - 1335-00127), and by the Danish Council for Strategic Research (Programme Commission on Strategic Growth Technologies). Innovation Fund Denmark (CMJM, MF, JG) and Danish Center for Scientific Computing (DCSC, DeIC) (JG).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3; Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Bluher M, 2007, DIABETES CARE, V30, P3110, DOI 10.2337/dc07-1257; Bollen PJA, 2005, LAB ANIM-UK, V39, P80, DOI 10.1258/0023677052886565; Bruun CS, 2013, LUNG, V191, P669, DOI 10.1007/s00408-013-9504-2; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Cirera S, 2014, ANIM GENET, V45, P59, DOI 10.1111/age.12082; Cirera S, 2014, METHODS MOL BIOL, V1182, P73, DOI 10.1007/978-1-4939-1062-5_7; Cirera Susanna, 2013, BMC Res Notes, V6, P472, DOI 10.1186/1756-0500-6-472; Civelek M, 2013, HUM MOL GENET, V22, P3023, DOI 10.1093/hmg/ddt159; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Haukeland JW, 2008, SCAND J GASTROENTERO, V43, P1241, DOI 10.1080/00365520802158614; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Keller P, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-7; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; Kogelman Lisette J. A., 2013, Frontiers in Genetics, V4, P29, DOI 10.3389/fgene.2013.00029; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Lean MEJ, 1998, LANCET, V351, P853, DOI 10.1016/S0140-6736(97)10004-6; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li HY, 2012, ANIM GENET, V43, P704, DOI 10.1111/j.1365-2052.2012.02332.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MA J, 2013, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0080041; Martin M, 2011, CUTADAPT REMOVES ADA; MERSMANN HJ, 1984, GROWTH, V48, P321; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stockl S, 2013, CELL PHYSIOL BIOCHEM, V31, P703, DOI 10.1159/000350089; Taskinen MR, 2011, ARTERIOSCL THROM VAS, V31, P2144, DOI 10.1161/ATVBAHA.111.224808; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445	69	39	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131650	10.1371/journal.pone.0131650	http://dx.doi.org/10.1371/journal.pone.0131650			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222688	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800018
J	Mette, C; Grabemann, M; Zimmermann, M; Strunz, L; Scherbaum, N; Wiltfang, J; Kis, B				Mette, Christian; Grabemann, Marco; Zimmermann, Marco; Strunz, Laura; Scherbaum, Norbert; Wiltfang, Jens; Kis, Bernhard			No Clear Association between Impaired Short-Term or Working Memory Storage and Time Reproduction Capacity in Adult ADHD Patients	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER; DEFICIT HYPERACTIVITY DISORDER; FUNCTIONAL NEUROANATOMY; BEHAVIORAL-INHIBITION; EXECUTIVE FUNCTION; CHILDREN; PERCEPTION; ADOLESCENTS; ACTIVATION; MECHANISMS	Objective Altered time reproduction is exhibited by patients with adult attention deficit hyperactivity disorder (ADHD). It remains unclear whether memory capacity influences the ability of adults with ADHD to reproduce time intervals. Method We conducted a behavioral study on 30 ADHD patients who were medicated with methylphenidate, 29 unmedicated adult ADHD patients and 32 healthy controls (HCs). We assessed time reproduction using six time intervals (1 s, 4 s, 6 s, 10 s, 24 s and 60 s) and assessed memory performance using the Wechsler memory scale. Results The patients with ADHD exhibited lower memory performance scores than the HCs. No significant differences in the raw scores for any of the time intervals (p > .05), with the exception of the variability at the short time intervals (1 s, 4 s and 6 s) (p < .01), were found between the groups. The overall analyses failed to reveal any significant correlations between time reproduction at any of the time intervals examined in the time reproduction task and working memory performance (p > .05). Conclusion We detected no findings indicating that working memory might influence time reproduction in adult patients with ADHD. Therefore, further studies concerning time reproduction and memory capacity among adult patients with ADHD must be performed to verify and replicate the present findings.	[Mette, Christian; Grabemann, Marco; Zimmermann, Marco; Strunz, Laura; Scherbaum, Norbert] Univ Duisburg Essen, Fac Med, Dept Psychiat & Psychotherapy, LVR Hosp Essen, Essen, Germany; [Wiltfang, Jens; Kis, Bernhard] Univ Med Ctr Goettingen, Dept Psychiat & Psychotherapy, Gottingen, Germany	University of Duisburg Essen; University of Gottingen	Kis, B (corresponding author), Univ Med Ctr Goettingen, Dept Psychiat & Psychotherapy, Gottingen, Germany.	Bernhard.kis@medizin.uni-goettingen.de	Kis, Bernhard/A-8731-2008; Cruz e Silva, Odete/AAH-5595-2020	Kis, Bernhard/0000-0003-3244-9737; Wiltfang, Jens/0000-0003-1492-5330	German Research Foundation; Gottingen University	German Research Foundation(German Research Foundation (DFG)); Gottingen University	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Advokat Claire, 2007, J Atten Disord, V10, P253, DOI 10.1177/1087054706292106; Alderson RM, 2013, J ABNORM PSYCHOL, V122, P532, DOI 10.1037/a0031742; Alderson RM, 2013, NEUROPSYCHOLOGY, V27, P287, DOI 10.1037/a0032371; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2001, NEUROPSYCHOLOGY, V15, P351, DOI 10.1037//0894-4105.15.3.351; Barkley RA, 2013, J CLIN CHILD ADOLESC, V42, P161, DOI 10.1080/15374416.2012.734259; Barkley Russell A, 2010, J Clin Psychiatry, V71, pe17, DOI 10.4088/JCP.9066tx1c; Beck AT, 1996, PSYCHOL ASSESS; Brown A, 2012, J PSYCHIATR RES, V46, P476, DOI 10.1016/j.jpsychires.2012.01.008; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Church RM, 2002, BEHAV PROCESS, V57, P261, DOI 10.1016/S0376-6357(02)00018-9; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Engelhardt PE, 2008, J ABNORM PSYCHOL, V117, P591, DOI 10.1037/a0012593; Fassbender C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027240; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; GIBBON J, 1991, LEARN MOTIV, V22, P3, DOI 10.1016/0023-9690(91)90015-Z; GIBBON J, 1990, COGNITION, V37, P23, DOI 10.1016/0010-0277(90)90017-E; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gooch D, 2011, J CHILD PSYCHOL PSYC, V52, P195, DOI 10.1111/j.1469-7610.2010.02312.x; Harting C, 2000, WECHSLER MEMORY SCAL; Hwang SL, 2010, J CHILD PSYCHOL PSYC, V51, P223, DOI 10.1111/j.1469-7610.2009.02163.x; Kasper LJ, 2012, CLIN PSYCHOL REV, V32, P605, DOI 10.1016/j.cpr.2012.07.001; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P21, DOI 10.1076/chin.7.1.21.3149; Kim S, 2014, CLIN NEUROPHYSIOL, V125, P1596, DOI 10.1016/j.clinph.2013.12.094; Ko C. H, 2015, J ATTEN DISORD; Ko CH, 2013, EUR ARCH PSY CLIN N, V263, P561, DOI 10.1007/s00406-013-0407-2; Lara AH, 2014, NAT NEUROSCI, V17, P876, DOI 10.1038/nn.3702; Laux PG, 1981, THEORETISCHE GRUND L; LEHRL S, 1995, MANUAL ZUM MWT B; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; McGee R, 2004, J ABNORM CHILD PSYCH, V32, P481, DOI 10.1023/B:JACP.0000037778.61929.1b; Meaux Julie B, 2003, J Pediatr Health Care, V17, P64, DOI 10.1016/S0891-5245(02)88326-2; Meck WH, 2013, BEHAV NEUROSCI, V127, P642, DOI 10.1037/a0034201; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Meck WH, 2004, COGNITIVE BRAIN RES, V21, P133, DOI 10.1016/j.cogbrainres.2004.07.010; Mette C, 2013, ACTA PSYCHIAT SCAND, V128, P124, DOI 10.1111/acps.12090; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Mullins C, 2005, J AM ACAD CHILD PSY, V44, P169, DOI 10.1097/00004583-200502000-00009; Noreika V, 2013, NEUROPSYCHOLOGIA, V51, P235, DOI 10.1016/j.neuropsychologia.2012.09.036; Oades RD, 2008, PROG BRAIN RES, V172, P543, DOI 10.1016/S0079-6123(08)00926-6; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Plummer C, 2009, CHILD NEUROPSYCHOL, V15, P147, DOI 10.1080/09297040802403690; Pollak Y, 2009, NEUROPSYCHOLOGY, V23, P679, DOI 10.1037/a0016281; Prevatt F, 2011, J ATTEN DISORD, V15, P531, DOI 10.1177/1087054710370673; Quinlan Donald M, 2003, J Atten Disord, V6, P143, DOI 10.1177/108705470300600401; Rattat AC, 2012, BEHAV RES METHODS, V44, P67, DOI 10.3758/s13428-011-0135-3; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Rommelse NNJ, 2007, J AM ACAD CHILD PSY, V46, P582, DOI 10.1097/chi.0b013e3180335af7; Rosler M, 2004, NERVENARZT, V75, P888, DOI 10.1007/s00115-003-1622-2; Schweitzer Julie B, 2006, Behav Brain Funct, V2, P43, DOI 10.1186/1744-9081-2-43; Seri Y, 2002, BRAIN COGNITION, V48, P553, DOI 10.1006/brcg.2001.1416; Swanson JM, 2003, J CLIN PSYCHIAT, V64, P35; Toplak ME, 2003, J CHILD PSYCHOL PSYC, V44, P888, DOI 10.1111/1469-7610.00173; Valera EM, 2005, BIOL PSYCHIAT, V57, P439, DOI 10.1016/j.biopsych.2004.11.034; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Valko L, 2010, J NEURAL TRANSM, V117, P1213, DOI 10.1007/s00702-010-0473-9; von Aster M., 2006, WECHSLER INTELLIGENZ, V2; West J, 2000, CHILD NEUROPSYCHOL, V6, P241, DOI 10.1076/chin.6.4.241.3140; Yang BR, 2007, BRAIN RES, V1170, P90, DOI 10.1016/j.brainres.2007.07.021; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	65	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133714	10.1371/journal.pone.0133714	http://dx.doi.org/10.1371/journal.pone.0133714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26221955	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800062
J	Morita, H; Obata, K; Abe, C; Shiba, D; Shirakawa, M; Kudo, T; Takahashi, S				Morita, Hironobu; Obata, Koji; Abe, Chikara; Shiba, Dai; Shirakawa, Masaki; Kudo, Takashi; Takahashi, Satoru			Feasibility of a Short-Arm Centrifuge for Mouse Hypergravity Experiments	PLOS ONE			English	Article							INTERNATIONAL-SPACE-STATION; RATS; ISS	To elucidate the pure impact of microgravity on small mammals despite uncontrolled factors that exist in the International Space Station, it is necessary to construct a 1 g environment in space. The Japan Aerospace Exploration Agency has developed a novel mouse habitat cage unit that can be installed in the Cell Biology Experiment Facility in the Kibo module of the International Space Station. The Cell Biology Experiment Facility has a short-arm centrifuge to produce artificial 1 g gravity in space for mouse experiments. However, the gravitational gradient formed inside the rearing cage is larger when the radius of gyration is shorter; this may have some impact on mice. Accordingly, biological responses to hypergravity induced by a short-arm centrifuge were examined and compared with those induced by a long-arm centrifuge. Hypergravity induced a significant Fos expression in the central nervous system, a suppression of body mass growth, an acute and transient reduction in food intake, and impaired vestibulomotor coordination. There was no difference in these responses between mice raised in a short-arm centrifuge and those in a long-arm centrifuge. These results demonstrate the feasibility of using a short-arm centrifuge for mouse experiments.	[Morita, Hironobu; Obata, Koji; Abe, Chikara] Gifu Univ, Grad Sch Med, Dept Physiol, Gifu, Japan; [Morita, Hironobu; Kudo, Takashi; Takahashi, Satoru] Japan Aerosp Explorat Agcy, Mouse Epigenet Project, ISS Kibo Expt, Tsukuba, Ibaraki, Japan; [Shiba, Dai; Shirakawa, Masaki] Japan Aerosp Explorat Agcy, JEM Utilizat Ctr, Human Spaceflight Technol Directorate, Tsukuba, Ibaraki, Japan; [Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan	Gifu University; Japan Aerospace Exploration Agency (JAXA); Japan Aerospace Exploration Agency (JAXA); University of Tsukuba; University of Tsukuba	Morita, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Physiol, Gifu, Japan.	zunzunmorita@gmail.com	Abe, Chikara/V-6174-2019	Abe, Chikara/0000-0003-3856-7494; Kudo, Takashi/0000-0001-5477-7235; Shiba, Dai/0000-0003-3808-5428	Japan Society for the Promotion of Science [24590298]; Japan Aerospace Exploration Agency [13YPTK-013584, 14YPTK-000980, 14YPTK005512]; Grants-in-Aid for Scientific Research [15K21745] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Aerospace Exploration Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HM: Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (24590298) http://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HM: Short arm centrifuge project commissioned from Japan Aerospace Exploration Agency (13YPTK-013584 and 14YPTK-000980) http://iss.jaxa.jp/kiboexp/participation/application/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ST: Prioritized research selected for life science from Japan Aerospace Exploration Agency (14YPTK005512) http://iss.jaxa.jp/kiboexp/participation/application/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe C, 2008, AM J PHYSIOL-REG I, V295, pR173, DOI 10.1152/ajpregu.00120.2008; Abe C, 2007, EXP BRAIN RES, V181, P639, DOI 10.1007/s00221-007-0961-9; Abe C, 2013, J APPL PHYSIOL, V115, P1082, DOI 10.1152/japplphysiol.00285.2013; Abe C, 2011, NEUROSCI LETT, V502, P138, DOI 10.1016/j.neulet.2011.06.041; Abe C, 2010, J APPL PHYSIOL, V109, P1635, DOI 10.1152/japplphysiol.00515.2010; Albi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048518; Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Brinckmann E, 2002, ADV SPACE RES, V30, P809, DOI 10.1016/S0273-1177(02)00401-5; Cancedda R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032243; Correll MJ, 2013, PLANTA, V238, P519, DOI 10.1007/s00425-013-1909-x; Hallil A, 2010, RADIAT PROT DOSIM, V138, P295, DOI 10.1093/rpd/ncp265; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Mazars C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091814; Reitz G, 2005, RADIAT PROT DOSIM, V116, P374, DOI 10.1093/rpd/nci262; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sasa M, 2001, Biol Sci Space, V15, P371, DOI 10.2187/bss.15.371; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Vesper SJ, 2008, RES MICROBIOL, V159, P432, DOI 10.1016/j.resmic.2008.06.001; Walton KD, 2005, J PHYSIOL-LONDON, V565, P593, DOI 10.1113/jphysiol.2004.074385; Yamaguchi N, 2014, MICROBES ENVIRON, V29, P250, DOI 10.1264/jsme2.ME14031; Yates BJ, 2005, J VESTIBUL RES-EQUIL, V15, P119	21	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133981	10.1371/journal.pone.0133981	http://dx.doi.org/10.1371/journal.pone.0133981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221724	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800091
J	Wang, Y; He, YQ; Zhao, XM; Ji, XW; Hong, Y; Wang, Y; Zhu, QL; Xu, B; Sun, Y				Wang, Yang; He, Yaqiong; Zhao, Xiaoming; Ji, Xiaowei; Hong, Yan; Wang, Yuan; Zhu, Qinling; Xu, Bin; Sun, Yun			Crinone Gel for Luteal Phase Support in Frozen-Thawed Embryo Transfer Cycles: A Prospective Randomized Clinical Trial in the Chinese Population	PLOS ONE			English	Article							INTRAMUSCULAR PROGESTERONE; VAGINAL GEL; IN-VITRO; PREGNANCY OUTCOMES; SUPPLEMENTATION; REPLACEMENT; CRYOPRESERVATION; EXPERIENCE; DELIVERY; THERAPY	To compare Crinone vaginal progesterone gel with intramuscularly injected progesterone for luteal phase support in progesterone-supplemented frozen-thawed embryo transfer (FET) cycles, a randomized prospective study of patients qualified for FET was conducted between September 2010 and January 2013 at a hospital in Shanghai, China. From the day of transformation into secretory phase endometrium (day 0), Crinone vaginal gel (90 mg/d) was administered to patients in the Gel Group, while progesterone (40 mg/d) was injected intramuscularly in patients in the Inj Group (n = 750 per group). All patients received oral dydrogesterone (20 mg/d) and estradiol valerate (4-8 mg/d). Day 3 embryos with the highest pre-frozen scores were transferred to patients in the two groups and the clinical outcomes compared. This study comprised 1,500 cycles (750 in each group). Twenty-nine cycles in the Gel Group and 24 in the Inj Group were withdrawn. There were no significant differences between groups in age, endometrial thickness, endometrial preparation time or number of embryos transferred. No significant differences were observed between the Gel Group and Inj Group in the rates of live birth (32.6% vs. 31.7%, P = 0.71), clinical pregnancy (40.1% vs. 40.6%, P = 0.831), implantation (25.8% vs. 25.3%, P = 0.772), abortion (16.3% vs. 18.3%, P = 0.514) or ectopic pregnancy (2.8% vs. 4.4%, P = 0.288). Multivariate logistic regression analysis revealed that the odds ratios (95% confidence intervals) for the rates of live birth, clinical pregnancy, abortion and ectopic pregnancy (Gel Group relative to Inj Group) were 1.036 (0.829-1.295), 0.971 (0.785-1.200), 0.919 (0.595-1.420) and 0.649 (0.261-1.614), respectively. Our study revealed that using Crinone vaginal gel in FET cycles achieved similar pregnancy outcomes to intramuscular progesterone, indicating that vaginal gel is a viable alternative to intramuscular injection.	[Wang, Yang; He, Yaqiong; Zhao, Xiaoming; Ji, Xiaowei; Hong, Yan; Wang, Yuan; Zhu, Qinling; Xu, Bin; Sun, Yun] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200030, Peoples R China; [Wang, Yang; He, Yaqiong; Zhao, Xiaoming; Ji, Xiaowei; Hong, Yan; Wang, Yuan; Zhu, Qinling; Xu, Bin; Sun, Yun] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China	Shanghai Jiao Tong University	Sun, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200030, Peoples R China.	syun163@163.com	Zhu, Qinling/AAG-1700-2021		National Natural Science Foundation of China [81370762]; Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China [12JC1405800]; National Basic Research Program (973 Program) [2014CB943300]; Research Special Fund of National Health and Family Planning Commission, China [201402004]; Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics [12DZ2260600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China; National Basic Research Program (973 Program)(National Basic Research Program of China); Research Special Fund of National Health and Family Planning Commission, China; Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics	This work was supported by the National Natural Science Foundation of China (Grant No. 81370762), the Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China (Grant No. 12JC1405800), The National Basic Research Program (973 Program) (Grant No. 2014CB943300), the Research Special Fund of National Health and Family Planning Commission, China (Grant No. 201402004), and Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics (Grant No. 12DZ2260600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelHafez FF, 2010, REPROD BIOMED ONLINE, V20, P209, DOI 10.1016/j.rbmo.2009.11.013; Alsbjerg B, 2013, REPROD BIOMED ONLINE, V26, P133, DOI 10.1016/j.rbmo.2012.10.012; Berger BM, 2008, FERTIL STERIL, V90, pS459; Berger BM, 2012, J ASSIST REPROD GEN, V29, P237, DOI 10.1007/s10815-011-9691-9; Cicinelli E, 2000, OBSTET GYNECOL, V95, P403, DOI 10.1016/S0029-7844(99)00542-6; Dal Prato L, 2008, REPROD BIOMED ONLINE, V16, P361; Gibbons WE, 1998, FERTIL STERIL, V69, P96, DOI 10.1016/S0015-0282(97)00457-3; Jobanputra K, 1999, FERTIL STERIL, V72, P980, DOI 10.1016/S0015-0282(99)00390-8; Kahraman S, 2010, FERTIL STERIL, V94, P761, DOI 10.1016/j.fertnstert.2009.10.004; Kaser DJ, 2012, FERTIL STERIL, V98, P1464, DOI 10.1016/j.fertnstert.2012.08.007; Loutradi KE, 2008, FERTIL STERIL, V90, P186, DOI 10.1016/j.fertnstert.2007.06.010; NAHOUL K, 1993, MATURITAS, V16, P185, DOI 10.1016/0378-5122(93)90064-O; Nawroth F, 2005, HUM REPROD, V20, P1127, DOI 10.1093/humrep/deh762; Rizner TL, 2011, STEROIDS, V76, P607, DOI 10.1016/j.steroids.2011.02.043; Schoolcraft WB, 2000, HUM REPROD, V15, P1284, DOI 10.1093/humrep/15.6.1284; Shapiro DB, 2014, HUM REPROD, V29, P1706, DOI 10.1093/humrep/deu121; Silverberg KM, 2012, FERTIL STERIL, V97, P344, DOI 10.1016/j.fertnstert.2011.11.018; Spencer T E, 2007, Soc Reprod Fertil Suppl, V64, P379; Tavaniotou A, 2000, HUM REPROD UPDATE, V6, P139, DOI 10.1093/humupd/6.2.139; Toner JP, 2000, HUM REPROD, V15, P166, DOI 10.1093/humrep/15.suppl_1.166; TROUNSON A, 1983, NATURE, V305, P707, DOI 10.1038/305707a0; Williams SC, 2000, FERTIL STERIL, V74, pS209; Yanushpolsky E, 2008, FERTIL STERIL, V89, P485, DOI 10.1016/j.fertnstert.2007.03.006; Yanushpolsky E, 2010, FERTIL STERIL, V94, P2596, DOI 10.1016/j.fertnstert.2010.02.033; Yanushpolsky E, 2011, FERTIL STERIL, V95, P617, DOI 10.1016/j.fertnstert.2010.04.039	25	19	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133027	10.1371/journal.pone.0133027	http://dx.doi.org/10.1371/journal.pone.0133027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222435	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800036
J	Yang, LX; Draief, M; Yang, XF				Yang, Lu-Xing; Draief, Moez; Yang, Xiaofan			The Impact of the Network Topology on the Viral Prevalence: A Node-Based Approach	PLOS ONE			English	Article							COMPUTER VIRUS MODEL; COMPLEX NETWORKS; EPIDEMIC DYNAMICS; SPREAD	This paper addresses the impact of the structure of the viral propagation network on the viral prevalence. For that purpose, a new epidemic model of computer virus, known as the node-based SLBS model, is proposed. Our analysis shows that the maximum eigenvalue of the underlying network is a key factor determining the viral prevalence. Specifically, the value range of the maximum eigenvalue is partitioned into three subintervals: viruses tend to extinction very quickly or approach extinction or persist depending on into which subinterval the maximum eigenvalue of the propagation network falls. Consequently, computer virus can be contained by adjusting the propagation network so that its maximum eigenvalue falls into the desired subinterval.	[Yang, Lu-Xing] Chongqing Univ, Coll Comp Sci, Chongqing 630044, Peoples R China; [Draief, Moez] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England; [Yang, Xiaofan] Chongqing Univ, Sch Software Engn, Chongqing 630044, Peoples R China	Chongqing University; Imperial College London; Chongqing University	Yang, XF (corresponding author), Chongqing Univ, Sch Software Engn, Chongqing 630044, Peoples R China.	xfyang1964@gmail.com		Yang, Lu-Xing/0000-0002-9229-5787	China Scholarship Council [201406050107]	China Scholarship Council(China Scholarship Council)	LY is supported by China Scholarship Council (grant no. 201406050107) during his visit in Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allen EJ, 1999, DYN CONTIN DISCRET I, V5, P271; Allen LJS, 2003, THEOR POPUL BIOL, V64, P439, DOI 10.1016/S0040-5809(03)00104-7; ANDERSON R M, 1991; Balthrop J, 2004, SCIENCE, V304, P527, DOI 10.1126/science.1095845; Banerjee S, ARXIV13120938V1; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Castellano C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218701; Draief M, 2008, ANN APPL PROBAB, V18, P359, DOI 10.1214/07-AAP470; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035103; Eshghi S, 2016, IEEE ACM T NETWORK, V24, P283, DOI 10.1109/TNET.2014.2364034; Gan CQ, 2014, COMMUN NONLINEAR SCI, V19, P92, DOI 10.1016/j.cnsns.2013.06.018; Ganesh A, 2005, IEEE INFOCOM SER, P1455; Huang CY, 2013, J SYST SOFTWARE, V86, P801, DOI 10.1016/j.jss.2012.11.027; Huang CY, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/473136; Jin Z, 2014, MATH BIOSCI ENG, V11, P1295, DOI 10.3934/mbe.2014.11.1295; Kephart J. O., 1993, Proceedings 1993 IEEE Computer Society Symposium on Research in Security and Privacy (Cat. No.93CH3290-4), P2, DOI 10.1109/RISP.1993.287647; Kephart J. O., 1991, Proceedings. 1991 IEEE Computer Society Symposium on Research in Security and Privacy (Cat. No.91CH2986-8), P343, DOI 10.1109/RISP.1991.130801; Khanafer A, 2014, AM CONTR C; LAJMANOVICH A, 1976, Mathematical Biosciences, V28, P221, DOI 10.1016/0025-5564(76)90125-5; Lin YS, 2014, J COMPLEX NETW, V2, P431, DOI 10.1093/comnet/cnu027; Mieghem P. V., 2012, GRAPH SPECTRA COMPLE; Mishra BK, 2011, APPL MATH COMPUT, V217, P8438, DOI 10.1016/j.amc.2011.03.041; Muroya Y, 2014, INT J COMPUT MATH, V91, P347, DOI 10.1080/00207160.2013.790534; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pastor-Satorras R., ARXIV14082701V1; Preciado VM, 2014, IEEE T CONTROL NETW, V1, P99, DOI 10.1109/TCNS.2014.2310911; Ren JG, 2012, NONLINEAR ANAL-REAL, V13, P376, DOI 10.1016/j.nonrwa.2011.07.048; Robinson RC, 2004, INTRO DYNAMICAL SYST; Sahneh FD, 2012, 50 IEEE C DEC CONTR; Sahneh FD, 2011, 50 IEEE C DEC CONTR; Shakeri H, 2015, MATH BIOSCI ENG, V12, P609, DOI 10.3934/mbe.2015.12.609; Sun GQ, 2010, J THEOR BIOL, V264, P95, DOI 10.1016/j.jtbi.2010.01.006; Van Mieghem P, 2009, IEEE ACM T NETWORK, V17, P1, DOI 10.1109/TNET.2008.925623; Wang Y, 2003, SYM REL DIST SYST, P25; Wang Y, 2012, NONLINEAR ANAL-REAL, V13, P543, DOI 10.1016/j.nonrwa.2011.07.033; Yang LX, 2014, PHYSICA A, V396, P173, DOI 10.1016/j.physa.2013.11.026; Yang LX, 2013, APPL MATH COMPUT, V219, P8705, DOI 10.1016/j.amc.2013.02.031; Yang LX, 2012, APPL MATH COMPUT, V219, P3914, DOI 10.1016/j.amc.2012.10.027; Yang LX, 2013, NONLINEAR ANAL-REAL, V14, P414, DOI 10.1016/j.nonrwa.2012.07.005; Yang XF, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/259671; Yorke J.-A., 1967, MATH SYST THEORY, V1, P353, DOI DOI 10.1007/BF01695169; Youssef M, 2011, J THEOR BIOL, V283, P136, DOI 10.1016/j.jtbi.2011.05.029; Zhang XG, 2013, MATH BIOSCI, V246, P242, DOI 10.1016/j.mbs.2013.10.001	45	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134507	10.1371/journal.pone.0134507	http://dx.doi.org/10.1371/journal.pone.0134507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222539	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800147
J	Buckhurst, HD; Gilmartin, B; Cubbidge, RP; Logan, NS				Buckhurst, Hetal D.; Gilmartin, Bernard; Cubbidge, Robert P.; Logan, Nicola S.			Measurement of Scleral Thickness in Humans Using Anterior Segment Optical Coherent Tomography	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE CHANGES; OCULAR RIGIDITY; CORNEAL; INJECTION; SHAPE	Anterior segment optical coherent tomography (AS-OCT, Visante; Zeiss) is used to examine meridional variation in anterior scleral thickness (AST) and its association with refractive error, ethnicity and gender. Scleral cross-sections of 74 individuals (28 males; 46 females; aged between 18-40 years (27.7 +/- 5.3)) were sampled twice in random order in 8 meridians: [ superior (S), inferior (I), nasal (N), temporal (T), superior-temporal (ST), superior-nasal (SN), inferior-temporal (IT) and inferior-nasal (IN)]. AST was measured in 1 mm anterior-to-posterior increments (designated the A-P distance) from the scleral spur (SS) over a 6mm distance. Axial length and refractive error were measured with a Zeiss IOLMaster biometer and an open-view binocular Shin-Nippon autorefractor. Intra-and inter-observer variability of AST was assessed for each of the 8 meridians. Mixed repeated measures ANOVAs tested meridional and A-P distance differences in AST with refractive error, gender and ethnicity. Only right eye data were analysed. AST (mean +/- SD) across all meridians and A-P distances was 725 +/- 46 mu m. Meridian SN was the thinnest (662 +/- 57 mu m) and I the thickest (806 +/- 60 mu m). Significant differences were found between all meridians (p<0.001), except S: ST, IT: IN, IT: N and IN: N. Significant differences between A-P distances were found except between SS and 6 mm and between 2 and 4 mm. AST measurements at 1mm (682 +/- 48 mu m) were the thinnest and at 6mm (818 +/- 49 mu m) the thickest (p<0.001); a significant interaction occurred between meridians and A-P distances (p<0.001). AST was significantly greater (p<0.001) in male subjects but no significant differences were found between refractive error or ethnicity. Significant variations in AST occur with regard to meridian and distance from the SS and may have utility in selecting optimum sites for pharmaceutical or surgical intervention.	[Buckhurst, Hetal D.] Univ Plymouth, Peninsula Allied Hlth Ctr, Sch Hlth Profess, Plymouth PL4 8AA, Devon, England; [Gilmartin, Bernard; Cubbidge, Robert P.; Logan, Nicola S.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Plymouth; Aston University	Buckhurst, HD (corresponding author), Univ Plymouth, Peninsula Allied Hlth Ctr, Sch Hlth Profess, Derriford Rd, Plymouth PL4 8AA, Devon, England.	hetal.buckhurst@plymouth.ac.uk	Logan, Nicola/ABC-9102-2020	Logan, Nicola S/0000-0002-0538-9516; Cubbidge, Robert P/0000-0002-7851-1375				Atchison DA, 2005, INVEST OPHTH VIS SCI, V46, P2698, DOI 10.1167/iovs.04-1506; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boubriak OA, 2003, EXP EYE RES, V76, P701, DOI 10.1016/S0014-4835(03)00053-8; Dimasi DP, 2010, BRIT J OPHTHALMOL, V94, P971, DOI 10.1136/bjo.2009.162735; Eilaghi A, 2010, ANN BIOMED ENG, V38, P1586, DOI 10.1007/s10439-009-9879-7; Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010; Fuest M, 2014, OPHTHAL PHYSL OPT, V34, P438, DOI 10.1111/opo.12134; Hollands H, 2007, CAN J OPHTHALMOL, V42, P807, DOI 10.3129/i07-172; KAISERKUPFER MI, 1985, T OPHTHAL SOC UK, V104, P191; Lam A, 2005, AM J OPHTHALMOL, V140, P329, DOI 10.1016/j.ajo.2005.02.014; Lee SB, 2004, EXP EYE RES, V78, P599, DOI 10.1016/S0014-4835(03)00211-2; Lehman BM, 2009, OPTOMETRY VISION SCI, V86, P181, DOI 10.1097/OPX.0b013e318198198d; Liu S, 2010, J GLAUCOMA, V19, P132, DOI 10.1097/IJG.0b013e3181a98ce4; McBrien NA, 2013, EXP EYE RES, V114, P128, DOI 10.1016/j.exer.2013.01.014; MIAO H, 2013, ACTA OPHTHALMOL, V91, P1; Mohamed-Noor J, 2009, J GLAUCOMA, V18, P32, DOI 10.1097/IJG.0b013e31816b2fd1; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Ohno-Matsui K, 2012, INVEST OPHTH VIS SCI, V53, P6046, DOI 10.1167/iovs.12-10161; Oliveira C, 2006, J GLAUCOMA, V15, P190, DOI 10.1097/01.ijg.0000212220.42675.c5; Pallikaris IG, 2006, AM J OPHTHALMOL, V141, P611, DOI 10.1016/j.ajo.2005.11.010; Pekel G, 2015, CORNEA, V34, P786, DOI 10.1097/ICO.0000000000000422; Radhakrishnan S, 2001, ARCH OPHTHALMOL-CHIC, V119, P1179, DOI 10.1001/archopht.119.8.1179; Royal College of Ophthalmologist, 2009, GUID INTR INJ PROC; Schmid KL, 2003, CURR EYE RES, V26, P65, DOI 10.1076/ceyr.26.2.65.14513; Taban M, 2010, OCUL IMMUNOL INFLAMM, V18, P305, DOI 10.3109/09273941003658292; Turgut Burak, 2009, J Clin Med Res, V1, P280, DOI 10.4021/jocmr2009.12.1280; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Yoo C, 2011, J GLAUCOMA, V20, P95, DOI 10.1097/IJG.0b013e3181dde051	29	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132902	10.1371/journal.pone.0132902	http://dx.doi.org/10.1371/journal.pone.0132902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218188	gold, Green Published, Green Accepted			2022-12-27	WOS:000358595900013
J	Verma, SK; Das Murmu, T				Verma, Sushant Kumar; Das Murmu, Thakur			Impact of Environmental and Disturbance Variables on Avian Community Structure along a Gradient of Urbanization in Jamshedpur, India	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; SPECIES-DIVERSITY; URBAN GRADIENT; BREEDING BIRDS; LAND-USE; BIODIVERSITY; CONSERVATION; POPULATION; LANDSCAPE; HABITAT	Gradient pattern analysis was used to investigate the impact of environmental and disturbance variables on species richness, species diversity, abundance and seasonal variation of birds in and around Jamshedpur, which is one of the fastest growing cities of India. It was observed that avian community structure is highly influenced by the vegetation habitat variables, food availability and human-related disturbance variables. A total of 61 species belonging to 33 families were recorded from the suburban area. 55 species belonging to 32 families were observed in nearby wildland habitat consisting of natural vegetation whereas only 26 species belonging to 18 families were observed in urban area. Results indicated that the suburban habitat had more complex bird community structure in terms of higher species richness, higher species diversity and higher evenness in comparison to urban and wildland habitat. Bird species richness and diversity varied across seasons. Maximum species richness and diversity was observed during spring season in all type of habitat. Most of the birds observed in urban areas were found to belong to either rare or irregular category on the basis of their abundance. The observed pattern of avian community structure is due to combined effect of both environmental and human related disturbance variables.	[Verma, Sushant Kumar] Guru Ghasidas Vishwavidyalaya, Dept Zool, Bilaspur, Chhattisgarh, India	Guru Ghasidas Vishwavidyalaya	Verma, SK (corresponding author), Guru Ghasidas Vishwavidyalaya, Dept Zool, Bilaspur, Chhattisgarh, India.	vermasushant2010@gmail.com	Verma, Sushant/AAU-1890-2020					Ali S, 2001, BOOK INDIAN BIRDS; [Anonymous], 2007, UN WORLD URBANIZATIO; [Anonymous], 2010, UN WORLD POP PROSP 2; Bhullar Simrath, 2000, Pacific Conservation Biology, V6, P171; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blair RB, 1999, ECOL APPL, V9, P164, DOI 10.1890/1051-0761(1999)009[0164:BABAAU]2.0.CO;2; Burke DM, 2000, ECOL APPL, V10, P1749, DOI 10.1890/1051-0761(2000)010[1749:LAFSEO]2.0.CO;2; Carr D, 2009, PROG HUM GEOG, V33, P355, DOI 10.1177/0309132508096031; Caula S, 2008, LANDSCAPE URBAN PLAN, V87, P1, DOI 10.1016/j.landurbplan.2008.03.006; Chapman KA, 2007, BIOL CONSERV, V135, P527, DOI 10.1016/j.biocon.2006.10.050; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; City Mayors, 2014, WORLDS FAST GROW URB; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2013, ESTIMATES STAT ESTIM; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Fernandez-Juricic E, 2005, MICROHABITAT SELECTI; Fernandez-Juricic E, 2000, CONSERV BIOL, V106, P129; Germaine SS, 1998, ECOL APPL, V8, P680, DOI 10.1890/1051-0761(1998)008[0680:RABBHA]2.0.CO;2; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gotelli N. J., 2001, NULL MODELS ECOLOGY; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grimmett R., 1998, BIRDS INDIAN SUBCONT, DOI DOI 10.3732/ajb.1000230; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Heileman MR, 2007, HABITAT EFFECTS BIRD; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HUTTO R. L., 1995, MONITORING BIRD POPU, P103; Inskipp T, 1996, ANNOTATED CHECKLIST; JOKIMAKI J, 1993, ORNIS FENNICA, V70, P71; Kazmierczak K, 2001, BIRD WATCHERS GUIDE; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marzluff J. M., 2001, AVIAN ECOLOGY URBANI; Marzluff JM, 1998, AVIAN CONSERVATION R; Mattu V. K., 2006, Indian Forester, V132, P1271; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Nolan PM, 2004, ANIM BEHAV, V67, P403, DOI 10.1016/j.anbehav.2003.03.018; Norris DR, 2007, CONDOR, V109, P535; Ramirez-Albores Jorge E., 2002, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V73, P91; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Sandstrom UG, 2006, LANDSCAPE URBAN PLAN, V77, P39, DOI 10.1016/j.landurbplan.2005.01.004; Sauter A, 2006, BEHAV ECOL SOCIOBIOL, V60, P465, DOI 10.1007/s00265-006-0187-z; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Soderstrom B, 2000, CONSERV BIOL, V14, P522, DOI 10.1046/j.1523-1739.2000.98564.x; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Styring AR, 2011, FOREST ECOL MANAG, V261, P531, DOI 10.1016/j.foreco.2010.11.003; Thakur ML., 2010, INDIAN BIRDS, V5, P162; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; United Nations, 2007, STAT WORLD POP 2007; Verma Sushant Kumar, 2011, Journal of Threatened Taxa, V3, P1764; Villegas Mariana, 2010, Urban Ecosystems, V13, P375, DOI 10.1007/s11252-010-0126-7; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014	57	12	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133383	10.1371/journal.pone.0133383	http://dx.doi.org/10.1371/journal.pone.0133383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218583	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900029
J	Wang, XY; Guo, YM; FitzGerald, G; Aitken, P; Tippett, V; Chen, D; Wang, XM; Tong, SL				Wang, Xiao Yu; Guo, Yuming; FitzGerald, Gerry; Aitken, Peter; Tippett, Vivienne; Chen, Dong; Wang, Xiaoming; Tong, Shilu			The Impacts of Heatwaves on Mortality Differ with Different Study Periods: A Multi-City Time Series Investigation	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; WAVES; TEMPERATURE; COLD	Background Different locations and study periods were used in the assessment of the relationships between heatwaves and mortality. However, little is known about the comparability and consistency of the previous effect estimates in the literature. This study assessed the heatwave-mortality relationship using different study periods in the three largest Australian cities (Brisbane, Melbourne and Sydney). Methods Daily data on climatic variables and mortality for the three cities were obtained from relevant government agencies between 1988 and 2011. A consistent definition of heatwaves was used for these cities. Poisson generalised additive model was fitted to assess the impact of heatwaves on mortality. Results Non-accidental and circulatory mortality significantly increased during heatwaves across the three cities even with different heatwave definitions and study periods. Using the summer data resulted in the largest increase in effect estimates compared to those using the warm season or the whole year data. Conclusion The findings may have implications for developing standard approaches to evaluating the heatwave-mortality relationship and advancing heat health warning systems. It also provides an impetus to methodological advance for assessing climate change-related health consequences.	[Wang, Xiao Yu; FitzGerald, Gerry; Tong, Shilu] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Guo, Yuming] Univ Queensland, Sch Populat Hlth, Fac Med & Biomed Sci, Brisbane, Qld, Australia; [Aitken, Peter] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Tippett, Vivienne] Queensland Univ Technol, Sch Clin Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Chen, Dong] CSIRO, Ecosyst Sci, Melbourne, Vic, Australia; [Wang, Xiaoming] CSIRO, Climate Adaptat & Sustainable Dev, Melbourne, Vic, Australia	Queensland University of Technology (QUT); University of Queensland; James Cook University; Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tong, SL (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia.	s.tong@qut.edu.au	Chen, Dong/A-6385-2011; Wang, Xiaoming/A-3804-2008; Guo, Yuming/I-8353-2018; Tippett, Vivienne/J-1224-2012	Chen, Dong/0000-0001-6495-678X; Wang, Xiaoming/0000-0002-6648-0057; Guo, Yuming/0000-0002-1766-6592; Fitzgerald, Gerard/0000-0002-5586-0097; Tippett, Vivienne/0000-0003-1660-0089	Australian Research Council [LP882699]; Horticulture Australia Limited using the Nursery Industry Levy [NY 11013]; CSIRO Climate Adaptation Flagship; Queensland Department of Environment and Resources Management, Department of Community Safety, Queensland Health and the Environmental Protection Agency; NHMRC research fellowship [553043]	Australian Research Council(Australian Research Council); Horticulture Australia Limited using the Nursery Industry Levy(Horticulture Australia Limited); CSIRO Climate Adaptation Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Queensland Department of Environment and Resources Management, Department of Community Safety, Queensland Health and the Environmental Protection Agency; NHMRC research fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was partly funded by the Australian Research Council (LP882699), Horticulture Australia Limited using the Nursery Industry Levy (Project # NY 11013) and CSIRO Climate Adaptation Flagship, the Queensland Department of Environment and Resources Management, Department of Community Safety, Queensland Health and the Environmental Protection Agency. ST was supported by a NHMRC research fellowship (#553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS (Australian Burean of Statistics), 2012, AUSTR BUR STAT REG P; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; [Anonymous], AGBM CLIM STAT AUSTR; Australian Bureau of Statistics (ABS), 2007, CLIM SYDN 2000 OL GA; Baccini M, 2011, J EPIDEMIOL COMMUN H, V65, P64, DOI 10.1136/jech.2008.085639; Barnett AG, 2012, ENVIRON RES, V112, P218, DOI 10.1016/j.envres.2011.12.010; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Buckley JP, 2014, EPIDEMIOLOGY, V25, P242, DOI 10.1097/EDE.0000000000000051; D'Ippoliti D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-37; Fouillet A, 2008, INT J EPIDEMIOL, V37, P309, DOI 10.1093/ije/dym253; Hajat S, 2010, J EPIDEMIOL COMMUN H, V64, P753, DOI 10.1136/jech.2009.087999; IPCC, CLIM CHANG 2013 PHYS; Linacre E., 2002, CLIMATES WEATHER EXP, DOI DOI 10.4324/9780203291030; Metzger KB, 2010, ENVIRON HEALTH PERSP, V118, P80, DOI 10.1289/ehp.0900906; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Pascal M, 2013, INT J BIOMETEOROL, V57, P21, DOI 10.1007/s00484-012-0530-1; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Schifano P, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-50; Son JY, 2012, ENVIRON HEALTH PERSP, V120, P566, DOI 10.1289/ehp.1103759; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Sturman A. P., 2006, WEATHER CLIMATE AUST; Tong SL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003579; Tong SL, 2010, INT J BIOMETEOROL, V54, P393, DOI 10.1007/s00484-009-0290-8; Vaneckova P, 2011, J APPL METEOROL CLIM, V50, P1165, DOI 10.1175/2011JAMC2632.1; Yu WW, 2011, SCI TOTAL ENVIRON, V409, P3431, DOI 10.1016/j.scitotenv.2011.05.027	26	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134233	10.1371/journal.pone.0134233	http://dx.doi.org/10.1371/journal.pone.0134233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217945	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900099
J	Crins, MHP; Roorda, LD; Smits, N; de Vet, HCW; Westhovens, R; Cella, D; Cook, KF; Revicki, D; van Leeuwen, J; Boers, M; Dekker, J; Terwee, CB				Crins, Martine H. P.; Roorda, Leo D.; Smits, Niels; de Vet, Henrica C. W.; Westhovens, Rene; Cella, David; Cook, Karon F.; Revicki, Dennis; van Leeuwen, Jaap; Boers, Maarten; Dekker, Joost; Terwee, Caroline B.			Calibration and Validation of the Dutch-Flemish PROMIS Pain Interference Item Bank in Patients with Chronic Pain	PLOS ONE			English	Article							NECK DISABILITY INDEX; REPORTED OUTCOMES; R PACKAGE; PHYSICAL FUNCTION; BACK-PAIN; RESPONSIVENESS; RELIABILITY; QUESTIONNAIRE; TRANSLATION; SHOULDER	The Dutch-Flemish PROMIS Group translated the adult PROMIS Pain Interference item bank into Dutch-Flemish. The aims of the current study were to calibrate the parameters of these items using an item response theory (IRT) model, to evaluate the cross-cultural validity of the Dutch-Flemish translations compared to the original English items, and to evaluate their reliability and construct validity. The 40 items in the bank were completed by 1085 Dutch chronic pain patients. Before calibrating the items, IRT model assumptions were evaluated using confirmatory factor analysis (CFA). Items were calibrated using the graded response model (GRM), an IRT model appropriate for items with more than two response options. To evaluate cross-cultural validity, differential item functioning (DIF) for language (Dutch vs. English) was examined. Reliability was evaluated based on standard errors and Cronbach's alpha. To evaluate construct validity correlations with scores on legacy instruments (e.g., the Disabilities of the Arm, Shoulder and Hand Questionnaire) were calculated. Unidimensionality of the Dutch-Flemish PROMIS Pain Interference item bank was supported by CFA tests of model fit (CFI = 0.986, TLI = 0.986). Furthermore, the data fit the GRM and showed good coverage across the pain interference continuum (threshold-parameters range: -3.04 to 3.44). The Dutch-Flemish PROMIS Pain Interference item bank has good cross-cultural validity (only two out of 40 items showing DIF), good reliability (Cronbach's alpha = 0.98), and good construct validity (Pearson correlations between 0.62 and 0.75). A computer adaptive test ( CAT) and Dutch-Flemish PROMIS short forms of the Dutch-Flemish PROMIS Pain Interference item bank can now be developed.	[Crins, Martine H. P.; Roorda, Leo D.] Reade, Amsterdam Rehabil Res Ctr, Amsterdam, Netherlands; [Smits, Niels] Vrije Univ Amsterdam, Med Ctr, Dept Clin Psychol, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Smits, Niels] Vrije Univ Amsterdam, Med Ctr, Dept Methodol, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [de Vet, Henrica C. W.; Boers, Maarten; Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Westhovens, Rene] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Louvain, Belgium; [Westhovens, Rene] Katholieke Univ Leuven, Univ Hosp, Rheumatol, Louvain, Belgium; [Cella, David; Cook, Karon F.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Revicki, Dennis] Evidera, Outcomes Res, Bethesda, MD USA; [van Leeuwen, Jaap] Leones Grp BV, Amsterdam, Netherlands; [Boers, Maarten] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Dekker, Joost] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [Dekker, Joost] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; KU Leuven; KU Leuven; Northwestern University; Feinberg School of Medicine; Evidera; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Crins, MHP (corresponding author), Reade, Amsterdam Rehabil Res Ctr, Amsterdam, Netherlands.	m.crins@reade.nl		de Vet, Henrica/0000-0002-5454-2804; Terwee, Caroline/0000-0003-4570-2826; Dekker, Joost/0000-0003-2027-0027	Dutch Arthritis Association [BP 10-1-261]; Dutch Scientific College of Physical Therapy; Leones Group BV & Outcomes Research	Dutch Arthritis Association; Dutch Scientific College of Physical Therapy; Leones Group BV & Outcomes Research	The Dutch-Flemish translation of the PROMIS item banks was supported by a grant from the Dutch Arthritis Association (BP 10-1-261). Funding for the current calibration study was provided by a grant from the Dutch Scientific College of Physical Therapy. Leones Group BV & Outcomes Research provided support in the form of salaries for co-authors Jaap van Leeuwen & Dennis Revicki retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ailliet L, 2015, EUR SPINE J, V24, P88, DOI 10.1007/s00586-014-3359-y; Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Beurskens AJHM, 1996, PAIN, V65, P71, DOI 10.1016/0304-3959(95)00149-2; Bot SDM, 2004, ANN RHEUM DIS, V63, P335, DOI 10.1136/ard.2003.007724; Brouwer S, 2004, DISABIL REHABIL, V26, P162, DOI 10.1080/09638280310001639713; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chang HH, 1996, APPL PSYCH MEAS, V20, P213, DOI 10.1177/014662169602000303; Choi SW, 2011, J STAT SOFTW, V39, P1; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Cook KF, 2014, QUAL LIFE RES; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; Crins M, CALIBRATION DU UNPUB; Deyo RA, 2014, EUR SPINE J, V23, P2028, DOI 10.1007/s00586-014-3540-3; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Edelen MO, 2015, QUAL LIFE RES, V24, P95, DOI 10.1007/s11136-013-0540-4; Embretson S. E., 2013, ITEM RESPONSE THEORY; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Fries J, 2011, J RHEUMATOL, V38, P1759, DOI 10.3899/jrheum.110402; Fries JF, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3461; Fries JF, 2009, J RHEUMATOL, V36, P2061, DOI 10.3899/jrheum.090358; GOMMANS IHB, 1997, NED TIJDSCHR FYSIOTH, V107, P28; Harstall C, 2003, PAIN CLIN UPDATES, V11, P1, DOI DOI 10.1016/S1070-7212(03)00004-6; Haverman L, 2015, QUAL LIFE RES; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Huisstede BMA, 2009, SPINE, V34, pE130, DOI 10.1097/BRS.0b013e318195a28b; Jorritsma W, 2012, EUR SPINE J, V21, P93, DOI 10.1007/s00586-011-1920-5; ke A, 1996, MEETINSTRUMENTEN CHR, P52; ke A, 1996, MEETINSTRUMENTEN CHR, P68; Khanna D, 2011, ARTHRIT CARE RES, V63, pS486, DOI 10.1002/acr.20581; Koke A, 1996, MEETINSTRUMENTEN CHR, P36; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; Magasi S, 2012, QUAL LIFE RES, V21, P739, DOI 10.1007/s11136-011-9990-8; Magis D, 2012, J STAT SOFTW, V48, P1; MCKINLEY RL, 1985, APPL PSYCH MEAS, V9, P49, DOI 10.1177/014662168500900105; Miles J, 2007, PERS INDIV DIFFER, V42, P869, DOI 10.1016/j.paid.2006.09.022; Mokken R. J., 1971, THEORY PROCEDURE SCA, DOI DOI 10.1515/9783110813203; Palmen C, 2004, NED TIJDSCHR FYSIOTH, V114, P30; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Reckases MD., 1979, J EDUC STATIST, V4, P207, DOI DOI 10.3102/10769986004003207; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Reid KJ, 2011, CURR MED RES OPIN, V27, P449, DOI 10.1185/03007995.2010.545813; Revicki DA, 2009, PAIN, V146, P158, DOI 10.1016/j.pain.2009.07.029; Rizopoulos D, 2007, J STAT SOFTW, V17, P1, DOI DOI 10.18637/jss.v017.i05; Rizopoulos D, 2007, LTM PACKAGE LATENT T; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sijtsma K, 2008, QUAL LIFE RES, V17, P275, DOI 10.1007/s11136-007-9281-6; Terwee CB, 2014, QUAL LIFE RES, V23, P1733, DOI 10.1007/s11136-013-0611-6; van der Ark L. A., 2007, J STAT SOFTW, V20, P1, DOI DOI 10.18637/JSS.V020.I11; Veehof Martine M, 2002, J Hand Ther, V15, P347; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vos CJ, 2006, EUR SPINE J, V15, P1729, DOI 10.1007/s00586-006-0119-7; YEN WM, 1993, J EDUC MEAS, V30, P187, DOI 10.1111/j.1745-3984.1993.tb00423.x; Zijlstra TR, 2007, RHEUMATOLOGY, V46, P131, DOI 10.1093/rheumatology/kel171	60	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134094	10.1371/journal.pone.0134094	http://dx.doi.org/10.1371/journal.pone.0134094			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7DN	26214178	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300049
J	Hsiao, CY; Yang, HY; Hsiao, MC; Hung, PH; Wang, MC				Hsiao, Chih-Yen; Yang, Huang-Yu; Hsiao, Meng-Chang; Hung, Peir-Haur; Wang, Ming-Cheng			Risk Factors for Development of Acute Kidney Injury in Patients with Urinary Tract Infection	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE PYELONEPHRITIS; SEPTIC SHOCK; DIALYSIS; DEATH; INSUFFICIENCY; BACTEREMIA; MORTALITY; THERAPY; DISEASE	Acute kidney injury (AKI) is associated with high morbidity and mortality. Urinary tract infection (UTI) may be associated with sepsis or septic shock, and cause sudden deterioration of renal function. This study investigated the clinical characteristics and change of renal function to identify the risk factors for development of AKI in UTI patients. This retrospective study was conducted in a tertiary referral center. From January 2006 to January 2013, a total of 790 UTI patients necessitating hospital admission were included for final analysis. Their demographic and clinical characteristics and comorbidities were collected and compared. Multivariate logistic regression analysis was performed to evaluate the risk factors for AKI in UTI patients. There were 97 (12.3%) patients developing AKI during hospitalization. Multivariate logistic regression analysis showed that patients with older age (OR 1.02, 95% CI 1.00-1.04, P = 0.04), diabetes mellitus (DM) (OR 2.23, 95% CI 1.35-3.68, P = 0002), upper UTI (OR 2.63, 95% CI 1.53-4.56, P = 0001), afebrile during hospitalization (OR 1.71, 95% CI 1.04-2.83, P = 0036) and lower baseline eGFR [baseline eGFR 45-59 mL/min/1.73 m(2) (OR 2.12, 95% CI 1.12-4.04, P = 0.022), baseline eGFR 30-44 mL/min/1.73 m(2) (OR 4.44, 95% CI 2.30-8.60 P < 0.001) baseline eGFR < 30 mL/min/1.73 m(2) (OR 4.72, 95% CI 2.13-10.45, P < 0.001), respectively] were associated with increased risk for development of AKI. were associated with increased risk for development of AKI. Physicians should pay attention to UTI patients at risk of AKI (advancing age, DM, upper UTI, afebrile, and impaired baseline renal function).	[Hsiao, Chih-Yen; Hung, Peir-Haur] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan; [Hsiao, Chih-Yen] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Yang, Huang-Yu] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Nephrol, Taoyuan, Taiwan; [Hsiao, Meng-Chang] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Hung, Peir-Haur] Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth, Tainan, Taiwan; [Wang, Ming-Cheng] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Nephrol, Tainan, Taiwan; [Yang, Huang-Yu] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Chia Nan University of Pharmacy & Science; Chang Gung Memorial Hospital; Chang Gung University; University of Alabama System; University of Alabama Birmingham; Chia Nan University of Pharmacy & Science; National Cheng Kung University; National Cheng Kung University Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wang, MC (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Nephrol, Tainan, Taiwan.	tsutsugamushi8901@gmail.com		YANG, HUANG-YU/0000-0001-6826-9717				BAKER LRI, 1979, Q J MED, V48, P603; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boscia J A, 1987, Infect Dis Clin North Am, V1, P893; Boyko EJ, 2002, DIABETES CARE, V25, P1778, DOI 10.2337/diacare.25.10.1778; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cotran RS, 1981, URINARY TRACT INFECT, P1571; Dalal Shalini, 2006, J Support Oncol, V4, P9; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Funfstuck R, 2006, INT J ANTIMICROB AG, V28, pS72, DOI 10.1016/j.ijantimicag.2006.05.004; Gilbert DN, 2006, CLIN J AM SOC NEPHRO, V1, P327, DOI 10.2215/CJN.01931105; GLECKMAN R, 1982, JAMA-J AM MED ASSOC, V248, P1478, DOI 10.1001/jama.248.12.1478; HOLLOWAY WA, 1984, GERIATRICS, V39, P48; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; JONES SR, 1992, CLIN INFECT DIS, V14, P243, DOI 10.1093/clinids/14.1.243; Kalra OP, 2009, J GLOB INFECT DIS, V1, P57, DOI 10.4103/0974-777X.52984; Kooman JP, 2000, NETH J MED, V57, P185, DOI 10.1016/S0300-2977(00)00063-2; Kushimoto S, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-14; Laupland KB, 2007, INFECTION, V35, P150, DOI 10.1007/s15010-007-6180-2; Lee CC, 2007, MEDICINE, V86, P138, DOI 10.1097/SHK.0b013e318067da56; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liangos O, 2012, MINERVA UROL NEFROL, V64, P51; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; LORENTZ WB, 1990, NEPHRON, V54, P256, DOI 10.1159/000185865; Ma RCW, 2007, DIABETES CARE, V30, P182, DOI 10.2337/dc06-2040; Medeiros P, 2014, CLIN EXP NEPHROL; Mori T, 2010, CONTRIB NEPHROL, V166, P40, DOI 10.1159/000314849; Nahar A, 2004, AM J MED SCI, V328, P121, DOI 10.1097/00000441-200408000-00009; Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002; Nicolle LE, 2001, INFECT MED, V18, P153; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Patterson JE, 1997, INFECT DIS CLIN N AM, V11, P735, DOI 10.1016/S0891-5520(05)70383-4; Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610; Qari FA, 2003, SAUDI MED J, V24, P1064; Robbins SL, 1944, NEW ENGL J MED, V231, P865, DOI 10.1056/NEJM194412282312601; ROBERTS NJ, 1991, REV INFECT DIS, V13, P462; Rosser CJ, 1999, AM J SURG, V177, P287, DOI 10.1016/S0002-9610(99)00048-3; Sant G R, 1987, Semin Urol, V5, P126; SCHAEFFER AJ, 1991, EUR UROL, V19, P2; Schappert S.M., 2011, VITAL HLTH STAT, V13, P1; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Singh P, 2010, CLIN J AM SOC NEPHRO, V5, P1690, DOI 10.2215/CJN.00830110; SMITH JW, 1989, AM J MED SCI, V297, P53, DOI 10.1097/00000441-198901000-00013; Soylemezoglu O., 1995, International Urology and Nephrology, V27, P137, DOI 10.1007/BF02551309; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thatte L, 1996, POSTGRAD MED, V100, P83, DOI 10.3810/pgm.1996.12.128; Tiruvoipati R, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-70; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wijeysundera DN, 2007, JAMA-J AM MED ASSOC, V297, P1801, DOI 10.1001/jama.297.16.1801; WOLK PJ, 1978, ARCH INTERN MED, V138, P1084, DOI 10.1001/archinte.138.7.1084	55	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133835	10.1371/journal.pone.0133835	http://dx.doi.org/10.1371/journal.pone.0133835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213991	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300034
J	Baltensperger, AP; Huettmann, F				Baltensperger, A. P.; Huettmann, F.			Predicted Shifts in Small Mammal Distributions and Biodiversity in the Altered Future Environment of Alaska: An Open Access Data and Machine Learning Perspective	PLOS ONE			English	Article							NO-ANALOG COMMUNITIES; CLIMATE-CHANGE; ELEVATIONAL GRADIENTS; DIVERSITY; DYNAMICS; CONSERVATISM; IMPACTS; ADAPTATION; EVOLUTION; PATTERNS	Climate change is acting to reallocate biomes, shift the distribution of species, and alter community assemblages in Alaska. Predictions regarding how these changes will affect the biodiversity and interspecific relationships of small mammals are necessary to pro-actively inform conservation planning. We used a set of online occurrence records and machine learning methods to create bioclimatic envelope models for 17 species of small mammals (rodents and shrews) across Alaska. Models formed the basis for sets of species-specific distribution maps for 2010 and were projected forward using the IPCC (Intergovernmental Panel on Climate Change) A2 scenario to predict distributions of the same species for 2100. We found that distributions of cold-climate, northern, and interior small mammal species experienced large decreases in area while shifting northward, upward in elevation, and inland across the state. In contrast, many southern and continental species expanded throughout Alaska, and also moved down-slope and toward the coast. Statewide community assemblages remained constant for 15 of the 17 species, but distributional shifts resulted in novel species assemblages in several regions. Overall biodiversity patterns were similar for both time frames, but followed general species distribution movement trends. Biodiversity losses occurred in the Yukon-Kuskokwim Delta and Seward Peninsula while the Beaufort Coastal Plain and western Brooks Range experienced modest gains in species richness as distributions shifted to form novel assemblages. Quantitative species distribution and biodiversity change projections should help land managers to develop adaptive strategies for conserving dispersal corridors, small mammal biodiversity, and ecosystem functionality into the future.	[Baltensperger, A. P.; Huettmann, F.] Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, EWHALE Lab, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Baltensperger, AP (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, EWHALE Lab, Fairbanks, AK 99775 USA.	abaltens@alaska.edu			University of Alaska Fairbanks	University of Alaska Fairbanks	APB received a 2014-15 Doctoral Dissertation Completion Fellowship from the University of Alaska Fairbanks that funded this research.	ACIA, 2005, ARCTIC CLIMATE IMPAC, P1042; Alo CA, 2008, J GEOPHYS RES BIOGEO, V113; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; Baltensperger A. P., 2015, CANADIAN J IN PRESS; Baltensperger AP, 2015, LANDSCAPE ECOL, V30, P681, DOI 10.1007/s10980-014-0150-8; Baltensperger AP, 2015, DETECTING EFFECTS EN; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Boden T. A., 2011, GLOBAL REGIONAL NATL; Booms TL, 2010, POLAR BIOL, V33, P347, DOI 10.1007/s00300-009-0711-5; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BUCKNER CH, 1964, CAN J ZOOLOG, V42, P259, DOI 10.1139/z64-026; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; CAREY AB, 1992, ECOL MONOGR, V62, P223, DOI 10.2307/2937094; Carleton MD, 2014, J MAMMAL, V95, P943, DOI 10.1644/14-MAMM-A-004; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dial RJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000453; Dobrowski SZ, 2013, GLOBAL CHANGE BIOL, V19, P241, DOI 10.1111/gcb.12026; Drew CA, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7390-0; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Forero-Medina G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013210; Fox JW, 2007, OIKOS, V116, P189, DOI 10.1111/j.2006.0030-1299.15280.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Glick P, 2011, MOVING CONSERVATION, P1; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Gotthans T, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON MICROWAVES, COMMUNICATIONS, ANTENNAS AND ELECTRONICS SYSTEMS (IEEE COMCAS 2013); Gough L, 2007, OIKOS, V116, P407, DOI 10.1111/j.0030-1299.2007.15449.x; Guisan A, 2007, ECOL LETT, V10, P435, DOI 10.1111/j.1461-0248.2007.01044.x; Hallett J, 2003, MAMMAL COMMUNITY DYN, P22; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hegel TM, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P273, DOI 10.1007/978-4-431-87771-4_16; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holland MM, 2003, CLIM DYNAM, V21, P221, DOI 10.1007/s00382-003-0332-6; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; Hope AG, 2013, NAT CLIM CHANGE, V3, P931, DOI 10.1038/NCLIMATE1926; Hope AG, 2010, J MAMMAL, V91, P1041, DOI 10.1644/09-MAMM-A-402.1; Huettmann F, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P189, DOI 10.1007/978-1-4419-7390-0_10; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Kerr J, 1998, ENVIRON MONIT ASSESS, V49, P263, DOI 10.1023/A:1005846910199; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; Li J, 2011, ENVIRON MODELL SOFTW, V26, P1647, DOI 10.1016/j.envsoft.2011.07.004; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lovejoy T.E., 2005, CLIMATE CHANGE BIODI; Luoma Daniel L., 2003, P343, DOI 10.1017/CBO9780511615757.011; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; MASER C, 1978, ECOLOGY, V59, P799, DOI 10.2307/1938784; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Monzon J, 2011, BIOSCIENCE, V61, P752, DOI 10.1525/bio.2011.61.10.5; Murphy K, 2010, CONNECTING ALASKA LA, P100; Novillo A, 2012, AUSTRAL ECOL, V37, P758, DOI 10.1111/j.1442-9993.2011.02336.x; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; Pank LF, 1974, BIBLIO SEED EATING M; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; PROST S, 2013, GLOBAL CHANGE BIOL, V19, P1; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Staudinger MD, 2013, FRONT ECOL ENVIRON, V11, P465, DOI 10.1890/120272; Stein BA, 2013, FRONT ECOL ENVIRON, V11, P502, DOI 10.1890/120277; Tape KD, 2012, ECOSYSTEMS, V15, P711, DOI 10.1007/s10021-012-9540-4; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vihma T, 2014, SURV GEOPHYS, V35, P1175, DOI 10.1007/s10712-014-9284-0; Wackernagel M, 1999, ECOL ECON, V29, P375, DOI 10.1016/S0921-8009(98)90063-5; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiersma YF, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7390-0_1; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; ZWEIG MH, 1993, CLIN CHEM, V39, P561	87	25	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132054	10.1371/journal.pone.0132054	http://dx.doi.org/10.1371/journal.pone.0132054			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207828	Green Published, gold			2022-12-27	WOS:000358622000021
J	Gao, JM; Huang, Y; Li, M; Zhao, HC; Zhao, Y; Li, R; Yan, J; Yu, Y; Qiao, J				Gao, Jiangman; Huang, Ying; Li, Min; Zhao, Hongcui; Zhao, Yue; Li, Rong; Yan, Jie; Yu, Yang; Qiao, Jie			Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice	PLOS ONE			English	Article							FACTOR-INDUCED ANGIOGENESIS; IN-VITRO; FOLLICULAR DEVELOPMENT; FACTOR EXPRESSION; VEGF; TRANSPLANTATION; APOPTOSIS; PROMOTES; SURVIVAL; CELLS	Objective One of the major obstacles to ovarian tissue preservation is delayed angiogenesis that leads follicles lost after transplantation. The aim of the present study was to investigate the effects of bFGF and VEGF on heterotopic transplanted ovarian tissue using a mouse model. Methods Female mice underwent bilateral ovariectomy. Ovarian tissues encapsulated by fibrin hydrogels were transplanted subcutaneously into recipient mice, in which ovarian hormonal cyclicity was absent. The fibrinogen solution was mixed with bFGF, VEGF, or a mixture of bFGF and VEGF. The grafts were recovered 21 days after transplantation. Follicle morphology and follicle numbers were observed by H&E staining. Blood vessels were observed in transplanted intra-ovarian tissue by CD31 antibody IHC staining. Daily vaginal cytology was performed to determine estrous cycle and functional restoration of transplanted ovarian tissue. Blood was collected weekly and serum FSH levels were measured with a radioimmunoassay kit. Apoptosis analysis was performed by anti-AC-3 staining and survivin mRNA expression. Results The number of primordial follicles and secondary follicles in the bFGF+VEGF group was significantly higher than in the control group. The vascular density in the bFGF+VEGF groups were significantly higher than in the bFGF and the VEGF groups; there was no significant difference between the bFGF and VEGF groups. Estrous cycle was earlier in the bFGF+VEGF group compared with the control group; all mice in this group restored ovarian function. Serum FSH levels in the bFGF+VEGF group were significantly lower than in the control group by day 14 post-transplantation. The AC-3-positive in control group was significantly higher compared with bFGF group and VEGF group, and in bFGF+VEGF group was significantly lower than bFGF group and VEGF group. Survivin mRNA expression in bFGF+VEGF group was significantly higher than control group. Conclusion The combination of bFGF and VEGF has beneficial effects on follicle survival, angiogenesis, and resumption of estrous cycles.	[Gao, Jiangman; Huang, Ying; Li, Min; Zhao, Hongcui; Zhao, Yue; Li, Rong; Yan, Jie; Yu, Yang; Qiao, Jie] Peking Univ, Dept Obstet & Gynecol, Ctr Reprod Med, Hosp 3, Beijing 100191, Peoples R China; [Gao, Jiangman; Huang, Ying; Zhao, Yue; Li, Rong; Yu, Yang; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Zhao, Hongcui; Li, Rong; Yan, Jie; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100191, Peoples R China	Peking University	Yan, J (corresponding author), Peking Univ, Dept Obstet & Gynecol, Ctr Reprod Med, Hosp 3, Beijing 100191, Peoples R China.	yanjiebjmu@bjmu.edu.cn; yuyang5012@hotmail.com		Yu, Yang/0000-0002-4310-1966; Qiao, Jie/0000-0003-2126-1376	Ministry of Science and Technology of China Grants (973 program) [2011CB944504, 2014CB943203]; National Natural Science Funds for general program [31371521, 31230047]	Ministry of Science and Technology of China Grants (973 program); National Natural Science Funds for general program	This work was supported in part by the Ministry of Science and Technology of China Grants (973 program; 2011CB944504 and 2014CB943203), and the National Natural Science Funds for general program (31371521 and 31230047).	Abir R, 2011, FERTIL STERIL, V95, P1205, DOI 10.1016/j.fertnstert.2010.07.1082; Abramovich D, 2006, BIOL REPROD, V75, P434, DOI 10.1095/biolreprod.106.051052; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Beamer B., 2010, HSS J, V6, P85, DOI [10. 1007/s11420-009- 9129-4, DOI 10.1007/S11420-009-9129-4, 10.1007/s11420-009-9129-4]; Danforth DR, 2003, BIOL REPROD, V68, P1736, DOI 10.1095/biolreprod.101.000679; De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112; Donnez J, 2013, NAT REV ENDOCRINOL, V9, P735, DOI 10.1038/nrendo.2013.205; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gao JM, 2013, HUM REPROD, V28, P2784, DOI 10.1093/humrep/det296; Grasselli F, 2002, REPROD DOMEST ANIM, V37, P362, DOI 10.1046/j.1439-0531.2002.00386.x; Hata Y, 1999, DIABETES, V48, P1145, DOI 10.2337/diabetes.48.5.1145; Hazzard TM, 2000, BEST PRACT RES CL OB, V14, P883, DOI 10.1053/beog.2000.0133; Hunter MG, 2004, ANIM REPROD SCI, V82-3, P461, DOI 10.1016/j.anireprosci.2004.05.013; Imbert R, 2014, HUM REPROD, V29, P1931, DOI 10.1093/humrep/deu158; Kolibianakis S, 2015, REPROD BIOMED ONLINE, V30, P4, DOI 10.1016/j.rbmo.2014.11.003; Labied S, 2013, TRANSPLANTATION, V95, P426, DOI 10.1097/TP.0b013e318279965c; Li PP, 2014, J BONE MINER METAB, V32, P627, DOI 10.1007/s00774-013-0538-6; Majima M, 2000, BRIT J PHARMACOL, V130, P641, DOI 10.1038/sj.bjp.0703327; Mandriota SJ, 1997, J CELL SCI, V110, P2293; Quintana R, 2004, FERTIL STERIL, V82, P1101, DOI 10.1016/j.fertnstert.2004.03.036; Saadeh PB, 2000, ENDOCRINOLOGY, V141, P2075, DOI 10.1210/en.141.6.2075; Santos JMS, 2014, REPROD DOMEST ANIM, V49, P522, DOI 10.1111/rda.12322; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.TEA.2011.0204, 10.1089/ten.tea.2011.0204]; Silber S, 2015, REPROD BIOMED ONLINE, V30, P643, DOI 10.1016/j.rbmo.2015.02.010; Soleimani R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019475; Sun XT, 2004, WORLD J GASTROENTERO, V10, P2524, DOI 10.3748/wjg.v10.i17.2524; Tille JC, 2001, J PHARMACOL EXP THER, V299, P1073; Wang L, 2013, J ASSIST REPROD GEN, V30, P1301, DOI 10.1007/s10815-013-0043-9; Wang TR, 2014, HUM REPROD, V29, P568, DOI 10.1093/humrep/det465; Yang H, 2008, FERTIL STERIL, V90, P1550, DOI 10.1016/j.fertnstert.2007.08.086; Yoshiji H, 2002, HEPATOLOGY, V35, P834, DOI 10.1053/jhep.2002.32541	32	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134035	10.1371/journal.pone.0134035	http://dx.doi.org/10.1371/journal.pone.0134035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208097	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000194
J	Gong, SJ; Hao, ZJ; Meng, JS; Liu, D; Wei, MR; Tao, J				Gong, Saijie; Hao, Zhaojun; Meng, Jiasong; Liu, Ding; Wei, Mengran; Tao, Jun			Digital Gene Expression Analysis to Screen Disease Resistance-Relevant Genes from Leaves of Herbaceous Peony (Paeonia lactiflora Pall.) Infected by Botrytis cinerea	PLOS ONE			English	Article							PROTEIN-KINASE; TRANSCRIPTOME; PLANTS; LIGNIFICATION; PATHOGENS; NETWORKS; TOBACCO; POPLARS; COMPLEX; BAK1	Herbaceous peony (Paeonia lactiflora Pall.) is a well-known traditional flower in China and is widely used for landscaping and garden greening due to its high ornamental value. However, disease spots usually appear after the flowering of the plant and may result in the withering of the plant in severe cases. This study examined the disease incidence in an herbaceous peony field in the Yangzhou region, Jiangsu Province. Based on morphological characteristics and molecular data, the disease in this area was identified as a gray mold caused by Botrytis cinerea. Based on previously obtained transcriptome data, eight libraries generated from two herbaceous peony cultivars 'Zifengyu' and 'Dafugui' with different susceptibilities to the disease were then analyzed using digital gene expression profiling (DGE). Thousands of differentially expressed genes (DEGs) were screened by comparing the eight samples, and these genes were annotated using the Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) database. The pathways related to plant-pathogen interaction, secondary metabolism synthesis and antioxidant system were concentrated, and 51, 76, and 13 disease resistance-relevant candidate genes were identified, respectively. The expression patterns of these candidate genes differed between the two cultivars: their expression of the disease-resistant cultivar 'Zifengyu' sharply increased during the early stages of infection, while it was relatively subdued in the disease-sensitive cultivar 'Dafugui'. A selection of ten candidate genes was evaluated by quantitative real-time PCR (qRT-PCR) to validate the DGE data. These results revealed the transcriptional changes that took place during the interaction of herbaceous peony with B. cinerea, providing insight into the molecular mechanisms of host resistance to gray mold.	[Gong, Saijie; Hao, Zhaojun; Meng, Jiasong; Liu, Ding; Wei, Mengran; Tao, Jun] Yangzhou Univ, Coll Hort & Plant Protect, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Tao, J (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	taojunyzu@163.com			Agricultural Science & Technology Independent Innovation Fund of Jiangsu Province [CX[13]2014]; Agricultural Science & Technology Support Project of Jiangsu Province [BE2013389]; College Natural Science Research of Jiangsu Province [14KJB210011]; Postgraduate Science Research Innovation Project of Jiangsu province [CXLX_1426]; Priority Academic Program Development from Jiangsu Government	Agricultural Science & Technology Independent Innovation Fund of Jiangsu Province; Agricultural Science & Technology Support Project of Jiangsu Province; College Natural Science Research of Jiangsu Province; Postgraduate Science Research Innovation Project of Jiangsu province; Priority Academic Program Development from Jiangsu Government	This work was supported by the Agricultural Science & Technology Independent Innovation Fund of Jiangsu Province (CX[13]2014), Agricultural Science & Technology Support Project of Jiangsu Province (BE2013389), College Natural Science Research of Jiangsu Province (14KJB210011), Postgraduate Science Research Innovation Project of Jiangsu province (CXLX_1426) and the Priority Academic Program Development from Jiangsu Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Ahmad S, 2011, PLANT PHYSIOL, V157, P317, DOI 10.1104/pp.111.180224; Alam AKMM, 2014, PLANT PATHOLOGY J, V30, P261, DOI 10.5423/PPJ.OA.03.2014.0023; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baniecki JF, 2000, BOTRYTIS BLIGHT PEON; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Blanco-Ulate B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00142; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Chen QZ., 2013, THESIS FUJIAN AGR FO; Chen SN., 2011, THESIS BEIJING FORES; Chen XiaoHong, 2006, Southwest China Journal of Agricultural Sciences, V19, P58; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Day B, 2005, PLANT CELL, V17, P1292, DOI 10.1105/tpc.104.030163; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dutartre L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-64; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fang Z. D., 1998, RES METHODS PLANT DI, V3ed Edn; Fox R. T. V., 2001, Mycologist, V15, P88; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Frias M, 2013, MOL PLANT PATHOL, V14, P191, DOI 10.1111/j.1364-3703.2012.00842.x; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hansen M.A, 2009, BOTRYTIS BLIGHT PEON; HE ZH, 2001, ACTA PHYTOPHYSIOL SI, V27, P281; Ho GD, 1999, PHYTOPATHOLOGY, V89, P673, DOI 10.1094/PHYTO.1999.89.8.673; Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o; Ibrahim T, 2014, PHILIPP J CROP SCI, V39, P27; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jouanin L, 2000, PLANT PHYSIOL, V123, P1363, DOI 10.1104/pp.123.4.1363; Kajita S, 2002, J SCI FOOD AGR, V82, P1216, DOI 10.1002/jsfa.1168; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keller M, 2003, PHYTOPATHOLOGY, V93, P316, DOI 10.1094/PHYTO.2003.93.3.316; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Lakshmanan V, 2012, PLANT PHYSIOL, V160, P1642, DOI 10.1104/pp.112.200386; Lan Y, 1987, J NANJING FORESTRY U, V1, P8; Lanot A, 2006, PLANT J, V48, P286, DOI 10.1111/j.1365-313X.2006.02872.x; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang Ye, 2011, Yichuan, V33, P1317, DOI 10.3724/SP.J.1005.2011.01317; Liu B, 2014, PLANT SCI, V227, P145, DOI 10.1016/j.plantsci.2014.08.001; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qiao ZC, 2009, THESIS XINJIANG AGR; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Rivera MC, 2006, PLANT DIS, V90, P970, DOI 10.1094/PD-90-0970B; Romeis T, 2000, PLANT CELL, V12, P803, DOI 10.1105/tpc.12.5.803; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Sun Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-852; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wagner A, 2007, P NATL ACAD SCI USA, V104, P11856, DOI 10.1073/pnas.0701428104; Wang GuangJin, 1997, Acta Phytopathologica Sinica, V27, P215; Wei JC, 1979, FUNDAL IDENTIFICATIO; White FF, 2000, CURR OPIN PLANT BIOL, V3, P291, DOI 10.1016/S1369-5266(00)00082-0; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; White-McDougall W. J., 1998, DIS PEONY; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Wu Y, 2013, J INTEGR PLANT BIOL, V55, P1271, DOI 10.1111/jipb.12123; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xing T, 2001, MOL PLANT MICROBE IN, V14, P1261, DOI 10.1094/MPMI.2001.14.10.1261; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Z., 1987, J HENAN AGR U, V21, P435; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045953; Zhang Z., 2006, FLORA FUNGORUM SINIC, V26; Zhao DQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-689; Zhao DaQiu, 2012, African Journal of Agricultural Research, V7, P2153; Zhao DQ, 2011, MOL BIOL REP, V38, P3935, DOI 10.1007/s11033-010-0510-7; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhao S, 2012, WORLD J MICROB BIOT, V28, P2919, DOI 10.1007/s11274-012-1102-6; Zou Q, 2000, PLANT PHYSL EXPT INS; 赵大球, 2011, [江苏农业科学, Jiangsu Agricultural Sciences], V39, P286; 朱丽梅, 2011, [江苏农业科学, Jiangsu Agricultural Sciences], V39, P134	88	6	7	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133305	10.1371/journal.pone.0133305	http://dx.doi.org/10.1371/journal.pone.0133305			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208357	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000077
J	James, L; Yan, K; Pence, L; Simpson, P; Bhattacharyya, S; Gill, P; Letzig, L; Kearns, G; Beger, R				James, Laura; Yan, Ke; Pence, Lisa; Simpson, Pippa; Bhattacharyya, Sudeepa; Gill, Pritmohinder; Letzig, Lynda; Kearns, Gregory; Beger, Richard			Comparison of Bile Acids and Acetaminophen Protein Adducts in Children and Adolescents with Acetaminophen Toxicity	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; LIQUID-CHROMATOGRAPHY; HEPATIC-INJURY; NITRIC-OXIDE; OVERDOSE; SERUM; TAURINE; HEPATOTOXICITY; MULTICENTER; NECROSIS	Metabolomics approaches have enabled the study of new mechanisms of liver injury in experimental models of drug toxicity. Disruption of bile acid homeostasis is a known mechanism of drug induced liver injury. The relationship of individual bile acids to indicators of oxidative drug metabolism (acetaminophen protein adducts) and liver injury was examined in children with acetaminophen overdose, hospitalized children with low dose exposure to acetaminophen, and children with no recent exposure to acetaminophen. Nine bile acids were quantified through targeted metabolomic analysis in the serum samples of the three groups. Bile acids were compared to serum levels of acetaminophen protein adducts and alanine aminotransferase. Glycodeoxycholic acid, taurodeoxycholic acid, and glycochenodeoxycholic acid were significantly increased in children with acetaminophen overdose compared to healthy controls. Among patients with acetaminophen overdose, bile acids were higher in subjects with acetaminophen protein adduct values > 1.0 nmol/mL and modest correlations were noted for three bile acids and acetaminophen protein adducts as follows: taurodeoxycholic acid (R=0.604; p<0.001), glycodeoxycholic acid (R=0.581; p<0.001), and glycochenodeoxycholic acid (R=0.571; p<0.001). Variability in bile acids was greater among hospitalized children receiving low doses of acetaminophen than in healthy children with no recent acetaminophen exposure. Compared to bile acids, acetaminophen protein adducts more accurately discriminated among children with acetaminophen overdose, children with low dose exposure to acetaminophen, and healthy control subjects. In children with acetaminophen overdose, elevations of conjugated bile acids were associated with specific indicators of acetaminophen metabolism and non-specific indicators of liver injury.	[James, Laura; Bhattacharyya, Sudeepa; Gill, Pritmohinder; Letzig, Lynda] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA; [James, Laura; Bhattacharyya, Sudeepa; Gill, Pritmohinder; Letzig, Lynda] Arkansas Childrens Hosp, Res Inst, Little Rock, AR 72202 USA; [Yan, Ke; Simpson, Pippa] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Pence, Lisa; Beger, Richard] Natl Ctr Toxicol Res, Div Syst Biol, Jefferson, AR 72079 USA; [Kearns, Gregory] Childrens Mercy Hosp, Div Pediat Pharmacol Med Toxicol & Therapeut Inno, Kansas City, MO 64108 USA	University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; Medical College of Wisconsin; US Food & Drug Administration (FDA); Children's Mercy Hospital	James, L (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA.	jameslaurap@uams.edu	simpson, pippa/AAI-8172-2020	simpson, pippa/0000-0003-1458-3748	National Institutes of Diabetes, Digestive and Kidney Diseases of the United States Department of Health and Human Services [DK75936]; Arkansas Biosciences Institute; Arkansas Tobacco Settlement Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R41DK079387, R42DK079387] Funding Source: NIH RePORTER	National Institutes of Diabetes, Digestive and Kidney Diseases of the United States Department of Health and Human Services; Arkansas Biosciences Institute; Arkansas Tobacco Settlement Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by a grant (DK75936 to LJ) from the National Institutes of Diabetes, Digestive and Kidney Diseases of the United States Department of Health and Human Services and the Arkansas Biosciences Institute which is funded by Arkansas Tobacco Settlement Funds.	Alander SW, 2000, ARCH PEDIAT ADOL MED, V154, P346, DOI 10.1001/archpedi.154.4.346; Aleksunes LM, 2008, TOXICOL APPL PHARM, V226, P74, DOI 10.1016/j.taap.2007.08.022; Bhattacharyya S PL, 2013, METABOLITES, V3, P1, DOI [10.3390/metabo3010001, DOI 10.3390/METABO3010001]; Bhattacharyya S, 2014, BIOMARK MED, V8, P147, DOI 10.2217/bmm.13.150; Bhushan B, 2013, AM J PATHOL, V183, P1518, DOI 10.1016/j.ajpath.2013.07.012; Bi HC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/985257; Chaudhuri S, 2011, TOXICOL APPL PHARM, V252, P211, DOI 10.1016/j.taap.2011.02.005; Chen C, 2009, CHEM RES TOXICOL, V22, P699, DOI 10.1021/tx800464q; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Das J, 2010, TOXICOLOGY, V269, P24, DOI 10.1016/j.tox.2010.01.003; Davern TJ, 2006, GASTROENTEROLOGY, V130, P687, DOI 10.1053/j.gastro.2006.01.033; Gardner CR, 1998, HEPATOLOGY, V27, P748, DOI 10.1002/hep.510270316; Hanawa N, 2008, J BIOL CHEM; James LP, 2008, CLIN PHARMACOL THER, V84, P684, DOI 10.1038/clpt.2008.190; James LP, 2009, DRUG METAB DISPOS, V37, P1779, DOI 10.1124/dmd.108.026195; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; James LP, 2012, EUR J CLIN PHARM; JAMES O, 1975, LANCET, V2, P579; Khandelwal N, 2011, HEPATOLOGY, V53, P567, DOI 10.1002/hep.24060; Kon K, 2004, HEPATOLOGY, V40, P1170, DOI 10.1002/hep.20437; Kostrubsky VE, 2003, TOXICOL SCI, V76, P220, DOI 10.1093/toxsci/kfg217; Lake AD, 2013, TOXICOL APPL PHARM, V268, P132, DOI 10.1016/j.taap.2013.01.022; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Legido-Quigley C, 2011, ELECTROPHORESIS, V32, P2063, DOI 10.1002/elps.201000512; Luo LN, 2014, TOXICOL SCI, V137, P12, DOI 10.1093/toxsci/kft221; Milkiewicz P, 2002, GUT, V51, P113, DOI 10.1136/gut.51.1.113; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; Muldrew KL, 2002, DRUG METAB DISPOS, V30, P446, DOI 10.1124/dmd.30.4.446; PUMFORD NR, 1990, BIOCHEM PHARMACOL, V40, P573, DOI 10.1016/0006-2952(90)90558-3; Redmond HP, 1996, ARCH SURG-CHICAGO, V131, P1280; RUMACK BH, 1975, PEDIATRICS, V55, P871; RUMACK BH, 1986, PEDIATR CLIN N AM, V33, P691; Schnackenberg LK, 2006, PHARMACOGENOMICS, V7, P1077, DOI 10.2217/14622416.7.7.1077; Schwartz EA, 2009, ANN EMERG MED, V54, P421, DOI 10.1016/j.annemergmed.2008.10.001; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852; Sun J., 2013, J MOL BIOMARKERS DIA, pS1; Sun J, 2008, J CHROMATOGR B ANALY; Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274; Woolbright BL, 2014, TOXICOL SCI, V142, P436, DOI 10.1093/toxsci/kfu195; Yamazaki M, 2013, TOXICOL APPL PHARM, V268, P79, DOI 10.1016/j.taap.2013.01.018	43	17	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131010	10.1371/journal.pone.0131010	http://dx.doi.org/10.1371/journal.pone.0131010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208104	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000014
J	Yuan, S; Lei, F; Liu, ZF; Tong, QP; Si, T; Xu, RX				Yuan, Shuai; Lei, Fan; Liu, Zhongfa; Tong, Qingping; Si, Ting; Xu, Ronald X.			Coaxial Electrospray of Curcumin-Loaded Microparticles for Sustained Drug Release	PLOS ONE			English	Article							PLGA NANOPARTICLES; ENCAPSULATION; MICROSPHERES; ANGIOGENESIS; PARTICLES; PROTEINS; DELIVERY; JETS	Curcumin exhibits superior anti-inflammatory, antiseptic and analgesic activities without significant side effects. However, clinical dissemination of this natural medicine is limited by its low solubility and poor bio-availability. To overcome this limitation, we propose to encapsulate curcumin in poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) by an improved coaxial electrospray (CES) process. This process is able to generate a stable cone-jet mode in a wide range of operation parameters in order to produce curcumin-loaded PLGA MPs with a clear core-shell structure and a designated size of several micrometers. In order to optimize the process outcome, the effects of primary operation parameters such as the applied electric voltages and the liquid flow rates are studied systemically. In vitro drug release experiments are also carried out for the CES-produced MPs in comparison with those by a single axial electrospray process. Our experimental results show that the CES process can be effectively controlled to encapsulate drugs of low aqueous solubility for high encapsulation efficiency and optimal drug release profiles.	[Yuan, Shuai; Xu, Ronald X.] Univ Sci & Technol China, Dept Precis Machinery & Precis Instrumentat, Hefei 230027, Anhui, Peoples R China; [Lei, Fan; Si, Ting] Univ Sci & Technol China, Dept Modern Mech, Hefei 230027, Anhui, Peoples R China; [Liu, Zhongfa] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Tong, Qingping] 105th Hosp PLA, Dept Ultrasound, Hefei 230031, Anhui, Peoples R China; [Si, Ting; Xu, Ronald X.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Si, T (corresponding author), Univ Sci & Technol China, Dept Modern Mech, Hefei 230027, Anhui, Peoples R China.	tsi@ustc.edu.cn; xu.202@osu.edu	Si, Ting/D-9203-2018	Si, Ting/0000-0001-9071-8646	National Natural Science Foundation of China [11472270, 81327803]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is partially supported by the National Natural Science Foundation of China (11472270, 81327803) and the Fundamental Research Funds for the Central Universities.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Almeria B, 2010, J COLLOID INTERF SCI, V343, P125, DOI 10.1016/j.jcis.2009.10.002; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013; Cohen-Sela E, 2009, J CONTROL RELEASE, V133, P90, DOI 10.1016/j.jconrel.2008.09.073; Ho ML, 2008, J CONTROL RELEASE, V128, P142, DOI 10.1016/j.jconrel.2008.02.012; Ji JL, 2012, ANTI-CANCER AGENT ME, V12, P210, DOI 10.2174/187152012800228733; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lee YH, 2010, J CONTROL RELEASE, V145, P58, DOI 10.1016/j.jconrel.2010.03.014; Li F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036304; Li L, 2007, MOL CANCER THER, V6, P1276, DOI 10.1158/1535-7163.MCT-06-0556; Lopez-Herrera JM, 2003, J AEROSOL SCI, V34, P535, DOI 10.1016/S0021-8502(03)00021-1; Loscertales IG, 2002, SCIENCE, V295, P1695, DOI 10.1126/science.1067595; Nath SD, 2013, INT J PHARMACEUT, V443, P87, DOI 10.1016/j.ijpharm.2012.12.037; Nie HM, 2010, J BIOMED MATER RES A, V95A, P709, DOI 10.1002/jbm.a.32867; Sato M, 2009, IEEE T DIELECT EL IN, V16, P320, DOI 10.1109/TDEI.2009.4815159; Si T, 2015, MICROFLUID NANOFLUID, V18, P967, DOI 10.1007/s10404-014-1486-8; Si T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.075003; Sou K, 2008, INT J PHARM, V352, P287, DOI 10.1016/j.ijpharm.2007.10.033; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Wichitnithad W, 2009, PHYTOCHEM ANALYSIS, V20, P314, DOI 10.1002/pca.1129; Xie JW, 2008, J COLLOID INTERF SCI, V317, P469, DOI 10.1016/j.jcis.2007.09.082; Xie JW, 2007, BIOTECHNOL BIOENG, V97, P1278, DOI 10.1002/bit.21334; Xu RX, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548878; Yao J, 2008, J AEROSOL SCI, V39, P987, DOI 10.1016/j.jaerosci.2008.07.003; Zhang LL, 2012, EXPERT REV MED DEVIC, V9, P595, DOI [10.1586/erd.12.58, 10.1586/ERD.12.58]; Zhu ZQ, 2015, LAB CHIP, V15, P646, DOI 10.1039/c4lc01032a	27	43	47	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132609	10.1371/journal.pone.0132609	http://dx.doi.org/10.1371/journal.pone.0132609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208167	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000035
J	Boudreau, PD; Monroe, EA; Mehrotra, S; Desfor, S; Korobeynikov, A; Sherman, DH; Murray, TF; Gerwick, L; Dorrestein, PC; Gerwick, WH				Boudreau, Paul D.; Monroe, Emily A.; Mehrotra, Suneet; Desfor, Shane; Korobeynikov, Anton; Sherman, David H.; Murray, Thomas F.; Gerwick, Lena; Dorrestein, Pieter C.; Gerwick, William H.			Expanding the Described Metabolome of the Marine Cyanobacterium Moorea producens JHB through Orthogonal Natural Products Workflows	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; MOLECULAR NETWORKING; HECTOCHLORIN; DEREPLICATION; FUNDAMENTALS; HALOGENATION; DOMAINS; GENOMES; REAGENT; POTENT	Moorea producens JHB, a Jamaican strain of tropical filamentous marine cyanobacteria, has been extensively studied by traditional natural products techniques. These previous bioassay and structure guided isolations led to the discovery of two exciting classes of natural products, hectochlorin (1) and jamaicamides A (2) and B (3). In the current study, mass spectrometry-based 'molecular networking' was used to visualize the metabolome of Moorea producens JHB, and both guided and enhanced the isolation workflow, revealing additional metabolites in these compound classes. Further, we developed additional insight into the metabolic capabilities of this strain by genome sequencing analysis, which subsequently led to the isolation of a compound unrelated to the jamaicamide and hectochlorin families. Another approach involved stimulation of the biosynthesis of a minor jamaicamide metabolite by cultivation in modified media, and provided insights about the underlying biosynthetic machinery as well as preliminary structure-activity information within this structure class. This study demonstrated that these orthogonal approaches are complementary and enrich secondary metabolomic coverage even in an extensively studied bacterial strain.	[Boudreau, Paul D.; Desfor, Shane; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Monroe, Emily A.] William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA; [Mehrotra, Suneet; Murray, Thomas F.] Creighton Univ, Dept Pharmacol, Sch Med, Omaha, NE 68178 USA; [Desfor, Shane] Calif State Univ San Marcos, Dept Biol, San Marcos, CA 92078 USA; [Korobeynikov, Anton] Russian Acad Sci, St Petersburg Acad Univ, Algorithm Biol Lab, St Petersburg 194021, Russia; [Korobeynikov, Anton] St Petersburg State Univ, Dept Math & Mech, St Petersburg 194021, Russia; [Korobeynikov, Anton] St Petersburg State Univ, Ctr Algorithm Biotechnol, St Petersburg 194021, Russia; [Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.; Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Creighton University; California State University System; California State University San Marcos; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University; Saint Petersburg State University; Saint Petersburg State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Gerwick, WH (corresponding author), Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	wgerwick@ucsd.edu	Korobeynikov, Anton/D-3555-2009; Dorrestein, Pieter/ABF-2930-2020	Korobeynikov, Anton/0000-0002-2937-9259; 	National Institutes of Health [NS053398, CA100851, CA108874, GM107550]; Russian Science Foundation [14-50-069]; Russian Science Foundation [14-50-00069] Funding Source: Russian Science Foundation; NATIONAL CANCER INSTITUTE [R01CA100851, P30CA023100, R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS053398 (to WHG and TFM), National Institutes of Health grant CA100851 (to WHG), National Institutes of Health grant CA108874 (to WHG, LG, and DHS), National Institutes of Health grant GM107550 (to WHG, LG, and PCD), and Russian Science Foundation grant 14-50-069 (to AK).	Bhushan R, 2004, AMINO ACIDS, V27, P231, DOI 10.1007/s00726-004-0118-0; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bruland KW, 1983, CHEM OCEANOGR, P172; BUTLER A, 1993, CHEM REV, V93, P1937, DOI 10.1021/cr00021a014; Cao ZY, 2008, J PHARMACOL EXP THER, V326, P604, DOI 10.1124/jpet.108.138230; Cao ZY, 2011, J PHARMACOL EXP THER, V336, P197, DOI 10.1124/jpet.110.171850; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Dalisay DS, 2009, J NAT PROD, V72, P732, DOI 10.1021/np8007649; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P1537, DOI 10.1021/bi052333k; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Engene N, 2012, INT J SYST EVOL MICR, V62, P1171, DOI 10.1099/ijs.0.033761-0; Esquenazi E, 2011, P NATL ACAD SCI USA, V108, P5226, DOI 10.1073/pnas.1012813108; Fenn JB, 2003, ANGEW CHEM INT EDIT, V42, P3871, DOI 10.1002/anie.200300605; Flatt PM, 2006, J NAT PROD, V69, P938, DOI 10.1021/np050523q; Fujimori DG, 2007, CURR OPIN CHEM BIOL, V11, P553, DOI 10.1016/j.cbpa.2007.08.002; Galonic DP, 2006, J AM CHEM SOC, V128, P3900, DOI 10.1021/ja060151n; Gao S, 2011, J COMPUT BIOL, V18, P1681, DOI 10.1089/cmb.2011.0170; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; Hayes R, 2014, J CHROMATOGR A, V1357, P36, DOI 10.1016/j.chroma.2014.05.010; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; Jabba SV, 2010, J PHARMACOL EXP THER, V332, P698, DOI 10.1124/jpet.109.161802; Jensen PR, 2014, J IND MICROBIOL BIOT, V41, P203, DOI 10.1007/s10295-013-1353-8; Johnson TA, 2010, J NAT PROD, V73, P359, DOI 10.1021/np900565a; Jones AC, 2011, P NATL ACAD SCI USA, V108, P8815, DOI 10.1073/pnas.1101137108; Kupce E, 2003, J MAGN RESON, V162, P300, DOI 10.1016/S1090-7807(02)00196-9; Link B, 2015, CUSTOMER RELATIONS L; Liu WT, 2014, J ANTIBIOT, V67, P99, DOI 10.1038/ja.2013.99; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Marquez BL, 2002, J NAT PROD, V65, P866, DOI 10.1021/np0106283; Mevers E, 2011, J NAT PROD, V74, P928, DOI 10.1021/np200077f; Miller B, 2014, J NAT PROD, V77, P92, DOI 10.1021/np400727r; Molinski TF, 2010, NAT PROD REP, V27, P321, DOI 10.1039/b920545b; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Ng J, 2009, NAT METHODS, V6, P596, DOI 10.1038/nmeth.1350; Nikolenko SI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S7; Nunnery JK, 2012, J ORG CHEM, V77, P4198, DOI 10.1021/jo300160e; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Ramaswamy AV, 2007, J NAT PROD, V70, P1977, DOI 10.1021/np0704250; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sundberg RJ, 2007, ADVANCED ORGANIC CHE, V300, P1018; Suntornchashwej S, 2005, J NAT PROD, V68, P951, DOI 10.1021/np0500124; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Watrous J, 2012, P NATL ACAD SCI USA, V109, pE1743, DOI 10.1073/pnas.1203689109; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	50	26	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133297	10.1371/journal.pone.0133297	http://dx.doi.org/10.1371/journal.pone.0133297			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222584	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800048
J	Bradesi, S; Karagiannides, I; Bakirtzi, K; Joshi, SM; Koukos, G; Iliopoulos, D; Pothoulakis, C; Mayer, EA				Bradesi, Sylvie; Karagiannides, Iordanes; Bakirtzi, Kyriaki; Joshi, Swapna Mahurkar; Koukos, Georgios; Iliopoulos, Dimitrios; Pothoulakis, Charalabos; Mayer, Emeran A.			Identification of Spinal Cord MicroRNA and Gene Signatures in a Model of Chronic Stress-Induced Visceral Hyperalgesia in Rat	PLOS ONE			English	Article							NEUROPATHIC PAIN; MESSENGER-RNA; IN-VITRO; INTERLEUKIN-6; ACTIVATION; EXPOSURE; MAINTENANCE; MICROGLIA; CYTOKINES; RESPONSES	Introduction Animal studies have shown that stress could induce epigenetic and transcriptomic alterations essential in determining the balance between adaptive or maladaptive responses to stress. We tested the hypothesis that chronic stress in rats deregulates coding and noncoding gene expression in the spinal cord, which may underline neuroinflammation and nociceptive changes previously observed in this model. Methods Male Wistar rats were exposed to daily stress or handled, for 10 days. At day 11, lumbar spinal segments were collected and processed for mRNA/miRNA isolation followed by expression profiling using Agilent SurePrint Rat Exon and Rat miRNA Microarray platforms. Differentially expressed gene lists were generated using the dChip program. Microarrays were analyzed using the Ingenuity Pathways Analysis (IPA) tool from Ingenuity Systems. Multiple methods were used for the analysis of miRNA-mRNA functional modules. Quantitative real time RT-PCR for Interleukin 6 signal transducer (gp130), the Signal Transducer And Activator Of Transcription 3 (STAT3), glial fibrillary acidic protein and mir-17-5p were performed to confirm levels of expression. Results Gene network analysis revealed that stress deregulated different inflammatory (IL-6, JAK/STAT, TNF) and metabolic (PI3K/AKT) signaling pathways. MicroRNA array analysis revealed a signature of 39 deregulated microRNAs in stressed rats. MicroRNA-gene network analysis showed that microRNAs are regulators of two gene networks relevant to inflammatory processes. Specifically, our analysis of miRNA-mRNA functional modules identified miR-17-5p as an important regulator in our model. We verified miR-17-5p increased expression in stress using qPCR and in situ hybridization. In addition, we observed changes in the expression of gp130 and STAT3 (involved in intracellular signaling cascades in response to gp130 activation), both predicted targets for miR-17-5p. A modulatory role of spinal mir17-5p in the modulation of visceral sensitivity was confirmed in vivo. Conclusion Using an integrative high throughput approach, our findings suggest a link between miR-17-5p increased expression and gp130/STAT3 activation providing new insight into the possible mechanisms mediating the effect of chronic stress on neuroinflammation in the spinal cord.	[Bradesi, Sylvie; Karagiannides, Iordanes; Joshi, Swapna Mahurkar; Pothoulakis, Charalabos; Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Oppenheimer Family Ctr Neurobiol Stress, Los Angeles, CA 90095 USA; [Karagiannides, Iordanes; Bakirtzi, Kyriaki] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Inflammatory Bowel Dis Ctr & Neuroendocrine Assay, Los Angeles, CA 90095 USA; [Joshi, Swapna Mahurkar; Koukos, Georgios; Iliopoulos, Dimitrios; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Syst Biomed, Los Angeles, CA 90095 USA; [Bradesi, Sylvie] Vet Adm, CURE Ctr, Greater Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bradesi, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Oppenheimer Family Ctr Neurobiol Stress, Los Angeles, CA 90095 USA.	sbradesi@ucla.edu	Koukos, Georgios/B-1544-2009; Iliopoulos, Dimitrios/AAE-9106-2019	Koukos, Georgios/0000-0002-9470-0651; 	National Institute of Health [5 R01 DA026597]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026597] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health 5 R01 DA026597 SB, http://www.nih.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Biala YN, 2011, HIPPOCAMPUS, V21, P1114, DOI 10.1002/hipo.20825; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bradesi S, 2010, NEUROGASTROENT MOTIL, V22, P499, DOI 10.1111/j.1365-2982.2010.01491.x; Bradesi S, 2011, AM J PHYSIOL-GASTR L, V301, pG580, DOI 10.1152/ajpgi.00182.2011; Brenn D, 2007, ARTHRITIS RHEUM, V56, P351, DOI 10.1002/art.22282; Brummett BH, 2012, BIOL PSYCHOL, V89, P94, DOI 10.1016/j.biopsycho.2011.09.013; Bryan K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1318; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Frank MG, 2014, PSYCHONEUROENDOCRINO, V40, P191, DOI 10.1016/j.psyneuen.2013.11.006; Girotti M, 2013, PSYCHONEUROENDOCRINO, V38, P1158, DOI 10.1016/j.psyneuen.2012.11.004; Golovatscka V, 2012, NEUROIMMUNOMODULAT, V19, P367, DOI 10.1159/000342092; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Larauche M, 2012, WORLD J GASTROENTERO, V18, P225, DOI 10.3748/wjg.v18.i3.225; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liu PY, 2012, GASTROENTEROLOGY, V142, P165, DOI 10.1053/j.gastro.2011.09.041; Malan-Muller S, 2013, MOL NEUROBIOL, V47, P726, DOI 10.1007/s12035-012-8374-6; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Nekovarova T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00099; Quarta S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-73; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Song DD, 2014, AM J PHYSL GASTROINT; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Tenorio G, 2013, PAIN, V154, P71, DOI 10.1016/j.pain.2012.09.008; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Zannas A.S., 2013, NEUROSCIENCE; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523	31	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0130938	10.1371/journal.pone.0130938	http://dx.doi.org/10.1371/journal.pone.0130938			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222740	gold, Green Published			2022-12-27	WOS:000358836800009
J	Saski, CA; Bhattacharjee, R; Scheffler, BE; Asiedu, R				Saski, Christopher A.; Bhattacharjee, Ranjana; Scheffler, Brian E.; Asiedu, Robert			Genomic Resources for Water Yam (Dioscorea alata L.): Analyses of EST-Sequences, De Novo Sequencing and GBS Libraries	PLOS ONE			English	Article							MILLET SETARIA-ITALICA; MICROSATELLITE MARKERS; DNA; GENERATION; RESISTANCE; ALIGNMENT	The reducing cost and rapid progress in next-generation sequencing techniques coupled with high performance computational approaches have resulted in large-scale discovery of advanced genomic resources in several model and non-model plant species. Yam (Dioscorea spp.) is a major food and cash crop in many countries but research efforts have been limited to understand the genetics and generate genomic information for the crop. The availability of a large number of genomic resources including genome-wide molecular markers will accelerate the breeding efforts and application of genomic selection in yams. In the present study, several methods including expressed sequence tags (EST)-sequencing, de novo sequencing, and genotyping-by-sequencing (GBS) profiles on two yam (Dioscorea alata L.) genotypes (TDa 95/00328 and TDa 95-310) was performed to generate genomic resources for use in its improvement programs. This includes a comprehensive set of EST-SSRs, genomic SSRs, whole genome SNPs, and reduced representation SNPs. A total of 1,152 EST-SSRs were developed from >40,000 EST-sequences generated from the two genotypes. A set of 388 EST-SSRs were validated as polymorphic showing a polymorphism rate of 34% when tested on two diverse parents targeted for anthracnose disease. In addition, approximately 40X de novo whole genome sequence coverage was generated for each of the two genotypes, and a total of 18,584 and 15,952 genomic SSRs were identified for TDa 95/00328 and TDa 95-310, respectively. A custom made pipeline resulted in the selection of 573 genomic SSRs common across the two genotypes, of which only eight failed, 478 being polymorphic and 62 monomorphic indicating a polymorphic rate of 83.5%. Additionally, 288,505 high quality SNPs were also identified between these two genotypes. Genotyping by sequencing reads on these two genotypes also revealed 36,790 overlapping SNP positions that are distributed throughout the genome. Our efforts in using different approaches in generating genomic resources provides a non-biased glimpse into the publicly available EST-sequences, yam genome, and GBS profiles with affirmation that the genomic complexity can be methodically unraveled and constitute a critical foundation for future studies in linkage mapping, germplasm analysis, and predictive breeding.	[Saski, Christopher A.] Clemson Univ, Genom & Computat Biol Lab, Inst Translat Genom, Clemson, SC USA; [Bhattacharjee, Ranjana; Asiedu, Robert] Int Inst Trop Agr, Biosci Ctr, Ibadan, Nigeria; [Scheffler, Brian E.] USDA ARS, Genom & Bioinformat Res Unit, Stoneville, MS 38776 USA	Clemson University; CGIAR; International Institute of Tropical Agriculture (IITA); United States Department of Agriculture (USDA)	Bhattacharjee, R (corresponding author), Int Inst Trop Agr, Biosci Ctr, PMB 5320, Ibadan, Nigeria.	r.bhattacharjee@cgiar.org	Asiedu, Robert/AAV-6512-2021; Bhattacharjee, Ranjana/AAN-1979-2020	Asiedu, Robert/0000-0001-8943-2376; Scheffler, Brian/0000-0003-1968-8952	USAID-Linkage grant through the International Institute of Tropical Agriculture; ARS [ARS-0425248] Funding Source: Federal RePORTER	USAID-Linkage grant through the International Institute of Tropical Agriculture(United States Agency for International Development (USAID)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	RB thanks USAID-Linkage grant awarded through the International Institute of Tropical Agriculture for sponsoring the research. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Brunner I, 2001, MOL ECOL, V10, P2079, DOI 10.1046/j.1365-294X.2001.01325.x; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Chen YC, 2011, PLOS ONE, V8; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Girma G, 2014, THEOR APPL GENET, V127, P1783, DOI 10.1007/s00122-014-2339-2; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Hochu I, 2006, MOL ECOL NOTES, V6, P137, DOI 10.1111/j.1471-8286.2005.01166.x; Lambel S, 2014, THEOR APPL GENET, V127, P2105, DOI 10.1007/s00122-014-2363-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Mignouna HD, 2002, THEOR APPL GENET, V105, P716, DOI 10.1007/s00122-002-0911-7; Mignouna HD, 2001, THEOR APPL GENET, V103, P52, DOI 10.1007/s001220000531; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Narina SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-100; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Petro D, 2011, EUPHYTICA, V179, P405, DOI 10.1007/s10681-010-0338-1; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Tabbasam N, 2014, PLANT SYST EVOL, V300, P559, DOI 10.1007/s00606-013-0891-x; Tostain S, 2006, MOL ECOL NOTES, V6, P173, DOI 10.1111/j.1471-8286.2005.01182.x; Uitdewilligen JGAML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062355; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Waldbieser GC, 2003, BIOTECHNIQUES, V35, P976, DOI 10.2144/03355st05; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78; Zhao H, 2015, SCI REPORTS, V5, P1	32	17	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134031	10.1371/journal.pone.0134031	http://dx.doi.org/10.1371/journal.pone.0134031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222616	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800098
J	Tesli, M; Kauppi, K; Bettella, F; Brandt, CL; Kaufmann, T; Espeseth, T; Mattingsdal, M; Agartz, I; Melle, I; Djurovic, S; Westlye, LT; Andreassen, OA				Tesli, Martin; Kauppi, Karolina; Bettella, Francesco; Brandt, Christine Lycke; Kaufmann, Tobias; Espeseth, Thomas; Mattingsdal, Morten; Agartz, Ingrid; Melle, Ingrid; Djurovic, Srdjan; Westlye, Lars T.; Andreassen, Ole A.			Altered Brain Activation during Emotional Face Processing in Relation to Both Diagnosis and Polygenic Risk of Bipolar Disorder	PLOS ONE			English	Article							PREFRONTAL CORTEX; SCHIZOPHRENIA; AMYGDALA; FMRI; ASSOCIATIONS; METAANALYSIS; RELIABILITY; NETWORKS; CHILDREN; SCALE	Objectives Bipolar disorder (BD) is a highly heritable disorder with polygenic inheritance. Among the most consistent findings from functional magnetic imaging (fMRI) studies are limbic hyper-activation and dorsal hypoactivation. However, the relation between reported brain functional abnormalities and underlying genetic risk remains elusive. This is the first cross-sectional study applying a whole-brain explorative approach to investigate potential influence of BD case-control status and polygenic risk on brain activation. Methods A BD polygenic risk score (PGRS) was estimated from the Psychiatric Genomics Consortium BD case-control study, and assigned to each individual in our independent sample (N=85 BD cases and 121 healthy controls (HC)), all of whom participated in an fMRI emotional faces matching paradigm. Potential differences in BOLD response across diagnostic groups were explored at whole-brain level in addition to amygdala as a region of interest. Putative effects of BD PGRS on brain activation were also investigated. Results At whole-brain level, BD cases presented with significantly lower cuneus/precuneus activation than HC during negative face processing (Z-threshold=2.3 as cluster-level correction). The PGRS was associated positively with increased right inferior frontal gyrus (rIFG) activation during negative face processing. For amygdala activation, there were no correlations with diagnostic status or PGRS. Conclusions These findings are in line with previous reports of reduced precuneus and altered rIFG activation in BD. While these results demonstrate the ability of PGRS to reveal underlying genetic risk of altered brain activation in BD, the lack of convergence of effects at diagnostic and PGRS level suggests that this relation is a complex one.	[Tesli, Martin; Kauppi, Karolina; Bettella, Francesco; Brandt, Christine Lycke; Kaufmann, Tobias; Espeseth, Thomas; Mattingsdal, Morten; Agartz, Ingrid; Melle, Ingrid; Djurovic, Srdjan; Westlye, Lars T.; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Tesli, Martin; Kauppi, Karolina; Bettella, Francesco; Brandt, Christine Lycke; Kaufmann, Tobias; Espeseth, Thomas; Melle, Ingrid; Djurovic, Srdjan; Westlye, Lars T.; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Espeseth, Thomas; Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Mattingsdal, Morten] Sorlandet Hosp HF, Kristiansand, Norway; [Agartz, Ingrid] Karolinska Hosp & Inst, HUBIN Project, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Div Med Genet, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska University Hospital; Diakonhjemmet Hospital; University of Oslo	Tesli, M (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway.	m.s.tesli@medisin.uio.no	Melle, Ingrid S/B-4858-2011; Andreassen, Ole A./AAY-7531-2020; Kaufmann, Tobias/M-8972-2017; Mattingsdal, Morten/Q-9367-2016	Melle, Ingrid S/0000-0002-9783-548X; Kaufmann, Tobias/0000-0002-4003-1018; Mattingsdal, Morten/0000-0003-4440-0324; Westlye, Lars T./0000-0001-8644-956X; Djurovic, Srdjan/0000-0002-8140-8061; Agartz, Ingrid/0000-0002-9839-5391; Kauppi, Karolina/0000-0003-4908-341X	Research Council of Norway [223273]; South East Health Authority [2013-123]; KG Jebsen Foundation	Research Council of Norway(Research Council of Norway); South East Health Authority; KG Jebsen Foundation	This work was supported by the Research Council of Norway (#223273), South East Health Authority (#2013-123), and KG Jebsen Foundation.	Andreassen OA, 2014, SCHIZOPHRENIA BULL, V40, P13, DOI 10.1093/schbul/sbt168; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Brandt CL, 2014, BRIT J PSYCHIAT, V204, P290, DOI 10.1192/bjp.bp.113.129254; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carre JM, 2012, SOC COGN AFFECT NEUR, V7, P213, DOI 10.1093/scan/nsq101; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Engh JA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-71; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Hajek T, 2013, J PSYCHIATR RES, V47, P1955, DOI 10.1016/j.jpsychires.2013.08.015; Hajek T, 2013, BIOL PSYCHIAT, V73, P144, DOI 10.1016/j.biopsych.2012.06.015; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Haxby JV, 2006, NAT NEUROSCI, V9, P1084, DOI 10.1038/nn0906-1084; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; Heinrich A, 2013, BIPOLAR DISORD, V15, P440, DOI 10.1111/bdi.12068; Houenou Josselin, 2012, Front Biosci (Elite Ed), V4, P593; Jogia J, 2011, MOL PSYCHIATR, V16, P1070, DOI 10.1038/mp.2011.49; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Meda SA, 2014, P NATL ACAD SCI USA, V111, pE2066, DOI 10.1073/pnas.1313093111; Ousdal OT, 2012, TWIN RES HUM GENET, V15, P273, DOI 10.1017/thg.2012.5; Pavuluri MN, 2009, J AM ACAD CHILD PSY, V48, P308, DOI 10.1097/CHI.0b013e3181948fc7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rasetti R, 2009, AM J PSYCHIAT, V166, P216, DOI 10.1176/appi.ajp.2008.08020261; Rich BA, 2008, DEV PSYCHOPATHOL, V20, P529, DOI 10.1017/S0954579408000266; Rich BA, 2008, J CHILD PSYCHOL PSYC, V49, P88, DOI 10.1111/j.1469-7610.2007.01819.x; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Tesli M, 2014, ACTA PSYCHIAT SCAND, V130, P311, DOI 10.1111/acps.12307; Tesli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056970; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Wegbreit E, 2014, JAMA PSYCHIAT, V71, P926, DOI 10.1001/jamapsychiatry.2014.660; Wessa M, 2010, MOL PSYCHIATR, V15, P1126, DOI 10.1038/mp.2009.103; Wessa M, 2009, INT REV PSYCHIATR, V21, P357, DOI 10.1080/09540260902962156; Whalley HC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.60; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	42	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134202	10.1371/journal.pone.0134202	http://dx.doi.org/10.1371/journal.pone.0134202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222050	Green Published, gold			2022-12-27	WOS:000358836800113
J	Edmonds, GW; Cote, HCF; Hampson, SE				Edmonds, Grant W.; Cote, Helene C. F.; Hampson, Sarah E.			Childhood Conscientiousness and Leukocyte Telomere Length 40 Years Later in Adult Women-Preliminary Findings of a Prospective Association	PLOS ONE			English	Article							PERSONALITY-TRAITS; ELEMENTARY-SCHOOL; EDUCATIONAL-ATTAINMENT; HEALTH; MORTALITY; LIFE; MIDLIFE; COHORT; MEN; ENVIRONMENTS	Leukocyte telomere length (LTL) shortens with age, and is a prospective marker of mortality related to cardiovascular disease. Many health behaviors and social environmental factors have been found to be associated with LTL. Several of these are also associated with conscientiousness, a dispositional personality trait. Conscientiousness is a propensity to be planful, adhere to social norms, and inhibit pre-potent responses. Like LTL, conscientiousness is prospectively related to mortality, possibly through cumulative effects on health over the life course via multiple pathways. As a result, we hypothesized that childhood levels of conscientiousness would predict LTL prospectively in adulthood. We selected a sample of 60 women in the Hawaii Personality and Health Cohort; 30 described by their teachers as high on conscientiousness in childhood and 30 described as low on the trait. Dried blood spot samples collected in adulthood 40 years later were used as sources of DNA for the LTL assay. Conscientiousness was associated with longer LTL (p=.02). Controlling for age did not account for this association. Controlling for education and physiological dysregulation partially attenuated the association, and the effect remained significant when accounting for differences in LTL across cultural groups. These results represent the first evidence that childhood personality prospectively predicts LTL 40 years later in adulthood. Our findings would be consistent with a mediation hypothesis whereby conscientiousness predicts life paths and trajectories of health that are reflected in rates of LTL erosion across the lifespan.	[Edmonds, Grant W.; Hampson, Sarah E.] Oregon Res Inst, Eugene, OR 97403 USA; [Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	Oregon Research Institute; University of British Columbia	Edmonds, GW (corresponding author), Oregon Res Inst, Eugene, OR 97403 USA.	gedmonds@ori.org			National Institute on Aging, National Institutes of Health [AG020048, R21AG045015]; Oregon Research Institute; NATIONAL INSTITUTE ON AGING [R21AG045015, R01AG020048] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oregon Research Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants AG020048 and R21AG045015 from the National Institute on Aging, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Aging or the National Institutes of Health. Additional support included pilot funds provided by the Oregon Research Institute. These funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler N, 2013, BRAIN BEHAV IMMUN, V27, P15, DOI 10.1016/j.bbi.2012.08.014; Bekaert S, 2005, ANTICANCER RES, V25, P3011; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305; Buchanan T, 2005, EUR J PSYCHOL ASSESS, V21, P115, DOI 10.1027/1015-5759.21.2.115; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chapman Benjamin P, 2011, J Aging Res, V2011, P759170, DOI 10.4061/2011/759170; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Cote HCF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039266; Der G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045166; Eaton NR, 2012, J GERONTOL A-BIOL, V67, P480, DOI 10.1093/gerona/gls090; Edmonds GW, 2013, J RES PERS, V47, P505, DOI 10.1016/j.jrp.2013.05.003; Epel ES, 2009, CURR DIR PSYCHOL SCI, V18, P6, DOI 10.1111/j.1467-8721.2009.01596.x; Epel ES, 2009, AGING-US, V1, P81; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Fjell AM, 2012, P NATL ACAD SCI USA, V109, P19620, DOI 10.1073/pnas.1208243109; Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Goldberg LR, 2001, J PERS, V69, P709, DOI 10.1111/1467-6494.695161; Hagger-Johnson GE, 2001, PERS INDIV DIFFER, V43, P1235; Hampson SE, 2007, HEALTH PSYCHOL, V26, P121, DOI 10.1037/0278-6133.26.1.121; Hampson SE, 2006, J PERS SOC PSYCHOL, V91, P763, DOI 10.1037/0022-3514.91.4.763; Hampson SE, 2013, HEALTH PSYCHOL, V32, P925, DOI 10.1037/a0031655; Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419; Hampson SE, 2001, J RES PERS, V35, P375, DOI 10.1006/jrpe.2001.2317; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Jackson JJ, 2010, J RES PERS, V44, P501, DOI 10.1016/j.jrp.2010.06.005; Jonassaint CR, 2011, INT J BEHAV MED, V18, P13, DOI 10.1007/s12529-009-9069-x; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kern ML, 2008, HEALTH PSYCHOL, V27, P505, DOI 10.1037/0278-6133.27.5.505; Lodi-Smith J, 2010, PSYCHOL HEALTH, V25, P305, DOI 10.1080/08870440902736964; Lonnqvist JE, 2011, EUR J PERSONALITY, V25, P306, DOI 10.1002/per.791; Mather J, 2011, J GERONTOL BIOL SCI, V61, P871; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Mottus R, 2013, PSYCHOSOM MED, V75, P11, DOI 10.1097/PSY.0b013e31827576cc; O'Donovan A, 2012, BRAIN BEHAV IMMUN, V26, P573, DOI 10.1016/j.bbi.2012.01.007; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Sadahiro R, 2014, EUR PSYCHIAT, V30, P187; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Strandberg TE, 2011, J GERONTOL A-BIOL, V66, P815, DOI 10.1093/gerona/glr064; Taylor MD, 2009, PSYCHOSOM MED, V71, P631, DOI 10.1097/PSY.0b013e3181a65298; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Woods SA, 2010, J APPL PSYCHOL, V95, P1045, DOI 10.1037/a0020600; Zanet DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057787	51	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134077	10.1371/journal.pone.0134077	http://dx.doi.org/10.1371/journal.pone.0134077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218760	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900075
J	Falcon-Urrutia, P; Carrasco, CM; Lois, P; Palma, V; Roth, AD				Falcon-Urrutia, Paulina; Carrasco, Carlos M.; Lois, Pablo; Palma, Veronica; Roth, Alejandro D.			Shh Signaling through the Primary Cilium Modulates Rat Oligodendrocyte Differentiation	PLOS ONE			English	Article							SONIC HEDGEHOG; GROWTH-FACTOR; NERVOUS-SYSTEM; CELLS; PRECURSORS; INHIBITORS; REGULATOR; MIGRATION; MYELIN	Primary Cilia (PC) are a very likely place for signal integration where multiple signaling pathways converge. Two major signaling pathways clearly shown to signal through the PC, Sonic Hedgehog (Shh) and PDGF-Ra, are particularly important for the proliferation and differentiation of oligodendrocytes, suggesting that their interaction occurs in or around this organelle. We identified PC in rat oligodendrocyte precursor cells (OPCs) and found that, while easily detectable in early OPCs, PC are lost as these cells progress to terminal differentiation. We confirmed the interaction between these pathways, as cyclopamine inhibition of Hedgehog function impairs both PDGF-mediated OPC proliferation and Shh-dependent cell branching. However, we failed to detect PDGF-Ra localization into the PC. Remarkably, ciliobrevin-mediated disruption of PC and reduction of OPC process extension was counteracted by recombinant Shh treatment, while PDGF had no effect. Therefore, while PDGFR alpha-dependent OPC proliferation and survival most probably does not initiate at the PC, still the integrity of this organelle and cilium-centered pathway is necessary for OPC survival and differentiation.	[Falcon-Urrutia, Paulina; Carrasco, Carlos M.; Lois, Pablo; Palma, Veronica; Roth, Alejandro D.] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Falcon-Urrutia, Paulina; Lois, Pablo; Palma, Veronica] FONDAP Ctr Genome Regulat, Santiago, Chile	Universidad de Chile	Palma, V (corresponding author), Univ Chile, Fac Sci, Dept Biol, Santiago, Chile.	vpalma@uchile.cl; alejroth@u.uchile.cl	Roth, Alejandro D/A-5086-2009	Roth, Alejandro D/0000-0001-5679-8136; Palma, Veronica/0000-0002-4320-7525; Falcon Urrutia, Paulina/0000-0003-4759-8540	Programa de Apoyo a la Investigacion de la Facultad de Ciencias; Fondo Nacional de Ciencia y Tecnologia (FONDECYT) [1140697]; FONDAP CENTER FOR GENOME REGULATION (Fondo Nacional de Desarrollo de Areas Prioritarias)	Programa de Apoyo a la Investigacion de la Facultad de Ciencias; Fondo Nacional de Ciencia y Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP CENTER FOR GENOME REGULATION (Fondo Nacional de Desarrollo de Areas Prioritarias)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was supported by the Programa de Apoyo a la Investigacion de la Facultad de Ciencias (www.ciencias.uchile.cl) to ADR, the Fondo Nacional de Ciencia y Tecnologia (FONDECYT No 1140697; http://www.conicyt.cl/fondecyt/) to VP, and the FONDAP CENTER FOR GENOME REGULATION (Fondo Nacional de Desarrollo de Areas Prioritarias; http://www.conicyt.cl/fondap/) to VP.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cenacchi G, 1996, ULTRASTRUCT PATHOL, V20, P537, DOI 10.3109/01913129609016358; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Espinosa-Jeffrey A, 2009, CURRENT PROTOCOLS ST, V2, P41; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Ichimura K, 2010, CELL TISSUE RES, V341, P197, DOI 10.1007/s00441-010-0983-7; Jain R, 2010, AM J RESP CELL MOL, V43, P731, DOI 10.1165/rcmb.2009-0328OC; Jarjour AA, 2004, NEUROSCIENTIST, V10, P99, DOI 10.1177/1073858403260751; Kim J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104070; Lelievre V, 2006, REGUL PEPTIDES, V137, P58, DOI 10.1016/j.regpep.2006.04.024; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Lunn KF, 1997, J NEUROSCI, V17, P4921; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Martinez C, 2011, J DENT RES, V90, P483, DOI 10.1177/0022034510391797; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Moser JJ, 2010, SEMIN CELL DEV BIOL, V21, P148, DOI 10.1016/j.semcdb.2009.06.006; Murray K, 2002, MOL CELL NEUROSCI, V19, P320, DOI 10.1006/mcne.2001.1079; Nery S, 2001, DEVELOPMENT, V128, P527; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Ortega JA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00254; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sasai N, 2012, WIRES DEV BIOL, V1, P753, DOI 10.1002/wdev.43; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Yoshimura K, 2012, DIFFERENTIATION, V83, pS78, DOI 10.1016/j.diff.2011.10.006	44	22	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133567	10.1371/journal.pone.0133567	http://dx.doi.org/10.1371/journal.pone.0133567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218245	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900036
J	Zhang, MZ; Zhang, Y; Ma, J; Guo, FM; Cao, Q; Zhang, Y; Zhou, B; Chai, JJ; Zhao, WQ; Zhao, RB				Zhang, Meizi; Zhang, Ying; Ma, Jun; Guo, Feima; Cao, Qian; Zhang, Yu; Zhou, Bin; Chai, Jijie; Zhao, Wenqing; Zhao, Renbin			The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CELL MESSENGER-RNA; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ADULT OBESITY; FOOD-INTAKE; 5' TERMINUS; ADIPOGENESIS; N6-METHYLADENOSINE; METHYLATION	FTO (fat mass and obesity associated gene) was genetically identified to be associated with body mass index (BMI), presumably through functional regulation of energy homeostasis. However, the cellular and molecular mechanisms by which FTO functions remain largely unknown. Using 3T3-L1 preadipocyte as a model to study the role of FTO in adipogenesis, we demonstrated that FTO is functionally required for 3T3-L1 differentiation. FTO knock-down with siRNA inhibited preadipocyte differentiation, whereas ectopic overexpression of FTO enhanced the process. The demethylase activity of FTO is required for differentiation. Level of N-6-methyladenosine (m(6)A) is decreased in cells over-expressing FTO. In contrast, overexpression of R96Q, a FTO missense mutant lack of demethylase activity, had no effect on cellular m(6)A level and impeded differentiation. Treatment with Rosiglitazone, a PPAR. agonist, could overcome the differentiation inhibition imposed by R96Q mutant, suggesting the effect of FTO is mediated through PPAR gamma.	[Zhang, Meizi; Zhang, Ying; Ma, Jun; Guo, Feima; Cao, Qian; Zhang, Yu; Zhao, Wenqing; Zhao, Renbin] China Acad Space Technol, Beijing Engn Res Ctr Space Biol, Space Biol Res & Technol Ctr, Beijing 100190, Peoples R China; [Zhou, Bin; Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University	Zhao, RB (corresponding author), China Acad Space Technol, Beijing Engn Res Ctr Space Biol, Space Biol Res & Technol Ctr, Beijing 100190, Peoples R China.	zhaorenbin@tsinghua.org.cn		Chai, Jijie/0000-0001-7591-3873				BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Bravard A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-4; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gan XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074235; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerhold DL, 2002, ENDOCRINOLOGY, V143, P2106, DOI 10.1210/en.143.6.2106; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karra E, 2013, J CLIN INVEST, V123, P3539, DOI 10.1172/JCI44403; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li JJ, 2007, BIOCHEM BIOPH RES CO, V357, P648, DOI 10.1016/j.bbrc.2007.03.184; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Luo WJ, 2008, EXP CELL RES, V314, P3382, DOI 10.1016/j.yexcr.2008.07.003; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Merkestein M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097162; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Muller TD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003223; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Rosen ED, 2000, GENE DEV, V14, P1293; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; SANEYOSHI M, 1969, BIOCHIM BIOPHYS ACTA, V190, P264, DOI 10.1016/0005-2787(69)90078-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Simon R, 2007, CANCER INFORM, V3, P11; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tews D, 2013, ENDOCRINOLOGY, V154, P3141, DOI 10.1210/en.2012-1873; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151	57	66	73	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133788	10.1371/journal.pone.0133788	http://dx.doi.org/10.1371/journal.pone.0133788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218273	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900047
J	Guo, P; Zeng, FF; Hu, XM; Zhang, DM; Zhu, SM; Deng, Y; Hao, YT				Guo, Pi; Zeng, Fangfang; Hu, Xiaomin; Zhang, Dingmei; Zhu, Shuming; Deng, Yu; Hao, Yuantao			Improved Variable Selection Algorithm Using a LASSO-Type Penalty, with an Application to Assessing Hepatitis B Infection Relevant Factors in Community Residents	PLOS ONE			English	Article							VIRUS-INFECTIONS; RISK-FACTORS; CHINA; POPULATION; SHRINKAGE; MODELS; REGRESSION; IMPACT	Objectives In epidemiological studies, it is important to identify independent associations between collective exposures and a health outcome. The current stepwise selection technique ignores stochastic errors and suffers from a lack of stability. The alternative LASSO-penalized regression model can be applied to detect significant predictors from a pool of candidate variables. However, this technique is prone to false positives and tends to create excessive biases. It remains challenging to develop robust variable selection methods and enhance predictability. Material and methods Two improved algorithms denoted the two-stage hybrid and bootstrap ranking procedures, both using a LASSO-type penalty, were developed for epidemiological association analysis. The performance of the proposed procedures and other methods including conventional LASSO, Bolasso, stepwise and stability selection models were evaluated using intensive simulation. In addition, methods were compared by using an empirical analysis based on large-scale survey data of hepatitis B infection-relevant factors among Guangdong residents. Results The proposed procedures produced comparable or less biased selection results when compared to conventional variable selection models. In total, the two newly proposed procedures were stable with respect to various scenarios of simulation, demonstrating a higher power and a lower false positive rate during variable selection than the compared methods. In empirical analysis, the proposed procedures yielding a sparse set of hepatitis B infection-relevant factors gave the best predictive performance and showed that the procedures were able to select a more stringent set of factors. The individual history of hepatitis B vaccination, family and individual history of hepatitis B infection were associated with hepatitis B infection in the studied residents according to the proposed procedures. Conclusions The newly proposed procedures improve the identification of significant variables and enable us to derive a new insight into epidemiological association analysis.	[Guo, Pi; Zeng, Fangfang; Hu, Xiaomin; Zhang, Dingmei; Zhu, Shuming; Deng, Yu; Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China; [Guo, Pi; Zeng, Fangfang; Hu, Xiaomin; Zhang, Dingmei; Zhu, Shuming; Deng, Yu; Hao, Yuantao] Sun Yat Sen Univ, Sch Publ Hlth, Hlth Informat Res Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Guo, Pi; Zeng, Fangfang; Hu, Xiaomin; Zhang, Dingmei; Zhu, Shuming; Deng, Yu; Hao, Yuantao] Sun Yat Sen Univ, Guangdong Key Lab Med, Lab Hlth Informat, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Hao, YT (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China.	haoyt@mail.sysu.edu.cn	Zhang, Dingmei/ABC-7476-2020; Hu, Xiaomin/GRY-1539-2022		National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX10004902, 2013ZX10004901]	National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2012ZX10004902, 2013ZX10004901). HYT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Avalos M, 2012, EPIDEMIOLOGY, V23, P706, DOI 10.1097/EDE.0b013e31825fa528; Bach FR., 2008, P 25 INT C MACHINE L, V33, P40, DOI [10.1145/1390156.1390161, DOI 10.1145/1390156.1390161]; Bach FR, 2008, J MACH LEARN RES, V9, P1179; Breiman L, 1996, ANN STAT, V24, P2350; Chen QX, 2013, STAT MED, V32, P3646, DOI 10.1002/sim.5783; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Galar M, 2012, IEEE T SYST MAN CY C, V42, P463, DOI 10.1109/TSMCC.2011.2161285; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; Greenland S, 2008, AM J EPIDEMIOL, V167, P523, DOI 10.1093/aje/kwm355; Guo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105470; Guo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100052; Guo P, 2014, GENOMICS, V103, P48, DOI 10.1016/j.ygeno.2013.11.001; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hesterberg T, 2008, STAT SURV, V2, P61, DOI 10.1214/08-SS035; Huang J, 2008, 392 U IOW; Kredler C, 1982, COMPSTAT 1982 5 S HE, P294; Leng CL, 2006, STAT SINICA, V16, P1273; Li XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-272; Luo ZB, 2012, INT J INFECT DIS, V16, pE82, DOI 10.1016/j.ijid.2011.10.009; Mansiaux Y, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-99; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Muggeo VMR, 2011, BIOINFORMATICS, V27, P161, DOI 10.1093/bioinformatics/btq647; Qian J, 2014, BIOMETRICS, V70, P153, DOI 10.1111/biom.12113; R Core Team, 2021, R LANGUAGE ENV STAT; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sabbe N, 2013, STAT MED, V32, P3143, DOI 10.1002/sim.5760; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Toh S, 2013, EPIDEMIOLOGY, V24, P349, DOI [10.1097/EDE.0b013e3182a71390, 10.1097/EDE.0b013e31828ac65e]; Walter S, 2009, EUR J EPIDEMIOL, V24, P733, DOI 10.1007/s10654-009-9411-2; Wang D, 2011, J AGR BIOL ENVIR ST, V16, P170, DOI 10.1007/s13253-010-0046-2; Wang SJ, 2011, ANN APPL STAT, V5, P468, DOI 10.1214/10-AOAS377; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Xia X, 2008, EPIDEMIOLOGY, V19, pS237; Zhang CY, 2013, BIOSCI TRENDS, V7, P7, DOI 10.5582/bst.2013.v7.1.7; Zhang H, 2011, INT J MED SCI, V8, P321, DOI 10.7150/ijms.8.321; Zhou XH, 2012, STAT MED, V31, P628, DOI 10.1002/sim.3980; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	43	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134151	10.1371/journal.pone.0134151	http://dx.doi.org/10.1371/journal.pone.0134151			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214802	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300053
J	Hanafi, NS; Abdullah, A; Lee, PY; Liew, SM; Chia, YC; Khoo, EM				Hanafi, Nik Sherina; Abdullah, Adina; Lee, Ping Yein; Liew, Su May; Chia, Yook Chin; Khoo, Ee Ming			Personal Continuity of Care in a University-Based Primary Care Practice: Impact on Blood Pressure Control	PLOS ONE			English	Article							GENERAL-PRACTICE; PATIENT SATISFACTION; PROVIDER CONTINUITY; DIABETES-MELLITUS; HYPERTENSION; OUTCOMES	Continuity of care is an important quality outcome of patient care. This study aimed to investigate the relationship between personal continuity and blood pressure (BP) control among the patients with hypertension in an academic primary care centre. Between January and May 2012, we conducted a retrospective review of medical records of patients with hypertension who had been followed up for at least 1 year in the Primary Care Clinic, University of Malaya Medical Centre, Malaysia. In this setting, doctors who provided care for hypertension included postgraduate family medicine trainees, non-trainee doctors and academic staff. Systematic random sampling (1: 4) was used for patient selection. BP control was defined as less than 130/80 mm Hg for patients with diabetes mellitus, proteinuria and chronic kidney disease and less than 140/90 mm Hg for all other patients. Continuity of care was assessed using the usual provider continuity index (UPCI), which is the ratio of patient visits to the usual provider to the total number of visits to all providers in 1 year. A UPC index of zero denotes no continuity while an index of one reflects perfect continuity with only the usual provider. We reviewed a total of 1060 medical records. The patients' mean age was 62.0 years (SD 10.4). The majority was women (59.2%) and married (85.7%). The mean number of visits in a year was 3.85 (SD 1.36). A total of 72 doctors had provided consultations (55 postgraduate family medicine trainees, 8 non-trainee doctors and 9 academic staff). The mean UPCI was 0.43 (SD 0.34). Target BP was achieved in 42% of the patients. There was no significant relationship between BP control and personal continuity after adjustment for total number of visits. Continuity of care was not associated with BP control in our centre. Further studies are needed to explore the reasons for this.	[Hanafi, Nik Sherina; Abdullah, Adina; Liew, Su May; Chia, Yook Chin; Khoo, Ee Ming] Univ Malaya, Fac Med, Dept Primary Care Med, UMPCRG, Kuala Lumpur, Malaysia; [Lee, Ping Yein] Univ Putra Malaysia, Dept Family Med, Serdang 43400, Malaysia	Universiti Malaya; Universiti Putra Malaysia	Hanafi, NS (corresponding author), Univ Malaya, Fac Med, Dept Primary Care Med, UMPCRG, Kuala Lumpur, Malaysia.	sherina@ummc.edu.my	Chin, Chia Yook/B-8379-2010; Chia, Yook Chin/L-2977-2019; Lee, Ping Yein/C-1923-2012; LIEW, Su May/B-8852-2010; Abdullah, Adina/J-1647-2012; Hanafi, Nik Sherina/B-9250-2010; KHOO, EE MING/B-8785-2010; abdullah, adina/E-1052-2014	Chin, Chia Yook/0000-0003-1995-0359; Lee, Ping Yein/0000-0002-0912-6043; LIEW, Su May/0000-0003-2865-7955; Abdullah, Adina/0000-0003-1545-7110; Hanafi, Nik Sherina/0000-0001-9140-0955; KHOO, EE MING/0000-0003-3191-1264; 	University of Malaya [UMRG RG335/11HTM, UMRG RG513/13HTM]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya (UMRG RG335/11HTM, UMRG RG513/13HTM) http://umresearch.um.edu.my/mainpage. php?module=Maklumat&kategori=86&id=62&papar=1 to EMK, SML, PYL, NSH, AA, and YCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agarwal G, 2008, BRIT J GEN PRACT, V58, P784, DOI 10.3399/bjgp08X342624; BAKER R, 1995, BRIT J GEN PRACT, V45, P654; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P205, DOI 10.2105/AJPH.64.3.205; BLANKFIELD RP, 1990, J FAM PRACTICE, V31, P69; BRESLAU N, 1976, J HEALTH SOC BEHAV, V17, P339, DOI 10.2307/2136712; ETTLINGER PRA, 1981, BRIT MED J, V282, P1192, DOI 10.1136/bmj.282.6271.1192; Fisher M, 2007, ETHNIC DIS, V17, P693; Gulliford MC, 2007, FAM PRACT, V24, P245, DOI 10.1093/fampra/cmm014; Guthrie B, 2000, BRIT MED J, V321, P734, DOI 10.1136/bmj.321.7263.734; Hennen B K, 1975, J Fam Pract, V2, P371; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Hong JS, 2010, J KOREAN MED SCI, V25, P1259, DOI 10.3346/jkms.2010.25.9.1259; Institute for Public Health, 2008, 3 NAT HLTH MORB SURV; Kementerian Kesihatan Malaysia, 2018, CLIN PRACTICE GUIDEL, V5th Edition; Khoo EM, 1998, ASIA-PAC J PUBLIC HE, V10, P81; Konrad TR, 2005, AM J PUBLIC HEALTH, V95, P2186, DOI 10.2105/AJPH.2004.046177; Koopman RJ, 2003, ARCH INTERN MED, V163, P1357, DOI 10.1001/archinte.163.11.1357; McWhinney I R, 1975, J Fam Pract, V2, P373; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; PHILLIPS DM, 1984, J FAM PRACTICE, V19, P793; Salzman BE, 2007, INTERNET J FAM PRACT, V5; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Sherina HN., 2003, ASIA PAC FAM MED, V2, P10, DOI [10.1046/j.1444-1683.2003.00044.x, DOI 10.1046/J.1444-1683.2003.00044.X]; STEINWACHS DM, 1979, MED CARE, V17, P551, DOI 10.1097/00005650-197906000-00001; Uijen AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042256; Uijen AA, 2012, FAM PRACT, V29, P264, DOI 10.1093/fampra/cmr104	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134030	10.1371/journal.pone.0134030	http://dx.doi.org/10.1371/journal.pone.0134030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7DN	26214304	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300043
J	Piper, BJ; Telku, HM; Lambert, DA				Piper, Brian J.; Telku, Hassenet M.; Lambert, Drew A.			A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks	PLOS ONE			English	Article							CLINICAL-TRIALS; DISCLOSURES; OUTCOMES; PUBLICATIONS; ASSOCIATION; PAYMENTS	Background Disclosure of potential conflicts of interest (CoI) is a standard practice for many biomedical journals but not for educational materials. The goal of this investigation was to determine whether the authors of pharmacology textbooks have undisclosed financial CoIs and to identify author characteristics associated with CoIs. Methods and Findings The presence of potential CoIs was evaluated by submitting author names (N = 403; 36.3% female) to a patent database (Google Scholar) as well as a database that reports on the compensation ($USD) received from 15 pharmaceutical companies (ProPublica's Dollars for Docs). All publications (N = 410) of the ten highest compensated authors from 2009 to 2013 and indexed in Pubmed were also examined for disclosure of additional companies that the authors received research support, consulted, or served on speaker's bureaus. A total of 134 patents had been awarded (Maximum = 18/author) to textbook authors. Relative to DiPiro's Pharmacotherapy: A Pathophysiologic Approach, contributors to Goodman and Gilman's Pharmacological Basis of Therapeutics and Katzung's Basic and Clinical Pharmacology were more frequently patent holders (OR = 6.45, P < .0005). Female authors were less likely than males to have >1 patent (OR = 0.15, P < .0005). A total of $2,411,080 USD (28.3% for speaking, 27.0% for consulting, and 23.9% for research), was received by 53 authors (Range = $299 to $310,000/author). Highly compensated authors were from multiple fields including oncology, psychiatry, neurology, and urology. The maximum number of additional companies, not currently indexed in the Dollars for Docs database, for which an author had potential CoIs was 73. Conclusions Financial CoIs are common among the authors of pharmacology and pharmacotherapy textbooks. Full transparency of potential CoIs, particularly patents, should become standard procedure for future editions of educational materials in pharmacology.	[Piper, Brian J.] Husson Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Bangor, ME 04401 USA; [Telku, Hassenet M.; Lambert, Drew A.] Husson Univ, Sch Pharm, Dept Pharm Practice, Bangor, ME 04401 USA		Piper, BJ (corresponding author), Bowdoin Coll, Brunswick, ME 04011 USA.	psy391@gmail.com						Brignardello-Petersen R, 2013, J AM DENT ASSOC, V144, P1165, DOI 10.14219/jada.archive.2013.0035; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Carpenter D, 2011, JAMA-J AM MED ASSOC, V305, P2007, DOI 10.1001/jama.2011.651; Chisholm-Burns M., 2013, PHARMACOTHERAPY PRIN; Companies Making Payments, 2015, COMP MAK PAYM; Cosgrove L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001190; DiPiro JT, 2014, PATHOPHYSIOLOGY PATH, V9th; Djubegovic B, 2000, LANCET, V356, P635; Drazen JM, 2010, NEW ENGL J MED, V363, P188, DOI 10.1056/NEJMe1006030; Goldcare B., 2012, BAD PHARMA DRUG COMP; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Hastings RC, 1996, JAMA-J AM MED ASSOC, V276, P99; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Jagsi R, 2009, CANCER-AM CANCER SOC, V115, P2783, DOI 10.1002/cncr.24315; Katzung B, 2013, BASIC CLIN PHARM; Kelly RE, 2006, PSYCHOL MED, V36, P1647, DOI 10.1017/S0033291706008567; Kesselheim AS, 2012, CANCER-AM CANCER SOC, V118, P188, DOI 10.1002/cncr.26237; Moy B, 2008, ONCOLOGIST, V13, P474, DOI 10.1634/theoncologist.2008-0098; Norris SL, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-24; Peppercorn J, 2007, CANCER-AM CANCER SOC, V109, P1239, DOI 10.1002/cncr.22528; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Rang H., 2011, RANG DALES PHARM; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Saver RS, 2014, CHEST, V145, P379, DOI 10.1378/chest.13-1719; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Siwek J, 2014, AM FAM PHYSICIAN, V89, P161; Stahl S, 2019, STAHLS ESSENTIAL PSY, V4th; Thacker P., 2009, FORBES; Weinfurt KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002128	29	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133261	10.1371/journal.pone.0133261	http://dx.doi.org/10.1371/journal.pone.0133261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214515	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300016
J	Clerencia-Sierra, M; Calderon-Larranaga, A; Martinez-Velilla, N; Vergara-Mitxeltorena, I; Aldaz-Herce, P; Poblador-Plou, B; Machon-Sobrado, M; Egues-Olazabal, N; Abellan-van Kan, G; Prados-Torres, A				Clerencia-Sierra, Mercedes; Calderon-Larranaga, Amaia; Martinez-Velilla, Nicolas; Vergara-Mitxeltorena, Itziar; Aldaz-Herce, Pablo; Poblador-Plou, Beatriz; Machon-Sobrado, Monica; Eguees-Olazabal, Nerea; Abellan-van Kan, Gabor; Prados-Torres, Alexandra			Multimorbidity Patterns in Hospitalized Older Patients: Associations among Chronic Diseases and Geriatric Syndromes	PLOS ONE			English	Article							HEALTH-SERVICES; RISK-FACTORS; FALLS; COMMUNITY; COMORBIDITY; DISABILITY; ADULTS; CARE; METAANALYSIS; POPULATION	Background/Objectives The clinical status of older individuals with multimorbidity can be further complicated by concomitant geriatric syndromes. This study explores multimorbidity patterns, encompassing both chronic diseases and geriatric syndromes, in geriatric patients attended in an acute hospital setting. Design Retrospective observational study. Setting Unit of Social and Clinical Assessment (UVSS), Miguel Servet University Hospital (HUMS), Zaragoza (Spain). Year, 2011. Participants A total of 924 hospitalized patients aged 65 years or older. Measurements Data on patients' clinical, functional, cognitive and social statuses were gathered through comprehensive geriatric assessments. To identify diseases and/or geriatric syndromes that cluster into patterns, an exploratory factor analysis was applied, stratifying by sex. The factors can be interpreted as multimorbidity patterns, i.e., diseases non-randomly associated with each other within the study population. The resulting patterns were clinically assessed by several physicians. Results The mean age of the study population was 82.1 years (SD 7.2). Multimorbidity burden was lower in men under 80 years, but increased in those over 80. Immobility, urinary incontinence, hypertension, falls, dementia, cognitive decline, diabetes and arrhythmia were among the 10 most frequent health problems in both sexes, with prevalence rates above 20%. Four multimorbidity patterns were identified that were present in both sexes: Cardiovascular, Induced Dependency, Falls and Osteoarticular. The number of conditions comprising these patterns was similar in men and women. Conclusion The existence of specific multimorbidity patterns in geriatric patients, such as the Induced Dependency and Falls patterns, may facilitate the early detection of vulnerability to stressors, thus helping to avoid negative health outcomes such as functional disability.	[Clerencia-Sierra, Mercedes] Miguel Servet Univ Hosp, Unit Social & Clin Assessment UVSS, Zaragoza, Spain; [Clerencia-Sierra, Mercedes; Calderon-Larranaga, Amaia; Poblador-Plou, Beatriz; Prados-Torres, Alexandra] Miguel Servet Univ Hosp, IIS Aragon, EpiChron Res Grp Chron Dis, Aragon Hlth Sci Inst IACS, Zaragoza, Spain; [Calderon-Larranaga, Amaia; Martinez-Velilla, Nicolas; Vergara-Mitxeltorena, Itziar; Poblador-Plou, Beatriz; Machon-Sobrado, Monica; Prados-Torres, Alexandra] Res Network Hlth Serv Chron Dis REDISSEC, Madrid, Spain; [Martinez-Velilla, Nicolas] Navarra Hlth Serv Osasunbidea, Geriatr Serv, Pamplona, Spain; [Vergara-Mitxeltorena, Itziar; Machon-Sobrado, Monica; Eguees-Olazabal, Nerea] IIS Biodonostia, Res Unit AP OSIS Gipuzkoa, San Sebastian, Spain; [Aldaz-Herce, Pablo] Navarra Hlth Serv Osasunbidea, San Juan Hlth Ctr, Pamplona, Spain; [Abellan-van Kan, Gabor] CHU Toulouse Purpan, Dept Geriatr Med, Gerontopole Toulouse, Frailty Day Hosp, Toulouse, France	Miguel Servet University Hospital; Miguel Servet University Hospital; Instituto de Investigacion Sanitaria Biodonostia; CHU de Toulouse	Calderon-Larranaga, A (corresponding author), Miguel Servet Univ Hosp, IIS Aragon, EpiChron Res Grp Chron Dis, Aragon Hlth Sci Inst IACS, Zaragoza, Spain.	acalderon.iacs@aragon.es	Poblador-Plou, Beatriz/ABC-7915-2020; Martinez-Velilla, Nicolas/A-6942-2017; Calderón-Larrañaga, Amaia/ABC-6828-2021; Prados-Torres, Alexandra/P-5818-2017	Poblador-Plou, Beatriz/0000-0002-5119-5093; Martinez-Velilla, Nicolas/0000-0001-9576-9960; Calderón-Larrañaga, Amaia/0000-0001-9064-9222; Prados-Torres, Alexandra/0000-0002-5704-6056	Trans-Pyrenean Biomedical Research Network (REFBIO) [REFBIO13/BIOD/002]	Trans-Pyrenean Biomedical Research Network (REFBIO)	This project has been funded by the Trans-Pyrenean Biomedical Research Network (REFBIO) for the establishment of a network of stable collaboration among biomedical research centers in the Pyrenees Area (European Program INTERREG IV POCTEFA-A; File: REFBIO13/BIOD/002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 2014, EUR UROL, V65, P565, DOI 10.1016/j.eururo.2013.10.032; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bardales MY, 2012, REV ESP GERIATR GERO, V47, P220, DOI [10.1016/j.regg.2012.02.014, DOI 10.1016/J.REGG.2012.02.014]; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2011, J AM GERIATR SOC, V59, P797, DOI 10.1111/j.1532-5415.2011.03391.x; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Defloor T, 2005, J WOUND OSTOMY CONT, V32, P302, DOI 10.1097/00152192-200509000-00006; Dodge HH, 2005, GERONTOLOGIST, V45, P222, DOI 10.1093/geront/45.2.222; Donald RP, 1985, FACTOR ANAL RELATED; Dong HJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-120; Formiga F, 2013, EUR J INTERN MED, V24, P40, DOI 10.1016/j.ejim.2012.11.003; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Guillen Llera F, 1972, REV ESP GERIATR GERO, V7, P339; Harwood RH, 2001, AGE AGEING, V30, P13, DOI 10.1093/ageing/30.suppl_4.13; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; John R, 2003, GERONTOLOGIST, V43, P649, DOI 10.1093/geront/43.5.649; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Konecny T, 2014, AM J CARDIOL, V114, P272, DOI 10.1016/j.amjcard.2014.04.030; Kubinger K., 2003, PSYCHOL SCI, V45, P106, DOI DOI 10.1177/014662169101500105; Kvelde T, 2013, J AM GERIATR SOC, V61, P694, DOI 10.1111/jgs.12209; Lafont C, 2011, J NUTR HEALTH AGING, V15, P645, DOI 10.1007/s12603-011-0335-7; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Lyles KW, 2001, J AM GERIATR SOC, V49, P827; MAHONEY F I, 1965, Md State Med J, V14, P61; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Montalvo JIG., 2008, REV ESP GERIATR GERO, V43, P316, DOI 10.1016/S0211-139X(08)73574-1; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; Multimorbidity. AGSEPotCoOAw, 2012, J AM GERIATR SOC, V60, P1957, DOI DOI 10.1111/J.1532-5415.2012.04187.X; Pagliarulo V, 2012, EUR UROL, V61, P11, DOI 10.1016/j.eururo.2011.08.026; Papaleontiou M, 2010, J AM GERIATR SOC, V58, P1353, DOI 10.1111/j.1532-5415.2010.02920.x; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Safford MM, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-007-0307-0; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Sociedad Espanola de Geriatria y Gerontologia SEdR, 2008, GUIA BUEN PRACT CLIN; Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; World Health Organization, 2007, MAGN FALLS WORLDW OV	49	52	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132909	10.1371/journal.pone.0132909	http://dx.doi.org/10.1371/journal.pone.0132909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208112	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000044
J	Cymerman, IA; Gozdz, A; Urbanska, M; Milek, J; Dziembowska, M; Jaworski, J				Cymerman, Iwona A.; Gozdz, Agata; Urbanska, Malgorzata; Milek, Jacek; Dziembowska, Magdalena; Jaworski, Jacek			Structural Plasticity of Dendritic Spines Requires GSK3 alpha and GSK3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; LONG-TERM DEPRESSION; CELL-PROLIFERATION; KINASE 3; TRAFFICKING; HIPPOCAMPUS; GSK-3-BETA; RECEPTORS; MIGRATION; MICE	Although memories appear to be elusive phenomena, they are stored in the network of physical connections between neurons. Dendritic spines, which are actin-rich dendritic protrusions, serve as the contact points between networked neurons. The spines' shape contributes to the strength of signal transmission. To acquire and store information, dendritic spines must remain plastic, i.e., able to respond to signals, by changing their shape. We asked whether glycogen synthase kinase (GSK) 3 alpha and GSK3 beta, which are implicated in diseases with neuropsychiatric symptoms, such as Alzheimer's disease, bipolar disease and schizophrenia, play a role in a spine structural plasticity. We used Latrunculin B, an actin polymerization inhibitor, and chemically induced Long-Term Depression to trigger fast spine shape remodeling in cultured hippocampal neurons. Spine shrinkage induced by either stimulus required GSK3 alpha activity. GSK3 beta activity was only important for spine structural changes after treatment with Latrunculin B. Our results indicate that GSK3 alpha is an essential component for short-term spine structural plasticity. This specific function should be considered in future studies of neurodegenerative diseases and neuropsychiatric conditions that originate from suboptimal levels of GSK3 alpha/beta activity.	[Cymerman, Iwona A.; Gozdz, Agata; Urbanska, Malgorzata; Jaworski, Jacek] Int Inst Mol & Cell Biol, Warsaw, Poland; [Milek, Jacek; Dziembowska, Magdalena] Nencki Inst, Neurobiol Lab, Warsaw, Poland; [Milek, Jacek; Dziembowska, Magdalena] Univ Warsaw, Ctr New Technol, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; University of Warsaw	Cymerman, IA (corresponding author), Int Inst Mol & Cell Biol, Warsaw, Poland.	icymerman@iimcb.gov.pl; jaworski@iimcb.gov.pl	Gozdz, Agata/AAD-2974-2022	Gozdz, Agata/0000-0001-8421-0598; Jaworski, Jacek/0000-0001-8760-7865; Urbanska, Malgorzata/0000-0001-9521-0366; Dziembowska, Magdalena/0000-0002-0650-6438	Polish National Science Centre [2011/01/M/NZ3/05413, 2011/01/B/NZ3/05397, 2011/01/N/NZ3/05409]; NCRD [ERA-NET NEURON/06/2011]; FP7 European Union grant [223276]; Foundation for Polish Science	Polish National Science Centre; NCRD; FP7 European Union grant; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This research was supported by the Polish National Science Centre-(http://www.ncn.gov.pl/) (2011/01/M/NZ3/05413, 2011/01/B/NZ3/05397 and 2011/01/N/NZ3/05409), ERA-NET NEURON/06/2011- (http://www.neuron-eranet.eu) (co-financed by NCRD) and FP7 European Union grant (#223276, "NeuroGSK3"). JJ is a recipient of "Mistrz" Professorial subsidy from the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Calabrese B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094787; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Gillespie JR, 2011, ENDOCRINOLOGY, V152, P1755, DOI 10.1210/en.2010-1412; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang W, 2008, J BIOL CHEM, V283, P20978, DOI 10.1074/jbc.M802588200; Kaidanovich-Beilin O, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00048; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lo Monte F, 2012, J MED CHEM, V55, P4407, DOI 10.1021/jm300309a; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Maurin H, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-27; Nelson CD, 2013, J NEUROSCI, V33, P12122, DOI 10.1523/JNEUROSCI.0131-13.2013; Ochs SM, 2015, MOL PSYCHIATR, V20, P482, DOI 10.1038/mp.2014.55; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Shahab L, 2014, HIPPOCAMPUS, V24, P1413, DOI 10.1002/hipo.22362; Shin S, 2014, ONCOGENE, V33, P1690, DOI 10.1038/onc.2013.113; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Steuber-Buchberger P, 2008, GENESIS, V46, P144, DOI 10.1002/dvg.20376; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134018	10.1371/journal.pone.0134018	http://dx.doi.org/10.1371/journal.pone.0134018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207897	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000192
J	Fukuda, H; Shimizu, S; Ishizaki, T				Fukuda, Haruhisa; Shimizu, Sayuri; Ishizaki, Tatsuro			Has the Reform of the Japanese Healthcare Provision System Improved the Value in Healthcare? A Cost-Consequence Analysis of Organized Care for Hip Fracture Patients	PLOS ONE			English	Article							HEART-FAILURE; TRANSITIONAL CARE; RANDOMIZED-TRIAL; INTERVENTION; PROGRAM	Objectives To assess the value of organized care by comparing the clinical outcomes and healthcare expenditure between the conventional Japanese "integrated care across specialties within one hospital" mode of providing healthcare and the prospective approach of "organized care across separate facilities within a community". Design Retrospective cohort study. Setting Two groups of hospitals were categorized according to healthcare delivery approach: the first group included 3 hospitals autonomously providing integrated care across specialties, and the second group included 4 acute care hospitals and 7 rehabilitative care hospitals providing organized care across separate facilities. Participants Patients aged 65 years and above who had undergone hip fracture surgery. Measurements Regression models adjusting for patient characteristics and clinical variables were used to investigate the impact of organized care on the improvements to the mobility capability of patients before and after hospitalization and the differences in healthcare resource utilization. Results The sample for analysis included 837 hip fracture surgery cases. The proportion of patients with either unchanged or improved mobility capability was not statistically associated with the healthcare delivery approaches. Total adjusted mean healthcare expenditure for integrated care and organized care were US$28,360 (95% confidence interval: 27,787-28,972) and US$21,951 (21,511-22,420), respectively, indicating an average increase of US$6,409 in organized care. Conclusion Our cost-consequence analysis underscores the need to further investigate the actual contribution of organized care to the provision of efficient and high-quality healthcare.	[Fukuda, Haruhisa] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 812, Japan; [Shimizu, Sayuri] Inst Hlth Econ & Policy, Tokyo, Japan; [Ishizaki, Tatsuro] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan	Kyushu University; Tokyo Metropolitan Institute of Gerontology	Fukuda, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka 812, Japan.	h_fukuda@hcam.med.kyushu-u.ac.jp			JSPS KAKENHI Grant [25713029]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was conducted as part of a research project in the Institute for Health Economics and Policy, and was supported by JSPS KAKENHI Grant Number 25713029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell H, 1998, BMJ-BRIT MED J, V316, P133; Coleman EA, 2003, J AM GERIATR SOC, V51, P556, DOI 10.1046/j.1532-5415.2003.51186.x; Daly BJ, 2005, CHEST, V128, P507, DOI 10.1378/chest.128.2.507; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Ministry of Health Labour and Welfare, PROP REF HEALTHC SYS; Ministry of Health Labour and Welfare, FUND CONC GUID REF H; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; OECD, 2011, HLTH GLANC 2011 OECD, DOI DOI 10.1787/HEALTH_GLANCE-2011-EN/; Office of the Prime Minister, REGARDING THE SOCIAL; Office of the Prime Minister, REG FUND POL STRUCT; Parry Carla, 2009, Home Health Care Serv Q, V28, P84, DOI 10.1080/01621420903155924; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Shervin N, 2007, CLIN ORTHOP RELAT R, V457, P5; Wakefield BJ, 2008, TELEMED J E-HEALTH, V14, P753, DOI 10.1089/tmj.2007.0131	16	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133694	10.1371/journal.pone.0133694	http://dx.doi.org/10.1371/journal.pone.0133694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208322	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000117
J	Orly, G; Manor, U; Gov, NS				Orly, Gilad; Manor, Uri; Gov, Nir S.			A Biophysical Model for the Staircase Geometry of Stereocilia	PLOS ONE			English	Article							HAIR-CELLS; ACTIN-FILAMENTS; BIRD COCHLEA; MECHANOELECTRICAL TRANSDUCTION; LOCALIZATION; ELONGATION; DYNAMICS; ESPIN; CHANNELS; ROOTLETS	Cochlear hair cell bundles, made up of 10s to 100s of individual stereocilia, are essential for hearing, and even relatively minor structural changes, due to mutations or injuries, can result in total deafness. Consistent with its specialized role, the staircase geometry (SCG) of hair cell bundles presents one of the most striking, intricate, and precise organizations of actin-based cellular shapes. Composed of rows of actin-filled stereocilia with increasing lengths, the hair cell's staircase-shaped bundle is formed from a progenitor field of smaller, thinner, and uniformly spaced microvilli with relatively invariant lengths. While recent genetic studies have provided a significant increase in information on the multitude of stereocilia protein components, there is currently no model that integrates the basic physical forces and biochemical processes necessary to explain the emergence of the SCG. We propose such a model derived from the biophysical and biochemical characteristics of actin-based protrusions. We demonstrate that polarization of the cell's apical surface, due to the lateral polarization of the entire epithelial layer, plays a key role in promoting SCG formation. Furthermore, our model explains many distinct features of the manifestations of SCG in different species and in the presence of various deafness-associated mutations.	[Orly, Gilad; Gov, Nir S.] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Manor, Uri] NIH, Sect Organelle Biol, Bethesda, MD 20892 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA	Gov, NS (corresponding author), Weizmann Inst Sci, Dept Chem Phys, POB 26, IL-76100 Rehovot, Israel.	nir.gov@weizmann.ac.il	GOV, NIR/K-1415-2012	GOV, NIR/0000-0001-7774-1139; Manor, Uri/0000-0002-9802-1955				Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Bashtanov ME, 2004, J PHYSIOL-LONDON, V559, P287, DOI 10.1113/jphysiol.2004.065565; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Ben Isaac E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022718; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chou SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014807; Fettiplace R, 2014, PHYSIOL REV, V94, P951, DOI 10.1152/physrev.00038.2013; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Gov NS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.018101; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; Hudspeth AJ, 2014, NAT REV NEUROSCI, V15, P600, DOI 10.1038/nrn3786; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Jacobo A, 2014, P NATL ACAD SCI USA; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; Manor U, 2011, CURR BIOL, V21, P167, DOI 10.1016/j.cub.2010.12.046; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Mburu P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011627; Mogensen MM, 2007, CELL MOTIL CYTOSKEL, V64, P496, DOI 10.1002/cm.20199; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Naoz M, 2008, BIOPHYS J, V95, P5706, DOI 10.1529/biophysj.108.143453; Nin F, 2012, P NATL ACAD SCI USA, V109, P21076, DOI 10.1073/pnas.1219379110; Orly G, 2014, BIOPHYS J, V107, P576, DOI 10.1016/j.bpj.2014.05.040; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; TILNEY LG, 1988, J CELL BIOL, V107, P2563, DOI 10.1083/jcb.107.6.2563; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; TILNEY LG, 1986, DEV BIOL, V116, P100, DOI 10.1016/0012-1606(86)90047-3; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Zampini V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001048; Zhuravlev PI, 2012, P NATL ACAD SCI USA, V109, P10849, DOI 10.1073/pnas.1200160109	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0127926	10.1371/journal.pone.0127926	http://dx.doi.org/10.1371/journal.pone.0127926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207893	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000002
J	Peron, G; Altwegg, R				Peron, Guillaume; Altwegg, Res			Departures from the Energy-Biodiversity Relationship in South African Passerines: Are the Legacies of Past Climates Mediated by Behavioral Constraints on Dispersal?	PLOS ONE			English	Article							GEOGRAPHICAL PATTERNS; SPECIES DISTRIBUTION; DIVERSITY PATTERNS; POTENTIAL IMPACTS; OCCUPANCY MODELS; TECTONIC UPLIFT; EVOLUTION; COMMUNITY; DISTRIBUTIONS; ORIGINS	Legacies of paleoclimates in contemporary biodiversity patterns have mostly been investigated with global datasets, or with weakly dispersive organisms, and as a consequence been interpreted in terms of geographical or physical constraints. If paleoclimatic legacies also occurred at the regional scale in the distributions of vagile organisms within biomes, they would rather suggest behavioral constraints on dispersal, i.e., philopatric syndromes. We examined 1) the residuals of the regression between contemporary energy and passerine species richness in South African biomes and 2) phylogenetic dispersion of passerine assemblages, using occupancy models and quarter-degree resolution citizen science data. We found a northeast to southwest gradient within mesic biomes congruent with the location of Quaternary mesic refugia, overall suggesting that as distance from refugia increased, more clades were lacking from local assemblages. A similar but weaker pattern was detected in the arid Karoo Biomes. In mobile organisms such as birds, behavioral constraints on dispersal appear strong enough to influence species distributions thousands of years after historical range contractions.	[Peron, Guillaume; Altwegg, Res] Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7701 Cape Town, South Africa; [Altwegg, Res] Univ Cape Town, African Climate & Dev Initiat, ZA-7701 Rondebosch, South Africa	University of Cape Town; University of Cape Town	Altwegg, R (corresponding author), Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7701 Cape Town, South Africa.	res.altwegg@gmail.com	PERON, Guillaume/C-5379-2013	PERON, Guillaume/0000-0002-6311-4377	National Research Foundation of South Africa [85802]; South African National Biodiversity Institute; U.S. Fish and Wildlife Service; Commonwealth of the Northern Mariana Islands Division of Fish Wildlife; French National Parks (PNF)	National Research Foundation of South Africa(National Research Foundation - South Africa); South African National Biodiversity Institute; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Commonwealth of the Northern Mariana Islands Division of Fish Wildlife; French National Parks (PNF)	This study was supported by a grant from the National Research Foundation of South Africa (Grant 85802) and by the South African National Biodiversity Institute. GP also received support from the U.S. Fish and Wildlife Service, the Commonwealth of the Northern Mariana Islands Division of Fish & Wildlife, and French National Parks (PNF). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; [Anonymous], 1878, TROPICAL NATURE OTHE; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Bentley J, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-27; Blach-Overgaard A, 2013, ECOLOGY, V94, P2426, DOI 10.1890/12-1577.1; Bled F, 2013, ECOL EVOL, V3, P4896, DOI 10.1002/ece3.858; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Boyd JH, 2014, TAXONOMY FLUX CHECKL; Broms KM, 2014, ECOL APPL, V24, P363, DOI 10.1890/12-2151.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chase BM, 2009, QUATERNARY SCI REV, V28, P301, DOI 10.1016/j.quascirev.2008.10.008; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; Clements JF, 2013, EBIRD CLEMENTS CHECK; Couvreur TLP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-54; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; De Klerk HM, 2002, DIVERS DISTRIB, V8, P147, DOI 10.1046/j.1472-4642.2002.00142.x; Delgado MD, 2011, BIOL REV, V86, P717, DOI 10.1111/j.1469-185X.2010.00167.x; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Demos TC, 2014, MOL PHYLOGENET EVOL, V71, P41, DOI 10.1016/j.ympev.2013.10.014; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P372, DOI 10.1111/j.1466-822x.2006.00228.x; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Finlayson C., 2011, AVIAN SURVIVORS HIST; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; FJELDSA J, 1994, BIODIVERS CONSERV, V3, P207, DOI 10.1007/BF00055939; Gill F, 2013, IOC WORLD BIRD LIST; Goldberg EE, 2007, AM NAT, V170, P297, DOI 10.1086/518946; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harrison JA, 1997, ATLAS SO AFRICAN BIR; Helm B, 2006, PLOS BIOL, V4, P611, DOI 10.1371/journal.pbio.0040110; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Huntley B, 2014, J BIOGEOGR, V41, P1338, DOI 10.1111/jbi.12288; Huntley B, 2012, DIVERS DISTRIB, V18, P769, DOI 10.1111/j.1472-4642.2012.00890.x; Hurlbert AH, 2014, ECOL LETT, V17, P401, DOI 10.1111/ele.12240; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Meller L, 2014, DIVERS DISTRIB, V20, P309, DOI 10.1111/ddi.12162; Mucina L., 2011, VEGETATION S AFRICA; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nichol JE, 1999, GEOGR J, V165, P79, DOI 10.2307/3060512; ORD K, 1975, J AM STAT ASSOC, V70, P120, DOI 10.2307/2285387; Partridge TC, 1999, QUATERN INT, V57-8, P207, DOI 10.1016/S1040-6182(98)00061-5; Pearse WD, 2013, ECOLOGY, V94, P2861, DOI 10.1890/12-1676.1; Peron G, 2015, ECOGRAPHY, P1; Peron G, 2015, GLOBAL CHANGE BIOL, V21, P3347, DOI 10.1111/gcb.12909; Peron G, 2010, J ANIM ECOL, V79, P317, DOI 10.1111/j.1365-2656.2009.01635.x; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085903; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; SCHULZE RE, 2007, S AFRICAN ATLAS CLIM; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stokes S, 1997, NATURE, V388, P154, DOI 10.1038/40596; Tolley KA, 2014, ECOLOGY EVOLUTION FY, P143; Verboom GA, 2009, MOL PHYLOGENET EVOL, V51, P44, DOI 10.1016/j.ympev.2008.01.037; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Voelker G, 2013, MOL ECOL, V22, P3333, DOI 10.1111/mec.12305; Walther BA, 2007, IBIS, V149, P701, DOI 10.1111/j.1474-919X.2007.00690.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x; Winger BM, 2014, P NATL ACAD SCI USA, V111, P12115, DOI 10.1073/pnas.1405000111	80	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133992	10.1371/journal.pone.0133992	http://dx.doi.org/10.1371/journal.pone.0133992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208300	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000186
J	Sandelin, LL; Tolf, C; Larsson, S; Wilhelmsson, P; Salaneck, E; Jaenson, TGT; Lindgren, PE; Olsen, B; Waldenstrom, J				Sandelin, Lisa Labbe; Tolf, Conny; Larsson, Sara; Wilhelmsson, Peter; Salaneck, Erik; Jaenson, Thomas G. T.; Lindgren, Per-Eric; Olsen, Bjorn; Waldenstrom, Jonas			Candidatus Neoehrlichia mikurensis in Ticks from Migrating Birds in Sweden	PLOS ONE			English	Article							IXODES-RICINUS TICKS; BORNE PATHOGENS; ANAPLASMA-PHAGOCYTOPHILUM; SPECIES IDENTIFICATION; INFECTIONS; RODENTS; SPP.	Candidatus Neoehrlichia mikurensis (CNM; family Anaplasmataceae) was recently recognized as a potential tick-borne human pathogen. The presence of CNM in mammals, in host-seeking Ixodes ticks and in ticks attached to mammals and birds has been reported recently. We investigated the presence of CNM in ornithophagous ticks from migrating birds. A total of 1,150 ticks (582 nymphs, 548 larvae, 18 undetermined ticks and two adult females) collected from 5,365 birds captured in south-eastern Sweden was screened for CNM by molecular methods. The birds represented 65 different species, of which 35 species were infested with one or more ticks. Based on a combination of morphological and molecular species identification, the majority of the ticks were identified as Ixodes ricinus. Samples were initially screened by real-time PCR targeting the CNM 16S rRNA gene, and confirmed by a second real-time PCR targeting the groEL gene. For positive samples, a 1260 base pair fragment of the 16S rRNA gene was sequenced. Based upon bacterial gene sequence identification, 2.1% (24/1150) of the analysed samples were CNM-positive. Twenty-two out of 24 CNM-positive ticks were molecularly identified as I. ricinus nymphs, and the remaining two were identified as I. ricinus based on morphology. The overall CNM prevalence in I. ricinus nymphs was 4.2%. None of the 548 tested larvae was positive. CNM-positive ticks were collected from 10 different bird species. The highest CNM-prevalences were recorded in nymphs collected from common redpoll (Carduelis flammea, 3/7), thrush nightingale (Luscinia luscinia, 2/29) and dunnock (Prunella modularis, 1/17). The 16S rRNA sequences obtained in this study were all identical to each other and to three previously reported European strains, two of which were obtained from humans. It is concluded that ornithophagous ticks may be infected with CNM and that birds most likely can disperse CNM-infected ticks over large geographical areas.	[Sandelin, Lisa Labbe; Salaneck, Erik; Jaenson, Thomas G. T.; Olsen, Bjorn] Uppsala Univ, Uppsala, Sweden; [Sandelin, Lisa Labbe] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden; [Tolf, Conny; Larsson, Sara; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden; [Wilhelmsson, Peter; Lindgren, Per-Eric] Linkoping Univ, Linkoping, Sweden	Uppsala University; Linnaeus University; Linkoping University	Waldenstrom, J (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Kalmar, Sweden.	jonas.waldenstrom@lnu.se	Waldenström, Jonas/E-4460-2013; Sandelin, Lisa Labbé/S-3387-2019; Labbé Sandelin, Lisa/A-5568-2013	Waldenström, Jonas/0000-0002-1152-4235; Sandelin, Lisa Labbé/0000-0002-5621-5655; Labbé Sandelin, Lisa/0000-0002-5621-5655; Olsen, Bjorn/0000-0002-4646-691X; Salaneck, Erik/0000-0002-0000-8948; Wilhelmsson, Peter/0000-0002-9200-2964	Medical Research Council of Southeast Sweden [FORSS-307591, FORSS-387231]; Carl Trygger's Foundation for Scientific Research; Langmanska kulturfonden; Magnus Bergvall's Foundation for Scientific Research; Helge Ax:son Johnson's Foundation; EU Interreg IVA project ScandTick	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carl Trygger's Foundation for Scientific Research; Langmanska kulturfonden; Magnus Bergvall's Foundation for Scientific Research; Helge Ax:son Johnson's Foundation; EU Interreg IVA project ScandTick	Funding for this study came from the Medical Research Council of Southeast Sweden (grant numbers FORSS-307591 and FORSS-387231), Carl Trygger's Foundation for Scientific Research, Langmanska kulturfonden, Magnus Bergvall's Foundation for Scientific Research, Helge Ax:son Johnson's Foundation and the EU Interreg IVA project ScandTick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2013, VECTOR-BORNE ZOONOT, V13, P438, DOI 10.1089/vbz.2012.1118; Andersson M, 2011, EMERG INFECT DIS, V17, P1716, DOI 10.3201/eid1709.101058; Andreasson K, 2014, RHEUMATOLOGY OXFORD; Arthur DR, 1963, BRITISH TICKS; Derdakova M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-160; Filippova NA, 1977, IXODID TICKS OF THE; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grankvist A, 2014, CLIN INFECT DIS, V58, P1716, DOI 10.1093/cid/ciu189; Hasle G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00048; Heylen D, 2014, TICKS TICK-BORNE DIS, V5, P693, DOI 10.1016/j.ttbdis.2014.05.006; Hillyard PD, 1996, SYNOPSES OF THE BRIT, V52; Hornok S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-128; Jahfari S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-74; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Li H, 2012, EMERG INFECT DIS, V18, P1636, DOI 10.3201/eid1810.120594; Lommano E, 2014, TICKS TICK-BORNE DIS, V5, P871, DOI 10.1016/j.ttbdis.2014.07.001; Lv JZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-93; Lv JZ, 2014, MITOCHONDR DNA, V25, P142, DOI 10.3109/19401736.2013.792052; Maurer FP, 2013, J CLIN MICROBIOL, V51, P169, DOI 10.1128/JCM.01955-12; Movila A, 2012, MED VET ENTOMOL; Richter D, 2013, PARASITOL RES, V112, P107, DOI 10.1007/s00436-012-3110-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schouls LM, 1999, J CLIN MICROBIOL, V37, P2215, DOI 10.1128/JCM.37.7.2215-2222.1999; Spitalska E, 2006, WIEN KLIN WOCHENSCHR, V118, P759, DOI 10.1007/s00508-006-0729-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vayssier-Taussat M, 2012, EMERG INFECT DIS, V18, P2063, DOI 10.3201/eid1812.120846; Welc-Faleciak R, 2014, J CLIN MICROBIOL, V52, P3072, DOI 10.1128/JCM.00741-14; Welinder-Olsson C, 2010, J CLIN MICROBIOL, V48, P1956, DOI 10.1128/JCM.02423-09; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433; Zhang RL, 2014, TICKS TICK-BORNE DIS, V5, P352, DOI 10.1016/j.ttbdis.2014.01.001	30	20	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133250	10.1371/journal.pone.0133250	http://dx.doi.org/10.1371/journal.pone.0133250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207834	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000071
J	Shao, YB; Sun, XF; He, YN; Liu, CJ; Liu, H				Shao, Yingbo; Sun, Xianfu; He, Yaning; Liu, Chaojun; Liu, Hui			Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer	PLOS ONE			English	Article							ONCOLOGY 2007 UPDATE; CA 15-3; AMERICAN SOCIETY; RECOMMENDATIONS; CA-15-3; EXPRESSION; DIAGNOSIS; THERAPY	Background & Aims The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in patients with breast cancer remains controversial. The present study aims to investigate the prognostic value of preoperative serum CEA and CA15-3 levels in breast cancer patients. Methods Serum preoperative CEA and CA 15-3 concentration levels were measured in a total of 432 breast cancer patients. The association of tumor markers levels with clinicopathological parameters and outcomes were analyzed. Results Elevated serum levels of CEA and CA15-3 were identified in 47 (10.9%) and 60(13.9%) patients, respectively. Larger tumor size, advanced axillary lymph nodal and TNM stage exhibited higher proportion of elevated CEA and CA15-3 levels. The elevation of CEA levels was significantly greater in patients with HER2 positive tumors, and the elevation of CA15-3 levels was significantly greater in ER negative breast patients. Univariate and multivariate Cox's regression analysis revealed that elevated preoperative CEA and CA 15-3 levels were independent prognostic factors for DFS and OS. When considering the combination of both markers levels, patients with both elevated markers presented the worst survival. Independent prognostic significance of elevated preoperative serum CEA and CA15-3 levels were reconfirmed in Luminal B breast cancer. Conclusions Preoperative serum levels of CEA and CA15-3 are independent prognostic parameters for breast cancer.	[Shao, Yingbo; Sun, Xianfu; He, Yaning; Liu, Chaojun; Liu, Hui] Zhengzhou Univ, Dept Breast Oncol, Affiliated Canc Hosp, Zhengzhou 450052, Peoples R China; [Shao, Yingbo; Sun, Xianfu; He, Yaning; Liu, Chaojun; Liu, Hui] Henan Prov Tumor Hosp, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Liu, H (corresponding author), Zhengzhou Univ, Dept Breast Oncol, Affiliated Canc Hosp, Zhengzhou 450052, Peoples R China.	liuhuimed@126.com	Liu, Chaojun/P-7848-2016	liu, chaojun/0000-0002-4676-3981	key scientific and technological projects of Science and Technology Department of Henan Province [122102310535]	key scientific and technological projects of Science and Technology Department of Henan Province	This work was supported by the key scientific and technological projects of Science and Technology Department of Henan Province (No. 122102310535).	Ades F, 2014, J CLIN ONCOL, V32, P2794, DOI 10.1200/JCO.2013.54.1870; Ali HQ, 2013, J PAK MED ASSOC, V63, P1138; Cardoso F, 2008, J CLIN ONCOL, V26, P2058, DOI 10.1200/JCO.2007.15.6638; Dai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058001; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Di Gioia D, 2011, TUMOR BIOL, V32, P777, DOI 10.1007/s13277-011-0180-7; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hashim ZM, 2014, INT J IMMUNOPATH PH, V27, P45, DOI 10.1177/039463201402700107; Incoronato M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-356; Laessig D, 2007, ANTICANCER RES, V27, P1963; Lee JS, 2013, ANN ONCOL, V24, P1225, DOI 10.1093/annonc/mds604; Lee JS, 2013, BREAST CANCER RES TR, V141, P477, DOI 10.1007/s10549-013-2695-7; Lonning PE, 2007, ANN ONCOL, V18, P3, DOI 10.1093/annonc/mdm260; Maric P, 2011, COLLEGIUM ANTROPOL, V35, P241; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Molina R, 2005, TUMOR BIOL, V26, P281, DOI 10.1159/000089260; Ogba N, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0489-4; Park BW, 2008, ANN ONCOL, V19, P675, DOI 10.1093/annonc/mdm538; Pedersen AC, 2013, CLIN CHEM LAB MED, V51, P1511, DOI 10.1515/cclm-2012-0488; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Samy N, 2010, CANCER BIOMARK, V6, P63, DOI 10.3233/CBM-2009-0119; Selz J, 2012, INT J RADIAT ONCOL, V84, P1123, DOI 10.1016/j.ijrobp.2012.02.047; Skrbo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113278; Soletormos G, 2004, EUR J CANCER, V40, P481, DOI 10.1016/j.ejca.2003.10.015; Uehara M, 2008, INT J CLIN ONCOL, V13, P447, DOI 10.1007/s10147-008-0773-3; Wu SL, 2014, APPL MATH LETT, V38, P57, DOI 10.1016/j.aml.2014.07.002; Zhou C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100159	28	114	116	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133830	10.1371/journal.pone.0133830	http://dx.doi.org/10.1371/journal.pone.0133830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207909	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000152
J	Angleman, SB; Santoni, G; Pilotto, A; Fratiglioni, L; Welmer, AK				Angleman, Sara B.; Santoni, Giola; Pilotto, Alberto; Fratiglioni, Laura; Welmer, Anna-Karin		MPI AGE Project Investigators	Multidimensional Prognostic Index in Association with Future Mortality and Number of Hospital Days in a Population-Based Sample of Older Adults: Results of the EU Funded MPI_AGE Project	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; LONG-TERM MORTALITY; MINI-MENTAL-STATE; VALIDATION; DEMENTIA; CARE; MULTIMORBIDITY; COMMUNITY; LIFE	Background The Multidimensional Prognostic Index (MPI) has been found to predict mortality in patients with a variety of clinical conditions. We aimed to assess the association of the MPI with future mortality and number of in-hospital days for the first time in a population-based cohort. Methods The study population consisted of 2472 persons, aged 66-99 years, from the Swedish National Study on Aging and Care in Kungsholmen, Sweden, who underwent the baseline visit 2001-4, and were followed up >10 years for in-hospital days and >12 years for mortality. The MPI was a modified version of the original and aggregated seven domains (personal and instrumental activities of daily living, cognitive function, illness severity and comorbidity, number of medications, co-habitation status, and nutritional status). The MPI score was divided into risk groups: low, medium and high. Number of in-hospital days (within 1, 3 and 10 years) and mortality data were derived from official registries. All analyses were age-stratified (sexagenarians, septuagenarians, octogenarians, nonagenarians). Results During the follow-up 1331 persons (53.8%) died. Laplace regression models, suggested that median survival in medium risk groups varied by age from 2.2-3.6 years earlier than for those in the corresponding low risk groups (p = 0.002-p<0.001), and median survival in high risk groups varied by age from 3.8-9.0 years earlier than for corresponding low risk groups (p<0.001). For nonagenarians, the median age at death was 3.8 years earlier in the high risk group than for the low risk group (p<0.001). The mean number of in-hospital days increased significantly with higher MPI risk score within 1 and 3 years for people of each age group. Conclusion For the first time, the effectiveness of MPI has been verified in a population-based cohort. Higher MPI risk scores associated with more days in hospital and with fewer years of survival, across a broad and stratified age range.	[Angleman, Sara B.; Santoni, Giola; Fratiglioni, Laura; Welmer, Anna-Karin] Karolinska Inst, Dept Neurobiol, Care Sci & Soc NVS, Aging Res Ctr, Stockholm, Sweden; [Angleman, Sara B.; Santoni, Giola; Fratiglioni, Laura; Welmer, Anna-Karin] Stockholm Univ, S-10691 Stockholm, Sweden; [Pilotto, Alberto] S Antonio Hosp, Azienda ULSS Padova 16, Geriatr Unit, Padua, Italy; [Pilotto, Alberto] EO Galliera Hosp, Frailty Area, Dept OrthoGeriatr Rehabil & Stabilizat, Genoa, Italy; [Fratiglioni, Laura] Karolinska Inst, Stockholm Gerontol Res Ctr, Dept NVS, Stockholm, Sweden; [Welmer, Anna-Karin] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Stockholm University; ULSS 6 Euganea; Ospedale Sant'antonio Padova; Ente Ospedaliero Ospedali Galliera; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Welmer, AK (corresponding author), Karolinska Inst, Dept Neurobiol, Care Sci & Soc NVS, Aging Res Ctr, Stockholm, Sweden.	anna-karin.welmer@ki.se	Cruz-Jentoft, Alfonso J/G-2675-2015; Topinkova, Eva/A-5076-2019; Trifiro, Gianluca/K-9744-2016; Welmer, Anna-Karin/AAL-3446-2021	Cruz-Jentoft, Alfonso J/0000-0001-7628-4861; Topinkova, Eva/0000-0002-6786-4116; Trifiro, Gianluca/0000-0003-1147-7296; Mattace-Raso, Francesco/0000-0002-1688-6497; Welmer, Anna-Karin/0000-0001-5819-8724; Santoni, Giola/0000-0002-9094-5037; Angleman, Sara/0000-0002-9520-5716	European Union [GA20131202]; Swedish National study on Aging and Care, SNAC: Ministry of Health and Social Affairs, Sweden; Swedish National study on Aging and Care, SNAC: participating County Councils and Municipalities; Swedish National study on Aging and Care, SNAC: Swedish Research Council	European Union(European Commission); Swedish National study on Aging and Care, SNAC: Ministry of Health and Social Affairs, Sweden; Swedish National study on Aging and Care, SNAC: participating County Councils and Municipalities; Swedish National study on Aging and Care, SNAC: Swedish Research Council	This work arised from the European project MPI_AGE (GA20131202) which has received funding from the European Union, in the framework of the Health Programme 2008-2013. The contents of this paper are the sole responsibility of the above mentioned Authors and can under no circumstances be regarded as reflecting the position of the European Union. This work was also supported by the funders of the Swedish National study on Aging and Care, SNAC (www.snac.org): the Ministry of Health and Social Affairs, Sweden, the participating County Councils and Municipalities, and the Swedish Research Council. Funder's Role: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; [Anonymous], 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI [10.1001/jama.2009.1871, DOI 10.1001/JAMA.2009.1871]; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bottai M, 2010, BIOMETRICAL J, V52, P487, DOI 10.1002/bimj.200900310; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Condelius A, 2008, ARCH GERONTOL GERIAT, V46, P41, DOI 10.1016/j.archger.2007.02.005; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallucci M, 2014, J ALZHEIMERS DIS, V42, P1461, DOI 10.3233/JAD-140516; Gill TM, 2012, JAMA-J AM MED ASSOC, V307, P199, DOI 10.1001/jama.2011.1992; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; HOOIJER C, 1992, INT J GERIATR PSYCH, V7, P559, DOI 10.1002/gps.930070805; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Kaiser MJ, 2011, J AM GERIATR SOC, V59, P2124, DOI 10.1111/j.1532-5415.2011.03659.x; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Pilotto A, 2008, REJUV RES, V11, P151, DOI 10.1089/rej.2007.0569; Pilotto A, 2013, J AM MED DIR ASSOC, V14, P287, DOI 10.1016/j.jamda.2013.01.005; Pilotto A, 2012, J NEPHROL, V25, pS79, DOI 10.5301/jn.5000162; Pilotto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029090; Pilotto A, 2010, CIRC-HEART FAIL, V3, P14, DOI 10.1161/CIRCHEARTFAILURE.109.865022; Pilotto A, 2009, J ALZHEIMERS DIS, V18, P191, DOI 10.3233/JAD-2009-1139; Pilotto A, 2009, J GERONTOL A-BIOL, V64, P880, DOI 10.1093/gerona/glp031; Pizzato S, 2015, EUR J CLIN NUTR, V69, P1113, DOI 10.1038/ejcn.2015.19; Sancarlo D, 2011, J NUTR HEALTH AGING, V15, P169, DOI 10.1007/s12603-010-0293-5; Sancarlo D, 2012, J NEUROL, V259, P670, DOI 10.1007/s00415-011-6241-4; Santoni G, 2005, PLOS ONE, V10; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; Volpato S, 2015, J GERONTOL A-BIOL, V70, P323, DOI 10.1093/gerona/glu167; WHO Collaborating Center for Drug Statistics Methodology, 2014, GUIDELINES FOR ATC C; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	32	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133789	10.1371/journal.pone.0133789	http://dx.doi.org/10.1371/journal.pone.0133789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222546	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800067
J	Sloniecka, M; Le Roux, S; Boman, P; Bystrom, B; Zhou, QJ; Danielson, P				Sloniecka, Marta; Le Roux, Sandrine; Boman, Peter; Bystrom, Berit; Zhou, Qingjun; Danielson, Patrik			Expression Profiles of Neuropeptides, Neurotransmitters, and Their Receptors in Human Keratocytes In Vitro and In Situ	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; KERATAN SULFATE PROTEOGLYCAN; 3-D COLLAGEN MATRICES; WOUND-HEALING MODEL; SUBSTANCE-P; NEUROKININ-1 RECEPTOR; CORNEAL KERATOCYTES; STROMAL CELLS; CHOLINE-ACETYLTRANSFERASE; ACETYLCHOLINE-RECEPTOR	Keratocytes, the quiescent cells of the corneal stroma, play a crucial role in corneal wound healing. Neuropeptides and neurotransmitters are usually associated with neuronal signaling, but have recently been shown to be produced also by non-neuronal cells and to be involved in many cellular processes. The aim of this study was to assess the endogenous intracellular and secreted levels of the neuropeptides substance P (SP) and neurokinin A (NKA), and of the neurotransmitters acetylcholine (ACh), catecholamines (adrenaline, noradrenaline and dopamine), and glutamate, as well as the expression profiles of their receptors, in human primary keratocytes in vitro and in keratocytes of human corneal tissue sections in situ. Cultured keratocytes expressed genes encoding for SP and NKA, and for catecholamine and glutamate synthesizing enzymes, as well as genes for neuropeptide, adrenergic and ACh (muscarinic) receptors. Keratocytes in culture produced SP, NKA, catecholamines, ACh, and glutamate, and expressed neurokinin-1 and -2 receptors (NK-1R and NK-2R), dopamine receptor D-2, muscarinic ACh receptors, and NDMAR1 glutamate receptor. Human corneal sections expressed SP, NKA, NK-1R, NK-2R, receptor D2, choline acetyl transferase (ChAT), M-3, M4 and M-5 muscarinic ACh receptors, glutamate, and NMDAR1, but not catecholamine synthesizing enzyme or the alpha(1) and beta(2) adrenoreceptors, nor M1 receptor. In addition, expression profiles assumed significant differences between keratocytes from the peripheral cornea as compared to those from the central cornea, as well as differences between keratocytes cultured under various serum concentrations. In conclusion, human keratocytes express an array of neuropeptides and neurotransmitters. The cells furthermore express receptors for neuropeptides/neurotransmitters, which suggests that they are susceptible to stimulation by these substances in the cornea, whether of neuronal or non-neuronal origin. As it has been shown that neuropeptides/neurotransmitters are involved in cell proliferation, migration, and angiogenesis, it is possible that they play a role in corneal wound healing.	[Sloniecka, Marta; Le Roux, Sandrine; Boman, Peter; Zhou, Qingjun; Danielson, Patrik] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Bystrom, Berit; Danielson, Patrik] Umea Univ, Dept Clin Sci Ophthalmol, Umea, Sweden; [Zhou, Qingjun] Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China	Umea University; Umea University; Shandong First Medical University & Shandong Academy of Medical Sciences	Sloniecka, M (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	marta.sloniecka@umu.se			national Swedish Research Council [521-2013-2612]; Swedish Society of Medicine [SLS-176511/-248321/-329341]; Cronqvist foundation [SLS-120651/-249071/-329561]; foundation Kronprinsessan Margaretas Arbetsnamnd for synskadade [2010/30 2012/26, 2013/10]; foundation Ogonfonden; National Natural Science Foundation of China [81170816]; J.C. Kempe and Seth M. Kempe Memorial Foundations [JCK-1222]	national Swedish Research Council(Swedish Research Council); Swedish Society of Medicine; Cronqvist foundation; foundation Kronprinsessan Margaretas Arbetsnamnd for synskadade; foundation Ogonfonden; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); J.C. Kempe and Seth M. Kempe Memorial Foundations	Financial support was obtained by P.D. from the national Swedish Research Council (grant no. 521-2013-2612), the J.C. Kempe and Seth M. Kempe Memorial Foundations (JCK-1222), the Swedish Society of Medicine (SLS-176511/-248321/-329341), the Cronqvist foundation (SLS-120651/-249071/-329561), the foundation Kronprinsessan Margaretas Arbetsnamnd for synskadade (2010/30 2012/26, 2013/10), the foundation Ogonfonden, and also through a regional agreement between Umea University and Vasterbotten County Council (ALF). Q.Z. was partially supported by the National Natural Science Foundation of China (81170816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearne M, 2010, EXP EYE RES, V91, P584, DOI 10.1016/j.exer.2010.07.013; Ainscough SL, 2011, EXP EYE RES, V92, P10, DOI 10.1016/j.exer.2010.10.004; Andersson G, 2008, REGUL PEPTIDES, V150, P81, DOI 10.1016/j.regpep.2008.02.005; Backman LJ, 2013, SCAND J MED SCI SPOR, V23, P687, DOI 10.1111/j.1600-0838.2011.01442.x; Backman LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027209; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Blais M, 2014, TISSUE ENG PT A, V20, P2180, DOI 10.1089/ten.tea.2013.0535; Brain SD, 1997, IMMUNOPHARMACOLOGY, V37, P133, DOI 10.1016/S0162-3109(97)00055-6; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Cheret J, 2014, J DERMATOL SCI, V74, P193, DOI 10.1016/j.jdermsci.2014.02.001; Cheret J, 2013, WOUND REPAIR REGEN, V21, P772, DOI 10.1111/wrr.12101; Cooke JP, 2007, LIFE SCI, V80, P2347, DOI 10.1016/j.lfs.2007.01.061; DAHL IM, 1981, EXP EYE RES, V32, P419, DOI 10.1016/S0014-4835(81)80021-8; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Eisenhofer G, 1996, J NEUROCHEM, V66, P1565; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Fong G, 2013, CELL TISSUE RES, V351, P465, DOI 10.1007/s00441-012-1530-5; Funderburgh JL, 1996, J BIOL CHEM, V271, P31431, DOI 10.1074/jbc.271.49.31431; Gill SS, 2001, TOXICOL PATHOL, V29, P208, DOI 10.1080/019262301317052486; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; GNADINGER MC, 1973, EXP EYE RES, V15, P395, DOI 10.1016/0014-4835(73)90155-3; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Gonzalez S, 2013, EXP EYE RES, V116, P169, DOI 10.1016/j.exer.2013.08.020; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Grueb M, 2006, GRAEF ARCH CLIN EXP, V244, P1191, DOI 10.1007/s00417-006-0263-0; Haas HS, 2013, ANTICANCER RES, V33, P1267; Haas HS, 2010, HEAD NECK-J SCI SPEC, V32, P1554, DOI 10.1002/hed.21438; HASSELL JR, 1992, INVEST OPHTH VIS SCI, V33, P547; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P3705, DOI 10.1073/pnas.77.6.3705; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; Ho WZ, 1997, J IMMUNOL, V159, P5654; Jester JV, 1996, CORNEA, V15, P505; JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730; JESTER JV, 1995, INVEST OPHTH VIS SCI, V36, P809; Julio-Pieper M, 2011, PHARMACOL REV, V63, P35, DOI 10.1124/pr.110.004036; Kim A, 2012, EXP CELL RES, V318, P741, DOI 10.1016/j.yexcr.2011.12.018; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; Lakshman N, 2012, INVEST OPHTH VIS SCI, V53, P1077, DOI 10.1167/iovs.11-8609; LAWRENSON JG, 1991, J ANAT, V177, P75; Levite M, 1998, J IMMUNOL, V160, P993; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; MASUR SK, 1993, INVEST OPHTH VIS SCI, V34, P2690; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; MIDURA RJ, 1989, J BIOL CHEM, V264, P1423; MINDEL JS, 1976, INVEST OPHTH VISUAL, V15, P808; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; MULLER LJ, 1995, INVEST OPHTH VIS SCI, V36, P2557; Munoz M, 2010, DISCOV MED, V10, P305; Musselmann K, 2005, J BIOL CHEM, V280, P32634, DOI 10.1074/jbc.m504724200; Nelson DA, 2004, FRONT BIOSCI-LANDMRK, V9, P2166, DOI 10.2741/1372; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Nicoletti F, 2007, PSYCHONEUROENDOCRINO, V32, pS40, DOI 10.1016/j.psyneuen.2007.04.015; Notara M, 2010, STEM CELL RES, V5, P188, DOI 10.1016/j.scr.2010.07.002; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Robert L, 2001, PATHOL BIOL, V49, P353, DOI 10.1016/S0369-8114(01)00144-4; Sarkar C, 2013, J NEUROIMMUNE PHARM, V8, P7, DOI 10.1007/s11481-012-9395-7; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Sloniecka M, 2015, INT IMMUNOPHARMACOL, V29, P57, DOI 10.1016/j.intimp.2015.05.039; VANALPHEN GWHM, 1957, ARCH OPHTHALMOL-CHIC, V58, P449; Watanabe M, 2002, JPN J OPHTHALMOL, V46, P616, DOI 10.1016/S0021-5155(02)00617-2; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; YUE BYJT, 1976, BIOCHEM J, V158, P567, DOI 10.1042/bj1580567; Zhao DZ, 2002, BIOCHEM J, V368, P665, DOI 10.1042/BJ20020950	66	37	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134157	10.1371/journal.pone.0134157	http://dx.doi.org/10.1371/journal.pone.0134157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214847	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300054
J	Dias, LFO; Dias, DV; Magnusson, WE				Dias, Lilian Fernandes Oliveira; Dias, David Valentim; Magnusson, William Ernest			Influence of Environmental Governance on Deforestation in Municipalities of the Brazilian Amazon	PLOS ONE			English	Article							DYNAMICS; IMPACTS	It has been argued that measuring governance at scales smaller than global could be an important management tool. However, current studies are conducted on a global scale and use expensive methods. In the present study, we assess whether the reported governance of Amazonian municipalities is related to reductions in deforestation. Economic activity (EA) affected general governance (G) positively (G = 0.81 + 1.19 * EA, F1, 98 = 77.36, p < 0.001). Environmental governance (EG) was not affected significantly (p = 0.43) by deforestation before 2000 (PD), but increased significantly (p < 0.001) with general governance (G) (EG = -0.29 + 0.04 PD+0.98*OG, F2,97 = 42.6, p < 0.001). Deforestation was not significantly related to environmental governance (p = 0.82). The only indirect effect of significant magnitude was the effect of the density of forest reserves on recent deforestation through deforestation before 2000, which was strongly negative (-0.49). It is possible to assess reported actions to promote municipal governance through official data. However, it is not enough to assume that general governance or environmental governance at the municipal level, as reflected in the official statistics, benefits environmental conservation. In fact, even at the level of nation states, at which most quantification of governance has been undertaken, it seems that the relationship between governance and environmental preservation is only an assumption, because we are aware of no study that supports that hypothesis quantitatively.	[Dias, Lilian Fernandes Oliveira; Dias, David Valentim; Magnusson, William Ernest] Inst Nacl de Pesquisas da Amazonia, CBIO, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia	Dias, LFO (corresponding author), Inst Nacl de Pesquisas da Amazonia, CBIO, Manaus, Amazonas, Brazil.	lilianfernandes@gmail.com			Amazonas Research Foundation (FAPEAM); National Council for Scientific Research (CNPq); National Institute for Science and Technology for Amazonian Biodiversity (INCT-CENBAM)	Amazonas Research Foundation (FAPEAM); National Council for Scientific Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Science and Technology for Amazonian Biodiversity (INCT-CENBAM)	LFOD thanks the Amazonas Research Foundation (FAPEAM) for a Masters scholarship and the National Institute for Amazonian Research (INPA) for the infrastructure support that enabled the development of the research. WEM holds a productivity scholarship from the National Council for Scientific Research (CNPq), and DVD holds a scholarship from the National Institute for Science and Technology for Amazonian Biodiversity (INCT-CENBAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A., 1989, EST AV, V3, P4, DOI [10.1590/S0103-40141989000100002, DOI 10.1590/S0103-40141989000100002]; Alencar A., 2004, DESMATAMENTO AMAZONI; Amaral EF do, 2000, ZONEAMENTO ECOLOGICO, V2, P79; [Anonymous], 2010, REV IBEROAMERICANA E; [Anonymous], 2005, MEGADIVERSIDADE; Araujo IV., 2011, P 3 ENABRI 2011; Azevedo AA, 2013, CERNE, V19, P111, DOI 10.1590/S0104-77602013000100014; Bank World, 1992, GOV DEV; BROWN IM, 2002, ECOLOGY LAND USE CON, P8; Buss PM, 2012, CIENC SAUDE COLETIVA, V17, P1479, DOI 10.1590/S1413-81232012000600012; Cardoso GD, 2013, AN ENC NAC ANPUR, P15; Cavalcante MMDA, 2011, REV FRANCOBRESILIENN, P11; Cavalcanti C., 2004, REV RED IBERO AM EC, V1, P1; Cruz NF, 2011, 8 C NAC ADM PUBL; de Almeida AN, 2013, FLORESTA AMBIENTE, P20143; Diniz V, 2010, C CONS GEST PUBL 3 B, VIII; Fearnside Philip M., 2006, Acta Amaz., V36, P395, DOI 10.1590/S0044-59672006000300018; FEARNSIDE PM, 1993, AMBIO, V22, P537; Fearnside PM, NCN NOVOS CADERNOS N, P12; Fearnside PM., 2010, SCI AM BRASIL ESPECI, P54; Fearnside PM, 2012, NCN NOVOS CADERNOS N; Fonseca Igor Ferraz da, 2009, Soc. estado., V24, P17; Franzese C, 2005, MUNICIPIO ESTADO UNI; Fukuyama F, 2013, GOVERNANCE, V26, P347, DOI 10.1111/gove.12035; Gomides JE, 2010, REV CIENCIAS GERENCI, V13, P177; Goncalves A., 2005, 14 ENC CONP; Instituto Brasileiro de Geografia e Estatistica (IBGE), PERF MUN BRAS; Kampel SA, 2005, ANALISE EXPLORATORIA; Kampel SA, 2000, ANALISE EXPLORATORIA; Kern AP, 2012, EVIDENCIAS RELACAO G; Kjaer AM., 2011, PUBLIC ADM IN PRESS; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lima JADS, 2014, BANCO MUNDIAL ESTRAT; Machado JS, 2013, SCI PLENA; Medina G, 2012, REV BRASILEIRA CIENC, V27; (MMA) Ministerio do Meio Ambiente (Brazil), DAD GEORR; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Rothberg D, 2013, OPINIAO PUBLICA CIDA; Santos RI, 2013, AMAZONIA ORG SUSTENT, V2, P23; Sayer J. A., 2012, Round Table (London), V101, P137, DOI 10.1080/00358533.2012.661531; Serrano ALM, 2013, AVALIACAO IMPACTO PO; Silva LDJDS, 2013, SOMANLU REV ESTUDOS, V12, P128; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Soares BS, 2001, BIOSCIENCE, V51, P1059, DOI 10.1641/0006-3568(2001)051[1059:MTSTPO]2.0.CO;2; Soares-Filho BS, 2005, CENARIOS DESMATAMENT, V19, P137; TORRES H. G., 2003, SAO PAULO PERSPECT, V17, P80, DOI DOI 10.1590/S0102-88392003000300009; Umemiya C, 2010, ENVIRON SCI POLICY, V13, P695, DOI 10.1016/j.envsci.2010.07.002; Valente E, 2012, ESTATISTICA SOC, V2; Viola E, 2013, 373 CEPS	49	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131425	10.1371/journal.pone.0131425	http://dx.doi.org/10.1371/journal.pone.0131425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208282	Green Published, gold			2022-12-27	WOS:000358622000016
J	Goovaerts, O; Jennes, W; Massinga-Loembe, M; Ondoa, P; Ceulemans, A; Vereecken, C; Worodria, W; Mayanja-Kizza, H; Colebunders, R; Kestens, L				Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ondoa, Pascale; Ceulemans, Ann; Vereecken, Chris; Worodria, William; Mayanja-Kizza, Harriet; Colebunders, Robert; Kestens, Luc		TB-IRIS Study Grp	Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome	PLOS ONE			English	Article							STARTING ANTIRETROVIRAL THERAPY; CO-INFECTED PATIENTS; HIV-1 INFECTION; RISK-FACTORS; HLA-DR; LYMPHOCYTES; EFFECTOR; IMMUNOPATHOGENESIS; DIFFERENTIATION; PREVENTION	Background Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an inflammatory complication in HIV-TB co-infected patients receiving antiretroviral therapy (ART). The role of disturbed T cell reconstitution in TB-IRIS is not well understood. We investigated T cell activation and maturation profiles in patients who developed TB-IRIS at different intervals during ART. Methods Twenty-two HIV-TB patients who developed early-onset TB-IRIS and 10 who developed late-onset TB-IRIS were matched for age, sex and CD4 count to equal numbers of HIV-TB patients who did not develop TB-IRIS. Flow cytometry analysis was performed on fresh blood, drawn before and after ART initiation and during TB-IRIS events. T cell activation and maturation was measured on CD4+ and CD8+ T cells using CD45RO, CD38, HLA-DR, CCR7 and CD27 antibodies. Results CD8+ T cell activation before ART was decreased in both early-onset (77% vs. 82%, p = 0.014) and late-onset (71% vs. 83%, p = 0.012) TB-IRIS patients compared to non-IRIS controls. After ART initiation, the observed differences in T cell activation disappeared. During late-onset, but not early-onset TB-IRIS, we observed a skewing from memory to terminal effector CD4+ and CD8+ T cell populations (p<0.028). Conclusion Our data provide evidence of reduced CD8+ T cell activation before ART as a common predisposing factor of early- and late-onset TB-IRIS. The occurrence of TB-IRIS itself was not marked by an over-activated CD8+ T cell compartment. Late-but not early- onset TB-IRIS was characterized by a more terminally differentiated T cell phenotype.	[Goovaerts, Odin; Jennes, Wim; Massinga-Loembe, Marguerite; Ceulemans, Ann; Vereecken, Chris; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Goovaerts, Odin; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Massinga-Loembe, Marguerite] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Massinga-Loembe, Marguerite] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Worodria, William; Mayanja-Kizza, Harriet] Mulago Hosp, Dept Med, Kampala, Uganda; [Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Worodria, William] Infect Dis Network Treatment & Res Africa INTERAC, Kampala, Uganda; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Epidemiol & Social Med, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp; Eberhard Karls University of Tubingen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Mulago National Referral Hospital; Makerere University; Institute of Tropical Medicine (ITM); University of Antwerp	Goovaerts, O (corresponding author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	Odin.Goovaerts@gmail.com	Mayanja-Kizza, Harriet/AAM-5372-2020; Locht, Camille/L-3516-2018; Jennes, Wim/M-2523-2013	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Jennes, Wim/0000-0002-3125-6389; Colebunders, Robert/0000-0002-1919-1340; Locht, Camille/0000-0001-7295-7336; Massinga Loembe, Marguerite/0000-0002-7822-566X	EC [LSHP-CT-2007-037659-TBIRIS]; Belgian Institute for Science and Technology (IWT)	EC(European CommissionEuropean Commission Joint Research Centre); Belgian Institute for Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was supported by EC FP6 Specific Targeted Research Project (STREP) grant LSHP-CT-2007-037659-TBIRIS. PhD student scholarship from the Belgian Institute for Science and Technology (IWT).	Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Barber DL, 2012, NAT REV MICROBIOL, V10, P150, DOI 10.1038/nrmicro2712; Beishuizen SJE, 2009, NETH J MED, V67, P327; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Burman W, 2007, INT J TUBERC LUNG D, V11, P1282; Conesa-Botella A, 2011, JAIDS-J ACQ IMM DEF, V58, P463, DOI 10.1097/QAI.0b013e31823801de; da Silva TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066095; Elliott JH, 2009, J INFECT DIS, V200, P1736, DOI 10.1086/644784; Espinosa E, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-21; Gagnon J, 2008, J IMMUNOL, V180, P7958, DOI 10.4049/jimmunol.180.12.7958; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS131, DOI 10.1002/cyto.b.20391; Goovaerts O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113101; Goovaerts O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081856; Grant PM, 2012, J INFECT DIS, V206, P1715, DOI 10.1093/infdis/jis604; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hazenberg MD, 2003, AIDS, V17, P1419, DOI 10.1097/00002030-200307040-00001; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Huyst V, 2007, ACTA CLIN BELG, V62, P126, DOI 10.1179/acb.2007.022; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; KESTENS L, 1992, AIDS, V6, P793, DOI 10.1097/00002030-199208000-00004; KESTENS L, 1994, CLIN EXP IMMUNOL, V95, P436, DOI 10.1111/j.1365-2249.1994.tb07015.x; Kestens L, 2008, CURR OPIN HIV AIDS, V3, P419, DOI 10.1097/COH.0b013e328302ebbb; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Manosuthi W, 2006, J INFECTION, V53, P357, DOI 10.1016/j.jinf.2006.01.002; Martin M, 2001, EUR J CLIN MICROBIOL, V20, P871, DOI 10.1007/s100960100631; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2008, AM J RESP CRIT CARE, V178, P1083, DOI 10.1164/rccm.200806-858OC; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch David M, 2007, AIDS Res Ther, V4, P9, DOI 10.1186/1742-6405-4-9; Murdoch David M, 2009, AIDS Res Ther, V6, P16, DOI 10.1186/1742-6405-6-16; Ondoa P, 2006, JAIDS-J ACQ IMM DEF, V41, P416, DOI 10.1097/01.qai.0000209901.12750.d0; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Plowden J, 2004, CELL IMMUNOL, V229, P86, DOI 10.1016/j.cellimm.2004.07.001; Radziewicz H, 2007, WORLD J GASTROENTERO, V13, P4848, DOI 10.3748/wjg.v13.i36.4848; Ruhwald M, 2007, AIDS, V21, P882, DOI 10.1097/QAD.0b013e3280b079c8; Sepulveda H, 1999, J IMMUNOL, V163, P1133; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Wellons MF, 2001, J INFECT DIS, V183, P1522, DOI 10.1086/320193; (WHO) WHO, 2012, IMPR DIAGN TREATM SM; Worodria W, 2012, ANTIVIR THER, V17, P841, DOI 10.3851/IMP2108; Worodria W, 2011, JAIDS-J ACQ IMM DEF, V58, P32, DOI 10.1097/QAI.0b013e3182255dc2; Worodria W, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/758350; Worodria William, 2009, Expert Rev Respir Med, V3, P147, DOI 10.1586/ers.09.8	48	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133924	10.1371/journal.pone.0133924	http://dx.doi.org/10.1371/journal.pone.0133924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208109	gold, Green Published			2022-12-27	WOS:000358622000174
J	Graebner, RC; Wise, M; Cuesta-Marcos, A; Geniza, M; Blake, T; Blake, VC; Butler, J; Chao, SM; Hole, DJ; Horsley, R; Jaiswal, P; Obert, D; Smith, KP; Ullrich, S; Hayes, PM				Graebner, Ryan C.; Wise, Mitchell; Cuesta-Marcos, Alfonso; Geniza, Matthew; Blake, Tom; Blake, Victoria C.; Butler, Joshua; Chao, Shiaomen; Hole, David J.; Horsley, Rich; Jaiswal, Pankaj; Obert, Don; Smith, Kevin P.; Ullrich, Steven; Hayes, Patrick M.			Quantitative Trait Loci Associated with the Tocochromanol (Vitamin E) Pathway in Barley	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; GAMMA-TOCOPHEROL; SERUM-CHOLESTEROL; BETA-GLUCAN; LINKAGE MAP; BIOSYNTHESIS; TOCOTRIENOLS; PREVENTION; GENOTYPE; DIOXIDE	The Genome-Wide Association Studies approach was used to detect Quantitative Trait Loci associated with tocochromanol concentrations using a panel of 1,466 barley accessions. All major tocochromanol types- alpha-, beta-, delta-,gamma-tocopherol and tocotrienol-were assayed. We found 13 single nucleotide polymorphisms associated with the concentration of one or more of these tocochromanol forms in barley, seven of which were within 2 cM of sequences homologous to cloned genes associated with tocochromanol production in barley and/or other plants. These associations confirmed a prior report based on bi-parental QTL mapping. This knowledge will aid future efforts to better understand the role of toco-chromanols in barley, with specific reference to abiotic stress resistance. It will also be useful in developing barley varieties with higher tocochromanol concentrations, although at current recommended daily consumption amounts, barley would not be an effective sole source of vitamin E. However, it could be an important contributor in the context of whole grains in a balanced diet.	[Graebner, Ryan C.; Cuesta-Marcos, Alfonso; Hayes, Patrick M.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Wise, Mitchell] USDA ARS, Cereal Crops Res, Madison, WI USA; [Geniza, Matthew; Jaiswal, Pankaj] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Blake, Tom] Montana State Univ, Plant Sci & Plant Pathol Dept, Bozeman, MT 59717 USA; [Blake, Victoria C.] USDA ARS, Crop Improvement & Genet Res, Albany, CA USA; [Butler, Joshua] Busch Agr Resources Inc, Ft Collins, CO USA; [Chao, Shiaomen] USDA ARS, Cereal Crops Res Unit, Fargo, ND USA; [Hole, David J.] Utah State Univ, Plants Soils & Climate Dept, Logan, UT 84322 USA; [Horsley, Rich] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Obert, Don] Limagrain Cereal Seeds, Lafayette, IN USA; [Smith, Kevin P.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Ullrich, Steven] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Oregon State University; United States Department of Agriculture (USDA); Oregon State University; Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; North Dakota State University Fargo; University of Minnesota System; University of Minnesota Twin Cities; Washington State University	Hayes, PM (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.	patrick.m.hayes@oregonstate.edu	Jaiswal, Pankaj/H-7599-2016; Hole, David J/A-7173-2008; Jaiswal, Pankaj/R-4214-2019	Jaiswal, Pankaj/0000-0002-1005-8383; Hole, David J/0000-0003-1325-3181; Jaiswal, Pankaj/0000-0002-1005-8383; Geniza, Matthew/0000-0003-4828-7891; Smith, Kevin/0000-0001-8253-3326	USDA-NIFA TCAP Project [2011-68002-30029]; USDA-NIFA Collaborative Project [2013-31100-06041]; Busch Agricultural Resources, Inc; Limagrain Cereal Seeds; ARS [ARS-0424878] Funding Source: Federal RePORTER	USDA-NIFA TCAP Project; USDA-NIFA Collaborative Project; Busch Agricultural Resources, Inc; Limagrain Cereal Seeds; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by USDA-NIFA TCAP Project No. 2011-68002-30029, and USDA-NIFA Collaborative Project No. 2013-31100-06041. Busch Agricultural Resources, Inc and Limagrain Cereal Seeds provided support in the form of salaries for authors JB & DO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger GL, 2013, THEOR APPL GENET, V126, P693, DOI 10.1007/s00122-012-2011-7; Blake VC, 2012, PLANT GENOME-US, V5, P81, DOI 10.3835/plantgenome2012.03.0002; Bruno RS, 2005, FREE RADIC BIOL MED, V40, P555; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chutimanitsakun Y, 2013, PLANT BREEDING, V132, P563, DOI 10.1111/pbr.12086; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collakova E, 2001, PLANT PHYSIOL, V127, P1113, DOI 10.1104/pp.010421; COONEY RV, 1993, P NATL ACAD SCI USA, V90, P1771, DOI 10.1073/pnas.90.5.1771; Cordero Z, 2010, CRIT REV FOOD SCI, V50, P420, DOI 10.1080/10408390802304230; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Desel C, 2005, J PLANT PHYSIOL, V162, P771, DOI 10.1016/j.jplph.2005.04.008; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Frank J, 2005, J PLANT PHYSIOL, V162, P834, DOI 10.1016/j.jplph.2005.04.017; Fratianni A, 2002, EUR FOOD RES TECHNOL, V215, P353, DOI 10.1007/s00217-002-0566-2; GEY KF, 1991, AM J CLIN NUTR, V53, pS326, DOI 10.1093/ajcn/53.1.326S; HANDELMAN GJ, 1985, J NUTR, V115, P807, DOI 10.1093/jn/115.6.807; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Hunter S., 2011, NUCLEIC ACIDS RES; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Maeda H, 2006, PLANT CELL, V18, P2710, DOI 10.1105/tpc.105.039404; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; Matsushita Y, 1996, GENE, V172, P207, DOI 10.1016/0378-1119(96)00054-6; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mohammadi M, 2014, MOL BREEDING, V34, P1229, DOI 10.1007/s11032-014-0112-5; Munne-Bosch S, 2005, J PLANT PHYSIOL, V162, P743, DOI 10.1016/j.jplph.2005.04.022; Munoz-Amatriain M, 2014, BRIEF FUNCT GENOMICS, V13, P341, DOI 10.1093/bfgp/elu006; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Navara S, 2014, THEOR APPL GENET, V127, P633, DOI 10.1007/s00122-013-2247-x; Oliver RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096276; Pauli D, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0037; PETERSON DM, 1993, CEREAL CHEM, V70, P157, DOI 10.1006/jcrs.1993.1016; QURESHI AA, 1991, AM J CLIN NUTR, V53, pS1021, DOI 10.1093/ajcn/53.4.1021S; QURESHI AA, 1986, J BIOL CHEM, V261, P544; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Sadre R, 2006, FEBS LETT, V580, P5357, DOI 10.1016/j.febslet.2006.09.002; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; THOMPSON JN, 1979, J LIQ CHROMATOGR, V2, P327, DOI 10.1080/01483917908060067; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; TRABER MG, 1992, J LIPID RES, V33, P1171; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Watts EJ, 2014, J MED FOOD; Yang JL, 2003, J NUTR SCI VITAMINOL, V49, P381, DOI 10.3177/jnsv.49.381	55	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133767	10.1371/journal.pone.0133767	http://dx.doi.org/10.1371/journal.pone.0133767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208213	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000135
J	Ou, MX; Song, YX; Li, SJ; Liu, GY; Jia, JY; Zhang, MQ; Zhang, HC; Yu, C				Ou, Meixian; Song, Yunxiao; Li, Shuijun; Liu, Gangyi; Jia, Jingying; Zhang, Menqi; Zhang, Haichen; Yu, Chen			LC-MS/MS Method for Serum Creatinine: Comparison with Enzymatic Method and Jaffe Method	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; GFR-ESTIMATING EQUATIONS; GLOMERULAR-FILTRATION-RATE; COMPENSATED JAFFE; GC-MS; IMPACT; INTERFERENCE; VALIDATION; CLEARANCE; ACCURACY	Accurate quantification of creatinine (Cre) is important to estimate glomerular filtration rate (GFR). Differences among various methods of Cre quantification were previously noted. This study aims to develop a liquid chromatography tandem mass spectrometry (LC-MS/MS) method for serum Cre and compare this method with clinical routine methods. LC-MS/MS analysis was performed on API 4000 triple quadrupole mass spectrometer coupled with an Agilent 1200 liquid chromatography system. After adding isotope-labeled Cre-d3 as internal standard, serum samples were prepared via a one-step protein precipitation with methanol. The LC-MS/MS method was compared with frequently used enzymatic method and Jaffe method. This developed method, with a total run time of 3 min, had a lower limit of quantification of 4.4 mu mol/L, a total imprecision of 1.15%-3.84%, and an average bias of 1.06%. No significant matrix effect, carryover, and interference were observed for the LC-MS/MS method. The reference intervals of serum Cre measured by LC-MS/MS assay were 41-79 mu mol/L for adult women, and 46-101 mu mol/L for adult men. Using LC-MS/MS as a reference, the enzymatic method showed an average bias of -2.1% and the Jaffe method showed a substantial average bias of 11.7%. Compared with the LC-MS/MS method, significant negative bias was observed for the enzymatic and Jaffe methods in hemolytic and lipimic samples. We developed a simple, specific, and accurate LC-MS/MS method to analyze serum Cre. Discordance existed among different methods.	[Ou, Meixian; Song, Yunxiao; Li, Shuijun; Liu, Gangyi; Jia, Jingying; Zhang, Menqi; Zhang, Haichen; Yu, Chen] Chinese Acad Sci, Shanghai Clin Res Ctr, Shanghai, Peoples R China; [Ou, Meixian; Li, Shuijun; Liu, Gangyi; Jia, Jingying; Zhang, Menqi; Yu, Chen] Shanghai Xuhui Cent Hosp, Cent Lab, Shanghai, Peoples R China; [Song, Yunxiao; Zhang, Haichen] Shanghai Xuhui Cent Hosp, Dept Clin Lab, Shanghai, Peoples R China	Chinese Academy of Sciences	Li, SJ (corresponding author), Chinese Acad Sci, Shanghai Clin Res Ctr, Shanghai, Peoples R China.	sjli@scrc.ac.cn		Jia, Jingying/0000-0002-2492-3219	Shanghai Xuhui Central Hospital [2012XHXH02]; Shanghai Xuhui District Commission of Health and Family Planning [SHXH201301]	Shanghai Xuhui Central Hospital; Shanghai Xuhui District Commission of Health and Family Planning	This work was supported by funds from Shanghai Xuhui Central Hospital (Grant#:2012XHXH02) and from Shanghai Xuhui District Commission of Health and Family Planning (Grant#:SHXH201301).	Agarwal R, 2005, AM J KIDNEY DIS, V45, P610, DOI 10.1053/j.ajkd.2005.01.010; Allegaert K, 2014, CLIN CHEM LAB MED, V52, pE107, DOI 10.1515/cclm-2013-1035; Allegaert K, 2012, J MATERN-FETAL NEO M, V25, P1678, DOI 10.3109/14767058.2012.657277; APPLE F, 1986, CLIN CHEM, V32, P388; Arlet JB, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-83; Bargnoux AS, 2011, CLIN LAB, V57, P357; Boutten A, 2013, CLIN CHIM ACTA, V419, P132, DOI 10.1016/j.cca.2013.01.021; Carobene A, 2014, CLIN CHIM ACTA, V427, P100, DOI 10.1016/j.cca.2013.10.001; Clinical and Laboratory Standards Institute, 2006, CLSI DOCUMENT EP10 A; Clinical and Laboratory Standards Institute, 2005, CLSI DOCUMENT EP7 A2; Clinical and Laboratory Standards Institute, 2007, CLSI DOCUMENT C50 A; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-9; Dodder NG, 2007, CLIN CHEM, V53, P1694, DOI 10.1373/clinchem.2007.090027; Fernandez-Fernandez M, 2015, ANAL CHEM, V87, P3755, DOI 10.1021/acs.analchem.5b00769; Fillee C, 2011, CLIN CHEM LAB MED, V49, P1987, DOI 10.1515/CCLM.2011.674; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; Harlan R, 2010, CLIN CHIM ACTA, V411, P1728, DOI 10.1016/j.cca.2010.07.013; Hetu PO, 2010, CLIN BIOCHEM, V43, P1158, DOI 10.1016/j.clinbiochem.2010.05.018; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; Kaiser T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090015; Koster RA, 2015, ANAL BIOANAL CHEM, V407, P1585, DOI 10.1007/s00216-014-8415-2; Liu WS, 2012, J CLIN LAB ANAL, V26, P206, DOI 10.1002/jcla.21495; Owen LJ, 2007, CLIN CHEM, V53, P370, DOI 10.1373/clinchem.2006.075846; Owen LJ, 2006, ANN CLIN BIOCHEM, V43, P118, DOI 10.1258/000456306776021544; Pauwels S, 2012, CLIN CHEM LAB MED, V50, P749, DOI [10.1515/cclm.2011.836, 10.1515/CCLM.2011.836]; Shepherd J, 2007, ANN CLIN BIOCHEM, V44, P384, DOI 10.1258/000456307780945660; Stevens LA, 2007, AM J KIDNEY DIS, V50, P21, DOI 10.1053/j.ajkd.2007.04.004; Stokes P, 2003, J CHROMATOGR B, V794, P125, DOI 10.1016/S1570-0232(03)00424-0; The Food and Drug Administration, 2001, FDA GUIDANCE FOR IND; WEBER JA, 1991, CLIN CHEM, V37, P695; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	31	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133912	10.1371/journal.pone.0133912	http://dx.doi.org/10.1371/journal.pone.0133912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207996	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000173
J	Taipale, SJ; Peltomaa, E; Hiltunen, M; Jones, RI; Hahn, MW; Biasi, C; Brett, MT				Taipale, Sami J.; Peltomaa, Elina; Hiltunen, Minna; Jones, Roger I.; Hahn, Martin W.; Biasi, Christina; Brett, Michael T.			Inferring Phytoplankton, Terrestrial Plant and Bacteria Bulk delta C-13 Values from Compound Specific Analyses of Lipids and Fatty Acids	PLOS ONE			English	Article							CARBON-ISOTOPE FRACTIONATION; MAJOR PHOTOSYNTHETIC PIGMENTS; FRESH-WATER ALGAE; HERBIVOROUS ZOOPLANKTON; METHANOTROPHIC BACTERIA; ALLOCHTHONOUS CARBON; INORGANIC CARBON; STABLE-ISOTOPES; CO2 FIXATION; LOCH-NESS	Stable isotope mixing models in aquatic ecology require delta C-13 values for food web end members such as phytoplankton and bacteria, however it is rarely possible to measure these directly. Hence there is a critical need for improved methods for estimating the delta C-13 ratios of phytoplankton, bacteria and terrestrial detritus from within mixed seston. We determined the delta C-13 values of lipids, phospholipids and biomarker fatty acids and used these to calculate isotopic differences compared to the whole-cell delta C-13 values for eight phytoplankton classes, five bacterial taxa, and three types of terrestrial organic matter (two trees and one grass). The lipid content was higher amongst the phytoplankton (9.5 +/- 4.0%) than bacteria (7.3 +/- 0.8%) or terrestrial matter (3.9 +/- 1.7%). Our measurements revealed that the delta C-13 values of lipids followed phylogenetic classification among phytoplankton (78.2% of variance was explained by class), bacteria and terrestrial matter, and there was a strong correlation between the delta C-13 values of total lipids, phospholipids and individual fatty acids. Amongst the phytoplankton, the isotopic difference between biomarker fatty acids and bulk biomass averaged -10.7 +/- 1.1 parts per thousand for Chlorophyceae and Cyanophyceae, and -6.1 +/- 1.7 parts per thousand for Cryptophyceae, Chrysophyceae and Diatomophyceae. For heterotrophic bacteria and for type I and type II methane-oxidizing bacteria our results showed a -1.3 +/- 1.3 parts per thousand, -8.0 +/- 4.4 parts per thousand, and -3.4 +/- 1.4 parts per thousand delta C-13 difference, respectively, between biomarker fatty acids and bulk biomass. For terrestrial matter the isotopic difference averaged -6.6 +/- 1.2 parts per thousand. Based on these results, the delta C-13 values of total lipids and biomarker fatty acids can be used to determine the delta C-13 values of bulk phytoplankton, bacteria or terrestrial matter with +/- 1.4 parts per thousand uncertainty (i.e., the pooled SD of the isotopic difference for all samples). We conclude that when compound-specific stable isotope analyses become more widely available, the determination of delta C-13 values for selected biomarker fatty acids coupled with established isotopic differences, offers a promising way to determine taxa-specific bulk delta C-13 values for the phytoplankton, bacteria, and terrestrial detritus embedded within mixed seston.	[Taipale, Sami J.; Peltomaa, Elina] Univ Helsinki, Lammi Biol Stn, Lammi, Finland; [Hiltunen, Minna] Univ Eastern Finland, Dept Biol, Joensuu, Finland; [Jones, Roger I.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Hahn, Martin W.] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria; [Biasi, Christina] Univ Eastern Finland, Dept Environm Sci, Kuopio, Finland; [Brett, Michael T.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of Helsinki; University of Eastern Finland; University of Jyvaskyla; University of Innsbruck; University of Eastern Finland; University of Washington; University of Washington Seattle	Taipale, SJ (corresponding author), Univ Helsinki, Lammi Biol Stn, Lammi, Finland.	samit@u.washington.edu	Hahn, Martin W./B-9998-2008; Jones, Roger I/C-7703-2011; Taipale, Sami/AAO-3492-2020; Biasi, Christina/E-1130-2013	Hahn, Martin W./0000-0003-0501-2556; Jones, Roger I/0000-0002-0835-8264; Biasi, Christina/0000-0002-7413-3354; Hiltunen, Minna/0000-0002-0003-3000; Peltomaa, Elina/0000-0002-2858-8358	Academy of Finland grant [251665]; Foundation for Research of Natural Resources in Finland grant; Foundation of Nessling grant	Academy of Finland grant(Academy of Finland); Foundation for Research of Natural Resources in Finland grant; Foundation of Nessling grant	This project was supported by the Academy of Finland grant (251665) to Sami Taipale, the Foundation for Research of Natural Resources in Finland grant to Elina Peltomaa and Foundation of Nessling grant to Christina Biasi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bade DL, 2006, AQUAT SCI, V68, P142, DOI 10.1007/s00027-006-0818-5; Bec A, 2011, METHODS ECOL EVOL, V2, P651, DOI 10.1111/j.2041-210X.2011.00111.x; BIDIGARE RR, 1991, ANAL CHEM, V63, P130, DOI 10.1021/ac00002a008; BLAIR N, 1985, APPL ENVIRON MICROB, V50, P996, DOI 10.1128/AEM.50.4.996-1001.1985; Boschker HTS, 2002, FEMS MICROBIOL ECOL, V40, P85, DOI 10.1111/j.1574-6941.2002.tb00940.x; Brett MT, 2014, LIMNOL OCEANOGR, V59, P1795, DOI 10.4319/lo.2014.59.5.1795; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Chikaraishi Y., 2014, TREATISE GEOCHEMISTR, P95; Cole JJ, 2006, ECOL LETT, V9, P558, DOI 10.1111/j.1461-0248.2006.00898.x; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Cowie BR, 2009, ORG GEOCHEM, V40, P956, DOI 10.1016/j.orggeochem.2009.06.004; DEMOTT WR, 1986, OECOLOGIA, V69, P334, DOI 10.1007/BF00377053; Dijkman NA, 2006, MAR ECOL PROG SER, V324, P113, DOI 10.3354/meps324113; FLATT JP, 1970, J LIPID RES, V11, P131; Francis TB, 2011, ECOL LETT, V14, P364, DOI 10.1111/j.1461-0248.2011.01597.x; Galloway AWE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130053; Galloway AWE, 2014, FRESHWATER BIOL, V59, P1902, DOI 10.1111/fwb.12394; Galloway AWE, 2012, J PHYCOL, V48, P956, DOI 10.1111/j.1529-8817.2012.01173.x; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; Hayes DG, 2006, J AM OIL CHEM SOC, V73, P253; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; HOLO H, 1986, ARCH MICROBIOL, V145, P173, DOI 10.1007/BF00446776; ISOnumbers (The Database of Stable Isotope Numbers), 2015, RES; Jahnke LL, 1999, GEOCHIM COSMOCHIM AC, V63, P79, DOI 10.1016/S0016-7037(98)00270-1; Jones RI, 2001, GLOBAL BIOGEOCHEM CY, V15, P863, DOI 10.1029/2001GB001423; Jones RI, 2000, FRESHWATER BIOL, V45, P219, DOI 10.1046/j.1365-2427.2000.00672.x; Kankaala P, 2010, AQUAT ECOL, V44, P781, DOI 10.1007/s10452-010-9316-x; Kritzberg ES, 2006, ECOSYSTEMS, V9, P489, DOI 10.1007/s10021-005-0115-5; Marty J, 2008, LIMNOL OCEANOGR-METH, V6, P51, DOI 10.4319/lom.2008.6.51; NICHOLS PD, 1986, J MICROBIOL METH, V5, P49, DOI 10.1016/0167-7012(86)90023-0; Pace ML, 2007, LIMNOL OCEANOGR, V52, P2177, DOI 10.4319/lo.2007.52.5.2177; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Ruess L, 2005, ECOLOGY, V86, P2075, DOI 10.1890/04-1399; Sachs JP, 1999, GEOCHIM COSMOCHIM AC, V63, P1431, DOI 10.1016/S0016-7037(99)00097-6; Schagerl M, 2003, ANN LIMNOL-INT J LIM, V39, P35, DOI 10.1051/limn/2003003; Schagerl M, 2003, ANN LIMNOL-INT J LIM, V39, P49, DOI 10.1051/limn/2003005; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; Strandberg U, 2014, LIPIDS, V49, P591, DOI 10.1007/s11745-014-3902-y; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; Taipale S, 2008, ECOLOGY, V89, P463, DOI 10.1890/07-0702.1; Taipale S, 2013, AQUAT MICROB ECOL, V71, P165, DOI 10.3354/ame01671; Taipale SJ, 2014, ECOLOGY, V95, P563, DOI 10.1890/13-0650.1; Templeton AS, 2006, GEOCHIM COSMOCHIM AC, V70, P1739, DOI 10.1016/j.gca.2005.12.002; Vadeboncoeur Y, 2014, FRESHW SCI, V33, P524, DOI 10.1086/676315; Van den Meersche K, 2009, LIMNOL OCEANOGR, V54, P62, DOI 10.4319/lo.2009.54.1.0062; van Dongen BE, 2002, MAR ECOL PROG SER, V232, P83, DOI 10.3354/meps232083; Vuorio K, 2006, FRESHWATER BIOL, V51, P807, DOI 10.1111/j.1365-2427.2006.01529.x; Vuorio K, 2007, FUND APPL LIMNOL, V169, P237, DOI 10.1127/1863-9135/2007/0169-0237; Wartiainen I, 2006, INT J SYST EVOL MICR, V56, P109, DOI 10.1099/ijs.0.63728-0; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Yang C, 2014, INLAND WATERS, V4, P233, DOI 10.5268/IW-4.2.700; Zhang CLL, 2002, CURR OPIN BIOTECH, V13, P25, DOI 10.1016/S0958-1669(02)00280-X	59	36	37	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133974	10.1371/journal.pone.0133974	http://dx.doi.org/10.1371/journal.pone.0133974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208114	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000184
J	Zhang, WH; Zhou, T				Zhang, Wanhong; Zhou, Tong			A Sparse Reconstruction Approach for Identifying Gene Regulatory Networks Using Steady-State Experiment Data	PLOS ONE			English	Article							DIFFERENTIAL-EQUATION MODELS; SIGNAL RECOVERY; INFERENCE; SYSTEMS; ALGORITHMS; BIOLOGY	Motivation Identifying gene regulatory networks (GRNs) which consist of a large number of interacting units has become a problem of paramount importance in systems biology. Situations exist extensively in which causal interacting relationships among these units are required to be reconstructed from measured expression data and other a priori information. Though numerous classical methods have been developed to unravel the interactions of GRNs, these methods either have higher computing complexities or have lower estimation accuracies. Note that great similarities exist between identification of genes that directly regulate a specific gene and a sparse vector reconstruction, which often relates to the determination of the number, location and magnitude of nonzero entries of an unknown vector by solving an underdetermined system of linear equations y = Phi x. Based on these similarities, we propose a novel framework of sparse reconstruction to identify the structure of a GRN, so as to increase accuracy of causal regulation estimations, as well as to reduce their computational complexity. Results In this paper, a sparse reconstruction framework is proposed on basis of steady-state experiment data to identify GRN structure. Different from traditional methods, this approach is adopted which is well suitable for a large-scale underdetermined problem in inferring a sparse vector. We investigate how to combine the noisy steady-state experiment data and a sparse reconstruction algorithm to identify causal relationships. Efficiency of this method is tested by an artificial linear network, a mitogen-activated protein kinase (MAPK) pathway network and the in silico networks of the DREAM challenges. The performance of the suggested approach is compared with two state-of-the-art algorithms, the widely adopted total least-squares (TLS) method and those available results on the DREAM project. Actual results show that, with a lower computational cost, the proposed method can significantly enhance estimation accuracy and greatly reduce false positive and negative errors. Furthermore, numerical calculations demonstrate that the proposed algorithm may have faster convergence speed and smaller fluctuation than other methods when either estimate error or estimate bias is considered.	[Zhang, Wanhong; Zhou, Tong] Qinghai Univ, Sch Chem Machinery, Xining, Qinghai, Peoples R China; [Zhang, Wanhong] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Qinghai University; Tsinghua University; Tsinghua University	Zhang, WH (corresponding author), Qinghai Univ, Sch Chem Machinery, Xining, Qinghai, Peoples R China.	zhangwh11@mails.tsinghua.edu.cn	Zhou, Tong/AAD-1593-2019		973 Program of China [2012CB316504]; National Natural Science Foundation of China [61174122, 61021063]; Specialized Research Fund for the Doctoral Program of Higher Education, P.R.C. [20110002110045]	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education, P.R.C.(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported in part by 973 Program of China (grant no. 2012CB316504), National Natural Science Foundation of China (grant nos. 61174122 and 61021063), and Specialized Research Fund for the Doctoral Program of Higher Education, P.R.C. (grant no. 20110002110045).	Akutsu T, 2003, THEOR COMPUT SCI, V298, P235, DOI 10.1016/S0304-3975(02)00425-5; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Andrec M, 2005, J THEOR BIOL, V232, P427, DOI 10.1016/j.jtbi.2004.08.022; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Candes EJ, 2008, CR MATH, V346, P589, DOI 10.1016/j.crma.2008.03.014; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Chang R, 2008, IEEE T KNOWL DATA EN, V20, P1587, DOI 10.1109/TKDE.2008.89; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Donoho DL, 2012, IEEE T INFORM THEORY, V58, P1094, DOI 10.1109/TIT.2011.2173241; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; Ferrazzi F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S2; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Iba H, 2008, INFORM SCIENCES, V178, P4453, DOI 10.1016/j.ins.2008.07.029; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Li Z, 2011, BIOINFORMATICS, V27, P2686, DOI 10.1093/bioinformatics/btr454; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Needell D, 2009, FOUND COMPUT MATH, V9, P317, DOI 10.1007/s10208-008-9031-3; Penfold CA, 2012, BIOINFORMATICS, V28, pI233, DOI 10.1093/bioinformatics/bts222; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Sarvotham S, 2006, PREPRINT; Shmulevich I., 2010, PROB BOOL NETW; Sontag ED, 2008, ESSAYS BIOCHEM, V45, P161, DOI 10.1042/BSE0450161; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang J, 2012, IEEE T SIGNAL PROCES, V60, P6202, DOI 10.1109/TSP.2012.2218810; Wang YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031194; Xiong J, 2013, CHIN CONTR CONF, P8235; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043819; Yun Z, 2004, I C CONT AUTOMAT ROB, P1049; Zhang WH, 2013, CHIN CONTR CONF, P1951; Zhou T, 2012, CHIN CONTR CONF, P7408; Zhou T, 2010, BIOINFORMATICS, V26, P2020, DOI 10.1093/bioinformatics/btq325	40	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130979	10.1371/journal.pone.0130979	http://dx.doi.org/10.1371/journal.pone.0130979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207991	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000013
J	Haran, J; Roques, A; Bernard, A; Robinet, C; Roux, G				Haran, Julien; Roques, Alain; Bernard, Alexis; Robinet, Christelle; Roux, Geraldine			Altitudinal Barrier to the Spread of an Invasive Species: Could the Pyrenean Chain Slow the Natural Spread of the Pinewood Nematode?	PLOS ONE			English	Article							MONOCHAMUS-GALLOPROVINCIALIS COLEOPTERA; POSTGLACIAL RE-COLONIZATION; WILT DISEASE; BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; GENETIC DIFFERENTIATION; ADMIXTURE PROPORTIONS; PROCESSIONARY MOTH; DNA PHYLOGEOGRAPHY; COMPUTER-PROGRAM	Mountain ranges may delimit the distribution of native species as well as constitute potential barriers to the spread of invasive species. The invasive pinewood nematode, Bursaphelenchus xylophilus, is a severe forest pest inducing pine wilt disease. It is vectored in Europe by a native long-horned beetle, Monochamus galloprovincialis. This study explored the potential of the Pyrenean chain to slow or prevent the natural spread of nematode-infested beetles from the Iberian Peninsula, where the nematode is established and is expanding its range, towards France and the rest of Europe. An analysis of the genetic structure and migration patterns of the beetle populations throughout the Pyrenean mountain range was combined with a spread model simulating the potential movements of nematode-infested beetles across it. The central part of the Pyrenees, which corresponds to the highest elevation zone, was shown to prevent gene flow between the French and Spanish populations of M. galloprovincialis on each side of the mountains. Conversely, strong admixture was detected between populations located on both sides of low elevation hills, and especially at the east and west extremities of the mountain range. Simulations of the spread of nematode-infested beetles under various thresholds of beetle survival and pine wilt disease expression gave results consistent with the variation in genetic make-up, suggesting that western and eastern hillsides may represent corridors favoring natural spread of the nematode from the Iberian Peninsula to France. Simulations also showed that temperature rise due to climate change may significantly reduce the extent of the barrier formed by highest elevations. Our results support the hypothesis that the Pyrenean chain represents a partial barrier to the natural spread of nematode-infested beetles. These results, which have to be considered together with potential human-assisted long-distance spread of the nematode, highlight priority zones for future pest monitoring and management programs. More generally, such an integrated approach could be used to assess the role of mountain chains in the potential spread of other invasive pests.	[Haran, Julien; Roques, Alain; Bernard, Alexis; Robinet, Christelle; Roux, Geraldine] INRA, Zool Forestiere UR633, F-45075 Orleans, France; [Haran, Julien; Roux, Geraldine] Univ Orleans, Orleans, France	INRAE; Universite de Orleans	Haran, J (corresponding author), INRA, Zool Forestiere UR633, F-45075 Orleans, France.	julien.haran@orleans.inra.fr		Robinet, Christelle/0000-0002-4933-4656; Roux, Geraldine/0000-0002-1116-2799	European project REPHRAME (FP7 Project, Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophilus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy) [KBBE.2010.1.4-09]; French Ministry of Research and Education	European project REPHRAME (FP7 Project, Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophilus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy); French Ministry of Research and Education	This work was funded by the European project REPHRAME KBBE.2010.1.4-09 (FP7 Project, Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophilus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy). First author was funded by the French Ministry of Research and Education.	[Anonymous], 2008, PINE WILT DISEASE; [Anonymous], 2013, 6 DREAL MID SECR GEN; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Bergdalh DR, 1988, J NEMATOL, V20, P206; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; Brasier C.M., 1987, POPULATIONS PLANT PA, P213; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Bucci G, 2007, MOL ECOL, V16, P2137, DOI 10.1111/j.1365-294X.2007.03275.x; Carrasco LR, 2010, ECOL MODEL, V221, P2068, DOI 10.1016/j.ecolmodel.2010.05.012; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chikhi L, 2001, GENETICS, V158, P1347; Choi SK, 2011, ANN ENTOMOL SOC AM, V104, P816, DOI 10.1603/AN11012; Choisy M, 2004, MOL ECOL, V13, P955, DOI 10.1111/j.1365-294X.2004.02107.x; Coates BS, 2009, J HERED, V100, P556, DOI 10.1093/jhered/esp028; Cooper SJB, 1993, INSECT MOL BIOL, V4, P49; Cornuet JM, 1999, GENETICS, V153, P1989; David G, 2014, J APPL ENTOMOL, V138, P566, DOI 10.1111/jen.12110; Demesure B, 1996, EVOLUTION, V50, P2515, DOI 10.1111/j.1558-5646.1996.tb03638.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eschen R, 2014, DIVERS DISTRIB, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans H. F., 1996, Bulletin OEPP, V26, P199, DOI 10.1111/j.1365-2338.1996.tb00594.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gruffudd H., 2013, Berichte aus dem Julius Kuhn-Institut, P82; Haran J, 2014, CONSERV GENET RESOUR, V6, P975, DOI 10.1007/s12686-014-0262-0; HELLRIGL K G, 1971, Redia, V52, P367; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Joger U, 2007, ZOOL ANZ, V246, P293, DOI 10.1016/j.jcz.2007.09.002; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karl I, 2009, FUNCT ECOL, V23, P1132, DOI 10.1111/j.1365-2435.2009.01607.x; King RA, 1998, MOL ECOL, V7, P1151, DOI 10.1046/j.1365-294x.1998.00432.x; Koutroumpa FA, 2013, BIOL J LINN SOC, V109, P354, DOI 10.1111/bij.12042; Langella O, 2001, MOL ECOL NOTES, V1, P357, DOI 10.1046/j.1471-8278.2001.00099.x; LINIT MJ, 1988, J NEMATOL, V20, P227; Lopez Sergio, 2012, Psyche (Cambridge), V2012, P1; Lopez-Moreno JI, 2008, INT J CLIMATOL, V28, P1535, DOI 10.1002/joc.1645; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Luchi N, 2011, FOREST PATHOL, V41, P270, DOI 10.1111/j.1439-0329.2010.00670.x; MAMIYA Y, 1988, J NEMATOL, V20, P219; Mas H., 2013, Berichte aus dem Julius Kuhn-Institut, P22; Miguel I, 2007, APIDOLOGIE, V38, P141, DOI 10.1051/apido:2007007; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Naves P, 2009, J PEST SCI, V82, P1, DOI 10.1007/s10340-008-0210-4; Naves PM, 2007, ENTOMOL FENNICA, V18, P193; Naves PM, 2006, ENTOMOL EXP APPL, V120, P99, DOI 10.1111/j.1570-7458.2006.00430.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pitt JPW, 2009, ECOL APPL, V19, P1176, DOI 10.1890/08-1777.1; Potter C, 2011, PHILOS T R SOC B, V366, P1966, DOI 10.1098/rstb.2010.0395; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Robinet C, 2007, GLOBAL ECOL BIOGEOGR, V16, P460, DOI 10.1111/j.1466-8238.2006.00302.x; Robinet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043366; Robinet C, 2011, BIOL INVASIONS, V13, P2981, DOI 10.1007/s10530-011-9983-0; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Roques A, 2014, CLIMATE CHA IN PRESS; Roques Alain, 2010, BioRisk, V4, P1; Rousselet J, 2010, J BIOGEOGR, V37, P1478, DOI 10.1111/j.1365-2699.2010.02289.x; RUTHERFORD TA, 1987, CAN J FOREST RES, V17, P1050, DOI 10.1139/x87-161; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Santucci F, 1998, MOL ECOL, V7, P1163, DOI 10.1046/j.1365-294x.1998.00436.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Schrey NM, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.11001; Schroeder T., 2009, Bulletin OEPP, V39, P179, DOI 10.1111/j.1365-2338.2009.02287.x; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Shigesada N., 1997, OXFORD SERIES ECOLOG; Shoda-Kagaya E, 2007, B ENTOMOL RES, V97, P167, DOI 10.1017/S000748530700483X; Soliman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045505; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TABERLET P, 1994, EVOLUTION, V48, P623, DOI 10.1111/j.1558-5646.1994.tb01349.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Takasu Fugo, 2000, Biological Invasions, V2, P141, DOI 10.1023/A:1010048725497; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Troltzsch K, 2009, FOREST ECOL MANAG, V257, P294, DOI 10.1016/j.foreco.2008.09.012; Vincent B, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2007083; Wallin Henrik, 2013, Norwegian Journal of Entomology, V60, P11; WALLIS GP, 1989, EVOLUTION, V43, P88, DOI 10.1111/j.1558-5646.1989.tb04209.x; Wiens JA, 2000, ECOLOGICAL CONSEQUEN, P9; Yamamura K, 2003, POPUL ECOL, V45, P149, DOI 10.1007/s10144-003-0152-x; Yoshimura A, 1999, ECOLOGY, V80, P1691, DOI 10.2307/176557; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Zhao B.G., 2008, PINE WILT DISEASE, P18	92	17	17	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134126	10.1371/journal.pone.0134126	http://dx.doi.org/10.1371/journal.pone.0134126			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222551	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800108
J	Lontok, KS; Zhang, H; Dougherty, MJ				Lontok, Katherine S.; Zhang, Hubert; Dougherty, Michael J.			Assessing the Genetics Content in the Next Generation Science Standards	PLOS ONE			English	Article								Science standards have a long history in the United States and currently form the backbone of efforts to improve primary and secondary education in science, technology, engineering, and math (STEM). Although there has been much political controversy over the influence of standards on teacher autonomy and student performance, little light has been shed on how well standards cover science content. We assessed the coverage of genetics content in the Next Generation Science Standards (NGSS) using a consensus list of American Society of Human Genetics (ASHG) core concepts. We also compared the NGSS against state science standards. Our goals were to assess the potential of the new standards to support genetic literacy and to determine if they improve the coverage of genetics concepts relative to state standards. We found that expert reviewers cannot identify ASHG core concepts within the new standards with high reliability, suggesting that the scope of content addressed by the standards may be inconsistently interpreted. Given results that indicate that the disciplinary core ideas (DCIs) included in the NGSS documents produced by Achieve, Inc. clarify the content covered by the standards statements themselves, we recommend that the NGSS standards statements always be viewed alongside their supporting disciplinary core ideas. In addition, gaps exist in the coverage of essential genetics concepts, most worryingly concepts dealing with patterns of inheritance, both Mendelian and complex. Finally, state standards vary widely in their coverage of genetics concepts when compared with the NGSS. On average, however, the NGSS support genetic literacy better than extant state standards.	[Lontok, Katherine S.; Zhang, Hubert; Dougherty, Michael J.] Amer Soc Human Genet, Bethesda, MD 20814 USA; [Dougherty, Michael J.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Lontok, KS (corresponding author), Amer Soc Human Genet, Bethesda, MD 20814 USA.	klontok@ashg.org		Lontok, Katherine/0000-0001-7127-340X				Academic Benchmarks, NEXT GEN SCI STAND A; Achieve I, 2013, READ NEXT GEN SCI ST; Achieve Inc, 2013, DEV OV; American Society of Clinical Oncology-College of American Pathologists Clinical Practice Guideline Update, 2013, REC HUM EP GROWTH FA; [Anonymous], 2013, DIG ED STAT 2013; Dougherty MJ, 2011, CBE-LIFE SCI EDUC, V10, P318, DOI 10.1187/cbe.10-09-0122; Dougherty MJ, 2009, AM J HUM GENET, V85, P6, DOI 10.1016/j.ajhg.2009.05.010; Finn Jr. CE, 2013, NGSS HAVE LANDED; Flockhart DA, 2008, GENET MED, V10, P139, DOI 10.1097/GIM.0b013e318163c35f; Freelon D, 2013, INT J INTERNET SCI, V8, P10; Gross P, 2013, FINAL EVALUATION NEX, P67; Harris P, 2013, 4 US STATES CONSIDER; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Hoffman M., 2007, REVOLUTIONIZING EART; Horak J, 2014, NEW JERSEY ADOPTS NE; Krippendorff K, 2004, QUAL QUANT, V38, P787, DOI 10.1007/s11135-004-8107-7; Lerner L. S., 2012, STATE STATE SCI STAN; Lombard M, 2010, PRACTICAL RESOURCES; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; National Center for Science Education, 2013, PROGR S CAR; National Research Council, 1996, NAT SCI ED STAND; National Science Teachers Association, 2014, ITS OFF STAT ILL AD; National Science Teachers Association, 2014, OR BEC 10 STAT DC AD; National Science Teachers Association, 2014, NEW JERS AD NEXT GEN; Natl Res Council, 2012, FRAMEWORK FOR K-12 SCIENCE EDUCATION: PRACTICES, CROSSCUTTING CONCEPTS, AND CORE IDEAS, P1; Next Generation Science Standards (NGSS), 2013, ACH INC BEH 26 STAT; Ravitch D., 1995, NATL STANDARDS AM ED; Redfield RJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001356; Robelen E.S.C., 2012, ED WEEK CURRICU 0629; SKOOG G, 2005, SCI ED, V14, P395, DOI DOI 10.1007/S11191-004-5611-Z; Smith MU, 2014, AM BIOL TEACH, V76, P224, DOI 10.1525/abt.2014.76.4.2; Studies NEA of the USC of T on SS, 1894, STUD NEA USC T SS RE; The Los Angeles Times, 2012, LOS ANGELES TIMES; Todd L, 2014, CASPER STAR TRI 0314; Wefer SH, 2008, CBE-LIFE SCI EDUC, V7, P155, DOI 10.1187/cbe.07-05-0026; Workosky C, 2014, OREGON BECOMES 10 ST; Workosky C, 2014, ITS OFFICIAL STATE I	37	8	8	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132742	10.1371/journal.pone.0132742	http://dx.doi.org/10.1371/journal.pone.0132742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222583	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800028
J	Stoltenburg, R; Schubert, T; Strehlitz, B				Stoltenburg, Regina; Schubert, Thomas; Strehlitz, Beate			In vitro Selection and Interaction Studies of a DNA Aptamer Targeting Protein A	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; STRUCTURAL BASIS; BINDING-SITE; IGG-BINDING; AFFINITY; IDENTIFICATION; LIGANDS; SELEX; RECOGNITION; MOLECULES	A new DNA aptamer targeting Protein A is presented. The aptamer was selected by use of the FluMag-SELEX procedure. The SELEX technology (Systematic Evolution of Ligands by EXponential enrichment) is widely applied as an in vitro selection and amplification method to generate target-specific aptamers and exists in various modified variants. FluMag-SELEX is one of them and is characterized by the use of magnetic beads for target immobilization and fluorescently labeled oligonucleotides for monitoring the aptamer selection progress. Structural investigations and sequence truncation experiments of the selected aptamer for Protein A led to the conclusion, that a stem-loop structure at its 5'-end including the 5'-primer binding site is essential for aptamer-target binding. Extensive interaction analyses between aptamer and Protein A were performed by methods like surface plasmon resonance, MicroScale Thermophoresis and bead-based binding assays using fluorescence measurements. The binding of the aptamer to its target was thus investigated in assays with immobilization of one of the binding partners each, and with both binding partners in solution. Affinity constants were determined in the low micromolar to submicromolar range, increasing to the nanomolar range under the assumption of avidity. Protein A provides more than one binding site for the aptamer, which may overlap with the known binding sites for immunoglobulins. The aptamer binds specifically to both native and recombinant Protein A, but not to other immunoglobulin-binding proteins like Protein G and L. Cross specificity to other proteins was not found. The application of the aptamer is directed to Protein A detection or affinity purification. Moreover, whole cells of Staphylococcus aureus, presenting Protein A on the cell surface, could also be bound by the aptamer.	[Stoltenburg, Regina] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Schubert, Thomas] 2bind GmbH, Regensburg, Germany; [Strehlitz, Beate] UFZ Helmholtz Ctr Environm Res, Dept Environm & Biotechnol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Stoltenburg, R (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany.	regina.stoltenburg@ufz.de	Strehlitz, Beate/H-3054-2019; Stoltenburg, Regina/D-5482-2015	Strehlitz, Beate/0000-0002-3211-0584; Stoltenburg, Regina/0000-0001-5361-6632; Schubert, Thomas/0000-0002-9709-3287	Federal Ministry of Education and Research (BMBF), Germany [02WM1027, 02WM1165]; 2bind GmbH; UFZ	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); 2bind GmbH; UFZ(Helmholtz Association)	This work was integrated in the joint project "International Water Research Alliance Saxony-IWAS" and was funded by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/en/index.php), Germany (02WM1027, 02WM1165). 2bind GmbH and UFZ provided support in the form of salaries for authors TS and BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1989, J BIOL CHEM, V264, P19740; AKERSTROM B, 1987, J BIOL CHEM, V262, P13388; AKERSTROM B, 1985, J IMMUNOL, V135, P2589; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Baumstummler A, 2014, LETT APPL MICROBIOL, V59, P422, DOI 10.1111/lam.12295; Bien J, 2011, J PATHOG, V2011, DOI 10.4061/2011/601905; BJORCK L, 1988, J IMMUNOL, V140, P1194; Boyacioglu O, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.37; BOYLE MDP, 1998, ENCY IMMUNOLOGY, P323; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chang YC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01863; Cheung YW, 2013, P NATL ACAD SCI USA, V110, P15967, DOI 10.1073/pnas.1309538110; Cruz-Aguado JA, 2008, J AGR FOOD CHEM, V56, P10456, DOI 10.1021/jf801957h; Daniel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075419; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Friedman AD, 2015, BIOMATERIALS, V36, P110, DOI 10.1016/j.biomaterials.2014.08.046; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Han SR, 2014, ANN MICROBIOL, V64, P883, DOI 10.1007/s13213-013-0720-z; Hasegawa H, 2008, SENSORS-BASEL, V8, P1090, DOI 10.3390/s8021090; Heilkenbrinker A, 2015, ANAL CHEM, V87, P677, DOI 10.1021/ac5034819; IBRAHIM S, 1993, SCAND J IMMUNOL, V38, P368, DOI 10.1111/j.1365-3083.1993.tb01739.x; Jansson B, 1998, FEMS IMMUNOL MED MIC, V20, P69, DOI 10.1016/S0928-8244(97)00108-9; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; KASTERN W, 1992, J BIOL CHEM, V267, P12820; Kobayashi SD, 2013, MBIO, V4, DOI 10.1128/mBio.00764-13; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maeng JS, 2012, J NANOSCI NANOTECHNO, V12, P5138, DOI 10.1166/jnn.2012.6369; Mallikaratchy PR, 2011, NUCLEIC ACIDS RES, V39, P2458, DOI 10.1093/nar/gkq996; Moon J, 2015, SENSORS-BASEL, V15, P8884, DOI 10.3390/s150408884; Paniel N, 2013, METHODS, V64, P229, DOI 10.1016/j.ymeth.2013.07.001; Peyret N., 2000, THESIS; Radom F, 2013, BIOTECHNOL ADV, V31, P1260, DOI 10.1016/j.biotechadv.2013.04.007; Rohloff JC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.49; Ruigrok VJB, 2012, CHEMBIOCHEM, V13, P829, DOI 10.1002/cbic.201100774; Saha K, 2003, ANAL CHEM, V75, P835, DOI 10.1021/ac0204911; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sorum M, 2013, PATHOG DIS, V67, P19, DOI 10.1111/2049-632X.12017; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423; Stoltenburg R, 2005, ANAL BIOANAL CHEM, V383, P83, DOI 10.1007/s00216-005-3388-9; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Strehlitz B, 2011, Germany patent, P1, Patent No. [DE 102011006610, 102011006610]; Szeitner Z, 2014, J PHARMACEUT BIOMED, V101, P58, DOI 10.1016/j.jpba.2014.04.018; Tothova P, 2014, BIOCHEMISTRY-US, V53, P7013, DOI 10.1021/bi500773c; Tucker WO, 2012, CURR PHARM DESIGN, V18, P2014; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turek Diane, 2013, World J Transl Med, V2, P67; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	51	53	5	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134403	10.1371/journal.pone.0134403	http://dx.doi.org/10.1371/journal.pone.0134403			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221730	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800141
J	Zhang, DL; Zhang, ZD; Li, JM; Chang, YB; Du, QJ; Pan, TH				Zhang, Dalong; Zhang, Zhongdian; Li, Jianming; Chang, Yibo; Du, Qingjie; Pan, Tonghua			Regulation of Vapor Pressure Deficit by Greenhouse Micro-Fog Systems Improved Growth and Productivity of Tomato via Enhancing Photosynthesis during Summer Season	PLOS ONE			English	Article							STOMATAL SIZE; FOGGING SYSTEMS; AIR HUMIDITY; WATER STATUS; LEAF-AREA; CONDUCTANCE; DENSITY; TEMPERATURE; TRANSPIRATION; ACCLIMATION	The role of a proposed micro-fog system in regulating greenhouse environments and enhancing tomato (Solanum lycopersicum L.) productivity during summer season was studied. Experiments were carried out in a multi-span glass greenhouse, which was divided into two identical compartments involving different environments: (1) without environment control and (2) with a micro-fog system operating when the air vapor pressure deficit (VPD) of greenhouse was higher than 0.5 KPa. The micro-fog system effectively alleviated heat stress and evaporative demand in the greenhouse during summer season. The physiologically favourable environment maintained by micro-fog treatment significantly enhanced elongation of leaf and stem, which contributed to a substantial elevation of final leaf area and shoot biomass. These improvements in physiological and morphological traits resulted in around 12.3% increase of marketable tomato yield per plant. Relative growth rate (RGR) of micro-fog treatment was also significantly higher than control plants, which was mainly determined by the substantial elevation in net assimilation rate (NAR), and to a lesser extent caused by leaf area ratio (LAR). Measurement of leaf gas exchange parameters also demonstrated that micro-fog treatment significantly enhanced leaf photosynthesis capacity. Taken together, manipulation of VPD in greenhouses by micro-fog systems effectively enhanced tomato growth and productivity via improving photosynthesis during summer season.	[Zhang, Dalong; Zhang, Zhongdian; Li, Jianming; Chang, Yibo; Du, Qingjie; Pan, Tonghua] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Li, JM (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	lijianming66@163.com			National Science Foundation of China [31471916]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China 31471916.	Abdel-Ghany AM, 2006, BIOSYST ENG, V94, P97, DOI 10.1016/j.biosystemseng.2006.02.008; APHALO PJ, 1991, PLANT CELL ENVIRON, V14, P127, DOI 10.1111/j.1365-3040.1991.tb01379.x; Arbel A, 2003, BIOSYST ENG, V84, P45, DOI 10.1016/S1537-5110(02)00216-7; Arbel A, 1999, J AGR ENG RES, V72, P129, DOI 10.1006/jaer.1998.0351; Athanasiou K, 2010, PLANT PHYSIOL, V152, P366, DOI 10.1104/pp.109.149351; BAKKER JC, 1991, SCI HORTIC-AMSTERDAM, V48, P205, DOI 10.1016/0304-4238(91)90128-L; Bunce JA, 1997, PLANT CELL ENVIRON, V20, P131, DOI 10.1046/j.1365-3040.1997.d01-3.x; Carins Murphy MR, 2014, PLANT CELL ENVIRON, V37, P124, DOI 10.1111/pce.12136; Codarin S, 2006, SCI HORTIC-AMSTERDAM, V108, P303, DOI 10.1016/j.scienta.2006.01.036; Drake PL, 2013, J EXP BOT, V64, P495, DOI 10.1093/jxb/ers347; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Kaiser H, 2009, PLANT CELL ENVIRON, V32, P1091, DOI 10.1111/j.1365-3040.2009.01990.x; Katsoulas N, 2009, SCI HORTIC-AMSTERDAM, V123, P90, DOI 10.1016/j.scienta.2009.08.004; Katsoulas N, 2001, AGR FOREST METEOROL, V106, P233, DOI 10.1016/S0168-1923(00)00211-2; KOCH GW, 1994, TREE PHYSIOL, V14, P347, DOI 10.1093/treephys/14.4.347; Lammertsma EI, 2011, P NATL ACAD SCI USA, V108, P4035, DOI 10.1073/pnas.1100371108; Lawson T, 2014, PLANT PHYSIOL, V164, P1556, DOI 10.1104/pp.114.237107; Li S, 2006, ACTA HORTIC, P393, DOI 10.17660/ActaHortic.2006.719.44; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Max JFJ, 2009, SCI HORTIC-AMSTERDAM, V122, P179, DOI 10.1016/j.scienta.2009.05.007; MIRANDA V, 1981, NEW PHYTOL, V88, P595, DOI 10.1111/j.1469-8137.1981.tb01735.x; Mortensen LM, 2000, SCI HORTIC-AMSTERDAM, V86, P299, DOI 10.1016/S0304-4238(00)00155-2; Muraoka H, 2000, PLANT CELL ENVIRON, V23, P235, DOI 10.1046/j.1365-3040.2000.00547.x; Nejad AR, 2008, J EXP BOT, V59, P289, DOI 10.1093/jxb/erm308; Ohyama K, 2008, ACTA HORTIC, P321, DOI 10.17660/ActaHortic.2008.797.45; Patane C, 2010, AGR WATER MANAGE, V97, P131, DOI 10.1016/j.agwat.2009.08.021; RADOGLOU KM, 1990, ANN BOT-LONDON, V65, P617, DOI 10.1093/oxfordjournals.aob.a087978; Schymanski SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054231; [沈明卫 Shen Mingwei], 2003, [农业机械学报, Transactions of the Chinese Society of Agricultural Machinery], V34, P65; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Teitel M, 2010, BIOSYST ENG, V106, P166, DOI 10.1016/j.biosystemseng.2010.03.007; Toida H, 2006, BIOSYST ENG, V93, P205, DOI 10.1016/j.biosystemseng.2005.11.003; Torre S, 2003, J AM SOC HORTIC SCI, V128, P598, DOI 10.21273/JASHS.128.4.0598; Tucci MLS, 2010, PHOTOSYNTHETICA, V48, P421, DOI 10.1007/s11099-010-0055-y; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Xu Z, 2008, J EXP BOT, V59, P3317, DOI 10.1093/jxb/ern185; Yamori W., 2013, J PLANT BIOCH PHYSL, V1, P113, DOI DOI 10.4172/2329-9029.1000113; Yamori W, 2011, PLANT J, V68, P966, DOI 10.1111/j.1365-313X.2011.04747.x; Zhang Jie, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P193; Zhang YJ, 2013, PLANT CELL ENVIRON, V36, P149, DOI 10.1111/j.1365-3040.2012.02563.x; Zhao Y, 2001, J AGR ENG RES, V78, P431, DOI 10.1006/jaer.2000.0649	42	34	38	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133919	10.1371/journal.pone.0133919	http://dx.doi.org/10.1371/journal.pone.0133919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221726	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800081
J	Kovari, H; Russmann, S; Ledergerber, B; Muller, D; Rotger, M; Velli, P; Cavassini, M; Ambrosioni, J; Bregenzer, A; Stockle, M; Bernasconi, E; Rauch, A; Speck, RF				Kovari, Helen; Russmann, Stefan; Ledergerber, Bruno; Mueller, Daniel; Rotger, Margalida; Velli, Pablo; Cavassini, Matthias; Ambrosioni, Juan; Bregenzer, Andrea; Stoeckle, Marcel; Bernasconi, Enos; Rauch, Andri; Speck, Roberto F.		Swiss HIV Cohort Study	Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ALPHA-2A PLUS RIBAVIRIN; INFECTED PATIENTS; GENETIC-VARIATION; VIRUS; PEGINTERFERON; IL28B	Background Ribavirin (RBV) is an essential component of most current hepatitis C (HCV) treatment regimens and still standard of care in the combination with pegylated interferon (pegIFN) to treat chronic HCV in resource limited settings. Study results in HIV/HCV-coinfected patients are contradicting as to whether RBV concentration correlates with sustained virological response (SVR). Methods We included 262 HCV treatment naive HIV/HCV-coinfected Swiss HIV Cohort Study (SHCS) participants treated with RBV and pegIFN between 01.01.2001-01.01.2010, 134 with HCV genotype (GT) 1/4, and 128 with GT 2/3 infections. RBV levels were measured retrospectively in stored plasma samples obtained between HCV treatment week 4 and end of therapy. Uni- and multivariable logistic regression analyses were used to evaluate the association between RBV concentration and SVR in GT 1/4 and GT 2/3 infections. The analyses were repeated stratified by treatment phase (week 4-12, 13-24, >24) and IL28B genotype (CC versus CT/TT). Results SVR rates were 35.1% in GT 1/4 and 70.3% in GT 2/3 infections. Overall, median RBV concentration was 2.0 mg/L in GT 1/4, and 1.9 mg/L in GT 2/3, and did not change significantly across treatment phases. Patients with SVR had similar RBV concentrations compared to patients without SVR in both HCV genotype groups. SVR was not associated with RBV levels >= 2.0 mg/L (GT 1/4, OR 1.19 [0.5-2.86]; GT 2/3, 1.94 [0.78-4.80]) and >= 2.5 mg/L (GT 1/4, 1.56 [0.64-3.84]; GT 2/3 2.72 [0.85-8.73]), regardless of treatment phase, and IL28B genotype. Conclusion In HIV/HCV-coinfected patients treated with pegIFN/RBV, therapeutic drug monitoring of RBV concentrations does not enhance the chance of HCV cure, regardless of HCV genotype, treatment phase and IL28B genotype.	[Kovari, Helen; Ledergerber, Bruno; Speck, Roberto F.] Univ Zurich, Univ Hosp, Div Infect Dis, Zurich, Switzerland; [Kovari, Helen; Ledergerber, Bruno; Speck, Roberto F.] Univ Zurich, Univ Hosp, Hosp Epidemiol, Zurich, Switzerland; [Russmann, Stefan] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Mueller, Daniel] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Rotger, Margalida; Velli, Pablo] Univ Hosp, Inst Microbiol, Lausanne, Switzerland; [Cavassini, Matthias] Univ Hosp, Div Infect Dis, Lausanne, Switzerland; [Ambrosioni, Juan] Univ Hosp, Div Infect Dis, Geneva, Switzerland; [Bregenzer, Andrea] Cantonal Hosp, Div Infect Dis, St Gallen, Switzerland; [Stoeckle, Marcel] Univ Hosp, Div Infect Dis, Basel, Switzerland; [Stoeckle, Marcel] Univ Hosp, Hosp Epidemiol, Basel, Switzerland; [Bernasconi, Enos] Osped Reg, Lugano, Switzerland; [Rauch, Andri] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern; University of Bern	Kovari, H (corresponding author), Univ Zurich, Univ Hosp, Div Infect Dis, Zurich, Switzerland.	helen.kovari@usz.ch	Rauch, Andri/E-9948-2017; Ledergerber, Bruno/B-5656-2009; Speck, Roberto F/O-2433-2016; cavassini, matthias/F-8987-2017	Rauch, Andri/0000-0001-5297-6062; Ledergerber, Bruno/0000-0002-6881-4401; cavassini, matthias/0000-0003-0933-7833; Speck, Roberto/0000-0002-8453-1137; Mueller, Daniel/0000-0002-4674-4019	Roche Pharma AG; Swiss HIV Cohort Study - Swiss National Science Foundation [148522]; SHCS project [650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070114, R01AI099026] Funding Source: NIH RePORTER	Roche Pharma AG(Roche Holding); Swiss HIV Cohort Study - Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); SHCS project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded within the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant #148522), by SHCS project #650, and by an unrestricted grant from Roche Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GUIDELINES SCREENING; Arase Y, 2004, J GASTROENTEROL, V39, P1090, DOI 10.1007/s00535-004-1483-x; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bodeau S, 2013, THER DRUG MONIT, V35, P791, DOI 10.1097/FTD.0b013e3182966dee; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chan AHW, 2009, ANN PHARMACOTHER, V43, P2044, DOI 10.1345/aph.1M225; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Crespo M, 2007, ANTIVIR THER, V12, P1217; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Glue P, 1999, SEMIN LIVER DIS, V19, P17; Hatu G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-150; Ioannou GN, 2013, ALIMENT PHARM THER, V38, P1373, DOI 10.1111/apt.12524; Jen JF, 2000, THER DRUG MONIT, V22, P555, DOI 10.1097/00007691-200010000-00010; Jin RY, 2012, AM J GASTROENTEROL, V107, P1675, DOI 10.1038/ajg.2012.306; Larrat S, 2003, ANTIMICROB AGENTS CH, V47, P124, DOI 10.1128/AAC.47.1.124-129.2003; Lopez-Cortes LF, 2008, CLIN PHARMACOL THER, V84, P573, DOI 10.1038/clpt.2008.110; Marucco DA, 2008, J ANTIMICROB CHEMOTH, V61, P919, DOI 10.1093/jac/dkn013; Morello J, 2008, J ANTIMICROB CHEMOTH, V62, P1174, DOI 10.1093/jac/dkn421; Morello J, 2010, ANTIMICROB AGENTS CH, V54, P1647, DOI 10.1128/AAC.01399-09; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nicot F, 2008, J MED VIROL, V80, P1523, DOI 10.1002/jmv.21227; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Slavenburg S, 2011, THER DRUG MONIT, V33, P40, DOI 10.1097/FTD.0b013e318205f892; Torres-Cornejo A, 2014, J VIRAL HEPATITIS, V21, P178, DOI 10.1111/jvh.12128; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133879	10.1371/journal.pone.0133879	http://dx.doi.org/10.1371/journal.pone.0133879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218843	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000358595900053
J	Salgotra, RK; Gupta, BB; Bhat, JA; Sharma, S				Salgotra, R. K.; Gupta, B. B.; Bhat, Javaid Akhter; Sharma, Sandeep			Genetic Diversity and Population Structure of Basmati Rice (Oryza sativa L.) Germplasm Collected from North Western Himalayas Using Trait Linked SSR Markers	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; VARIETIES; CULTIVARS; IDENTIFICATION; ACCESSIONS; DISTANCE; PANELS	One hundred forty one basmati rice genotypes collected from different geographic regions of North Western Himalayas were characterized using 40 traits linked microsatellite markers. Number of alleles detected by the abovementioned primers were 112 with a maximum and minimum frequency of 5 and 2 alleles, respectively. The maximum and minimum polymorphic information content values were found to be 0.63 and 0.17 for the primers RM206 and RM213, respectively. The genetic similarity coefficient for the most number of pairs ranged between of 0.2-0.9 with the average value of 0.60 for all possible combinations, indicating moderate genetic diversity among the chosen genotypes. Phylogenetic cluster analysis of the SSR data based on distance divided all genotypes into four groups (I, II, III and IV), whereas model based clustering method divided these genotypes into five groups (A, B, C, D and E). However, the result from both the analysis are in well agreement with each other for clustering on the basis of place of collection and geographic region, except the local basmati genotypes which clustered into three subpopulations in structure analysis comparison to two clusters in distance based clustering. The diverse genotypes and polymorphic trait linked microsatellites markers in the present study will be used for the identification of quantitative trait loci/genes for different economically important traits to be utilized in molecular breeding programme of rice in the future.	[Salgotra, R. K.; Sharma, Sandeep] Sher e Kashmir Univ Agr Sci & Technol Jammu, Sch Biotechnol, Jammu, J&K, India; [Gupta, B. B.; Bhat, Javaid Akhter] Sher e Kashmir Univ Agr Sci & Technol Jammu, Div Plant Breeding & Genet, Jammu, J&K, India	Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu); Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu)	Salgotra, RK (corresponding author), Sher e Kashmir Univ Agr Sci & Technol Jammu, Sch Biotechnol, Jammu, J&K, India.	rks_2959@rediffmail.com	Gupta, Brij B/E-9813-2011	Gupta, Brij B/0000-0003-4929-4698; Salgotra, Romesh Kumar/0000-0001-7605-0926	Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi [102/IFD/SAN/1727/2011-12]	Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi(Department of Biotechnology (DBT) India)	102/IFD/SAN/1727/2011-12, dated 23-08-2011 Department of Biotechnology, Ministry of Science and Technology, Govt. of India, New Delhi for sanctioning the project entitled, "Assessment of genetic diversity of Basmati rice using molecular markers and in situ conservation through participatory approach" under which the present work was undertaken aT Sher-e-Kashmir University of Agricultural Sciences &Tecnology of Jammu, (J&K) India.	Allhgholipour M, 2014, GENETIKA-BELGRADE, V46, P187, DOI 10.2298/GENSR1401187A; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Archak S, 2007, ELECTROPHORESIS, V28, P2396, DOI 10.1002/elps.200600646; Babu BK, 2014, MOL BIOL REP, V41, P4329, DOI 10.1007/s11033-014-3304-5; Chakhonkaen S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-19; Chaudhary RC, 2001, SPECIALITY RICES OF THE WORLD: BREEDING, PRODUCTION AND MARKETING, P3; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Chuang HY, 2011, BOT STUD, V52, P393; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Deshmukh R, 2010, FUNCT INTEGR GENOMIC, V10, P339, DOI 10.1007/s10142-010-0167-2; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Herrera TG, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue5-fulltext-6; Islam M.M., 2012, J BIOSCI BIOTECHNOL, V1, P107; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jairin J, 2009, FIELD CROP RES, V110, P263, DOI 10.1016/j.fcr.2008.09.009; Jayamani P, 2007, CROP SCI, V47, P879, DOI 10.2135/cropsci2006.04.0236; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; NEI M, 1978, GENETICS, V89, P583; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; Pessoa-Filho M, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-23; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Rabbani MA, 2010, PAK J BOT, V42, P2551; Ram SG, 2007, J APPL GENET, V48, P337, DOI 10.1007/BF03195230; Rashid M, 2009, AFR J BIOTECHNOL, V8, P6777; Sakthivel K, 2009, BIOTECHNOL ADV, V27, P468, DOI 10.1016/j.biotechadv.2009.04.001; Sarker M.M., 2013, J BANGLADESH AGRIC U, V11, P233, DOI 10.3329/jbau.v11i2.19900; Shah SM, 2013, PAK J BOT, V45, P423; Singh D, 2011, AFR J BIOTECHNOL, V10, P499; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Sivaranjani AKP, 2010, CURR SCI INDIA, V99, P221; Tessier C, 1999, THEOR APPL GENET, V98, P171, DOI 10.1007/s001220051054; Thompson JA, 1998, CROP SCI, V38, P1348, DOI [10.2135/cropsci1998.0011183X003800050034x, 10.2135/cropsci1998.0011183X003800050035x]; Thomson MJ, 2007, THEOR APPL GENET, V114, P559, DOI 10.1007/s00122-006-0457-1; Thomson MJ, 2009, RICE, V2, P80, DOI 10.1007/s12284-009-9023-1; Vinita Pachauri, 2013, Australian Journal of Crop Science, V7, P923; Wang CH, 2014, HEREDITY, V112, P489, DOI 10.1038/hdy.2013.130; Yadav S, 2013, J GENET, V92, P3; Yu SB, 2003, THEOR APPL GENET, V108, P131, DOI 10.1007/s00122-003-1400-3; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhang T, 2010, RICE SCI, V17, P288, DOI 10.1016/S1672-6308(09)60029-9	47	40	43	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0131858	10.1371/journal.pone.0131858	http://dx.doi.org/10.1371/journal.pone.0131858			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218261	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900003
J	Zhang, XQ; Li, JM; Wei, DP; Li, B; Ma, YB				Zhang, Xiaoqing; Li, Jumei; Wei, Dongpu; Li, Bo; Ma, Yibing			Predicting Soluble Nickel in Soils Using Soil Properties and Total Nickel	PLOS ONE			English	Article							CONTAMINATED SOILS; ORGANIC-MATTER; HUMIC SUBSTANCES; HEAVY-METALS; SPECIATION; NI; CU; CD; BINDING; ZN	Soil soluble nickel (Ni) concentration is very important for determining soil Ni toxicity. In the present study, the relationships between soil properties, total and soluble Ni concentrations in soils were developed in a wide range of soils with different properties and climate characteristics. The multiple regressions showed that soil pH and total soil Ni concentrations were the most significant parameters in predicting soluble Ni concentrations with the adjusted determination coefficients (R-adj(2)) values of 0.75 and 0.68 for soils spiked with soluble Ni salt and the spiked soils leached with artificial rainwater to mimic field conditions, respectively. However, when the soils were divided into three categories (pH < 7, 7-8 and > 8), they obtained better predictions with R-adj(2) values of 0.78-0.90 and 0.79-0.94 for leached and unleached soils, respectively. Meanwhile, the other soil properties, such as amorphous Fe and Al oxides and clay, were also found to be important for determining soluble Ni concentrations, indicating that they were also presented as active adsorbent surfaces. Additionally, the whole soil speciation including bulk soil properties and total soils Ni concentrations were analyzed by mechanistic speciation models WHAM VI and Visual MINTEQ3.0. It was found that WHAM VI provided the best predictions for the soils with pH < 7, was relatively reasonable for pH 7 to 8, and gave an overestimation for pH > 8. The Visual MINTEQ3.0 could provide better estimation for pH < 8 and meanwhile quite reasonable results for pH > 8. These results indicated the possibility and applicability of these models to predict soil soluble Ni concentration by soil properties.	[Zhang, Xiaoqing] Hubei Univ Nationalities, Sch Forestry & Hort, Enshi 445000, Hubei Province, Peoples R China; [Li, Jumei; Wei, Dongpu; Li, Bo] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100081, Peoples R China; [Ma, Yibing] Univ Jinan, Sch Resources & Environm, Jinan 250022, Shandong, Peoples R China	Hubei Minzu University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; University of Jinan	Ma, YB (corresponding author), Univ Jinan, Sch Resources & Environm, Jinan 250022, Shandong, Peoples R China.	ybma@caas.ac.cn		Ma, Yibing/0000-0002-9340-8181	Special Fund for Environmental Protection Scientific Research in the Public Interest [201509032]; Nickel Producers Environmental Research Association; International Copper Association; Rio Tinto Pty Ltd.	Special Fund for Environmental Protection Scientific Research in the Public Interest; Nickel Producers Environmental Research Association; International Copper Association; Rio Tinto Pty Ltd.	The manuscript was financially supported by Special Fund for Environmental Protection Scientific Research in the Public Interest (Project no. 201509032), the International Copper Association, Rio Tinto Pty Ltd., and the Nickel Producers Environmental Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe L, 2002, J COLLOID INTERF SCI, V247, P259, DOI 10.1006/jcis.2001.8125; Bonten LTC, 2008, GEODERMA, V146, P303, DOI 10.1016/j.geoderma.2008.06.005; Buekers J, 2007, EUR J SOIL SCI, V58, P1514, DOI 10.1111/j.1365-2389.2007.00958.x; Contin M, 2007, GEODERMA, V140, P164, DOI 10.1016/j.geoderma.2007.03.017; Dijkstra JJ, 2004, ENVIRON SCI TECHNOL, V38, P4390, DOI 10.1021/es049885v; Fairbrother A, 2007, ECOTOX ENVIRON SAFE, V68, P145, DOI 10.1016/j.ecoenv.2007.03.015; Gandois L, 2010, EUR J SOIL SCI, V61, P271, DOI 10.1111/j.1365-2389.2009.01215.x; Gustafsson JP, 2003, EUR J SOIL SCI, V54, P295, DOI 10.1046/j.1365-2389.2003.00526.x; Gustafsson JP, 2003, ENVIRON SCI TECHNOL, V37, P2767, DOI 10.1021/es026249t; Li B, 2011, ECOTOX ENVIRON SAFE, V74, P459, DOI 10.1016/j.ecoenv.2010.10.021; Li B, 2009, ECOTOX ENVIRON SAFE, V72, P1760, DOI 10.1016/j.ecoenv.2009.05.003; Nolan AL, 2009, J ENVIRON QUAL, V38, P485, DOI 10.2134/jeq2006.0275; Oorts K, 2007, ENVIRON TOXICOL CHEM, V26, P1130, DOI 10.1897/06-533R.1; Parat C, 2009, ANAL CHIM ACTA, V648, P157, DOI 10.1016/j.aca.2009.06.052; Ponizovsky AA, 2006, ENVIRON TOXICOL CHEM, V25, P671, DOI 10.1897/04-621R.1; Sauve S, 2000, ENVIRON SCI TECHNOL, V34, P1125, DOI 10.1021/es9907764; Sauve S, 2003, ENVIRON SCI TECHNOL, V37, P5191, DOI 10.1021/es030059g; Shi ZQ, 2012, ENVIRON SCI TECHNOL, V46, P2212, DOI 10.1021/es202376c; Sjostedt CS, 2010, ENVIRON SCI TECHNOL, V44, P8587, DOI 10.1021/es102415r; Thakali S, 2006, ENVIRON SCI TECHNOL, V40, P7085, DOI 10.1021/es061171s; Tipping E, 2003, ENVIRON POLLUT, V125, P213, DOI 10.1016/S0269-7491(03)00058-7; Tipping E, 2002, GEOCHIM COSMOCHIM AC, V66, P3211, DOI 10.1016/S0016-7037(02)00930-4; TIPPING E, 1995, EUR J SOIL SCI, V46, P77, DOI 10.1111/j.1365-2389.1995.tb01814.x; Tye AM, 2004, EUR J SOIL SCI, V55, P579, DOI 10.1111/j.1365-2389.2004.00627.x; Weng LP, 2001, ENVIRON SCI TECHNOL, V35, P4436, DOI 10.1021/es010085j; Weng LP, 2004, ENVIRON SCI TECHNOL, V38, P156, DOI 10.1021/es030053r; Ytreberg E, 2011, ENVIRON SCI TECHNOL, V45, P3145, DOI 10.1021/es1039166; Zarcinas BA, 1996, COMMUN SOIL SCI PLAN, V27, P1331, DOI 10.1080/00103629609369636	28	10	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133920	10.1371/journal.pone.0133920	http://dx.doi.org/10.1371/journal.pone.0133920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217951	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900055
J	Zhou, HW; Deng, HJ; Huang, DG; Zhu, ML				Zhou, Huiwei; Deng, Huijie; Huang, Degen; Zhu, Minling			Hedge Scope Detection in Biomedical Texts: An Effective Dependency-Based Method	PLOS ONE			English	Article								Hedge detection is used to distinguish uncertain information from facts, which is of essential importance in biomedical information extraction. The task of hedge detection is often divided into two subtasks: detecting uncertain cues and their linguistic scope. Hedge scope is a sequence of tokens including the hedge cue in a sentence. Previous hedge scope detection methods usually take all tokens in a sentence as candidate boundaries, which inevitably generate a large number of negatives for classifiers. The imbalanced instances seriously mislead classifiers and result in lower performance. This paper proposes a dependency-based candidate boundary selection method (DCBS), which selects the most likely tokens as candidate boundaries and removes the exceptional tokens which have less potential to improve the performance based on dependency tree. In addition, we employ the composite kernel to integrate lexical and syntactic information and demonstrate the effectiveness of structured syntactic features for hedge scope detection. Experiments on the CoNLL-2010 Shared Task corpus show that our method achieves 71.92% F1-score on the golden standard cues, which is 4.11% higher than the system without using DCBS. Although the candidate boundary selection method is only evaluated on hedge scope detection here, it can be popularized to other kinds of scope learning tasks.	[Zhou, Huiwei; Deng, Huijie; Huang, Degen] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China; [Zhu, Minling] Beijing Informat Sci & Technol Univ, Sch Comp, Beijing, Peoples R China	Dalian University of Technology; Beijing Information Science & Technology University	Zhou, HW (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	zhouhuiwei@dlut.edu.cn			National Natural Science Foundation of China [61272375, 61173100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 61272375 and 61173100, http://www.nsfc.gov.cn/Portal0/default152.htm).	[Anonymous], 2006, P C N AM CHAPT ASS C, DOI DOI 10.3115/1220835.1220872; APOSTOLOVA E, 2011, P 49 ANN M ASS COMP, V2, P283; Bokharaeian B., 2013, P 2 JOINT C LEX COMP, P644; Collins M, 2002, ADV NEUR IN, V14, P625; Farkas Richard, 2010, P 14 C COMP NAT LANG, P1; He LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065814; Liu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060954; Morante R., 2010, P 14 C COMP NAT LANG, P40; Morante R., 2009, P WORKSH BIONLP, P28; Moschitti A., 2006, P 10 C COMP NAT LANG, P61; Ovrelid L., 2010, P 23 INT C COMP LING, P1379; Ozgur Arzucan, 2009, P 2009 C EMPIRICAL M, P1398; Plank B, 2013, P 51 ANN M ASS COMP, V1, P1498; Qi Su, 2013, Chinese Lexical Semantics. 14th Workshop, CLSW 2013. Revised Selected Papers: LNCS 8229, P436, DOI 10.1007/978-3-642-45185-0_46; Szarvas G., 2008, P WORKSHOP CURRENT T, P38; Szarvas G, 2012, COMPUT LINGUIST, V38, P335, DOI 10.1162/COLI_a_00098; Velldal E, 2012, COMPUT LINGUIST, V38, P369, DOI 10.1162/COLI_a_00126; Wei Z. Y., 2013, P 51 ANN M ASS COMP, P58; [周惠巍 Zhou Huiwei], 2013, [中文信息学报, Journal of Chinese Information Processing], V27, P137; Zhou HW, 2011, CHINESE J ELECTRON, V20, P476; Zhu Q., 2010, P 2010 C EMP METH NA, P714; Zou Bowei, 2013, P 2013 C EMP METH NA, P968	22	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133715	10.1371/journal.pone.0133715	http://dx.doi.org/10.1371/journal.pone.0133715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218847	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900043
J	Pereira, MR; Mercaldi, GF; Maester, TC; Balan, A; Lemos, EGD				Pereira, Mariana Rangel; Mercaldi, Gustavo Fernando; Maester, Thais Carvalho; Balan, Andrea; de Macedo Lemos, Eliana Gertrudes			Est16, a New Esterase Isolated from a Metagenomic Library of a Microbial Consortium Specializing in Diesel Oil Degradation	PLOS ONE			English	Article							CLASSIFICATION; IDENTIFICATION; ENZYMES	Lipolytic enzymes have attracted attention from a global market because they show enormous biotechnological potential for applications such as detergent production, leather processing, cosmetics production, and use in perfumes and biodiesel. Due to the intense demand for biocatalysts, a metagenomic approach provides methods of identifying new enzymes. In this study, an esterase designated as Est16 was selected from 4224 clones of a fosmid metagenomic library, revealing an 87% amino acid identity with an esterase/lipase (accession number ADM63076.1) from an uncultured bacterium. Phylogenetic studies showed that the enzyme belongs to family V of bacterial lipolytic enzymes and has sequence and structural similarities with an aryl-esterase from Pseudomonas fluorescens and a patented Anti-Kazlauskas lipase (patent number US20050153404). The protein was expressed and purified as a highly soluble, thermally stable enzyme that showed a preference for basic pH. Est16 exhibited activity toward a wide range of substrates and the highest catalytic efficiency against p-nitrophenyl butyrate and p-nitrophenyl valerate. Est16 also showed tolerance to the presence of organic solvents, detergents and metals. Based on molecular modeling, we showed that the large alpha-beta domain is conserved in the patented enzymes but not the substrate pocket. Here, it was demonstrated that a metagenomic approach is suitable for discovering the lipolytic enzyme diversity and that Est16 has the biotechnological potential for use in industrial processes.	[Pereira, Mariana Rangel; Mercaldi, Gustavo Fernando; Balan, Andrea] Brazilian Ctr Res Energy & Mat CNPEM, Natl Lab Biosci LNBio, Campinas, SP, Brazil; [Pereira, Mariana Rangel; Maester, Thais Carvalho] Univ Sao Paulo, Sao Paulo, SP, Brazil; [Pereira, Mariana Rangel; Maester, Thais Carvalho; de Macedo Lemos, Eliana Gertrudes] Sao Paulo State Univ, Dept Technol, Jaboticabal, SP, Brazil; [Mercaldi, Gustavo Fernando] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Balan, Andrea] Univ Sao Paulo, Inst Biomed Sci 2, Dept Microbiol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Lemos, EGD (corresponding author), Sao Paulo State Univ, Dept Technol, Jaboticabal, SP, Brazil.	egerle@fcav.unesp.br	Pereira, Mariana/GSE-3546-2022; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; Mercaldi, Gustavo Fernando/AGB-3253-2022; Balan, Andrea/D-1891-2014; LEMOS, ELIANA GM/A-3604-2008	de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; Mercaldi, Gustavo Fernando/0000-0003-1445-6060; Balan, Andrea/0000-0001-6199-3198; LEMOS, ELIANA GM/0000-0002-1119-7748	Sao Paulo Research Foundation [2011/09136-7]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Sao Paulo Research Foundation (grant number: 2011/09136-7, http://www.fapesp.br/) to MRP.	Accorsini FR, 2012, BRAZ J MICROBIOL, V43, P116, DOI [10.1590/S1517-83822012000100013, 10.1590/S1517-838220120001000013]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Paixao DAA, 2010, REV BRAS CIENC SOLO, V34, P773, DOI 10.1590/S0100-06832010000300019; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bornscheuer UT, 2006, HYDROLASES IN ORGANIC SYNTHESIS: REGIO- AND STEREOSELECTIVE BIOTRANSFORMATIONS, 2ND EDITION, P1; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Brault G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091872; Casas-Godoy L, 2012, METHODS MOL BIOL, V861, P3, DOI 10.1007/978-1-61779-600-5_1; CBMT, 2008, MARK BUS INT CO REV; Cheeseman JD, 2004, ACTA CRYSTALLOGR D, V60, P1237, DOI 10.1107/S0907444904010522; DeLano WL., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fang ZM, 2014, J MICROBIOL BIOTECHN, V24, P771, DOI 10.4014/jmb.1311.11071; Global Industry Analysts, 2004, IND ENZY GLOB MULT M; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Jeon JH, 2012, APPL MICROBIOL BIOT, V93, P623, DOI 10.1007/s00253-011-3433-x; Jiang Y, 2011, CHEMBIOCHEM, V12, P768, DOI 10.1002/cbic.201000693; Jin P, 2012, BIORESOURCE TECHNOL, V116, P234, DOI 10.1016/j.biortech.2011.10.087; JunGang Li, 2010, Microb Cell Fact, V9, P83, DOI 10.1186/1475-2859-9-83; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Panda T, 2005, APPL MICROBIOL BIOT, V67, P160, DOI 10.1007/s00253-004-1840-y; Peng Q, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-1; Rees HC, 2003, EXTREMOPHILES, V7, P415, DOI 10.1007/s00792-003-0339-2; Roh C, 2013, APPL BIOCHEM BIOTECH, V171, P1750, DOI 10.1007/s12010-013-0464-z; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 2001, MOL CLONING LAB MANU; Seo S, 2014, WORLD J MICROB BIOT, V30, P879, DOI 10.1007/s11274-013-1496-9; Steele HL, 2009, J MOL MICROB BIOTECH, V16, P25, DOI 10.1159/000142892; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao W, 2011, J MICROBIOL, V49, P178, DOI 10.1007/s12275-011-1102-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Yu EY, 2011, APPL MICROBIOL BIOT, V90, P573, DOI 10.1007/s00253-011-3132-7	36	25	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133723	10.1371/journal.pone.0133723	http://dx.doi.org/10.1371/journal.pone.0133723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214846	gold, Green Submitted, Green Published			2022-12-27	WOS:000358594300026
J	Yan, LB; Kanada, M; Zhang, JY; Okazaki, S; Terakawa, S				Yan, Libo; Kanada, Masamitsu; Zhang, Jinyan; Okazaki, Shigetoshi; Terakawa, Susumu			Photodynamic Treatment of Tumor with Bacteria Expressing KillerRed	PLOS ONE			English	Article							CANCER GENE-THERAPY; DELIVERY; VECTORS; OXYGEN; CELLS	Photodynamic therapy (PDT) is a cancer treatment modality in which a photosensitizing dye is administered and exposed to light to kill tumor cells via the production of reactive oxygen species (ROS). A fundamental obstacle for PDT is the low specificity for staining solid tumors with dyes. Recently, a tumor targeting system guided by anaerobic bacteria was proposed for tumor imaging and treatment. Here, we explore the feasibility of the genetically encoded photosensitizer KillerRed, which is expressed in Escherichia coli, to treat tumors. Using nitroblue tetrazolium (NBT), we detected a lengthy ROS diffusion from the bodies of KillerRed-expressing bacteria in vitro, which demonstrated the feasibility of using bacteria to eradicate cells in their surroundings. In nude mice, Escherichia coli (E. coli) expressing KillerRed (KR-E. coli) were subcutaneously injected into xenografts comprising CNE2 cells, a human nasopharyngeal carcinoma cell line, and HeLa cells, a human cervical carcinoma cell line. KR-E. coli seemed to proliferate rapidly in the tumors as observed under an imaging system. When the intensity of fluorescence increased and the fluorescent area became as large as the tumor one day after KR-E. coli injection, the KR-E. coli-bearing tumor was irradiated with an orange light (lambda = 540 - 580 nm). In all cases, the tumors became necrotic the next day and were completely eliminated in a few days. No necrosis was observed after the irradiation of tumors injected with a vehicle solution or a vehicle carrying the E. coli without KillerRed. In successfully treated mice, no tumor recurrence was observed for more than two months. E. coli genetically engineered for KillerRed expression are highly promising for the diagnosis and treatment of tumors when the use of bacteria in patients is cleared for infection safety.	[Yan, Libo; Kanada, Masamitsu; Zhang, Jinyan; Okazaki, Shigetoshi; Terakawa, Susumu] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine	Terakawa, S (corresponding author), Tokoha Univ, Dept Hlth Sci, Aoi Ku, Shizuoka, Japan.	terakawa@sz.tokoha-u.ac.jp	Kanada, Masamitsu/AAP-1664-2020	Zhang, Jinyan/0000-0002-9874-2744	Hamamatsu University School of Medicine	Hamamatsu University School of Medicine	This work was supported partly by an intramural grant for "Cancer Research by Photonics" from Hamamatsu University School of Medicine to S. T. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146; Baumler W, 1999, BRIT J CANCER, V80, P360, DOI 10.1038/sj.bjc.6690363; Brown SB, 2004, LANCET ONCOL, V5, P497, DOI 10.1016/S1470-2045(04)01529-3; Bulina ME, 2006, NAT PROTOC, V1, P947, DOI 10.1038/nprot.2006.89; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Chen J, 2002, CANCER J, V8, P154, DOI 10.1097/00130404-200203000-00009; Cronin M, 2012, CANCER GENE THER, V19, P731, DOI 10.1038/cgt.2012.59; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Ell C, 1998, GUT, V43, P345, DOI 10.1136/gut.43.3.345; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; KHAN AU, 1979, P NATL ACAD SCI USA, V76, P6047, DOI 10.1073/pnas.76.12.6047; Lemmon MJ, 1997, GENE THER, V4, P791, DOI 10.1038/sj.gt.3300468; Liu SC, 2002, GENE THER, V9, P291, DOI 10.1038/sj.gt.3301659; [刘世东 Liu Shidong], 2011, [中国全科医学, Chinese General Practice], V14, P987; Min JJ, 2008, MOL IMAGING BIOL, V10, P54, DOI 10.1007/s11307-007-0120-5; Mose J R, 1967, Med Klin, V62, P189; Mueller G, 2010, J PHOTOCH PHOTOBIO B, V98, P95, DOI 10.1016/j.jphotobiol.2009.11.009; Nishiyama N, 2007, NEW J CHEM, V31, P1074, DOI 10.1039/b616050f; Nishiyama N, 2009, ADV DRUG DELIVER REV, V61, P327, DOI 10.1016/j.addr.2009.01.004; Odo J, 2010, CHEM PHARM BULL, V58, P1576, DOI 10.1248/cpb.58.1576; Okazaki S, 2010, CHEM PHYS LETT, V485, P202, DOI 10.1016/j.cplett.2009.12.055; ROSENTHAL I, 1995, INT J RADIAT BIOL, V67, P85, DOI 10.1080/09553009514550111; Ryan RM, 2009, GENE THER, V16, P329, DOI 10.1038/gt.2008.188; Serebrovskaya EO, 2011, BIOCHEM J, V435, P65, DOI 10.1042/BJ20101217; Serebrovskaya EO, 2009, P NATL ACAD SCI USA, V106, P9221, DOI 10.1073/pnas.0904140106; Shirmanova MV, 2012, J BIOPHOTONICS, V10, P1; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sternberg ED, 1998, TETRAHEDRON, V54, P4151, DOI 10.1016/S0040-4020(98)00015-5; Sznol M, 2000, J CLIN INVEST, V105, P1027, DOI 10.1172/JCI9818; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; THIELE EH, 1964, CANCER RES, V24, P222; van Dongen GAMS, 2004, ADV DRUG DELIVER REV, V56, P31, DOI 10.1016/j.addr.2003.09.003; Vegh RB, 2011, CHEM COMMUN, V47, P4887, DOI 10.1039/c0cc05713d; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937	37	16	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0131518	10.1371/journal.pone.0131518	http://dx.doi.org/10.1371/journal.pone.0131518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213989	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300006
J	Castello, A; Prieto, L; Ederra, M; Salas-Trejo, D; Vidal, C; Sanchez-Contador, C; Santamarina, C; Pedraz, C; Moreo, P; Aragones, N; Perez-Gomez, B; Lope, V; Vioque, J; Pollan, M				Castello, Adela; Prieto, Leandro; Ederra, Maria; Salas-Trejo, Dolores; Vidal, Carmen; Sanchez-Contador, Carmen; Santamarina, Carmen; Pedraz, Carmen; Moreo, Pilar; Aragones, Nuria; Perez-Gomez, Beatriz; Lope, Virginia; Vioque, Jesus; Pollan, Marina		DDM-Spain Res Grp	Association between the Adherence to the International Guidelines for Cancer Prevention and Mammographic Density	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; ADULT WEIGHT-GAIN; BREAST-CANCER; POSTMENOPAUSAL WOMEN; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; BODY-SIZE; RISK; DIETARY; SMOKING	Introduction Mammographic density (MD) is considered a strong predictor of Breast Cancer (BC). The objective of the present study is to explore the association between MD and the compliance with the World Cancer Research Fund and the American Institute for Cancer Research (WCRF/AICR) recommendations for cancer prevention. Methods Data of 3584 women attending screening from a population-based multicenter cross-sectional study (DDM-Spain) collected from October 7, 2007 through July 14, 2008, was used to calculate a score that measures the level of compliance with the WCRF/AICR recommendations: R1)Maintain adequate body weight; R2)Be physically active; 3R)Limit the intake of high density foods; R4)Eat mostly plant foods; R5)Limit the intake of animal foods; R6)Limit alcohol intake; R7)Limit salt and salt preserved food intake; R8)Meet nutritional needs through diet. The association between the score and MD (assessed by a single radiologist using a semi-quantitative scale) was evaluated using ordinal logistic models with random center-specific intercepts adjusted for the main determinants of MD. Stratified analyses by menopausal status and smoking status were also carried out. Results A higher compliance with the WCRF/AICR recommendations was associated with lower MD (OR1-unit increase = 0.93 95%CI:0.86;0.99). The association was stronger in postmenopausal women (OR = 0.91 95%CI:0.84;0.99) and nonsmokers (OR = 0.87;95%CI:0.80;0.96 for nonsmokers, OR = 1.01 95%CI:0.91;1.12 for smokers, P-interaction = 0.042). Among nonsmokers, maintaining adequate body weight (OR = 0.81 95%CI:0.65;1.01), practicing physical activity (OR = 0.68 95%CI:0.48;0.96) and moderating the intake of high-density foods (OR = 0.58 95%CI:0.40;0.86) and alcoholic beverages (OR = 0.76 95%CI:0.55;1.05) were the recommendations showing the strongest associations with MD. Conclusions postmenopausal women and non-smokers with greater compliance with the WCRF/AICR guidelines have lower MD. These results may provide guidance to design specific recommendations for screening attendants with high MD and therefore at higher risk of developing BC.	[Castello, Adela; Prieto, Leandro; Aragones, Nuria; Perez-Gomez, Beatriz; Lope, Virginia; Pollan, Marina] Inst Salud Carlos III, Natl Ctr Epidemiol, Canc Epidemiol Unit, Madrid, Spain; [Castello, Adela; Perez-Gomez, Beatriz; Lope, Virginia; Vioque, Jesus; Pollan, Marina] Inst Salud Carlos III, Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Castello, Adela; Aragones, Nuria; Perez-Gomez, Beatriz; Lope, Virginia; Pollan, Marina] IIS Puerta de Hierro IDIPHIM, Oncol & Hematol Area, Canc Epidemiol Res Grp, Madrid, Spain; [Ederra, Maria] Inst Publ Hlth, Navarre Breast Canc Screening Program, Pamplona, Spain; [Salas-Trejo, Dolores] Gen Directorate Publ Hlth, Valencian Breast Canc Screening Program, Valencia, Spain; [Vidal, Carmen] Catalonian Inst Oncol ICO, Canc Prevent & Control Unit, Barcelona, Spain; [Sanchez-Contador, Carmen] Reg Author Hlth & Consumer Affairs, Balear Isl Breast Canc Screening Program, Palma De Mallorca, Islas Baleares, Spain; [Santamarina, Carmen] Galician Reg Hlth Author, Galician Breast Canc Screening Program, La Coruna, Spain; [Pedraz, Carmen] Gen Directorate Publ Hlth, Castile Leon Breast Canc Screening Program, Burgos, Spain; [Moreo, Pilar] Aragon Hlth Serv, Aragon Breast Canc Screening Program, Zaragoza, Spain; [Vioque, Jesus] Univ Miguel Hernandez, Sant Joan dAlacant, Spain	Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Catalan Institute of Oncology; Universidad Miguel Hernandez de Elche	Castello, A (corresponding author), Inst Salud Carlos III, Natl Ctr Epidemiol, Canc Epidemiol Unit, Madrid, Spain.	acastello@isciii.es	SalasTrejo, Dolores/S-1139-2017; Pollan, Marina/M-3259-2014; Aragones, Nuria/O-5962-2015; Castelló, Adela/C-3829-2014; vioque, jesus/A-1066-2008; LOPE, VIRGINIA/S-4774-2016; Perez-Gomez, Beatriz/C-4715-2012; Vidal, Carmen/H-4029-2016	Pollan, Marina/0000-0002-4328-1565; Aragones, Nuria/0000-0003-0983-2156; Castelló, Adela/0000-0002-1308-9927; vioque, jesus/0000-0002-2284-148X; LOPE, VIRGINIA/0000-0002-6986-4021; Perez-Gomez, Beatriz/0000-0002-4299-8214; Vidal, Carmen/0000-0003-2768-2710	FIS (Health Research Fund) Research Grant [FIS PI060386]; Spanish Ministy of Health [EC11-273]; FIS Sara Borrell contract [CD110/00018]; Spanish Federation of Breast Cancer Patients [FECMA 485 EPY 1170-10]	FIS (Health Research Fund) Research Grant; Spanish Ministy of Health; FIS Sara Borrell contract; Spanish Federation of Breast Cancer Patients	This study was supported by FIS PI060386 FIS (Health Research Fund) Research Grant; EC11-273 Research Grant from the Spanish Ministy of Health; CD110/00018 FIS Sara Borrell contract; FECMA 485 EPY 1170-10 grant from the Spanish Federation of Breast Cancer Patients.	Assi V, 2012, NAT REV CLIN ONCOL, V9, P33, DOI 10.1038/nrclinonc.2011.173; Berube S, 2008, AM J CLIN NUTR, V87, P1400, DOI 10.1093/ajcn/87.5.1400; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Brand JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081876; Cabanes A, 2011, BREAST CANCER RES TR, V129, P135, DOI 10.1007/s10549-011-1414-5; Castello A, 2015, PLOS ONE IN PRESS; Castells X, 2007, 200601 AATRM; Catsburg C, 2014, INT J CANCER, V135, P2444, DOI 10.1002/ijc.28887; Centers for Disease Control and Prevention (US) National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (US), 2010, PUBL REP SURG GEN; Gabriel KP, 2013, MED SCI SPORT EXER, V45, P1515, DOI 10.1249/MSS.0b013e318289a7f8; Garcia-Arenzana N, 2014, INT J CANCER, V134, P1916, DOI 10.1002/ijc.28513; Garcia-Arenzana N, 2012, MENOPAUSE, V19, P1121, DOI 10.1097/gme.0b013e3182544925; Garrido-Estepa M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-485; Gu FY, 2013, CANCER EPIDEM BIOMAR, V22, P58, DOI 10.1158/1055-9965.EPI-12-0909; Harrell Jr FE, 2001, REGRESSION MODELING, P16; Harris HR, 2011, AM J EPIDEMIOL, V174, P909, DOI 10.1093/aje/kwr225; Hastert TA, 2013, CANCER EPIDEM BIOMAR, V22, P1498, DOI 10.1158/1055-9965.EPI-13-0210; Hvidtfeldt UA, 2012, CANCER EPIDEM BIOMAR, V21, P1203, DOI 10.1158/1055-9965.EPI-12-0310; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Lope V, 2012, BREAST CANCER RES TR, V132, P1137, DOI 10.1007/s10549-011-1936-x; Luo JH, 2011, AM J EPIDEMIOL, V174, P919, DOI 10.1093/aje/kwr192; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; Martin LJ, 2009, BREAST CANCER RES TR, V113, P163, DOI 10.1007/s10549-008-9904-9; Masala G, 2006, INT J CANCER, V118, P1782, DOI 10.1002/ijc.21558; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; Mishra GD, 2011, CANCER CAUSE CONTROL, V22, P227, DOI 10.1007/s10552-010-9690-7; Organization WH, 2009, GLOB HLTH RISKS MORT; Pollan M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3380; Pollan M, 2012, BREAST CANCER RES TR, V134, P823, DOI 10.1007/s10549-012-2108-3; Rauh C, 2013, EUR J CANCER PREV, V22, P259, DOI 10.1097/CEJ.0b013e328359cb81; Romaguera D, 2012, AM J CLIN NUTR, V96, P150, DOI 10.3945/ajcn.111.031674; Samimi G, 2008, BREAST CANCER RES TR, V109, P113, DOI 10.1007/s10549-007-9631-7; Sung J, 2011, BREAST CANCER RES TR, V128, P567, DOI 10.1007/s10549-011-1469-3; Takata Y, 2007, EUR J CANCER PREV, V16, P409, DOI 10.1097/01.cej.0000243852.05104.02; Thomson CA, 2014, CANCER PREV RES, V7, P42, DOI 10.1158/1940-6207.CAPR-13-0258; Tseng M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1781; Tseng M, 2011, INT J CANCER, V128, P418, DOI 10.1002/ijc.25338; Vachon CM, 2000, CANCER EPIDEM BIOMAR, V9, P151; Vioque J, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-26; Voevodina O, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-203; Voon NSMF, 2011, ASIAN PAC J CANCER P, V12, P1969; WCRF/AICR, 2010, CONT UPD PROJ REP; WCRF/AICR, 2009, POL ACT CANC PREV FO; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yaghjyan L, 2012, BREAST CANCER RES TR, V135, P367, DOI 10.1007/s10549-012-2152-z; Yochum L, 2014, CANCER CAUSE CONTROL, V25, P1247, DOI 10.1007/s10552-014-0432-0	48	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132684	10.1371/journal.pone.0132684	http://dx.doi.org/10.1371/journal.pone.0132684			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208331	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000037
J	Kouzaki, Y; Maeda, T; Sasaki, H; Tamura, S; Hamamoto, T; Yuki, A; Sato, A; Miyahira, Y; Kawana, A				Kouzaki, Yuji; Maeda, Takuya; Sasaki, Hiroaki; Tamura, Shinsuke; Hamamoto, Takaaki; Yuki, Atsushi; Sato, Akinori; Miyahira, Yasushi; Kawana, Akihiko			A Simple and Rapid Identification Method for Mycobacterium bovis BCG with Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX; PNEUMOCYSTIS PNEUMONIA; SENSITIVE DETECTION; DIAGNOSIS; KIT; DIFFERENTIATION; VACCINATION; POLYMORPHISMS; METAANALYSIS; PERFORMANCE	Bacillus Calmette-Guerin (BCG) is widely used as a live attenuated vaccine against Mycobacterium tuberculosis and is an agent for standard prophylaxis against the recurrence of bladder cancer. Unfortunately, it can cause severe infectious diseases, especially in immunocompromised patients, and the ability to immediately distinguish BCG from other M. tuberculosis complexes is therefore important. In this study, we developed a simple and easy-to-perform identification procedure using loop-mediated amplification (LAMP) to detect deletions within the region of difference, which is deleted specifically in all M. bovis BCG strains. Reactions were performed at 64 degrees C for 30 min and successful targeted gene amplifications were detected by real-time turbidity using a turbidimeter and visual inspection of color change. The assay had an equivalent detection limit of 1.0 pg of genomic DNA using a turbidimeter whereas it was 10 pg with visual inspection, and it showed specificity against 49 strains of 44 pathogens, including M. tuberculosis complex. The expected LAMP products were confirmed through identical melting curves in real-time LAMP procedures. We employed the Procedure for Ultra Rapid Extraction (PURE) kit to isolate mycobacterial DNA and found that the highest sensitivity limit with a minimum total cell count of mycobacterium ( including DNA purification with PURE) was up to 1 x 10(3) cells/reaction, based on color changes under natural light with FDA reagents. The detection limit of this procedure when applied to artificial serum, urine, cerebrospinal fluid, and bronchoalveolar lavage fluid samples was also about 1 x 10(3) cells/reaction. Therefore, this substitute method using conventional culture or clinical specimens followed by LAMP combined with PURE could be a powerful tool to enable the rapid identification of M. bovis BCG as point-of-care testing. It is suitable for practical use not only in resource-limited situations, but also in any clinical situation involving immunocompromised patients because of its convenience, rapidity, and cost effectiveness.	[Kouzaki, Yuji; Maeda, Takuya; Sasaki, Hiroaki; Kawana, Akihiko] Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Pulm Med, Saitama, Japan; [Tamura, Shinsuke] Natl Def Med Coll, Dept Pediat, Saitama, Japan; [Hamamoto, Takaaki; Yuki, Atsushi] Natl Def Med Coll Hosp, Dept Lab Med, Saitama, Japan; [Sato, Akinori] Natl Def Med Coll, Dept Urol, Saitama, Japan; [Miyahira, Yasushi] Natl Def Med Coll, Dept Global Infect Dis & Trop Med, Saitama, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan	Maeda, T (corresponding author), Natl Def Med Coll, Dept Internal Med, Div Infect Dis & Pulm Med, Saitama, Japan.	tmaeda@ndmc.ac.jp	Sato, Akinori/P-9453-2019; Sasaki, Hiroaki/AAC-9789-2022	Sato, Akinori/0000-0001-9011-1756; Sasaki, Hiroaki/0000-0003-3414-1146; Maeda, Takuya/0000-0003-0912-4643				Adams ER, 2010, AM J TROP MED HYG, V82, P591, DOI 10.4269/ajtmh.2010.09-0369; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; FLOYD MM, 1992, J CLIN MICROBIOL, V30, P1327, DOI 10.1128/JCM.30.5.1327-1330.1992; FROTHINGHAM R, 1995, J CLIN MICROBIOL, V33, P840, DOI 10.1128/JCM.33.4.840-844.1995; Gonzalez OY, 2003, CLIN INFECT DIS, V36, P140, DOI 10.1086/344908; Grange GM, 1996, GUIDELINES SPECIATIO; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; JONES WD, 1975, J CLIN MICROBIOL, V1, P391, DOI 10.1128/JCM.1.4.391-392.1975; Kawano S, 2014, J MED CASE REP, V16, P254; Kawano S, 2015, J INFECT CHEMOTHER, V21, P224, DOI 10.1016/j.jiac.2014.09.004; Kouzaki Y, 2015, INTERNAL MED, V54, P1447, DOI 10.2169/internalmedicine.54.4615; KROGER L, 1995, J INFECT DIS, V172, P574, DOI 10.1093/infdis/172.2.574; Mikita K, 2014, PARASITOL INT, V63, P785, DOI 10.1016/j.parint.2014.07.007; MILSTIEN JB, 1990, B WORLD HEALTH ORGAN, V68, P93; Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629; Niemann S, 2000, J CLIN MICROBIOL, V38, P152; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ou XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094544; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Rodrigues LC, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5974; Sadeghi-Shabestari M, 2009, INT J INFECT DIS, V13, pE420, DOI 10.1016/j.ijid.2009.02.008; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1016/S0022-5347(05)64273-5; Talbot EA, 1997, J CLIN MICROBIOL, V35, P566, DOI 10.1128/JCM.35.3.566-569.1997; Talbot EA, 1997, CLIN INFECT DIS, V24, P1139, DOI 10.1086/513642; Tortoli E, 1999, J CLIN MICROBIOL, V37, P3578, DOI 10.1128/JCM.37.11.3578-3582.1999; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; VANSOOLINGEN D, 1992, J CLIN MICROBIOL, V30, P1772, DOI 10.1128/JCM.30.7.1772-1777.1992; Yamamura M, 2009, JPN J INFECT DIS, V62, P20; Zhu RY, 2009, J MICROBIOL METH, V78, P339, DOI 10.1016/j.mimet.2009.07.006	36	8	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133759	10.1371/journal.pone.0133759	http://dx.doi.org/10.1371/journal.pone.0133759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208001	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000133
J	Livingstone, M; Sikstrom, K; Robert, PA; Uze, G; Larsson, O; Pellegrini, S				Livingstone, Mark; Sikstrom, Kristina; Robert, Philippe A.; Uze, Gilles; Larsson, Ola; Pellegrini, Sandra			Assessment of mTOR-Dependent Translational Regulation of Interferon Stimulated Genes	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; KINASE-C-DELTA; P70 S6 KINASE; I INTERFERONS; GENOME-WIDE; DIFFERENTIAL TRANSLATION; MAMMALIAN TARGET; HUMAN CANCER; CELL-SIZE; PKC-DELTA	Type-I interferon (IFN)-induced activation of the mammalian target of rapamycin (mTOR) signaling pathway has been implicated in translational control of mRNAs encoding interferon-stimulated genes (ISGs). However, mTOR-sensitive translatomes commonly include mRNAs with a 5' terminal oligopyrimidine tract (TOP), such as those encoding ribosomal proteins, but not ISGs. Because these translatomes were obtained under conditions when ISG expression is not induced, we examined the mTOR-sensitive translatome in human WISH cells stimulated with IFN beta. The mTOR inhibitor Torin1 resulted in a repression of global protein synthesis, including that of ISG products, and translation of all but 3 ISG mRNAs (TLR3, NT5C3A, and RNF19B) was not selectively more sensitive to mTOR inhibition. Detailed studies of NT5C3A revealed an IFN-induced change in transcription start site resulting in a switch from a non-TOP to a TOP-like transcript variant and mTOR sensitive translation. Thus, we show that, in the cell model used, translation of the vast majority of ISG mRNAs is not selectively sensitive to mTOR activity and describe an uncharacterized mechanism wherein the 5'-UTR of an mRNA is altered in response to a cytokine, resulting in a shift from mTOR-insensitive to mTOR-sensitive translation.	[Livingstone, Mark; Robert, Philippe A.; Pellegrini, Sandra] Inst Pasteur, CNRS URA1961, Cytokine Signaling Unit, Paris, France; [Sikstrom, Kristina; Larsson, Ola] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Uze, Gilles] Univ Montpellier 2, CNRS UMR5235, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Pellegrini, S (corresponding author), Inst Pasteur, CNRS URA1961, Cytokine Signaling Unit, Paris, France.	Ola.Larsson@ki.se; sandra.pellegrini@pasteur.fr	Pellegrini, Sandra/Y-6351-2019; Robert, Philippe A./Z-2816-2019; Uzé, Gilles/O-6383-2019	Pellegrini, Sandra/0000-0001-5837-7589; Robert, Philippe A./0000-0003-1345-5015; Larsson, Ola/0000-0003-1412-1308; Uze, Gilles/0000-0002-4150-5772; Livingstone, Mark/0000-0002-2757-7008	Pasteur Foundation; Swedish Research Council; Wallenberg Academy Fellows program	Pasteur Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg Academy Fellows program	This research was supported by funding (to ML) from the Pasteur Foundation, institutional support from Institut Pasteur and CNRS, and grants from the Swedish Research Council and the Wallenberg Academy Fellows program (to OL).	Aksoy P, 2009, PHARMACOGENET GENOM, V19, P567, DOI 10.1097/FPC.0b013e32832c14b8; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Colman H, 2013, J VIROL, V87, P6668, DOI 10.1128/JVI.00538-13; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Eliseeva IA, 2013, TRANSLATION, V1, P18; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Furic L, 2009, CURR ONCOL, V16, P59; Genolet R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-33; Gingras AC, 2001, GENE DEV, V15, P2852; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kaur S, 2005, EXP HEMATOL, V33, P550, DOI 10.1016/j.exphem.2005.01.014; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2014, J BIOL CHEM, V289, P6581, DOI 10.1074/jbc.M113.537852; Kroczynska B, 2011, J BIOL CHEM, V286, P1147, DOI 10.1074/jbc.M110.183566; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Larsson O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012302; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Larsson O, 2011, BIOINFORMATICS, V27, P1440, DOI 10.1093/bioinformatics/btr146; Larsson O, 2010, P NATL ACAD SCI USA, V107, P21487, DOI 10.1073/pnas.1006821107; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Li YZ, 2005, J BIOL CHEM, V280, P10001, DOI 10.1074/jbc.M410972200; Livingstone Mark, 2012, F1000Res, V1, P4, DOI 10.12688/f1000research.1-4.v1; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; MARUYAMA K, 1994, GENE, V138, P171; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Rastogi R, 2013, J BIOL CHEM, V288, P33966, DOI 10.1074/jbc.M113.492702; Rees DC, 2003, BRIT J HAEMATOL, V120, P375, DOI 10.1046/j.1365-2141.2003.03980.x; Rich SA, 1996, J BIOL CHEM, V271, P1118, DOI 10.1074/jbc.271.2.1118; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Schmeisser H, 2013, AUTOPHAGY, V9, P683, DOI 10.4161/auto.23921; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tait S, 2010, P NATL ACAD SCI USA, V107, P17627, DOI 10.1073/pnas.1008242107; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Tomoo K, 2006, J BIOCHEM, V140, P237, DOI 10.1093/jb/mvj143; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Wang XR, 2008, CANCER BIOL THER, V7, P1952, DOI 10.4161/cbt.7.12.6944; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zhao JW, 2010, MOL IMMUNOL, V48, P294, DOI 10.1016/j.molimm.2010.07.014	65	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133482	10.1371/journal.pone.0133482	http://dx.doi.org/10.1371/journal.pone.0133482			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207988	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000093
J	Spitzer, E; Mercado, J; Islas, F; Rothenbuhler, M; Kurmann, R; Zurcher, F; Krahenmann, P; Llerena, N; Juni, P; Torres, P; Pilgrim, T				Spitzer, Ernest; Mercado, Jorge; Islas, Fabian; Rothenbuehler, Martina; Kurmann, Reto; Zuercher, Fabian; Kraehenmann, Peter; Llerena, Nassip; Jueni, Peter; Torres, Pedro; Pilgrim, Thomas			Screening for Rheumatic Heart Disease among Peruvian Children: A Two-Stage Sampling Observational Study	PLOS ONE			English	Article							PREVALENCE	Background The objective of the study was to evaluate the implications of different classifications of rheumatic heart disease on estimated prevalence, and to systematically assess the importance of incidental findings from echocardiographic screening among schoolchildren in Peru. Methods We performed a cluster randomized observational survey using portable echocardiography among schoolchildren aged 5 to 16 years from randomly selected public and private schools in Arequipa, Peru. Rheumatic heart disease was defined according to the modified World Health Organization (WHO) criteria and the World Heart Federation (WHF) criteria. Findings Among 1395 eligible students from 40 classes and 20 schools, 1023 (73%) participated in the present survey. The median age of the children was 11 years (interquartile range [IQR] 8-13 years) and 50% were girls. Prevalence of possible, probable and definite rheumatic heart disease according to the modified WHO criteria amounted to 19.7/1000 children and ranged from 10.2/1000 among children 5 to 8 years of age to 39.8/1000 among children 13 to 16 years of age; the prevalence of borderline/definite rheumatic heart disease according to the WHF criteria was 3.9/1000 children. 21 children (2.1%) were found to have congenital heart disease, 8 of which were referred for percutaneous or surgical intervention. Conclusions Prevalence of RHD in Peru was considerably lower compared to endemic regions in sub-Saharan Africa, southeast Asia, and Oceania; and paralleled by a comparable number of undetected congenital heart disease. Strategies to address collateral findings from echocardiographic screening are necessary in the setup of active surveillance programs for RHD.	[Spitzer, Ernest; Kurmann, Reto; Zuercher, Fabian; Kraehenmann, Peter; Pilgrim, Thomas] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Mercado, Jorge; Torres, Pedro] Inst Cardiol CardioSalud, Arequipa, Peru; [Islas, Fabian] Univ Hosp San Carlos, Madrid, Spain; [Rothenbuehler, Martina] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Rothenbuehler, Martina] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Llerena, Nassip; Torres, Pedro] Natl Hosp Carlos Alberto Seguin Escobedo, Arequipa, Peru; [Jueni, Peter] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland	University of Bern; University Hospital of Bern; Hospital Clinico San Carlos; University of Bern; University of Bern; University of Bern	Pilgrim, T (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	thomas.pilgrim@insel.ch	Pilgrim, Thomas/AAS-9120-2021; Juni, Peter/Q-8700-2016	Pilgrim, Thomas/0000-0001-8721-4068; Juni, Peter/0000-0002-5985-0670; Rothenbuhler, Martina/0000-0001-8009-4104; LLERENA NAVARRO, NASSIP/0000-0001-9436-4099; Spitzer, Ernest/0000-0003-2371-5431	UBS Optimus Foundation; Gottfried and Julia Bangerter-Rhyner Foundation; European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology; Research Grant of the Spanish Society of Cardiology	UBS Optimus Foundation; Gottfried and Julia Bangerter-Rhyner Foundation; European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology; Research Grant of the Spanish Society of Cardiology	The study was supported by research grants of the UBS Optimus Foundation and the Gottfried and Julia Bangerter-Rhyner Foundation. Dr. Spitzer received a Research Fellowship of the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology and a Research Grant of the Spanish Society of Cardiology. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Adams C, 2012, CAN J SURG, V55, P171, DOI 10.1503/cjs.029910; Beaton A, 2014, PEDIATR CARDIOL, V35, P1259, DOI 10.1007/s00246-014-0925-3; Bhaya M, 2011, ECHOCARDIOGR-J CARD, V28, P929, DOI 10.1111/j.1540-8175.2011.01487.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chen QH, 2008, CHINESE MED J-PEKING, V121, P2469, DOI 10.1097/00029330-200812020-00001; Colquhoun SM, 2014, INT J CARDIOL, V173, P284, DOI 10.1016/j.ijcard.2014.03.004; Cunningham M, 2009, MORE JUST KAPPA COEF, P1; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Joncas M., SAMPLE DESIGN TIMSS; Kane A, 2013, INT J CARDIOL, V168, P888, DOI 10.1016/j.ijcard.2012.10.090; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; MIAO CY, 1988, J AM COLL CARDIOL, V12, P224, DOI 10.1016/0735-1097(88)90378-6; Mirabel M, 2015, INT J CARDIOL, V188, P89, DOI 10.1016/j.ijcard.2015.04.007; Paar JA, 2010, AM J CARDIOL, V105, P1809, DOI 10.1016/j.amjcard.2010.01.364; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; Rizvi SF, 2004, HEART, V90, P394, DOI 10.1136/hrt.2003.025981; Roberts K, 2014, CIRCULATION, V129, P1953, DOI 10.1161/CIRCULATIONAHA.113.003495; Rothenbuhler M, 2014, LANCET GLOB HEALTH, V2, pE717, DOI 10.1016/S2214-109X(14)70310-9; Saxena A, 2011, HEART, V97, P2018, DOI 10.1136/heartjnl-2011-300792; United Nations Development Programme, HUM DEV REP; World Health Organization, GROWTH REF 5 19 YEAR; Wright J, 2014, PEDIATRICS, V133, pE561, DOI 10.1542/peds.2013-3284; Zheng JY, 2013, AM J CARDIOL, V112, P1468, DOI 10.1016/j.amjcard.2013.07.028	24	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133004	10.1371/journal.pone.0133004	http://dx.doi.org/10.1371/journal.pone.0133004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208006	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000053
J	Sumida, K; Chong, Y; Miyake, N; Akahoshi, T; Yasuda, M; Shimono, N; Shimoda, S; Maehara, Y; Akashi, K				Sumida, Kosuke; Chong, Yong; Miyake, Noriko; Akahoshi, Tomohiko; Yasuda, Mitsuhiro; Shimono, Nobuyuki; Shimoda, Shinji; Maehara, Yoshihiko; Akashi, Koichi			Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study	PLOS ONE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; XANTHOMONAS-MALTOPHILIA; MORTALITY; THERAPY	Stenotrophomonas maltophilia is an important nosocomial bacterial pathogen, as is Pseudomonas aeruginosa. Differentiation of these bacteria as bacteremic agents is critical in the clinical setting and to define a therapeutic strategy; however, the associated factors and prognosis for S. maltophilia bacteremia have not been fully evaluated to adequately characterize these factors. We first conducted a matched case-control study to clarify these questions. A total of 30 case patients with S. maltophilia bacteremia were compared with 30 control patients with P. aeruginosa bacteremia between January 2005 and August 2014, according to matching criteria based on underlying disease, age, and gender. The 30-day mortality rate for the case patients (53.3%) was significantly higher than that of the control group (30.0%) (P = 0.047, using the log-rank test). Conditional logistic regression analysis showed that the predisposing factors specific for the detection of S. maltophilia bacteremia were indwelling artificial products other than a central venous catheter, ICU stay, and previous use of anti-MRSA drugs. The high severity of illness was associated with mortality in both case and control patients. Interestingly, inappropriate antimicrobial treatment was an additional independent risk factor for mortality in only the case patients with S. maltophilia bacteremia (odds ratio = 13.64, P = 0.048). Monotherapy with fluoroquinolones inactive against the S. maltophiliaisolates was mainly responsible for the inappropriate treatment. These results suggest that more precise prediction and more appropriate treatment might improve the prognosis of patients with S. maltophilia bacteremia.	[Sumida, Kosuke; Akahoshi, Tomohiko; Yasuda, Mitsuhiro; Maehara, Yoshihiko] Kyushu Univ Hosp, Emergency & Crit Care Ctr, Fukuoka 812, Japan; [Chong, Yong; Miyake, Noriko; Shimoda, Shinji; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Med & Biosyst Sci, Fukuoka 812, Japan; [Shimono, Nobuyuki] Kyushu Univ Hosp, Ctr Study Global Infect, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Chong, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Med & Biosyst Sci, Fukuoka 812, Japan.	ychong@gj9.so-net.ne.jp	Akahoshi, Tomohiko/AAU-4886-2021					Apisarnthanarak A, 2003, INFECT CONT HOSP EP, V24, P269, DOI 10.1086/502197; Araoka H, 2010, EUR J CLIN MICROBIOL, V29, P605, DOI 10.1007/s10096-010-0882-6; Ba BB, 2004, ANTIMICROB AGENTS CH, V48, P946, DOI 10.1128/AAC.48.3.946-953.2004; Cho SY, 2014, ANTIMICROB AGENTS CH, V58, P581, DOI 10.1128/AAC.01682-13; CLSI, 2012, M02A11 CLSI; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fihman V, 2012, J INFECTION, V64, P391, DOI 10.1016/j.jinf.2012.01.001; Friedman ND, 2002, J INFECTION, V45, P47, DOI 10.1053/jinf.2002.0978; Garazi M, 2012, J HOSP INFECT, V81, P114, DOI 10.1016/j.jhin.2012.02.008; Paez JIG, 2008, EUR J CLIN MICROBIOL, V27, P901, DOI 10.1007/s10096-008-0518-2; Hotta G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112208; Labarca JA, 2000, CLIN INFECT DIS, V30, P195, DOI 10.1086/313591; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Metan G, 2005, ANTIMICROB AGENTS CH, V49, P3980, DOI 10.1128/AAC.49.9.3980-3981.2005; Metan G, 2006, SCAND J INFECT DIS, V38, P527, DOI 10.1080/00365540500452481; Micozzi A, 2000, CLIN INFECT DIS, V31, P705, DOI 10.1086/314043; Muder RR, 1996, CLIN INFECT DIS, V22, P508, DOI 10.1093/clinids/22.3.508; Safdar A, 2007, CLIN INFECT DIS, V45, P1602, DOI 10.1086/522998; Senol E, 2002, CLIN INFECT DIS, V34, P1653, DOI 10.1086/340707; VICTOR MA, 1994, SCAND J INFECT DIS, V26, P163, DOI 10.3109/00365549409011780; Wang YL, 2014, ANTIMICROB AGENTS CH, V58, P176, DOI 10.1128/AAC.01324-13	22	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133731	10.1371/journal.pone.0133731	http://dx.doi.org/10.1371/journal.pone.0133731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208218	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000125
J	Bordoy, AE; Chatterjee, A				Bordoy, Antoni E.; Chatterjee, Anushree			Cis-Antisense Transcription Gives Rise to Tunable Genetic Switch Behavior: A Mathematical Modeling Approach	PLOS ONE			English	Article							COLI RNA-POLYMERASE; ESCHERICHIA-COLI; MESSENGER-RNA; BIDIRECTIONAL PROMOTERS; STAPHYLOCOCCUS-AUREUS; BACTERIOPHAGE 186; VIRULENCE GENE; EXPRESSION; INTERFERENCE; OPERON	Antisense transcription has been extensively recognized as a regulatory mechanism for gene expression across all kingdoms of life. Despite the broad importance and extensive experimental determination of cis-antisense transcription, relatively little is known about its role in controlling cellular switching responses. Growing evidence suggests the presence of non-coding cis-antisense RNAs that regulate gene expression via antisense interaction. Recent studies also indicate the role of transcriptional interference in regulating expression of neighboring genes due to traffic of RNA polymerases from adjacent promoter regions. Previous models investigate these mechanisms independently, however, little is understood about how cells utilize coupling of these mechanisms in advantageous ways that could also be used to design novel synthetic genetic devices. Here, we present a mathematical modeling framework for antisense transcription that combines the effects of both transcriptional interference and cis-antisense regulation. We demonstrate the tunability of transcriptional interference through various parameters, and that coupling of transcriptional interference with cis-antisense RNA interaction gives rise to hypersensitive switches in expression of both antisense genes. When implementing additional positive and negative feed-back loops from proteins encoded by these genes, the system response acquires a bistable behavior. Our model shows that combining these multiple-levels of regulation allows fine-tuning of system parameters to give rise to a highly tunable output, ranging from a simple-first order response to biologically complex higher-order response such as tunable bistable switch. We identify important parameters affecting the cellular switch response in order to provide the design principles for tunable gene expression using antisense transcription. This presents an important insight into functional role of antisense transcription and its importance towards design of synthetic biological switches.	[Bordoy, Antoni E.; Chatterjee, Anushree] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Chatterjee, Anushree] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Chatterjee, A (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	chatterjee@colorado.edu	Bordoy, Antoni E./AAI-1705-2019	Bordoy, Antoni E./0000-0002-1165-542X	William M. Keck Foundation; Balsells Foundation; University of Colorado	William M. Keck Foundation(W.M. Keck Foundation); Balsells Foundation; University of Colorado	This work was supported by William M. Keck Foundation and University of Colorado start-up funds to AC. AEB was supported by Balsells Graduate fellowship from Balsells Foundation and University of Colorado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Andre G, 2008, NUCLEIC ACIDS RES, V36, P5955, DOI 10.1093/nar/gkn601; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chatterjee A, 2008, CURR OPIN BIOTECH, V19, P475, DOI 10.1016/j.copbio.2008.08.010; Chatterjee A, 2013, P NATL ACAD SCI USA, V110, P7086, DOI 10.1073/pnas.1212256110; Chatterjee A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021974; Chatterjee A, 2011, P NATL ACAD SCI USA, V108, P9721, DOI 10.1073/pnas.1101569108; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; Crampton N, 2006, NUCLEIC ACIDS RES, V34, P5416, DOI 10.1093/nar/gkl668; Dodd IB, 2007, J MOL BIOL, V369, P1200, DOI 10.1016/j.jmb.2007.04.041; Dodd IB, 2002, MOL MICROBIOL, V45, P697, DOI 10.1046/j.1365-2958.2002.03038.x; Duhring U, 2006, P NATL ACAD SCI USA, V103, P7054, DOI 10.1073/pnas.0600927103; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Trevino-Quintanilla LG, 2013, CURR GENOMICS, V14, P378, DOI 10.2174/1389202911314060007; Giangrossi M, 2010, NUCLEIC ACIDS RES, V38, P3362, DOI 10.1093/nar/gkq025; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; Gottesman S, 2011, COLD SPRING HARB PER, V3, P1, DOI DOI 10.1101/CSHPERSPECT.A003798; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Guo YX, 2014, NUCLEIC ACIDS RES, V42, P6448, DOI 10.1093/nar/gku279; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079; Hoe CH, 2013, INT J MED MICROBIOL, V303, P217, DOI 10.1016/j.ijmm.2013.04.002; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Johnson CM, 2010, J BACTERIOL, V192, P1634, DOI 10.1128/JB.01525-09; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; KRUMMEL B, 1992, J MOL BIOL, V225, P239, DOI 10.1016/0022-2836(92)90918-A; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Licht A, 2011, MICROBIOL-SGM, V157, P1000, DOI 10.1099/mic.0.047209-0; Lutz R, 2001, NUCLEIC ACIDS RES, V29, P3873, DOI 10.1093/nar/29.18.3873; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mason E, 2013, MOL MICROBIOL, V90, P716, DOI 10.1111/mmi.12394; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Monti L, 2009, INT J ONCOL, V34, P1099, DOI 10.3892/ijo_00000237; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murchland I, 2014, J BIOL CHEM, V289, P32094, DOI 10.1074/jbc.M114.608026; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Peterson EJR, 2014, NUCLEIC ACIDS RES, V42, P11291, DOI 10.1093/nar/gku777; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Record M. T., 1996, ESCHERICHIA COLI RNA; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Sayed N, 2012, NAT STRUCT MOL BIOL, V19, P105, DOI 10.1038/nsmb.2193; Sesto N, 2013, NAT REV MICROBIOL, V11, P75, DOI 10.1038/nrmicro2934; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Shokeen S, 2010, PLASMID, V64, P26, DOI 10.1016/j.plasmid.2010.03.002; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Sneppen K, 2005, J MOL BIOL, V346, P399, DOI 10.1016/j.jmb.2004.11.075; Stazic D, 2011, NUCLEIC ACIDS RES, V39, P4890, DOI 10.1093/nar/gkr037; Stork M, 2007, J BACTERIOL, V189, P3479, DOI 10.1128/JB.00619-06; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; THISTED T, 1992, J MOL BIOL, V223, P41, DOI 10.1016/0022-2836(92)90714-U; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o; Xu J, 2000, J BACTERIOL, V182, P3165, DOI 10.1128/JB.182.11.3165-3174.2000; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Xue ZH, 2014, NATURE, V514, P650, DOI 10.1038/nature13671; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	94	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133873	10.1371/journal.pone.0133873	http://dx.doi.org/10.1371/journal.pone.0133873			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222133	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800074
J	de Oliveira, JT; Ribeiro, C; Barros, R; Gomes, C; de Matos, AJ; Reis, CA; Rutteman, GR; Gartner, F				de Oliveira, Joana T.; Ribeiro, Claudia; Barros, Rita; Gomes, Catarina; de Matos, Augusto J.; Reis, Celso A.; Rutteman, Gerard R.; Gaertner, Fatima			Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis	PLOS ONE			English	Article							BREAST-CARCINOMA CELLS; PROSTATE-CANCER; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; EPITHELIAL-CELLS; MUC1; PHOSPHORYLATION; ANGIOGENESIS; PATHWAY; MICROENVIRONMENT	The tumor microenvironment encompasses several stressful conditions for cancer cells such as hypoxia, oxidative stress and pH alterations. Galectin-3, a well-studied member of the beta-galactoside-binding animal family of lectins has been implicated in multiple steps of metastasis as cell-cell and cell-ECM adhesion, promotion of angiogenesis, cell proliferation and resistance to apoptosis. However, both its aberrantly up-and down-regulated expression was observed in several types of cancer. Thus, the mechanisms that regulate galectin-3 expression in neoplastic settings are not clear. In order to demonstrate the putative role of hypoxia in regulating galectin-3 expression in canine mammary tumors (CMT), in vitro and in vivo studies were performed. In malignant CMT cells, hypoxia was observed to induce expression of galectin-3, a phenomenon that was almost completely prevented by catalase treatment of CMT-U27 cells. Increased galectin-3 expression was confirmed at the mRNA level. Under hypoxic conditions the expression of galectin-3 shifts from a predominant nuclear location to cytoplasmic and membrane expressions. In in vivo studies, galectin-3 was overexpressed in hypoxic areas of primary tumors and well-established metastases. Tumor hypoxia thus up-regulates the expression of galectin-3, which may in turn increase tumor aggressiveness.	[de Oliveira, Joana T.; Ribeiro, Claudia; Barros, Rita; Gomes, Catarina; Reis, Celso A.; Gaertner, Fatima] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Oporto, Portugal; [de Oliveira, Joana T.; Ribeiro, Claudia; Barros, Rita; Gomes, Catarina; Reis, Celso A.; Gaertner, Fatima] Univ Porto, Inst Mol Pathol & Immunol IPATIMUP, P-4100 Oporto, Portugal; [de Oliveira, Joana T.; de Matos, Augusto J.; Reis, Celso A.; Gaertner, Fatima] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [de Oliveira, Joana T.] Lusophone Univ Humanities & Technol, Fac Vet Med, Lisbon, Portugal; [de Matos, Augusto J.] Univ Porto, Food & Agrarian Sci & Technol Inst ICETA, Anim Sci & Study Cent CECA, P-4100 Oporto, Portugal; [Rutteman, Gerard R.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Rutteman, Gerard R.] Specialist Vet Ctr De Wagenrenk, Utrecht, Netherlands	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Lusofona University; Universidade de Lisboa; Universidade do Porto; Utrecht University	de Oliveira, JT (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.	joanao@ipatimup.pt	Gomes, Catarina/CAJ-5505-2022; Gomes, Catarina/AAU-4636-2020; Gomes, Catarina/AAC-3325-2021; Gartner, Maria de Fatima/A-3530-2010; Barros, Rita/C-1072-2012; Ribeiro, Ana Claudia/E-6906-2015; Reis, Celso/B-9969-2008	Gomes, Catarina/0000-0002-0352-6783; Gartner, Maria de Fatima/0000-0002-5302-0086; Barros, Rita/0000-0002-1667-7329; Ribeiro, Ana Claudia/0000-0002-1723-5055; Reis, Celso/0000-0002-0286-6639	Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao (POCI) do Quadro Comunitario de Apoio III"; Portuguese Foundation for Science and Technology [PTDC/CVT/117610/2010, SFRH/ BPD/ 68276/ 2010, SFRH/ BPD/ / 201]	Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao (POCI) do Quadro Comunitario de Apoio III"; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao 2010 (POCI 2010) do Quadro Comunitario de Apoio III" and Project grant no. PTDC/CVT/117610/2010. RB (SFRH/ BPD/ 68276/ 2010) and CG (SFRH/ BPD/ / 201) acknowledge the Portuguese Foundation for Science and Technology. Institute of Molecular Pathology and Immunology is an Associate Laboratory of the Portuguese Ministry of Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2007, BIOCHEM BIOPH RES CO, V358, P241, DOI 10.1016/j.bbrc.2007.04.114; Al-Salam S, 2013, INT J CLIN EXP PATHO, V6, P853; Andre S, 2007, FEBS J, V274, P3233, DOI 10.1111/j.1742-4658.2007.05851.x; Aubert S, 2009, CANCER RES, V69, P5707, DOI 10.1158/0008-5472.CAN-08-4905; Baba A.I, 2007, COMP ONCOLOGY 2; Bachmann IM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-362; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; Rego MJBD, 2013, MED MOL MORPHOL, V46, P92, DOI 10.1007/s00795-013-0013-4; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; BROWN JM, 1979, BRIT J RADIOL, V52, P650, DOI 10.1259/0007-1285-52-620-650; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Castronovo V, 1996, J PATHOL, V179, P43, DOI 10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N; Choi YK, 2004, J COMP PATHOL, V131, P242, DOI 10.1016/j.jcpa.2004.02.002; de Oliveira JT, 2010, GLYCOBIOLOGY, V20, P1341, DOI 10.1093/glycob/cwq103; de Oliveira JT, 2011, INT J DEV BIOL, V55, P823, DOI 10.1387/ijdb.113359jt; DEO JT, 2014, ANTICANCER RES, V34, P2211; Doverhag C, 2010, NEUROBIOL DIS, V38, P36, DOI 10.1016/j.nbd.2009.12.024; Ellerhorst J, 1999, UROL RES, V27, P362, DOI 10.1007/s002400050164; Favaro E, 2011, GENOME MED, V3, DOI 10.1186/gm271; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Gartner F, 2013, GALECTINS POTENTIAL; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hashimoto K, 2011, NAGOYA J MED SCI, V73, P15; Haudek KC, 2010, BBA-GEN SUBJECTS, V1800, P181, DOI 10.1016/j.bbagen.2009.07.005; HELLMEN E, 1992, IN VITRO CELL DEV-AN, V28A, P309, DOI 10.1007/BF02877054; Hockel M, 1996, CANCER RES, V56, P4509; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Kitamoto S, 2013, ONCOGENE, V32, P4614, DOI 10.1038/onc.2012.478; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; Le Mercier M, 2008, TOXICOL APPL PHARM, V229, P172, DOI 10.1016/j.taap.2008.01.009; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lukyanov P, 2005, BIOCHEM BIOPH RES CO, V338, P1031, DOI 10.1016/j.bbrc.2005.10.033; LYNG H, 1992, CANCER RES, V52, P584; Mah LY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008821; Malagolini N, 2009, GLYCOBIOLOGY, V19, P172, DOI 10.1093/glycob/cwn122; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P2504, DOI 10.4161/cc.10.15.16585; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Mengwasser J, 2002, GLYCOBIOLOGY, V12, P129, DOI 10.1093/glycob/12.2.129; Montero AJ, 2012, BREAST CANCER RES TR, V132, P747, DOI 10.1007/s10549-011-1919-y; Nakahara S, 2007, CANCER METAST REV, V26, P605, DOI 10.1007/s10555-007-9095-6; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Ndubuizu OI, 2010, BRAIN RES, V1366, P101, DOI 10.1016/j.brainres.2010.09.064; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oliveira JTd, 2012, DYNAMIC TUNING GALEC; Qutub AA, 2008, MOL CELL BIOL, V28, P5106, DOI 10.1128/MCB.00060-08; Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Reis CA, 1998, INT J CANCER, V79, P402, DOI 10.1002/(SICI)1097-0215(19980821)79:4<402::AID-IJC16>3.0.CO;2-6; Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]; Sanjuan X, 1997, GASTROENTEROLOGY, V113, P1906, DOI 10.1016/S0016-5085(97)70010-6; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Snyder SA, 2008, VET COMP ONCOL, V6, P213, DOI 10.1111/j.1476-5829.2008.00163.x; Song SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042699; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05	67	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134458	10.1371/journal.pone.0134458	http://dx.doi.org/10.1371/journal.pone.0134458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222311	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800145
J	Deliyanti, D; Zhang, Y; Khong, F; Berka, DR; Stapleton, DI; Kelly, DJ; Wilkinson-Berka, JL				Deliyanti, Devy; Zhang, Yuan; Khong, Fay; Berka, David R.; Stapleton, David I.; Kelly, Darren J.; Wilkinson-Berka, Jennifer L.			FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; GLYCATION END-PRODUCTS; RETINAL NEOVASCULARIZATION; ADHESION MOLECULE-1; VITREOUS FLUID; (MREN-2)27 RAT; HEART-FAILURE; EXPRESSION; TRANILAST; INHIBITION	Diabetic retinopathy features inflammation as well as injury to glial cells and the microvasculature, which are influenced by hypertension and overactivity of the renin-angiotensin system. FT011 is an anti-inflammatory and anti-fibrotic agent that has been reported to attenuate organ damage in diabetic rats with cardiomyopathy and nephropathy. However, the potential therapeutic utility of FT011 for diabetic retinopathy has not been evaluated. We hypothesized that FT011 would attenuate retinopathy in diabetic Ren-2 rats, which exhibit hypertension due to an overactive extra-renal renin-angiotensin system. Diabetic rats were studied for 8 and 32 weeks and received intravitreal injections of FT011 (50 mu M) or vehicle (0.9% NaCl). Comparisons were to age-matched controls. In the 8-week study, retinal inflammation was examined by quantitating vascular leukocyte adherence, microglial/macrophage density and the expression of inflammatory mediators. Macroglial Muller cells which exhibit a pro-inflammatory and pro-angiogenic phenotype in diabetes, were evaluated in the 8-week study as well as in culture following exposure to hyperglycaemia and FT011 (10, 30, 100 mu M) for 72 hours. In the 32-week study, severe retinal vasculopathy was examined by quantitating acellular capillaries and extracellular matrix proteins. In diabetic rats, FT011 reduced retinal leukostasis, microglial density and mRNA levels of intercellular adhesion molecule-1 (ICAM-1). In Muller cells, FT011 reduced diabetes-induced gliosis and vascular endothelial growth factor (VEGF) immunolabeling and the hyperglycaemic-induced increase in ICAM-1, monocyte chemoattractant protein-1, CCL20, cytokine-induced neutrophil chemoattractant-1, VEGF and IL-6. Late intervention with FT011 reduced acellular capillaries and the elevated mRNA levels of collagen IV and fibronectin in diabetic rats. In conclusion, the protective effects of FT011 in cardiorenal disease extend to key elements of diabetic retinopathy and highlight its potential as a treatment approach.	[Deliyanti, Devy; Berka, David R.; Wilkinson-Berka, Jennifer L.] Monash Univ, Dept Pathol & Immunol, Melbourne, Vic 3004, Australia; [Zhang, Yuan; Khong, Fay; Kelly, Darren J.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Stapleton, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	Monash University; St Vincent's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Wilkinson-Berka, JL (corresponding author), Monash Univ, Dept Pathol & Immunol, Melbourne, Vic 3004, Australia.	jennifer.wilkinson-berka@monash.edu	Deliyanti, Devy/I-1562-2014; Wilkinson-Berka, Jennifer/D-4232-2011	Deliyanti, Devy/0000-0002-0390-3454; Kelly, Darren/0000-0003-4850-3929; Wilkinson-Berka, Jennifer/0000-0003-3512-4030	National Health and Medical Research Council of Australia; Peggy and Lesley Cranbourne Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Peggy and Lesley Cranbourne Foundation	National Health and Medical Research Council of Australia provided a Senior Research Fellowship to JWB. The study was partially supported by a Peggy and Lesley Cranbourne Foundation grant to DIS.	Adachi T, 2010, INVEST OPHTH VIS SCI, V51, P3954, DOI 10.1167/iovs.09-4161; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Batenburg WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100954; Berka JLW, 2009, CIRC RES, V104, P124, DOI 10.1161/CIRCRESAHA.108.176008; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chen M, 2013, CURR MED CHEM, V20, P3234, DOI 10.2174/09298673113209990025; Connelly KA, 2007, CARDIOVASC RES, V76, P280, DOI 10.1016/j.cardiores.2007.06.022; Curtis TM, 2004, DIABETES-METAB RES, V20, P28, DOI 10.1002/dmrr.431; DANSER AHJ, 1989, J CLIN ENDOCR METAB, V68, P160, DOI 10.1210/jcem-68-1-160; Deliyanti D, 2014, ARTERIOSCL THROM VAS, V34, P2033, DOI 10.1161/ATVBAHA.114.303792; FRANKEN AAM, 1988, J HYPERTENS, V6, pS461, DOI 10.1097/00004872-198812040-00145; Gao Hua, 2003, Trans Am Ophthalmol Soc, V101, P183; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilbert RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047160; He J, 2015, BLOCKADE VASCULAR EN, V2015; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Kelly DJ, 1998, KIDNEY INT, V54, P343, DOI 10.1046/j.1523-1755.1998.00019.x; Kim SY, 2005, DIABETES, V54, P1534, DOI 10.2337/diabetes.54.5.1534; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Lange CAK, 2011, AM J OPHTHALMOL, V152, P406, DOI 10.1016/j.ajo.2011.02.014; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; McCarthy CA, 2013, CLIN EXP PHARMACOL P, V40, P571, DOI 10.1111/1440-1681.12099; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Mifsud S, 2003, NEPHRON PHYSIOL, V95, P83, DOI DOI 10.1159/000074845.PMID:14694265; Miller AG, 2010, DIABETES, V59, P3208, DOI 10.2337/db10-0552; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyazawa K, 1995, ATHEROSCLEROSIS, V118, P213, DOI 10.1016/0021-9150(95)05607-6; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Moravski CJ, 2003, AM J PATHOL, V162, P151, DOI 10.1016/S0002-9440(10)63806-0; Moravski CJ, 2000, HYPERTENSION, V36, P1099, DOI 10.1161/01.HYP.36.6.1099; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Phipps JA, 2007, INVEST OPHTH VIS SCI, V48, P927, DOI 10.1167/iovs.06-0892; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Schoenberger SD, 2012, INVEST OPHTH VIS SCI, V53, P5906, DOI 10.1167/iovs.12-10410; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Stitt A, 2002, DIABETES, V51, P2826, DOI 10.2337/diabetes.51.9.2826; Takehana Y, 1999, INVEST OPHTH VIS SCI, V40, P459; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wilkinson-Berka JL, 2014, ANTIOXID REDOX SIGN, V20, P2726, DOI 10.1089/ars.2013.5357; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Wilkinson-Berka JL, 2012, PEPTIDES, V36, P142, DOI 10.1016/j.peptides.2012.04.008; Wilkinson-Berka JL, 2007, AM J HYPERTENS, V20, P423, DOI 10.1016/j.amjhyper.2006.09.018; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yuuki T, 2001, J DIABETES COMPLICAT, V15, P257, DOI 10.1016/S1056-8727(01)00155-6; Zammit SC, 2009, BIOORG MED CHEM LETT, V19, P7003, DOI 10.1016/j.bmcl.2009.09.120; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang WB, 2011, IMMUNOTHERAPY-UK, V3, P609, DOI [10.2217/imt.11.24, 10.2217/IMT.11.24]; Zhang Y, 2012, EUR J HEART FAIL, V14, P549, DOI 10.1093/eurjhf/hfs011; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	54	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134392	10.1371/journal.pone.0134392	http://dx.doi.org/10.1371/journal.pone.0134392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222724	Green Published, gold			2022-12-27	WOS:000358836800139
J	Frakes, RA; Belden, RC; Wood, BE; James, FE				Frakes, Robert A.; Belden, Robert C.; Wood, Barry E.; James, Frederick E.			Landscape Analysis of Adult Florida Panther Habitat	PLOS ONE			English	Article							PUMAS PUMA-CONCOLOR; SELECTION; CONSERVATION; FORESTS; WINTER; EDGE; SIZE	Historically occurring throughout the southeastern United States, the Florida panther is now restricted to less than 5% of its historic range in one breeding population located in southern Florida. Using radio-telemetry data from 87 prime-aged (>= 3 years old) adult panthers (35 males and 52 females) during the period 2004 through 2013 (28,720 radio-locations), we analyzed the characteristics of the occupied area and used those attributes in a random forest model to develop a predictive distribution map for resident breeding panthers in southern Florida. Using 10-fold cross validation, the model was 87.5 % accurate in predicting presence or absence of panthers in the 16,678 km(2) study area. Analysis of variable importance indicated that the amount of forests and forest edge, hydrology, and human population density were the most important factors determining presence or absence of panthers. Sensitivity analysis showed that the presence of human populations, roads, and agriculture (other than pasture) had strong negative effects on the probability of panther presence. Forest cover and forest edge had strong positive effects. The median model-predicted probability of presence for panther home ranges was 0.81 (0.82 for females and 0.74 for males). The model identified 5579 km(2) of suitable breeding habitat remaining in southern Florida; 1399 km(2) (25%) of this habitat is in non-protected private ownership. Because there is less panther habitat remaining than previously thought, we recommend that all remaining breeding habitat in south Florida should be maintained, and the current panther range should be expanded into south-central Florida. This model should be useful for evaluating the impacts of future development projects, in prioritizing areas for panther conservation, and in evaluating the potential impacts of sea-level rise and changes in hydrology.	[Frakes, Robert A.; Belden, Robert C.; Wood, Barry E.] US Fish & Wildlife Serv, South Florida Ecol Serv Off, Vero Beach, FL 32960 USA; [James, Frederick E.] Everglades Natl Pk, Natl Pk Serv, South Florida Nat Resources Ctr, Homestead, FL USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior	Frakes, RA (corresponding author), US Fish & Wildlife Serv, South Florida Ecol Serv Off, 1339 20th St, Vero Beach, FL 32960 USA.	frakesr@comcast.net						BELDEN RC, 1988, J WILDLIFE MANAGE, V52, P660, DOI 10.2307/3800927; Benson JF, 2008, J WILDLIFE MANAGE, V72, P405, DOI 10.2193/2007-264; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Comiskey EJ, 2002, CONSERV ECOL, V6; Cox JJ, 2006, J WILDLIFE MANAGE, V70, P1778, DOI 10.2193/0022-541X(2006)70[1778:FPHUNA]2.0.CO;2; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dalrymple George H., 1996, Bulletin of the Florida Museum of Natural History, V39, P173; Dees CS, 2001, J WILDLIFE MANAGE, V65, P141, DOI 10.2307/3803287; Duever M. J., 1986, BIG CYPRESS NATL PRE; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fish U. S. and Wildlife Service, 2008, FLOR PANTH REC PLAN; Florida Fish and Wildlife Conservation Commission, 2014, ANN REP RES MAN FLOR; Franklin J, 2009, MAPPING SPECIES DIST; Holmes BR, 2006, WILDLIFE BIOL, V12, P201, DOI 10.2981/0909-6396(2006)12[201:UOOEAF]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jones Jr FK, 1965, FLORIDA GAME FRESH W; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Labisky R.G., 1995, POPULATION DYNAMICS; Land ED, 2008, J WILDLIFE MANAGE, V72, P633, DOI 10.2193/2007-136; Laundre JW, 2007, AM MIDL NAT, V157, P221, DOI 10.1674/0003-0031(2007)157[221:IOEHOS]2.0.CO;2; Laundre JW, 2003, WILDLIFE BIOL, V9, P123, DOI 10.2981/wlb.2003.034; Logan K.A., 2001, DESERT PUMA EVOLUTIO; Maehr David S., 1990, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V44, P310; MAEHR DS, 1995, CONSERV BIOL, V9, P1008, DOI 10.1111/j.1523-1739.2005.00286.x-i1; MAEHR DS, 2002, CLEAN TECHNOL ENVIR, V3, P398, DOI DOI 10.1007/S10098-001-0129-4; McBride RT, 2012, SYNOPTIC SURVE UNPUB; Milborrow S., 2015, PLOT MODELS RESPONSE; Onorato DP, 2011, ANIM CONSERV, V14, P196, DOI 10.1111/j.1469-1795.2010.00415.x; Quigley Howard, 2010, P59; Riley SJ, 2001, ENVIRON MANAGE, V28, P317, DOI 10.1007/s0026702503; Schwab AC, 2006, THESIS U S FLORIDA; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Severinghaus CW, 1969, DEER N AM, P57; South Florida Natural Resources Center, DATAFOREVER DAT; South Florida Water Management District, 2009, FLOR LAND US COV CLA; South Florida Water Management District, DBHYDRO ENV DAT; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Thatcher CA, 2009, J MAMMAL, V90, P918, DOI 10.1644/08-MAMM-A-219.1; Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034; U. S. Army Corps of Engineers, SW FLOR FEAS STUD SW; U. S. Census Bureau, 2011, TIGER LIN SHAP FLOR; U. S. Geological Survey, HIGH ACC EL DAT PROJ; US Fish and Wildlife Service, S FLOR EC SERV OFF H	43	13	14	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133044	10.1371/journal.pone.0133044	http://dx.doi.org/10.1371/journal.pone.0133044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222526	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800037
J	Song, MG; Ryoo, IG; Choi, HY; Choi, BH; Kim, ST; Heo, TH; Lee, JY; Park, PH; Kwak, MK				Song, Min-gu; Ryoo, In-geun; Choi, Hye-young; Choi, Bo-hyun; Kim, Sang-Tae; Heo, Tae-Hwe; Lee, Joo Young; Park, Pil-Hoon; Kwak, Mi-Kyoung			NRF2 Signaling Negatively Regulates Phorbol-12-Myristate-13-Acetate (PMA)-Induced Differentiation of Human Monocytic U937 Cells into Pro-Inflammatory Macrophages	PLOS ONE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; CELLULAR STRESS; PHORBOL ESTER; ACTIVATION; PHOSPHORYLATION; MECHANISMS	Blood monocytes are recruited to injured tissue sites and differentiate into macrophages, which protect against pathogens and repair damaged tissues. Reactive oxygen species (ROS) are known to be an important contributor to monocytes' differentiation and macrophages' function. NF-E2-related factor 2 (NRF2), a transcription factor regulating cellular redox homeostasis, is known to be a critical modulator of inflammatory responses. We herein investigated the role of NRF2 in macrophage differentiation using the human monocytic U937 cell line and phorbol-12-myristate-13-acetate (PMA). In U937 cells with NRF2 silencing, PMA-stimulated cell adherence was significantly facilitated when compared to control U937 cells. Both transcript and protein levels for pro-inflammatory cytokines, including interleukine-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) were highly elevated in PMA-stimulated NRF2-silenced U937 compared to the control. In addition, PMA-inducible secretion of monocyte chemotactic protein 1 (MCP-1) was significantly high in NRF2-silenced U937. As an underlying mechanism, we showed that NRF2-knockdown U937 retained high levels of cellular ROS and endoplasmic reticulum (ER) stress markers expression; and subsequently, PMA-stimulated levels of Ca2+ and PKC alpha were greater in NRF2-knockdown U937 cells, which caused enhanced nuclear accumulation of nuclear factor-kappa B (NF kappa B) p50 and extracellular signal-regulated kinase (ERK)-1/2 phosphorylation. Whereas the treatment of NRF2-silenced U937 cells with pharmacological inhibitors of NF kappa B or ERK1/2 largely blocked PMA-induced IL-1 beta and IL-6 expression, indicating that these pathways are associated with cell differentiation. Taken together, our results suggest that the NRF2 system functions to suppress PMA-stimulated U937 cell differentiation into pro-inflammatory macrophages and provide evidence that the ROS-PKC alpha-ERK-NF kappa B axis is involved in PMA-facilitated differentiation of NRF2-silenced U937 cells.	[Song, Min-gu; Park, Pil-Hoon] Yeungnam Univ, Coll Pharm, Gyongsan 712749, Gyeongsangbuk D, South Korea; [Ryoo, In-geun; Choi, Hye-young; Choi, Bo-hyun; Heo, Tae-Hwe; Lee, Joo Young; Kwak, Mi-Kyoung] Catholic Univ Korea, Coll Pharm, Bucheon 420743, Gyeonggi Do, South Korea; [Kim, Sang-Tae] Seoul Natl Univ, Bundang Hosp, Songnam 463707, Gyeonggi Do, South Korea	Yeungnam University; Catholic University of Korea; Seoul National University (SNU)	Kwak, MK (corresponding author), Catholic Univ Korea, Coll Pharm, Bucheon 420743, Gyeonggi Do, South Korea.	mkwak@catholic.ac.kr			National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013R1A2A2A01015497]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning	This study was financially supported by the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A2A2A01015497).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Bobilev I, 2011, CANCER BIOL THER, V11, P317, DOI 10.4161/cbt.11.3.14098; Bocci V, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00004; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; CAVENDER DE, 1991, J LEUKOCYTE BIOL, V49, P566, DOI 10.1002/jlb.49.6.566; Chen BC, 2001, BRIT J PHARMACOL, V134, P1055, DOI 10.1038/sj.bjp.0704334; Chen HM, 2013, CELL BIOL INT, V37, P1215, DOI 10.1002/cbin.10156; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; Choi BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107158; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Fan HC, 2014, BIOCHEM PHARMACOL, V88, P139, DOI 10.1016/j.bcp.2014.01.006; Garcia A, 1999, EXP HEMATOL, V27, P353, DOI 10.1016/S0301-472X(98)00038-1; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hinoi E, 2007, BONE, V40, P337, DOI 10.1016/j.bone.2006.08.016; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Jung KA, 2015, MOL PHARMACOL, V87, P465, DOI 10.1124/mol.114.096065; Jung KA, 2013, TOXICOL LETT, V218, P39, DOI 10.1016/j.toxlet.2012.12.026; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Kuhn AM, 2011, FREE RADICAL BIO MED, V50, P1382, DOI 10.1016/j.freeradbiomed.2011.02.036; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Liu H, 2008, P NATL ACAD SCI USA, V105, P15926, DOI 10.1073/pnas.0808346105; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; Martinon F, 2012, MICROBES INFECT, V14, P1293, DOI 10.1016/j.micinf.2012.07.005; Naldini A, 1998, J CELL PHYSIOL, V177, P76, DOI 10.1002/(SICI)1097-4652(199810)177:1<76::AID-JCP8>3.0.CO;2-B; Otte A, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-20; Park CK, 2014, BONE, V63, P36, DOI 10.1016/j.bone.2014.01.025; PEDRINACI S, 1990, INT J CANCER, V45, P294, DOI 10.1002/ijc.2910450215; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Ruotsalainen AK, 2013, CARDIOVASC RES, V98, P107, DOI 10.1093/cvr/cvt008; Ryoo IG, 2015, ARCH PHARM RES, V38, P272, DOI 10.1007/s12272-014-0380-y; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Song JW, 2013, TOX RESEARCH, V29, P235, DOI 10.5487/TR.2013.29.4.235; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; VANROOZENDAAL KEP, 1990, EXP CELL RES, V190, P137, DOI 10.1016/0014-4827(90)90155-4; Zhang GL, 2014, ACTA BIOCH BIOPH SIN, V46, P540, DOI 10.1093/abbs/gmu042; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029	57	27	27	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134235	10.1371/journal.pone.0134235	http://dx.doi.org/10.1371/journal.pone.0134235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222138	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800114
J	Turner, L; Kelly, B; Boyland, E; Bauman, AE				Turner, Laura; Kelly, Bridget; Boyland, Emma; Bauman, Adrian E.			Measuring Food Brand Awareness in Australian Children: Development and Validation of a New Instrument	PLOS ONE			English	Article							LOGO RECOGNITION; TELEVISION; EXTENT	Background Children's exposure to food marketing is one environmental determinant of childhood obesity. Measuring the extent to which children are aware of food brands may be one way to estimate relative prior exposures to food marketing. This study aimed to develop and validate an Australian Brand Awareness Instrument (ABAI) to estimate children's food brand awareness. Methods The ABAI incorporated 30 flashcards depicting food/drink logos and their corresponding products. An abbreviated version was also created using 12 flashcards (ABAI-a). The ABAI was presented to 60 primary school aged children (7-11 yrs) attending two Australian after-school centres. A week later, the full-version was repeated on approximately half the sample (n=27) and the abbreviated-version was presented to the remaining half (n=30). The test-retest reliability of the ABAI was analysed using Intra-class correlation coefficients. The concordance of the ABAI-a and full-version was assessed using Bland-Altman plots. The 'nomological' validity of the full tool was investigated by comparing children's brand awareness with food marketing-related variables (e.g. television habits, intake of heavily promoted foods). Results Brand awareness increased with age (p<0.01) but was not significantly correlated with other variables. Bland-Altman analyses showed good agreement between the ABAI and ABAI-a. Reliability analyses revealed excellent agreement between the two administrations of the full-ABAI. Conclusions The ABAI was able to differentiate children's varying levels of brand awareness. It was shown to be a valid and reliable tool and may allow quantification of brand awareness as a proxy measure for children's prior food marketing exposure.	[Turner, Laura] Univ Wollongong, Fac Social Sci, Sch Hlth & Soc, Wollongong, NSW, Australia; [Kelly, Bridget] Univ Wollongong, Fac Social Sci, Early Start Res Inst, Wollongong, NSW, Australia; [Boyland, Emma] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England; [Bauman, Adrian E.] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia	University of Wollongong; University of Wollongong; University of Liverpool; University of Sydney	Kelly, B (corresponding author), Univ Wollongong, Fac Social Sci, Early Start Res Inst, Wollongong, NSW, Australia.	bkelly@uow.edu.au	Kelly, Bridget/AAW-9549-2021	Kelly, Bridget/0000-0003-3111-6279; Boyland, Emma/0000-0001-8384-4994				Aaker D. A, 1991, MANAGING BRAND EQUIT; Arredondo E, 2009, J COMMUN HEALTH, V34, P73, DOI 10.1007/s10900-008-9119-3; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV UPD; Australian Bureau of Statistics, 2011, SOC IND AR 2011; BAHN KD, 1986, J CONSUM RES, V13, P382, DOI 10.1086/209077; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Boyland EJ, 2012, APPETITE, V58, P658, DOI 10.1016/j.appet.2011.11.017; Cairns G, 2013, APPETITE, V62, P209, DOI 10.1016/j.appet.2012.04.017; Carter OBJ, 2011, SOC SCI MED, V72, P962, DOI 10.1016/j.socscimed.2011.01.018; Connor SM, 2006, PEDIATRICS, V118, P1478, DOI 10.1542/peds.2005-2837; Forman J, 2009, APPETITE, V53, P76, DOI 10.1016/j.appet.2009.05.015; Franchin L, 2012, PROG NUTR, V14, P132; Fuchs M, 2008, SYMPOSIUM, V11, P522; GOLDBERG ME, 1990, J MARKETING RES, V27, P445, DOI 10.2307/3172629; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Huang R, 2012, J BUS RES, V65, P92, DOI 10.1016/j.jbusres.2011.02.003; Karras DJ, 1997, ACAD EMERG MED, V4, P64, DOI 10.1111/j.1553-2712.1997.tb03646.x; Kelly B, 2015, J PUB HLTH, V105, P86; Kelly B, 2007, PUBLIC HEALTH NUTR, V10, P1234, DOI 10.1017/S1368980007687126; Kelly B, 2011, AUST NZ J PUBL HEAL, V35, P131, DOI 10.1111/j.1753-6405.2011.00612.x; King L, 2013, PUBLIC HEALTH NUTR, V16, P2249, DOI 10.1017/S1368980012004429; Kopelman CA, 2007, J PUBLIC HEALTH-UK, V29, P358, DOI 10.1093/pubmed/fdm067; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; MIZERSKI R, 1995, J MARKETING, V59, P58, DOI 10.2307/1252328; NSW Ministry of Health, 2010, NSW SCH PHYS ACT NUT; Roberts M, 2007, INT J ADVERT, V26, P357, DOI 10.1080/02650487.2007.11073018; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; Schwartz M, 1991, JAMA-J AM MED ASSOC, V266, P31; Story Mary, 2004, Int J Behav Nutr Phys Act, V1, P3, DOI 10.1186/1479-5868-1-3; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Ueda P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047000; United Nations, 2010, PRIV SECT SHOULD STO; Valkenburg PM, 2005, J APPL DEV PSYCHOL, V26, P456, DOI 10.1016/j.appdev.2005.04.004; Vecchio M, 2013, OPEN OBES J, V5, P30; Vecchio MG, 2014, INDIAN J PEDIATR, V81, pS23, DOI 10.1007/s12098-014-1447-y; *WHO, 2010, SET REC MARK FOODS N; WHO, 2012, COMPR GLOB MON FRAM	37	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133972	10.1371/journal.pone.0133972	http://dx.doi.org/10.1371/journal.pone.0133972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222624	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800088
J	Xie, JG; Yang, ZX; Liang, LL				Xie, Jianguang; Yang, Zhaoxu; Liang, Leilei			Investigation of Low Heat Accumulation Asphalt Mixture and Its Impact on Urban Heat Environment	PLOS ONE			English	Article								This study is focused on investigating the effectiveness of low heat accumulation asphalt mixture and its impact on the urban heat environment. Infrared radiation experiments showed that the temperature of the asphalt mixture decreased with the increase in far-infrared radiant material. The results also revealed that, compared to asphalt with 0% far-infrared radiant content, the asphalt material with a certain ratio of far-infrared radiation material had higher stability at high and low temperatures as well as good water absorption capacity. The Marshall stability of the specimen mixed with 6% far-infrared radiant was higher by 12.2% and had a residual stability of up to 98.9%. Moreover, the low-temperature splitting tensile strength of the asphalt mixture with 6% far-infrared radiation material increased by 21.3%. The friction coefficient of the asphalt mixtures with 6% and 12% far-infrared radiation material increased by 17.7% and 26.9%, respectively.	[Xie, Jianguang; Yang, Zhaoxu; Liang, Leilei] Nanjing Univ Aeronaut & Astronaut, Dept Civil Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics	Xie, JG (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Civil Engn, Nanjing, Jiangsu, Peoples R China.	xiejg@nuaa.edu.cn			National Natural Science Foundation of China [51078183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 51078183).	Brown E.R., 1993, 935 NCAT; Chen JA, 1997, HIGHWAYS, V12, P18; Chen XL, 2006, REMOTE SENS ENVIRON, V104, P133, DOI 10.1016/j.rse.2005.11.016; Chiu CT, 2007, CONSTR BUILD MATER, V21, P1027, DOI 10.1016/j.conbuildmat.2006.02.005; Fan WX, 2002, COAST ENV, V8, P12; Gibbons CJ, 1996, J AM PLAN ASS, V62, P243; Hao P., 1997, J CHONGQING JIAOTONG, V16, P80; Ibrahim MA, 2006, J CONSTR BUILD MAT, V20, P982; Maurice GE, 1999, APPR MILL 1999 APA N; Moghadas NF, 2010, J CONSTR BUILD MAT, V24, P1158; National Standards of the People's Republic of China, 2004, F402004 JTG NAT STAN; National Standards of the People's Republic of China, 2000, JTJ0522000 NAT STAND; Ni BS, 2009, COMMUN SCI TECHNOL H, V32, P22; Ren R, 2008, J INNER MONGOLIA AGR, V29, P144; Sarah B, 1998, PROFESSIONAL ROOFING; Shen J, 2005, URBAN ROADS BRIDGES, V9, P43; Wang JY, 2010, J HIGHW CONSTR MAINT, V224, P175; Wu JB, 2011, THEOR APPL CLIMATOL, V103, P489, DOI 10.1007/s00704-010-0323-6; Yang Wen-juan, 2008, Journal of Highway and Transportation Research and Development, V25, P147; Zhang DL, 2000, HIGHWAY, V5, P63; Zhang X, 2006, J JINLING I TECHNOL, V2, P69; Zhou LW, 2005, THESIS HEBEI U TECHN	22	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133829	10.1371/journal.pone.0133829	http://dx.doi.org/10.1371/journal.pone.0133829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222762	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800069
J	Bojakowski, K; Janusz, G; Grabowska, I; Zegrocka-Stendel, O; Surowiecka-Pastewka, A; Kowalewska, M; Maciejko, D; Koziak, K				Bojakowski, Krzysztof; Janusz, Gabriela; Grabowska, Iwona; Zegrocka-Stendel, Oliwia; Surowiecka-Pastewka, Agnieszka; Kowalewska, Magdalena; Maciejko, Dorota; Koziak, Katarzyna			Rat Model of Parkes Weber Syndrome	PLOS ONE			English	Article							BLOOD-FLOW RESTRICTION; INTENSITY RESISTANCE EXERCISE; MUSCLE PROTEIN-SYNTHESIS; VASCULAR ANOMALIES; SATELLITE CELLS; GROWTH; MALFORMATIONS; REGENERATION; OSTEOBLASTS; MUTATIONS	The Parkes Weber syndrome is a congenital vascular malformation, characterized by varicose veins, arterio-venous fistulas and overgrown limbs. No broadly accepted animal model of Parkes Weber syndrome has been described. We created side-to-side arteriovenous fistula between common femoral vessels with proximal non-absorbable ligature on common femoral vein limiting the enlargement of the vein diameter in Wistar rats. Contralateral limb was sham operated. Invasive blood pressure measurements in both iliac and inferior cava veins were performed in rats 30 days after fistula creation. Tight circumference and femoral bone length were measured. Histopathology and morphology of soleus muscle, extensor digitorum longus muscle, and the common femoral vessel were analyzed. 30 days following arterio-venous fistula creation, a statistically significant elevation of blood pressure in common iliac vein and limb overgrowth was observed. Limb enlargement was caused by muscle overgrowth, varicose veins formation and bone elongation. Arteriovenous fistula with proximal outflow limitation led to significant increase of femoral vein circumference and venous wall thickness. Our study indicates that the described rat model mimics major clinical features characteristic for the human Parkes Weber syndrome: presence of arterio-venous fistula, venous hypertension and dilatation, varicose veins formation, and the limb hypertrophy. We reveal that limb overgrowth is caused by bone elongation, muscle hypertrophy, and venous dilatation. The newly established model will permit detailed studies on the mechanisms underlying the disease and on the efficacy of novel therapeutic strategies for the Parkes Weber syndrome treatment.	[Bojakowski, Krzysztof; Janusz, Gabriela; Zegrocka-Stendel, Oliwia; Surowiecka-Pastewka, Agnieszka; Kowalewska, Magdalena; Maciejko, Dorota; Koziak, Katarzyna] Med Univ Warsaw, Dept Immunol Biochem & Nutr, Warsaw, Poland; [Bojakowski, Krzysztof] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland; [Grabowska, Iwona] Univ Warsaw, Fac Biol, Dept Cytol, Warsaw, Poland; [Kowalewska, Magdalena] Maria Sklodowska Curie Mem Canc Ctr, Dept Mol & Translat Oncol, Warsaw, Poland; [Kowalewska, Magdalena] Inst Oncol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Koziak, K (corresponding author), Med Univ Warsaw, Dept Immunol Biochem & Nutr, Warsaw, Poland.	katarzyna.koziak@wum.edu.pl	Grabowska, Iwona/AAY-8564-2021; Zegrocka-Stendel, Oliwia/T-8148-2018	Grabowska, Iwona/0000-0001-6455-9434; Zegrocka-Stendel, Oliwia/0000-0001-6481-372X; Bojakowski, Krzysztof/0000-0001-6899-8741; Kowalewska, Magdalena/0000-0002-3413-9612	European Union Operational Program "Innovative Economy" grant [POIG.01.01.02-14-072/09]	European Union Operational Program "Innovative Economy" grant	This work was supported by the European Union Operational Program "Innovative Economy" grant No. POIG.01.01.02-14-072/09. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J TRAIN SCI EXERC SP, V16, P199; Araldi E, 2010, BONE, V47, P190, DOI 10.1016/j.bone.2010.04.606; BASSAGLIA Y, 1995, J MUSCLE RES CELL M, V16, P420, DOI 10.1007/BF00114507; Breugem CC, 2004, BRIT J PLAST SURG, V57, P754, DOI 10.1016/j.bjps.2004.05.006; Burrows PE, 2013, P NATL ACAD SCI USA, V110, P8621, DOI 10.1073/pnas.1222722110; Enjolras O, 2004, J PEDIATR ORTHOP B, V13, P349, DOI 10.1097/01202412-200411000-00001; Fernandez-Pineda I, 2009, ANN VASC SURG, V23, DOI 10.1016/j.avsg.2008.08.021; Fry CS, 2010, J APPL PHYSIOL, V108, P1199, DOI 10.1152/japplphysiol.01266.2009; Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007; Giron-Vallejo O, 2013, ANN VASC SURG, V27, P820, DOI 10.1016/j.avsg.2013.01.001; Kalhovde JM, 2005, J PHYSIOL-LONDON, V562, P847, DOI 10.1113/jphysiol.2004.073684; Kawasaki J, 2014, J CLIN INVEST, V124, P2774, DOI 10.1172/JCI67084; Konner K, 2003, J AM SOC NEPHROL, V14, P1669, DOI 10.1097/01.ASN.0000069219.88168.39; Kubo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037934; Lapinski PE, 2007, GENESIS, V45, P762, DOI 10.1002/dvg.20354; Lee BB, 2004, J VASC SURG, V39, P590, DOI 10.1016/j.jvs.2003.10.048; Loenneke JP, 2012, MED HYPOTHESES, V78, P523, DOI 10.1016/j.mehy.2012.01.024; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Moraczewski J, 1996, ACTA BIOCHIM POL, V43, P693; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; NONAKA I, 1983, ACTA NEUROPATHOL, V60, P167, DOI 10.1007/BF00691863; Parsa Cameron F, 2013, Trans Am Ophthalmol Soc, V111, P180; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Takarada Y, 2000, J APPL PHYSIOL, V88, P61, DOI 10.1152/jappl.2000.88.1.61; Tombran-Tink J, 2004, BIOCHEM BIOPH RES CO, V316, P573, DOI 10.1016/j.bbrc.2004.02.076; Weber FP, 1907, BRIT J DERMATOL, V19, P231; Zimowska M, 2001, J CELL PHYSIOL, V188, P178, DOI 10.1002/jcp.1106; Ziyeh S, 2004, EUR RADIOL, V14, P2025, DOI 10.1007/s00330-004-2274-8	28	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133752	10.1371/journal.pone.0133752	http://dx.doi.org/10.1371/journal.pone.0133752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217941	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900044
J	Hrkac, M; Wurm, MF; Kuhn, AB; Schubotz, RI				Hrkac, Mari; Wurm, Moritz F.; Kuehn, Anne B.; Schubotz, Ricarda I.			Objects Mediate Goal Integration in Ventrolateral Prefrontal Cortex during Action Observation	PLOS ONE			English	Article							HUMAN BRAIN; RECOGNITION; MEMORY; FMRI	Actions performed by others are mostly not observed in isolation, but embedded in sequences of actions tied together by an overarching goal. Therefore, preceding actions can modulate the observer's expectations in relation to the currently perceived action. Ventrolateral prefrontal cortex (vlPFC), and inferior frontal gyrus (IFG) in particular, is suggested to subserve the integration of episodic as well as semantic information and memory, including action scripts. The present fMRI study investigated if activation in IFG varies with the effort to integrate expected and observed action, even when not required by the task. During an fMRI session, participants were instructed to attend to short videos of single actions and to deliver a judgment about the actor's current goal. We manipulated the strength of goal expectation induced by the preceding action, implementing the parameter "goal-relatedness" between the preceding and the currently observed action. Moreover, since objects point to the probability of certain actions, we also manipulated whether the current and the preceding action shared at least one object or not. We found an interaction between the two factors goal-relatedness and shared object: IFG activation increased the weaker the goal-relatedness between the preceding and the current action was, but only when they shared at least one object. Here, integration of successive action steps was triggered by the reappearing (shared) object but hampered by a weak goal-relatedness between the actually observed manipulation. These findings foster the recently emerging view that IFG is enhanced by goal-related conflicts during action observation.	[Hrkac, Mari; Schubotz, Ricarda I.] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Hrkac, Mari; Wurm, Moritz F.; Kuehn, Anne B.; Schubotz, Ricarda I.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Wurm, Moritz F.] Univ Trento, Ctr Mind Brain Sci, I-38100 Mattarello, TN, Italy	University of Munster; Max Planck Society; University of Trento	Wurm, MF (corresponding author), Univ Trento, Ctr Mind Brain Sci, Via Regole 101, I-38100 Mattarello, TN, Italy.	moritz.wurm@unitn.it	Schubotz, Ricarda/B-2871-2013; Wurm, Moritz/AAB-2603-2019	Wurm, Moritz/0000-0003-4358-9815; Schubotz, Ricarda/0000-0001-5802-6869	Max Planck Institute	Max Planck Institute(Max Planck Society)	The Max Planck Institute financed the fMRI study (http://www.nf.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Grafman J., 2002, PRINCIPLES FRONTAL L, P292, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0019; Green AE, 2010, CEREB CORTEX, V20, P70, DOI 10.1093/cercor/bhp081; Hrkac M, 2014, HUM BRAIN MAPP, V35, P2178, DOI 10.1002/hbm.22319; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kroger S, 2012, BRAIN RES, V1430, P52, DOI 10.1016/j.brainres.2011.10.031; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lohmann G, 2008, 11 INT C MED IM COMP, P1; Newman SD, 2013, BRAIN TOPOGR, V26, P458, DOI 10.1007/s10548-012-0264-8; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; Phillips WA, 2013, BEHAV BRAIN SCI, V36, P222, DOI 10.1017/S0140525X12002257; Schank RC., 1977, SCRIPTS PLANS GOALS; Talairach J, 1988, CO PLANAR STEREOTAXI; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Woodward AL, 2000, PSYCHOL SCI, V11, P73, DOI 10.1111/1467-9280.00218; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Wurm MF, 2014, BEHAV BRAIN RES, V274, P108, DOI 10.1016/j.bbr.2014.07.053; Wurm MF, 2012, NEUROIMAGE, V59, P1551, DOI 10.1016/j.neuroimage.2011.08.038	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134316	10.1371/journal.pone.0134316	http://dx.doi.org/10.1371/journal.pone.0134316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218102	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900112
J	Jee, HB; Park, MJ; Lee, HS; Park, MS; Kim, MJ; Chung, YE				Jee, Han Bum; Park, Min Jung; Lee, Hye Sun; Park, Mi-Suk; Kim, Myeong-Jin; Chung, Yong Eun			Is Non-Contrast CT Adequate for the Evaluation of Hepatic Metastasis in Patients Who Cannot Receive Iodinated Contrast Media?	PLOS ONE			English	Article							COLORECTAL LIVER METASTASES; HELICAL CT; SPIRAL CT; PET; MANAGEMENT; ULTRASOUND; TIME	Objective To evaluate the appropriateness of follow-up with only non-enhanced CT (NECT) in patients with gastrointestinal cancer. Subjects and Methods This retrospective study included 323 patients with colorectal and gastric cancer who underwent two consecutive CT examinations (CT1 and CT2), including non-contrast and portal venous phase CT images, with an interval of 1 year. Patients were divided into 2 groups: Group A included patients with no hepatic metastasis on CT1 and with or without newly developed metastasis on CT2 to evaluate the diagnostic performance of NECT for detecting newly developed hepatic metastasis; Group B included patients with known hepatic metastasis both on CT1 and CT2 to evaluate the accuracy of NECT for the assessment of hepatic metastasis based on RECIST criteria (version 1.1). Contrast-enhanced CT (CECT) images were considered as reference standards. Results Group A included 172 patients (M:F = 107: 65; mean age, 62.6 years). Among them, 57 patients had 95 metastases (mean size, 2.2 +/- 1.3 cm). Per patient and per lesion sensitivity for diagnosing newly developed hepatic metastasis was 56.1-66.7% and 52.6-56.8%, respectively. In terms of small metastases (<1.5 cm), per lesion sensitivity was significantly decreased to 28.1-34.4% (P<0.05). Metastasis size measurements were significantly smaller on NECT (P<0.001) compared with reference standards. In Group B, the accuracy of response evaluation based on RECIST criteria was 65.6-72.2%. Conclusions NECT showed inadequate diagnostic performances in both detecting newly developed hepatic metastasis and evaluating the response of hepatic metastasis based on RECIST criteria.	[Jee, Han Bum; Park, Mi-Suk; Kim, Myeong-Jin; Chung, Yong Eun] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul 120749, South Korea; [Park, Min Jung] Ajou Univ, Sch Med, Dept Radiol, Suwon 441749, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Ajou University; Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul 120749, South Korea.	yelv@yuhs.ac	Lee, Hye Sun/J-2154-2015; Kim, Myeong-Jin/E-1623-2011	Lee, Hye Sun/0000-0001-6328-6948; Chung, Yong Eun/0000-0003-0811-9578; Park, Mi-Suk/0000-0001-5817-2444; Kim, Myeong-Jin/0000-0001-7949-5402	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014-31-0623]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014-31-0623). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albrecht T, 2003, EUR RADIOL, V13, pN79, DOI 10.1007/s00330-003-0012-2; BERLAND LL, 1982, AM J ROENTGENOL, V138, P853, DOI 10.2214/ajr.138.5.853; BRINK JA, 1995, RADIOLOGY, V197, P83, DOI 10.1148/radiology.197.1.7568859; Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094; Chung YE, 2006, J COMPUT ASSIST TOMO, V30, P182, DOI 10.1097/00004728-200603000-00003; Chung YE, 2015, ULTRASONOGRAPHY, V34, P3, DOI 10.14366/usg.14034; COX IH, 1991, RADIOLOGY, V181, P18, DOI 10.1148/radiology.181.1.1887031; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Frederick MG, 1997, J COMPUT ASSIST TOMO, V21, P229, DOI 10.1097/00004728-199703000-00012; Kinkel K, 2002, RADIOLOGY, V224, P748, DOI 10.1148/radiol.2243011362; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Mainenti PP, 2010, ABDOM IMAGING, V35, P511, DOI 10.1007/s00261-009-9555-2; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Moulton CA, 2014, JAMA-J AM MED ASSOC, V311, P1863, DOI 10.1001/jama.2014.3740; Nazarian LN, 1999, RADIOLOGY, V213, P825, DOI 10.1148/radiology.213.3.r99dc29825; Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729; Park JH, 2001, ACAD RADIOL, V8, P698, DOI 10.1016/S1076-6332(03)80576-7; Quaia E, 2006, EUR RADIOL, V16, P1599, DOI 10.1007/s00330-006-0192-7; Robinson PJA, 2000, BRIT J RADIOL, V73, P234, DOI 10.1259/bjr.73.867.10817037; Ruers TJM, 2009, J NUCL MED, V50, P1036, DOI 10.2967/jnumed.109.063040; Schima Wolfgang, 2005, Cancer Imaging, V5 Spec No A, pS149, DOI 10.1102/1470-7330.2005.0035; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; SILVERMAN PM, 1995, AM J ROENTGENOL, V165, P73, DOI 10.2214/ajr.165.1.7785637; Soussan M, 2010, EUR RADIOL, V20, P1715, DOI 10.1007/s00330-009-1700-3; van Kessel CS, 2012, ANN SURG ONCOL, V19, P2805, DOI 10.1245/s10434-012-2300-z	25	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134133	10.1371/journal.pone.0134133	http://dx.doi.org/10.1371/journal.pone.0134133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218533	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900083
J	Kwak, J; Jo, HH; Luttinen, T; Kosonen, I				Kwak, Jaeyoung; Jo, Hang-Hyun; Luttinen, Tapio; Kosonen, Iisakki			Effects of Switching Behavior for the Attraction on Pedestrian Dynamics	PLOS ONE			English	Article							SOCIAL FORCE MODEL; CROWD; ENVIRONMENTS; CONVERSION; ATTENTION; SALES	Walking is a fundamental activity of our daily life not only for moving to other places but also for interacting with surrounding environment. While walking on the streets, pedestrians can be aware of attractions like shopping windows. They can be influenced by the attractions and some of them might shift their attention towards the attractions, namely switching behavior. As a first step to incorporate the switching behavior, this study investigates collective effects of switching behavior for an attraction by developing a behavioral model. Numerical simulations exhibit different patterns of pedestrian behavior depending on the strength of the social influence and the average length of stay. When the social influence is strong along with a long length of stay, a saturated phase can be defined at which all the pedestrians have visited the attraction. If the social influence is not strong enough, an unsaturated phase appears where one can observe that some pedestrians head for the attraction while others walk in their desired direction. These collective patterns of pedestrian behavior are summarized in a phase diagram by comparing the number of pedestrians who visited the attraction to the number of passersby near the attraction. Measuring the marginal benefits with respect to the strength of the social influence and the average length of stay enables us to identify under what conditions enhancing these variables would be more effective. The findings from this study can be understood in the context of the pedestrian facility management, for instance, for retail stores.	[Kwak, Jaeyoung; Luttinen, Tapio; Kosonen, Iisakki] Aalto Univ, Dept Civil & Environm Engn, Espoo, Finland; [Jo, Hang-Hyun] Pohang Univ Sci & Technol, BK21plus Phys Devis, Pohang, South Korea; [Jo, Hang-Hyun] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Jo, Hang-Hyun] Aalto Univ, Dept Comp Sci, Espoo, Finland	Aalto University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Aalto University	Kwak, J (corresponding author), Aalto Univ, Dept Civil & Environm Engn, Espoo, Finland.	jaeyoung.kwak@aalto.fi	Jo, Hang-Hyun/F-4666-2012; Luttinen, Tapio/G-2343-2013	Jo, Hang-Hyun/0000-0002-4214-9204; Luttinen, Tapio/0000-0002-8830-9787; Kwak, Jaeyoung/0000-0002-9627-3569	Aalto University School of Engineering Doctoral Program; Aalto University postdoctoral program; Mid-career Researcher Program through the National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning [2014030018]; Basic Science Research Program through the National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning [2014046922]	Aalto University School of Engineering Doctoral Program; Aalto University postdoctoral program; Mid-career Researcher Program through the National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning	JK was supported by Aalto University School of Engineering Doctoral Program. HJ was supported by Aalto University postdoctoral program and by Mid-career Researcher Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (2014030018), and Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (2014046922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEARDEN WO, 1989, J CONSUM RES, V15, P473, DOI 10.1086/209186; Blue VJ, 2001, TRANSPORT RES B-METH, V35, P293, DOI 10.1016/S0191-2615(99)00052-1; Bruce Goldstein E., 2007, SENSATION PERCEPTION; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; CHILDERS TL, 1992, J CONSUM RES, V19, P198, DOI 10.1086/209296; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; Gallup AC, 2012, P NATL ACAD SCI USA, V109, P7245, DOI 10.1073/pnas.1116141109; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 2000, PHYS REV LETT, V84, P1240, DOI 10.1103/PhysRevLett.84.1240; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Johanssons A, 2007, ADV COMPLEX SYST, p[10, 271], DOI DOI 10.1142/S0219525907001355; Kaltcheva VD, 2006, J MARKETING, V70, P107, DOI 10.1509/jmkg.2006.70.1.107; Kwak J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062810; Lam SY, 2001, MARKET SCI, V20, P194, DOI 10.1287/mksc.20.2.194.10192; Lamarche F, 2004, COMPUT GRAPH FORUM, V23, P509, DOI 10.1111/j.1467-8659.2004.00782.x; MILGRAM S, 1969, J PERS SOC PSYCHOL, V13, P79, DOI 10.1037/h0028070; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Nicolis SC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.268104; Perdikaki O, 2012, M&SOM-MANUF SERV OP, V14, P145, DOI 10.1287/msom.1110.0356; Seyfried A, 2006, PHYSICA A, V368, P232, DOI 10.1016/j.physa.2005.11.052; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Wickens C.D., 1999, ENG PSYCHOL HUMAN PE, V3; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Xu S, 2010, IEEE T INTELL TRANSP, V11, P153, DOI 10.1109/TITS.2009.2036152; Yu W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046105; Yu WJ, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026112; Zanlungo F, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68005; Zanlungo F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012811	30	4	5	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133668	10.1371/journal.pone.0133668	http://dx.doi.org/10.1371/journal.pone.0133668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218430	Green Published, gold			2022-12-27	WOS:000358595900038
J	Schippers, P; Hemerik, L; Baveco, JM; Verboom, J				Schippers, Peter; Hemerik, Lia; Baveco, Johannes M.; Verboom, Jana			Rapid Diversity Loss of Competing Animal Species in Well-Connected Landscapes	PLOS ONE			English	Article							WOODPECKER DENDROCOPOS-MEDIUS; SQUIRREL SCIURUS-CAROLINENSIS; GREAT SPOTTED WOODPECKERS; NEUTRAL-THEORY; HABITAT FRAGMENTATION; RIVERINE FOREST; CLIMATE-CHANGE; COEXISTENCE; ABUNDANCE; METAPOPULATIONS	Population viability of a single species, when evaluated with metapopulation based landscape evaluation tools, always increases when the connectivity of the landscape increases. However, when interactions between species are taken into account, results can differ. We explore this issue using a stochastic spatially explicit meta-community model with 21 competing species in five different competitive settings: (1) weak, coexisting competition, (2) neutral competition, (3) strong, excluding competition, (4) hierarchical competition and (5) random species competition. The species compete in randomly generated landscapes with various fragmentation levels. With this model we study species loss over time. Simulation results show that overall diversity, the species richness in the entire landscape, decreases slowly in fragmented landscapes whereas in well-connected landscapes rapid species losses occur. These results are robust with respect to changing competitive settings, species parameters and spatial configurations. They indicate that optimal landscape configuration for species conservation differs between metapopulation approaches, modelling species separately and meta-community approaches allowing species interactions. The mechanism behind this is that species in well-connected landscapes rapidly outcompete each other. Species that become abundant, by chance or by their completive strength, send out large amounts of dispersers that colonize and take over other patches that are occupied by species that are less abundant. This mechanism causes rapid species loss. In fragmented landscapes the colonization rate is lower, and it is difficult for a new species to establish in an already occupied patch. So, here dominant species cannot easily take over patches occupied by other species and higher diversity is maintained for a longer time. These results suggest that fragmented landscapes have benefits for species conservation previously unrecognized by the landscape ecology and policy community. When species interactions are important, landscapes with a low fragmentation level can be better for species conservation than well-connected landscapes. Moreover, our results indicate that metapopulation based landscape evaluation tools may overestimate the value of connectivity and should be replaced by more realistic meta-community based tools.	[Schippers, Peter; Verboom, Jana] Wageningen Univ & Res Ctr, Dept Alterra Biodivers & Policy, NL-6700 AA Wageningen, Netherlands; [Hemerik, Lia] Wageningen Univ, Dept Math & Stat Methods, Biometris, NL-6700 AA Wageningen, Netherlands; [Baveco, Johannes M.] Wageningen Univ & Res Ctr, Dept Alterra Environm Risk Assessment, NL-6700 AA Wageningen, Netherlands; [Schippers, Peter] Wageningen Univ, Dept Forest Ecol & Forest Management, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Schippers, P (corresponding author), Wageningen Univ & Res Ctr, Dept Alterra Biodivers & Policy, POB 47, NL-6700 AA Wageningen, Netherlands.	peter.schippers@wur.nl	Schippers, Peter/H-2920-2012	Hemerik, Lia/0000-0002-6892-2840	W.O.T. of the Dutch ministry of economic affairs	W.O.T. of the Dutch ministry of economic affairs	The research was supported by the W.O.T. of the Dutch ministry of economic affairs.	Abbott I, 2000, J BIOGEOGR, V27, P333, DOI 10.1046/j.1365-2699.2000.00409.x; Abrams PA, 2004, ECOL LETT, V7, P929, DOI 10.1111/j.1461-0248.2004.00644.x; Allee W., 1938, SOCIAL LIFE ANIMALS; Allee W.C, 1931, ANIMAL AGGREGATION S; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; Baz A, 1996, BIODIVERS CONSERV, V5, P493, DOI 10.1007/BF00056393; BAZ A, 1995, J BIOGEOGR, V22, P129, DOI 10.2307/2846077; Bertolino S, 2003, BIOL CONSERV, V109, P351, DOI 10.1016/S0006-3207(02)00161-1; Bertolino S, 2008, CURR SCI INDIA, V95, P903; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; Cooper SE, 2012, WILDLIFE BIOL, V18, P366, DOI 10.2981/11-093; Etienne RS, 2005, CURRENT THEMES IN THEORETICAL BIOLOGY: A DUTCH PERSPECTIVE, P203, DOI 10.1007/1-4020-2904-7_8; Gu WD, 2002, LANDSCAPE ECOL, V17, P699, DOI 10.1023/A:1022993317717; Hale ML, 2004, CONSERV GENET, V5, P167, DOI 10.1023/B:COGE.0000030001.86288.12; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Karsai I, 2011, ECOL MODEL, V222, P447, DOI 10.1016/j.ecolmodel.2010.11.002; Kosenko SM, 2001, ZOOL ZH, V80, P71; Kosinski Z, 2006, ANN ZOOL FENN, V43, P198; Kosinski Z, 2004, ORNIS FENNICA, V81, P145; Kosinski Z, 2004, ACTA ORNITHOL, V39, P29, DOI 10.3161/068.039.0108; Kosinski Z, 2006, BIRD STUDY, V53, P237, DOI 10.1080/00063650609461438; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; MAC ARTHUR ROBERT H., 1967; May F, 2012, OIKOS, V121, P942, DOI 10.1111/j.1600-0706.2011.20078.x; Nagelkerke CJ, 2002, CONCEPTS APPL LANDSC, P330; Neuhauser C, 1999, ANN APPL PROBAB, V9, P1226; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; Opdam P, 2003, LANDSCAPE ECOL, V18, P113, DOI 10.1023/A:1024429715253; Parmesan C, 1999, NATURE, V399, P747; PETTERSSON B, 1985, HOLARCTIC ECOL, V8, P53; PETTERSSON B, 1983, HOLARCTIC ECOL, V6, P263; PETTERSSON B, 1985, BIOL CONSERV, V32, P335, DOI 10.1016/0006-3207(85)90022-9; Prakash S, 2002, THEOR POPUL BIOL, V62, P231, DOI 10.1006/tpbi.2002.1611; Ripa J, 2000, OIKOS, V90, P89, DOI 10.1034/j.1600-0706.2000.900109.x; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schippers P, 2014, ECOL COMPLEX, V17, P20, DOI 10.1016/j.ecocom.2013.07.002; Schippers P, 2011, ECOGRAPHY, V34, P909, DOI 10.1111/j.1600-0587.2011.06712.x; Schippers P, 2011, ECOL MODEL, V222, P3061, DOI 10.1016/j.ecolmodel.2011.05.022; Schippers P, 2009, POPUL ECOL, V51, P459, DOI 10.1007/s10144-009-0159-z; Schmickl T, 2010, ECOL MODEL, V221, P1089, DOI 10.1016/j.ecolmodel.2009.12.028; Shoemaker KT, 2014, J APPL ECOL, V51, P735, DOI 10.1111/1365-2664.12223; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Verboom J, 2001, BIOL CONSERV, V100, P89, DOI 10.1016/S0006-3207(00)00210-X; VERBOOM J, 1991, OIKOS, V61, P149, DOI 10.2307/3545332; Verboom J, 2010, LANDSCAPE ECOL, V25, P1289, DOI 10.1007/s10980-010-9497-7; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Vos CC, 2001, AM NAT, V157, P24, DOI 10.1086/317004	57	6	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132383	10.1371/journal.pone.0132383	http://dx.doi.org/10.1371/journal.pone.0132383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218682	Green Published, gold			2022-12-27	WOS:000358595900008
J	Yuan, J; Li, MZ; Lin, SJ				Yuan, Jian; Li, Meizhen; Lin, Senjie			An Improved DNA Extraction Method for Efficient and Quantitative Recovery of Phytoplankton Diversity in Natural Assemblages	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RIBOSOMAL-RNA GENE; CYTOCHROME-B GENE; PCR; QUANTIFICATION; COMMUNITIES; REGIONS; ENVIRONMENT; SEQUENCES; ABUNDANCE	Marine phytoplankton are highly diverse with different species possessing different cell coverings, posing challenges for thoroughly breaking the cells in DNA extraction yet preserving DNA integrity. While quantitative molecular techniques have been increasingly used in phytoplankton research, an effective and simple method broadly applicable to different lineages and natural assemblages is still lacking. In this study, we developed a bead-beating protocol based on our previous experience and tested it against 9 species of phytoplankton representing different lineages and different cell covering rigidities. We found the bead-beating method enhanced the final yield of DNA (highest as 2 folds) in comparison with the non-bead-beating method, while also preserving the DNA integrity. When our method was applied to a field sample collected at a subtropical bay located in Xiamen, China, the resultant ITS clone library revealed a highly diverse assemblage of phytoplankton and other micro-eukaryotes, including Archaea, Amoebozoa, Chlorophyta, Ciliphora, Bacillariophyta, Dinophyta, Fungi, Metazoa, etc. The appearance of thecate dinoflagellates, thin-walled phytoplankton and "naked" unicellular organisms indicates that our method could obtain the intact DNA of organisms with different cell coverings. All the results demonstrate that our method is useful for DNA extraction of phytoplankton and environmental surveys of their diversity and abundance.	[Yuan, Jian; Li, Meizhen; Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Yuan, Jian; Li, Meizhen; Lin, Senjie] Xiamen Univ, Marine Biodivers & Global Change Res Ctr, Xiamen, Fujian, Peoples R China; [Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	Xiamen University; Xiamen University; University of Connecticut	Lin, SJ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016		National Natural Science Foundation of China [41176091, 41330959]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China grant 41176091 and 41330959 (http://www.nsfc.gov.cn/publish/portal1/) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, J PHYCOL, V32, P424, DOI 10.1111/j.0022-3646.1996.00424.x; Aguilera A, 2006, SYST APPL MICROBIOL, V29, P593, DOI 10.1016/j.syapm.2006.01.006; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; ANDERSON DM, 1994, SCI AM, V271, P62, DOI 10.1038/scientificamerican0894-62; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bessetti J., 2007, J MICROBIOL METH, V28, P159; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bradford TM, 2013, FRESHWATER BIOL, V58, P2401, DOI 10.1111/fwb.12219; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Charvet S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00422; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Connell L, 2002, PHYCOLOGIA, V41, P15, DOI 10.2216/i0031-8884-41-1-15.1; Eiler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053516; Erdner DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022965; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; FUHRMAN JA, 1988, APPL ENVIRON MICROB, V54, P1426, DOI 10.1128/AEM.54.6.1426-1429.1988; Ghiglione JF, 2012, P NATL ACAD SCI USA, V109, P17633, DOI 10.1073/pnas.1208160109; Gomez F, 2014, ACTA PROTOZOOL, V53, P63, DOI 10.4467/16890027AP.13.0021.1118; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Kohli GS, 2014, HARMFUL ALGAE, V39, P134, DOI 10.1016/j.hal.2014.07.007; Krsek M, 1999, J MICROBIOL METH, V39, P1, DOI 10.1016/S0167-7012(99)00093-7; Lin S, 2008, INT J ENVIRON POLLUT, V33, P381, DOI 10.1504/IJEP.2008.020569; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Liu JQ, 2008, HARMFUL ALGAE, V7, P1, DOI 10.1016/j.hal.2007.04.009; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Pinhassi J, 2005, APPL ENVIRON MICROB, V71, P7650, DOI 10.1128/AEM.71.12.7650-7660.2005; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Simon D, 1998, WATER RES, V32, P2220, DOI 10.1016/S0043-1354(97)00452-1; Stern RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042780; Thi NMN, 2011, J MICROBIOL METH, V84, P33, DOI 10.1016/j.mimet.2010.10.008; Wang L, 2014, HARMFUL ALGAE, V31, P100, DOI 10.1016/j.hal.2013.10.013; Wang Qu-yuan, 2013, Yingyong Shengtai Xuebao, V24, P541; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Yuan J, 2012, HARMFUL ALGAE, V17, P83, DOI 10.1016/j.hal.2012.03.004; Zhang H, 2005, APPL ENVIRON MICROB, V71, P7053, DOI 10.1128/AEM.71.11.7053-7063.2005; Zhang H, 2002, APPL ENVIRON MICROB, V68, P989, DOI 10.1128/AEM.68.2.989-994.2002; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zhuang YY, 2013, HARMFUL ALGAE, V26, P71, DOI 10.1016/j.hal.2013.04.002	43	31	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133060	10.1371/journal.pone.0133060	http://dx.doi.org/10.1371/journal.pone.0133060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218575	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900017
J	Lansky, A; Johnson, C; Oraka, E; Sionean, C; Joyce, MP; DiNenno, E; Crepaz, N				Lansky, Amy; Johnson, Christopher; Oraka, Emeka; Sionean, Catlainn; Joyce, M. Patricia; DiNenno, Elizabeth; Crepaz, Nicole			Estimating the Number of Heterosexual Persons in the United States to Calculate National Rates of HIV Infection	PLOS ONE			English	Article							MEN; SEX	Background This study estimated the proportions and numbers of heterosexuals in the United States (U.S.) to calculate rates of heterosexually acquired human immunodeficiency virus (HIV) infection. Quantifying the burden of disease can inform effective prevention planning and resource allocation. Methods Heterosexuals were defined as males and females who ever had sex with an opposite-sex partner and excluded those with other HIV risks: persons who ever injected drugs and males who ever had sex with another man. We conducted meta-analysis using data from 3 national probability surveys that measured lifetime (ever) sexual activity and injection drug use among persons aged 15 years and older to estimate the proportion of heterosexuals in the United States population. We then applied the proportion of heterosexual persons to census data to produce population size estimates. National HIV infection rates among heterosexuals were calculated using surveillance data (cases attributable to heterosexual contact) in the numerators and the heterosexual population size estimates in the denominators. Results Adult and adolescent heterosexuals comprised an estimated 86.7% (95% confidence interval: 84.1%-89.3%) of the U. S. population. The estimate for males was 84.1% (CI: 81.2%-86.9%) and for females was 89.4% (95% CI: 86.9%-91.8%). The HIV diagnosis rate for 2013 was 5.2 per 100,000 heterosexuals and the rate of persons living with diagnosed HIV infection in 2012was 104 per 100,000 heterosexuals aged 13 years or older. Rates of HIV infection were >20 times as high among black heterosexuals compared to white heterosexuals, indicating considerable disparity. Rates among heterosexual men demonstrated higher disparities than overall population rates for men. Conclusions The best available data must be used to guide decision-making for HIV prevention. HIV rates among heterosexuals in the U.S. are important additions to cost effectiveness and other data used to make critical decisions about resources for prevention of HIV infection.	[Lansky, Amy; Johnson, Christopher; Sionean, Catlainn; Joyce, M. Patricia; DiNenno, Elizabeth; Crepaz, Nicole] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Oraka, Emeka] Ctr Dis Control & Prevent, ICF Int, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lansky, A (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	ALansky@cdc.gov						[Anonymous], 2004, SUDAAN REL 9 1 COMP; [Anonymous], 2005, COMPREHENSIVE METAAN; [Anonymous], 2011, SAS VERS 9 3 COMP PR; Centers for Disease Control and Prevention, 2015, HIV SURVEILLANCE S, V20; Centers for Disease Control and Prevention, 2012, HIV SURVEILLANCE S, V17; Centers for Disease Control and Prevention, 2015, HIV SURV REP 2013, V25; Chandra Anjani, 2012, Natl Health Stat Report, P1; Chandra Anjani, 2011, Natl Health Stat Report, P1; Dinenno Elizabeth A, 2012, Open AIDS J, V6, P169, DOI 10.2174/1874613601206010169; Harris N, 2013, MMWR-MORBID MORTAL W, V62, P757; Hedges LV, 1998, FIXED RANDOM EFFECTS; Herbenick D, 2010, J SEX MED, V7, P255, DOI 10.1111/j.1743-6109.2010.02012.x; Higgins J, 2011, COCHRANE COLLAB, V5, P1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Lansky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097596; Lieb S, 2011, PUBLIC HEALTH REP, V126, P60, DOI 10.1177/003335491112600110; Miles IJ, 2013, MMWR-MORBID MORTAL W, V62, P183; Oster AM, 2015, J URBAN HEALTH, V92, P733, DOI 10.1007/s11524-015-9970-3; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rao SR, 2008, HEALTH SERV OUTCOME, V8, P98, DOI 10.1007/s10742-008-0032-0; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; U.S. Census Bureau, 2012, POP EST ENT DAT	22	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133543	10.1371/journal.pone.0133543	http://dx.doi.org/10.1371/journal.pone.0133543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214309	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300022
J	Madeddu, S; Woods, TA; Mukherjee, P; Sturdevant, D; Butchi, NB; Peterson, KE				Madeddu, Silvia; Woods, Tyson A.; Mukherjee, Piyali; Sturdevant, Dan; Butchi, Niranjan B.; Peterson, Karin E.			Identification of Glial Activation Markers by Comparison of Transcriptome Changes between Astrocytes and Microglia following Innate Immune Stimulation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ALZHEIMER-DISEASE; DENDRITIC CELLS; NERVOUS-SYSTEM; UP-REGULATION; EXPRESSION; VIRUS; CYTOKINES; TLR7; INTERFERON	The activation of astrocytes and microglia is often associated with diseases of the central nervous system (CNS). Understanding how activation alters the transcriptome of these cells may offer valuable insight regarding how activation of these cells mediate neurological damage. Furthermore, identifying common and unique pathways of gene expression during activation may provide new insight into the distinct roles these cells have in the CNS during infection and inflammation. Since recent studies indicate that TLR7 recognizes not only viral RNA but also microRNAs that are released by damaged neurons and elevated during neurological diseases, we first examined the response of glial cells to TLR7 stimulation using microarray analysis. Microglia were found to generate a much stronger response to TLR7 activation than astrocytes, both in the number of genes induced as well as fold induction. Although the primary pathways induced by both cell types were directly linked to immune responses, microglia also induced pathways associated with cellular proliferation, while astrocytes did not. Targeted analysis of a subset of the upregulated genes identified unique mRNA, including Ifi202b which was only upregulated by microglia and was found to be induced during both retroviral and bunyavirus infections in the CNS. In addition, other genes including Birc3 and Gpr84 as well as two expressed sequences AW112010 and BC023105 were found to be induced in both microglia and astrocytes and were upregulated in the CNS following virus infection. Thus, expression of these genes may a useful measurement of glial activation during insult or injury to the CNS.	[Madeddu, Silvia; Woods, Tyson A.; Mukherjee, Piyali; Butchi, Niranjan B.; Peterson, Karin E.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Sturdevant, Dan] NIAID, Res Technol Branch, RML, NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Peterson, KE (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	petersonka@niaid.nih.gov	Peterson, Karin/D-1492-2016	Peterson, Karin/0000-0003-4177-7249	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health; Sardinia Regional Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001102, ZIAAI001101] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health; Sardinia Regional Government(Regione Sardegna); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health. The authors gratefully acknowledge the Sardinia Regional Government for the financial support of Silvia Maddeddu through her Ph.D. scholarship (P.O.R. Sardegna F.S.E Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007-2013).	Aguirre A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/893521; Bennett RS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-25; Bennett RS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-41; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Du M, 2010, J VIROL, V84, P11076, DOI 10.1128/JVI.01022-10; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201; Gorina R, 2009, GLIA, V57, P93, DOI 10.1002/glia.20738; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Guedes J, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/186872; Gurley C, 2008, PPAR RES, V2008, DOI 10.1155/2008/453120; He WA, 2014, P NATL ACAD SCI USA, V111, P4525, DOI 10.1073/pnas.1402714111; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kallfass C, 2012, J VIROL, V86, P11223, DOI 10.1128/JVI.01093-12; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Lee H, 2013, CURR PROTEIN PEPT SC, V14, P33, DOI 10.2174/1389203711314010006; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Olivieri F, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-11; Perez CJ, 2013, J HERED, V104, P565, DOI 10.1093/jhered/est023; Possel H, 2000, GLIA, V32, P51, DOI 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4; RANSOHOFF RM, 1993, FASEB J, V7, P592, DOI 10.1096/fasebj.7.6.8472896; Robertson SJ, 1997, J VIROL, V71, P5287, DOI 10.1128/JVI.71.7.5287-5294.1997; Roth-Cross JK, 2008, J VIROL, V82, P9829, DOI 10.1128/JVI.01199-08; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Sioud M, 2006, TRENDS MOL MED, V12, P167, DOI 10.1016/j.molmed.2006.02.004; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tang SQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5657; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Vogel H, 2012, HUM MOL GENET, V21, P3845, DOI 10.1093/hmg/dds213; Vontell R, 2013, DEV NEUROSCI-BASEL, V35, P130, DOI 10.1159/000346158; Winkler CW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005407; Yang Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-80; Yin Q, 2013, CELL REP, V4, P327, DOI 10.1016/j.celrep.2013.06.024; Yu DD, 2006, ADV EXP MED BIOL, V581, P407; Zhang ZR, 2005, J NEUROIMMUNOL, V164, P154, DOI 10.1016/j.jneuroim.2005.03.014; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	52	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0127336	10.1371/journal.pone.0127336	http://dx.doi.org/10.1371/journal.pone.0127336			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214311	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300001
J	Zhang, XQ; Pan, Y; Yu, CH; Xu, CF; Xu, L; Li, YM; Chen, WX				Zhang, Xue-qun; Pan, Yue; Yu, Chao-hui; Xu, Cheng-fu; Xu, Lei; Li, You-ming; Chen, Wei-xing			PDIA3 Knockdown Exacerbates Free Fatty Acid-Induced Hepatocyte Steatosis and Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN LIVER-CELLS; NONALCOHOLIC STEATOHEPATITIS; DISEASE; ACTIVATION; LIPOAPOPTOSIS; PROGRESSION; LIPOGENESIS; CIRRHOSIS	Nonalcoholic fatty liver disease (NAFLD) has emerged as one of the most common chronic liver disease over the past decades. Endoplasmic reticulum stress (ERS) plays a pivotal role during the development of NAFLD. This study aims to analyze the potential role of protein disulfide isomerase A3 precursor (PDIA3), one of the ER chaperones, in free fatty acid-induced cell model of NAFLD. Human liver L02 cell line was treated with sodium palmitate for 24 hours, which developed severe intracellular lipid accumulation. The increased protein level of PDIA3 was detected via immunoblotting analysis in the fat loaded cell models of NAFLD. siRNA-mediated knockdown of PDIA3 in L02 cells not only increased the cellular lipid accumulation, but also exacerbated hepatocytes apoptosis induced by sodium palmitate. Further investigation revealed that knockdown of PDIA3 up-regulated protein expression of fatty acid synthase (FAS), a key enzyme involved in fatty acid synthesis. PDIA3 knockdown also up-regulated key molecules of ERS pathway, including glucose-regulated protein 78 (GRP78), phospho-PKR-like ER kinase (p-PERK), and C/EBP homologous protein (CHOP). Our results suggested that ER chaperone PDIA3 plays a pivotal role in FFA-induced hepatocyte steatosis and apoptosis.	[Zhang, Xue-qun; Pan, Yue; Yu, Chao-hui; Xu, Cheng-fu; Li, You-ming; Chen, Wei-xing] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Lei] Ningbo 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China	Zhejiang University	Chen, WX (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zhangxuequn720@163.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, Han/0000-0001-9985-3035	National Key Basic Research Development Program [2012CB524905]; National Science and Technology Support Plan Project [2012BAI06B04]; National Natural Science Foundation of China [30900677, 81070315, 81100278, 81470838, 81300703, 81170378, 81230012, 81270487]; Zhejiang Provincial Natural Science Foundation of China [Y2090463]; International Science and Technology Cooperation Projects of Zhejiang Province [2013C24010]; Science Foundation of Health Bureau of Zhejiang Province [2012RCA026]	National Key Basic Research Development Program(National Basic Research Program of China); National Science and Technology Support Plan Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); International Science and Technology Cooperation Projects of Zhejiang Province; Science Foundation of Health Bureau of Zhejiang Province	The study was supported by National Key Basic Research Development Program (No. 2012CB524905); National Science and Technology Support Plan Project (No. 2012BAI06B04); National Natural Science Foundation of China, (No. 30900677, No. 81070315, No. 81100278, No. 81470838, No. 81300703, No. 81170378, No. 81230012 and No. 81270487); Zhejiang Provincial Natural Science Foundation of China (No. Y2090463); International Science and Technology Cooperation Projects of Zhejiang Province (No. 2013C24010), and Science Foundation of Health Bureau of Zhejiang Province (No. 2012RCA026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Boden G, 2011, METHOD ENZYMOL, V489, P67, DOI 10.1016/B978-0-12-385116-1.00004-2; Bravo R, 2013, INT REV CEL MOL BIO, V301, P215, DOI 10.1016/B978-0-12-407704-1.00005-1; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Cao J, 2014, DIGEST DIS SCI, V59, P346, DOI 10.1007/s10620-013-2896-2; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Dihazi H, 2013, J CELL SCI, V126, P3649, DOI 10.1242/jcs.125088; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gentile CL, 2011, ANTIOXID REDOX SIGN, V15, P505, DOI 10.1089/ars.2010.3790; Glimcher LH, 2009, ANN NY ACAD SCI, V1173, pE2, DOI 10.1111/j.1749-6632.2009.04956.x; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pagliassotti MJ, 2007, ENDOCRINOLOGY, V148, P3338, DOI 10.1210/en.2006-1710; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Rinella Mary E, 2011, Hepatology, V54, P1600, DOI 10.1002/hep.24553; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zhang XQ, 2010, HEPATOLOGY, V51, P1190, DOI 10.1002/hep.23486	35	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133882	10.1371/journal.pone.0133882	http://dx.doi.org/10.1371/journal.pone.0133882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214517	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300037
J	Green, DE; Murphy, TC; Kang, BY; Searles, CD; Hart, M				Green, David E.; Murphy, Tamara C.; Kang, Bum-Yong; Searles, Charles D.; Hart, Michael			PPAR gamma Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21	PLOS ONE			English	Article							HYPERTENSION; EXPRESSION; ROSIGLITAZONE; MIR-21; LUNG; ACTIVATION; RESISTANCE; INHIBITION; MOUSE; PTEN	Pulmonary hypertension (PH) is a progressive and often fatal disorder whose pathogenesis involves pulmonary artery smooth muscle cell (PASMC) proliferation. Although modern PH therapies have significantly improved survival, continued progress rests on the discovery of novel therapies and molecular targets. MicroRNA (miR)-21 has emerged as an important non-coding RNA that contributes to PH pathogenesis by enhancing vascular cell proliferation, however little is known about available therapies that modulate its expression. We previously demonstrated that peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists attenuated hypoxia-induced HPASMC proliferation, vascular remodeling and PH through pleiotropic actions on multiple targets, including transforming growth factor (TGF)-beta 1 and phosphatase and tensin homolog deleted on chromosome 10 (PTEN). PTEN is a validated target of miR-21. We therefore hypothesized that antiproliferative effects conferred by PPAR. activation are mediated through inhibition of hypoxia-induced miR-21 expression. Human PASMC monolayers were exposed to hypoxia then treated with the PPAR. agonist, rosiglitazone (RSG, 10 mu M), or in parallel, C57Bl/6J mice were exposed to hypoxia then treated with RSG. RSG attenuated hypoxic increases in miR-21 expression in vitro and in vivo and abrogated reductions in PTEN and PASMC proliferation. Antiproliferative effects of RSG were lost following siRNA-mediated PTEN depletion. Furthermore, miR-21mimic decreased PTEN and stimulated PASMC proliferation, whereas miR-21 inhibition increased PTEN and attenuated hypoxia-induced HPASMC proliferation. Collectively, these results demonstrate that PPAR gamma ligands regulate proliferative responses to hypoxia by preventing hypoxic increases in miR-21 and reductions in PTEN. These findings further clarify molecular mechanisms that support targeting PPAR gamma to attenuate pathogenic derangements in PH.	[Green, David E.; Murphy, Tamara C.; Kang, Bum-Yong; Hart, Michael] Emory Univ, Dept Med, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Searles, Charles D.] Emory Univ, Dept Med, Atlanta Vet Affairs Med Ctr, Div Cardiol, Atlanta, GA 30322 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Green, DE (corresponding author), Emory Univ, Dept Med, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	degree4@emory.edu			Veterans Affairs Career Development -02 [1 IK2 BX001707-01A1]; National Institutes of Health R01 [HL102167]; Veterans Affairs Merit Review Award [101BX001910-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001707] Funding Source: NIH RePORTER	Veterans Affairs Career Development -02; National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Veterans Affairs Career Development -02 (1 IK2 BX001707-01A1)- http://www.research.va.gov/funding/-to DG, the National Institutes of Health R01 (HL102167) http://www.grants.nih.gov/grants/funding/r01.htm- to CH, and the Veterans Affairs Merit Review Award (101BX001910-01) http://www.research.va.gov/funding/to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382; Ameshima S, 2003, CIRC RES, V92, P1162, DOI 10.1161/01.RES.0000073585.50092.14; [Anonymous], 2010, BASIC SCIENCE OF PUL; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Bertero T, 2015, J BIOL CHEM, V290, P2069, DOI 10.1074/jbc.M114.617845; Bijli KM, 2015, FREE RADICAL BIO MED, V80, P111, DOI 10.1016/j.freeradbiomed.2014.12.019; Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Gao M, 2011, SHOCK, V36, P228, DOI 10.1097/SHK.0b013e318225b29a; Gong KZ, 2011, AM J PHYSIOL-LUNG C, V301, pL899, DOI 10.1152/ajplung.00062.2011; Green David E, 2011, Pulm Circ, V1, P33; Green DE, 2012, AM J RESP CELL MOL, V47, P718, DOI 10.1165/rcmb.2011-0418OC; GREEN DE, 2012, PULM CIRC, V2, P483, DOI DOI 10.4103/2045-8932.105037; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Horita H, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000188; Jamaluddin MS, 2011, EXPERT REV MOL DIAGN, V11, P79, DOI [10.1586/erm.10.103, 10.1586/ERM.10.103]; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Joshi Sachindra R, 2011, Pulm Circ, V1, P357, DOI 10.4103/2045-8932.87301; Kang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079503; Kang BY, 2011, AM J PHYSIOL-LUNG C, V301, pL881, DOI 10.1152/ajplung.00195.2011; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim EK, 2010, RESPIROLOGY, V15, P659, DOI 10.1111/j.1440-1843.2010.01756.x; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Lee J, 2013, DIABETIC PATIENTS TH, V19, P99; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu YH, 2012, HYPERTENSION, V60, P1471, DOI 10.1161/HYPERTENSIONAHA.112.198887; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XH, 2013, FREE RADICAL BIO MED, V63, P151, DOI 10.1016/j.freeradbiomed.2013.05.013; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Matsuda Yasushi, 2005, Nihon Kokyuki Gakkai Zasshi, V43, P283; Meloche J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005157; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Pi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035283; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rabinovitch M, 2010, ADV EXP MED BIOL, V661, P447, DOI 10.1007/978-1-60761-500-2_29; Ravi Y, 2013, CELL BIOCHEM BIOPHYS, V67, P363, DOI 10.1007/s12013-011-9332-z; Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010; Stenmark KR, 2010, PEDIATR CRIT CARE ME, V11, pS85, DOI 10.1097/PCC.0b013e3181c76db3; Sutliff Roy L, 2010, Ther Adv Respir Dis, V4, P143, DOI 10.1177/1753465809369619; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tan XH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-21; Tian J, 2009, PHYSIOL GENOMICS, V40, P48, DOI 10.1152/physiolgenomics.00094.2009; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; White Kevin, 2012, Pulm Circ, V2, P278, DOI 10.4103/2045-8932.101395; Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011; Zhang DX, 2014, LIFE SCI, V98, P39, DOI 10.1016/j.lfs.2013.12.208; Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR	62	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133391	10.1371/journal.pone.0133391	http://dx.doi.org/10.1371/journal.pone.0133391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208095	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000084
J	Mwatelah, RS; Lwembe, RM; Osman, S; Ogutu, BR; Aman, R; Kitawi, RC; Wangai, LN; Oloo, FA; Kokwaro, GO; Ochieng, W				Mwatelah, Ruth S.; Lwembe, Raphael M.; Osman, Saida; Ogutu, Bernhards R.; Aman, Rashid; Kitawi, Rose C.; Wangai, Laura N.; Oloo, Florence A.; Kokwaro, Gilbert O.; Ochieng, Washingtone			Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast	PLOS ONE			English	Article							DRUG USE; HIV PREVENTION; RISK; POPULATIONS; BEHAVIORS; INFECTION; SERVICES; MOMBASA; PEOPLE	Background Injection drug use is steadily rising in Kenya. We assessed the prevalence of both human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) infections among injecting heroin users (IHUs) at the Kenyan Coast. Methods A total of 186 IHUs (mean age, 33 years) from the Omari rehabilitation center program in Malindi were consented and screened for HIV-1 and HCV by serology and PCR and their CD4 T-cells enumerated by FACS. Results Prevalence of HIV-1 was 87.5%, that of HCV was 16.4%, co-infection was 17.9% and 18/152 (11.8%) were uninfected. Only 5.26% of the HIV-1 negative injectors were HCV positive. Co-infection was higher among injectors aged 30 to 40 years (20.7%) and among males (22.1%) than comparable groups. About 35% of the injectors were receiving antiretroviral treatment (ART). Co-infection was highest among injectors receiving D4T (75%) compared to those receiving AZT (21.6%) or TDF (10.5%) or those not on ART (10.5%). Mean CD4 T-cells were 404 (95% CI, 365 - 443) cells/mm(3) overall, significantly lower for co-infected (mean, 146; 95% CI 114 - 179 cells/mm(3)) than HIV mono infected (mean, 437, 95% CI 386 - 487 cells/mm(3), p<0.001) or uninfected (mean, 618, 95% CI 549 - 687 cells/mm(3), p<0.001) injectors and lower for HIV mono-infected than uninfected injectors (p=0.002). By treatment arm, CD4 T-cells were lower for injectors receiving D4T (mean, 78; 95% CI, 0.4 - 156 cells/mm(3)) than TDF (mean 607, 95% CI, 196 - 1018 cells/mm(3), p=0.005) or AZT (mean 474, 95% CI - 377 - 571 cells/mm(3), p=0.004). Conclusion Mono and dual infections with HIV-1 and HCV is high among IHUs in Malindi, but ART coverage is low. The co-infected IHUs have elevated risk of immunodeficiency due to significantly depressed CD4 T-cell numbers. Coinfection screening, treatment-as-prevention for both HIV and HCV and harm reduction should be scaled up to alleviate infection burden.	[Mwatelah, Ruth S.; Ogutu, Bernhards R.; Aman, Rashid; Kitawi, Rose C.; Oloo, Florence A.; Ochieng, Washingtone] Strathmore Univ, Ctr Res Therapeut Sci, Nairobi, Kenya; [Mwatelah, Ruth S.; Kitawi, Rose C.] Inst Trop Med & Infect Dis, Nairobi, Kenya; [Mwatelah, Ruth S.; Kitawi, Rose C.; Wangai, Laura N.] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Lwembe, Raphael M.; Osman, Saida; Ochieng, Washingtone] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Ogutu, Bernhards R.] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya; [Ogutu, Bernhards R.; Aman, Rashid; Kokwaro, Gilbert O.; Ochieng, Washingtone] Strathmore Univ, Inst Healthcare Management, Nairobi, Kenya; [Aman, Rashid] African Ctr Clin Trials, Nairobi, Kenya; [Oloo, Florence A.] Tech Univ Kenya, Nairobi, Kenya	Strathmore University; Jomo Kenyatta University of Agriculture & Technology; Kenya Medical Research Institute; Kenya Medical Research Institute; Strathmore University; Technical University of Kenya	Ochieng, W (corresponding author), Strathmore Univ, Ctr Res Therapeut Sci, Nairobi, Kenya.	ochiengwashingtone@gmail.com		Mwatelah, Ruth/0000-0001-5761-1169; Ochieng, Washingtone/0000-0002-9035-4405	Consortium for National Health Research (CNHR) [RCDG-2012-005]; Kenya medical Research Institute (KEMRI) [IRG51/2]	Consortium for National Health Research (CNHR); Kenya medical Research Institute (KEMRI)	This study was funded partly by the Consortium for National Health Research (CNHR; www.cnhrkenya.org), Grant# RCDG-2012-005 awarded to WO and partly by Internal Research Grant from the Kenya medical Research Institute (KEMRI; www.kemri.org), Grant# IRG51/2 awarded to RML.	Ahamad K, 2014, AM J DRUG ALCOHOL AB, V40, P151, DOI 10.3109/00952990.2013.860983; [Anonymous], 2011, GUID ANT THER KEN; Bailey JR, 2015, J INFECT DIS, V212, P914, DOI 10.1093/infdis/jiv139; Barreiro P, 2014, ANTIVIR RES, V105, P1, DOI 10.1016/j.antiviral.2014.02.004; Barrett L, 2011, J VIRAL HEPATITIS, V18, P170, DOI 10.1111/j.1365-2893.2010.01293.x; Beckerleg S, 2006, SUBST USE MISUSE, V41, P1029, DOI 10.1080/10826080600667193; Beckerleg S, 2004, DRUG-EDUC PREV POLIC, V11, P67, DOI 10.1080/0968763031000140192; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; Brodish P, 2011, DRUG ALCOHOL DEPEN, V119, P138, DOI 10.1016/j.drugalcdep.2011.05.030; Chami G, 2013, DRUG ALCOHOL DEPEN, V132, P486, DOI 10.1016/j.drugalcdep.2013.03.011; Cho KT, 2014, FORENSIC SCI INT, V235, P78, DOI 10.1016/j.forsciint.2013.12.006; Datta D, 2009, SAHARA J-J SOC ASP H, V6, P170, DOI 10.1080/17290376.2009.9724945; de Vos AS, 2012, EPIDEMICS-NETH, V4, P57, DOI 10.1016/j.epidem.2012.01.001; Deveau C, 2006, AFRICAN J DRUG ALCOH, V5, P95; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Githuka G, 2014, JAIDS-J ACQ IMM DEF, V66, pS46, DOI 10.1097/QAI.0000000000000137; Gyarmathy VA, 2014, AIDS BEHAV, V18, P505, DOI 10.1007/s10461-014-0702-6; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Kitawi RC, 2015, AIDS RES HUM RETROV, V31, P452, DOI [10.1089/aid.2014.0306, 10.1089/AID.2014.0306]; Liao MZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-172; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Meijerink H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18844; Mishra RK, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-5; Muasya T, 2008, East Afr Med J, V85, P318; National AIDS and STI Control Programme (NASCOP), MOST AT RISK POP UNV; National AIDS Control Council, 2009, KEN HIV PREV RESP MO; National AIDS Control Council of Kenya, 2014, KEN AIDS RESP PROGR; Needle RH, 2005, INT J DRUG POLICY, V16, pS45, DOI 10.1016/j.drugpo.2005.02.009; Ng'ang'a A, 2014, JAIDS-J ACQ IMM DEF, V66, pS27, DOI 10.1097/QAI.0000000000000102; Njuki R, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-77; Nzomo TJ, 2015, AIDS RES HUM RETROV, V31, P550, DOI [10.1089/aid.2015.0031, 10.1089/AID.2015.0031]; Ochieng W, 2015, JAIDS-J ACQ IMM DEF, V69, pE49, DOI 10.1097/QAI.0000000000000580; Ochieng Washingtone, 2006, Afr Health Sci, V6, P3; Petersen Z, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-13; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Reid SR, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-24; Republic of Kenya, 2013, NATL FOOD SAFETY POL; Rogalska-Plonska M, 2015, VIRAL IMMUNOL, V28, P145, DOI 10.1089/vim.2014.0114; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Simon D, 2014, EPIDEMIOL INFECT, V142, P2616, DOI 10.1017/S0950268814000041; Smith DB, 2014, J NEUROVIROL, V20, P28, DOI 10.1007/s13365-013-0225-3; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sypsa V, 2015, AM J PUBLIC HEALTH, V105, P196, DOI 10.2105/AJPH.2013.301656; Syvertsen JL, 2015, DRUG ALCOHOL DEPEN, V151, P262, DOI 10.1016/j.drugalcdep.2015.02.037; UNAIDS, GLOB REP UNAIDS REP; United Nations Office on Drugs and Crim (UNDOC), WORLD DRUG REP 2011; Waruiru W, 2014, JAIDS-J ACQ IMM DEF, V66, pS3, DOI 10.1097/QAI.0000000000000114	48	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132287	10.1371/journal.pone.0132287	http://dx.doi.org/10.1371/journal.pone.0132287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208212	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000025
J	Shen, P; Zhang, H; Su, ZL; Wang, SJ; Xu, HX				Shen, Pei; Zhang, Hong; Su, Zhaoliang; Wang, Shengjun; Xu, Huaxi			In Silico Analysis of Tumor Necrosis Factor alpha-Induced Protein 8-Like-1 (TIPE1) Protein	PLOS ONE			English	Article							TNFAIP8 OVEREXPRESSION; IMMUNE HOMEOSTASIS; CELL-LINES; METASTASIS; EXPRESSION; CANCER; IDENTIFICATION; ACTIVATION; PROLIFERATION; REGULATOR	Tumor necrosis factor alpha-induced protein 8 (TNFAIP8)-like protein 1 (TIPE1) was a member of TNFAIP8 family. Previous studies have shown that TIPE1 could induce apoptosis in hepatocellular carcinoma. In this study, we attempted to predict its potential structure. Bioinformatic analysis of TIPE1 was performed to predict its potential structure using the bioinfomatic web services or softwares. The results showed that the amino acid sequences of TIPE1 were well conserved in mammals. No signal peptide and no transmembrane domain existed in human TIPE1. The aliphatic index of TIPE1 was 100.75 and the theoretical pI was 9.57. TIPE1 was a kind of stable protein and its grand average of hydropathicity was -0.108. Various post-translational modifications were also speculated to exist in TIPE1. In addition, the results of Swiss-Model Server and Swiss-Pdb Viewer program revealed that the predicted three-dimensional structure of TIPE1 protein was stable and it may accord with the rule of stereochemistry. TIPE1 was predicted to interact with FBXW5, caspase8 and so on. In conclusion, TIPE1 may be a stable protein with no signal peptide and no transmembrane domain. The bioinformatic analysis of TIPE1 will provide the basis for the further study on the function of TIPE1.	[Shen, Pei; Su, Zhaoliang; Wang, Shengjun; Xu, Huaxi] Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Hong] Yangzhou Univ, Clin Coll 4, Dept Clin Lab, Nantong Rich Hosp, Nantong, Jiangsu, Peoples R China; [Shen, Pei] Nantong Univ, Affiliated Hosp, Lab Med Ctr, Nantong, Jiangsu, Peoples R China	Jiangsu University; Yangzhou University; Nantong University	Xu, HX (corresponding author), Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Jiangsu, Peoples R China.	xuhx@ujs.edu.cn			Graduate Student Research and Innovation Program of Jiangsu Province [CXLX12_0677]	Graduate Student Research and Innovation Program of Jiangsu Province	This work was supported by Graduate Student Research and Innovation Program of Jiangsu Province (CXLX12_0677).	Cao XL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-149; Cui J, 2011, MOL IMMUNOL, V48, P1548, DOI 10.1016/j.molimm.2011.04.023; Fayngerts SA, 2014, CANCER CELL, V26, P465, DOI 10.1016/j.ccr.2014.07.025; Freundt EC, 2008, CELL, V133, P401, DOI 10.1016/j.cell.2008.04.017; Ha JY, 2014, J NEUROCHEM, V129, P527, DOI [10.1111/jnc.12643, 10.1111/j.1471-4159.2013.12643.x]; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Li XM, 2014, CANCER BIOMARK, V14, P233, DOI 10.3233/CBM-140402; Liu QQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126176; Liu TB, 2014, TUMOR BIOL, V35, P5805, DOI 10.1007/s13277-014-1770-y; Liu TB, 2014, HUM PATHOL, V45, P1251, DOI 10.1016/j.humpath.2014.02.005; Lou YW, 2014, J IMMUNOL, V193, P1064, DOI 10.4049/jimmunol.1400415; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Randhawa R, 2015, GENE, V562, P40, DOI 10.1016/j.gene.2015.02.056; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Wang LC, 2014, TUMOR BIOL, V35, P2319, DOI 10.1007/s13277-013-1307-9; Yang M, 2014, HISTOPATHOLOGY, V65, P517, DOI 10.1111/his.12413; Zhang SY, 2010, BBA-MOL BASIS DIS, V1802, P1078, DOI 10.1016/j.bbadis.2010.08.003; Zhang X, 2009, NAT STRUCT MOL BIOL, V16, P89, DOI 10.1038/nsmb.1522; Zhang YH, 2015, INT J ONCOL, V46, P254, DOI 10.3892/ijo.2014.2725; Zhang Z, 2015, ONCOGENE, V34, P2566, DOI 10.1038/onc.2014.208	23	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134114	10.1371/journal.pone.0134114	http://dx.doi.org/10.1371/journal.pone.0134114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207809	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000211
J	Torres-Espinola, FJ; Berglund, SK; Garcia-Valdes, LM; Segura, MT; Jerez, A; Campos, D; Moreno-Torres, R; Rueda, R; Catena, A; Perez-Garcia, M; Campoy, C				Torres-Espinola, Francisco J.; Berglund, Staffan K.; Garcia-Valdes, Luz Ma; Teresa Segura, Ma; Jerez, Antonio; Campos, Daniel; Moreno-Torres, Rosario; Rueda, Ricardo; Catena, Andres; Perez-Garcia, Miguel; Campoy, Cristina		PREOBE Team	Maternal Obesity, Overweight and Gestational Diabetes Affect the Offspring Neurodevelopment at 6 and 18 Months of Age - A Follow Up from the PREOBE Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; PREPREGNANCY OVERWEIGHT; CHILD NEURODEVELOPMENT; INFANTS; RISK; SUPPLEMENTATION; INTRAUTERINE; PERFORMANCE; EXPERIENCES; PREGNANCY	Background Brain development in fetal life and early infancy is critical to determine lifelong performance in various neuropsychological domains. Metabolic pathologies such as overweight, obesity, and gestational diabetes in pregnant women are prevalent and increasing risk factors that may adversely affect long-term brain development in their offspring. Objective The objective of this research was to investigate the influence of maternal metabolic pathologies on the neurodevelopment of the offspring at 6 and 18 months of life. Design This was a prospective case-control study of 331 mother- and child pairs from Granada, Spain. The mothers were included during pregnancy into four groups according to their pre-gestational body mass index and their gestational diabetes status; overweight (n:56), obese (n:64), gestational diabetic (n:79), and healthy normal weight controls (n:132). At 6 months and 18 months we assessed the children with the Bayley III scales of neurodevelopment. Results At 6 months (n=215), we found significant group differences in cognition composite language, and expressive language. Post hoc test revealed unexpectedly higher scores in the obese group compared to the normal weight group and a similar trend in overweight and diabetic group. The effects on language remained significant after adjusting for confounders with an adjusted odds ratio for a value above median in composite language score of 3.3 (95% CI: 1.1, 10.0; p=0.035) for children of obese mothers. At 18 month (n=197), the off-spring born to obese mothers had lost five points in language composite scores and the previous differences in language and cognition was replaced by a suggestive trend of lower gross motor scores in the overweight, obese, and diabetic groups. Conclusions Infants of obese mothers had a temporary accelerated development of cognition and language, followed by a rapid deceleration until 18 months of age, particularly of language scores. This novel observation prompts further confirmative studies to explore possible placental and neurodevelopmental mechanisms involved.	[Torres-Espinola, Francisco J.; Berglund, Staffan K.; Garcia-Valdes, Luz Ma; Teresa Segura, Ma; Jerez, Antonio; Campos, Daniel; Moreno-Torres, Rosario; Campoy, Cristina] Univ Granada, Ctr Excellence Paediat Res EURISTIKOS, Granada, Spain; [Berglund, Staffan K.] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden; [Jerez, Antonio; Campoy, Cristina] Univ Granada, Dept Paediat, Granada, Spain; [Rueda, Ricardo] Abbott Labs, R&D Dept, Granada, Spain; [Catena, Andres; Perez-Garcia, Miguel] Univ Granada, Mind Brain & Behav Int Res Ctr CIMCYC, Granada, Spain	University of Granada; Umea University; University of Granada; University of Granada	Campoy, C (corresponding author), Univ Granada, Ctr Excellence Paediat Res EURISTIKOS, Granada, Spain.	ccampoy@ugr.es	Campoy, Cristina/F-4946-2017; Catena, Andres/I-2159-2015; perez, miguel/GXF-5077-2022; Rusanova, Iryna/B-9068-2019; García, Miguel Pérez/F-9630-2010; Alvarez, J. Carlos/R-9722-2019; Altmae, Signe/J-2441-2015; LORENTE, JOSE A./B-8372-2008; Anjos, Tania/E-6917-2011	Campoy, Cristina/0000-0002-9860-6785; Catena, Andres/0000-0002-0775-5751; Rusanova, Iryna/0000-0002-9034-7600; García, Miguel Pérez/0000-0003-4775-7556; Alvarez, J. Carlos/0000-0002-5884-9918; Martinez-Zaldivar Moreno, Cristina/0000-0003-4643-0236; Altmae, Signe/0000-0002-0708-1865; Desoye, Gernot/0000-0002-5715-3230; Campos Consuegra, Daniel/0000-0003-0755-3823; Segura, Maria Teresa/0000-0003-4269-7662; LORENTE, JOSE A./0000-0002-9892-7386; Agil, Ahmad/0000-0003-0164-9648; Anjos, Tania/0000-0002-9596-1626; Miranda Leon, Maria Teresa/0000-0002-6254-7402	Spanish Ministry of Innovation and Science; Junta de Andalucia: Excellence Projects [P06-CTS-02341]; Spanish Ministry of Education [SB2010-0025]; Spanish Ministry of Economy and Competitiveness [BFU2012-40254-C03-01]; Abbott Laboratories, Granada, Spain	Spanish Ministry of Innovation and Science(Spanish Government); Junta de Andalucia: Excellence Projects(Junta de Andalucia); Spanish Ministry of Education(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Abbott Laboratories, Granada, Spain	This study was funded by Spanish Ministry of Innovation and Science. Junta de Andalucia: Excellence Projects (P06-CTS-02341); Spanish Ministry of Education (Grant no. SB2010-0025); Spanish Ministry of Economy and Competitiveness (BFU2012-40254-C03-01); Further support was received by Abbott Laboratories, Granada, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was registered at www.ClinicalTrials.gov, identifier: NCT01634464).	Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Aylward GP, 2014, J DEV BEHAV PEDIATR, V35, P394, DOI 10.1097/01.DBP.0000452240.39511.d4; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bayley N., 2019, BAYLEY SCALES INFANT; Braun K, 1996, Z KLIN PSYCH PSYCHIA, V44, P253; Brion MJ, 2011, PEDIATRICS, V127, pE202, DOI 10.1542/peds.2010-0651; Casas M, 2013, INT J EPIDEMIOL, V42, P506, DOI 10.1093/ije/dyt002; Clausen TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067107; Cusick SE, 2012, ARCH PEDIAT ADOL MED, V166, P481, DOI 10.1001/archpediatrics.2012.199; DeBoer T, 2005, DEV MED CHILD NEUROL, V47, P525, DOI 10.1017/S0012162205001039; deReginer RA, 2000, J PEDIATR-US, V137, P777, DOI 10.1067/mpd.2000.109149; Dionne G, 2008, PEDIATRICS, V122, pE1073, DOI 10.1542/peds.2007-3028; Favaro A, 2006, ARCH GEN PSYCHIAT, V63, P82, DOI 10.1001/archpsyc.63.1.82; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S; Hadders-Algra M, 2011, AM J CLIN NUTR, V94, p1874S, DOI 10.3945/ajcn.110.001065; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Heikura U, 2008, AM J EPIDEMIOL, V167, P169, DOI 10.1093/aje/kwm291; Herring SJ, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.01.039; Hinkle SN, 2012, INT J OBESITY, V36, P1312, DOI 10.1038/ijo.2012.143; Huang LS, 2014, INT J EPIDEMIOL, V43, P783, DOI 10.1093/ije/dyu030; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Langie SAS, 2012, BEST PRACT RES CL EN, V26, P613, DOI 10.1016/j.beem.2012.03.004; LAUCHT M, 1992, PRAX KINDERPSYCHOL K, V41, P274; Neggers YH, 2003, ACTA OBSTET GYN SCAN, V82, P235, DOI 10.1034/j.1600-0412.2003.00090.x; Nielsen GL, 2010, DIABETIC MED, V27, P786, DOI 10.1111/j.1464-5491.2010.03024.x; Ornoy A, 2001, J PEDIATR ENDOCR MET, V14, P681; Robinson M, 2013, J DEV ORIG HLTH DIS, V4, P42, DOI 10.1017/S2040174412000578; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Sesma HW, 2003, DEV PSYCHOPATHOL, V15, P991, DOI 10.1017/S0954579403000488; Tanda R, 2013, MATERN CHILD HLTH J, V17, P222, DOI 10.1007/s10995-012-0964-4; Tomalski P, 2010, CURR OPIN PSYCHIATR, V23, P233, DOI 10.1097/YCO.0b013e3283387a8c; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; Van Lieshout RJ, 2013, NUTR REV, V71, pS95, DOI 10.1111/nure.12059; Van Lieshout RJ, 2013, CHILD PSYCHIAT HUM D, V44, P382, DOI 10.1007/s10578-012-0332-z	36	54	56	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133010	10.1371/journal.pone.0133010	http://dx.doi.org/10.1371/journal.pone.0133010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208217	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000055
J	Calderon-Gierszal, EL; Prins, GS				Calderon-Gierszal, Esther L.; Prins, Gail S.			Directed Differentiation of Human Embryonic Stem Cells into Prostate Organoids In Vitro and its Perturbation by Low-Dose Bisphenol A Exposure	PLOS ONE			English	Article							EPITHELIAL-CELLS; GENE-EXPRESSION; HOMEOBOX GENE; ESTROGENS; CANCER; GLAND; CARCINOGENESIS; DISEASE; URINARY; TISSUE	Studies using rodent and adult human prostate stem-progenitor cell models suggest that developmental exposure to the endocrine disruptor Bisphenol-A (BPA) can predispose to prostate carcinogenesis with aging. Unknown at present is whether the embryonic human prostate is equally susceptible to BPA during its natural developmental window. To address this unmet need, we herein report the construction of a pioneer in vitro human prostate developmental model to study the effects of BPA. The directed differentiation of human embryonic stem cells (hESC) into prostatic organoids in a spatial system was accomplished with precise temporal control of growth factors and steroids. Activin-induced definitive endoderm was driven to prostate specification by combined exposure to WNT10B and FGF10. Matrigel culture for 20-30 days in medium containing R-Spondin-1, Noggin, EGF, retinoic acid and testosterone was sufficient for mature prostate organoid development. Immunofluorescence and gene expression analysis confirmed that organoids exhibited cytodifferentiation and functional properties of the human prostate. Exposure to 1 nM or 10 nM BPA throughout differentiation culture disturbed early morphogenesis in a dose-dependent manner with 1 nM BPA increasing and 10 nM BPA reducing the number of branched structures formed. While differentiation of branched structures to mature organoids seemed largely unaffected by BPA exposure, the stem-like cell population increased, appearing as focal stem cell nests that have not properly entered lineage commitment rather than the rare isolated stem cells found in normally differentiated structures. These findings provide the first direct evidence that low-dose BPA exposure targets hESC and perturbs morphogenesis as the embryonic cells differentiate towards human prostate organoids, suggesting that the developing human prostate may be susceptible to disruption by in utero BPA exposures.	[Prins, Gail S.] Univ Illinois, Dept Urol, Coll Med, Chicago, IL 60607 USA; Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Prins, GS (corresponding author), Univ Illinois, Dept Urol, Coll Med, Chicago, IL 60607 USA.	gprins@uic.edu			National Institutes of Health [R01-ES015584, RC2-ES018758, ES022071]; Michael Reese Research and Education Foundation; NATIONAL CANCER INSTITUTE [R01CA172220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022071, RC2ES018758, R01ES015584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Reese Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01-ES015584, RC2-ES018758 and ES022071, and the Michael Reese Research and Education Foundation to GSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik I, 2005, CANCER RES, V65, P358; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Biemann R, 2014, OBESITY FACTS, V7, P48, DOI 10.1159/000358913; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Callan AC, 2013, INT J HYG ENVIR HEAL, V216, P641, DOI 10.1016/j.ijheh.2012.10.002; Chen M, 2009, ENDOCRINOLOGY, V150, P251, DOI 10.1210/en.2008-0044; COLBORN T, 1995, ENVIRON HEALTH PERSP, V103, P135, DOI 10.2307/3432522; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; DODDS E. C, 1936, NATURE [LONDON], V137, P996, DOI 10.1038/137996a0; Edlow AG, 2012, REPROD TOXICOL, V34, P1, DOI 10.1016/j.reprotox.2012.03.009; Fenichel P, 2012, HUM REPROD, V27, P983, DOI 10.1093/humrep/der451; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Gerona RR, 2013, ENVIRON SCI TECHNOL, V47, P12477, DOI 10.1021/es402764d; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Gupta C, 2000, P SOC EXP BIOL MED, V224, P61, DOI 10.1046/j.1525-1373.2000.22402.x; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Ho SM, 2015, EXPOSURE OF HUMAN PR; Hu WY, 2011, ENDOCRINOLOGY, V152, P2150, DOI 10.1210/en.2010-1377; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Jin YR, 2012, INT J BIOCHEM CELL B, V44, P2278, DOI 10.1016/j.biocel.2012.09.006; Keil KP, 2012, DIFFERENTIATION, V84, P232, DOI 10.1016/j.diff.2012.07.005; Kim HG, 1999, HISTOL HISTOPATHOL, V14, P1175, DOI 10.14670/HH-14.1175; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Kuruto-Niwa R, 2007, CHEMOSPHERE, V66, P1160, DOI 10.1016/j.chemosphere.2006.06.073; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Margel D, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000311; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; McPherson SJ, 2001, ENDOCRINOLOGY, V142, P2458, DOI 10.1210/en.142.6.2458; Mehta V, 2011, DEV DYNAM, V240, P2548, DOI 10.1002/dvdy.22741; Moad M, 2013, EUR UROL, V64, P753, DOI 10.1016/j.eururo.2013.03.054; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nahar MS, 2013, J BIOCHEM MOL TOXIC, V27, P116, DOI 10.1002/jbt.21459; Okada M, 2008, BIOMED RES-TOKYO, V29, P163, DOI 10.2220/biomedres.29.163; Ouji Y, 2013, BIOCHEM BIOPH RES CO, V438, P493, DOI 10.1016/j.bbrc.2013.07.108; Prins GS, 2008, DIFFERENTIATION, V76, P641, DOI 10.1111/j.1432-0436.2008.00277.x; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Prins GS, 2006, ANN NY ACAD SCI, V1089, P1, DOI 10.1196/annals.1386.009; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; PRINS GS, 1991, ENDOCRINOLOGY, V129, P3187, DOI 10.1210/endo-129-6-3187; Prins GS, 2014, ENDOCRINOLOGY; Quesada I, 2002, FASEB J, V16, P1671, DOI 10.1096/fj.02-0313fje; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sajiki J, 2003, CHEMOSPHERE, V51, P55, DOI 10.1016/S0045-6535(02)00789-0; Santos FCA, 2006, BIOL REPROD, V75, P370, DOI 10.1095/biolreprod.106.051789; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Tang WY, 2012, ENDOCRINOLOGY, V153, P42, DOI 10.1210/en.2011-1308; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; Thomson AA, 1999, DEVELOPMENT, V126, P3693; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-25; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vrooman LA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004949; WANG MC, 1981, PROSTATE, V2, P89, DOI 10.1002/pros.2990020109; Watson CS, 2007, MOL CELL ENDOCRINOL, V274, P1, DOI 10.1016/j.mce.2007.05.011; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wend P, 2012, ACTA PHYSIOL, V204, P34, DOI 10.1111/j.1748-1716.2011.02296.x; Yang LQ, 2013, TOXICOL LETT, V218, P187, DOI 10.1016/j.toxlet.2013.01.026; Zaviacic M, 2000, HISTOL HISTOPATHOL, V15, P131, DOI 10.14670/HH-15.131; Zhao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064503	68	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133238	10.1371/journal.pone.0133238	http://dx.doi.org/10.1371/journal.pone.0133238			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222054	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800043
J	Mizunoya, W; Miyahara, H; Okamoto, S; Akahoshi, M; Suzuki, T; Do, MKQ; Ohtsubo, H; Komiya, Y; Lan, M; Waga, T; Iwata, A; Nakazato, K; Ikeuchi, Y; Anderson, JE; Tatsumi, R				Mizunoya, Wataru; Miyahara, Hideo; Okamoto, Shinpei; Akahoshi, Mariko; Suzuki, Takahiro; Do, Mai-Khoi Q.; Ohtsubo, Hideaki; Komiya, Yusuke; Lan, Mu; Waga, Toshiaki; Iwata, Akira; Nakazato, Koichi; Ikeuchi, Yoshihide; Anderson, Judy E.; Tatsumi, Ryuichi			Improvement of Endurance Based on Muscle Fiber-Type Composition by Treatment with Dietary Apple Polyphenols in Rats	PLOS ONE			English	Article							CHEMOREPELLENT SEMAPHORIN 3A; ACTIVATED RECEPTOR-DELTA; HEAVY-CHAIN ISOFORMS; SKELETAL-MUSCLE; SATELLITE CELLS; SLOW MUSCLES; WISTAR RATS; EXPRESSION; MICE; DIFFERENTIATION	A recent study demonstrated a positive effect of apple polyphenol (APP) intake on muscle endurance of young-adult animals. While an enhancement of lipid metabolism may be responsible, in part, for the improvement, the contributing mechanisms still need clarification. Here we show that an 8-week intake of 5% (w/w) APP in the diet, up-regulates two features related to fiber type: the ratio of myosin heavy chain (MyHC) type IIx/IIb and myoglobin protein expression in plantaris muscle of 9-week-old male Fischer F344 rats compared to pair-fed controls (P < 0.05). Results were demonstrated by our SDS-PAGE system specialized for MyHC isoform separation and western blotting of whole muscles. Animal-growth profiles (food intake, body-weight gain, and internal-organ weights) did not differ between the control and 5% APP-fed animals (n = 9/group). Findings may account for the increase in fatigue resistance of lower hind limb muscles, as evidenced by a slower decline in the maximum isometric planter-flexion torque generated by a 100-s train of electrical stimulation of the tibial nerve. Additionally, the fatigue resistance was lower after 8 weeks of a 0.5% APP diet than after 5% APP, supporting an APP-dose dependency of the shift in fiber-type composition. Therefore, the present study highlights a promising contribution of dietary APP intake to increasing endurance based on fiber-type composition in rat muscle. Results may help in developing a novel strategy for application in animal sciences, and human sports and age-related health sciences.	[Mizunoya, Wataru; Miyahara, Hideo; Okamoto, Shinpei; Akahoshi, Mariko; Suzuki, Takahiro; Do, Mai-Khoi Q.; Ohtsubo, Hideaki; Komiya, Yusuke; Lan, Mu; Ikeuchi, Yoshihide; Tatsumi, Ryuichi] Kyushu Univ, Grad Sch Agr, Dept Anim & Marine Bioresource Sci, Hakozaki, Fukuoka, Japan; [Waga, Toshiaki] Asahi Brewery Co Ltd, Fundamental Res Lab, Moriya, Ibaraki, Japan; [Iwata, Akira] Osaka Prefecture Univ, Fac Comprehens Rehabil, Dept Phys Therapy, Habikino, Osaka, Japan; [Nakazato, Koichi] Nippon Sport Sci Univ, Grad Sch Hlth & Sport Sci, Dept Exercise Physiol, Fukasawa, Tokyo, Japan; [Anderson, Judy E.] Univ Manitoba, Fac Sci, Dept Biol Sci, Winnipeg, MB, Canada	Kyushu University; Asahi Group Holdings Ltd.; Osaka Metropolitan University; Nippon Sport Science University; University of Manitoba	Tatsumi, R (corresponding author), Kyushu Univ, Grad Sch Agr, Dept Anim & Marine Bioresource Sci, Hakozaki, Fukuoka, Japan.	rtatsumi@agr.kyushu-u.ac.jp	Mizunoya, Wataru/W-1674-2019	Mizunoya, Wataru/0000-0002-2258-1964; Komiya, Yusuke/0000-0003-3225-2491; Iwata, Akira/0000-0002-5002-2553	Japan Society for the Promotion of Science (JSPS) [20658067, 23658242, 19380152, 22380145, 25292164, 24248045]; JSPS [26712023, 22580136]; Discovery Grant from the Natural Sciences and Engineering Research Council of Canada; Asahi Breweries, Ltd.; Grants-in-Aid for Scientific Research [26450390] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Discovery Grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Asahi Breweries, Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Challenging Exploratory Research 20658067, 23658242, Scientific Research (B) 19380152, 22380145, 25292164 and Scientific Research (A) 24248045 from the Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/j-grantsinaid/index.html; http://www.jsps.go.jp/j-inv/index.html) (all to RT) and by Grants-in-Aid for Young Scientists (A) 26712023 and Scientific Research (C) 22580136 from JSPS (http://www.jsps.go.jp/j-grantsinaid/index. html; http://www.jsps.go.jp/j-inv/index.html) (to WM). The research was also supported by funds from a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) (to JEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Asahi Breweries, Ltd. provided support in the form of a salary for author TW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abe T, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/907565; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bhat KPL, 2001, ANTIOXID REDOX SIGN, V3, P1041, DOI 10.1089/152308601317203567; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P399, DOI 10.1113/jphysiol.1960.sp006394; Buller AJ, 1958, J PHYSL, V143, P23, DOI [10.1113/jphysiol.1958.sp1958143suppltoc, DOI 10.1113/JPHYSI0L.1958.SP1958143SUPPLT0C]; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Do MKQ, 2012, ANIM SCI J, V83, P712, DOI 10.1111/j.1740-0929.2012.01057.x; Do MKQ, 2011, AM J PHYSIOL-CELL PH, V301, pC1270, DOI 10.1152/ajpcell.00257.2011; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Hendgen-Cotta UB, 2010, J EXP BIOL, V213, P2734, DOI 10.1242/jeb.041178; Iwata A, 2010, MUSCLE NERVE, V41, P694, DOI 10.1002/mus.21567; Kamga C, 2012, NITRIC OXIDE-BIOL CH, V26, P251, DOI 10.1016/j.niox.2012.03.005; Kanda T, 1998, BIOSCI BIOTECH BIOCH, V62, P1284, DOI 10.1271/bbb.62.1284; Kang YK, 2011, MEAT SCI, V89, P384, DOI 10.1016/j.meatsci.2011.04.019; Khan M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-85; Khan M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-177; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085636; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Mizunoya W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080152; Mukai R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045048; Mukai R, 2010, J NAT PROD, V73, P1708, DOI 10.1021/np100240y; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Nakazato K, 2007, MED SCI SPORT EXER, V39, P934, DOI 10.1249/mss.0b013e31803df4bc; Nakazato K, 2006, EXP ANIM TOKYO, V55, P383, DOI 10.1538/expanim.55.383; Nakazato K, 2010, MOL NUTR FOOD RES, V54, P364, DOI 10.1002/mnfr.200900145; Sakaguchi S, 2014, INT J BIOCHEM CELL B, V54, P272, DOI 10.1016/j.biocel.2014.05.032; SALMONS S, 1969, J PHYSIOL-LONDON, V201, P535, DOI 10.1113/jphysiol.1969.sp008771; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sato Y, 2013, ANIM SCI J, V84, P185, DOI 10.1111/asj.12014; Sawano S, 2014, ANIM SCI J, V85, P994, DOI 10.1111/asj.12264; Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b; Shono Jun-ichi, 2013, Anim Sci J, V84, P744, DOI 10.1111/asj.12105; STRETER FA, 1973, NATURE-NEW BIOL, V241, P17, DOI 10.1038/newbio241017a0; Suzuki T, 2013, EMBO WORKSHOP ON SEM; Suzuki T, 2014, FASEB SCIENCE RESEAR; Suzuki T, 2013, INT J BIOCHEM CELL B, V45, P476, DOI 10.1016/j.biocel.2012.10.003; Tatsumi R, 2009, AM J PHYSIOL-CELL PH, V297, pC238, DOI 10.1152/ajpcell.00161.2009; Wang YX, 2005, PLOS BIOL, V3, P177, DOI 10.1371/journal.pbio.0030061	46	23	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134303	10.1371/journal.pone.0134303	http://dx.doi.org/10.1371/journal.pone.0134303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222548	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800127
J	Rompikuntal, PK; Vdovikova, S; Duperthuy, M; Johnson, TL; Ahlund, M; Lundmark, R; Oscarsson, J; Sandkvist, M; Uhlin, BE; Wai, SN				Rompikuntal, Pramod K.; Vdovikova, Svitlana; Duperthuy, Marylise; Johnson, Tanya L.; Ahlund, Monika; Lundmark, Richard; Oscarsson, Jan; Sandkvist, Maria; Uhlin, Bernt Eric; Wai, Sun Nyunt			Outer Membrane Vesicle-Mediated Export of Processed PrtV Protease from Vibrio cholerae	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; POLYCYSTIC KIDNEY-DISEASE; SP STRAIN O-7; ESCHERICHIA-COLI; II SECRETION; METALLOPROTEASE PRTV; VIRULENCE FACTORS; MARINE BACTERIUM; SUICIDE VECTOR; CLYA CYTOTOXIN	Background Outer membrane vesicles (OMVs) are known to release from almost all Gram-negative bacteria during normal growth. OMVs carry different biologically active toxins and enzymes into the surrounding environment. We suggest that OMVs may therefore be able to transport bacterial proteases into the target host cells. We present here an analysis of the Vibrio cholerae OMV-associated protease PrtV. Methodology/Principal Findings In this study, we demonstrated that PrtV was secreted from the wild type V. cholerae strain C6706 via the type II secretion system in association with OMVs. By immunoblotting and electron microscopic analysis using immunogold labeling, the association of PrtV with OMVs was examined. We demonstrated that OMV-associated PrtV was biologically active by showing altered morphology and detachment of cells when the human ileocecum carcinoma (HCT8) cells were treated with OMVs from the wild type V. cholerae strain C6706 whereas cells treated with OMVs from the prtV isogenic mutant showed no morphological changes. Furthermore, OMV-associated PrtV protease showed a contribution to bacterial resistance towards the antimicrobial peptide LL-37. Conclusion/Significance Our findings suggest that OMVs released from V. cholerae can deliver a processed, biologically active form of PrtV that contributes to bacterial interactions with target host cells.	[Rompikuntal, Pramod K.; Vdovikova, Svitlana; Duperthuy, Marylise; Uhlin, Bernt Eric; Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Rompikuntal, Pramod K.; Vdovikova, Svitlana; Duperthuy, Marylise; Lundmark, Richard; Uhlin, Bernt Eric; Wai, Sun Nyunt] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Johnson, Tanya L.; Sandkvist, Maria] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Ahlund, Monika; Lundmark, Richard] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Oscarsson, Jan] Umea Univ, Dept Odontol, Oral Microbiol, S-90187 Umea, Sweden	Umea University; Umea University; University of Michigan System; University of Michigan; Umea University; Umea University	Wai, SN (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	sun.nyunt.wai@umu.se	Duperthuy, Marylise/AFO-2793-2022; Uhlin, Bernt Eric/AAO-6292-2021	Duperthuy, Marylise/0000-0002-9226-9343; Uhlin, Bernt Eric/0000-0002-2991-8072; Wai, Sun Nyunt/0000-0003-4793-4671	Swedish Research Council [2014-4401, 2013-2392, 2010-3031, 2012-4638, 353-2010-7074, 349-2007-8673]; Umea University; NIH [R01AI49294]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049294] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SNW was supported by the Swedish Research Council project grants 2014-4401 (VR-NT) and 2013-2392 (VR-MH). BEU was supported by the Swedish Research Council project grants 2010-3031 (VR-MH) and 2012-4638 (VR-NT). The Laboratory for Molecular Infection Medicine Sweden (MIMS) is supported by Umea University and the Swedish Research Council (353-2010-7074). This work was performed as part of the Umea Centre for Microbial Research (UCMR) Linnaeus Program supported by Umea University and the Swedish Research Council (349-2007-8673). Funding website: URL: http://www.vr.se. MS was supported by NIH (R01AI49294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bielig H, 2011, INFECT IMMUN, V79, P1418, DOI 10.1128/IAI.00754-10; Bielig H, 2011, GUT MICROBES, V2, P274, DOI 10.4161/gmic.2.5.18091; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Chatterjee S, 1998, J BACTERIOL, V180, P901, DOI 10.1128/JB.180.4.901-908.1998; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Duperthuy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003620; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Edwin A, 2013, FEBS OPEN BIO, V3, P263, DOI 10.1016/j.fob.2013.06.003; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Elluri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106731; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; FINKELSTEIN RA, 1992, INFECT IMMUN, V60, P472, DOI 10.1128/IAI.60.2.472-478.1992; FINKELSTEIN RA, 1982, INFECT IMMUN, V36, P1199, DOI 10.1128/IAI.36.3.1199-1208.1982; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Jochumsen N, 2011, MICROBIOL-SGM, V157, P2647, DOI 10.1099/mic.0.049445-0; Johansson J, 2000, CELL, V102, P475, DOI 10.1016/S0092-8674(00)00052-0; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; Kaparakis-Liaskos M., 2015, NAT REV IMMUNOL; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kateb B, 2010, METHODS MOL BIOL, V651, P307, DOI 10.1007/978-1-60761-786-0_18; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Lehner T, 2000, EUR J IMMUNOL, V30, P2245, DOI 10.1002/1521-4141(2000)30:8<2245::AID-IMMU2245>3.0.CO;2-7; Levin BR, 1996, CURR BIOL, V6, P1389, DOI 10.1016/S0960-9822(96)00738-5; Lindmark B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-220; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Medina A, 2010, WOUND REPAIR REGEN, V18, P245, DOI 10.1111/j.1524-475X.2010.00580.x; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miyamoto K, 2002, BIOSCI BIOTECH BIOCH, V66, P416, DOI 10.1271/bbb.66.416; Nakasone N, 1998, INFECT IMMUN, V66, P4726, DOI 10.1128/IAI.66.10.4726-4728.1998; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Nordin JZ, 2015, NANOMEDICINE; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; Ou GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007806; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Premjani V, 2014, FEMS MICROBIOL LETT, V355, P185, DOI 10.1111/1574-6968.12463; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Sorensen Ole E., 2008, V15, P61, DOI 10.1159/000136315; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uhlin B.E., 2014, PATHOGENIC ESCHERICH, P161; Vaitkevicius K, 2008, FEBS J, V275, P3167, DOI 10.1111/j.1742-4658.2008.06470.x; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Vanhove AS, 2015, ENVIRON MICROBIOL, V17, P1152, DOI 10.1111/1462-2920.12535; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	65	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134098	10.1371/journal.pone.0134098	http://dx.doi.org/10.1371/journal.pone.0134098			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222047	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800103
J	Saw, LE; Lim, FKS; Carrasco, LR				Saw, Le E.; Lim, Felix K. S.; Carrasco, Luis R.			The Relationship between Natural Park Usage and Happiness Does Not Hold in a Tropical City-State	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GREEN SPACE; LIFE EVENTS; URBAN HEAT; HEALTH; ENVIRONMENTS; STRESS; PREFERENCE; ASSOCIATIONS; SATISFACTION	Previous studies have shown that contact with urban green spaces can produce positive effects on people's stress, health and well-being levels. However, much of this research has been conducted in the temperate regions of Europe or North America. Additionally, most studies have only compared the effects of urban and natural areas on health and wellbeing, but not made a finer distinction between different types of urban green spaces. We tested the relationship between well-being and the access or use of different types of green spaces among young adults in Singapore, a tropical city-state. The results showed that extraversion and emotional stability increased subjective well-being, positive affect and life satisfaction and decreased stress and negative affect. In addition, we found that level of physical activity increased positive affect and health problems increased negative affect. Neither access to green spaces nor the use of green spaces in Singapore significantly affected the well-being metrics considered, contradicting findings in the temperate regions of the world. We hypothesize that the differences in temperature and humidity and the higher greenery and biodiversity levels outside parks in Singapore could explain this phenomenon. Our results thus question the universality of the relationship between well-being and park usage and highlight the need for more research into the multifaceted effects of green spaces on well-being in the tropics.	[Saw, Le E.; Lim, Felix K. S.; Carrasco, Luis R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	Carrasco, LR (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsctlr@nus.edu.sg	Carrasco, Luis R/H-8017-2012	Carrasco, Luis R/0000-0002-2894-1473; Lim, Felix/0000-0003-1227-460X	Tier 2 grant from the Ministry of Education of Singapore [WBS R154000574112]	Tier 2 grant from the Ministry of Education of Singapore(Ministry of Education, Singapore)	LRC and FKSL received funding from: Tier 2 grant from the Ministry of Education of Singapore, WBS R154000574112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews F. M., 1976, SOCIAL INDICATORS OF; BALLING JD, 1982, ENVIRON BEHAV, V14, P5, DOI 10.1177/0013916582141001; Barton K, 2015, MUMIN; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; BOP Consulting, 2014, WORLD CITIES CULTURE; Burnham K. P., 2002, MODEL SELECTION AND; Carballeira M, 2014, PSYECOLOGY, V1, P371; CLARK LA, 1988, J PERS SOC PSYCHOL, V54, P296, DOI 10.1037/0022-3514.54.2.296; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Cummins RA, 2003, SOC INDIC RES, V64, P225, DOI 10.1023/A:1024712527648; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fan YL, 2011, HEALTH PLACE, V17, P1202, DOI 10.1016/j.healthplace.2011.08.008; Faris REL, 1939, MENTAL DISORDERS IN; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gerdtham U.-G., 2001, J SOC EC, V30, P553, DOI [10.1016/S1053-5357(01)00118-4, DOI 10.1016/S1053-5357(01)00118-4]; Giles-Corti B, 2003, AM J PUBLIC HEALTH, V93, P1583, DOI 10.2105/AJPH.93.9.1583; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Grahn Patrik, 2003, Urban Forestry & Urban Greening, V2, P001, DOI 10.1078/1618-8667-00019; Grahn P, 2010, LANDSCAPE URBAN PLAN, V94, P264, DOI 10.1016/j.landurbplan.2009.10.012; Groenewegen PP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-149; Hall P, 2000, URBAN FUTURE 21 A GL; Hamer M, 2009, BRIT J SPORT MED, V43, P1111, DOI 10.1136/bjsm.2008.046243; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Haslam N, 2009, PERS INDIV DIFFER, V46, P40, DOI 10.1016/j.paid.2008.09.001; HOLM S, 1979, SCAND J STAT, V6, P65; Hong Kong Bird Watching Society, 2015, LIST OF HK BIRDS 201; Kaplan R, 1989, THE EXPERIENCE OF NA; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; KAPLAN S, 1972, PERCEPT PSYCHOPHYS, V12, P354, DOI 10.3758/BF03207221; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Lafortezza R, 2009, URBAN FOR URBAN GREE, V8, P97, DOI 10.1016/j.ufug.2009.02.003; Leyden KM, 2003, AM J PUBLIC HEALTH, V93, P1546, DOI 10.2105/AJPH.93.9.1546; Maas J, 2009, HEALTH PLACE, V15, P586, DOI 10.1016/j.healthplace.2008.09.006; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McKenzie K, 2013, J AFFECT DISORDERS, V150, P1019, DOI 10.1016/j.jad.2013.05.032; Mitchell R, 2013, SOC SCI MED, V91, P130, DOI 10.1016/j.socscimed.2012.04.012; MOORE EO, 1981, J ENVIRON SYST, V11, P17, DOI 10.2190/KM50-WH2K-K2D1-DM69; National Parks Board, 2015, WILDLIFE IN SINGAPOR; National Parks Board, 2010, 4TH NATIONAL REPORT; Nordh H, 2009, URBAN FOR URBAN GREE, V8, P225, DOI 10.1016/j.ufug.2009.06.003; Oliveira S, 2011, BUILD ENVIRON, V46, P2186, DOI 10.1016/j.buildenv.2011.04.034; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Pretty J, 2007, J ENVIRON PLANN MAN, V50, P211, DOI 10.1080/09640560601156466; Rasciute S, 2010, KYKLOS, V63, P256, DOI 10.1111/j.1467-6435.2010.00472.x; Romans S, 2011, SOC PSYCH PSYCH EPID, V46, P567, DOI 10.1007/s00127-010-0222-2; The New York State Ornithological Association Inc, 2014, CHECKLIST OF THE BIR; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; TOTALS BL, 2015, CHANGES, V157, P186; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; ULRICH R S, 1992, P93; Ulrich R. S., 1983, BEHAV NATURAL ENV, P85, DOI [10.1007/978-1-4613-3539-9_4, DOI 10.1007/978-1-4613-3539-9_4]; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; ULRICH RS, 1984, SCIENCE, V224, P420, DOI 10.1126/science.6143402; UN/DESA, 2014, WORLD URB PROSP 2014; van den Berg AE, 2007, J SOC ISSUES, V63, P79, DOI 10.1111/j.1540-4560.2007.00497.x; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Watson D, 1997, EXTRAVERSION AND ITS; West MJ, 1986, LANDSCAPE VIEWS AND; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; White R, 1998, ENVIRONMENT AND MENTAL HEALTH, P175; Wilson E.O., 1984, P1; Wilson Edward O., 2007, pXIII; Wong KoonKwai, 2009, Managing Leisure, V14, P125, DOI 10.1080/13606710902752653; Wong NH, 2005, HABITAT INT, V29, P547, DOI 10.1016/j.habitatint.2004.04.008	71	42	43	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133781	10.1371/journal.pone.0133781	http://dx.doi.org/10.1371/journal.pone.0133781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222280	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800065
J	Schwen, LO; Schenk, A; Kreutz, C; Timmer, J; Rodriguez, MMB; Kuepfer, L; Preusser, T				Schwen, Lars Ole; Schenk, Arne; Kreutz, Clemens; Timmer, Jens; Rodriguez, Maria Matilde Bartolome; Kuepfer, Lars; Preusser, Tobias			Representative Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations	PLOS ONE			English	Article							PULSATILE INSULIN-SECRETION; LOCALIZED ADJOINT METHODS; IN-VIVO EXTRAPOLATION; DRUG-METABOLIZING-ENZYMES; ARTERIAL BUFFER RESPONSE; PERFUSED-RAT-LIVER; BLOOD-FLOW; NONALCOHOLIC STEATOHEPATITIS; CYTOCHROME-P450 EXPRESSION; 1ST-PASS ELIMINATION	The mammalian liver plays a key role for metabolism and detoxification of xenobiotics in the body. The corresponding biochemical processes are typically subject to spatial variations at different length scales. Zonal enzyme expression along sinusoids leads to zonated metabolization already in the healthy state. Pathological states of the liver may involve liver cells affected in a zonated manner or heterogeneously across the whole organ. This spatial heterogeneity, however, cannot be described by most computational models which usually consider the liver as a homogeneous, well-stirred organ. The goal of this article is to present a methodology to extend whole-body pharmacokinetics models by a detailed liver model, combining different modeling approaches from the literature. This approach results in an integrated four-scale model, from single cells via sinusoids and the organ to the whole organism, capable of mechanistically representing metabolization inhomogeneity in livers at different spatial scales. Moreover, the model shows circulatory mixing effects due to a delayed recirculation through the surrounding organism. To show that this approach is generally applicable for different physiological processes, we show three applications as proofs of concept, covering a range of species, compounds, and diseased states: clearance of midazolam in steatotic human livers, clearance of caffeine in mouse livers regenerating from necrosis, and a parameter study on the impact of different cell entities on insulin uptake in mouse livers. The examples illustrate how variations only discernible at the local scale influence substance distribution in the plasma at the whole-body level. In particular, our results show that simultaneously considering variations at all relevant spatial scales may be necessary to understand their impact on observations at the organism scale.	[Schwen, Lars Ole; Preusser, Tobias] Fraunhofer MEVIS, Bremen, Germany; [Schenk, Arne; Kuepfer, Lars] Bayer Technol Serv, Computat Syst Biol, Leverkusen, Germany; [Schenk, Arne] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, Aachen, Germany; [Kreutz, Clemens; Timmer, Jens] Univ Freiburg, Inst Phys, Freiburg Ctr Data Anal & Modeling FDM, D-79106 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Rodriguez, Maria Matilde Bartolome] Univ Freiburg, Med Ctr, Clin Internal Med Mol Biol 2, D-79106 Freiburg, Germany; [Kuepfer, Lars] Rhein Westfal TH Aachen, Inst Appl Microbiol, Aachen, Germany; [Preusser, Tobias] Jacobs Univ Bremen, D-28759 Bremen, Germany	Bayer AG; RWTH Aachen University; University of Freiburg; University of Freiburg; University of Freiburg; RWTH Aachen University; Jacobs University	Schwen, LO (corresponding author), Fraunhofer MEVIS, Bremen, Germany.	ole.schwen@mevis.fraunhofer.de	Schwen, Lars Ole/AAI-8048-2020; Kuepfer, Lars/F-5795-2012; Kreutz, Clemens/ABC-9732-2020; Kuepfer, Lars/AAD-5884-2022	Schwen, Lars Ole/0000-0003-0195-9603; Kreutz, Clemens/0000-0002-8796-5766; Kuepfer, Lars/0000-0002-8741-7786	German Ministry of Education and Research (BMBF) via the systems biology network Virtual Liver [0315769, 0315747, 0315766]; Bayer Technology Services	German Ministry of Education and Research (BMBF) via the systems biology network Virtual Liver(Federal Ministry of Education & Research (BMBF)); Bayer Technology Services	This work was supported by the German Ministry of Education and Research (BMBF) via the systems biology network Virtual Liver (http://www.virtual-liver.de/), grant numbers 0315769 (LOS, TP), 0315747 (AS, LK), and 0315766 (CK, JT, MMBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bayer Technology Services provided support in the form of salaries for authors AS and LK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abu-Zahra TN, 2000, DRUG METAB DISPOS, V28, P807; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Anissimov YG, 2002, J PHARMACOKINET PHAR, V29, P131, DOI 10.1023/A:1019703607647; [Anonymous], 2010, TRANSPORT PHENOMENA; [Anonymous], 2011, THESIS; ATKINSON AJ, 1979, ANNU REV PHARMACOL, V19, P105, DOI 10.1146/annurev.pa.19.040179.000541; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; BASS L, 1978, J THEOR BIOL, V72, P161, DOI 10.1016/0022-5193(78)90023-1; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bessems M, 2006, LAB ANIM-UK, V40, P236, DOI 10.1258/002367706777611460; Binning P, 2002, ADV WATER RESOUR, V25, P147, DOI 10.1016/S0309-1708(01)00051-3; Bjorkman S, 2005, BRIT J CLIN PHARMACO, V59, P691, DOI 10.1111/j.1365-2125.2004.02225.x; Bois FY, 2010, TOXICOLOGY, V278, P256, DOI 10.1016/j.tox.2010.06.007; BORNER W, 1964, ARCH KREISLAUFFORSCH, V43, P221, DOI 10.1007/BF02120035; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; Brill MJE, 2014, CLIN PHARMACOKINET, V53, P931, DOI 10.1007/s40262-014-0166-x; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; Buechler C, 2011, CURR DRUG METAB, V12, P24, DOI 10.2174/138920011794520035; Buters JTM, 1996, PHARMACOGENETICS, V6, P291, DOI 10.1097/00008571-199608000-00002; Cabrera M., 2012, INTRAVITAL, V1, P107, DOI DOI 10.4161/INTV.23423; Capitan V, 2012, EUR RADIOL, V22, P2161, DOI 10.1007/s00330-012-2468-4; CELIA MA, 1990, ADV WATER RESOUR, V13, P187, DOI 10.1016/0309-1708(90)90041-2; Chow ECY, 2013, CURR DRUG METAB, V14, P57; Cohen S. D., 1996, Computers in Physics, V10, P138; Couinaud C., 1957, LE FOIE ETUDES ANATO; Debbaut C, 2014, COMPUT METHOD BIOMEC, V17, P1295, DOI 10.1080/10255842.2012.744399; Drasdo D, 2014, ARCH TOXICOL, V88, P2071, DOI 10.1007/s00204-014-1384-6; Eipel C, 2010, WORLD J GASTROENTERO, V16, P6046, DOI 10.3748/wjg.v16.i48.6046; Eissing T, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00004; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Ewing RE, 2001, J COMPUT APPL MATH, V128, P423, DOI 10.1016/S0377-0427(00)00522-7; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Fasel JHD, 2013, J CLIN IMAG SCI, V3, DOI 10.4103/2156-7514.120803; FEHLBERG E, 1970, COMPUTING, V6, P61, DOI 10.1007/BF02241732; Fiebig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031179; FORKER EL, 1978, AM J PHYSIOL, V235, pE648, DOI 10.1152/ajpendo.1978.235.6.E648; Francque S, 2010, LIVER INT, V30, P365, DOI 10.1111/j.1478-3231.2009.02136.x; Franzen LE, 2005, MODERN PATHOL, V18, P912, DOI 10.1038/modpathol.3800370; Galassi M, 2013, GNU SCIENTIFIC LIBRA; Gasselhuber A, 2012, INT J HYPERTHER, V28, P337, DOI 10.3109/02656736.2012.677930; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Gebhardt R, 2014, WORLD J GASTROENTERO, V20, P8491, DOI 10.3748/wjg.v20.i26.8491; Goldstein NS, 2005, AM J CLIN PATHOL, V123, P382, DOI [10.1309/EY72F1EN0XCB1KXX, 10.1309/EY72F1EN9XCB1KXX]; GORES GJ, 1986, HEPATOLOGY, V6, P511, DOI 10.1002/hep.1840060331; Gross ES, 1999, J HYDRAUL ENG-ASCE, V125, P32, DOI 10.1061/(ASCE)0733-9429(1999)125:1(32); Gupta SC, 2006, FLUID MECHANICS AND; Hairer E, 1996, SOLVING ORDINARY DIF, V14; HAUSSINGER D, 1985, J HEPATOL, V1, P3, DOI 10.1016/S0168-8278(85)80063-5; HEIZMANN P, 1983, BRIT J CLIN PHARMACO, V16, pS43, DOI 10.1111/j.1365-2125.1983.tb02270.x; Hijmans BS, 2014, BIOCHIMIE, V96, P121, DOI 10.1016/j.biochi.2013.06.007; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Holzhutter HG, COMMUNICATION; Homeyer A, 2013, COMPUT MED IMAG GRAP, V37, P313, DOI 10.1016/j.compmedimag.2013.05.002; Hunt CA, 2006, J PHARMACOKINET PHAR, V33, P737, DOI 10.1007/s10928-006-9031-3; Ierapetritou MG, 2009, CTS-CLIN TRANSL SCI, V2, P228, DOI 10.1111/j.1752-8062.2009.00092.x; Ijaz S, 2003, MICROCIRCULATION, V10, P447, DOI 10.1038/sj.mn.7800206; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Karcaaltincaba M, 2007, EUR J RADIOL, V61, P33, DOI 10.1016/j.ejrad.2006.11.005; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; KOO A, 1975, Q J EXP PHYSIOL CMS, V60, P261, DOI 10.1113/expphysiol.1975.sp002320; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; KREJCIE TC, 1994, J PHARMACOL EXP THER, V269, P609; Kreutz C, 2011, THESIS; Kuepfer L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.70; Kuntz E, 2008, HEPATOLOGY TEXTBOOK; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; LASKA EM, 1984, JAMA-J AM MED ASSOC, V251, P1711, DOI 10.1001/jama.251.13.1711; Lautt WW, 2007, HEPATOL RES, V37, P891, DOI 10.1111/j.1872-034X.2007.00148.x; Li P, 2011, DRUG METAB DISPOS, V39, P571, DOI 10.1124/dmd.110.036806; Lindros KO, 1997, GEN PHARMACOL, V28, P191, DOI 10.1016/S0306-3623(96)00183-8; Lippert J, 2012, CPT-PHARMACOMET SYST, V1, DOI [10.1038/psp.2012.14, 10.1038/psp.2012.22]; Lonardo A, 2005, ALIMENT PHARM THER, V22, P64, DOI 10.1111/j.1365-2036.2005.02600.x; Maharaj AR, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.45; MAHARAJ B, 1986, LANCET, V1, P523; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Matveyenko AV, 2008, AM J PHYSIOL-ENDOC M, V295, pE569, DOI 10.1152/ajpendo.90335.2008; Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649; Meyer M, 2012, DRUG METAB DISPOS, V40, P892, DOI 10.1124/dmd.111.043174; MILLER DL, 1979, GASTROENTEROLOGY, V76, P965; Miners JO, 1996, GEN PHARMACOL-VASC S, V27, P245, DOI 10.1016/0306-3623(95)02014-4; MISBIN RI, 1976, AM J PHYSIOL, V230, P171, DOI 10.1152/ajplegacy.1976.230.1.171; Muller M, 2009, BILDVERARBEITUNG MED, P36, DOI DOI 10.1007/978-3-540-93860-6_8; Neubauer T, 2005, ADV WATER RESOUR, V28, P1292, DOI 10.1016/j.advwatres.2005.04.010; Ohtani O, 2008, ANAT REC, V291, P643, DOI 10.1002/ar.20681; Oyama T, 2007, FRONT BIOSCI-LANDMRK, V12, P2299, DOI 10.2741/2232; PALSSON BO, 1984, J THEOR BIOL, V111, P273, DOI 10.1016/S0022-5193(84)80211-8; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688; Pang KS, 2007, AAPS J, V9, pE268, DOI 10.1208/aapsj0902030; Pang KS, 2010, J PHARMACOKINET PHAR, V37, P591, DOI 10.1007/s10928-010-9185-x; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; POND SM, 1984, CLIN PHARMACOKINET, V9, P1, DOI 10.2165/00003088-198409010-00001; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Porksen N, 2002, DIABETOLOGIA, V45, P3, DOI 10.1007/s125-002-8240-x; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Press WH, 1992, NUMERICAL RECIPIES I; Puhl G, 2003, TRANSPLANTATION, V75, P756, DOI 10.1097/01.TP.0000056634.18191.1A; Rani HP, 2006, J BIOMECH, V39, P551, DOI 10.1016/j.jbiomech.2004.11.029; REVES JG, 1985, ANESTHESIOLOGY, V62, P310, DOI 10.1097/00000542-198503000-00017; Ricken T, 2014, BIOMECH MODEL MECHAN, P1; Rostami-Hodjegan A, 2012, CLIN PHARMACOL THER, V92, P50, DOI 10.1038/clpt.2012.65; Rumpf AG, 2011, QUOCMESH SOFTWARE LI; Russell TF, 2002, ADV WATER RESOUR, V25, P1215, DOI 10.1016/S0309-1708(02)00104-5; SAVILLE BA, 1992, DRUG METAB REV, V24, P49, DOI 10.3109/03602539208996290; Schaller S, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.40; Schliess F, 2014, HEPATOLOGY, V60, P2040, DOI 10.1002/hep.27136; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schreiner W., 2001, COMMENTS THEOR BIOL, P103; Schwen LO, 2015, J THEOR BIOL, V365, P289, DOI 10.1016/j.jtbi.2014.10.026; Schwen LO, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003499; Schwen LO, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/357687; Schwen LO, 2015, ZONATED QUANTIFICATI; Schwen LO, 2014, PRESENTATION AT VPH; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Selle D, 2002, IEEE T MED IMAGING, V21, P1344, DOI 10.1109/TMI.2002.801166; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Shestopaloff YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099836; Siggers JH, 2014, BIOMECH MODEL MECHAN, V13, P363, DOI 10.1007/s10237-013-0516-x; Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491; TANAKA E, 1994, PHARMACOL TOXICOL, V75, P150, DOI 10.1111/j.1600-0773.1994.tb00338.x; Tanaka T, 2003, J VASC INTERV RADIOL, V14, P63, DOI 10.1097/01.RVI.0000052292.26939.59; Teutsch HF, 1999, HEPATOLOGY, V29, P494, DOI 10.1002/hep.510290243; Thiel C, 2015, J PHARM SCI-US, V104, P191, DOI 10.1002/jps.24214; Thummel KE, 1996, CLIN PHARMACOL THER, V59, P491, DOI 10.1016/S0009-9236(96)90177-0; Upton RN, 2004, BRIT J ANAESTH, V92, P475, DOI 10.1093/bja/aeh089; Vag JE, 1996, ADV WATER RESOUR, V19, P297, DOI 10.1016/0309-1708(96)00006-1; VAUPEL P, 1989, CANCER RES, V49, P6449; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; WANG H, 1995, IMA J NUMER ANAL, V15, P405, DOI 10.1093/imanum/15.3.405; Wang H, 1998, NUMER METH PART D E, V14, P739, DOI 10.1002/(SICI)1098-2426(199811)14:6<739::AID-NUM3>3.0.CO;2-R; Wang H, 1999, J COMPUT PHYS, V152, P120, DOI 10.1006/jcph.1999.6239; Wang H, 2001, SIAM J NUMER ANAL, V38, P1846, DOI 10.1137/S0036142999362389; Webborn PJH, 2007, XENOBIOTICA, V37, P1090, DOI 10.3109/00498250701557266; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Weiss M, 2011, EUR J PHARM SCI, V44, P359, DOI 10.1016/j.ejps.2011.08.018; WILKINSON GR, 1987, PHARMACOL REV, V39, P1; Willmann Stefan, 2003, Biosilico, V1, P121, DOI 10.1016/S1478-5382(03)02342-4; Willmann S, 2012, J PHARM PHARMACOL, V64, P997, DOI 10.1111/j.2042-7158.2012.01534.x; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yoon M, 2012, CRIT REV TOXICOL, V42, P633, DOI 10.3109/10408444.2012.692115; Yoon YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068600; Younes A, 2008, COMMUN NUMER METH EN, V24, P897, DOI 10.1002/cnm.996	148	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133653	10.1371/journal.pone.0133653	http://dx.doi.org/10.1371/journal.pone.0133653			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222615	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800058
J	Vogelaar, CF; Konig, B; Krafft, S; Estrada, V; Brazda, N; Ziegler, B; Faissner, A; Muller, HW				Vogelaar, Christina Francisca; Koenig, Brigitte; Krafft, Stefanie; Estrada, Veronica; Brazda, Nicole; Ziegler, Brigida; Faissner, Andreas; Mueller, Hans Werner			Pharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibrotic Scarring and in Rat Spinal Cord Injury In Vivo	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; GROWTH-FACTOR-BETA; CENTRAL-NERVOUS-SYSTEM; AXON GROWTH; GLIAL SCAR; TRANSFORMING GROWTH-FACTOR-BETA-1; EXTRACELLULAR-MATRIX; NEURITE OUTGROWTH; IRON CHELATORS; UP-REGULATION	Lesion-induced scarring is a major impediment for regeneration of injured axons in the central nervous system (CNS). The collagen-rich glial-fibrous scar contains numerous axon growth inhibitory factors forming a regeneration-barrier for axons. We demonstrated previously that the combination of the iron chelator 2,2'-bipyridine-5,5'-decarboxylic acid (BPYDCA) and 8-Br-cyclic AMP (cAMP) inhibits scar formation and collagen deposition, leading to enhanced axon regeneration and partial functional recovery after spinal cord injury. While BPY-DCA is not a clinical drug, the clinically approved iron chelator deferoxamine mesylate (DFO) may be a suitable alternative for anti-scarring treatment (AST). In order to prove the scar-suppressing efficacy of DFO we modified a recently published in vitro model for CNS scarring. The model comprises a co-culture system of cerebral astrocytes and meningeal fibroblasts, which form scar-like clusters when stimulated with transforming growth factor-beta (TGF-beta). We studied the mechanisms of TGF-beta-induced CNS scarring and compared the efficiency of different putative pharmacological scar-reducing treatments, including BPY-DCA, DFO and cAMP as well as combinations thereof. We observed modulation of TGF-beta-induced scarring at the level of fibroblast proliferation and contraction as well as specific changes in the expression of extracellular matrix molecules and axon growth inhibitory proteins. The individual and combinatorial pharmacological treatments had distinct effects on the cellular and molecular aspects of in vitro scarring. DFO could be identified as a putative anti-scarring treatment for CNS trauma. We subsequently validated this by local application of DFO to a dorsal hemisection in the rat thoracic spinal cord. DFO treatment led to significant reduction of scarring, slightly increased regeneration of corticospinal tract as well as ascending CGRP-positive axons and moderately improved locomotion. We conclude that the in vitro model for CNS scarring is suitable for efficient pre-screening and identification of putative scar-suppressing agents prior to in vivo application and validation, thus saving costs, time and laboratory animals.	[Vogelaar, Christina Francisca; Koenig, Brigitte; Krafft, Stefanie; Estrada, Veronica; Brazda, Nicole; Ziegler, Brigida; Mueller, Hans Werner] Univ Dusseldorf, Dept Neurol, Mol Neurobiol Lab, Dusseldorf, Germany; [Vogelaar, Christina Francisca] Johannes Gutenberg Univ Mainz, Inst Microanat & Neurobiol, D-55122 Mainz, Germany; [Faissner, Andreas] Ruhr Univ Bochum, Inst Cellular Morphol & Mol Neurobiol, Bochum, Germany	Heinrich Heine University Dusseldorf; Johannes Gutenberg University of Mainz; Ruhr University Bochum	Vogelaar, CF (corresponding author), Univ Dusseldorf, Dept Neurol, Mol Neurobiol Lab, Dusseldorf, Germany.	Tineke.vogelaar@unimedizin-mainz.de	Vogelaar, Christina/AAA-8484-2021; Faissner, Andreas/A-5314-2008	Vogelaar, Christina/0000-0002-9683-7336; Faissner, Andreas/0000-0002-2211-8259	Research Committee University of Dusseldorf [Az.:52/08]; Deutsche Forschungsgemeinschaft [SFB 590, TP C2]; European Cooperation in Science and Technology (ECMNET); DFG-Research Training Group 1033	Research Committee University of Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Cooperation in Science and Technology (ECMNET); DFG-Research Training Group 1033	Research Committee University of Dusseldorf (Az.:52/08): http://www.medizin.hhu.de/dekanat/gremien-und-kommissionen/kommissionen/forschungskommission.html, Deutsche Forschungsgemeinschaft (SFB 590, TP C2) http://www.biologie.hhu.de/forschung-biologie/sfb/sfb-590.html, European Cooperation in Science and Technology (ECMNET) http://www.cost.eu/COST_Actions/bmbs/Actions/BM1001, DFG-Research Training Group 1033 http://www.grk1033.hhu.de/.	Adcock KH, 2004, EUR J NEUROSCI, V20, P1425, DOI 10.1111/j.1460-9568.2004.03573.x; Asher RA, 2000, J NEUROSCI, V20, P2427; AZZI G, 1990, MATRIX, V9, P479, DOI 10.1016/S0934-8832(11)80017-X; Bahr M, 1996, J NEUROBIOL, V30, P281, DOI 10.1002/(SICI)1097-4695(199606)30:2<281::AID-NEU9>3.0.CO;2-1; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beerepoot LV, 1996, CANCER RES, V56, P3747; Befort K, 2003, EUR J NEUROSCI, V18, P911, DOI 10.1046/j.1460-9568.2003.02827.x; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Deller T, 1997, NEUROSCIENCE, V81, P829, DOI 10.1016/S0306-4522(97)00194-2; Dobbertin A, 2010, EXP NEUROL, V225, P60, DOI 10.1016/j.expneurol.2010.04.019; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Echeverry S, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-16; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FAISSNER A, 1990, J NEUROCHEM, V54, P1004, DOI 10.1111/j.1471-4159.1990.tb02350.x; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Grimpe B, 2004, J NEUROSCI, V24, P1393, DOI 10.1523/JNEUROSCI.4986-03.2004; Guth L, 1999, ANN NY ACAD SCI, V890, P366, DOI 10.1111/j.1749-6632.1999.tb08017.x; HALES NJ, 1993, J MED CHEM, V36, P3853, DOI 10.1021/jm00076a014; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hamrick SEG, 2005, NEUROSCI LETT, V379, P96, DOI 10.1016/j.neulet.2004.12.080; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Heck N, 2003, GLIA, V41, P382, DOI 10.1002/glia.10184; Heck N, 2007, MOL CELL NEUROSCI, V36, P71, DOI 10.1016/j.mcn.2007.06.002; Howland MA, 1996, J TOXICOL-CLIN TOXIC, V34, P491, DOI 10.3109/15563659609028006; Iannotti CA, 2011, EXP NEUROL, V230, P3, DOI 10.1016/j.expneurol.2010.03.010; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; IMAI Y, 1994, ENDOCR J, V41, P645, DOI 10.1507/endocrj.41.645; Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jordan LM, 1998, ANN NY ACAD SCI, V860, P83, DOI 10.1111/j.1749-6632.1998.tb09040.x; JUNGHANS U, 1995, EUR J NEUROSCI, V7, P2341, DOI 10.1111/j.1460-9568.1995.tb00655.x; Kappler J, 1997, EUR J NEUROSCI, V9, P306, DOI 10.1111/j.1460-9568.1997.tb01401.x; Kicic A, 2001, CANCER, V92, P3093, DOI 10.1002/1097-0142(20011215)92:12<3093::AID-CNCR10107>3.0.CO;2-B; Kimura-Kuroda J, 2010, MOL CELL NEUROSCI, V43, P177, DOI 10.1016/j.mcn.2009.10.008; King VR, 2004, NEUROSCIENCE, V126, P173, DOI 10.1016/j.neuroscience.2004.03.035; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Kohta M, 2009, NEUROSCI RES, V65, P393, DOI 10.1016/j.neures.2009.08.017; Komuta Y, 2010, CELL MOL NEUROBIOL, V30, P101, DOI 10.1007/s10571-009-9435-x; Koops A, 1996, MOL BRAIN RES, V41, P65, DOI 10.1016/0169-328X(96)00067-8; Kozlov AK, 2014, P NATL ACAD SCI USA, V111, P3591, DOI 10.1073/pnas.1401459111; Kruse F, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00026; LAI YL, 1983, J APPL PHYSIOL, V54, P1754, DOI 10.1152/jappl.1983.54.6.1754; Lankhorst AJ, 1999, J NEUROTRAUM, V16, P323, DOI 10.1089/neu.1999.16.323; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; LLOYD JB, 1991, BIOCHEM PHARMACOL, V41, P1361, DOI 10.1016/0006-2952(91)90109-I; McTigue DM, 2000, EXP NEUROL, V163, P220, DOI 10.1006/exnr.2000.7372; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; OBRIEN MF, 1994, SPINE, V19, P2321, DOI 10.1097/00007632-199410150-00012; PALMER C, 1994, STROKE, V25, P1039, DOI 10.1161/01.STR.25.5.1039; Park SM, 2008, CELL PROLIFERAT, V41, P248, DOI 10.1111/j.1365-2184.2008.00514.x; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Rathore KI, 2012, GLIA, V60, P738, DOI 10.1002/glia.22303; Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008; Saletta F, 2011, J BIOL CHEM, V286, P35396, DOI 10.1074/jbc.M111.273060; Samuni Y, 1999, CANCER RES, V59, P405; Schira J, 2012, BRAIN, V135, P431, DOI 10.1093/brain/awr222; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; SCHMALENBACH C, 1993, J CHEM NEUROANAT, V6, P229, DOI 10.1016/0891-0618(93)90044-5; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; SHELLSWELL GB, 1979, FEBS LETT, V106, P305, DOI 10.1016/0014-5793(79)80520-7; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Simonart T, 2000, J INVEST DERMATOL, V115, P893, DOI 10.1046/j.1523-1747.2000.00119.x; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; Takeuchi M, 2012, NEUROREPORT, V23, P712, DOI 10.1097/WNR.0b013e3283567196; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; TSCHANK G, 1987, BIOCHEM J, V248, P625, DOI 10.1042/bj2480625; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Vogelaar CF, 2004, NEUROSCIENCE, V125, P645, DOI 10.1016/j.neuroscience.2004.02.006; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; Wang XH, 2009, J CLIN NEUROSCI, V16, P818, DOI 10.1016/j.jocn.2008.09.014; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721	86	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134371	10.1371/journal.pone.0134371	http://dx.doi.org/10.1371/journal.pone.0134371			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222542	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800137
J	Bergmann, C; Ten Bosch, L; Fikkert, P; Boves, L				Bergmann, Christina; Ten Bosch, Louis; Fikkert, Paula; Boves, Lou			Modelling the Noise-Robustness of Infants' Word Representations: The Impact of Previous Experience	PLOS ONE			English	Article							SPEECH RECOGNITION; VARIABILITY; DATABASE; SOUNDS; NAME	During language acquisition, infants frequently encounter ambient noise. We present a computational model to address whether specific acoustic processing abilities are necessary to detect known words in moderate noise-an ability attested experimentally in infants. The model implements a general purpose speech encoding and word detection procedure. Importantly, the model contains no dedicated processes for removing or cancelling out ambient noise, and it can replicate the patterns of results obtained in several infant experiments. In addition to noise, we also addressed the role of previous experience with particular target words: does the frequency of a word matter, and does it play a role whether that word has been spoken by one or multiple speakers? The simulation results show that both factors affect noise robustness. We also investigated how robust word detection is to changes in speaker identity by comparing words spoken by known versus unknown speakers during the simulated test. This factor interacted with both noise level and past experience, showing that an increase in exposure is only helpful when a familiar speaker provides the test material. Added variability proved helpful only when encountering an unknown speaker. Finally, we addressed whether infants need to recognise specific words, or whether a more parsimonious explanation of infant behaviour, which we refer to as matching, is sufficient. Recognition involves a focus of attention on a specific target word, while matching only requires finding the best correspondence of acoustic input to a known pattern in the memory. Attending to a specific target word proves to be more noise robust, but a general word matching procedure can be sufficient to simulate experimental data stemming from young infants. A change from acoustic matching to targeted recognition provides an explanation of the improvements observed in infants around their first birthday. In summary, we present a computational model incorporating only the processes infants might employ when hearing words in noise. Our findings show that a parsimonious interpretation of behaviour is sufficient and we offer a formal account of emerging abilities.	[Bergmann, Christina; Ten Bosch, Louis; Fikkert, Paula; Boves, Lou] Radboud Univ Nijmegen, Ctr Language Studies, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bergmann, C (corresponding author), PSL Res Univ, Ecole Normale Super, Dept Etudes Cognit, Lab Sci Cognit & Psycholinguist ENS EHESS CNRS, Paris, France.	chbergma@gmail.com	Bergmann, Christina/J-2765-2014	Bergmann, Christina/0000-0003-2656-9070; Fikkert, Paula/0000-0001-7317-2100; ten bosch, louis/0000-0002-0152-9024	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [360-70-350]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	The present work was supported by grant no. 360-70-350 from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (http://www.nwo.nl/) to LB, PF to support the work of CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbaum KS, 2011, COGNITIVE SCI, V35, P1105, DOI 10.1111/j.1551-6709.2011.01181.x; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; Barker BA, 2004, COGNITION, V94, pB45, DOI 10.1016/j.cognition.2004.06.001; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Bergmann C, 2015, INWORDDB DATABASE IN; Bergmann C, 2013, FRONT PSYCHOL, V4, P1; Bergmann C, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2910; Bregman A.S., 1994, AUDITORY SCENE ANAL; Coleman J, 2005, SPEECH LANGUAGE PROC; Dale PS, 1996, BEHAV RES METH INS C, V28, P125, DOI 10.3758/BF03203646; Driesen J, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P1711; Eichenbaum H., 2011, COGNITIVE NEUROSCIEN, V2, DOI [10.1093/acprof:oso/9780199778614.001.0001, DOI 10.1093/ACPROF:OSO/9780199778614.001.0001]; Gaskell MG, 1997, LANG COGNITIVE PROC, V12, P613, DOI 10.1080/016909697386646; GLEITMAN LR, 1994, PHILOS T ROY SOC B, V346, P71, DOI 10.1098/rstb.1994.0130; Gogate LJ, 2010, PSYCHOL REV, V117, P496, DOI 10.1037/a0019049; Gout A, 2004, J MEM LANG, V51, P548, DOI 10.1016/j.jml.2004.07.002; Hermansky H, 2011, SADHANA-ACAD P ENG S, V36, P729, DOI 10.1007/s12046-011-0044-2; Hollich G, 2005, CHILD DEV, V76, P598, DOI 10.1111/j.1467-8624.2005.00866.x; Johnson EK, 2008, INFANCY, V13, P440, DOI 10.1080/15250000802329321; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; MANDEL DR, 1995, PSYCHOL SCI, V6, P314, DOI 10.1111/j.1467-9280.1995.tb00517.x; Moerel M, 2012, J NEUROSCI, V32, P14205, DOI 10.1523/JNEUROSCI.1388-12.2012; Ness SR, 2012, AUDITORY SPARSE CODI; Newman RS, 2008, CURR DIR PSYCHOL SCI, V17, P229, DOI 10.1111/j.1467-8721.2008.00580.x; Newman RS, 2013, J ACOUST SOC AM, V133, pEL377, DOI 10.1121/1.4798269; Newman RS, 2009, ATTEN PERCEPT PSYCHO, V71, P822, DOI 10.3758/APP.71.4.822; Newman RS, 2005, DEV PSYCHOL, V41, P352, DOI 10.1037/0012-1649.41.2.352; Newman RS, 1996, PERCEPT PSYCHOPHYS, V58, P1145, DOI 10.3758/BF03207548; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Parise E, 2012, PSYCHOL SCI, V23, P728, DOI 10.1177/0956797612438734; Polka L, 2008, INFANCY, V13, P421, DOI 10.1080/15250000802329297; POLLACK I, 1975, J ACOUST SOC AM, V57, pS5, DOI 10.1121/1.1995329; Pols LCW, 1996, SPEECH COMMUN, V19, P161, DOI 10.1016/0167-6393(96)00033-7; Rost GC, 2009, DEVELOPMENTAL SCI, V12, P339, DOI 10.1111/j.1467-7687.2008.00786.x; Roy D, 2006, LECT NOTES ARTIF INT, V4211, P192; Roy DK, 2002, COGNITIVE SCI, V26, P113, DOI 10.1207/s15516709cog2601_4; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2007, HDB CHILD PSYCHOL CO, P59; Schatz T., 2013, INTERSPEECH 2013, P1781; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Smith LB, 2011, DEVELOPMENTAL SCI, V14, P9, DOI 10.1111/j.1467-7687.2009.00947.x; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; Synnaeve G, 2014, SPEECH FEATURES PIPE; Thiessen ED, 2013, COGNITIVE SCI, V37, P310, DOI 10.1111/cogs.12011; van de Weijer J., 1998, LANGUAGE INPUT WORD; Van hamme H, 2011, SIGN PROC AD SPARS S, P119; Van Hamme H, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2554; VARGA A, 1993, SPEECH COMMUN, V12, P247, DOI 10.1016/0167-6393(93)90095-3; Verberne S, 2010, COMPUT LINGUIST, V36, P229, DOI 10.1162/coli.2010.09-032-R1-08-034; Versteegh M, 2013, P INT; Versteegh M, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2930; Wachs T.D., 1986, CHILDRENS ENV Q, V3, P23; Wade NJ, 2012, VISUAL PERCEPTION IN; Werker JF, 2005, LANG LEARN DEV, V1, P197, DOI 10.1080/15475441.2005.9684216; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Yu C., 2013, PSYCHONOMIC B REV, V1, P1	56	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132245	10.1371/journal.pone.0132245	http://dx.doi.org/10.1371/journal.pone.0132245			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218504	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900005
J	Gonzalez-Gadea, ML; Scheres, A; Tobon, CA; Damm, J; Baez, S; Huepe, D; Marino, J; Marder, S; Manes, F; Abrevaya, S; Ibanez, A				Luz Gonzalez-Gadea, Maria; Scheres, Anouk; Andres Tobon, Carlos; Damm, Juliane; Baez, Sandra; Huepe, David; Marino, Julian; Marder, Sandra; Manes, Facundo; Abrevaya, Sofia; Ibanez, Agustin			Stop Saying That It Is Wrong! Psychophysiological, Cognitive, and Metacognitive Markers of Children's Sensitivity to Punishment	PLOS ONE			English	Article							IOWA GAMBLING TASK; COOL EXECUTIVE FUNCTION; AGE-RELATED-CHANGES; DECISION-MAKING; HEART-RATE; FUTURE CONSEQUENCES; ADOLESCENTS; PERFORMANCE; INSENSITIVITY; HYPOTHESIS	Neurodevelopmental evidence suggests that children's main decision-making strategy is to avoid options likely to induce punishment. However, the cognitive and affective factors contributing to children's avoidance to high punishment frequency remain unknown. The present study explored psychophysiological, cognitive, and metacognitive processes associated with sensitivity to punishment frequency. We evaluated 54 participants (between 8 and 15 years old) with a modified Iowa Gambling Task for children (IGT-C) which included options with varying long-term profit and punishment frequencies. Skin conductance responses (SCRs) were recorded during this task. Additionally, we assessed IGT-C metacognitive knowledge, fluid intelligence, and executive functions. Participants exhibited behavioral avoidance and high anticipatory SCRs to options with high frequency of punishment. Moreover, age, IGT-C metacognitive knowledge, and inhibitory control were associated with individual differences in sensitivity to punishment frequency. Our results suggest that children's preference for infrequently punished decisions is partially explained by psychophysiological signals as well as task complexity and development of cognitive control.	[Luz Gonzalez-Gadea, Maria; Baez, Sandra; Manes, Facundo; Abrevaya, Sofia; Ibanez, Agustin] Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina; [Luz Gonzalez-Gadea, Maria; Baez, Sandra; Manes, Facundo; Ibanez, Agustin] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, RA-1033 Buenos Aires, DF, Argentina; [Luz Gonzalez-Gadea, Maria; Baez, Sandra; Manes, Facundo; Ibanez, Agustin] Diego Port Univ, Fac Psychol, UDP INECO Fdn Core Neurosci UIFCoN, Santiago, Chile; [Scheres, Anouk] Radboud Univ Nijmegen, Inst Behav Sci, Dev Psychol, NL-6525 ED Nijmegen, Netherlands; [Andres Tobon, Carlos] Univ Antioquia, Fac Med, Grp Neurociencias Antioquia, Medellin, Colombia; [Andres Tobon, Carlos] Univ Antioquia, Fac Med, Grp Neuropsicol & Conducta, Medellin, Colombia; [Damm, Juliane] Univ Leipzig, D-04109 Leipzig, Germany; [Huepe, David] Univ Diego Port, Lab Cognit & Social Neurosci, Santiago, Chile; [Marino, Julian] Univ Nacl Cordoba, Lab Neuroimagenes, RA-5000 Cordoba, Argentina; [Marder, Sandra] UNLP, Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina; [Marder, Sandra] UNLP, Fac Psicol, La Plata, Buenos Aires, Argentina; [Manes, Facundo; Ibanez, Agustin] Australian Res Council, Ctr Excellence Cognit & its Disorders, Randwick, NSW, Australia; [Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Radboud University Nijmegen; Universidad de Antioquia; Universidad de Antioquia; Leipzig University; University Diego Portales; National University of Cordoba; Comision de Investigaciones Cientificas; National University of La Plata; National University of La Plata	Ibanez, A (corresponding author), Inst Cognit Neurol INECO, Buenos Aires, DF, Argentina.	aibanez@ineco.org.ar	Ibanez, Agustin/H-7976-2015	Ibanez, Agustin/0000-0001-6758-5101; Tobon, Carlos Andres/0000-0002-5787-6279; Huepe, David/0000-0001-8351-5314; Abrevaya, Sofia/0000-0003-4091-9962; Baez, Sandra/0000-0003-0875-1709; Marder, Sandra Esther/0000-0002-6027-7322	National Council of Scientific and Technological Research (CONICET); National Committee of Scientific and Technological Research (CONICYT); National Fund for Scientific and Technological Development (FONDECYT) [1130920]; CONICYT; FONDECYT [1140114]; Fund for Scientific and Technological Research (FONCyT) for Scientific and Technological Projects (PICT) [2012-0412, FONCyT-PICT 2012-1309, FONCyT-PICT 2012-0412]; Foundation of the Institute of Cognitive Neurology (INECO)	National Council of Scientific and Technological Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Committee of Scientific and Technological Research (CONICYT); National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fund for Scientific and Technological Research (FONCyT) for Scientific and Technological Projects (PICT); Foundation of the Institute of Cognitive Neurology (INECO)	This research was partially supported by grants from National Council of Scientific and Technological Research (CONICET), National Committee of Scientific and Technological Research (CONICYT) and National Fund for Scientific and Technological Development (FONDECYT) - Regular 1130920, CONICYT and FONDECYT - Regular 1140114, Fund for Scientific and Technological Research (FONCyT) for Scientific and Technological Projects (PICT) 2012-0412, FONCyT-PICT 2012-1309, FONCyT-PICT 2012-0412, and Foundation of the Institute of Cognitive Neurology (INECO).	Aite A, 2014, COGN BEHAV NEUROL, V27, P59, DOI 10.1097/WNN.0000000000000027; Aite A, 2012, J EXP CHILD PSYCHOL, V113, P286, DOI 10.1016/j.jecp.2012.05.008; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Brevers D, 2014, J GAMBL STUD, V30, P141, DOI 10.1007/s10899-012-9348-3; Brevers D, 2013, J GAMBL STUD, V29, P119, DOI 10.1007/s10899-012-9292-2; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Carlson SM, 2009, CHILD DEV, V80, P1076, DOI 10.1111/j.1467-8624.2009.01318.x; Cartoceti Romina., 2009, REV FONOAUDIOLOGICA, V52, P9; Cassotti M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00915; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Crone EA, 2005, CHILD NEUROPSYCHOL, V11, P245, DOI 10.1080/092970490911261; Crone EA, 2004, DEV PSYCHOL, V40, P1228, DOI 10.1037/0012-1649.40.6.1228; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Crone EA, 2004, PSYCHOPHYSIOLOGY, V41, P531, DOI 10.1111/j.1469-8986.2004.00197.x; Crone EA, 2003, PERS INDIV DIFFER, V35, P1625, DOI 10.1016/S0191-8869(02)00386-0; Crone EA, 2007, CHILD DEV, V78, P1288, DOI 10.1111/j.1467-8624.2007.01066.x; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dawson ME, 2000, HDB PSYCHOPHYSIOLOGY; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fernie G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00687; Figner B., 2011, HDB PROCESS TRACING; Gullick MM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00584; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Hongwanishkul D, 2005, DEV NEUROPSYCHOL, V28, P617, DOI 10.1207/s15326942dn2802_4; Hooper CJ, 2004, DEV PSYCHOL, V40, P1148, DOI 10.1037/0012-1649.40.6.1148; Huizenga HM, 2007, DEVELOPMENTAL SCI, V10, P814, DOI 10.1111/j.1467-7687.2007.00621.x; Jansen BRJ, 2012, J EXP CHILD PSYCHOL, V111, P87, DOI 10.1016/j.jecp.2011.07.006; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Mackinlay R, 2006, BRAIN COGNITION, V61, P14, DOI 10.1016/j.bandc.2005.12.006; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Masunami T, 2009, INT J PSYCHOPHYSIOL, V72, P283, DOI 10.1016/j.ijpsycho.2009.01.007; Newell BR, 2014, BEHAV BRAIN SCI, V37, P1, DOI 10.1017/S0140525X12003214; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Prencipe A, 2011, J EXP CHILD PSYCHOL, V108, P621, DOI 10.1016/j.jecp.2010.09.008; Raven J. C., 1992, RAVEN MANUAL; Sadler D. R., 1998, ASSESS EDUC, V5, P77, DOI DOI 10.1080/0969595980050104; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Smith DG, 2012, DEV PSYCHOL, V48, P1180, DOI 10.1037/a0026342; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Spreen O, 1969, Cortex, V5, P170; Torralva T, 2012, J ATTENTION DISORDER; Van Duijvenvoorde ACK, 2012, DEV PSYCHOL, V48, P192, DOI 10.1037/a0025601; van Duijvenvoorde ACK, 2010, DEV NEUROPSYCHOL, V35, P539, DOI 10.1080/87565641.2010.494749; Varma S, 2011, COGNITION, V121, P363, DOI 10.1016/j.cognition.2011.08.005; Wechsler D, 1974, WECHSLER INTELLIGENC; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Zelazo PD, 2004, TRENDS COGN SCI, V8, P12, DOI 10.1016/j.tics.2003.11.001	54	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133683	10.1371/journal.pone.0133683	http://dx.doi.org/10.1371/journal.pone.0133683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218584	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900040
J	Messaoudene, M; Perier, A; Fregni, G; Neves, E; Zitvogel, L; Cremer, I; Chanal, J; Sastre-Garau, X; Deschamps, L; Marinho, E; Larousserie, F; Maubec, E; Avril, MF; Caignard, A				Messaoudene, Meriem; Perier, Aurelie; Fregni, Giulia; Neves, Emmanuelle; Zitvogel, Laurence; Cremer, Isabelle; Chanal, Johan; Sastre-Garau, Xavier; Deschamps, Lydia; Marinho, Eduardo; Larousserie, Frederique; Maubec, Eve; Avril, Marie-Francoise; Caignard, Anne			Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; NATURAL-KILLER-CELLS; CUTANEOUS MELANOMA; DENDRITIC CELLS; GASTRIC-CANCER; BREAST-CANCER; METASTATIC MELANOMA; MALIGNANT-MELANOMA; PROGNOSTIC VALUE; LYMPHANGIOGENESIS	Melanomas are aggressive skin tumors characterized by high metastatic potential. Our previous results indicate that Natural Killer (NK) cells may control growth of melanoma. The main defect of blood NK cells was a decreased expression of activating NCR1/NKp46 receptor and a positive correlation of NKp46 expression with disease outcome in stage IV melanoma patients was found. In addition, in stage III melanoma patients, we identified a new subset of mature NK cells in macro-metastatic Lymph nodes (LN). In the present studies, we evaluated the numbers of NK cells infiltrating primary cutaneous melanoma and analyzed immune cell subsets in a series of sentinel lymph nodes (SLN). First, we show that NKp46(+) NK cells infiltrate primary cutaneous melanoma. Their numbers were related to age of patients and not to Breslow thickness. Then, a series of patients with tumor-negative or -positive sentinel lymph nodes matched for Breslow thickness of the cutaneous melanoma was constituted. We investigated the distribution of macrophages (CD68), endothelial cells, NK cells, granzyme B positive (GrzB(+)) cells and CD8(+) T cells in the SLN. Negative SLN (SLN-) were characterized by frequent adipose involution and follicular hyperplasia compared to positive SLN (SLN+). High densities of macrophages and endothelial cells (CD34), prominent in SLN+, infiltrate SLN and may reflect a tumor favorable microenvironment. Few but similar numbers of NK and GrzB(+) cells were found in SLN- and SLN+: NK cells and GrzB(+) cells were not correlated. Numerous CD8(+) T cells infiltrated SLN with a trend for higher numbers in SLN-. Moreover, CD8(+) T cells and GrzB(+) cells correlated in SLN- not in SLN+. We also observed that the numbers of CD8(+) T cells negatively correlated with endothelial cells in SLN-. The numbers of NK, GrzB(+) or CD8(+) T cells had no significant impact on overall survival. However, we found that the 5 year-relapse rate was higher in SLN with higher numbers of NK cells.	[Messaoudene, Meriem; Fregni, Giulia; Neves, Emmanuelle; Caignard, Anne] Hop St Louis, Inst Univ Hematol, INSERMU1160, F-75010 Paris, France; [Perier, Aurelie; Zitvogel, Laurence] Inst Gustave Roussy, INSERM, CIC, U1015, F-94805 Villejuif, France; [Cremer, Isabelle] Ctr Rech Cordeliers, F-75006 Paris, France; [Chanal, Johan; Avril, Marie-Francoise] Univ Paris 05, Hosp Cochin, AP HP, Dept Dermatol, Paris, France; [Sastre-Garau, Xavier] Inst Curie, Biopathol Dept, Paris, France; [Deschamps, Lydia; Marinho, Eduardo; Maubec, Eve] Univ Paris Diderot, Hosp Bichat, AP HP, Dept Dermatol, F-75018 Paris, France; [Deschamps, Lydia; Marinho, Eduardo; Maubec, Eve] Univ Paris Diderot, Hosp Bichat, Dept Pathol, F-75018 Paris, France; [Larousserie, Frederique] Univ Paris 05, Hosp Cochin, AP HP, Dept Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Caignard, A (corresponding author), Hop St Louis, Inst Univ Hematol, INSERMU1160, 1 Ave Claude Vellefaux, F-75010 Paris, France.	anne.caignard@inserm.fr	Caignard, Anne/F-8159-2013; Maubec, Eve/V-4296-2017; Cremer, Isabelle/D-4278-2017	Caignard, Anne/0000-0001-9923-6045; Maubec, Eve/0000-0003-1658-6686; Cremer, Isabelle/0000-0002-0963-1031; Sastre-Garau, Xavier/0000-0001-5992-2083; ZITVOGEL, laurence/0000-0003-1596-0998	INSERM, l'Association pour la Recherche contre le Cancer (ARC) [3964]; la Fondation de France [FDF 2011-20363]; la Societe Francaise de Dermatologie (SFD; la Ligue Nationale contre le Cancer (Comite Ile de France); l'INCa (Canceropole Ile de France); Ligue Nationale contre le Cancer; Assistance Publique des Hopitaux de Paris (APHP) (DRCD, Immumela program), Institut National du Cancer [PLBIO 2011-6]; PAIR Melanoma Association pour la recherche sur le cancer Ligue Nationale contre le Cancer	INSERM, l'Association pour la Recherche contre le Cancer (ARC); la Fondation de France(Fondation de France); la Societe Francaise de Dermatologie (SFD; la Ligue Nationale contre le Cancer (Comite Ile de France); l'INCa (Canceropole Ile de France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Assistance Publique des Hopitaux de Paris (APHP) (DRCD, Immumela program), Institut National du Cancer; PAIR Melanoma Association pour la recherche sur le cancer Ligue Nationale contre le Cancer	This work was supported by grants from INSERM, l'Association pour la Recherche contre le Cancer (ARC, 3964 to AC), la Fondation de France (FDF 2011-20363 to AC), la Societe Francaise de Dermatologie (SFD, grant for Dr. JC), la Ligue Nationale contre le Cancer (Comite Ile de France to AC), l'INCa (Canceropole Ile de France), Assistance Publique des Hopitaux de Paris (APHP) (DRCD, Immumela program), Institut National du Cancer: PLBIO 2011-6 and PAIR Melanoma 2013 Association pour la recherche sur le cancer Ligue Nationale contre le Cancer. MM is the recipient of a PhD grant from Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimi F, 2012, J CLIN ONCOL, V30, P2678, DOI 10.1200/JCO.2011.37.8539; Balch CM, 2014, ANN SURG ONCOL, V21, P1075, DOI 10.1245/s10434-013-3464-x; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Campillo JA, 2013, IMMUNOGENETICS, V65, P333, DOI 10.1007/s00251-013-0682-0; Cochran AJ, 2004, ANN SURG ONCOL, V11, p156S, DOI 10.1245/ASO.2004.12.923; Donizy P, 2015, ANTICANCER RES, V35, P351; Freeman SR, 2013, DERMATOL SURG, V39, P1800, DOI 10.1111/dsu.12351; Fregni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076928; Fregni G, 2012, ONCOIMMUNOLOGY, V1, P38, DOI 10.4161/onci.1.1.18312; Fregni G, 2011, CLIN CANCER RES, V17, P2628, DOI 10.1158/1078-0432.CCR-10-2084; Gonin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075694; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Ishigami S, 2000, CLIN CANCER RES, V6, P2611; Ishigami S, 2003, ANTICANCER RES, V23, P4079; Ishigami S, 2003, J GASTROINTEST SURG, V7, P735, DOI 10.1016/S1091-255X(03)00076-3; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.3.CO;2-M; Ishigami S, 2000, CANCER LETT, V159, P103, DOI 10.1016/S0304-3835(00)00542-5; Kurahara H, 2013, PANCREAS, V42, P155, DOI 10.1097/MPA.0b013e318254f2d1; Mansfield AS, 2012, VIRCHOWS ARCH, V461, P639, DOI 10.1007/s00428-012-1338-4; Mansfield AS, 2011, MODERN PATHOL, V24, P487, DOI 10.1038/modpathol.2010.227; Mansfield AS, 2011, VIRCHOWS ARCH, V459, P391, DOI 10.1007/s00428-011-1145-3; Messaoudene M, 2014, CANCER RES, V74, P81, DOI 10.1158/0008-5472.CAN-13-1303; Movassagh M, 2004, CANCER RES, V64, P2192, DOI 10.1158/0008-5472.CAN-03-2969; Naumova E, 2007, CANCER IMMUNOL IMMUN, V56, P95, DOI 10.1007/s00262-006-0151-9; Platonova S, 2011, CANCER RES, V71, P5412, DOI 10.1158/0008-5472.CAN-10-4179; Poindexter NJ, 2004, BREAST CANCER RES, V6, pR408, DOI 10.1186/bcr808; Rughani MG, 2012, EJSO-EUR J SURG ONC, V38, P936, DOI 10.1016/j.ejso.2012.04.011; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Taylor RC, 2007, J CLIN ONCOL, V25, P869, DOI 10.1200/JCO.2006.08.9755; Tomasello E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00344; Vallacchi V, 2014, CANCER RES, V74, P130, DOI 10.1158/0008-5472.CAN-13-1672	31	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133363	10.1371/journal.pone.0133363	http://dx.doi.org/10.1371/journal.pone.0133363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218530	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900028
J	O'Brien, KR; Scheffer, M; van Nes, EH; van der Lee, R				O'Brien, Katherine R.; Scheffer, Marten; van Nes, Egbert H.; van der Lee, Romy			How to Break the Cycle of Low Workforce Diversity: A Model for Change	PLOS ONE			English	Article							AFFIRMATIVE-ACTION; SEX-DIFFERENCES; STEREOTYPE THREAT; MALE-FEMALE; GENDER; SCIENCE; WOMEN; PERFORMANCE; CONFLICT; PARADOX	Social justice concerns but also perceived business advantage are behind a widespread drive to increase workplace diversity. However, dominance in terms of ethnicity, gender or other aspects of diversity has been resistant to change in many sectors. The different factors which contribute to low diversity are often hotly contested and difficult to untangle. We propose that many of the barriers to change arise from self-reinforcing feedbacks between low group diversity and inclusivity. Using a dynamic model, we demonstrate how bias in employee appointment and departure can trap organizations in a state with much lower diversity than the applicant pool: a workforce diversity "poverty trap". Our results also illustrate that if turnover rate is low, employee diversity takes a very long time to change, even in the absence of any bias. The predicted rate of change in workforce composition depends on the rate at which employees enter and leave the organization, and on three measures of inclusion: applicant diversity, appointment bias and departure bias. Quantifying these three inclusion measures is the basis of a new, practical framework to identify barriers and opportunities to increasing workforce diversity. Because we used a systems approach to investigate underlying feedback mechanisms rather than context-specific causes of low workforce diversity, our results are applicable across a wide range of settings.	[O'Brien, Katherine R.] Univ Queensland, Sch Chem Engn, St Lucia, Qld 4072, Australia; [Scheffer, Marten; van Nes, Egbert H.] Wageningen Univ, Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands; [van der Lee, Romy] Leiden Univ, Inst Psychol, Social & Org Psychol Unit, NL-2300 RB Leiden, Netherlands	University of Queensland; Wageningen University & Research; Leiden University; Leiden University - Excl LUMC	O'Brien, KR (corresponding author), Univ Queensland, Sch Chem Engn, St Lucia, Qld 4072, Australia.	k.obrien@uq.edu.au	O'Brien, Katherine/W-3011-2019; van Nes, Egbert H/F-2681-2011; O'Brien, Katherine R/J-3198-2014	O'Brien, Katherine/0000-0001-8972-9161; O'Brien, Katherine R/0000-0001-8972-9161; van Nes, Egbert/0000-0002-6345-104X; van der Lee, Romy/0000-0002-6144-7047	University of Queensland Faculty of Engineering Architecture and IT Special Studies Leave Program	University of Queensland Faculty of Engineering Architecture and IT Special Studies Leave Program	KOB's contribution to the project was funded by the University of Queensland Faculty of Engineering Architecture and IT Special Studies Leave Program 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2014, 41020 ABS; ABS, 2012, 41250 ABS; Baxter K, 2014, COMMUNICATION; Bell, 2009, WOMEN SCI AUSTR MAXI; Castilla EJ, 2010, ADMIN SCI QUART, V55, P543, DOI 10.2189/asqu.2010.55.4.543; Catalyst, 2013, WHY DIVERSITY MATTER; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; Crosby FJ, 2003, AM PSYCHOL, V58, P93, DOI 10.1037/0003-066X.58.2.93; de Wit FRC, 2012, J APPL PSYCHOL, V97, P360, DOI 10.1037/a0024844; Does S, 2011, J EXP SOC PSYCHOL, V47, P562, DOI 10.1016/j.jesp.2010.12.024; Dovidio JF, 1996, J SOC ISSUES, V52, P51, DOI 10.1111/j.1540-4560.1996.tb01848.x; Eagly A. H., 2009, GLASS CEILING 21 CEN, P21, DOI DOI 10.1037/11863-002; Earley PC, 2000, ACAD MANAGE J, V43, P26, DOI 10.2307/1556384; Ellemers N, 2012, RES ORGAN BEHAV, V32, P163, DOI 10.1016/j.riob.2012.10.003; Ellemers N, 2012, SCIENCE, V336, P848, DOI 10.1126/science.1220987; ELY RJ, 1994, ADMIN SCI QUART, V39, P203, DOI 10.2307/2393234; Ensher EA, 1997, J VOCAT BEHAV, V50, P460, DOI 10.1006/jvbe.1996.1547; Fouad N, 2011, 827553 NSF U WISC MI; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Groysberg B, 2013, HARVARD BUS REV, V91, P68; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; Heilman ME, 2007, J APPL PSYCHOL, V92, P81, DOI 10.1037/0021-9010.92.1.81; Heilman ME, 2004, J APPL PSYCHOL, V89, P416, DOI 10.1037/0021-9010.89.3.416; Heilman ME, 2001, J SOC ISSUES, V57, P657, DOI 10.1111/0022-4537.00234; Hilton D, 2013, NATURE, V497, P7, DOI 10.1038/497007a; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; Jehn KA, 1999, ADMIN SCI QUART, V44, P741, DOI 10.2307/2667054; Kahneman D., 2011, THINKING FAST SLOW; Kaiser CR, 2013, J PERS SOC PSYCHOL, V104, P504, DOI 10.1037/a0030838; Kalev A, 2006, AM SOCIOL REV, V71, P589, DOI 10.1177/000312240607100404; Kanter R. M., 1977, NUMBERS MINORITIES M, P206; Lawson KA, 2007, MED J AUSTRALIA, V186, P547, DOI 10.5694/j.1326-5377.2007.tb01036.x; Leonard JS, 2006, IND LABOR RELAT REV, V59, P547, DOI 10.1177/001979390605900402; Lowery BS, 2006, J PERS SOC PSYCHOL, V90, P961, DOI 10.1037/0022-3514.90.6.961; Martell RF, 1996, AM PSYCHOL, V51, P157, DOI 10.1037/0003-066X.51.2.157; Miller DI, 2014, J ED PSYCHOL; Milliken FJ, 1996, ACAD MANAGE REV, V21, P402, DOI 10.2307/258667; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Nosek BA, 2011, AM EDUC RES J, V48, P1125, DOI 10.3102/0002831211410683; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; O'Brien KR, 2012, OIKOS, V121, P999, DOI 10.1111/j.1600-0706.2012.20601.x; Page SE, 2008, DIFFERENCE POWER DIV; Parker JN, 2010, SCIENTOMETRICS, V85, P129, DOI 10.1007/s11192-010-0234-4; Reaves, 2010, LOCAL POLICE DEP 200; Reuben E, 2014, P NATL ACAD SCI USA, V111, P4403, DOI 10.1073/pnas.1314788111; Ring IT, 2002, MED J AUSTRALIA, V177, P629, DOI 10.5694/j.1326-5377.2002.tb04989.x; Riska E, 2011, MATURITAS, V68, P264, DOI 10.1016/j.maturitas.2010.09.010; Robinson G., 1997, ACAD MANAGE PERSPECT, V11, P21, DOI [10.5465/AME.1997.9709231661, DOI 10.5465/AME.1997.9709231661]; Sacco JM, 2005, J APPL PSYCHOL, V90, P203, DOI 10.1037/0021-9010.90.2.203; SACKETT PR, 1991, J APPL PSYCHOL, V76, P263, DOI 10.1037/0021-9010.76.2.263; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Seibert SE, 2001, ACAD MANAGE J, V44, P219, DOI 10.2307/3069452; Sheltzer JM, 2014, P NATL ACAD SCI USA, V111, P10107, DOI 10.1073/pnas.1403334111; Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]; Smith WA, 2007, AM BEHAV SCI, V51, P551, DOI 10.1177/0002764207307742; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Thatcher SMB, 2003, GROUP DECIS NEGOT, V12, P217, DOI 10.1023/A:1023325406946; van Knippenberg D, 2004, J APPL PSYCHOL, V89, P1008, DOI 10.1037/0021-9010.89.6.1008; van Knippenberg D, 2007, ANNU REV PSYCHOL, V58, P515, DOI 10.1146/annurev.psych.58.110405.085546; Williams KY, 1998, RES ORGAN BEHAV, V20, P77	65	19	19	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133208	10.1371/journal.pone.0133208	http://dx.doi.org/10.1371/journal.pone.0133208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26217957	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900022
J	Zito, S; Vankan, D; Bennett, P; Paterson, M; Phillips, CJC				Zito, Sarah; Vankan, Dianne; Bennett, Pauleen; Paterson, Mandy; Phillips, Clive J. C.			Cat Ownership Perception and Caretaking Explored in an Internet Survey of People Associated with Cats	PLOS ONE			English	Article							FREE-ROAMING CATS; FERAL DOMESTIC CATS; SHELTER PRACTICES; ATTITUDES; BEHAVIORS; MANAGEMENT; WELFARE; ADMISSIONS; ONLINE; URBAN	People who feed cats that they do not perceive they own (sometimes called semi-owners) are thought to make a considerable contribution to unwanted cat numbers because the cats they support are generally not sterilized. Understanding people's perception of cat ownership and the psychology underlying cat semi-ownership could inform approaches to mitigate the negative effects of cat semi-ownership. The primary aims of this study were to investigate cat ownership perception and to examine its association with human-cat interactions and caretaking behaviours. A secondary aim was to evaluate a definition of cat semi-ownership (including an association time of >= 1 month and frequent feeding), revised from a previous definition proposed in the literature to distinguish cat semi-ownership from casual interactions with unowned cats. Cat owners and semi-owners displayed similar types of interactions and caretaking behaviours. Nevertheless, caretaking behaviours were more commonly displayed towards owned cats than semi-owned cats, and semi-owned cats were more likely to have produced kittens (p<0.01). All interactions and caretaking behaviours were more likely to be displayed towards cats in semi-ownership relationships compared to casual interaction relationships. Determinants of cat ownership perception were identified (p<0.05) and included association time, attachment, perceived cat friendliness and health, and feelings about unowned cats, including the acceptability of feeding unowned cats. Encouraging semi-owners to have the cats they care for sterilized may assist in reducing the number of unwanted kittens and could be a valuable alternative to trying to prevent semi-ownership entirely. Highly accessible semi-owner "gatekeepers" could help to deliver education messages and facilitate the provision of cat sterilization services to semi-owners. This research enabled semi-ownership to be distinguished from casual interaction relationships and can assist welfare and government agencies to identify cat semi-owners in order to develop strategies to address this source of unwanted cats.	[Zito, Sarah; Phillips, Clive J. C.] Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton, Qld, Australia; [Vankan, Dianne] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Bennett, Pauleen] La Trobe Univ, Sch Psychol & Publ Hlth, Bendigo, Vic, Australia; [Paterson, Mandy] RSPCA Queensland, Wacol, Qld, Australia	University of Queensland; University of Queensland; La Trobe University	Zito, S (corresponding author), Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton Campus, Gatton, Qld, Australia.	s.zito@uq.edu.au	; Bennett, Pauleen/C-2138-2016	Paterson, Mandy/0000-0003-4564-9877; Bennett, Pauleen/0000-0001-5864-4464	Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia; Royal Society for the Prevention of Cruelty to Animals (RSPCA) Queensland	Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia; Royal Society for the Prevention of Cruelty to Animals (RSPCA) Queensland	The Royal Society for the Prevention of Cruelty to Animals (RSPCA) Australia and Queensland both contributed financially to this project (www.rspca.org.au and www.rspcaqld.org.au). Dr. Mandy Paterson, who works as the Principal Scientist for RSPCA Queensland, had a role in study design, data analysis, decision to publish, and preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Alberthsen C, 2013, AUST VET J, V91, P35, DOI 10.1111/avj.12013; Alberthsen C, 2014, THESIS U QUEENSLAND; Aronson E., 1969, ADV EXP SOC PSYCHOL, P1, DOI [10.1016/s0065-2601(08)60075-1, DOI 10.1016/S0065-2601(08)60075-1]; Aronson E., 2013, SOCIAL PSYCHOL; Aronson Elliot, 1998, COGNITIVE DISSONANCE, P21; Australian Bureau of Statistics, 2011, CENS HOM; Australian Companion Animal Council, 2010, CONTR PET CAR IND AU; Baltar F, 2012, INTERNET RES, V22, P57, DOI 10.1108/10662241211199960; Bhutta CB, 2012, SOCIOL METHOD RES, V41, P57, DOI 10.1177/0049124112440795; Cassese EC, 2013, PS-POLIT SCI POLIT, V46, P775, DOI 10.1017/S1049096513001029; Centonze LA, 2002, J AM VET MED ASSOC, V220, P1627, DOI 10.2460/javma.2002.220.1627; Denny E., 2010, REV CAT ECOLOGY MANA; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Emmel N, 2007, SOCIOL RES ONLINE, V12; Farnworth MJ, 2010, J APPL ANIM WELF SCI, V13, P180, DOI 10.1080/10888700903584846; Finkler H, 2012, PREV VET MED, V104, P125, DOI 10.1016/j.prevetmed.2011.11.006; Finkler H, 2011, ANTHROZOOS, V24, P31, DOI 10.2752/175303711X12923300467320; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gunaseelan S, 2013, ANTHROZOOS, V26, P199, DOI 10.2752/175303713X13636846944123; Haspel C., 1992, Anthrozoos, V3, P155, DOI 10.2752/089279390787057630; Hood J., 1998, PET OWNERSHIP ASIAN; Katcher AH, 1983, SAFETY INTIMACY PHYS, P112; Levy JK, 2003, J AM VET MED ASSOC, V223, P202, DOI 10.2460/javma.2003.223.202; Lord LK, 2008, JAVMA-J AM VET MED A, V232, P1159, DOI 10.2460/javma.232.8.1159; Lord LK, 2007, JAVMA-J AM VET MED A, V230, P1835, DOI 10.2460/javma.230.12.1835; Loyd KAT, 2012, ANTHROZOOS, V25, P337, DOI 10.2752/175303712X13403555186299; MacArthur SL, 2012, MADD SHELT MED C; Marston LC, 2009, J APPL ANIM WELF SCI, V12, P189, DOI 10.1080/10888700902955948; Mornement K, 2012, ANTHROZOOS, V25, P457, DOI 10.2752/175303712X13479798785850; Natoli E, 1999, ANTHROZOOS, V12, P16, DOI 10.2752/089279399787000408; Natoli E, 2006, PREV VET MED, V77, P180, DOI 10.1016/j.prevetmed.2006.06.005; Neidhart Laura, 2002, Journal of Applied Animal Welfare Science, V5, P175, DOI 10.1207/S15327604JAWS0503_02; Paterson M, 2014, ANIM PUB, P169; Phillips C, 2011, ANIMALS-BASEL, V1, P7, DOI 10.3390/ani1010007; Riva G, 2003, CYBERPSYCHOL BEHAV, V6, P73, DOI 10.1089/109493103321167983; Rochberg-Halton E, 1979, THESIS U CHIGACO CHI; Rohlf VI, 2012, ANTHROZOOS, V25, P171, DOI 10.2752/175303712X13316289505341; Rohlf VI, 2010, ANTHROZOOS, V23, P143, DOI 10.2752/175303710X12682332909972; Slater MR, 2008, PREV VET MED, V85, P267, DOI 10.1016/j.prevetmed.2008.02.001; Spindel ME, 2013, J FELINE MED SURG, V15, P323, DOI 10.1177/1098612X13477801; Toribio JALM, 2009, J FELINE MED SURG, V11, P449, DOI 10.1016/j.jfms.2008.06.010; Toukhsati SR, 2007, ANTHROZOOS, V20, P131, DOI 10.2752/175303707X207927; Toukhsati Samia R, 2012, Animals (Basel), V2, P611, DOI 10.3390/ani2040611; Toukhsati SR, 2012, ANTHROZOOS, V25, P61, DOI 10.2752/175303712X13240472427195; Victorian Government, 2013, DOM AN MAN PLAN 1 JU; Webb C, 2008, AAWS INT AN WELF C G; Webb C., 1995, MANAGEMENT UNOWNED C; Zito S, 2015, J APPL ANIM IN PRESS	51	33	33	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133293	10.1371/journal.pone.0133293	http://dx.doi.org/10.1371/journal.pone.0133293			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218243	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900025
J	Blumental, S; Granger-Farbos, A; Moisi, JC; Soullie, B; Leroy, P; Njanpop-Lafourcade, BM; Yaro, S; Nacro, B; Hallin, M; Koeck, JL				Blumental, Sophie; Granger-Farbos, Alexandra; Moisi, Jennifer C.; Soullie, Bruno; Leroy, Philippe; Njanpop-Lafourcade, Berthe-Marie; Yaro, Seydou; Nacro, Boubacar; Hallin, Marie; Koeck, Jean-Louis			Virulence Factors of Streptococcus pneumoniae. Comparison between African and French Invasive Isolates and Implication for Future Vaccines	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; SURFACE PROTEIN-A; CAPSULAR SEROTYPES; DISEASE; PNEUMOLYSIN; MENINGITIS; IMMUNOGENICITY; IDENTIFICATION; IMMUNIZATION; DIVERSITY	Background Many surface proteins thought to promote Streptocococcus pneumoniae virulence have recently been discovered and are currently being considered as future vaccine targets. We assessed the prevalence of 16 virulence genes among 435 S. pneumoniae invasive isolates from France and the "African meningitis belt" region, with particular focus on serotype 1 (Sp1), to compare their geographical distribution, assess their association with site of infection and evaluate their potential interest as new vaccine candidates. Methods Detection by PCR of pspA (+families), pspC (+pspC.4), pavA, lytA, phtA, B,D,E, nanA,B,C, rrgA (Pilus-1), sipA (Pilus-2), pcpA and psrp was performed on all isolates, as well as antibiotic resistance testing and MLVA typing (+MLST on 54 representative strains). Determination of ply alleles was performed by sequencing (Sp1 isolates). Results MLVA and virulence genes profiles segregated Sp1 isolates into 2 groups that followed continent distribution. The ply allele 5 and most of the genes that were variable (nanC, Pilus-2, psrp, pcpA, phtD) were present in the French Sp1 isolates (PMEN clone Sweden(1)-28, ST306) but absent from the African ones. Whereas all African Sp1 isolates clustered into a single MLST CC (CC217), MLVA distinguished two CCs that followed temporal evolution. Pilus-2 and psrp were more prevalent in bacteraemic pneumonia yielded isolates and phtB in meningitis-related isolates. Considering vaccine candidates, phtD was less prevalent than anticipated (50%) and pcpA varied importantly between France and Africa (98% versus 34%). Pilus-1 was carried by 7-11% of isolates and associated with beta-lactams resistance. Conclusions Most virulence genes were carried by the European ST306 clone but were lacking on Sp1 isolates circulating in the African meningitis belt, where a more serious pattern of infection is observed. While virulence proteins are now considered as vaccine targets, the geographical differences in their prevalence could affect the efficacy expected from future vaccines.	[Blumental, Sophie] Hop Univ Enfants Reine Fabiola, Paediat Infect Dis Unit, Brussels, Belgium; [Granger-Farbos, Alexandra; Soullie, Bruno; Leroy, Philippe; Koeck, Jean-Louis] Hop Instruct Armees Robert Picque, Dept Biol, Mol Biol Lab, Bordeaux, France; [Moisi, Jennifer C.; Njanpop-Lafourcade, Berthe-Marie] Agence Med Prevent, Paris, France; [Yaro, Seydou] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Nacro, Boubacar] Ctr Hosp Univ Souro Sanou, Paediat Unit, Bobo Dioulasso, Burkina Faso; [Hallin, Marie] IRIS Lab, Ctr Mol Diag, Brussels, Belgium	Agence de Medecine Preventive; Centre Muraz	Blumental, S (corresponding author), Hop Univ Enfants Reine Fabiola, Paediat Infect Dis Unit, Brussels, Belgium.	sophie.blumental@ulb.ac.be			Belgian Kids' Funds; Iris Research Network	Belgian Kids' Funds; Iris Research Network	This study was supported by two scientific research grants received from the Belgian Kids' Funds and the Iris Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Angoulvant F, 2014, CLIN INFECT DIS, V58, P918, DOI 10.1093/cid/ciu006; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bercion R, 2008, J TROP PEDIATRICS, V54, P125, DOI 10.1093/tropej/fmm075; Berglund J, 2014, CLIN VACCINE IMMUNOL, V21, P56, DOI 10.1128/CVI.00430-13; Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019668; Everett DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044250; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Garnacho-Montero J, 2012, DIAGN MICR INFEC DIS, V73, P39, DOI 10.1016/j.diagmicrobio.2012.02.002; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hamidou AA, 2007, 13 C ACT PHAR MARS F; Hanquet G, 2010, EMERG INFECT DIS, V16, P1428, DOI 10.3201/eid1609.100102; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hyams C, 2013, INFECT IMMUN, V81, P354, DOI 10.1128/IAI.00862-12; Imai S, 2011, CLIN MICROBIOL INFEC, V17, P1409, DOI 10.1111/j.1469-0691.2010.03446.x; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Kerr AR, 2006, INFECT IMMUN, V74, P5319, DOI 10.1128/IAI.00543-06; Koeck JL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-66; Kothari N, 2015, VACCINE, V33, P783, DOI 10.1016/j.vaccine.2014.12.032; Mann B, 2014, J INFECT DIS, V209, P1116, DOI 10.1093/infdis/jit502; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pettigrew MM, 2006, INFECT IMMUN, V74, P3360, DOI 10.1128/IAI.01442-05; Prymula R, 2014, VACCINE, V32, P3025, DOI 10.1016/j.vaccine.2014.03.066; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Selva L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041587; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Syk A, 2014, J INFECT DIS, V210, P4, DOI 10.1093/infdis/jiu038; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Verhoeven D, 2014, VACCINE, V32, P3205, DOI 10.1016/j.vaccine.2014.04.004; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	50	23	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133885	10.1371/journal.pone.0133885	http://dx.doi.org/10.1371/journal.pone.0133885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214695	Green Submitted, gold, Green Published			2022-12-27	WOS:000358594300038
J	Severijns, D; Octavia, JR; Kerkhofs, L; Coninx, K; Lamers, I; Feys, P				Severijns, Deborah; Octavia, Johanna Renny; Kerkhofs, Lore; Coninx, Karin; Lamers, Ilse; Feys, Peter			Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis	PLOS ONE			English	Article							MEAN POWER FREQUENCY; MOTOR FATIGUE; UPPER-LIMB; MUSCLE; STRENGTH; PROTOCOLS; DOMINANCE; RESPONSES; SIGNAL; GRIP	Background People with multiple sclerosis (MS) are encouraged to engage in exercise programs but an increased experience of fatigue may impede sustained participation in training sessions. A high number of movements is, however, needed for obtaining optimal improvements after rehabilitation. Methods This cross-sectional study investigated whether people with MS show abnormal fatigability during a robot-mediated upper limb movement trial. Sixteen people with MS and sixteen healthy controls performed five times three minutes of repetitive shoulder anteflexion movements. Movement performance, maximal strength, subjective upper limb fatigue and surface electromyography (median frequency and root mean square of the amplitude of the electromyography (EMG) signal of the anterior deltoid) were recorded during or in-between these exercises. After fifteen minutes of rest, one extra movement bout was performed to investigate how rest influences performance. Results A fifteen minutes upper limb movement protocol increased the perceived upper limb fatigue and induced muscle fatigue, given a decline in maximal anteflexion strength and changes of both the amplitude and the median frequency of EMG the anterior deltoid. In contrast, performance during the 3 minutes of anteflexion movements did not decline. There was no relation between changes in subjective fatigue and the changes in the amplitude and the median frequency of the anterior deltoid muscle, however, there was a correlation between the changes in subjective fatigue and changes in strength in people with MS. People with MS with upper limb weakness report more fatigue due to the repetitive movements, than people with MS with normal upper limb strength, who are comparable to healthy controls. The weak group could, however, keep up performance during the 15 minutes of repetitive movements. Discussion and Conclusion Albeit a protocol of repetitive shoulder anteflexion movements did not elicit a performance decline, fatigue feelings clearly increased in both healthy controls and people with MS, with the largest increase in people with MS with upper limb weakness. Objective fatigability was present in both groups with a decline in the muscle strength and increase of muscle fatigue, shown by changes in the EMG parameters. However, although weak people with multiple sclerosis experienced more fatigue, the objective signs of fatigability were less obvious in weak people with MS, perhaps because this subgroup has central limiting factors, which influence performance from the start of the movements.	[Severijns, Deborah; Lamers, Ilse; Feys, Peter] Hasselt Univ, BIOMED, Fac Med & Life Sci, REVAL Rehabil Res Ctr, Diepenbeek, Belgium; [Octavia, Johanna Renny] Parahyangan Catholic Univ, Dept Ind Engn, Bandung 40141, Indonesia; [Octavia, Johanna Renny; Coninx, Karin] Hasselt Univ, tUL, iMinds, Expertise Ctr Digital Media, Diepenbeek, Belgium; [Kerkhofs, Lore] Rehabil & MS Ctr Overpelt, Overpelt, Belgium	Hasselt University; Universitas Katolik Parahyangan; Hasselt University; IMEC	Severijns, D (corresponding author), Hasselt Univ, BIOMED, Fac Med & Life Sci, REVAL Rehabil Res Ctr, Diepenbeek, Belgium.	deborah.severijns@uhasselt.be	Octavia, Johanna Renny/ABE-2566-2020	Octavia, Johanna Renny/0000-0002-5581-2634; Feys, Peter/0000-0002-5680-5495; Lamers, Ilse/0000-0001-6147-4769				Bastiaens H, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975507, DOI 10.1109/ICORR.2011.5975507; Bertoni R, 2015, MULT SCLER; Bohannon R W, 1998, J Hand Ther, V11, P258; Burd NA, 2012, APPL PHYSIOL NUTR ME, V37, P551, DOI [10.1139/h2012-022, 10.1139/H2012-022]; Carpinella I, 2012, IEEE T NEUR SYS REH, V20, P351, DOI 10.1109/TNSRE.2012.2187462; Chopp JN, 2011, CLIN BIOMECH, V26, P40, DOI 10.1016/j.clinbiomech.2010.09.001; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Crenshaw AG, 2000, ACTA PHYSIOL SCAND, V170, P119, DOI 10.1046/j.1365-201x.2000.00765.x; Dalgas U, 2010, MULT SCLER J, V16, P480, DOI 10.1177/1352458509360040; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Djaldetti R, 1996, NEUROLOGY, V46, P632, DOI 10.1212/WNL.46.3.632; Dobkin BH, 2008, NEUROREHAB NEURAL RE, V22, P105, DOI 10.1177/1545968308315046; Feys P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0043-3; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; Fuller JR, 2009, J ELECTROMYOGR KINES, V19, P1043, DOI 10.1016/j.jelekin.2008.10.009; Gijbels D, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-5; Gordon NM, 2012, J NEUROPHYSIOL, V108, P1501, DOI 10.1152/jn.01144.2011; Hayward K, 2010, DISABIL REHABIL, V32, P1973, DOI 10.3109/09638288.2010.481027; Hermens H.J., 1999, ROESSINGH RES DEV, V8, P11; Hummel A, 2005, EUR J APPL PHYSIOL, V95, P321, DOI 10.1007/s00421-005-0014-7; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Kister Ilya, 2013, Int J MS Care, V15, P146, DOI 10.7224/1537-2073.2012-053; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Konz S, 1998, INT J IND ERGONOM, V22, P67, DOI 10.1016/S0169-8141(97)00068-1; Kos D, 2003, ACTA NEUROL BELG, V103, P185; Krebs Herman Igo, 2012, Am J Phys Med Rehabil, V91, pS290, DOI 10.1097/PHM.0b013e31826bcd80; Lamers I, 2014, ARCH PHYS MED REHAB, V95, P1184, DOI 10.1016/j.apmr.2014.02.023; Lamers I, 2013, MULT SCLER J, V19, P1341, DOI 10.1177/1352458513475832; MERLETTI R, 1984, EUR J APPL PHYSIOL, V52, P258, DOI 10.1007/BF01015206; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OBERG T, 1990, EUR J APPL PHYSIOL, V61, P362, DOI 10.1007/BF00236054; Octavia JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/345728; Octavia JR, 2015, MULTIPLE SCLEROSIS I, V2015, P11; Phan-Ba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034744; Schwid SR, 1999, NEUROLOGY, V53, P743, DOI 10.1212/WNL.53.4.743; Sehle A, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-59; Severijns D, 2015, J REHABIL MED, V47, P154, DOI 10.2340/16501977-1897; Steens A, 2011, NEUROIMAGE; Steens A, 2012, NEUROREHAB NEURAL RE, V26, P48, DOI 10.1177/1545968311416991; Surakka J, 2004, CLIN REHABIL, V18, P652, DOI 10.1191/0269215504cr781oa; Szucs K, 2009, MED BIOL ENG COMPUT, V47, P487, DOI 10.1007/s11517-009-0485-5; Thickbroom GW, 2006, J NEUROL, V253, P1048, DOI 10.1007/s00415-006-0159-2; Turner DL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00184; Wens I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108158; Werle S, 2009, J HAND SURG-EUR VOL, V34E, P76, DOI 10.1177/1753193408096763; Wittstein J, 2010, J SHOULDER ELB SURG, V19, P874, DOI 10.1016/j.jse.2010.01.018; Zwarts MJ, 2008, CLIN NEUROPHYSIOL, V119, P2, DOI 10.1016/j.clinph.2007.09.126	47	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133729	10.1371/journal.pone.0133729	http://dx.doi.org/10.1371/journal.pone.0133729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213990	gold, Green Published			2022-12-27	WOS:000358594300027
J	Bibault, JE; Mirabel, X; Lacornerie, T; Tresch, E; Reynaert, N; Lartigau, E				Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Tresch, Emmanuelle; Reynaert, Nick; Lartigau, Eric			Adapted Prescription Dose for Monte Carlo Algorithm in Lung SBRT: Clinical Outcome on 205 Patients	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; CANCER; THERAPY; ELECTRON; SABR	Purpose SBRT is the standard of care for inoperable patients with early-stage lung cancer without lymph node involvement. Excellent local control rates have been reported in a large number of series. However, prescription doses and calculation algorithms vary to a great extent between studies, even if most teams prescribe to the D95 of the PTV. Type A algorithms are known to produce dosimetric discrepancies in heterogeneous tissues such as lungs. This study was performed to present a Monte Carlo (MC) prescription dose for NSCLC adapted to lesion size and location and compare the clinical outcomes of two cohorts of patients treated with a standard prescription dose calculated by a type A algorithm or the proposed MC protocol. Patients and Methods Patients were treated from January 2011 to April 2013 with a type B algorithm (MC) prescription with 54 Gy in three fractions for peripheral lesions with a diameter under 30 mm, 60 Gy in 3 fractions for lesions with a diameter over 30 mm, and 55 Gy in five fractions for central lesions. Clinical outcome was compared to a series of 121 patients treated with a type A algorithm (TA) with three fractions of 20 Gy for peripheral lesions and 60 Gy in five fractions for central lesions prescribed to the PTV D95 until January 2011. All treatment plans were recalculated with both algorithms for this study. Spearman's rank correlation coefficient was calculated for GTV and PTV. Local control, overall survival and toxicity were compared between the two groups. Results 205 patients with 214 lesions were included in the study. Among these, 93 lesions were treated with MC and 121 were treated with TA. Overall survival rates were 86% and 94% at one and two years, respectively. Local control rates were 79% and 93% at one and two years respectively. There was no significant difference between the two groups for overall survival (p = 0.785) or local control (p = 0.934). Fifty-six patients (27%) developed grade I lung fibrosis without clinical consequences. GTV size was a prognostic factor for overall survival (HR = 1.026, IC95% [1.01-1.041], p<0.001) and total dose was a prognostic factor for local control (HR = 0.924, IC95% [0.870-0.982], p = 0.011). D50 of the GTV calculated with MC correlated poorly with the D95 of the PTV calculated with TA (r = 0.116) for lesions with a diameter of 20 mm or less. For lesions larger than 20 mm, spearman correlation was higher (r = 0.618), but still insufficient. Conclusion No difference in local control or overall survival was found between patients treated with a type A or a type B algorithm in our cohort. A size and location adapted GTV-based prescription method could be used with a type B algorithm. External validation of these results is warranted.	[Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Reynaert, Nick; Lartigau, Eric] Oscar Lambret Comprehens Canc Ctr, Acad Radiat Oncol Dept, Lille, France; [Tresch, Emmanuelle] Oscar Lambret Comprehens Canc Ctr, Dept Biostat, Lille, France; [Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Reynaert, Nick; Lartigau, Eric] Univ Lille 2, Fac Med, Lille, France; [Bibault, Jean-Emmanuel; Mirabel, Xavier; Lacornerie, Thomas; Tresch, Emmanuelle; Reynaert, Nick; Lartigau, Eric] Maison Reg Rech Clin, ONCOLille, Lille, France	UNICANCER; Centre Oscar Lambret; UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille	Lartigau, E (corresponding author), Oscar Lambret Comprehens Canc Ctr, Acad Radiat Oncol Dept, 3 Rue Frederic Combemale, Lille, France.	e-lartigau@o-lambret.fr	lartigau, eric/GSI-5327-2022	Bibault, Jean-Emmanuel/0000-0002-1728-6776; Lacornerie, Thomas/0000-0001-8994-5999; Mirabel, Xavier/0000-0002-6546-7627; Reynaert, Nick/0000-0001-9221-9103	Accuray	Accuray	The radiation therapy department at the Oscar Lambret Comprehensive Cancer Center has a clinical research program partially funded by Accuray. Dr. Lartigau has been acting Chief Medical Officer at Accuray from April 2014 until September 2014 and has participated in coordination of the study, provided mentorship and edited the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPM, 2004, TISS INH CORR MEG PH; Aarup LR, 2009, RADIOTHER ONCOL, V91, P405, DOI 10.1016/j.radonc.2009.01.008; Das IJ, 2008, MED PHYS, V35, P206, DOI 10.1118/1.2815356; Deng J, 2001, PHYS MED BIOL, V46, P1429, DOI 10.1088/0031-9155/46/5/308; Deng J, 2000, PHYS MED BIOL, V45, P411, DOI 10.1088/0031-9155/45/2/311; Ding GX, 2007, MED PHYS, V34, P2985, DOI 10.1118/1.2745923; Guckenberger M, 2010, RADIOTHER ONCOL, V97, P65, DOI 10.1016/j.radonc.2010.04.027; Huang K, 2012, RADIOTHER ONCOL, V102, P335, DOI 10.1016/j.radonc.2011.12.018; Hurkmans CW, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-1; Jiang SB, 2000, MED PHYS, V27, P180, DOI 10.1118/1.598883; Jones AO, 2005, MED PHYS, V32, P766, DOI 10.1118/1.1861154; Knoos T, 2006, PHYS MED BIOL, V51, P5785, DOI 10.1088/0031-9155/51/22/005; Kry SF, 2013, INT J RADIAT ONCOL, V85, pE95, DOI 10.1016/j.ijrobp.2012.08.039; Lacornerie T, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0223-5; Latifi K, 2014, INT J RADIAT ONCOL, V88, P1108, DOI 10.1016/j.ijrobp.2013.12.047; Li J, 2012, INT J RADIAT ONCOL, V84, P508, DOI 10.1016/j.ijrobp.2011.12.005; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Olsen JR, 2011, INT J RADIAT ONCOL, V81, pE299, DOI 10.1016/j.ijrobp.2011.01.038; Rassiah-Szegedi P, 2006, ACTA ONCOL, V45, P989, DOI 10.1080/02841860600919225; Sharma SC, 2010, J APPL CLIN MED PHYS, V11, P170, DOI 10.1120/jacmp.v11i1.3142; Solda F, 2013, RADIOTHER ONCOL, V109, P1, DOI 10.1016/j.radonc.2013.09.006; van Zyp NCV, 2010, RADIOTHER ONCOL, V96, P55, DOI 10.1016/j.radonc.2010.04.009; Vanderstraeten B, 2006, MED PHYS, V33, P3149, DOI 10.1118/1.2241992; Xiao Y, 2009, INT J RADIAT ONCOL, V73, P1235, DOI 10.1016/j.ijrobp.2008.11.019	24	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133617	10.1371/journal.pone.0133617	http://dx.doi.org/10.1371/journal.pone.0133617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207808	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000111
J	LaDisa, JF; Bozdag, S; Olson, J; Ramchandran, R; Kersten, JR; Eddinger, TJ				LaDisa, John F., Jr.; Bozdag, Serdar; Olson, Jessica; Ramchandran, Ramani; Kersten, Judy R.; Eddinger, Thomas J.			Gene Expression in Experimental Aortic Coarctation and Repair: Candidate Genes for Therapeutic Intervention?	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SARCOPLASMIC-RETICULUM CA2+-ATPASE; PLASMA-RENIN ACTIVITY; BLOOD-PRESSURE; CARDIAC-HYPERTROPHY; ARTERIAL-HYPERTENSION; HEART-DISEASE; FOLLOW-UP; HEMODYNAMICS; ASSOCIATION	Coarctation of the aorta (CoA) is a constriction of the proximal descending thoracic aorta and is one of the most common congenital cardiovascular defects. Treatments for CoA improve life expectancy, but morbidity persists, particularly due to the development of chronic hypertension (HTN). Identifying the mechanisms of morbidity is difficult in humans due to confounding variables such as age at repair, follow-up duration, coarctation severity and concurrent anomalies. We previously developed an experimental model that replicates aortic pathology in humans with CoA without these confounding variables, and mimics correction at various times using dissolvable suture. Here we present the most comprehensive description of differentially expressed genes (DEGs) to date from the pathology of CoA, which were obtained using this model. Aortic samples (n=4/group) from the ascending aorta that experiences elevated blood pressure (BP) from induction of CoA, and restoration of normal BP after its correction, were analyzed by gene expression microarray, and enriched genes were converted to human orthologues. 51 DEGs with > 6 fold-change (FC) were used to determine enriched Gene Ontology terms, altered pathways, and association with National Library of Medicine Medical Subject Headers (MeSH) IDs for HTN, cardiovascular disease (CVD) and CoA. The results generated 18 pathways, 4 of which (cell cycle, immune system, hemostasis and metabolism) were shared with MeSH ID's for HTN and CVD, and individual genes were associated with the CoA MeSH ID. A thorough literature search further uncovered association with contractile, cytoskeletal and regulatory proteins related to excitation-contraction coupling and metabolism that may explain the structural and functional changes observed in our experimental model, and ultimately help to unravel the mechanisms responsible for persistent morbidity after treatment for CoA.	[LaDisa, John F., Jr.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [LaDisa, John F., Jr.] Med Coll Wisconsin, Dept Med, Div Cardiovasc Med, Milwaukee, WI 53226 USA; [LaDisa, John F., Jr.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [LaDisa, John F., Jr.] Childrens Hosp Wisconsin, Herma Heart Ctr, Milwaukee, WI 53201 USA; [Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Olson, Jessica] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Childrens Hosp Wisconsin, Dev Vasc Biol Program, Milwaukee, WI 53201 USA; [Kersten, Judy R.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Kersten, Judy R.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Eddinger, Thomas J.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Marquette University	LaDisa, JF (corresponding author), Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA.	john.ladisa@marquette.edu		Olson, Jessica/0000-0002-8941-794X	Academic Research Enhancement Award from the National Institutes of Health [R15HL096096-01]; Departments of Biological Sciences and Biomedical Engineering at Marquette University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL096096] Funding Source: NIH RePORTER	Academic Research Enhancement Award from the National Institutes of Health; Departments of Biological Sciences and Biomedical Engineering at Marquette University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an Academic Research Enhancement Award from the National Institutes of Health (R15HL096096-01 to JFL), assistance from the Alvin and Marion Birnschein Foundation (to JFL), and support from the Departments of Biological Sciences and Biomedical Engineering at Marquette University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM EA, 1969, AM J CARDIOL, V23, P396, DOI 10.1016/0002-9149(69)90520-7; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; Bonaventura D, 2011, LIFE SCI, V89, P595, DOI 10.1016/j.lfs.2011.07.022; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; CASTA A, 1982, CLIN CARDIOL, V5, P551; Chang KC, 1997, J CLIN INVEST, V100, P1742, DOI 10.1172/JCI119699; Cheng GM, 1996, ARCH BIOCHEM BIOPHYS, V329, P65, DOI 10.1006/abbi.1996.0192; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840; Craig DB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-84; Dai HJ, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas061; Deng J, 2009, EUR J PHARMACOL, V608, P42, DOI 10.1016/j.ejphar.2009.01.048; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehret GB, 2009, EUR J HUM GENET, V17, P1650, DOI 10.1038/ejhg.2009.94; FALLO F, 1983, CLIN EXP HYPERTENS A, V5, P321, DOI 10.3109/10641968309069491; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Figueroa CA, 2010, J VASC SURG, V51, P1488, DOI 10.1016/j.jvs.2010.01.058; Gallego-Delgado J, 2006, J AM SOC NEPHROL, V17, pS159, DOI 10.1681/ASN.2006080937; GARDINER HM, 1994, CIRCULATION, V89, P1745, DOI 10.1161/01.CIR.89.4.1745; GIDDING SS, 1985, CIRCULATION, V71, P495, DOI 10.1161/01.CIR.71.3.495; Gorman CL, 2010, METHODS MOL BIOL, V616, P253, DOI 10.1007/978-1-60761-461-6_16; Hager A, 2007, J THORAC CARDIOV SUR, V134, P738, DOI 10.1016/j.jtcvs.2007.04.027; Hager A, 2011, INT J CARDIOL, V151, P63, DOI 10.1016/j.ijcard.2010.04.090; Hand BD, 2006, LIFE SCI, V79, P1413, DOI 10.1016/j.lfs.2006.04.003; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ibarra-Lara L, 2010, EUR J PHARMACOL, V627, P185, DOI 10.1016/j.ejphar.2009.10.039; Kaushal S, 2009, ANN THORAC SURG, V88, P1932, DOI 10.1016/j.athoracsur.2009.08.035; Krishnan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028979; Kuehl K, 2010, BIRTH DEFECTS RES A, V88, P101, DOI 10.1002/bdra.20630; Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14; Kvitting JPE, 2009, ANN THORAC SURG, V87, P342, DOI 10.1016/j.athoracsur.2008.08.072; Liu W, 2013, CIRC-HEART FAIL, V6, P833, DOI 10.1161/CIRCHEARTFAILURE.112.000123; Lompre AM, 1999, CLIN EXP PHARMACOL P, V26, P553, DOI 10.1046/j.1440-1681.1999.03079.x; Marques FZ, 2010, HYPERTENSION, V56, P319, DOI 10.1161/HYPERTENSIONAHA.110.155366; Menon A, 2012, AM J PHYSIOL-HEART C, V303, pH1304, DOI 10.1152/ajpheart.00420.2012; Menon A, 2012, J PHARMACOL TOX MET, V65, P18, DOI 10.1016/j.vascn.2011.10.003; Morgan NV, 2011, J CLIN INVEST, V121, P695, DOI 10.1172/JCI41931; Morrison TM, 2009, J VASC SURG, V49, P1029, DOI 10.1016/j.jvs.2008.11.056; Nielsen JC, 2005, CIRCULATION, V111, P622, DOI 10.1161/01.CIR.0000154549.53684.64; O'Sullivan JJ, 2002, HEART, V88, P163, DOI 10.1136/heart.88.2.163; Oliveros J.C., VENNY INTERACTIVE TO; Ong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068335; OROURKE MF, 1971, CIRCULATION, V44, P281, DOI 10.1161/01.CIR.44.2.281; Pacileo G, 2001, AM J CARDIOL, V87, P748, DOI 10.1016/S0002-9149(00)01495-8; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Perloff JK, 2003, CLIN RECOGNITION CON; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; PETTERSSON G, 1985, ACTA PHARMACOL TOX, V57, P184, DOI 10.1111/bcpt.1985.57.3.184; Pfaltzgraff ER, 2014, J MOL CELL CARDIOL, V69, P88, DOI 10.1016/j.yjmcc.2014.01.016; Qin ZX, 2014, J MOL CELL CARDIOL, V72, P56, DOI 10.1016/j.yjmcc.2014.02.019; Qu JX, 2007, J MOL CELL CARDIOL, V43, P319, DOI 10.1016/j.yjmcc.2007.06.006; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosenthal E, 2001, J AM COLL CARDIOL, V38, P1524, DOI 10.1016/S0735-1097(01)01573-X; Rouine-Rapp Kathryn, 2003, Pediatr Crit Care Med, V4, P327, DOI 10.1097/01.PCC.0000075557.41987.A3; Rudemiller N, 2014, HYPERTENSION, V63, P559, DOI 10.1161/HYPERTENSIONAHA.113.02191; Ruggiero A, 2013, CARDIOVASC RES, V97, P44, DOI 10.1093/cvr/cvs294; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; Sealy W C, 1967, Ann Thorac Surg, V3, P15; SEHESTED J, 1984, SCAND J THORAC CARD, P1; Tagariello A, 2012, CURR MOL MED, V12, P199, DOI 10.2174/156652412798889027; Taguchi K, 2007, EUR J PHARMACOL, V556, P121, DOI 10.1016/j.ejphar.2006.11.026; Van Hove CE, 2009, BRIT J PHARMACOL, V158, P920, DOI 10.1111/j.1476-5381.2009.00396.x; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; WERNING C, 1969, CIRCULATION, V40, P731, DOI 10.1161/01.CIR.40.5.731; WOLINSKY H, 1967, CIRC RES, V20, P99, DOI 10.1161/01.RES.20.1.99; Wu CH, 2005, LIFE SCI, V78, P347, DOI 10.1016/j.lfs.2005.04.077; Zhang F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S7; Zwadlo C, 2006, TOXICOL APPL PHARM, V213, P224, DOI 10.1016/j.taap.2005.10.012	69	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133356	10.1371/journal.pone.0133356	http://dx.doi.org/10.1371/journal.pone.0133356			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207811	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000081
J	Li, XB; Shen, LZ; Shang, XQ; Liu, WB				Li, Xianbin; Shen, Liangzhong; Shang, Xuequn; Liu, Wenbin			Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway	PLOS ONE			English	Article							CELL LUNG-CANCER; FOCAL ADHESION KINASE; SET ENRICHMENT ANALYSIS; NF-KAPPA-B; COLORECTAL-CANCER; COLON-CANCER; GENE SET; PROGNOSTIC-SIGNIFICANCE; CIGARETTE-SMOKING; INDUCED-APOPTOSIS	Pathway analysis is a common approach to gain insight from biological experiments. Signaling-pathway impact analysis (SPIA) is one such method and combines both the classical enrichment analysis and the actual perturbation on a given pathway. Because this method focuses on a single pathway, its resolution generally is not very high because the differentially expressed genes may be enriched in a local region of the pathway. In the present work, to identify cancer-related pathways, we incorporated a recent subpathway analysis method into the SPIA method to form the "sub-SPIA method." The original subpathway analysis uses the k-clique structure to define a subpathway. However, it is not sufficiently flexible to capture subpathways with complex structure and usually results in many overlapping subpathways. We therefore propose using the minimal-spanning-tree structure to find a subpathway. We apply this approach to colorectal cancer and lung cancer datasets, and our results show that sub-SPIA can identify many significant pathways associated with each specific cancer that other methods miss. Based on the entire pathway network in the Kyoto Encyclopedia of Genes and Genomes, we find that the pathways identified by sub-SPIA not only have the largest average degree, but also are more closely connected than those identified by other methods. This result suggests that the abnormality signal propagating through them might be responsible for the specific cancer or disease.	[Li, Xianbin; Shen, Liangzhong; Liu, Wenbin] Wenzhou Univ, Dept Phys & Elect Informat Engn, Wenzhou, Zhejiang, Peoples R China; [Shang, Xuequn] Northwestern Polytech Univ, Sch Comp Sci & Technol, Xian 710072, Peoples R China	Wenzhou University; Northwestern Polytechnical University	Liu, WB (corresponding author), Wenzhou Univ, Dept Phys & Elect Informat Engn, Wenzhou, Zhejiang, Peoples R China.	wbliu6910@126.com	liu, wenbin/ABD-9826-2020	li, xianbin/0000-0001-8212-9761	National Science Foundation of China [61272018, 60970065, 61332014, 61272121]; Zhejiang Provincial Natural Science Foundation of China [R1110261, LY13F010007]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	Funding was provided by National Science Foundation of China (Grants No. 61272018(WL), No. 60970065(WL), No. 61332014(SQ), and No. 61272121(SQ)), the Zhejiang Provincial Natural Science Foundation of China (Grant No. R1110261 (WL), LY13F010007(SL)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkader I, 2005, ONCOL REP, V14, P1527; Albasri A, 2014, ANTICANCER RES, V34, P3969; Amado NG, 2014, INT J MOL SCI, V15, P12094, DOI 10.3390/ijms150712094; [Anonymous], 2013, EURO SURVEILL, V18; Argaw A, 2011, J NEUROSCI, V31, P1489, DOI 10.1523/JNEUROSCI.4134-09.2011; Astin Margaret, 2011, Br J Gen Pract, V61, pe231, DOI 10.3399/bjgp11X572427; Au NHC, 2004, J PATHOL, V204, P101, DOI 10.1002/path.1612; Baby J, 2007, CANCER LETT, V255, P85, DOI 10.1016/j.canlet.2007.03.024; Benjamini Y, 2001, ANN STAT, V29, P1165; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Cao LL, 2014, INT J ONCOL, V44, P1207, DOI 10.3892/ijo.2014.2266; Chen QY, 2011, INT J MOL MED, V28, P769, DOI 10.3892/ijmm.2011.775; Chen WS, 2011, FRONT BIOSCI-LANDMRK, V16, P1172, DOI 10.2741/3782; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Dobashi Y, 2005, PATHOL INT, V55, P95, DOI 10.1111/j.1440-1827.2005.01799.x; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Dy GK, 2014, J THORAC ONCOL, V9, P1278, DOI 10.1097/JTO.0000000000000248; Fang XC, 2013, CANCER TREAT REV, V39, P77, DOI 10.1016/j.ctrv.2012.06.001; Grossi V, 2014, WORLD J GASTROENTERO, V20, P9744, DOI 10.3748/wjg.v20.i29.9744; Gupta J, 2014, CANCER CELL, V25, P484, DOI 10.1016/j.ccr.2014.02.019; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Han JW, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0937; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Havel LS, 2015, ONCOGENE, V34, P1979, DOI 10.1038/onc.2014.123; Heffler M, 2013, CANCER BIOL THER, V14, P761, DOI 10.4161/cbt.25185; Hirashima T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-770; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Hu TH, 2014, CANCER LETT, V354, P417, DOI 10.1016/j.canlet.2014.08.012; Huang MY, 2011, ONCOL REP, V25, P1297, DOI 10.3892/or.2011.1193; Ishibashi K, 2009, SURG TODAY, V39, P1032, DOI 10.1007/s00595-009-3994-9; Jacob L, 2012, ANN APPL STAT, V6, P561, DOI 10.1214/11-AOAS528; Je EM, 2013, PATHOLOGY, V45, P645, DOI 10.1097/PAT.0000000000000007; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanaan Z, 2010, GENET TEST MOL BIOMA, V14, P347, DOI 10.1089/gtmb.2009.0197; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Khelwatty SA, 2013, FRONT BIOSCI-LANDMRK, V18, P394, DOI 10.2741/4110; Kono K, 1998, INT J CANCER, V78, P301, DOI 10.1002/(SICI)1097-0215(19981029)78:3<301::AID-IJC7>3.0.CO;2-Z; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; Koshiol J, 2011, BRIT J CANCER, V105, P320, DOI 10.1038/bjc.2011.221; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Li CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047326; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021131; Liu XX, 2013, INT J ONCOL, V43, P1925, DOI 10.3892/ijo.2013.2124; Liu ZH, 2014, INT J CLIN EXP PATHO, V7, P870; Lourenco FC, 2014, GUT, V63, P480, DOI 10.1136/gutjnl-2012-303883; Lu Xue, 2014, Oncol Lett, V7, P1992; Malusecka E, 1999, FOLIA HISTOCHEM CYTO, V37, P19; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Martini P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks866; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neradugomma NK, 2014, CARCINOGENESIS, V35, P795, DOI 10.1093/carcin/bgt379; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Pan T, 2013, ONCOL LETT, V5, P521, DOI 10.3892/ol.2012.1064; Pasto A, 2014, CANCER RES, V74, P2106, DOI 10.1158/0008-5472.CAN-13-2022; Pesson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087761; Pooja T, 2014, EUR J PHARMACOL, V742, P55, DOI 10.1016/j.ejphar.2014.08.028; Qiu X, 2012, MINERVA MED, V103, P151; Rahnenfuhrer J, 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1055, DOI 10.2202/1544-6115.1055]; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Rubinson DA, 2014, INVEST NEW DRUG, V32, P113, DOI 10.1007/s10637-013-9956-5; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Samonis G, 2003, J CLIN MICROBIOL, V41, P5820, DOI 10.1128/JCM.41.12.5820-5822.2003; Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745; Sebastian-Leon P, BMC SYST BIOL, V82014, P121; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan X, 2014, TUMOR BIOL, V35, P12189, DOI 10.1007/s13277-014-2527-3; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Varol Y, 2014, INT J TUBERC LUNG D, V18, P1121, DOI 10.5588/ijtld.14.0152; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vincenzi B, 2006, HISTOL HISTOPATHOL, V21, P423, DOI 10.14670/HH-21.423; Wang LH, 2014, BRIT J CANCER, V110, P341, DOI 10.1038/bjc.2013.752; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Warin RF, 2014, J AGR FOOD CHEM, V62, P1352, DOI 10.1021/jf405573e; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xu B, 2010, NEUROSCIENCE, V169, P932, DOI 10.1016/j.neuroscience.2010.05.025; Yao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078086; You DJ, 2014, J BIOL CHEM, V289, P17709, DOI 10.1074/jbc.M114.553552; Zheng F, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-36; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zuo L, 2013, FOOD CHEM TOXICOL, V62, P892, DOI 10.1016/j.fct.2013.10.028	88	30	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132813	10.1371/journal.pone.0132813	http://dx.doi.org/10.1371/journal.pone.0132813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207919	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000042
J	Mueller-Tribbensee, SM; Karna, M; Khalil, M; Neurath, MF; Reeh, PW; Engel, MA				Mueller-Tribbensee, Sonja M.; Karna, Manoj; Khalil, Mohammad; Neurath, Markus F.; Reeh, Peter W.; Engel, Matthias A.			Differential Contribution of TRPA1, TRPV4 and TRPM8 to Colonic Nociception in Mice	PLOS ONE			English	Article							RECEPTOR POTENTIAL VANILLOID-4; INFLAMMATORY RESPONSES; CATION CHANNEL; ION CHANNELS; SUBSTANCE-P; MOUSE COLON; VR-OAC; MENTHOL; PAIN; HYPERSENSITIVITY	Background Various transient receptor potential (TRP) channels in sensory neurons contribute to the transduction of mechanical stimuli in the colon. Recently, even the cold-sensing menthol receptor TRPM(melastatin) 8 was suggested to be involved in murine colonic mechanonociception. Methods To analyze the roles of TRPM8, TRPA1 and TRPV4 in distension-induced colonic nociception and pain, TRP-deficient mice and selective pharmacological blockers in wild-type mice (WT) were used. Visceromotor responses (VMR) to colorectal distension (CRD) in vivo were recorded and distension/pressure-induced CGRP release from the isolated murine colon ex vivo was measured by EIA. Results Distension-induced colonic CGRP release was markedly reduced in TRPA1(-/-) and TRPV4(-/-) mice at 90/150 mmHg compared to WT. In TRPM8-deficient mice the reduction was only distinct at 150 mmHg. Exposure to selective pharmacological antagonists (HC030031, 100 mu M; RN1734, 10 mu M; AMTB, 10 mu M) showed corresponding effects. The unselective TRP blocker ruthenium red (RR, 10 mu M) was as efficient in inhibiting distension-induced CGRP release as the unselective antagonists of mechanogated DEG/ENaC (amiloride, 100 mu M) and stretch-activated channels (gadolinium, 50 mu M). VMR to CRD revealed prominent deficits over the whole pressure range (up to 90 mmHg) in TRPA1(-/-) and TRPV4(-/-) but not TRPM8(-/-) mice; the drug effects of the TRP antagonists were again highly consistent with the results from mice lacking the respective TRP receptor gene. Conclusions TRPA1 and TRPV4 mediate colonic distension pain and CGRP release and appear to govern a wide and congruent dynamic range of distensions. The role of TRPM8 seems to be confined to signaling extreme noxious distension, at least in the healthy colon.	[Mueller-Tribbensee, Sonja M.; Karna, Manoj; Reeh, Peter W.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Khalil, Mohammad; Neurath, Markus F.; Engel, Matthias A.] Univ Klinikum Erlangen, Dept Med 1, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Engel, MA (corresponding author), Univ Klinikum Erlangen, Dept Med 1, Erlangen, Germany.	matthias.engel@uk-erlangen.de	Engel, Matthias/W-5831-2018; Reeh, Peter W./J-8981-2012	Reeh, Peter W./0000-0002-4367-094X	Federal Ministry of Edu. Res. [BMBF0315449C]; Marohn-Stiftung; ELAN; IZKF; Universitatsbund of the Friedrich-Alexander-Universitat Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft (DFG) [EN 1060/2-1]	Federal Ministry of Edu. Res.; Marohn-Stiftung; ELAN; IZKF; Universitatsbund of the Friedrich-Alexander-Universitat Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	P. W. R. was supported by the Federal Ministry of Edu. & Res. (BMBF0315449C); M. A. E. received support from the Marohn-Stiftung, ELAN, IZKF and Universitatsbund of the Friedrich-Alexander-Universitat Erlangen-Nurnberg and the Deutsche Forschungsgemeinschaft (DFG EN 1060/2-1).	Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Banke TG, 2011, BRAIN RES, V1381, P21, DOI 10.1016/j.brainres.2011.01.021; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Blackshaw LA, 2010, GUT, V59, P126, DOI 10.1136/gut.2009.179523; BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Brierley SM, 2010, AUTON NEUROSCI-BASIC, V153, P58, DOI 10.1016/j.autneu.2009.07.017; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Carter R, 2007, GASTROENTEROLOGY, V133, P184, DOI 10.1053/j.gastro.2007.04.042; Cattaruzza F, 2010, AM J PHYSIOL-GASTR L, V298, pG81, DOI 10.1152/ajpgi.00221.2009; Cenac N, 2008, GASTROENTEROLOGY, V135, P937, DOI 10.1053/j.gastro.2008.05.024; Chan CLH, 2003, LANCET, V361, P385, DOI 10.1016/S0140-6736(03)12392-6; Choung RS, 2011, GASTROENTEROL CLIN N, V40, P1, DOI 10.1016/j.gtc.2010.12.006; Christianson JA, 2007, NAT PROTOC, V2, P2624, DOI 10.1038/nprot.2007.392; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Davidson JB, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01651.x; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Engel MA, 2011, GASTROENTEROLOGY, V141, P1346, DOI 10.1053/j.gastro.2011.07.002; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gonlachanvit S, 2009, NEUROGASTROENT MOTIL, V21, P23, DOI 10.1111/j.1365-2982.2008.01167.x; Hamill OP, 1996, PHARMACOL REV, V48, P231; Harrington AM, 2011, PAIN, V152, P1459, DOI 10.1016/j.pain.2011.01.027; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Hosoya T, 2014, NEUROGASTROENT MOTIL, V26, P1112, DOI 10.1111/nmo.12368; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Karashima Y, 2008, PFLUG ARCH EUR J PHY, V457, P77, DOI 10.1007/s00424-008-0493-6; Kim D, 2008, AM J PHYSIOL-CELL PH, V295, pC92, DOI 10.1152/ajpcell.00023.2008; Kuhn FJP, 2009, J BIOL CHEM, V284, P4102, DOI 10.1074/jbc.M806651200; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; Loukin S, 2010, J BIOL CHEM, V285, P27176, DOI 10.1074/jbc.M110.143370; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Munaron Luca, 2011, World J Biol Chem, V2, P59, DOI 10.4331/wjbc.v2.i4.59; Pedersen SF, 2006, AM J PHYSIOL-CELL PH, V291, pC1286, DOI 10.1152/ajpcell.00325.2005; Poole DP, 2011, GASTROENTEROLOGY, V141, P565, DOI 10.1053/j.gastro.2011.04.049; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Roza C, 2001, PAIN, V93, P213, DOI 10.1016/S0304-3959(01)00318-9; Sipe WEB, 2008, AM J PHYSIOL-GASTR L, V294, pG1288, DOI 10.1152/ajpgi.00002.2008; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002; Wrigley PJ, 2009, BRIT J PHARMACOL, V157, P371, DOI 10.1111/j.1476-5381.2009.00167.x; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008	56	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0128242	10.1371/journal.pone.0128242	http://dx.doi.org/10.1371/journal.pone.0128242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207981	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000003
J	Placencio, VR; Ichimura, A; Miyata, T; DeClerck, YA				Placencio, Veronica R.; Ichimura, Atsuhiko; Miyata, Toshio; DeClerck, Yves A.			Small Molecule Inhibitors of Plasminogen Activator Inhibitor-1 Elicit Anti-Tumorigenic and Anti-Angiogenic Activity	PLOS ONE			English	Article							TUMOR PROGRESSION; PAI-1 DEFICIENCY; MECHANISM; APOPTOSIS; TYPE-1; CELLS	Numerous studies have shown a paradoxical positive correlation between elevated levels of plasminogen activator inhibitior-1 (PAI-1) in tumors and blood of cancer patients with poor clinical outcome, suggesting that PAI-1 could be a therapeutic target. Here we tested two orally bioavailable small molecule inhibitors of PAI-1 (TM5275 and TM5441) for their efficacy in pre-clinical models of cancer. We demonstrated that these inhibitors decreased cell viability in several human cancer cell lines with an IC50 in the 9.7 to 60.3 mu M range and induced intrinsic apoptosis at concentrations of 50 mu M. In vivo, oral administration of TM5441 (20 mg/kg daily) to HT1080 and HCT116 xenotransplanted mice increased tumor cell apoptosis and had a significant disruptive effect on the tumor vasculature that was associated with a decrease in tumor growth and an increase in survival that, however, were not statistically significant. Pharmacokinetics studies indicated an average peak plasma concentration of 11.4 mu M one hour after oral administration and undetectable levels 23 hours after administration. The effect on tumor vasculature in vivo was further examined in endothelial cells (EC) in vitro and this analysis indicated that both TM5275 and TM5441 inhibited EC branching in a 3D Matrigel assay at concentrations where they had little effect on EC apoptosis. These studies bring novel insight on the activity of PAI-1 inhibitors and provide important information for the future design of inhibitors targeting PAI-1 as therapeutic agents in cancer.	[Placencio, Veronica R.; DeClerck, Yves A.] Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Bone Marrow Transplan, Los Angeles, CA 90089 USA; [Placencio, Veronica R.; DeClerck, Yves A.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Ichimura, Atsuhiko; Miyata, Toshio] Tohoku Univ, Grad Sch Med, Miyagi, Japan; [DeClerck, Yves A.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California; Children's Hospital Los Angeles; Tohoku University; University of Southern California	DeClerck, YA (corresponding author), Univ So Calif, Dept Pediat, Div Hematol Oncol & Blood & Bone Marrow Transplan, Los Angeles, CA 90089 USA.	declerck@usc.edu	Miyata, Toshio/A-4872-2010	Ichimura, Atsuhiko/0000-0003-0366-5211; DeClerck, Yves/0000-0002-3688-0113	NIH [5 R01 CA 129377]; NATIONAL CANCER INSTITUTE [R01CA129377] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH 5 R01 CA 129377 to YAD and VRP.	Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Chen YB, 2004, J CELL BIOCHEM, V92, P178, DOI 10.1002/jcb.20058; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; Fang H, 2012, JNCI-J NATL CANCER I, V104, P1470, DOI 10.1093/jnci/djs377; Fay WP, 1997, BLOOD, V90, P204; Foekens JA, 2000, CANCER RES, V60, P636; Fortenberry YM, 2013, EXPERT OPIN THER PAT, V23, P801, DOI 10.1517/13543776.2013.782393; Gomes-Giacoia E, 2013, MOL CANCER THER, V12, P2697, DOI 10.1158/1535-7163.MCT-13-0500; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Huang WT, 2012, AM J RESP CELL MOL, V46, P87, DOI 10.1165/rcmb.2011-0139OC; Isogai C, 2001, CANCER RES, V61, P5587; Iwaki T, 2012, THROMB RES, V129, pE161, DOI 10.1016/j.thromres.2011.10.008; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Lademann UA, 2008, THROMB HAEMOSTASIS, V100, P1041, DOI 10.1160/TH08-04-0266; Mashiko S, 2015, CANC BIOL THER; Masuda T, 2013, MOL CANCER THER, V12, P2378, DOI 10.1158/1535-7163.MCT-13-0041; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mouchess ML, 2006, J COMPUT ASSIST TOMO, V30, P525, DOI 10.1097/00004728-200605000-00030; Pelisch N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124510; Placencio VR, 2015, CANC RES; R Core Team, 2014, LANG ENV STAT COMP; Rossignol P, 2006, J THROMB HAEMOST, V4, P664, DOI 10.1111/j.1538-7836.2005.01765.x; Schneider DJ, 2008, THROMB HAEMOSTASIS, V100, P1037, DOI 10.1160/TH08-04-0234; StataCorp, 2021, STATA STAT SOFTWARE; Van de Craen B, 2012, THROMB RES, V130, P576, DOI 10.1016/j.thromres.2012.06.023; Vercauteren E, 2012, J THROMB HAEMOST, V10, P2555, DOI 10.1111/jth.12036; Yamaoka N, 2011, CHEM PHARM BULL, V59, P215, DOI 10.1248/cpb.59.215; Zoellner H, 1998, THROMB RES, V91, P209, DOI 10.1016/S0049-3848(98)00087-5	37	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133786	10.1371/journal.pone.0133786	http://dx.doi.org/10.1371/journal.pone.0133786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207899	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000142
J	Xie, Y; Liu, SF; Zhao, YF; Zhang, L; Zhao, Y; Liu, BH; Guo, ZJ				Xie, Ying; Liu, Shufeng; Zhao, Yufei; Zhang, Lan; Zhao, Yue; Liu, Binghui; Guo, Zhanjun			Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							PROMOTER MUTATIONS; VIRAL LOAD; RISK; GENOTYPE; CORE; EPIDEMIOLOGY; CARRIERS; LEVEL	Hepatitis B virus (HBV) DNA is prone to mutations because of the proofreading deficiencies of HBV polymerase. We have identified hepatocellular carcinoma (HCC) survival-associated HBV mutations in the X protein region of HBV DNA. In the present study, we extend our research to assess HCC survival-associated HBV mutations in the HBV precore/core (PreC/C) region. The PreC/C region was amplified and sequenced and the HBV mutations were identified according to the NCBI database (http://www.ncbi.nlm.nih.gov/genome/5536). The relationships between the mutations in the PreC/C region and HCC survival were analyzed. Survival curves were generated using the Kaplan-Meier method, and comparisons between the curves were made using the log-rank test. Multivariate survival analysis was performed using a Cox proportional hazards model. After adjusting for clinical characteristics, the 1915, 2134, 2221, 2245 and 2288 mutational sites were identified as statistically significant independent predictors of HCC survival by multivariate survival analysis using a Cox proportional hazards model. In addition, the mutational site of 1896 was identified for its association with survival at a borderline significance level. A total of five mutations in the precore/core region were identified as independent predictors of postoperative survival in HCC patients. The analysis of HBV DNA mutations may help identify patient subgroups with poor prognosis and may help refine therapeutic decisions regarding HCC patients.	[Xie, Ying; Liu, Shufeng; Liu, Binghui] Hebei Med Univ, Hebei Key Lab Lab Anim Sci, Shijiazhuang, Hebei Province, Peoples R China; [Zhao, Yufei; Zhang, Lan; Zhao, Yue; Guo, Zhanjun] Hebei Med Univ, Hosp 4, Dept Gastroenterol & Hepatol, Shijiazhuang, Peoples R China; [Xie, Ying] Peking Union Med Coll, Inst Lab Anim Sci, Beijing, Peoples R China	Hebei Medical University; Hebei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Peking Union Medical College	Guo, ZJ (corresponding author), Hebei Med Univ, Hosp 4, Dept Gastroenterol & Hepatol, Shijiazhuang, Peoples R China.	zjguo5886@aliyun.com			Key basic research program of Hebei [14967713D]; Construction Program of Hebei Scientific Conditions [13967607D]	Key basic research program of Hebei; Construction Program of Hebei Scientific Conditions	ZG was supported by Key basic research program of Hebei (14967713D), and SL was supported by the Construction Program of Hebei Scientific Conditions (13967607D). But these funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen JS, 2007, J CLIN VIROL, V38, P238, DOI 10.1016/j.jcv.2006.12.007; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Jang JW, 2012, CANCER SCI, V103, P296, DOI 10.1111/j.1349-7006.2011.02170.x; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; Lin CL, 2007, J GASTROEN HEPATOL, V22, P1098, DOI 10.1111/j.1440-1746.2006.04515.x; Liu CJ, 2006, J INFECT DIS, V194, P594, DOI 10.1086/505883; Liu CJ, 2006, J INFECT DIS, V193, P1258, DOI 10.1086/502978; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Maki A, 2007, ANN SURG ONCOL, V14, P1182, DOI 10.1245/s10434-006-9049-1; Minagawa M, 2003, ANN SURG, V238, P703, DOI 10.1097/01.sla.0000094549.11754.e6; OKADA S, 1994, GASTROENTEROLOGY, V106, P1618, DOI 10.1016/0016-5085(94)90419-7; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Wang CJ, 2011, BIOCHEM BIOPH RES CO, V406, P493, DOI 10.1016/j.bbrc.2011.02.088; Xie Y, 2014, TUMOR BIOL, V35, P10325, DOI 10.1007/s13277-014-2331-0; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yousif M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095377; Yu MC, 2000, CAN J GASTROENTEROL, V14, P703, DOI 10.1155/2000/371801; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Zheng JX, 2011, J VIRAL HEPATITIS, V18, pE423, DOI 10.1111/j.1365-2893.2011.01458.x	22	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133393	10.1371/journal.pone.0133393	http://dx.doi.org/10.1371/journal.pone.0133393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208136	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000085
J	Harini, K; Sowdhamini, R				Harini, K.; Sowdhamini, Ramanathan			Computational Approaches for Decoding Select Odorant-Olfactory Receptor Interactions Using Mini-Virtual Screening	PLOS ONE			English	Article							AUTOMATED DOCKING; MOLECULAR-BASIS; EXPRESSION; PROTEINS; MODEL; DISCRIMINATION; IDENTIFICATION; SPECIFICITY; SIMILARITY; ALDEHYDES	Olfactory receptors (ORs) belong to the class A G-Protein Coupled Receptor superfamily of proteins. Unlike G-Protein Coupled Receptors, ORs exhibit a combinatorial response to odors/ligands. ORs display an affinity towards a range of odor molecules rather than binding to a specific set of ligands and conversely a single odorant molecule may bind to a number of olfactory receptors with varying affinities. The diversity in odor recognition is linked to the highly variable transmembrane domains of these receptors. The purpose of this study is to decode the odor-olfactory receptor interactions using in silico docking studies. In this study, a ligand (odor molecules) dataset of 125 molecules was used to carry out in silico docking using the GLIDE docking tool (SCHRODINGER Inc Pvt LTD). Previous studies, with smaller datasets of ligands, have shown that orthologous olfactory receptors respond to similarly-tuned ligands, but are dramatically different in their efficacy and potency. Ligand docking results were applied on homologous pairs (with varying sequence identity) of ORs from human and mouse genomes and ligand binding residues and the ligand profile differed among such related olfactory receptor sequences. This study revealed that homologous sequences with high sequence identity need not bind to the same/ similar ligand with a given affinity. A ligand profile has been obtained for each of the 20 receptors in this analysis which will be useful for expression and mutation studies on these receptors.	[Harini, K.; Sowdhamini, Ramanathan] Natl Ctr Biol Sci TIFR, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Sowdhamini, R (corresponding author), Natl Ctr Biol Sci TIFR, GKVK Campus,Bellary Rd, Bangalore, Karnataka, India.	mini@ncbs.res.in			Indo-Japan Department of Biotechnology Grant [BT/IC/Japan (BI)/01/2010]	Indo-Japan Department of Biotechnology Grant	KH was funded by Indo-Japan Department of Biotechnology Grant (BT/IC/Japan (BI)/01/2010).	Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200; Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Baud O, 2011, BIOCHEMISTRY-US, V50, P843, DOI 10.1021/bi1017396; Bavan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092064; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; Bolton EE, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-32; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brodin M, 2009, CHEM SENSES, V34, P625, DOI 10.1093/chemse/bjp044; CAIN WS, 1974, ANN NY ACAD SCI, V237, P427, DOI 10.1111/j.1749-6632.1974.tb49876.x; Charlier L, 2012, CELL MOL LIFE SCI, V69, P4205, DOI 10.1007/s00018-012-1116-0; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Cometto-Muniz JE, 2010, CHEM SENSES, V35, P289, DOI 10.1093/chemse/bjq018; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Floriano WB, 2000, P NATL ACAD SCI USA, V97, P10712, DOI 10.1073/pnas.97.20.10712; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Gromiha MM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S1; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Harini K, 2012, BIOINFORM BIOL INSIG, V6, P33, DOI 10.4137/BBI.S8990; Harini K, 2012, J MOL BIOCHEM, P1; Hindle SA, 2002, J COMPUT AID MOL DES, V16, P129, DOI 10.1023/A:1016399411208; JORGENSEN WL, 1991, SCIENCE, V254, P954, DOI 10.1126/science.1719636; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; KOSHLAND DE, 1963, SCIENCE, V142, P1533, DOI 10.1126/science.142.3599.1533; Krautwurst D, 2008, CHEM BIODIVERS, V5, P842, DOI 10.1002/cbdv.200890099; Krautwurst Dietmar, 2013, Methods Mol Biol, V1003, P85, DOI 10.1007/978-1-62703-377-0_6; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kurland MD, 2010, BIOCHEMISTRY-US, V49, P6302, DOI 10.1021/bi100976w; Lai Peter C., 2012, Frontiers in Genetics, V3, P61, DOI 10.3389/fgene.2012.00061; Madala PK, 2012, J CHEM INF MODEL, V52, P1401, DOI 10.1021/ci2005498; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Mathew D, 2013, P NATL ACAD SCI USA, V110, pE2134, DOI 10.1073/pnas.1306976110; Meier R, 2010, J CHEM INF MODEL, V50, P879, DOI 10.1021/ci900467x; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagarathnam B, 2014, BIOINFORM BIOL INSIG, V8, P147, DOI 10.4137/BBI.S14858; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; Niimura Y, 2005, GENE, V346, P13, DOI 10.1016/j.gene.2004.09.025; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Perola E, 2004, PROTEINS, V56, P235, DOI 10.1002/prot.20088; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schmuker M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-11; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Singer MS, 2000, CHEM SENSES, V25, P155, DOI 10.1093/chemse/25.2.155; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Topin J, 2014, CHEM-EUR J, V20, P10227, DOI 10.1002/chem.201402486; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211	70	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131077	10.1371/journal.pone.0131077	http://dx.doi.org/10.1371/journal.pone.0131077			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221959	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800012
J	Spotswood, EN; Bartolome, JW; Allen-Diaz, B				Spotswood, Erica N.; Bartolome, James W.; Allen-Diaz, Barbara			Hotspots of Community Change: Temporal Dynamics Are Spatially Variable in Understory Plant Composition of a California Oak Woodland	PLOS ONE			English	Article							BETA DIVERSITY; CLIMATE-CHANGE; VARIABILITY; HETEROGENEITY; BIODIVERSITY; STABILITY; RESPONSES; PATTERNS; DRIVERS; PRODUCTIVITY	Community response to external drivers such climate and disturbance can lead to fluctuations in community composition, or to directional change. Temporal dynamics can be influenced by a combination of drivers operating at multiple spatial scales, including external landscape scale drivers, local abiotic conditions, and local species pools. We hypothesized that spatial variation in these factors can create heterogeneity in temporal dynamics within landscapes. We used understory plant species composition from an 11 year dataset from a California oak woodland to compare plots where disturbance was experimentally manipulated with the removal of livestock grazing and a prescribed burn. We quantified three properties of temporal variation: compositional change (reflecting the appearance and disappearance of species), temporal fluctuation, and directional change. Directional change was related most strongly to disturbance type, and was highest at plots where grazing was removed during the study. Temporal fluctuations, compositional change, and directional change were all related to intrinsic abiotic factors, suggesting that some locations are more responsive to external drivers than others. Temporal fluctuations and compositional change were linked to local functional composition, indicating that environmental filters can create subsets of the local species pool that do not respond in the same way to external drivers. Temporal dynamics are often assumed to be relatively static at the landscape scale, provided disturbance and climate are continuous. This study shows that local and landscape scale factors jointly influence temporal dynamics creating hotspots that are particularly responsive to climate and disturbance. Thus, adequate predictions of response to disturbance or to changing climate will only be achieved by considering how factors at multiple spatial scales influence community resilience and recovery.	[Spotswood, Erica N.; Bartolome, James W.; Allen-Diaz, Barbara] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Allen-Diaz, Barbara] Univ Calif, Dept Agr & Nat Resources, Oakland, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Spotswood, EN (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	espots@berkeley.edu			Integrated Hardwood Management Program; University of California Department of Agriculture and Natural Resources	Integrated Hardwood Management Program; University of California Department of Agriculture and Natural Resources(University of California System)	This project was funded primarily through the Integrated Hardwood Management Program which is a program with the University of California Department of Agriculture and Natural Resources (http://ucanr.edu/sites/oak_range/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Adler PB, 2008, AM NAT, V172, pE186, DOI 10.1086/591678; Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Bartolome JW, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P367; BARTOLOME JW, 1979, J ECOL, V67, P273, DOI 10.2307/2259350; Beckman NG, 2013, BIOTROPICA, V45, P666, DOI 10.1111/btp.12071; Bretz F., 2011, MULTIPLE COMPARISONS; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Collins SL, 2015, AM NAT, V185, pE30, DOI 10.1086/679315; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; D'Antonio C, 2000, ECOLOGY RESTORATION; Elmendorf SC, 2011, ECOLOGY, V92, P602, DOI 10.1890/10-0535.1; Fernandez-Going BM, 2012, ECOLOGY, V93, P2104, DOI 10.1890/11-2003.1; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Gaertner M, 2012, RESTOR ECOL, P265, DOI [10.1002/9781118223130.CH20, DOI 10.1002/9781118223130.CH20]; Gea-Izquierdo G, 2007, APPL VEG SCI, V10, P343, DOI 10.1111/j.1654-109X.2007.tb00433.x; George M, 2001, ANR PUBLICATION; Geroy IJ, 2011, HYDROL PROCESS, V25, P3836, DOI 10.1002/hyp.8281; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Grime JP, 2008, P NATL ACAD SCI USA, V105, P10028, DOI 10.1073/pnas.0711567105; Hallett LM, 2014, ECOLOGY, V95, P1693, DOI 10.1890/13-0895.1; He NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026506; HEADY HAROLD F., 1959, JOUR RANGE MANAGEMENT, V12, P180, DOI 10.2307/3894848; HEADY HF, 1958, ECOLOGY, V39, P402, DOI 10.2307/1931750; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jackson RD, 2002, PLANT ECOL, V162, P49, DOI 10.1023/A:1020363603900; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Korhonen JJ, 2010, ECOLOGY, V91, P508, DOI 10.1890/09-0392.1; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Lewis D, 2000, J HYDROL, V240, P106, DOI 10.1016/S0022-1694(00)00337-1; Mariotte P, 2013, BASIC APPL ECOL, V14, P217, DOI 10.1016/j.baae.2013.02.003; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Morecroft MD, 2012, J APPL ECOL, V49, P547, DOI [10.1111/j.1365-2664.2012.02136.x, 10.1111/j.1365-2664.2012.02147.x]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; NOYMEIR I, 1989, J ECOL, V77, P290, DOI 10.2307/2260930; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; R Core Team, 2018, R LANG ENV STAT COMP; Seabloom EW, 2005, ECOL MONOGR, V75, P199, DOI 10.1890/03-0841; Stahlheber KA, 2013, BIOL CONSERV, V157, P300, DOI 10.1016/j.biocon.2012.09.008; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Thibault KM, 2004, ECOLOGY, V85, P2649, DOI 10.1890/04-0321; Troeh F.R., 1993, SOILS SOIL FERTILITY, VFifth edition; VANDERMAAREL E, 1993, J VEG SCI, V4, P179, DOI 10.2307/3236103; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; White EP, 2010, PHILOS T R SOC B, V365, P3633, DOI 10.1098/rstb.2010.0280; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yoshioka PM, 2008, MAR ECOL PROG SER, V368, P309, DOI 10.3354/meps07728; Zuur Alain F., 2009, P1	66	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133501	10.1371/journal.pone.0133501	http://dx.doi.org/10.1371/journal.pone.0133501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222069	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800053
J	Uddin, GMN; Larsen, MH; Barco, L; Phu, TM; Dalsgaard, A				Uddin, Gazi Md. Noor; Larsen, Marianne Halberg; Barco, Lisa; Tran Minh Phu; Dalsgaard, Anders			Clonal Occurrence of Salmonella Weltevreden in Cultured Shrimp in the Mekong Delta, Vietnam	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; IMPORTED FOODS; SEROVARS; SEAFOOD; HUMANS; FISH; PREVALENCE; PROTOCOLS; PULSENET	This study investigated the occurrence, serovar and antimicrobial resistance of Salmonella spp. in shrimp samples from intensive and extensive farms located in three different provinces in the Mekong Delta, Vietnam. Shrimp from 11 of the 48 farms all contained S. Weltevreden, except for one farm yielding S. Agona, with no difference in Salmonella occurrence between the two production systems. Pulsed field gel electrophoresis (PFGE) of S. Weltevreden showed closely related XbaI pulse types, suggesting a clonal relationship despite the farms and shrimp samples being epidemiologically unrelated. S. Weltevreden was susceptible to most antimicrobials tested, with a few strains being resistant to florfenicol, chloramphenicol, sulfamethoxazole or trimethoprim. Future studies of the ecology of S. Weltevreden should establish if this serovar may survive better and even multiply in warm-water shrimp farm environments compared to other Salmonella serovars.	[Uddin, Gazi Md. Noor; Larsen, Marianne Halberg; Dalsgaard, Anders] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Barco, Lisa] Ist Zooprofilatt Sperimentale Venezie, World Org Anim Hlth OIE, Natl Reference Lab Salmonella, Padua, Italy; [Tran Minh Phu] Can Tho Univ, Coll Aquaculture & Fisheries, Can Tho City, Vietnam	University of Copenhagen; IZS delle Venezie; Can Tho University	Dalsgaard, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark.	adal@sund.ku.dk	; Barco, Lisa/K-2284-2016	Larsen, Marianne Halberg/0000-0001-6242-6937; Tran, Minh Phu/0000-0002-2521-0667; Barco, Lisa/0000-0002-6247-248X	University of Copenhagen; EU [222889]	University of Copenhagen; EU(European Commission)	This study was funded by the University of Copenhagen through a PhD fellowship to G.M.N. Uddin. The work presented is also part of and supported by the EU funded project "Sustaining Ethical Aquaculture Trade" (SEAT project no 222889: www.seatglobal.eu).	AABO S, 1993, MOL CELL PROBE, V7, P171, DOI 10.1006/mcpr.1993.1026; Aarestrup FM, 2003, J ANTIMICROB CHEMOTH, V52, P715, DOI 10.1093/jac/dkg426; Amagliani G, 2012, FOOD RES INT, V45, P780, DOI 10.1016/j.foodres.2011.06.022; [Anonymous], 2007, ANIMAL FECES AND IN; Arcangioli MA, 1999, FEMS MICROBIOL LETT, V174, P327, DOI 10.1016/S0378-1097(99)00161-5; Asai Y, 2008, J FOOD PROTECT, V71, P1460, DOI 10.4315/0362-028X-71.7.1460; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Center for Disease Control and Prevention, 2014, DRINKING WATER; Clinical and Laboratory Standard Institute, 2012, CLSI DOCUMENT M100 S; Clinical and Laboratory Standard Institute, 2008, CLSI DOCUMENT M31A3; Food and Agriculture Organization of the United Nations, 2010, FAO EXPERT WORKSHOP; Heinitz ML, 2000, J FOOD PROTECT, V63, P579, DOI 10.4315/0362-028X-63.5.579; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Jackson BR, 2013, EMERG INFECT DIS, V19, P1239, DOI 10.3201/eid1908.121511; Joseph B, 2001, INT J FOOD MICROBIOL, V64, P367, DOI 10.1016/S0168-1605(00)00466-9; Koonse B, 2005, J FOOD PROTECT, V68, P2527, DOI 10.4315/0362-028X-68.12.2527; Kumar R, 2009, J APPL MICROBIOL, V106, P515, DOI 10.1111/j.1365-2672.2008.04020.x; Kumar R, 2008, LETT APPL MICROBIOL, V46, P221, DOI 10.1111/j.1472-765X.2007.02286.x; Martinez-Urtaza J, 2004, APPL ENVIRON MICROB, V70, P2089, DOI 10.1128/AEM.70.4.2089-2097.2004; Nesse LL, 2005, EPIDEMIOL INFECT, V133, P53, DOI 10.1017/S0950268804003279; Ogasawara N, 2008, J VET MED SCI, V70, P1159, DOI 10.1292/jvms.70.1159; Pal A, 2009, FOOD MICROBIOL, V26, P317, DOI 10.1016/j.fm.2008.12.003; Parente L. S., 2011, Brazilian Journal of Veterinary Research and Animal Science, V48, P46; Phan LT, 2011, SEAT DELIVERABLE; Phan TT, 2005, J FOOD PROTECT, V68, P1077, DOI 10.4315/0362-028X-68.5.1077; Ponce E, 2008, FOOD MICROBIOL, V25, P29, DOI 10.1016/j.fm.2007.09.001; Rahimi E., 2013, Comparative Clinical Pathology, V22, P59, DOI 10.1007/s00580-011-1368-3; Ribeiro RV, 2010, LETT APPL MICROBIOL, V51, P611, DOI 10.1111/j.1472-765X.2010.02946.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Simental L, 2008, APPL ENVIRON MICROB, V74, P5918, DOI 10.1128/AEM.01139-08; de Carvalho FCT, 2009, REV CIENC AGRON, V40, P549; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2011, THE DANISH INTEGRATE, P67; Thong KL, 2002, J CLIN MICROBIOL, V40, P2498, DOI 10.1128/JCM.40.7.2498-2503.2002; Vo ATT, 2006, VET MICROBIOL, V113, P153, DOI 10.1016/j.vetmic.2005.10.034; Weill F, 2007, WHO COLLAB ORATING C; Yam WC, 2000, WATER RES, V34, P51, DOI 10.1016/S0043-1354(99)00105-0; Yasin Rohani M., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P457; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500; Zhao SH, 2003, INT J FOOD MICROBIOL, V84, P87, DOI 10.1016/S0168-1605(02)00402-6	40	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134252	10.1371/journal.pone.0134252	http://dx.doi.org/10.1371/journal.pone.0134252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222547	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800117
J	de Souza, BM; Michels, M; Sortica, DA; Boucas, AP; Rheinheimer, J; Buffon, MP; Bauer, AC; Canani, LH; Crispim, D				de Souza, Bianca Marmontel; Michels, Marcus; Sortica, Denise Alves; Boucas, Ana Paula; Rheinheimer, Jakeline; Buffon, Marjorie Piuco; Bauer, Andrea Carla; Canani, Luis Henrique; Crispim, Daisy			Polymorphisms of the UCP2 Gene Are Associated with Glomerular Filtration Rate in Type 2 Diabetic Patients and with Decreased UCP2 Gene Expression in Human Kidney	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2; HIGH GLUCOSE; OBESITY; RISK; DISEASE; PCR; COMPLICATIONS; NEPHROPATHY; RETINOPATHY; METABOLISM	Introduction Uncoupling protein 2 (UCP2) reduces production of reactive oxygen species (ROS) by mitochondria. ROS overproduction is one of the major contributors to the pathogenesis of chronic diabetic complications, such as diabetic kidney disease (DKD). Thus, deleterious polymorphisms in the UCP2 gene are candidate risk factors for DKD. In this study, we investigated whether UCP2 -866G/A, Ala55Val and Ins/Del polymorphisms were associated with DKD in patients with type 2 diabetes mellitus (T2DM), and whether they had an effect on UCP2 gene expression in human kidney tissue biopsies. Materials and Methods In a case-control study, frequencies of the UCP2 -866G/A, Ala55Val and Ins/Del polymorphisms as well as frequencies of the haplotypes constituted by them were analyzed in 287 T2DM patients with DKD and 281 T2DM patients without this complication. In a cross-sectional study, UCP2 gene expression was evaluated in 42 kidney biopsy samples stratified according to the presence of the UCP2 mutated -866A/55Val/Ins haplotype. Results In the T2DM group, multivariate logistic regression analysis showed that the -866A/55Val/Ins haplotype was an independent risk factor for DKD (OR = 2.136, 95% CI 1.036-4.404), although neither genotype nor allele frequencies of the individual polymorphisms differed between case and control groups. Interestingly, T2DM patients carrying the mutated haplotype showed decreased estimated glomerular filtration rate (eGFR) when compared to subjects with the reference haplotype (adjusted P=0.035). In kidney biopsy samples, UCP2 expression was significantly decreased in UCP2 mutated haplotype carriers when compared to kidneys from patients with the reference haplotype (0.32 +/- 1.20 vs. 1.85 +/- 1.16 n fold change; adjusted P<0.000001). Discussion Data reported here suggest that the UCP2 -866A/55Val/Ins haplotype is associated with an increased risk for DKD and with a lower eGFR in T2DM patients. Furthermore, this mutated haplotype was associated with decreased UCP2 gene expression in human kidneys.	[de Souza, Bianca Marmontel; Michels, Marcus; Sortica, Denise Alves; Boucas, Ana Paula; Rheinheimer, Jakeline; Buffon, Marjorie Piuco; Bauer, Andrea Carla; Canani, Luis Henrique; Crispim, Daisy] Hosp Clin Porto Alegre, Div Endocrine, Porto Alegre, RS, Brazil; [de Souza, Bianca Marmontel; Sortica, Denise Alves; Boucas, Ana Paula; Rheinheimer, Jakeline; Buffon, Marjorie Piuco; Canani, Luis Henrique; Crispim, Daisy] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Crispim, D (corresponding author), Hosp Clin Porto Alegre, Div Endocrine, Porto Alegre, RS, Brazil.	dcmoreira@hcpa.edu.br	Canani, Luis H/G-9686-2012; Bauer, Andrea C/I-7813-2015; Crispim, Daisy/R-5170-2019	Canani, Luis H/0000-0002-1813-4491; Bauer, Andrea C/0000-0002-5041-4792; Crispim, Daisy/0000-0001-5095-9269; Silva Michels, Marcus/0000-0001-6737-7142; Boucas, Ana Paula/0000-0002-1563-1513	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at Hospital de Clinicas de Porto Alegre; CNPq	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at Hospital de Clinicas de Porto Alegre; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was partially supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES) and Fundo de Incentivo a Pesquisa e Eventos (FIPE) at Hospital de Clinicas de Porto Alegre. D Crispim and LH Canani are recipients of scholarships from CNPq.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Brondani LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096411; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Camargo JL, 1998, SCAND J CLIN LAB INV, V58, P521, DOI 10.1080/00365519850186337; Canani LH, 1999, DIABETES, V48, P909, DOI 10.2337/diabetes.48.4.909; Canani LH, 2005, DIABETES, V54, P3326, DOI 10.2337/diabetes.54.11.3326; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; Carpena MP, 2010, ARQ BRAS ENDOCRINOL, V54, P253, DOI 10.1590/S0004-27302010000300002; Cassell PG, 1999, DIABETOLOGIA, V42, P688, DOI 10.1007/s001250051216; Chen XL, 2014, RENAL FAILURE, V36, P1298, DOI 10.3109/0886022X.2014.930650; Crispim D, 2010, CLIN ENDOCRINOL, V72, P612, DOI 10.1111/j.1365-2265.2009.03684.x; Cui Y, 2006, EXP EYE RES, V83, P807, DOI 10.1016/j.exer.2006.03.024; Dalgaard LT, 2011, J OBES, V2011, DOI 10.1155/2011/340241; de Souza BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054259; de Souza BM, 2012, EXP EYE RES, V94, P49, DOI 10.1016/j.exer.2011.11.004; de Souza BM, 2011, ARQ BRAS ENDOCRINOL, V55, P239, DOI 10.1590/S0004-27302011000400001; Dhamrait SS, 2004, EUR HEART J, V25, P468, DOI 10.1016/j.ehj.2004.01.007; Donadelli M, 2014, CELL MOL LIFE SCI, V71, P1171, DOI 10.1007/s00018-013-1407-0; Doria A, 2010, CURR DIABETES REP, V10, P467, DOI 10.1007/s11892-010-0147-x; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Erlanson-Albertsson C, 2002, NUTR NEUROSCI, V5, P1, DOI 10.1080/10284150290007038; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Fisler JS, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-38; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Friederich M, 2008, BIOCHIM BIOPHYS ACTA, P7; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; He Y, 2014, INT J MOL MED, V33, P1275, DOI 10.3892/ijmm.2014.1676; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jia JJ, 2009, OBES REV, V10, P519, DOI 10.1111/j.1467-789X.2009.00569.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT, V3, pS1; Lindholm E, 2004, J DIABETES COMPLICAT, V18, P103, DOI 10.1016/S1056-8727(03)00019-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oberkofler H, 2005, ARTERIOSCL THROM VAS, V25, P604, DOI 10.1161/01.ATV.0000153141.42033.22; Oberkofler H, 1997, J LIPID RES, V38, P2125; Pezzolesi MG, 2013, MED CLIN N AM, V97, P91, DOI 10.1016/j.mcna.2012.10.005; Qiu WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041391; Rich SS, 2006, J AM SOC NEPHROL, V17, P353, DOI 10.1681/ASN.2005070770; Ritz E, 2011, CONTRIB NEPHROL, V170, P19, DOI 10.1159/000324939; Rudofsky G, 2006, DIABETES CARE, V29, P89, DOI 10.2337/diacare.29.01.06.dc05-0757; Rudofsky G, 2007, HORM METAB RES, V39, P306, DOI 10.1055/s-2007-973816; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tripath G, 2008, CLIN BIOCHEM, V41, P525, DOI 10.1016/j.clinbiochem.2008.01.009; Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431; Wang H, 2004, AM J PHYSIOL-ENDOC M, V286, pE1, DOI 10.1152/ajpendo.00231.2003; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Zelmanovitz T, 1997, DIABETES CARE, V20, P516, DOI 10.2337/diacare.20.4.516; Zelmanovitz T, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-10	49	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132938	10.1371/journal.pone.0132938	http://dx.doi.org/10.1371/journal.pone.0132938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218518	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900016
J	Doppler, K; Appeltshauser, L; Kramer, HH; Ng, JKM; Meinl, E; Villmann, C; Brophy, P; Dib-Hajj, SD; Waxman, SG; Weishaupt, A; Sommer, C				Doppler, Kathrin; Appeltshauser, Luise; Kraemer, Heidrun H.; Ng, Judy King Man; Meinl, Edgar; Villmann, Carmen; Brophy, Peter; Dib-Hajj, Sulayman D.; Waxman, Stephen G.; Weishaupt, Andreas; Sommer, Claudia			Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy	PLOS ONE			English	Article							ANTIBODIES	Multifocal motor neuropathy is an immune mediated disease presenting with multifocal muscle weakness and conduction block. IgM auto-antibodies against the ganglioside GM1 are detectable in about 50% of the patients. Auto-antibodies against the paranodal proteins contactin-1 and neurofascin-155 and the nodal protein neurofascin-186 have been detected in subgroups of patients with chronic inflammatory demyelinating polyneuropathy. Recently, auto-antibodies against neurofascin-186 and gliomedin were described in more than 60% of patients with multifocal motor neuropathy. In the current study, we aimed to validate this finding, using a combination of different assays for auto-antibody detection. In addition we intended to detect further auto-antibodies against paranodal proteins, specifically contactin-1 and neurofascin-155 in multifocal motor neuropathy patients' sera. We analyzed sera of 33 patients with well-characterized multifocal motor neuropathy for IgM or IgG anti-contactin-1, anti-neurofascin-155 or -186 antibodies using enzyme-linked immunosorbent assay, binding assays with transfected human embryonic kidney 293 cells and murine teased fibers. We did not detect any IgM or IgG auto-antibodies against contactin-1, neurofascin-155 or -186 in any of our multifocal motor neuropathy patients. We conclude that autoantibodies against contactin-1, neurofascin-155 and -186 do not play a relevant role in the pathogenesis in this cohort with multifocal motor neuropathy.	[Doppler, Kathrin; Appeltshauser, Luise; Weishaupt, Andreas; Sommer, Claudia] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Kraemer, Heidrun H.] Univ Hosp Giessen, Dept Neurol, Giessen, Germany; [Ng, Judy King Man; Meinl, Edgar] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany; [Villmann, Carmen] Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Brophy, Peter] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Adm Med Ctr, Ctr Neurosci & Regenerat Res, West Haven, CT 06516 USA	University of Wurzburg; University Hospital of Giessen & Marburg; University of Munich; University of Wurzburg; University of Edinburgh; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Doppler, K (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany.	Doppler_K@ukw.de	Waxman, Stephen/Z-2507-2019; Sommer, Claudia/A-9820-2010; Appeltshauser, Luise/GLR-0497-2022	Waxman, Stephen/0000-0001-5718-7177; Sommer, Claudia/0000-0002-7064-5002; Appeltshauser, Luise/0000-0001-5248-4009; Meinl, Edgar/0000-0002-2570-6785; Ng, Judy King Man/0000-0002-4741-4652; Doppler, Kathrin/0000-0003-2883-0009	University of Wurzberg; Graduate School of Life Sciences of the University of Wurzburg; Rehabilitation Research Service; Medical Research Service, Department of Veterans Affairs, United States of America	University of Wurzberg; Graduate School of Life Sciences of the University of Wurzburg; Rehabilitation Research Service; Medical Research Service, Department of Veterans Affairs, United States of America	The study was supported by research funds of the University of Wurzberg. Supported by a grant of the Graduate School of Life Sciences of the University of Wurzburg in the laboratory of SDH and SGW was supported in part by grants from the Rehabilitation Research Service and Medical Research Service, Department of Veterans Affairs, United States of America.	Bain PG, 1996, NEUROLOGY, V47, P678, DOI 10.1212/WNL.47.3.678; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Devaux JJ, 2012, J PERIPHER NERV SYST, V17, P62, DOI 10.1111/j.1529-8027.2012.00372.x; Doppler K, 2015, J NEUROL NEUROSUR PS, V86, P720, DOI 10.1136/jnnp-2014-309916; Liu CJ, 2001, J BIOL CHEM, V276, P46553, DOI 10.1074/jbc.M108699200; Medical Research Council, 1981, AIDS EX PER NERV SYS; Ng JKM, 2012, NEUROLOGY, V79, P2241, DOI 10.1212/WNL.0b013e31827689ad; Nobile-Orazio E, 2014, J NEUROL NEUROSUR PS, V85, P754, DOI 10.1136/jnnp-2013-305755; Notturno F, 2014, J NEUROIMMUNOL; Piepers S, 2010, J NEUROIMMUNOL, V229, P256, DOI 10.1016/j.jneuroim.2010.08.023; Querol L, 2014, NEUROLOGY, V82, P879, DOI 10.1212/WNL.0000000000000205; Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; van Schaik IN, 2010, J PERIPHER NERV SYST, V15, P295, DOI 10.1111/j.1529-8027.2010.00290.x; Vlam L, 2013, J CLIN IMMUNOL, V33, pS38, DOI 10.1007/s10875-012-9779-8; Yan W, 2014, J NEUROIMMUNOL	16	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134274	10.1371/journal.pone.0134274	http://dx.doi.org/10.1371/journal.pone.0134274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218529	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900105
J	Reynolds, V; Lloyd, AW; English, CJ; Lyons, P; Dodd, H; Hobaiter, C; Newton-Fisher, N; Mullins, C; Lamon, N; Schel, AM; Fallon, B				Reynolds, Vernon; Lloyd, Andrew W.; English, Christopher J.; Lyons, Peter; Dodd, Howard; Hobaiter, Catherine; Newton-Fisher, Nicholas; Mullins, Caroline; Lamon, Noemie; Schel, Anne Marijke; Fallon, Brittany			Mineral Acquisition from Clay by Budongo Forest Chimpanzees	PLOS ONE			English	Article							WILD CHIMPANZEES; SOIL CONSUMPTION; KIBALE FOREST; UGANDA; GEOPHAGY; COLOBUS; SODIUM; DIET	Chimpanzees of the Sonso community, Budongo Forest, Uganda were observed eating clay and drinking clay-water from waterholes. We show that clay, clay-rich water, and clay obtained with leaf sponges, provide a range of minerals in different concentrations. The presence of aluminium in the clay consumed indicates that it takes the form of kaolinite. We discuss the contribution of clay geophagy to the mineral intake of the Sonso chimpanzees and show that clay eaten using leaf sponges is particularly rich in minerals. We show that termite mound soil, also regularly consumed, is rich in minerals. We discuss the frequency of clay and termite soil geophagy in the context of the disappearance from Budongo Forest of a formerly rich source of minerals, the decaying pith of Raphia farinifera palms.	[Reynolds, Vernon] Univ Oxford, Sch Anthropol, Oxford, England; [Lloyd, Andrew W.; English, Christopher J.; Lyons, Peter; Dodd, Howard] Univ Brighton, Sch Environm & Technol, Brighton, E Sussex, England; [Reynolds, Vernon; Hobaiter, Catherine; Lamon, Noemie; Schel, Anne Marijke; Fallon, Brittany] Budongo Conservat Field Stn, Masindi, Uganda; [Hobaiter, Catherine; Mullins, Caroline; Fallon, Brittany] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Newton-Fisher, Nicholas] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Lamon, Noemie] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Schel, Anne Marijke] Univ Utrecht, Anim Ecol, Utrecht, Netherlands	University of Oxford; University of Brighton; University of St Andrews; University of Kent; University of Neuchatel; Utrecht University	Reynolds, V (corresponding author), Univ Oxford, Sch Anthropol, Oxford, England.	vreynolds@btopenworld.com	Lloyd, Andrew/D-1369-2011	Lloyd, Andrew/0000-0003-2778-8195; Newton-Fisher, Nicholas/0000-0002-7657-2641; Hobaiter, Cat/0000-0002-3893-0524	Mohamed bin Zayed Species Conservation Fund; Primate Action Fund of Conservation International; Royal Zoological Society of Scotland	Mohamed bin Zayed Species Conservation Fund; Primate Action Fund of Conservation International; Royal Zoological Society of Scotland	Financial supprot was provided by the Mohamed bin Zayed Species Conservation Fund (http://www.speciesconservation.org/). Additional support came from the Primate Action Fund of Conservation International, and the Royal Zoological Society of Scotland via its support to BCFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, NATL RES COUNCIL NUT; Hladik C. M., 1977, PRIMATE ECOLOGY, P324; Hladik Claude, 2007, CONSUMING INEDIBLE, P121; Hladik Claude Marcel, 1996, Evolutionary Anthropology, V5, P58, DOI 10.1002/(SICI)1520-6505(1996)5:2<58::AID-EVAN5>3.0.CO;2-S; Hladik CM, 2003, ANTHROPOLOGIE, V41, P9; JOHNS T, 1991, AM J CLIN NUTR, V53, P448, DOI 10.1093/ajcn/53.2.448; Klein N, 2008, NATURWISSENSCHAFTEN, V95, P325, DOI 10.1007/s00114-007-0333-0; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Krief S, 2015, ANTIQUITY, V89, P464, DOI 10.15184/aqy.2014.7; Lambe TW, 1969, SOIL MECH, P52; Mahaney WC, 1997, PRIMATES, V38, P159, DOI 10.1007/BF02382006; Mahaney WC, 2005, INT J PRIMATOL, V26, P1375, DOI 10.1007/s10764-005-8857-7; Mahaney WC, 1996, PRIMATES, V37, P121, DOI 10.1007/BF02381400; Matsubayashi H, 2007, ECOL RES, V22, P742, DOI 10.1007/s11284-006-0313-4; OATES JF, 1978, BIOTROPICA, V10, P241, DOI 10.2307/2387676; Petimar J, AF J ECOL UNPUB; Quiatt D, 2006, PRIMATES W UGANDA; Reynolds V, 1998, OECOLOGIA, V115, P331, DOI 10.1007/s004420050524; Reynolds V., 2012, AFR PRIMATES, V7, P156; Reynolds V., 2005, CHIMPANZEES BUDONGO; Reynolds V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006194; Rode KD, 2003, INT J PRIMATOL, V24, P541, DOI 10.1023/A:1023788330155; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480; Rozin P., 1976, ADV STUD BEHAV, V6, P21, DOI [10. 1016/S0065-3454(08)60081-9, DOI 10.1016/S0065-3454(08)60081-9]; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257	27	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134075	10.1371/journal.pone.0134075	http://dx.doi.org/10.1371/journal.pone.0134075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218593	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358595900073
J	Dou, J; Bui, DT; Yunus, AP; Jia, K; Song, X; Revhaug, I; Xia, H; Zhu, ZF				Dou, Jie; Bui, Dieu Tien; Yunus, Ali P.; Jia, Kun; Song, Xuan; Revhaug, Inge; Xia, Huan; Zhu, Zhongfan			Optimization of Causative Factors for Landslide Susceptibility Evaluation Using Remote Sensing and GIS Data in Parts of Niigata, Japan	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CERTAINTY-FACTOR; ROAD SECTION; BIVARIATE; ZONATION; AREA; INTEGRATION; STATISTICS; RESOLUTION; CATCHMENT	This paper assesses the potentiality of certainty factor models (CF) for the best suitable causative factors extraction for landslide susceptibility mapping in the Sado Island, Niigata Prefecture, Japan. To test the applicability of CF, a landslide inventory map provided by National Research Institute for Earth Science and Disaster Prevention (NIED) was split into two subsets: (i) 70% of the landslides in the inventory to be used for building the CF based model; (ii) 30% of the landslides to be used for the validation purpose. A spatial database with fifteen landslide causative factors was then constructed by processing ALOS satellite images, aerial photos, topographical and geological maps. CF model was then applied to select the best subset from the fifteen factors. Using all fifteen factors and the best subset factors, landslide susceptibility maps were produced using statistical index (SI) and logistic regression (LR) models. The susceptibility maps were validated and compared using landslide locations in the validation data. The prediction performance of two susceptibility maps was estimated using the Receiver Operating Characteristics (ROC). The result shows that the area under the ROC curve (AUC) for the LR model (AUC = 0.817) is slightly higher than those obtained from the SI model (AUC = 0.801). Further, it is noted that the SI and LR models using the best subset outperform the models using the fifteen original factors. Therefore, we conclude that the optimized factor model using CF is more accurate in predicting landslide susceptibility and obtaining a more homogeneous classification map. Our findings acknowledge that in the mountainous regions suffering from data scarcity, it is possible to select key factors related to landslide occurrence based on the CF models in a GIS platform. Hence, the development of a scenario for future planning of risk mitigation is achieved in an efficient manner.	[Dou, Jie; Yunus, Ali P.] Univ Tokyo, Dept Nat Environm Studies, Kashiwa, Chiba, Japan; [Bui, Dieu Tien] Telemark Univ Coll, Dept Business Adm & Comp Sci, Geog Informat Syst Grp, Telemark, Norway; [Jia, Kun] Beijing Normal Univ, Sch Geog, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Song, Xuan] Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba, Japan; [Revhaug, Inge] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway; [Xia, Huan] Guizhou Univ Finance & Econ, Guiyang, Peoples R China; [Zhu, Zhongfan] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China	University of Tokyo; University College of Southeast Norway; Beijing Normal University; University of Tokyo; Norwegian University of Life Sciences; Guizhou University of Finance & Economics; Beijing Normal University	Dou, J (corresponding author), Univ Tokyo, Dept Nat Environm Studies, Kashiwa, Chiba, Japan.	doujie@csis.u-tokyo.ac.jp; songxuan@csis.u-tokyo.ac.jp	Jia, Kun/Q-6539-2016; Dou, Jie/K-2809-2013; ALI, YUNUS/O-7015-2019; Yunus, Ali P./K-9965-2013; Song, Xuan/L-8086-2018; Tien Bui, Dieu/K-2125-2012	Jia, Kun/0000-0001-8586-4243; Dou, Jie/0000-0001-5930-199X; ALI, YUNUS/0000-0001-6852-145X; Song, Xuan/0000-0003-4042-7888; Tien Bui, Dieu/0000-0001-5161-6479; Zhu, Zhongfan/0000-0003-0579-608X	JST, Strategic International Collaborative Research Program (SICORP); Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [26730113]	JST, Strategic International Collaborative Research Program (SICORP); Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by, JST, Strategic International Collaborative Research Program (SICORP); Grant-in-Aid for Young Scientists (26730113(tel:26730113)) of Japan's Ministry of Education, Culture, Sports, Science, and Technology (MEXT).	Ahmed B, 2015, LANDSLIDES, V12, P1077, DOI 10.1007/s10346-014-0521-x; Aleotti P., 1999, B ENG GEOL ENVIRON, V58, P21, DOI [10.1007/s100640050066, DOI 10.1007/S100640050066]; Anbazhagan S, 2014, J MT SCI-ENGL, V11, P1308, DOI 10.1007/s11629-012-2618-9; Ayalew L, 2005, ENG GEOL, V81, P432, DOI 10.1016/j.enggeo.2005.08.004; Bahsan E, 2014, ENG GEOL, V172, P85, DOI 10.1016/j.enggeo.2014.01.005; Bai SB, 2011, ENVIRON EARTH SCI, V62, P139, DOI 10.1007/s12665-010-0509-3; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Binaghi E, 1998, NAT HAZARDS, V17, P77, DOI 10.1023/A:1008001724538; Brabb EE, 1984, P 4 INT S LANDSL TOR, P307; Catani F, 2013, NAT HAZARD EARTH SYS, V13, P2815, DOI 10.5194/nhess-13-2815-2013; Chung CF, 1993, NONRENEWABLE RESOURC, V2, P122, DOI DOI 10.1007/BF02272809; Conoscenti C, 2015, GEOMORPHOLOGY, V242, P49, DOI 10.1016/j.geomorph.2014.09.020; Costanzo D, 2012, NAT HAZARD EARTH SYS, V12, P327, DOI 10.5194/nhess-12-327-2012; Cross M, 1998, GEOL SOC ENG GEOL SP, P247; Dai FC, 2003, EARTH SURF PROC LAND, V28, P527, DOI 10.1002/esp.456; Devkota KC, 2013, NAT HAZARDS, V65, P135, DOI 10.1007/s11069-012-0347-6; Bui DT, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/974638; Bui DT, 2011, NAT HAZARDS, V59, P1413, DOI 10.1007/s11069-011-9844-2; Dou J., 2014, LANDSLIDE SCI SAFER, P419; Dou J, 2015, NAT HAZARDS, V78, P1749, DOI 10.1007/s11069-015-1799-2; Dou J, 2015, NAT HAZARDS, V78, P1021, DOI 10.1007/s11069-015-1756-0; Dou J, 2015, TERR ATMOS OCEAN SCI, V26, P227, DOI 10.3319/TAO.2014.12.02.07(EOSI); Dou J, 2015, REMOTE SENS-BASEL, V7, P4318, DOI 10.3390/rs70404318; Felicisimo A, 2013, LANDSLIDES, V10, P175, DOI 10.1007/s10346-012-0320-1; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Guzzetti F, 1999, GEOMORPHOLOGY, V31, P181, DOI 10.1016/S0169-555X(99)00078-1; Irigaray C, 2007, NAT HAZARDS, V41, P61, DOI 10.1007/s11069-006-9027-8; Jamsawang P, 2015, ENG GEOL, V188, P159, DOI 10.1016/j.enggeo.2015.01.017; Jebur MN, 2014, REMOTE SENS ENVIRON, V152, P150, DOI 10.1016/j.rse.2014.05.013; Jie Dou, 2009, Proceedings of the SPIE - The International Society for Optical Engineering, V7471, DOI 10.1117/12.836328; Komac M, 2012, GEOL Q, V56, P41; Lee CT, 2008, ENG GEOL, V100, P43, DOI 10.1016/j.enggeo.2008.03.004; Lee S, 2005, ENVIRON GEOL, V47, P982, DOI 10.1007/s00254-005-1228-z; Lee S, 2004, GEOSCI J, V8, P51, DOI 10.1007/BF02910278; Lee S, 2007, LANDSLIDES, V4, P33, DOI 10.1007/s10346-006-0047-y; Lucas PJF, 2001, KNOWL-BASED SYST, V14, P327, DOI 10.1016/S0950-7051(00)00073-3; Magliulo P, 2008, NAT HAZARDS, V47, P411, DOI 10.1007/s11069-008-9230-x; Martinez-Alvarez F, 2013, KNOWL-BASED SYST, V50, P198, DOI 10.1016/j.knosys.2013.06.011; Matanle P., 2008, PROJECT OFFICE PHILI, P42; Meinhardt M, 2015, GEOMORPHOLOGY, V234, P80, DOI 10.1016/j.geomorph.2014.12.042; Neuhauser B, 2012, LANDSLIDES, V9, P511, DOI 10.1007/s10346-011-0305-5; Nolasco-Javier D, 2015, NAT HAZARDS, V78, P1587, DOI 10.1007/s11069-015-1790-y; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ohlmacher GC, 2007, ENG GEOL, V91, P117, DOI 10.1016/j.enggeo.2007.01.005; Peng L, 2014, GEOMORPHOLOGY, V204, P287, DOI 10.1016/j.geomorph.2013.08.013; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pourghasemi H, 2013, GEOMAT NAT HAZ RISK, V4, P93, DOI 10.1080/19475705.2012.662915; Pradhan B, 2013, COMPUT GEOSCI-UK, V51, P350, DOI 10.1016/j.cageo.2012.08.023; Pradhan B, 2010, ENVIRON MODELL SOFTW, V25, P747, DOI 10.1016/j.envsoft.2009.10.016; Shahabi H, 2013, ARAB J GEOSCI, V6, P3885, DOI 10.1007/s12517-012-0650-2; Shortliffe EH., 1975, MATH BIOSCI, V23, P351, DOI [10.1016/0025-5564(75)90047-4, DOI 10.1016/0025-5564(75)90047-4]; Suzen ML, 2004, ENG GEOL, V71, P303, DOI 10.1016/S0013-7952(03)00143-1; Tofani V, 2014, REMOTE SENS-BASEL, V6, P907, DOI 10.3390/rs6020907; vanWesten CJ, 1997, GEOL RUNDSCH, V86, P404, DOI 10.1007/s005310050149; Wang HB, 2008, LANDSLIDES, V5, P387, DOI 10.1007/s10346-008-0131-6; Wang LJ, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073561; Wu Q, 2008, GEOINFORMATICS 2008, V7144, DOI [10.1117/12.812837, DOI 10.1117/12.812837]; Yalcin A, 2011, CATENA, V85, P274, DOI 10.1016/j.catena.2011.01.014; Yilmaz C, 2012, ENVIRON EARTH SCI, V65, P2161, DOI 10.1007/s12665-011-1196-4; Zhu J, 2010, J ANHUI AGR SCI, V38, P10828	60	133	136	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133262	10.1371/journal.pone.0133262	http://dx.doi.org/10.1371/journal.pone.0133262			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214691	Green Accepted, gold, Green Published			2022-12-27	WOS:000358594300017
J	Filip, S; Vougas, K; Zoidakis, J; Latosinska, A; Mullen, W; Spasovski, G; Mischak, H; Vlahou, A; Jankowski, J				Filip, Szymon; Vougas, Konstantinos; Zoidakis, Jerome; Latosinska, Agnieszka; Mullen, William; Spasovski, Goce; Mischak, Harald; Vlahou, Antonia; Jankowski, Joachim			Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine	PLOS ONE			English	Article							PEPTIDE LIGAND LIBRARIES; CHRONIC KIDNEY-DISEASE; PROTEOME ANALYSIS; MASS-SPECTROMETRY; BIOMARKER DISCOVERY; PLASMA-PROTEINS; AFFINITY-CHROMATOGRAPHY; HUMAN SERUM; IDENTIFICATION; ALBUMIN	Proteome analysis of complex biological samples for biomarker identification remains challenging, among others due to the extended range of protein concentrations. High-abundance proteins like albumin or IgG of plasma and urine, may interfere with the detection of potential disease biomarkers. Currently, several options are available for the depletion of abundant proteins in plasma. However, the applicability of these methods in urine has not been thoroughly investigated. In this study, we compared different, commercially available immunodepletion and ion-exchange based approaches on urine samples from both healthy subjects and CKD patients, for their reproducibility and efficiency in protein depletion. A starting urine volume of 500 mu L was used to simulate conditions of a multi-institutional biomarker discovery study. All depletion approaches showed satisfactory reproducibility (n=5) in protein identification as well as protein abundance. Comparison of the depletion efficiency between the unfractionated and fractionated samples and the different depletion strategies, showed efficient depletion in all cases, with the exception of the ion-exchange kit. The depletion efficiency was found slightly higher in normal than in CKD samples and normal samples yielded more protein identifications than CKD samples when using both initial as well as corresponding depleted fractions. Along these lines, decrease in the amount of albumin and other targets as applicable, following depletion, was observed. Nevertheless, these depletion strategies did not yield a higher number of identifications in neither the urine from normal nor CKD patients. Collectively, when analyzing urine in the context of CKD biomarker identification, no added value of depletion strategies can be observed and analysis of unfractionated starting urine appears to be preferable.	[Filip, Szymon; Vougas, Konstantinos; Zoidakis, Jerome; Latosinska, Agnieszka; Vlahou, Antonia] Biomed Res Fdn Acad Athens, Div Biotechnol, Athens, Greece; [Filip, Szymon; Latosinska, Agnieszka] Charite, D-13353 Berlin, Germany; [Mullen, William; Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Spasovski, Goce] Ss Cyril & Methodius Univ Skopje, Dept Nephrol, Skopje, Macedonia; [Mischak, Harald] Mosa Diagnost GmbH, Hannover, Germany; [Jankowski, Joachim] Univ Hosp RWTH Aachen, Inst Mol Cardiovasc Res, Aachen, Germany	Academy of Athens; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Glasgow; Saints Cyril & Methodius University of Skopje; Modular Open Systems Approach (MOSA) Solutions; RWTH Aachen University; RWTH Aachen University Hospital	Jankowski, J (corresponding author), Univ Hosp RWTH Aachen, Inst Mol Cardiovasc Res, Aachen, Germany.	jjankowski@ukaachen.de	Filip, Szymon/J-8866-2019; Zoidakis, Jerome/P-9599-2018; Zoidakis, Jerome/AAO-8236-2021; Mullen, William/GWC-8078-2022	Filip, Szymon/0000-0003-2175-6176; Zoidakis, Jerome/0000-0002-4557-3430; Zoidakis, Jerome/0000-0002-4557-3430; Vlahou, Antonia/0000-0003-3284-5713; Latosinska, Agnieszka/0000-0001-8917-2412; Mullen, William/0000-0002-5685-1563; Vougas, Konstantinos/0000-0002-8873-4740; Mischak, Harald/0000-0003-0323-0306	Clinical and system -omics for the identification of the Molecular Determinants of established Chronic Kidney Disease (iMODE-CKD) [PEOPLE-ITN-GA-2013-608332]	Clinical and system -omics for the identification of the Molecular Determinants of established Chronic Kidney Disease (iMODE-CKD)	The research presented in this manuscript was supported by "Clinical and system -omics for the identification of the Molecular Determinants of established Chronic Kidney Disease (iMODE-CKD, PEOPLE-ITN-GA-2013-608332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Afkarian M, 2010, MOL CELL PROTEOMICS, V9, P2195, DOI 10.1074/mcp.M110.000992; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Boschetti E, 2008, BIOTECHNIQUES, V44, P663, DOI 10.2144/000112762; Brott DA, 2014, DRUG DES DEV THER, V8, P227, DOI 10.2147/DDDT.S54956; Chen CL, 2013, J PROTEOMICS, V85, P28, DOI 10.1016/j.jprot.2013.04.024; Cheung RCF, 2012, APPL MICROBIOL BIOT, V96, P1411, DOI 10.1007/s00253-012-4507-0; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; Doucette AA, 2011, EXPERT REV PROTEOMIC, V8, P787, DOI [10.1586/EPR.11.67, 10.1586/epr.11.67]; Duong-Ly KC, 2014, METHOD ENZYMOL, V541, P105, DOI 10.1016/B978-0-12-420119-4.00009-4; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Filip S, 2014, BIOANALYSIS, V6, P2549, DOI 10.4155/bio.14.210; Filippone S., 2014, ENCY POLYM NANOMATER, P1, DOI [10.1586/14789450.2014.926224, DOI 10.1586/14789450.2014.926224]; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; Fountoulakis M, 2004, AMINO ACIDS, V27, P249, DOI 10.1007/s00726-004-0141-1; Goo YA, 2010, INT BRAZ J UROL, V36, P79; Goo YA, 2010, INT BRAZ J UROL, V36, P78; Goo YA, 2012, J PROTEOME RES, V11, P5650, DOI 10.1021/pr3004437; Goo YA, 2010, INT BRAZ J UROL, V36, P464, DOI 10.1590/S1677-55382010000400010; Granger J, 2005, PROTEOMICS, V5, P4713, DOI 10.1002/pmic.200401331; Hortin GL, 2007, PHARMACOGENOMICS, V8, P237, DOI 10.2217/14622416.8.3.237; Jungbauer A, 2009, METHOD ENZYMOL, V463, P349, DOI 10.1016/S0076-6879(09)63022-6; Kullolli M, 2013, J CHROMATOGR B, V939, P10, DOI 10.1016/j.jchromb.2013.09.008; Kushnir Mark M, 2009, J Biomol Tech, V20, P101; Law KP, 2013, EXPERT REV PROTEOMIC, V10, P551, DOI 10.1586/14789450.2013.858022; Magagnotti C, 2010, CLIN CHEM LAB MED, V48, P531, DOI 10.1515/CCLM.2010.109; Magistroni R, 2009, NEPHROL DIAL TRANSPL, V24, P1672, DOI 10.1093/ndt/gfp020; Martin-Lorenzo M, 2014, ELECTROPHORESIS, V35, P2634, DOI 10.1002/elps.201300601; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; Mischak H, 2015, NAT REV NEPHROL, V11, P221, DOI 10.1038/nrneph.2014.247; Mischak H, 2010, PROTEOM CLIN APPL, V4, P464, DOI 10.1002/prca.200900189; Moser AC, 2010, BIOANALYSIS, V2, P769, DOI [10.4155/bio.10.31, 10.4155/BIO.10.31]; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Righetti PG, 2008, MASS SPECTROM REV, V27, P596, DOI 10.1002/mas.20178; Righetti PG, 2015, ANAL CHEM, V87, P293, DOI 10.1021/ac502171b; Righetti PG, 2015, METHODS MOL BIOL, V1243, P55, DOI 10.1007/978-1-4939-1872-0_4; Serang O, 2012, STAT INTERFACE, V5, P3; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Thomas R, 2008, PRIMARY CARE, V35, P329, DOI 10.1016/j.pop.2008.01.008; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Urh M, 2009, METHOD ENZYMOL, V463, P417, DOI 10.1016/S0076-6879(09)63026-3; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zerefos PG, 2012, PROTEOMICS, V12, P391, DOI 10.1002/pmic.201100212	47	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133773	10.1371/journal.pone.0133773	http://dx.doi.org/10.1371/journal.pone.0133773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208298	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000358622000136
J	Fonseca, AJ; Taeko, D; Chaves, TA; Amorim, LDD; Murari, RSW; Miranda, AE; Chen, ZG; Burk, RD; Ferreira, LCL				Fonseca, Allex Jardim; Taeko, Daniela; Chaves, Thiciane Araujo; da Costa Amorim, Lucia Dayanny; Wanderley Murari, Raisa Saron; Miranda, Angelica Espinosa; Chen, Zigui; Burk, Robert David; Lima Ferreira, Luiz Carlos			HPV Infection and Cervical Screening in Socially Isolated Indigenous Women Inhabitants of the Amazonian Rainforest	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; TRIBAL POPULATION; GENETIC-STRUCTURE; YANOMAMA INDIANS; TYPE-16 VARIANTS; PREVALENCE; WAPISHANA; SEQUENCES; PEOPLE; CANCER	Objective Indigenous women from the Amazon regions have some of the highest rates of cervical cancer in the world. This study evaluated cervical cytology and human papillomavirus (HPV) in native women that differ by lifestyle and interaction with western society. Yanomami women are isolated deep in the Amazon with a hunter/gatherer lifestyle. Macuxi and Wapishana women live in proximity to western society. Methods To select a representative group of women from each district, random cluster sampling was used, considering each registered village as a cluster. Cervical samples were collected for cytology and HPV detection and typing by PCR amplification and next generation sequencing. The study was approved by the National IRB and by tribal leaders. Results 664 native women were enrolled from 13 indigenous villages (76% participation rate). Yanomami women had higher rates of abnormal cytology (5.1% vs. 1.8%, p = 0.04) and prevalent HR-HPV (34.1% vs. 19.2%, p<0.001). Yanomami women >35y of age were significantly more likely to have HR-HPV, whereas women <= 35y did not significantly differ between groups. Prevalence of HPV was significantly different amongst geographically clustered Yanomami women (p<0.004). The most prevalent HPV types in the entire group were HPV31 (8.7%), HPV16 (5.9%) and HPV18 (4.4%). Conclusion Isolated endogenous Yanomami women were more likely to be HPV+ and rates increased with age. Study of HPV in isolated hunter-gather peoples suggests that long-term persistence is a characteristic of prehistoric humans and patterns reflecting decreased prevalence with age in western society represents recent change. These studies have implications for cervical cancer prevention and viral-host relationships.	[Fonseca, Allex Jardim] Univ Estado Amazonas, Trop Med Fdn Dr Heitor Vieira Dourado, Postgrad Program Trop Med, Manaus, Amazonas, Brazil; [Fonseca, Allex Jardim; Taeko, Daniela; Chaves, Thiciane Araujo; da Costa Amorim, Lucia Dayanny; Wanderley Murari, Raisa Saron] Univ Fed Roraima, Dept Hlth Sci Res, Boa Vista, Brazil; [Miranda, Angelica Espinosa] Univ Fed Espirito Santo, Ctr Infect Dis, Maruipe, Vitoria, Brazil; [Chen, Zigui; Burk, Robert David] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Burk, Robert David] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA; [Burk, Robert David] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Burk, Robert David] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, New York, NY USA; [Lima Ferreira, Luiz Carlos] Univ Estado Amazonas, Trop Med Fdn Dr Heitor Vieira Dourado, Dept Trop Pathol, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade Federal de Roraima; Universidade Federal do Espirito Santo; Yeshiva University; Yeshiva University; Yeshiva University; Yeshiva University; Universidade do Estado do Amazonas	Fonseca, AJ (corresponding author), Univ Estado Amazonas, Trop Med Fdn Dr Heitor Vieira Dourado, Postgrad Program Trop Med, Manaus, Amazonas, Brazil.	allex.j.fonseca@gmail.com	Miranda, Angelica/AAE-5571-2021; Chen, Zigui/E-8490-2017	Chen, Zigui/0000-0002-8577-1298; Miranda, Angelica/0000-0002-5556-8379; fonseca, allex/0000-0002-1715-5469	CNPq/Instituto de Amparo a Ciencia, Tecnologia e Inovacao - RR	CNPq/Instituto de Amparo a Ciencia, Tecnologia e Inovacao - RR	This study was partially funded by CNPq/Instituto de Amparo a Ciencia, Tecnologia e Inovacao - RR. Sources from Universidade do Estado do Amazonas (Brazil) were used for data collection and data analysis. Sources from Laboratory Burk/Albert Einstein College of Medicine (USA) were used to laboratory and data analysis.	Bonanni P, 2009, VACCINE, V27, pA46, DOI 10.1016/j.vaccine.2008.10.085; Brasil. Ministerio da Saude, INC CANC BRAS EST 20; Brasil. Ministerio da Saude. Instituto Nacional de Cancer, 2011, DIR BRAS RASTR CANC; Brito EB, 2002, EPIDEMIOL INFECT, V128, P485, DOI 10.1017/S0950268802006908; Castro MM, 2011, GENET MOL RES, V10, P186, DOI 10.4238/vol10-1gmr992; Clarke MA, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-12; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Coimbra Jr CEA, 2003, QUESTOES DE SAUDE RE; Coimbra Junior CEA, 2000, CIENC SAUDE COLETIVA, V5, P125, DOI DOI 10.1590/S1413-81232000000100011; Cruz Isabel Cristina Fonseca da, 2004, Rev. esc. enferm. USP, V38, P448; da Fonseca AJ, 2010, REV BRAS GINECOL OBS, V32, P386, DOI 10.1590/S0100-72032010000800005; Dangour AD, 2003, HUM BIOL, V75, P227, DOI 10.1353/hub.2003.0031; de Oliveira GF, 2011, REV PANAM SALUD PUBL, V29, P315, DOI 10.1590/S1020-49892011000500003; Riscado JLD, 2010, SAUDE SOC, V19, P96, DOI 10.1590/S0104-12902010000600010; Early J., 1990, POPULATION DYNAMICS; Early JD, 2000, XILIXANA YANOMAMI AM; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GIBBONS A, 1991, SCIENCE, V252, P1616, DOI 10.1126/science.2047870; Girianelli VR, 2006, EUR J CANCER PREV, V15, P504, DOI 10.1097/01.cej.0000220630.08352.7a; Ayres ARG, 2010, REV SAUDE PUBL, V44; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kightlinger RS, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.015; Krambeck WM, 2008, CLIN EXP OBSTET GYN, V35, P175; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; ONG CK, 1994, J INFECT DIS, V170, P1086, DOI 10.1093/infdis/170.5.1086; Picconi MA, 2003, J MED VIROL, V69, P546, DOI 10.1002/jmv.10343; Rocha DAP, 2013, INFECT DIS OBSTET GY, V2013; Rosa MI, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.033; ROTHHAMMER F, 1973, AM J HUM GENET, V25, P152; SALZANO FM, 1980, ANN HUM BIOL, V7, P129, DOI 10.1080/03014468000004151; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; da Rocha AKS, 2011, REV PANAM SALUD PUBL, V29, P41; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; SOKAL RR, 1986, GENETICS, V114, P259; Sole Pla MC, 2012, REV BRAS CANCEROL, V58, P461; SPIELMAN RS, 1974, SCIENCE, V184, P637, DOI 10.1126/science.184.4137.637; Tonon SA, 2004, INT J INFECT DIS, V8, P13, DOI 10.1016/j.ijid.2003.03.001; WARD RH, 1975, AM J HUM GENET, V27, P1; WHO. ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), SUMM REP HPV CERV CA; World Health Organization (WHO), 2007, HLTH IND PEOPL	45	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133635	10.1371/journal.pone.0133635	http://dx.doi.org/10.1371/journal.pone.0133635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207895	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000112
J	Harris, RB; Wang, WY; Badinqiuying; Smith, AT; Bedunah, DJ				Harris, Richard B.; Wang Wenying; Badinqiuying; Smith, Andrew T.; Bedunah, Donald J.			Herbivory and Competition of Tibetan Steppe Vegetation in Winter Pasture: Effects of Livestock Exclosure and Plateau Pika Reduction	PLOS ONE			English	Article							DELAYED SPRING PHENOLOGY; ALPINE GRASSLANDS; GRAZING-EXCLUSION; OCHOTONA-CURZONIAE; RANGELAND DEGRADATION; ABOVEGROUND BIOMASS; LAND-USE; RESPONSES; BIODIVERSITY; ECOSYSTEMS	Rangeland degradation has been identified as a serious concern in alpine regions of western China on the Qinghai-Tibetan plateau (QTP). Numerous government-sponsored programs have been initiated, including many that feature long-term grazing prohibitions and some that call for eliminating pastoralism altogether. As well, government programs have long favored eliminating plateau pikas (Ochotona curzoniae), assumed to contribute to degraded conditions. However, vegetation on the QTP evolved in the presence of herbivory, suggesting that deleterious effects from grazing are, to some extent, compensated for by reduced plant-plant competition. We examined the dynamics of common steppe ecosystem species as well as physical indicators of rangeland stress by excluding livestock and reducing pika abundance on experimental plots, and following responses for 4 years. We established 12 fenced livestock exclosures within pastures grazed during winter by local pastoralists, and removed pikas on half of these. We established paired, permanent vegetation plots within and outside exclosures and measured indices of erosion and biomass of common plant species. We observed modest restoration of physical site conditions (reduced bare soil, erosion, greater vegetation cover) with both livestock exclusion and pika reduction. As expected in areas protected from grazing, we observed a reduction in annual productivity of plant species avoided by livestock and assumed to compete poorly when protected from grazing. Contrary to expectation, we observed similar reductions in annual productivity among palatable, perennial graminoids under livestock exclusion. The dominant grass, Stipa purpurea, displayed evidence of density-dependent growth, suggesting that intra-specific competition exerted a regulatory effect on annual production in the absence of grazing. Complete grazing bans on winter pastures in steppe habitats on the QTP may assist in the recovery of highly eroded pastures, but may not increase annual vegetative production.	[Harris, Richard B.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Wang Wenying] Qinghai Normal Univ, Xining, Qinghai, Peoples R China; [Badinqiuying; Smith, Andrew T.] Arizona State Univ, Dept Life Sci, Tempe, AZ USA; [Bedunah, Donald J.] Univ Montana, Dept Forest Management, Missoula, MT 59812 USA	University of Montana System; University of Montana; Qinghai Normal University; Arizona State University; Arizona State University-Tempe; University of Montana System; University of Montana	Harris, RB (corresponding author), Washington Dept Fish & Wildlife, Olympia, WA 98501 USA.	rharris@montana.com			US National Science Foundation [0815441]	US National Science Foundation(National Science Foundation (NSF))	Support was provided by US National Science Foundation grant 0815441 [http://www.nsf.gov/awardsearch/showAward?AWD_ID=0815441]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur AD, 2008, BIOL CONSERV, V141, P1972, DOI 10.1016/j.biocon.2008.05.010; Augustine DJ, 2013, ECOL APPL, V23, P850, DOI 10.1890/12-0890.1; Cao JJ, 2013, J ARID ENVIRON, V97, P3, DOI 10.1016/j.jaridenv.2013.05.002; Chen H, 2011, P NATL ACAD SCI USA, V108, pE93, DOI 10.1073/pnas.1100091108; Chen SB, 2006, CLIMATIC CHANGE, V76, P291, DOI 10.1007/s10584-006-9080-z; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; Del-Val EK, 2005, J ECOL, V93, P1005, DOI 10.1111/j.1365-2745.2005.01011.x; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Detling James K., 2006, P65; Dong SK, 2010, AFR J AGR RES, V5, P3542; Fan Naichang, 1999, ACIAR Monograph Series, V59, P285; Frauenfeld OW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005230; Gao YH, 2014, J CLIMATE, V27, P1876, DOI 10.1175/JCLI-D-13-00321.1; Gao YH, 2011, ARID LAND RES MANAG, V25, P164, DOI 10.1080/15324982.2011.554954; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Harris R.B., 2008, WILDLIFE CONSERVATIO; Harris RB, 2010, PASTORALISM, V1, P325; Harris RB, 2014, J MAMMAL, V95, P1207, DOI 10.1644/14-MAMM-A-021; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Hogan BW, 2010, THESIS AZ ARIZONA ST; Holzner W, 2001, BODENKULTUR, V52, P37; Hutchinson M., 2001, ANUSPLIN VERSION 4 2; Hutchinson MF, 2001, INT J GEOGR INF SCI, V9, P385; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; Lai CH, 2003, BIODIVERS CONSERV, V12, P1901, DOI 10.1023/A:1024161409110; Li XL, 2013, LAND DEGRAD DEV, V24, P72, DOI 10.1002/ldr.1108; Li YY, 2013, J ENVIRON MANAGE, V128, P393, DOI 10.1016/j.jenvman.2013.05.058; Liu YS, 1995, INTEGRATING PEOPLE W, P63; Luan JW, 2014, ECOL ENG, V64, P262, DOI 10.1016/j.ecoleng.2013.12.057; Luedeling E, 2011, P NATL ACAD SCI USA, V108, pE95, DOI 10.1073/pnas.1103336108; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Miehe G, 2011, J ARID ENVIRON, V75, P711, DOI 10.1016/j.jaridenv.2011.03.001; Miehe G, 2008, AMBIO, V37, P272, DOI 10.1579/0044-7447(2008)37[272:SADOTK]2.0.CO;2; Miehe G, 2014, QUATERNARY SCI REV, V86, P190, DOI 10.1016/j.quascirev.2013.12.004; National Research Council (NRC) Committee on Rangeland Classification, 1994, RANG HLTH NEW METH C; Oesterheld M, 2004, OIKOS, V107, P576, DOI 10.1111/j.0030-1299.2004.13442.x; Pech RP, 2007, J APPL ECOL, V44, P615, DOI 10.1111/j.1365-2664.2007.01287.x; Piao SL, 2011, AGR FOREST METEOROL, V151, P1599, DOI 10.1016/j.agrformet.2011.06.016; Qu JP, 2013, MAMM BIOL, V78, P68, DOI 10.1016/j.mambio.2012.09.005; Retzer V, 2007, BASIC APPL ECOL, V8, P147, DOI 10.1016/j.baae.2006.05.002; Ryavec K. E., 1998, GeoJournal, V44, P61, DOI 10.1023/A:1006815130932; Schaller GB., 1998, WILDLIFE TIBETAN STE; Shang ZH, 2014, RANGELAND J, V36, P267, DOI 10.1071/RJ14008; Shang ZH, 2013, PLANT SOIL, V364, P229, DOI 10.1007/s11104-012-1362-9; Shen MG, 2011, AGR FOREST METEOROL, V151, P1711, DOI 10.1016/j.agrformet.2011.07.003; Shen MG, 2011, P NATL ACAD SCI USA, V108, pE91, DOI 10.1073/pnas.1018390108; Shi XM, 2013, ECOL ENG, V57, P183, DOI 10.1016/j.ecoleng.2013.04.032; SHI Y, 1983, Acta Theriologica Sinica, V3, P181; SMITH A E, 1990, P14; Smith Andrew T., 2006, P285; Smith AT, 1999, ANIM CONSERV, V2, P235, DOI 10.1111/j.1469-1795.1999.tb00069.x; Smith AT, IUCN RED LIST THREAT; Sun JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099299; Wang LW, 2008, J GEOGR SCI, V18, P73, DOI 10.1007/s11442-008-0073-x; Wang XD, 2008, J ARID ENVIRON, V72, P1929, DOI 10.1016/j.jaridenv.2008.06.005; Wangdwei M, 2013, J MAMMAL, V94, P1077, DOI 10.1644/12-MAMM-A-253.1; Wei D, 2012, PLANT SOIL, V359, P45, DOI 10.1007/s11104-011-1105-3; Wilson MC, 2015, AMBIO, V44, P16, DOI 10.1007/s13280-014-0568-x; Wu GL, 2009, PLANT SOIL, V319, P115, DOI 10.1007/s11104-008-9854-3; Wu JS, 2014, ARCT ANTARCT ALP RES, V46, P419, DOI 10.1657/1938-4246-46.2.419; Wu JS, 2013, RANGELAND ECOL MANAG, V66, P454, DOI 10.2111/REM-D-12-00051.1; Wu JianShuang, 2012, Journal of Resources and Ecology, V3, P236; Wu N, 2002, ERDKUNDE, V56, P2, DOI DOI 10.3112/ERDKUNDE.2002.01.01; Xu AC, 2006, URSUS, V17, P132; Yan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081466; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yang ZL, 2013, OECOLOGIA, V171, P495, DOI 10.1007/s00442-012-2433-6; Yeh ET, 2011, AREA, V43, P165, DOI 10.1111/j.1475-4762.2010.00976.x; Yi SH, 2011, P NATL ACAD SCI USA, V108, pE94, DOI 10.1073/pnas.1100394108; Yu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049230; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhang YM, 2003, MAMMAL REV, V33, P284, DOI 10.1046/j.1365-2907.2003.00020.x; Zhang YQ, 1996, ARCTIC ALPINE RES, V28, P203, DOI 10.2307/1551761; Zhao L, 2004, GLOBAL PLANET CHANGE, V43, P19, DOI 10.1016/j.gloplacha.2004.02.003; Zhou Huakun, 2005, Grassland Science, V51, P191, DOI 10.1111/j.1744-697X.2005.00028.x	78	39	43	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132897	10.1371/journal.pone.0132897	http://dx.doi.org/10.1371/journal.pone.0132897			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208005	gold, Green Published			2022-12-27	WOS:000358622000043
J	Koer, ZA; Carter, R; Wu, G; Zhang, JH; Webster, RG				Koer, Zeynep A.; Carter, Robert; Wu, Gang; Zhang, Jinghui; Webster, Robert G.			The Genomic Contributions of Avian H1N1 Influenza A Viruses to the Evolution of Mammalian Strains	PLOS ONE			English	Article							PROTEIN; ORIGIN; SWINE; GENE	Among the influenza A viruses (IAVs) in wild aquatic birds, only H1, H2, and H3 subtypes have caused epidemics in humans. H1N1 viruses of avian origin have also caused 3 of 5 pandemics. To understand the reappearance of H1N1 in the context of pandemic emergence, we investigated whether avian H1N1 IAVs have contributed to the evolution of human, swine, and 2009 pandemic H1N1 IAVs. On the basis of phylogenetic analysis, we concluded that the polymerase gene segments (especially PB2 and PA) circulating in North American avian H1N1 IAVs have been reintroduced to swine multiple times, resulting in different lineages that led to the emergence of the 2009 pandemic H1N1 IAVs. Moreover, the similar topologies of hemagglutinin and nucleoprotein and neuraminidase and matrix gene segments suggest that each surface glycoprotein coevolved with an internal gene segment within the H1N1 subtype. The genotype of avian H1N1 IAVs of Charadriiformes origin isolated in 2009 differs from that of avian H1N1 IAVs of Anseriformes origin. When the antigenic sites in the hemagglutinin of all 31 North American avian H1N1 IAVs were considered, 60%-80% of the amino acids at the antigenic sites were identical to those in 1918 and/or 2009 pandemic H1N1 viruses. Thus, although the pathogenicity of avian H1N1 IAVs could not be inferred from the phylogeny due to the small dataset, the evolutionary process within the H1N1 IAV subtype suggests that the circulation of H1N1 IAVs in wild birds poses a continuous threat for future influenza pandemics in humans.	[Koer, Zeynep A.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Carter, Robert; Wu, Gang; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Webster, Robert G.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia	St Jude Children's Research Hospital; St Jude Children's Research Hospital; King Abdulaziz University	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.	robert.webster@stjude.org	Zhang, Jing/GWZ-7332-2022; Wu, Gang/M-8012-2014; Kocer, Zeynep A./P-8983-2019	Wu, Gang/0000-0002-1678-5864; Kocer, Zeynep A./0000-0001-9178-0142	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services [HHSN266200700005C]; ALSAC (American Lebanese Syrian Associated Charities); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ALSAC (American Lebanese Syrian Associated Charities)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Contract No. HHSN266200700005C from the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, and by ALSAC (American Lebanese Syrian Associated Charities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; KANEGAE Y, 1994, ARCH VIROL, V134, P17, DOI 10.1007/BF01379103; Kocer ZA, 2013, J VIROL; Kocer ZA, 2014, SCI REP-UK, V4, DOI 10.1038/srep07455; Kocer ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041609; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SCHOLTISSEK C, 1983, VIROLOGY, V129, P521, DOI 10.1016/0042-6822(83)90194-0; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tong S, 2013, NEW WORLD BATS ARE R; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109	28	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133795	10.1371/journal.pone.0133795	http://dx.doi.org/10.1371/journal.pone.0133795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208281	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000146
J	van der Plas, AGM; Vissers, KC; Francke, AL; Donker, GA; Jansen, WJJ; Deliens, L; Onwuteaka-Philipsen, BD				van der Plas, Annicka G. M.; Vissers, Kris C.; Francke, Anneke L.; Donker, Ge A.; Jansen, Wim J. J.; Deliens, Luc; Onwuteaka-Philipsen, Bregje D.			Involvement of a Case Manager in Palliative Care Reduces Hospitalisations at the End of Life in Cancer Patients; A Mortality Follow-Back Study in Primary Care	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; PREFERENCES	Background Case managers have been introduced in primary palliative care in the Netherlands; these are nurses with expertise in palliative care who offer support to patients and informal carers in addition to the care provided by the general practitioner (GP) and home-care nurse. Objectives To compare cancer patients with and without additional support from a case manager on: 1) the patients' general characteristics, 2) characteristics of care and support given by the GP, 3) palliative care outcomes. Methods This article is based on questionnaire data provided by GPs participating in two different studies: the Sentimelc study (280 cancer patients) and the Capalca study (167 cancer patients). The Sentimelc study is a mortality follow-back study amongst a representative sample of GPs that monitors the care provided via GPs to a general population of end-of-life patients. Data from 2011 and 2012 were analysed. The Capalca study is a prospective study investigating the implementation and outcome of the support provided by case managers in primary palliative care. Data were gathered between March 2011 and December 2013. Results The GP is more likely to know the preferred place of death (OR 7.06; CI 3.47-14.36), the place of death is more likely to be at the home (OR 2.16; CI 1.33-3.51) and less likely to be the hospital (OR 0.26; CI 0.13-0.52), and there are fewer hospitalisations in the last 30 days of life (none: OR 1.99; CI 1.12-3.56 and one: OR 0.54; CI 0.30-0.96), when cancer patients receive additional support from a case manager compared with patients receiving the standard GP care. Conclusions Involvement of a case manager has added value in addition to palliative care provided by the GP, even though the role of the case manager is 'only' advisory and he or she does not provide hands-on care or prescribe medication.	[van der Plas, Annicka G. M.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [van der Plas, Annicka G. M.; Francke, Anneke L.; Jansen, Wim J. J.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, Ctr Expertise Palliat Care, Amsterdam, Netherlands; [van der Plas, Annicka G. M.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Vissers, Kris C.] Radboud Univ Nijmegen, Dept Anaesthesiol Pain & Palliat Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Francke, Anneke L.] NIVEL Netherlands Inst Hlth Serv Res, Nursing Care, Utrecht, Netherlands; [Donker, Ge A.] NIVEL Primary Care Database, Sentinel Practices, Utrecht, Netherlands; [Jansen, Wim J. J.] Vrije Univ Amsterdam, Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands; [Deliens, Luc] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Deliens, Luc] Univ Ghent, Brussels, Belgium; [Deliens, Luc] Vrije Univ Brussel, End Of Life Care Res Grp, Ghent, Belgium; [Deliens, Luc] Univ Ghent, B-9000 Ghent, Belgium	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Netherlands Institute for Health Services Research; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Ghent University	van der Plas, AGM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	eol@vumc.nl	Vissers, Kris C.P./D-3569-2009; Vissers, Kris/H-8110-2014; Donker, Gé/AAX-8564-2021	Vissers, Kris C.P./0000-0002-2919-6356; Vissers, Kris/0000-0002-2919-6356; Deliens, Luc/0000-0002-8158-2422; van der Plas, Annicka/0000-0003-4599-1795; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248	Netherlands Organisation for Health Research and Development (ZonMw) [80-82100-98-066]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The authors wish to thank the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 80-82100-98-066] for their financial support. The funders had no role in study design, data collection and analysis, selection of respondents, decision to publish, or preparation of the manuscript.	Abarshi E, 2011, J PALLIAT MED, V14, P323, DOI 10.1089/jpm.2010.0312; Abarshi E, 2009, J PAIN SYMPTOM MANAG, V38, P568, DOI 10.1016/j.jpainsymman.2008.12.007; Becker G, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-43; Central Bureau for Statistics, POP COUNT; College Bescherming Persoonsgegevens [Dutch Data Protection Authority], INF DUTCH DAT PROT A; de Korte-Verhoef MC, 2014, THESIS VU U; De Roo ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093762; Dutch Government, WET BESCH PERS; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Groot MM, 2005, PALLIATIVE MED, V19, P111, DOI 10.1191/0269216305pm937oa; Ko W, 2013, EUR J CANCER, V49, P1967, DOI 10.1016/j.ejca.2013.01.006; Middelburg-Hebly M, 2014, PALLIATIEVE ZORG BEE; Minkman MMN, 2009, HEALTH SOC CARE COMM, V17, P485, DOI 10.1111/j.1365-2524.2009.00850.x; Nursing Staff Panel, 2012, SURV END LIF CAR; Quill TE, 2013, NEW ENGL J MED, V368, P1173, DOI 10.1056/NEJMp1215620; Rolden HJA, 2014, SOC SCI MED, V120, P110, DOI 10.1016/j.socscimed.2014.09.020; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Van den Block L, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-73; van der Plas AGM, BMC PALLIAT IN PRESS; van der Plas AGM, 2014, J PALLIATIV IN PRESS; van der Plas AGM, 2013, INT J NURS STUD, V50, P1504, DOI 10.1016/j.ijnurstu.2013.03.002; van der Velden Lud F J, 2009, BMC Palliat Care, V8, P4, DOI 10.1186/1472-684X-8-4; Vroomen JM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-132	26	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133197	10.1371/journal.pone.0133197	http://dx.doi.org/10.1371/journal.pone.0133197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208099	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000064
J	Yuan, AD; Hassinger, L; Rao, MV; Julien, JP; Miller, CCJ; Nixon, RA				Yuan, Aidong; Hassinger, Linda; Rao, Mala V.; Julien, Jean-Pierre; Miller, Christopher C. J.; Nixon, Ralph A.			Dissociation of Axonal Neurofilament Content from Its Transport Rate	PLOS ONE			English	Article							MOLECULAR-MASS SUBUNIT; IN-VIVO; RADIAL GROWTH; HEAVY SUBUNIT; PHOSPHORYLATED TAIL; ALPHA-INTERNEXIN; TRIPLET PROTEINS; CELL NEURONS; MICE LACKING; MOUSE MODEL	The axonal cytoskeleton of neurofilament (NF) is a long-lived network of fibrous elements believed to be a stationary structure maintained by a small pool of transported cytoskeletal precursors. Accordingly, it may be predicted that NF content in axons can vary independently from the transport rate of NF. In the present report, we confirm this prediction by showing that human NFH transgenic mice and transgenic mice expressing human NFL Ser55 (Asp) develop nearly identical abnormal patterns of NF accumulation and distribution in association with opposite changes in NF slow transport rates. We also show that the rate of NF transport in wild-type mice remains constant along a length of the optic axon where NF content varies 3-fold. Moreover, knockout mice lacking NFH develop even more extreme (6-fold) proximal to distal variation in NF number, which is associated with a normal wild-type rate of NF transport. The independence of regional NF content and NF transport is consistent with previous evidence suggesting that the rate of incorporation of transported NF precursors into a metabolically stable stationary cytoskeletal network is the major determinant of axonal NF content, enabling the generation of the striking local variations in NF number seen along axons.	[Yuan, Aidong; Rao, Mala V.; Nixon, Ralph A.] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Yuan, Aidong; Rao, Mala V.; Nixon, Ralph A.] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Nixon, Ralph A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Hassinger, Linda] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA; [Julien, Jean-Pierre] Univ Laval, Dept Anat & Physiol, Ctr Rech, CHU Laval, Quebec City, PQ, Canada; [Miller, Christopher C. J.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Miller, Christopher C. J.] Kings Coll London, Inst Psychiat, Clin Neurosci, London WC2R 2LS, England	Nathan Kline Institute for Psychiatric Research; New York University; New York University; Harvard University; McLean Hospital; Laval University; University of London; King's College London; University of London; King's College London	Yuan, AD (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA.	yuan@nki.rfmh.org; nixon@nki.rfmh.org		Nixon, Ralph A/0000-0001-5124-1021; Miller, Christopher/0000-0002-5130-1845; Rao, Mala/0000-0001-7985-2414	National Institutes on Aging Grant [AG05604]; United Kingdom Medical Research Council; Wellcome Trust; Medical Research Council [G0501573] Funding Source: researchfish; MRC [G0501573] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG005604, R37AG005604] Funding Source: NIH RePORTER	National Institutes on Aging Grant; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes on Aging Grant AG05604 (AY RAN MVR). The United Kingdom Medical Research Council and the Wellcome Trust (CCJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; BENNETT GS, 1985, J CELL BIOL, V100, P1799, DOI 10.1083/jcb.100.5.1799; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Brown A, 1998, J CELL SCI, V111, P455; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Francis F, 2005, J NEUROSCI RES, V79, P442, DOI 10.1002/jnr.20399; Gibb BJM, 1998, J NEUROCHEM, V70, P492; Gibb BJM, 1996, J NEUROCHEM, V66, P1306; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; GRIFFIN JW, 1978, SCIENCE, V202, P633, DOI 10.1126/science.81524; Grubb MS, 2011, J NEUROSCI, V31, P16049, DOI 10.1523/JNEUROSCI.4064-11.2011; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; Hirokawa N., 1991, NEURONAL CYTOSKELETO, P5; Hirokawa Nobutaka, 1993, Current Opinion in Neurobiology, V3, P724, DOI 10.1016/0959-4388(93)90144-N; HOFFMAN PN, 1983, J NEUROSCI, V3, P1694; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; Jacomy H, 1999, J NEUROCHEM, V73, P972, DOI 10.1046/j.1471-4159.1999.0730972.x; Jung CH, 2004, J NEUROSCI, V24, P9486, DOI 10.1523/JNEUROSCI.1665-04.2004; Jung CW, 1999, CELL MOTIL CYTOSKEL, V42, P230, DOI 10.1002/(SICI)1097-0169(1999)42:3<230::AID-CM6>3.3.CO;2-1; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; LEWIS SE, 1988, J CELL BIOL, V107, P2689, DOI 10.1083/jcb.107.6.2689; Li YY, 2012, J NEUROSCI, V32, P746, DOI 10.1523/JNEUROSCI.4926-11.2012; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; MONACO S, 1985, P NATL ACAD SCI USA, V82, P920, DOI 10.1073/pnas.82.3.920; NAKAGAWA T, 1995, J CELL BIOL, V129, P411, DOI 10.1083/jcb.129.2.411; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Rao MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044320; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Rao MV, 2002, J CELL BIOL, V158, P681, DOI 10.1083/jcb.200202037; Rao MV, 1998, J CELL BIOL, V143, P171, DOI 10.1083/jcb.143.1.171; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; Sanchez I, 2000, J CELL BIOL, V151, P1013, DOI 10.1083/jcb.151.5.1013; SCHLAEPFER WW, 1990, J NEUROCHEM, V55, P453, DOI 10.1111/j.1471-4159.1990.tb04157.x; Shen H, 2010, NEUROSCIENCE, V170, P16, DOI 10.1016/j.neuroscience.2010.07.014; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Yabe JT, 1999, J CELL SCI, V112, P3799; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5; Yuan A, 2015, MOL PSYCHIATR, V20, P986, DOI [10.1038/mp.2015.45, 10.1038/mp.2015.99]; Yuan AD, 1999, CELL MOL NEUROBIOL, V19, P733, DOI 10.1023/A:1006953022763; Yuan AD, 2000, CELL MOL NEUROBIOL, V20, P623, DOI 10.1023/A:1007090422866; Yuan AD, 2006, NEUROSCI LETT, V393, P264, DOI 10.1016/j.neulet.2005.10.029; Yuan AD, 1997, BRAIN RES, V771, P203, DOI 10.1016/S0006-8993(97)00766-X; Yuan AD, 2003, J NEUROSCI, V23, P9452; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Yuan AD, 2012, J NEUROSCI, V32, P8501, DOI 10.1523/JNEUROSCI.1081-12.2012; Yuan AD, 2011, ADV NEUROBIOL, V3, P189, DOI 10.1007/978-1-4419-6787-9_8; Yuan AD, 2011, ADV NEUROBIOL, V3, P503, DOI 10.1007/978-1-4419-6787-9_21; Yuan AD, 2009, J NEUROSCI, V29, P11316, DOI 10.1523/JNEUROSCI.1942-09.2009; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	61	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133848	10.1371/journal.pone.0133848	http://dx.doi.org/10.1371/journal.pone.0133848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208164	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000155
J	Abu Bakar, MR; Kadir, AA; Wahab, SZA; Karim, AHA; Hussain, NHN; Noor, NM; Omar, J; Bae, SB; Mahmood, WHW; Razak, AA; Yunus, R				Abu Bakar, Mohd Rizal; Kadir, Azidah Abdul; Wahab, Siti Zubaidah Abdul; Karim, Ahmad Helmy Abdul; Hussain, Nik Hazlina Nik; Noor, Norhayati Mohd; Omar, Julia; Bae, Saringat Bin Bai; Mahmood, Wan Haslindawani Wan; Razak, Asrenee Abdul; Yunus, Rohaizan			Randomized Controlled Trial on the Effect of Channa striatus Extract on Measurement of the Uterus, Pulsatility Index, Resistive Index of Uterine Artery and Superficial Skin Wound Artery in Post Lower Segment Caesarean Section Women	PLOS ONE			English	Article							HEALING PROPERTIES; VAGINAL DELIVERY; CETRIMIDE CREAM; BLOOD-FLOW; PUERPERIUM; HARUAN; ACID	Aim To compare the mean of anteroposterior (AP) measurements of the uterus in longitudinal and oblique transverse planes, and the pulsatility index (PI) and resistive index (RI) of the uterine artery and superficial skin wound artery between patients taking Channa striatus and placebo. Background Channa striatus, also known as haruan, is a fresh water snakehead fish consumed in many parts of Southeast Asia. Channa striatus is also normally consumed by women postpartum to promote wound healing as well as to reduce post-operative pain. Methodology This study is a randomised, double blind, placebo-controlled study conducted in women after Lower Segment Caesarean Section (LSCS). Subjects were randomised to either a Channa striatus or a placebo group and were given a daily dosage of 500 mg of Channa striatus extract or 500 mg maltodextrin, respectively, for six weeks post LSCS. The anteroposterior measurements of the uterus in the longitudinal and oblique transverse planes, and the pulsatility index (PI) and resistive index (RI) of the uterine and superficial skin wound arteries were assessed using pelvic Gray-scale ultrasound and Doppler ultrasound at baseline (Day 3) and at two weeks, four weeks and six weeks post-operatively. Results Sixty-six subjects were randomised into the study with 33 in the Channa striatus group and 33 in the placebo group. No significant differences were detected in terms of the pulsatility index (PI) and the resistive index (RI) of the uterine and superficial skin wound arteries between the Channa striatus and placebo groups. However, in the Channa striatus group, the AP measurements of the uterus on the longitudinal and oblique transverse planes were significantly lower compared to the placebo group (p<0.05 and p<0.001, respectively). Conclusion Daily intake of Channa striatus extract results in marked differences compared to placebo in terms of uterine involution and recovery in women post LSCS.	[Abu Bakar, Mohd Rizal] Univ Sains Malaysia, Adv Med & Dent Inst, Kubang Kerian, Malaysia; [Kadir, Azidah Abdul; Wahab, Siti Zubaidah Abdul; Karim, Ahmad Helmy Abdul; Hussain, Nik Hazlina Nik; Noor, Norhayati Mohd; Omar, Julia; Mahmood, Wan Haslindawani Wan; Razak, Asrenee Abdul] Univ Sains Malaysia, Sch Med Sci, Kubang Kerian, Malaysia; [Bae, Saringat Bin Bai] Univ Sains Malaysia, Sch Pharmaceut Sci, Kubang Kerian, Malaysia; [Yunus, Rohaizan] Int Med Univ, Seremban, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; International Medical University Malaysia	Kadir, AA (corresponding author), Univ Sains Malaysia, Sch Med Sci, Kubang Kerian, Malaysia.	azidahkb@usm.my	Kadir, Azidah Abdul/E-5006-2012; Nik Hussain, Nik Hazlina/G-5453-2015; Norhayati, Mohd Noor/E-3868-2012; Omar, Julia/AAM-5077-2020; Norhayati, Mohd Noor/ABH-3248-2021; Ab Razak, Asrenee/N-1604-2015	Kadir, Azidah Abdul/0000-0003-1039-6304; Nik Hussain, Nik Hazlina/0000-0002-9476-062X; Norhayati, Mohd Noor/0000-0002-6372-1476; Norhayati, Mohd Noor/0000-0002-6372-1476; Omar, Julia/0000-0003-4165-2673; Ab Razak, Asrenee/0000-0002-0832-2560	Universiti Sains Malaysia [1001/PPSP/812090]	Universiti Sains Malaysia(Universiti Sains Malaysia)	The study was funded by Universiti Sains Malaysia, Grant Number: 1001/PPSP/812090. Azidah Abdul Kadir received the grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bdour ANA, 2004, SAUDI MED J, V25, P41; Azidah AK, 2014, AGRO FOOD IND HI TEC, V25, P44; Baie SH, 2000, J ETHNOPHARMACOL, V73, P15, DOI 10.1016/S0378-8741(00)00253-1; Baie SH, 2000, J ETHNOPHARMACOL, V71, P93, DOI 10.1016/S0378-8741(99)00184-1; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Ho M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/918291; Hong Min, 2003, Zhongguo Zhong Yao Za Zhi, V28, P1162; Jais AMM, 1998, GEN PHARMACOL, V30, P561, DOI 10.1016/S0306-3623(97)00305-4; JAIS AMM, 1994, GEN PHARMACOL, V25, P947, DOI 10.1016/0306-3623(94)90101-5; Lee P.G., 1991, NATURE MALAYSIA, V16, P113; Mat Jais AM, 2007, B LATINOAM CARIBE PL, V6, P53; Mohd Shafri M A, 2012, Malays J Nutr, V18, P125; Mulic-Lutvica A, 2007, ACTA OBSTET GYN SCAN, V86, P1207, DOI 10.1080/00016340701621569; Nakai Y, 1997, EUR J OBSTET GYN R B, V74, P121, DOI 10.1016/S0301-2115(97)02760-7; Negishi H, 1999, ARCH GYNECOL OBSTET, V263, P13, DOI 10.1007/s004040050253; OBrien WF, 1995, CLIN PERINATOL, V22, P973, DOI 10.1016/S0095-5108(18)30265-3; Salamonsen LA, 2003, REPRODUCTION, V125, P301, DOI 10.1530/rep.0.1250301; Somchit MN., 2004, J ORIENT PHARM EXP M, V4, P91; Syed Hassan SAA, 2012, MALAYS J MED SCI, V19, P87; Takamoto N, 1998, CONNECT TISSUE RES, V37, P163, DOI 10.3109/03008209809002436; TEKAY A, 1993, AM J OBSTET GYNECOL, V168, P190, DOI 10.1016/S0002-9378(12)90913-8; van Schoubroeck D, 2004, ULTRASOUND OBST GYN, V23, P378, DOI 10.1002/uog.963; Zakaria ZA, 2007, CLIN EXP PHARMACOL P, V34, P198, DOI 10.1111/j.1440-1681.2007.04572.x; Zhao Ding, 2006, Zhongguo Zhong Yao Za Zhi, V31, P243	24	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133514	10.1371/journal.pone.0133514	http://dx.doi.org/10.1371/journal.pone.0133514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222158	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800054
J	Alexandre, J; Hof, T; Puddu, PE; Rouet, R; Guinamard, R; Manrique, A; Beygui, F; Salle, L; Milliez, P				Alexandre, Joachim; Hof, Thomas; Puddu, Paolo Emilio; Rouet, Rene; Guinamard, Romain; Manrique, Alain; Beygui, Farzin; Salle, Laurent; Milliez, Paul			Rapid and MR-Independent I-K1 Activation by Aldosterone during Ischemia-Reperfusion	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; INWARD RECTIFIER CURRENT; MINERALOCORTICOID RECEPTOR; MYOCARDIAL-INFARCTION; POTASSIUM CURRENT; ATRIAL-FIBRILLATION; PLASMA-ALDOSTERONE; CA2+ CURRENT; K+ CHANNELS; QT SYNDROME	In ST elevation myocardial infarction (STEMI) context, clinical studies have shown the deleterious effect of high aldosterone levels on ventricular arrhythmia occurrence and cardiac mortality. Previous in vitro reports showed that during ischemia-reperfusion, aldosterone modulates K+ currents involved in the holding of the resting membrane potential (RMP). The aim of this study was to assess the electrophysiological impact of aldosterone on I-K1 current during myocardial ischemia-reperfusion. We used an in vitro model of "border zone" using right rabbit ventricle and standard microelectrode technique followed by cell-attached recordings from freshly isolated rabbit ventricular cardiomyocytes. In microelectrode experiments, aldosterone (10 and 100 nmol/L, n=7 respectively) increased the action potential duration (APD) dispersion at 90% between ischemic and normoxic zones (from 95 +/- 4 ms to 116 +/- 6 ms and 127 +/- 5 ms respectively, P<0.05) and reperfusion-induced sustained premature ventricular contractions occurrence (from 2/12 to 5/7 preparations, P<0.05). Conversely, potassium canrenoate 100 nmol/L and RU 28318 1 mu mol/l alone did not affect AP parameters and premature ventricular contractions occurrence (except Vmax which was decreased by potassium canrenoate during simulated-ischemia). Furthermore, aldosterone induced a RMP hyperpolarization, evoking an implication of a K+ current involved in the holding of the RMP. Cell-attached recordings showed that aldosterone 10 nmol/L quickly activated (within 6.2 +/- 0.4 min) a 30 pS K+-selective current, inward rectifier, with pharmacological and biophysical properties consistent with the I-K1 current (NPo = 1.9 +/- 0.4 in control vs NPo=3.0 +/- 0.4, n=10, P<0.05). These deleterious effects persisted in presence of RU 28318, a specific MR antagonist, and were successfully prevented by potassium canrenoate, a non specific MR antagonist, in both microelectrode and patch-clamp recordings, thus indicating a MR-independent I-K1 activation. In this ischemia-reperfusion context, aldosterone induced rapid and MR-independent deleterious effects including an arrhythmia substrate (increased APD(90) dispersion) and triggered activities (increased premature ventricular contractions occurrence on reperfusion) possibly related to direct I-K1 activation.	[Alexandre, Joachim; Beygui, Farzin; Milliez, Paul] CHU Caen, Dept Cardiol, F-14000 Caen, France; [Alexandre, Joachim; Hof, Thomas; Rouet, Rene; Guinamard, Romain; Manrique, Alain; Salle, Laurent; Milliez, Paul] Univ Caen Basse Normandie, EA Signalisat Electrophysiol & Imagerie Lesions I, Caen, France; [Puddu, Paolo Emilio] Univ Roma La Sapienza, Dept Cardiovasc Sci, I-00185 Rome, Italy; [Rouet, Rene; Guinamard, Romain; Manrique, Alain; Beygui, Farzin; Salle, Laurent; Milliez, Paul] Univ Caen Basse Normandie, Sch Med, F-14000 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Sapienza University Rome; Universite de Caen Normandie; Universite de Franche-Comte	Milliez, P (corresponding author), CHU Caen, Dept Cardiol, F-14000 Caen, France.	milliez-p@chu-caen.fr	Puddu, Paolo Emilio/G-6180-2012; Alexandre, Joachim/ABE-6176-2020; Alexandre, Joachim/ABE-2490-2020	Puddu, Paolo Emilio/0000-0002-6191-7838; Alexandre, Joachim/0000-0002-9197-8404; 	Federation Francaise de Cardiologie	Federation Francaise de Cardiologie	JA was supported by the Federation Francaise de Cardiologie.	Alexandre J, 2015, J CARDIOVASC PHARM T, V20, P313, DOI 10.1177/1074248414557036; Alexandre J, 2014, J CARDIOVASC PHARM, V64, P134, DOI 10.1097/FJC.0000000000000097; Alexandre J, 2014, J CARDIOVASC PHARM, V63, P49, DOI 10.1097/FJC.0000000000000023; Alexandre Joachim, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P52; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Azibani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038197; Barbato JC, 2004, HYPERTENSION, V44, P751, DOI 10.1161/01.HYP.0000144466.11568.7e; Bebarova M, 2014, J PHYSIOL PHARMACOL, V65, P497; Benitah JP, 1999, CIRC RES, V85, P1139; Beygui F, 2006, CIRCULATION, V114, P2604, DOI 10.1161/CIRCULATIONAHA.106.634626; Beygui F, 2013, INT J CARDIOL, V167, P73, DOI 10.1016/j.ijcard.2011.11.076; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Boixel C, 2006, AM J PHYSIOL-HEART C, V290, pH2257, DOI 10.1152/ajpheart.01060.2005; Brette F, 2013, J MOL CELL CARDIOL, V57, P96, DOI 10.1016/j.yjmcc.2013.01.012; Caballero R, 2003, CIRCULATION, V107, P889, DOI 10.1161/01.CIR.0000048189.58449.F7; Christ M, 1999, VITAM HORM, V57, P325; Collins A, 2005, J CELL PHYSIOL, V202, P76, DOI 10.1002/jcp.20093; CORABOEUF E, 1974, J PHARMACOL EXP THER, V191, P128; Deo M, 2013, P NATL ACAD SCI USA, V110, P4291, DOI 10.1073/pnas.1218154110; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; ELSHERIF N, 1982, CIRC RES, V51, P152, DOI 10.1161/01.RES.51.2.152; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Ferrario CM, 2015, CIRC RES, V116, P206, DOI 10.1161/CIRCRESAHA.116.302706; Girerd N, 2013, EUR J HEART FAIL, V15, P1228, DOI 10.1093/eurjhf/hft100; KIYOSUE T, 1993, J PHYSIOL-LONDON, V468, P85, DOI 10.1113/jphysiol.1993.sp019761; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; LOMBES M, 1995, CIRCULATION, V92, P175, DOI 10.1161/01.CIR.92.2.175; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; Mihailidou AS, 2004, ENDOCRINOLOGY, V145, P773, DOI 10.1210/en.2003-1137; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; MURDOCK DK, 1980, CIRCULATION, V61, P175, DOI 10.1161/01.CIR.61.1.175; Niederer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060323; OLIVER MF, 1994, LANCET, V343, P155, DOI 10.1016/S0140-6736(94)90939-3; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Paajanen V, 2004, AM J PHYSIOL-REG I, V286, pR405, DOI 10.1152/ajpregu.00500.2003; Perrier R, 2005, J PHYSIOL-LONDON, V569, P153, DOI 10.1113/jphysiol.2005.092692; Piao L, 2007, BASIC RES CARDIOL, V102, P416, DOI 10.1007/s00395-007-0659-y; Picard S, 1998, J MOL CELL CARDIOL, V30, P2613, DOI 10.1006/jmcc.1998.0819; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 2005, J AM COLL CARDIOL, V46, P425, DOI 10.1016/j.jacc.2005.04.038; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Reil JC, 2012, EUR HEART J, V33, P2098, DOI 10.1093/eurheartj/ehr266; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; Shah NC, 2007, J HYPERTENS, V25, P2345, DOI 10.1097/HJH.0b013e3282e9a72d; Shimizu W, 1998, CIRCULATION, V98, P2314, DOI 10.1161/01.CIR.98.21.2314; Stambler BS, 2009, HEART RHYTHM, V6, P776, DOI 10.1016/j.hrthm.2009.02.005; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Thomsen MB, 2006, PHARMACOL THERAPEUT, V112, P150, DOI 10.1016/j.pharmthera.2005.04.009; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; Wehling M, 1998, J CLIN ENDOCR METAB, V83, P3517, DOI 10.1210/jc.83.10.3517; WEHLING M, 1992, AM J PHYSIOL, V263, pE974, DOI 10.1152/ajpendo.1992.263.5.E974; Wenzel S, 2010, BASIC RES CARDIOL, V105, P247, DOI 10.1007/s00395-009-0059-6	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132592	10.1371/journal.pone.0132592	http://dx.doi.org/10.1371/journal.pone.0132592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222262	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800025
J	Pander, J; van Huis-Tanja, L; Bohringer, S; van der Straaten, T; Gelderblom, H; Punt, C; Guchelaar, HJ				Pander, Jan; van Huis-Tanja, Lieke; Bohringer, Stefan; van der Straaten, Tahar; Gelderblom, Hans; Punt, Cornelis; Guchelaar, Henk-Jan			Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE LEVELS; EXPRESSION; IDENTIFICATION; CHEMOTHERAPY; ACTIVATION; MUTATIONS; CARCINOMA; EFFICACY; MARKERS; GENES	Purpose Despite expanding options for systemic treatment, survival for metastatic colorectal cancer (mCRC) remains limited and individual response is difficult to predict. In search of pre-treatment predictors, pharmacogenetic research has mainly used a candidate gene approach. Genome wide association (GWA) studies offer the benefit of simultaneously analyzing a large number of SNPs, in both known and still unidentified functional regions. Using a GWA approach, we searched for genetic markers affecting progression free survival (PFS) in mCRC patients treated with first-line capecitabine, oxaliplatin and bevacizumab (CAPOX-B), with or without cetuximab. Patients and Methods 755 patients were included in the CAIRO2-trial, a multicenter phase III trial, randomizing between first-line treatment with CAPOX-B versus CAPOX-B plus cetuximab. Germline DNA and complete clinical information was available from 553 patients and genome wide genotyping was performed, using Illumina's OmniExpress beadchip arrays, with 647,550 markers passing all quality checks. Another 2,202,473 markers were imputated by using HapMap2. Association with PFS was analysed using a Cox proportional hazards model. Results One marker, rs885036, associated significantly with PFS (P = 2.17x10(-8)) showing opposite effects on PFS depending on treatment arm. The minor allele was associated with increased PFS in patients receiving cetuximab. A cluster of markers located on chromosome 8 associated with PFS, irrespective of treatment arm (P-values of 2.30x10(-7) to 1.04x10(-6)). Conclusion This is the first GWA study to find SNPs affecting PFS in mCRC patients treated with CAPOX-B, either with or without cetuximab. Rs885036 is a potential predictive marker for cetuximab efficacy. These markers need to be validated in independent treatment cohorts.	[Pander, Jan; van der Straaten, Tahar; Guchelaar, Henk-Jan] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-2300 RC Leiden, Netherlands; [van Huis-Tanja, Lieke; Gelderblom, Hans] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands; [Bohringer, Stefan] Leiden Univ, Med Ctr, Dept Biostat & Bioinformat, NL-2300 RC Leiden, Netherlands; [Punt, Cornelis] Acad Med Ctr Amsterdam, Dept Med Oncol, NL-1100 DD Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Guchelaar, HJ (corresponding author), Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, POB 9600, NL-2300 RC Leiden, Netherlands.	h.j.guchelaar@lumc.nl	guchelaar, henk-jan/AAP-1381-2021	Guchelaar, Henk-Jan/0000-0002-7085-1383; Gelderblom, Hans/0000-0001-9270-8636	Dutch Cancer Society [UL2009-4528]; Dutch Cancer Foundation KWF [200502]; Roche; Merck-Serono; Sanofi-Aventis; DxS	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Cancer Foundation KWF(KWF Kankerbestrijding); Roche(Roche Holding); Merck-Serono(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); DxS	This pharmacogenetic substudy was financially supported by a grant from the Dutch Cancer Society UL2009-4528. The Dutch Colorectal Cancer Group (DCCG) CAIRO2 study was supported by the Dutch Cancer Foundation KWF (Grant 200502) and by unrestricted scientific grants from Roche, Merck-Serono, Sanofi-Aventis and DxS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2010, J LIPID RES, V51, P2143, DOI 10.1194/jlr.M004762; [Anonymous], DAT SINGL NUCL POL D; Azuma M, 2007, PHARMACOGENOMICS, V8, P1705, DOI 10.2217/14622416.8.12.1705; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coon M, 2003, MOL CANCER THER, V2, P1067; D'Arrigo A, 2005, INT J CANCER, V115, P256, DOI 10.1002/ijc.20883; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Edwards MS, 2012, COLORECTAL DIS, V14, pe31, DOI 10.1111/j.1463-1318.2011.02765.x; Fernandez-Rozadilla C, 2013, PHARMACOGENOMICS J, V13, P209, DOI 10.1038/tpj.2012.2; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Jiao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052535; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kim JC, 2011, CLIN CANCER RES, V17, P1200, DOI 10.1158/1078-0432.CCR-10-1907; Kim JC, 2010, CANCER SCI, V101, P1007, DOI 10.1111/j.1349-7006.2009.01461.x; Kudo T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-32; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Mansilla F, 2009, J MOL MED, V87, P85, DOI 10.1007/s00109-008-0409-0; Pander J, 2011, ANN ONCOL, V22, P1147, DOI 10.1093/annonc/mdq572; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Phipps AI, 2015, GASTROENTEROLOGY, V148, P77, DOI 10.1053/j.gastro.2014.09.038; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saltz L, 2012, CLIN COLORECTAL CANC, V11, P101, DOI 10.1016/j.clcc.2011.05.006; Scartozzi M, 2012, BRIT J CANCER, V106, P799, DOI 10.1038/bjc.2012.17; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stadler ZK, 2010, J CLIN ONCOL, V28, P4255, DOI 10.1200/JCO.2009.25.7816; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Yarnall JM, 2013, CANCER EPIDEMIOL, V37, P324, DOI 10.1016/j.canep.2012.12.008	38	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131091	10.1371/journal.pone.0131091	http://dx.doi.org/10.1371/journal.pone.0131091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222057	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800013
J	Curto-Reyes, V; Kirschmann, G; Pertin, M; Drexler, SK; Decosterd, I; Suter, MR				Curto-Reyes, Verdad; Kirschmann, Guylene; Pertin, Marie; Drexler, Stephan K.; Decosterd, Isabelle; Suter, Marc R.			Neuropathic Pain Phenotype Does Not Involve the NLRP3 Inflammasome and Its End Product Interleukin-1 beta in the Mice Spared Nerve Injury Model	PLOS ONE			English	Article							SPINAL GLIAL ACTIVATION; NECROSIS-FACTOR-ALPHA; RAT SCIATIC-NERVE; THERMAL HYPERALGESIA; IL-1-BETA SECRETION; BRAIN-INJURY; EXPRESSION; CORD; INJECTION; RECEPTORS	The NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome is one of the main sources of interleukin-1 beta (IL-1 beta) and is involved in several inflammatory-related pathologies. To date, its relationship with pain has not been studied in depth. The aim of our study was to elucidate the role of NLRP3 inflammasome and IL-1 beta production on neuropathic pain. Results showed that basal pain sensitivity is unaltered in NLRP3(-/-) mice as well as responses to formalin test. Spared nerve injury (SNI) surgery induced the development of mechanical allodynia and thermal hyperalgesia in a similar way in both genotypes and did not modify mRNA levels of the NLRP3 inflammasome components in the spinal cord. Intrathecal lipopolysaccharide (LPS) injection increases apoptosis-associated speck like protein (ASC), caspase-1 and IL-1 beta expression in both wildtype and NLRP3(-/-) mice. Those data suggest that NLRP3 is not involved in neuropathic pain and also that other sources of IL-1 beta are implicated in neuroinflammatory responses induced by LPS.	[Curto-Reyes, Verdad; Kirschmann, Guylene; Pertin, Marie; Decosterd, Isabelle; Suter, Marc R.] Lausanne Univ Hosp CHUV, Pain Ctr, Dept Anesthesiol, Lausanne, Switzerland; [Curto-Reyes, Verdad; Kirschmann, Guylene; Pertin, Marie; Decosterd, Isabelle; Suter, Marc R.] Univ Lausanne, Lausanne, Switzerland; [Curto-Reyes, Verdad; Kirschmann, Guylene; Pertin, Marie; Decosterd, Isabelle] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Drexler, Stephan K.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; University of Lausanne	Suter, MR (corresponding author), Lausanne Univ Hosp CHUV, Pain Ctr, Dept Anesthesiol, Lausanne, Switzerland.	marc.suter@chuv.ch	Menendez, Luis/AAH-1542-2019	Menendez, Luis/0000-0003-1617-4171	Swiss National Science Foundation grants [310030A_124996, 33CM30-124117]; IASP Early Career Grant - ScanDesign Foundation BY INGER JENS BRUUN; Swiss Society of Anesthesiology	Swiss National Science Foundation grants(Swiss National Science Foundation (SNSF)); IASP Early Career Grant - ScanDesign Foundation BY INGER JENS BRUUN; Swiss Society of Anesthesiology	Swiss National Science Foundation grants 310030A_124996 (ID) and 33CM30-124117 (MRS and ID), the 2011 IASP Early Career Grant funded by the ScanDesign Foundation BY INGER & JENS BRUUN (MRS) and the Swiss Society of Anesthesiology (MRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baamonde A, 2007, LIFE SCI, V81, P673, DOI 10.1016/j.lfs.2007.07.003; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Cahill CM, 2003, BRAIN RES, V960, P209, DOI 10.1016/S0006-8993(02)03885-4; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Clark AK, 2010, J NEUROSCI, V30, P573, DOI 10.1523/JNEUROSCI.3295-09.2010; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Cordero MD, 2014, ANTIOXID REDOX SIGN, V20, P1169, DOI 10.1089/ars.2013.5198; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; Falchi M, 2001, DRUG EXP CLIN RES, V27, P97; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; Fu D, 2006, NEUROCHEM RES, V31, P333, DOI 10.1007/s11064-005-9032-4; FUKUOKA H, 1994, BRAIN RES, V657, P133, DOI 10.1016/0006-8993(94)90960-1; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gruber-Schoffnegger D, 2013, J NEUROSCI, V33, P6540, DOI 10.1523/JNEUROSCI.5087-12.2013; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Gustafson-Vickers SL, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-63; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Jia HB, 2013, NEUROSCI LETT, V543, P130, DOI 10.1016/j.neulet.2013.03.046; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Klusakova I, 2009, ANN ANAT, V191, P248, DOI 10.1016/j.aanat.2009.02.007; Kuipers MT, 2012, ANESTHESIOLOGY, V116, P1104, DOI 10.1097/ALN.0b013e3182518bc0; Lee HL, 2004, NEUROREPORT, V15, P2807; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lopes AH, 2015, PAIN, V156, P451, DOI 10.1097/01.j.pain.0000460322.72396.53; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; OKA T, 1993, BRAIN RES, V624, P61, DOI 10.1016/0006-8993(93)90060-Z; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Piller Nicolas, 2013, BMC Res Notes, V6, P266, DOI 10.1186/1756-0500-6-266; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Shi FS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-73; da Silva KABS, 2011, PAIN, V152, P1872, DOI 10.1016/j.pain.2011.04.005; Sung CS, 2004, BRAIN RES, V1015, P145, DOI 10.1016/j.brainres.2004.04.068; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Tadano T, 1999, LIFE SCI, V65, P255, DOI 10.1016/S0024-3205(99)00244-1; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Winkelstein BA, 2001, J COMP NEUROL, V439, P127; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	62	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133707	10.1371/journal.pone.0133707	http://dx.doi.org/10.1371/journal.pone.0133707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218747	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900042
J	Nishihara, E; Hirokawa, M; Ito, M; Fukata, S; Nakamura, H; Amino, N; Miyauchi, A				Nishihara, Eijun; Hirokawa, Mitsuyoshi; Ito, Mitsuru; Fukata, Shuji; Nakamura, Hirotoshi; Amino, Nobuyuki; Miyauchi, Akira			Graves' Disease Patients with Persistent Hyperthyroidism and Diffuse Lymphoplasmacytic Infiltration in the Thyroid Show No Histopathological Compatibility with IgG4-Related Disease	PLOS ONE			English	Article							HASHIMOTOS-THYROIDITIS; IGG4	Background IgG4-related disease is a novel disease entity characterized by diffuse lymphoplasmacytic infiltration rich in IgG4-positive plasma cells and fibrosis into multiple organs. There is still controversy over whether some thyroid diseases are actually IgG4-related disease. The objective of this study was to elucidate the clinicopathological features of Graves' disease with diffuse lymphoplasmacytic infiltration in the thyroid. Patients and Methods Among 1,484 Graves' disease patients who underwent thyroidectomy, we examined their histopathological findings including the degree of lymphoplasmacytic and fibrotic infiltration and levels of IgG4-positive plasma cells in the thyroid. Their clinical pictures were defined by laboratory and ultrasonographic evaluation. Results A total of 11 patients (0.74%) showed diffuse lymphoplasmacytic infiltration in the stroma of the thyroid gland. Meanwhile, other patients showed variable lymphoid infiltration ranging from absent to focally dense but no aggregation of plasma cells in the thyroid gland. Based on the diagnostic criteria of IgG4-related disease, 5 of the 11 subjects had specifically increased levels of IgG4-positive plasma cells in the thyroid. Fibrotic infiltration was present in only 1 patient developing hypothyroidism after anti-thyroid drug treatment for 4 years, but not in the other 10 patients with persistent hyperthyroidism. Obliterative phlebitis was not identified in any of the 11 subjects. Thyroid ultrasound examination showed 1 patient developing hypothyroidism who had diffuse hypoechogenicity, but the other hyperthyroid patients had a coarse echo texture. Conclusions In our study, Graves' disease patients with persistent hyperthyroidism who had diffuse lymphoplasmacytic infiltration rich in IgG4-positive plasma cells in the thyroid showed no concomitant fibrosis or obliterative phlebitis.	[Nishihara, Eijun; Hirokawa, Mitsuyoshi; Ito, Mitsuru; Fukata, Shuji; Nakamura, Hirotoshi; Amino, Nobuyuki; Miyauchi, Akira] Kuma Hosp, Ctr Excellence Thyroid Care, Kobe, Hyogo, Japan	Kuma Hospital	Nishihara, E (corresponding author), Kuma Hosp, Ctr Excellence Thyroid Care, Kobe, Hyogo, Japan.	nishihara@kuma-h.or.jp	Nishihara, Eijun/AAU-9152-2021	Nishihara, Eijun/0000-0003-1786-0077; Hirokawa, Mitsuyoshi/0000-0001-5558-7142; Miyauchi, Akira/0000-0003-0041-197X				Biddinger PW, 2009, DIAGNOSTIC PATHOLOGY, P60; Biddinger PW, 2009, DIAGNOSTIC PATHOLOGY, P39; Bozkirli E, 2014, CLIN ENDOCR IN PRESS; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; FATOURECHI V, 1971, MAYO CLIN PROC, V46, P682; Hammerstad SS, 2014, THYROID, V24, P537, DOI 10.1089/thy.2013.0287; HAYASHI N, 1986, J CLIN ULTRASOUND, V14, P123, DOI 10.1002/jcu.1870140208; Kawashima ST, 2014, ENDOCRINE, V45, P236, DOI 10.1007/s12020-013-9988-9; KNECHT H, 1981, VIRCHOWS ARCH A, V393, P215, DOI 10.1007/BF00431078; Kojima M, 2010, PATHOBIOLOGY, V77, P267, DOI 10.1159/000319873; Li YQ, 2012, MODERN PATHOL, V25, P1086, DOI 10.1038/modpathol.2012.68; Li YQ, 2010, J CLIN ENDOCR METAB, V95, P1309, DOI 10.1210/jc.2009-1794; Li YQ, 2009, PATHOL INT, V59, P636, DOI 10.1111/j.1440-1827.2009.02419.x; Nishihara E, 2008, THYROID, V18, P1221, DOI 10.1089/thy.2008.0096; Nishihara E, 2013, THYROID, V23, P1496, DOI 10.1089/thy.2013.0181; Rapoport B, 2014, J CLIN ENDOCR METAB, V99, P4060, DOI 10.1210/jc.2014-3011; SOSTRE S, 1991, J ENDOCRINOL INVEST, V14, P115, DOI 10.1007/BF03350281; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Takeshima K, 2014, THYROID, V24, P736, DOI 10.1089/thy.2013.0448; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z	20	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134143	10.1371/journal.pone.0134143	http://dx.doi.org/10.1371/journal.pone.0134143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218874	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900087
J	Thiam, AR; Pincet, F				Thiam, Abdou Rachid; Pincet, Frederic			The Energy of COPI for Budding Membranes	PLOS ONE			English	Article							LIPID DROPLETS; CURVATURE; TENSION; DEFORMATIONS; MECHANISMS; STABILITY; TRANSPORT; PROTEINS; VESICLES; FISSION	As a major actor of cellular trafficking, COPI coat proteins assemble on membranes and locally bend them to bud 60 nm-size coated particles. Budding requires the energy of the coat assembly to overcome the one necessary to deform the membrane which primarily depends on the bending modulus and surface tension, gamma. Using a COPI-induced oil nano-droplet formation approach, we modulated the budding of nanodroplets using various amounts and types of surfactant. We found a Heaviside-like dependence between the budding efficiency and.: budding was only dependent on. and occurred beneath 1.3 mN/m. With the sole contribution of. to the membrane deformation energy, we assessed that COPI supplies similar to 1500 k(B)T for budding particles from membranes, which is consistent with common membrane deformation energies. Our results highlight how a simple remodeling of the composition of membranes could mechanically modulate budding in cells.	[Thiam, Abdou Rachid; Pincet, Frederic] Univ Paris Diderot, Univ Paris 06, Ecole Normale Super Paris, CNRS,Lab Phys Stat, F-75005 Paris, France; [Thiam, Abdou Rachid; Pincet, Frederic] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Yale University	Thiam, AR (corresponding author), Univ Paris Diderot, Univ Paris 06, Ecole Normale Super Paris, CNRS,Lab Phys Stat, 24 Rue Lhomond, F-75005 Paris, France.	thiam@lps.ens.fr; pincet@lps.ens.fr		PINCET, FREDERIC/0000-0002-4243-2157	 [PIOF-GA-2011-299292]		This work was supported by International Outgoing Fellowship no PIOF-GA-2011-299292 to ART.	Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Faini M, 2012, SCIENCE, V336, P1451, DOI 10.1126/science.1221443; Foret L, 2008, P NATL ACAD SCI USA, V105, P14763, DOI 10.1073/pnas.0801173105; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Kabalnov A, 1996, LANGMUIR, V12, P276, DOI 10.1021/la950359e; Kabalnov A, 1996, J COLLOID INTERF SCI, V184, P227, DOI 10.1006/jcis.1996.0615; Kozlov MM, 2002, TRAFFIC, V3, P256, DOI 10.1034/j.1600-0854.2002.030403.x; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Manneville JB, 2008, P NATL ACAD SCI USA, V105, P16946, DOI 10.1073/pnas.0807102105; Marsh D, 2006, CHEM PHYS LIPIDS, V144, P146, DOI 10.1016/j.chemphyslip.2006.08.004; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; Pinot M, 2010, MOL MEMBR BIOL, V27, P428, DOI 10.3109/09687688.2010.510485; Saleem M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7249; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Sens P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238101; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Thiam AR, 2013, P NATL ACAD SCI USA, V110, P13244, DOI 10.1073/pnas.1307685110; Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yeung A, 2000, COLLOID SURFACE A, V174, P169, DOI 10.1016/S0927-7757(00)00509-4; Yildirim OE, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1938227; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	29	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133757	10.1371/journal.pone.0133757	http://dx.doi.org/10.1371/journal.pone.0133757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218078	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900045
J	Wang, JY; Li, L; Zhang, Z; Qiu, HP; Li, DM; Fang, Y; Jiang, H; Chai, RY; Mao, XQ; Wang, YL; Sun, GC				Wang, Jiaoyu; Li, Ling; Zhang, Zhen; Qiu, Haiping; Li, Dongmei; Fang, Yuan; Jiang, Hua; Chai, Rong Yao; Mao, Xueqin; Wang, Yanli; Sun, Guochang			One of Three Pex11 Family Members Is Required for Peroxisomal Proliferation and Full Virulence of the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							MEDIATED PLANT INFECTION; WORONIN BODY FORMATION; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; BETA-OXIDATION; BIOGENESIS; GRISEA; DIVISION; GENE	Peroxisomes play important roles in metabolisms of eukaryotes and infection of plant fungal pathogens. These organelles proliferate by de novo formation or division in response to environmental stimulation. Although the assembly of peroxisomes was documented in fungal pathogens, their division and its relationship to pathogenicity remain obscure. In present work, we analyzed the roles of three Pex11 family members in peroxisomal division and pathogenicity of the rice blast fungus Magnaporthe oryzae. Deletion of MoPEX11A led to fewer but enlarged peroxisomes, and impaired the separation of Woronin bodies from peroxisomes, while deletion of MoPEX11B or MoPEX11C put no evident impacts to peroxisomal profiles. MoPEX11A mutant exhibited typical peroxisome related defects, delayed conidial germination and appressoria formation, and decreased appressorial turgor and host penetration. As a result, the virulence of MoPEX11A mutant was greatly reduced. Deletion of MoPEX11B and MoPEX11C did not alter the virulence of the fungus. Further, double or triple deletions of the three genes were unable to enhance the virulence decrease in MoPEX11A mutant. Our data indicated that MoPEX11A is the main factor modulating peroxisomal division and is required for full virulence of the fungus.	[Wang, Jiaoyu; Li, Ling; Zhang, Zhen; Qiu, Haiping; Li, Dongmei; Fang, Yuan; Jiang, Hua; Chai, Rong Yao; Mao, Xueqin; Wang, Yanli; Sun, Guochang] Zhejiang Acad Agr Sci, Inst Plant Protect Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Li, Ling] Zhejiang Agr & Forest Univ, Sch Agr & Food Sci, Hangzhou, Zhejiang, Peoples R China; [Fang, Yuan] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang A&F University; Zhejiang Normal University	Sun, GC (corresponding author), Zhejiang Acad Agr Sci, Inst Plant Protect Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China.	sungc01@sina.com			National Natural Science Foundation of China [30900933, 31170136, 31470249, 30970082]; National Basic Research Program (973) from the Ministry of Science and Technology of China [2012CB722504]; Zhejiang Provincial Natural Science Foundation [Q13C140004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973) from the Ministry of Science and Technology of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by the grants (No. 30900933, 31170136 and 31470249 to JW and 30970082 to GS) from National Natural Science Foundation of China and the National Basic Research Program (973) (No. 2012CB722504) from the Ministry of Science and Technology of China and the grants (Q13C140004 to YF) from Zhejiang Provincial Natural Science Foundation (http://www.nsfc.gov.cn/Portal0/default152.htm; http://www.973.gov.cn/AreaAppl.aspx; http://www.zjnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe I, 1998, FEBS LETT, V431, P468, DOI 10.1016/S0014-5793(98)00815-1; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Bonnet C, 2006, MOL MICROBIOL, V62, P157, DOI 10.1111/j.1365-2958.2006.05353.x; Camoes F, 2009, J INHERIT METAB DIS, V32, P163, DOI 10.1007/s10545-008-1018-3; Cepinska MN, 2011, TRAFFIC, V12, P925, DOI 10.1111/j.1600-0854.2011.01198.x; CRAWFORD MS, 1986, GENETICS, V114, P1111; Delille HK, 2010, J CELL SCI, V123, P2750, DOI 10.1242/jcs.062109; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Elgersma Y, 1996, BBA-REV BIOMEMBRANES, V1286, P269, DOI 10.1016/S0304-4157(96)00012-3; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Escano CS, 2009, EUKARYOT CELL, V8, P296, DOI 10.1128/EC.00197-08; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Fagarasanu A, 2010, NAT REV MOL CELL BIO, V11, P644, DOI 10.1038/nrm2960; Fujihara N, 2010, MOL PLANT MICROBE IN, V23, P436, DOI 10.1094/MPMI-23-4-0436; Geuze HJ, 2003, MOL BIOL CELL, V14, P2900, DOI 10.1091/mbc.E02-11-0734; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Huber A, 2012, TRAFFIC, V13, P157, DOI 10.1111/j.1600-0854.2011.01290.x; Hynes MJ, 2010, FEMS MICROBIOL LETT, V306, P67, DOI 10.1111/j.1574-6968.2010.01934.x; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch J, 2012, J CELL SCI, V125, P3813, DOI 10.1242/jcs.102178; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Krensel P, 2006, EUR J CELL BIOL, V85, P55; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085252; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Lingard MJ, 2006, J CELL SCI, V119, P1961, DOI 10.1242/jcs.02904; Lingard MJ, 2009, P NATL ACAD SCI USA, V106, P4561, DOI 10.1073/pnas.0811329106; Liu FF, 2008, J CELL BIOL, V180, P325, DOI 10.1083/jcb.200705049; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Magliano P, 2011, J BIOL CHEM, V286, P42133, DOI 10.1074/jbc.M111.279687; Managadze D, 2007, TRAFFIC, V8, P687, DOI 10.1111/j.1600-0854.2007.00560.x; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Nagotu S, 2010, TRAFFIC, V11, P175, DOI 10.1111/j.1600-0854.2009.01019.x; NOTTEGHEM JL, 1992, PHYTOPATHOLOGY, V82, P421, DOI 10.1094/Phyto-82-421; Opalinski L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035490; Orth T, 2007, PLANT CELL, V19, P333, DOI 10.1105/tpc.106.045831; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Rho HS, 2001, MOL CELLS, V12, P407; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Schluter A, 2010, NUCLEIC ACIDS RES, V38, pD800, DOI 10.1093/nar/gkp935; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Tanaka A, 2003, BIOCHEM BIOPH RES CO, V300, P819, DOI 10.1016/S0006-291X(02)02936-4; Tey WK, 2005, MOL BIOL CELL, V16, P2651, DOI 10.1091/mbc.e04-10-0937; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; van der Klei Ida J, 2013, Subcell Biochem, V69, P135, DOI 10.1007/978-94-007-6889-5_8; Vanacova S, 2003, INT J PARASITOL, V33, P235, DOI 10.1016/S0020-7519(02)00267-9; VANDENBOSCH H, 1993, BIOCHIMIE, V75, P183, DOI 10.1016/0300-9084(93)90076-5; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P802, DOI 10.1631/jzus.B0860001; Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475	64	9	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134249	10.1371/journal.pone.0134249	http://dx.doi.org/10.1371/journal.pone.0134249			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218097	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900101
J	Ranaivomanana, P; Raharimanga, V; Dubois, PM; Richard, V; Razanamparany, VR				Ranaivomanana, Paulo; Raharimanga, Vaomalala; Dubois, Patrice M.; Richard, Vincent; Razanamparany, Voahangy Rasolofo			Study of the BCG Vaccine-Induced Cellular Immune Response in Schoolchildren in Antananarivo, Madagascar	PLOS ONE			English	Article							TUBERCULIN SKIN-TEST; CALMETTE-GUERIN VACCINATION; GAMMA RELEASE ASSAYS; ROUTINE CLINICAL-PRACTICE; INTERFERON-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IFN-GAMMA; INFECTION; CHILDREN	Objective Although the Bacillus Calmette-Guerin vaccine (BCG) protects young children against serious forms of TB, protection against pulmonary TB is variable. We assessed BCG vaccine-induced cellular immune responses and determined for how long they could be detected during childhood in Antananarivo, Madagascar. Methods We assessed BCG vaccine-induced cellular immune responses by TST and IGRA (in-house ELISPOT assay) using BCG and PPD as stimulation antigen, and compared results between vaccinated and non-vaccinated schoolchildren of two age groups, 6-7 and 13-14 years old. Results Three hundred and sixty-three healthy schoolchildren were enrolled. TST was performed on 351 children and IGRA on 142. A high proportion (66%; 229/343) of the children had no TST reactivity (induration size 0 mm). TST-positive responses (>= 15 mm) were more prevalent among 13-14 year-old (31.7%) than 6-7 year old (16.5%) children, both in the non-vaccinated (43% vs. 9%, p<0.001) and vaccinated (29% vs. 13%, p=0.002) subgroups. There were no significant differences in TST responses between vaccinated and non-vaccinated children in either of the age groups. The IGRA response to BCG and to PPD stimulation was not significantly different according to BCG vaccination record or to age group. A high rate (15.5%; 22/142) of indeterminate IGRA responses was observed. There was very poor agreement between TST and IGRA-PPD findings (k=0.08) and between TST and IGRA-BCG findings (k=0.02) Conclusion Analysis of TST and IGRA response to stimulation with BCG and PPD revealed no difference in immune response between BCG-vaccinated and non-vaccinated children; also no decrease of the BCG vaccine-induced cellular immune response over time was observed. We conclude that TST and IGRA have limitations in assessing a role of BCG or tuberculosis- related immunity.	[Ranaivomanana, Paulo; Razanamparany, Voahangy Rasolofo] Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo, Madagascar; [Raharimanga, Vaomalala; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Dubois, Patrice M.] Immunovacc Consulting, Hevillers, Belgium; [Richard, Vincent] Inst Pasteur, Epidemiol Unit, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Razanamparany, VR (corresponding author), Inst Pasteur Madagascar, Mycobacteria Unit, Antananarivo, Madagascar.	vrasolof@pasteur.mg		Vincent, RICHARD/0000-0002-6961-1753	Institut Pasteur de Madagascar (IPM); EDCTP [EDCTP GC_ct_05_32080]; ImmunoVacc Consulting	Institut Pasteur de Madagascar (IPM); EDCTP; ImmunoVacc Consulting	This work was funded by a grant from the Institut Pasteur de Madagascar (IPM) and EDCTP (EDCTP GC_ct_05_32080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ImmunoVacc Consulting provided support in the form of salaries for author PMD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abebe F, 2012, CLIN EXP IMMUNOL, V169, P213, DOI 10.1111/j.1365-2249.2012.04614.x; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Beffa P, 2008, EUR RESPIR J, V31, P842, DOI 10.1183/09031936.00117207; Bergeri I, 2002, Med Trop (Mars), V62, P634; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Escobar AL, 2004, INT J TUBERC LUNG D, V8, P45; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; HARBOE M, 1981, AM REV RESPIR DIS, V124, P80; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Jenum S, 2014, PEDIAT INFECT DIS J; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Kaufmann SHE, 2010, J INTERN MED, V267, P337, DOI 10.1111/j.1365-2796.2010.02216.x; Kleinert S, 2012, ANN RHEUM DIS, V71, P1791, DOI 10.1136/annrheumdis-2011-200941; Kobashi Y, 2009, EUR RESPIR J, V33, P812, DOI 10.1183/09031936.00075008; Lagrange P H, 1977, Dev Biol Stand, V38, P223; Lee YM, 2013, INFECT CHEMOTHER, V45, P44, DOI 10.3947/ic.2013.45.1.44; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Lutwama F, 2014, J INFECT DIS, V209, P887, DOI 10.1093/infdis/jit570; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Marchant A, 1999, J IMMUNOL, V163, P2249; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015; Moodie Z, 2012, METHODS MOL BIOL, V792, P185, DOI 10.1007/978-1-61779-325-7_15; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Pang Y, 2015, VACCINE, V33, P209, DOI 10.1016/j.vaccine.2014.10.030; Raharimanga V, 2012, TROP MED INT HEALTH, V17, P871, DOI 10.1111/j.1365-3156.2012.03013.x; Rakotosamimanana N, 2012, CLIN VACCINE IMMUNOL, V17, P1094; Ratovoson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095494; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Salehzadeh F., 2009, International Journal of Tropical Medicine, V4, P37; Sayyahfar S, 2014, J EPIDEMIOL GLOB HEA, V4, P45, DOI 10.1016/j.jegh.2013.09.002; Shaik J, 2013, PAEDIAT RESP REV; Sleiman R, 2007, PEDIATR INFECT DIS J, V26, P134, DOI 10.1097/01.inf.0000253058.48277.86; Smith SG, 2012, EUR J IMMUNOL, V42, P2511, DOI 10.1002/eji.201142297; Smith SG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-35; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Suciliene E, 1999, INT J TUBERC LUNG D, V3, P956; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2014, WHO REPORT 2014	56	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0127590	10.1371/journal.pone.0127590	http://dx.doi.org/10.1371/journal.pone.0127590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214514	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300002
J	Reddin, CJ; Docmac, F; O'Connor, NE; Bothwell, JH; Harrod, C				Reddin, Carl J.; Docmac, Felipe; O'Connor, Nessa E.; Bothwell, John H.; Harrod, Chris			Coastal Upwelling Drives Intertidal Assemblage Structure and Trophic Ecology	PLOS ONE			English	Article							HUMBOLDT CURRENT SYSTEM; BOTTOM-UP; SOUTH-AFRICA; TOP-DOWN; COMMUNITY REGULATION; SPECIES RICHNESS; STABLE-ISOTOPES; FOOD WEBS; NORTHERN; DELTA-N-15	Similar environmental driving forces can produce similarity among geographically distant ecosystems. Coastal oceanic upwelling, for example, has been associated with elevated biomass and abundance patterns of certain functional groups, e.g., corticated macroalgae. In the upwelling system of Northern Chile, we examined measures of intertidal macrobenthic composition, structure and trophic ecology across eighteen shores varying in their proximity to two coastal upwelling centres, in a hierarchical sampling design (spatial scales of >1 and >10 km). The influence of coastal upwelling on intertidal communities was confirmed by the stable isotope values (delta C-13 and delta N-15) of consumers, including a dominant suspension feeder, grazers, and their putative resources of POM, epilithic biofilm, and macroalgae. We highlight the utility of muscle delta N-15 from the suspension feeding mussel, Perumytilus purpuratus, as a proxy for upwelling, supported by satellite data and previous studies. Where possible, we used corrections for broader-scale trends, spatial autocorrelation, ontogenetic dietary shifts and spatial baseline isotopic variation prior to analysis. Our results showed macroalgal assemblage composition, and benthic consumer assemblage structure, varied significantly with the intertidal influence of coastal upwelling, especially contrasting bays and coastal headlands. Coastal topography also separated differences in consumer resource use. This suggested that coastal upwelling, itself driven by coastline topography, influences intertidal communities by advecting nearshore phytoplankton populations offshore and cooling coastal water temperatures. We recommend the isotopic values of benthic organisms, specifically long-lived suspension feeders, as in situ alternatives to offshore measurements of upwelling influence.	[Reddin, Carl J.; O'Connor, Nessa E.; Harrod, Chris] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Docmac, Felipe; Harrod, Chris] Univ Antofagasta, Inst Ciencias Nat Alexander Von Humboldt, Antofagasta, Chile; [O'Connor, Nessa E.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Bothwell, John H.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Queens University Belfast; Universidad de Antofagasta; Queens University Belfast; Durham University	Reddin, CJ (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	creddin01@qub.ac.uk	Reddin, Carl J/D-2154-2016; Harrod, Chris/A-8830-2008	Reddin, Carl J/0000-0001-5930-1164; Harrod, Chris/0000-0002-5353-1556; O'Connor, Nessa/0000-0002-3133-0913; Bothwell, John/0000-0003-2964-5980	Department of Employment and Learning Northern Ireland; Comision Nacional de Investigacion Cientifica y Tecnologica project [MEL 81105006]	Department of Employment and Learning Northern Ireland; Comision Nacional de Investigacion Cientifica y Tecnologica project	CJR was funded by the Department of Employment and Learning Northern Ireland as part of his PhD thesis. CH & FD were funded through the Comision Nacional de Investigacion Cientifica y Tecnologica project MEL 81105006.	Allan EL, 2010, ESTUAR COAST SHELF S, V87, P463, DOI 10.1016/j.ecss.2010.02.004; Barnes C, 2007, FUNCT ECOL, V21, P356, DOI 10.1111/j.1365-2435.2006.01224.x; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Bode A, 2006, MAR ECOL PROG SER, V318, P89, DOI 10.3354/meps318089; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BOSMAN AL, 1987, OECOLOGIA, V72, P226, DOI 10.1007/BF00379273; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Bustamante RH, 1996, J EXP MAR BIOL ECOL, V196, P1, DOI 10.1016/0022-0981(95)00093-3; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Castilla JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110301; Castilla JC, 2008, REV BIOL MAR OCEANOG, V43, P457; Carr ME, 2003, DEEP-SEA RES PT II, V50, P3199, DOI 10.1016/j.dsr2.2003.07.015; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; Dubois S, 2007, MAR ECOL PROG SER, V336, P151, DOI 10.3354/meps336151; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; ENCEP, 2012, NIN SO OSC ENSO DIAG; Escribano R, 2004, CONT SHELF RES, V24, P37, DOI 10.1016/j.csr.2003.09.005; Escribano R, 2002, OCEANOGRAPHY ECOLOGY, P145; Feldman GC, 2014, OCEAN COLOR WEB AQUA; Fernandez M, 2000, REV CHIL HIST NAT, V73, P797; Fonseca T., 1987, INVESTIGACIONES PESQ, V34, P33; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; GOUGH L, 1994, OIKOS, V70, P271, DOI 10.2307/3545638; Hill JM, 2006, MAR ECOL PROG SER, V318, P63, DOI 10.3354/meps318063; Hill JM, 2008, ESTUAR COAST SHELF S, V80, P261, DOI 10.1016/j.ecss.2008.08.005; Kelaher BP, 2005, ESTUAR COAST SHELF S, V63, P155, DOI 10.1016/j.ecss.2004.10.017; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Lagos NA, 2008, ECOL MONOGR, V78, P245, DOI 10.1890/07-0041.1; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lefebvre S, 2009, MAR ECOL PROG SER, V390, P27, DOI 10.3354/meps08187; LESSER MP, 1992, J EXP MAR BIOL ECOL, V165, P91, DOI 10.1016/0022-0981(92)90291-H; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lorrain A, 2002, J EXP MAR BIOL ECOL, V275, P47, DOI 10.1016/S0022-0981(02)00220-4; Mallela J, 2008, MAR ECOL PROG SER, V368, P41, DOI 10.3354/meps07589; Maloy AP, 2013, MAR BIOL, V160, P479, DOI 10.1007/s00227-012-2105-4; Marin V., 2003, INVEST MAR, V31, P47, DOI DOI 10.4067/S0717-71782003000200005; Marincovich L. Jr., 1973, Natural Hist Mus Los Angeles Co Sci Bull, VNo. 16, P1; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mendez LT, 2002, GUIA BIODIVERSIDAD N; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; MENGE BA, 1992, ECOLOGY, V73, P755, DOI 10.2307/1940155; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; MULLIN MM, 1984, LIMNOL OCEANOGR, V29, P1267, DOI 10.4319/lo.1984.29.6.1267; Ng JSS, 2007, MAR CHEM, V103, P97, DOI 10.1016/j.marchem.2006.09.001; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; O'Connor NE, 2013, GLOBAL CHANGE BIOL, V19, P431, DOI 10.1111/gcb.12061; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; Oksanen J., 2007, COMMUN ECOL PACK, P631; Osorio F., 2012, R PACKAGE VERSION 02, V3, P4; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pinones A, 2007, CIENC MAR, V33, P37, DOI 10.7773/cm.v33i1.1226; R Core Team, 2021, R LANGUAGE ENV STAT; Richoux NB, 2014, MARINE ECOLOGY; Rivadeneira MM, 2010, AQUAT CONSERV, V20, P74, DOI 10.1002/aqc.1051; Romero OZ, 2002, GUIA BIODIVERSIDAD N; Rossi F, 2004, LIMNOL OCEANOGR, V49, P408, DOI 10.4319/lo.2004.49.2.0408; ROUGHGARDEN J, 1994, PHILOS T ROY SOC B, V343, P79, DOI 10.1098/rstb.1994.0010; Sanford E, 2001, MAR ECOL PROG SER, V209, P143, DOI 10.3354/meps209143; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Santelices B., 1989, ALGAS MARINAS CHILE; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Schmidt K, 2003, LIMNOL OCEANOGR, V48, P277, DOI 10.4319/lo.2003.48.1.0277; SIGMAN DM, 2009, ENCY OCEAN SCI, P40, DOI DOI 10.1016/B978-012374473-9.00632-9; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Smit AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081944; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tapia FJ, 2009, PROG OCEANOGR, V83, P278, DOI 10.1016/j.pocean.2009.07.035; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Ulloa O, 2001, GEOPHYS RES LETT, V28, P1591, DOI 10.1029/2000GL011548; Vokhshoori NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098087; WARTENBERG D, 1985, SYST ZOOL, V34, P259, DOI 10.2307/2413147; WHITTAKER R H, 1975, P385; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060	80	27	27	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0130789	10.1371/journal.pone.0130789	http://dx.doi.org/10.1371/journal.pone.0130789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214806	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000358594300004
J	Hoffmann, KQ; McGovern, M; Chiu, CC; de Pablo, JJ				Hoffmann, Kyle Quynn; McGovern, Michael; Chiu, Chi-cheng; de Pablo, Juan J.			Secondary Structure of Rat and Human Amylin across Force Fields	PLOS ONE			English	Article							ISLET AMYLOID POLYPEPTIDE; PROTEIN-FOLDING SIMULATIONS; ALPHA-HELICAL STATES; PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; DIABETES-MELLITUS; FIBRIL FORMATION; IAPP; PEPTIDE; MECHANICS	The aggregation of human amylin has been strongly implicated in the progression of Type II diabetes. This 37-residue peptide forms a variety of secondary structures, including random coils, alpha-helices, and beta-hairpins. The balance between these structures depends on the chemical environment, making amylin an ideal candidate to examine inherent biases in force fields. Rat amylin differs from human amylin by only 6 residues; however, it does not form fibrils. Therefore it provides a useful complement to human amylin in studies of the key events along the aggregation pathway. In this work, the free energy of rat and human amylin was determined as a function of alpha-helix and beta-hairpin content for the Gromos96 53a6, OPLS-AA/L, CHARMM22/CMAP, CHARMM22*, Amberff99sb*-ILDN, and Amberff03w force fields using advanced sampling techniques, specifically bias exchange metadynamics. This work represents a first systematic attempt to evaluate the conformations and the corresponding free energy of a large, clinically relevant disordered peptide in solution across force fields. The NMR chemical shifts of rIAPP were calculated for each of the force fields using their respective free energy maps, allowing us to quantitatively assess their predictions. We show that the predicted distribution of secondary structures is sensitive to the choice of force-field: Gromos53a6 is biased towards beta-hairpins, while CHARMM22/CMAP predicts structures that are overly alpha-helical. OPLS-AA/L favors disordered structures. Amberff99sb*-ILDN, AmberFF03w and CHARMM22* provide the balance between secondary structures that is most consistent with available experimental data. In contrast to previous reports, our findings suggest that the equilibrium conformations of human and rat amylin are remarkably similar, but that subtle differences arise in transient alpha-helical and beta-strand containing structures that the human peptide can more readily adopt. We hypothesize that these transient states enable dynamic pathways that facilitate the formation of aggregates and, eventually, amyloid fibrils.	[Hoffmann, Kyle Quynn; McGovern, Michael; de Pablo, Juan J.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Chiu, Chi-cheng] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan; [de Pablo, Juan J.] Argonne Natl Lab, Argonne, IL 60439 USA	University of Chicago; National Cheng Kung University; United States Department of Energy (DOE); Argonne National Laboratory	de Pablo, JJ (corresponding author), Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.	depablo@uchicago.edu	de Pablo, Juan/AAJ-9161-2021	Chiu, Chi-cheng/0000-0003-2385-6947	National Science Foundation, Division of Engineering, Chemical, Bioengineering, Environmental and Thermal Systems [CBET 1264021]	National Science Foundation, Division of Engineering, Chemical, Bioengineering, Environmental and Thermal Systems	This work is supported by the National Science Foundation, Division of Engineering, Chemical, Bioengineering, Environmental and Thermal Systems, CBET 1264021. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Andrews MN, 2011, BIOPHYS CHEM, V156, P43, DOI 10.1016/j.bpc.2010.12.007; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Baftizadeh F, 2012, J AM CHEM SOC, V134, P3886, DOI 10.1021/ja210826a; BALASUBRAMANIAM A, 1991, PEPTIDES, V12, P919, DOI 10.1016/0196-9781(91)90038-Q; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Branduardi D, 2005, J AM CHEM SOC, V127, P9147, DOI 10.1021/ja0512780; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; CARTER EA, 1989, CHEM PHYS LETT, V156, P472, DOI 10.1016/S0009-2614(89)87314-2; Chiu CC, 2013, BIOPHYS J, V105, P1227, DOI 10.1016/j.bpj.2013.07.029; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cino EA, 2012, J CHEM THEORY COMPUT, V8, P2725, DOI 10.1021/ct300323g; CLARK A, 1990, DIABETOLOGIA, V33, P285, DOI 10.1007/BF00403322; CLARK A, 1987, LANCET, V2, P231; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Crespo Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055701; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dupuis NF, 2011, J AM CHEM SOC, V133, P7240, DOI 10.1021/ja1081537; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; Engel MFM, 2006, J MOL BIOL, V356, P783, DOI 10.1016/j.jmb.2005.12.020; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Garcia AE, 2002, P NATL ACAD SCI USA, V99, P2782, DOI 10.1073/pnas.042496899; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; H&ouml;ppener J, N ENGL J MED, V343, P411; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jha S, 2009, J MOL BIOL, V389, P907, DOI 10.1016/j.jmb.2009.04.077; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; Lee CC, 2012, BIOPHYS J, V102, P1059, DOI 10.1016/j.bpj.2012.01.039; Li DW, 2010, J PHYS CHEM LETT, V1, P246, DOI 10.1021/jz9001345; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; Lindorff-Larsen K., 2012, PLOS ONE, V7, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0032131, 10.1371/journal.pone.0032131]; Lindorff-Larsen K, 2012, J AM CHEM SOC, V134, P3787, DOI 10.1021/ja209931w; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makin OS, 2004, J MOL BIOL, V335, P1279, DOI 10.1016/j.jmb.2003.11.048; Matveyenko AV, 2006, ILAR J, V47, P225, DOI 10.1093/ilar.47.3.225; McGovern M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818153; Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/nchem.1293, 10.1038/NCHEM.1293]; Miller C, 2013, J PHYS CHEM B, V117, P16066, DOI 10.1021/jp409755y; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mittal J, 2010, BIOPHYS J, V99, pL26, DOI 10.1016/j.bpj.2010.05.005; Murphy RD, 2012, BIOPHYS CHEM, V167, P1, DOI 10.1016/j.bpc.2012.03.010; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Okur A, 2003, J COMPUT CHEM, V24, P21, DOI 10.1002/jcc.10184; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Opie EL, 1901, J EXP MED, V5, P527, DOI 10.1084/jem.5.5.527; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patapati KK, 2011, BIOPHYS J, V101, P1766, DOI 10.1016/j.bpj.2011.08.044; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Piana S, 2007, J PHYS CHEM B, V111, P4553, DOI 10.1021/jp067873l; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Pietrucci F, 2009, J CHEM THEORY COMPUT, V5, P2197, DOI 10.1021/ct900202f; Qi RX, 2014, BIOMACROMOLECULES, V15, P122, DOI 10.1021/bm401406e; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Reddy AS, 2010, BIOPHYS J, V98, P443, DOI 10.1016/j.bpj.2009.10.029; Sakagashira S, 2000, AM J PATHOL, V157, P2101, DOI 10.1016/S0002-9440(10)64848-1; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Scalisi S, 2010, CHEMBIOCHEM, V11, P1856, DOI 10.1002/cbic.201000090; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Shim SH, 2009, P NATL ACAD SCI USA, V106, P6614, DOI 10.1073/pnas.0805957106; Singh S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4798460; Singh S, 2012, ANNU REV CHEM BIOMOL, V3, P369, DOI 10.1146/annurev-chembioeng-062011-081032; Singh S, 2011, J STAT PHYS, V145, P932, DOI 10.1007/s10955-011-0301-0; Smit B, 2001, FROM ALGORITHMS TO A; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Todorova N, 2008, J PHYS CHEM B, V112, P11137, DOI 10.1021/jp076825d; Todorova N, 2009, J PHYS CHEM B, V113, P3556, DOI 10.1021/jp809776v; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; WESTERMARK P, 1987, AM J PATHOL, V127, P414; WESTERMARK P, 1972, UPSALA J MED SCI, V77, P91, DOI 10.1517/03009734000000014; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Wu C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003211; Yoda T, 2004, CHEM PHYS LETT, V386, P460, DOI 10.1016/j.cplett.2004.01.078; Yonemoto IT, 2008, BIOCHEMISTRY-US, V47, P9900, DOI 10.1021/bi800828u	116	54	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134091	10.1371/journal.pone.0134091	http://dx.doi.org/10.1371/journal.pone.0134091			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221949	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800102
J	Radev, Z; Hermel, JM; Elipot, Y; Bretaud, S; Arnould, S; Duchateau, P; Ruggiero, F; Joly, JS; Sohm, F				Radev, Zlatko; Hermel, Jean-Michel; Elipot, Yannick; Bretaud, Sandrine; Arnould, Sylvain; Duchateau, Philippe; Ruggiero, Florence; Joly, Jean-Stephane; Sohm, Frederic			A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; COLLAGEN-VI DEFICIENCY; AQUATIC SURFACE RESPIRATION; SKELETAL-MUSCLE; MITOCHONDRIAL DYSFUNCTION; CYCLOPHILIN INHIBITOR; EXTRACELLULAR-MATRIX; GENETIC MODEL; ULLRICH; BEHAVIOR	Presently, human collagen VI-related diseases such as Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) remain incurable, emphasizing the need to unravel their etiology and improve their treatments. In UCMD, symptom onset occurs early, and both diseases aggravate with ageing. In zebrafish fry, morpholinos reproduced early UCMD and BM symptoms but did not allow to study the late phenotype. Here, we produced the first zebrafish line with the human mutation frequently found in collagen VI-related disorders such as UCMD and BM. We used a transcription activator-like effector nuclease (TALEN) to design the col6a1(ama605003)-line with a mutation within an essential splice donor site, in intron 14 of the col6a1 gene, which provoke an in-frame skipping of exon 14 in the processed mRNA. This mutation at a splice donor site is the first example of a template-independent modification of splicing induced in zebrafish using a targetable nuclease. This technique is readily expandable to other organisms and can be instrumental in other disease studies. Histological and ultrastructural analyzes of homozygous and heterozygous mutant fry and 3 months post-fertilization (mpf) fish revealed co-dominantly inherited abnormal myofibers with disorganized myofibrils, enlarged sarcoplasmic reticulum, altered mitochondria and misaligned sarcomeres. Locomotion analyzes showed hypoxia-response behavior in 9 mpf col6a1 mutant unseen in 3 mpf fish. These symptoms worsened with ageing as described in patients with collagen VI deficiency. Thus, the col6a1(ama605003)-line is the first adult zebrafish model of collagen VI-related diseases; it will be instrumental both for basic research and drug discovery assays focusing on this type of disorders.	[Radev, Zlatko; Sohm, Frederic] INRA, AMAGEN, UMS 1374, Jouy En Josas, Domaine De Vilv, France; [Radev, Zlatko; Sohm, Frederic] CNRS, AMAGEN, UMS 3504, Gif Sur Yvette, France; [Hermel, Jean-Michel] CNRS, INRA CASBAH Team, UMR 9197, NEURO Psi, Gif Sur Yvette, France; [Elipot, Yannick; Joly, Jean-Stephane] CNRS, NEURO Psi, DECA Team, UMR 9197, Gif Sur Yvette, France; [Bretaud, Sandrine; Ruggiero, Florence] Univ Lyon 1, CNRS, ENS Lyon, Inst Genom Fonct Lyon,UMR 5242, F-69365 Lyon, France; [Arnould, Sylvain; Duchateau, Philippe] CELLECTIS SA, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Hermel, JM (corresponding author), CNRS, INRA CASBAH Team, UMR 9197, NEURO Psi, Gif Sur Yvette, France.	jmhermel@inaf.cnrs-gif.fr; sohm@inaf.cnrs-gif.fr		BRETAUD, SANDRINE/0000-0002-1430-7359; RUGGIERO, Florence/0000-0003-2915-5359	Cellectis SA; Physiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA); CELLECTIS SA [13000408]; Animaux Modeles Aquatiques et GENetique (AMAGEN) [439549]; Fondation de la Recherche Medicale (FRM) [ING201401129350]; Conseil General de l'Essonne; French National Research Agency [ANR-10-INSB-04-01]; TEFOR-Investissement d'avenir [ANR-II-INBS-0014]	Cellectis SA(Cellartis); Physiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA); CELLECTIS SA(Cellartis); Animaux Modeles Aquatiques et GENetique (AMAGEN); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Conseil General de l'Essonne(General Electric); French National Research Agency(French National Research Agency (ANR)); TEFOR-Investissement d'avenir(French National Research Agency (ANR))	Cellectis SA supported the project in the form of a participation to ZR salary and to the running cost of the project and provided research material (i.e. the TALEN). SA and PD participated to the design of the TALEN and the technical choices related to gene targeting and to mutation detection. SA and PD did not participate to the choice of the gene to target nor did they participate to data collection or the analysis made to characterize the isolated mutants. ZR's PhD thesis was financed by Physiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA; contrat number NA; http://www.phase.inra.fr), CELLECTIS SA (#13000408; http://www.cellectis.com/) and Animaux Modeles Aquatiques et GENetique (AMAGEN, #439549; http://www.inaf.cnrs-gif.fr/neuro-psi/amagen.html); YE was supported by the Fondation de la Recherche Medicale (FRM; #ING201401129350; http://www.frm.org). The electron microscopy facilities of the Imagif Cell Biology Unit of the Gif campus (www.imagif.cnrs.fr) is supported by the Conseil General de l'Essonne (http://www.essonne.fr). The authors acknowledge the France-BioImaging infrastructure (http://france-bioimaging.org) supported by the French National Research Agency (ANR-10-INSB-04-01; http://www.agence-nationale-recherche.fr). This work has benefited from the support of TEFOR-Investissement d'avenir (#ANR-II-INBS-0014; http://tefor.net/main/pages/main/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for ZR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdallah SJ, 2015, J EXP BIOL, V218, P1777, DOI 10.1242/jeb.116343; Ahlborn LB, 2015, FAM CANCER, V14, P129, DOI 10.1007/s10689-014-9747-y; Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0; Bernardi P, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011387; Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009; Bertini Enrico, 2002, Eur J Paediatr Neurol, V6, P193, DOI 10.1053/ejpn.2002.0593; BETHLEM J, 1976, BRAIN, V99, P91, DOI 10.1093/brain/99.1.91; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bushby KMD, 2014, ADV EXP MED BIOL, V802, P185, DOI 10.1007/978-94-007-7893-1_12; CARLSEN F, 1961, J BIOPHYS BIOCHEM CY, V11, P95, DOI 10.1083/jcb.11.1.95; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Charvet Benjamin, 2012, Muscles Ligaments Tendons J, V2, P53; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; Clement EM, 2012, NEUROMUSCULAR DISORD, V22, P522, DOI 10.1016/j.nmd.2012.01.010; Deconinck N, 2015, J NEUROL NEUROSUR PS, V86, P1337, DOI 10.1136/jnnp-2013-307245; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gardner JC, 2014, HUM MUTAT, V35, P1354, DOI 10.1002/humu.22679; Gattazzo F, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00244; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Goody MF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001409; Grobler LA, 2004, BRIT J SPORT MED, V38, P697, DOI 10.1136/bjsm.2003.006502; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Haq RU, 1999, NEUROLOGY, V52, P174, DOI 10.1212/WNL.52.1.174; Hermanns-Le T, 2014, ULTRASTRUCT PATHOL, V38, P164, DOI 10.3109/01913123.2013.829151; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jiang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069089; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; Jonz MG, 2005, J EXP BIOL, V208, P1537, DOI 10.1242/jeb.01564; Jonz MG, 2006, RESP PHYSIOL NEUROBI, V154, P139, DOI 10.1016/j.resp.2006.01.004; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Kopp MU, 1997, EUR J BIOCHEM, V249, P489, DOI 10.1111/j.1432-1033.1997.00489.x; KRAMER DL, 1983, ENVIRON BIOL FISH, V8, P49, DOI 10.1007/BF00004945; KRAMER DL, 1983, ENVIRON BIOL FISH, V9, P145, DOI 10.1007/BF00690859; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; KUO HJ, 1995, EUR J BIOCHEM, V232, P364, DOI 10.1111/j.1432-1033.1995.364zz.x; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Maraldi NM, 2009, ADV ENZYME REGUL, V49, P197, DOI 10.1016/j.advenzreg.2008.12.009; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; McNeil DG, 2007, FRESHWATER BIOL, V52, P412, DOI 10.1111/j.1365-2427.2006.01705.x; Merlini L, 2008, NEUROTHERAPEUTICS, V5, P613, DOI 10.1016/j.nurt.2008.08.004; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Nolte H, 2014, J PROTEOME RES, V13, P2162, DOI 10.1021/pr5000335; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Nozu K, 2014, CLIN J AM SOC NEPHRO, V9, P1958, DOI 10.2215/CJN.04140414; Okada M, 2007, NEUROLOGY, V69, P1035, DOI 10.1212/01.wnl.0000271387.10404.4e; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Pan TC, 2014, J BIOL CHEM, V289, P10293, DOI 10.1074/jbc.M114.549311; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a; Pepe Guglielmina, 2002, Neuromuscul Disord, V12, P296, DOI 10.1016/S0960-8966(01)00275-9; Petrini S, 2007, NEUROMUSCULAR DISORD, V17, P587, DOI 10.1016/j.nmd.2007.04.010; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Quijano-Roy S, 2014, NEUROMUSCULAR DISORD, V24, P125, DOI 10.1016/j.nmd.2013.11.002; Ramanoudjame L, 2012, NEUROMUSCULAR DISORD, V22, P828, DOI 10.1016/j.nmd.2012.06.089; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Rouede D, 2014, BIOMED OPT EXPRESS, V5, P858, DOI 10.1364/BOE.5.000858; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Salminen A, 2014, AGEING RES REV, V16, P45, DOI 10.1016/j.arr.2014.05.004; Shakarchi K, 2013, J EXP BIOL, V216, P869, DOI 10.1242/jeb.079657; Solares Perez A, 2012, NEUROMUSCULAR DISORD, V22, P827, DOI [10.1016/j.nmd.2012.06.088, DOI 10.1016/J.NMD.2012.06.088]; Tagliavini Francesca, 2013, Muscles Ligaments Tendons J, V3, P281; Telfer WR, 2010, HUM MOL GENET, V19, P2433, DOI 10.1093/hmg/ddq126; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Valton J, 2014, METHODS, V69, P151, DOI 10.1016/j.ymeth.2014.06.013; van der Kooi AJ, 2006, ARCH NEUROL-CHICAGO, V63, P1617, DOI 10.1001/archneur.63.11.1617; Yonekawa T, 2015, J NEUROL NEUROSUR PS, V86, P280, DOI 10.1136/jnnp-2013-307052; Zamurs LK, 2015, J BIOL CHEM, V290, P4272, DOI 10.1074/jbc.M114.632208; Zou Y, 2008, J NEUROPATH EXP NEUR, V67, P144, DOI 10.1097/nen.0b013e3181634ef7; Zulian A, 2014, HUM MOL GENET, V23, P5353, DOI 10.1093/hmg/ddu254	88	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133986	10.1371/journal.pone.0133986	http://dx.doi.org/10.1371/journal.pone.0133986			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221953	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800092
J	Spiousas, I; Etchemendy, PE; Vergara, RO; Calcagno, ER; Eguia, MC				Spiousas, Ignacio; Etchemendy, Pablo E.; Vergara, Ramiro O.; Calcagno, Esteban R.; Eguia, Manuel C.			An Auditory Illusion of Proximity of the Source Induced by Sonic Crystals	PLOS ONE			English	Article							REVERBERANT ENERGY RATIO; DISTANCE PERCEPTION; LEVEL DISCRIMINATION; NEGATIVE REFRACTION; EGOCENTRIC DISTANCE; BINAURAL LOUDNESS; SOUND-ATTENUATION; RIGID CYLINDERS; ACOUSTIC-WAVES; CUES	In this work we report an illusion of proximity of a sound source created by a sonic crystal placed between the source and a listener. This effect seems, at first, paradoxical to naive listeners since the sonic crystal is an obstacle formed by almost densely packed cylindrical scatterers. Even when the singular acoustical properties of these periodic composite materials have been studied extensively (including band gaps, deaf bands, negative refraction, and birrefringence), the possible perceptual effects remain unexplored. The illusion reported here is studied through acoustical measurements and a psychophysical experiment. The results of the acoustical measurements showed that, for a certain frequency range and region in space where the focusing phenomenon takes place, the sonic crystal induces substantial increases in binaural intensity, direct-to-reverberant energy ratio and interaural cross-correlation values, all cues involved in the auditory perception of distance. Consistently, the results of the psychophysical experiment revealed that the presence of the sonic crystal between the sound source and the listener produces a significant reduction of the perceived relative distance to the sound source.	[Spiousas, Ignacio; Etchemendy, Pablo E.; Vergara, Ramiro O.; Calcagno, Esteban R.; Eguia, Manuel C.] Univ Nacl Quilmes, Lab Acust & Percepc Sonora, Bernal, Buenos Aires, Argentina		Eguia, MC (corresponding author), Univ Nacl Quilmes, Lab Acust & Percepc Sonora, Bernal, Buenos Aires, Argentina.	meguia@unq.edu.ar	Etchemendy, Pablo Esteban/AAE-1387-2019	Etchemendy, Pablo Esteban/0000-0001-9015-4190; Vergara, Ramiro Oscar/0000-0003-0504-0434; Spiousas, Ignacio/0000-0002-0283-4696	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 114-200801-00016]; Universidad Nacional de Quilmes (UNQ) [PUNQ 976/11]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Quilmes (UNQ)	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (http://www.conicet.gov.ar/), PIP 114-200801-00016 (MCE, ROV). This work was also supported by Universidad Nacional de Quilmes (UNQ) (http://www.unq.edu.ar), PUNQ 976/11 (MCE, ROV, IS, PEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2008, ACOUSTICS UNDERGROUN, P4167; Akeroyd MA, 2007, J ACOUST SOC AM, V121, P1077, DOI 10.1121/1.2404927; Ando Y, 2000, J SOUND VIB, V232, P101, DOI 10.1006/jsvi.1999.2687; Begault DR, 2001, J AUDIO ENG SOC, V49, P904; Blauert J., 1997, SPATIAL HEARING PSYC; BREMER CD, 1977, AM J PSYCHOL, V90, P645, DOI 10.2307/1421738; Brimijoin WO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083068; Bronkhorst A.W., 2002, MODELING AUDITORY DI; Bronkhorst A.W., 2001, PHYSL PSYCHOL BASES, P184; Bronkhorst AW, 1999, NATURE, V397, P517, DOI 10.1038/17374; BUUS S, 1990, J ACOUST SOC AM, V87, P2643, DOI 10.1121/1.399057; BUUS S, 1991, J ACOUST SOC AM, V90, P1371, DOI 10.1121/1.401928; Catic J, 2013, J ACOUST SOC AM, V134, P1232, DOI 10.1121/1.4812264; Cervera F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.023902; Chen LS, 2004, APPL PHYS LETT, V85, P1072, DOI 10.1063/1.1781351; Cicek A, 2012, J APPL PHYS, V111, DOI 10.1063/1.3676581; COLEMAN PD, 1963, PSYCHOL BULL, V60, P302, DOI 10.1037/h0045716; Dattorro J, 1997, J AUDIO ENG SOC, V45; Declercq NF, 2007, J ACOUST SOC AM, V121, P2011, DOI 10.1121/1.2709842; Farina A, 2000, AUDIO ENG SOC CONV, V108; Feng L, 2006, PHYS REV LETT, V96, DOI [10.1103/PhysRevLett.96.014301, 10.1103/PhysrevLett.96.014301]; Fluitt, 2013, AUDITORY PERCEPTION; Gupta BC, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036603; Hartmann WM, 1996, J ACOUST SOC AM, V99, P3678, DOI 10.1121/1.414965; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; HOLM S, 1979, SCAND J STAT, V6, P65; Holway A, P NATL ACAD SCI, P32; Knight David, 2010, THESIS U SOUTHAMPTON; Kolarik A, 2013, J ACOUST SOC AM, V134, P3395, DOI 10.1121/1.4824395; Kopco N, 2011, J ACOUST SOC AM, V130, P1530, DOI 10.1121/1.3613705; Larsen E, 2008, J ACOUST SOC AM, V124, P450, DOI 10.1121/1.2936368; Litovsky RY, 1999, J ACOUST SOC AM, V106, P1633, DOI 10.1121/1.427914; LITTLE AD, 1992, PERCEPTION, V21, P405, DOI 10.1068/p210405; Lokki T, 2011, J ACOUST SOC AM, V130, pEL345, DOI 10.1121/1.3647866; Lokki T, 2011, J ACOUST SOC AM, V129, pEL223, DOI 10.1121/1.3579145; Lu MH, 2007, NAT MATER, V6, P744, DOI 10.1038/nmat1987; Lubman D, 2010, J ACOUST SOC AM, V127, P193, DOI [10.1121/1.3384859, DOI 10.1121/1.3384859]; Lubman D, 2013, P MEET ACOUST, V19, DOI [10.1121/1.4800220, DOI 10.1121/1.4800220]; Madison G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008151; MAJERNIK V, 1978, ACUSTICA, V39, P117; MARTINEZSALA R, 1995, NATURE, V378, P241, DOI 10.1038/378241a0; MERSHON DH, 1979, PERCEPTION, V8, P311, DOI 10.1068/p080311; MERSHON DH, 1975, PERCEPT PSYCHOPHYS, V18, P409, DOI 10.3758/BF03204113; Moller H, 1996, J AUDIO ENG SOC, V44, P451; Moore BCJ, 2007, J ACOUST SOC AM, V121, P1604, DOI 10.1121/1.2431331; Nielsen SH, 1992, AUDIO ENG SOC CONV, V92, P3307; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; POLLACK I, 1959, J ACOUST SOC AM, V31, P1250, DOI 10.1121/1.1907852; Raman CV, 1922, P R SOC LOND A-CONTA, V100, P424, DOI 10.1098/rspa.1922.0007; Sanchez-Perez JV, 1998, PHYS REV LETT, V80, P5325, DOI 10.1103/PhysRevLett.80.5325; Shinn-Cunningham BG, 2000, P IEEE PCM, V2000, P227; Sukhovich A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014301; TOOLE FE, 1970, J ACOUST SOC AM, V48, P943, DOI 10.1121/1.1912233; Vassilantonopoulos SL, 2001, ACUSTICA, V87, P604; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409; Zahorik P, 2002, J ACOUST SOC AM, V112, P2110, DOI 10.1121/1.1506692; Zhang XD, 2004, APPL PHYS LETT, V85, P341, DOI 10.1063/1.1772854	60	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133271	10.1371/journal.pone.0133271	http://dx.doi.org/10.1371/journal.pone.0133271			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222281	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800045
J	Stalder, K; Vaz, PK; Gilkerson, JR; Baker, R; Whiteley, P; Ficorilli, N; Tatarczuch, L; Portas, T; Skogvold, K; Anderson, GA; Devlin, JM				Stalder, Kathryn; Vaz, Paola K.; Gilkerson, James R.; Baker, Rupert; Whiteley, Pam; Ficorilli, Nino; Tatarczuch, Liliana; Portas, Timothy; Skogvold, Kim; Anderson, Garry A.; Devlin, Joanne M.			Prevalence and Clinical Significance of Herpesvirus Infection in Populations of Australian Marsupials	PLOS ONE			English	Article							COMMON WOMBATS; GAMMAHERPESVIRUS; DISEASE; IDENTIFICATION; REACTIVATION; MORTALITIES; MANGE; CATS	Herpesviruses have been reported in several marsupial species, but molecular classification has been limited to four herpesviruses in macropodids, a gammaherpesvirus in two antechinus species (Antechinus flavipes and Antechinus agilis), a gammaherpesvirus in a potoroid, the eastern bettong (Bettongia gaimardi) and two gammaherpesviruses in koalas (Phascolarctos cinereus). In this study we examined a range of Australian marsupials for the presence of herpesviruses using molecular and serological techniques, and also assessed risk factors associated with herpesvirus infection. Our study population included 99 koalas (Phascolarctos cinereus), 96 eastern grey kangaroos (Macropus giganteus), 50 Tasmanian devils (Sarcophilus harrisii) and 33 common wombats (Vombatus ursinius). In total, six novel herpesviruses (one alphaherpesvirus and five gammaherpesviruses) were identified in various host species. The overall prevalence of detection of herpesvirus DNA in our study population was 27.2% (95% confidence interval (CI) of 22.6-32.2%), but this varied between species and reached as high as 45.4% (95% CI 28.1-63.7%) in common wombats. Serum antibodies to two closely related macropodid herpesviruses (macropodid herpesvirus 1 and 2) were detected in 44.3% (95% CI 33.1-55.9%) of animals tested. This also varied between species and was as high as 92% (95% CI 74.0-99.0%) in eastern grey kangaroos. A number of epidemiological variables were identified as positive predictors for the presence of herpesvirus DNA in the marsupial samples evaluated. The most striking association was observed in koalas, where the presence of Chlamydia pecorum DNA was strongly associated with the presence of herpesvirus DNA (Odds Ratio = 60, 95% CI 12.1-297.8). Our results demonstrate the common presence of herpesviruses in Australian marsupials and provide directions for future research.	[Stalder, Kathryn; Vaz, Paola K.; Gilkerson, James R.; Whiteley, Pam; Ficorilli, Nino; Tatarczuch, Liliana; Anderson, Garry A.; Devlin, Joanne M.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia; [Stalder, Kathryn; Baker, Rupert] Healesville Sanctuary, Australian Wildlife Hlth Ctr, Healesville, Vic, Australia; [Portas, Timothy] Tidbinbilla Nat Reserve, Vet & Res Ctr, Paddys River, ACT, Australia; [Skogvold, Kim] Murdoch Univ, Sch Vet & Life Sci, Conservat Med Program, Perth, WA, Australia; [Skogvold, Kim] Perth Zoo, Perth Zoo Vet Dept, S Perth, WA, Australia	University of Melbourne; Murdoch University	Devlin, JM (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia.	devlinj@unimelb.edu.au	Vaz, Paola K./D-8713-2015	Vaz, Paola K./0000-0001-6877-7383; Gilkerson, James/0000-0003-1801-4817; Tatarczuch, Liliana/0000-0001-9556-0753; Devlin, Joanne/0000-0003-0400-9670	Ian Potter Foundation; Vizard Foundation; Australian Research Council	Ian Potter Foundation; Vizard Foundation; Australian Research Council(Australian Research Council)	This work was supported by the Ian Potter Foundation. PW works with Wildlife Health Surveillance Victoria and receives support from The Vizard Foundation. JMD is supported by a fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ACLAND HM, 1981, J WILDLIFE DIS, V17, P471, DOI 10.7589/0090-3558-17.3.471; Amery-Gale J, 2014, J WILDLIFE DIS, V50, P334, DOI 10.7589/2013-07-165; Cai Y, 2002, J VET MED SCI, V64, P215, DOI 10.1292/jvms.64.215; CALLINAN RB, 1981, J WILDLIFE DIS, V17, P311, DOI 10.7589/0090-3558-17.2.311; Chmielewicz B, 2003, XENOTRANSPLANTATION, V10, P349, DOI 10.1034/j.1399-3089.2003.02074.x; DICKSON J, 1980, AUST VET J, V56, P463, DOI 10.1111/j.1751-0813.1980.tb02657.x; FINNIE EP, 1976, AUST VET J, V52, P294, DOI 10.1111/j.1751-0813.1976.tb00123.x; GASKELL RM, 1977, VET REC, V100, P128, DOI 10.1136/vr.100.7.128; Guliani S, 1999, VET MICROBIOL, V68, P59, DOI 10.1016/S0378-1135(99)00061-9; JOHNSON MA, 1985, ARCH VIROL, V85, P313, DOI 10.1007/BF01314240; Jones SM, 2005, AUST J ZOOL, V53, P339, DOI 10.1071/ZO05043; KERR A, 1981, AUST VET J, V57, P347, DOI 10.1111/j.1751-0813.1981.tb05847.x; Kibur M, 2000, SEX TRANSM DIS, V27, P425, DOI 10.1097/00007435-200009000-00001; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Martin RW, 1998, AUST VET J, V76, P411, DOI 10.1111/j.1751-0813.1998.tb12391.x; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Meier J, 2005, J CLIN MICROBIOL, V43, P1318, DOI 10.1128/JCM.43.3.1318-1324.2005; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Portas T, 2014, J WILDLIFE DIS, V50, P210, DOI 10.7589/2013-08-202; Roizman B, 2001, FIELDS VIROL, P2381; ROTHWELL JT, 1988, AUST VET J, V65, P360, DOI 10.1111/j.1751-0813.1988.tb14269.x; Shizuma Toru, 2008, Kansenshogaku Zasshi, V82, P451; Skerratt LF, 1999, J WILDLIFE DIS, V35, P633, DOI 10.7589/0090-3558-35.4.633; Skerratt LF, 2004, AUST J ZOOL, V52, P303, DOI 10.1071/ZO02061; Smith JA, 2008, VET MICROBIOL, V129, P236, DOI 10.1016/j.vetmic.2007.11.019; Stalder K, 2013, THESIS U MELBOURNE; Sykes JE, 1999, J VET INTERN MED, V13, P153, DOI 10.1892/0891-6640(1999)013&lt;0153:POFPAF&gt;2.3.CO;2; UREN J, 1966, EXP CELL RES, V43, P677, DOI 10.1016/0014-4827(66)90043-7; Vaz P, 2011, J WILDLIFE DIS, V47, P787, DOI 10.7589/0090-3558-47.3.787; Vaz P, 2012, J WILDLIFE DIS, V48, P226, DOI 10.7589/0090-3558-48.1.226; Vaz PK, 2013, J WILDLIFE DIS, V49, P143, DOI 10.7589/2012-01-027; WEBBER CE, 1978, AUST J EXP BIOL MED, V56, P351, DOI 10.1038/icb.1978.38; Wilcox RS, 2011, AUST VET J, V89, P55, DOI 10.1111/j.1751-0813.2010.00662.x; WILKS CR, 1981, J COMP PATHOL, V91, P461, DOI 10.1016/0021-9975(81)90019-0	35	26	26	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133807	10.1371/journal.pone.0133807	http://dx.doi.org/10.1371/journal.pone.0133807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222660	gold, Green Published			2022-12-27	WOS:000358836800068
J	Tan, MF; Gao, T; Liu, WQ; Zhang, CY; Yang, X; Zhu, JW; Teng, MY; Li, L; Zhou, R				Tan, Mei-Fang; Gao, Ting; Liu, Wan-Quan; Zhang, Chun-Yan; Yang, Xi; Zhu, Jia-Wen; Teng, Mu-Ye; Li, Lu; Zhou, Rui			MsmK, an ATPase, Contributes to Utilization of Multiple Carbohydrates and Host Colonization of Streptococcus suis	PLOS ONE			English	Article							GLUCAN-DEGRADING ENZYME; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; GLYCOGEN-METABOLISM; ZOONOTIC PATHOGEN; ABC TRANSPORTERS; MOUSE INTESTINE; MUTANS; PNEUMONIAE; IDENTIFICATION	Acquisition and metabolism of carbohydrates are essential for host colonization and pathogenesis of bacterial pathogens. Different bacteria can uptake different lines of carbohydrates via ABC transporters, in which ATPase subunits energize the transport though ATP hydrolysis. Some ABC transporters possess their own ATPases, while some share a common ATPase. Here we identified MsmK, an ATPase from Streptococcus suis, an emerging zoonotic bacterium causing dead infections in pigs and humans. Genetic and biochemistry studies revealed that the MsmK was responsible for the utilization of raffinose, melibiose, maltotetraose, glycogen and maltotriose. In infected mice, the msmK-deletion mutant showed significant defects of survival and colonization when compared with its parental and complementary strains. Taken together, MsmK is an ATPase that contributes to multiple carbohydrates utilization and host colonization of S. suis. This study gives new insight into our understanding of the carbohydrates utilization and its relationship to the pathogenesis of this zoonotic pathogen.	[Tan, Mei-Fang; Gao, Ting; Liu, Wan-Quan; Zhang, Chun-Yan; Yang, Xi; Zhu, Jia-Wen; Teng, Mu-Ye; Li, Lu; Zhou, Rui] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Gao, Ting] Hubei Acad Agr Sci, Inst Anim Husb & Vet, Wuhan 430064, Peoples R China; [Li, Lu; Zhou, Rui] Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Hubei Academy of Agricultural Sciences	Zhou, R (corresponding author), Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Peoples R China.	rzhou@mail.hzau.edu.cn			International S & T Cooperation Program of China (ISTCP) [2013DFG32360]; National Basic Research Program of China (973 Program) [2012CB518802]	International S & T Cooperation Program of China (ISTCP); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the International S & T Cooperation Program of China (ISTCP grant no. 2013DFG32360) and the National Basic Research Program of China (973 Program grant no. 2012CB518802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; [Anonymous], 2001, STREPTOCOCCUS SUIS, V46, P140; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Benarroch EE, 2010, NEUROLOGY, V74, P919, DOI 10.1212/WNL.0b013e3181d3e44b; Bourassa L, 2009, MOL MICROBIOL, V72, P124, DOI 10.1111/j.1365-2958.2009.06629.x; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dubreuil JD, 1996, MICROBIOL-UK, V142, P837, DOI 10.1099/00221287-142-4-837; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Feng YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00710; Ferrando ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089334; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; FRENCH GL, 1989, J MED MICROBIOL, V28, P275, DOI 10.1099/00222615-28-4-275; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Gough H, 1996, ARCH ORAL BIOL, V41, P141, DOI 10.1016/0003-9969(95)00121-2; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Grenier D, 2009, VET J, V179, P292, DOI 10.1016/j.tvjl.2007.09.005; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Henrissat B, 2002, TRENDS GENET, V18, P437, DOI 10.1016/S0168-9525(02)02734-8; HOFHERR L, 1979, AM J MED TECHNOL, V45, P127; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Kotrba P, 2001, J BIOSCI BIOENG, V92, P502, DOI 10.1263/jbb.92.502; Li W, 2009, FEMS MICROBIOL LETT, V292, P123, DOI 10.1111/j.1574-6968.2008.01476.x; Li W, 2011, FEMS MICROBIOL LETT, V316, P115, DOI 10.1111/j.1574-6968.2010.02200.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marion C, 2011, INFECT IMMUN, V79, P4193, DOI 10.1128/IAI.05290-11; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Mccoy JG, 2015, BBA-GEN SUBJECTS, V1850, P577, DOI 10.1016/j.bbagen.2014.03.013; MEURMAN JH, 1987, CARIES RES, V21, P353, DOI 10.1159/000261039; MORMANN JE, 1981, CARIES RES, V15, P166; PUYET A, 1993, J MOL BIOL, V230, P800, DOI 10.1006/jmbi.1993.1202; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Shelburne SA, 2009, MOL MICROBIOL, V74, P159, DOI 10.1111/j.1365-2958.2009.06858.x; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; TAO L, 1993, J DENT RES, V72, P1386, DOI 10.1177/00220345930720100701; TARAVEL FR, 1983, EUR J BIOCHEM, V130, P147; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; TILLOTSON GS, 1982, J CLIN PATHOL, V35, P468, DOI 10.1136/jcp.35.4.468; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; Webb AJ, 2007, J BACTERIOL, V189, P3322, DOI 10.1128/JB.01633-06; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wilson WA, 2010, FEMS MICROBIOL REV, V34, P952, DOI 10.1111/j.1574-6976.2010.00220.x; Zhang AD, 2009, VACCINE, V27, P1348, DOI 10.1016/j.vaccine.2008.12.047; Zhang TF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-85; Zheng F, 2011, INFECT IMMUN, V79, P1319, DOI 10.1128/IAI.00193-10; Zhu HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091971	58	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0130792	10.1371/journal.pone.0130792	http://dx.doi.org/10.1371/journal.pone.0130792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222651	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800008
J	Whitfield, MG; Soeters, HM; Warren, RM; York, T; Sampson, SL; Streicher, EM; van Helden, PD; van Rie, A				Whitfield, Michael G.; Soeters, Heidi M.; Warren, Robin M.; York, Talita; Sampson, Samantha L.; Streicher, Elizabeth M.; van Helden, Paul D.; van Rie, Annelies			A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; PNCA GENE-MUTATIONS; MGIT 960 SYSTEM; DRUG SUSCEPTIBILITY ASSAY; RAPID DETECTION; PHENOTYPIC CHARACTERIZATION; ANTITUBERCULOSIS DRUGS; TESTING SUSCEPTIBILITY; TREATMENT FAILURE; SPUTUM SPECIMENS	Background Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability to eradicate persister bacilli. The worldwide burden of PZA resistance remains poorly described. Methods Systematic PubMed, Science Direct and Scopus searches for articles reporting phenotypic (liquid culture drug susceptibility testing or pyrazinamidase activity assays) and/or genotypic (polymerase chain reaction or DNA sequencing) PZA resistance. Global and regional summary estimates were obtained from random-effects meta-analysis, stratified by presence or risk of multidrug resistant TB (MDR-TB). Regional summary estimates were combined with regional WHO TB incidence estimates to determine the annual burden of PZA resistance. Information on single nucleotide polymorphisms (SNPs) in the pncA gene was aggregated to obtain a global summary. Results Pooled PZA resistance prevalence estimate was 16.2% (95% CI 11.2-21.2) among all TB cases, 41.3%(29.0-53.7) among patients at high MDR-TB risk, and 60.5% (52.3-68.6) among MDR-TB cases. The estimated global burden is 1.4 million new PZA resistant TB cases annually, about 270,000 in MDR-TB patients. Among 1,815 phenotypically resistant isolates, 608 unique SNPs occurred at 397 distinct positions throughout the pncA gene. Interpretation PZA resistance is ubiquitous, with an estimated one in six incident TB cases and more than half of all MDR-TB cases resistant to PZA globally. The diversity of SNPs across the pncA gene complicates the development of rapid molecular diagnostics. These findings caution against relying on PZA in current and future TB drug regimens, especially in MDR-TB patients.	[Whitfield, Michael G.; Warren, Robin M.; York, Talita; Sampson, Samantha L.; Streicher, Elizabeth M.; van Helden, Paul D.] Univ Stellenbosch, SA MRC Ctr TB Res, ZA-7600 Stellenbosch, South Africa; [Whitfield, Michael G.; Warren, Robin M.; York, Talita; Sampson, Samantha L.; Streicher, Elizabeth M.; van Helden, Paul D.] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, ZA-7600 Stellenbosch, South Africa; [Whitfield, Michael G.; Warren, Robin M.; York, Talita; Sampson, Samantha L.; Streicher, Elizabeth M.; van Helden, Paul D.] Univ Stellenbosch, Div Mol Biol & Human Genet, ZA-7600 Stellenbosch, South Africa; [Whitfield, Michael G.; Warren, Robin M.; York, Talita; Sampson, Samantha L.; Streicher, Elizabeth M.; van Helden, Paul D.] Univ Stellenbosch, Fac Med & Hlth Sci, ZA-7600 Stellenbosch, South Africa; [Soeters, Heidi M.; van Rie, Annelies] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [van Rie, Annelies] Univ Antwerp, Fac Med, Int Hlth Unit, Epidemiol & Social Med, B-2020 Antwerp, Belgium	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Stellenbosch University; University of North Carolina; University of North Carolina Chapel Hill; University of Antwerp	Warren, RM (corresponding author), Univ Stellenbosch, SA MRC Ctr TB Res, ZA-7600 Stellenbosch, South Africa.	rw1@sun.ac.za	Soeters, Heidi/H-3271-2019; Streicher, Elizabeth/O-9597-2019; Whitfield, Michael Gordon/V-6489-2019; Van Rie, Annelies/C-2082-2017; Streicher, Elizabeth M/I-7780-2018	Soeters, Heidi/0000-0002-9415-9340; Streicher, Elizabeth/0000-0003-3901-1981; Whitfield, Michael Gordon/0000-0002-5956-8384; Van Rie, Annelies/0000-0001-7666-3263; Streicher, Elizabeth M/0000-0003-3901-1981; Warren, Robin/0000-0001-5741-7358; sampson, samantha/0000-0002-9596-8019	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [R01AI099026]; NIH training grant [2T32AI070114]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation (NRF) of South Africa [UID 86539]; NRF of South Africa; Medical Research Council of South Africa [UID 89519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099026] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); NRF of South Africa; Medical Research Council of South Africa(South African Medical Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AVR and MGW are partially funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), grant R01AI099026. HMS was partially supported by the NIH training grant 2T32AI070114. SLS is funded by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF) of South Africa, award number UID 86539. MGW funded by the NRF of South Africa and the Medical Research Council of South Africa, grant UID 89519. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2012, J CLIN MICROBIOL, V50, P3726, DOI 10.1128/JCM.00620-12; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Ando H, 2010, CLIN MICROBIOL INFEC, V16, P1164, DOI 10.1111/j.1469-0691.2009.03078.x; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Aono A, 2002, DIAGN MICR INFEC DIS, V44, P347, DOI 10.1016/S0732-8893(02)00471-6; Aragon LM, 2007, J ANTIMICROB CHEMOTH, V60, P655, DOI 10.1093/jac/dkm252; Arora J, 2013, DIAGN MICR INFEC DIS, V77, P380, DOI 10.1016/j.diagmicrobio.2013.08.014; Barco P, 2006, J ANTIMICROB CHEMOTH, V58, P930, DOI 10.1093/jac/dkl363; Barreto AMW, 2002, MEM I OSWALDO CRUZ, V97, P263, DOI 10.1590/S0074-02762002000200021; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P108; Bhuju S, 2013, INFECT GENET EVOL, V19, P1, DOI 10.1016/j.meegid.2013.06.008; Bishop KS, 2001, INT J TUBERC LUNG D, V5, P952; Brown TJ, 2000, J MED MICROBIOL, V49, P651, DOI 10.1099/0022-1317-49-7-651; Chan RCY, 2007, J ANTIMICROB CHEMOTH, V59, P866, DOI 10.1093/jac/dkm054; Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; Chedore P, 2010, J CLIN MICROBIOL, V48, P300, DOI 10.1128/JCM.01775-09; Cheng SJ, 2000, ANTIMICROB AGENTS CH, V44, P528, DOI 10.1128/AAC.44.3.528-532.2000; Chiu YC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-240; Choi JH, 2010, CHEST, V137, P393, DOI 10.1378/chest.09-0150; Clemente WT, 2008, DIAGN MICR INFEC DIS, V62, P199, DOI 10.1016/j.diagmicrobio.2008.06.013; Cuevas-Cordoba B, 2013, INFECT GENET EVOL, V19, P330, DOI 10.1016/j.meegid.2012.12.013; Cui ZL, 2013, J CLIN MICROBIOL, V51, P1374, DOI 10.1128/JCM.03197-12; Daum LT, 2012, J CLIN MICROBIOL, V50, P3831, DOI 10.1128/JCM.01893-12; Davies AP, 2000, J CLIN MICROBIOL, V38, P3686, DOI 10.1128/JCM.38.10.3686-3688.2000; Denkin S, 2005, J MED MICROBIOL, V54, P1127, DOI 10.1099/jmm.0.46129-0; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11; Djuretic T, 2002, THORAX, V57, P477, DOI 10.1136/thorax.57.6.477; Doustdar F, 2009, MICROB DRUG RESIST, V15, P251, DOI 10.1089/mdr.2009.0066; Duque A, 2013, J CLIN MICROBIOL, V51, P3403, DOI 10.1128/JCM.01357-13; Endoh T, 2002, EPIDEMIOL INFECT, V128, P337, DOI 10.1017/S0950268801006744; Escalante P., 1998, Tubercle and Lung Disease, V79, P111, DOI 10.1054/tuld.1998.0013; Espasa M, 2012, J CLIN MICROBIOL, V50, P488, DOI 10.1128/JCM.06432-11; Fattorini L, 1999, MICROB DRUG RESIST, V5, P265, DOI 10.1089/mdr.1999.5.265; Fonseca LD, 2012, J BRAS PNEUMOL, V38, P630, DOI 10.1590/S1806-37132012000500013; Fredricks BA, 2006, J MICROBIOL METH, V67, P266, DOI 10.1016/j.mimet.2006.03.020; Ghiraldi LD, 2011, CLIN MICROBIOL INFEC, V17, P1792, DOI 10.1111/j.1469-0691.2011.03508.x; Granich RM, 2000, ARCH INTERN MED, V160, P639, DOI 10.1001/archinte.160.5.639; Hannan MM, 2001, J CLIN MICROBIOL, V39, P647, DOI 10.1128/JCM.39.2.647-650.2001; Hirano K, 1998, TUBERCLE LUNG DIS, V78, P117, DOI 10.1016/S0962-8479(98)80004-X; Hoffner S, 2013, INT J TUBERC LUNG D, V17, P1486, DOI 10.5588/ijtld.13.0195; Hou L, 2000, EPIDEMIOL INFECT, V124, P227, DOI 10.1017/S0950268899003635; Huang TS, 2003, ANTIMICROB AGENTS CH, V47, P3672, DOI 10.1128/AAC.47.11.3672-3673.2003; Huang WC, 2013, JPN J INFECT DIS, V66, P89, DOI 10.7883/yoken.66.89; Huang ZK, 2013, CHINESE MED J-PEKING, V126, P4334, DOI 10.3760/cma.j.issn.0366-6999.20130108; Hung Nguyen Van, 2013, BMC Res Notes, V6, P444, DOI 10.1186/1756-0500-6-444; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Jnawali HN, 2013, DIAGN MICR INFEC DIS, V76, P187, DOI 10.1016/j.diagmicrobio.2013.02.035; Jonmalung J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-223; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Kelly PM, 2006, INT J TUBERC LUNG D, V10, P167; Kelly PM, 2005, INT J TUBERC LUNG D, V9, P81; Khan MY, 2001, INT J ANTIMICROB AG, V17, P415, DOI 10.1016/S0924-8579(01)00298-9; Khurram M, 2012, J INFECT DEV COUNTR, V6, P29, DOI 10.3855/jidc.1738; Kim HJ, 2012, INT J TUBERC LUNG D, V16, P98, DOI 10.5588/ijtld.10.0739; Kontos F, 2003, J MICROBIOL METH, V55, P331, DOI 10.1016/S0167-7012(03)00142-8; Krishnamurthy A, 2004, Indian J Med Microbiol, V22, P166; LaBombardi VJ, 2002, J CLIN MICROBIOL, V40, P2238, DOI 10.1128/JCM.40.6.2238-2239.2002; Lee Ann S. G., 2002, International Journal of Infectious Diseases, V6, P48, DOI 10.1016/S1201-9712(02)90136-0; Lee KW, 2001, J KOREAN MED SCI, V16, P537, DOI 10.3346/jkms.2001.16.5.537; Lemaitre N, 1999, ANTIMICROB AGENTS CH, V43, P1761, DOI 10.1128/AAC.43.7.1761; Li H, 2014, J CLIN MICROBIOL, V52, P260, DOI 10.1128/JCM.02285-13; Linger Y, 2014, J CLIN MICROBIOL, V52, P2100, DOI 10.1128/JCM.00238-14; Louw GE, 2006, INT J TUBERC LUNG D, V10, P802; Marttila HJ, 1999, ANTIMICROB AGENTS CH, V43, P1764, DOI 10.1128/AAC.43.7.1764; MCDERMOTT W, 1954, AM REV TUBERC PULM, V70, P748; Mestdagh M, 1999, ANTIMICROB AGENTS CH, V43, P2317, DOI 10.1128/AAC.43.9.2317; Miotto P, 2014, MBIO, V5, DOI 10.1128/mBio.01819-14; Mirabal NC, 2010, J CLIN MICROBIOL, V48, P2729, DOI 10.1128/JCM.00311-10; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Miyagi C, 2004, DIAGN MICR INFEC DIS, V48, P111, DOI 10.1016/j.diagmicrobio.2003.09.013; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morlock GP, 2000, ANTIMICROB AGENTS CH, V44, P2291, DOI 10.1128/AAC.44.9.2291-2295.2000; Mphahlele M, 2008, J CLIN MICROBIOL, V46, P3459, DOI 10.1128/JCM.00973-08; Muthaiah M, 2010, INT J MOL SCI, V11, P2670, DOI 10.3390/ijms11072670; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; Napiorkowska A, 2014, INT J TUBERC LUNG D, V18, P454, DOI 10.5588/ijtld.13.0457; Napiorkowska Agnieszka, 2010, Pneumonol Alergol Pol, V78, P256; Ndung'u PW, 2012, J INFECT DEV COUNTR, V6, P33, DOI 10.3855/jidc.2281; Nutini S, 1998, INT J TUBERC LUNG D, V2, P484; Pandey S, 2009, PATHOLOGY, V41, P582, DOI 10.1080/00313020903071587; Pardini M, 2007, J CHEMOTHERAPY, V19, P106, DOI 10.1179/joc.2007.19.1.106; Park SK, 2001, BMC INFECT DIS, V1, part. no., DOI 10.1186/1471-2334-1-4; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Pholwat S, 2014, TUBERCULOSIS, V94, P20, DOI 10.1016/j.tube.2013.10.006; Piersimoni C, 2013, J CLIN MICROBIOL, V51, P291, DOI 10.1128/JCM.01838-12; Portugal I, 2004, ANTIMICROB AGENTS CH, V48, P2736, DOI 10.1128/AAC.48.7.2736-2738.2004; Ribeiro LB, 2012, J BRAS PNEUMOL, V38, P740, DOI 10.1590/S1806-37132012000600009; Rodrigues VDFS, 2005, ANTIMICROB AGENTS CH, V49, P444, DOI 10.1128/AAC.49.1.444-446.2005; Sachais BS, 1998, MOL DIAGN, V3, P229, DOI 10.1016/S1084-8592(98)80045-3; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Saravia JC, 2005, INT J TUBERC LUNG D, V9, P421; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Sharma B, 2010, INDIAN J MED RES, V132, P72; Sheen P, 2009, J CLIN MICROBIOL, V47, P2937, DOI 10.1128/JCM.01594-08; Shenai Shubhada, 2009, Indian J Tuberc, V56, P82; Shi RR, 2010, TOHOKU J EXP MED, V221, P97, DOI 10.1620/tjem.221.97; Shi W, 2014, EMERGING MICROBES IN, V3; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Simons SO, 2012, J CLIN MICROBIOL, V50, P428, DOI 10.1128/JCM.05435-11; Simpson G, 2011, INT J TUBERC LUNG D, V15, P551, DOI 10.5588/ijtld.10.0347; Singh P, 2007, J CLIN MICROBIOL, V45, P76, DOI 10.1128/JCM.00951-06; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Somoskovi A, 2007, J CLIN MICROBIOL, V45, P595, DOI 10.1128/JCM.01454-06; Stoffels K, 2012, ANTIMICROB AGENTS CH, V56, P5186, DOI 10.1128/AAC.05385-11; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Streicher EM, 2014, J CLIN MICROBIOL, V52, P4056, DOI 10.1128/JCM.02438-14; Su WJ, 2008, J FORMOS MED ASSOC, V107, P259, DOI 10.1016/S0929-6646(08)60145-X; Suzuki Y, 2002, J CLIN MICROBIOL, V40, P501, DOI 10.1128/JCM.40.2.501-507.2002; Tan YJ, 2014, J CLIN MICROBIOL, V52, P291, DOI 10.1128/JCM.01903-13; Tasneen R, 2008, ANTIMICROB AGENTS CH, V52, P3664, DOI 10.1128/AAC.00686-08; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; Tracevska T, 2004, ANTIMICROB AGENTS CH, V48, P3209, DOI 10.1128/AAC.48.8.3209-3210.2004; Watcharasamphankul Worawan, 2013, Journal of the Medical Association of Thailand, V96, P1218; WAYNE LG, 1974, AM REV RESPIR DIS, V109, P147; Werngren J, 2012, ANTIMICROB AGENTS CH, V56, P1253, DOI 10.1128/AAC.05894-11; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOBAL TUBERCULOSIS; WHO, 2010, MULTIDRUG AND EXTENS; World Health Organization, 2008, GUIDELINES FOR THE P; Yuksel P, 2009, NEW MICROBIOL, V32, P153; Zhang H, 2009, J INT MED RES, V37, P1430, DOI 10.1177/147323000903700517; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhang Y, 2002, J MED MICROBIOL, V51, P42, DOI 10.1099/0022-1317-51-1-42; Zhang Y, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P235; Zhang Y, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0023-2013; Zhdanova S, 2013, EMERG INFECT DIS, V19, P1649, DOI 10.3201/eid1910.121108; Zhou M., 2011, PLOS ONE, V6; Zimhony O, 2004, J BACTERIOL, V186, P4051, DOI 10.1128/JB.186.13.4051-4055.2004; Zimic M, 2010, INFECT GENET EVOL, V10, P346, DOI 10.1016/j.meegid.2009.11.016; Zumla A, 2014, THE LANCET INFECTIOU	135	89	94	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133869	10.1371/journal.pone.0133869	http://dx.doi.org/10.1371/journal.pone.0133869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218737	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900052
J	Bigna, JJR; Noubiap, JJN; Agbor, AA; Plottel, CS; Billong, SC; Ayong, APR; Koulla-Shiro, S				Bigna, Jean Joel R.; Noubiap, Jean Jacques N.; Agbor, Ako A.; Plottel, Claudia S.; Billong, Serge Clotaire; Ayong, Andre Patrick R.; Koulla-Shiro, Sinata			Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaounde Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013)	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; DOSING FREQUENCY; ADULTS; ADHERENCE; HAART; DEATH; START	Background Understanding contributors to mortality during the initial phase of tuberculosis (TB) treatment in patients co-infected with HIV would guide targeted interventions to improve survival. The aim of this study was to ascertain the incidence of death during the initial 2 months (new cases) and 3 months (retreatment cases) of TB treatment and to assess correlates of mortality in HIV co-infected patients. Methods We conducted a hospital-based retrospective cohort study from January 2006 to December 2013 at Yaounde Central Hospital, Cameroon. We reviewed medical records to identify co-infected TB/HIV inpatients aged 15 years and older who died during TB treatment. Death was defined as any death occurring during TB treatment, as per World Health Organization recommendations. We collected socio-demographic, clinical and laboratory data. We conducted multivariable logistic binary regression analysis to identify factors associated with death during the intensive phase of TB treatment. Magnitudes of associations were expressed by adjusted odds ratio (aOR) with 95% confidence interval. A p value < 0.05 was considered statistically significant. Results The 99 patients enrolled had a mean age of 39.5 (standard deviation 10.9) years and 53% were male. Patients were followed for 276.3 person-months of observation (PMO). Forty nine patients were died during intensive phase of TB treatment. Death incidence during the intensive phase of TB treatment was 32.2 per 100 PMO. Having a non-AIDS comorbidity (aOR 2.47, 95% CI 1.22-5.02, p = 0.012), having extra-pulmonary TB (aOR 1.89, 95% CI 1.05-3.43, p = 0.035), and one year increase in duration of known HIV infection (aOR 1.23, 95% CI 1.004-1.49) were independently associated with death during the intensive phase of TB treatment. Conclusions Mortality incidence during intensive phase of TB treatment was high among TB/HIV co-infected patients during TB treatment; and strongly associated with extra pulmonary TB suggesting advanced stage of immunosuppression and non-AIDS comorbidities. Early HIV diagnosis and care and good management of non-comorbidities can reduce this incidence.	[Bigna, Jean Joel R.] Pasteur Ctr Cameroon, Dept Epidemiol & Publ Hlth, Yaounde, Cameroon; [Noubiap, Jean Jacques N.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Noubiap, Jean Jacques N.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Noubiap, Jean Jacques N.] Med Diag Ctr, Yaounde, Cameroon; [Agbor, Ako A.; Billong, Serge Clotaire; Koulla-Shiro, Sinata] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Plottel, Claudia S.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Billong, Serge Clotaire] Minist Publ Hlth, Natl AIDS Control Comm, Yaounde, Cameroon; [Ayong, Andre Patrick R.] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Koulla-Shiro, Sinata] Yaounde Cent Hosp, Infect Dis Unit, Yaounde, Cameroon	University of Cape Town; University of Cape Town; University of Yaounde I; New York University; NYU Langone Medical Center	Bigna, JJR (corresponding author), Pasteur Ctr Cameroon, Dept Epidemiol & Publ Hlth, Yaounde, Cameroon.	bignarimjj@yahoo.fr	; Bigna, Jean Joel/A-1781-2015	Noubiap, Jean Jacques/0000-0002-7722-9757; Plottel, Claudia S./0000-0001-6088-6534; Bigna, Jean Joel/0000-0001-8018-6279				Agbor AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115211; Assawasuwannakit P, 2015, J CLIN PHARM THER, V40, P24, DOI 10.1111/jcpt.12219; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Coleman CI, 2012, J MANAGE CARE PHARM, V18, P527, DOI 10.18553/jmcp.2012.18.7.527; Cox JA, 2010, AIDS REV, V12, P183; Deribe Kebede, 2015, J Int Assoc Provid AIDS Care, V14, P269, DOI 10.1177/2325957413500528; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Feasey NA, 2013, J CLIN MICROBIOL, V51, P2311, DOI 10.1128/JCM.00330-13; Griffin J. P., 2009, TXB PHARM MED; Haddow LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040623; Heaney RP, 2001, J NUTR, V131, p1344S, DOI 10.1093/jn/131.4.1344S; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Jonnalagada S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-921; Little R. J. A., 1987, STAT ANAL MISSING DA; Luetkemeyer AF, 2014, JAIDS-J ACQ IMM DEF, V65, P423, DOI 10.1097/QAI.0000000000000030; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Mfinanga SG, 2014, LANCET INFECT DIS, V14, P563, DOI 10.1016/S1473-3099(14)70733-9; Mungrue Kameel, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P170, DOI 10.1177/1545109709331471; Naidoo K, 2013, CURR OPIN INFECT DIS, V26, P35, DOI 10.1097/QCO.0b013e32835ba8f9; Pokrovskaya AV, 2014, TERAPEVT ARKH, V86, P20; Programme National de lutte contre la Tuberculose, 2012, GUID PERS SANT YAOUN; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Saini SD, 2009, AM J MANAG CARE, V15, pE22; Sharma SK, 2011, INDIAN J MED RES, V134, P866, DOI 10.4103/0971-5916.92632; Shaweno Debebe, 2012, BMC Res Notes, V5, P682, DOI 10.1186/1756-0500-5-682; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Wilson EMP, 2013, IMMUNOL REV, V254, P343, DOI 10.1111/imr.12064; World Health Organization, 2014, CAM TUB PROF WHO; World Health Organization, 2014, WHO AFR REG CAM STAT; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132394	10.1371/journal.pone.0132394	http://dx.doi.org/10.1371/journal.pone.0132394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214516	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300009
J	Chandrashekar, DS; Dey, P; Acharya, KK				Chandrashekar, Darshan Shimoga; Dey, Poulami; Acharya, Kshitish K.			GREAM: A Web Server to Short-List Potentially Important Genomic Repeat Elements Based on Over-/Under-Representation in Specific Chromosomal Locations, Such as the Gene Neighborhoods, within or across 17 Mammalian Species	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; DNA; MOUSE; TRANSCRIPTOME; EVOLUTION; INVERTEBRATES; METHYLATION; VERTEBRATES; EXPRESSION; LANDSCAPE	Background Genome-wide repeat sequences, such as LINEs, SINEs and LTRs share a considerable part of the mammalian nuclear genomes. These repeat elements seem to be important for multiple functions including the regulation of transcription initiation, alternative splicing and DNA methylation. But it is not possible to study all repeats and, hence, it would help to short-list before exploring their potential functional significance via experimental studies and/or detailed in silico analyses. Result We developed the 'Genomic Repeat Element Analyzer for Mammals' (GREAM) for analysis, screening and selection of potentially important mammalian genomic repeats. This web-server offers many novel utilities. For example, this is the only tool that can reveal a categorized list of specific types of transposons, retro-transposons and other genome-wide repetitive elements that are statistically over-/under-represented in regions around a set of genes, such as those expressed differentially in a disease condition. The output displays the position and frequency of identified elements within the specified regions. In addition, GREAM offers two other types of analyses of genomic repeat sequences: a) enrichment within chromosomal region(s) of interest, and b) comparative distribution across the neighborhood of orthologous genes. GREAM successfully short-listed a repeat element (MER20) known to contain functional motifs. In other case studies, we could use GREAM to short-list repetitive elements in the azoospermia factor a (AZFa) region of the human Y chromosome and those around the genes associated with rat liver injury. GREAM could also identify five over-represented repeats around some of the human and mouse transcription factor coding genes that had conserved expression patterns across the two species. Conclusion GREAM has been developed to provide an impetus to research on the role of repetitive sequences in mammalian genomes by offering easy selection of more interesting repeats in various contexts/regions. GREAM is freely available at http://resource.ibab.ac.in/GREAM/.	[Chandrashekar, Darshan Shimoga; Dey, Poulami; Acharya, Kshitish K.] Inst Bioinformat & Appl Biotechnol, Bangalore 560100, Karnataka, India; [Chandrashekar, Darshan Shimoga; Dey, Poulami] Manipal Univ, Manipal 576104, Karnataka, India; [Acharya, Kshitish K.] Shodhaka Life Sci Pvt Ltd, IBAB, Bangalore 560100, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Acharya, KK (corresponding author), Inst Bioinformat & Appl Biotechnol, Biotech Pk, Bangalore 560100, Karnataka, India.	kshitish@ibab.ac.in			Department of Electronics and Information Technology (DeitY), Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics'	Department of Electronics and Information Technology (DeitY), Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics'	This work was supported by an institutional grant to Institute of Bioinformatics and Biotechnology (IBAB) from Department of Electronics and Information Technology (DeitY), Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics'.	Ade C, 2013, CURR OPIN VIROL, V3, P639, DOI 10.1016/j.coviro.2013.09.002; Belan E, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-22; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Chandrashekar DS, 2015, COMP NONCOMMERCIAL R; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Emery PTJ, 1999, P ROY SOC B-BIOL SCI, V266, P1677, DOI 10.1098/rspb.1999.0831; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Grandi Fiorella C, 2013, Mob Genet Elements, V3, pe25674; Haider S, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R90, 10.1186/gb-2012-13-10-r90]; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Krull M, 2007, GENOME RES, V17, P1139, DOI 10.1101/gr.6320607; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lerat E, 2010, HEREDITY, V104, P520, DOI 10.1038/hdy.2009.165; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; Li JF, 2012, GENOME RES, V22, P870, DOI 10.1101/gr.130740.111; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Makarevitch I, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1004915, 10.1371/journal.pgen.1005566]; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mattarucchi E, 2008, GENE CHROMOSOME CANC, V47, P625, DOI 10.1002/gcc.20568; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Newman MR, 2014, RADIAT RES, V181, P65, DOI 10.1667/RR13460.1; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; Ross SM, 2010, INTRO PROBABILITY ST, VFourth, P147; Schonbach C, 2004, BRIEF BIOINFORM, V5, P107, DOI 10.1093/bib/5.2.107; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sela N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r59; Sela N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010907; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; Steinhoff C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-144; Tang W, 2000, P NATL ACAD SCI USA, V97, P6025, DOI 10.1073/pnas.110139897; Tawa GJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pope.0107230, DOI 10.1371/JOURNAL.POPE.0107230]; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Zabala G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111959	47	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133647	10.1371/journal.pone.0133647	http://dx.doi.org/10.1371/journal.pone.0133647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208093	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000114
J	Chumova, Z; Krejcikova, J; Mandakova, T; Suda, J; Travnicek, P				Chumova, Zuzana; Krejcikova, Jana; Mandakova, Terezie; Suda, Jan; Travnicek, Pavel			Evolutionary and Taxonomic Implications of Variation in Nuclear Genome Size: Lesson from the Grass Genus Anthoxanthum (Poaceae)	PLOS ONE			English	Article							BUTTERCUPS RANUNCULUS-ADONEUS; L S LAT; DNA-CONTENT; FLOW-CYTOMETRY; INTRASPECIFIC VARIATION; NATURAL-POPULATIONS; C-VALUE; ODORATUM; HYBRIDIZATION; CYTOTYPES	The genus Anthoxanthum (sweet vernal grass, Poaceae) represents a taxonomically intricate polyploid complex with large phenotypic variation and its evolutionary relationships still poorly resolved. In order to get insight into the geographic distribution of ploidy levels and assess the taxonomic value of genome size data, we determined C- and Cx-values in 628 plants representing all currently recognized European species collected from 197 populations in 29 European countries. The flow cytometric estimates were supplemented by conventional chromosome counts. In addition to diploids, we found two low (rare 3x and common 4x) and one high (similar to 16x-18x) polyploid levels. Mean holoploid genome sizes ranged from 5.52 pg in diploid A. alpinum to 44.75 pg in highly polyploid A. amarum, while the size of monoploid genomes ranged from 2.75 pg in tetraploid A. alpinum to 9.19 pg in diploid A. gracile. In contrast to Central and Northern Europe, which harboured only limited cytological variation, a much more complex pattern of genome sizes was revealed in the Mediterranean, particularly in Corsica. Eight taxonomic groups that partly corresponded to traditionally recognized species were delimited based on genome size values and phenotypic variation. Whereas our data supported the merger of A. aristatum and A. ovatum, eastern Mediterranean populations traditionally referred to as diploid A. odoratum were shown to be cytologically distinct, and may represent a new taxon. Autopolyploid origin was suggested for 4x A. alpinum. In contrast, 4x A. odoratum seems to be an allopolyploid, based on the amounts of nuclear DNA. Intraspecific variation in genome size was observed in all recognized species, the most striking example being the A. aristatum/ovatum complex. Altogether, our study showed that genome size can be a useful taxonomic marker in Anthoxathum to not only guide taxonomic decisions but also help resolve evolutionary relationships in this challenging grass genus.	[Chumova, Zuzana; Krejcikova, Jana; Suda, Jan; Travnicek, Pavel] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Mandakova, Terezie] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Suda, Jan; Travnicek, Pavel] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Travnicek, Pavel] Univ South Bohemia, Fac Agr, Ctr Biotechnol, Ceske Budejovice, Czech Republic	Charles University Prague; Masaryk University Brno; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Chumova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	zuza.chumova@gmail.com	Chumova, Zuzana/AAK-5786-2020; Mandakova, Terezie/E-1365-2012; Travnicek, Pavel/G-9028-2012; Suda, Jan/D-3369-2013; Chumova, Zuzana/I-6323-2016	Chumova, Zuzana/0000-0002-6865-6183; Travnicek, Pavel/0000-0002-5806-1645; Suda, Jan/0000-0001-8964-9153; Chumova, Zuzana/0000-0002-6865-6183; Mandakova, Terezie/0000-0001-6485-0563	Charles University in Prague (GAUK project) [145/2006, 9661/2009, 5414/2013]; Academy of Sciences of the Czech Republic [RVO 67985939]; EU Education for Competitiveness Operational Programme (European Social Fund) [CZ.1.07/2.3.00/30.0006, CZ.1.07/2.3.00/30.0037]; EU Education for Competitiveness Operational Programme (Czech State Budget) [CZ.1.07/2.3.00/30.0006, CZ.1.07/2.3.00/30.0037]	Charles University in Prague (GAUK project); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); EU Education for Competitiveness Operational Programme (European Social Fund); EU Education for Competitiveness Operational Programme (Czech State Budget)	The research was financially supported by Charles University in Prague (GAUK projects 145/2006, 9661/2009 and 5414/2013. Additional support was supplied by long-term research development project No. RVO 67985939 provided by the Academy of Sciences of the Czech Republic and the Postdoc USB projects no. CZ.1.07/2.3.00/30.0006 and CZ.1.07/2.3.00/30.0037 realized through the EU Education for Competitiveness Operational Programme (funded by the European Social Fund and the Czech State Budget). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainouche ML, 2009, BIOL INVASIONS, V11, P1159, DOI 10.1007/s10530-008-9383-2; Allred KW, 2007, FLORA N AM, V24; [Anonymous], 1982, FLORA DITALIA; Baack EJ, 2005, EVOLUTION, V59, P1936; Baack EJ, 2004, AM J BOT, V91, P1783, DOI 10.3732/ajb.91.11.1783; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Betekhtin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115108; BORRILL M, 1963, GENETICA, V34, P183, DOI 10.1007/BF01664189; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Clayton WD, GRASSBASE ONLINE WOR; Conert HJ, 1988, ILLUSTRIERTE FLORA M; CREBER HMC, 1994, NEW PHYTOL, V128, P555, DOI 10.1111/j.1469-8137.1994.tb03001.x; Defilipps R.A., 1980, FLORA EUROPAEA; Dixon CJ, 2009, MOL PHYLOGENET EVOL, V50, P74, DOI 10.1016/j.ympev.2008.10.009; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Duchoslav M, 2013, ANN BOT-LONDON, V111, P419, DOI 10.1093/aob/mcs297; Eilam T, 2009, GENOME, V52, P275, DOI 10.1139/G09-004; Favarger C., 1984, PLANT BIOSYSTEMATICS, P453, DOI DOI 10.1016/B978-0-12-295680-5.50033-0; FELBER F, 1987, TAXON, V36, P573, DOI 10.2307/1221848; Felber F., 1987, THESIS UNIN NEUCHATE; FelberGirard M, 1996, NEW PHYTOL, V133, P531, DOI 10.1111/j.1469-8137.1996.tb01921.x; Fernandes A., 1969, B SOC BROT 2, V43, P3; Filipova L, 2006, PRESLIA, V78, P317; Greilhuber J, 2005, ANN BOT-LONDON, V95, P91, DOI 10.1093/aob/mci004; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; HEDBERG I, 1986, Acta Universitatis Upsaliensis Symbolae Botanicae Upsalienses, V27, P147; HEDBERG I, 1967, SYMB BOT UPSAL, V18, P5; HEDBERG I, 1970, HEREDITAS-GENETISK A, V64, P153; Hedberg I., 1990, SOMMERFELTIA, V11, P97; Jersakova J, 2010, EVOL ECOL, V24, P1199, DOI 10.1007/s10682-010-9356-7; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; JONES K, 1964, CHROMOSOMA, V15, P248, DOI 10.1007/BF00321511; KATTERMANN G., 1931, Planta, V12, P732, DOI 10.1007/BF01912442; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; Kur P, 2012, PRESLIA, V84, P905; LAURIE DA, 1985, HEREDITY, V55, P307, DOI 10.1038/hdy.1985.112; LOPEZGONZALEZ G, 1994, ANAL JARDIN BOTANICO, V51, P309; Loureiro J, 2010, PRESLIA, V82, P3; Mandak B, 2012, FLORA, V207, P530, DOI 10.1016/j.flora.2012.03.010; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Muyt A., 2001, BUSH INVADERS SE AUS; Ostergren G., 1942, HEREDITAS, V28, P242; Otto F, 1990, Methods Cell Biol, V33, P105; Parthasarathy N, 1939, ANN BOT-LONDON, V3, P43, DOI 10.1093/oxfordjournals.aob.a085057; Pecinka A, 2006, ANN BOT-LONDON, V98, P117, DOI 10.1093/aob/mcl077; Pereira MP, 2007, SYST BOT, V32, P43, DOI 10.1600/036364407780360201; Perny M, 2008, BOT J LINN SOC, V157, P475, DOI 10.1111/j.1095-8339.2008.00819.x; Petersen G, 2004, SYST BOT, V29, P862, DOI 10.1600/0363644042451080; Pimentel lM, 2003, BOCCONEA, V16, P731; Pimentel M, 2008, BOT J LINN SOC, V156, P237, DOI 10.1111/j.1095-8339.2007.00738.x; Pimentel M, 2007, MOL PHYLOGENET EVOL, V44, P667, DOI 10.1016/j.ympev.2007.04.006; Pimentel M, 2007, BOT J LINN SOC, V155, P179, DOI 10.1111/j.1095-8339.2007.00693.x; Pimentel M, 2013, ANN BOT-LONDON, V112, P1015, DOI 10.1093/aob/mct170; Pimentel M, 2010, BOT J LINN SOC, V164, P53, DOI 10.1111/j.1095-8339.2010.01068.x; Prancl J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105997; Reeves G, 1998, ANN BOT-LONDON, V82, P99, DOI 10.1006/anbo.1998.0751; Slovak M, 2009, PLANT SYST EVOL, V278, P187, DOI 10.1007/s00606-008-0137-5; Smarda P, 2006, ANN BOT-LONDON, V98, P665, DOI 10.1093/aob/mcl150; Smarda P, 2010, PRESLIA, V82, P41; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Soltis DE, 2009, P NATL ACAD SCI USA, V106, P5455, DOI 10.1073/pnas.0901994106; Suda J, 2007, AM J BOT, V94, P1391, DOI 10.3732/ajb.94.8.1391; Suda J, 2006, TAXON, V55, P447, DOI 10.2307/25065591; Suda J, 2010, PRESLIA, V82, P97; Suda J, 2010, PRESLIA, V82, P1; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; TEPPNER H, 1970, OSTERR BOT Z, V118, P280, DOI 10.1007/BF01377862; Teppner H, 1998, PHYTON-ANN REI BOT A, V38, P307; TEPPNER H, 2002, FRITSCHIANA, V31, P1; Travnicek P, 2013, FOLIA GEOBOT, V48, P271, DOI 10.1007/s12224-013-9151-7; Travnicek P, 2012, ANN BOT-LONDON, V110, P977, DOI 10.1093/aob/mcs171; Travnicek P, 2011, ANN BOT-LONDON, V107, P77, DOI 10.1093/aob/mcq217; Valdes B., 1973, Legascalia, V3, P99; Watson L., 1992, The grass genera of the world.; Zeroual-Humbert-Droz C, 1999, LOVE BOT HELV, V109, P217	76	25	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133748	10.1371/journal.pone.0133748	http://dx.doi.org/10.1371/journal.pone.0133748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207824	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000131
J	Lei, Y; Yu, H; Dong, Y; Yang, J; Ye, W; Wang, Y; Chen, W; Jia, Z; Xu, Z; Li, Z; Zhang, F				Lei, Y.; Yu, H.; Dong, Y.; Yang, J.; Ye, W.; Wang, Y.; Chen, W.; Jia, Z.; Xu, Z.; Li, Z.; Zhang, F.			Characterization of N-Glycan Structures on the Surface of Mature Dengue 2 Virus Derived from Insect Cells	PLOS ONE			English	Article							DC-SIGN; LECTIN MICROARRAY; DENDRITIC CELLS; INFECTION; GLYCOSYLATION; GLYCOPROTEINS; EXPRESSION; VACCINES; DOMAIN; MODEL	DENV envelope glycoprotein (E) is responsible for interacting with host cell receptors and is the main target for the development of a dengue vaccine based on an induction of neutralizing antibodies. It is well known that DENV E glycoprotein has two potential N-linked glycosylation sites at Asn67 and Asn153. The N-glycans of E glycoprotein have been shown to influence the proper folding of the protein, its cellular localization, its interactions with receptors and its immunogenicity. However, the precise structures of the N-glycans that are attached to E glycoprotein remain elusive, although the crystal structure of DENV E has been determined. This study characterized the structures of envelope protein N-linked glycans on mature DENV-2 particles derived from insect cells via an integrated method that used both lectin microarray and MALDI-TOF-MS. By combining these methods, a high heterogeneity of DENV N-glycans was found. Five types of N-glycan were identified on DENV2, including mannose, GalNAc, GlcNAc, fucose and sialic acid; high mannose-type N-linked oligosaccharides and the galactosylation of N-glycans were the major structures that were found. Furthermore, a complex between a glycan on DENV and the carbohydrate recognition domain (CRD) of DC-SIGN was mimicked with computational docking experiments. For the first time, this study provides a comprehensive understanding of the N-linked glycan profile of whole DENV-2 particles derived from insect cells.	[Lei, Y.; Dong, Y.; Yang, J.; Ye, W.; Wang, Y.; Xu, Z.; Zhang, F.] Fourth Mil Med Univ, Dept Microbiol, Sch Preclin Med, Xian 710032, Shaanxi, Peoples R China; [Yu, H.; Chen, W.; Li, Z.] Northwest Univ, Lab Funct Glyc, Coll Life Sci, Xian 710069, Peoples R China; [Jia, Z.] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710038, Peoples R China; [Jia, Z.] Fourth Mil Med Univ, Tangdu Hosp, Ctr Liver Dis, Xian 710038, Peoples R China	Air Force Military Medical University; Northwest University Xi'an; Air Force Military Medical University; Air Force Military Medical University	Li, Z (corresponding author), Northwest Univ, Lab Funct Glyc, Coll Life Sci, 229 Taibai Beilu, Xian 710069, Peoples R China.	zhengli@nwu.edu.cn; flzhang@fmmu.edu.cn	Yu, Hanjie/E-7819-2016; lei, yingfeng/I-2986-2017	Yu, Hanjie/0000-0003-2684-8715; Ye, Wei/0000-0002-3980-8547	"Major infectious diseases such as AIDS and viral hepatitis prevention and control" technology major special projects grant [2013ZX10004609]; National Natural Science Foundation of China (NSFC) [31370193]	"Major infectious diseases such as AIDS and viral hepatitis prevention and control" technology major special projects grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a "Major infectious diseases such as AIDS and viral hepatitis prevention and control" technology major special projects grant to J.Z.S. (No. 2013ZX10004609) and a National Natural Science Foundation of China (NSFC) grant to Y.F.L. (No. 31370193).	Alen MMF, 2012, ANTIVIR RES, V96, P280, DOI 10.1016/j.antiviral.2012.10.007; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Christian EA, 2013, P NATL ACAD SCI USA, V110, P18662, DOI 10.1073/pnas.1310962110; Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0; Harrington J, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/756832; Hidari KIPJ, 2011, EXPERT REV ANTI-INFE, V9, P983, DOI [10.1586/ERI.11.115, 10.1586/eri.11.115]; Hu S, 2009, PROTEOM CLIN APPL, V3, P148, DOI 10.1002/prca.200800153; JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481; Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10; Kobayashi Y, 2014, ONCOL REP, V31, P1121, DOI 10.3892/or.2014.2979; Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09; Moi ML, 2010, J GEN VIROL, V91, P103, DOI 10.1099/vir.0.014829-0; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Qin YN, 2013, J PROTEOME RES, V12, P2742, DOI 10.1021/pr400096w; Rakus JF, 2011, ANNU REV ANAL CHEM, V4, P367, DOI 10.1146/annurev-anchem-061010-113951; Reiding KR, 2014, ANAL CHEM, V86, P5784, DOI 10.1021/ac500335t; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; SMITH GW, 1985, J GEN VIROL, V66, P559, DOI 10.1099/0022-1317-66-3-559; Tan ZQ, 2014, J PROTEOME RES, V13, P2783, DOI 10.1021/pr401185z; Thomas SJ, 2014, ANN NY ACAD SCI, V1323, P140, DOI 10.1111/nyas.12413; Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI 10.1016/S0065-3527(10)77001-9; van Kooyk Y, 2013, MOL IMMUNOL, V55, P143, DOI 10.1016/j.molimm.2012.10.031; Varga N, 2014, BIOMATERIALS, V35, P4175, DOI 10.1016/j.biomaterials.2014.01.014; Yauch LE, 2014, ADV VIRUS RES, V88, P315, DOI 10.1016/B978-0-12-800098-4.00007-6; Yu HJ, 2012, J PROTEOME RES, V11, P5277, DOI 10.1021/pr300484j; Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13	28	28	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132122	10.1371/journal.pone.0132122	http://dx.doi.org/10.1371/journal.pone.0132122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208004	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000023
J	Nishimatsu, H; Suzuki, E; Saito, Y; Niimi, A; Nomiya, A; Yamada, D; Homma, Y				Nishimatsu, Hiroaki; Suzuki, Etsu; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Yamada, Daisuke; Homma, Yukio			Neuromedin B Restores Erectile Function by Protecting the Cavernous Body and the Nitrergic Nerves from Injury in a Diabetic Rat Model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; BOMBESIN-RELATED PEPTIDES; MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; APOPTOSIS SURVIVAL FACTOR; PREFERRING RECEPTORS; HYPERTHYROID RATS; GENE-TRANSFER; FOOD-INTAKE; AGED RAT	Erectile dysfunction (ED) is a major health problem worldwide and affects approximately 75% of diabetic patients, likely due to severely damaged cavernous body. While screening for cytokines produced by adipose tissue-derived stem cells, we detected neuromedin B (NMB). To explore a potential treatment option for ED, we examined whether NMB was capable of restoring erectile function. We also examined the potential mechanism by which NMB could restore erectile function. Male Wistar rats were injected with streptozotocin (STZ) to induce diabetes. An adenovirus expressing NMB (AdNMB) was injected into the penis 6 weeks after STZ administration. Four weeks after the injection of AdNMB, erectile function, penile histology, and protein expression were analyzed. As assessed by the measurement of intracavernous pressure, AdNMB injection significantly restored erectile function compared with the injection of an adenovirus expressing green fluorescent protein. This restoration was associated with conservation of the cavernous body structure and neural nitric oxide synthase (nNOS)-expressing nerves, together with recovery of a-smooth muscle actin, vascular endothelial-cadherin, and nNOS expression. Furthermore, NMB significantly stimulated the survival of SH-SY5Y cells derived from human neuroblastoma tissue with characteristics similar to neurons. Collectively, these results suggested that NMB restored erectile function via protection of the cavernous body from injury and stimulation of the survival of the associated nerves. NMB may be useful to treat ED patients with a severely damaged cavernous body.	[Nishimatsu, Hiroaki; Saito, Yasuho; Niimi, Aya; Nomiya, Akira; Yamada, Daisuke; Homma, Yukio] Univ Tokyo, Dept Urol, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Etsu] St Marianna Univ, Inst Med Sci, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168512, Japan	University of Tokyo; Saint Marianna University	Suzuki, E (corresponding author), St Marianna Univ, Inst Med Sci, Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168512, Japan.	esuzuki-tky@umin.ac.jp			FUGAKU TRUST FOR MEDICINAL RESEARCH; Ministry of Education, Culture, Sports, Science and Technology of Japan [24592422, 24592423]	FUGAKU TRUST FOR MEDICINAL RESEARCH; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grants-in-aid of the FUGAKU TRUST FOR MEDICINAL RESEARCH (http://www.smtb.jp/personal/entrustment/management/public/example/list.html), a Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan #24592422 (http://www.jsps.go.jp), and a Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan #24592423 (http://www.jsps.go.jp).	Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x; Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Bivalacqua TJ, 2001, BIOL REPROD, V65, P1371, DOI 10.1095/biolreprod65.5.1371; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1278, DOI 10.1152/ajpheart.00685.2006; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; Champion HC, 1999, P NATL ACAD SCI USA, V96, P11648, DOI 10.1073/pnas.96.20.11648; Christ GJ, 1998, AM J PHYSIOL-HEART C, V275, pH600, DOI 10.1152/ajpheart.1998.275.2.H600; Dey J, 2002, MAYO CLIN PROC, V77, P276, DOI 10.4065/77.3.276; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556; Kato H, 1997, ENDOCRINOLOGY, V138, P2615, DOI 10.1210/en.138.6.2615; Kendirci M, 2010, J UROLOGY, V184, P1560, DOI 10.1016/j.juro.2010.05.088; KILGORE WR, 1993, NEUROPEPTIDES, V24, P43, DOI 10.1016/0143-4179(93)90039-D; Kim IG, 2013, TISSUE ENG PT A, V19, P14, DOI [10.1089/ten.TEA.2011.0654, 10.1089/ten.tea.2011.0654]; Kim W, 2003, FASEB J, V17, P1937, DOI 10.1096/fj.02-1209fje; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Ladenheim EE, 1997, AM J PHYSIOL-REG I, V272, pR433, DOI 10.1152/ajpregu.1997.272.1.R433; Magee TR, 2002, BIOL REPROD, V67, P20, DOI 10.1093/biolreprod/67.1.20; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Merali Z, 2002, CELL MOL LIFE SCI, V59, P272, DOI 10.1007/s00018-002-8422-x; Merali Z, 1999, NEUROPEPTIDES, V33, P376, DOI 10.1054/npep.1999.0054; Merali Z, 2006, J NEUROSCI, V26, P10387, DOI 10.1523/JNEUROSCI.1219-06.2006; Milusheva EA, 1998, PEPTIDES, V19, P549, DOI 10.1016/S0196-9781(97)00467-1; MINAMINO N, 1983, BIOCHEM BIOPH RES CO, V114, P541, DOI 10.1016/0006-291X(83)90814-8; Mishra SK, 2012, J NEUROSCI, V32, P8686, DOI 10.1523/JNEUROSCI.1533-12.2012; Nishimatsu H, 2001, PEPTIDES, V22, P1913, DOI 10.1016/S0196-9781(01)00521-6; Nishimatsu H, 2013, J SEX MED, V10, P1707, DOI 10.1111/jsm.12177; Nishimatsu H, 2012, J SEX MED, V9, P482, DOI 10.1111/j.1743-6109.2011.02469.x; Nykanen AI, 2006, CIRC RES, V98, P1373, DOI 10.1161/01.RES.0000225987.52765.13; Park HJ, 2011, CANCER LETT, V312, P117, DOI 10.1016/j.canlet.2011.08.014; Park HJ, 2009, EXP CELL RES, V315, P3359, DOI 10.1016/j.yexcr.2009.08.009; PazosMoura CC, 1996, P SOC EXP BIOL MED, V211, P353; Pu XY, 2007, ASIAN J ANDROL, V9, P83, DOI 10.1111/j.1745-7262.2007.00215.x; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; RETTORI V, 1992, P NATL ACAD SCI USA, V89, P3035, DOI 10.1073/pnas.89.7.3035; Ryu JK, 2012, J SEX MED, V9, P3051, DOI 10.1111/j.1743-6109.2012.02962.x; SEVERI C, 1991, AM J PHYSIOL, V260, pG683, DOI 10.1152/ajpgi.1991.260.5.G683; Siroky MB, 2003, J UROLOGY, V170, pS24, DOI 10.1097/01.ju.0000075361.35942.17; Sun C, 2012, INT J ANDROL, V35, P601, DOI 10.1111/j.1365-2605.2012.01250.x; Suzuki E, 2002, CIRC RES, V90, P1004, DOI 10.1161/01.RES.0000017629.70769.CC; Suzuki E, 2000, J BIOL CHEM, V275, P3637, DOI 10.1074/jbc.275.5.3637; Takahashi M, 2010, AM J PHYSIOL-HEART C, V298, pH415, DOI 10.1152/ajpheart.00391.2009; VIGNE P, 1995, EUR J BIOCHEM, V233, P414, DOI 10.1111/j.1432-1033.1995.414_2.x	43	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133874	10.1371/journal.pone.0133874	http://dx.doi.org/10.1371/journal.pone.0133874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207818	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000161
J	Serra, N; Rosales, R; Masana, L; Vallve, JC				Serra, Noem; Rosales, Roser; Masana, Lluis; Vallve, Joan-Carles			Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition	PLOS ONE			English	Article							STATIN THERAPY; PLAQUE NEOVASCULARIZATION; ATHEROSCLEROTIC PLAQUES; PROTEIN FIBULIN-1; COLLAGEN CONTENT; MATRIX; MECHANISMS; DISEASE; BINDING; STABILIZATION	The composition and structure of the extracellular matrix (ECM) in the vascular wall and in the atherosclerotic plaque are important factors that determine plaque stability. Statins can stabilize atherosclerotic plaques by modulating ECM protein expression. Fibulins are important components of the ECM. We evaluated the in vitro effect of simvastatin on the expression of fibulin-1, -2, -4 and -5 in human coronary artery smooth muscle cells (SMCs) and the mechanisms involved. Cells were incubated with simvastatin (0.05-1 mu M), mevalonate (100 and 200 mu M), geranylgeranyl pyrophosphate (GGPP) (15 mu M), farnesyl pyrophosphate (FPP) (15 mu M), the Rho kinase (ROCK) inhibitor Y-27632 (15 and 20 mu M), the Rac-1 inhibitor (another member of Rho family) NSC23766 (100 mu M), arachidonic acid (a RhoA/ROCK activator, 25-100 mu M) and other fatty acids that are not activators of RhoA/ROCK (25100 mu M). Gene expression was analyzed by quantitative real-time PCR, and fibulin protein levels were analyzed by western blotting and ELISA. Simvastatin induced a significant increase in mRNA and protein levels of fibulin-2 at 24 hours of incubation (p<0.05), but it did not affect fibulin-1, -4, and -5 expression. Mevalonate and GGPP were able to reverse simvastatin's effect, while FPP did not. In addition, Y-27632, but not NSC23766, significantly increased fibulin-2 expression. Furthermore, activation of the RhoA/ROCK pathway with arachidonic acid decreased fibulin-2 mRNA. Simvastatin increased mRNA levels and protein expression of the ECM protein fibulin-2 through a RhoA and Rho-Kinase-mediated pathway. This increase could affect the composition and structure of the ECM.	[Serra, Noem; Rosales, Roser; Masana, Lluis; Vallve, Joan-Carles] Univ Rovira & Virgili, Fac Med, Unitat Recerca Lipids & Arteriosclerosi,Inst Inve, CIBER Diabet & Enfermedades Metab Asociadas CIBER, E-43201 Reus, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat Rovira i Virgili	Vallve, JC (corresponding author), Univ Rovira & Virgili, Fac Med, Unitat Recerca Lipids & Arteriosclerosi,Inst Inve, CIBER Diabet & Enfermedades Metab Asociadas CIBER, C St Llorenc 21, E-43201 Reus, Catalonia, Spain.	jc.vallve@urv.cat	Vallvé, Joan-Carles/T-6742-2019; Rosales, Roser/AAF-9511-2021; MASANA, LUIS/M-7002-2019	Vallvé, Joan-Carles/0000-0001-8711-9618; Rosales, Roser/0000-0002-9386-7169; MASANA, LUIS/0000-0002-0789-4954; Serra, Noemi/0000-0002-2277-351X	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [FIS PI030786]; Centro de Investigacion Biomedica de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Centro de Investigacion Biomedica de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	This work was supported by a grant from the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, [FIS PI030786]; and Centro de Investigacion Biomedica de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM).	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Babelova A, 2013, CURR OPIN PHARMACOL, V13, P260, DOI 10.1016/j.coph.2013.01.004; Bellosta S, 1998, ARTERIOSCL THROM VAS, V18, P1671, DOI 10.1161/01.ATV.18.11.1671; Birnbaum Y, 2012, CURR ATHEROSCLER REP, V14, P135, DOI 10.1007/s11883-012-0232-5; Brown M, 2014, BRIT J CANCER, V110, P2099, DOI 10.1038/bjc.2014.99; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Fukumoto Y, 2001, CIRCULATION, V103, P993; Garcia MC, 2011, FEBS LETT, V585, P618, DOI 10.1016/j.febslet.2011.01.035; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Green J, 2014, ATHEROSCLEROSIS, V232, P277, DOI 10.1016/j.atherosclerosis.2013.11.052; Gu YC, 2000, BRIT J HAEMATOL, V109, P305, DOI 10.1046/j.1365-2141.2000.02011.x; Hattori K, 2012, JACC-CARDIOVASC IMAG, V5, P169, DOI 10.1016/j.jcmg.2011.11.012; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hu B, 2012, CANCER RES, V72, P3873, DOI 10.1158/0008-5472.CAN-12-1060; Jeziorska M, 1999, J PATHOL, V188, P189; Laugesen E, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-107; Li MX, 2008, EUR J PHARMACOL, V591, P219, DOI 10.1016/j.ejphar.2008.06.082; Libby P, 2003, AM J CARDIOL, V91, p4B, DOI 10.1016/S0002-9149(02)03267-8; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Longmate WM, 2014, J INVEST DERMATOL, V134, P1609, DOI 10.1038/jid.2014.10; Mackay J, 2004, WHO ATLAS HEART DIS; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Nakamura T, 2008, J CARDIOVASC PHARM, V51, P365, DOI 10.1097/FJC.0b013e318165dcad; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Papke CL, 2014, MATRIX BIOL, V37, P142, DOI 10.1016/j.matbio.2014.02.004; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Sasaki T, 1996, J CELL SCI, V109, P2895; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Sawyer SL, 2013, AM J MED GENET A, V161A, P1148, DOI 10.1002/ajmg.a.35827; Schaar JA, 2004, EUR HEART J, V25, P1077, DOI 10.1016/j.ehj.2004.01.002; Scholze A, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-6; SHAH PK, 1995, CIRCULATION, V92, P1565; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Sideek MA, 2014, MATRIX BIOL, V34, P114, DOI 10.1016/j.matbio.2013.10.007; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Takarada S, 2009, ATHEROSCLEROSIS, V202, P491, DOI 10.1016/j.atherosclerosis.2008.05.014; ten Kate GL, 2010, CURR PROB CARDIOLOGY, V35, P556, DOI 10.1016/j.cpcardiol.2010.09.002; Utani A, 1997, J BIOL CHEM, V272, P2814, DOI 10.1074/jbc.272.5.2814; Vallve JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043051; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wu XJ, 1997, ARTERIOSCL THROM VAS, V17, P3347, DOI 10.1161/01.ATV.17.11.3347; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	56	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133875	10.1371/journal.pone.0133875	http://dx.doi.org/10.1371/journal.pone.0133875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207907	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000162
J	Tanner, JJ; Mareci, TH; Okun, MS; Bowers, D; Libon, DJ; Price, CC				Tanner, Jared J.; Mareci, Thomas H.; Okun, Michael S.; Bowers, Dawn; Libon, David J.; Price, Catherine C.			Temporal Lobe and Frontal-Subcortical Dissociations in Non-Demented Parkinson's Disease with Verbal Memory Impairment	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DEMENTIA; CORTEX; NEUROPSYCHOLOGY; MICROSTRUCTURE; SEGMENTATION; PROGRESSION; NETWORKS; CRITERIA; ROBUST	Objective The current investigation examined verbal memory in idiopathic non-dementia Parkinson's disease and the significance of the left entorhinal cortex and left entorhinal-retrosplenial region connections (via temporal cingulum) on memory impairment in Parkinson's disease. Methods Forty non-demented Parkinson's disease patients and forty non-Parkinson's disease controls completed two verbal memory tests - a wordlist measure (Philadelphia repeatable Verbal Memory Test) and a story measure (Logical Memory). All participants received T1-weighted and diffusion magnetic resonance imaging (3T; Siemens) sequences. Left entorhinal volume and left entorhinal-retrosplenial connectivity (temporal cingulum edge weight) were the primary imaging variables of interest with frontal lobe thickness and subcortical structure volumes as dissociating variables. Results Individuals with Parkinson's disease showed worse verbal memory, smaller entorhinal volumes, but did not differ in entorhinal-retrosplenial connectivity. For Parkinson's disease entorhinal-retrosplenial edge weight had the strongest associations with verbal memory. A subset of Parkinson's disease patients (23%) had deficits (z-scores < -1.5) across both memory measures. Relative to non-impaired Parkinson's peers, this memory-impaired group had smaller entorhinal volumes. Discussion Although entorhinal cortex volume was significantly reduced in Parkinson's disease patients relative to non-Parkinson's peers, only white matter connections associated with the entorhinal cortex were significantly associated with verbal memory performance in our sample. There was also no suggestion of contribution from frontal-subcortical gray or frontal white matter regions. These findings argue for additional investigation into medial temporal lobe gray and white matter connectivity for understanding memory in Parkinson's disease.	[Tanner, Jared J.; Bowers, Dawn; Price, Catherine C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Mareci, Thomas H.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Okun, Michael S.] Univ Florida, Dept Neurol, UF Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Libon, David J.] Drexel Univ, Coll Med, Drexel Neurosci Inst, Philadelphia, PA 19104 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Drexel University	Price, CC (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	cep23@phhp.ufl.edu	Mareci, Thomas Harold/D-7745-2011	Mareci, Thomas Harold/0000-0003-4700-2364; Tanner, Jared/0000-0001-6821-0029; Okun, Michael/0000-0002-6247-9358; Price, Catherine/0000-0001-5994-0644	National Institutes of Health National Institute of Neurological Disorders and Stroke [K23NS60660, R01NR014810, R01NS082386]; Center for Movement Disorders and Neurorestoration; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award [UL1TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427, UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS060660, R01NS082386] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Movement Disorders and Neurorestoration; National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health National Institute of Neurological Disorders and Stroke K23NS60660 (CP), R01NR014810 (CP) and R01NS082386 (CP), and in part by the Center for Movement Disorders and Neurorestoration, and the National Institutes of Health/National Center for Advancing Translational Sciences Clinical and Translational Science Award to the University of Florida UL1TR000064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondi MW, 2014, J ALZHEIMERS DIS, V42, P275, DOI 10.3233/JAD-140276; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Briggs GG, CORTEX, V11, P230; Bronnick K, 2011, NEUROPSYCHOLOGY, V25, P114, DOI 10.1037/a0020857; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Filoteo JV, 1997, J CLIN EXP NEUROPSYC, V19, P878, DOI 10.1080/01688639708403768; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Goldman JG, 2012, MOVEMENT DISORD, V27, P727, DOI 10.1002/mds.24938; Gratwicke J, 2015, BRAIN, V138, P1454, DOI 10.1093/brain/awv104; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; Heaton RK, 2004, PSYCHOL ASSESS RESOU; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Jak AJ, 2009, INT REV NEUROBIOL, V84, P81, DOI 10.1016/S0074-7742(09)00405-X; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jian B, 2007, NEUROIMAGE, V37, P164, DOI 10.1016/j.neuroimage.2007.03.074; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Kalaitzakis ME, 2009, PARKINSONISM RELAT D, V15, P196, DOI 10.1016/j.parkreldis.2008.05.007; Libon DJ, 2014, J ALZHEIMERS DIS, V42, P999, DOI 10.3233/JAD-132147; Libon DJ, 2011, J INT NEUROPSYCH SOC, V17, P905, DOI 10.1017/S1355617711000944; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Matteau E, 2011, AM J ALZHEIMERS DIS, V26, P389, DOI 10.1177/1533317511412046; McDonald CR, 2014, CORTEX, V58, P139, DOI 10.1016/j.cortex.2014.05.014; Osborne J.W., 2010, PRACTICAL ASSESS RES, V15, P1, DOI [10.7275/qbpc-gk17, DOI 10.7275/QBPC-GK17]; Price CC, 2010, J INT NEUROPSYCH SOC, V16, P846, DOI 10.1017/S135561771000072X; Price CC, 2009, CLIN NEUROPSYCHOL, V23, P944, DOI 10.1080/13854040802681664; Price CC, 2012, JINS, V18, P200; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Troster AI, 2011, J INT NEUROPSYCH SOC, V17, P393, DOI 10.1017/S1355617711000257; Vogt BA, 2000, TRENDS NEUROSCI, V23, P195, DOI 10.1016/S0166-2236(00)01579-4; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zahodne LB, 2011, CLIN NEUROPSYCHOL, V25, P348, DOI 10.1080/13854046.2011.562869; Zgaljardic Dennis J, 2003, Cogn Behav Neurol, V16, P193, DOI 10.1097/00146965-200312000-00001; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256	49	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133792	10.1371/journal.pone.0133792	http://dx.doi.org/10.1371/journal.pone.0133792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208170	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000145
J	Wang, N; Zheng, Y; Duan, NB; Zhang, ZY; Ji, XH; Jiang, SH; Sun, SS; Yang, L; Bai, Y; Fei, ZJ; Chen, XS				Wang, Nan; Zheng, Yi; Duan, Naibin; Zhang, Zongying; Ji, Xiaohao; Jiang, Shenghui; Sun, Shasha; Yang, Long; Bai, Yang; Fei, Zhangjun; Chen, Xuesen			Comparative Transcriptomes Analysis of Red- and White-Fleshed Apples in an F-1 Population of Malus sieversii f. niedzwetzkyana Crossed with M. domestica 'Fuji'	PLOS ONE			English	Article							GENE-EXPRESSION; MYB-GENE; ANTHOCYANIN BIOSYNTHESIS; ASCORBATE PEROXIDASE; CONFERS TOLERANCE; MOLECULAR-CLONING; ABIOTIC STRESS; SALT STRESS; FRUIT; DROUGHT	Transcriptome profiles of the red- and white-fleshed apples in an F-1 segregating population of Malus sieversii f. Niedzwetzkyana and M. domestica 'Fuji' were generated using the next-generation high-throughput RNA sequencing (RNA-Seq) technology and compared. A total of 114 differentially expressed genes (DEGs) were obtained, of which 88 were up-regulated and 26 were down-regulated in red-fleshed apples. The 88 up-regulated genes were enriched with those related to flavonoid biosynthetic process and stress responses. Further analysis identified 22 genes associated with flavonoid biosynthetic process and 68 genes that may be related to stress responses. Furthermore, the expression of 20 up-regulated candidate genes (10 related to flavonoid biosynthesis, two encoding MYB transcription factors and eight related to stress responses) and 10 down-regulated genes were validated by quantitative real-time PCR. After exploring the possible regulatory network, we speculated that flavonoid metabolism might be involved in stress responses in red-fleshed apple. Our findings provide a theoretical basis for further enriching gene resources associated with flavonoid synthesis and stress responses of fruit trees and for breeding elite apples with high flavonoid content and/or increased stress tolerances.	[Wang, Nan; Duan, Naibin; Zhang, Zongying; Ji, Xiaohao; Jiang, Shenghui; Sun, Shasha; Yang, Long; Chen, Xuesen] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Wang, Nan; Duan, Naibin; Zhang, Zongying; Ji, Xiaohao; Jiang, Shenghui; Sun, Shasha; Yang, Long; Chen, Xuesen] Shandong Agr Univ, Coll Hort Sci, Tai An, Shandong, Peoples R China; [Zheng, Yi; Bai, Yang; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Duan, Naibin] Shandong Acad Agr Sci, Shandong Ctr Crop Germplasm Resources, Jinan, Shandong, Peoples R China; [Yang, Long] Shandong Agr Univ, Tobacco Lab, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Cornell University; Boyce Thompson Institute for Plant Research; Shandong Academy of Agricultural Sciences; Shandong Agricultural University	Chen, XS (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	chenxs@sdau.edu.cn	Zheng, Yi/F-6150-2016; Wang, Nan/GRY-3150-2022; Jiang, Shenghui/HHS-5691-2022; shi, zhensheng/GXN-3967-2022; Fei, Zhangjun/H-5152-2012	Zheng, Yi/0000-0002-8042-7770; Jiang, Shenghui/0000-0003-3550-9037; Duan, Naibin/0000-0003-0443-0406; Yang, Long/0000-0002-9990-8398	Special Fund for Agro-scientific Research in the Public Interest [201303093]; Natl. Natural Science Foundation of China [31171932]; National Key Basic Research Program of China from Ministry of Science and Technology and Agriculture of the People's Republic of China [2011CB100606]	Special Fund for Agro-scientific Research in the Public Interest; Natl. Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China from Ministry of Science and Technology and Agriculture of the People's Republic of China	This work was financially supported by Special Fund for Agro-scientific Research in the Public Interest (to XSC, grant no. 201303093, URL: http://www.most.gov.cn/), Natl. Natural Science Foundation of China (to XSC, grant no. 31171932, URL: http://www.nsfc.gov.cn/) and National Key Basic Research Program of China (to XSC, grant no. 2011CB100606, URL: http://www.most.gov.cn/) from Ministry of Science and Technology and Agriculture of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRITT BH, 2003, COMPACT FRUIT TREE, V36, P15; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt D, 2013, MOL BIOL REP, V40, P1155, DOI 10.1007/s11033-012-2157-z; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cao H, 2008, ACTA HORTICULTURAE S, V35, P1351; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chen XS, 1994, J SHANDONG AGR U, V25, P36; [陈学森 Chen Xuesen], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P2193; Chen XueSen, 2010, Journal of Fruit Science, V27, P598; Chen Xuesen, 2007, Journal of Genetics and Genomics, V34, P171, DOI 10.1016/S1673-8527(07)60018-6; Chen YH, 2006, J INTEGR PLANT BIOL, V48, P1084, DOI 10.1111/j.1744-7909.2006.00311.x; Cho WK, 2014, MOL BIOL REP, V41, P1469, DOI 10.1007/s11033-013-2992-6; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; Conn S, 2008, J EXP BOT, V59, P3621, DOI 10.1093/jxb/ern217; Csiszar J, 2014, PLANT PHYSIOL BIOCH, V78, P15, DOI 10.1016/j.plaphy.2014.02.010; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; De Vos M, 2006, PLANT SIGNAL BEHAV, V1, P305, DOI 10.4161/psb.1.6.3512; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Feng Tao, 2007, Journal of Fruit Science, V24, P571; Feng TingTing, 2007, Journal of Fruit Science, V24, P199; Fini A, 2011, PLANT SIGNAL BEHAV, V168, P204; Galle Agnes, 2008, Acta Biologica Szegediensis, V52, P95; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Ithal N, 2004, PLANT SCI, V166, P1505, DOI 10.1016/j.plantsci.2004.02.002; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Ji XH, 2015, PLANT CELL TISS ORG, V120, P325, DOI 10.1007/s11240-014-0609-y; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Kussmaul L, 2015, PNAS, V103, P7607; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Liu ZH, 2013, BIOTECHNOL LETT, V35, P1765, DOI 10.1007/s10529-013-1277-4; Liu ZunChun, 2012, Journal of Fruit Science, V29, P722; Liu ZunChun, 2010, Scientia Agricultura Sinica, V43, P358; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Moyano E, 1996, PLANT CELL, V8, P1519, DOI 10.1105/tpc.8.9.1519; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Patra B, 2013, BBA-GENE REGUL MECH, V1829, P1236, DOI 10.1016/j.bbagrm.2013.09.006; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Reddy AM, 2007, METAB ENG, V9, P95, DOI 10.1016/j.ymben.2006.09.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Sharma S, 2010, PLANT CELL ENVIRON, V33, P1838, DOI 10.1111/j.1365-3040.2010.02188.x; Shu HR, 1999, APPLE SCI, P26; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao F., 2006, J PLANT GENETIC RESO, V7, P270; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umemura H, 2013, PLANTA, V238, P65, DOI 10.1007/s00425-013-1875-3; van Nocker S, 2012, EUPHYTICA, V185, P281, DOI 10.1007/s10681-011-0579-7; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang Y, 2012, NANO, V7, DOI 10.1142/S1793292012500427; Wang YanLing, 2010, Scientia Agricultura Sinica, V43, P2735; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; [吴传金 WU Chuanjin], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P243; [肖庆生 Xiao Qingsheng], 2012, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V34, P123; Xu F, 2008, MOL CELLS, V26, P536; Xu Qian, 2009, BMC GENOMICS, V10, P1; [许瑞瑞 Xu Ruirui], 2012, [园艺学报, Acta Horticulturae Sinica], V39, P2049; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Yu SW, 2008, ACTA BIOCH BIOPH SIN, V40, P1005, DOI 10.1111/j.1745-7270.2008.00489.x; Yu Y, 2003, PROGR BIOTECHNOLOGY, V2003; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang ChunYu, 2009, Acta Horticulturae Sinica, V36, P7; Zhang ChunYu, 2009, Scientia Agricultura Sinica, V42, P597; Zhang Chunyu, 2007, Journal of Genetics and Genomics, V34, P947, DOI 10.1016/S1673-8527(07)60106-4; Zhang JiYu, 2011, Scientia Agricultura Sinica, V44, P990; Zhang XiaoYan, 2008, Acta Horticulturae Sinica, V35, P1351; Zhang YanMin, 2009, Acta Horticulturae Sinica, V36, P447; Zhao LingLing, 2008, Journal of Fruit Science, V25, P151; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950	87	20	22	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133468	10.1371/journal.pone.0133468	http://dx.doi.org/10.1371/journal.pone.0133468			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207813	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000091
J	Carrick, DM; Mehaffey, MG; Sachs, MC; Altekruse, S; Camalier, C; Chuaqui, R; Cozen, W; Das, B; Hernandez, BY; Lih, CJ; Lynch, CF; Makhlouf, H; McGregor, P; McShane, LM; Rohan, JP; Walsh, WD; Williams, PM; Gillanders, EM; Mechanic, LE; Schully, SD				Carrick, Danielle Mercatante; Mehaffey, Michele G.; Sachs, Michael C.; Altekruse, Sean; Camalier, Corinne; Chuaqui, Rodrigo; Cozen, Wendy; Das, Biswajit; Hernandez, Brenda Y.; Lih, Chih-Jian; Lynch, Charles F.; Makhlouf, Hala; McGregor, Paul; McShane, Lisa M.; Rohan, JoyAnn Phillips; Walsh, William D.; Williams, Paul M.; Gillanders, Elizabeth M.; Mechanic, Leah E.; Schully, Sheri D.			Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue	PLOS ONE			English	Article							FFPE TUMOR-TISSUES; SOMATIC MUTATIONS; CANCER; IDENTIFICATION; CONFIDENCE; CARCINOMA; SAMPLES; FROZEN	Next Generation Sequencing (NGS) technologies are used to detect somatic mutations in tumors and study germ line variation. Most NGS studies use DNA isolated from whole blood or fresh frozen tissue. However, formalin-fixed paraffin-embedded (FFPE) tissues are one of the most widely available clinical specimens. Their potential utility as a source of DNA for NGS would greatly enhance population-based cancer studies. While preliminary studies suggest FFPE tissue may be used for NGS, the feasibility of using archived FFPE specimens in population based studies and the effect of storage time on these specimens needs to be determined. We conducted a study to determine whether DNA in archived FFPE high-grade ovarian serous adenocarcinomas from Surveillance, Epidemiology and End Results (SEER) registries Residual Tissue Repositories (RTR) was present in sufficient quantity and quality for NGS assays. Fifty-nine FFPE tissues, stored from 3 to 32 years, were obtained from three SEER RTR sites. DNA was extracted, quantified, quality assessed, and subjected to whole exome sequencing (WES). Following DNA extraction, 58 of 59 specimens (98%) yielded DNA and moved on to the library generation step followed by WES. Specimens stored for longer periods of time had significantly lower coverage of the target region (6% lower per 10 years, 95% CI: 3-10%) and lower average read depth (40x lower per 10 years, 95% CI: 18-60), although sufficient quality and quantity of WES data was obtained for data mining. Overall, 90% (53/59) of specimens provided usable NGS data regardless of storage time. This feasibility study demonstrates FFPE specimens acquired from SEER registries after varying lengths of storage time and under varying storage conditions are a promising source of DNA for NGS.	[Carrick, Danielle Mercatante; Altekruse, Sean; Gillanders, Elizabeth M.; Mechanic, Leah E.; Schully, Sheri D.] NCI, DCCPS, Rockville, MD 20850 USA; [Mehaffey, Michele G.; Camalier, Corinne; Das, Biswajit; Lih, Chih-Jian; McGregor, Paul; Rohan, JoyAnn Phillips; Walsh, William D.; Williams, Paul M.] Leidos Biomed Res Inc, Mol Characterizat & Clin Assay Dev Lab, Frederick, MD 21702 USA; [Mehaffey, Michele G.; Camalier, Corinne; Das, Biswajit; Lih, Chih-Jian; McGregor, Paul; Rohan, JoyAnn Phillips; Walsh, William D.; Williams, Paul M.] Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Sachs, Michael C.; Chuaqui, Rodrigo; Makhlouf, Hala; McShane, Lisa M.] NCI, DCTD, Rockville, MD 20850 USA; [Cozen, Wendy] Univ So Calif, USC Keck Sch Med, Los Angeles, CA 90089 USA; [Hernandez, Brenda Y.] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA; [Lynch, Charles F.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Iowa	Carrick, DM (corresponding author), NCI, DCCPS, 9609 Med Ctr Dr, Rockville, MD 20850 USA.	Danielle.Carrick@nih.gov	McShane, Lisa/GXM-8870-2022	Sachs, Michael/0000-0002-1279-8676	National Cancer Institute [N01-PC-35143, P30CA014089]; Hawaii Tumor Registry [N01-PC-35137]; University of Hawaii Cancer Center Pathology Shared Resource; California Department of Health Services; National Cancer Institute, National Institutes of Health; Department of Health and Human Services [N01-PC-2010-00035]; Centers for Disease Control and Prevention [1U58DP000807-3]; Leidos Biomedical Research Inc.; NATIONAL CANCER INSTITUTE [P30CA086862, P30CA014089, P30CA071789] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hawaii Tumor Registry; University of Hawaii Cancer Center Pathology Shared Resource; California Department of Health Services; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Leidos Biomedical Research Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported in part in Iowa by contract N01-PC-35143 from the National Cancer Institute, and by the Hawaii Tumor Registry (N01-PC-35137) and the University of Hawaii Cancer Center Pathology Shared Resource. Collection of data used in this publication was supported in part by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services under Contract No. N01-PC-2010-00035; and grant number 1U58DP000807-3 from the Centers for Disease Control and Prevention, and by award number P30CA014089 from the National Cancer Institute. This study was funded by the National Institutes of Health, National Cancer Institute. NCI and a NCI contract laboratory (Leidos) staff members were involved in the design of this study, lab analyses, statistical analyses, pathology reviews, data interpretation, and writing/reviewing the manuscript. The corresponding author, DMC, had full access to all the data in the study and had final responsibility for the decision to submit for publication. Leidos Biomedical Research Inc. provided support in the form of salaries for authors MM, CC, BD, CJL, PM, JPR, WWand PMW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MD, 2012, MODERN PATHOL, V25, P1599, DOI 10.1038/modpathol.2012.121; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berg JS, 2013, GENET MED, V15, P860, DOI 10.1038/gim.2013.133; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Corless CL, 2012, CANCER DISCOV, V2, P23, DOI 10.1158/2159-8290.CD-11-0319; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Feldman AL, 2011, BLOOD, V117, P915, DOI 10.1182/blood-2010-08-303305; Goodman MT, 2005, HUM PATHOL, V36, P812, DOI 10.1016/j.humpath.2005.03.010; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Holbrook JD, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-119; KapaBiosystems, 2014, KAPA HUM GEN DNA QUA; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Van Allen EM, 2014, PROSTATE CANCER P D, V17, P23, DOI 10.1038/pcan.2013.37; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Yost SE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks299	26	71	71	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0127353	10.1371/journal.pone.0127353	http://dx.doi.org/10.1371/journal.pone.0127353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222067	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800003
J	Chen, CW; Yao, Y; Zhang, L; Xu, MJ; Jiang, JP; Dou, TH; Lin, W; Zhao, GP; Huang, MR; Zhou, Y				Chen, Chengwen; Yao, Ye; Zhang, Liang; Xu, Minjie; Jiang, Jianping; Dou, Tonghai; Lin, Wei; Zhao, Guoping; Huang, Minren; Zhou, Yan			A Comprehensive Analysis of the Transcriptomes of Marssonina brunnea and Infected Poplar Leaves to Capture Vital Events in Host-Pathogen Interactions	PLOS ONE			English	Article							REGULATORY NETWORKS; GENE-EXPRESSION; INFERENCE; RECEPTOR; DISEASE; GENOME; MODEL	Background Understanding host-pathogen interaction mechanisms helps to elucidate the entire infection process and focus on important events, and it is a promising approach for improvement of disease control and selection of treatment strategy. Time-course host-pathogen transcriptome analyses and network inference have been applied to unravel the direct or indirect relationships of gene expression alterations. However, time series analyses can suffer from absent time points due to technical problems such as RNA degradation, which limits the application of algorithms that require strict sequential sampling. Here, we introduce an efficient method using independence test to infer an independent network that is exclusively concerned with the frequency of gene expression changes. Results Highly resistant NL895 poplar leaves and weakly resistant NL214 leaves were infected with highly active and weakly active Marssonina brunnea, respectively, and were harvested at different time points. The independent network inference illustrated the top 1,000 vital fungus- poplar relationships, which contained 768 fungal genes and 54 poplar genes. These genes could be classified into three categories: a fungal gene surrounded by many poplar genes; a poplar gene connected to many fungal genes; and other genes (possessing low degrees of connectivity). Notably, the fungal gene M6_ 08342 (a metalloprotease) was connected to 10 poplar genes, particularly including two disease-resistance genes. These core genes, which are surrounded by other genes, may be of particular importance in complicated infection processes and worthy of further investigation. Conclusions We provide a clear framework of the interaction network and identify a number of candidate key effectors in this process, which might assist in functional tests, resistant clone selection, and disease control in the future.	[Chen, Chengwen; Yao, Ye; Xu, Minjie; Jiang, Jianping; Dou, Tonghai; Lin, Wei; Zhou, Yan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Chen, Chengwen; Zhang, Liang; Xu, Minjie; Jiang, Jianping; Zhao, Guoping; Zhou, Yan] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Chen, Chengwen] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Yao, Ye; Lin, Wei] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Yao, Ye; Lin, Wei] Fudan Univ, Sch Math Sci, Shanghai 200433, Peoples R China; [Huang, Minren] Nanjing Forestry Univ, Jiangsu Key Lab Poplar Germplasm Enhancement & Va, Nanjing, Jiangsu, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University; Nanjing Forestry University	Zhou, Y (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	zhouy@chgc.sh.cn	CHEN, CHEN/HDM-6657-2022; chen, chen wen/GZM-3705-2022; Lin, Wei/C-9640-2011	Lin, Wei/0000-0002-1863-4306; Zhao, Guo-Ping/0000-0002-7621-6620	National High-tech R&D Program (863 Program) [2012AA020409]; National Basic Research Program (973 Program) [2011CB111610]; National S&T Basic Work Program [2009FY120100]; National Natural Science Foundation of China [11322111, 61273014]; Shanghai Postdoctoral Sustentation Fund [13R21420700]; Science and Technology Commission of Shanghai Municipality [11JC1400900, 12ZR1421300]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program (973 Program)(National Basic Research Program of China); National S&T Basic Work Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Postdoctoral Sustentation Fund; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is supported by National High-tech R&D Program (863 Program, Grant No. 2012AA020409), National Basic Research Program (973 Program, Grant No. 2011CB111610), National S&T Basic Work Program (Grant No. 2009FY120100), National Natural Science Foundation of China (Grant No. 11322111 and 61273014), Shanghai Postdoctoral Sustentation Fund (Grant No. 13R21420700), and Science and Technology Commission of Shanghai Municipality Grant No. 11JC1400900 and 12ZR1421300).	Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Beare JA, 1999, ENVIRON POLLUT, V105, P409, DOI 10.1016/S0269-7491(99)00034-2; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Duplessis S, 2009, CRIT REV PLANT SCI, V28, P309, DOI 10.1080/07352680903241063; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gallie D.R., 2013, SCIENTIFICA, DOI DOI 10.1155/2013/795964; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gupta SK, 2012, INDIAN J PHARMACOL, V44, P143, DOI 10.4103/0253-7613.91895; Han ZM, 2000, THEOR APPL GENET, V100, P614, DOI 10.1007/s001220050081; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kemppainen M, 2009, ENVIRON MICROBIOL, V11, P1878, DOI 10.1111/j.1462-2920.2009.01912.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee EJ, 2007, PLANT CELL PHYSIOL, V48, P405, DOI 10.1093/pcp/pcm009; Li Z, 2011, BIOINFORMATICS, V27, P2686, DOI 10.1093/bioinformatics/btr454; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Mobini R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-19; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Somssich IE, 1996, P NATL ACAD SCI USA, V93, P14199, DOI 10.1073/pnas.93.24.14199; Son YS, 2008, PATTERN RECOGN LETT, V29, P232, DOI 10.1016/j.patrec.2007.09.015; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Usadel B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00048; Wang Z, 2014, EUKARYOT CELL, V13, P154, DOI 10.1128/EC.00248-13; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Ying SH, 2011, BIOL CONTROL, V59, P255, DOI 10.1016/j.biocontrol.2011.07.005; Yonekura-Sakakibara K, 2012, CURRENT OPINION BIOT; Zhou S, 2007, J HUM HYPERTENS, V21, P861, DOI 10.1038/sj.jhh.1002244; Zhu S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-382	36	11	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134246	10.1371/journal.pone.0134246	http://dx.doi.org/10.1371/journal.pone.0134246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222429	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800116
J	Jroundi, F; Gonzalez-Munoz, MT; Sterflinger, K; Pinar, G				Jroundi, Fadwa; Teresa Gonzalez-Munoz, Maria; Sterflinger, Katja; Pinar, Guadalupe			Molecular Tools for Monitoring the Ecological Sustainability of a Stone Bio-Consolidation Treatment at the Royal Chapel, Granada	PLOS ONE			English	Article							ENDOLITHIC BACTERIAL COMMUNITIES; GREEN NONSULFUR BACTERIA; CALCITE PRECIPITATION; MICROBIAL COMMUNITIES; MICROCOLONIAL FUNGI; CULTURAL-HERITAGE; LIMESTONE; MONUMENTS; FRESCOES; BIOMINERALIZATION	Background Biomineralization processes have recently been applied in situ to protect and consolidate decayed ornamental stone of the Royal Chapel in Granada (Spain). While this promising method has demonstrated its efficacy regarding strengthening of the stone, little is known about its ecological sustainability. Methodology/Principal Findings Here, we report molecular monitoring of the stone-autochthonous microbiota before and at 5, 12 and 30 months after the bio-consolidation treatment (medium/long-term monitoring), employing the well-known molecular strategy of DGGE analyses. Before the bio-consolidation treatment, the bacterial diversity showed the exclusive dominance of Actinobacteria (100%), which decreased in the community (44.2%) after 5 months, and Gamma-proteobacteria (30.24%) and Chloroflexi (25.56%) appeared. After 12 months, Gamma-proteobacteriavanished from the community and Cyanobacteria (22.1%) appeared and remained dominant after thirty months, when the microbiota consisted of Actinobacteria (42.2%) and Cyanobacteria (57.8%) only. Fungal diversity showed that the Ascomycota phylum was dominant before treatment (100%), while, after five months, Basidiomycota (6.38%) appeared on the stone, and vanished again after twelve months. Thirty months after the treatment, the fungal population started to stabilize and Ascomycota dominated on the stone (83.33%) once again. Members of green algae (Chlorophyta, Viridiplantae) appeared on the stone at 5, 12 and 30 months after the treatment and accounted for 4.25%, 84.77% and 16.77%, respectively. Conclusions The results clearly show that, although a temporary shift in the bacterial and fungal diversity was observed during the first five months, most probably promoted by the application of the bio-consolidation treatment, the microbiota tends to regain its initial stability in a few months. Thus, the treatment does not seem to have any negative side effects on the stone-autochthonous microbiota over that time. The molecular strategy employed here is suggested as an efficient monitoring tool to assess the impact on the stone-autochthonous microbiota of the application of biomineralization processes as a restoration/conservation procedure.	[Jroundi, Fadwa; Teresa Gonzalez-Munoz, Maria] Univ Granada, Fac Sci, Dept Microbiol, Granada, Spain; [Sterflinger, Katja; Pinar, Guadalupe] Univ Nat Resources & Life Sci, VIBT BOKU, Dept Biotechnol, Vienna, Austria	University of Granada; University of Natural Resources & Life Sciences, Vienna	Jroundi, F (corresponding author), Univ Granada, Fac Sci, Dept Microbiol, Granada, Spain.	fadwa@ugr.es	Pinar, Guadalupe/I-8959-2016; Jroundi, Fadwa/AAN-8363-2021; Jroundi, Fadwa/K-5724-2014	Pinar, Guadalupe/0000-0001-7881-8572; Jroundi, Fadwa/0000-0002-6532-1441; Sterflinger, Katja/0000-0002-0296-6728	European Regional Development Fund (ERDF); Junta de Andalucia (Spain); "Fortalecimiento de la I+D+i" program from the University of Granada; Junta de Andalucia [BIO-103]; Spanish Government through "Jose Castillejo" program from the "Ministerio de Educacion, Cultura y Deporte" (I+D+i); Austrian Science Fund (FWF) [V194-B20];  [RNM-3493]	European Regional Development Fund (ERDF)(European Commission); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); "Fortalecimiento de la I+D+i" program from the University of Granada; Junta de Andalucia(Junta de Andalucia); Spanish Government through "Jose Castillejo" program from the "Ministerio de Educacion, Cultura y Deporte" (I+D+i); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); 	This work was supported by the European Regional Development Fund (ERDF), Junta de Andalucia (Spain) and the "Fortalecimiento de la I+D+i" program from the University of Granada, co-financed by grant RNM-3493 and Research Group BIO-103 from Junta de Andalucia, as well as by the Spanish Government through "Jose Castillejo" program from the "Ministerio de Educacion, Cultura y Deporte" (I+D+i 2008-2011), and by the Austrian Science Fund (FWF) under Grant "Elise-Richter V194-B20". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Bang SS, 2001, ENZYME MICROB TECH, V28, P404, DOI 10.1016/S0141-0229(00)00348-3; Batista JF, 2000, BIODEGRADATION, V11, P441, DOI 10.1023/A:1011620023116; Beer M, 2002, FEMS MICROBIOL LETT, V207, P179, DOI 10.1016/S0378-1097(01)00561-4; BIANCHI A, 1980, INT BIODETERIOR, V16, P45; Billi D, 2000, APPL ENVIRON MICROB, V66, P1489, DOI 10.1128/AEM.66.4.1489-1492.2000; Bjornsson L, 2002, MICROBIOL-SGM, V148, P2309, DOI 10.1099/00221287-148-8-2309; Bogomolova EV, 2003, MYCOTAXON, V86, P195; Boomer SM, 2002, APPL ENVIRON MICROB, V68, P346, DOI 10.1128/AEM.68.1.346-355.2002; BOQUET E, 1973, NATURE, V246, P527, DOI 10.1038/246527a0; Bruand A, 1999, SOIL SCI SOC AM J, V63, P164, DOI 10.2136/sssaj1999.03615995006300010023x; Brusetti L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-220; Burford EP, 2006, GEOMICROBIOL J, V23, P599, DOI 10.1080/01490450600964375; Capodicasa S, 2010, INT BIODETER BIODEGR, V64, P727, DOI 10.1016/j.ibiod.2010.08.006; Cappitelli F, 2009, MICROB ECOL, V57, P633, DOI 10.1007/s00248-008-9441-4; Chouaia B, 2012, J BACTERIOL, V194, P2752, DOI 10.1128/JB.00320-12; COLLIER PJ, 1990, J APPL BACTERIOL, V69, P578, DOI 10.1111/j.1365-2672.1990.tb01551.x; Coutinho ML, 2013, INT BIODETER BIODEGR, V84, P322, DOI 10.1016/j.ibiod.2012.05.028; de los Rios A, 2012, INT BIODETER BIODEGR, V67, P64, DOI 10.1016/j.ibiod.2011.10.010; Dick J, 2006, BIODEGRADATION, V17, P357, DOI 10.1007/s10532-005-9006-x; Herrero AD, 2006, AEROBIOLOGIA, V22, P135, DOI 10.1007/s10453-006-9025-z; Docampo S, 2011, SCI TOTAL ENVIRON, V409, P835, DOI 10.1016/j.scitotenv.2010.10.048; Eppard M, 1996, ARCH MICROBIOL, V166, P12, DOI 10.1007/s002030050350; Ettenauer J, 2011, SCI TOTAL ENVIRON, V409, P5337, DOI 10.1016/j.scitotenv.2011.08.063; Ettenauer J, 2010, INT J ASTROBIOL, V9, P59, DOI 10.1017/S1473550409990383; Gaylarde CC, 2012, CURR MICROBIOL, V64, P85, DOI 10.1007/s00284-011-0034-y; Gladis F, 2010, BIOFOULING, V26, P89, DOI 10.1080/08927010903278184; Gleeson DB, 2006, MICROB ECOL, V51, P526, DOI 10.1007/s00248-006-9052-x; Gonz?lez-Mu?oz M.T., 2008, COALITION, V15, P12; Gonzalez JM, 2005, INT MICROBIOL, V8, P189; Gonzalez-Mu&ntilde;oz MT, 2008, Spanish patent, Patent No. [WO2008/009771 A1, 2008009771AI]; Gorbushina AA, 2000, INT BIODETER BIODEGR, V46, P277, DOI 10.1016/S0964-8305(00)00103-7; Gtari M, 2012, FEMS MICROBIOL ECOL, V80, P566, DOI 10.1111/j.1574-6941.2012.01320.x; Heuer H, 1999, APPL ENVIRON MICROB, V65, P1045; Horath T, 2009, MICROB ECOL, V58, P290, DOI 10.1007/s00248-008-9483-7; Jimenez-Lopez C, 2007, CHEMOSPHERE, V68, P1929, DOI 10.1016/j.chemosphere.2007.02.044; Jimenez-Lopez C, 2008, INT BIODETER BIODEGR, V62, P352, DOI 10.1016/j.ibiod.2008.03.002; Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021; Jroundi F, 2013, PROCEEDINGS OF THE 8, VIII, P159; Jroundi F, 2014, ACTA BIOMATER, V10, P3844, DOI 10.1016/j.actbio.2014.03.007; Jroundi F, 2012, SCI TOTAL ENVIRON, V425, P89, DOI 10.1016/j.scitotenv.2012.02.059; Jroundi F, 2010, MICROB ECOL, V60, P39, DOI 10.1007/s00248-010-9665-y; Kusumi A, 2013, MICROBES ENVIRON, V28, P422, DOI 10.1264/jsme2.ME13033; Lacey J, 1981, BIOL CONIDIAL FUNGI, V1, P373; Laiz L, 2003, ENVIRON MICROBIOL, V5, P72, DOI 10.1046/j.1462-2920.2003.00381.x; Le Metayer-Levrel G, 1999, SEDIMENT GEOL, V126, P25, DOI 10.1016/S0037-0738(99)00029-9; McNamara CJ, 2006, MICROB ECOL, V51, P51, DOI 10.1007/s00248-005-0200-5; Michaelsen A, 2006, INT BIODETER BIODEGR, V58, P133, DOI 10.1016/j.ibiod.2006.06.019; Monger HC, 1996, SOIL SCI SOC AM J, V60, P519, DOI 10.2136/sssaj1996.03615995006000020026x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P2237, DOI 10.1093/nar/18.suppl.2237; Pinar G, 2015, MICROB ECOL, V69, P118, DOI 10.1007/s00248-014-0481-7; Pinar G, 2010, MICROB ECOL, V60, P15, DOI 10.1007/s00248-010-9661-2; Portillo MC, 2009, SCI TOTAL ENVIRON, V407, P4876, DOI 10.1016/j.scitotenv.2009.05.038; Ramachandran SK, 2001, ACI MATER J, V98, P3; Rodriguez-Navarro C, 2003, APPL ENVIRON MICROB, V69, P2182, DOI 10.1128/AEM.69.4.2182-2193.2003; Rodriguez-Navarro C., 2015, RESTOR BUILD MONUMEN, V21, P9, DOI [10.1515/rbm-2015-0002, DOI 10.1515/RBM-2015-0002, DOI 10.1515/rbm-2015-0002]; Rodriguez-Navarro C, 2012, APPL ENVIRON MICROB, V78, P4017, DOI 10.1128/AEM.07044-11; Sambrook J., 1989, MOLECULAR CLONING A; SAMPO S, 1989, INT BIODETERIOR, V25, P343, DOI 10.1016/0265-3036(89)90014-6; Sanmartin P, 2011, BIODEGRADATION, V22, P763, DOI 10.1007/s10532-010-9402-8; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5; Sert HB, 2007, ANTON LEEUW INT J G, V91, P217, DOI 10.1007/s10482-006-9111-9; SORLINI C, 1987, INT BIODETERIOR, V23, P167, DOI 10.1016/0265-3036(87)90052-2; STALEY JT, 1982, SCIENCE, V215, P1093, DOI 10.1126/science.215.4536.1093; Sterflinger K, 2001, ANTON LEEUW INT J G, V80, P275, DOI 10.1023/A:1013060308809; Sterflinger K, 1997, GEOMICROBIOL J, V14, P219, DOI 10.1080/01490459709378045; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Suihko ML, 2007, SYST APPL MICROBIOL, V30, P494, DOI 10.1016/j.syapm.2007.05.001; Tang Y, 2012, GEOMICROBIOL J, V29, P213, DOI 10.1080/01490451.2011.558560; Tiano P, 1999, J MICROBIOL METH, V36, P139, DOI 10.1016/S0167-7012(99)00019-6; Urzi C, 2001, ENVIRON MICROBIOL, V3, P471, DOI 10.1046/j.1462-2920.2001.00217.x; Urzi C, 2004, INT J SYST EVOL MICR, V54, P253, DOI 10.1099/ijs.0.02745-0; Urzi C, 1998, INT BIODETER BIODEGR, V42, P45, DOI 10.1016/S0964-8305(98)00045-6; Urzi C., 2001, AEROBIOLOGIA, V17, P11, DOI [DOI 10.1023/A:1007652300354, 10.1023/A:1007652300354]; VERRECCHIA EP, 1993, J SEDIMENT PETROL, V63, P1000; Walker JJ, 2007, APPL ENVIRON MICROB, V73, P3497, DOI 10.1128/AEM.02656-06; Warscheid T, 2000, INT BIODETER BIODEGR, V46, P343, DOI 10.1016/S0964-8305(00)00109-8; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wollenzien U, 1997, ANTON LEEUW INT J G, V71, P281, DOI 10.1023/A:1000157803954; Yan Fei, 2012, Weishengwu Xuebao, V52, P629; Young ME, 2008, ENVIRON GEOL, V56, P631, DOI 10.1007/s00254-008-1455-1; Zanardini E, 2000, INT BIODETER BIODEGR, V45, P35, DOI 10.1016/S0964-8305(00)00043-3	85	9	9	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132465	10.1371/journal.pone.0132465	http://dx.doi.org/10.1371/journal.pone.0132465			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222040	Green Published, gold			2022-12-27	WOS:000358836800023
J	Murawaki, Y				Murawaki, Yugo			Spatial Structure of Evolutionary Models of Dialects in Contact	PLOS ONE			English	Article							PHYLOGENETIC NETWORKS; HORIZONTAL TRANSMISSION; TREES; CONSTRUCTION; DIFFUSION; EXPANSION; LANGUAGES; DISTANCE; SUPPORT; HISTORY	Phylogenetic models, originally developed to demonstrate evolutionary biology, have been applied to a wide range of cultural data including natural language lexicons, manuscripts, folktales, material cultures, and religions. A fundamental question regarding the application of phylogenetic inference is whether trees are an appropriate approximation of cultural evolutionary history. Their validity in cultural applications has been scrutinized, particularly with respect to the lexicons of dialects in contact. Phylogenetic models organize evolutionary data into a series of branching events through time. However, branching events are typically not included in dialectological studies to interpret the distributions of lexical terms. Instead, dialectologists have offered spatial interpretations to represent lexical data. For example, new lexical items that emerge in a politico-cultural center are likely to spread to peripheries, but not vice versa. To explore the question of the tree model's validity, we present a simple simulation model in which dialects form a spatial network and share lexical items through contact rather than through common ancestors. We input several network topologies to the model to generate synthetic data. We then analyze the synthesized data using conventional phylogenetic techniques. We found that a group of dialects can be considered tree-like even if it has not evolved in a temporally tree-like manner but has a temporally invariant, spatially tree-like structure. In addition, the simulation experiments appear to reproduce unnatural results observed in reconstructed trees for real data. These results motivate further investigation into the spatial structure of the evolutionary history of dialect lexicons as well as other cultural characteristics.	Kyushu Univ, Dept Adv Informat Technol, Grad Sch Informat Sci & Elect Engn, Fukuoka 812, Japan	Kyushu University	Murawaki, Y (corresponding author), Kyushu Univ, Dept Adv Informat Technol, Grad Sch Informat Sci & Elect Engn, Fukuoka 812, Japan.	murawaki@ait.kyushu-u.ac.jp			 [26730122]		This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) (grant number: 26730122, http://kaken.nii.ac.jp/d/p/26730122.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; [Anonymous], 1872, VERWANDTSCHAFTSVERH; Barbancon F, 2013, DIACHRONICA, V30, P143, DOI 10.1075/dia.30.2.01bar; Barbrook AC, 1998, NATURE, V394, P839, DOI 10.1038/29667; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Campbell Lyle., 2004, HIST LINGUISTICS INT, VSecondedition; Currie TE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0695; Currie TE, 2010, PHILOS T R SOC B, V365, P3903, DOI 10.1098/rstb.2010.0014; Darwin C, 1859, ORIGIN SPECIES MEANS; Delre SA, 2010, J PROD INNOVAT MANAG, V27, P267, DOI 10.1111/j.1540-5885.2010.00714.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EXCOFFIER L, 1992, GENETICS, V131, P479; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Hirayama Teruo, 1992, GENDAI NIHONGO HOGEN; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Holland BR, 2002, MOL BIOL EVOL, V19, P2051, DOI 10.1093/oxfordjournals.molbev.a004030; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kagyu-ko Yanagita K., 1930, KAGYU K; Kamei T, 1973, NIHONGO KEITORON NO, P91; Karlsson S, 2004, ICELANDIC LANGUAGE; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Kerswill P., 2003, SOCIAL DIALECTOLOGY, P223; Labov W, 2007, LANGUAGE, V83, P344, DOI 10.1353/lan.2007.0082; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062243; Lee S, 2011, P ROY SOC B-BIOL SCI, V278, P3662, DOI 10.1098/rspb.2011.0518; Matthews LJ, 2012, HUM NATURE-INT BIOS, V23, P218, DOI 10.1007/s12110-012-9138-8; Nakamoto M, 1983, RYUKYU GOISHI NO KEN, P15; Nakamoto M, 1981, ZUSETSU RYUKYUGO JIT; Nakhleh L, 2005, LANGUAGE, V81, P382, DOI 10.1353/lan.2005.0078; Nelson-Sathi S, 2011, P ROY SOC B-BIOL SCI, V278, P1794, DOI 10.1098/rspb.2010.1917; Nicholls GK, 2008, J ROY STAT SOC B, V70, P545, DOI 10.1111/j.1467-9868.2007.00648.x; Nichols J, 2008, LANG LINGUIST COMPAS, V2, P760, DOI 10.1111/j.1749-818x.2008.00082.x; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Ogino C, 2011, STUDIES JAPANESE LAN, V7, P39; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Ross RM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3065; Schleicher A, 1853, ALLGEMEINE MONATSSCH, V3, P786; Serafim LA, 2008, AMST STUD THEORY HIS, V294, P79; Shimabukuro Moriyo, 2007, ACCENTUAL HIST JAPAN; Swadesh M., 1952, P AM PHILOS SOC, V96, P452, DOI DOI 10.2307/3143802; Swadesh Morris, 1971, ORIGIN DIVERSIFICATI; Temkin I, 2007, CURR ANTHROPOL, V48, P146, DOI 10.1086/510463; Tojo M, 1927, KOKUGO NO HOGEN KUKA; Trudgill P, 2000, DIALECTS ENGLAND, V2nd; Upton C., 2006, ATLAS ENGLISH DIALEC, V2nd; Warnow T, 2006, PHYLOGENETIC METHODS, P75; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Whitman J, 2011, RICE, V4, P149, DOI 10.1007/s12284-011-9080-0; Wright S, 1943, GENETICS, V28, P114	54	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134335	10.1371/journal.pone.0134335	http://dx.doi.org/10.1371/journal.pone.0134335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CO0JM	26221958	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800132
J	Pimentel, MS; Faleiro, F; Diniz, M; Machado, J; Pousao-Ferreira, P; Peck, MA; Portner, HO; Rosa, R				Pimentel, Marta S.; Faleiro, Filipa; Diniz, Mario; Machado, Jorge; Pousao-Ferreira, Pedro; Peck, Myron A.; Poertner, Hans O.; Rosa, Rui			Oxidative Stress and Digestive Enzyme Activity of Flatfish Larvae in a Changing Ocean	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; EARLY-LIFE STAGES; HSP70 EXPRESSION; SOLEA-SENEGALENSIS; THERMAL TOLERANCE; ACIDIFICATION; HISTORY; FISH; IMPACT; CO2	Until now, it is not known how the antioxidant and digestive enzymatic machinery of fish early life stages will change with the combined effects of future ocean acidification and warming. Here we show that high pCO(2) (similar to 1600 mu atm) significantly decreased metabolic rates (up to 27.4 %) of flatfish larvae, Solea senegalensis, at both present (18 degrees C) and warmer temperatures (+4 degrees C). Moreover, both warming and hypercapnia increased the heat shock response and the activity of antioxidant enzymes, namely catalase (CAT) and glutathione S-transferase (GST), mainly in post-metamorphic larvae (30 dph). The lack of changes in the activity of CAT and GST of pre-metamorphic larvae (10 dph) seems to indicate that earlier stages lack a fully-developed antioxidant defense system. Nevertheless, the heat shock and antioxidant responses of post-metamorphic larvae were not enough to avoid the peroxidative damage, which was greatly increased under future environmental conditions. Digestive enzymatic activity of S. senegalensis larvae was also affected by future predictions. Hypercapnic conditions led to a decrease in the activity of digestive enzymes, both pancreatic (up to 26.1 % for trypsin and 74.5 % for amylase) and intestinal enzymes (up to 36.1 % for alkaline phosphatase) in post-metamorphic larvae. Moreover, the impact of ocean acidification and warming on some of these physiological and biochemical variables (namely, lower OCR and higher HSP and MDA levels) were translated into larvae performance, being significantly correlated with decreased larval growth and survival or increased incidence of skeletal deformities. The increased vulnerability of flatfish early life stages under future ocean conditions is expected to potentially determine recruitment and population dynamics in marine ecosystems.	[Pimentel, Marta S.; Faleiro, Filipa; Rosa, Rui] Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, MARE Marine & Environm Sci Ctr, P-2750374 Cascais, Portugal; [Pimentel, Marta S.; Machado, Jorge] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal; [Diniz, Mario] Univ Nova Lisboa, Fac Ciencias & Tecnol, REQUIMTE, Dept Quim,Ctr Quim Fina & Biotecnol, P-2829516 Caparica, Portugal; [Pousao-Ferreira, Pedro] Inst Portugues Mar & Atmosfera, P-8700305 Olhao, Portugal; [Peck, Myron A.] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, D-22767 Hamburg, Germany; [Poertner, Hans O.] Alfred Wegener Inst Polar & Marine Res, Anim Ecophysiol, D-27515 Bremerhaven, Germany	Universidade de Lisboa; Universidade do Porto; Universidade Nova de Lisboa; Instituto Portugues do Mar e da Atmosfera; University of Hamburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Pimentel, MS (corresponding author), Univ Lisbon, Fac Ciencias, Lab Maritimo Guia, MARE Marine & Environm Sci Ctr, Av Nossa Senhora do Cabo 939, P-2750374 Cascais, Portugal.	mcrsilva@fc.ul.pt	/AAL-3738-2021; Faleiro, Filipa/I-8097-2012; Pousão-Ferreira, Pedro/H-3689-2014; Ferreira, Pedro/HDO-1346-2022; Diniz, Mário/C-7849-2013; Rosa, Rui/A-4580-2009; Pimentel, Marta S./I-4844-2012; Peck, Myron A/H-6164-2011; Pimentel, Marta S/H-3229-2014; Pörtner, Hans-O./K-9429-2016; Quality, Aquaculture Seafood/AAD-7718-2019	Faleiro, Filipa/0000-0003-4315-1856; Pousão-Ferreira, Pedro/0000-0001-6746-764X; Diniz, Mário/0000-0003-1571-0366; Rosa, Rui/0000-0003-2801-5178; Peck, Myron A/0000-0001-7423-1854; Pimentel, Marta S/0000-0003-3248-4479; Pörtner, Hans-O./0000-0001-6535-6575; Machado, Jorge/0000-0003-4570-5445	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/81928/2011, SFRH/BPD/79038/2011, PTDC/MAR/0908066/2008, PTDC/AAG-GLO/3342/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	The Portuguese Foundation for Science and Technology (FCT) supported this study through a doctoral grant to MSP (SFRH/BD/81928/2011), a post-doc grant to FF (SFRH/BPD/79038/2011) and project grants to RR (PTDC/MAR/0908066/2008 and PTDC/AAG-GLO/3342/2012).	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Abele D, 2002, J EXP BIOL, V205, P1831; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aguilera J, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P58; AlvarezSalgado XA, 1997, CONT SHELF RES, V17, P1247, DOI 10.1016/S0278-4343(97)00014-9; [Anonymous], 2005, FUNCTIONAL METABOLIS; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bignami S, 2013, GLOBAL CHANGE BIOL, V19, P996, DOI 10.1111/gcb.12133; BISBAL GA, 1995, J FISH BIOL, V47, P277, DOI 10.1006/jfbi.1995.0133; Borges AV, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001385; BOULHIC M, 1992, AQUACULTURE, V102, P373, DOI 10.1016/0044-8486(92)90190-V; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; CAHU CL, 1994, COMP BIOCHEM PHYS A, V109, P213, DOI 10.1016/0300-9629(94)90123-6; COUSIN JCB, 1987, J FISH BIOL, V30, P15, DOI 10.1111/j.1095-8649.1987.tb05728.x; CRANE RK, 1979, BIOCHIM BIOPHYS ACTA, V554, P264, DOI 10.1016/0005-2736(79)90024-5; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Fernandez I, 2008, AQUACULTURE, V283, P102, DOI 10.1016/j.aquaculture.2008.06.037; Fernandez I, 2009, AQUACULTURE, V295, P250, DOI 10.1016/j.aquaculture.2009.06.046; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Guppy M, 2004, COMP BIOCHEM PHYS B, V139, P435, DOI 10.1016/j.cbpc.2004.02.019; HAUSAMEN TU, 1967, CLIN CHIM ACTA, V15, P241, DOI 10.1016/0009-8981(67)90060-5; Henning Susan J., 1994, P571; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HOLM H, 1988, J NUTR, V118, P515, DOI 10.1093/jn/118.4.515; Infante JLZ, 2001, COMP BIOCHEM PHYS C, V130, P477, DOI 10.1016/S1532-0456(01)00274-5; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Lesser MP, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P9; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Lopes AR, 2013, DEEP-SEA RES PT I, V82, P10, DOI 10.1016/j.dsr.2013.07.014; Luft JC, 1999, CELL STRESS CHAPERON, V4, P162, DOI 10.1379/1466-1268(1999)004<0162:HEAFDE>2.3.CO;2; Malanga G, 2004, AQUAT TOXICOL, V69, P299, DOI 10.1016/j.aquatox.2004.05.008; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; METAIS P, 1968, ANN BIOL CLIN-PARIS, V26, P133; Metzger R, 2007, J THERM BIOL, V32, P144, DOI 10.1016/j.jtherbio.2007.01.010; Mirkes PE, 1997, MUTAT RES, V396, P63; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; Munday PL, 2012, J EXP BIOL, V215, P3865, DOI 10.1242/jeb.074765; Munday PL, 2009, P ROY SOC B-BIOL SCI, V276, P3275, DOI 10.1098/rspb.2009.0784; P&ouml;rtner HO, 2014, OCEAN SYSTEMS CLIMAT; P&ouml;rtner HO, 2012, ANTARCTIC ECOSYSTEMS, P360; Perez FF, 1999, J MARINE SYST, V19, P27, DOI 10.1016/S0924-7963(98)00022-0; Pimentel MS, 2014, J EXP BIOL, V217, P2062, DOI 10.1242/jeb.092635; Pimentel MS, 2012, MAR BIOL, V159, P2051, DOI 10.1007/s00227-012-1991-9; Portner HO, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002561; Ramnanan CJ, 2006, J EXP BIOL, V209, P677, DOI 10.1242/jeb.02052; Ribeiro L, 1999, AQUACULTURE, V179, P465, DOI 10.1016/S0044-8486(99)00180-5; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosa R, 2014, GLOBAL CHANGE BIOL, V20, P3068, DOI 10.1111/gcb.12621; Rosa R, 2014, J EXP BIOL, V217, P518, DOI 10.1242/jeb.096081; Rosa R, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1695; Rosa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038282; Sarazin G, 1999, WATER RES, V33, P290, DOI 10.1016/S0043-1354(98)00168-7; Sokolova IM, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P263; Stumpp M, 2013, DIGESTION SEA URCHIN; Takle H, 2005, AQUACULTURE, V249, P515, DOI 10.1016/j.aquaculture.2005.04.043; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Tseng YC, 2013, COMP BIOCHEM PHYS A, V165, P119, DOI 10.1016/j.cbpa.2013.02.005; Viant MR, 2003, FISH PHYSIOL BIOCHEM, V29, P159, DOI 10.1023/B:FISH.0000035938.92027.81; Walther K, 2009, BIOGEOSCIENCES, V6, P2207, DOI 10.5194/bg-6-2207-2009; Zambonino-Infante J.L., 2008, FEEDING DIGESTIVE FU, P281, DOI 10.1201/b10749-8	70	82	84	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134082	10.1371/journal.pone.0134082	http://dx.doi.org/10.1371/journal.pone.0134082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221723	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800101
J	Shanmugam, M; El Abbar, F; Ramasubbu, N				Shanmugam, Mayilvahanan; El Abbar, Faiha; Ramasubbu, Narayanan			Transcriptome Profiling of Wild-Type and pga-Knockout Mutant Strains Reveal the Role of Exopolysaccharide in Aggregatibacter actinomycetemcomitans	PLOS ONE			English	Article							ACETYLGLUCOSAMINE SURFACE POLYSACCHARIDE; DIFFERENTIAL EXPRESSION ANALYSIS; ESCHERICHIA-COLI; BIOFILM FORMATION; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; GENE-EXPRESSION; DISPERSIN-B; BIOSYNTHESIS; ADHESIN; PGAABCD	Exopolysaccharides have a diverse set of functions in most bacteria including a mechanistic role in protecting bacteria against environmental stresses. Among the many functions attributed to the exopolysaccharides, biofilm formation, antibiotic resistance, immune evasion and colonization have been studied most extensively. The exopolysaccharide produced by many Gram positive as well as Gram negative bacteria including the oral pathogen Aggregatibacter actinomycetemcomitans is the homopolymer of beta(1,6)-linked N-acetylglucosamine. Recently, we reported that the PGA-deficient mutant of A. actinomycetemcomitans failed to colonize or induce bone resorption in a rat model of periodontal disease, and the colonization genes, apiA and aae, were significantly down regulated in the mutant strain. To understand the role of exopolysaccharide and the pga locus in the global expression of A. actinomycetemcomitans, we have used comparative transcriptome profiling to identify differentially expressed genes in the wild-type strain in relation to the PGA-deficient strain. Transcriptome analysis revealed that about 50% of the genes are differently expressed (P < 0.05 and fold change >1.5). Our study demonstrated that the absence of the pga locus affects the genes involved in peptidoglycan recycling, glycogen storage, and virulence. Further, using confocal microscopy and plating assays, we show that the viability of pga mutant strain is significantly reduced during biofilm growth. Thus, this study highlights the importance of pga genes and the exopolysaccharide in the virulence of A. actinomycetemcomitans.	[Shanmugam, Mayilvahanan; El Abbar, Faiha; Ramasubbu, Narayanan] Rutgers State Univ, Sch Dent Med, Dept Oral Biol, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Ramasubbu, N (corresponding author), Rutgers State Univ, Sch Dent Med, Dept Oral Biol, Newark, NJ 07102 USA.	ramasun1@sdm.rutgers.edu			United States Public Health Service, National Institutes of Health, National Institute of Dental and Cranofacial Research [DE022544]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022544] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Health, National Institute of Dental and Cranofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the United States Public Health Service, National Institutes of Health, National Institute of Dental and Cranofacial Research DE022544; NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Gulez G, 2014, MICROBIOLOGYOPEN, V3, P457, DOI 10.1002/mbo3.180; Isaza MP, 2008, INFECT IMMUN, V76, P3561, DOI 10.1128/IAI.01687-07; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Izano EA, 2007, J DENT RES, V86, P618, DOI 10.1177/154405910708600707; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jorth P, 2013, J BACTERIOL, V195, P4991, DOI 10.1128/JB.00875-13; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Ruffing AM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-17; Rupani D, 2008, ORAL MICROBIOL IMMUN, V23, P127, DOI 10.1111/j.1399-302X.2007.00399.x; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Shanmugam M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117487; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Venketaraman V, 2008, MICROB PATHOGENESIS, V45, P173, DOI 10.1016/j.micpath.2008.05.007; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x	36	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134285	10.1371/journal.pone.0134285	http://dx.doi.org/10.1371/journal.pone.0134285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221956	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800122
J	Shaw, R; Kundu, S				Shaw, Rahul; Kundu, Sudip			Metabolic Plasticity and Inter-Compartmental Interactions in Rice Metabolism: An Analysis from Reaction Deletion Study	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ARABIDOPSIS-THALIANA; CARBON ASSIMILATION; STRESS; MODEL; CHLOROPLASTS; MITOCHONDRIA; REDUNDANCY; NETWORK; LIGHT	More than 20% of the total caloric intake of human population comes from rice. The expression of rice genes and hence, the concentration of enzymatic proteins might vary due to several biotic and abiotic stresses. It in turn, can influence the overall metabolism and survivability of rice plant. Thus, understanding the rice cellular metabolism, its plasticity and potential readjustments under different perturbations can help rice biotechnologists to design efficient rice cultivars. Here, using the flux balance analysis (FBA) method, with the help of in-silico reaction deletion strategy, we study the metabolic plasticity of genome-scale metabolic model of rice leaf. A set of 131 reactions, essential for the production of primary biomass precursors is identified; deletion of any of them can inhibit the overall biomass production. Usability Index (I-U) for the rest of the reactions are estimated and based on this parameter, they are classified into three categories-maximally-favourable, quasi-favourable and unfavourable for the primary biomass production. The lower value of 1 - I-U of a reaction suggests that the cell cannot easily bypass it for biomass production. While some of the alternative paths are energetically equally efficient, others demand for higher photon. The variations in (i) ATP/NADPH ratio, (ii) exchange of metabolites through chloroplastic transporters and (iii) total biomass production are also presented here. Mutual metabolic dependencies of different cellular compartments are also demonstrated.	[Shaw, Rahul; Kundu, Sudip] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, W Bengal, India; [Kundu, Sudip] Univ Calcutta, Ctr Excellence Syst Biol & Biomed Engn, TEQIP, Kolkata 700009, W Bengal, India	University of Calcutta; University of Calcutta	Kundu, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, 92 APC Rd, Kolkata 700009, W Bengal, India.	skbmbg@caluniv.ac.in			Council of Scientific & Industrial Research, Govt. of India; Center of Excellence, TEQIP-II, University of Calcutta [09/028(0922)/2014-EMR-I]	Council of Scientific & Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Center of Excellence, TEQIP-II, University of Calcutta	RS is supported by a research fellowship provided by the Council of Scientific & Industrial Research, Govt. of India. This work is supported by the Center of Excellence, TEQIP-II, University of Calcutta (Sanction No. 09/028(0922)/2014-EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Atkin O, 2004, PHOTOSYNTHESIS, P153; Barve A, 2012, P NATL ACAD SCI USA, V109, pE1121, DOI 10.1073/pnas.1113065109; Brinkmann H, 1996, PLANT MOL BIOL, V30, P65, DOI 10.1007/BF00017803; Bustos DM, 2002, FEBS LETT, V530, P169, DOI 10.1016/S0014-5793(02)03455-5; Chen RZ, 2007, PLANT CELL, V19, P847, DOI 10.1105/tpc.106.044123; Cheung CYM, 2013, GENOME SCALE METABOL; Dobson PD, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-145; Edwards JS, 2000, BIOTECHNOL PROGR, V16, P927, DOI 10.1021/bp0000712; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Fresco L, 2005, J FOOD COMPOS ANAL, V18, P249, DOI 10.1016/j.jfca.2004.09.006; Gardestrom P, 1996, BBA-BIOENERGETICS, V1275, P38, DOI 10.1016/0005-2728(96)00047-3; Guo L, 2012, PLANT CELL, V24, P2200, DOI 10.1105/tpc.111.094946; Hodges M, 2002, J EXP BOT, V53, P905, DOI 10.1093/jexbot/53.370.905; Hoefnagel MHN, 1998, BBA-BIOENERGETICS, V1366, P235, DOI 10.1016/S0005-2728(98)00126-1; Huang SX, 2002, PLANT MOL BIOL, V48, P805, DOI 10.1023/A:1014868320552; JOHNSON MD, 1994, PLANT PHYSIOL, V105, P1023, DOI 10.1104/pp.105.3.1023; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Marri L, 2005, J EXP BOT, V56, P73, DOI 10.1093/jxb/eri020; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Padmasree K, 2002, CRIT REV BIOCHEM MOL, V37, P71, DOI 10.1080/10409230290771465; Poolman MG, 2006, IEE P SYST BIOL, V153, P375, DOI 10.1049/ip-syb:20060010; Poolman MG, 2013, PLANT PHYSIOL, V162, P1060, DOI 10.1104/pp.113.216762; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Price ND, 2002, GENOME RES, V12, P760, DOI 10.1101/gr.218002; Raghavendra AS, 2003, TRENDS PLANT SCI, V8, P546, DOI 10.1016/j.tplants.2003.09.015; Reeves AR, 2012, METHODS MOL BIOL, V834, P153, DOI 10.1007/978-1-61779-483-4_11; Saha R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021784; Schwender J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00668; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang CL, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S9	33	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133899	10.1371/journal.pone.0133899	http://dx.doi.org/10.1371/journal.pone.0133899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222686	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800079
J	Ju, H; Jones, M; Mishra, GD				Ju, Hong; Jones, Mark; Mishra, Gita D.			A U-Shaped Relationship between Body Mass Index and Dysmenorrhea: A Longitudinal Study	PLOS ONE			English	Article							WOMENS HEALTH AUSTRALIA; RISK-FACTORS; MENSTRUAL CYCLES; RIGHT WEIGHT; PAIN; MENARCHE; FAT; MAINTENANCE; PREVALENCE; SEVERITY	Background Both obesity and dysmenorrhea are prevalent among women. Few population-based longitudinal studies investigate the association between body mass index (BMI) and dysmenorrhea yielding mixed results, especially for obesity. This study aims to investigate the long-term association between BMI and dysmenorrhea. Methods 9,688 women from a prospective population-based cohort study were followed for 13 years. Data were collected through self-reported questionnaires. The longitudinal association between dysmenorrhea and BMI or BMI change was investigated by logistic regression analysis using generalized estimating equations to account for the repeated measures. Results When the women were aged 22 to 27 years, approximately 11% were obese, 7% underweight, and 25% reported dysmenorrhea. Compared to women with a normal weight, significantly higher odds of reporting dysmenorrhea were detected for both women who were underweight (odds ratio (OR) 1.34, 95% confidence interval (CI) 1.15, 1.57) and obese (OR 1.22, 95% CI 1.11, 1.35). Compared to women who remained at normal weight or overweight over time, significant risk was detected for women who: remained underweight or obese (OR 1.33, 95% CI 1.20, 1.48), were underweight despite weight gain (OR 1.33, 95% CI 1.12, 1.58), became underweight (OR 1.28, 95% CI 1.02, 1.61). However the higher risk among obese women disappeared when they lost weight (OR 1.06, 95% CI 0.85, 1.32). Conclusions A U-shaped association was revealed between dysmenorrhea and BMI, revealing a higher risk of dysmenorrhea for both underweight and obese women. Maintaining a healthy weight over time may be important for women to have pain-free periods.	[Ju, Hong; Jones, Mark; Mishra, Gita D.] Univ Queensland, Sch Publ Hlth, Ctr Longitudinal & Life Course Res, Brisbane, Qld, Australia	University of Queensland	Ju, H (corresponding author), Univ Queensland, Sch Publ Hlth, Ctr Longitudinal & Life Course Res, Brisbane, Qld, Australia.	h.ju@uq.edu.au	Jones, Mark/I-2720-2016	Jones, Mark/0000-0001-6858-9710; Mishra, Gita/0000-0001-6003-4884				Allen SS, 2014, ADDICT BEHAV, V39, P901, DOI 10.1016/j.addbeh.2014.01.029; Barnard K, 2003, J WOMENS HEALTH, V12, P911, DOI 10.1089/154099903770948140; Barnard ND, 2000, OBSTET GYNECOL, V95, P245, DOI 10.1016/S0029-7844(99)00525-6; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bettendorf B, 2008, OBSTET GYNECOL SURV, V63, P597, DOI 10.1097/OGX.0b013e31817f15ff; Brown WJ, 1999, J WOMEN HEALTH GEN-B, V8, P681, DOI 10.1089/jwh.1.1999.8.681; Brown WJ, 1998, WOMEN HEALTH, V28, P23; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FRISCH RE, 1990, BAILLIERE CLIN OB GY, V4, P419, DOI 10.1016/S0950-3552(05)80302-5; FRISCH RE, 1994, P NUTR SOC, V53, P113, DOI 10.1079/PNS19940015; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; Harlow SD, 1996, BRIT J OBSTET GYNAEC, V103, P1134, DOI 10.1111/j.1471-0528.1996.tb09597.x; Hassan S, 2014, PAIN, V155, P2448, DOI 10.1016/j.pain.2014.08.027; Hirata Mari, 2002, Nihon Koshu Eisei Zasshi, V49, P516; Jones M, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-32; Ju H, 2014, MATURITAS, V78, P99, DOI 10.1016/j.maturitas.2014.03.008; Ju H, 2014, EPIDEMIOL REV, V36, P104, DOI 10.1093/epirev/mxt009; Jukic AMZ, 2008, EPIDEMIOLOGY, V19, P846, DOI 10.1097/EDE.0b013e318187ac9e; Jungheim ES, 2012, OBSTET GYN CLIN N AM, V39, P479, DOI 10.1016/j.ogc.2012.09.002; Latthe P, 2006, BMJ-BRIT MED J, V332, P749, DOI 10.1136/bmj.38748.697465.55; Lentz G, 2012, COMPREHENSIVE GYNECO; Madhubala C, 2012, J OBSTET GYN INDIA, V62, P442, DOI 10.1007/s13224-012-0171-7; Montero P, 1996, J BIOSOC SCI, V28, P315, DOI 10.1017/S0021932000022380; MOORE JW, 1982, INT J CANCER, V29, P17, DOI 10.1002/ijc.2910290105; National Health Performance Authority, 2011, HLTH COMM OV OB RAT; Nohara M, 2011, IND HEALTH, V49, P228, DOI 10.2486/indhealth.MS1047; Ohde S, 2008, INT J GYNECOL OBSTET, V100, P13, DOI 10.1016/j.ijgo.2007.06.039; Ozerdogan N, 2009, INT J GYNECOL OBSTET, V107, P39, DOI 10.1016/j.ijgo.2009.05.010; SCOTT EC, 1982, J ADOLESCENT HEALTH, V2, P249, DOI 10.1016/S0197-0070(82)80059-4; Shillington AM, 2012, J CHILD ADOLES SUBST, V21, P333, DOI 10.1080/1067828X.2012.710026; SUNDELL G, 1990, BRIT J OBSTET GYNAEC, V97, P588, DOI 10.1111/j.1471-0528.1990.tb02545.x; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P2494, DOI 10.1158/1055-9965.EPI-06-0671; ZAHRADNIK HP, 1984, ARCH GYNECOL, V236, P99, DOI 10.1007/BF02134006	33	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134187	10.1371/journal.pone.0134187	http://dx.doi.org/10.1371/journal.pone.0134187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218569	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900094
J	Kim, HS; Kim, YH; Woo, JS; Hyun, SJ				Kim, Han-Sung; Kim, Young-Hoon; Woo, Jung-Sik; Hyun, Sook-Jung			An Analysis of Organizational Performance Based on Hospital Specialization Level and Strategy Type	PLOS ONE			English	Article							RURAL HOSPITALS; HEALTH-CARE; COST; EFFICIENCY; BEHAVIOR; IMPACT	Introduction Hospitals are studying the focused factory concept and attempting to increase their power in a competitive industry by becoming more specialized. Methodology This study uses the information theory index (ITI) and the Herfindahl-Hirschman index (HHI) to analyze the extent of specialization by Korean hospitals that receive national health insurance reimbursements. Hierarchical regression analysis is used to assess the impact of hospital specialization on the following four aspects of operational performance: productivity, profitability, efficiency and quality of care. Study Results The results show that a focused strategy (high HHI) improves the income and adjusted number of patients per specialist through the efficient utilization of human resources. However, a diversified strategy (high ITI) improves the hospital utilization ratio, income per bed and adjusted number of patients per bed (controlling for material resources such as beds). In addition, as the concentration index increases, case-mix mortality rates and referral rates decrease, indicating that specialization has a positive relationship with quality of care.	[Kim, Han-Sung] Korea Polytech, Dept Healthcare Informat, Seoul, South Korea; [Kim, Young-Hoon] Eulji Univ, Grad Sch, Dept Healthcare Management, Gyeonggi, South Korea; [Woo, Jung-Sik] Cheju Halla Univ, Dept Hlth Adm, Jeju, South Korea; [Hyun, Sook-Jung] Baekseok Arts Univ, Dept Management & Adm, Seoul, South Korea	Eulji University	Kim, YH (corresponding author), Eulji Univ, Grad Sch, Dept Healthcare Management, Gyeonggi, South Korea.	zongi@naver.com						Baum NH, 1999, UROLOGY TIMES, V27, P22; Begun JW, 2004, HEALTH CARE MANAGE R, V29, P31, DOI 10.1097/00004010-200401000-00005; Bigelow B, 1989, Med Care Rev, V46, P295, DOI 10.1177/107755878904600305; Bourgeois LJ., 1980, ACAD MANAGE REV, V5, P25, DOI [DOI 10.5465/AMR.1980.4288844, DOI 10.2307/257802]; Capkun V, 2012, INT J OPER PROD MAN, V32, P468, DOI 10.1108/01443571211223103; Casey John, 2004, Mod Healthc, V34, P21; Choudhry S, 2005, HLTH AFF MILLWOOD, V24; Cleverley W O, 1992, Health Care Manage Rev, V17, P27; Daft R. L, 1995, ORG THEORY DESIGN, V5th; Dobson A, 2005, HLTH AFF MILLWOOD, V24; Domrzalski D, 2002, NEW MEXICO BUSI 0812; DRANOVE D, 1992, RAND J ECON, V23, P247, DOI 10.2307/2555987; Duncan W.J., 1998, ACAD MANAGE EXEC, V12, P6, DOI [10.5465/ame.1998.1109046, DOI 10.5465/AME.1998.1109046]; Eastaugh S R, 2001, J Health Care Finance, V28, P61; EASTAUGH SR, 1992, HOSP HEALTH SERV ADM, V37, P223; Essletzbichler J, 2003, REG STUD, V37, P753, DOI 10.1080/0034340032000128695; EVANS RG, 1972, CAN J ECONOMICS, V5, P398, DOI 10.2307/134141; FAHEY L, 1986, J MANAGE, V12, P167, DOI 10.1177/014920638601200203; Fine A, 2004, HOSP HLTH NETW, V22; GINN GO, 1992, HOSP HEALTH SERV ADM, V37, P291; GINSBERG A, 1988, STRATEGIC MANAGE J, V9, P559, DOI 10.1002/smj.4250090604; GOLLOP FM, 1991, REV ECON STAT, V73, P318, DOI 10.2307/2109523; Herzlinger RE, 2004, JAMA-J AM MED ASSOC, V292, P1213, DOI 10.1001/jama.292.10.1213; Herzlinger RE, 2002, HARVARD BUS REV, V80, P44; Herzlinger RE, 1997, MARKET DRIVEN HEALTH; Kher U, 2006, TIME, V168, P68; Kher Unmesh, 2006, Time, V168, P64; Kilduff P, 2002, INT J NEW PROD DEV I, V4, P11; Lee KS, 2008, HEALTH POLICY, V87, P41, DOI 10.1016/j.healthpol.2007.10.003; Leung GM, 2000, BRIT MED J, V320, P942; Lo Sasso AT, 2004, HEALTH SERV RES, V39, P1071, DOI 10.1111/j.1475-6773.2004.00274.x; Luke R D, 1991, Med Care Rev, V48, P207, DOI 10.1177/002570879104800204; Luke RD, 2000, HLTH CARE MANAGEMENT, P394; Medicare Payment Advisory Commission (MedPAC), 2005, PHYS OWN SPEC HOSP; Meyer H, 1998, HOSP HEALTH NETWORK, V72, P24; Mick S S, 1993, J Rural Health, V9, P99, DOI 10.1111/j.1748-0361.1993.tb00502.x; ROBINSON JC, 1985, J HEALTH ECON, V4, P333, DOI 10.1016/0167-6296(85)90012-8; Romano M, 2001, MOD HEALTHCARE, V31, P30; Romano M, 2001, MODERN HEALTHCARE, V31, P26; SKINNER W, 1974, HARVARD BUS REV, V52, P113; Smith H L, 1992, Health Care Manage Rev, V17, P63; Smith Robert B, 2002, Healthc Financ Manage, V56, P76; Succi MJ, 1997, HEALTH SERV RES, V31, P679; Tabachnick B. G., 2001, USING MULTIVARIATE S; Trinh HQ, 2000, HEALTH CARE MANAGE R, V25, P48, DOI 10.1097/00004010-200010000-00005; Trinh HQ, 1999, HEALTH CARE MANAGE R, V24, P42; Trinh HQ, 2002, HEALTH SERV RES, V37, P145; Urquhart DJB, 2004, CONSUMER DRIVEN HLTH, P627; Walker T, 1998, MANAGED HEALTHCARE, V8, P51; Womack JamesP., 1990, MACHINE CHANGED WORL; ZAJAC EJ, 1989, STRATEGIC MANAGE J, V10, P413, DOI 10.1002/smj.4250100503; Zajac EJ, 2000, HLTH CARE MANAGEMENT; Zwanziger J, 1996, MED CARE, V34, P361, DOI 10.1097/00005650-199604000-00007; [No title captured]; [No title captured]	55	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132257	10.1371/journal.pone.0132257	http://dx.doi.org/10.1371/journal.pone.0132257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218570	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900006
J	Ooi, CP; Rotureau, B; Gribaldo, S; Georgikou, C; Julkowska, D; Blisnick, T; Perrot, S; Subota, I; Bastin, P				Ooi, Cher-Pheng; Rotureau, Brice; Gribaldo, Simonetta; Georgikou, Christina; Julkowska, Daria; Blisnick, Thierry; Perrot, Sylvie; Subota, Ines; Bastin, Philippe			The Flagellar Arginine Kinase in Trypanosoma brucei Is Important for Infection in Tsetse Flies	PLOS ONE			English	Article							CELL MORPHOGENESIS; AFRICAN TRYPANOSOMES; PARAFLAGELLAR ROD; MIXED INFECTIONS; CREATINE-KINASE; PROTEIN; MOTILITY; LOCALIZATION; PARASITE; CYCLE	African trypanosomes are flagellated parasites that cause sleeping sickness. Parasites are transmitted from one mammalian host to another by the bite of a tsetse fly. Trypanosoma brucei possesses three different genes for arginine kinase (AK) including one (AK3) that encodes a protein localised to the flagellum. AK3 is characterised by the presence of a unique amino-terminal insertion that specifies flagellar targeting. We show here a phylogenetic analysis revealing that flagellar AK arose in two independent duplication events in T. brucei and T. congolense, the two species of African trypanosomes that infect the tsetse midgut. In T. brucei, AK3 is detected in all stages of parasite development in the fly (in the midgut and in the salivary glands) as well as in bloodstream cells, but with predominance at insect stages. Genetic knockout leads to a slight reduction in motility and impairs parasite infectivity towards tsetse flies in single and competition experiments, both phenotypes being reverted upon expression of an epitope-tagged version of AK3. We speculate that this flagellar arginine kinase is important for T. brucei infection of tsetse, especially in the context of mixed infections and that its flagellar targeting relies on a system equivalent to that discovered for calflagins, a family of trypanosome flagellum calcium binding proteins.	[Ooi, Cher-Pheng; Rotureau, Brice; Georgikou, Christina; Julkowska, Daria; Blisnick, Thierry; Perrot, Sylvie; Subota, Ines; Bastin, Philippe] Inst Pasteur, INSERM, Trypanosome Cell Biol Unit, U1201, F-75015 Paris, France; [Gribaldo, Simonetta] Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bastin, P (corresponding author), Inst Pasteur, INSERM, Trypanosome Cell Biol Unit, U1201, 25 Rue Dr Roux, F-75015 Paris, France.	pbastin@pasteur.fr	Rotureau, Brice/B-2460-2014; Ooi, Cher-Pheng/Q-9635-2018; Bastin, Philippe/O-4230-2019; Bastin, Philippe/E-6688-2017; gribaldo, simonetta/AAW-4377-2020	Rotureau, Brice/0000-0003-0671-8999; Ooi, Cher-Pheng/0000-0002-1503-1155; Bastin, Philippe/0000-0002-3042-8679; gribaldo, simonetta/0000-0002-7662-021X	Institut Pasteur; Centre National de la Recherche Scientifique (CNRS); DIM Ilede-France postdoctoral fellowship [DIM-MALINF-110071]; French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Fonds National de la Recherche du Luxembourg fellowship [TR-PHD BFR 07-023]; Roux post-doctoral fellowship (Institut Pasteur)	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); DIM Ilede-France postdoctoral fellowship; French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); Fonds National de la Recherche du Luxembourg fellowship(Luxembourg National Research Fund); Roux post-doctoral fellowship (Institut Pasteur)	This work was funded by the Institut Pasteur and by the Centre National de la Recherche Scientifique (CNRS). CPO was funded by a DIM Ilede-France postdoctoral fellowship (DIM-MALINF-110071) and by a French Government Investissement d'Avenir programme, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (ANR-10-LABX-62-IBEID). IS was funded by a Fonds National de la Recherche du Luxembourg (TR-PHD BFR 07-023) fellowship and DJ by a Roux post-doctoral fellowship (Institut Pasteur). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron DM, 2007, J CELL SCI, V120, P1513, DOI 10.1242/jcs.004846; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Bringaud F, ENERGY METABOLISM TR; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BRUN R, 1979, ACTA TROP, V36, P289; Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069; Canepa GE, 2011, COMP BIOCHEM PHYS B, V160, P40, DOI 10.1016/j.cbpb.2011.05.006; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Durand-Dubief M, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; EVANS DA, 1979, J PROTOZOOL, V26, P557, DOI 10.1111/j.1550-7408.1979.tb04195.x; Fernandez P, 2007, PROTEINS, V69, P209, DOI 10.1002/prot.21557; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Heddergott N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003023; Huet D, 2014, ELIFE, V3, DOI 10.7554/eLife.02419; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Jamonneau V, 2004, PARASITOLOGY, V129, P693, DOI 10.1017/S0031182004005876; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kubi C, 2005, J MED ENTOMOL, V42, P1035, DOI 10.1603/0022-2585(2005)042[1035:AOTTFD]2.0.CO;2; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lehane MJ, 2000, PARASITOLOGY, V120, P583, DOI 10.1017/S0031182099005983; LERAY D, 1977, ANN SOC BELG MED TR, V57, P369; Lopez MA, 2015, EUKARYOT CELL, V14, P104, DOI 10.1128/EC.00217-14; Maric D, 2011, J BIOL CHEM, V286, P33109, DOI 10.1074/jbc.M111.240895; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Miranda MR, 2009, PARASITOLOGY, V136, P1201, DOI 10.1017/S0031182009990448; Noguchi M, 2001, J EXP BIOL, V204, P1063; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ooi Cher-Pheng, 2013, Front Cell Infect Microbiol, V3, P71, DOI 10.3389/fcimb.2013.00071; OVERATH P, 1986, EUR J BIOCHEM, V160, P175, DOI 10.1111/j.1432-1033.1986.tb09955.x; Overath P, ENDOCYTOSIS MEMBRANE; Peacock L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-109; Pereira CA, 2000, J BIOL CHEM, V275, P1495, DOI 10.1074/jbc.275.2.1495; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; REDDY SRR, 1992, EUR J BIOCHEM, V206, P251, DOI 10.1111/j.1432-1033.1992.tb16923.x; Rotureau B, 2014, CELL MICROBIOL, V16, P425, DOI 10.1111/cmi.12230; Rotureau B, 2014, J CELL SCI, V127, P204, DOI 10.1242/jcs.136424; Rotureau B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00053; Rotureau B, 2011, CELL MICROBIOL, V13, P705, DOI 10.1111/j.1462-5822.2010.01566.x; Rotureau B, 2009, CELL MICROBIOL, V11, P710, DOI 10.1111/j.1462-5822.2009.01295.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Sun SY, 2013, J CELL SCI, V126, P520, DOI 10.1242/jcs.113621; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; TETLEY L, 1985, J CELL SCI, V74, P1; TOMBES RM, 1987, BIOPHYS J, V52, P75, DOI 10.1016/S0006-3495(87)83190-9; TOMBES RM, 1995, METHOD CELL BIOL, V47, P467, DOI 10.1016/S0091-679X(08)60846-8; Urbaniak MD, GLOBAL QUANTITATIVE, DOI [10.1021/pr400086y, DOI 10.1021/PR400086Y]; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004493; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Wang Q, 2006, CELL, V125, P549, DOI 10.1016/j.cell.2006.02.044; Wingard Jennifer N, 2008, J Biol Chem, V283, P23388, DOI 10.1074/jbc.M803178200; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; Yanagisawa H, 2001, BIOCHEM BIOPH RES CO, V288, P443, DOI 10.1006/bbrc.2001.5776; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	72	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133676	10.1371/journal.pone.0133676	http://dx.doi.org/10.1371/journal.pone.0133676			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218532	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900039
J	Purser, A				Purser, Autun			A Time Series Study of Lophelia pertusa and Reef Megafauna Responses to Drill Cuttings Exposure on the Norwegian Margin	PLOS ONE			English	Article							COLD-WATER CORAL; PROPELLER MOUND; ROCKALL TROUGH; NORTH-SEA; DEEP; SEDIMENT; SCLERACTINIA; SIZE; DISCHARGE; COMMUNITY	As hotspots of local biodiversity in the deep sea, preservation of cold-water coral reef communities is of great importance. In European waters the most extensive reefs are found at depths of 300 - 500 m on the continental margin. In Norwegian waters many of these reefs are located in areas of interest for oil and gas exploration and production. In this study drilling was carried out in the Morvin drill field in proximity to a number of small Lophelia pertusa coral reefs (closest reefs 100 m upstream and 350 m downstream of point of waste drill material release). In a novel monitoring study, ROV video surveys of 9 reefs were conducted prior, during, immediately after and > 1 year after drilling operations. Behavior of coral polyps inhabiting reefs exposed to differing concentrations of drill cuttings and drilling fluids (waste drilling material) were compared. Levels of expected exposure to these waste materials were determined for each reef by modelling drill cutting transport following release, using accurate in-situ hydrodynamic data collected during the drilling period and drill cutting discharge data as parameters of a dispersal model. The presence / absence of associate reef species (Acesta excavata, Paragorgia arborea and Primnoa resedaeformis) were also determined from each survey video. There were no significant differences in Lophelia pertusa polyp behavior in corals modelled to have been exposed to pulses of > 25 ppm drill cutting material and those modelled to be exposed to negligible concentrations of material. From the video data collected, there were no observed degradations of reef structure over time, nor reductions of associate fauna abundance, regardless of modelled exposure concentration at any of the surveyed reefs. This study focused exclusively on adult fauna, and did not assess the potential hazard posed by waste drilling material to coral or other larvae. Video data was collected by various ROV's, using different camera and lighting setups throughout the survey campaign, making comparison of observations prior, during and post drilling problematic. A standardization of video monitoring in future monitoring campaigns is recommended.	Jacobs Univ Bremen, Oceanlab, D-28759 Bremen, Germany	Jacobs University	Purser, A (corresponding author), Jacobs Univ Bremen, Oceanlab, D-28759 Bremen, Germany.	a.purser@jacobs-university.de		Purser, Autun/0000-0001-5427-0151	Statoil	Statoil	This project was funded by Statoil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the author's 818 adherence to PLOS ONE policies on sharing data and materials.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allers E, 2013, MAR POLLUT BULL, V74, P132, DOI 10.1016/j.marpolbul.2013.07.016; Armstrong CW, 2008, MAR POLICY, V32, P66, DOI 10.1016/j.marpol.2007.04.007; Bell N, 1999, NATURE, V402, P601, DOI 10.1038/45127; Berov D., 2007, THESIS JACOBS U BREM; Beuck L, 2005, ERLANGEN EARTH C SER, P915, DOI 10.1007/3-540-27673-4_47; Beuck L, 2007, FACIES, V53, P157, DOI 10.1007/s10347-006-0094-9; Blanchard A, 2014, MAR POLICY, V43, P313, DOI 10.1016/j.marpol.2013.07.001; Briffa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021963; Brock R, 2009, MAR ECOL PROG SER, V397, P355, DOI 10.3354/meps08303; Bronner U, 2013, SPE EUR HSE C EXH C, DOI [10.2118/164949-MS, DOI 10.2118/164949-MS]; Brooke SD, 2009, MAR ECOL PROG SER, V390, P137, DOI 10.3354/meps08191; Brooke S, 2013, MAR BIOL, V160, P139, DOI 10.1007/s00227-012-2071-x; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Cairns SD, 2007, B MAR SCI, V81, P311; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Curran KJ, 2002, CONT SHELF RES, V22, P405, DOI 10.1016/S0278-4343(01)00082-6; Dahl MP, 2013, THESIS U GOTHENBURG; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Dodds LA, 2009, MAR ECOL PROG SER, V397, P113, DOI 10.3354/meps08143; Durell G, 2006, MAR ENVIRON RES, V62, P194, DOI 10.1016/j.marenvres.2006.03.013; Ellis JI, 2012, MAR ECOL PROG SER, V456, P285, DOI 10.3354/meps09622; Fossa JH, 2005, ERLANGEN EARTH C SER, P359, DOI 10.1007/3-540-27673-4_18; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Fossa Skjoldal H.R, 2010, HDB MARINE FISHERIES, P215; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; Frost TK, 2014, SPE INT C HLTH SAF E; Gates AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044114; Godo OR, 2014, MAR POLLUT BULL, V84, P236, DOI 10.1016/j.marpolbul.2014.05.007; Guihen D, 2013, J SEA RES, V78, P36, DOI 10.1016/j.seares.2012.12.007; Guinan J, 2009, MAR ECOL PROG SER, V375, P125, DOI 10.3354/meps07739; Hauge KH, 2014, MAR POLICY, V44, P82, DOI 10.1016/j.marpol.2013.07.008; Henry LA, 2007, DEEP-SEA RES PT I, V54, P654, DOI 10.1016/j.dsr.2007.01.005; Hovland M, 2010, MAR PETROL GEOL, V27, P1190, DOI 10.1016/j.marpetgeo.2010.02.005; Hovland Martin, 2008, P1; Iversen P.E., 2011, GUIDELINES OFFSHORE; Jarnegren J, 2006, J EXP MAR BIOL ECOL, V334, P122, DOI 10.1016/j.jembe.2006.01.014; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Jonsson LG, 2004, MAR ECOL PROG SER, V284, P163, DOI 10.3354/meps284163; Kutti T, 2014, DEEP-SEA RES PT II, V99, P122, DOI 10.1016/j.dsr2.2013.07.021; Laberg JS, 2000, MAR GEOL, V171, P95, DOI 10.1016/S0025-3227(00)00112-2; Larsson AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102222; Larsson AI, 2013, MAR POLLUT BULL, V70, P176, DOI 10.1016/j.marpolbul.2013.02.033; Larsson AI, 2011, MAR POLLUT BULL, V62, P1159, DOI 10.1016/j.marpolbul.2011.03.041; Lepland A, 2008, ENVIRON GEOL, V56, P119, DOI 10.1007/s00254-007-1145-4; Lessard-Pilon SA, 2010, DEEP-SEA RES PT II, V57, P1882, DOI 10.1016/j.dsr2.2010.05.013; Lundalv T, 2008, 4 INT S DEEP SEA COR; Mortensen P, 2005, MAR BIOL, V147, P775, DOI 10.1007/s00227-005-1604-y; Mortensen P.B., 2006, P 10 INT COR REEF S, P1849; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Mortensen PB, 2001, J MAR BIOL ASSOC UK, V81, P581, DOI 10.1017/S002531540100426X; Mortensen PB, 1998, SARSIA, V83, P433, DOI 10.1080/00364827.1998.10413702; Neff J., 2011, PRODUCED WATER, P3, DOI DOI 10.1007/978-1-4614-0046-2_1; Neff J.M., 1987, P469; Netto SA, 2010, ENVIRON MONIT ASSESS, V167, P49, DOI 10.1007/s10661-010-1515-3; Orejas C, 2011, MAR ECOL PROG SER, V429, P57, DOI 10.3354/meps09104; Orejas C, 2009, MAR ECOL PROG SER, V397, P37, DOI 10.3354/meps08314; Pabortsava K, 2011, MAR POLLUT BULL, V62, P2170, DOI 10.1016/j.marpolbul.2011.07.002; Purser A, 2013, BIOGEOSCIENCES, V10, P5779, DOI 10.5194/bg-10-5779-2013; Purser A., 2013, METHODS OCEANOGR, V5, P1, DOI 10.1016/j.mio.2013.07.001; Purser A, 2013, CONT SHELF RES, V54, P37, DOI 10.1016/j.csr.2012.12.013; Purser A, 2012, MAR POLLUT BULL, V64, P2309, DOI 10.1016/j.marpolbul.2012.08.003; Purser A, 2010, J EXP MAR BIOL ECOL, V395, P55, DOI 10.1016/j.jembe.2010.08.013; Reed M., 2002, SPE INT C HLTH SAF E, DOI [10.2118/73856-MS, DOI 10.2118/73856-MS]; ROBERTS JM, 2009, COLDW COR BIOL GEOL, P1; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Ruggeberg A, 2007, INT J EARTH SCI, V96, P57, DOI 10.1007/s00531-005-0504-1; Rye H, 1998, ENVIRON MODELL SOFTW, V13, P431, DOI 10.1016/S1364-8152(98)00048-6; Rye Henrik, 2008, Integrated Environmental Assessment and Management, V4, P194, DOI 10.1897/IEAM_2007-039; Saasen A, 2013, PARTICUL SCI TECHNOL, V31, P85, DOI 10.1080/02726351.2011.648824; Safina C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001049; Santos MFL, 2010, ENVIRON MONIT ASSESS, V167, P65, DOI 10.1007/s10661-010-1518-0; Schaanning MT, 2008, J EXP MAR BIOL ECOL, V361, P49, DOI 10.1016/j.jembe.2008.04.014; Smit MGD, 2008, ENVIRON TOXICOL CHEM, V27, P1006, DOI 10.1897/07-339.1; STAFFORDSMITH MG, 1992, AUST J MAR FRESH RES, V43, P683, DOI 10.1071/MF9920683; Tenningen E, 2011, ENV MONITORING REPOR; Tracey DM, 2011, MAR ECOL PROG SER, V430, P1, DOI 10.3354/meps09164; Trannum HC, 2011, MAR ECOL PROG SER, V442, P23, DOI 10.3354/meps09340; Trannum HC, 2010, J EXP MAR BIOL ECOL, V383, P111, DOI 10.1016/j.jembe.2009.12.004; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; Wesseling I, 1999, MAR ECOL PROG SER, V176, P11, DOI 10.3354/meps176011; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25; WILSON JB, 1979, J MAR BIOL ASSOC UK, V59, P165, DOI 10.1017/S0025315400046257	88	27	27	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134076	10.1371/journal.pone.0134076	http://dx.doi.org/10.1371/journal.pone.0134076			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218658	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900074
J	Tijchon, E; Schenau, DV; van Opzeeland, F; Tirone, F; Hoogerbrugge, PM; Van Leeuwen, FN; Scheijen, B				Tijchon, Esther; Schenau, Dorette van Ingen; van Opzeeland, Fred; Tirone, Felice; Hoogerbrugge, Peter M.; Van Leeuwen, Frank N.; Scheijen, Blanca			Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton	PLOS ONE			English	Article							POLYCOMB GROUP GENES; HOX GENES; ENDOCHONDRAL OSSIFICATION; EXPRESSION; MICE; SEGMENTATION; PROGRESSION; LEUKEMIA; E2F6; PATHOGENESIS	Btg1 and Btg2 encode highly homologous proteins that are broadly expressed in different cell lineages, and have been implicated in different types of cancer. Btg1 and Btg2 have been shown to modulate the function of different transcriptional regulators, including Hox and Smad transcription factors. In this study, we examined the in vivo role of the mouse Btg1 and Btg2 genes in specifying the regional identity of the axial skeleton. Therefore, we examined the phenotype of Btg1 and Btg2 single knockout mice, as well as novel generated Btg1(-/-); Btg2(-/-) double knockout mice, which were viable, but displayed a non-mendelian inheritance and smaller litter size. We observed both unique and overlapping phenotypes reminiscent of homeotic transformation along the anterior-posterior axis in the single and combined Btg1 and Btg2 knockout animals. Both Btg1(-/-) and Btg2(-/-) mice displayed partial posterior transformation of the seventh cervical vertebra, which was more pronounced in Btg1(-/-); Btg2(-/-) mice, demonstrating that Btg1 and Btg2 act in synergy. Loss of Btg2, but not Btg1, was sufficient for complete posterior transformation of the thirteenth thoracic vertebra to the first lumbar vertebra. Moreover, Btg2(-/-) animals displayed complete posterior transformation of the sixth lumbar vertebra to the first sacral vertebra, which was only partially present at a low frequency in Btg1(-/-) mice. The Btg1(-/-); Btg2(-/-) animals showed an even stronger phenotype, with L5 to S1 transformation. Together, these data show that both Btg1 and Btg2 are required for normal vertebral patterning of the axial skeleton, but each gene contributes differently in specifying the identity along the anterior-posterior axis of the skeleton.	[Tijchon, Esther; Schenau, Dorette van Ingen; Van Leeuwen, Frank N.; Scheijen, Blanca] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Oncol, NL-6525 ED Nijmegen, Netherlands; [van Opzeeland, Fred] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Tirone, Felice] CNR, Fdn Santa Lucia, Inst Cell Biol & Neurobiol, I-00143 Rome, Italy; [Hoogerbrugge, Peter M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); IRCCS Santa Lucia	Scheijen, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Oncol, NL-6525 ED Nijmegen, Netherlands.	Blanca.Scheijen@radboudumc.nl	Hoogerbrugge, Peter M./H-8049-2014; Tijchon, Esther/A-1679-2016; Scheijen, Blanca/E-3523-2016; van Leeuwen, Frank/AAQ-6799-2020; Tirone, Felice/P-6745-2014	Scheijen, Blanca/0000-0001-8029-9230; van Leeuwen, Frank/0000-0003-1107-6513; Tirone, Felice/0000-0002-0980-4377	Stichting Kinderen Kankervrij (KiKA) grant [77]	Stichting Kinderen Kankervrij (KiKA) grant	Funding provided by Stichting Kinderen Kankervrij (KiKA) grant-77; https://www.kika.nl/?gclid=CMW-652BlMQCFS7MtAod1H8AzA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2001, DEVELOPMENT, V128, P1587; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bel S, 1998, DEVELOPMENT, V125, P3543; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Casaca A, 2014, DEV DYNAM, V243, P24, DOI 10.1002/dvdy.24007; Cernilogar FM, 2005, BIOCHEM CELL BIOL, V83, P322, DOI 10.1139/o05-040; Core N, 1997, DEVELOPMENT, V124, P721; Courel M, 2008, DEV DYNAM, V237, P1232, DOI 10.1002/dvdy.21516; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Farioli-Vecchioli S, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00124; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Hirsinger E, 2000, INT REV CYTOL, V198, P1; HORAN GSB, 1994, P NATL ACAD SCI USA, V91, P12644, DOI 10.1073/pnas.91.26.12644; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mallo M, 2009, INT J DEV BIOL, V53, P1469, DOI 10.1387/ijdb.072276mm; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Radulovic V, 2013, LEUKEMIA, V27, P523, DOI 10.1038/leu.2012.368; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sheng SH, 2014, TUMOR BIOL, V35, P3317, DOI 10.1007/s13277-013-1437-0; Soung DY, 2012, J BONE MINER RES, V27, P1585, DOI 10.1002/jbmr.1601; Storre J, 2002, EMBO REP, V3, P695, DOI 10.1093/embo-reports/kvf141; Sun Q, 2013, TUMOR BIOL, V34, P4017, DOI 10.1007/s13277-013-0992-8; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Tschopp P, 2011, ANNU REV GENET, V45, P145, DOI 10.1146/annurev-genet-102209-163429; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Zhao Y, 2013, INT J MOL SCI, V14, P19670, DOI 10.3390/ijms141019670	41	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0131481	10.1371/journal.pone.0131481	http://dx.doi.org/10.1371/journal.pone.0131481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218146	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900002
J	van Hateren, KJJ; Landman, GWD; Arnold, JFH; Joosten, H; Groenier, KH; Navis, GJ; Sparwasser, A; Bakker, SJL; Bilo, HJG; Kleefstra, N				van Hateren, Kornelis J. J.; Landman, Gijs W. D.; Arnold, Jarinke F. H.; Joosten, Hanneke; Groenier, Klaas H.; Navis, Gerjan J.; Sparwasser, Andrea; Bakker, Stephan J. L.; Bilo, Henk J. G.; Kleefstra, Nanne			Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)	PLOS ONE			English	Article							BIOMARKERS; ENKEPHALIN; PEPTIDES; OPIOIDS; STROKE; PAIN	Background Two previous studies concluded that proenkephalin A (PENK-A) had predictive capabilities for stroke severity, recurrent myocardial infarction, heart failure and mortality in patients with stroke and myocardial infarction. Objectives This study aimed to investigate the value of PENK-A as a biomarker for predicting mortality in patients with type 2 diabetes mellitus. Methods Patients with type 2 diabetes mellitus were included from the prospective observational ZODIAC (Zwolle Outpatient Diabetes project Integrating Available Care) study. The present analysis incorporated two ZODIAC cohorts (1998 and 2001). Since blood was drawn for 1204 out of 1688 patients (71%), and information on relevant confounders was missing in 47 patients, the final sample comprised 1157 patients. Cox proportional hazard models were used for evaluating the relationship between PENK-A and (cardiovascular) mortality. Risk prediction capabilities were assessed with Harrell's C statistics and the integrated discrimination improvement (IDI). Results After a follow-up period of 14 years, 525 (45%) out of 1157 patients had died, of which 224 (43%) were attributable to cardiovascular factors. Higher Log PENK-A levels were not independently associated with increased (cardiovascular) mortality. Patients with PENK-A values in the highest tertile had a 49% (95% CI 1%-121%) higher risk of cardiovascular mortality compared to patients in the reference category (lowest tertile). C-values were not different after removing PENK-A from the Cox models and there were no significant differences in IDI values. Conclusions The associations between PENK-A and mortality were strongly attenuated after accounting for all traditional risk factors. Furthermore, PENK-A did not seem to have additional value beyond conventional risk factors when predicting all-cause and cardiovascular mortality.	[van Hateren, Kornelis J. J.; Landman, Gijs W. D.; Arnold, Jarinke F. H.; Joosten, Hanneke; Groenier, Klaas H.; Bilo, Henk J. G.; Kleefstra, Nanne] Isala, Ctr Diabet, Zwolle, Netherlands; [Landman, Gijs W. D.] Gelre Hosp, Dept Internal Med, Apeldoorn, Netherlands; [Joosten, Hanneke; Navis, Gerjan J.; Bakker, Stephan J. L.; Bilo, Henk J. G.; Kleefstra, Nanne] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Groenier, Klaas H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Sparwasser, Andrea] BRAHMS GmbH Thermo Fisher Sci, Res Dept, Hennigsdorf, Germany; [Bilo, Henk J. G.] Isala, Dept Internal Med, Zwolle, Netherlands; [Kleefstra, Nanne] Langerhans Med Res Grp, Zwolle, Netherlands	Gelre Hospitals; University of Groningen; University of Groningen; Thermo Fisher Scientific; Brahms AG; Langerhans Medical Research Group	van Hateren, KJJ (corresponding author), Isala, Ctr Diabet, Zwolle, Netherlands.	k.j.j.van.hateren@isala.nl	Landman, Gijs/AAJ-5540-2021	Landman, Gijs/0000-0002-6852-6450; Kleefstra, Nanne/0000-0003-1473-8519				Barron BA, 1999, CARDIOVASC RES, V43, P13, DOI 10.1016/S0008-6363(99)00112-1; Doehner W, 2012, J AM COLL CARDIOL, V60, P346, DOI 10.1016/j.jacc.2012.04.024; Ernst A, 2006, PEPTIDES, V27, P1835, DOI 10.1016/j.peptides.2006.03.008; GIUGLIANO D, 1987, METABOLISM, V36, P286, DOI 10.1016/0026-0495(87)90190-9; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hilden J, 2014, EPIDEMIOLOGY, V25, P265, DOI 10.1097/EDE.0000000000000063; Hilden J, 2014, STAT MED, V33, P3405, DOI 10.1002/sim.5804; Leibowitz SF, 2007, PHYSIOL BEHAV, V91, P513, DOI 10.1016/j.physbeh.2007.03.018; Lu M, 2005, J NEUROSCI METH, V143, P209, DOI 10.1016/j.jneumeth.2004.10.002; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; Margaret S, 2014, STAT BIOSCI, DOI [10.1007/s12561-014-9118-0, DOI 10.1007/S12561-014-9118-0]; May S, 1998, LIFETIME DATA ANAL, V4, P109, DOI 10.1023/A:1009612305785; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Ng LL, 2014, J AM COLL CARDIOL, V63, P280, DOI 10.1016/j.jacc.2013.09.037; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Schemper M, 2000, BIOMETRICS, V56, P249, DOI 10.1111/j.0006-341X.2000.00249.x; Ubink-Vetmaat LJ, 2005, NETH J MED, V63, P103; Vuong C, 2010, ENDOCR REV, V31, P98, DOI 10.1210/er.2009-0009; WATKINS WB, 1980, J HISTOCHEM CYTOCHEM, V28, P1170, DOI 10.1177/28.11.6107317; Yamamoto Y, 2002, CURR PROTEIN PEPT SC, V3, P587, DOI 10.2174/1389203023380404	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133065	10.1371/journal.pone.0133065	http://dx.doi.org/10.1371/journal.pone.0133065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218633	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900018
J	Zhang, SJ; Chakrabarty, PK; Fleites, LA; Rayside, PA; Hopkins, DL; Gabriel, DW				Zhang, Shujian; Chakrabarty, Pranjib K.; Fleites, Laura A.; Rayside, Patricia A.; Hopkins, Donald L.; Gabriel, Dean W.			Three New Pierce's Disease Pathogenicity Effectors Identified Using Xylella fastidiosa Biocontrol Strain EB92-1	PLOS ONE			English	Article							ZONULA-OCCLUDENS TOXIN; ORYZAE PV. ORYZAE; 2-COMPONENT SYSTEM; VIRULENCE; SECRETION; PLANT; ENZYMES; GENOME; GACA; COLONIZATION	Xylella fastidiosa (X. fastidiosa) infects a wide range of plant hosts and causes economically serious diseases, including Pierce's Disease (PD) of grapevines. X. fastidiosa biocontrol strain EB92-1 was isolated from elderberry and is infectious and persistent in grapevines but causes only very slight symptoms under ideal conditions. The draft genome of EB92-1 revealed that it appeared to be missing genes encoding 10 potential PD pathogenicity effectors found in Temecula1. Subsequent PCR and sequencing analyses confirmed that EB92-1 was missing the following predicted effectors found in Temecula1: two type II secreted enzymes, including a lipase (LipA; PD1703) and a serine protease (PD0956); two identical genes encoding proteins similar to Zonula occludens toxins (Zot; PD0915 and PD0928), and at least one relatively short, hemagglutinin-like protein (PD0986). Leaves of tobacco and citrus inoculated with cell-free, crude protein extracts of E. coli BL21(DE3) overexpressing PD1703 exhibited a hypersensitive response (HR) in less than 24 hours. When cloned into shuttle vector pBBR1MCS-5, PD1703 conferred strong secreted lipase activity to Xanthomonas citri, E. coli and X. fastidiosa EB92-1 in plate assays. EB92-1/PD1703 transformants also showed significantly increased disease symptoms on grapevines, characteristic of PD. Genes predicted to encode PD0928 (Zot) and a PD0986 (hemagglutinin) were also cloned into pBBR1MCS-5 and moved into EB92-1; both transformants also showed significantly increased symptoms on V. vinifera vines, characteristic of PD. Together, these results reveal that PD effectors include at least a lipase, two Zot-like toxins and a possibly redundant hemagglutinin, none of which are necessary for parasitic survival of X. fastidiosa populations in grapevines or elderberry.	[Zhang, Shujian; Chakrabarty, Pranjib K.; Fleites, Laura A.; Rayside, Patricia A.; Gabriel, Dean W.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Hopkins, Donald L.] Univ Florida, Mid Florida Res & Educ Ctr, Apopka, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gabriel, DW (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	dgabr@ufl.edu	rolshausen, philippe/F-7999-2011		University of California Pierce's Disease Research Grants Program [2009-244]	University of California Pierce's Disease Research Grants Program	University of California Pierce's Disease Research Grants Program, project 2009-244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparna G, 2009, PLANT CELL, V21, P1860, DOI 10.1105/tpc.109.066886; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Cui Y, 2001, MOL PLANT MICROBE IN, V14, P516, DOI 10.1094/MPMI.2001.14.4.516; da Silva VS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-474; DAVIS MJ, 1980, PHYTOPATHOLOGY, V70, P425, DOI 10.1094/Phyto-70-425; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; GOODWIN PH, 1988, PHYSIOL MOL PLANT P, V32, P1, DOI 10.1016/S0885-5765(88)80002-X; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Guilhabert MR, 2001, MOL PLANT MICROBE IN, V14, P701, DOI 10.1094/MPMI.2001.14.6.701; Hagemann M, 2006, ARCH MICROBIOL, V185, P449, DOI 10.1007/s00203-006-0115-7; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hopkins DL, 2005, PLANT DIS, V89, P1348, DOI 10.1094/PD-89-1348; HOPKINS DL, 1985, PHYTOPATHOLOGY, V75, P713, DOI 10.1094/Phyto-75-713; Jha G, 2005, MOL PLANT MICROBE IN, V18, P891, DOI 10.1094/MPMI-18-0891; Jha G, 2007, MOL PLANT MICROBE IN, V20, P31, DOI 10.1094/MPMI-20-0031; Karyekar CS, 2003, J PHARM SCI-US, V92, P414, DOI 10.1002/jps.10310; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Matsumoto A, 2012, MICROBIOLOGYOPEN, V1, P33, DOI 10.1002/mbo3.6; Matsumoto A, 2010, APPL ENVIRON MICROB, V76, P4092, DOI 10.1128/AEM.03034-09; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; MOLLENHAUER HH, 1974, J BACTERIOL, V119, P612, DOI 10.1128/JB.119.2.612-618.1974; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; Perez-Donoso AG, 2010, PLANT PHYSIOL, V152, P1748, DOI 10.1104/pp.109.148791; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Rajeshwari R, 2005, MOL PLANT MICROBE IN, V18, P830, DOI 10.1094/MPMI-18-0830; Reddy JD, 2007, MOL PLANT MICROBE IN, V20, P403, DOI 10.1094/MPMI-20-4-0403; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Roper MC, 2007, MOL PLANT MICROBE IN, V20, P411, DOI 10.1094/MPMI-20-4-0411; Rossi M, 2002, IMMUNOL LETT, V81, P217, DOI 10.1016/S0165-2478(02)00038-X; SAMAD MYA, 1989, J MICROBIOL METH, V9, P51, DOI 10.1016/0167-7012(89)90030-4; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Shi XY, 2009, APPL ENVIRON MICROB, V75, P2275, DOI 10.1128/AEM.01964-08; Stehr F, 2004, FEMS YEAST RES, V4, P401, DOI 10.1016/S1567-1356(03)00205-8; Stevenson JF, 2005, PLANT DIS, V89, P543, DOI 10.1094/PD-89-0543; Stevenson JF, 2004, AM J ENOL VITICULT, V55, P238; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Thorne ET, 2006, AM J ENOL VITICULT, V57, P1; Uzzau S, 1999, MICROB PATHOGENESIS, V27, P377, DOI 10.1006/mpat.1999.0312; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Voegel TM, 2010, MICROBIOL-SGM, V156, P2172, DOI 10.1099/mic.0.037564-0; Zhang S, 2011, J BACTERIOL, V193, P5576, DOI 10.1128/JB.05430-11	47	25	25	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133796	10.1371/journal.pone.0133796	http://dx.doi.org/10.1371/journal.pone.0133796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218423	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900048
J	Ong, JH; Burnham, D; Escudero, P				Ong, Jia Hoong; Burnham, Denis; Escudero, Paola			Distributional Learning of Lexical Tones: A Comparison of Attended vs. Unattended Listening	PLOS ONE			English	Article							INFANT-DIRECTED SPEECH; PHONETIC PERCEPTION; 1ST YEAR; DISCRIMINATION; ENGLISH; FACILITATION; PHONEMES; CHILDREN; CHINESE; SOUNDS	This study examines whether non-tone language listeners can acquire lexical tone categories distributionally and whether attention in the training phase modulates the effect of distributional learning. Native Australian English listeners were trained on a Thai lexical tone minimal pair and their performance was assessed using a discrimination task before and after training. During Training, participants either heard a Unimodal distribution that would induce a single central category, which should hinder their discrimination of that minimal pair, or a Bimodal distribution that would induce two separate categories that should facilitate their discrimination. The participants either heard the distribution passively (Experiments 1A and 1B) or performed a cover task during training designed to encourage auditory attention to the entire distribution (Experiment 2). In passive listening (Experiments 1A and 1B), results indicated no effect of distributional learning: the Bimodal group did not outperform the Unimodal group in discriminating the Thai tone minimal pairs. Moreover, both Unimodal and Bimodal groups improved above chance on most test aspects from Pretest to Posttest. However, when participants' auditory attention was encouraged using the cover task (Experiment 2), distributional learning was found: the Bimodal group outperformed the Unimodal group on a novel test syllable minimal pair at Posttest relative to at Pretest. Furthermore, the Bimodal group showed above-chance improvement from Pretest to Posttest on three test aspects, while the Unimodal group only showed above-chance improvement on one test aspect. These results suggest that non-tone language listeners are able to learn lexical tones distributionally but only when auditory attention is encouraged in the acquisition phase. This implies that distributional learning of lexical tones is more readily induced when participants attend carefully during training, presumably because they are better able to compute the relevant statistics of the distribution.	[Ong, Jia Hoong; Burnham, Denis; Escudero, Paola] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia	Western Sydney University	Ong, JH (corresponding author), Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia.	jia.ong@uws.edu.au	Burnham, Denis/L-3742-2019; Escudero, Paola/Q-5310-2019	Burnham, Denis/0000-0002-1980-3458; Escudero, Paola/0000-0002-8071-7663; Ong, Jia Hoong/0000-0003-1503-8311	MARCS Institute Higher Degree Research Training Scheme	MARCS Institute Higher Degree Research Training Scheme	This research was supported by The MARCS Institute Higher Degree Research Training Scheme awarded to JHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J.A., 2005, LEXICAL TONE PERCEPT, P397; Best CT, 2001, J ACOUST SOC AM, V109, P775, DOI 10.1121/1.1332378; Broselow E., 1987, INTERLANGUAGE PHONOL, P350; Burnham D, 2002, SCIENCE, V296, P1435, DOI 10.1126/science.1069587; Burnham D, 2007, 2 LANG SPEECH LEARN; Burnham D, 2014, APPL PSYCHOLINGUIST; Burnham D., 2001, P INT C AUD VIS SPEE, P155; Chao Y. R., 1930, MAITRE PHONETIQUE, V45, P24; Chen A, 2014, RISES FALLS DUTCH MA, P83; Escudero P, 2014, COGNITION, V133, P408, DOI 10.1016/j.cognition.2014.07.002; Escudero P, 2011, J ACOUST SOC AM, V130, pEL206, DOI 10.1121/1.3629144; Fiser J, 2002, P NATL ACAD SCI USA, V99, P15822, DOI 10.1073/pnas.232472899; FRY DB, 1962, LANG SPEECH, V5, P171, DOI 10.1177/002383096200500401; Garcia A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00110; Gomes H, 2000, PSYCHOPHYSIOLOGY, V37, P807, DOI 10.1111/1469-8986.3760807; GOTO H, 1971, NEUROPSYCHOLOGIA, V9, P317, DOI 10.1016/0028-3932(71)90027-3; Gulian M, 2007, P INT C PHON SCI SAA, P3; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Liu LQ, 2014, COGNITION, V133, P385, DOI 10.1016/j.cognition.2014.06.004; Mattock K, 2008, COGNITION, V106, P1367, DOI 10.1016/j.cognition.2007.07.002; Mattock K, 2006, INFANCY, V10, P241, DOI 10.1207/s15327078in1003_3; Maye J, 2001, PROC ANN BUCLD, P480; Maye J, 2000, PROC ANN BUCLD, P522; Maye J, 2008, DEVELOPMENTAL SCI, V11, P122, DOI 10.1111/j.1467-7687.2007.00653.x; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Ohman S., 1979, FRONTIERS SPEECH COM, P127; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Perfors A., 2012, P 34 ANN C COGN SCI, P839; Perfors A, 2010, COGNITION IN FLUX, P1613; Rattanasone NX, 2013, J PHONETICS, V41, P332, DOI 10.1016/j.wocn.2013.06.001; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Shafer VL, 2005, J COGNITIVE NEUROSCI, V17, P1168, DOI 10.1162/0898929054475217; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Tillmann B, 2010, Q J EXP PSYCHOL, V63, P1646, DOI 10.1080/17470210903511228; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Wanrooij K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109806; Wanrooij K, 2013, J PHONETICS, V41, P307, DOI 10.1016/j.wocn.2013.03.005; Wayland R, 2010, J PHONETICS, V38, P654, DOI 10.1016/j.wocn.2010.10.001; Wayland RP, 2004, LANG LEARN, V54, P681, DOI 10.1111/j.1467-9922.2004.00283.x; Werker JF, 2007, COGNITION, V103, P147, DOI 10.1016/j.cognition.2006.03.006; Werker JF, 2012, CURR DIR PSYCHOL SCI, V21, P221, DOI 10.1177/0963721412449459; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; Xu N, 2010, SPEECH PROSODY; Yeung HH, 2013, J MEM LANG, V68, P123, DOI 10.1016/j.jml.2012.09.004; Yip M., 2002, TONE	52	16	16	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133446	10.1371/journal.pone.0133446	http://dx.doi.org/10.1371/journal.pone.0133446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7DN	26214002	gold, Green Submitted, Green Published			2022-12-27	WOS:000358594300020
J	Chen, X; Zhang, R; Xiao, Y; Dong, JQ; Niu, X; Kong, WJ				Chen, Xiong; Zhang, Rui; Xiao, Ying; Dong, Jiaqi; Niu, Xun; Kong, Weijia			Reliability and Validity of the Beijing Version of the Montreal Cognitive Assessment in the Evaluation of Cognitive Function of Adult Patients with OSAHS	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; BRIEF SCREENING TOOL; MINI-MENTAL-STATE; NEUROCOGNITIVE FUNCTION; PARKINSONS-DISEASE; HYPOPNEA SYNDROME; ASSESSMENT MOCA; IMPAIRMENT; DYSFUNCTION; POPULATION	Background The patients with obstructive sleep apnea hypopnea syndrome (OSAHS) tend to develop cognitive deficits, which usually go unrecognized, and can affect their daily life. The Beijing version of the Montreal cognitive assessment (MoCA-BJ), a Chinese version of MoCA, has been used for the assessment of cognitive functions of OSAHS patients in clinical practice. So far, its reliability and validity have not been tested. This study examined the reliability and validity of MoCA-BJ in a cohort of adult OSAHS patients. Methods 152 OSAHS patients, ranging from mild, moderate to severe, 49 primary snoring subjects and 40 normal controls were evaluated for cognitive functions by employing both MoCA-BJ and the Mini Mental State Examination (MMSE). Forty of them were re-tested by MoCA-BJ 14 days after the first test. Internal consistency, test-retest reliability, discriminate and concurrent validity of MoCA-BJ were analyzed. Results Internal consistency reliability by Cronbach's alpha was adequate (0.73). Intra-class correlation coefficient (ICC), an measure of test-retest reliability, was 0.87 (P<0.001). The total MoCA-BJ scores were significant higher in normal controls than in OSAHS groups (p<0.05). The performances of visuospatial ability in severe OSAHS group were significantly weaker than in normal controls and primary snoring group. The performances of executive ability in severe OSAHS patients were weaker than in normal controls. An optimal cut-off between normal controls and non-normal subjects was at 26 points (total MoCA score). Moreover, cut-off between non-severe and severe OSAHS was at 2 points on visuospatial subscale. Analysis of the correlation between MoCA total scores and MMSE total scores revealed a statistically significant, though relatively weak, correlation (r=0.41, P<0.05). Conclusion In conclusion, our study showed that the Beijing version of the MoCA was reliable and stable. The MoCA-BJ was capable of detecting cognitive dysfunction by visuospatial and total MoCA-BJ score.	[Chen, Xiong; Zhang, Rui; Xiao, Ying; Dong, Jiaqi; Niu, Xun; Kong, Weijia] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Otolaryngol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Kong, WJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Otolaryngol, Wuhan 430074, Peoples R China.	entwjkong@hust.edu.cn		Kong, Wei-Jia/0000-0001-5410-2297				American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; BEDARD MA, 1991, J CLIN EXP NEUROPSYC, V13, P950, DOI 10.1080/01688639108405110; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Chen R, 2011, RESPIROLOGY, V16, P842, DOI 10.1111/j.1440-1843.2011.01979.x; CHESHIRE K, 1992, ARCH INTERN MED, V152, P538, DOI 10.1001/archinte.152.3.538; FINDLEY LJ, 1986, CHEST, V90, P686, DOI 10.1378/chest.90.5.686; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; GREENBERG GD, 1987, SLEEP, V10, P254, DOI 10.1093/sleep/10.3.254; Iber C., 2007, AASM MANUAL SCORING; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kingshott RN, 2000, AM J RESP CRIT CARE, V161, P866, DOI 10.1164/ajrccm.161.3.9905053; Kuo TF, 2000, SLEEP S2, V23, P58; Lauer C. J., 1998, Journal of Sleep Research, V7, P148; Lee Michelle M., 1999, Sleep Breath, V3, P13, DOI 10.1007/s11325-999-0013-8; Lu J, 2011, J GERIATR PSYCH NEUR, V24, P184, DOI 10.1177/0891988711422528; Mathieu A, 2008, SLEEP MED, V9, P112, DOI 10.1016/j.sleep.2007.03.014; McLennan SN, 2011, J GERIATR PSYCH NEUR, V24, P33, DOI 10.1177/0891988710390813; Morisson F, 1997, SLEEP RES, V26, P438; Munoz A, 2000, EUR RESPIR J, V15, P676, DOI 10.1034/j.1399-3003.2000.15d09.x; Naegele B, 2006, SLEEP, V29, P533, DOI 10.1093/sleep/29.4.533; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Ozdilek B, 2014, CLIN NEUROPSYCHOL, V28, P333, DOI 10.1080/13854046.2014.881554; Pietrini P, 1998, SLEEP S3, P82; Redline S, 1997, SLEEP, V20, P160, DOI 10.1093/sleep/20.2.160; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Saunamaki T, 2009, EUR NEUROL, V62, P237, DOI 10.1159/000232156; Shpirer I, 2012, SLEEP BREATH, V16, P821, DOI 10.1007/s11325-011-0582-1; Wang WH, 2012, ASIAN PAC J TROP MED, V5, P906, DOI 10.1016/S1995-7645(12)60169-2; Xiao Y, 2011, J HUAZHONG U SCI-MED, V31, P413, DOI 10.1007/s11596-011-0392-5; YU ESH, 1989, J GERONTOL, V44, pS97, DOI 10.1093/geronj/44.3.S97; Yu J, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-156; Zhang X, 2011, SLEEP MED, V12, P335, DOI 10.1016/j.sleep.2010.08.015; Zozula R, 1998, SLEEP S3, V21, P71	38	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132361	10.1371/journal.pone.0132361	http://dx.doi.org/10.1371/journal.pone.0132361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208289	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000026
J	Finlay-Jones, AL; Rees, CS; Kane, RT				Finlay-Jones, Amy L.; Rees, Clare S.; Kane, Robert T.			Self-Compassion, Emotion Regulation and Stress among Australian Psychologists: Testing an Emotion Regulation Model of Self-Compassion Using Structural Equation Modeling	PLOS ONE			English	Article							SECONDARY TRAUMATIC STRESS; LOVING-KINDNESS MEDITATION; VICARIOUS TRAUMATIZATION; MENTAL-HEALTH; MINDFULNESS; CARE; PERSONALITY; BURNOUT; PROFESSIONALS; NEUROTICISM	Psychologists tend to report high levels of occupational stress, with serious implications for themselves, their clients, and the discipline as a whole. Recent research suggests that self-compassion is a promising construct for psychologists in terms of its ability to promote psychological wellbeing and resilience to stress; however, the potential benefits of self-compassion are yet to be thoroughly explored amongst this occupational group. Additionally, while a growing body of research supports self-compassion as a key predictor of psychopathology, understanding of the processes by which self-compassion exerts effects on mental health outcomes is limited. Structural equation modelling (SEM) was used to test an emotion regulation model of self-compassion and stress among psychologists, including postgraduate trainees undertaking clinical work (n = 198). Self-compassion significantly negatively predicted emotion regulation difficulties and stress symptoms. Support was also found for our preliminary explanatory model of self-compassion, which demonstrates the mediating role of emotion regulation difficulties in the self-compassion-stress relationship. The final self-compassion model accounted for 26.2% of variance in stress symptoms. Implications of the findings and limitations of the study are discussed.	[Finlay-Jones, Amy L.; Rees, Clare S.; Kane, Robert T.] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia	Curtin University	Finlay-Jones, AL (corresponding author), Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA 6845, Australia.	amy.finlay-jones@curtin.edu.au	Finlay-Jones, Amy/F-8955-2018	Finlay-Jones, Amy/0000-0002-1336-4001				Adams SA, 2008, TRAIN EDUC PROF PSYC, V2, P26, DOI 10.1037/1931-3918.2.1.26; Aldao A., 2010, CLIN PSYCHOL REV, V30, P217, DOI [10.1016/j.cpr.2009.11.004, DOI 10.1016/j.cpr.2009.11.004, DOI 10.1016/J.CPR.2009.11.004]; Allen AB, 2010, SOC PERSONAL PSYCHOL, V4, P107, DOI 10.1111/j.1751-9004.2009.00246.x; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arch JJ, 2014, PSYCHONEUROENDOCRINO, V42, P49, DOI 10.1016/j.psyneuen.2013.12.018; Baer RA., 2010, ASSESSING MINDFULNES, P135; Baird K, 2006, COUNS PSYCHOL Q, V19, P181, DOI 10.1080/09515070600811899; Bardeen JR, 2012, J PSYCHOPATHOL BEHAV, V34, P382, DOI 10.1007/s10862-012-9280-y; Barnard LK, 2012, PASTOR PSYCHOL, V61, P149, DOI 10.1007/s11089-011-0377-0; Barnard LK, 2011, REV GEN PSYCHOL, V15, P289, DOI 10.1037/a0025754; Barnett JE, 2007, PROF PSYCHOL-RES PR, V38, P603, DOI 10.1037/0735-7028.38.6.603; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boellinghaus I, 2014, MINDFULNESS, V5, P129, DOI 10.1007/s12671-012-0158-6; Boellinghaus I, 2013, TRAIN EDUC PROF PSYC, V7, P267, DOI 10.1037/a0033092; BOLGER N, 1991, J PERS, V59, P355, DOI 10.1111/j.1467-6494.1991.tb00253.x; Breines JG, 2015, SELF IDENTITY, V14, P390, DOI 10.1080/15298868.2015.1005659; Breines JG, 2014, BRAIN BEHAV IMMUN, V37, P109, DOI 10.1016/j.bbi.2013.11.006; Bride BE, 2007, CLIN SOC WORK J, V35, P155, DOI 10.1007/s10615-007-0091-7; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; BROWNE MW, 1984, BRIT J MATH STAT PSY, V37, P62, DOI 10.1111/j.2044-8317.1984.tb00789.x; Butler S., 2005, PROFESSIONAL SCH COU, V9, P55, DOI [DOI 10.5330/PRSC.9.1.17N4415L163720U5, 10.5330/prsc.9.1.17n4415l163720u5]; Campbell-Sills L., 2007, HDB EMOTION REGULATI, P542; CHEMTOB CM, 1989, PROF PSYCHOL-RES PR, V20, P294, DOI 10.1037/0735-7028.20.5.294; CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103; Colli A, 2014, AM J PSYCHIAT, V171, P102, DOI 10.1176/appi.ajp.2013.13020224; Craig CD, 2010, ANXIETY STRESS COPIN, V23, P319, DOI 10.1080/10615800903085818; CUSHWAY D, 1992, BRIT J CLIN PSYCHOL, V31, P169, DOI 10.1111/j.2044-8260.1992.tb00981.x; Cushway D., 2005, STRESS PSYCHOTHERAPI, P18; D'Souza F, 2011, BEHAV CHANGE, V28, P17, DOI 10.1375/bech.28.1.17; Diedrich A, 2014, BEHAV RES THER, V58, P43, DOI 10.1016/j.brat.2014.05.006; Enochs W.K., 2004, FAM J, V12, P396, DOI [10.1177/1066480704267240, DOI 10.1177/1066480704267240, https://doi.org/10.1177/1066480704267240]; Galhardo A, 2013, J CLIN PSYCHOL MED S, V20, P497, DOI 10.1007/s10880-013-9370-3; Germer CK, 2013, J CLIN PSYCHOL, V69, P856, DOI 10.1002/jclp.22021; Gilbert P., 2005, COMPASSION CONCEPTUA, P9, DOI DOI 10.4324/9780203003459; Gilroy PJ, 2002, PROF PSYCHOL-RES PR, V33, P402, DOI 10.1037//0735-7028.33.4.402; Gratz K. L., 2010, ASSESSING MINDFULNES; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; GROSS JJ, 1995, CLIN PSYCHOL-SCI PR, V2, P151, DOI 10.1111/j.1468-2850.1995.tb00036.x; Gross JJ., 2006, HDB EMOTION REGULATI, P3; Gunthert KC, 1999, J PERS SOC PSYCHOL, V77, P1087, DOI 10.1037/0022-3514.77.5.1087; Guy JD, 1987, PERSONAL LIFE PSYCHO; Hannigan B., 2004, J MENT HEALTH, V93, P235, DOI [10.1080/09638230410001700871, DOI 10.1080/09638230410001700871]; Hayes AM, 2004, CLIN PSYCHOL-SCI PR, V11, P255, DOI 10.1093/clipsy/bph080; Heffernan M, 2010, INT J NURS PRACT, V16, P366, DOI 10.1111/j.1440-172X.2010.01853.x; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Hofmann SG, 2011, CLIN PSYCHOL REV, V31, P1126, DOI 10.1016/j.cpr.2011.07.003; Hollis-Walker L, 2011, PERS INDIV DIFFER, V50, P222, DOI 10.1016/j.paid.2010.09.033; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Irving Julie Anne, 2009, Complement Ther Clin Pract, V15, P61, DOI 10.1016/j.ctcp.2009.01.002; John O, 1991, BIG 5 INVENTORY VERS; Joreskog K. G., 2013, LISREL 9 10; Kearney DJ, 2013, J TRAUMA STRESS, V26, P426, DOI 10.1002/jts.21832; Kendler KS, 2003, PSYCHOL MED, V33, P1193, DOI 10.1017/S0033291703008298; Keng SL, 2012, J COGN PSYCHOTHER, V26, P270, DOI 10.1891/0889-8391.26.3.270; Klimecki O., 2011, PATHOLOGICAL ALTRUIS, P368; Klimecki OM, 2013, CEREB CORTEX, V23, P1552, DOI 10.1093/cercor/bhs142; Kline RB, 2005, PRINCIPLES PRACTICE; Knox S, 2006, PROF PSYCHOL-RES PR, V37, P547, DOI 10.1037/0735-7028.37.5.547; Kokkonen M, 2001, EUR J PERSONALITY, V15, P407, DOI 10.1002/per.425; Kopp MS, 2010, J PSYCHOSOM RES, V69, P211, DOI 10.1016/j.jpsychores.2009.09.006; Krieger T, 2013, BEHAV THER, V44, P501, DOI 10.1016/j.beth.2013.04.004; Kuyken W, 2000, CLIN PSYCHOL PSYCHOT, V7, P394, DOI 10.1002/1099-0879(200011)7:5<394::AID-CPP268>3.3.CO;2-F; Lambert MJ, 2001, PSYCHOTHERAPY, V38, P357, DOI 10.1037/0033-3204.38.4.357; Leary MR, 2007, J PERS SOC PSYCHOL, V92, P887, DOI 10.1037/0022-3514.92.5.887; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; MacBeth A, 2012, CLIN PSYCHOL REV, V32, P545, DOI 10.1016/j.cpr.2012.06.003; MCCRAE RR, 1990, STRESS MEDICINE, V6, P237, DOI 10.1002/smi.2460060309; Mennin DS, 2002, CLIN PSYCHOL-SCI PR, V9, P85, DOI 10.1093/clipsy/9.1.85; Mental Health Workforce Advisory Committee, 2008, MENTAL HEALTH WORKFO; Miranda R, 2013, COGNITIVE THER RES, V37, P786, DOI 10.1007/s10608-013-9524-5; Neff KD., 2009, HDB INDIVIDUAL DIFFE, P561; Neff K, 2003, SELF IDENTITY, V2, P85, DOI 10.1080/15298860390129863; Neff KD, 2007, J RES PERS, V41, P908, DOI 10.1016/j.jrp.2006.08.002; Neff KD, 2007, J RES PERS, V41, P139, DOI 10.1016/j.jrp.2006.03.004; Neff KD, 2005, SELF IDENTITY, V4, P263, DOI 10.1080/13576500444000317; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Neff KD, 2013, SELF IDENTITY, V12, P160, DOI 10.1080/15298868.2011.649546; Neff KD, 2013, SELF IDENTITY, V12, P78, DOI 10.1080/15298868.2011.639548; Neff KD, 2009, J PERS, V77, P23, DOI 10.1111/j.1467-6494.2008.00537.x; Newsome S, 2012, J SPEC GROUP WORK, V37, P297, DOI 10.1080/01933922.2012.690832; Norcross J. C., 2007, LEAVING IT OFFICE GU; O'Halloran MS, 2001, TEACH PSYCHOL, V28, P92, DOI 10.1207/S15328023TOP2802_03; Orgeta V, 2009, AGING MENT HEALTH, V13, P818, DOI 10.1080/13607860902989661; Patsiopoulos AT, 2011, PROF PSYCHOL-RES PR, V42, P301, DOI 10.1037/a0024482; Pearlman L. A., 1995, COMPASSION FATIGUE C, P150, DOI DOI 10.1037/0021-9010.88.5.879; Pugesek BH, 1998, FUNCT ECOL, V12, P853; Raab K, 2014, J HEALTH CARE CHAPL, V20, P95, DOI 10.1080/08854726.2014.913876; Radeke JT, 2000, PROF PSYCHOL-RES PR, V31, P82, DOI 10.1037/0735-7028.31.1.82; Raes F, 2011, CLIN PSYCHOL PSYCHOT, V18, P250, DOI 10.1002/cpp.702; Raes F, 2010, PERS INDIV DIFFER, V48, P757, DOI 10.1016/j.paid.2010.01.023; Renjilian D., 1998, J COLL STUDENT PSYCH, V13, P39, DOI [DOI 10.1300/J035V13N01_04, 10.1300/J035v13n01_04]; Roemer L., 2009, MINDFULNESS ACCEPTAN; Roemer L, 2009, BEHAV THER, V40, P142, DOI 10.1016/j.beth.2008.04.001; Ronnestad MH, 2003, J CAREER DEV, V30, P5, DOI 10.1177/089484530303000102; Rosenberg T, 2006, J MARITAL FAM THER, V32, P87, DOI 10.1111/j.1752-0606.2006.tb01590.x; Sabin-Farrell R, 2003, CLIN PSYCHOL REV, V23, P449, DOI 10.1016/S0272-7358(03)00030-8; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schaufeli W., 1998, BURNOUT COMPANION ST; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Shapiro S.L., 2009, ART SCI MINDFULNESS, DOI [DOI 10.1037/11885-007, 10. 1037/11885-000]; Shapiro S. L., 2005, INT J STRESS MANAGE, V12, P164, DOI [10.1037/1072-5245.12.2.164, DOI 10.1037/1072-5245.12.2.164]; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Sirois FM, 2015, HEALTH PSYCHOL, V34, P661, DOI 10.1037/hea0000158; Sirois FM, 2015, SELF IDENTITY, V14, P334, DOI 10.1080/15298868.2014.996249; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Skovholt TM, 2011, COUNSEL PSYCHOTHER, P1; Skovholt TM, 2003, J CAREER DEV, V30, P45, DOI 10.1177/089484530303000103; Soto CJ, 2008, J PERS SOC PSYCHOL, V94, P718, DOI 10.1037/0022-3514.94.4.718; Sprang G, 2007, J LOSS TRAUMA, V12, P259, DOI 10.1080/15325020701238093; Stafford-Brown J, 2012, J CLIN PSYCHOL, V68, DOI 10.1002/jclp.21844; Starcke K, 2012, NEUROSCI BIOBEHAV R, V36, P1228, DOI 10.1016/j.neubiorev.2012.02.003; Terry ML, 2011, SELF IDENTITY, V10, P352, DOI 10.1080/15298868.2011.558404; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Veilleux JC, 2011, PROF PSYCHOL-RES PR, V42, P222, DOI 10.1037/a0023650; Vettese LC, 2011, INT J MENT HEALTH AD, V9, P480, DOI 10.1007/s11469-011-9340-7; Wan C., 1996, LISREL ANAL INTERACT; Werner K, 2010, TXB EMOTION REGULATI, P13, DOI DOI 10.1016/J.CPR.2016.10.005; Wise EH, 2012, PROF PSYCHOL-RES PR, V43, P487, DOI 10.1037/a0029446; Yarnell LM, 2013, SELF IDENTITY, V12, P146, DOI 10.1080/15298868.2011.649545	120	121	122	10	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133481	10.1371/journal.pone.0133481	http://dx.doi.org/10.1371/journal.pone.0133481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26207900	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000092
J	Lopez-Lopez, MT; Scionti, G; Oliveira, AC; Duran, JDG; Campos, A; Alaminos, M; Rodriguez, IA				Lopez-Lopez, Modesto T.; Scionti, Giuseppe; Oliveira, Ana C.; Duran, Juan D. G.; Campos, Antonio; Alaminos, Miguel; Rodriguez, Ismael A.			Generation and Characterization of Novel Magnetic Field-Responsive Biomaterials	PLOS ONE			English	Article							SCAFFOLDS; NANOPARTICLES; FIBRIN; BONE; REPAIR	We report the preparation of novel magnetic field-responsive tissue substitutes based on biocompatible multi-domain magnetic particles dispersed in a fibrin-agarose biopolymer scaffold. We characterized our biomaterials with several experimental techniques. First we analyzed their microstructure and found that it was strongly affected by the presence of magnetic particles, especially when a magnetic field was applied at the start of polymer gelation. In these samples we observed parallel stripes consisting of closely packed fibers, separated by more isotropic net-like spaces. We then studied the viability of oral mucosa fibroblasts in the magnetic scaffolds and found no significant differences compared to positive control samples. Finally, we analyzed the magnetic and mechanical properties of the tissue substitutes. Differences in microstructural patterns of the tissue substitutes correlated with their macroscopic mechanical properties. We also found that the mechanical properties of our magnetic tissue substitutes could be reversibly tuned by noncontact magnetic forces. This unique advantage with respect to other biomaterials could be used to match the mechanical properties of the tissue substitutes to those of potential target tissues in tissue engineering applications.	[Lopez-Lopez, Modesto T.; Duran, Juan D. G.] Univ Granada, Dept Appl Phys, Fac Sci, Granada, Spain; [Lopez-Lopez, Modesto T.; Scionti, Giuseppe; Oliveira, Ana C.; Duran, Juan D. G.; Campos, Antonio; Alaminos, Miguel; Rodriguez, Ismael A.] Inst Invest Biosanitaria Ibs GRANADA, Granada, Spain; [Scionti, Giuseppe; Oliveira, Ana C.; Campos, Antonio; Alaminos, Miguel; Rodriguez, Ismael A.] Univ Granada, Dept Histol, Fac Med, Granada, Spain; [Rodriguez, Ismael A.] Natl Univ Cordoba, Dept Histol, Sch Dent, Cordoba, Argentina	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; National University of Cordoba	Lopez-Lopez, MT (corresponding author), Univ Granada, Dept Appl Phys, Fac Sci, Granada, Spain.	modesto@ugr.es; ismaelrodriguez18@hotmail.com	Rodriguez, Ismael/C-7812-2019; Duran, Juan/GRZ-0839-2022; Lopez-Lopez, Modesto T/K-7327-2012; Oliveira, Ana Carolina/GRF-1435-2022; ALAMINOS, MIGUEL/N-9960-2016	Lopez-Lopez, Modesto T/0000-0002-9068-7795; ALAMINOS, MIGUEL/0000-0003-4876-2672; Scionti, Giuseppe/0000-0003-2128-0104; Campos, A/0000-0003-4061-8182	Spanish Ministry of Economy and Competitiveness - FEDER funds, EU [FIS2013-41821-R]; Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III - FEDER funds, EU) [FIS PI14/0955, FIS PI14/1343, PI11/01582]; Junta de Andalucia, Spain (Consejeria de Innovacion, Ciencia y Empleo-Proyectos de Excelencia) [P10-CTS-6060]	Spanish Ministry of Economy and Competitiveness - FEDER funds, EU; Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III - FEDER funds, EU); Junta de Andalucia, Spain (Consejeria de Innovacion, Ciencia y Empleo-Proyectos de Excelencia)(Junta de Andalucia)	This work was supported by FIS2013-41821-R (http://www.mineco.gob.es/): Spanish Ministry of Economy and Competitiveness (co-funded by FEDER funds, EU) to MTLL, GS, JDGD and IAR; FIS PI14/0955 (http://www.mineco.gob.es/): Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III-co-funded by FEDER funds, EU) to AC and MA; FIS PI14/1343 (http://www.mineco.gob.es/): Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III -co-funded by FEDER funds, EU) to AC and MA; PI11/01582 (http://www.mineco.gob.es/): Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III -co-funded by FEDER funds, EU) to AC and MA; and P10-CTS-6060 (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html) Junta de Andalucia, Spain (Consejeria de Innovacion, Ciencia y Empleo-Proyectos de Excelencia) to AC and MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Baddour JA, 2012, BIRTH DEFECTS RES C, V96, P1, DOI 10.1002/bdrc.21006; Banobre-Lopez M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3561149; Bock N, 2010, ACTA BIOMATER, V6, P786, DOI 10.1016/j.actbio.2009.09.017; Bossis G, 2002, LECT NOTES PHYS, V594, P202; Capito RM, 2003, IEEE ENG MED BIOL, V22, P42, DOI 10.1109/MEMB.2003.1256271; Christensen R. M., 1991, MECH COMPOSITE MAT; Das B, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035003; De Santis R, 2011, J APPL POLYM SCI, V122, P3599, DOI 10.1002/app.34771; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Ge L, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/11/115029; Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832; Gloria A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0833; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Hu H, 2013, RSC ADV, V3, P879, DOI 10.1039/c2ra22726f; Hu SH, 2007, J MAGN MAGN MATER, V310, P2871, DOI 10.1016/j.jmmm.2006.11.081; Jiles D.C., 1998, INTRO MAGNETISM MAGN; Jolly MR, 1996, J INTEL MAT SYST STR, V7, P613, DOI 10.1177/1045389X9600700601; Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014; Lai KL, 2012, RSC ADV, V2, P13007, DOI 10.1039/c2ra22376g; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Li YH, 2013, ADV FUNCT MATER, V23, P660, DOI 10.1002/adfm.201201708; Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015; Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x; Pabbruwe MB, 2009, BIOMATERIALS, V30, P4277, DOI 10.1016/j.biomaterials.2009.02.052; Panseri S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-32; Rodriguez IA, 2012, J TISSUE ENG REGEN M, V6, P636, DOI 10.1002/term.466; Rodriguez MA, 2013, CRYOBIOLOGY, V67, P355, DOI 10.1016/j.cryobiol.2013.10.003; Rosensweig RE, 1998, FERROHYDRODYNAMICS; Scionti G, 2014, J BIOMED MATER RES A, V102, P2573, DOI 10.1002/jbm.a.34929; Singh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091584; Skaat H, 2012, ADV HEALTHC MATER, V1, P168, DOI 10.1002/adhm.201100056; Tampieri A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015104; Tampieri A, 2012, ACTA BIOMATER, V8, P843, DOI 10.1016/j.actbio.2011.09.032; Thanikaivelan P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00230; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Vinuela-Prieto JM, 2015, J PERIODONTAL RES, V50, P658, DOI 10.1111/jre.12247; Zeng XB, 2012, INT J NANOMED, V7, P3365, DOI 10.2147/IJN.S32264; Zeng XB, 2013, J INORG MATER, V28, P79, DOI 10.3724/SP.J.1077.2013.12107; Zhu YF, 2013, J MATER CHEM B, V1, P1279, DOI 10.1039/c2tb00262k; Ziv-Polat O, 2012, INT J NANOMED, V7, P1259, DOI 10.2147/IJN.S26533	41	40	41	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133878	10.1371/journal.pone.0133878	http://dx.doi.org/10.1371/journal.pone.0133878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207995	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000163
J	Samaniego, CS; Suh, JH; Chattopadhyay, A; Olivares, K; Guy, N; Sivils, JC; Dey, P; Yumoto, F; Fletterick, RJ; Strom, AM; Gustafsson, JA; Webb, P; Cox, MB				Samaniego, Cheryl Storer; Suh, Ji Ho; Chattopadhyay, Arundhati; Olivares, Karen; Guy, Naihsuan; Sivils, Jeffrey C.; Dey, Prasenjit; Yumoto, Fumiaki; Fletterick, Robert J.; Strom, Anders M.; Gustafsson, Jan-Ake; Webb, Paul; Cox, Marc B.			The FKBP52 Cochaperone Acts in Synergy with beta-Catenin to Potentiate Androgen Receptor Signaling	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; DOMAIN; WNT; ACTIVATION; PATHWAY; DISEASE; BINDING; ROLES; CELLS	FKBP52 and beta-catenin have emerged in recent years as attractive targets for prostate cancer treatment. beta-catenin interacts directly with the androgen receptor (AR) and has been characterized as a co-activator of AR-mediated transcription. FKBP52 is a positive regulator of AR in cellular and whole animal models and is required for the development of androgen-dependent tissues. We previously characterized an AR inhibitor termed MJC13 that putatively targets the AR BF3 surface to specifically inhibit FKBP52-regulated AR signaling. Predictive modeling suggests that beta-catenin interacts with the AR hormone binding domain on a surface that overlaps with BF3. Here we demonstrate that FKBP52 and beta-catenin interact directly in vitro and act in concert to promote a synergistic up-regulation of both hormone-independent and -dependent AR signaling. Our data demonstrate that FKBP52 promotes beta-catenin interaction with AR and is required for beta-catenin co-activation of AR activity in prostate cancer cells. MJC13 effectively blocks beta-catenin interaction with the AR LBD and the synergistic up-regulation of AR by FKBP52 and beta-catenin. Our data suggest that co-regulation of AR by FKBP52 and beta-catenin does not require FKBP52 PPIase catalytic activity, nor FKBP52 binding to Hsp90. However, the FKBP52 proline-rich loop that overhangs the PPIase pocket is critical for synergy.	[Samaniego, Cheryl Storer; Olivares, Karen; Guy, Naihsuan; Sivils, Jeffrey C.; Cox, Marc B.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Samaniego, Cheryl Storer; Olivares, Karen; Guy, Naihsuan; Sivils, Jeffrey C.; Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Samaniego, Cheryl Storer] Kettering Univ, Dept Chem & Biochem, Flint, MI USA; [Suh, Ji Ho; Chattopadhyay, Arundhati; Webb, Paul] Methodist Hosp, Res Inst, Genom Med, Houston, TX 77030 USA; [Dey, Prasenjit; Strom, Anders M.; Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Dey, Prasenjit; Strom, Anders M.; Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Yumoto, Fumiaki; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Kettering University; The Methodist Hospital System; The Methodist Hospital - Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of California System; University of California San Francisco	Cox, MB (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	mbcox@utep.edu		Cox, Marc/0000-0001-7854-2676	National Institute on Minority Health and Health Disparities [2G12MD007592]; National Institutes of Health; American Recovery and Reinvestment Act (ARRA) funds through National Institute of General Medical Sciences [SC1GM084863]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110444-P1, RP110444-P2, RP110444-P3, RP110444-C2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM084863] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act (ARRA) funds through National Institute of General Medical Sciences; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by grants to the Border Biomedical Research Center (http://science.utep.edu/bbrc/) from the National Institute on Minority Health and Health Disparities (grant number 2G12MD007592; http://www.nimhd.nih.gov/) from the National Institutes of Health. M.B.C. was supported in part by American Recovery and Reinvestment Act (ARRA) funds through grant number SC1GM084863 to M.B.C. from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/Pages/default.aspx). These studies were also supported in part by Cancer Prevention and Research Institute of Texas (CPRIT; http://www.cprit.state.tx.us/) grants to J.A.G. (RP110444-P1), M.B.C. (RP110444-P2), and P.W. (RP110444-P3 and RP110444-C2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cano LQ, 2013, MOL CELL ENDOCRINOL, V369, P52, DOI 10.1016/j.mce.2013.01.023; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Cluning C, 2013, MOL ENDOCRINOL, V27, P1020, DOI 10.1210/me.2012-1023; Cox MB, 2007, MOL ENDOCRINOL, V21, P2956, DOI 10.1210/me.2006-0547; Cronauer MV, 2005, INT J ONCOL, V26, P1033; De Leon JT, 2011, P NATL ACAD SCI USA, V108, P11878, DOI 10.1073/pnas.1105160108; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Erlejman AG, 2014, CURR PROTEIN PEPT SC, V15, P205, DOI 10.2174/1389203715666140331113753; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Jehle K, 2014, J BIOL CHEM, V289, P8839, DOI 10.1074/jbc.M113.534859; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Liang S, 2016, PHARM DEV TECHNOL, V21, P121, DOI 10.3109/10837450.2014.979946; Liang Su, 2014, Am J Mod Chromatogr, V1, P1; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Truica CI, 2000, CANCER RES, V60, P4709; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang Juan, 2011, Clinical Oncology and Cancer Research, V8, P85, DOI 10.1007/s11805-011-0564-x; Yamaoka M, 2010, CLIN CANCER RES, V16, P4319, DOI 10.1158/1078-0432.CCR-10-0255; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134015	10.1371/journal.pone.0134015	http://dx.doi.org/10.1371/journal.pone.0134015			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207810	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000191
J	Dash, C; Gascoigne, E; Gillanders, K; Gooi, H				Dash, Clive; Gascoigne, Ernie; Gillanders, Kate; Gooi, Hock			Experience with Subgam, a Subcutaneously Administered Human Normal Immunoglobulin (ClinicalTrials.gov-NCT02247141)	PLOS ONE			English	Article							PRIMARY ANTIBODY DEFICIENCIES; IGG REPLACEMENT THERAPY; QUALITY-OF-LIFE; SELF-INFUSIONS; SAFETY; EFFICACY; PHARMACOKINETICS; MANAGEMENT; DIAGNOSIS; CHILDREN	Background and Objectives A multi-centre, non-comparative study examining the efficacy and safety of Subgam, a normal immunoglobulin (IgG) given weekly as a rapid subcutaneous infusion to patients with primary immune deficiency (PID), is reported. Also included is a summary of adverse drug reactions associated with the use of marketed Subgam in the UK. Materials and Methods 50 patients with stable PID on IgG therapy were enrolled: Stage 1 included three infusions with prior IgG product followed by 6 months with Subgam, Stage 2 involved long-term Subgam therapy up to 4 years. Results Stage 1, 85% of the subjects aged >12 years and 93% of the subjects aged <12 years achieved IgG levels >= 6 and >= 4 g/L, respectively at all observations. There were 3.62 infections/patient/year during Subgam treatment. The most common product-related events were infusion site reactions (50% of patients). Recent post-hoc pharmacokinetics analysis of the post-infusion serum total IgG concentration indicated that the mean dose-normalised incremental IgG AUC tau following intravenous dosing (120.5 g.day/L) was 1.64-fold that of the dose-normalised mean incremental IgG AUC tau following subcutaneous dosing (73.6 g.day/L), corresponding to an estimated IgG bioavailability for subcutaneous dosing of 61%. Only 34 post-licensing adverse reactions have been received in 30 patients over a period of 10 years; fourteen were classed as serious as defined by the ICH guidelines on good clinical practice. The most common post-licensing adverse reaction was infusion site reaction (7 reports). There were 7 reports of flu-like symptoms (pyrexia/shivering/rigors/feeling hot or cold), 2 other reports of combined flu-like symptoms and infusion site reactions, 5 reports of generalised skin reactions, and 3 reports of combined infusion site and skin reactions. There were also reports of anaphylaxis (2 reports) and 8 other adverse events (including headache). In conclusion, Subgam is effective and well tolerated in the treatment of PID.	[Dash, Clive] CD Consultants, St Albans, Herts, England; [Gascoigne, Ernie; Gillanders, Kate] Bio Prod Lab Ltd BPL, Dept Med, Elstree, Herts, England; [Gooi, Hock] Kings Coll Hosp London, Dept Clin Immunol & Allergy, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Gillanders, K (corresponding author), Bio Prod Lab Ltd BPL, Dept Med, Elstree, Herts, England.	kate.gillanders@bpl.co.uk			Bio Products Laboratory limited (BPL); BPL	Bio Products Laboratory limited (BPL); BPL	E. Gascoigne and K. Gillanders are employees of Bio Products Laboratory limited (BPL), whose company funded this study. C. Dash is self-employed and has acted as the Medical Director (medically qualified person) for BPL through CD Consultants. H. Gooi, was the Principal Investigator for the study and received payment from BPL for participation in the study. Subgam is marketed in the United Kingdom, Cyprus and Columbia.	Abolhassani H, 2012, J CLIN IMMUNOL, V32, P1180, DOI 10.1007/s10875-012-9720-1; [Anonymous], 1994, ICH HARM TRIP GUID C; [Anonymous], 2000, CPMPBPWG38895; Berger M, 2004, CLIN IMMUNOL, V112, P1, DOI 10.1016/j.clim.2004.02.002; Berger M, 2011, CURR OPIN ALLERGY CL, V11, P532, DOI 10.1097/ACI.0b013e32834c22da; Berger M, 2011, CLIN IMMUNOL, V139, P133, DOI 10.1016/j.clim.2011.01.006; Chapel HM, 2000, J CLIN IMMUNOL, V20, P94, DOI 10.1023/A:1006678312925; CHAPEL HM, 1994, BRIT MED J, V308, P581, DOI 10.1136/bmj.308.6928.581; Gardulf A, 1996, CLIN IMMUNOTHER, V6, P108, DOI 10.1007/BF03259507; Gardulf A, 2004, J ALLERGY CLIN IMMUN, V114, P936, DOI 10.1016/j.jaci.2004.06.053; Gardulf A, 1993, IMMUNODEFICIENCY, V4, P1; Gardulf A, 2006, J CLIN IMMUNOL, V26, P177, DOI 10.1007/s10875-006-9002-x; Gaspar J, 1998, ARCH DIS CHILD, V79, P48, DOI 10.1136/adc.79.1.48; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH, 1996, ICH HARM TRIP GUID G; Nicolay U, 2006, J CLIN IMMUNOL, V26, P65, DOI 10.1007/s10875-006-8905-x; Ochs HD, 2006, J CLIN IMMUNOL, V26, P265, DOI 10.1007/s10875-006-9021-7; Rosen FS, 1997, CLIN EXP IMMUNOL, V109, P1; Stein MR, 2006, J ALLERGY CLIN IMMUN, V117, pS108, DOI 10.1016/j.jaci.2005.12.432; Thepot S, 2010, J CLIN IMMUNOL, V30, P602, DOI 10.1007/s10875-010-9417-2; Wasserman RL, 2010, CLIN EXP IMMUNOL, V161, P518, DOI 10.1111/j.1365-2249.2010.04195.x; Wasserman RL, 2011, J CLIN IMMUNOL, V31, P323, DOI 10.1007/s10875-011-9512-z; Wood P, 2007, CLIN EXP IMMUNOL, V149, P410, DOI 10.1111/j.1365-2249.2007.03432.x	22	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131565	10.1371/journal.pone.0131565	http://dx.doi.org/10.1371/journal.pone.0131565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222441	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800016
J	Song, CG; Huang, JJ; Li, YJ; Xia, Y; Wang, Y; Bi, XW; Jiang, WQ; Huang, HQ; Lin, TY; Li, ZM				Song, Chen-Ge; Huang, Jia-Jia; Li, Ya-Jun; Xia, Yi; Wang, Yu; Bi, Xi-Wen; Jiang, Wen-Qi; Huang, Hui-Qiang; Lin, Tong-Yu; Li, Zhi-Ming			Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis	PLOS ONE			English	Article							LYMPHOPROLIFERATIVE DISORDERS; RITUXIMAB-CHOP; OPEN-LABEL; DLBCL; LENALIDOMIDE; CHEMOTHERAPY; COMBINATION; INHIBITOR; IBRUTINIB; THERAPY	Background Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) in the elderly has rarely been reported. This study aimed to explore the clinical characteristics and prognosis of this entity. Methods In situ hybridization (ISH) analysis of Epstein-Barr virus (EBV) and immunohistochemistry was performed in 230 tumor specimens from consecutive de novo DLBCL patients over 50 years old. A matched-case control analysis (1:3) was utilized to compare EBV-positive and EBV-negative DLBCL in the elderly. Results A total of 16 patients (7.0%) were diagnosed with EBV-positive DLBCL. Of these 16 cases, the median age was 62 years, with a male to female ratio of 11:5. Elderly EBV-positive DLBCL patients had a higher incidence of non-germinal center B-cell (non-GCB) subtypes (87.5%) and high Ki67 (75%) and CD30 expression (93.8%). For EBV-positive patients undergoing initial chemotherapy, 7 of 16 (43.8%) had complete remission, 2 (12.5%) had partial remission, 2 (12.5%) had stable disease, and 5 (31.3%) had progressive disease. The median overall survival was 9 months for the EBV-positive patients. A matched-case control analysis suggested that EBV-positive patients had inferior survival outcomes compared with EBV-negative patients (3-year progression-free survival [PFS]: 25% vs. 76.7%, respectively; 3-year overall survival [OS]: 25% vs. 77.4%, respectively; P<0.001). Conclusion EBV-positive DLBCL of the elderly is associated with an inferior clinical course and inferior survival outcomes. The role of EBV in this disease and the optimal management of this subgroup warrants further investigation.	[Song, Chen-Ge; Huang, Jia-Jia; Xia, Yi; Wang, Yu; Bi, Xi-Wen; Jiang, Wen-Qi; Huang, Hui-Qiang; Lin, Tong-Yu; Li, Zhi-Ming] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Li, Ya-Jun] Tumor Hosp Hunan Prov, Changsha, Hunan, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Li, ZM (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	lzmsysu@hotmail.com	jiang, wen/GYI-9662-2022		National Natural Science Foundation of China [81472759, 81301903]; Guangdong Natural Science Foundation [S2013010016331]; Science and Technology Planning Project of Guangdong Province, China [2014J4100163]; Science and Technology Planning Project of Guangzhou, China [2013B021800142]; Fundamental Research Funds for the Central Universities [10ykpy36]; Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China; Science and Technology Planning Project of Guangzhou, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center	This work was supported by the National Natural Science Foundation of China (project number: 81472759, 81301903), Guangdong Natural Science Foundation (project number: S2013010016331), Science and Technology Planning Project of Guangdong Province, China (project number: 2014J4100163), Science and Technology Planning Project of Guangzhou, China (project number: 2013B021800142), Fundamental Research Funds for the Central Universities (project number: 10ykpy36), and Research Award Funds for Outstanding Young Researchers in Sun Yat-Sen Cancer Center.	Bellas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098169; Chang ST, 2014, J CLIN PATHOL, V67, P326, DOI 10.1136/jclinpath-2013-201905; Cohen M, 2014, INT J CANCER, V135, P2816, DOI 10.1002/ijc.28942; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Dasmahapatra G, 2013, BRIT J HAEMATOL, V161, P43, DOI 10.1111/bjh.12206; Davids MS, 2014, FUTURE ONCOL, V10, P957, DOI 10.2217/fon.14.51; Desai M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-55; Elstrom RL, 2012, LEUKEMIA LYMPHOMA, V53, P1469, DOI 10.3109/10428194.2012.656629; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hu SM, 2013, BLOOD, V121, P2715, DOI 10.1182/blood-2012-10-461848; Kato H, 2014, CANCER SCI, V105, P537, DOI 10.1111/cas.12389; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064158; Li YJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-84; Michallet AS, 2012, CURR OPIN ONCOL, V24, P461, DOI 10.1097/CCO.0b013e3283562036; Montes-Moreno S, 2012, MODERN PATHOL, V25, P968, DOI 10.1038/modpathol.2012.52; Muller C, 2012, BLOOD, V119, P3276, DOI 10.1182/blood-2011-09-380949; Murawski N, 2014, ANN ONCOL, V25, P1800, DOI 10.1093/annonc/mdu208; Nikiforow S, 2014, J CLIN ONCOL, V32, P830, DOI 10.1200/JCO.2013.53.2994; Nowakowski GS, 2015, J CLIN ONCOL, V33, P251, DOI 10.1200/JCO.2014.55.5714; Ogura M, 2014, CANCER SCI, V105, P840, DOI 10.1111/cas.12435; Ok CY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.82; Ok CY, 2014, CLIN CANCER RES, V20, P2338, DOI 10.1158/1078-0432.CCR-13-3157; Ok CY, 2013, BLOOD, V122, P328, DOI 10.1182/blood-2013-03-489708; Oki Y, 2014, BRIT J HAEMATOL, V166, P891, DOI 10.1111/bjh.12982; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Park S, 2007, BLOOD, V110, P972, DOI 10.1182/blood-2007-01-067769; Recher C, 2011, LANCET, V378, P1858, DOI 10.1016/S0140-6736(11)61040-4; Shimoyama Y, 2008, CANCER SCI, V99, P1085, DOI 10.1111/j.1349-7006.2008.00813.x; Vitolo U, 2014, LANCET ONCOL, V15, P730, DOI 10.1016/S1470-2045(14)70191-3; Younes A, 2014, LANCET ONCOL, V15, P1019, DOI 10.1016/S1470-2045(14)70311-0	31	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133973	10.1371/journal.pone.0133973	http://dx.doi.org/10.1371/journal.pone.0133973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222726	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800089
J	Sun, XL; He, GZ; Wang, XY; Xu, SJ; Ju, JS; Xu, XL				Sun, Xiaoliang; He, Guangzheng; Wang, Xiaoyan; Xu, Shujing; Ju, Jiansong; Xu, Xiaoling			Crystal Structure of a Thermostable Alanine Racemase from Thermoanaerobacter tengcongensis MB4 Reveals the Role of Gln360 in Substrate Selection	PLOS ONE			English	Article							D-AMINO ACIDS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; X-RAY; BACILLUS-STEAROTHERMOPHILUS; SALMONELLA-TYPHIMURIUM; CYCLOSERINE; SITE; PURIFICATION; TUBERCULOSIS	Pyridoxal 5'-phosphate (PLP) dependent alanine racemase catalyzes racemization of L-Ala to D-Ala, a key component of the peptidoglycan network in bacterial cell wall. It has been extensively studied as an important antimicrobial drug target due to its restriction in eukaryotes. However, many marketed alanine racemase inhibitors also act on eukaryotic PLP-dependent enzymes and cause side effects. A thermostable alanine racemase (Alr(Tt)) from Thermoanaerobacter tengcongensis MB4 contains an evolutionarily non-conserved residue Gln360 in inner layer of the substrate entryway, which is supposed to be a key determinant in substrate specificity. Here we determined the crystal structure of Alr(Tt) in complex with L-Ala at 2.7 angstrom resolution, and investigated the role of Gln360 by saturation mutagenesis and kinetic analysis. Compared to typical bacterial alanine racemase, presence of Gln360 and conformational changes of active site residues disrupted the hydrogen bonding interactions necessary for proper PLP immobilization, and decreased both the substrate affinity and turnover number of Alr(Tt). However, it could be complemented by introduction of hydrophobic amino acids at Gln360, through steric blocking and interactions with a hydrophobic patch near active site pocket. These observations explained the low racemase activity of Alr(Tt), revealed the essential role of Gln360 in substrate selection, and its preference for hydrophobic amino acids especially Tyr in bacterial alanine racemization. Our work will contribute new insights into the alanine racemization mechanism for antimicrobial drug development.	[Sun, Xiaoliang; Wang, Xiaoyan; Xu, Xiaoling] Hangzhou Normal Univ, Sch Med, Inst Ageing Res, Hangzhou, Zhejiang, Peoples R China; [He, Guangzheng; Xu, Shujing; Ju, Jiansong] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China	Hangzhou Normal University; Hebei Normal University	Ju, JS (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China.	jujiansong@hotmail.com; xuxl@hznu.edu.cn	Xu, Xiaoling/ABC-2449-2021; Jiansong, Ju/R-2177-2019	Xu, Xiaoling/0000-0001-8995-1213; 	National Natural Science Foundation of China [31400630]; Zhejiang Provincial Natural Science Foundation of China [LY14C050002]; Natural Science Foundation of Hebei Province [C2015205212]; Starting Foundation for Natural Science from Hangzhou Normal University [PE13002004007]; HZNUARI-Pilot Research Grant [PD11001006007011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Starting Foundation for Natural Science from Hangzhou Normal University; HZNUARI-Pilot Research Grant	This work is supported by the National Natural Science Foundation of China under Grant No. 31400630(XLX), Zhejiang Provincial Natural Science Foundation of China under Grant No. LY14C050002 (XLX), Natural Science Foundation of Hebei Province (No. C2015205212, JSJ), the Starting Foundation for Natural Science from Hangzhou Normal University (No. PE13002004007, XLX), and the HZNUARI-Pilot Research Grant(No. PD11001006007011, XLX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asojo OA, 2014, ACTA CRYSTALLOGR D, V70, P1922, DOI 10.1107/S1399004714009419; Au K, 2008, ACTA CRYSTALLOGR F, V64, P327, DOI 10.1107/S1744309108007252; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; COPIE V, 1988, BIOCHEMISTRY-US, V27, P4966, DOI 10.1021/bi00414a002; Counago RM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-53; Davis E, 2014, ACTA CRYSTALLOGR F, V70, P1199, DOI 10.1107/S2053230X14017725; Dong H, 2013, ACTA CRYSTALLOGR F, V69, P660, DOI 10.1107/S1744309113011743; Drsata J, 2005, J PHARMACEUT BIOMED, V37, P1173, DOI 10.1016/j.jpba.2004.10.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espaillat A, 2014, ACTA CRYSTALLOGR D, V70, P79, DOI 10.1107/S1399004713024838; Fenn TD, 2003, BIOCHEMISTRY-US, V42, P5775, DOI 10.1021/bi027022d; HASHIMOTO A, 1992, J CHROMATOGR-BIOMED, V582, P41, DOI 10.1016/0378-4347(92)80300-F; Im H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-116; Ju JS, 2011, J BIOCHEM, V149, P83, DOI 10.1093/jb/mvq120; Ju JS, 2009, J BIOSCI BIOENG, V107, P225, DOI 10.1016/j.jbiosc.2008.11.005; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; LAMBERT MP, 1972, J BACTERIOL, V110, P978, DOI 10.1128/JB.110.3.978-987.1972; LeMagueres P, 2005, BIOCHEMISTRY-US, V44, P1471, DOI 10.1021/bi0486583; LeMagueres P, 2003, BIOCHEMISTRY-US, V42, P14752, DOI 10.1021/bi030165v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milligan DL, 2007, J BACTERIOL, V189, P8381, DOI 10.1128/JB.01201-07; Morollo AA, 1999, BIOCHEMISTRY-US, V38, P3293, DOI 10.1021/bi9822729; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ono K, 2006, PHYTOCHEMISTRY, V67, P856, DOI 10.1016/j.phytochem.2006.02.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palani K, 2013, ACTA CRYSTALLOGR F, V69, P15, DOI 10.1107/S1744309112047276; Patrick WM, 2002, CHEMBIOCHEM, V3, P789, DOI 10.1002/1439-7633(20020802)3:8<789::AID-CBIC789>3.0.CO;2-D; Priyadarshi A, 2009, BBA-PROTEINS PROTEOM, V1794, P1030, DOI 10.1016/j.bbapap.2009.03.006; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; Silverman R B, 1988, J Enzyme Inhib, V2, P73, DOI 10.3109/14756368809040714; SODA K, 1968, ANAL BIOCHEM, V25, P228, DOI 10.1016/0003-2697(68)90095-X; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Strych U, 2002, J BACTERIOL, V184, P4321, DOI 10.1128/JB.184.15.4321-4325.2002; Strych U, 2000, CURR MICROBIOL, V41, P290, DOI 10.1007/s002840010136; Uo T, 2001, J BACTERIOL, V183, P2226, DOI 10.1128/JB.183.7.2226-2233.2001; WALSH CT, 1989, J BIOL CHEM, V264, P2393; WASSERMAN SA, 1983, J BACTERIOL, V153, P1439, DOI 10.1128/JB.153.3.1439-1450.1983; WASSERMAN SA, 1984, BIOCHEMISTRY-US, V23, P5182, DOI 10.1021/bi00317a015; Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200; WILD J, 1985, MOL GEN GENET, V198, P315, DOI 10.1007/BF00383013; Wu DL, 2008, PROTEIN SCI, V17, P1066, DOI 10.1110/ps.083495908; Xue YF, 2001, INT J SYST EVOL MICR, V51, P1335, DOI 10.1099/00207713-51-4-1335; Xue ZW, 2013, EXTREMOPHILES, V17, P611, DOI 10.1007/s00792-013-0545-5; YEW WW, 1993, CLIN INFECT DIS, V17, P288, DOI 10.1093/clinids/17.2.288; Yokoigawa K, 2003, FEMS MICROBIOL LETT, V221, P263, DOI 10.1016/S0378-1097(03)00216-7; Yoshikawa N, 2002, COMP BIOCHEM PHYS B, V133, P445, DOI 10.1016/S1096-4959(02)00187-2	46	2	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133516	10.1371/journal.pone.0133516	http://dx.doi.org/10.1371/journal.pone.0133516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218070	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900034
J	Wang, JX; Lu, KP; Song, Y; Zhao, S; Ma, WJ; Xuan, QJ; Tang, DB; Zhao, H; Liu, L; Zhang, QY				Wang, Jingxuan; Lu, Kangping; Song, Ying; Zhao, Shu; Ma, Wenjie; Xuan, Qijia; Tang, Dabei; Zhao, Hong; Liu, Lei; Zhang, Qingyuan			RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; LYS3ASN POLYMORPHISM; OSTEOPROTEGERIN OPG; TURNOVER MARKERS; FRACTURE; RANKL/RANK/OPG; ACUPUNCTURE; ANASTROZOLE; EXPRESSION	Background Breast cancer patients treated with aromatase inhibitors (AIs) may experience musculoskeletal adverse events (MS-AEs). Several studies have confirmed that the RANKL/RANK/OPG signaling pathway plays a dominant role in bone health. Therefore, this study aimed to analyze the relationship between the serum levels of RANKL, OPG and their SNPs (single nucleotide polymorphisms) with AI-related MS-AEs. Methodology and Principal Findings Patients with early stage, hormone-sensitive breast cancer who were receiving AI therapy were enrolled. We included 208 cases with AI-related MS-AEs and 212 without (controls). The levels of estradiol, bone-turnover markers, multiple inflammatory cytokines, RANKL, OPG and lumbar spine BMD were measured, and questionnaires were completed. We analyzed 29 SNPs of RANKL, RANK and OPG using Sequenom MassARRAY assays and PCR-based TaqMan assays. The levels of bone-turnover markers and RANKL and the ratio of RANKL/OPG were higher in patients with AI-related MS-AEs than controls (all p < 0.05). A genetic assay showed that the RANKL SNP rs7984870 and OPG SNP rs2073618 were associated with AI-related MS-AEs. In patients with AI-related MS-AEs, rs7984870 CC and rs2073618 CC were risk genotypes. Carriers of the rs7984870 CC genotype were more likely to have a higher RANKL level and RANKL/OPG ratio than carriers of the GG genotype, and carriers of the rs2073618 CC genotype were more likely to have a lower OPG level and a higher RANKL/OPG ratio than carriers of the GG genotype (all p < 0.05). Moreover, risk genotypes were associated with higher levels of serum CTX and PINP and a lower lumbar spine BMD (all p < 0.05). Conclusions and Significance In conclusion, the RANKL and OPG risk genotypes synergize to negatively impact bone health and predispose breast cancer patients to AI-related MS-AEs.	[Wang, Jingxuan; Lu, Kangping; Song, Ying; Zhao, Shu; Ma, Wenjie; Xuan, Qijia; Tang, Dabei; Zhao, Hong; Liu, Lei; Zhang, Qingyuan] Harbin Med Univ, Hosp 3, Dept Med Oncol, Harbin, Peoples R China	Harbin Medical University	Zhang, QY (corresponding author), Harbin Med Univ, Hosp 3, Dept Med Oncol, Harbin, Peoples R China.	zqywsci@163.com			National Natural Science Foundation [81001026, 81472490]; Backbone Teachers Foundation of Heilongjiang Education Department [1252G038]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Backbone Teachers Foundation of Heilongjiang Education Department	This work was supported by grants from the National Natural Science Foundation (81001026 and 81472490) and Backbone Teachers Foundation of Heilongjiang Education Department(1252G038).	Bao T, 2014, CANCER-AM CANCER SOC, V120, P381, DOI 10.1002/cncr.28352; Baud'huin M, 2007, EXPERT REV ANTICANC, V7, P221, DOI 10.1586/14737140.7.2.221; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Bruzzese V, 2011, INT J IMMUNOPATH PH, V24, P1099, DOI 10.1177/039463201102400430; Chen Q, 2004, HORM METAB RES, V36, P674, DOI 10.1055/s-2004-826013; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coleman RE, 2007, LANCET ONCOL, V8, P119, DOI 10.1016/S1470-2045(07)70003-7; Dizdar O, 2009, J CLIN ONCOL, V27, P4955, DOI 10.1200/JCO.2008.20.5435; Dougall WC, 2012, CLIN CANCER RES, V18, P326, DOI 10.1158/1078-0432.CCR-10-2507; Eastell R, 2006, J BONE MINER RES, V21, P1215, DOI 10.1359/JBMR.060508; Ellis GK, 2008, J CLIN ONCOL, V26, P4875, DOI 10.1200/JCO.2008.16.3832; Ellis GK, 2009, BREAST CANCER RES TR, V118, P81, DOI 10.1007/s10549-009-0352-y; Goss PE, 2008, J CLIN ONCOL, V26, P1948, DOI 10.1200/JCO.2007.11.6798; Henry NL, 2010, BRIT J CANCER, V103, P291, DOI 10.1038/sj.bjc.6605768; Ingle JN, 2010, J CLIN ONCOL, V28, P4674, DOI 10.1200/JCO.2010.28.5064; Jonat W, 2006, LANCET ONCOL, V7, P991, DOI 10.1016/S1470-2045(06)70948-2; Jorgensen HL, 2004, J BONE MINER METAB, V22, P132, DOI 10.1007/s00774-003-0461-3; Kim JG, 2007, MENOPAUSE, V14, P913, DOI 10.1097/gme.0b013e31802d976f; Kyvernitakis I, 2014, J CANCER RES CLIN, V140, P159, DOI 10.1007/s00432-013-1557-3; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lappin DF, 2007, J CLIN PERIODONTOL, V34, P271, DOI 10.1111/j.1600-051X.2007.01048.x; Melton LJ, 2012, J BONE MINER RES, V27, P1196, DOI 10.1002/jbmr.1556; Moffett SP, 2008, J CLIN ENDOCR METAB, V93, P2002, DOI 10.1210/jc.2007-1019; Morales L, 2008, J CLIN ONCOL, V26, P3147, DOI 10.1200/JCO.2007.15.4005; Oh B, 2013, ACUPUNCT MED, V31, P264, DOI 10.1136/acupmed-2012-010309; Piedra M, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-168; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Santen RJ, 2011, J CLIN ENDOCR METAB, V96, P308, DOI 10.1210/jc.2010-1679; Takahashi S, 2012, BREAST CANCER RES TR, V133, P685, DOI 10.1007/s10549-012-1973-0; Tan WF, 2010, ARTHRITIS RHEUM-US, V62, P2864, DOI 10.1002/art.27589; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547; Zhao HY, 2005, OSTEOPOROSIS INT, V16, P1519, DOI 10.1007/s00198-005-1865-9; Zupan J, 2010, J STEROID BIOCHEM, V118, P102, DOI 10.1016/j.jsbmb.2009.10.013	36	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133964	10.1371/journal.pone.0133964	http://dx.doi.org/10.1371/journal.pone.0133964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218592	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900061
J	Kaewseekhao, B; Naranbhai, V; Roytrakul, S; Namwat, W; Paemanee, A; Lulitanond, V; Chaiprasert, A; Faksri, K				Kaewseekhao, Benjawan; Naranbhai, Vivek; Roytrakul, Sittiruk; Namwat, Wises; Paemanee, Atchara; Lulitanond, Viraphong; Chaiprasert, Angkana; Faksri, Kiatichai			Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Treatment	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIMYCOBACTERIAL RESPONSES; PROTECTIVE IMMUNITY; RELEASE ASSAYS; IFN-BETA; EXPRESSION; MACROPHAGES; SERUM; GENE; SECRETION	Biomarkers for determining clearance of Mycobacterium tuberculosis (Mtb) infection during anti-tuberculosis therapy or following exposure could facilitate enhanced monitoring and treatment. We screened for biomarkers indicating clearance of Mtb infection in vitro. A comparative proteomic analysis was performed using GeLC MSI/MS. Intracellular and secreted proteomes from activated THP-1 cells infected with the Mtb H37Rv strain (MOI = 1) and treated with isoniazid and rifampicin for 1 day (infection stage) and 5 days (clearance stage) were analyzed. Host proteins associated with early infection (n = 82), clearance (n = 121), sustained in both conditions (n = 34) and suppressed by infection (n = 46) were elucidated. Of the potential clearance markers, SSFA2 and CAECAM18 showed the highest and lowest protein intensities, respectively. A western blot of CAECAM18 validated the LC MS/MS result. For three clearance markers (SSFA2, PARP14 and PSME4), in vivo clinical validation was concordantly reported in previous patient cohorts. A network analysis revealed that clearance markers were enriched amongst four protein interaction networks centered on: (i) CD44/CCND1, (ii) IFN-beta 1/NF-kappa B, (iii) TP53/TGF-beta and (iv) IFN-gamma/CCL2. After infection, proteins associated with proliferation, and recruitment of immune cells appeared to be enriched possibly reflecting recruitment of defense mechanisms. Counteracting proteins (CASP3 vs. Akt and NF-kappa B vs. TP53) associated with apoptosis regulation and its networks were enriched among the early and sustained infection biomarkers, indicating host-pathogen competition. The BRCA1/2 network was suppressed during infection, suggesting that cell proliferation suppression is a feature of Mtb survival. Our study provides insights into the mechanisms of host-Mtb interaction by comparing the stages of infection clearance. The identified clearance biomarkers may be useful in monitoring tuberculosis treatment.	[Kaewseekhao, Benjawan; Namwat, Wises; Lulitanond, Viraphong; Faksri, Kiatichai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Kaewseekhao, Benjawan; Namwat, Wises; Lulitanond, Viraphong; Faksri, Kiatichai] Khon Kaen Univ, Fac Med, Res & Diagnost Ctr Emerging Infect Dis RCEID, Khon Kaen, Thailand; [Naranbhai, Vivek] Univ Oxford, Nuffield Dept Med, Oxford, England; [Naranbhai, Vivek] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Program Res South Africa, Kwa Zulu, South Africa; [Roytrakul, Sittiruk; Paemanee, Atchara] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Chaiprasert, Angkana] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand	Khon Kaen University; Khon Kaen University; University of Oxford; University of Kwazulu Natal; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Faksri, K (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	kiatichai@kku.ac.th		Naranbhai, Vivek/0000-0003-4281-8882; Paemanee, Atchara/0000-0001-9206-3153; Faksri, Kiatichai/0000-0001-5022-4182	MRG research grant from the Thailand Research Fund [MRG5580024]; Wellcome Trust [090532/Z/09/Z]	MRG research grant from the Thailand Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by MRG research grant 2012 (MRG5580024) from the Thailand Research Fund. Part of this work was supported by a Wellcome Trust core facilities grant 090532/Z/09/Z (Wellcome Trust Centre for Human Genetics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Azzurri A, 2006, INT J IMMUNOPATH PH, V19, P199; Barroso EC, 2009, AM J TROP MED HYG, V81, P322, DOI 10.4269/ajtmh.2009.81.322; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; De Groote MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061002; Dupont S, 2004, CANCER LETT, V213, P129, DOI 10.1016/j.canlet.2004.06.008; Ehtesham NZ, 2011, TUBERCULOSIS, V91, P293, DOI 10.1016/j.tube.2011.04.007; Elkington PTG, 2005, J IMMUNOL, V175, P5333, DOI 10.4049/jimmunol.175.8.5333; Elston Rebecca, 2012, J Signal Transduct, V2012, P294097, DOI 10.1155/2012/294097; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fujikawa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085612; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Honeyborne I, 2011, J CLIN MICROBIOL, V49, P3905, DOI 10.1128/JCM.00547-11; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; John SH, 2012, BIOMARKERS, V17, P1, DOI 10.3109/1354750X.2011.628048; Kipnis A, 2003, J LEUKOCYTE BIOL, V74, P992, DOI 10.1189/jlb.0603301; Kunnath-Velayudhan S, 2012, J INFECT DIS, V206, P697, DOI 10.1093/infdis/jis421; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; Liu JY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-506; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Sandhu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038080; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; Sitzmann Brandon D, 2010, Open Longev Sci, V3, P38; Sloan DJ, 2012, J CLIN MICROBIOL, V50, P2315, DOI 10.1128/JCM.00043-12; Song SH, 2014, ANN LAB MED, V34, P345, DOI 10.3343/alm.2014.34.5.345; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Sow FB, 2011, TUBERCULOSIS, V91, P314, DOI 10.1016/j.tube.2011.03.003; Tanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-71; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; Verrall AJ, 2014, IMMUNOLOGY, V141, P506, DOI 10.1111/imm.12223; Vissac C, 2002, CLIN CHIM ACTA, V320, P101, DOI 10.1016/S0009-8981(02)00055-4; Wallis RS, 2000, AM J RESP CRIT CARE, V161, P1076, DOI 10.1164/ajrccm.161.4.9903087; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Yim HCH, 2011, P NATL ACAD SCI USA, V108, P17749, DOI 10.1073/pnas.1104892108; Zhang JX, 2012, CLIN CHIM ACTA, V413, P883, DOI 10.1016/j.cca.2012.01.036; Zhou JJ, 2014, FEBS LETT, V588, P566, DOI 10.1016/j.febslet.2013.11.041	47	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134168	10.1371/journal.pone.0134168	http://dx.doi.org/10.1371/journal.pone.0134168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214306	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300057
J	Reil, D; Imholt, C; Eccard, JA; Jacob, J				Reil, Daniela; Imholt, Christian; Eccard, Jana Anja; Jacob, Jens			Beech Fructification and Bank Vole Population Dynamics - Combined Analyses of Promoters of Human Puumala Virus Infections in Germany	PLOS ONE			English	Article							FAGUS-SYLVATICA L.; HANTAVIRUS INFECTION; NEPHROPATHIA-EPIDEMICA; LYME-DISEASE; RISK-FACTORS; CLETHRIONOMYS-GLAREOLUS; RODENT POPULATIONS; TEMPORAL DYNAMICS; RENAL-FAILURE; OUTBREAKS	The transmission of wildlife zoonoses to humans depends, amongst others, on complex interactions of host population ecology and pathogen dynamics within host populations. In Europe, the Puumala virus (PUUV) causes nephropathia epidemica in humans. In this study we investigated complex interrelations within the epidemic system of PUUV and its rodent host, the bank vole (Myodes glareolus). We suggest that beech fructification and bank vole abundance are both decisive factors affecting human PUUV infections. While rodent host dynamics are expected to be directly linked to human PUUV infections, beech fructification is a rather indirect predictor by serving as food source for PUUV rodent hosts. Furthermore, we examined the dependence of bank vole abundance on beech fructification. We analysed a 12-year (2001-2012) time series of the parameters: beech fructification (as food resource for the PUUV host), bank vole abundance and human incidences from 7 Federal States of Germany. For the first time, we could show the direct interrelation between these three parameters involved in human PUUV epidemics and we were able to demonstrate on a large scale that human PUUV infections are highly correlated with bank vole abundance in the present year, as well as beech fructification in the previous year. By using beech fructification and bank vole abundance as predictors in one model we significantly improved the degree of explanation of human PUUV incidence. Federal State was included as random factor because human PUUV incidence varies considerably among states. Surprisingly, the effect of rodent abundance on human PUUV infections is less strong compared to the indirect effect of beech fructification. Our findings are useful to facilitate the development of predictive models for host population dynamics and the related PUUV infection risk for humans and can be used for plant protection and human health protection purposes.	[Reil, Daniela; Imholt, Christian; Jacob, Jens] Inst Plant Protect Hort & Forests Vertebrate Res, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Munster, Germany; [Reil, Daniela; Eccard, Jana Anja] Univ Potsdam, Inst Biochem & Biol Anim Ecol, Potsdam, Germany	Julius Kuhn-Institut; University of Potsdam	Reil, D (corresponding author), Inst Plant Protect Hort & Forests Vertebrate Res, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Munster, Germany.	daniela.reil@jki.bund.de	Jacob, Jens/AAZ-7850-2020; Jacob, Jens/C-2189-2013	Jacob, Jens/0000-0002-5136-6606; 	Federal Environment Agency (UBA) within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) [3709 41 401]	Federal Environment Agency (UBA) within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB)	This study was commissioned and funded by the Federal Environment Agency (UBA) within the Environment Research Plan of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (BMUB) (grant number 3709 41 401). The funders had no role in study design, data collection and analysis, or decision to publish. An employee of UBA provided comments and authorised the manuscript.	Abu Sin M, 2007, EMERG INFECT DIS, V13, P1364, DOI 10.3201/eid1309.070552; ANDRZEJEWSKI R, 1975, Acta Theriologica, V20, P23; Bennett E, 2010, EPIDEMIOL INFECT, V138, P91, DOI 10.1017/S095026880999029X; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; Clement J, 1987, Adv Exp Med Biol, V212, P251; Clement J, 1996, LANCET, V347, P336, DOI 10.1016/S0140-6736(96)90519-X; Clement J, 2010, NEPHROL DIAL TRANSPL, V25, P1740, DOI 10.1093/ndt/gfq122; Clement J, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-1; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; Crowcroft NS, 1999, BMJ-BRIT MED J, V318, P1737, DOI 10.1136/bmj.318.7200.1737; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; Eccard JA, 2001, CAN J ZOOL, V79, P1743, DOI 10.1139/cjz-79-10-1743; Eichhorn J, 2010, MANUAL METHODS CRITE; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; Faulde M, 2000, NEPHROL DIAL TRANSPL, V15, P751, DOI 10.1093/ndt/15.6.751; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; Hansson Lennart, 2000, Polish Journal of Ecology, V48, P163; Haredasht SA, 2013, ZOONOSES PUBLIC HLTH, V60, P461, DOI 10.1111/zph.12021; Heyman P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00237; Imholt C, 2015, PEST MANAG SCI, V71, P166, DOI 10.1002/ps.3838; Jacob J., 2010, RODENT OUTBREAKS ECO, P207; JENSEN TS, 1982, OECOLOGIA, V54, P184, DOI 10.1007/BF00378391; JENSEN TS, 1985, OIKOS, V44, P149, DOI 10.2307/3544056; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kallio ER, 2007, ECOLOGY, V88, P1911, DOI 10.1890/06-1620.1; Kallio ER, 2006, P ROY SOC B-BIOL SCI, V273, P2771, DOI 10.1098/rspb.2006.3645; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Kang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006149; Khalil H, 2014, VECTOR-BORNE ZOONOT, V14, P537, DOI 10.1089/vbz.2013.1562; Killilea ME, 2008, ECOHEALTH, V5, P167, DOI 10.1007/s10393-008-0171-3; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Makary P, 2010, EPIDEMIOL INFECT, V138, P1484, DOI 10.1017/S0950268810000087; Mertens M, 2011, MED MICROBIOL IMMUN, V200, P263, DOI 10.1007/s00430-011-0203-4; Meyer BJ, 2000, TRENDS MICROBIOL, V8, P61, DOI 10.1016/S0966-842X(99)01658-3; Mills James N., 2006, BIODIVERSITY-OTTAWA, V7, P9; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Olsson GE, 2003, EMERG INFECT DIS, V9, P1395, DOI 10.3201/eid0911.030275; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Overgaard R, 2007, FORESTRY, V80, P553, DOI 10.1093/forestry/cpm020; Piechotowski I, 2008, PARASITOL RES, V103, pS131, DOI 10.1007/s00436-008-1055-8; Piovesan G, 2001, CAN J BOT, V79, P1039, DOI 10.1139/cjb-79-9-1039; PUCEK Z, 1993, ACTA THERIOL, V38, P199, DOI 10.4098/AT.arch.93-18; R Development Core team, 2014, R A LANGUAGE AND ENV; Sauvage F, 2007, EPIDEMIOL INFECT, V135, P46, DOI 10.1017/S0950268806006595; Schauber EM, 2005, ECOL APPL, V15, P575, DOI 10.1890/03-5370; Schlegel M, 2014, ROLE OF ANIMALS IN EMERGING VIRAL DISEASES, P235, DOI 10.1016/B978-0-12-405191-1.00010-7; Schlegel M, 2012, VIRUS GENES, V45, P48, DOI 10.1007/s11262-012-0736-7; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; SCHMALJOHN CS, 1985, SCIENCE, V227, P1041, DOI 10.1126/science.2858126; Schmidt W, 2006, ALLG FORST JAGDZTG, V177, P9; Schmitz F, 2004, DIE ZWEITE BUNDESWAL; Schwarz AC, 2009, EMERG INFECT DIS, V15, P1032, DOI 10.3201/eid1507.081413; Selas V, 2006, OECOLOGIA, V147, P625, DOI 10.1007/s00442-005-0326-7; Sumibcay L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-34; Tersago K, 2009, EPIDEMIOL INFECT, V137, P250, DOI 10.1017/S0950268808000940; Vaheri A, 2013, REV MED VIROL, V23, P35, DOI 10.1002/rmv.1722; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Verhagen Ron, 2000, Polish Journal of Ecology, V48, P113; VIRO P, 1985, ACTA THERIOL, V30, P259, DOI 10.4098/AT.arch.85-17; ZEIER M, 1986, DEUT MED WOCHENSCHR, V111, P207, DOI 10.1055/s-2008-1068427	63	38	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134124	10.1371/journal.pone.0134124	http://dx.doi.org/10.1371/journal.pone.0134124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214509	Green Submitted, gold, Green Published			2022-12-27	WOS:000358594300051
J	Witkowski, W; Vermeire, J; Landi, A; Naessens, E; Vanderstraeten, H; Nauwynck, H; Favoreel, H; Verhasselt, B				Witkowski, Wojciech; Vermeire, Jolien; Landi, Alessia; Naessens, Evelien; Vanderstraeten, Hanne; Nauwynck, Hans; Favoreel, Herman; Verhasselt, Bruno			Vpx-Independent Lentiviral Transduction and shRNA-Mediated Protein Knock-Down in Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							SAMHD1 RESTRICTS; HIV-1 INFECTION; MACROPHAGES; PATHOGENESIS; ACTIVATION	The function of dendritic cells (DCs) in the immune system is based on their ability to sense and present foreign antigens. Powerful tools to research DC function and to apply in cell-based immunotherapy are either silencing or overexpression of genes achieved by lentiviral transduction. To date, efficient lentiviral transduction of DCs or their monocyte derived counterparts (MDDCs) required high multiplicity of infection (MOI) or the exposure to the HIV-2/SIV protein Vpx to degrade viral restriction factor SAM domain and HD domain-containing protein 1 (SAMHD1). Here we present a Vpx-independent method for efficient (>95%) transduction of MDDCs at lower MOI. The protocol can be used both for ectopic gene expression and knock-down. Introducing shRNA targeting viral entry receptor CD4 and restriction factor SAMHD1 into MDDCs resulted in down-regulation of targeted proteins and, consequently, expected impact on HIV infection. This protocol for MDDCs transduction is robust and free of the potential risk arising from the use of Vpx which creates a virus infection-prone environment, potentially dangerous in clinical setting.	[Witkowski, Wojciech; Vermeire, Jolien; Landi, Alessia; Naessens, Evelien; Vanderstraeten, Hanne; Verhasselt, Bruno] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Nauwynck, Hans] Univ Ghent, Virol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Favoreel, Herman] Univ Ghent, Immunol Lab, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Verhasselt, B (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, De Pintelaan 185, B-9000 Ghent, Belgium.	bruno.verhasselt@ugent.be	; Favoreel, Herman/H-8712-2013	Verhasselt, Bruno/0000-0002-4645-1144; Nauwynck, Hans/0000-0001-5470-0713; Favoreel, Herman/0000-0003-4993-6857	Research Foundation-Flanders (FWO); Ghent University (Geconcerteerde Onderzoeksactie) [BOF11/GOA/013]	Research Foundation-Flanders (FWO)(FWO); Ghent University (Geconcerteerde Onderzoeksactie)	The authors are supported by grants to BV from the Research Foundation-Flanders (FWO) and to BV, HN and HF from Ghent University (Geconcerteerde Onderzoeksactie BOF11/GOA/013). WW, JV and AL are PhD Fellows and BV is a Senior Clinical Investigator of the FWO.	Anguille S, 2014, LANCET ONCOL, V15, pE257, DOI 10.1016/S1470-2045(13)70585-0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Breckpot K, 2004, HUM GENE THER, V15, P562, DOI 10.1089/104303404323142015; Breckpot K, 2007, HUM GENE THER, V18, P536, DOI 10.1089/hum.2007.006; Chauveau L, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0131-7; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Dornadula G, 1999, VIROLOGY, V253, P10, DOI 10.1006/viro.1998.9465; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Imbeault M, 2009, VIROLOGY, V393, P160, DOI 10.1016/j.virol.2009.07.009; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Landi A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0118-4; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Metelo J, 2011, CYTOSKELETON, V68, P434, DOI 10.1002/cm.20521; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Piguet V, 2002, J INVEST DERMATOL, V119, P365, DOI 10.1046/j.1523-1747.2002.01840.x; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Rouas R, 2002, CANCER GENE THER, V9, P715, DOI 10.1038/sj.cgt.7700500; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Schnell T, 2000, HUM GENE THER, V11, P439, DOI 10.1089/10430340050015905; Schroers R, 2000, MOL THER, V1, P171, DOI 10.1006/mthe.2000.0027; Smits ELJM, 2009, HUM GENE THER, V20, P1106, DOI 10.1089/hum.2009.145; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859	30	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133651	10.1371/journal.pone.0133651	http://dx.doi.org/10.1371/journal.pone.0133651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208151	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000115
J	Hildur, K; Templado, C; Zock, JP; Giraldo, J; Pozo-Rodriguez, F; Frances, A; Monyarch, G; Rodriguez-Trigo, G; Rodriguez-Rodriguez, E; Souto, A; Gomez, FP; Anto, JM; Barbera, JA; Fuster, C				Hildur, Kristin; Templado, Cristina; Zock, Jan-Paul; Giraldo, Jesus; Pozo-Rodriguez, Francisco; Frances, Alexandra; Monyarch, Gemma; Rodriguez-Trigo, Gema; Rodriguez-Rodriguez, Emma; Souto, Ana; Gomez, Federico P.; Anto, Josep M.; Albert Barbera, Joan; Fuster, Carme			Follow-Up Genotoxic Study: Chromosome Damage Two and Six Years after Exposure to the Prestige Oil Spill	PLOS ONE			English	Article							CANCER-RISK; COMET ASSAY; LONG-TERM; ABERRATIONS; LYMPHOCYTES; WORKERS; BENZENE; DNA; INSTABILITY; METABOLISM	Background The north-west coast of Spain was heavily contaminated by the Prestige oil spill, in 2002. Individuals who participated in the clean-up tasks showed increased chromosome damage two years after exposure. Long-term clinical implications of chromosome damage are still unknown. Objective To realize a follow-up genotoxic study to detect whether the chromosome damage persisted six years after exposure to the oil. Design Follow-up study. Setting Fishermen cooperatives in coastal villages. Participants Local fishermen who were highly exposed (n = 52) and non-exposed (n = 23) to oil seven years after the spill. Measurements Chromosome damage in circulating lymphocytes. Results Chromosome damage in exposed individuals persists six years after oil exposure, with a similar incidence than those previously detected four years before. A surprising increase in chromosome damage in non-exposed individual was found six years after Prestige spill vs. those detected two years after the exposure. Limitations The sample size and the possibility of some kind of selection bias should be considered. Genotoxic results cannot be extrapolated to the approximately 300,000 individuals who participated occasionally in clean-up tasks. Conclusion The persistence of chromosome damage detected in exposed individuals six years after oil exposure seems to indicate that the cells of the bone marrow are affected. A surprising increase in chromosome damage in non-exposed individuals detected in the follow-up study suggests an indirect exposition of these individuals to some oil compounds or to other toxic agents during the last four years. More long-term studies are needed to confirm the presence of chromosome damage in exposed and non-exposed fishermen due to the association between increased chromosomal damage and increased risk of cancer. Understanding and detecting chromosome damage is important for detecting cancer in its early stages. The present work is the first follow-up cytogenetic study carried out in lymphocytes to determine genotoxic damage evolution between two and six years after oil exposure in same individuals.	[Hildur, Kristin; Templado, Cristina; Frances, Alexandra; Fuster, Carme] UAB, Fac Med, Unitat Biol Cellular & Genet Med, Bellaterra, Spain; [Zock, Jan-Paul; Anto, Josep M.] Ctr Recerca Epidemiol Ambiental CREAL, Barcelona, Spain; [Zock, Jan-Paul; Anto, Josep M.] Hosp Mar Med Res Inst, Barcelona, Spain; [Zock, Jan-Paul; Anto, Josep M.] CIBER Epidemiol & Salut Publ CIBERESP, Barcelona, Spain; [Giraldo, Jesus] UAB, Fac Med, Unitat Bioestad, Bellaterra, Spain; [Giraldo, Jesus] UAB, Fac Med, Inst Neurociencies, Bellaterra, Spain; [Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Dept Med Resp, Unidad Epidemiol Clin, E-28041 Madrid, Spain; [Pozo-Rodriguez, Francisco; Rodriguez-Trigo, Gema; Gomez, Federico P.; Albert Barbera, Joan] CIBER Enfermedades Resp CIBERES, Bunyola, Mallorca, Spain; [Rodriguez-Trigo, Gema] Hosp Clin San Carlos, Dept Med Resp, Madrid, Spain; [Rodriguez-Rodriguez, Emma; Souto, Ana] Univ A Coruna, Complexo Hosp, Dept Med Resp, La Coruna, Spain; [Gomez, Federico P.; Albert Barbera, Joan] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Med Resp, Barcelona, Spain; [Anto, Josep M.] UPF, Barcelona, Spain	Autonomous University of Barcelona; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Clinico San Carlos; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pompeu Fabra University	Fuster, C (corresponding author), UAB, Fac Med, Unitat Biol Cellular & Genet Med, Bellaterra, Spain.	carme.fuster@uab.es	Giraldo, Jesus/F-9881-2011; Anto, J M/H-2676-2014; Zock, Jan-Paul/P-5034-2018	Giraldo, Jesus/0000-0001-7082-4695; Anto, J M/0000-0002-4736-8529; Zock, Jan-Paul/0000-0002-2941-6259; Templado, Cristina/0000-0002-4602-9488	Health Institute Carlos III FEDER/ERDF [PI03/1685, PI07/0086]; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Comissionat per a Universitats i Recerca from Generalitat de Catalunya [SGR14-903, FI-00312]; Centro de Investigacion en Red de Enfermedades Respiratorias; Universidad Autonoma de Barcelona [PS-456-01/08]	Health Institute Carlos III FEDER/ERDF; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Comissionat per a Universitats i Recerca from Generalitat de Catalunya; Centro de Investigacion en Red de Enfermedades Respiratorias; Universidad Autonoma de Barcelona	This study was provided by grants from the Health Institute Carlos III FEDER/ERDF (PI03/1685; PI07/0086), Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR), Comissionat per a Universitats i Recerca from Generalitat de Catalunya (SGR14-903; FI-00312), Centro de Investigacion en Red de Enfermedades Respiratorias and Universidad Autonoma de Barcelona (PS-456-01/08).	Aguilera F, 2010, J APPL TOXICOL, V30, P291, DOI 10.1002/jat.1521; Albaiges J, 2006, MAR POLLUT BULL, V53, P205, DOI 10.1016/j.marpolbul.2006.03.012; Anderson D, 1996, ENVIRON HEALTH PERSP, V104, P609, DOI 10.2307/3432831; Anderson D, 2013, METHODS MOL BIOL, V1044, P347, DOI 10.1007/978-1-62703-529-3_18; BARRIOS L, 1991, HUM GENET, V88, P39, DOI 10.1007/BF00204926; Boffetta P, 2007, AM J EPIDEMIOL, V165, P36, DOI 10.1093/aje/kwj367; Bonassi S, 2000, CANCER RES, V60, P1619; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; Bosch X, 2003, SCIENCE, V302, P1485; Chaty S, 2008, ARCH TOXICOL, V82, P75, DOI 10.1007/s00204-007-0243-0; CLARE MG, 1984, BRIT J IND MED, V41, P249; Cole J, 1997, ENVIRON MOL MUTAGEN, V30, P97; de la Chica RA, 2005, JAMA-J AM MED ASSOC, V293, P1212, DOI 10.1001/jama.293.10.1212; Dusinska M, 2008, MUTAGENESIS, V23, P191, DOI 10.1093/mutage/gen007; Fracasso ME, 2010, TOXICOL LETT, V192, P22, DOI 10.1016/j.toxlet.2009.04.028; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Goldstein BD, 2011, NEW ENGL J MED, V364, P1334, DOI 10.1056/NEJMra1007197; Greenbaum IF, 1997, HUM GENET, V101, P109, DOI 10.1007/s004390050596; Hagmar L, 2004, CANCER RES, V64, P2258, DOI 10.1158/0008-5472.CAN-03-3360; Halldorsson HP, 2004, MAR ENVIRON RES, V54, P471; Laffon B, 2006, ENVIRON INT, V32, P342, DOI 10.1016/j.envint.2005.07.002; Laffon B, 2006, FOOD CHEM TOXICOL, V44, P1714, DOI 10.1016/j.fct.2006.05.010; Laffon B, 2014, MUTAT RES-GEN TOX EN, V760, P10, DOI 10.1016/j.mrgentox.2013.09.013; Lemiere S, 2005, MUTAT RES-GEN TOX EN, V581, P11, DOI 10.1016/j.mrgentox.2004.10.015; Lim HH, 2013, FOOD CHEM, V138, P791, DOI 10.1016/j.foodchem.2012.11.059; Liou SH, 1999, CANCER RES, V59, P1481; LITTLEFIELD LG, 1986, MUTAT RES, V170, P145, DOI 10.1016/0165-1218(86)90028-5; Monyarch G., 2010, THESIS U AUTONOMA BA, P106; Monyarch G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081276; Paz-y-Mino C, 2008, ANN NY ACAD SCI, V1140, P121, DOI 10.1196/annals.1454.013; Perez Cadahia B, 2004, COMP BIOCH PHYSL, V138, P453; Perez-Cadahia B, 2008, MUTAT RES-GEN TOX EN, V653, P117, DOI 10.1016/j.mrgentox.2008.04.002; Perez-Cadahia B, 2008, CHEMOSPHERE, V71, P447, DOI 10.1016/j.chemosphere.2007.10.053; Perez-Cadahia B, 2007, ENVIRON INT, V33, P176, DOI 10.1016/j.envint.2006.09.006; Perez-Cadahia B, 2006, THESCIENTIFICWORLDJO, V6, P1221, DOI 10.1100/tsw.2006.206; Perez-Cadahia B, 2008, ENVIRON HEALTH INSIG, V2, P83; Peters S, 2011, AM J EPIDEMIOL, V174, P490, DOI 10.1093/aje/kwr114; Rappaport SM, 2013, CARCINOGENESIS, V34, P2, DOI 10.1093/carcin/bgs382; Rodriguez-Trigo G, 2007, ARCH BRONCONEUMOL, V43, P628; Rodriguez-Trigo G, 2010, ANN INTERN MED, V153, P489, DOI 10.7326/0003-4819-153-8-201010190-00279; Roma-Torres J, 2006, MUTAT RES-GEN TOX EN, V604, P19, DOI 10.1016/j.mrgentox.2005.12.005; Rossner P, 2005, ENVIRON HEALTH PERSP, V113, P517, DOI 10.1289/ehp.6925; Shafer LG, 2013, ISCN 2013 INT SYSTEM; Suspiro A, 2011, TOXICOL LETT, V207, P42, DOI 10.1016/j.toxlet.2011.08.022; Tompa A, 2005, INT J HYG ENVIR HEAL, V208, P509, DOI 10.1016/j.ijheh.2005.01.029; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tunca BT, 1996, ENVIRON HEALTH PERSP, V104, P1313, DOI 10.1289/ehp.961041313; Wang LP, 2012, CHEM RES TOXICOL, V25, P1303, DOI 10.1021/tx3001169; Zhang LP, 2002, CRIT REV TOXICOL, V32, P1, DOI 10.1080/20024091064165; Zock JP, 2007, AM J RESP CRIT CARE, V176, P610, DOI 10.1164/rccm.200701-016OC; Zock JP, 2012, OCCUP ENVIRON MED, V69, P508, DOI 10.1136/oemed-2011-100614	51	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132413	10.1371/journal.pone.0132413	http://dx.doi.org/10.1371/journal.pone.0132413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221948	Green Published, gold			2022-12-27	WOS:000358836800022
J	Mampaey, E; Fieuw, A; Van Laethem, T; Ferdinande, L; Claes, K; Ceelen, W; Van Nieuwenhove, Y; Pattyn, P; De Man, M; De Ruyck, K; Van Roy, N; Geboes, K; Laurent, S				Mampaey, Evi; Fieuw, Annelies; Van Laethem, Thalia; Ferdinande, Liesbeth; Claes, Kathleen; Ceelen, Wim; Van Nieuwenhove, Yves; Pattyn, Piet; De Man, Marc; De Ruyck, Kim; Van Roy, Nadine; Geboes, Karen; Laurent, Stephanie			Focus on 16p13.3 Locus in Colon Cancer	PLOS ONE			English	Article							TUMOR MICROSATELLITE-INSTABILITY; COPY NUMBER ALTERATIONS; COLORECTAL-CANCER; STAGE-II; INTEGRATED ANALYSIS; GENOMIC ALTERATIONS; ADJUVANT TREATMENT; IDENTIFICATION; METAANALYSIS; EXPRESSION	Background With one million new cases of colorectal cancer (CRC) diagnosed annually in the world, CRC is the third most commonly diagnosed cancer in the Western world. Patients with stage I-III CRC can be cured with surgery but are at risk for recurrence. Colorectal cancer is characterized by the presence of chromosomal deletions and gains. Large genomic profiling studies have however not been conducted in this disease. The number of a specific genetic aberration in a tumour sample could correlate with recurrence-free survival or overall survival, possibly leading to its use as biomarker for therapeutic decisions. At this point there are not sufficient markers for prediction of disease recurrence in colorectal cancer, which can be used in the clinic to discriminate between stage II patients who will benefit from adjuvant chemotherapy. For instance, the benefit of adjuvant chemotherapy has been most clearly demonstrated in stage III disease with an approximately 30 percent relative reduction in the risk of disease recurrence. The benefits of adjuvant chemotherapy in stage II disease are less certain, the risk for relapse is much smaller in the overall group and the specific patients at risk are hard to identify. Materials and Methods In this study, array-comparative genomic hybridization analysis (array-CGH) was applied to study high-resolution DNA copy number alterations in 93 colon carcinoma samples. These genomic data were combined with parameters like KRAS mutation status, microsatellite status and clinicopathological characteristics. Results Both large and small chromosomal losses and gains were identified in our sample cohort. Recurrent gains were found for chromosome 1q, 7, 8q, 13 and 20 and losses were mostly found for 1p, 4, 8p, 14, 15, 17p, 18, 21 and 22. Data analysis demonstrated that loss of chromosome 4 is linked to a worse prognosis in our patients series. Besides these alterations, two interesting small regions of overlap were identified, which could be associated with disease recurrence. Gain of the 16p13.3 locus (including the RNA binding protein, fox-1 homolog gene, RBFOX1) was linked with a worse recurrence-free survival in our patient cohort. On the other hand, loss of RBFOX1 was only found in patients without disease recurrence. Most interestingly, above mentioned characteristics were also found in stage II patients, for whom there is a high medical need for the identification of new prognostic biomarkers. Conclusions In conclusion, copy number variation of the 16p13.3 locus seems to be an important parameter for prediction of disease recurrence in colon cancer.	[Mampaey, Evi; De Man, Marc; Geboes, Karen; Laurent, Stephanie] Ghent Univ Hosp, Dept Gastroenterol Digest Oncol, Ghent, Belgium; [Fieuw, Annelies; Van Laethem, Thalia; Claes, Kathleen; Van Roy, Nadine] Univ Ghent, Dept Med Genet, B-9000 Ghent, Belgium; [Ferdinande, Liesbeth] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium; [Ceelen, Wim; Van Nieuwenhove, Yves; Pattyn, Piet] Ghent Univ Hosp, Dept Gastrointestinal Surg, Ghent, Belgium; [De Ruyck, Kim] Univ Ghent, Dept Basic Med Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University	Mampaey, E (corresponding author), Ghent Univ Hosp, Dept Gastroenterol Digest Oncol, Ghent, Belgium.	evi.mampaey@ugent.be	Geboes, Karen P/E-1752-2018; Claes, Kathleen/AFR-6830-2022	Geboes, Karen P/0000-0002-1003-666X; Claes, Kathleen/0000-0003-0841-7372; De Ruyck, Kim/0000-0001-9921-644X	Belgian government: FPS Health, Food Chain Safety and Environment; DG Health Care - Cell Cancer Plan (National Cancer Plan)	Belgian government: FPS Health, Food Chain Safety and Environment; DG Health Care - Cell Cancer Plan (National Cancer Plan)	This research was supported by grants from the Belgian government: FPS Health, Food Chain Safety and Environment, and DG Health Care - Cell Cancer Plan (National Cancer Plan - action 29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Andre T, 2006, ANN SURG ONCOL, V13, P887, DOI 10.1245/ASO.2006.07.003; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Bardi G, 2004, J CLIN ONCOL, V22, P2623, DOI 10.1200/JCO.2004.11.014; Benson AB, 2014, ANN SURG ONCOLOGY; Benson AB, 2013, J NATL COMPR CANC NE, V11, P519, DOI 10.6004/jnccn.2013.0069; Brosens RPM, 2011, CELL ONCOL, V34, P215, DOI 10.1007/s13402-011-0042-8; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Bubb VJ, 1996, ONCOGENE, V12, P2641; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Choucair KA, 2012, TRANSL ONCOL, V5, P453, DOI 10.1593/tlo.12286; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Hawkins NJ, 2009, MODERN PATHOL, V22, P1588, DOI 10.1038/modpathol.2009.130; Huang YT, 2009, J CLIN ONCOL, V27, P2660, DOI 10.1200/JCO.2008.18.7906; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Katoh H, 2005, J HEPATOL, V43, P863, DOI 10.1016/j.jhep.2005.05.033; Kiehl TR, 2001, MAMM GENOME, V12, P595, DOI 10.1007/s00335-001-2056-4; Knutsen T, 2010, GENE CHROMOSOME CANC, V49, P204, DOI 10.1002/gcc.20730; Krijgsman O, 2012, GENE CHROMOSOME CANC, V51, P344, DOI 10.1002/gcc.21920; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Loo LWM, 2013, GENE CHROMOSOME CANC, V52, P450, DOI 10.1002/gcc.22043; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Menten B, 2005, BMC BIOINFORMATICS, V6; Mikhail FM, 2011, AM J MED GENET A, V155A, P2386, DOI 10.1002/ajmg.a.34177; MIYAKI M, 1990, CANCER RES, V50, P7166; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Nash GM, 2010, ANN SURG ONCOL, V17, P416, DOI 10.1245/s10434-009-0713-0; Phillips KA, 2007, MED CARE, V45, P160, DOI 10.1097/01.mlr.0000246612.35245.21; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Sawada T, 2013, GENE CHROMOSOME CANC, V52, P140, DOI 10.1002/gcc.22013; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Sengupta N, 2013, MOL CANCER, V12; Shen H, 2008, CANCER GENET CYTOGEN, V181, P100, DOI 10.1016/j.cancergencyto.2007.11.012; Shi ZZ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-52; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Siegel RL, 2012, CANCER EPIDEM BIOMAR, V21, P411, DOI 10.1158/1055-9965.EPI-11-1020; Stambolian D, 2013, HUM MOL GENET, V22, P2754, DOI 10.1093/hmg/ddt116; Toyota M, 1999, CANCER RES, V59, P2307; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; VANDENBERG FM, 1989, J PATHOL, V157, P193, DOI 10.1002/path.1711570304; Verhulst J, 2012, J CLIN PATHOL, V65, P381, DOI 10.1136/jclinpath-2011-200340; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Wong JJL, 2007, GUT, V56, P140, DOI 10.1136/gut.2005.088799; Xie T, 2012, PLOS ONE, V7; Zhao WW, 2013, MOL CYTOGENET, V6; Zhou DE, 2013, PLOS ONE, V8	53	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131421	10.1371/journal.pone.0131421	http://dx.doi.org/10.1371/journal.pone.0131421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222184	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800014
J	Rukhlenko, OS; Dudchenko, OA; Zlobina, KE; Guria, GT				Rukhlenko, Oleksii S.; Dudchenko, Olga A.; Zlobina, Ksenia E.; Guria, Georgy Th.			Mathematical Modeling of Intravascular Blood Coagulation under Wall Shear Stress	PLOS ONE			English	Article							SPATIAL-ASPECTS; THROMBUS FORMATION; CLOTTING DYNAMICS; PLATELET-ADHESION; ENDOTHELIUM; MECHANISMS; INFLAMMATION; AGGREGATION; FIBRINOGEN; RUPTURE	Increased shear stress such as observed at local stenosis may cause drastic changes in the permeability of the vessel wall to procoagulants and thus initiate intravascular blood coagulation. In this paper we suggest a mathematical model to investigate how shear stress-induced permeability influences the thrombogenic potential of atherosclerotic plaques. Numerical analysis of the model reveals the existence of two hydrodynamic thresholds for activation of blood coagulation in the system and unveils typical scenarios of thrombus formation. The dependence of blood coagulation development on the intensity of blood flow, as well as on geometrical parameters of atherosclerotic plaque is described. Relevant parametric diagrams are drawn. The results suggest a previously unrecognized role of relatively small plaques (resulting in less than 50% of the lumen area reduction) in atherothrombosis and have important implications for the existing stenting guidelines.	[Rukhlenko, Oleksii S.; Zlobina, Ksenia E.; Guria, Georgy Th.] Natl Res Ctr Hematol, Moscow, Russia; [Rukhlenko, Oleksii S.; Dudchenko, Olga A.; Guria, Georgy Th.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Rukhlenko, Oleksii S.] Cherkasy Natl Univ, Cherkassy, Ukraine	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Moscow Institute of Physics & Technology	Guria, GT (corresponding author), Natl Res Ctr Hematol, Moscow, Russia.	guria@blood.ru	Guria, Georgy/L-6873-2013; Rukhlenko, Oleksii S/G-6893-2014; Zlobina, Ksenia/G-6767-2014	Guria, Georgy/0000-0002-5579-9820; Rukhlenko, Oleksii S/0000-0003-1863-4987; Zlobina, Ksenia/0000-0001-6592-0965	Russian Scientific Foundation [14-14-00990]	Russian Scientific Foundation(Russian Science Foundation (RSF))	GTh had won Russian Scientific Foundation (http://rscf.ru/) grant (grant no. 14-14-00990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; ALEVRIADOU BR, 1993, BLOOD, V81, P1263; Anand M, 2005, PATHOPHYSIOL HAEMO T, V34, P109, DOI 10.1159/000089931; Anand M., 2003, J THEOR MED, V5, P183, DOI [10.1080/10273660412331317415, DOI 10.1080/10273660412331317415]; ATAULLAKHANOV FI, 1994, BIOFIZIKA+, V39, P89; ATAULLAKHANOV FI, 1994, BIOFIZIKA+, V39, P97; BACHMANN L, 1975, MAKROMOL CHEM, V176, P2603; Badimon L, 2011, THROMB HAEMOSTASIS, V105, pS34, DOI 10.1160/THS10-11-0717; Bates ER, 2007, J AM COLL CARDIOL, V49, P126, DOI 10.1016/j.jacc.2006.10.021; Chulichkov AL, 2000, MATH MODELING, V12, P76; Davies MJ, 2000, HEART, V83, P361, DOI 10.1136/heart.83.3.361; Davies MT, 1994, CIRCULATION, V90, P2013; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Dirksen MT, 1998, CIRCULATION, V98, P2000, DOI 10.1161/01.CIR.98.19.2000; Doi M., 1988, THEORY POLYM DYNAMIC; Echeverri LF, 2015, B MATH BIOL, V77, P156, DOI 10.1007/s11538-014-0055-3; Eeckhout E, 1999, EUR HEART J, V20, P1014, DOI 10.1053/euhj.1998.1395; Favaloro EJ, 2011, THROMB RES, V127, pS13, DOI 10.1016/S0049-3848(10)70148-1; Friedlander S. K., 2000, SMOKE DUST HAZE FUND; GERTZ SD, 1990, AM J CARDIOL, V66, P1368, DOI 10.1016/0002-9149(90)91170-B; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Guria GT, 2010, J ENG MATH, V66, P293, DOI 10.1007/s10665-009-9340-9; Guria G.T., 2000, MATEMATICHESKOE MODE, V12, P39; Guria GT, 2009, DISCRETE CONT DYN-A, V25, P175, DOI 10.3934/dcds.2009.25.175; Guria K, 2015, THROMB RES, V135, P423, DOI 10.1016/j.thromres.2014.12.014; Guy RD, 2007, MATH MED BIOL, V24, P111, DOI 10.1093/imammb/dql022; Hemker HC, 2012, J THROMB HAEMOST, V10, P1470, DOI 10.1111/j.1538-7836.2012.04802.x; Henderson A, 2007, PARAVIEW GUIDE PARAL; Herrero MA, 2005, PROG NONLIN, V63, P309; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hirsch C, 2007, NUMERICAL COMPUTATION OF INTERNAL AND EXTERNAL FLOWS, VOL 1: FUNDAMENTALS OF COMPUTATIONAL FLUID DYNAMICS, 2ND EDITION, P1; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; Jasak H., 1996, THESIS U LONDON LOND; Lee KW, 2003, BLOOD COAGUL FIBRIN, V14, P605, DOI 10.1097/00001721-200310000-00001; LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3; Lobanov AI, 2005, PATHOPHYSIOL HAEMO T, V34, P121, DOI 10.1159/000089932; Lobanov AI, 1997, PHYSTECH J, V3, P96; LOBANOV AI, 1997, MAT MODELIROVANIE, V9, P83; Makris GC, 2010, BRIT J RADIOL, V83, P729, DOI 10.1259/bjr/49957752; Melkumyants A. M., 2012, Uspekhi Fiziologicheskikh Nauk, V43, P45; Nayfeh A H, 2008, PERTURBATION METHODS; Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275; Nield D.A., 2006, CONVECTION POROUS ME, V24; OpenFOAM, 2009, OP SOURC CFD TOOLB U; Oran E.S., 2001, NUMERICAL SIMULATION; Patankar S.V., 2018, NUMERICAL HEAT TRANS; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; REININGER AJ, 1994, THROMB RES, V74, P629, DOI 10.1016/0049-3848(94)90219-4; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119; [Рухленко Алексей Сергеевич Rukhlenko A.S.], 2012, [Труды Московского физико-технического института, Trudy Moskovskogo fiziko-tekhnicheskogo instituta], V4, P192; [Рухленко Алексей Сергеевич Rukhlenko A.S.], 2012, [Компьютерные исследования и моделирование, Computer Research and Modeling, Komp'yuternye issledovaniya i modelirovanie], V4, P155; Runyon MK, 2008, J AM CHEM SOC, V130, P3458, DOI 10.1021/ja076301r; Sadat U, 2010, EXPERT REV CARDIOVAS, V8, P1469, DOI [10.1586/erc.10.130, 10.1586/ERC.10.130]; Schmelzer JWP, 2005, NUCLEATION THEORY AND APPLICATIONS, P1, DOI 10.1002/3527604790; Schmidt RF, 1989, HUMAN PHYSL; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Shirinskii VP, 2006, CARDIOLOGICHESKY VES, V1, P39; Shirinsky V. P., 2011, Uspekhi Fiziologicheskikh Nauk, V42, P18; Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P456, DOI 10.1038/ncpcardio0298; Slezov VV., 2009, KINETICS 1 ORDER PHA; Strobl G., 2007, PHYS POLYM CONCEPTS; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; Uzlova SG, 2009, THESIS NATL RES CTR; Uzlova SG, 2008, B BAKOULEV SCI CTR C, P55; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Virchow R., 1856, PHLEBOSE THROMBOSE G; Volkenstein M., 1977, MOL BIOPHYSICS; Wagenvoord R, 2006, J THROMB HAEMOST, V4, P1331, DOI 10.1111/j.1538-7836.2006.01967.x; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wu KK, 1996, ANNU REV MED, V47, P315	73	13	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134028	10.1371/journal.pone.0134028	http://dx.doi.org/10.1371/journal.pone.0134028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222505	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800097
J	Heidegger, I; Fritz, J; Klocker, H; Pichler, R; Bektic, J; Horninger, W				Heidegger, Isabel; Fritz, Josef; Klocker, Helmut; Pichler, Renate; Bektic, Jasmin; Horninger, Wolfgang			Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program	PLOS ONE			English	Article							ANTIGEN; MEN; MORTALITY; NG/ML	Objective To reduce the number of unnecessary biopsies in patients with benign prostatic disease, however, without missing significant PCa the present study re-evaluates the age-dependent PSA cut-offs in the Tyrol Prostate Cancer (PCa) early detection program. Patients and Methods The study population included 2225 patients who underwent prostate biopsy due to elevated PSA levels at our department. We divided our patient collective into four age groups: <= 49 years (n = 178), 50-59 years (n = 597), 60-69 years (n = 962) and >= 70 years (n = 488). We simulated different scenarios for PSA cut-off values between 1.25 and 6 ng/mL and fPSA% between 15 and 21% for all four age groups and calculated sensitivity, specificity, confidence intervals and predictive values. Results PCa was detected in 1218 men (54.7%). We found that in combination with free PSA <= 21% the following PSA cut-offs had the best cancer specificity: 1.75 ng/ml for men <= 49 years and 50-59 years, 2.25 ng/ml for men aged 60-69 years and 3.25 ng/ml for men >= 70 years. Using these adjusted PSA cut-off values all significant tumors are recognized in all age groups, yet the number of biopsies is reduced. Overall, one biopsy is avoided in 13 to 14 men (number needed to screen = 13.3, reduction of biopsies = 7.5%) when decision regarding biopsy is done according to the "new" cut-off values instead of the "old" ones. For the different age groups the number needed to screen to avoid one biopsy varied between 9.2 (<= 49 years) and 17.4 (50-59 years). Conclusion With "new", fine-tuned PSA cut-offs we detect all relevant PCa with a significant reduction of biopsies compared to the "old" cut-off values. Optimization of age-specific PSA cut-offs is one step towards a smarter strategy in the Tyrol PCa Early Detection Program.	[Heidegger, Isabel; Pichler, Renate; Bektic, Jasmin; Horninger, Wolfgang] Med Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria; [Fritz, Josef] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Heidegger, Isabel; Klocker, Helmut] Med Univ Innsbruck, Div Expt Urol, Dept Urol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Horninger, W (corresponding author), Med Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria.	wolfgang.horninger@uki.at	Bektic, Jasmin/AAB-3952-2021; Klocker, Helmut/AAI-7130-2020; Fritz, Josef/P-9587-2016	Fritz, Josef/0000-0003-1342-3435				Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Astigueta JC, 2010, ACTAS UROL ESP, V34, P327, DOI 10.1016/S2173-5786(10)70078-0; AUA guidlines prostate cancer, 2014, AUA GUIDLINES PROSTA; Bartsch G, 2008, BJU INT, V101, P809, DOI 10.1111/j.1464-410X.2008.07502.x; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Candas B, 2000, PROSTATE, V45, P19; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; CHRISTENSSON A, 1993, J UROLOGY, V150, P100, DOI 10.1016/S0022-5347(17)35408-3; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; D'Elia C, 2014, MOL CLIN ONCOL, V2, P1145, DOI 10.3892/mco.2014.370; Djavan B, 2010, EUR UROL, V57, P928, DOI 10.1016/j.eururo.2010.03.002; Heidegger I, 2012, ANTICANCER RES, V32, P5481; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Horninger W, 2001, J UROLOGY, V165, P1143, DOI 10.1016/S0022-5347(05)66451-8; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Junker D, 2014, AM J ROENTGENOL, V202, pW263, DOI 10.2214/AJR.13.11061; Loeb S, 2012, BJU INT, V110, P381, DOI 10.1111/j.1464-410X.2011.10943.x; Oberaigner W, 2012, INT J PUBLIC HEALTH, V57, P57, DOI 10.1007/s00038-011-0266-4; Parker PM, 2011, UROLOGY, V78, P110, DOI 10.1016/j.urology.2010.12.046; Phillips Robert, 2014, Nat Rev Urol, V11, P483, DOI 10.1038/nrurol.2014.210; Schroder FH, 2014, LANCET; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Sokoll LJ, 2003, UROLOGY, V61, P274, DOI 10.1016/S0090-4295(02)02398-1; Strope SA, 2010, NAT REV UROL, V7, P487, DOI 10.1038/nrurol.2010.120; Wolters T, 2009, EUR UROL, V55, P385, DOI 10.1016/j.eururo.2008.02.046	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134134	10.1371/journal.pone.0134134	http://dx.doi.org/10.1371/journal.pone.0134134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218594	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900084
J	Koukou, D; Chatzichristou, P; Trimis, G; Siahanidou, T; Skiathitou, AV; Koutouzis, EI; Syrogiannopoulos, GA; Lourida, A; Michos, AG; Syriopoulou, VP				Koukou, Dimitra; Chatzichristou, Panagiota; Trimis, Georgios; Siahanidou, Tania; Skiathitou, Anna-Venetia; Koutouzis, Emmanouil I.; Syrogiannopoulos, George A.; Lourida, Athanasia; Michos, Athanasios G.; Syriopoulou, Vassiliki P.			Rotavirus Gastroenteritis in a Neonatal Unit of a Greek Tertiary Hospital: Clinical Characteristics and Genotypes	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NOSOCOMIAL ROTAVIRUS; TRYPSIN-INHIBITORS; RISK-FACTORS; INFECTION; DIARRHEA; INFANTS; STRAIN; INDIA; SURVEILLANCE	Introduction Rotavirus (RV) infection in neonatal age can be mild or even asymptomatic. Several studies have reported that RV is responsible for 31%-87% of pediatric nosocomial diarrhea and causes gastroenteritis outbreaks in pediatric and neonatal units. Objectives Study clinical characteristics, genotypes and risk factors of RV infection in neonatal age. Methods A prospective study was conducted from April 2009 till April 2013 in the neonatal special care unit of the largest tertiary pediatric hospital of Greece. Fecal samples and epidemiological data were collected from each neonate with gastrointestinal symptoms. RV antigen was detected with a rapid immunochromatography test. RV positive samples were further genotyped with RT PCR and sequencing using specific VP7 and VP4 primers. Results Positive for RV were 126/415 samples (30.4%). Mean age of onset was 18 days. Seventy four cases (58%) were hospital acquired. Seasonality of RV infection did not differ significantly throughout the year with the exception of 4 outbreaks. Genotypes found during the study period were G4P[8] (58.7%), G1P[8] (14.7%), G12P[8] (9.3%), G3P[8] (9.3%), G12P [6] (5.3%), G9P[8] (1.3%) and G2P[4] (1.3%). RV cases presented with: diarrhea (81%), vomiting (26.2%), fever (34.9%), dehydration (28.6%), feeding intolerance (39.7%), weight loss (54%), whilst 19% of cases were asymptomatic. Comparing community with hospital acquired cases differences in clinical manifestations were found. Conclusions Significant incidence of nosocomially transmitted RV infection in neonatal age including asymptomatic illness exists. Genotypes causing nosocomial outbreaks are not different from community strains. Circulating vaccines can be effective in prevention of nosocomial RV infection through herd immunity.	[Koukou, Dimitra; Chatzichristou, Panagiota; Siahanidou, Tania; Skiathitou, Anna-Venetia; Lourida, Athanasia; Michos, Athanasios G.; Syriopoulou, Vassiliki P.] Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece; [Trimis, Georgios] VIANEX Sanofi Pasteur MSD, Vaccine Unit, Athens, Greece; [Koutouzis, Emmanouil I.] Aghia Sophia Childrens Hosp, Dept Microbiol, Athens, Greece; [Syrogiannopoulos, George A.] Univ Thessaly, Gen Univ Hosp Larissa, Dept Pediat, Larisa, Greece	National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Sanofi-Aventis; The Aghia Sophia Children's Hospital; General University Hospital of Larissa; University of Thessaly	Syriopoulou, VP (corresponding author), Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece.	vsyriop@med.uoa.gr	Michos, Athanasios/H-2389-2012; Siahanidou, Tania/AAC-3850-2020	Siahanidou, Tania/0000-0001-8991-0649; Michos, Athanasios/0000-0003-1745-1118	GlaxoSmithKline Biologicals; Sanofi Pasteur MSD through the Centre for Infections, Health Protection Agency, London, United Kingdom; Vaccine Unit of VIANEX Athens-Greece; VIANEX/Sanofi Pasteur MSD	GlaxoSmithKline Biologicals(GlaxoSmithKline); Sanofi Pasteur MSD through the Centre for Infections, Health Protection Agency, London, United Kingdom; Vaccine Unit of VIANEX Athens-Greece; VIANEX/Sanofi Pasteur MSD	The study was supported by grants jointly from GlaxoSmithKline Biologicals and Sanofi Pasteur MSD through the Centre for Infections, Health Protection Agency, London, United Kingdom and from Vaccine Unit of VIANEX Athens-Greece. VIANEX/Sanofi Pasteur MSD provided support in the form of a salary for author GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the 'author contributions' section.	AKINCI A, 1991, TURKISH J PEDIATR, V33, P153; Arvay ML, 2009, J INFECT DIS, V200, pS85, DOI 10.1086/605062; BANATVALA JE, 1978, J AM VET MED ASSOC, V173, P527; Bass ES, 2007, PEDIATR REV, V28, P183, DOI 10.1542/pir.28-5-183; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; Bishop RF, 1997, J PAEDIATR CHILD H, V33, P80, DOI 10.1111/j.1440-1754.1997.tb00998.x; BLAKE PA, 1993, J INFECT DIS, V167, P627, DOI 10.1093/infdis/167.3.627; CAMERON DJS, 1975, LANCET, V2, P124; Chandran A, 2006, J PEDIATR-US, V149, P441, DOI 10.1016/j.jpeds.2006.04.054; CICIRELLO HG, 1994, PEDIATR INFECT DIS J, V13, P720, DOI 10.1097/00006454-199408000-00008; Civardi E, 2013, AM J INFECT CONTROL, V41, P854, DOI 10.1016/j.ajic.2013.01.026; CUNNINGHAM AS, 1987, J PEDIATR-US, V110, P658, DOI 10.1016/S0022-3476(87)80574-7; Das BK, 1994, J CLIN MICROBIOL, V32, P1820; de Rougemont A, 2009, PATHOL BIOL, V57, P86, DOI 10.1016/j.patbio.2008.08.004; DEARLOVE J, 1983, BRIT MED J, V286, P1473, DOI 10.1136/bmj.286.6376.1473; DUFFY LC, 1986, AM J DIS CHILD, V140, P1164, DOI 10.1001/archpedi.1986.02140250090041; DUNN SJ, 1993, J CLIN MICROBIOL, V31, P165, DOI 10.1128/JCM.31.1.165-169.1993; Ford-Jones EL, 2000, ARCH PEDIAT ADOL MED, V154, P586, DOI 10.1001/archpedi.154.6.586; Gentsch JR, 1996, J INFECT DIS, V174, pS30, DOI 10.1093/infdis/174.Supplement_1.S30; Gianino P, 2002, J HOSP INFECT, V50, P13, DOI 10.1053/jhin.2001.1129; GLASS RI, 1986, ACTA PAEDIATR SCAND, V75, P713, DOI 10.1111/j.1651-2227.1986.tb10279.x; Gomara MI, 2004, J CLIN MICROBIOL, V42, P2541, DOI 10.1128/JCM.42.6.2541-2547.2004; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; JAYASHREE S, 1988, J MED VIROL, V26, P333, DOI 10.1002/jmv.1890260313; KAPIKIAN AZ, 1993, JAMA-J AM MED ASSOC, V269, P627, DOI 10.1001/jama.269.5.627; Kilgore PE, 1996, PEDIATR INFECT DIS J, V15, P672, DOI 10.1097/00006454-199608000-00007; Kim CR, 2009, INFECT CONT HOSP EP, V30, P893, DOI 10.1086/599285; Konstantopoulos A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003570; Koukou D, 2011, J MED VIROL, V83, P165, DOI 10.1002/jmv.21945; Lebenthal A, 1999, JPEN-PARENTER ENTER, V23, pS3, DOI 10.1177/014860719902300502; Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637; Linhares AC, 2002, J MED VIROL, V67, P418, DOI 10.1002/jmv.10089; Malek MA, 2006, PEDIATRICS, V117, P1887, DOI 10.1542/peds.2005-2351; Marshall J, 2003, J CLIN VIROL, V28, P331, DOI 10.1016/S1386-6532(03)00081-7; MCLEAN BS, 1981, J CLIN MICROBIOL, V13, P22, DOI 10.1128/JCM.13.1.22-29.1981; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 1998, J INFECT DIS, V177, P13, DOI 10.1086/513808; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Ramachandran M, 1996, J CLIN MICROBIOL, V34, P436, DOI 10.1128/JCM.34.2.436-439.1996; Ramani S, 2008, PEDIATR INFECT DIS J, V27, P719, DOI 10.1097/INF.0b013e3181715170; Ratner AJ, 2001, INFECT CONT HOSP EP, V22, P299, DOI 10.1086/501904; Rogers M, 2000, AM J INFECT CONTROL, V28, P378, DOI 10.1067/mic.2000.109908; ROTBART HA, 1983, J PEDIATR-US, V103, P454, DOI 10.1016/S0022-3476(83)80427-2; SANTOSHAM M, 1982, LANCET, V1, P1070; Sharma R, 2002, PEDIATR INFECT DIS J, V21, P1099, DOI 10.1097/00006454-200212000-00003; Shim JO, 2012, PEDIATR NEONATOL, V53, P18, DOI 10.1016/j.pedneo.2011.11.005; Shim SY, 2010, J MED VIROL, V82, P700, DOI 10.1002/jmv.21698; STEELE AD, 1995, J CLIN MICROBIOL, V33, P1516, DOI 10.1128/JCM.33.6.1516-1519.1995; Syriopoulou V, 2011, ACTA PAEDIATR, V100, P732, DOI 10.1111/j.1651-2227.2010.02127.x; Tai IC, 2012, J MICROBIOL IMMUNOL, V45, P15, DOI 10.1016/j.jmii.2011.09.023; TAM JSL, 1990, J CLIN MICROBIOL, V28, P1033, DOI 10.1128/JCM.28.5.1033-1038.1990; TIMENETSKY MDST, 1994, J CLIN MICROBIOL, V32, P2622, DOI 10.1128/JCM.32.10.2622-2624.1994; TOTTERDELL BM, 1976, ARCH DIS CHILD, V51, P924, DOI 10.1136/adc.51.12.924; Trimis G, 2011, VACCINE, V29, P7292, DOI 10.1016/j.vaccine.2011.07.092; WEINBERG RJ, 1984, PEDIATRICS, V74, P250; Widdowson MA, 2002, INFECT CONT HOSP EP, V23, P665, DOI 10.1086/501991	56	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133891	10.1371/journal.pone.0133891	http://dx.doi.org/10.1371/journal.pone.0133891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214830	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300039
J	Ounap, K; Leetsi, L; Matsoo, M; Kurg, R				Ounap, Kadri; Leetsi, Lilian; Matsoo, Maarja; Kurg, Reet			The Stability of Ribosome Biogenesis Factor WBSCR22 Is Regulated by Interaction with TRMT112 via Ubiquitin-Proteasome Pathway	PLOS ONE			English	Article							TRANSFER-RNA; PROTEIN; YEAST; TRM112; CANCER; METHYLTRANSFERASES; IDENTIFICATION; GENOME; GROWTH; TRANSLATION	The human WBSCR22 protein is a 18S rRNA methyltransferase involved in pre-rRNA processing and ribosome 40S subunit biogenesis. Recent studies have shown that the protein function in ribosome synthesis is independent of its enzymatic activity. In this work, we have studied the WBSCR22 protein interaction partners by SILAC-coupled co-immunoprecipitation assay and identified TRMT112 as the interaction partner of WBSCR22. Knock-down of TRMT112 expression decreased the WBSCR22 protein level in mammalian cells, suggesting that the stability of WBSCR22 is regulated through the interaction with TRMT112. The localization of the TRMT112 protein is determined by WBSCR22, and the WBSCR22-TRMT112 complex is localized in the cell nucleus. We provide evidence that the interaction between WBSCR22/Bud23 and TRMT112/Trm112 is conserved between mammals and yeast, suggesting that the function of TRMT112 as a co-activator of methyltransferases is evolutionarily conserved. Finally, we show that the transiently expressed WBSCR22 protein is ubiquitinated and degraded through the proteasome pathway, revealing the tight control of the WBSCR22 protein level in the cells.	[Ounap, Kadri; Leetsi, Lilian; Matsoo, Maarja; Kurg, Reet] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia	University of Tartu	Kurg, R (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	reet.kurg@ut.ee	Kurg, Reet/J-2829-2015	Kurg, Reet/0000-0001-7188-9693; Ounap, Kadri/0000-0001-7397-3231	Estonian Ministry of Education and Research [IUT20-27]; European Regional Development Fund through the Center of Excellence in Chemical Biology	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund through the Center of Excellence in Chemical Biology(European Commission)	This work was supported by institutional research funding (IUT20-27) of the Estonian Ministry of Education and Research and by the European Regional Development Fund through the Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Figaro S, 2008, FEBS LETT, V582, P2352, DOI 10.1016/j.febslet.2008.05.045; Figaro S, 2012, MOL CELL BIOL, V32, P2254, DOI 10.1128/MCB.06623-11; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gu TT, 2012, ACTA HISTOCHEM CYTOC, V45, P113, DOI 10.1267/ahc.11047; Haag S, 2015, RNA, V21, P180, DOI 10.1261/rna.047910.114; Han YH, 2009, ONCOL REP, V22, P215, DOI 10.3892/or_00000427; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Hu ZB, 2010, PLANT J, V61, P600, DOI 10.1111/j.1365-313X.2009.04085.x; Jangani M, 2014, J BIOL CHEM, V289, P8931, DOI 10.1074/jbc.M113.540906; Letoquarta J, 2014, P NATL ACAD SCI USA, V111, pE5518, DOI 10.1073/pnas.1413089111; Liger D, 2011, NUCLEIC ACIDS RES, V39, P6249, DOI 10.1093/nar/gkr176; Mazauric MH, 2010, J BIOL CHEM, V285, P18505, DOI 10.1074/jbc.M110.113100; Montanaro L, 2012, BBA-REV CANCER, V1825, P101, DOI 10.1016/j.bbcan.2011.10.006; Nakazawa Y, 2011, CANCER RES, V71, P1146, DOI 10.1158/0008-5472.CAN-10-2695; Ohbayashi I, 2011, PLANT J, V67, P49, DOI 10.1111/j.1365-313X.2011.04574.x; Ounap K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075686; Petersen-Mahrt SK, 1999, EMBO J, V18, P1014, DOI 10.1093/emboj/18.4.1014; Purushothaman SK, 2005, MOL CELL BIOL, V25, P4359, DOI 10.1128/MCB.25.11.4359-4370.2005; Ruggero D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012336; Sardana R, 2012, MOL BIOL CELL, V23, P4313, DOI 10.1091/mbc.E12-05-0370; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Stefanska B, 2014, CLIN CANCER RES, V20, P3118, DOI 10.1158/1078-0432.CCR-13-0283; Studte P, 2008, MOL MICROBIOL, V69, P1266, DOI 10.1111/j.1365-2958.2008.06358.x; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Teng T, 2013, CURR OPIN GENET DEV, V23, P63, DOI 10.1016/j.gde.2013.02.001; Tiedemann RE, 2012, CANCER RES, V72, P757, DOI 10.1158/0008-5472.CAN-11-2781; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; Varjak M, 2013, J VIROL, V87, P10295, DOI 10.1128/JVI.01105-13; von Mikecz Anna, 2008, V463, P191, DOI 10.1007/978-1-59745-406-3_14; Vosa L, 2012, J VIROL, V86, P348, DOI 10.1128/JVI.05606-11; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Zorbas C, 2015, MOL BIOL CELL, V26, P2080, DOI 10.1091/mbc.E15-02-0073	34	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133841	10.1371/journal.pone.0133841	http://dx.doi.org/10.1371/journal.pone.0133841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214185	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300035
J	Doggett, K; Turkel, N; Willoughby, LF; Ellul, J; Murray, MJ; Richardson, HE; Brumby, AM				Doggett, Karen; Turkel, Nezaket; Willoughby, Lee F.; Ellul, Jason; Murray, Michael J.; Richardson, Helena E.; Brumby, Anthony M.			BTB-Zinc Finger Oncogenes Are Required for Ras and Notch-Driven Tumorigenesis in Drosophila	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; EYE DEVELOPMENT; IMAGINAL DISCS; TEMPORAL IDENTITY; TUMOR-SUPPRESSOR; JAK/STAT PATHWAY; FEEDBACK LOOP; JNK ACTIVITY; PROTEIN	During tumorigenesis, pathways that promote the epithelial-to-mesenchymal transition (EMT) can both facilitate metastasis and endow tumor cells with cancer stem cell properties. To gain a greater understanding of how these properties are interlinked in cancers we used Drosophila epithelial tumor models, which are driven by orthologues of human oncogenes (activated alleles of Ras and Notch) in cooperation with the loss of the cell polarity regulator, scribbled (scrib). Within these tumors, both invasive, mesenchymal-like cell morphology and continual tumor overgrowth, are dependent upon Jun N-terminal kinase (JNK) activity. To identify JNK-dependent changes within the tumors we used a comparative microarray analysis to define a JNK gene signature common to both Ras and Notch-driven tumors. Amongst the JNK-dependent changes was a significant enrichment for BTB-Zinc Finger (ZF) domain genes, including chronologically inappropriate morphogenesis (chinmo). chinmo was upregulated by JNK within the tumors, and overexpression of chinmo with either Ras(V12) or N-intra was sufficient to promote JNK-independent epithelial tumor formation in the eye/antennal disc, and, in cooperation with Ras(V12), promote tumor formation in the adult midgut epithelium. Chinmo primes cells for oncogene-mediated transformation through blocking differentiation in the eye disc, and promoting an escargot-expressing stem or enteroblast cell state in the adult midgut. BTB-ZF genes are also required for Ras and Notch-driven overgrowth of scrib mutant tissue, since, although loss of chinmo alone did not significantly impede tumor development, when loss of chinmo was combined with loss of a functionally related BTB-ZF gene, abrupt, tumor overgrowth was significantly reduced. abrupt is not a JNK-induced gene, however, Abrupt is present in JNK-positive tumor cells, consistent with a JNK-associated oncogenic role. As some mammalian BTB-ZF proteins are also highly oncogenic, our work suggests that EMT-promoting signals in human cancers could similarly utilize networks of these proteins to promote cancer stem cell states.	[Doggett, Karen; Turkel, Nezaket; Willoughby, Lee F.; Richardson, Helena E.; Brumby, Anthony M.] Peter MacCallum Canc Ctr, Div Res, Cell Cycle & Dev Lab, Melbourne, Vic, Australia; [Ellul, Jason] Peter MacCallum Canc Ctr, Bioinformat Core Facil, Div Res, Melbourne, Vic, Australia; [Murray, Michael J.; Brumby, Anthony M.] Univ Melbourne, Sch Biosci, Melbourne, Vic 3052, Australia; [Richardson, Helena E.] Peter MacCallum Canc Ctr, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Richardson, Helena E.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3052, Australia; [Richardson, Helena E.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3052, Australia; [Richardson, Helena E.] La Trobe Univ, Sch Mol Sci, Bundoora, Vic 3086, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; La Trobe University	Doggett, K (corresponding author), Walter & Eliza Hall Inst Med Res, Dev & Canc Div, Melbourne, Vic 3052, Australia.	karen.doggett@wehi.edu.au	Richardson, Helena E/A-8080-2013	Richardson, Helena E/0000-0003-3852-4953; Ellul, Jason/0000-0002-6046-5139; Turkel, Nezaket/0000-0002-4480-7282	National Health and Medical Research Council Australia [509051, 400211]; Peter MacCallum Internal funds; National Health and Medical Research Council Australia	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Peter MacCallum Internal funds; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council Australia #509051 to AMB and #400211 to HER and AMB, and Peter MacCallum Internal funds to HER. HER is supported by a Senior Research Fellowship from the National Health and Medical Research Council Australia.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Bolstad B., 2004, LOW LEVEL ANALYSIS O; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Brumby AM, 2011, GENETICS; Bunker BD, 2015, ELIFE, V4, DOI 10.7554/eLife.03189; Campbell K, 2011, DEV CELL, V21, P1051, DOI 10.1016/j.devcel.2011.10.005; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Costoya Jose A., 2007, Briefings in Functional Genomics & Proteomics, V6, P8, DOI 10.1093/bfgp/elm002; Davie K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004994; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; Flaherty MS, 2009, DEV DYNAM, V238, P2235, DOI 10.1002/dvdy.21989; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Go MJ, 1998, DEVELOPMENT, V125, P2031; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jal Wu, R WITH CONTRIBUTIONS; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karim FD, 1998, DEVELOPMENT, V125, P1; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Kulshammer E, 2012, J CELL SCI; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; Lee JD, 2001, DEVELOPMENT, V128, P1519; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Manhire-Heath R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3790; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rousset R, 2010, DEVELOPMENT, V137, P2177, DOI 10.1242/dev.050781; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song HJ, 2002, GENETICS, V162, P1703; Spradling AC, 1999, GENETICS, V153, P135; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Sustar A, 2011, DEV BIOL, V356, P576, DOI 10.1016/j.ydbio.2011.06.018; Team RC, 2014, R A LANGUAGE AND ENV; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Turkel N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003627; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; VanZomeren-Dohm A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-41; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Wu KJ, 2011, BIOSCIENCE REP, V31, P449, DOI 10.1042/BSR20100114; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Wu YC, 2012, DEV CELL, V23, P202, DOI 10.1016/j.devcel.2012.05.013; Xie G, 2011, INT J ONCOL; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	87	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132987	10.1371/journal.pone.0132987	http://dx.doi.org/10.1371/journal.pone.0132987			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207831	Green Published, gold			2022-12-27	WOS:000358622000051
J	Siryani, I; Jama, M; Rumman, N; Marzouqa, H; Kannan, M; Lyon, E; Hindiyeh, M				Siryani, Issa; Jama, Mohamed; Rumman, Nisreen; Marzouqa, Hiyam; Kannan, Moein; Lyon, Elaine; Hindiyeh, Musa			Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine	PLOS ONE			English	Article							GENE; IDENTIFICATION; DIAGNOSIS; SPECTRUM	Cystic fibrosis (CF) is an autosomal recessive inherited life-threatening disorder that causes severe damage to the lungs and the digestive system. In Palestine, mutations in the Cystic Fibrosis Transmembrane Conductance Regulator gene (CFTR) that contributes to the clinical presentation of CF are ill defined. A cohort of thirty three clinically diagnosed CF patients from twenty one different Palestinian families residing in the central and southern part of Palestine were incorporated in this study. Sweat chloride testing was performed using the Sweat Chek Conductivity Analyzer (ELITECH Group, France) to confirm the clinical diagnosis of CF. In addition, nucleic acid from the patients' blood samples was extracted and the CFTR mutation profiles were assessed by direct sequencing of the CFTR 27 exons and the intron-exon boundaries. For patient's DNA samples where no homozygous or two heterozygous CFTR mutations were identified by exon sequencing, DNA samples were tested for deletions or duplications using SALSA MLPA probemix P091-D1 CFTR assay. Sweat chloride testing confirmed the clinical diagnosis of CF in those patients. All patients had NaCl conductivity > 60 mmol/l. In addition, nine different CFTR mutations were identified in all 21 different families evaluated. These mutations were c.1393-1G>A, F508del, W1282X, G85E, c.313delA, N1303K, deletion exons 17a-17b-18, deletion exons 17a-17b and Q1100P. c.1393-1G>A was shown to be the most frequent occurring mutation among tested families. We have profiled the underling mutations in the CFTR gene of a cohort of 21 different families affected by CF. Unlike other studies from the Arab countries where F508del was reported to be the most common mutation, in southern/central Palestine, the c.1393-1G>A appeared to be the most common. Further studies are needed per sample size and geographic distribution to account for other possible CFTR genetic alterations and their frequencies. Genotype/phenotype assessments are also recommended and finally carrier frequency should be ascertained.	[Siryani, Issa; Rumman, Nisreen; Marzouqa, Hiyam; Hindiyeh, Musa] Caritas Baby Hosp, Bethlehem, Palestine; [Siryani, Issa; Kannan, Moein; Hindiyeh, Musa] Bethlehem Univ, Bethlehem, Palestine; [Siryani, Issa; Hindiyeh, Musa] Palestinian Forum Med Res, Ramallah, Palestine; [Jama, Mohamed; Lyon, Elaine] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84112 USA; [Lyon, Elaine] Univ Utah, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Lyon, E (corresponding author), ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84112 USA.	lyone@aruplab.com; mousa.hindiyeh@crb-mail.org			Caritas Baby Hospital Medical Research Fund [MRC-04]	Caritas Baby Hospital Medical Research Fund	This study was supported by Caritas Baby Hospital Medical Research Fund (MRC-04).	Chiba-Falek O, 1998, EUR J HUM GENET, V6, P181, DOI 10.1038/sj.ejhg.5200174; Chou LS, 2005, J MOL DIAGN, V7, P111, DOI 10.1016/S1525-1578(10)60016-5; des Georges Marie, 2004, J Cyst Fibros, V3, P265, DOI 10.1016/j.jcf.2004.04.008; Diana A, 2012, GENE, V497, P90, DOI 10.1016/j.gene.2012.01.061; DORK T, 1993, GENOMICS, V15, P688, DOI 10.1006/geno.1993.1127; Farra C, 2010, J CYST FIBROS, V9, P406, DOI 10.1016/j.jcf.2010.08.001; Laufer-Cahana A, 1999, Hum Mutat, V14, P543, DOI 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU16>3.0.CO;2-V; LeGrys VA, 2007, J PEDIATR-US, V151, P85, DOI 10.1016/j.jpeds.2007.03.002; Lerer I, 1999, Hum Mutat, V13, P337, DOI 10.1002/(SICI)1098-1004(1999)13:4<337::AID-HUMU13>3.0.CO;2-C; Lezana Jose Luis, 2003, J Cyst Fibros, V2, P1, DOI 10.1016/S1569-1993(02)00146-7; Mall MA, 2014, EUR RESPIR J, V44, P1042, DOI 10.1183/09031936.00228013; Nikolic A, 2014, J CYST FIBROS, V13, P111, DOI 10.1016/j.jcf.2013.07.001; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Padoa C, 1999, J MED GENET, V36, P41; Paracchini V, 2012, JIMD REP, V4, P17, DOI 10.1007/8904_2011_55; Quint A, 2005, AM J MED GENET A, V136A, P246, DOI 10.1002/ajmg.a.30823; Rohlfs EM, 2011, CLIN CHEM, V57, P841, DOI 10.1373/clinchem.2010.159285; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Schrijver I, 2005, J MOL DIAGN, V7, P375, DOI 10.1016/S1525-1578(10)60567-3; Shah U, 2009, TROP MED INT HEALTH, V14, P542, DOI 10.1111/j.1365-3156.2009.02253.x; Sharma N, 2009, ANN HUM GENET, V73, P26, DOI 10.1111/j.1469-1809.2008.00477.x; Stern RC, 1997, NEW ENGL J MED, V336, P487, DOI 10.1056/NEJM199702133360707; Svensson AM, 2010, GENET TEST MOL BIOMA, V14, P171, DOI 10.1089/gtmb.2009.0099; Wahab A, 2004, J TROP PEDIATRICS, V50, P120, DOI 10.1093/tropej/50.2.120	24	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133890	10.1371/journal.pone.0133890	http://dx.doi.org/10.1371/journal.pone.0133890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208274	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000166
J	Yang, CY; Powell, CA; Duan, YP; Shatters, R; Zhang, MQ				Yang, Chuanyu; Powell, Charles A.; Duan, Yongping; Shatters, Robert; Zhang, Muqing			Antimicrobial Nanoemulsion Formulation with Improved Penetration of Foliar Spray through Citrus Leaf Cuticles to Control Citrus Huanglongbing	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER-ASIATICUS; SAO-PAULO-STATE; GREENING DISEASE; DELIVERY-SYSTEMS; PLANT CUTICLES; SURFACTANTS; PERMEABILITY; SINENSIS; NANOPARTICLES; MOLECULES	Huanglongbing (HLB) is the most serious disease affecting the citrus industry worldwide to date. The causal agent, Candidatus Liberibacter asiaticus (Las), resides in citrus phloem, which makes it difficult to effectively treat with chemical compounds. In this study, a transcuticular nanoemulsion formulation was developed to enhance the permeation of an effective antimicrobial compound (ampicillin; Amp) against HLB disease through the citrus cuticle into the phloem via a foliar spray. The results demonstrated that efficiency of cuticle isolation using an enzymatic method (pectinase and cellulase) was dependent on the citrus cultivar and Las-infection, and it was more difficult to isolate cuticles from valencia orange (Citrus sinensis) and HLB-symptomatic leaves. Of eight adjuvants tested, Brij 35 provided the greatest increase in permeability of the HLB-affected cuticle with a 3.33-fold enhancement of cuticular permeability over water control. An in vitro assay using Bacillus subtilis showed that nanoemulsion formulations containing Amp (droplets size = 5.26 +/- 0.04 nm and 94 +/- 1.48 nm) coupled with Brij 35 resulted in greater inhibitory zone diameters (5.75 mm and 6.66 mm) compared to those of Brij 35 (4.34 mm) and Amp solution (2.83 mm) alone. Furthermore, the nanoemulsion formulations eliminated Las bacteria in HLB-affected citrus in planta more efficiently than controls. Our study shows that a water in oil (W/O) nanoemulsion formulation may provide a useful model for the effective delivery of chemical compounds into citrus phloem via a foliar spray for controlling citrus HLB.	[Yang, Chuanyu; Zhang, Muqing] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Peoples R China; [Yang, Chuanyu; Powell, Charles A.; Zhang, Muqing] Univ Florida, Indian River Res & Educ Ctr, IFAS, Ft Pierce, FL USA; [Duan, Yongping; Shatters, Robert] USDA ARS, Hort Res Lab, Ft Pierce, FL USA; [Zhang, Muqing] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agri B, Nanning 530004, Peoples R China	Fujian Agriculture & Forestry University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Guangxi University	Zhang, MQ (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Peoples R China.	mqzhang@ufl.edu		yang, chuanyu/0000-0003-1194-208X; Shatters, Robert/0000-0002-3903-772X; zhang, muqing/0000-0003-3138-3422	Citrus Research and Development Foundation [584, 617]; Guangxi Natural Science Foundation [2013GXNSFCB1902]; Guangxi international Cooperation Project [1347004-7]; ARS [ARS-0423073] Funding Source: Federal RePORTER	Citrus Research and Development Foundation; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi international Cooperation Project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was provided by Citrus Research and Development Foundation (project#584, #617 and their enhancement), Guangxi Natural Science Foundation (project 2013GXNSFCB1902) and Guangxi international Cooperation Project (project 1347004-7).	Adjonu R, 2014, FOOD HYDROCOLLOID, V41, P169, DOI 10.1016/j.foodhyd.2014.04.007; Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; [Anonymous], 2012, ECONOMIC IMPACTS OF; BAKER EA, 1975, J SCI FOOD AGR, V26, P1093, DOI 10.1002/jsfa.2740260807; Bell TA, 1958, BOT GAZ, P192; Bondada BR, 2006, J HORTIC SCI BIOTECH, V81, P219; Bondada BR, 2001, HORTSCIENCE, V36, P1061, DOI 10.21273/HORTSCI.36.6.1061; Bouchemal K, 2004, INT J PHARM, V280, P241, DOI 10.1016/j.ijpharm.2004.05.016; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; BREUER MM, 1979, J SOC COSMET CHEM, V30, P41; Castella M, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-62; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Fisher R. A., 1946, Statistical methods for research workers.; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hull H M, 1970, Residue Rev, V31, P1; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jo YK, 2009, PLANT DIS, V93, P1037, DOI 10.1094/PDIS-93-10-1037; Jones B, 2009, J QUAL TECHNOL, V41, P340, DOI 10.1080/00224065.2009.11917790; Kim JS, 2009, PHYTOPATHOLOGY, V99, P50, DOI 10.1094/PHYTO-99-1-0050; KOLATTUKUDY PE, 1985, ANNU REV PHYTOPATHOL, V23, P223, DOI 10.1146/annurev.py.23.090185.001255; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li Y, 2012, FOOD HYDROCOLLOID, V27, P517, DOI 10.1016/j.foodhyd.2011.08.017; Lopes SA, 2008, PLANT DIS, V92, P21, DOI 10.1094/PDIS-92-1-0021; Lovelyn C., 2011, J BIOMATERIALS NANOB, V2, P626, DOI [DOI 10.4236/JBNB.2011.225075, 10.4236/jbnb.2011.225075]; Martinelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074256; Mason TG, 2006, J PHYS-CONDENS MAT, V18, pR635, DOI 10.1088/0953-8984/18/41/R01; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohammed AR, 2007, J AGRON CROP SCI, V193, P324, DOI 10.1111/j.1439-037X.2007.00268.x; NARIANI TK, 1973, CURR SCI INDIA, V42, P513; Ocsoy I, 2013, ACS NANO, V7, P8972, DOI 10.1021/nn4034794; Orbovic V, 2007, HORTSCIENCE, V42, P1405, DOI 10.21273/HORTSCI.42.6.1405; Ozturk B, 2014, J FOOD ENG, V142, P57, DOI 10.1016/j.jfoodeng.2014.06.015; Park ES, 2000, INT J PHARM, V209, P109, DOI 10.1016/S0378-5173(00)00559-7; Pathan IB, 2009, TROP J PHARM RES, V8, P173; ROE JH, 1955, J BIOL CHEM, V212, P335; Roy S, 1996, J AM SOC HORTIC SCI, V121, P1179, DOI 10.21273/JASHS.121.6.1179; Saftner RA, 1997, J AM SOC HORTIC SCI, V122, P386, DOI 10.21273/JASHS.122.3.386; SCHONHERR J, 1986, PLANT CELL ENVIRON, V9, P459, DOI 10.1111/j.1365-3040.1986.tb01761.x; SCHONHERR J, 1979, PLANTA, V144, P391, DOI 10.1007/BF00391583; Schreiber L, 1995, J EXP BOT, V46, P1915, DOI 10.1093/jxb/46.12.1915; SKOSS JESSE D., 1955, BOT GAZ, V117, P55, DOI 10.1086/335891; SOLEL Z, 1973, PHYTOPATHOLOGY, V63, P505, DOI 10.1094/Phyto-63-505; STOCK D, 1993, PESTIC SCI, V38, P165, DOI 10.1002/ps.2780380211; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; WALTERS KA, 1988, J PHARM PHARMACOL, V40, P525, DOI 10.1111/j.2042-7158.1988.tb05295.x; Young JA, 2002, J CHEM EDUC, V79, P1202, DOI 10.1021/ed079p1202.2; Zhang MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111032; Zhang MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076331; Zhang MQ, 2012, PHYTOPATHOLOGY, V102, P567, DOI 10.1094/PHYTO-09-11-0265; Zhang MQ, 2011, PHYTOPATHOLOGY, V101, P1097, DOI 10.1094/PHYTO-09-10-0262; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239	52	34	38	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133826	10.1371/journal.pone.0133826	http://dx.doi.org/10.1371/journal.pone.0133826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207823	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000151
J	Zheng, X; Zhang, NJ; Zhang, XS; Hao, LX; Su, QR; Wang, HJ; Meng, KY; Zhang, BL; Liu, JF; Wang, HQ; Luo, HM; Li, L; Li, H; Ma, C				Zheng, Xiang; Zhang, Ningjing; Zhang, Xiaoshu; Hao, Lixin; Su, Qiru; Wang, Haijun; Meng, Kongyan; Zhang, Binglin; Liu, Jianfeng; Wang, Huaqing; Luo, Huiming; Li, Li; Li, Hui; Ma, Chao			Investigation of a Measles Outbreak in China to Identify Gaps in Vaccination Coverage, Routes of Transmission, and Interventions	PLOS ONE			English	Article							IMMUNIZATION; ELIMINATION; MIGRATION; CAMPAIGN; EPIDEMIC; CHILDREN; INDIA	Background A measles outbreak occurred in a western county of China in 2013, the year after China's historic nadir of measles. We conducted a field investigation to identify gaps in measles vaccination coverage and immunization program weaknesses, and to provide recommendations for measles outbreak response and immunization program improvement. Methods We analyzed surveillance data from 2008 to 2013 to describe the measles epidemiology of the county. Measles-containing vaccine coverage was estimated using two methods: previously-reported administrative coverage and an estimation of coverage by clinic-kept vaccination records (n = 542). We conducted a rapid field coverage assessment in a migrant population village to evaluate coverage after emergency vaccination. We conducted a review of hospital records of measles cases to address the role hospital transmission played during the early stage of this outbreak. Results There were 153 cases in the outbreak, primarily among children too young to vaccinate, unvaccinated children less than 3 years old, and adults. Measles-containing vaccine coverage by the field assessment showed that 20% of children aged 8-17 months had zero doses, and 9% of >= 2 years old children had fewer than two doses. The vaccination statuses of all adult cases were either zero doses or unknown. At least 61% of cases had been hospitalized. The proportion of cases who had been hospital-exposed 7 to 21 days prior to rash onset decreased from 52% to 22% after hospitals strengthen their isolation measures. Conclusions This outbreak was a result of measles vaccination coverage gaps among young children and adults, and insufficient hospital isolation of cases. The lower coverage seen in the field estimation compared with reported coverage showed that reported coverage could have been overestimated. Hospitals were sites of transmission in the early stage of the outbreak. A strict hospital isolation policy could decrease spread of measles. Emergency vaccination was associated with stopping measles transmission in low coverage areas.	[Zheng, Xiang; Hao, Lixin; Su, Qiru; Wang, Huaqing; Luo, Huiming; Li, Li; Ma, Chao] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Zheng, Xiang] Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [Zheng, Xiang] Taizhou Prefecture Ctr Dis Control & Prevent, Taizhou Prefecture, Zhejiang, Peoples R China; [Zhang, Ningjing; Zhang, Xiaoshu; Zhang, Binglin; Liu, Jianfeng; Li, Hui] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Wang, Haijun] Longnan Prefecture Ctr Dis Control & Prevent, Longnan Prefecture, Gansu, Peoples R China; [Meng, Kongyan] Wudu Cty Ctr Dis Control & Prevent, Longnan Prefecture, Gansu, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Li, H (corresponding author), Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China.	lihui9208@163.com; maachao@163.com						Biellik RJ, 1997, B WORLD HEALTH ORGAN, V75, P367; Canavati S, 2011, B WORLD HEALTH ORGAN, V89, P528, DOI 10.2471/BLT.10.084244; Choi WS, 2011, J INFECT DIS, V204, pS483, DOI 10.1093/infdis/jir087; Dabral M, 2009, INDIAN PEDIATR, V46, P957; Gao J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-139; He J, 2013, CHINA TROPICAL MED, V13, P1217, DOI 10.13604/j.cnki.46-1064/r.2013.10.007; Hu XJ, 2012, VACCINE, V30, P5721, DOI 10.1016/j.vaccine.2012.07.007; Kelly HA, 2002, MED J AUSTRALIA, V176, P50, DOI 10.5694/j.1326-5377.2002.tb04278.x; Kiros GE, 2004, SOC SCI MED, V59, P2603, DOI 10.1016/j.socscimed.2004.04.009; Kusuma YS, 2010, TROP MED INT HEALTH, V15, P1326, DOI 10.1111/j.1365-3156.2010.02628.x; Ma C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0752-z; Marshall TM, 2003, J INFECT DIS, V187, pS97, DOI 10.1086/368041; National Health and Family Planning Commission of the People's Republic of China, 2009, CHIN NAT MEASL SURV; RIVERA ME, 1991, J PEDIATR-US, V119, P183, DOI 10.1016/S0022-3476(05)80725-5; Shi XJ, 2013, J MODERN PREV MED, V40, P3200; Sun MP, 2010, VACCINE, V28, P1264, DOI 10.1016/j.vaccine.2009.11.015; Weston KM, 2006, COMMUN DIS INTELL, V30, P358; Xiong CL, 2006, CHIN J VACC IMMUN, V12, P350; Xuechun, 2007, CHIN J VACCINE IMMUN, V13, P165, DOI 10.3969/j.1006-916X.2007.02.017; ZHU X, 2008, CHIN J VACC IMMUN, V14, P398	20	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133983	10.1371/journal.pone.0133983	http://dx.doi.org/10.1371/journal.pone.0133983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208216	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000185
J	Bateson, M; Emmerson, M; Ergun, G; Monaghan, P; Nettle, D				Bateson, Melissa; Emmerson, Michael; Erguen, Goekce; Monaghan, Pat; Nettle, Daniel			Opposite Effects of Early-Life Competition and Developmental Telomere Attrition on Cognitive Biases in Juvenile European Starlings	PLOS ONE			English	Article							CHILDHOOD ADVERSITIES; ANIMAL EMOTION; LENGTH; DYNAMICS; MORTALITY; MANIPULATION; PERFORMANCE; HUSBANDRY; PESSIMISM; BEHAVIOR	Moods are enduring affective states that we hypothesise should be affected by an individual's developmental experience and its current somatic state. We tested whether early-life adversity, induced by manipulating brood size, subsequently altered juvenile European starlings' (Sturnus vulgaris) decisions in a judgment bias task designed to provide a cognitive measure of mood. We predicted that starlings from larger broods, specifically those that had experienced more nest competitors larger than themselves would exhibit reduced expectation of reward, indicative of a 'pessimistic', depression-like mood. We used a go/no-go task, in which 30 starlings were trained to probe a grey card disc associated with a palatable mealworm hidden underneath and avoid a different shade of grey card disc associated with a noxious quinine-injected mealworm hidden underneath. Birds' response latencies to the trained stimuli and also to novel, ambiguous stimuli intermediate between these were subsequently tested. Birds that had experienced greater competition in the nest were faster to probe trained stimuli, and it was therefore necessary to control statistically for this difference in subsequent analyses of the birds' responses to the ambiguous stimuli. As predicted, birds with more, larger nest competitors showed relatively longer latencies to probe ambiguous stimuli, suggesting reduced expectation of reward and a 'pessimistic', depression-likemood. However, birds with greater developmental telomere attrition-a measure of cellular aging associated with increased morbidity and reduced life-expectancy that we argue could be used as a measure of somatic state -showed shorter latencies to probe ambiguous stimuli. This would usually be interpreted as evidence for a more positive or 'optimistic' affective state. Thus, increased competition in the nest and poor current somatic state appear to have opposite effects on cognitive biases. Our results lead us to question whether increased expectation of reward when presented with ambiguous stimuli always indicates a more positive affective state. We discuss the possibility that birds in poor current somatic state may adopt a 'hungry' cognitive phenotype that could drive behaviour commonly interpreted as 'optimism' in food-rewarded cognitive bias tasks.	[Bateson, Melissa; Emmerson, Michael; Erguen, Goekce; Nettle, Daniel] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bateson, Melissa; Emmerson, Michael; Erguen, Goekce; Nettle, Daniel] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Monaghan, Pat] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; University of Glasgow	Bateson, M (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	melissa.bateson@ncl.ac.uk	Bateson, Melissa/AAE-7075-2022; Bateson, Melissa/B-1874-2008; Monaghan, Pat/E-6810-2015	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191; Nettle, Daniel/0000-0001-9089-2599	Newcastle University; BBSRC [NC/K000802/1, BB/J016446/1, BB/J015091/1]; ERC [ERC AdG 268926]; Biotechnology and Biological Sciences Research Council [BB/J015091/1, BB/J016446/1] Funding Source: researchfish	Newcastle University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Newcastle University (Bateson/Nettle), the BBSRC under grant numbers NC/K000802/1 (Bateson), BB/J016446/1 (Bateson/Nettle) and BB/J015091/1 (Monaghan), and the ERC under grant number ERC AdG 268926 (Monaghan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2008, LAB ANIM-UK, V42, P111, DOI 10.1258/la.2007.007006; Baciadonna L, 2015, ANIM WELFARE, V24, P81, DOI 10.7120/09627286.24.1.081; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; Barnett CA, 2012, BEHAV ECOL, V23, P418, DOI 10.1093/beheco/arr206; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bateson M, 2007, ANIM WELFARE, V16, P33; Bateson M, 2015, PEERJ, V3, DOI 10.7717/peerj.998; Bateson M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2140; Bateson M, 2011, CAN J PSYCHIAT, V56, P707, DOI 10.1177/070674371105601202; Bateson M, 2010, ILAR J, V51, P394, DOI 10.1093/ilar.51.4.394; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Bloxham L, 2014, ANIM BEHAV, V91, P33, DOI 10.1016/j.anbehav.2014.02.025; Bonaparte KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023775; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; Brust V, 2014, BEHAV PROCESS, V103, P320, DOI 10.1016/j.beproc.2014.01.019; Brydges NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048143; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chaby LE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00328; Feenders G, 2013, ANIM BEHAV, V86, P127, DOI 10.1016/j.anbehav.2013.05.002; Field A, 2013, DISCOVERING STAT USI; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; Green DM, 1966, SIGNAL DETECTION THE; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Hales CA, 2014, BRIT J PHARMACOL, V171, P4524, DOI 10.1111/bph.12603; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Houston AI, 1999, MODELS ADAPTIVE BEHA; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Lovallo WR, 2013, INT J PSYCHOPHYSIOL, V90, P8, DOI 10.1016/j.ijpsycho.2012.10.006; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; McLaughlin KA, 2012, ARCH GEN PSYCHIAT, V69, P1151, DOI 10.1001/archgenpsychiatry.2011.2277; MCNAMARA JM, 1992, B MATH BIOL, V54, P355; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Needham BL, 2015, MOL PSYCHIATR, V20, P520, DOI 10.1038/mp.2014.89; Nesse RM, 2009, AM PSYCHOL, V64, P129, DOI 10.1037/a0013503; Nesse RM, 2005, EVOL HUM BEHAV, V26, P88, DOI 10.1016/j.evolhumbehav.2004.08.002; Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1610; Nettle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083617; Nettle D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1343; Nettle D, 2012, CURR BIOL, V22, pR712, DOI 10.1016/j.cub.2012.06.020; Nettle D, 2009, J THEOR BIOL, V257, P100, DOI 10.1016/j.jtbi.2008.10.033; Nussey DH, 2014, METHODS ECOL EVOL, V5, P299, DOI 10.1111/2041-210X.12161; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Revelle W., 2015, PSYCH PROCEDURES PER; Starling MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107794; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Verhulst S, 2013, EUR J EPIDEMIOL, V28, P859, DOI 10.1007/s10654-013-9845-4; WRIGHT J, 1990, ANIM BEHAV, V40, P462, DOI 10.1016/S0003-3472(05)80526-3; Wright J, 1990, BEHAV ECOL, V1, P116, DOI 10.1093/beheco/1.2.116	58	24	24	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132602	10.1371/journal.pone.0132602	http://dx.doi.org/10.1371/journal.pone.0132602			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222390	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358836800026
J	Chit, A; Roiz, J; Aballea, S				Chit, Ayman; Roiz, Julie; Aballea, Samuel			An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model	PLOS ONE			English	Article							SEASONAL INFLUENZA; UNITED-STATES; EFFICACY; ADULTS; IMMUNIZATION; METAANALYSIS; VACCINATION; CHILDREN; NETWORK	Ontario, Canada, immunizes against influenza using a trivalent inactivated influenza vaccine (IIV3) under a Universal Influenza Immunization Program (UIIP). The UIIP offers IIV3 free-of-charge to all Ontarians over 6 months of age. A newly approved quadrivalent inactivated influenza vaccine (IIV4) offers wider protection against influenza B disease. We explored the expected cost-utility and budget impact of replacing IIV3 with IIV4, within the context of Ontario's UIIP, using a probabilistic and static cost-utility model. Wherever possible, epidemiological and cost data were obtained from Ontario sources. Canadian or U.S. sources were used when Ontario data were not available. Vaccine efficacy for IIV3 was obtained from the literature. IIV4 efficacy was derived from meta-analysis of strain-specific vaccine efficacy. Conservatively, herd protection was not considered. In the base case, we used IIV3 and IIV4 prices of $5.5/dose and $7/dose, respectively. We conducted a sensitivity analysis on the price of IIV4, as well as standard univariate and multivariate statistical uncertainty analyses. Over a typical influenza season, relative to IIV3, IIV4 is expected to avert an additional 2,516 influenza cases, 1,683 influenza-associated medical visits, 27 influenza-associated hospitalizations, and 5 influenza-associated deaths. From a societal perspective, IIV4 would generate 76 more Quality Adjusted Life Years (QALYs) and a net societal budget impact of $4,784,112. The incremental cost effectiveness ratio for this comparison was $63,773/QALY. IIV4 remains cost-effective up to a 53% price premium over IIV3. A probabilistic sensitivity analysis showed that IIV4 was cost-effective with a probability of 65% for a threshold of $100,000/QALY gained. IIV4 is expected to achieve reductions in influenza-related morbidity and mortality compared to IIV3. Despite not accounting for herd protection, IIV4 is still expected to be a cost-effective alternative to IIV3 up to a price premium of 53%. Our conclusions were robust in the face of sensitivity analyses.	[Chit, Ayman] Sanofi Pasteur, Hlth Outcomes & Econ North Amer, Toronto, ON, Canada; [Chit, Ayman] Univ Toronto, Fac Pharm, Toronto, ON, Canada; [Roiz, Julie] Creat Ceut Ltd, London, England; [Aballea, Samuel] Creat Ceut SARL, Paris, France	Sanofi-Aventis; University of Toronto	Chit, A (corresponding author), Sanofi Pasteur, Hlth Outcomes & Econ North Amer, Toronto, ON, Canada.	Ayman.chit@sanofipasteur.com			Sanofi Pasteur	Sanofi Pasteur	The study was funded by Sanofi Pasteur. The study was funded by Sanofi Pasteur through the provision of author salaries and research material. The authors of the study had full control of study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; [Anonymous], 2015, CAN CONS PRIC IND; [Anonymous], 2003, JOINT CANADA US SURV; [Anonymous], 2015, CAN HOURL LAB COSTS; Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Canadian Agency for Drugs and Technology in Health, 2015, PAN CAN ONC DRUG REV; Clements KM, 2014, HUM VACC IMMUNOTHER, V10, P1171, DOI 10.4161/hv.28221; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Frey S, 2010, CLIN INFECT DIS, V51, P997, DOI 10.1086/656578; GlaxoSmithKline, 2014, FLULAVAL TETR PROD M; Greenberg DP, 2013, VACCINE, V31, P770, DOI 10.1016/j.vaccine.2012.11.074; Heinonen S, 2011, LANCET INFECT DIS, V11, P23, DOI 10.1016/S1473-3099(10)70255-3; Janjua NZ, 2012, J INFECT DIS, V205, P1858, DOI 10.1093/infdis/jis283; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Langley JM, 2014, EXPERT REV VACCINES, V13, P1291, DOI 10.1586/14760584.2014.939637; Lee BY, 2012, VACCINE, V30, P7443, DOI 10.1016/j.vaccine.2012.10.025; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Organisation for Economic Co-operation and Development. StatExtracts, 2013, STATEXTRACTS UNIT LA; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Pogany L, 2006, QUAL LIFE RES, V15, P143, DOI 10.1007/s11136-005-0198-7; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; Sanofi Pasteur, 2014, FLUZ QUADR PROD MON; Schanzer DL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-90; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Statistics Canada, 2013, POP LIF EXP EST; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Van Bellinghen LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098437; You JHS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0618-9; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	39	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133606	10.1371/journal.pone.0133606	http://dx.doi.org/10.1371/journal.pone.0133606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222538	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800057
J	Schafer, MJ; Dolgalev, I; Alldred, MJ; Heguy, A; Ginsberg, SD				Schafer, Marissa J.; Dolgalev, Igor; Alldred, Melissa J.; Heguy, Adriana; Ginsberg, Stephen D.			Calorie Restriction Suppresses Age-Dependent Hippocampal Transcriptional Signatures	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GENE-EXPRESSION; NEUROTROPHIN EXPRESSION; MOUSE MODEL; MICE; PROFILE; MEMORY; LTP; NEURODEGENERATION; PLASTICITY	Calorie restriction (CR) enhances longevity and mitigates aging phenotypes in numerous species. Physiological responses to CR are cell-type specific and variable throughout the lifespan. However, the mosaic of molecular changes responsible for CR benefits remains unclear, particularly in brain regions susceptible to deterioration during aging. We examined the influence of long-term CR on the CA1 hippocampal region, a key learning and memory brain area that is vulnerable to age-related pathologies, such as Alzheimer's disease (AD). Through mRNA sequencing and NanoString nCounter analysis, we demonstrate that one year of CR feeding suppresses age-dependent signatures of 882 genes functionally associated with synaptic transmission-related pathways, including calcium signaling, long-term potentiation (LTP), and Creb signaling in wild-type mice. By comparing the influence of CR on hippocampal CA1 region transcriptional profiles at younger-adult (5 months, 2.5 months of feeding) and older-adult (15 months, 12.5 months of feeding) timepoints, we identify conserved upregulation of proteome quality control and calcium buffering genes, including heat shock 70 kDa protein 1b (Hspa1b) and heat shock 70 kDa protein 5 (Hspa5), protein disulfide isomerase family A member 4 (Pdia4) and protein disulfide isomerase family A member 6 (Pdia6), and calreticulin (Calr). Expression levels of putative neuroprotective factors, klotho (Kl) and transthyretin (Ttr), are also elevated by CR in adulthood, although the global CR-specific expression profiles at younger and older timepoints are highly divergent. At a previously unachieved resolution, our results demonstrate conserved activation of neuroprotective gene signatures and broad CR-suppression of age-dependent hippocampal CA1 region expression changes, indicating that CR functionally maintains a more youthful transcriptional state within the hippocampal CA1 sector.	[Schafer, Marissa J.; Ginsberg, Stephen D.] NYU, Cell & Mol Biol Program, Langone Med Ctr, New York, NY 11201 USA; [Schafer, Marissa J.; Alldred, Melissa J.; Ginsberg, Stephen D.] Nathan S Kline Inst Psychiat Res, Ctr Dementa Res, Orangeburg, NY USA; [Dolgalev, Igor; Heguy, Adriana] NYU, Genome Technol Ctr, Langone Med Ctr, New York, NY USA; [Alldred, Melissa J.; Ginsberg, Stephen D.] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Heguy, Adriana] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Ginsberg, Stephen D.] NYU, Dept Neurosci & Physiol, Langone Med Ctr, New York, NY USA	New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Ginsberg, SD (corresponding author), NYU, Cell & Mol Biol Program, Langone Med Ctr, New York, NY 11201 USA.	ginsberg@nki.rfmh.org	, SDG/AAB-3329-2022; Dolgalev, Igor/AAY-6406-2020; Heguy, Adriana/GPP-3907-2022	Dolgalev, Igor/0000-0003-4451-126X; Ginsberg, Stephen/0000-0002-1797-4288	National Institutes of Health [AG043375, AG014449, AG017617, GM007238, RR029893, TR000038]; Alzheimer's Association [IIRG-12-237253]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617, P01AG014449, R01AG043375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health grants AG043375, AG014449, AG017617, GM007238, RR029893, TR000038, and the Alzheimer's Association (IIRG-12-237253).	Abraham CR, 2012, FUTURE MED CHEM, V4, P1671, DOI [10.4155/fmc.12.134, 10.4155/FMC.12.134]; Alldred MJ, 2015, BRAIN STRUC IN PRESS, DOI [10.1007/s00429-014-0839-0, DOI 10.1007/S00429-014-0839-C]; Bi H, 2002, J NEUROL SCI, V200, P11, DOI 10.1016/S0022-510X(02)00087-4; Blalock EM, 2003, J NEUROSCI, V23, P3807; Bough KJ, 2003, EPILEPSIA, V44, P752, DOI 10.1046/j.1528-1157.2003.55502.x; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Dong HX, 2012, J ALZHEIMERS DIS, V28, P579, DOI 10.3233/JAD-2011-111328; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Eckles-Smith K, 2000, MOL BRAIN RES, V78, P154, DOI 10.1016/S0169-328X(00)00088-7; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO;2-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hemond P, 2005, NEUROSCIENCE, V135, P413, DOI 10.1016/j.neuroscience.2005.05.044; HORI N, 1992, NEUROREPORT, V3, P1085, DOI 10.1097/00001756-199212000-00013; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MOROIFETTERS SE, 1989, NEUROBIOL AGING, V10, P317, DOI 10.1016/0197-4580(89)90042-0; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Oh MM, 2013, J NEUROSCI, V33, P7905, DOI 10.1523/JNEUROSCI.5457-12.2013; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Pawlowski TL, 2009, BRAIN RES, V1256, P101, DOI 10.1016/j.brainres.2008.12.039; PELLEGRINIGIAMPIETRO DE, 1994, NEUROSCIENCE, V61, P41, DOI 10.1016/0306-4522(94)90058-2; Prins D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004069; Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Schafer MJ, 2015, NEUROBIOL AGING, V36, P1293, DOI 10.1016/j.neurobiolaging.2014.10.043; Schroeder JE, 2010, BBA-MOL BASIS DIS, V1802, P840, DOI 10.1016/j.bbadis.2010.04.007; Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032; Stanika RI, 2010, NEUROBIOL DIS, V37, P403, DOI 10.1016/j.nbd.2009.10.020; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Verbitsky M, 2004, LEARN MEMORY, V11, P253, DOI 10.1101/lm.68204; Wang J., 2005, FASEB J, V18, P1; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Yamamoto Y, 2009, PHYSIOL GENOMICS, V39, P227, DOI 10.1152/physiolgenomics.00082.2009; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Ye X, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.004; Zeier Z, 2011, MECH AGEING DEV, V132, P8, DOI 10.1016/j.mad.2010.10.006	50	43	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133923	10.1371/journal.pone.0133923	http://dx.doi.org/10.1371/journal.pone.0133923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221964	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800082
J	Yang, L; Xu, L; Schoepf, UJ; Wichmann, JL; Fox, MA; Yan, J; Fan, ZM; Zhang, ZQ				Yang, Lin; Xu, Lei; Schoepf, U. Joseph; Wichmann, Julian L.; Fox, Mary A.; Yan, Jing; Fan, Zhanming; Zhang, Zhaoqi			Prospectively ECG-Triggered Sequential Dual-Source Coronary CT Angiography in Patients with Atrial Fibrillation: Influence of Heart Rate on Image Quality and Evaluation of Diagnostic Accuracy	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; ARTERY-DISEASE; RADIATION-EXPOSURE; GATED 16-MDCT; MOTION	Objectives To evaluate the effects of mean heart rate (HR) and heart rate variation (HRV) on image quality and diagnostic accuracy of prospectively ECG-triggered sequential dual-source coronary CT angiography (CCTA) in patients with atrial fibrillation (AF). Methods Eighty-five patients (49 women, 36 men; mean age 62.1 +/- 9.5 years) with persistent AF underwent prospectively ECG-triggered sequential second-generation dual-source CCTA. Tube current and voltage were adjusted according to body mass index (BMI) and iterative reconstruction was used. Image quality of coronary segments (four-point scale) and presence of significant stenosis (>50%) were evaluated. Diagnostic accuracy was analyzed in 30 of the 85 patients who underwent additional invasive coronary angiography (ICA). Results Only 8 of 1102 (0.7%) segments demonstrated poor image quality. No significant impact on image quality was found for mean HR (94.9 +/- 21.8 bpm; r = 0.034, p = 0.758; F = 0.413, p = 0.663) or HRV (67.5 +/- 22.8 bpm; r = 0.097, p = 0.377; F = 0.111, p = 0.895). On per-segment analysis, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 89.7% (26/29), 99.4% (355/357), 92.9% (26/28), and 99.2% (355/358), respectively, with excellent correlation (kappa = 0.91) with ICA. Mean effective dose was 3.3 +/- 1.0 mSv. Conclusions Prospectively ECG-triggered sequential dual-source CCTA provides diagnostic image quality and good diagnostic accuracy for detection of coronary stenosis in AF patients without significant influence by HR or HRV.	[Yang, Lin; Xu, Lei; Fan, Zhanming; Zhang, Zhaoqi] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Schoepf, U. Joseph; Wichmann, Julian L.; Fox, Mary A.] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [Yan, Jing] Siemens Healthcare China, Shanghai, Peoples R China	Capital Medical University; Medical University of South Carolina; Siemens AG	Xu, L (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China.	leixu2001@hotmail.com			Excellent Talents from Beijing City [2011D003034000030]; High Levels of Health Technical Personnel in Beijing City Health System [2013-3-011]	Excellent Talents from Beijing City; High Levels of Health Technical Personnel in Beijing City Health System	This work has been supported by a grant for Excellent Talents from Beijing City (2011D003034000030), and grant for High Levels of Health Technical Personnel in Beijing City Health System (2013-3-011). Jing Yan, is employed by a commercial company: Siemens Healthcare China. This funder only provided support in the form of salaries for author Jing Yan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatap G, 2002, DRUG AGING, V19, P819, DOI 10.2165/00002512-200219110-00002; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001; Hausleiter J, 2012, JACC-CARDIOVASC IMAG, V5, P484, DOI 10.1016/j.jcmg.2011.12.017; Heuschmid M, 2005, AM J ROENTGENOL, V184, P1413, DOI 10.2214/ajr.184.5.01841413; Hoffmann MHK, 2005, RADIOLOGY, V234, P86, DOI 10.1148/radiol.2341031408; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Klass O, 2009, EUR RADIOL, V19, P829, DOI 10.1007/s00330-008-1222-4; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071; Lee AM, 2012, J CARDIOVASC COMPUT, V6, P172, DOI 10.1016/j.jcct.2012.04.003; Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9; Lu B, 2001, INVEST RADIOL, V36, P250, DOI 10.1097/00004424-200105000-00002; Mao SS, 2000, J COMPUT ASSIST TOMO, V24, P253, DOI 10.1097/00004728-200003000-00012; Martuscelli E, 2004, EUR HEART J, V25, P1043, DOI 10.1016/j.ehj.2004.03.024; Mayurasakorn Sureeporn, 2008, Journal of the Medical Association of Thailand, V91, P1076; Nieman K, 2002, HEART, V88, P470, DOI 10.1136/heart.88.5.470; Oncel D, 2007, RADIOLOGY, V245, P703, DOI 10.1148/radiol.2453070094; Pugliese F, 2006, EUR RADIOL, V16, P575, DOI 10.1007/s00330-005-0041-0; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Rist C, 2009, INVEST RADIOL, V44, P159, DOI 10.1097/RLI.0b013e3181948b05; Schlattmann P, 2011, EUR RADIOL, V21, P1904, DOI 10.1007/s00330-011-2142-2; Schoenhagen P, 2004, RADIOLOGY, V232, P7, DOI 10.1148/radiol.2321021803; Schoepf UJ, 2004, RADIOLOGY, V232, P18, DOI 10.1148/radiol.2321030636; Shim SS, 2005, AM J ROENTGENOL, V184, P649, DOI 10.2214/ajr.184.2.01840649; Shuman WP, 2008, RADIOLOGY, V248, P431, DOI 10.1148/radiol.2482072192; Srichai MB, 2013, J CARDIOVASC COMPUT, V7, P102, DOI 10.1016/j.jcct.2013.02.002; Stolzmann P, 2008, RADIOLOGY, V249, P71, DOI 10.1148/radiol.2483072032; Sun ZH, 2006, EUR J RADIOL, V60, P279, DOI 10.1016/j.ejrad.2006.06.009; Uehara M, 2011, INT J CARDIOL, V150, P65, DOI 10.1016/j.ijcard.2010.02.032; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Vembar M, 2003, MED PHYS, V30, P1683, DOI 10.1118/1.1582812; Vorre MM, 2013, RADIOLOGY, V267, P376, DOI 10.1148/radiol.13121224; Wang YN, 2008, EUR J RADIOL, V68, P434, DOI 10.1016/j.ejrad.2008.09.011; Weustink AC, 2008, RADIOLOGY, V248, P792, DOI 10.1148/radiol.2483072098; Xu L, 2013, EUR RADIOL, V23, P1822, DOI 10.1007/s00330-013-2793-2; Xu L, 2010, INT J CARDIOVAS IMAG, V26, P17, DOI 10.1007/s10554-009-9576-5; Yang L, 2009, AM J ROENTGENOL, V193, P795, DOI 10.2214/AJR.08.2012	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134194	10.1371/journal.pone.0134194	http://dx.doi.org/10.1371/journal.pone.0134194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221952	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800112
J	Yoshitake, H; Hashii, N; Kawasaki, N; Endo, S; Takamori, K; Hasegawa, A; Fujiwara, H; Araki, Y				Yoshitake, Hiroshi; Hashii, Noritaka; Kawasaki, Nana; Endo, Shuichiro; Takamori, Kenji; Hasegawa, Akiko; Fujiwara, Hiroshi; Araki, Yoshihiko			Chemical Characterization of N-Linked Oligosaccharide As the Antigen Epitope Recognized by an Anti-Sperm Auto-Monoclonal Antibody, Ts4	PLOS ONE			English	Article							CELL-SPECIFIC ANTIGEN; EPIDERMAL-GROWTH-FACTOR; BISECTING GLCNAC; MOUSE TESTIS; MOLECULAR CHARACTERIZATION; STRUCTURAL ASSESSMENT; STEM-CELLS; TEX101; GLYCOPROTEIN; GLYCANS	Ts4, an anti-sperm auto-monoclonal antibody, possesses immunoreactivity to the acrosomal region of mouse epididymal spermatozoa. In addition, the mAb shows specific immunoreactivity to reproduction-related regions such as testicular germ cells and early embryo. Our qualitative study previously showed that the antigen epitope for Ts4 contained a N-linked common oligosaccharide (OS) chain on testicular glycoproteins as determined by Western blotting for testicular glycoproteins after treatment with several glycohydrolases. Since the distribution of the Ts4-epitope is unique, the OS chain in Ts4-epitope may have role(s) in the reproductive process. The aim of this study was to clarify the molecular structure of the Ts4-epitope, particularly its OS moiety. Using Ts4 immunoprecipitation combined with liquid chromatography and multiple-stage mass spectrometry, the candidate carbohydrate structure in the Ts4-epitope is proposed to be N-linked fucosylated agalacto-biantennary with bisecting N-acetylglucosamine (GlcNAc) or with N-acetylgalactosamine-GlcNAc motif. Further binding analyses using various lectins against the mouse testicular Ts4-immunoprecipitants revealed that Phaseolus vulgaris erythroagglutinin and Pisum sativum agglutinin showed positive staining of the bands corresponding to Ts4 reactive proteins. Moreover, the immunoreactivity of Ts4 against the testicular extract was completely abrogated after digestion with beta-N-acetylglucosaminidase. These results show that the Ts4-epitope contains agalacto-biantennary N-glycan with bisecting GlcNAc carrying fucose residues.	[Yoshitake, Hiroshi; Endo, Shuichiro; Takamori, Kenji; Araki, Yoshihiko] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Chiba, Japan; [Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo, Japan; [Endo, Shuichiro; Araki, Yoshihiko] Juntendo Univ, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo, Japan; [Hasegawa, Akiko] Hyogo Coll Med, Dept Obstet & Gynecol, Nishinomiya, Hyogo 6638501, Japan; [Fujiwara, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Kanazawa, Ishikawa, Japan	Juntendo University; National Institute of Health Sciences - Japan; Juntendo University; Hyogo College of Medicine; Kanazawa University	Araki, Y (corresponding author), Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Chiba, Japan.	yaraki@juntendo.ac.jp	FUJIWARA, Hiroshi/J-8401-2015	FUJIWARA, Hiroshi/0000-0003-3098-9406	JSPS KAKENHI [21592111, 25462575, 23390389, 24592609]; "High-Tech Research Center" Project for Private Universities: matching fund from the Minister of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [26293358] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); "High-Tech Research Center" Project for Private Universities: matching fund from the Minister of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI, Grants-in Aid for General Scientific Research, Grant Numbers 21592111, 25462575 (YA), 23390389 (HF), 24592609 (HY) and "High-Tech Research Center" Project for Private Universities: matching fund subsidy from the Minister of Education, Culture, Sports, Science, and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; ARAKI Y, 1987, J REPROD IMMUNOL, V11, P193, DOI 10.1016/0165-0378(87)90057-X; Araki Yoshihiko, 1998, Journal of Reproduction and Development, V44, P215, DOI 10.1262/jrd.44.215; BIERHUIZEN MFA, 1989, GLYCOCONJUGATE J, V6, P195, DOI 10.1007/BF01050648; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; CHIEN SM, 1974, IMMUNOCHEMISTRY, V11, P501, DOI 10.1016/0019-2791(74)90122-0; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; EYLAR EH, 1962, J BIOL CHEM, V237, P1021; Fujihara Y, 2013, P NATL ACAD SCI USA, V110, P8111, DOI 10.1073/pnas.1222166110; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Haab BB, 2012, PROTEOM CLIN APPL, V6, P346, DOI 10.1002/prca.201200014; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2010, METHOD ENZYMOL, V480, P445, DOI 10.1016/S0076-6879(10)80019-9; ISOJIMA S, 1989, HUM REPROD, V4, P605, DOI 10.1093/oxfordjournals.humrep.a136951; Itoh S, 2006, J CHROMATOGR A, V1103, P296, DOI 10.1016/j.chroma.2005.11.043; Jin H, 2006, ZYGOTE, V14, P201, DOI 10.1017/S0967199406003753; JOHNSON SW, 1991, COMP BIOCHEM PHYS B, V99, P479, DOI 10.1016/0305-0491(91)90327-A; Kimura Y, 1999, EUR J BIOCHEM, V264, P168, DOI 10.1046/j.1432-1327.1999.00598.x; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Kurita A, 2001, BIOL REPROD, V64, P935, DOI 10.1095/biolreprod64.3.935; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE N, 1990, J BIOL CHEM, V265, P20476; MILLERPODRAZA H, 1982, BIOCHEMISTRY-US, V21, P3265, DOI 10.1021/bi00257a003; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; NARASIMHAN S, 1986, CARBOHYD RES, V149, P65, DOI 10.1016/S0008-6215(00)90370-7; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Nash R, 2007, STEM CELLS, V25, P974, DOI 10.1634/stemcells.2006-0224; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; OSAWA T, 1987, ANNU REV BIOCHEM, V56, P21, DOI 10.1146/annurev.biochem.56.1.21; Rebbaa A, 1997, J BIOL CHEM, V272, P9275; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Shirai Y, 2009, J REPROD DEVELOP, V55, P240, DOI 10.1262/jrd.20156; Takayama T, 2005, BIOL REPROD, V72, P1315, DOI 10.1095/biolreprod.104.038810; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Tsukamoto H, 2006, BIOCHEM BIOPH RES CO, V345, P229, DOI 10.1016/j.bbrc.2006.04.070; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; WONGMADDEN ST, 1995, GLYCOBIOLOGY, V5, P19, DOI 10.1093/glycob/5.1.19; Yoshitake H, 2009, BIOL REPROD, V81, P326; Yoshitake H, 2008, J REPROD IMMUNOL, V79, P1, DOI 10.1016/j.jri.2008.05.001; Yoshitake H, 2011, J REPROD IMMUNOL, V90, P202, DOI 10.1016/j.jri.2011.04.010	44	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133784	10.1371/journal.pone.0133784	http://dx.doi.org/10.1371/journal.pone.0133784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222427	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800066
J	Johnson, AC; Nagle, KJ; Tremble, SM; Cipolla, MJ				Johnson, Abbie Chapman; Nagle, Keith J.; Tremble, Sarah M.; Cipolla, Marilyn J.			The Contribution of Normal Pregnancy to Eclampsia	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GABA(A) RECEPTORS; OVARIAN CYCLE; PREECLAMPSIA; EXCITABILITY; AUTOREGULATION; PLASTICITY; RELEVANCE; CHILDREN; FLOW	Eclampsia, clinically defined as unexplained seizure in a woman with preeclampsia, is a life threatening complication unique to the pregnant state. However, a subpopulation of women with seemingly uncomplicated pregnancies experience de novo seizure without preeclamptic signs or symptoms, suggesting pregnancy alone may predispose the brain to seizure. Here, we hypothesized that normal pregnancy lowers seizure threshold and investigated mechanisms by which pregnancy may affect seizure susceptibility, including neuroinflammation and plasticity of gamma-aminobutyric acid type A receptor (GABA(A)R) subunit expression. Seizure threshold was determined by quantifying the amount of pentylenetetrazole (PTZ) required to elicit electrical seizure in Sprague Dawley rats that were either nonpregnant (Nonpreg, n = 7) or pregnant (Preg; d20, n = 6). Seizure-induced vasogenic edema was also measured. Further, activation of microglia, a measure of neuroinflammation (n = 6-8/group), and GABA(A)R delta- and gamma 2-subunit protein expression in the cerebral cortex and hippocampus (n = 6/group) was determined. Seizure threshold was lower in Preg compared to Nonpreg rats (36.7 +/- 9.6 vs. 65.0 +/- 14.5 mg/kg PTZ; p<0.01) that was associated with greater vasogenic edema formation (78.55 +/- 0.11 vs. 78.04 +/- 0.19% water; p<0.05). The % of active microglia was similar between groups; however, pregnancy was associated with downregulation of cortical GABA(A)R-delta and hippocampal GABA(A)R-gamma 2 expression. Overall, pregnancy appears to be a state of increased seizure susceptibility that is not due to neuroinflammation, but rather is associated with reduced expression of GABA(A)R subunits and greater edema. Understanding neurophysiological changes occurring in normal pregnancy could allow for better prevention and management of de novo seizure, including pathologic states such as eclampsia.	[Johnson, Abbie Chapman; Nagle, Keith J.; Tremble, Sarah M.; Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Obstet Gynecol & Reprod Sci, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Cipolla, MJ (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	Marilyn.Cipolla@uvm.edu			National Institutes of Health, National Institute of Neurologic Disorders and Stroke [RO1 NS045940]; National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement [RO1 NS 045940-06S1]; American Heart Association [14PRE18590005]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045940] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, National Institute of Neurologic Disorders and Stroke grant RO1 NS045940 to MJC (URL: http://www.ninds.nih.gov/); National Institutes of Health, National Institute of Neurologic Disorders and Stroke Neural Environment Cluster Supplement RO1 NS 045940-06S1 to MJC (URL: http://www.ninds.nih.gov/); and the American Heart Association Fellowship 14PRE18590005 to ACJ (URL: http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629; Aukes AM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.033; Aukes AM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.044; Biggio G, 2009, INT REV NEUROBIOL, V85, P73, DOI 10.1016/S0074-7742(09)85006-X; Brewer J, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.015; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Cipolla MJ, 2012, HYPERTENSION, V60, P705, DOI 10.1161/HYPERTENSIONAHA.112.198952; Cipolla MJ, 2012, EXP NEUROL, V234, P398, DOI 10.1016/j.expneurol.2012.01.005; Cipolla MJ, 2011, J APPL PHYSIOL, V110, P329, DOI 10.1152/japplphysiol.01159.2010; Cipolla MJ, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000196948.15019.28; Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; Donaldson J O, 1994, Adv Neurol, V64, P25; DONALDSON JO, 1994, HYPERTENS PREGNANCY, V13, P115, DOI 10.3109/10641959409009565; Donaldson JO, 1989, NEUROLOGY PREGNANCY, P269; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Euser AG, 2007, HYPERTENSION, V49, P334, DOI 10.1161/01.HYP.0000255791.54655.29; Herd MB, 2007, PHARMACOL THERAPEUT, V116, P20, DOI 10.1016/j.pharmthera.2007.03.007; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Johnson AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113670; Kanayama N, 1997, J HYPERTENS, V15, P383, DOI 10.1097/00004872-199715040-00009; Katz VL, 2000, AM J OBSTET GYNECOL, V182, P1389, DOI 10.1067/mob.2000.106178; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Maguire Jamie, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS84, DOI 10.1016/j.psyneuen.2009.06.019; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Olson DM, 2001, PEDIATRICS, V108, P163, DOI 10.1542/peds.108.1.163; Oztas B, 2003, PROG NEURO-PSYCHOPH, V27, P701, DOI 10.1016/S0278-5846(03)00084-8; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rich-Edwards JW, 2014, CHESLEYS HYPERTENSIV; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; SCHWARTZ RB, 1992, AM J ROENTGENOL, V159, P379, DOI 10.2214/ajr.159.2.1632361; SIBAI BM, 1990, AM J OBSTET GYNECOL, V163, P1049, DOI 10.1016/0002-9378(90)91123-T; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Thoresen M, 1997, ELECTROEN CLIN NEURO, V102, P152, DOI 10.1016/S0921-884X(96)96509-1; Zeeman GG, 2004, AM J OBSTET GYNECOL, V190, P714, DOI 10.1016/j.ajog.2003.09.015	42	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133953	10.1371/journal.pone.0133953	http://dx.doi.org/10.1371/journal.pone.0133953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218425	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900059
J	Julian, MW; Strange, HR; Ballinger, MN; Hotchkiss, RS; Papenfuss, TL; Crouser, ED				Julian, Mark W.; Strange, Heather R.; Ballinger, Megan N.; Hotchkiss, Richard S.; Papenfuss, Tracey L.; Crouser, Elliott D.			Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and-9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes	PLOS ONE			English	Article							HUMANS IN-VIVO; DENDRITIC CELLS; ENDOTOXIN TOLERANCE; IMMUNE-SYSTEM; SEPTIC SHOCK; T-CELLS; CPG-DNA; MYCOBACTERIUM-TUBERCULOSIS; TLR2-MEDIATED TOLERANCE; PROGRAMMED DEATH-1	Objective Immune suppression during critical illness predisposes to serious infections. We sought to determine the mechanisms regulating tolerance and cross-tolerance to common pro-inflammatory danger signals in a model that recapitulates the intact in vivo immune response. Materials and Methods Flt3-expanded splenocytes obtained from wild-type or matching IRAK-M knockout (IRAK-M-/-), C57BL/6, male mice (8-10 weeks old) were treated repeatedly or alternately with either LPS or CpGA DNA, agonists of Toll-like receptor (TLR)-4 and -9, respectively, over successive 24-hour periods. Supernatants were collected following each 24-hour period with cytokine release (ELISA) and splenocyte IRAK-M expression (Western blot) determined. Tolerance and cross-tolerance were assessed in the absence or presence of programmed death receptor (PD)-1 blocking antibody or IL-7 pre-treatment. Main Results Splenocytes notably exhibited both tolerance and cross-tolerance to subsequent treatments with either LPS or CpGA DNA. The character of tolerance and cross-tolerance in this model was distinct following initial LPS or CpGA treatment in that TNF alpha and IFN gamma release (not IL-10) were suppressed following LPS; whereas, initial CpGA treatment suppressed TNF alpha, IFN gamma and IL-10 release in response to subsequent stimulation (LPS or CpGA). Tolerance and cross-tolerance were unrelated to IL-10 release or PD-1 but were attenuated in IRAK-M-/-splenocytes. IL-7 significantly suppressed IRAK-M expression and restored TNF alpha and IFN gamma production without influencing IL-10 release. Conclusions In summary, acute immune tolerance and cross-tolerance in response to LPS or CpGA were distinct in that LPS selectively suppressed pro-inflammatory cytokine responses; whereas, CpGA suppressed both pro- and anti-inflammatory responses. The induction of tolerance and cross-tolerance in response to common danger signals was mechanistically unrelated to IL-10 or PD-1 but was directly influenced by IRAK-M expression. IL-7 reduced IRAK-M expression and attenuated immune tolerance induced by either LPS or CpGA, and thus may be useful for reversal of immune tolerance in the setting of critical illness.	[Julian, Mark W.; Ballinger, Megan N.; Crouser, Elliott D.] Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Strange, Heather R.; Papenfuss, Tracey L.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, Dept Med, St Louis, MO USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL); Washington University (WUSTL)	Crouser, ED (corresponding author), Wexner Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	Elliott.Crouser@osumc.edu	Crouser, Elliott/ABC-2602-2021; Crouser, Elliott/E-2933-2011	Ballinger, Megan/0000-0002-2202-3049	National Institutes of Health [R21-AI083912, RO3-AI62740]; DHLRI Davis Developmental Grant; Wexner Medical Center at The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083912, R03AI062740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHLRI Davis Developmental Grant; Wexner Medical Center at The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by National Institutes of Health R21-AI083912 (EDC), National Institutes of Health RO3-AI62740 (EDC), and DHLRI Davis Developmental Grant, Wexner Medical Center at The Ohio State University (EDC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Ballinger MN, 2012, J IMMUNOL, V189, P356, DOI 10.4049/jimmunol.1103124; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; Boomer JS, 2014, VIRULENCE, V5, P45, DOI [10.4161/viru.26516, 10.4161/viru.27794]; Castegren M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053221; Chang K, 2014, CRIT CARE, V18, DOI 10.1186/cc13176; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cho HY, 2009, IMMUNOL LETT, V127, P39, DOI 10.1016/j.imlet.2009.08.011; Cook CH, 2007, J INFECT DIS, V196, P1273, DOI 10.1086/522433; Dalpke AH, 2005, IMMUNOLOGY, V116, P203, DOI 10.1111/j.1365-2567.2005.02211.x; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Dolgachev VA, 2012, J TRAUMA ACUTE CARE, V72, P614, DOI 10.1097/TA.0b013e318243d9b1; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; Faust SM, 2013, J CLIN INVEST, V123, P2994, DOI 10.1172/JCI68205; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Guillerey C, 2012, BLOOD, V120, P90, DOI 10.1182/blood-2012-02-410936; Heagy W, 2000, SHOCK, V14, P271, DOI 10.1097/00024382-200014030-00005; Heagy Wyrta, 2003, Surg Infect (Larchmt), V4, P171, DOI 10.1089/109629603766956960; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hutchins NIA, 2014, TRENDS MOL MED, V20, P224, DOI 10.1016/j.molmed.2014.01.002; Ilyinskii PO, 2006, J VIROL, V80, P7146, DOI 10.1128/JVI.02745-05; Iversen AC, 2009, J IMMUNOL, V182, P5672, DOI 10.4049/jimmunol.0801268; Jiang HR, 2002, J LEUKOCYTE BIOL, V72, P978; Julian MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072354; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; Kawasaki T, 2001, ANESTH ANALG, V92, P1322; Kim YI, 2008, J BIOL CHEM, V283, P15258, DOI 10.1074/jbc.M709549200; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi T, 2012, J IMMUNOL, V189, P1792, DOI 10.4049/jimmunol.1200042; Koenen P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2719; KROEMER G, 1993, ADV IMMUNOL, V53, P157, DOI 10.1016/S0065-2776(08)60500-3; Lee N, 2013, INFLUENZA OTHER RESP, V7, P666, DOI 10.1111/irv.12109; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Li LQ, 2000, SCAND J IMMUNOL, V51, P361; Liu ZJ, 2008, J SURG RES, V150, P34, DOI 10.1016/j.jss.2007.12.759; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Mach N, 2000, CANCER RES, V60, P3239; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Miller ML, 2014, P NATL ACAD SCI USA, V111, P7397, DOI 10.1073/pnas.1315398111; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nalos M, 2012, AM J RESP CRIT CARE, V185, P110, DOI 10.1164/ajrccm.185.1.110; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Papenfuss TL, 2007, J LEUKOCYTE BIOL, V82, P1510, DOI 10.1189/jlb.0406257; Parra M, 2009, CLIN VACCINE IMMUNOL, V16, P1025, DOI 10.1128/CVI.00067-09; Perona-Wright G, 2006, EUR J IMMUNOL, V36, P2367, DOI 10.1002/eji.200535722; Rixen D, 1996, J TRAUMA, V41, P581, DOI 10.1097/00005373-199610000-00001; Shindo Y, 2015, SHOCK, V43, P334, DOI 10.1097/SHK.0000000000000317; Sieben M, 2013, INT J CANCER, V132, P2548, DOI 10.1002/ijc.27938; Sly LM, 2004, IMMUNITY, P21; Souza-Fonseca-Guimaraes F, 2012, J IMMUNOL, V188, P5850, DOI 10.4049/jimmunol.1103616; Techasaensiri B, 2010, PEDIATR INFECT DIS J, V29, P519, DOI 10.1097/INF.0b013e3181cdafc2; Torcia MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039853; Turner DJ, 2002, MICROBIOL-SGM, V148, P2929, DOI 10.1099/00221287-148-10-2929; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Weijer S, 2002, J INFECT DIS, V186, P1748, DOI 10.1086/345675; Wurzel DF, 2014, CLIN INFECT DIS, V59, P34, DOI 10.1093/cid/ciu225; Xiong YB, 2013, J LEUKOCYTE BIOL, V94, P291, DOI 10.1189/jlb.0812401; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Yeo SJ, 2003, J IMMUNOL, V170, P1052, DOI 10.4049/jimmunol.170.2.1052; Yue SC, 2010, J IMMUNOL, V184, P268, DOI 10.4049/jimmunol.0800924; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354; Zhou F, 2012, EUR J IMMUNOL, V42, P1449, DOI 10.1002/eji.201141733; Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	72	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132921	10.1371/journal.pone.0132921	http://dx.doi.org/10.1371/journal.pone.0132921			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218271	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900014
J	Koffman, JS; Arnspang, EC; Marlar, S; Nejsum, LN				Koffman, Jennifer S.; Arnspang, Eva C.; Marlar, Saw; Nejsum, Lene N.			Opposing Effects of cAMP and T259 Phosphorylation on Plasma Membrane Diffusion of the Water Channel Aquaporin-5 in Madin-Darby Canine Kidney Cells	PLOS ONE			English	Article							ACINAR-CELLS; TRAFFICKING; SALIVARY; TRANSLOCATION; LOCALIZATION; PERMEABILITY; ENDOCYTOSIS; INHIBITION; EXPRESSION; SECRETION	Aquaporin-5 (AQP5) facilitates passive water transport in glandular epithelia in response to secretory stimuli via intracellular pathways involving calcium release, cAMP and protein kinase A (PKA). In epithelial plasma membranes, AQP5 may be acutely regulated to facilitate water transport in response to physiological stimuli by changes in protein modifications, interactions with proteins and lipids, nanoscale membrane domain organization, and turnover rates. Such regulatory mechanisms could potentially be associated with alteration of diffusion behavior, possibly resulting in a change in the plasma membrane diffusion coefficient of AQP5. We aimed to test the short-term regulatory effects of the above pathways, by measuring lateral diffusion of AQP5 and an AQP5 phospho-mutant, T259A, using k-space Image Correlation Spectroscopy of quantum dot-and EGFP-labeled AQP5. Elevated cAMP and PKA inhibition significantly decreased lateral diffusion of AQP5, whereas T259A mutation showed opposing effects; slowing diffusion without stimulation and increasing diffusion to basal levels after cAMP elevation. Thus, lateral diffusion of AQP5 is significantly regulated by cAMP, PKA, and T259 phosphorylation, which could be important for regulating water flow in glandular secretions.	[Nejsum, Lene N.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; Aarhus Univ, Interdisciplinary Nanosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Nejsum, LN (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	nejsum@mbg.au.dk	Arnspang, Eva C/Y-1132-2018	Arnspang, Eva C/0000-0002-3095-4070; Nejsum, Lene Niemann/0000-0003-4368-8821	Graduate School of Science and Technology (GSST), AU; Lundbeck Junior Group Leader Fellowship from the Lundbeck Foundation	Graduate School of Science and Technology (GSST), AU; Lundbeck Junior Group Leader Fellowship from the Lundbeck Foundation	This work was supported by a Lundbeck Junior Group Leader Fellowship to LNN from the Lundbeck Foundation (http://www. lundbeckfoundation.com/). Additionally, this work was funded by the Graduate School of Science and Technology (GSST), AU, to JSK and SM (http://talent.au.dk/phd/scienceandtechnology/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnspang EC, 2014, JOVE-J VIS EXP, DOI 10.3791/51074; BAUM BJ, 1993, ANN NY ACAD SCI, V694, P17; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Delporte C, 1996, J BIOL CHEM, V271, P22070, DOI 10.1074/jbc.271.36.22070; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Ganguly S, 2008, BIOPHYS J, V95, P451, DOI 10.1529/biophysj.107.125732; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Gresz V, 2004, AM J PHYSIOL-GASTR L, V287, pG151, DOI 10.1152/ajpgi.00480.2003; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Hasegawa T, 2011, AM J PHYSIOL-CELL PH, V301, pC667, DOI 10.1152/ajpcell.00058.2011; He XJ, 1997, PFLUG ARCH EUR J PHY, V433, P260; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Inoue R, 2013, J DERMATOL SCI, V70, P26, DOI 10.1016/j.jdermsci.2013.01.013; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V265, P94, DOI 10.1006/bbrc.1999.1630; Ishikawa Y, 2000, FEBS LETT, V477, P253, DOI 10.1016/S0014-5793(00)01763-4; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Ishikawa Y, 1998, BIOCHEM BIOPH RES CO, V245, P835, DOI 10.1006/bbrc.1998.8395; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kolin DL, 2006, BIOPHYS J, V91, P3061, DOI 10.1529/biophysj.106.082768; Kosugi-Tanaka C, 2006, BBA-MOL CELL RES, V1763, P337, DOI 10.1016/j.bbamcr.2006.02.005; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Kusumi A, 2014, NAT CHEM BIOL, V10, P524, DOI [10.1038/NCHEMBIO.1558, 10.1038/nchembio.1558]; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Marlar S, 2014, BBA-BIOMEMBRANES, V1838, P2404, DOI 10.1016/j.bbamem.2014.06.005; Marlar S, 2014, AM J PHYSIOL-CELL PH, V306, pC598, DOI 10.1152/ajpcell.00132.2013; Moeller HB, 2014, J CELL SCI, V127, P3174, DOI 10.1242/jcs.150680; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Song YL, 2002, J PHYSIOL-LONDON, V541, P561, DOI 10.1113/jphysiol.2001.020180; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; Tada J, 1999, BIOCHEM BIOPH RES CO, V266, P443, DOI 10.1006/bbrc.1999.1828; Tham DKL, 2011, AM J PHYSIOL-RENAL, V301, pF396, DOI 10.1152/ajprenal.00315.2010; Umenishi F, 2000, BIOPHYS J, V78, P1024, DOI 10.1016/S0006-3495(00)76661-6; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Wellner RB, 2001, BIOCHEM BIOPH RES CO, V285, P1253, DOI 10.1006/bbrc.2001.5287; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Yang F, 2003, J BIOL CHEM, V278, P32173, DOI 10.1074/jbc.M305149200; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200	51	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133324	10.1371/journal.pone.0133324	http://dx.doi.org/10.1371/journal.pone.0133324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218429	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900027
J	Kong, YH; Zanaruddin, SNS; Lau, SH; Ramanathan, A; Kallarakkal, TG; Vincent-Chong, VK; Mustafa, WMW; Abraham, MT; Rahman, ZAA; Zain, RB; Cheong, SC				Kong, Yink Heay; Zanaruddin, Sharifah Nurain Syed; Lau, Shin Hin; Ramanathan, Anand; Kallarakkal, Thomas George; Vincent-Chong, Vui King; Mustafa, Wan Mahadzir Wan; Abraham, Mannil Thomas; Rahman, Zainal Ariff Abdul; Zain, Rosnah Binti; Cheong, Sok Ching			Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LYMPH-NODE METASTASIS; E-CADHERIN EXPRESSION; LAMININ-5 GAMMA-2 CHAIN; ADHESION MOLECULES; INVASIVE FRONT; UP-REGULATION; BETA-CATENIN; CANCER-CELLS; TONGUE	Oral squamous cell carcinoma (OSCC) is an aggressive disease accounting for more than 260,000 cancer cases diagnosed and 128,000 deaths worldwide. A large majority of cancer deaths result from cancers that have metastasized beyond the primary tumor. The relationship between genetic changes and clinical outcome can reflect the biological events that promote cancer's aggressive behavior, and these can serve as molecular markers for improved patient management and survival. To this end, epithelial-mesenchymal transition (EMT) is a major process that promotes tumor invasion and metastasis, making EMT-related proteins attractive diagnostic biomarkers and therapeutic targets. In this study, we used immunohistochemistry to study the expression of a panel of transcription factors (TWIST1, SNAI1/2, ZEB1 and ZEB2) and other genes intimately related to EMT (CDH1 and LAMC2) at the invasive tumor front of OSCC tissues. The association between the expression of these proteins and clinico-pathological parameters were examined with Pearson Chi-square and correlation with survival was analyzed using Kaplan Meier analysis. Our results demonstrate that there was a significant differential expression of CDH1, LAMC2, SNAI1/2 and TWIST1 between OSCC and normal oral mucosa (NOM). Specifically, CDH1 loss was significantly associated with Broder's grading, while diffused LAMC2 was similarly associated with non-cohesive pattern of invasion. Notably, co-expression of TWIST1 and ZEB2 in OSCC was significantly associated with poorer overall survival, particularly in patients without detectable lymph node metastasis. This study demonstrates that EMT-related proteins are differentially expressed in OSCC and that the co-expression of TWIST1 and ZEB2 could be of clinical value in identifying patients with poor survival for appropriate patient management.	[Kong, Yink Heay; Ramanathan, Anand; Kallarakkal, Thomas George; Rahman, Zainal Ariff Abdul; Zain, Rosnah Binti; Cheong, Sok Ching] Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur, Malaysia; [Kong, Yink Heay; Zanaruddin, Sharifah Nurain Syed; Cheong, Sok Ching] Canc Res Initiat Fdn, Oral Canc Res Team, Subang Jaya, Selangor, Malaysia; [Lau, Shin Hin] Inst Med Res, Stomatol Unit, Kuala Lumpur 50588, Malaysia; [Ramanathan, Anand; Kallarakkal, Thomas George; Vincent-Chong, Vui King; Rahman, Zainal Ariff Abdul; Zain, Rosnah Binti] Univ Malaya, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Mustafa, Wan Mahadzir Wan] Hosp Kuala Lumpur, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Abraham, Mannil Thomas] Tengku Ampuan Rahimah Hosp, Dept Oral & Maxillofacial Surg, Klang, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Universiti Malaya	Cheong, SC (corresponding author), Univ Malaya, Fac Dent, Dept Oromaxillofacial Surg & Med Sci, Kuala Lumpur, Malaysia.	sokching.cheong@carif.com.my	George, Thomas/B-7774-2010; Ramanathan, Anand/J-2943-2014	George, Thomas/0000-0002-5986-6170; Ramanathan, Anand/0000-0001-6496-7139	University Malaya High Impact Research MOHE Grant [UM.C/625/1/HIR/MOHE/DENT-03]	University Malaya High Impact Research MOHE Grant	This study was funded by University Malaya High Impact Research MOHE Grant (UM.C/625/1/HIR/MOHE/DENT-03). Author who received the funding: ZAAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bankfalvi A, 2000, J ORAL PATHOL MED, V29, P291, DOI 10.1034/j.1600-0714.2000.290701.x; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Diniz-Freitas M, 2006, ORAL ONCOL, V42, P190, DOI 10.1016/j.oraloncology.2005.07.010; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Fendrich V, 2009, EUR J ENDOCRINOL, V160, P695, DOI 10.1530/EJE-08-0662; Franz M, 2007, J MOL HISTOL, V38, P183, DOI 10.1007/s10735-007-9086-5; Franz M, 2009, HISTOCHEM CELL BIOL, V131, P651, DOI 10.1007/s00418-009-0559-3; Galvan JA, 2010, LUNG CANCER, V69, P289, DOI 10.1016/j.lungcan.2009.12.010; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gomez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018023; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Jang TJ, 2009, KOREAN J PATHOL, V43, P523, DOI 10.4132/KoreanJPathol.2009.43.6.523; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657; Kaur J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067361; KUMAGAI S, 1994, HEAD NECK-J SCI SPEC, V16, P51, DOI 10.1002/hed.2880160111; Kuratomi Y, 2006, ORAL ONCOL, V42, P73, DOI 10.1016/j.oraloncology.2005.06.013; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lim KP, 2005, ONCOL REP, V14, P963; Maeda G, 2005, INT J ONCOL, V27, P1535; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Masuda R, 2012, BIOMED RES-TOKYO, V33, P309, DOI 10.2220/biomedres.33.309; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mehendiratta Monica, 2014, J Oral Maxillofac Pathol, V18, P217, DOI 10.4103/0973-029X.140753; Mostaan LV, 2011, PATHOL RES PRACT, V207, P448, DOI 10.1016/j.prp.2011.04.001; OKA H, 1993, CANCER RES, V53, P1696; Ono Y, 1999, CANCER, V85, P2315, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2315::AID-CNCR3>3.0.CO;2-Y; Patel V, 2002, INT J CANCER, V99, P583, DOI 10.1002/ijc.10403; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pyo SW, 2007, J CRANIO MAXILL SURG, V35, P1, DOI 10.1016/j.jcms.2006.11.004; Ren D, 2014, CELL TISSUE RES; Richter P, 2011, J ORAL PATHOL MED, V40, P46, DOI 10.1111/j.1600-0714.2010.00936.x; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Sakamoto K, 2012, ANN SURG ONCOL, V19, P612, DOI 10.1245/s10434-011-2052-1; Salo S, 1999, MATRIX BIOL, V18, P197, DOI 10.1016/S0945-053X(99)00012-8; Sawair FA, 2003, J ORAL PATHOL MED, V32, P1, DOI 10.1034/j.1600-0714.2003.00060.x; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; SCHIPPER JH, 1991, CANCER RES, V51, P6328; Severino P, 2008, BMC RES NOTES, P1113; Shaw RJ, 2010, HEAD NECK-J SCI SPEC, V32, P714, DOI 10.1002/hed.21244; Soini Y, 2011, BMC CANCER, P1173; Spiro RH, 1999, HEAD NECK-J SCI SPEC, V21, P408, DOI 10.1002/(SICI)1097-0347(199908)21:5<408::AID-HED5>3.0.CO;2-E; Stewart CJR, 2011, HISTOPATHOLOGY, V58, P720, DOI 10.1111/j.1365-2559.2011.03787.x; Tanaka N, 2003, BRIT J CANCER, V89, P557, DOI 10.1038/sj.bjc.6601124; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Usami Y, 2008, J PATHOL, V215, P330, DOI 10.1002/path.2365; Wang C, 2012, INT J CANCER, V130, P2249, DOI 10.1002/ijc.26226; Wang C, 2011, J ORAL PATHOL MED, V40, P545, DOI 10.1111/j.1600-0714.2011.01041.x; Wang XH, 2009, ORAL SURG ORAL MED O, V107, P547, DOI 10.1016/j.tripleo.2008.11.021; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Woolgar JA, 2006, ORAL ONCOL, V42, P229, DOI 10.1016/j.oraloncology.2005.05.008; Wushou A, 2012, J ORAL MAXIL SURG, V70, P1473, DOI 10.1016/j.joms.2011.06.212; Yang TL, 2011, ORAL ONCOL, V47, P720, DOI 10.1016/j.oraloncology.2011.04.006; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; Zain RB, 2012, CELL TISSUE BANK; Zanaruddin SNS, 2013, HUM PATHOL, V44, P417, DOI 10.1016/j.humpath.2012.06.007; Zhang KJ, 2011, LAB INVEST, V91, P426, DOI 10.1038/labinvest.2010.201; Zhao XL, 2011, J CELL MOL MED, V15, P691, DOI 10.1111/j.1582-4934.2010.01052.x	70	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134045	10.1371/journal.pone.0134045	http://dx.doi.org/10.1371/journal.pone.0134045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214683	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300045
J	Trastulli, S; Cirocchi, R; Desiderio, J; Coratti, A; Guarino, S; Renzi, C; Corsi, A; Boselli, C; Santoro, A; Minelli, L; Parisi, A				Trastulli, Stefano; Cirocchi, Roberto; Desiderio, Jacopo; Coratti, Andrea; Guarino, Salvatore; Renzi, Claudio; Corsi, Alessia; Boselli, Carlo; Santoro, Alberto; Minelli, Liliana; Parisi, Amilcare			Robotic versus Laparoscopic Approach in Colonic Resections for Cancer and Benign Diseases: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SHORT-TERM OUTCOMES; CONVENTIONAL COLORECTAL RESECTIONS; RIGHT COLECTOMY; INTRACORPOREAL ANASTOMOSIS; INFLAMMATORY RESPONSE; ECONOMIC CONSEQUENCES; DIVERTICULAR-DISEASE; RIGHT HEMICOLECTOMY; SURGERY; QUALITY	Objectives The aim of this systematic review and meta-analysis is to compare robotic colectomy (RC) with laparoscopic colectomy (LC) in terms of intraoperative and postoperative outcomes. Materials and Methods A systematic literature search was performed to retrieve comparative studies of robotic and laparoscopic colectomy. The databases searched were PubMed, Embase and the Cochrane Central Register of Controlled Trials from January 2000 to October 2014. The Odds ratio, Risk difference and Mean difference were used as the summary statistics. Results A total of 12 studies, which included a total of 4,148 patients who had undergone robotic or laparoscopic colectomy, were included and analyzed. RC demonstrated a longer operative time (MD 41.52, P<0.00001) and higher cost (MD 2.42, P<0.00001) than did LC. The time to first flatus passage (MD -0.51, P = 0.003) and the length of hospital stay (MD -0.68, P = 0.01) were significantly shorter after RC. Additionally, the intraoperative blood loss (MD -16.82, P<0.00001) was significantly less in RC. There was also a significantly lower incidence of overall postoperative complications (OR 0.74, P = 0.02) and wound infections (RD -0.02, P = 0.03) after RC. No differences in the postoperative ileus, in the anastomotic leak, or in the conversion to open surgery rate and in the number of harvested lymph nodes outcomes were found between the approaches. Conclusions The present meta-analysis, mainly based on observational studies, suggests that RC is more time-consuming and expensive than laparoscopy but that it results in faster recovery of bowel function, a shorter hospital stay, less blood loss and lower rates of both overall postoperative complications and wound infections.	[Trastulli, Stefano; Cirocchi, Roberto; Desiderio, Jacopo; Parisi, Amilcare] St Maria Hosp, Dept Gastrointestinal Surg, Terni, Italy; [Trastulli, Stefano; Cirocchi, Roberto; Desiderio, Jacopo; Parisi, Amilcare] St Maria Hosp, Liver Unit, Terni, Italy; [Coratti, Andrea] Careggi Univ Hosp, Dept Oncol, Div Oncol & Robot Surg, Florence, Italy; [Guarino, Salvatore; Santoro, Alberto] Univ Roma La Sapienza, Dept Surg Sci, I-00185 Rome, Italy; [Renzi, Claudio; Corsi, Alessia; Boselli, Carlo] Univ Perugia, Dept Gen & Oncol Surg, I-06100 Perugia, Italy; [Minelli, Liliana] Univ Perugia, Publ Hlth Sect, Dept Expt Med, I-06100 Perugia, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; Sapienza University Rome; University of Perugia; University of Perugia	Trastulli, S (corresponding author), St Maria Hosp, Dept Gastrointestinal Surg, Terni, Italy.	stefano.trastulli@hotmail.it	Renzi, Claudio/S-6031-2019; Desiderio, Jacopo/AAD-1926-2022; Cirocchi, Roberto/I-1197-2014	Renzi, Claudio/0000-0002-7022-3336; Cirocchi, Roberto/0000-0002-2457-0636; Minelli, Liliana/0000-0002-9535-0737				Bertani E, 2011, INT J COLORECTAL DIS, V26, P1317, DOI 10.1007/s00384-011-1270-0; Casillas MA, 2014, AM J SURG, V208, P33, DOI 10.1016/j.amjsurg.2013.08.028; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; D'Annibale A, 2010, ANN SURG ONCOL, V17, P2856, DOI 10.1245/s10434-010-1175-0; DeNoto G, 2006, J LAPAROENDOSC ADV S, V16, P551, DOI 10.1089/lap.2006.16.551; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; deSouza AL, 2010, DIS COLON RECTUM, V53, P1000, DOI 10.1007/DCR.0b013e3181d32096; Deutsch GB, 2012, SURG ENDOSC, V26, P956, DOI 10.1007/s00464-011-1977-6; Doorly MG, 2012, SURG CLIN N AM, V92, P259, DOI 10.1016/j.suc.2012.01.010; Fung AKY, 2013, DIS COLON RECTUM, V56, P786, DOI 10.1097/DCR.0b013e318285b810; Gaertner WB, 2013, WORLD J SURG, V37, P629, DOI 10.1007/s00268-012-1872-x; Goossens-Laan CA, 2011, EUR UROL, V59, P775, DOI 10.1016/j.eururo.2011.01.037; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Haas Jason M, 2012, WMJ, V111, P161; Halabi WJ, 2013, WORLD J SURG, V37, P2782, DOI 10.1007/s00268-013-2024-7; Helvind NM, 2013, SURG ENDOSC, V27, P2575, DOI 10.1007/s00464-013-2792-z; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Iyer S, 2009, J MANAGE CARE PHARM, V15, P485, DOI 10.18553/jmcp.2009.15.6.485; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kanji A, 2011, INT J MED ROBOT COMP, V7, P401, DOI 10.1002/rcs.432; Kehlet H, 2006, REGION ANESTH PAIN M, V31, P47, DOI 10.1016/j.rapm.2005.10.005; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Keller DS, 2014, SURG ENDOSC, V28, P212, DOI 10.1007/s00464-013-3163-5; Kuhry E, 2008, CANCER TREAT REV, V34, P498, DOI 10.1016/j.ctrv.2008.03.011; Lim DR, 2013, SURG ENDOSC, V27, P1379, DOI 10.1007/s00464-012-2619-3; Lujan HJ, 2013, J ROBOT SURG, V7, P95, DOI 10.1007/s11701-011-0320-5; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Memon S, 2012, ANN SURG ONCOL, V19, P2095, DOI 10.1245/s10434-012-2270-1; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morpurgo E, 2013, J LAPAROENDOSC ADV S, V23, P414, DOI 10.1089/lap.2012.0404; Ordemann J, 2001, SURG ENDOSC, V15, P600, DOI 10.1007/s004640090032; Ortiz-Oshiro E, 2012, INT J MED ROBOT COMP, V8, P360, DOI 10.1002/rcs.1426; Park JS, 2012, BRIT J SURG, V99, P1219, DOI 10.1002/bjs.8841; Petrucciani N, 2015, J MINIM ACCESS SURG, V11, P22, DOI 10.4103/0972-9941.147678; Rangel SJ, 2003, J PEDIATR SURG, V38, P390, DOI 10.1053/jpsu.2003.50114; Rawlings AL, 2007, SURG ENDOSC, V21, P1701, DOI 10.1007/s00464-007-9231-y; Reza MM, 2006, BRIT J SURG, V93, P921, DOI 10.1002/bjs.5430; Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404; Scarpinata R, 2013, DIS COLON RECTUM, V56, P253, DOI 10.1097/DCR.0b013e3182694595; Schwenk W, 2000, LANGENBECK ARCH SURG, V385, P2, DOI 10.1007/s004230050002; Senagore AJ, 2010, CLIN EXP GASTROENTER, V3, P87; Shepard D. S., 1999, J MENT HEALTH POLICY, V2, P91, DOI DOI 10.1002/(SICI)1099-176X(199906)2:23.0.CO;2-I; Siddiqui MRS, 2010, WORLD J SURG, V34, P2883, DOI 10.1007/s00268-010-0762-3; Spinoglio G, 2008, DIS COLON RECTUM, V51, P1627, DOI 10.1007/s10350-008-9334-0; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Trastulli S, 2012, COLORECTAL DIS, V14, pE134, DOI 10.1111/j.1463-1318.2011.02907.x; Trastulli S, 2015, SURG ENDOSC, V29, P1512, DOI 10.1007/s00464-014-3835-9; Trastulli S, 2013, INT J COLORECTAL DIS, V28, P807, DOI 10.1007/s00384-012-1604-6; Tsui C, 2012, SOC AM GASTROINTESTI; Tyler JA, 2013, DIS COLON RECTUM, V56, P458, DOI 10.1097/DCR.0b013e31827085ec; Whelan RL, 2003, SURG ENDOSC, V17, P972, DOI 10.1007/s00464-001-8263-y; Wu ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094878; Yang YZ, 2012, ANN SURG ONCOL, V19, P3727, DOI 10.1245/s10434-012-2429-9	56	43	47	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134062	10.1371/journal.pone.0134062	http://dx.doi.org/10.1371/journal.pone.0134062			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214845	gold, Green Submitted, Green Published			2022-12-27	WOS:000358594300047
J	Chatziandreou, I; Tsioli, P; Sakellariou, S; Mourkioti, I; Giannopoulou, I; Levidou, G; Korkolopoulou, P; Patsouris, E; Saetta, AA				Chatziandreou, Ilenia; Tsioli, Panagiota; Sakellariou, Stratigoula; Mourkioti, Ioanna; Giannopoulou, Ioanna; Levidou, Georgia; Korkolopoulou, Penelope; Patsouris, Efstratios; Saetta, Angelica A.			Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; KRAS MUTATIONS; ACTIVATING MUTATIONS; CLINICAL-FEATURES; EGFR MUTATIONS; MET; BRAF; INHIBITORS	Background Selection of NSCLC patients for targeted therapy is currently based upon the presence of sensitizing mutations in EGFR and EML4/ALK translocations. The heterogeneity of molecular alterations in lung cancer has led to the ongoing discovery of potential biomarkers and targets in order to improve survival. Aim This study aimed to detect alterations in EGFR, KRAS, BRAF, PIK3CA, MET-gene copy number and ALK rearrangements in a large cohort of 956 NSCLC patients of Hellenic origin using highly sensitive techniques and correlations with clinicopathological characteristics. Results Mutations were detected in EGFR 10.6%(101 out of 956 samples), KRAS 26.5% (191 out of 720 samples), BRAF 2.5% (12 out of 471 samples), PIK3CA 3.8% (7 out of 184 samples), MET gene amplification was detected in 18% (31 out of 170) and ALK rearrangements in 3.7% (4 out of 107 samples). EGFR mutations were detected in exon 19 (61.4% of mutant cases), exon 21 p.Leu858Arg (19.8%), exon 20 (15.8%), exon 18 (2.9%) and were correlated with gender histology, smoking status and TTF1 staining. p.Thr790Met mutant cases (3.9%) displayed concurrent mutations in exons 19 or 21. Negative TTF-1 staining showed strong negative predictive value for the presence of EGFR mutations. KRAS mutations were associated with histology, the most common mutation being p.Gly12Cys (38%). Discussion In conclusion, only 89 patients were eligible for EGFR-TKIs and ALK inhibitors therapy, whereas 257 patients showed other alterations, highlighting the necessity for a detailed molecular profiling potentially leading to more efficient individualized therapies for NSCLC patients.	[Chatziandreou, Ilenia; Tsioli, Panagiota; Sakellariou, Stratigoula; Mourkioti, Ioanna; Giannopoulou, Ioanna; Levidou, Georgia; Korkolopoulou, Penelope; Patsouris, Efstratios; Saetta, Angelica A.] Univ Athens, Sch Med, Dept Pathol 1, Laikon Gen Hosp, GR-11527 Athens, Greece	Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens	Chatziandreou, I (corresponding author), Univ Athens, Sch Med, Dept Pathol 1, Laikon Gen Hosp, GR-11527 Athens, Greece.	hchatzian@med.uoa.gr		CHATZIANDREOU, ILENIA/0000-0002-4940-5581; Saetta, Angelica A./0000-0002-4862-3413				Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Cai YR, 2011, ONCOL LETT, V2, P257, DOI 10.3892/ol.2010.229; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Cardarella S, 2013, CLIN CANCER RES, V19, P4532, DOI 10.1158/1078-0432.CCR-13-0657; Cardarella S, 2012, J THORAC ONCOL, V7, P1767, DOI 10.1097/JTO.0b013e3182745bcb; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Cheng Liang, 2012, Chinese Journal of Pathology, V41, P715, DOI 10.3760/cma.j.issn.0529-5807.2012.10.019; Cortes-Funes H, 2005, ANN ONCOL, V16, P1081, DOI 10.1093/annonc/mdi221; Carpeno JD, 2013, TRANSL LUNG CANCER R, V2, P142, DOI 10.3978/j.issn.2218-6751.2013.02.07; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dimou Anastasios, 2011, Patholog Res Int, V2011, P312346, DOI 10.4061/2011/312346; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Go H, 2010, J THORAC ONCOL, V5, P305, DOI 10.1097/JTO.0b013e3181ce3d1d; Gruber K, 2015, J THORAC ONCOL, V10, P713, DOI 10.1097/JTO.0000000000000427; Han CB, 2012, CANCER LETT, V314, P63, DOI 10.1016/j.canlet.2011.09.012; Hantson Inge, 2014, Transl Respir Med, V2, P9, DOI 10.1186/s40247-014-0009-0; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Herreros-Villanueva M, 2011, MOL BIOL REP, V38, P1315, DOI 10.1007/s11033-010-0232-x; Hirsch FR, 2013, J THORAC ONCOL, V8, P373, DOI 10.1097/JTO.0b013e31827ed0ff; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Korkolopoulou P, 2012, BJU INT, V110, pE1237, DOI 10.1111/j.1464-410X.2012.11569.x; Kubo T, 2009, INT J CANCER, V124, P1778, DOI 10.1002/ijc.24150; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Langer C, 2011, PHARMACOL THERAPEUT, P36; Leary AF, 2012, EUR J CANCER, V48, P61, DOI 10.1016/j.ejca.2011.09.022; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Levidou G, 2012, WORLD JOURNAL OF SUR, P47, DOI [10.1186/PREACCEPT-1032136556616351, DOI 10.1186/PREACCEPT-1032136556616351]; Li CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107276; Li S, 2014, BRIT J CANCER, V110, P2812, DOI 10.1038/bjc.2014.210; Li YY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054369, 10.1371/journal.pone.0055108, 10.1371/journal.pone.0062036, 10.1371/journal.pone.0052093, 10.1371/journal.pone.0063648, 10.1371/journal.pone.0066567, 10.1371/journal.pone.0077685, 10.1371/journal.pone.0071994]; Ludovini V, 2012, CANCER CHEMOTH PHARM, V69, P1289, DOI 10.1007/s00280-012-1829-7; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Sanchez-Torres JM, 2013, TRANSL LUNG CANCER R, V2, P244, DOI 10.3978/j.issn.2218-6751.2013.04.01; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Munfus-McCray D, 2011, HUM PATHOL, V42, P1447, DOI 10.1016/j.humpath.2010.12.011; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Okuda K, 2008, CANCER SCI, V99, P2280, DOI 10.1111/j.1349-7006.2008.00916.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Reungwetwattana T, 2012, CLIN LUNG CANCER, V13, P252, DOI 10.1016/j.cllc.2011.09.004; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Roberts PJ, 2010, J CLIN ONCOL, V28, P4769, DOI 10.1200/JCO.2009.27.4365; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Serizawa M, 2014, CANCER-AM CANCER SOC, V120, P1471, DOI 10.1002/cncr.28604; Shan L, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-3; Shaw AT, 2011, J NATL COMPR CANC NE, V9, P1335, DOI 10.6004/jnccn.2011.0115; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soria JC, 2012, CANCER TREAT REV, V38, P416, DOI 10.1016/j.ctrv.2011.10.003; Sun PL, 2012, J THORAC ONCOL, V7, P323, DOI 10.1097/JTO.0b013e3182381515; Tasioudi KE, 2012, PATHOL RES PRACT, V208, P398, DOI 10.1016/j.prp.2012.05.009; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; Vincenten J, 2012, J THORAC ONCOL, V7, P1522, DOI 10.1097/JTO.0b013e3182635a91; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110617; Wu JY, 2011, MEDICINE, V90, P159, DOI 10.1097/MD.0b013e31821a16f4; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zhang Xiaozhu, 2008, Int J Med Sci, V5, P209; Zhao FZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117333	74	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133859	10.1371/journal.pone.0133859	http://dx.doi.org/10.1371/journal.pone.0133859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208325	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000157
J	Chen, XQ; Lin, ZH; Xue, M; Si, JM; Chen, SJ				Chen, Xueqin; Lin, Zhenghua; Xue, Meng; Si, Jianmin; Chen, Shujie			Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ABERRANT METHYLATION; GENE-EXPRESSION; SERUM; MARKERS	Gastric cancer (GC) remains one of the most common digestive cancers worldwide; however, most patients present at an advanced stage at initial diagnosis. Zic1 is a novel candidate tumor suppressor gene that is epigenetically silenced in GC. In this study, we investigated Zic1 promoter methylation in plasma DNA as a novel molecular marker for the early diagnosis and monitoring of GC. Methylation-specific polymerase chain reaction (MSP) assay was performed to detect Zic1 promoter methylation in plasma DNA from 20 healthy subjects, 50 gastric intraepithelial neoplasia patients, and 104 GC patients. The Zic1 promoter methylation rate in the plasma samples from the healthy control group was 0%, but it reached 54.0% in the intraepithelial neoplasia group and 60.6% in the GC group. The latter two values were significantly higher than that found in the healthy control group (p < 0.05), with a 100% specificity for intraepithelial neoplasia and GC diagnosis. The positive predictive value of plasma Zic1 promoter methylation for the diagnosis of intraepithelial neoplasia and GC was 100%. Methylation status in the GC group was not significantly associated with tumor size, tumor differentiation, lymph node metastasis, TNM staging, or tumor invasion (p > 0.05). Assessment of the significance of detection of the carcino-embryonic antigen (CEA) level and Zic1 promoter methylation rate for GC diagnosis revealed that the sensitivity of Zic1 promoter methylation was significantly higher than that of the CEA level as a marker and that the combined measurement of these two indices (parallel testing) improved sensitivity. Taken together, our results suggest that the Zic1 promoter methylation rate in plasma-derived DNA is of great significance for the early screening of GC and monitoring of tumorigenesis. Zic1 promoter methylation may serve as a novel non-invasive plasma biomarker for the early detection of GC and for risk assessment in high-risk populations. The combined measurement of the Zic1 promoter methylation rate and CEA level (parallel testing) may enhance the current guidelines for the early diagnosis of GC.	[Chen, Xueqin; Lin, Zhenghua; Xue, Meng; Si, Jianmin; Chen, Shujie] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Xueqin; Lin, Zhenghua; Xue, Meng; Si, Jianmin; Chen, Shujie] Zhejiang Univ, Inst Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Chen, SJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	chensj77@hotmail.com			National Natural Science Foundation of China [81302070, 81372623]; Zhejiang Provincial Medical and health general research plan [2014KYB121]; Zhejiang Provincial Department of Education research plan [Y201327398]; Zhejiang province key science and technology innovation team [2013TD13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Medical and health general research plan; Zhejiang Provincial Department of Education research plan; Zhejiang province key science and technology innovation team	This work was funded by the National Natural Science Foundation of China (81302070, 81372623) (http://www.nsfc.gov.cn), Zhejiang Provincial Medical and health general research plan (2014KYB121) (http://www.zjwst.gov.cn/), Zhejiang Provincial Department of Education research plan (Y201327398) (http://www.zjedu.gov.cn), and Zhejiang province key science and technology innovation team (2013TD13) (http://www.zjkjt.gov.cn/). The funder Shujie Chen conceived and designed the experiments for this manuscript.	Brill E, 2010, CANCER RES, V70, P6891, DOI 10.1158/0008-5472.CAN-10-0745; Chen L, 2012, DIS MARKERS, V32, P195, DOI [10.1155/2012/473251, 10.3233/DMA-2011-0877]; Fock KM, 2014, ALIMENT PHARM THER, V40, P250, DOI 10.1111/apt.12814; Harder J, 2006, Praxis (Bern 1994), V95, P1021; Ichikawa D, 2004, ANTICANCER RES, V24, P2477; Ikoma H, 2007, HEPATO-GASTROENTEROL, V54, P946; Ikoma H, 2006, ANTICANCER RES, V26, P2313; Koike H, 2005, HEPATO-GASTROENTEROL, V52, P1293; Koike H, 2004, J SURG ONCOL, V87, P182, DOI 10.1002/jso.20106; Nakamura J, 2014, WORLD J GASTROENTERO, V20, P11991, DOI 10.3748/wjg.v20.i34.11991; Pourebrahim R, 2007, FEBS LETT, V581, P5122, DOI 10.1016/j.febslet.2007.09.061; Rashid A, 2001, AM J PATHOL, V159, P1129, DOI 10.1016/S0002-9440(10)61789-0; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Wang LJ, 2009, BIOCHEM BIOPH RES CO, V379, P959, DOI 10.1016/j.bbrc.2008.12.180; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Yamanaka M, 2003, INT J CANCER, V106, P382, DOI 10.1002/ijc.11227; Yokota N, 1996, CANCER RES, V56, P377; Zheng YA, 2011, CLIN BIOCHEM, V44, P1405, DOI 10.1016/j.clinbiochem.2011.09.006; Zhong J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-290	20	4	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133906	10.1371/journal.pone.0133906	http://dx.doi.org/10.1371/journal.pone.0133906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207911	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000172
J	Chen, YP; Wei, QQ; Ou, RW; Cao, B; Chen, XP; Zhao, B; Guo, XY; Yang, Y; Chen, K; Wu, Y; Song, W; Shang, HF				Chen, YongPing; Wei, Qian-Qian; Ou, RuWei; Cao, Bei; Chen, XuePing; Zhao, Bi; Guo, XiaoYan; Yang, Yuan; Chen, Ke; Wu, Ying; Song, Wei; Shang, Hui-Fang			Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; POLYMORPHISM; RISK; LOCI; PD	Background The polymorphisms of alpha-synuclein (SNCA), rs3775444, rs3822086 and rs11931074 that are strongly associated with Parkinson's disease (PD) in Caucasian populations, were examined in this study to elucidate the role of polymorphisms in different ethnic backgrounds. The possible associations of these three polymorphisms were also investigated in PD, amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in a Chinese population based on the overlapping of clinical manifestations and pathological characteristics of these three neurodegenerative diseases. Methods A total of 1276 PD, 885 sporadic ALS (SALS), 364 MSA patients, and 846 healthy controls (HCs) were included. All subjects were genotyped for the three polymorphisms using Sequenom iPLEX Assay technology. Results Significant differences in the genotype distributions (p = 5.99E-06 and p = 4.98E-06, respectively) and the minor allele frequency (MAF) (p = 2.16E-06 and p = 2.15E-06, respectively) of SNCA rs3822086 (C) and rs11931074 (G) were observed between PD and HCs. However, no differences were found in the genotype distributions and MAF of SNCA rs3775444 (T) between PD and HCs. Haplotype that incorporated the three SNPs further strengthened the association with PD (best haplotype, p = 9.62E-005). No significant differences in the genotype distributions and MAF of the SNPs were found between SALS and HCs, MSA and HCs, and subgroups of PD and SALS. However, the MAF of SNCA rs3775444 (T) was significantly higher in MSA patients with frontal lobe dysfunction than MSA patients without dysfunction (p = 0.0002, OR 2.53, 95% CI: 1.55-4.15). Conclusion Our results suggest that the rs3822086 (C) allele and rs11931074 (G) allele in SNCA decrease the risk for PD, and SNCA rs11931074 may affect frontal lobe dysfunction of MSA in the Chinese population. However, these SNCA polymorphisms are not likely a common cause of SALS or MSA.	[Chen, YongPing; Wei, Qian-Qian; Ou, RuWei; Cao, Bei; Chen, XuePing; Zhao, Bi; Guo, XiaoYan; Chen, Ke; Wu, Ying; Song, Wei; Shang, Hui-Fang] Sichuan Univ, Dept Neurol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Chen, YongPing; Wei, Qian-Qian; Ou, RuWei; Cao, Bei; Chen, XuePing; Zhao, Bi; Guo, XiaoYan; Chen, Ke; Wu, Ying; Song, Wei; Shang, Hui-Fang] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Chen, YongPing; Wei, Qian-Qian; Ou, RuWei; Cao, Bei; Chen, XuePing; Zhao, Bi; Guo, XiaoYan; Chen, Ke; Wu, Ying; Song, Wei; Shang, Hui-Fang] Sichuan Univ, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China; [Yang, Yuan] Sichuan Univ, Dept Med Genet, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Shang, HF (corresponding author), Sichuan Univ, Dept Neurol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	hfshang2002@163.com	Chen, Yong-Ping/ABC-4645-2021	yang, yuan/0000-0002-9206-0312	National Science Fund of China [81371394]; National Basic Research Program of China [2015CB856400]; Science and Technology Bureau Fund of Sichuan Province [2014FZ0072]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Bureau Fund of Sichuan Province	The present study was supported by the funding of the National Science Fund of China (Grant No. 81371394), supported in part by the National Basic Research Program of China (No: 2015CB856400), and the Science and Technology Bureau Fund of Sichuan Province (2014FZ0072).	Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655; Chung SJ, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.05.022; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gouras Gunnar K, 2013, Int J Cell Biol, V2013, P141083, DOI 10.1155/2013/141083; Guo XY, 2014, EUR J NEUROL, V21, P1337, DOI 10.1111/ene.12490; Guo XY, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.014; Hermosura MC, 2007, BBA-MOL BASIS DIS, V1772, P822, DOI 10.1016/j.bbadis.2007.02.008; Hu YC, 2012, J NEUROL, V259, P497, DOI 10.1007/s00415-011-6209-4; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Liu J, 2013, MOVEMENT DISORD, V28, P1892, DOI 10.1002/mds.25599; MAJOORKRAKAUER D, 1994, NEUROLOGY, V44, P1872, DOI 10.1212/WNL.44.10.1872; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sun ZF, 2015, INT J NEUROSCI, V125, P612, DOI 10.3109/00207454.2014.990013; Wu-Chou YH, 2013, PARKINSONISM RELAT D, V19, P251, DOI 10.1016/j.parkreldis.2012.10.019	24	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133776	10.1371/journal.pone.0133776	http://dx.doi.org/10.1371/journal.pone.0133776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208350	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000137
J	Gillespie, D				Gillespie, Dirk			Algorithm for the Time-Propagation of the Radial Diffusion Equation Based on a Gaussian Quadrature	PLOS ONE			English	Article								The numerical integration of the time-dependent spherically-symmetric radial diffusion equation from a point source is considered. The flux through the source can vary in time, possibly stochastically based on the concentration produced by the source itself. Fick's one-dimensional diffusion equation is integrated over a time interval by considering a source term and a propagation term. The source term adds new particles during the time interval, while the propagation term diffuses the concentration profile of the previous time step. The integral in the propagation term is evaluated numerically using a combination of a new diffusion-specific Gaussian quadrature and interpolation on a diffusion-specific grid. This attempts to balance accuracy with the least number of points for both integration and interpolation. The theory can also be extended to include a simple reaction-diffusion equation in the limit of high buffer concentrations. The method is unconditionally stable. In fact, not only does it converge for any time step Delta t, the method offers one advantage over other methods because Delta t can be arbitrarily large; it is solely defined by the timescale on which the flux source turns on and off.	Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Rush University	Gillespie, D (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, 1750 West Harrison St,Suite 1289, Chicago, IL 60612 USA.	dirk_gillespie@rush.edu			American Heart Association [14GRNT20380691]	American Heart Association(American Heart Association)	This work was done during the term of Award 14GRNT20380691 from the American Heart Association (www.heart.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton G., 1989, ELEMENTS GREENS FUNC; Bers DM, 2001, EXCITATION CONTRACTI; Conlisk A.T., 2012, ESSENTIALS MICRO NAN; Crank J, 1980, MATH DIFFUSION; Cussler E. L, 2009, DIFFUSION MASS TRANS; Fick, 1855, PHILOS MAG, V170, P59, DOI [10.1080/14786445508641925, DOI 10.1080/14786445508641925, 10.1016/0376-7388(94)00230-V]; Fick A., 1855, ANN PHYS-NEW YORK, V170, P59, DOI [10.1002/andp.18551700105, DOI 10.1002/ANDP.18551700105]; FORNBERG B, 1988, MATH COMPUT, V51, P699, DOI 10.1090/S0025-5718-1988-0935077-0; GOLUB GH, 1969, MATH COMPUT, V23, P221, DOI 10.2307/2004418; Gradshteyn I. S., 2014, TABLE INTEGRALS SERI; GREENGARD L, 1991, SIAM J SCI STAT COMP, V12, P79, DOI 10.1137/0912004; Li JR, 2007, J COMPUT PHYS, V226, P1891, DOI 10.1016/j.jcp.2007.06.021; Neher E., 1986, CALCIUM ELECTROGENES, V14, P80; Press W. H., 1992, ART SCI COMPUTING; Stern MD, 2013, J GEN PHYSIOL, V142, P257, DOI 10.1085/jgp.201311034	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132273	10.1371/journal.pone.0132273	http://dx.doi.org/10.1371/journal.pone.0132273			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208111	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000024
J	Hirano, T; Murakami, T; Ono, H; Sakurai, A; Tominaga, T; Takahashi, T; Nagai, K; Doi, T; Abe, H				Hirano, Takahiro; Murakami, Taichi; Ono, Hiroyuki; Sakurai, Akiko; Tominaga, Tatsuya; Takahashi, Toshikazu; Nagai, Kojiro; Doi, Toshio; Abe, Hideharu			A Novel Interaction between FLICE-Associated Huge Protein (FLASH) and E2A Regulates Cell Proliferation and Cellular Senescence via Tumor Necrosis Factor (TNF)-Alpha-p21WAF1/CIP1 Axis	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; GLOMERULAR MESANGIAL CELLS; KINASE INHIBITOR P21; HUMAN FIBROBLASTS; MATRIX EXPANSION; IN-VIVO; EXPRESSION; RAT; GLOMERULONEPHRITIS; APOPTOSIS	Dysregulation of the cell proliferation has been implicated in the pathophysiology of a number of diseases. Cellular senescence limits proliferation of cancer cells, preventing tumorigenesis and restricting tissue damage. However, the role of cellular senescence in proliferative nephritis has not been determined. The proliferative peak in experimental rat nephritis coincided with a peak in E2A expression in the glomeruli. Meanwhile, E12 (an E2A-encoded transcription factor) did not promote proliferation of Mesangial cells (MCs) by itself. We identified caspase-8-binding protein FLICE-associated huge protein (FLASH) as a novel E2A-binding partner by using a yeast two-hybrid screening. Knockdown of FLASH suppressed proliferation of MCs. This inhibitory effect was partially reversed by the knockdown of E2A. In addition, the knockdown of FLASH induced cyclin-dependent kinase inhibitor p21WAF1/CIP1 (p21) expression, but did not affect p53 expression. Furthermore, overexpression of E12 and E47 induced p21, but not p53 in MCs, in the absence of FLASH. We also demonstrated that E2A and p21 expression at the peak of proliferation was followed by significant induction of FLASH in mesangial areas in rat proliferative glomerulonephritis. Moreover, we revealed that FLASH negatively regulates cellular senescence via the interaction with E12. We also demonstrated that FLASH is involved in the TNF-alpha-induced p21 expressions. These results suggest that the functional interaction of E2A and FLASH play an important role in cell proliferation and cellular senescence via regulation of p21 expression in experimental glomerulonephritis.	[Hirano, Takahiro; Murakami, Taichi; Ono, Hiroyuki; Sakurai, Akiko; Tominaga, Tatsuya; Takahashi, Toshikazu; Nagai, Kojiro; Doi, Toshio; Abe, Hideharu] Univ Tokushima, Dept Nephrol, Grad Sch, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University	Abe, H (corresponding author), Univ Tokushima, Dept Nephrol, Grad Sch, Inst Hlth Biosci, Tokushima 770, Japan.	abeabe@tokushima-u.ac.jp			Kidney Foundation of Japan [JKFB09-41]; Kidney Foundation, Japan [JKFB13-34];  [24659279];  [2459120]	Kidney Foundation of Japan; Kidney Foundation, Japan(Kidney Foundation, Japan); ; 	This work was supported by a grant from The Kidney Foundation of Japan (JKFB09-41), by funds from The Kidney Foundation, Japan (JKFB13-34), and by Grants-in-Aid for Scientific Research (24659279 and 2459120).	Abe H, 2012, J BIOL CHEM, V287, P20430, DOI 10.1074/jbc.M111.275610; AUSIELLO DA, 1980, J CLIN INVEST, V65, P754, DOI 10.1172/JCI109723; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CHEVREMONT M, 1951, NATURE, V167, P772, DOI 10.1038/167772a0; Coates SSA, 2007, J PHARMACOL EXP THER, V322, P70, DOI 10.1124/jpet.106.118018; Conlon Thomas M., 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-11; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; ENG E, 1994, KIDNEY INT, V45, pS45; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; FOGO A, 1989, SEMIN NEPHROL, V9, P329; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jefferson JA, 1999, J NEPHROL, V12, P297; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Ledent Valerie, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-6-RESEARCH0030; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Makibayashi K, 2001, AM J PATHOL, V158, P1733, DOI 10.1016/S0002-9440(10)64129-6; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Monkawa T, 2006, NEPHRON EXP NEPHROL, V102, pE8, DOI 10.1159/000088311; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Pagliuca A, 2000, CANCER RES, V60, P1376; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Roninson IB, 2003, CANCER RES, V63, P2705; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rowe SJ, 2002, J IMMUNOL, V169, P6401, DOI 10.4049/jimmunol.169.11.6401; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rutherford MN, 1998, AM J PATHOL, V153, P165, DOI 10.1016/S0002-9440(10)65557-5; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Serhan CN, 2004, HISTOCHEM CELL BIOL, V122, P305, DOI 10.1007/s00418-004-0695-8; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SIMONSON MS, 1993, NUCLEIC ACIDS RES, V21, P5767, DOI 10.1093/nar/21.24.5767; STRIKER LJ, 1989, SEMIN NEPHROL, V9, P318; Takahashi T, 2005, J BIOL CHEM, V280, P7100, DOI 10.1074/jbc.M411064200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; YAMAMOTO T, 1994, KIDNEY INT, V45, P916, DOI 10.1038/ki.1994.122; YAMAMOTO T, 1987, J IMMUNOL, V138, P3758	56	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133205	10.1371/journal.pone.0133205	http://dx.doi.org/10.1371/journal.pone.0133205			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208142	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000065
J	Rotonda, C; Anota, A; Mercier, M; Bastien, B; Lacoste, G; Limacher, JM; Quoix, E; Bonnetain, F				Rotonda, Christine; Anota, Amelie; Mercier, Mariette; Bastien, Berangere; Lacoste, Gisele; Limacher, Jean-Marc; Quoix, Elisabeth; Bonnetain, Franck			Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial	PLOS ONE			English	Article							CHEMOTHERAPY; SURVIVAL; PREDICTOR; THERAPY	Background This study describes the effect of TG4010 vaccine on Health related Quality of Life (HRQOL) in patients with stage IIIb and IV non-small-cell lung cancer (NSCLC). Methods 148 patients with advanced NSCLC expressing MUC1 were randomly assigned to receive TG4010 plus chemotherapy or chemotherapy alone. HRQOL was assessed with the Functional Assessment of Cancer Therapy-Lung (FACT-L) at baseline and every 6 weeks until disease progression. Time until definitive deterioration (TUDD) of the four well-being dimensions of the FACT-L physical (PWB), functional (FWB), emotional (EWB) and social wellbeing (SWB) and the Lung Cancer Subscale (LCS) domains were analyzed for a 5-point minimal clinically important difference. Results No difference of TUDD of HRQOL has been found between treatment arms. No prognostic factors have been found to have a significant impact on the TUDD of PWB, SWB and LCS domains. The gender, the performance status and the smoking habits seemed to be associated with a shorter TUDD of EWB domain. The smokers and the former smokers seemed to present a shorter TUDD of FWB domain. Conclusion This study suggests that adding therapeutic vaccination with TG4010 to standard chemotherapy in patients with advanced NSCLC is associated with a similar evolution in HRQOL compared to chemotherapy alone.	[Rotonda, Christine; Anota, Amelie; Mercier, Mariette; Bonnetain, Franck] Natl Qual Life Oncol Platform, Nancy, France; [Rotonda, Christine] INSERM, CIC EC CIE6, Nancy, France; [Rotonda, Christine] CHU Nancy, Clin Epidemiol & Evaluat Dept, Nancy, France; [Anota, Amelie; Mercier, Mariette; Bonnetain, Franck] Univ Franche Comte, EA 3181, F-25030 Besancon, France; [Anota, Amelie; Bonnetain, Franck] CHU Besancon, Methodol & Qual Life Unit Oncol, F-25030 Besancon, France; [Bastien, Berangere; Lacoste, Gisele; Limacher, Jean-Marc] Transgene SA, Illkirch Graffenstaden, France; [Quoix, Elisabeth] Hop Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; Transgene SA; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Anota, A (corresponding author), Natl Qual Life Oncol Platform, Nancy, France.	aanota@chu-besancon.fr		, Christine/0000-0002-8854-0591	Transgene SAS; ADNA, a French government; Transgene SA	Transgene SAS(Transgene SA); ADNA, a French government; Transgene SA(Transgene SA)	This study was supported by Transgene SAS and by ADNA, a French government-funded programme for personalised medicine. GL, BB and JML are full time employees of Transgene SA. Transgene SA provided support in the form of salaries for authors GL, BB and JML, and as the sponsor of the study was involved in the study design, data collection and analysis, decision to publish, or review of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belani CP, 2006, LUNG CANCER, V53, P231, DOI 10.1016/j.lungcan.2006.05.003; Bonnetain F, 2010, EUR J CANCER, V46, P2753, DOI 10.1016/j.ejca.2010.07.023; Braun DP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-353; Butts C, 2005, J CLIN ONCOL, V23, P6674, DOI 10.1200/JCO.2005.13.011; CELLA DF, 1995, LUNG CANCER-J IASLC, V12, P199, DOI 10.1016/0169-5002(95)00450-F; Claassens L, 2011, J CLIN ONCOL, V29, P2104, DOI 10.1200/JCO.2010.32.3683; Decoster L, 2012, ANN ONCOL, V23, P1387, DOI 10.1093/annonc/mdr564; Dharma-Wardene M, 2004, QUAL LIFE RES, V13, P1209, DOI 10.1023/B:QURE.0000037481.36604.eb; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; Gridelli C, 2001, ANN ONCOL, V12, pS21, DOI 10.1093/annonc/12.suppl_3.S21; Hollen PJ, 1996, SEMIN ONCOL, V23, P31; Matsuda A, 2012, EXP THER MED, V3, P134, DOI 10.3892/etm.2011.368; Montazeri A, 2001, LUNG CANCER, V31, P233, DOI 10.1016/S0169-5002(00)00179-3; O'Brien MER, 2004, ANN ONCOL, V15, P906, DOI 10.1093/annonc/mdh220; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pallis AG, 2009, EUR J CANCER, V45, P2473, DOI 10.1016/j.ejca.2009.06.005; Quoix E, 2011, LANCET ONCOL, V12, P1125, DOI 10.1016/S1470-2045(11)70259-5; Rossi Antonio, 2009, Curr Drug Discov Technol, V6, P91; Saad ED, 2012, CANCER TREAT REV, V38, P807, DOI 10.1016/j.ctrv.2012.02.012; Somerfield MR, 1997, J CLIN ONCOL, V15, P2996; Team RDC, 2010, R LANG ENV STAT COMP	22	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132568	10.1371/journal.pone.0132568	http://dx.doi.org/10.1371/journal.pone.0132568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207902	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000032
J	Thielen, J; van den Broek, P; Farquhar, J; Desain, P				Thielen, Jordy; van den Broek, Philip; Farquhar, Jason; Desain, Peter			Broad-Band Visually Evoked Potentials: Re (con)volution in Brain-Computer Interfacing	PLOS ONE			English	Article								Brain-Computer Interfaces (BCIs) allow users to control devices and communicate by using brain activity only. BCIs based on broad-band visual stimulation can outperform BCIs using other stimulation paradigms. Visual stimulation with pseudo-random bit-sequences evokes specific Broad-Band Visually Evoked Potentials (BBVEPs) that can be reliably used in BCI for high-speed communication in speller applications. In this study, we report a novel paradigm for a BBVEP-based BCI that utilizes a generative framework to predict responses to broad-band stimulation sequences. In this study we designed a BBVEP-based BCI using modulated Gold codes to mark cells in a visual speller BCI. We defined a linear generative model that decomposes full responses into overlapping single-flash responses. These single- flash responses are used to predict responses to novel stimulation sequences, which in turn serve as templates for classification. The linear generative model explains on average 50% and up to 66% of the variance of responses to both seen and unseen sequences. In an online experiment, 12 participants tested a 6 x 6 matrix speller BCI. On average, an online accuracy of 86% was reached with trial lengths of 3.21 seconds. This corresponds to an Information Transfer Rate of 48 bits per minute (approximately 9 symbols per minute). This study indicates the potential to model and predict responses to broad-band stimulation. These predicted responses are proven to be well-suited as templates for a BBVEP-based BCI, thereby enabling communication and control by brain activity only.	[Thielen, Jordy; van den Broek, Philip; Farquhar, Jason; Desain, Peter] Radboud Univ Nijmegen, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Thielen, J (corresponding author), Radboud Univ Nijmegen, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands.	jordy.thielen@gmail.com	Desain, Peter/D-1267-2012; Thielen, Jordy/AAD-3685-2021; Thielen, Jordy/Q-8599-2018	Thielen, Jordy/0000-0002-6264-0367; 	BrainGain Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06011]	BrainGain Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	This work was supported by BrainGain Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (SSM06011, P. Desain).	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Capilla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014543; DESAIN P, 2008, 4 INT BCI WORKSH TRA; Desain P, 2014, NL Patent, Patent No. 2013245; Desain P, 2015, DANS; Desain P, 2009, US Patent, Patent No. [US20110251511, 20110251511]; Farquhar J., 2008, P 4 INT BCI WORKSH T, P50; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; GOLD R, 1967, IEEE T INFORM THEORY, V13, P619, DOI 10.1109/TIT.1967.1054048; Golomb SW, 1982, SHIFT REGISTER SEQUE, P78; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Lalor EC, 2006, NEUROIMAGE, V32, P1549, DOI 10.1016/j.neuroimage.2006.05.054; Schreuder M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036025; Schreuder M, 2011, IEEE ENG MED BIO, P4580, DOI 10.1109/IEMBS.2011.6091134; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Spuler M, 2012, P 20 EUR S ART NEUR, P103, DOI [10.13140/2.1.2186.7526, DOI 10.13140/2.1.2186.7526]; Sutter E. E., 1984, Proceedings of the Symposium on Biosensors (Cat. No. 84CH2068-5), P95; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Tan P., 2006, INTRO DATA MINING; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231	25	28	38	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133797	10.1371/journal.pone.0133797	http://dx.doi.org/10.1371/journal.pone.0133797			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208328	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000147
J	Weng, J; Dong, SS; He, HJ; Chen, FY; Peng, XG				Weng, Jian; Dong, Shanshan; He, Hongjian; Chen, Feiyan; Peng, Xiaogang			Reducing Individual Variation for fMRI Studies in Children by Minimizing Template Related Errors	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; SPATIAL NORMALIZATION; FUNCTIONAL MRI; DECISION-MAKING; WORKING-MEMORY; HEAD SIZE; BRAIN; IMAGES; ADULTS; REGISTRATION	Spatial normalization is an essential process for group comparisons in functional MRI studies. In practice, there is a risk of normalization errors particularly in studies involving children, seniors or diseased populations and in regions with high individual variation. One way to minimize normalization errors is to create a study-specific template based on a large sample size. However, studies with a large sample size are not always feasible, particularly for children studies. The performance of templates with a small sample size has not been evaluated in fMRI studies in children. In the current study, this issue was encountered in a working memory task with 29 children in two groups. We compared the performance of different templates: a study-specific template created by the experimental population, a Chinese children template and the widely used adult MNI template. We observed distinct differences in the right orbitofrontal region among the three templates in between-group comparisons. The study-specific template and the Chinese children template were more sensitive for the detection of between-group differences in the orbitofrontal cortex than the MNI template. Proper templates could effectively reduce individual variation. Further analysis revealed a correlation between the BOLD contrast size and the norm index of the affine transformation matrix, i.e., the SFN, which characterizes the difference between a template and a native image and differs significantly across subjects. Thereby, we proposed and tested another method to reduce individual variation that included the SFN as a covariate in group-wise statistics. This correction exhibits outstanding performance in enhancing detection power in group-level tests. A training effect of abacus-based mental calculation was also demonstrated, with significantly elevated activation in the right orbitofrontal region that correlated with behavioral response time across subjects in the trained group.	[Weng, Jian; Dong, Shanshan; Chen, Feiyan] Zhejiang Univ, Dept Phys, Bio X Lab, Hangzhou 310003, Zhejiang, Peoples R China; [He, Hongjian] Zhejiang Univ, Dept Biomed Engn, Ctr Brain Imaging Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Peng, Xiaogang] First Hosp Qiqihar, Qiqihar, Heilongjiang, Peoples R China	Zhejiang University; Zhejiang University	He, HJ (corresponding author), Zhejiang Univ, Dept Biomed Engn, Ctr Brain Imaging Sci & Technol, Hangzhou 310003, Zhejiang, Peoples R China.	hehongj@gmail.com	Chen, Feiyan/AAD-8940-2022	Chen, Feiyan/0000-0003-3730-1651	863 Program [2012AA011603, 2012AA011602]; National Natural Science Foundation of China [030900389, 31270026]; Fundamental Research Funds for the Central Universities [2014QNA3005, JS 7-15-2015, SF 04042242]	863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work has been funded by grants included: the 863 Program (2012AA011603, 2012AA011602), the National Natural Science Foundation of China (No. 030900389, No. 31270026), and the Fundamental Research Funds for the Central Universities (Program No. 2014QNA3005) by Dr. Feiyan Chen who has the role in data collecting." (JS 7-15-2015, SF 04042242)	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Chen FY, 2006, NEUROSCI LETT, V403, P46, DOI 10.1016/j.neulet.2006.04.041; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Frindel C, 2009, MED IMAGE ANAL, V13, P405, DOI 10.1016/j.media.2009.01.002; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Geng XJ, 2009, NEUROIMAGE, V47, P1341, DOI 10.1016/j.neuroimage.2009.04.024; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Hoeksma MR, 2005, CLIN NEUROPHYSIOL, V116, P1188, DOI 10.1016/j.clinph.2004.12.021; Huang CM, 2010, J NEUROSCI METH, V189, P257, DOI 10.1016/j.jneumeth.2010.03.021; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Li YX, 2013, BRAIN RES, V1539, P24, DOI 10.1016/j.brainres.2013.09.030; LoPresti ML, 2008, J NEUROSCI, V28, P3718, DOI 10.1523/JNEUROSCI.0464-08.2008; Luo YS, 2014, HUM BRAIN MAPP, V35, P3880, DOI 10.1002/hbm.22444; MATHALON DH, 1993, PSYCHIAT RES-NEUROIM, V50, P121, DOI 10.1016/S0165-1781(05)80006-X; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; Pollari M, 2007, I S BIOMED IMAGING, P768, DOI 10.1109/ISBI.2007.356965; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Schon K, 2008, NEUROIMAGE, V39, P857, DOI 10.1016/j.neuroimage.2007.09.023; Shen S, 2007, MAGN RESON IMAGING, V25, P1385, DOI 10.1016/j.mri.2007.03.025; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Uchiyama HT, 2013, BRAIN DEV-JPN, V35, P228, DOI 10.1016/j.braindev.2012.04.005; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wang ZZ, 2004, PROC CVPR IEEE, P228; Weisstein E. W., MATRIX NORM MATHWORL; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Yeo BTT, 2010, IEEE T MED IMAGING, V29, P1424, DOI 10.1109/TMI.2010.2049497; Yoon U, 2009, NEUROIMAGE, V45, P769, DOI 10.1016/j.neuroimage.2008.12.046	36	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134195	10.1371/journal.pone.0134195	http://dx.doi.org/10.1371/journal.pone.0134195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207985	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000213
J	D'Hulst, C; Heulens, I; Van der Aa, N; Goffin, K; Koole, M; Porke, K; Van De Velde, M; Rooms, L; Van Paesschen, W; Van Esch, H; Van Laere, K; Kooy, RF				D'Hulst, Charlotte; Heulens, Inge; Van der Aa, Nathalie; Goffin, Karolien; Koole, Michel; Porke, Kathleen; Van De Velde, Marc; Rooms, Liesbeth; Van Paesschen, Wim; Van Esch, Hilde; Van Laere, Koen; Kooy, R. Frank			Positron Emission Tomography (PET) Quantification of GABA(A) Receptors in the Brain of Fragile X Patients	PLOS ONE			English	Article							IN-VIVO; C-11 FLUMAZENIL; MOUSE MODEL; SUBUNIT; BINDING; MECHANISMS; DEFICITS	Over the last several years, evidence has accumulated that the GABA(A) receptor is compromised in animal models for fragile X syndrome (FXS), a common hereditary form of intellectual disability. In mouse and fly models, agonists of the GABA(A) receptor were able to rescue specific consequences of the fragile X mutation. Here, we imaged and quantified GABA(A) receptors in vivo in brain of fragile X patients using Positron Emission Topography (PET) and [C-11] flumazenil, a known high-affinity and specific ligand for the benzodiazepine site of GABA(A) receptors. We measured regional GABA(A) receptor availability in 10 fragile X patients and 10 control subjects. We found a significant reduction of on average 10% in GABA(A) receptor binding potential throughout the brain in fragile X patients. In the thalamus, the brain region showing the largest difference, the GABA(A) receptor availability was even reduced with 17%. This is one of the first reports of a PET study of human fragile X brain and directly demonstrates that the GABA(A) receptor availability is reduced in fragile X patients. The study reinforces previous hypotheses that the GABA(A) receptor is a potential target for rational pharmacological treatment of fragile X syndrome.	[D'Hulst, Charlotte; Heulens, Inge; Van der Aa, Nathalie; Rooms, Liesbeth; Kooy, R. Frank] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Van der Aa, Nathalie] Univ Antwerp Hosp, Dept Med Genet, Antwerp, Belgium; [Goffin, Karolien; Koole, Michel; Van Laere, Koen] Univ Hosp Leuven, Div Nucl Med & Mol Imaging, Leuven, Belgium; [Porke, Kathleen] Univ Hosp Leuven, Dept Neuropsychol, Leuven, Belgium; [Van De Velde, Marc] Univ Hosp Leuven, Dept Anaesthesiol, Leuven, Belgium; [Van Paesschen, Wim] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Van Esch, Hilde] Univ Hosp, Ctr Human Genet, Leuven, Belgium; [Van Esch, Hilde] KULeuven, Leuven, Belgium	University of Antwerp; University of Antwerp; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven	Kooy, RF (corresponding author), Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium.	Frank.Kooy@uantwerpen.be	Van+Esch, Hilde/AAU-5688-2020; Kooy, Frank/F-5276-2014; Van Paesschen, Wim/A-4540-2010	Kooy, Frank/0000-0003-2024-0485; Van Paesschen, Wim/0000-0002-8535-1699; Van Esch, Hilde/0000-0002-9604-5726; Koole, Michel/0000-0001-5862-640X	FRAXA; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen); Research Foundation Flanders (FWO); Jerome Lejeune; National Fragile X Foundation (William & Enid Rosen Research Fund)	FRAXA; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); Jerome Lejeune; National Fragile X Foundation (William & Enid Rosen Research Fund)	This study was supported through grants of FRAXA, the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT Vlaanderen), Research Foundation Flanders (FWO), Jerome Lejeune and the National Fragile X Foundation (William & Enid Rosen Research Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141; Barnard EA, 1998, PHARMACOL REV, V50, P291; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Braat S, 2015, CELL CYCLE, V14, P2985, DOI 10.4161/15384101.2014.989114; Braat S, 2015, NEUROPHARMACOLOGY, V88, P48, DOI 10.1016/j.neuropharm.2014.06.028; Braat S, 2014, DRUG DISCOV TODAY, V19, P510, DOI 10.1016/j.drudis.2014.01.013; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Colak D, 2014, SCIENCE, V343, P1002, DOI 10.1126/science.1245831; Cummings JL, 2007, NEUROLOGY, V69, P1622, DOI 10.1212/01.wnl.0000295996.54210.69; D'Hulst C, 2009, J MED GENET, V46, P577, DOI 10.1136/jmg.2008.064667; D'Hulst C, 2007, TRENDS NEUROSCI, V30, P425, DOI 10.1016/j.tins.2007.06.003; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; D'Hulst C, 2009, BRAIN RES, V1253, P176, DOI 10.1016/j.brainres.2008.11.075; Errijgers V, 2004, CYTOGENET GENOME RES, V105, P448, DOI 10.1159/000078218; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Heulens I, 2012, BEHAV BRAIN RES, V229, P244, DOI 10.1016/j.bbr.2012.01.031; Heulens I, 2011, FRONT BIOSCI-LANDMRK, V16, P1211, DOI 10.2741/3785; Holopainen IE, 2001, ANN NEUROL, V49, P110, DOI 10.1002/1531-8249(200101)49:1<110::AID-ANA17>3.0.CO;2-T; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Kooy RF, 1997, HUMAN GENOME METHODS, P23; Levenga J, 2010, TRENDS MOL MED, V16, P516, DOI 10.1016/j.molmed.2010.08.005; Lucignani G, 2004, NEUROIMAGE, V22, P22, DOI 10.1016/j.neuroimage.2003.10.050; Menold MM, 2001, J NEUROGENET, V15, P245, DOI 10.3109/01677060109167380; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Musumeci SA, 1999, EPILEPSIA, V40, P1092, DOI 10.1111/j.1528-1157.1999.tb00824.x; Olmos-Serrano JL, 2011, DEV NEUROSCI-BASEL, V33, P395, DOI 10.1159/000332884; Olmos-Serrano JL, 2010, J NEUROSCI, V30, P9929, DOI 10.1523/JNEUROSCI.1714-10.2010; Perkins AC, 2004, CURR PHARM DESIGN, V10, P2907, DOI 10.2174/1381612043383476; Salmi E, 2008, NEUROIMAGE, V41, P260, DOI 10.1016/j.neuroimage.2008.02.035; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Sundaram SK, 2005, MENT RETARD DEV D R, V11, P325, DOI 10.1002/mrdd.20086; Van Laere K, 2006, J NUCL MED, V47, P740; Van Laere K, 2008, BIOL PSYCHIAT, V64, P153, DOI 10.1016/j.biopsych.2008.01.021; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330	36	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131486	10.1371/journal.pone.0131486	http://dx.doi.org/10.1371/journal.pone.0131486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222316	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800015
J	Higashiyama, Y; Takeda, K; Someya, Y; Kuroiwa, Y; Tanaka, F				Higashiyama, Yuichi; Takeda, Katsuhiko; Someya, Yoshiaki; Kuroiwa, Yoshiyuki; Tanaka, Fumiaki			The Neural Basis of Typewriting: A Functional MRI Study	PLOS ONE			English	Article							WRITTEN WORD PRODUCTION; LESION LOCALIZATION; CORTEX INVOLVEMENT; MENTAL ROTATION; PREMOTOR CORTEX; AGRAPHIA; FMRI; MEMORY; MOTOR; ACTIVATIONS	To investigate the neural substrate of typewriting Japanese words and to detect the difference between the neural substrate of typewriting and handwriting, we conducted a functional magnetic resonance imaging (fMRI) study in 16 healthy volunteers. All subjects were skillful touch typists and performed five tasks: a typing task, a writing task, a reading task, and two control tasks. Three brain regions were activated during both the typing and the writing tasks: the left superior parietal lobule, the left supramarginal gyrus, and the left premotor cortex close to Exner's area. Although typing and writing involved common brain regions, direct comparison between the typing and the writing task revealed greater left posteromedial intraparietal cortex activation in the typing task. In addition, activity in the left premotor cortex was more rostral in the typing task than in the writing task. These findings suggest that, although the brain circuits involved in Japanese typewriting are almost the same as those involved in handwriting, there are brain regions that are specific for typewriting.	[Higashiyama, Yuichi; Kuroiwa, Yoshiyuki; Tanaka, Fumiaki] Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan; [Higashiyama, Yuichi; Takeda, Katsuhiko] Int Univ Hlth & Welf, Mita Hosp, Dept Neurol, Tokyo, Japan; [Someya, Yoshiaki] Keio Univ, Ctr Adv Res Log & Sensibil, Tokyo, Japan	Yokohama City University; International University of Health & Welfare; Keio University	Tanaka, F (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa 232, Japan.	ftanaka@yokohama-cu.ac.jp						ALEXANDER MP, 1992, ARCH NEUROL-CHICAGO, V49, P246, DOI 10.1001/archneur.1992.00530270060019; ALEXANDER MP, 1992, BRAIN LANG, V43, P83, DOI 10.1016/0093-934X(92)90022-7; Amano S., 2000, NTT DATABASE SERIES; BEAUVOIS MF, 1981, BRAIN, V104, P21, DOI 10.1093/brain/104.1.21; Beeson PM, 2003, APHASIOLOGY, V17, P647, DOI 10.1080/02687030344000067; Buchwald A, 2009, COGN NEUROPSYCHOL, V26, P724, DOI 10.1080/02643291003707332; Cloutman L, 2009, ANN NEUROL, V66, P249, DOI 10.1002/ana.21693; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cook Fabian Alexander Blyth, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-200257; Dejerine JJ, 1892, CONTRIBUTION A LETUD; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Exner S., 1881, UNTERSUCHUNGEN UBER; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Fujii N, 2000, J NEUROPHYSIOL, V83, P1764, DOI 10.1152/jn.2000.83.3.1764; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Grefkes C, 2004, NEUROIMAGE, V23, P1494, DOI 10.1016/j.neuroimage.2004.08.031; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Katanoda K, 2001, HUM BRAIN MAPP, V13, P34, DOI 10.1002/hbm.1023; Magrassi L, 2010, BRAIN RES, V1346, P145, DOI 10.1016/j.brainres.2010.05.046; Menon V, 2001, COGNITIVE BRAIN RES, V12, P337, DOI 10.1016/S0926-6410(01)00063-5; Neggers SFW, 2006, NEUROIMAGE, V31, P320, DOI 10.1016/j.neuroimage.2005.12.028; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otsuki M, 2002, EUR NEUROL, V47, P136, DOI 10.1159/000047971; Purcell JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00239; Purcell JJ, 2011, NEUROIMAGE, V55, P750, DOI 10.1016/j.neuroimage.2010.11.042; Rapp B, 2002, COGN NEUROPSYCHOL, V19, P1, DOI 10.1080/0264329014300060; Rapp B, 2011, J COGNITIVE NEUROSCI, V23, P4067, DOI 10.1162/jocn_a_00109; Rapp B, 2011, J COGNITIVE NEUROSCI, V23, P1180, DOI 10.1162/jocn.2010.21507; ROELTGEN DP, 1984, BRAIN, V107, P811, DOI 10.1093/brain/107.3.811; Roux FE, 2014, CORTEX, V50, P64, DOI 10.1016/j.cortex.2013.09.012; Roux FE, 2010, CORTEX, V46, P1204, DOI 10.1016/j.cortex.2010.03.001; Roux FE, 2009, ANN NEUROL, V66, P537, DOI 10.1002/ana.21804; Ryu DW, 2012, ALZ DIS ASSOC DIS, V26, P285, DOI 10.1097/WAD.0b013e318231e614; Sakurai Y, 2007, BEHAV NEUROL, V18, P99, DOI 10.1155/2007/906417; SALTHOUSE TA, 1986, PSYCHOL BULL, V99, P303, DOI 10.1037/0033-2909.99.3.303; Sato M, 1983, No To Shinkei, V35, P1145; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; SHALLICE T, 1981, BRAIN, V104, P413, DOI 10.1093/brain/104.3.413; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Sugihara G, 2006, NEUROIMAGE, V32, P1837, DOI 10.1016/j.neuroimage.2006.05.035; TANAKA Y, 1987, CORTEX, V23, P679, DOI 10.1016/S0010-9452(87)80058-8; TOHGI H, 1995, J NEUROL NEUROSUR PS, V58, P629, DOI 10.1136/jnnp.58.5.629; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vingerhoets G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00151; Voyer D, 1995, BRAIN COGNITION, V29, P326, DOI 10.1006/brcg.1995.1285	47	10	10	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134131	10.1371/journal.pone.0134131	http://dx.doi.org/10.1371/journal.pone.0134131			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218431	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900082
J	Kirsten, TB; Chaves-Kirsten, GP; Bernardes, S; Scavone, C; Sarkis, JE; Bernardi, MM; Felicio, LF				Kirsten, Thiago Berti; Chaves-Kirsten, Gabriela P.; Bernardes, Suene; Scavone, Cristoforo; Sarkis, Jorge E.; Bernardi, Maria Martha; Felicio, Luciano F.			Lipopolysaccharide Exposure Induces Maternal Hypozincemia, and Prenatal Zinc Treatment Prevents Autistic-Like Behaviors and Disturbances in the Striatal Dopaminergic and mTOR Systems of Offspring	PLOS ONE			English	Article							IMMUNE ACTIVATION; ORGANOPHOSPHATE PESTICIDE; NEURODEVELOPMENTAL DAMAGE; INDUCED TERATOGENICITY; SPECTRUM DISORDERS; SOCIAL-BEHAVIOR; AMNIOTIC-FLUID; RODENT MODELS; BRAIN-INJURY; DOUBLE-BLIND	Autism is characterized by social deficits, repetitive behaviors, and cognitive inflexibility. The risk factors appear to include genetic and environmental conditions, such as prenatal infections and maternal dietary factors. Previous investigations by our group have demonstrated that prenatal exposure to lipopolysaccharide (LPS), which mimics infection by gram-negative bacteria, induces autistic-like behaviors. To understand the causes of autistic-like behaviors, we evaluated maternal serum metal concentrations, which are involved in intrauterine development and infection/inflammation. We identified reduced maternal levels of zinc, magnesium, selenium and manganese after LPS exposure. Because LPS induced maternal hypozincemia, we treated dams with zinc in an attempt to prevent or ease the impairments in the offspring. We evaluated the social and cognitive autistic-like behaviors and brain tissues of the offspring to identify the central mechanism that triggers the development of autism. Prenatal LPS exposure impaired play behaviors and T-maze spontaneous alternations, i.e., it induced autistic-like behaviors. Prenatal LPS also decreased tyrosine hydroxylase levels and increased the levels of mammalian target of rapamycin (mTOR) in the striatum. Thus, striatal dopaminergic impairments may be related to autism. Moreover, excessive signaling through the mTOR pathway has been considered a biomarker of autism, corroborating our rat model of autism. Prenatal zinc treatment prevented these autistic-like behaviors and striatal dopaminergic and mTOR disturbances in the offspring induced by LPS exposure. The present findings revealed a possible relation between maternal hypozincemia during gestation and the onset of autism. Furthermore, prenatal zinc administration appears to have a beneficial effect on the prevention of autism.	[Kirsten, Thiago Berti; Felicio, Luciano F.] Univ Sao Paulo, Dept Pathol, Sch Vet Med, Sao Paulo, Brazil; [Kirsten, Thiago Berti; Bernardi, Maria Martha] Univ Paulista, Environm & Expt Pathol, Sao Paulo, Brazil; [Chaves-Kirsten, Gabriela P.; Scavone, Cristoforo] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Bernardes, Suene] Univ Sao Paulo, Inst Phys, Sao Paulo, Brazil; [Sarkis, Jorge E.] Univ Sao Paulo, Inst Energy & Nucl Res IPEN, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo	Kirsten, TB (corresponding author), Univ Sao Paulo, Dept Pathol, Sch Vet Med, Sao Paulo, Brazil.	thik@outlook.com	Bernardi, Maria/T-6813-2019; Kirsten, Thiago Berti/AAS-2166-2021; Scavone, Cristoforo/C-1580-2012; Bernardi, M. M./H-8418-2012; Scavone, Cristoforo/AFK-9950-2022; Felicio, Luciano F/C-1083-2012; Scavone, Cristoforo/ABB-8279-2021	Kirsten, Thiago Berti/0000-0002-4032-4355; Scavone, Cristoforo/0000-0002-1206-0882; Bernardi, M. M./0000-0002-6860-9416; Scavone, Cristoforo/0000-0002-1206-0882; Felicio, Luciano F/0000-0002-9068-8317; Scavone, Cristoforo/0000-0002-1206-0882	Sao Paulo Research Foundation (FAPESP) [2012/07007-8, 2013/01610-7, 2009/51886-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio)	This research was supported by the Sao Paulo Research Foundation (FAPESP grant 2012/ 07007-8, 2013/01610-7 and thematic grant 2009/51886-3) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi OO, 2012, AFR HEALTH SCI, V12, P153, DOI 10.4314/ahs.v12i2.12; Akhondzadeh S, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-9; Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P155; Anwary S A, 2011, Mymensingh Med J, V20, P252; Anzolin DG, 2012, MAR POLLUT BULL, V64, P1402, DOI 10.1016/j.marpolbul.2012.04.018; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Barrington JW, 1996, BRIT J OBSTET GYNAEC, V103, P130, DOI 10.1111/j.1471-0528.1996.tb09663.x; Bilici M, 2004, PROG NEURO-PSYCHOPH, V28, P181, DOI 10.1016/j.pnpbp.2003.09.034; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; Carey LC, 2003, BIRTH DEFECTS RES A, V67, P240, DOI 10.1002/bdra.10035; Caulfield LE, 2010, AM J CLIN NUTR, V92, P130, DOI 10.3945/ajcn.2010.29407; Chaves GP, 2008, J NEUROSCI RES, V86, P1626, DOI 10.1002/jnr.21613; Chua JSC, 2012, BRAIN BEHAV IMMUN, V26, P326, DOI 10.1016/j.bbi.2011.10.002; Chua JSC, 2006, PEDIATR RES, V59, P355, DOI 10.1203/01.pdr.0000199906.37619.9c; Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022; DSM-IV, 1994, PERV DEV DIS, P65; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Fernell Elisabeth, 2013, Clin Epidemiol, V5, P33, DOI 10.2147/CLEP.S41714; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; FOSTER HD, 1993, MED HYPOTHESES, V40, P61, DOI 10.1016/0306-9877(93)90198-Y; Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; GUVENC H, 1995, PEDIATRICS, V95, P879; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Johnson NL, 2013, J NURS SCHOLARSHIP, V45, P69, DOI 10.1111/j.1547-5069.2012.01483.x; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; King JC, 2000, AM J CLIN NUTR, V71, p1334S, DOI 10.1093/ajcn/71.5.1334s; Kirsten TB, 2008, THESIS U SAO PAULO S; Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kirsten TB, 2010, NEUROIMMUNOMODULAT, V17, P240, DOI 10.1159/000290040; Kirsten TB, 2011, PHYSIOL BEHAV, V104, P417, DOI 10.1016/j.physbeh.2011.04.049; Kirsten TB, 2011, LIFE SCI, V89, P15, DOI 10.1016/j.lfs.2011.04.023; Kirsten TB, 2010, BEHAV BRAIN RES, V211, P77, DOI 10.1016/j.bbr.2010.03.009; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; KYNAST G, 1986, GYNECOL OBSTET INVES, V21, P117, DOI 10.1159/000298940; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Maywald M, 2015, J TRACE ELEM MED BIO, V29, P24, DOI 10.1016/j.jtemb.2014.06.003; McGuire SO, 2001, EXP NEUROL, V169, P219, DOI 10.1006/exnr.2001.7688; McPheeters ML, 2011, PEDIATRICS, V127, pE1312, DOI 10.1542/peds.2011-0427; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Meyer U, 2012, NEUROPHARMACOLOGY, V62, P1308, DOI 10.1016/j.neuropharm.2011.01.009; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Munhoz CD, 2003, NEUROPHARMACOLOGY, V45, P1151, DOI 10.1016/S0028-3908(03)00278-8; Nakasato A, 2008, BRAIN RES, V1193, P128, DOI 10.1016/j.brainres.2007.11.043; Narita N, 2002, PEDIATR RES, V52, P576, DOI 10.1203/01.PDR.0000028406.01104.76; Okada Y, 2013, J TOXICOL SCI, V38, P363, DOI 10.2131/jts.38.363; PANKSEPP J, 1980, BEHAV NEURAL BIOL, V30, P197, DOI 10.1016/S0163-1047(80)91077-8; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pletnikov MV, 1999, BEHAV BRAIN RES, V100, P43, DOI 10.1016/S0166-4328(98)00111-9; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; Rong YQ, 1996, J NEUROCHEM, V67, P662; Ryu JM, 2009, J CELL PHYSIOL, V218, P558, DOI 10.1002/jcp.21628; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Santos SB, 2012, VIABILIDADE MEDIDA E; SCHOLL TO, 1993, AM J EPIDEMIOL, V137, P1115, DOI 10.1093/oxfordjournals.aje.a116615; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Soto AMS, 2013, LIFE SCI, V92, P852, DOI 10.1016/j.lfs.2013.03.003; Spatling L, 1989, Magnes Res, V2, P271; Summers BL, 2006, PEDIATR RES, V59, P66, DOI 10.1203/01.pdr.0000190573.23893.13; Theoharides TC, 2009, EXPERT OPIN PHARMACO, V10, P2127, DOI 10.1517/14656560903107789; Timofeeva OA, 2008, NEUROTOXICOL TERATOL, V30, P38, DOI 10.1016/j.ntt.2007.10.002; Timofeeva OA, 2008, BRAIN RES BULL, V77, P404, DOI 10.1016/j.brainresbull.2008.08.019; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Veenstra-VanderWeele J, 2012, NEUROPSYCHOPHARMACOL, V37, P196, DOI 10.1038/npp.2011.185; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Wang HS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00028; Wink LK, 2010, EXPERT OPIN EMERG DR, V15, P481, DOI 10.1517/14728214.2010.487860; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Wood RJ, 2009, NUTR REV, V67, P416, DOI 10.1111/j.1753-4887.2009.00214.x	87	34	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134565	10.1371/journal.pone.0134565	http://dx.doi.org/10.1371/journal.pone.0134565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218250	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900124
J	Wang, GL; Sun, S; Xing, GM; Wu, XJ; Wang, F; Xiong, AS				Wang, Guang-Long; Sun, Sheng; Xing, Guo-Ming; Wu, Xue-Jun; Wang, Feng; Xiong, Ai-Sheng			Morphological Characteristics, Anatomical Structure, and Gene Expression: Novel Insights into Cytokinin Accumulation during Carrot Growth and Development	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; DAUCUS-CAROTA L.; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; PLANT DEVELOPMENT; CELL-DIVISION; KINASE CKI1; BIOSYNTHESIS; PERCEPTION; SENESCENCE	Cytokinins have been implicated in normal plant growth and development. These bioactive molecules are essential for cell production and expansion in higher plants. Carrot is an Apiaceae vegetable with great value and undergoes significant size changes over the process of plant growth. However, cytokinin accumulation and its potential roles in carrot growth have not been elucidated. To address this problem, carrot plants at five stages were collected, and morphological and anatomical characteristics and expression profiles of cytokinin-related genes were determined. During carrot growth and development, cytokinin levels were the highest at the second stage in the roots, whereas relatively stable levels were observed in the petioles and leaves. DcCYP735A2 showed high expression at stage 2 in the roots, which may contribute largely to the higher cytokinin level at this stage. However, expression of most metabolic genes did not follow a pattern similar to that of cytokinin accumulation, indicating that cytokinin biosynthesis was regulated through a complex network. Genes involved in cytokinin signal perception and transduction were also integrated to normal plant growth and development. The results from the present work suggested that cytokinins may regulate plant growth in a stage-dependent manner. Our work would shed novel insights into cytokinin accumulation and its potential roles during carrot growth. Further studies regarding carrot cytokinins may be achieved by modification of the genes involved in cytokinin biosynthesis, inactivation, and perception.	[Wang, Guang-Long; Wu, Xue-Jun; Wang, Feng; Xiong, Ai-Sheng] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Sun, Sheng; Xing, Guo-Ming] Shanxi Agr Univ, Coll Hort, Taigu 030801, Peoples R China	Nanjing Agricultural University; Shanxi Agricultural University	Xiong, AS (corresponding author), Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	xiongaisheng@njau.edu.cn	Wang, Guang-Long/ABC-2687-2020	Xiong, Ai-Sheng/0000-0002-7900-5001	New Century Excellent Talents in University [NCET-11-0670]; Jiangsu Natural Science Foundation [BK20130027]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Shanxi Province Coal Based Key Scientific and Technological Project [FT201402-07]	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions; Shanxi Province Coal Based Key Scientific and Technological Project	The research was supported by the New Century Excellent Talents in University (NCET-11-0670); Jiangsu Natural Science Foundation (BK20130027); Priority Academic Program Development of Jiangsu Higher Education Institutions; and Shanxi Province Coal Based Key Scientific and Technological Project (FT201402-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Carimi F, 2004, PLANT SCI, V166, P963, DOI 10.1016/j.plantsci.2003.12.016; CHEN CM, 1985, PLANT PHYSIOL, V78, P510, DOI 10.1104/pp.78.3.510; Cheng C.-Y, 2014, MOL BIOL PLANT SCI 2, P269, DOI [10.1007/978-1-4614-7570-5_14, DOI 10.1007/978-1-4614-7570-5_14]; DEIKMAN J, 1995, PLANT PHYSIOL, V108, P47, DOI 10.1104/pp.108.1.47; Deng Y, 2010, PLANT CELL, V22, P1232, DOI 10.1105/tpc.108.065128; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; El-Showk S, 2013, DEVELOPMENT, V140, P1373, DOI 10.1242/dev.086371; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Galichet A, 2008, PLANT PHYSIOL, V146, P1155, DOI 10.1104/pp.107.107425; Gapper NE, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.34; Guo YF, 2011, PLANT PHYSIOL, V156, P1612, DOI 10.1104/pp.111.177022; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Heyl A, 2003, CURR OPIN PLANT BIOL, V6, P480, DOI 10.1016/S1369-5266(03)00087-6; Houba-Herin N, 1999, PLANT J, V17, P615, DOI 10.1046/j.1365-313X.1999.00408.x; Hradilova J, 2007, J PLANT GROWTH REGUL, V26, P229, DOI 10.1007/s00344-007-9011-x; Huang Y, 2015, MOL BIOL REP, V42, P893, DOI 10.1007/s11033-014-3826-x; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Jeon J, 2013, PLANT PHYSIOL, V161, P408, DOI 10.1104/pp.112.207621; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kieber JJ, 2010, PLANT PHYSIOL, V154, P487, DOI 10.1104/pp.110.161596; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Luby CH, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.15; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Moreira S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056370; Moreno JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058144; Ordaz-Ortiz JJ, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.2; Pekarova B, 2011, PLANT J, V67, P827, DOI 10.1111/j.1365-313X.2011.04637.x; Ren B, 2009, CELL RES, V19, P1178, DOI 10.1038/cr.2009.88; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Shimizu-Sato S, 2001, PLANT PHYSIOL, V127, P1405, DOI 10.1104/pp.010841; Sieberer T, 2003, CURR BIOL, V13, P837, DOI 10.1016/S0960-9822(03)00327-0; Song JC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-78; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Takei K, 2002, J EXP BOT, V53, P971, DOI 10.1093/jexbot/53.370.971; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Tian C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117569; Tokuji Y, 2003, J PLANT PHYSIOL, V160, P133, DOI 10.1078/0176-1617-00892; Veach YK, 2003, PLANT PHYSIOL, V131, P1374, DOI 10.1104/pp.017210; Wang GL, 2015, PLANT PHYSIOL BIOCH, V94, P10, DOI 10.1016/j.plaphy.2015.04.014; Wang GL, 2015, MOL GENET GENOMICS, V290, P1379, DOI 10.1007/s00438-015-0999-5; Wang YP, 2011, PLANT J, V68, P249, DOI 10.1111/j.1365-313X.2011.04683.x; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Wingler A, 1998, PLANT PHYSIOL, V116, P329, DOI 10.1104/pp.116.1.329; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Xu ZS, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau096; Xu ZS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0262-y; Yang YM, 2001, PLANT GROWTH REGUL, V35, P233; Zhang KR, 2005, PLANT PHYSIOL, V137, P308, DOI 10.1104/pp.104.051938; Zhang WJ, 2013, CURR BIOL, V23, P1979, DOI 10.1016/j.cub.2013.08.008	54	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134166	10.1371/journal.pone.0134166	http://dx.doi.org/10.1371/journal.pone.0134166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218147	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900090
J	Yoo, HS; Yun, HJ; Chung, SJ; Sunwoo, MK; Lee, JM; Sohn, YH; Lee, PH				Yoo, Han Soo; Yun, Hyuk Jin; Chung, Seok Jong; Sunwoo, Mun Kyung; Lee, Jong-Min; Sohn, Young Ho; Lee, Phil Hyu			Patterns of Neuropsychological Profile and Cortical Thinning in Parkinson's Disease with Punding	PLOS ONE			English	Article							IMPULSE CONTROL DISORDERS; AUTOMATED 3-D EXTRACTION; DOPAMINE; BEHAVIOR; CORTEX; MRI; DYSREGULATION; DEMENTIA; SURFACES; INSIGHTS	Background Punding, one of dopamine replacement treatment related complications, refers to aimless and stereotyped behaviors. To identify possible neural correlates of punding behavior in patients with Parkinson's disease (PD), we investigated the patterns of cognitive profiles and cortical thinning. Methods Of the 186 subjects with PD screened during the study period, we prospectively enrolled 10 PD patients with punding and 43 without punding on the basis of a structured interview. We performed comprehensive neuropsychological tests and voxel-based and regions-of-interest (ROIs)-based cortical thickness analysis between PD patients with and without punding. Results The prevalence of punding in patients with PD was 5.4%. Punding behaviors were closely related to previous occupations or hobbies and showed a temporal relationship to changes of levodopa-equivalent dose (LED). Significant predisposing factors were a long duration of PD and intake of medications of PD, high total daily LED, dyskinesia, and impulse control disorder. Punding severity was correlated with LED (p = 0.029). The neurocognitive assessment revealed that PD patients with punding showed more severe cognitive deficits in the color Stroop task than did those without punding (p = 0.022). Voxel-based analysis showed that PD-punders had significant cortical thinning in the dorsolateral prefrontal area relative to controls. Additionally, ROI-based analysis revealed that cortical thinning in PD-punders relative to PD-nonpunders was localized in the prefrontal cortices, extending into orbitofrontal area. Conclusions We demonstrated that PD patients with punding performed poorly on cognitive tasks in frontal executive functions and showed severe cortical thinning in the dorsolateral prefrontal and orbitofrontal areas. These findings suggest that prefrontal modulation may be an essential component in the development of punding behavior in patients with PD.	[Yoo, Han Soo; Chung, Seok Jong; Sunwoo, Mun Kyung; Sohn, Young Ho; Lee, Phil Hyu] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Yoo, Han Soo; Chung, Seok Jong; Sunwoo, Mun Kyung; Sohn, Young Ho; Lee, Phil Hyu] Yonsei Univ, Coll Med, Brain Res Inst, Seoul, South Korea; [Yun, Hyuk Jin; Lee, Jong-Min] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Lee, Phil Hyu] Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University	Lee, PH (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	phisland@chol.net		Yoo, Han Soo/0000-0001-7846-6271; Sohn, Young H./0000-0001-6533-2610; Yun, Hyuk Jin/0000-0002-9876-314X; Lee, Phil Hyu/0000-0001-9931-8462; Chung, Seok Jong/0000-0001-6086-3199	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea [HI14C0093]	Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C0093). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SW, 2005, BRAIN, V128, P201, DOI 10.1093/brain/awh329; Avila A, 2011, NEUROLOGIA, V26, P166, DOI 10.1016/j.nrl.2010.09.007; Bathgate D, 2001, ACTA NEUROL SCAND, V103, P367, DOI 10.1034/j.1600-0404.2001.2000236.x; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Best M, 2002, P NATL ACAD SCI USA, V99, P8448, DOI 10.1073/pnas.112604099; CHRISTENSON GA, 1994, J CLIN PSYCHIAT, V55, P5; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Evans AH, 2006, ANN NEUROL, V59, P852, DOI 10.1002/ana.20822; Evans AH, 2004, CURR OPIN NEUROL, V17, P393, DOI 10.1097/01.wco.0000137528.23126.41; Fasano A, 2010, MOL PSYCHIATR, V15, P560, DOI 10.1038/mp.2009.95; Fasano A, 2008, DRUG ALCOHOL DEPEN, V96, P178, DOI 10.1016/j.drugalcdep.2008.02.005; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Giovannoni G, 2000, J NEUROL NEUROSUR PS, V68, P423, DOI 10.1136/jnnp.68.4.423; Hayashi T, 2013, P NATL ACAD SCI USA, V110, P4422, DOI 10.1073/pnas.1212185110; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kang Y., 2012, SEOUL NEUROPSYCHOLOG, V2nd; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kulisevsky J, 2009, J NEUROL, V256, P816, DOI 10.1007/s00415-009-5001-1; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Miwa H, 2007, J NEUROL, V254, P61, DOI 10.1007/s00415-007-5010-x; Miyasaki JM, 2007, MOVEMENT DISORD, V22, P1179, DOI 10.1002/mds.21296; Muresanu DF, 2012, J NEUROL SCI, V316, P15, DOI 10.1016/j.jns.2012.01.016; Park A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/485063; Pontone G, 2006, NEUROLOGY, V67, P1258, DOI 10.1212/01.wnl.0000238401.76928.45; Ray N, 2010, CLIN EEG NEUROSCI, V41, P87, DOI 10.1177/155005941004100208; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smeding HMM, 2005, J NEUROL, V252, P176, DOI 10.1007/s00415-005-0628-z; Spencer AH, 2011, MOVEMENT DISORD, V26, P578, DOI 10.1002/mds.23508; STUSS DT, 1986, BRAIN LANG, V28, P66, DOI 10.1016/0093-934X(86)90091-X; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volle E, 2002, NEUROLOGY, V58, P488, DOI 10.1212/WNL.58.3.488; Zijdenbos A, 1996, LECT NOTES COMPUT SC, V1131, P439, DOI 10.1007/BFb0046984	37	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134468	10.1371/journal.pone.0134468	http://dx.doi.org/10.1371/journal.pone.0134468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218765	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900119
J	Yu, GW; Tan, MJ; Chong, YX; Long, XX				Yu, Guangwei; Tan, Meijuan; Chong, Yunxiao; Long, Xinxian			Spatial Variation of Phosphorous Retention Capacity in Subsurface Flow Constructed Wetlands: Effect of Wetland Type and Inflow Loading	PLOS ONE			English	Article							REMOVAL; WATER; VEGETATION; NITROGEN; LONGEVITY; MEDIA; REDOX	For verification of spatial distribution of phosphorous retention capacity in constructed wetlands systems(CWs), two horizontal subsurface flow(HSSF) CWs and two vertical subsurface flow(VSSF) CWs, using sand as substrate and Typha latifolia as wetland plants, were constructed and put into use for synthetic wastewater treatment. Five months later, significant spatial variations of TP and inorganic phosphorus(Ca-P, Fe-P and Al-P) were observed, which were found to be greatly affected by CWs type and hydraulic loading. The results revealed that though spatial distribution of Fe-P and Al-P displayed a similar order of substrate content as "rhizosphere" > "near-rhizosphere" > "non-rhizosphere" and "inflow section" > "outflow section" regardless of types and loading, the distribution of Ca-P was positively correlated to that of Fe-P and Al-P in HSSF CWs, while negative correlation was shown in VSSF CWs. As a result, TP spatial distribution in HSSF CWs demonstrated a greater dissimilarity than that in VSSF CWs. For HSSF CWs with low hydraulic loading, the lowest TP content was found in non-rhizosphere substrate of outflow section, while the highest one was discovered in rhizonsphere substrate of inflow section. The values in 6 parts of areas ranged from 0.138 g.kg(-1) to 2.710 g.kg(-1), which also were from -33.5% to 1209% compared to the control value. On contrast, spatial difference of TP content in substrates of VSSF CWs was insignificant, with a variation ranging from 0.776 g.kg(-1) to 1.080 g.kg(-1), that was 275% to 421% higher than the control value. In addition, when hydraulic loading was increased, TP content in VSSF CWs sharply decreased, ranging from 0.210 g.kg(-1) to 0.634 g.kg(-1). Meanwhile, dissimilarity of TP spatial distribution in HSSF CWs was reduced, with TP content ranging from 0.258 g.kg(-1) to 2.237 g.kg(-1). The results suggested that P spatial distribution should be taken into account for CWs design and operation.	[Yu, Guangwei; Tan, Meijuan; Chong, Yunxiao; Long, Xinxian] South China Agr Univ, Coll Nat Resource & Environm, Dept Environm Sci & Engn, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Chong, YX (corresponding author), South China Agr Univ, Coll Nat Resource & Environm, Dept Environm Sci & Engn, Guangzhou 510642, Guangdong, Peoples R China.	cyx04@scau.edu.cn			National Natural Science Foundation of China [50908090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by National Natural Science Foundation of China (No. 50908090). It had an important role in study design, data collection and analysis.	Ann Y, 2000, ECOL ENG, V14, P157; Arias CA, 2001, WATER RES, V35, P1159, DOI 10.1016/S0043-1354(00)00368-7; Babatunde AO, 2009, CHEM ENG J, V152, P8, DOI 10.1016/j.cej.2009.03.020; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Bezbaruah AN, 2004, BIOTECHNOL BIOENG, V88, P60, DOI 10.1002/bit.20208; Bryhn AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005417; Cao Xue-ying, 2012, Huanjing Kexue, V33, P4033; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093130; Dickopp J, 2011, ECOL ENG, V37, P1647, DOI 10.1016/j.ecoleng.2011.06.030; Ding Y, 2014, ECOL ENG, V70, P446, DOI 10.1016/j.ecoleng.2014.06.008; Drizo A, 1999, WATER RES, V33, P3595, DOI 10.1016/S0043-1354(99)00082-2; Drizo A, 2002, ENVIRON SCI TECHNOL, V36, P4642, DOI 10.1021/es011502v; Erler DV, 2011, SCI TOTAL ENVIRON, V409, P5359, DOI 10.1016/j.scitotenv.2011.08.052; Faulwetter JL, 2009, ECOL ENG, V35, P987, DOI 10.1016/j.ecoleng.2008.12.030; Garcia J, 2003, ECOL ENG, V21, P129, DOI 10.1016/j.ecoleng.2003.10.001; Golterman HL, 1995, HYDROBIOLOGIA, V315, P39, DOI 10.1007/BF00028629; Headley TR, 2005, ECOL ENG, V25, P567, DOI 10.1016/j.ecoleng.2005.07.012; Herrmann I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069017; Li LF, 2008, BIORESOURCE TECHNOL, V99, P1656, DOI 10.1016/j.biortech.2007.04.001; Liu CX, 2009, FRONT ENVIRON SCI EN, V3, P477, DOI 10.1007/s11783-009-0155-8; Maine MA, 2007, SCI TOTAL ENVIRON, V380, P75, DOI 10.1016/j.scitotenv.2006.11.036; Martin M, 2013, ECOL ENG, V61, P34, DOI 10.1016/j.ecoleng.2013.09.046; Moustafa MZ, 2012, ECOL ENG, V42, P134, DOI 10.1016/j.ecoleng.2012.01.028; Munch C, 2005, WATER SCI TECHNOL, V51, P185, DOI 10.2166/wst.2005.0316; O'Neill A, 2011, BIORESOURCE TECHNOL, V102, P5024, DOI 10.1016/j.biortech.2011.01.075; Reddy KR, 1999, CRIT REV ENV SCI TEC, V29, P83, DOI 10.1080/10643389991259182; Reddy KR, 1997, WATER SCI TECHNOL, V35, P1, DOI 10.1016/S0273-1223(97)00046-2; Richardson J, 2000, WETLAND SOILS THEIR; Seo DC, 2005, WATER RES, V39, P2445, DOI 10.1016/j.watres.2005.04.032; SEPA of PRC, 2002, TECHN SPEC REQ MON S; Tietz A, 2007, SCI TOTAL ENVIRON, V380, P163, DOI 10.1016/j.scitotenv.2006.11.034; Trang N.T.D., 2010, ECOL ENG, V36, P527, DOI DOI 10.1016/J.ECOLENG.2009.11.022; Truu M, 2009, SCI TOTAL ENVIRON, V407, P3958, DOI 10.1016/j.scitotenv.2008.11.036; van Diggelen JMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111106; Vohla C, 2011, ECOL ENG, V37, P70, DOI 10.1016/j.ecoleng.2009.08.003; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; Westholm LJ, 2006, WATER RES, V40, P23, DOI 10.1016/j.watres.2005.11.006; White JR, 2006, SOIL SCI SOC AM J, V70, P1242, DOI 10.2136/sssaj2003.0339; White JR, 2004, HYDROL PROCESS, V18, P343, DOI [10.1002/hyp.1379, 10.1002/hyp,1379]; Yang Y, 2012, WATER SCI TECHNOL, V66, P1022, DOI 10.2166/wst.2012.277; Yates CR, 2009, ECOL ENG, V35, P1693, DOI 10.1016/j.ecoleng.2009.05.005	41	7	7	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134010	10.1371/journal.pone.0134010	http://dx.doi.org/10.1371/journal.pone.0134010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218872	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900064
J	Beduschi, GD; Figueiredo, AE; Olandoski, M; Pecoits, R; Barretti, P; de Moraes, TP				Beduschi, Gabriela de Carvalho; Figueiredo, Ana Elizabeth; Olandoski, Marcia; Pecoits-Filho, Roberto; Barretti, Pasqual; de Moraes, Thyago Proenca		Ctr Contributed BRAZPD	Automated Peritoneal Dialysis Is Associated with Better Survival Rates Compared to Continuous Ambulatory Peritoneal Dialysis: A Propensity Score Matching Analysis	PLOS ONE			English	Article							OUTCOMES	Introduction The impact of peritoneal dialysis modality on patient survival and peritonitis rates is not fully understood, and no large-scale randomized clinical trial (RCT) is available. In the absence of a RCT, the use of an advanced matching procedure to reduce selection bias in large cohort studies may be the best approach. The aim of this study is to compare automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) according to peritonitis risk, technique failure and patient survival in a large nation-wide PD cohort Methods This is a prospective cohort study that included all incident PD patients with at least 90 days of PD recruited in the BRAZPD study. All patients who were treated exclusively with either APD or CAPD were matched for 15 different covariates using a propensity score calculated with the nearest neighbor method. Clinical outcomes analyzed were overall mortality, technique failure and time to first peritonitis. For all analysis we also adjusted the curves for the presence of competing risks with the Fine and Gray analysis. Results After the matching procedure, 2,890 patients were included in the analysis (1,445 in each group). Baseline characteristics were similar for all covariates including: age, diabetes, BMI, Center-experience, coronary artery disease, cancer, literacy, hypertension, race, previous HD, gender, pre-dialysis care, family income, peripheral artery disease and year of starting PD. Mortality rate was higher in CAPD patients (SHR1.44 CI95% 1.21-1.71) compared to APD, but no difference was observed for technique failure (SHR0.83 CI95% 0.69-1.02) nor for time till the first peritonitis episode (SHR0.96 CI95% 0.93-1.11). Conclusion In the first large PD cohort study with groups balanced for several covariates using propensity score matching, PD modality was not associated with differences in neither time to first peritonitis nor in technique failure. Nevertheless, patient survival was significantly better in APD patients.	[Beduschi, Gabriela de Carvalho; Olandoski, Marcia; Pecoits-Filho, Roberto; de Moraes, Thyago Proenca] UNESP, Sch Med, Botucatu, SP, Brazil; [Figueiredo, Ana Elizabeth] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Grad Program Med & Hlth Sci, Porto Alegre, RS, Brazil; [Barretti, Pasqual] Pontificia Univ Catolica do Parana PUCPR, Sch Med, Curitiba, Parana, Brazil	Universidade Estadual Paulista; Pontificia Universidade Catolica Do Rio Grande Do Sul	de Moraes, TP (corresponding author), UNESP, Sch Med, Botucatu, SP, Brazil.	thyago.moraes@pucpr.br	de Moraes, Thyago Proenca/M-9400-2014; Figueiredo, Ana/GWU-6748-2022; Barretti, Pasqual/AAK-7934-2021; Figueiredo, Ana Elizabeth/C-2137-2013; Pecoits-Filho, Roberto/K-7986-2013	de Moraes, Thyago Proenca/0000-0002-2983-3968; Barretti, Pasqual/0000-0003-4979-4836; Figueiredo, Ana Elizabeth/0000-0002-8555-8649; Pecoits-Filho, Roberto/0000-0002-0255-6710; OLANDOSKI, MARCIA/0000-0002-0979-3604	Baxter Healthcare; Clinical Evidence Council Program from Baxter Healthcare	Baxter Healthcare; Clinical Evidence Council Program from Baxter Healthcare	This study was funded by Baxter Healthcare. The current data extraction and analysis was supported by an investigator driven study grant provided to PUCPR, as part of the Clinical Evidence Council Program from Baxter Healthcare. The sponsor had no participation in the study design data analysis or preparation of the manuscript.	Badve SV, 2008, KIDNEY INT, V73, P480, DOI 10.1038/sj.ki.5002705; Bieber SD, 2014, AM J KIDNEY DIS, V63, P1027, DOI 10.1053/j.ajkd.2013.11.025; Cnossen TT, 2011, PERITON DIALYSIS INT, V31, P679, DOI 10.3747/pdi.2010.00004; DEFIJTER CWH, 1994, ANN INTERN MED, V120, P264, DOI 10.7326/0003-4819-120-4-199402150-00002; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ho DE., 2011, J STAT SOFTW, V42, P1, DOI DOI 10.18637/JSS.V042.I08; Johnson DW, 2010, NEPHROL DIAL TRANSPL, V25, P1973, DOI 10.1093/ndt/gfp780; Lan PG, 2014, CLIN J AM SOC NEPHRO, V9, P1091, DOI 10.2215/CJN.09730913; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Mehrotra R, 2011, ARCH INTERN MED, V171, P110, DOI 10.1001/archinternmed.2010.352; Mehrotra R, 2009, KIDNEY INT, V76, P97, DOI 10.1038/ki.2009.94; Michels WM, 2009, CLIN J AM SOC NEPHRO, V4, P943, DOI 10.2215/CJN.04440908; Moraes TPd, 2014, PERITONEAL IN PRESS; Mujais S, 2006, KIDNEY INT, V70, pS133, DOI 10.1038/sj.ki.5001930; Nessim SJ, 2009, CLIN J AM SOC NEPHRO, V4, P1195, DOI 10.2215/CJN.00910209; Oo TN, 2005, AM J KIDNEY DIS, V45, P372, DOI 10.1053/j.ajkd.2004.10.008; Sanchez AR, 2008, KIDNEY INT, V73, pS76, DOI 10.1038/sj.ki.5002606; Sun CY, 2011, PERITON DIALYSIS INT, V31, P301, DOI 10.3747/pdi.2010.00072; Verduijn M, 2011, NEPHROL DIAL TRANSPL, V26, P56, DOI 10.1093/ndt/gfq661	19	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134047	10.1371/journal.pone.0134047	http://dx.doi.org/10.1371/journal.pone.0134047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214801	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300046
J	Certad, G; Dupouy-Camet, J; Gantois, N; Hammouma-Ghelboun, O; Pottier, M; Guyot, K; Benamrouz, S; Osman, M; Delaire, B; Creusy, C; Viscogliosi, E; Dei-Cas, E; Aliouat-Denis, CM; Follet, J				Certad, Gabriela; Dupouy-Camet, Jean; Gantois, Nausicaa; Hammouma-Ghelboun, Ourida; Pottier, Muriel; Guyot, Karine; Benamrouz, Sadia; Osman, Marwan; Delaire, Baptiste; Creusy, Colette; Viscogliosi, Eric; Dei-Cas, Eduardo; Aliouat-Denis, Cecile Marie; Follet, Jerome			Identification of Cryptosporidium Species in Fish from Lake Geneva (Lac Leman) in France	PLOS ONE			English	Article							N. SP APICOMPLEXA; SPARUS-AURATA L.; SUBTYPE ANALYSIS; EXPOSURE; CALVES; EPIDEMIOLOGY; BALTIMORE; GENOTYPES; BACTERIA; MOLNARI	Cryptosporidium, a protozoan parasite that can cause severe diarrhea in a wide range of vertebrates including humans, is increasingly recognized as a parasite of a diverse range of wildlife species. However, little data are available regarding the identification of Cryptosporidium species and genotypes in wild aquatic environments, and more particularly in edible freshwater fish. To evaluate the prevalence of Cryptosporidiumspp. in fish from Lake Geneva (Lac Leman) in France, 41 entire fish and 100 fillets (cuts of fish flesh) were collected from fishery suppliers around the lake. Nested PCR using degenerate primers followed by sequence analysis was used. Five fish species were identified as potential hosts of Cryptosporidium: Salvelinus alpinus, Esox lucius, Coregonus lavaretus, Perca fluviatilis, and Rutilus rutilus. The presence of Cryptosporidium spp. was found in 15 out of 41 fish (37%), distributed as follows: 13 (87%) C. parvum, 1 (7%) C. molnari, and 1 (7%) mixed infection (C. parvum and C. molnari). C. molnari was identified in the stomach, while C. parvum was found in the stomach and intestine. C. molnari was also detected in 1 out of 100 analyzed fillets. In order to identify Cryptosporidium subtypes, sequencing of the highly polymorphic 60-kDa glycoprotein (gp60) was performed. Among the C. parvum positive samples, three gp60 subtypes were identified: IIaA15G2R1, IIaA16G2R1, and IIaA17G2R1. Histological examination confirmed the presence of potential developmental stages of C. parvum within digestive epithelial cells. These observations suggest that C. parvum is infecting fish, rather than being passively carried. Since C. parvum is a zoonotic species, fish potentially contaminated by the same subtypes found in terrestrial mammals would be an additional source of infection for humans and animals, and may also contribute to the contamination of the environment with this parasite. Moreover, the risk of human transmission is strengthened by the observation of edible fillet contamination.	[Certad, Gabriela; Gantois, Nausicaa; Guyot, Karine; Benamrouz, Sadia; Osman, Marwan; Viscogliosi, Eric; Dei-Cas, Eduardo; Aliouat-Denis, Cecile Marie] Univ Lille, Biol & Div Pathogenes Eucaryotes Emergents BDEEP, Ctr Infect & Immunite Lille, Inst Pasteur Lille,INSERM U1019,CNRS UMR 8402, Lille, France; [Dupouy-Camet, Jean] Univ Paris 05, Hop Cochin, AP HP, Parasitol Mycol, Paris, France; [Hammouma-Ghelboun, Ourida; Follet, Jerome] Inst Super Agr Lille, Lab Biotechnol & Gest Agents Pathogenes Agr, Lille, France; [Pottier, Muriel; Aliouat-Denis, Cecile Marie] Univ Lille, Fac Pharm, Lille, France; [Benamrouz, Sadia] Univ Catholique Lille, Fac Libre Sci & Technol Lille, Ecol & Biodiversite, Lille, France; [Osman, Marwan] Univ Libanaise, Ctr AZM Rech Biotechnol & Ses Applicat, Lab Microbiol Sante & Environm, Tripoli, Lebanon; [Delaire, Baptiste; Creusy, Colette] Grp Hosp Univ Catholique Lille, Serv Anat & Cytol Pathol, Lille, France; [Dei-Cas, Eduardo] Univ Lille Nord France, Ctr Hosp Reg & Univ Lille, Lille, France; [Follet, Jerome] Univ Valenciennes, Laboratoire BioMEMS, Univ Lille, CNRS,ISEN,IEMN,Inst Elect Microelect & Nanotechno, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Universite Catholique de Lille; Lebanese University; Universite Catholique de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Centrale Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite Polytechnique Hauts-de-France	Certad, G (corresponding author), Univ Lille, Biol & Div Pathogenes Eucaryotes Emergents BDEEP, Ctr Infect & Immunite Lille, Inst Pasteur Lille,INSERM U1019,CNRS UMR 8402, Lille, France.	gabriela.certad@pasteur-lille.fr	Osman, Marwan/AAD-3784-2021; Aliouat-Denis, Cecile-Marie/P-1934-2016	Osman, Marwan/0000-0002-6235-2760; FOLLET, Jerome/0000-0001-8992-6819; Aliouat-Denis, Cecile-Marie/0000-0001-8388-4662; Viscogliosi, Eric/0000-0002-5805-7179	French National Research Agency [ANR-10-ALIA-004]; regional competitiveness center, AQUIMER (Boulogne s/mer, France)	French National Research Agency(French National Research Agency (ANR)); regional competitiveness center, AQUIMER (Boulogne s/mer, France)	This work was supported by the French National Research Agency (grant no. ANR-10-ALIA-004) and the regional competitiveness center, AQUIMER (Boulogne s/mer, France).	Alvarez-Pellitero P, 2004, DIS AQUAT ORGAN, V62, P133, DOI 10.3354/dao062133; Alvarez-Pellitero P, 2002, INT J PARASITOL, V32, P1007, DOI 10.1016/S0020-7519(02)00058-9; Barugahare R, 2011, APPL ENVIRON MICROB, V77, P1878, DOI 10.1128/AEM.02691-10; Certad G, 2010, INT J PARASITOL, V40, P1469, DOI 10.1016/j.ijpara.2010.07.007; Diaz P, 2010, PARASITOLOGY, V137, P1187, DOI 10.1017/S0031182010000181; Fayer R, 2004, TRENDS PARASITOL, V20, P531, DOI 10.1016/j.pt.2004.08.008; Follet J, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-116; Fuchslin HP, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13683; Garcia-Presedo I, 2013, VET PARASITOL, V196, P497, DOI 10.1016/j.vetpar.2013.04.017; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Gofti-Laroche L, 2003, OUTBREAK GASTROENTER; Graczyk TK, 2007, APPL ENVIRON MICROB, V73, P4069, DOI 10.1128/AEM.00166-07; Koinari M, 2013, VET PARASITOL, V198, P1, DOI 10.1016/j.vetpar.2013.08.031; McOliver CC, 2009, AM J PUBLIC HEALTH, V99, P1116, DOI 10.2105/AJPH.2008.151654; Morine M, 2012, VET PARASITOL, V190, P578, DOI 10.1016/j.vetpar.2012.06.036; Murphy BG, 2009, J VET DIAGN INVEST, V21, P722, DOI 10.1177/104063870902100523; Ng J, 2008, EXP PARASITOL, V119, P192, DOI 10.1016/j.exppara.2008.01.010; Pote J, 2009, ENVIRON MONIT ASSESS, V154, P337, DOI 10.1007/s10661-008-0401-8; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Reid A, 2010, VET PARASITOL, V168, P190, DOI 10.1016/j.vetpar.2009.11.015; Roberts JD, 2007, J TOXICOL ENV HEAL A, V70, P1568, DOI 10.1080/15287390701384791; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Ryan U, 2015, EXP PARASITOL, V150, P31, DOI 10.1016/j.exppara.2015.01.009; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Ryan U, 2012, PARASITOLOGY, V139, P1673, DOI 10.1017/S0031182012001151; Sitja-Bobadilla A, 2005, APPL ENVIRON MICROB, V71, P131, DOI 10.1128/AEM.71.1.131-139.2005; Thevenon F, 2012, ECOTOX ENVIRON SAFE, V78, P50, DOI 10.1016/j.ecoenv.2011.11.005; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	29	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133047	10.1371/journal.pone.0133047	http://dx.doi.org/10.1371/journal.pone.0133047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26213992	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300013
J	Lombard, C; Andre, F; Paul, J; Wanty, C; Vosters, O; Bernard, P; Pilette, C; Dupont, P; Sokal, EM; Smets, F				Lombard, Catherine; Andre, Floriane; Paul, Jerome; Wanty, Catherine; Vosters, Olivier; Bernard, Pierre; Pilette, Charles; Dupont, Pierre; Sokal, Etienne M.; Smets, Francoise			Clinical Parameters vs Cytokine Profiles as Predictive Markers of IgE-Mediated Allergy in Young Children	PLOS ONE			English	Article							T-CELLS; IMMUNOGLOBULIN-E; FOOD ALLERGY; SENSITIZATION; PREVALENCE; DISTINCT; LINEAGE; IL-15	Background Allergy afflicts one third of children, negatively impacting their quality of life and generating a significant socio-economic burden. To this day, this disorder remains difficult to diagnose early in young patients, with no predictive test available. Objective This study was designed to correlate cytokine profiles with clinical phenotypes of allergy development. Methods Three hundred patients were recruited and followed from birth to 18 months of age. They were given a clinical exam at birth and at 2, 6, 12, and 18 months of age, with skin prick tests at 6, and 18 months, in order to have a record of their medical history and determine their allergic status. In addition, mononuclear cells from 131 patients were isolated from cord blood and from peripheral blood samples at 2, 6 and 18 months of age, to analyse their cytokine and chemokine production. Results Cord blood mononuclear cells (CBMCs) from future Immunoglobulin (Ig) E-mediated allergic children produced significantly less Interleukin (IL)-12p70 and IL-15 than cells from the rest of the cohort. Multivariate analyses revealed that the best predictive model of allergy was built on cytokine data, whereas the best predictive model of IgE-mediated allergy was built on clinical parameters. Conclusions and clinical relevance Although univariate analyses can yield interesting information regarding the immune responses of allergic children, finding predictive markers of the disorder will likely rely on monitoring multiple parameters. Nonetheless these analyses suggest a potential key role for IL-15 in the development of atopic disease. In addition, the study highlights the importance of clinical parameters in predicting the development of IgE-mediated allergy.	[Lombard, Catherine; Andre, Floriane; Sokal, Etienne M.; Smets, Francoise] Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Pediat Hepatol & Cell Therapy, B-1200 Brussels, Belgium; [Paul, Jerome; Dupont, Pierre] Louvain Sch Engn, ICTEAM Inst, Machine Learning Grp, INGI Dept, Louvain La Neuve, Belgium; [Wanty, Catherine; Sokal, Etienne M.; Smets, Francoise] Clin Univ St Luc, Paediat Gastroenterol & Hepatol Unit, B-1200 Brussels, Belgium; [Vosters, Olivier] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Dupont, Pierre] Clin Univ St Luc, Obstetr Unit, B-1200 Brussels, Belgium; [Pilette, Charles] Catholic Univ Louvain, Pole Pneumol ENT & Dermatol, IREC, Clin Univ St Luc,Pneumol Dept, B-1200 Brussels, Belgium; [Pilette, Charles] Ctr Allergy, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Lombard, C (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Pediat Hepatol & Cell Therapy, B-1200 Brussels, Belgium.	catherine.lombard@uclouvain.be		Lombard, Catherine/0000-0002-5653-9545; Sokal, Etienne/0000-0001-5597-4708	government of the Walloon Region; GlaxoSmithKline Biologicals [FIRST 051/6261-CRISTALL study]	government of the Walloon Region; GlaxoSmithKline Biologicals(GlaxoSmithKline)	This work was supported by a grant from the government of the Walloon Region and GlaxoSmithKline Biologicals (FIRST 051/6261-CRISTALL study). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Aoi N, 2006, J ALLERGY CLIN IMMUN, V117, P1359, DOI 10.1016/j.jaci.2006.02.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Chen CM, 2010, INT J HYG ENVIR HEAL, V213, P1, DOI 10.1016/j.ijheh.2009.12.003; Daemen A, 2009, IEEE ENG MED BIO, P5913, DOI 10.1109/IEMBS.2009.5334847; Dhami S, 2015, J ROY SOC MED, V108, P229, DOI 10.1177/0141076814562982; Costa AJF, 2011, PEDIAT ALLERG IMM-UK, V22, pe133, DOI 10.1111/j.1399-3038.2010.00988.x; Fiocchi A, 2006, ALLERGY ASTHMA PROC, V27, P178, DOI 10.2500/aap.2006.27.2850; Guyon I., 2006, FEATURE EXTRACTION F, V207; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; Husby S, 2008, J PEDIATR GASTR NUTR, V47, pS49, DOI 10.1097/01.mpg.0000338813.97803.16; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; KINIWA M, 1992, J CLIN INVEST, V90, P262, DOI 10.1172/JCI115846; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Lifschitz C, 2015, EUR J PEDIATR, V174, P141, DOI 10.1007/s00431-014-2422-3; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nadeau C, 2003, MACH LEARN, V52, P239, DOI 10.1023/A:1024068626366; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; Nilsson C, 2004, CLIN EXP ALLERGY, V34, P373, DOI 10.1111/j.1365-2222.2004.01896.x; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Pandiyan P, 2012, J IMMUNOL, V189, P4237, DOI 10.4049/jimmunol.1201476; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PATRICK EA, 1970, INFORM CONTROL, V16, P128, DOI 10.1016/S0019-9958(70)90081-1; Piippo-Savolainen E, 2008, ACTA PAEDIATR, V97, P5, DOI 10.1111/j.1651-2227.2007.00558.x; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	36	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132753	10.1371/journal.pone.0132753	http://dx.doi.org/10.1371/journal.pone.0132753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214693	Green Submitted, gold, Green Published			2022-12-27	WOS:000358594300010
J	Qiu, C; Qian, SH; Sun, XH; Zhou, CD; Meng, FR				Qiu, Chen; Qian, Shaohong; Sun, Xinghuai; Zhou, Chuandi; Meng, Fanrong			Axial Myopia Is Associated with Visual Field Prognosis of Primary Open-Angle Glaucoma	PLOS ONE			English	Article							RISK-FACTORS; INTRAOCULAR-PRESSURE; REFRACTIVE ERROR; PROGRESSION; EYES; POPULATION; PREDICT; SCLERA; DAMAGE	Purpose To identify whether myopia was associated with the visual field (VF) progression of primary open-angle glaucoma (POAG). Methods A total of 270 eyes of 270 POAG followed up for more than 3 years with >= 9 reliable VFs by Octopus perimetry were retrospectively reviewed. Myopia was divided into: mild myopia (-2.99 diopter [D], 0), moderate myopia (-5.99, 3.00 D), marked myopia (-9.00, -6.00 D) and non-myopia (0 D or more). An annual change in the mean defect (MD) slope >0.22 dB/y and 0.30 dB/y was defined as fast progression, respectively. Logistic regression was performed to determine prognostic factors for VF progression. Results For the cutoff threshold at 0.22 dB/y, logistic regression showed that vertical cup-to-disk ratio (VCDR; p = 0.004) and the extent of myopia (p = 0.002) were statistically significant. When logistic regression was repeated after excluding the extent of myopia, axial length (AL; p = 0.008, odds ratio [OR] = 0.796) reached significance, as did VCDR (p = 0.001). Compared to eyes with AL <= 23 mm, the OR values were 0.334 (p = 0.059), 0.309 (p = 0.044), 0.266 (p = 0.019), 0.260 (p = 0.018), respectively, for 23 <AL <= 24 mm, 24 <AL <= 25 mm, 25 <AL <= 26 mm, and AL>26 mm. The significance of vertical cup-to-disk ratio of (p = 0.004) and the extent of myopia (p = 0.008) did not change for the cutoff threshold at 0.30dB/y. Conclusions VCDR and myopia were associated with VF prognosis of POAG. Axial myopia may be a protective factor against VF progression.	[Qiu, Chen; Qian, Shaohong; Sun, Xinghuai; Meng, Fanrong] Fudan Univ, Shanghai Med Coll, Throat Hosp, Dept Ophthalmol Eye & Ear Nose, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai 200433, Peoples R China; [Zhou, Chuandi] Shanghai Jiao Tong Univ, Peoples Hosp Shanghai 1, Dept Ophthalmol, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University	Qian, SH (corresponding author), Fudan Univ, Shanghai Med Coll, Throat Hosp, Dept Ophthalmol Eye & Ear Nose, Shanghai 200433, Peoples R China.	qsh2304@163.com						Araie M, 2012, ACTA OPHTHALMOL, V90, pe337, DOI 10.1111/j.1755-3768.2012.02425.x; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Casson RJ, 2007, CLIN EXP OPHTHALMOL, V35, P739, DOI 10.1111/j.1442-9071.2007.01619.x; Chihara E, 1997, OPHTHALMOLOGICA, V211, P66, DOI 10.1159/000310760; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Fukuchi T, 2013, J GLAUCOMA, V22, P689, DOI 10.1097/IJG.0b013e318264b779; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Grodum K, 2001, ACTA OPHTHALMOL SCAN, V79, P560, DOI 10.1034/j.1600-0420.2001.790603.x; Ishida K, 2000, AM J OPHTHALMOL, V129, P707, DOI 10.1016/S0002-9394(00)00441-4; Jeong DW, 2014, INVEST OPHTH VIS SCI, V55, P2148, DOI 10.1167/iovs.13-13607; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Komori S, 2014, GRAEF ARCH CLIN EXP, V252, P1963, DOI 10.1007/s00417-014-2767-3; Lee JM, 2014, INVEST OPHTH VIS SCI, V55, P2228, DOI 10.1167/iovs.13-12261; Lee YA, 2008, J FORMOS MED ASSOC, V107, P952, DOI 10.1016/S0929-6646(09)60019-X; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Okumura Y, 2012, OPHTHALMOLOGICA, V228, P36, DOI 10.1159/000335978; Papp A, 2001, OPHTHALMOLOGICA, V215, P87, DOI 10.1159/000050835; Perera SA, 2010, ARCH OPHTHALMOL-CHIC, V128, P900, DOI 10.1001/archophthalmol.2010.125; Sakata R, 2013, J GLAUCOMA, V22, P250, DOI 10.1097/IJG.0b013e31823298fb; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Sohn SW, 2010, AM J OPHTHALMOL, V149, P831, DOI 10.1016/j.ajo.2009.12.033; Steinhart MR, 2012, MOL VIS, V18, P1093; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tezel G, 2001, ARCH OPHTHALMOL-CHIC, V119, P813	28	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133189	10.1371/journal.pone.0133189	http://dx.doi.org/10.1371/journal.pone.0133189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214313	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300015
J	Chiodo, L; Malliavin, TE; Maragliano, L; Cottone, G; Ciccotti, G				Chiodo, Letizia; Malliavin, Therese E.; Maragliano, Luca; Cottone, Grazia; Ciccotti, Giovanni			A Structural Model of the Human alpha 7 Nicotinic Receptor in an Open Conformation	PLOS ONE			English	Article							GATED ION-CHANNEL; ACETYLCHOLINE-BINDING-PROTEIN; X-RAY-STRUCTURE; MOLECULAR-DYNAMICS SIMULATION; AGONIST BINDING; STRUCTURE VALIDATION; CRYSTAL-STRUCTURES; GATING MECHANISM; OPEN-STATE; LOOP	Nicotinic acetylcholine receptors (nAchRs) are ligand-gated ion channels that regulate chemical transmission at the neuromuscular junction. Structural information is available at low resolution from open and closed forms of an eukaryotic receptor, and at high resolution from other members of the same structural family, two prokaryotic orthologs and an eukaryotic GluCl channel. Structures of human channels however are still lacking. Homology modeling and Molecular Dynamics simulations are valuable tools to predict structures of unknown proteins, however, for the case of human nAchRs, they have been unsuccessful in providing a stable open structure so far. This is due to different problems with the template structures: on one side the homology with prokaryotic species is too low, while on the other the open eukaryotic GluCl proved itself unstable in several MD studies and collapsed to a dehydrated, non-conductive conformation, even when bound to an agonist. Aim of this work is to obtain, by a mixing of state-of-the-art homology and simulation techniques, a plausible prediction of the structure (still unknown) of the open state of human alpha 7 nAChR complexed with epibatidine, from which it is possible to start structural and functional test studies. To prevent channel closure we employ a restraint that keeps the transmembrane pore open, and obtain in this way a stable, hydrated conformation. To further validate this conformation, we run four long, unbiased simulations starting from configurations chosen at random along the restrained trajectory. The channel remains stable and hydrated over the whole runs. This allows to assess the stability of the putative open conformation over a cumulative time of 1 mu s, 800 ns of which are of unbiased simulation. Mostly based on the analysis of pore hydration and size, we suggest that the obtained structure has reasonable chances to be (at least one of the possible) structures of the channel in the open conformation.	[Chiodo, Letizia] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Malliavin, Therese E.] Inst Pasteur, Paris, France; [Malliavin, Therese E.] CNRS, UMR 3528, Unite Bioinformat Struct, Paris, France; [Maragliano, Luca] Ist Italiano Tecnol, Ctr Synapt Neurosci, Genoa, Italy; [Cottone, Grazia] Univ Palermo, Dept Chem & Phys, Palermo, Italy; [Cottone, Grazia; Ciccotti, Giovanni] Univ Coll Dublin, Sch Phys, Dublin 2, Ireland; [Ciccotti, Giovanni] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	Istituto Italiano di Tecnologia - IIT; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Istituto Italiano di Tecnologia - IIT; University of Palermo; University College Dublin; Sapienza University Rome	Cottone, G (corresponding author), Univ Palermo, Dept Chem & Phys, Palermo, Italy.	grazia.cottone@unipa.it	Maragliano, Luca/A-8294-2010; Chiodo, Letizia/G-9609-2012; Cottone, Grazia/E-8734-2012	Maragliano, Luca/0000-0002-5705-6967; Chiodo, Letizia/0000-0002-8278-7075; Cottone, Grazia/0000-0001-6923-6394; Malliavin, Therese/0000-0002-3276-3366	Science Foundation of Ireland (SFI) [08-IN.1-I1869]; Istituto Italiano di Tecnologia (IIT) [N.259SIMBEDD]; University of Palermo (FFR program)	Science Foundation of Ireland (SFI)(Science Foundation Ireland); Istituto Italiano di Tecnologia (IIT)(Istituto Italiano di Tecnologia - IIT); University of Palermo (FFR program)	This work was supported by Science Foundation of Ireland (SFI, grant 08-IN.1-I1869, G. Ciccotti, http://www.sfi.ie/), Istituto Italiano di Tecnologia (IIT, seed project grant N.259SIMBEDD, G. Ciccotti, http://www.iit.it/it/home.html), and University of Palermo (FFR program 2012/2013, www.unipa.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Amiri S, 2007, PROTEIN ENG DES SEL, V20, P353, DOI 10.1093/protein/gzm029; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Baptista-Hon DT, 2013, J BIOL CHEM, V288, P21558, DOI 10.1074/jbc.M113.481689; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Bondarenko V, 2014, BBA-BIOMEMBRANES, V1838, P1389, DOI 10.1016/j.bbamem.2013.12.018; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bourne Y, 2006, J MOL NEUROSCI, V30, P103, DOI 10.1385/JMN:30:1:103; Bourne Y, 2010, P NATL ACAD SCI USA, V107, P6076, DOI 10.1073/pnas.0912372107; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng MH, 2012, J PHYS CHEM B, V116, P13637, DOI 10.1021/jp3074915; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; Costa V, 2003, BRIT J PHARMACOL, V140, P921, DOI 10.1038/sj.bjp.0705498; CZERMINSKI R, 1990, INT J QUANTUM CHEM, P167; DeLano WL, 2002, THE PYMOL MOLECULAR; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Edink E, 2011, J AM CHEM SOC, V133, P5363, DOI 10.1021/ja110571r; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Grazioso G, 2008, J COMPUT CHEM, V29, P2593, DOI 10.1002/jcc.21019; Haddadian EJ, 2008, J PHYS CHEM B, V112, P13981, DOI 10.1021/jp804868s; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henchman RH, 2003, BIOPHYS J, V85, P3007, DOI 10.1016/S0006-3495(03)74720-1; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Hung A, 2005, BIOPHYS J, V88, P3321, DOI 10.1529/biophysj.104.052878; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kinde MN, 2015, STRUCTURE, V23, P995, DOI 10.1016/j.str.2015.03.017; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Lindert S, 2013, J CHEM THEORY COMPUT, V9, P3843, DOI 10.1021/ct400260c; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Murail S, 2011, BIOPHYS J, V100, P1642, DOI 10.1016/j.bpj.2011.02.032; Naveh ZMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088555; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Quigley D, 2004, J CHEM PHYS, V120, P11432, DOI 10.1063/1.1755657; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samson AO, 2008, BIOCHEMISTRY-US, V47, P4065, DOI 10.1021/bi702272j; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; Song C, 2010, BIOPHYS J, V98, P404, DOI 10.1016/j.bpj.2009.10.032; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tsetlin V, 2009, CURR OPIN PHARMACOL, V9, P306, DOI 10.1016/j.coph.2009.03.005; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Ulens C, 2009, J MED CHEM, V52, P2372, DOI 10.1021/jm801400g; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whatley VJ, 1996, INT REV NEUROBIOL, V39, P113, DOI 10.1016/S0074-7742(08)60665-0; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Yaffe E, 2008, NUCLEIC ACIDS RES, V36, pW210, DOI 10.1093/nar/gkn223; Yan D, 2005, MOL PHARMACOL, V68, P365, DOI 10.1124/mol.105.011957; Yoluk O, 2013, BIOPHYS J, V105, P640, DOI 10.1016/j.bpj.2013.06.037; Yu RL, 2014, BIOCHEMISTRY-US, V53, P6041, DOI 10.1021/bi500815f; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	109	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133011	10.1371/journal.pone.0133011	http://dx.doi.org/10.1371/journal.pone.0133011			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208301	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000056
J	de Souza, LCL; Mendonca, VRR; Garcia, GBC; Brandao, EC; Barral-Netto, M				Lima de Souza, Ligia Correia; Mendonca, Vitor R. R.; Garcia, Gabriela B. C.; Brandao, Ediele C.; Barral-Netto, Manoel			Medical Specialty Choice and Related Factors of Brazilian Medical Students and Recent Doctors	PLOS ONE			English	Article							CONTROLLABLE LIFE-STYLE; CAREER CHOICES; FAMILY MEDICINE; SCHOOL; PREFERENCES; PLANS; RESIDENTS; DECLINE; GENDER; TRENDS	Background Choosing a medical specialty is an important, complex, and not fully understood process. The present study investigated the factors that are related to choosing and rejecting medical specialties in a group of students and recent medical doctors. Methodology and Findings A cross-sectional survey of 1,223 medical students and doctors was performed in Brazil in 2012. A standardized literature-based questionnaire was applied that gathered preferable or rejected specialties, and asked questions about extracurricular experiences and the influence of 14 factors on a Likert-type scale from 0 to 4. Specialties were grouped according to lifestyle categories: controllable and uncontrollable, which were subdivided into primary care, internal medicine, and surgical specialties. Notably, the time period of rejection was usually earlier than the time period of intended choice (p < 0.0001, chi(2) = 107.2). The choice mainly occurred during the internship period in medical school (n = 466; 38.7%). An overall large frequency of participation in extracurricular activities was observed (n = 1,184; 95.8%), which were highly associated with the respective medical area. Orthopedic surgery had the highest correlation with participation in specialty-specific organized groups (OR = 59.9, 95% CI = 21.6-166.3) and psychiatry was correlated with participation in research groups (OR = 18.0, 95% CI = 9.0-36.2). With regard to influential factors in controllable lifestyle specialties, "financial reason" (mean score +/- standard deviation: 2.8 +/- 1.0; median = 3) and "personal time" (3.1 +/- 1.3; median = 4) were important factors. In primary care, these factors were less important (1.7 +/- 1.3 and 1.7 +/- 1.5, respectively; median = 2 for both), and higher scores were observed for "curricular internship" (3.2 +/- 1.1, median = 4) and "social commitment" (2.6 +/- 1.3, median = 3). Conclusion The present findings provide important insights into developing strategies to stimulate interest in specialties based on the needs of the Brazilian healthcare system.	[Lima de Souza, Ligia Correia; Mendonca, Vitor R. R.; Garcia, Gabriela B. C.; Barral-Netto, Manoel] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Lima de Souza, Ligia Correia; Mendonca, Vitor R. R.; Barral-Netto, Manoel] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Garcia, Gabriela B. C.] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil; [Brandao, Ediele C.] Fundacao Tecn Educ Souza Marques, Rio De Janeiro, Brazil; [Barral-Netto, Manoel] Inst Nacl Ciencia & Tecnol Invest Imunol iii INCT, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal da Bahia	Barral-Netto, M (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.	mbarral@bahia.fiocruz.br	Barral-Netto, Manoel/B-3904-2009	Barral-Netto, Manoel/0000-0002-5823-7903				ACP (American College of Physicians), 2014, INT MED SUBSP; Alves CL, 2013, MED EDUC, V47, P617, DOI 10.1111/medu.12154; CFM (Conselho Federal de Medicina), 2011, LEV EL CFM CREM PONT; CFM-Conselho Federal de Medicina, 2013, PLENARIA DO CFM APRO; Chang PY, 2006, J FORMOS MED ASSOC, V105, P489, DOI 10.1016/S0929-6646(09)60189-3; Cleland J, 2012, MED EDUC, V46, P473, DOI 10.1111/j.1365-2923.2012.04218.x; Cleland JA, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-151; CRUZ J. A. S., 2010, REV MED SAO PAULO, V89, P32, DOI [10.1590/1981-52712015v43n2RB20180158, DOI 10.1590/1981-52712015V43N2RB20180158]; DeZee KJ, 2011, ACAD MED, V86, P187, DOI 10.1097/ACM.0b013e3182045ec9; Dorsey ER, 2005, ACAD MED, V80, P791, DOI 10.1097/00001888-200509000-00002; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Ferreira R A, 2000, Rev Assoc Med Bras (1992), V46, P224; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Gill H, 2012, CAN FAM PHYSICIAN, V58, pE649; Goldacre MJ, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-32; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; Ibrahim M, 2014, MED TEACH, V36, P1064, DOI 10.3109/0142159X.2014.923560; IOM (Institute of Medicine), 2008, RET AG AM BUILD HLTH; Kassebaum DG, 1996, ACAD MED, V71, P198, DOI 10.1097/00001888-199602000-00030; Khader Y, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-32; Knox Kjersti E, 2008, WMJ, V107, P369; Lambert EM, 2005, ACAD MED, V80, P797, DOI 10.1097/00001888-200509000-00003; Lefevre JH, 2010, MED EDUC, V44, P603, DOI 10.1111/j.1365-2923.2010.03707.x; Maiorova T, 2008, MED EDUC, V42, P554, DOI 10.1111/j.1365-2923.2008.03008.x; Marschall JG, 2003, WORLD J SURG, V27, P249, DOI 10.1007/s00268-002-6642-8; Martins M. A., 2013, ESTUDANTES MED MED B; Morley CP, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.21194; Newton DA, 2003, JAMA-J AM MED ASSOC, V290, P1179, DOI 10.1001/jama.290.9.1179; Olson Douglas P., 2011, Yale Journal of Biology and Medicine, V84, P195; Pego-Fernandes PM, 2010, SAO PAULO MED J, V128, P257, DOI 10.1590/S1516-31802010000500002; Peres Cristiane Martins, 2007, Rev. bras. educ. med., V31, P203, DOI 10.1590/S0100-55022007000300002; Saigal Priya, 2007, BMC Med Educ, V7, P31, DOI 10.1186/1472-6920-7-31; Scheffer M., 2013, DEMOGRAFIA MED BRASI, V02; Schwartz MD, 2011, ARCH INTERN MED, V171, P744, DOI 10.1001/archinternmed.2011.139; SCHWARTZ RW, 1989, J SURG RES, V47, P189, DOI 10.1016/0022-4804(89)90105-4; Soethout MBM, 2008, MED TEACH, V30, pE15, DOI 10.1080/01421590701759614; Sousa Ivy Quirino de, 2014, Rev. bras. educ. med., V38, P79, DOI 10.1590/S0100-55022014000100011; Svirko Elena, 2014, JRSM Open, V5, p2054270414554050, DOI 10.1177/2054270414554050; Takeda Y, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-125; van der Horst K, 2010, MED EDUC, V44, P595, DOI 10.1111/j.1365-2923.2010.03631.x; Villanueva T, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4508; West CP, 2012, JAMA-J AM MED ASSOC, V308, P2241, DOI 10.1001/jama.2012.47535; Wetterneck TB, 2002, ARCH INTERN MED, V162, P649, DOI 10.1001/archinte.162.6.649; Woodworth PA, 2000, AM J SURG, V180, P570, DOI 10.1016/S0002-9610(00)00543-2; Wright B, 2004, CAN MED ASSOC J, V170, P1920, DOI 10.1503/cmaj.1031111; Wright S, 1997, J GEN INTERN MED, V12, P53, DOI 10.1007/s11606-006-0007-1; Zarkovic Andrea, 2006, N Z Med J, V119, pU1851	47	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133585	10.1371/journal.pone.0133585	http://dx.doi.org/10.1371/journal.pone.0133585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208007	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000103
J	Murphy, JN; Harris, KD; Buriak, JM				Murphy, Jeffrey N.; Harris, Kenneth D.; Buriak, Jillian M.			Automated Defect and Correlation Length Analysis of Block Copolymer Thin Film Nanopatterns	PLOS ONE			English	Article							LINE-EDGE ROUGHNESS; ORDER-DISORDER TRANSITION; DIBLOCK COPOLYMERS; ORIENTATION; DENSITY; IMPACT; LITHOGRAPHY; FEATURES; PHASE; NANOLITHOGRAPHY	Line patterns produced by lamellae- and cylinder-forming block copolymer (BCP) thin films are of widespread interest for their potential to enable nanoscale patterning over large areas. In order for such patterning methods to effectively integrate with current technologies, the resulting patterns need to have low defect densities, and be produced in a short timescale. To understand whether a given polymer or annealing method might potentially meet such challenges, it is necessary to examine the evolution of defects. Unfortunately, few tools are readily available to researchers, particularly those engaged in the synthesis and design of new polymeric systems with the potential for patterning, to measure defects in such line patterns. To this end, we present an image analysis tool, which we have developed and made available, to measure the characteristics of such patterns in an automated fashion. Additionally we apply the tool to six cylinder-forming polystyrene-block- poly(2-vinylpyridine) polymers thermally annealed to explore the relationship between the size of each polymer and measured characteristics including line period, linewidth, defect density, line-edge roughness (LER), line-width roughness (LWR), and correlation length. Finally, we explore the line-edge roughness, line-width roughness, defect density, and correlation length as a function of the image area sampled to determine each in a more rigorous fashion.	[Murphy, Jeffrey N.; Buriak, Jillian M.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Murphy, Jeffrey N.; Harris, Kenneth D.; Buriak, Jillian M.] Natl Inst Nanotechnol NINT, Edmonton, AB, Canada	University of Alberta; National Research Council Canada	Murphy, JN (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB, Canada.	jnmurphy@ualberta.ca; jburiak@ualberta.ca	Murphy, Jeffrey N./F-1119-2010	Murphy, Jeffrey N./0000-0001-9180-9187; Buriak, Jillian Mary/0000-0002-9567-4328	NSERC; Izaak Walton Killam Memorial Scholarship, Killam Trusts; Canada Research Chair of Nanomaterials	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Izaak Walton Killam Memorial Scholarship, Killam Trusts; Canada Research Chair of Nanomaterials	JNM: NSERC Postgraduate Doctoral Scholarship, 2010-2013 (http://www.nserc-crsng.gc.ca) JNM: Izaak Walton Killam Memorial Scholarship, Killam Trusts, 2012-2014 (http://www.killamlaureates. ca) JMB: NSERC Discovery Grant, 2008-2014, 2014-2019 (http://www.nserc-crsng.gc.ca) JMB: Canada Research Chair of Nanomaterials (http://www.chairschaires.gc.ca/home-accueil-eng. aspx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir NM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063025; Adutler-Lieber S, 2014, J AUTOIMMUN, V54, P100, DOI 10.1016/j.jaut.2014.05.003; [Anonymous], 2013, EMERGING RESEARCH MA; [Anonymous], 2011, EMERGING RESEARCH MA; [Anonymous], 2011, TEMPLATETYPEDEF ANSW; Asenov A, 2003, IEEE T ELECTRON DEV, V50, P1254, DOI 10.1109/TED.2003.813457; Bates CM, 2014, MACROMOLECULES, V47, P2, DOI 10.1021/ma401762n; Bates CM, 2012, SCIENCE, V338, P775, DOI 10.1126/science.1226046; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Beardsley TM, 2011, MACROMOLECULES, V44, P6209, DOI 10.1021/ma200966a; Bencher C, 2012, PROC SPIE, V8323, DOI 10.1117/12.917993; Berry BC, 2007, NANO LETT, V7, P2789, DOI 10.1021/nl071354s; Bita I, 2008, SCIENCE, V321, P939, DOI 10.1126/science.1159352; Black CT, 2001, APPL PHYS LETT, V79, P409, DOI 10.1063/1.1383805; Brillinger DR, 2011, INTERNATIONAL ENCYCL, P531; Campbell IP, 2013, MACROMOLECULES, V46, P9599, DOI 10.1021/ma401704m; Campbell IP, 2013, ACS MACRO LETT, V2, P918, DOI 10.1021/mz400269k; Chai J, 2007, NAT NANOTECHNOL, V2, P500, DOI 10.1038/nnano.2007.227; Chang MY, 2002, MACROMOLECULES, V35, P4437, DOI 10.1021/ma0201025; Cushen JD, 2012, ACS NANO, V6, P3424, DOI 10.1021/nn300459r; Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Faas FGA, 2012, J CELL BIOL, V198, P457, DOI 10.1083/jcb.201201140; Fukukawa K, 2005, MACROMOLECULES, V38, P263, DOI 10.1021/ma049217u; Garetz BA, 1996, MACROMOLECULES, V29, P4675, DOI 10.1021/ma9600724; Gopalan P, 2006, MATERIAL MATTERS, V1, P6; Harrison C, 2000, SCIENCE, V290, P1558, DOI 10.1126/science.290.5496.1558; Harrison C, 2000, MACROMOLECULES, V33, P857, DOI 10.1021/ma991551g; Harrison CK, 1999, BLOCK COPOLYMER MICR; Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778; Hawker CJ, 2001, CHEM REV, V101, P3661, DOI 10.1021/cr990119u; Hawker CJ, 1997, ACCOUNTS CHEM RES, V30, P373, DOI 10.1021/ar960248m; Hong SW, 2013, ACS NANO, V7, P9684, DOI 10.1021/nn402639g; Horvat A, 2008, ACS NANO, V2, P1143, DOI 10.1021/nn800181m; Hu XC, 2005, FARADAY DISCUSS, V128, P103, DOI 10.1039/b403881a; In I, 2006, LANGMUIR, V22, P7855, DOI 10.1021/la060748g; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Isawa M, 2013, PROC SPIE, V8681, DOI 10.1117/12.2010915; Jeong CK, 2014, NANO LETT, V14, P7031, DOI 10.1021/nl503402c; Jin C, 2014, ACS NANO, V8, P3979, DOI 10.1021/nn5009098; Jung YS, 2007, NANO LETT, V7, P2046, DOI 10.1021/nl070924l; Kim E, 2013, ACS NANO, V7, P1952, DOI 10.1021/nn3051264; Kim HW, 2004, IEEE T ELECTRON DEV, V51, P1984, DOI 10.1109/TED.2004.839115; Kim SO, 2003, NATURE, V424, P411, DOI 10.1038/nature01775; Kim Y, 2005, LANGMUIR, V21, P10444, DOI 10.1021/la047122f; Kleman M., 1983, POINTS LINES AND WAL; Kruss S, 2010, ADV MATER, V22, P5499, DOI 10.1002/adma.201003055; Landini G, 2013, AUTO LOCAL THRESHOLD; Lynd NA, 2005, MACROMOLECULES, V38, P8803, DOI 10.1021/ma051025r; Lynd NA, 2007, MACROMOLECULES, V40, P8050, DOI 10.1021/ma070962r; Majewski PW, 2015, ACS NANO, V9, P3896, DOI 10.1021/nn5071827; Mansky P, 1997, PHYS REV LETT, V79, P237, DOI 10.1103/PhysRevLett.79.237; Mistark PA, 2009, ACS NANO, V3, P3987, DOI 10.1021/nn901245w; Nagpal U, 2012, ACS MACRO LETT, V1, P418, DOI 10.1021/mz200245s; Niemeyer K., 2012, ARS TECHNICA; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Park S, 2008, ADV MATER, V20, P681, DOI 10.1002/adma.200701997; Patrone PN, 2012, MACROMOLECULES, V45, P9507, DOI 10.1021/ma301421j; Patrone PN, 2012, PROC SPIE, V8323, DOI 10.1117/12.918038; Peters AJ, 2013, PROC SPIE, V8680, DOI 10.1117/12.2021443; Poelma JE, 2012, ACS NANO, V6, P10845, DOI 10.1021/nn304217y; Qiang Z, 2014, SOFT MATTER, V10, P6068, DOI 10.1039/c4sm00875h; Qiang Z, 2014, MACROMOLECULES, V47, P1109, DOI 10.1021/ma402131j; Rasband W., 2006, IMAGEJ; Rehse S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051805; Ross CA, 2008, J VAC SCI TECHNOL B, V26, P2489, DOI 10.1116/1.2981079; Ruiz R, 2008, SCIENCE, V321, P936, DOI 10.1126/science.1157626; Ruiz R, 2011, ACS NANO, V5, P79, DOI 10.1021/nn101561p; Scherdel S, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2747598; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steinhogl W, 2004, MICROELECTRON ENG, V76, P126, DOI 10.1016/j.mee.2004.07.005; Stoykovich MP, 2007, ACS NANO, V1, P168, DOI 10.1021/nn700164p; Stoykovich MP, 2005, SCIENCE, V308, P1442, DOI 10.1126/science.1111041; Stucchi M, 2007, MICROELECTRON ENG, V84, P2733, DOI 10.1016/j.mee.2007.05.038; Sweat DP, 2014, MACROMOLECULES, V47, P6687, DOI 10.1021/ma501597g; Takahashi H, 2012, MACROMOLECULES, V45, P6253, DOI 10.1021/ma300993x; Tavakkoli KGA, 2012, SCIENCE, V336, P1294, DOI 10.1126/science.1218437; Tseng YC, 2010, POLYMERS-BASEL, V2, P470, DOI 10.3390/polym2040470; Vigild ME, 1998, MACROMOLECULES, V31, P5702, DOI 10.1021/ma9716746; Williams EH, 2012, J CELL BIOL, V198, P271, DOI 10.1083/jcb.201207117; Windows Minesweeper, 2013, WINDOWS MINESWEEPER; Wu N., 2014, THESIS; Wu NLY, 2013, ACS NANO, V7, P5595, DOI 10.1021/nn401968t; Wu NLY, 2012, NANO LETT, V12, P264, DOI 10.1021/nl203488a; Yang XM, 2009, ACS NANO, V3, P1844, DOI 10.1021/nn900073r; ZHANG TY, 1984, COMMUN ACM, V27, P236, DOI 10.1145/357994.358023; Zhang XJ, 2011, MACROMOLECULES, V44, P9752, DOI 10.1021/ma202064t; Zhang XJ, 2010, ACS NANO, V4, P7021, DOI 10.1021/nn102387c	89	53	54	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133088	10.1371/journal.pone.0133088	http://dx.doi.org/10.1371/journal.pone.0133088			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207990	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000063
J	Bibby, BAS; Reynolds, JV; Maher, SG				Bibby, Becky A. S.; Reynolds, John V.; Maher, Stephen G.			MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma	PLOS ONE			English	Article							PREOPERATIVE CHEMORADIOTHERAPY; CANCER CELLS; SURGERY; CHEMORADIATION; CHEMOTHERAPY; RADIATION; THERAPY; MIRNAS; TIME	Oesophageal adenocarcinoma (OAC) is the sixth most common cause of cancer deaths worldwide, and the 5-year survival rate for patients diagnosed with the disease is approximately 17%. The standard of care for locally advanced disease is neoadjuvant chemotherapy or, more commonly, combined neoadjuvant chemoradiation therapy (neo-CRT) prior to surgery. Unfortunately, similar to 60-70% of patients will fail to respond to neo-CRT. Therefore, the identification of biomarkers indicative of patient response to treatment has significant clinical implications in the stratification of patient treatment. Furthermore, understanding the molecular mechanisms underpinning tumour response and resistance to neo-CRT will contribute towards the identification of novel therapeutic targets for enhancing OAC sensitivity to CRT. MicroRNAs (miRNA/miR) function to regulate gene and protein expression and play a causal role in cancer development and progression. MiRNAs have also been identified as modulators of key cellular pathways associated with resistance to CRT. Here, to identify miRNAs associated with resistance to CRT, pre-treatment diagnostic biopsy specimens from patients with OAC were analysed using miRNA-profiling arrays. In pre-treatment biopsies miR-330-5p was the most downregulated miRNA in patients who subsequently failed to respond to neo-CRT. The role of miR-330 as a potential modulator of tumour response and sensitivity to CRT in OAC was further investigated in vitro. Through vector-based overexpression the E2F1/p-AKT survival pathway, as previously described, was confirmed as a target of miR-330 regulation. However, miR-330-mediated alterations to the E2F1/p-AKT pathway were insufficient to significantly alter cellular sensitivity to chemotherapy (cisplatin and 5-flurouracil). In contrast, silencing of miR-330-5p enhanced, albeit subtly, cellular resistance to clinically relevant doses of radiation. This study highlights the need for further investigation into the potential of miR-330-5p as a predictive biomarker of patient sensitivity to neo-CRT and as a novel therapeutic target for manipulating cellular sensitivity to neo-CRT in patients with OAC.	[Bibby, Becky A. S.; Maher, Stephen G.] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, N Humberside, England; [Reynolds, John V.; Maher, Stephen G.] St James Hosp, Trin Coll Dublin, Inst Mol Med, Dept Surg, Dublin 8, Ireland	University of Hull; Trinity College Dublin	Maher, SG (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, N Humberside, England.	s.maher@hull.ac.uk	Maher, Stephen/HHM-9099-2022	Reynolds, John V/0000-0002-5501-9521; Maher, Stephen/0000-0003-0126-7906	Cancer and Polio Research Fund; Irish Cancer Society [CRF10MAH]; University of Hull PhD scholarship	Cancer and Polio Research Fund; Irish Cancer Society; University of Hull PhD scholarship	This work was supported by the Cancer and Polio Research Fund (www.cprf.org.uk) awarded to SGM and the Irish Cancer Society (www.cancer.ie) CRF10MAH awarded to SGM. BASB is supported by a University of Hull PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Amin M, 2015, EXP MOL PATHOL, V98, P411, DOI 10.1016/j.yexmp.2015.03.002; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GIRLING DJ, 1992, EUR J CANCER, V28A, P1003, DOI 10.1016/0959-8049(92)90170-7; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Gwynne S, 2014, CLIN ONCOL-UK, V26, P522, DOI 10.1016/j.clon.2014.05.015; Gwynne S, 2013, CLIN ONCOL-UK, V25, P368, DOI 10.1016/j.clon.2013.01.006; Hotte GJ, 2012, RADIAT RES, V177, P272, DOI 10.1667/RR2776.1; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Kelsen DP, 2000, CANCER J, V6, pS177; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li YF, 2013, BIOCHEM BIOPH RES CO, V431, P560, DOI 10.1016/j.bbrc.2013.01.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynam-Lennon N, 2012, J MOL MED, V90, P1449, DOI 10.1007/s00109-012-0924-x; Lynam-Lennon N, 2010, RADIAT RES, V174, P703, DOI 10.1667/RR2295.1; Maher SG, 2009, ANN SURG, V250, P729, DOI 10.1097/SLA.0b013e3181bce7e1; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Mao YQ, 2013, ONCOL REP, V30, P327, DOI 10.3892/or.2013.2452; Mukherjee S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1062-y; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Qu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046010; Reynolds JV, 2007, ANN SURG, V245, P707, DOI 10.1097/01.sla.0000254367.15810.38; Sakai NS, 2013, SEMIN CANCER BIOL, V23, P512, DOI 10.1016/j.semcancer.2013.08.005; Shapiro J, 2014, ANN SURG, V260, P807, DOI 10.1097/SLA.0000000000000966; Skinner HD, 2014, CANCER-AM CANCER SOC, V120, P3635, DOI 10.1002/cncr.28911; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506; Toulany M, 2007, MOL CANCER RES, V5, P863, DOI 10.1158/1541-7786.MCR-06-0297; Urschel JD, 2003, AM J SURG, V185, P538, DOI 10.1016/S0002-9610(03)00066-7; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Yao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095060; Yoo JK, 2014, EXP GERONTOL, V58, P139, DOI 10.1016/j.exger.2014.07.020	40	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134180	10.1371/journal.pone.0134180	http://dx.doi.org/10.1371/journal.pone.0134180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221725	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800111
J	Han, LJ; Li, J; Chen, YT; Zhang, MJ; Qian, L; Chen, Y; Wu, ZZ; Xu, Y; Li, JW				Han, Lijuan; Li, Jie; Chen, Yanting; Zhang, Meijuan; Qian, Lai; Chen, Yan; Wu, Zhengzheng; Xu, Yun; Li, Jingwei			Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke	PLOS ONE			English	Article							HUMAN TISSUE KALLIKREIN; ISCHEMIC-STROKE; INHIBITING APOPTOSIS; IMMUNOCYTOCHEMICAL LOCALIZATION; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; LIMB ISCHEMIA; BRAIN-INJURY; APELIN; INFLAMMATION	Angiogenesisis a key restorative mechanism in response to ischemia, and pro-angiogenic therapy could be beneficial in stroke. Accumulating experimental and clinical evidence suggest that human urinary kallidinogenase (HUK) improves stroke outcome, but the underlying mechanisms are not clear. The aim of current study was to verify roles of HUK in post-ischemic angiogenesis and identify relevant mediators. In rat middle cerebral artery occlusion (MCAO) model, we confirmed that HUK treatment could improve stroke outcome, indicated by reduced infarct size and improved neurological function. Notably, the F-18-FDG micro-PET scan indicated that HUK enhanced cerebral perfusion in rats after MCAO treatment. In addition, HUK promotespost-ischemic angiogenesis, with increased vessel density as well as up-regulated VEGF andapelin/APJ expression in HUK-treated MCAO mice. In endothelial cell cultures, induction of VEGF and apelin/APJ expression, and ERK1/2 phosphorylation by HUK was further confirmed. These changes were abrogated by U0126, a selective ERK1/2 inhibitor. Moreover, F13A, a competitive antagonist of APJ receptor, significantly suppressed HUK-induced VEGF expression. Furthermore, angiogenic functions of HUK were inhibited in the presence of selective bradykinin B1 or B2 receptor antagonist both in vitro and in vivo. Our findings indicate that HUK treatment promotes post-ischemic angiogenesis and cerebral perfusion via activation of bradykinin B1 and B2 receptors, which is potentially due to enhancement expression of VEGF and apelin/APJ in ERK1/2 dependent way.	[Han, Lijuan; Li, Jie; Chen, Yanting; Zhang, Meijuan; Qian, Lai; Chen, Yan; Wu, Zhengzheng; Xu, Yun; Li, Jingwei] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China; [Han, Lijuan; Chen, Yanting; Zhang, Meijuan; Qian, Lai; Chen, Yan; Wu, Zhengzheng; Xu, Yun; Li, Jingwei] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Yun; Li, Jingwei] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Xu, Yun; Li, Jingwei] Jiangsu Prov Stroke Ctr Diag & Therapy, Nanjing, Jiangsu, Peoples R China; [Xu, Yun; Li, Jingwei] Nanjing Neuropsychiat Clin Med Ctr, Nanjing, Jiangsu, Peoples R China; [Li, Jie] Jiangsu Univ, Affiliated Yixing Peoples Hosp, Dept Neurol, Yixing, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Jiangsu University	Xu, Y (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; ljw323@yeah.net		Schirmer, Claire/0000-0002-7994-1190	National Natural Science Foundation of China [81171085, 81230026, 81200896, 81400971]; Outstanding Researcher Program of Jiangsu Province [LJ 201101]; Natural Science Foundation of Jiangsu Province [BK 2009037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Researcher Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China, https://isisn.nsfc.gov.cn/egrantweb/, grant numbers: 81171085, 81230026 (YX), 81200896 (JL), 81400971 (YC); Outstanding Researcher Program of Jiangsu Province, http://www.jswst.gov.cn/index.html, grant number: LJ 201101 (YX); the Natural Science Foundation of Jiangsu Province, https://isisn.nsfc.gov.cn/egrantweb/, grant number: BK 2009037 (YX).	Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Chang LL, 2011, BRAIN BEHAV IMMUN, V25, P260, DOI 10.1016/j.bbi.2010.09.017; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Chen ZB, 2010, J CEREBR BLOOD F MET, V30, P1356, DOI 10.1038/jcbfm.2010.19; Crafts TD, 2015, CYTOKINE, V71, P385, DOI 10.1016/j.cyto.2014.08.005; Emanueli C, 2004, ARCH MAL COEUR VAISS, V97, P679; Emanueli C, 2003, CURR PHARM DESIGN, V9, P589, DOI 10.2174/1381612033391315; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hagiwara M, 2008, HUM GENE THER, V19, P807, DOI [10.1089/hum.2008.016, 10.1089/hgt.2008.016]; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Kidoya H, 2012, J BIOCHEM, V152, P125, DOI 10.1093/jb/mvs071; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Li PY, 2014, STROKE, V45, P857, DOI 10.1161/STROKEAHA.113.004100; Liu JL, 2014, PROG NEUROBIOL, V115, P138, DOI 10.1016/j.pneurobio.2013.11.004; Liu L, 2009, J NEUROSCI RES, V87, P3576, DOI 10.1002/jnr.22151; Liu L, 2009, EXP NEUROL, V219, P453, DOI 10.1016/j.expneurol.2009.06.021; Lu RY, 2012, CNS NEUROSCI THER, V18, P395, DOI 10.1111/j.1755-5949.2012.00305.x; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Pizard A, 2008, BIOL CHEM, V389, P701, DOI 10.1515/BC.2008.081; Pons S, 2008, EUR J HEART FAIL, V10, P343, DOI 10.1016/j.ejheart.2008.02.002; Porcu P, 2002, CIRCULATION, V105, P67, DOI 10.1161/hc0102.101360; Smith RS, 2008, BIOL CHEM, V389, P725, DOI 10.1515/BC.2008.084; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Yao YY, 2008, CARDIOVASC RES, V80, P354, DOI 10.1093/cvr/cvn223; Yoshida H, 2000, HYPERTENSION, V35, P25, DOI 10.1161/01.HYP.35.1.25; Zhang Canfei, 2012, J Evid Based Med, V5, P31, DOI 10.1111/j.1756-5391.2012.01167.x; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	35	40	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134543	10.1371/journal.pone.0134543	http://dx.doi.org/10.1371/journal.pone.0134543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222055	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800153
J	Lacy, BE; Schey, R; Shiff, SJ; Lavins, BJ; Fox, SM; Jia, XWD; Blakesley, RE; Hao, XM; Cronin, JA; Currie, MG; Kurtz, CB; Johnston, JM; Lembo, AJ				Lacy, Brian E.; Schey, Ron; Shiff, Steven J.; Lavins, Bernard J.; Fox, Susan M.; Jia, Xinwei D.; Blakesley, Rick E.; Hao, Xinming; Cronin, Jacquelyn A.; Currie, Mark G.; Kurtz, Caroline B.; Johnston, Jeffrey M.; Lembo, Anthony J.			Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUANYLATE-CYCLASE-C; PHARMACOLOGICAL MANAGEMENT; FUNCTIONAL CONSTIPATION; GASTROINTESTINAL-TRACT; DISTENSION; PAIN; ACTIVATION; EFFICACY; EVALUATE	Background Abdominal bloating is a common and bothersome symptom of chronic idiopathic constipation. The objective of this trial was to evaluate the efficacy and safety of linaclotide in patients with chronic idiopathic constipation and concomitant moderate-to-severe abdominal bloating. Methods This Phase 3b, randomized, double-blind, placebo-controlled clinical trial randomized patients to oral linaclotide (145 or 290 mu g) or placebo once daily for 12 weeks. Eligible patients met Rome II criteria for chronic constipation upon entry with an average abdominal bloating score >= 5 (self-assessment: 0 10-point numerical rating scale) during the 14-day baseline period. Patients reported abdominal symptoms (including bloating) and bowel symptoms daily; adverse events were monitored. The primary responder endpoint required patients to have >= 3 complete spontaneous bowel movements/week with an increase of >= 1 from baseline, for >= 9 of 12 weeks. The primary endpoint compared linaclotide 145 mu g vs. placebo. Results The intent-to-treat population included 483 patients (mean age=47.3 years, female=91.5%, white=67.7%). The primary endpoint was met by 15.7% of linaclotide 145 mu g patients vs. 7.6% of placebo patients (P<0.05). Both linaclotide doses significantly improved abdominal bloating vs. placebo (P<0.05 for all secondary endpoints, controlling for multiplicity). Approximately one-third of linaclotide patients (each group) had >= 50% mean decrease from baseline in abdominal bloating vs. 18% of placebo patients (P<0.01). Diarrhea was reported in 6% and 17% of linaclotide 145 and 290 mu g patients, respectively, and 2% of placebo patients. AEs resulted in premature discontinuation of 5% and 9% of linaclotide 145 mu g and 290 mu g patients, respectively, and 6% of placebo patients. Conclusions Once-daily linaclotide (145 and 290 mu g) significantly improved bowel and abdominal symptoms in chronic idiopathic constipation patients with moderate-to-severe baseline abdominal bloating; in particular, linaclotide significantly improved abdominal bloating compared to placebo, an important finding given the lack of agents available to treat abdominal bloating in chronic idiopathic constipation patients.	[Lacy, Brian E.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Schey, Ron] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [Shiff, Steven J.; Fox, Susan M.; Jia, Xinwei D.; Blakesley, Rick E.] Forest Labs LLC, Subsidiary Actavis Plc, Jersey City, NJ USA; [Lavins, Bernard J.; Hao, Xinming; Cronin, Jacquelyn A.; Currie, Mark G.; Kurtz, Caroline B.; Johnston, Jeffrey M.] Ironwood Pharmaceut, Cambridge, MA 02142 USA; [Lembo, Anthony J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Dartmouth College; University of Iowa; Ironwood Pharmaceuticals, Inc.; Harvard University; Beth Israel Deaconess Medical Center	Cronin, JA (corresponding author), Ironwood Pharmaceut, Cambridge, MA 02142 USA.	jcronin@ironwoodpharma.com			Forest Laboratories, LLC; Ironwood Pharmaceuticals, Inc.	Forest Laboratories, LLC; Ironwood Pharmaceuticals, Inc.	This trial was funded by Forest Laboratories, LLC and Ironwood Pharmaceuticals, Inc. The funding sources were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Agrawal A, 2008, GASTROENTEROLOGY, V134, P1882, DOI 10.1053/j.gastro.2008.02.096; Bryant AP, 2010, LIFE SCI, V86, P760, DOI 10.1016/j.lfs.2010.03.015; Busby RW, 2013, J PHARMACOL EXP THER, V344, P196, DOI 10.1124/jpet.112.199430; Busby RW, 2010, EUR J PHARMACOL, V649, P328, DOI 10.1016/j.ejphar.2010.09.019; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; Chang L, 2014, GASTROENTEROLOGY, V147, P1149, DOI 10.1053/j.gastro.2014.09.002; Chey WD, 2012, AM J GASTROENTEROL, V107, P1702, DOI 10.1038/ajg.2012.254; Drossman DA, 1999, ROME 2 MULTINATIONAL; Drossman DA, 2000, CHAPTER 7 FUNCTIONAL, P360; Eutamene H, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01385.x; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gudsoorkar VS, 2013, EXPERT OPIN EMERG DR, V18, P365, DOI 10.1517/14728214.2013.831068; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Houghton LA, 2011, BEST PRACT RES CL GA, V25, P141, DOI 10.1016/j.bpg.2010.12.009; Jiang X, 2008, GUT, V57, P756, DOI 10.1136/gut.2007.142810; Johanson JF, 2007, ALIMENT PHARM THER, V25, P599, DOI 10.1111/j.1365-2036.2006.03238.x; Koch A, 1997, DIS COLON RECTUM, V40, P902, DOI 10.1007/BF02051196; Lacy Brian E, 2011, Gastroenterol Hepatol (N Y), V7, P729; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Murray K, 2014, AM J GASTROENTEROL, V109, P110, DOI 10.1038/ajg.2013.386; Rao S, 2012, AM J GASTROENTEROL, V107, P1714, DOI 10.1038/ajg.2012.255; Rey E, 2014, AM J GASTROENTEROL; SANDLER RS, 1987, DIGEST DIS SCI, V32, P841, DOI 10.1007/BF01296706; Seo AY, 2013, J NEUROGASTROENTEROL, V19, P433, DOI 10.5056/jnm.2013.19.4.433; Shekhar C, 2013, GASTROENTEROLOGY, V145, P749, DOI 10.1053/j.gastro.2013.07.014; Silos-Santiago I, 2013, PAIN, V154, P1820, DOI 10.1016/j.pain.2013.05.044; Singh S, 2010, GASTROENTEROL CLIN N, V39, P509, DOI 10.1016/j.gtc.2010.08.001; Tremolaterra F, 2006, GASTROENTEROLOGY, V130, P1062, DOI 10.1053/j.gastro.2005.12.036; US Food and Drug Administration, 2012, GUID IND IRR BOW SYN; Villoria A, 2011, AM J GASTROENTEROL, V106, P815, DOI 10.1038/ajg.2010.408; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Wong RK, 2010, AM J GASTROENTEROL, V105, P2228, DOI 10.1038/ajg.2010.200	32	45	47	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134349	10.1371/journal.pone.0134349	http://dx.doi.org/10.1371/journal.pone.0134349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222318	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800135
J	Gao, P; Liao, Z; Wang, XX; Bao, LF; Fan, MH; Li, XM; Wu, CW; Xia, SW				Gao, Peng; Liao, Zhi; Wang, Xin-xing; Bao, Lin-fei; Fan, Mei-hua; Li, Xiao-min; Wu, Chang-wen; Xia, Shu-wei			Layer-by-Layer Proteomic Analysis of Mytilus galloprovincialis Shell	PLOS ONE			English	Article								Bivalve shell is a biomineralized tissue with various layers/microstructures and excellent mechanical properties. Shell matrix proteins (SMPs) pervade and envelop the mineral crystals and play essential roles in biomineralization. Despite that Mytilus is an economically important bivalve, only few proteomic studies have been performed for the shell, and current knowledge of the SMP set responsible for different shell layers of Mytilus remains largely patchy. In this study, we observed that Mytilus galloprovincialis shell contained three layers, including nacre, fibrous prism, and myostracum that is involved in shell-muscle attachment. A parallel proteomic analysis was performed for these three layers. By combining LC-MS/ MS analysis with Mytilus EST database interrogations, a whole set of 113 proteins was identified, and the distribution of these proteins in different shell layers followed a mosaic pattern. For each layer, about a half of identified proteins are unique and the others are shared by two or all of three layers. This is the first description of the protein set exclusive to nacre, myostracum, and fibrous prism in Mytilus shell. Moreover, most of identified proteins in the present study are novel SMPs, which greatly extended biomineralization-related protein data of Mytilus. These results are useful, on one hand, for understanding the roles of SMPs in the deposition of different shell layers. On the other hand, the identified protein set of myostracum provides candidates for further exploring the mechanism of adductor muscle-shell attachment.	[Gao, Peng; Xia, Shu-wei] Ocean Univ Chinese, Coll Chem & Chem Engn, Qingdao, Peoples R China; [Gao, Peng; Liao, Zhi; Wang, Xin-xing; Bao, Lin-fei; Fan, Mei-hua; Wu, Chang-wen] Zhejiang Ocean Univ, Lab Marine Biol Prot Engn, Zhoushan, Zhejiang, Peoples R China; [Li, Xiao-min] Chinese Acad Fishery Sci, Ctr Biotechnol, Beijing, Peoples R China	Ocean University of China; Zhejiang Ocean University; Chinese Academy of Fishery Sciences	Xia, SW (corresponding author), Ocean Univ Chinese, Coll Chem & Chem Engn, Qingdao, Peoples R China.	shuweixia@yahoo.com	Wang, Xinxing/AAU-6356-2021	Liao, Zhi/0000-0003-0688-7346	Natural Science Foundation of Zhejiang [LY14C100001]; Open Foundation from Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education [2015DF02]; National College Students' Innovative Entrepreneurial Training Plan [201410340002]	Natural Science Foundation of Zhejiang(Natural Science Foundation of Zhejiang Province); Open Foundation from Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education; National College Students' Innovative Entrepreneurial Training Plan	This work was supported by the Natural Science Foundation of Zhejiang under Grant LY14C100001; The Open Foundation from Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education under Grant 2015DF02; and The National College Students' Innovative Entrepreneurial Training Plan under Grant 201410340002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck S, 1996, CONNECT TISSUE RES, V35, P365, DOI 10.3109/03008209609029213; Blank S, 2003, J MICROSC, V212; Caroline J, 2010, BMC GENOMICS, P11; Carriker MR, 1996, THE E OYSTER; Carter JG, 1990, SKELETAL BIOMINERALI, P1; Checa A, 2005, BIOMATERIALS, V26; Estevez-Calvar N, 2011, DEV COMP IMMUNOLOGY, V35; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Falini G, 1996, SCIENCE, P271; Ferjani I, 2010, BIOCH BIOPHYSICA ACT, V1804; Funabara D, 2001, FISH SCI, V67; Galtsoff PA, 1964, THE AM OYSTER; Gregoie C, 1961, J BIOPHYSICAL BIOCH, P9; HARE PE, 1963, SCIENCE, V139, P216, DOI 10.1126/science.139.3551.216; Hofmann SL, 1989, J BIOL CHEM, V264; Huang J, 2007, BIOCH BIOPHYS ACTA, V1770; Jackson DJ, 2010, MOL BIOL EVOLUTION, V27; Kouchinsky A, 2000, ACTA PALAEONTOLOGICA, V45; Lee SW, 2007, MICRON, V38, P58, DOI 10.1016/j.micron.2006.03.018; Lee SW, 2011, MICRON, V42, P60, DOI 10.1016/j.micron.2010.08.001; Lowenstam HA, 1989, BIOMINERALIZATION; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Mann S., 2011, BIOMINERALIZATION PR; Marie B, 2012, P NATL ACAD SCI, V109; Marie B, 2011, MARINE BIOTECHNOLOGY, V13; Marie B, 2011, J MOL EVOL, V72, P531, DOI 10.1007/s00239-011-9451-6; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Oaki Y, 2005, ANGEW CHEM INT ED, V44; Peters W, 1972, COMP BIOCH PHYSL B, P41; Schonitzer V, 2007, BMC STRUCTURAL BIOL, P7; Sellinger A, 1998, NATURE, P394; Shen X, 1997, J BIOL CHEM, V272; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2007, BIOSCIENCE BIOTECHNO, V71; Suzuki M, 2011, CHEMBIOCHEM, V12, P2478, DOI 10.1002/cbic.201100317; TAYLOR JD, 1990, HYDROBIOLOGIA, V193, P199, DOI 10.1007/BF00028077; Weiss IM, 2001, BIOCH BIOPHYSICAL RE, V285; Weiss IM, 2006, J STRUCTURAL BIOL, V153; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; Yin Y, 2005, BIOCHEMISTRY, V44; Zhang G., 2012, NATURE, V490; Zhao H, 2006, J BIOL CHEM, V281	44	52	57	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133913	10.1371/journal.pone.0133913	http://dx.doi.org/10.1371/journal.pone.0133913			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218932	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900054
J	Gebrehiwot, TG; Sebastian, MS; Edin, K; Goicolea, I				Gebrehiwot, Tesfay Gebregzabher; Sebastian, Miguel San; Edin, Kerstin; Goicolea, Isabel			The Health Extension Program and Its Association with Change in Utilization of Selected Maternal Health Services in Tigray Region, Ethiopia: A Segmented Linear Regression Analysis	PLOS ONE			English	Article							CARE SERVICES; DETERMINANTS; DISTRICT; ACCESS; TIME	Background In 2003, the Ethiopian Ministry of Health established the Health Extension Program (HEP), with the goal of improving access to health care and health promotion activities in rural areas of the country. This paper aims to assess the association of the HEP with improved utilization of maternal health services in Northern Ethiopia using institution-based retrospective data. Methods Average quarterly total attendances for antenatal care (ANC), delivery care (DC) and postnatal care (PNC) at health posts and health care centres were studied from 2002 to 2012. Regression analysis was applied to two models to assess whether trends were statistically significant. One model was used to estimate the level and trend changes associated with the immediate period of intervention, while changes related to the post-intervention period were estimated by the other. Results The total number of consultations for ANC, DC and PNC increased constantly, particularly after the late-intervention period. Increases were higher for ANC and PNC at health post level and for DC at health centres. A positive statistically significant upward trend was found for DC and PNC in all facilities (p<0.01). The positive trend was also present in ANC at health centres (p = 0.04), but not at health posts. Conclusion Our findings revealed an increase in the use of antenatal, delivery and post-natal care after the introduction of the HEP. We are aware that other factors, that we could not control for, might be explaining that increase. The figures for DC and PNC are however low and more needs to be done in order to increase the access to the health care system as well as the demand for these services by the population. Strengthening of the health information system in the region needs also to be prioritized.	[Gebrehiwot, Tesfay Gebregzabher] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia; [Gebrehiwot, Tesfay Gebregzabher; Sebastian, Miguel San; Edin, Kerstin; Goicolea, Isabel] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden; [Edin, Kerstin] Umea Univ, Dept Nursing, Umea, Sweden	Mekelle University; Umea University; Umea University	Gebrehiwot, TG (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia.	tesfig@yahoo.com		Goicolea, Isabel/0000-0002-8114-4705	Umea Centre for Global Health Research - FAS; Swedish Council for Working Life and Social Research [2006-1512]	Umea Centre for Global Health Research - FAS; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The organization Etiopia-Utopia covered the expenses of data collection for this research. This work was partly supported by the Umea Centre for Global Health Research, funded by FAS, the Swedish Council for Working Life and Social Research (Grant no. 2006-1512).	Accorsi S, 2010, T ROY SOC TROP MED H, V104, P336, DOI 10.1016/j.trstmh.2009.12.009; Admassie A, 2009, J DEV EFFECT, V1, P430, DOI 10.1080/19439340903375724; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; [Anonymous], 2010, MILL DEV GOALS REP; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Bilal KN, 2011, HEWS IN ETHIOPIA IMP, P433; Biratu TB, 2000, ETHIOP J HEALTH DEV, V20, P84; Bradley EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035042; Brazier E, 2009, SOC SCI MED, V69, P682, DOI 10.1016/j.socscimed.2009.06.023; Central Statistical Agency Ethiopia and ICF International Ethiopian demographic and health survey 2011, 2011, CENTR STAT AG ETH IC, P270; Central statistics agency, 2014, ETH MIN HLTH SURV; De Allegri M, 2011, HEALTH POLICY, V99, P210, DOI 10.1016/j.healthpol.2010.10.010; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Federal Ministry of Health, 2004, HLTH EXT PROGR IMPL; Federal Ministry of Health, 2007, HLTH EXT PROGR ETH; Federal Ministry of Health, 2011, HLTH SEC DEV PROGR 4; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gebrehiwot T, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-137; Gebrehiwot T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-113; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Hanlon C, 2010, ARCH WOMEN MENT HLTH, V13, P385, DOI 10.1007/s00737-010-0149-3; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; Karim AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065160; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mekonnen Y, 2003, J HEALTH POPUL NUTR, V21, P374; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Mushi D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-14; Nigussie M, 2004, ETHIOP J HEATH DEV, V18, P145; Parkhurst JO, 2005, HEALTH POLICY, V73, P127, DOI 10.1016/j.healthpol.2004.11.001; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Phyllida T, 2004, LANCET, V364, P900; Rasanathan K, 2011, J EPIDEMIOL COMMUN H, V65, P656, DOI 10.1136/jech.2009.093914; Roman T, 2010, Q HLTH B FEDERAL MIN; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Starrs AM, 2007, LANCET, V370, P1285, DOI 10.1016/S0140-6736(07)61549-9; Stekelenburg J, 2004, TROP MED INT HEALTH, V9, P390, DOI 10.1111/j.1365-3156.2004.01202.x; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; Tigray Health Bureau, 2010, TIGR HLTH BUR PROF 2; Tigray Health Bureau, 2012, TIGR REG HLTH BUR HL; Tsegay Y, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-30; UNFPA, 2008, SUMM STAT REP 2007 P; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WHO, 2008, WORLD HLTH REP PRIM; Wilkinson D, 2001, B WORLD HEALTH ORGAN, V79, P665; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	50	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0131195	10.1371/journal.pone.0131195	http://dx.doi.org/10.1371/journal.pone.0131195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218074	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900001
J	Lean, QY; Eri, RD; Randall-Demllo, S; Sohal, SS; Stewart, N; Peterson, GM; Gueven, N; Patel, RP				Lean, Qi Ying; Eri, Rajaraman D.; Randall-Demllo, Sarron; Sohal, Sukhwinder Singh; Stewart, Niall; Peterson, Gregory M.; Gueven, Nuri; Patel, Rahul P.			Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses	PLOS ONE			English	Article							LOW-MOLECULAR-WEIGHT; ACTIVE ULCERATIVE-COLITIS; DEXTRAN SULFATE SODIUM; BOWEL-DISEASE; HEPARIN ENOXAPARIN; INTESTINAL INFLAMMATION; CYTOKINE PRODUCTION; ADJUVANT THERAPY; CROHNS-DISEASE; LICHEN-PLANUS	Inflammatory bowel diseases, such as ulcerative colitis, cause significant morbidity and decreased quality of life. The currently available treatments are not effective in all patients, can be expensive and have potential to cause severe side effects. This prompts the need for new treatment modalities. Enoxaparin, a widely used antithrombotic agent, is reported to possess anti-inflammatory properties and therefore we evaluated its therapeutic potential in a mouse model of colitis. Acute colitis was induced in male C57BL/6 mice by administration of dextran sulfate sodium (DSS). Mice were treated once daily with enoxaparin via oral or intraperitoneal administration and monitored for colitis activities. On termination (day 8), colons were collected for macroscopic evaluation and cytokine measurement, and processed for histology and immunohistochemistry. Oral but not intraperitoneal administration of enoxaparin significantly ameliorated DSS-induced colitis. Oral enoxaparin-treated mice retained their body weight and displayed less diarrhea and fecal blood loss compared to the untreated colitis group. Colon weight in enoxaparin-treated mice was significantly lower, indicating reduced inflammation and edema. Histological examination of untreated colitis mice showed a massive loss of crypt architecture and goblet cells, infiltration of immune cells and the presence of edema, while all aspects of this pathology were alleviated by oral enoxaparin. Reduced number of macrophages in the colon of oral enoxaparin-treated mice was accompanied by decreased levels of pro-inflammatory cytokines. Oral enoxaparin significantly reduces the inflammatory pathology associated with DSS-induced colitis in mice and could therefore represent a novel therapeutic option for the management of ulcerative colitis.	[Lean, Qi Ying; Stewart, Niall; Peterson, Gregory M.; Gueven, Nuri; Patel, Rahul P.] Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia; [Lean, Qi Ying] Univ Teknol MARA, Fac Pharm, Puncak Alam, Selangor, Malaysia; [Eri, Rajaraman D.; Randall-Demllo, Sarron; Sohal, Sukhwinder Singh] Univ Tasmania, Fac Hlth, Sch Hlth Sci, Hobart, Tas, Australia; [Sohal, Sukhwinder Singh; Peterson, Gregory M.] Univ Tasmania, Fac Hlth, Breathe Well Ctr Res Excellence Chron Resp Dis &, Sch Med, Hobart, Tas, Australia; [Peterson, Gregory M.] Univ Tasmania, Fac Hlth, Sch Med, Hlth Serv Innovat Tasmania, Hobart, Tas, Australia	University of Tasmania; Universiti Teknologi MARA; University of Tasmania; University of Tasmania; University of Tasmania	Patel, RP (corresponding author), Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia.	Rahul.Patel@utas.edu.au	Eri, Raj/AAD-1185-2020; Lean, Qi Ying/G-1680-2019; Randall-Demllo, Sarron Y/B-3326-2018; Eri, Rajaraman/AAM-3214-2020	Eri, Raj/0000-0003-1688-8043; Lean, Qi Ying/0000-0003-0331-8607; Peterson, Gregory/0000-0002-6764-3882; Patel, Rahul/0000-0001-9344-1013; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Guven, Nuri/0000-0003-3782-767X	Royal Hobart Hospital Research Foundation, Hobart, Tasmania, Australia; University of Tasmania, Australia; Pharmacy, School of Medicine - Medicines Australia	Royal Hobart Hospital Research Foundation, Hobart, Tasmania, Australia; University of Tasmania, Australia; Pharmacy, School of Medicine - Medicines Australia	This study was supported by The Royal Hobart Hospital Foundation's Research Grant (RHHRF) from Royal Hobart Hospital Research Foundation, Hobart, Tasmania, Australia; and Faculty of Health Science Strategic Seed Funding Grant and Research Enhancement Grants Scheme from University of Tasmania, Australia. Qi Ying Lean is supported by a Scholarship from Pharmacy, School of Medicine, funded by Medicines Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Belmiro CLR, 2009, J BIOL CHEM, V284, P11267, DOI 10.1074/jbc.M807211200; Bento AF, 2011, AM J PATHOL, V178, P1153, DOI 10.1016/j.ajpath.2010.11.052; Bisio A, 2009, THROMB HAEMOSTASIS, V102, P865, DOI 10.1160/TH09-02-0081; Bloom S, 2004, ALIMENT PHARM THER, V19, P871, DOI 10.1111/j.1365-2036.2004.01926.x; Celasco G, 2010, ALIMENT PHARM THER, V31, P375, DOI 10.1111/j.1365-2036.2009.04194.x; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Day R, 1999, DIGEST DIS SCI, V44, P2508, DOI 10.1023/A:1026647308089; de Bievre MA, 2007, INFLAMM BOWEL DIS, V13, P753, DOI 10.1002/ibd.20085; Dotan I, 2001, DIGEST DIS SCI, V46, P2239, DOI 10.1023/A:1011979418914; Dotan I, 2001, ALIMENT PHARM THER, V15, P1687, DOI 10.1046/j.1365-2036.2001.01079.x; Eri R, 2012, METHODS MOL BIOL, V844, P261, DOI 10.1007/978-1-61779-527-5_19; Fareed J, 2004, CURR PHARM DESIGN, V10, P983, DOI 10.2174/1381612043452811; Ferrante M, 2008, J CROHNS COLITIS, V2, P219, DOI 10.1016/j.crohns.2008.03.004; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; GAFFNEY PR, 1995, AM J GASTROENTEROL, V90, P220; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Hayashi Y, 2009, SCAND J GASTROENTERO, V44, P1323, DOI 10.3109/00365520903262414; Heinsbroek SEM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001069; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Hodak E, 1998, J AM ACAD DERMATOL, V38, P564, DOI 10.1016/S0190-9622(98)70118-5; Ishiguro Y, 1999, J GASTROENTEROL, V34, P66, DOI 10.1007/s005350050218; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kaya S, 2004, SCAND J GASTROENTERO, V39, P613, DOI 10.1080/00365520410004622; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Korzenik JR, 1998, DIGEST DIS SCI, V43, P1800, DOI 10.1023/A:1018800207063; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Lever Rebecca, 2012, Handb Exp Pharmacol, P281, DOI 10.1007/978-3-642-23056-1_12; Lever R, 2010, EUR J PHARMACOL, V630, P137, DOI 10.1016/j.ejphar.2009.12.015; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; Luo JY, 2011, BIOMED PHARMACOTHER, V65, P111, DOI 10.1016/j.biopha.2010.12.013; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Oshima T, 2008, J GASTROEN HEPATOL, V23, pS146, DOI 10.1111/j.1440-1746.2008.05405.x; Paliwal R, 2012, MED RES REV, V32, P388, DOI 10.1002/med.20217; Panes J, 2000, GASTROENTEROLOGY, V119, P903, DOI 10.1053/gast.2000.18159; Pastorelli L, 2008, ALIMENT PHARM THER, V28, P581, DOI 10.1111/j.1365-2036.2008.03757.x; Patel RP, 2008, J PHARMACEUT BIOMED, V46, P30, DOI 10.1016/j.jpba.2007.10.009; Pellequer Y, 2007, J PHARMACOL EXP THER, V321, P726, DOI 10.1124/jpet.106.117226; Queiroz KCS, 2011, MOL MED, V17, P1119, DOI 10.2119/molmed.2011.00138; Rai R, 2002, J AM ACAD DERMATOL, V46, P141, DOI 10.1067/mjd.2002.117389; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rose WA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-41; Sands BE, 2007, J CLIN PHARMACOL, V47, P930, DOI 10.1177/0091270007301623; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Steinbach EC, 2014, INFLAMM BOWEL DIS, V20, P166, DOI 10.1097/MIB.0b013e3182a69dca; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Torkvist L, 1999, ALIMENT PHARM THERAP, V13, P1323; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Vrij AA, 2001, SCAND J GASTROENTERO, V36, P41, DOI 10.1080/003655201753265091; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wang X, 2011, DIGEST DIS SCI, V56, P1047, DOI 10.1007/s10620-010-1398-8; Weisser SB, 2011, J LEUKOCYTE BIOL, V90, P483, DOI 10.1189/jlb.0311124; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Yang SK, 2002, AM J GASTROENTEROL, V97, P126; Ye HP, 2013, J PHARMACEUT BIOMED, V85, P99, DOI 10.1016/j.jpba.2013.06.033; Zezos P, 2006, ALIMENT PHARM THER, V23, P1443, DOI 10.1111/j.1365-2036.2006.02870.x; Zheng B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095441; Zhu W, 2014, IMMUNOL INVEST, V43, P638, DOI 10.3109/08820139.2014.909456	63	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134259	10.1371/journal.pone.0134259	http://dx.doi.org/10.1371/journal.pone.0134259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218284	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900103
J	Nikitorowicz-Buniak, J; Denton, CP; Abraham, D; Stratton, R				Nikitorowicz-Buniak, Joanna; Denton, Christopher P.; Abraham, David; Stratton, Richard			Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGF beta Signaling within Lesional Scleroderma Skin	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; IN-VIVO; EXPRESSION; SNAIL; CLASSIFICATION; CYTOKINES; FIBROSIS; SUBSETS; CELLS	The origin of myofibroblasts in fibrotic conditions remains unknown and in systemic sclerosis (SSc) it has been proposed that activation of local fibroblasts, trans-differentiation of perivascular or vascular cells, recruitment of fibrocyte progenitors, or epithelial to mesenchymal transition (EMT) could be contributing. Data from our laboratory indicate that the epidermis in scleroderma is activated with the keratinocytes exhibiting a phenotype normally associated with tissue repair, including phosphorylation profiles indicative of TGF beta signaling. Since TGF beta is a known inducer of EMT, we investigated if there is evidence of this process in the SSc epidermis. In order to validate antibodies and primers, EMT was modeled in HaCaT cells cultured in the presence of TGF beta 1. Skin sections were stained with phosho-SMAD2/3, as well as with epithelial and mesenchymal markers. Moreover, mRNA levels of transcription factors associated with EMT were studied in epidermal blister sheets. We observed critical changes in the scleroderma epidermis; showing significantly increased nuclear translocation of phosphorylated Smad2/3, consistent with active TGF beta signaling in SSc keratinocytes. While profound EMT could be induced in keratinocytes in vitro with the appearance of SNAI1/2 and FSP-1, and an accompanying loss of E-cadherin, in the scleroderma skin active TGF beta signaling was accompanied by only partial EMT-like changes characterised by induction of SNAI1 alone and with no loss of E-cadherin. Together, our findings support a model of altered differentiation and TGF beta dependent activation of scleroderma epithelial cells leading to a partially evoked EMT like process in the fibrotic skin.	[Nikitorowicz-Buniak, Joanna; Denton, Christopher P.; Abraham, David; Stratton, Richard] UCL Med Sch, Ctr Rheumatol & Connect Tissue Dis, Res Dept Inflammat, Div Med, London NW3 2PF, England	University of London; University College London	Stratton, R (corresponding author), UCL Med Sch, Ctr Rheumatol & Connect Tissue Dis, Res Dept Inflammat, Div Med, Rowland Hill St, London NW3 2PF, England.	r.stratton@ucl.ac.uk		Nikitorowicz-Buniak, Joanna/0000-0002-7510-3843	Arthritis Research UK [18925]; Raynaud's and Scleroderma Foundation UK; Scleroderma Society UK; Rosetree's Trust; Rosetrees Trust [M429, M494] Funding Source: researchfish; Versus Arthritis [19427] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Raynaud's and Scleroderma Foundation UK; Scleroderma Society UK; Rosetree's Trust(Rosetrees Trust); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	This project was funded by Arthritis Research UK project grant 18925, the Raynaud's and Scleroderma Foundation UK, the Scleroderma Society UK, and the Rosetree's Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cormier K, 2014, ANTI-CANCER AGENT ME, V14, P35, DOI 10.2174/18715206113136660333; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Gillespie J, 2011, ANN RHEUM DIS, V70, DOI 10.1136/ard.2010.149104.18; Hieronymus T., 2014, SEMINARS CELL DEV BI; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; KOCH AE, 1993, PATHOBIOLOGY, V61, P239, DOI 10.1159/000163802; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; Leopold PL, 2012, SEMIN CANCER BIOL, V22, P471, DOI 10.1016/j.semcancer.2012.07.003; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lindley LE, 2010, BIOCHEM BIOPH RES CO, V399, P659, DOI 10.1016/j.bbrc.2010.07.138; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons JG, 2008, CANCER RES, V68, P4525, DOI 10.1158/1078-0432.CCR-07-6735; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McCormack N, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-36; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Nakamura M, 2011, BRIT J DERMATOL, V164, P204, DOI 10.1111/j.1365-2133.2010.10021.x; Nikitorowicz-Buniak J, 2014, J INVEST DERMATOL; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Postlethwaite AE, 2004, CURR OPIN RHEUMATOL, V16, P733, DOI 10.1097/01.bor.0000139310.77347.9c; Rhodes LE, 1999, ACTA DERM-VENEREOL, V79, P288; Sanders YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116995; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Sonnylal S, 2013, J CELL SCI, V126, P2164, DOI 10.1242/jcs.111302; Tao J, 2011, EUR J DERMATOL, V21, P731, DOI 10.1684/ejd.2011.1469; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126015; Yasukawa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064281; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	33	43	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134092	10.1371/journal.pone.0134092	http://dx.doi.org/10.1371/journal.pone.0134092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217927	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900077
J	Haanstra, TM; Tilbury, C; Kamper, SJ; Tordoir, RL; Vlieland, TPMV; Nelissen, RGHH; Cuijpers, P; de Vet, HCW; Dekker, J; Knol, DL; Ostelo, RW				Haanstra, Tsjitske M.; Tilbury, Claire; Kamper, Steven J.; Tordoir, Rutger L.; Vlieland, Thea P. M. Vliet; Nelissen, Rob G. H. H.; Cuijpers, Pim; de Vet, Henrica C. W.; Dekker, Joost; Knol, Dirk L.; Ostelo, Raymond W.			Can Optimism, Pessimism, Hope, Treatment Credibility and Treatment Expectancy Be Distinguished in Patients Undergoing Total Hip and Total Knee Arthroplasty?	PLOS ONE			English	Article							PATIENTS PREOPERATIVE EXPECTATIONS; PSYCHOMETRIC PROPERTIES; FIT INDEXES; SELF-ESTEEM; PAIN; VALIDATION; PREDICTORS; RECOVERY; EFFICACY; OUTCOMES	Objectives The constructs optimism, pessimism, hope, treatment credibility and treatment expectancy are associated with outcomes of medical treatment. While these constructs are grounded in different theoretical models, they nonetheless show some conceptual overlap. The purpose of this study was to examine whether currently available measurement instruments for these constructs capture the conceptual differences between these constructs within a treatment setting. Methods Patients undergoing Total Hip and Total Knee Arthroplasty (THA and TKA) (Total N = 361; 182 THA; 179 TKA), completed the Life Orientation Test-Revised for optimism and pessimism, the Hope Scale, the Credibility Expectancy Questionnaire for treatment credibility and treatment expectancy. Confirmatory factor analysis was used to examine whether the instruments measure distinct constructs. Four theory-driven models with one, two, four and five latent factors were evaluated using multiple fit indices and Delta x(2) tests, followed by some posthoc models. Results The results of the theory driven confirmatory factor analysis showed that a five factor model in which all constructs loaded on separate factors yielded the most optimal and satisfactory fit. Posthoc, a bifactor model in which (besides the 5 separate factors) a general factor is hypothesized accounting for the commonality of the items showed a significantly better fit than the five factor model. All specific factors, except for the hope factor, showed to explain a substantial amount of variance beyond the general factor. Conclusion Based on our primary analyses we conclude that optimism, pessimism, hope, treatment credibility and treatment expectancy are distinguishable in THA and TKA patients. Postdoc, we determined that all constructs, except hope, showed substantial specific variance, while also sharing some general variance.	[Haanstra, Tsjitske M.; Kamper, Steven J.; de Vet, Henrica C. W.; Ostelo, Raymond W.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Haanstra, Tsjitske M.; Kamper, Steven J.; de Vet, Henrica C. W.; Ostelo, Raymond W.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Tilbury, Claire; Vlieland, Thea P. M. Vliet; Nelissen, Rob G. H. H.] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands; [Kamper, Steven J.] Univ Sydney, George Inst Global Hlth, Musculoskeletal Div, Sydney, NSW 2006, Australia; [Tordoir, Rutger L.] Rijnland Ziekenhuis, Dept Orthopaed, Leiderdorp, Netherlands; [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Dekker, Joost] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [Dekker, Joost] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Knol, Dirk L.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Ostelo, Raymond W.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Ostelo, Raymond W.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; George Institute for Global Health; University of Sydney; Rijnland Hospital; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Haanstra, TM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	t.haanstra@vumc.nl	Cuijpers, Pim/G-1703-2013; Nelissen, Rob/AAD-8134-2020; Vlieland, Thea Vliet/AAJ-8119-2020; Ostelo, Raymond/GSE-2602-2022	Nelissen, Rob/0000-0003-1228-4162; Vlieland, Thea Vliet/0000-0001-6322-3859; Dekker, Joost/0000-0003-2027-0027; de Vet, Henrica/0000-0002-5454-2804; Ostelo, Raymond/0000-0001-7679-7210; Kamper, Steven/0000-0003-3012-5499	Dutch Arthritis Association, grant LRR (department orthopaedics LUMC)	Dutch Arthritis Association, grant LRR (department orthopaedics LUMC)	The collection of data used for this manuscript was supported by the Dutch Arthritis Association, grant LRR (department orthopaedics LUMC). funders website: (www.reumafonds.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat H, 2000, ANN BEHAV MED, V22, P127, DOI 10.1007/BF02895776; Alarcon GM, 2013, PERSONALITY INDIVIDU; Brouwer D, 2008, PSYCHOL ASSESSMENT, V20, P310, DOI 10.1037/1040-3590.20.3.310; Bruininks P, 2005, MOTIV EMOTION, V29, P327, DOI 10.1007/s11031-006-9010-4; Bryan FB, 2004, J SOC CLIN PSYCHOL, V23, P273, DOI 10.1521/jscp.23.2.273.31018; Campbell P, 2013, PAIN, V154, P1783, DOI 10.1016/j.pain.2013.05.035; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Chemers MM, 2000, PERS SOC PSYCHOL B, V26, P267, DOI 10.1177/0146167200265001; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Dawn AG, 2004, SURV OPHTHALMOL, V49, P513, DOI 10.1016/j.survophthal.2004.06.004; de Groot IB, 2007, OSTEOARTHR CARTILAGE, V15, P104, DOI 10.1016/j.joca.2006.06.014; de Groot IB, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-16; de Rooij A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-218; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; FLOOD AB, 1993, MED CARE, V31, P1043, DOI 10.1097/00005650-199311000-00006; Fontaine KR, 1999, J CLIN PSYCHOL, V55, P141; Gallagher MW, 2009, J POSIT PSYCHOL, V4, P548, DOI 10.1080/17439760903157166; Glaesmer H, 2012, BRIT J HEALTH PSYCH, V17, P432, DOI 10.1111/j.2044-8287.2011.02046.x; Guttmann L, 1945, PSYCHOMETRIKA, V10, P255; Herzberg PY, 2006, PSYCHOL ASSESSMENT, V18, P433, DOI 10.1037/1040-3590.18.4.433; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iles RA, 2013, J BACK MUSCULOSJKELE; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Laferton JAC, 2013, AM HEART J, V165, P1, DOI 10.1016/j.ahj.2012.10.007; Magaletta PR, 1999, J CLIN PSYCHOL, V55, P539, DOI 10.1002/(SICI)1097-4679(199905)55:5<539::AID-JCLP2>3.3.CO;2-7; Main CJ, 2010, BEST PRACT RES CL RH, V24, P205, DOI 10.1016/j.berh.2009.12.012; Mancuso CA, 2008, CLIN ORTHOP RELAT R, V466, P424, DOI 10.1007/s11999-007-0052-z; Millsap RE, 2004, MULTIVAR BEHAV RES, V39, P479, DOI 10.1207/S15327906MBR3903_4; Muthen L.K., 2010, MPLUS USERS GUIDE; Pinto PR, 2013, J PAIN, V14, P502, DOI 10.1016/j.jpain.2012.12.020; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Sears Samuel F, 2004, J Cardiopulm Rehabil, V24, P324, DOI 10.1097/00008483-200409000-00008; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Smeets RJEM, 2008, CLIN J PAIN, V24, P305, DOI 10.1097/AJP.0b013e318164aa75; Smith TW, 2006, ANNU REV CLIN PSYCHO, V2, P435, DOI 10.1146/annurev.clinpsy.2.022305.095257; Smits IAM, 2014, EUROPEAN J PSYCHOL A; Snyder C. R, 2001, OPTIMISM PESSIMISM I, P101, DOI [10.1037/10385-005, DOI 10.1037/10385-005]; Snyder C.R., 2000, HDB HOPE THEORY MEAS; Snyder CR, 1999, HEART AND SOUL OF CHANGE, P179, DOI 10.1037/11132-005; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Ten Klooster PM, 2010, PSYCHOL GEZONDH, V38, P89; Vissers MM, 2012, SEMIN ARTHRITIS RHEU, V41, P576, DOI 10.1016/j.semarthrit.2011.07.003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	45	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133730	10.1371/journal.pone.0133730	http://dx.doi.org/10.1371/journal.pone.0133730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7DN	26214176	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300028
J	Locatelli, D; Terao, M; Kurosaki, M; Zanellati, MC; Pletto, DR; Finardi, A; Colciaghi, F; Garattini, E; Battaglia, GS				Locatelli, Denise; Terao, Mineko; Kurosaki, Mami; Zanellati, Maria Clara; Pletto, Daniela Rita; Finardi, Adele; Colciaghi, Francesca; Garattini, Enrico; Battaglia, Giorgio Stefano			Different Stability and Proteasome-Mediated Degradation Rate of SMN Protein Isoforms	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL MOTOR-NEURON; ACTIN MESSENGER-RNA; DETERMINING GENE; DISEASE SEVERITY; AXONAL-SURVIVAL; A-SMN; COMPLEX; LOCALIZATION; IDENTIFICATION	The key pathogenic steps leading to spinal muscular atrophy (SMA), a genetic disease characterized by selective motor neuron degeneration, are not fully clarified. The full-length SMN protein (FL-SMN), the main protein product of the disease gene SMN1, plays an established role in the cytoplasm in snRNP biogenesis ultimately leading to mRNA splicing within the nucleus. It is also involved in the mRNA axonal transport. However, to what extent the impairment of these two SMN functions contributes to SMA pathogenesis remains unknown. A shorter SMN isoform, axonal-SMN or a-SMN, with more specific axonal localization, has been discovered, but whether it might act in concert with FL-SMN in SMA pathogenesis is not known. As a first step in defining common or divergent intracellular roles of FL-SMN vs a-SMN proteins, we here characterized the turn-over of both proteins and investigated which pathway contributed to a-SMN degradation. We performed real time western blot and confocal immunofluorescence analysis in easily controllable in vitro settings. We analyzed co-transfected NSC34 and HeLa cells and cell clones stably expressing both a-SMN and FL-SMN proteins after specific blocking of transcript or protein synthesis and inhibition of known intracellular degradation pathways. Our data indicated that whereas the stability of both FL-SMN and a-SMN transcripts was comparable, the a-SMN protein was characterized by a much shorter half-life than FL-SMN. In addition, as already demonstrated for FL-SMN, the Ub/proteasome pathway played a major role in the a-SMN protein degradation. We hypothesize that the faster degradation rate of a-SMN vs FL-SMN is related to the protection provided by the protein complex in which FL-SMN is assembled. The diverse a-SMN vs FL-SMN C-terminus may dictate different protein interactions and complex formation explaining the different localization and role in the neuronal compartment, and the lower expression and stability of a-SMN.	[Locatelli, Denise; Zanellati, Maria Clara; Pletto, Daniela Rita; Finardi, Adele; Colciaghi, Francesca; Battaglia, Giorgio Stefano] IRCCS Neurol Inst C Besta, Mol Neuroanat & Pathogenesis Unit, Milan, Italy; [Terao, Mineko; Kurosaki, Mami; Garattini, Enrico] IRCCS, Ist Ric Farmacol Mario Negri, Mol Biol Lab, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Locatelli, D (corresponding author), IRCCS Neurol Inst C Besta, Mol Neuroanat & Pathogenesis Unit, Milan, Italy.	denise.locatelli@istituto-besta.it	Colciaghi, Francesca/J-8772-2016; terao, mineko/AAU-8089-2020; Finardi, Adele/K-3970-2016; Garattini, Enrico/AAI-1998-2019; Terao, Mineko/AAA-6415-2020; KUROSAKI, Mami/ABG-2224-2020; Locatelli, Denise/J-8655-2016	Colciaghi, Francesca/0000-0002-6487-380X; Finardi, Adele/0000-0001-6156-975X; Terao, Mineko/0000-0002-9976-9869; KUROSAKI, Mami/0000-0001-8231-713X; Locatelli, Denise/0000-0001-9783-7111; Garattini, Enrico/0000-0001-8983-886X	Telethon-Italy Foundation [GGP13081]; Girotondo/ONLUS association; Smarathon-ONLUS association; Italian Ministry of Health	Telethon-Italy Foundation(Fondazione Telethon); Girotondo/ONLUS association; Smarathon-ONLUS association; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by financial supports from Telethon-Italy Foundation (GGP13081), Girotondo/ONLUS and Smarathon-ONLUS associations and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Battaglia G, 1997, HUM MOL GENET, V6, P1961, DOI 10.1093/hmg/6.11.1961; Brichta L, 2008, HUM GENET, V123, P141, DOI 10.1007/s00439-007-0455-7; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Fuentes JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015769; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Han KJ, 2012, J BIOL CHEM, V287, P43741, DOI 10.1074/jbc.M112.372318; Heier CR, 2007, J CHILD NEUROL, V22, P1013, DOI 10.1177/0883073807305669; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Kwon JE, 2011, FEBS LETT, V585, P1287, DOI 10.1016/j.febslet.2011.04.011; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Locatelli D, 2012, J BIOL CHEM, V287, P25782, DOI 10.1074/jbc.M112.362830; Locatelli D, 2012, J NEUROCHEM, V121, P465, DOI 10.1111/j.1471-4159.2012.07689.x; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; PEARN J, 1980, LANCET, V1, P919; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Robbins KL, 2014, HUM MOL GENET, V23, P4559, DOI 10.1093/hmg/ddu169; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Sleigh JN, 2011, DIS MODEL MECH, V4, P457, DOI 10.1242/dmm.007245; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Todd AG, 2010, J MOL BIOL, V401, P681, DOI 10.1016/j.jmb.2010.06.058; Twombly R, 2003, J NATL CANCER I, V95, P845, DOI 10.1093/jnci/95.12.845; Vitali T, 1999, HUM MOL GENET, V8, P2525, DOI 10.1093/hmg/8.13.2525; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Yamada H, 2015, PEDIATR NEUROL, V52, P638, DOI 10.1016/j.pediatrneurol.2015.02.023; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134163	10.1371/journal.pone.0134163	http://dx.doi.org/10.1371/journal.pone.0134163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214005	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300055
J	Kumar, MAS; Peluso, M; Chaudhary, P; Dhawan, J; Beheshti, A; Manickam, K; Thapar, U; Pena, L; Natarajan, M; Hlatky, L; Demple, B; Naidu, M				Kumar, M. A. Suresh; Peluso, Michael; Chaudhary, Pankaj; Dhawan, Jasbeer; Beheshti, Afshin; Manickam, Krishnan; Thapar, Upasna; Pena, Louis; Natarajan, Mohan; Hlatky, Lynn; Demple, Bruce; Naidu, Mamta			Fractionated Radiation Exposure of Rat Spinal Cords Leads to Latent Neuro-Inflammation in Brain, Cognitive Deficits, and Alterations in Apurinic Endonuclease 1	PLOS ONE			English	Article							BASE EXCISION; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; STEM/PROGENITOR CELLS; OBJECT RECOGNITION; CLUSTERED LESIONS; INDUCED APOPTOSIS; DNA-REPAIR; IRRADIATION; DIFFERENTIATION; NEUROINFLAMMATION	Ionizing radiation causes degeneration of myelin, the insulating sheaths of neuronal axons, leading to neurological impairment. As radiation research on the central nervous system has predominantly focused on neurons, with few studies addressing the role of glial cells, we have focused our present research on identifying the latent effects of single/fractionated -low dose of low/high energy radiation on the role of base excision repair protein Apurinic Endonuclease-1, in the rat spinal cords oligodendrocyte progenitor cells' differentiation. Apurinic endonuclease-1 is predominantly upregulated in response to oxidative stress by low-energy radiation, and previous studies show significant induction of Apurinic Endonuclease-1 in neurons and astrocytes. Our studies show for the first time, that fractionation of protons cause latent damage to spinal cord architecture while fractionation of HZE (Si-28) induce increase in APE1 with single dose, which then decreased with fractionation. The oligodendrocyte progenitor cells differentiation was skewed with increase in immature oligodendrocytes and astrocytes, which likely cause the observed decrease in white matter, increased neuro-inflammation, together leading to the observed significant cognitive defects.	[Kumar, M. A. Suresh] Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; [Peluso, Michael; Beheshti, Afshin; Hlatky, Lynn; Naidu, Mamta] Tufts Univ, Sch Med, GeneSys Res Inst, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Chaudhary, Pankaj] Queens Univ, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Dhawan, Jasbeer] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Manickam, Krishnan; Natarajan, Mohan] UTHSCSA, Dept Pathol, San Antonio, TX USA; [Thapar, Upasna; Demple, Bruce] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Pena, Louis] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA	Columbia University; Tufts University; Queens University Belfast; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health San Antonio; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Naidu, M (corresponding author), Tufts Univ, Sch Med, GeneSys Res Inst, Ctr Canc Syst Biol, Boston, MA 02111 USA.	mamta@cancer-systems-biology.org	Beheshti, Afshin/AAH-7267-2019; Beheshti, Afshin/N-2241-2014	Beheshti, Afshin/0000-0003-4643-531X; Chaudhary, Pankaj/0000-0002-0381-3635	NASA [NNX11AO89G, NNAX13AD74G, NNX13AJ01G]	NASA(National Aeronautics & Space Administration (NASA))	NASA grants, NNX11AO89G and NNAX13AD74G to MN; NASA grant NNX13AJ01G to LH.	Abzullaouf S., 2006, AUSTRAL ASIAN J CANC, V5, P297; ALLEN JC, 1991, NEUROLOGY, V41, P148, DOI 10.1212/WNL.41.1.148; Beckendorf V, 2004, INT J RADIAT ONCOL, V60, P1056, DOI 10.1016/j.ijrobp.2004.05.033; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Butler Jerome M, 2006, Curr Treat Options Oncol, V7, P517, DOI 10.1007/s11864-006-0026-5; Chang PW, 2005, INT J RADIAT BIOL, V81, P115, DOI 10.1080/09553000500103009; Dhawan J, 2011, FUTUR NEUROL, V6, P823, DOI 10.2217/FNL.11.55; Dianov GL, 2001, BIOESSAYS, V23, P745, DOI 10.1002/bies.1104; Druzhyna NM, 2003, GLIA, V42, P370, DOI 10.1002/glia.10230; Englander EW, 2008, MECH AGEING DEV, V129, P475, DOI 10.1016/j.mad.2008.02.001; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fike JR, 2011, REV NEUROL-FRANCE, V167, P746, DOI 10.1016/j.neurol.2011.07.005; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Fukuda A, 2005, J NEUROCHEM, V92, P569, DOI 10.1111/j.1471-4159.2004.02894.x; Fung H, 2011, J BIOL CHEM, V286, P4968, DOI 10.1074/jbc.M110.146498; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giedzinski E, 2005, RADIAT RES, V164, P540, DOI 10.1667/RR3369.1; Grossman R, 2012, FUTUR NEUROL, V7, P329, DOI 10.2217/FNL.12.25; Harrison JF, 2005, NUCLEIC ACIDS RES, V33, P4660, DOI 10.1093/nar/gki759; HELLER MJ, 1974, BIOCHEMISTRY-US, V13, P1623, DOI 10.1021/bi00705a011; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jedinak A, 2011, ANTICANCER RES, V31, P379; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kovalchuk O, 2004, MOL CANCER RES, V2, P567; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Malyarchuk S, 2008, NUCLEIC ACIDS RES, V36, P4872, DOI 10.1093/nar/gkn450; Mettler FA, 1985, MED EFFECTS IONIZING, P172; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Naidu MD, 2010, J RADIAT RES, V51, P393, DOI 10.1269/jrr.09077; Paap B, 2008, NUCLEIC ACIDS RES, V36, P2717, DOI 10.1093/nar/gkn118; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; Philippo H, 2005, RADIAT RES, V163, P636, DOI 10.1667/0033-7587(2005)163[0636:RCOGPA]2.0.CO;2; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rabin BM, 2009, ADV SPACE RES, V43, P1193, DOI 10.1016/j.asr.2009.01.015; Raji NS, 2002, INT J DEV NEUROSCI, V20, P491, DOI 10.1016/S0736-5748(02)00079-5; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Shukitt-Hale B, 2004, ADV SPACE RES-SERIES, V33, P1334, DOI 10.1016/j.asr.2003.10.038; Tsujii H, 2004, RADIOTHER ONCOL, V73, pS41, DOI 10.1016/S0167-8140(04)80012-4; VRDOLJAK E, 1992, INT J RADIAT BIOL, V62, P475, DOI 10.1080/09553009214552361; Xie JY, 2010, CL LYMPH MYELOM LEUK, V10, P385, DOI 10.3816/CLML.2010.n.072; Zaky A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-26; Zou GM, 2007, BLOOD, V109, P1917, DOI 10.1182/blood-2006-08-044172	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133016	10.1371/journal.pone.0133016	http://dx.doi.org/10.1371/journal.pone.0133016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208353	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000057
J	Lee, YC; Lee, CH; Tsai, HP; An, HW; Lee, CM; Wu, JC; Chen, CS; Huang, SH; Hwang, J; Cheng, KT; Leiw, PL; Chen, CL; Lin, CM				Lee, Yu-Chieh; Lee, Chii-Hong; Tsai, Hsiang-Ping; An, Herng-Wei; Lee, Chi-Ming; Wu, Jen-Chine; Chen, Chien-Shu; Huang, Shih-Hao; Hwang, Jaulang; Cheng, Kur-Ta; Leiw, Phui-Ly; Chen, Chi-Long; Lin, Chun-Mao			Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer	PLOS ONE			English	Article							CYCLIN D1; COLORECTAL-CANCER; CARCINOMA-CELLS; EVODIAMINE; APOPTOSIS; INHIBITION; TUMORS; EXPRESSION; AUTOPHAGY; VITRO	DNA topoisomerase I (TOP1) levels of several human neoplasms are higher than those of normal tissues. TOP1 inhibitors are widely used in treating conventional therapy-resistant ovarian cancers. However, patients may develop resistance to TOP1 inhibitors, hampering chemotherapy success. In this study, we examined the mechanisms associated with the development of camptothecin (CPT) resistance in ovarian cancers and identified evodiamine (EVO), a natural product with TOP1 inhibiting activity that overcomes the resistance. The correlations among TOP1 levels, cancer staging, and overall survival (OS) were analyzed. The effect of EVO on CPT-resistant ovarian cancer was evaluated in vitro and in vivo. TOP1 was associated with poor prognosis in ovarian cancers (p = 0.024). EVO induced apoptosis that was detected using flow cytometry and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. The tumor size decreased significantly in the EVO treatment group compared with the control group (p < 0.01) in a xenograft mouse model. Effects of drugs targeting TOP1 for prognosis and therapy in CPT-resistant ovarian cancer are anticipated. EVO with TOP1 can be developed as an antiproliferative agent for overcoming CPT resistance in ovarian cancers.	[Lee, Yu-Chieh; An, Herng-Wei; Lee, Chi-Ming] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Lee, Chii-Hong; Leiw, Phui-Ly] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, New Taipei City, Taiwan; [Tsai, Hsiang-Ping; Hwang, Jaulang; Cheng, Kur-Ta; Lin, Chun-Mao] Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan; [Wu, Jen-Chine] Chang Gung Mem Hosp, Ctr Stem Cells & Translat Canc Res, Gueishan, Taoyuan County, Taiwan; [Chen, Chien-Shu] China Med Univ, Sch Pharm, Taichung, Taiwan; [Huang, Shih-Hao] Taipei Coll Maritime Technol, Dept Food & Beverage Management, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ, Dept Pathol, Coll Med, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Chang Gung Memorial Hospital; China Medical University Taiwan; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lin, CM (corresponding author), Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan.	cmlin@tmu.edu.tw		Lin, Chun-Mao/0000-0002-8366-4026	National Science Council, Taiwan [NSC101-2320-B-038-023]; Ministry of Health Welfare [MOHW104-TDU-B-212-113001]; Taipei Medical University-Shuang Ho Hospital [101TMU-SHH-10]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health Welfare; Taipei Medical University-Shuang Ho Hospital	This study was supported by grants from the National Science Council, Taiwan (NSC101-2320-B-038-023), the Ministry of Health & Welfare (MOHW104-TDU-B-212-113001), and Taipei Medical University-Shuang Ho Hospital (101TMU-SHH-10).	Al Sawah E, 2015, J CANCER RES CLIN, V141, P237, DOI 10.1007/s00432-014-1797-x; Barbieri F, 1999, CLIN CANCER RES, V5, P1837; Batey MA, 2013, MOL CANCER THER, V12, P959, DOI 10.1158/1535-7163.MCT-12-0707; Bhutia SK, 2010, P NATL ACAD SCI USA, V107, P22243, DOI 10.1073/pnas.1009479107; Bonneau C, 2015, GYNECOL ONCOL, V136, P112, DOI 10.1016/j.ygyno.2014.10.024; Chan KKL, 2011, ANN ONCOL, V22, P2241, DOI 10.1093/annonc/mdq749; Chen Y, 2014, ASIAN PAC J CANCER P, V15, P10351, DOI 10.7314/APJCP.2014.15.23.10351; Chiou JF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep228; Dai JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042706; Day CP, 2009, PIGM CELL MELANOMA R, V22, P283, DOI 10.1111/j.1755-148X.2009.00545.x; Dong GQ, 2012, J MED CHEM, V55, P7593, DOI 10.1021/jm300605m; Dou J, 2011, CELL BIOL INT, V35, P227, DOI 10.1042/CBI20100347; Du J, 2013, ONCOL REP, V30, P685, DOI 10.3892/or.2013.2498; Hunakova L, 2014, TOXICOL LETT, V230, P479, DOI 10.1016/j.toxlet.2014.08.018; Ikeguchi M, 2011, SURG TODAY, V41, P1196, DOI 10.1007/s00595-011-4546-7; Jiao J, 2013, ONCOTARGETS THER, V6, P667, DOI 10.2147/OTT.S44177; Kim HS, 2012, APOPTOSIS, V17, P938, DOI 10.1007/s10495-012-0719-0; Lee JC, 2015, CANCER LETT, V360, P310, DOI 10.1016/j.canlet.2015.02.034; Li DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045058; Li J, 2009, ONCOL REP, V21, P1605, DOI 10.3892/or_00000394; Liang Xiaobing, 2011, Chemother Res Pract, V2011, P715469, DOI 10.1155/2011/715469; Matrone A, 2010, INT J GYNECOL CANCER, V20, P203, DOI 10.1111/IGC.0b013e3181c8ca12; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Nguyen HG, 2014, ONCOGENE, V33, P4521, DOI 10.1038/onc.2014.25; Olszewski U, 2012, NEOPLASIA, V14, P813, DOI 10.1593/neo.12962; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pan XB, 2012, PHYTOMEDICINE, V19, P618, DOI 10.1016/j.phymed.2012.02.003; Perego P, 2012, BIOCHEM PHARMACOL, V83, P27, DOI 10.1016/j.bcp.2011.09.021; Proszek J, 2014, SENSORS-BASEL, V14, P1195, DOI 10.3390/s140101195; Rasul A, 2012, ONCOL REP, V27, P1481, DOI 10.3892/or.2012.1694; Ryan D, 2010, PIGM CELL MELANOMA R, V23, P542, DOI 10.1111/j.1755-148X.2010.00720.x; Sereno M, 2012, INT J ONCOL, V40, P2104, DOI 10.3892/ijo.2012.1378; Siu WY, 2004, MOL CANCER THER, V3, P621; Surowiak P, 2006, HISTOL HISTOPATHOL, V21, P713, DOI 10.14670/HH-21.713; Tsai HP, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-49; Tsunetoh S, 2010, CANCER BIOL THER, V10, P1138, DOI 10.4161/cbt.10.11.13443; Wang KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067297; Wang LF, 1997, CANCER RES, V57, P1516; Worsley SD, 1997, GYNECOL ONCOL, V64, P189, DOI 10.1006/gyno.1996.4569; Wu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112220; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791; Yang J, 2013, CANCER LETT, V328, P243, DOI 10.1016/j.canlet.2012.09.019; Yang L, 2014, MOL MED REP, V9, P1147, DOI 10.3892/mmr.2014.1924; Yu H, 2013, MOLECULES, V18, P1826, DOI 10.3390/molecules18021826; Yu SH, 2011, PLANTA MED, V77, P907, DOI 10.1055/s-0030-1250682; Yue GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065164; Zhang JW, 2014, BIOCHEM PHARMACOL, V90, P265, DOI 10.1016/j.bcp.2014.05.009; Zhang Y, 2004, J ASIAN NAT PROD RES, V6, P19, DOI 10.1080/1028602031000119772; Zhang YX, 2011, CANCER LETT, V304, P21, DOI 10.1016/j.canlet.2011.01.022	49	23	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132579	10.1371/journal.pone.0132579	http://dx.doi.org/10.1371/journal.pone.0132579			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207989	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000033
J	Srivastava, G; Somasundaram, RT; Walfish, PG; Ralhan, R				Srivastava, Gunjan; Somasundaram, Raj Thani; Walfish, Paul G.; Ralhan, Ranju			Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy	PLOS ONE			English	Article							SUPERFICIAL BLADDER-CANCER; CLINICAL-STUDIES GROUP; NECK-CANCER; ADVANCED HEAD; PHASE-II; INTRAPERITONEAL THERAPY; INDUCTION CHEMOTHERAPY; MOLECULAR TARGET; HIGH-RISK; EO9	Oral squamous cell carcinoma (OSCC) patients diagnosed in late stages have limited chemotherapeutic options underscoring the great need for development of new anticancer agents for more effective disease management. We aimed to investigate the anticancer potential of Apaziquone, [EOquin, USAN, E09, 3-hydroxy-5-aziridinyl-1-methyl-2(1H-indole- 4,7-dione)-prop-beta-en-alpha-ol], a pro-drug belonging to a class of anti-cancer agents called bioreductive alkylating agents, for OSCC. Apaziquone treatment inhibited cell proliferation and induced apoptosis in OSCC cells in vitro. Apaziquone treated OSCC cells showed increased activation of Caspase 9 and Caspase 3, and Poly (ADP ribose) polymerase (PARP) cleavage suggesting induction of apoptosis by apaziquone in oral cancer cells. Importantly, apaziquone treatment significantly reduced oral tumor xenograft volume in immunocompromised NOD/SCID/Crl mice without causing apparent toxicity to normal tissues. In conclusion, our in vitro and in vivo studies identified and demonstrated the pre-clinical efficacy of Apaziquone, as a potential novel anti-cancer therapeutic candidate for oral cancer management.	[Srivastava, Gunjan; Somasundaram, Raj Thani; Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Alex & Simona Shnaider Res Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.; Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Walfish, Paul G.] Univ Toronto, Toronto, ON, Canada; [Walfish, Paul G.; Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Alex & Simona Shnaider Res Lab Mol Oncol, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca			Spectrum Pharmaceuticals Inc. (Irvine, CA)	Spectrum Pharmaceuticals Inc. (Irvine, CA)	The financial support of this work was provided by Spectrum Pharmaceuticals Inc. (Irvine, CA). The funders approved the study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the Canadian Institutes of Health Research for Chair in Advanced Cancer Diagnostics (RR), and Alex and Simona Shnaider Chair in Thyroid Cancer (PGW).	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bhide SA, 2008, BRIT J CANCER, V99, P57, DOI 10.1038/sj.bjc.6604444; Brana I, 2012, ANN ONCOL, V23, P178, DOI 10.1093/annonc/mds322; Budach W, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-28; Ceelen WP, 2010, NAT REV CLIN ONCOL, V7, P108, DOI 10.1038/nrclinonc.2009.217; Choudry GA, 2001, BRIT J CANCER, V85, P1137, DOI 10.1054/bjoc.2001.2056; COLLARD J, 1995, BRIT J CANCER, V71, P1199, DOI 10.1038/bjc.1995.233; Denaro N, 2014, RADIOTHER ONCOL, V110, P16, DOI 10.1016/j.radonc.2013.08.016; Dirix LY, 1996, EUR J CANCER, V32A, P2019, DOI 10.1016/0959-8049(96)00226-2; El Deen DAS, 2012, MED ONCOL, V29, P3367, DOI 10.1007/s12032-012-0269-x; Ferlay J., 2013, IARC CANCERBASE, V11; Gibson MK, 2005, J CLIN ONCOL, V23, P3562, DOI 10.1200/JCO.2005.01.057; Gomez DR, 2009, INT J RADIAT ONCOL, V73, P1096, DOI 10.1016/j.ijrobp.2008.05.024; Harari PM, 2009, SEMIN RADIAT ONCOL, V19, P63, DOI 10.1016/j.semradonc.2008.09.009; Hendricksen K, 2012, J UROLOGY, V187, P1195, DOI 10.1016/j.juro.2011.11.101; HENDRIKS HR, 1993, EUR J CANCER, V29A, P897, DOI 10.1016/S0959-8049(05)80434-4; Kaur J, 2003, ORAL ONCOL, V39, P806, DOI 10.1016/S1368-8375(03)00084-8; Kaur J, 2014, INT J CANCER, V134, P1379, DOI 10.1002/ijc.28473; Le Tourneau C, 2008, CURR OPIN ONCOL, V20, P256, DOI 10.1097/CCO.0b013e3282f9b575; Li ZL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1227-8; Lu Z, 2010, FUTURE ONCOL, V6, P1625, DOI 10.2217/FON.10.100; Macha MA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-655; Major AG, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/319489; Martens-de Kemp SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061555; Matta A, 2010, MOL CANCER THER, V9, P2676, DOI 10.1158/1535-7163.MCT-10-0312; Matta A, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-6; Nagao T, 2011, J ONCOL, V2011, DOI 10.1155/2011/318145; Pavlidis N, 1996, ANN ONCOL, V7, P529; Phillips RM, 2013, BRIT J PHARMACOL, V168, P11, DOI 10.1111/j.1476-5381.2012.01996.x; Pignon JP, 2007, INT J RADIAT ONCOL, V69, pS112, DOI 10.1016/j.ijrobp.2007.04.088; Puri R, 2006, J UROLOGY, V176, P1344, DOI 10.1016/j.juro.2006.06.047; Rousseau A, 2012, ATLAS GENET CYTOGENE, V16, P145, DOI DOI 10.4267/2042/46948; SCHELLENS JHM, 1994, J NATL CANCER I, V86, P906, DOI 10.1093/jnci/86.12.906; Scully C, 2008, ORAL ONCOL, V44, P211, DOI 10.1016/j.oraloncology.2008.01.006; van der Heijden AG, 2006, J UROLOGY, V176, P1349, DOI 10.1016/j.juro.2006.06.007; Wu CF, 2008, HEAD NECK-J SCI SPEC, V30, P611, DOI 10.1002/hed.20751; Yunaiyama D, 2014, JPN J RADIOL, V32, P708, DOI 10.1007/s11604-014-0370-5; Yutkin V, 2012, EXPERT OPIN INV DRUG, V21, P251, DOI 10.1517/13543784.2012.646081	38	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133735	10.1371/journal.pone.0133735	http://dx.doi.org/10.1371/journal.pone.0133735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208303	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000126
J	Sun, JJ; Wu, Y; Lu, YM; Zhang, HZ; Wang, T; Yang, XQ; Sun, MH; Wang, CF				Sun, Juan-Juan; Wu, Yong; Lu, Yong-Ming; Zhang, Hui-Zhi; Wang, Tao; Yang, Xiao-Qun; Sun, Meng-Hong; Wang, Chao-Fu			Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; COMMON CLONAL ORIGIN; URINARY-BLADDER; CYCLIN D1; CANCER; EXPRESSION; TRACT; P53; TUMOR; MICRODISSECTION	Urothelial carcinoma (UC) comprises a heterogeneous group of epithelial neoplasms with diverse biological behaviors and variable clinical outcomes. Distinguishing UC histological subtypes has become increasingly important because prognoses and therapy can dramatically differ among subtypes. In clinical work, overlapping morphological findings between low-grade noninvasive UC (LGNUC), which exhibits an inverted growth pattern, and inverted urothelial papilloma (IUP) can make subclassification difficult. We propose a combination of immunohistochemistry (IHC) and molecular cytogenetics for subtyping these clinical entities. In our study, tissue microarray immunohistochemical profiles of Ki-67, p53, cytokeratin 20 (CK20) and cyclinD1 were assessed. Molecular genetic alterations such as the gain of chromosomes 3, 7 or 17 or the homozygous loss of 9p21 were also assessed for their usefulness in differentiating these conditions. Based on our analysis, Ki-67 and CK20 may be useful for the differential diagnosis of these two tumor types. Fluorescence in situ hybridization (FISH) can also provide important data in cases in which the malignant nature of an inverted urothelial neoplasm is unclear. LGNUC with an inverted growth pattern that is negative for both Ki-67 and CK20 can be positively detected using FISH.	[Sun, Juan-Juan; Wu, Yong; Lu, Yong-Ming; Zhang, Hui-Zhi; Wang, Tao; Yang, Xiao-Qun; Sun, Meng-Hong; Wang, Chao-Fu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Sun, Juan-Juan; Wu, Yong; Zhang, Hui-Zhi; Wang, Tao; Sun, Meng-Hong; Wang, Chao-Fu] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Sun, Juan-Juan; Wu, Yong; Wang, Tao; Yang, Xiao-Qun; Sun, Meng-Hong; Wang, Chao-Fu] Fudan Univ, Inst Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, CF (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China.	wangchaofu@126.com	Wang, Chao/GXF-8353-2022	Wu, Yong/0000-0003-3764-3846				Amin MB, 1997, AM J SURG PATHOL, V21, P1057, DOI 10.1097/00000478-199709000-00010; ANDERSTROM C, 1982, J UROLOGY, V127, P1132, DOI 10.1016/S0022-5347(17)54266-4; Broussard JN, 2004, HUM PATHOL, V35, P1499, DOI 10.1016/j.humpath.2004.09.010; CAMERON KM, 1976, BRIT J UROL, V48, P567, DOI 10.1111/j.1464-410X.1976.tb06703.x; Cheng L, 2005, AM J PATHOL, V166, P1533, DOI 10.1016/S0002-9440(10)62369-3; Cheng L, 2004, CANCER-AM CANCER SOC, V101, P183, DOI 10.1002/cncr.20343; Cheng L, 2002, CANCER-AM CANCER SOC, V94, P104, DOI 10.1002/cncr.10151; Cheon Jun, 1995, Journal of Korean Medical Science, V10, P103; Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915; DEMEESTER LJ, 1975, CANCER, V36, P505, DOI 10.1002/1097-0142(197508)36:2<505::AID-CNCR2820360229>3.0.CO;2-L; Drew PA, 1996, MODERN PATHOL, V9, P989; EBLE JN, WHO CLASSIFICATION T; ESRIG D, 1993, AM J PATHOL, V143, P1389; Harnden P, 1999, LANCET, V353, P974, DOI 10.1016/S0140-6736(98)05383-5; HENDERSON DW, 1975, VIRCHOWS ARCH A, V366, P177, DOI 10.1007/BF00427408; Ho H, 2006, UROLOGY, V68, P333, DOI 10.1016/j.urology.2006.03.014; Humphrey Peter A, 2004, Ann Diagn Pathol, V8, P380, DOI 10.1053/j.anndiagpath.2004.08.012; Jones P A, 1993, Semin Urol, V11, P177; Jones TD, 2005, CANCER-AM CANCER SOC, V104, P1901, DOI 10.1002/cncr.21466; Jones TD, 2005, CLIN CANCER RES, V11, P6512, DOI 10.1158/1078-0432.CCR-05-0891; Jones TD, 2007, AM J SURG PATHOL, V31, P1861, DOI 10.1097/PAS.0b013e318060cb9d; KIMURA G, 1987, UROL INT, V42, P30, DOI 10.1159/000281846; KNOWLES MA, 1994, CANCER RES, V54, P531; KUNIMI K, 1994, EUR UROL, V26, P149; KUNZE E, 1983, CANCER-AM CANCER SOC, V51, P348, DOI 10.1002/1097-0142(19830115)51:2<348::AID-CNCR2820510231>3.0.CO;2-O; Lee K, 2010, J KOREAN MED SCI, V25, P1449, DOI 10.3346/jkms.2010.25.10.1449; Mallofre C, 2003, MODERN PATHOL, V16, P187, DOI 10.1097/01.MP.0000056628.38714.5D; MATTELAER J, 1988, UROLOGY, V32, P192, DOI 10.1016/0090-4295(88)90383-4; PALVIO DHB, 1985, SCAND J UROL NEPHROL, V19, P299, DOI 10.3109/00365598509180275; Perez-Montiel D, 2008, DIAGN HISTOPATHOL, V14, P48; Picozzi S, 2013, UROL ONCOL-SEMIN ORI, V31, P1584, DOI 10.1016/j.urolonc.2012.03.009; POTTS IF, 1963, J UROLOGY, V90, P175, DOI 10.1016/S0022-5347(17)64384-2; RISIO M, 1988, EUR UROL, V14, P333; ROMANELLI R, 1986, Pathologica (Genoa), V78, P89; ROSIN MP, 1995, CANCER RES, V55, P5213; Rozanski TA, 1996, J UROLOGY, V155, P1391, DOI 10.1016/S0022-5347(01)66280-3; RUPPERT JM, 1993, CANCER RES, V53, P5093; Sgambato A, 2002, INT J CANCER, V97, P671, DOI 10.1002/ijc.10055; Shariat SF, 2006, HUM PATHOL, V37, P1568, DOI 10.1016/j.humpath.2006.05.017; Shariat SF, 2010, BJU INT, V105, P489, DOI 10.1111/j.1464-410X.2009.08742.x; SPEVACK L, 1995, J UROLOGY, V153, P1202, DOI 10.1016/S0022-5347(01)67552-9; SPRUCK CH, 1994, CANCER RES, V54, P784; Sudo Toshio, 2003, Urology, V61, P837, DOI 10.1016/S0090-4295(02)02521-9; Sung MT, 2007, J PATHOL, V211, P420, DOI 10.1002/path.2129; Sung MT, 2006, CANCER, V107, P2622, DOI 10.1002/cncr.22311; Sung MT, 2006, MODERN PATHOL, V19, P1289, DOI 10.1038/modpathol.3800667; Urakami S, 1996, BRIT J UROL, V77, P55, DOI 10.1046/j.1464-410X.1996.08209.x; Valero PJA, 1995, ARCH ESP UROL, V48, P887; Wasco MJ, 2010, HUM PATHOL, V41, P163, DOI 10.1016/j.humpath.2009.07.015; Witjes JA, 1997, J UROLOGY, V158, P1500, DOI 10.1016/S0022-5347(01)64253-8; Ye YK, 2010, CLIN EXP MED, V10, P153, DOI 10.1007/s10238-009-0088-3	51	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133530	10.1371/journal.pone.0133530	http://dx.doi.org/10.1371/journal.pone.0133530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208279	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000096
J	Zhang, K; Gao, BS; Wang, YT; Wang, G; Wang, WG; Zhu, YX; Yao, LY; Gu, YM; Chen, M; Zhou, HL; Fu, YW				Zhang, Kun; Gao, Baoshan; Wang, Yuantao; Wang, Gang; Wang, Weigang; Zhu, Yaxiang; Yao, Liyu; Gu, Yiming; Chen, Mo; Zhou, Honglan; Fu, Yaowen			Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis	PLOS ONE			English	Article							CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; GLOMERULAR HYPERTENSION; CELL-PROLIFERATION; GRAFT-SURVIVAL; NITRIC-OXIDE; RISK-FACTOR	Since the association of serum uric acid and kidney transplant graft outcome remains disputable, we sought to evaluate the predictive value of uric acid level for graft survival/function and the factors could affect uric acid as time varies. A consecutive cohort of five hundred and seventy three recipients transplanted during January 2008 to December 2011 were recruited. Data and laboratory values of our interest were collected at 1, 3, 6, 12, 24 and 36 months post-transplant for analysis. Cox proportional hazard model, and multiple regression equation were built to adjust for the possible confounding variables and meet our goals as appropriate. The current cohort study lasts for 41.86 +/- 15.49 months. Uric acid level is proven to be negatively associated with eGFR at different time point after adjustment for age, body mass index and male gender (standardized beta ranges from -0.15 to -0.30 with all P<0.001). Males with low eGFR but high level of TG were on CSA, diuretics and RAS inhibitors and experienced at least one episode of acute rejection and diabetic issue were associated with a higher mean uric acid level. Hyperuricemia was significantly an independent predictor of pure graft failure (hazard ratio=4.01, 95% CI: 1.25-12.91, P=0.02) after adjustment. But it was no longer an independent risk factor for graft loss after adjustment. Interestingly, higher triglyceride level can make incidence of graft loss (hazard ratio=1.442, for each unit increase millimoles per liter 95% CI: 1.008-2.061, P=0.045) and death (hazard ratio=1.717, 95% CI: 1.105-2.665, P=0.016) more likely. The results of our study suggest that post-transplant elevated serum uric acid level is an independent predictor of long-term graft survival and graft function. Together with the high TG level impact on poor outcomes, further investigations for therapeutic effect are needed.	[Zhang, Kun; Gao, Baoshan; Wang, Yuantao; Wang, Gang; Wang, Weigang; Zhu, Yaxiang; Yao, Liyu; Gu, Yiming; Chen, Mo; Zhou, Honglan; Fu, Yaowen] Jilin Univ, Dept Urol, Transplant Ctr, Hosp 1, Changchun 130023, Jilin, Peoples R China	Jilin University	Zhou, HL (corresponding author), Jilin Univ, Dept Urol, Transplant Ctr, Hosp 1, Changchun 130023, Jilin, Peoples R China.	walkerzhouhl@163.com; fuyaowen@medmail.com.cn	deng, qiongxia/A-3206-2017					Akalin E, 2008, TRANSPLANTATION, V86, P652, DOI 10.1097/TP.0b013e3181814f5b; Akgul A, 2007, TRANSPL P, V39, P1023, DOI 10.1016/j.transproceed.2007.03.028; Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Feig DI, 2006, CURR HYPERTENS REP, V8, P111, DOI 10.1007/s11906-006-0005-z; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; Gerhardt U, 1999, CLIN TRANSPLANT, V13, P375, DOI 10.1034/j.1399-0012.1999.130502.x; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Haririan A, 2011, AM J TRANSPLANT, V11, P1943, DOI 10.1111/j.1600-6143.2011.03613.x; Haririan A, 2010, TRANSPLANTATION, V89, P573, DOI 10.1097/TP.0b013e3181c73c18; Hong Q, 2012, CELL CALCIUM, V51, P402, DOI 10.1016/j.ceca.2012.01.003; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039457; Iseki K, 2004, AM J KIDNEY DIS, V44, P642, DOI 10.1016/S0272-6386(04)00934-5; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Kasiske BL, 1998, AM J KIDNEY DIS, V32, pS142, DOI 10.1053/ajkd.1998.v32.pm9820472; Kato M, 2005, AM J CARDIOL, V96, P1576, DOI 10.1016/j.amjcard.2005.07.068; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Lapsia V, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.06.021; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy AR, 2014, VALUE HEALTH, V17, P254, DOI 10.1016/j.jval.2014.01.001; LINDHOLM A, 1995, TRANSPLANTATION, V60, P451, DOI 10.1097/00007890-199509000-00008; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079675; Mazali FC, 2011, SEMIN NEPHROL, V31, P466, DOI 10.1016/j.semnephrol.2011.08.012; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Mazzali M, 2001, TRANSPLANTATION, V71, P900, DOI 10.1097/00007890-200104150-00014; Meier-Kriesche HU, 2009, CLIN J AM SOC NEPHRO, V4, P1655, DOI 10.2215/CJN.02700409; Navaneethan SD, 2009, NEPHROL DIAL TRANSPL, V24, P1260, DOI 10.1093/ndt/gfn621; Numakura K, 2012, TRANSPLANTATION, V94, P145, DOI 10.1097/TP.0b013e318254391b; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; Ray C, 2009, NEW ENGL J MED, V360, P1460, DOI 10.1056/NEJMc090170; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Sanchez-Lozada LG, 2002, AM J PHYSIOL-RENAL, V283, pF1105, DOI 10.1152/ajprenal.00170.2002; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Short Robert A, 2005, Am J Nephrol, V25, P36, DOI 10.1159/000084073; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Svensson M, 2012, CURR OPIN ORGAN TRAN, V17, P393, DOI 10.1097/MOT.0b013e3283560a3b; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075	46	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133834	10.1371/journal.pone.0133834	http://dx.doi.org/10.1371/journal.pone.0133834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208103	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000154
J	Zhao, XF; Hu, HT; Li, JS; Shang, HC; Zheng, HZ; Niu, JF; Shi, XM; Wang, S				Zhao, Xiao-Feng; Hu, Han-Tong; Li, Jia-Shen; Shang, Hong-Cai; Zheng, Hai-Zhen; Niu, Jian-Fei; Shi, Xue-Ming; Wang, Shu			Is Acupuncture Effective for Hypertension? A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							BLOOD-PRESSURE; BURDEN	Objective To determine the efficacy of acupuncture for hypertension. Method Seven electronic databases were searched on April 13, 2014 to include eligible randomized controlled trials (RCTs). Data were extracted and risk of bias was assessed. Subgroup analyses and meta-analysis were performed. Results 23 RCTs involving 1788 patients were included. Most trials had an unclear risk of bias regarding allocation concealment, blinding, incomplete outcome data and selective reporting. Compared with sham acupuncture plus medication, a meta-analysis of 2 trials revealed that acupuncture as an adjunct to medication was more effective on systolic (SBP) and diastolic (DBP) blood pressure change magnitude (n=170, SBP: mean difference (MD)= -7.47.95% confidence intervals (CI): -10.43 to -4.51, I-2 = 0%; DBP: -4.22,-6.26 to -2.18, 0%). A subgroup analysis of 4 trials also showed acupuncture combined with medication was superior to medication on efficacy rate (n=230, odds ratio (OR)=4.19, 95% CI: 1.65 to 10.67, I-2 =0%). By contrast, compared with medication, acupuncture alone showed no significant effect on SBP /DBP after intervention and efficacy rate in the subgroup analysis. (7 trials with 510 patients, SBP: MD=-0.56, 95% CI:-3.02 to 1.89, I-2 =60%; DBP: -1.01,-2.26 to 0.24, 23%; efficacy rate: 10 trials with 963 patients, OR=1.14, 95% CI: 0.70 to 1.85, I-2 =54%). Adverse events were inadequately reported in most RCTs. Conclusion Our review provided evidence of acupuncture as an adjunctive therapy to medication for treating hypertension, while the evidence for acupuncture alone lowing BP is insufficient. The safety of acupuncture is uncertain due to the inadequate reporting of it. However, the current evidence might not be sufficiently robust against methodological flaws and significant heterogeneity of the included RCTs. Larger high-quality trials are required.	[Zhao, Xiao-Feng; Hu, Han-Tong; Li, Jia-Shen; Zheng, Hai-Zhen; Niu, Jian-Fei] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Inst Acupuncture & Moxibust, Tianjin, Peoples R China; [Hu, Han-Tong; Li, Jia-Shen; Shang, Hong-Cai; Zheng, Hai-Zhen; Niu, Jian-Fei] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Shi, Xue-Ming; Wang, Shu] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Dept Acupuncture & Moxibust, Tianjin, Peoples R China; [Zhao, Xiao-Feng; Wang, Shu] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Key Lab Acupuncture Tianjin, Tianjin, Peoples R China	Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Zhao, XF (corresponding author), Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Inst Acupuncture & Moxibust, Tianjin, Peoples R China.	zhxf67@163.com	Zheng, Haizhen/GMW-7096-2022; Hu, Hantong/AAU-9912-2021; shang, hongcai/H-1257-2014; 胡, 汉通/GYJ-2069-2022	Hu, Hantong/0000-0001-8759-5083; 	National Basic Research Program of China (973 Program) [2012CB518505]; Inheritance Studio of famous veteran doctors of TCM of Xue-Ming Shi	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Inheritance Studio of famous veteran doctors of TCM of Xue-Ming Shi	The current work was partially supported by the National Basic Research Program of China (973 Program, No. 2012CB518505) and the Inheritance Studio of famous veteran doctors of TCM of Xue-Ming Shi. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen BG., 2006, SHANGHAI ZHENJIU ZAZ, V25, P15; Chen J, 2006, THESIS GUANGZHOU U T; Chen Jun, 2010, Zhongguo Zhen Jiu, V30, P896; Deeks J., 2011, COCHRANE HDB SYST RE, V5; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Feng Guoxiang, 2003, ZHONGGUO ZHEN JIU, V23, P193; Flachskampf FA, 2007, CIRCULATION, V115, P3121, DOI 10.1161/CIRCULATIONAHA.106.661140; Guo Yuhong, 2007, ACTA CHIN MED PHARM, V35, P51, DOI DOI 10.1016/J.IJOM.2012.01.007; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hu HT, 2014, INT J CARDIOL, V177, P610, DOI 10.1016/j.ijcard.2014.09.121; Huang Fan, 2007, Zhongguo Zhen Jiu, V27, P403; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim HM, 2012, J ALTERN COMPLEM MED, V18, P918, DOI 10.1089/acm.2011.0508; Kim LW, 2010, ALTERN THER HEALTH M, V16, P18; Kraft K, 1999, FORSCH KOMPLEMENTMED, V6, P74, DOI 10.1159/000021223; Lee H, 2009, AM J HYPERTENS, V22, P122, DOI 10.1038/ajh.2008.311; Lee XQ, 2008, LIAONING J TRADI CHI, V35, P919; Li DZ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/279478; Liao Hui, 2006, ZHONGGUO ZHEN JIU, V26, P92; Liu T, 2007, EVID-BASED COMPL ALT, V4, P3, DOI 10.1093/ecam/nel061; Ma Chaoyang, 2011, NEW J TRADIT CHIN ME, V43, P89; Ma CY., 2002, GUIDING PRINCIPLE CL; Macklin EA, 2006, HYPERTENSION, V48, P838, DOI 10.1161/01.HYP.0000241090.28070.4c; Madsen MV, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3115; Pater C, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-6; Qu T, 2009, HUBEI J TRADI CHIN M, V31, P8; Shen ZK., 2007, SHAANXI ZHONGYI, V28, P1377; Tjen-A-Looi SC, 2013, AM J PHYSIOL-REG I, V304, pR321, DOI 10.1152/ajpregu.00451.2012; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Wan Wen-jun, 2009, Zhongguo Zhen Jiu, V29, P349; Wang J, 2013, INT J CARDIOL, V169, P317, DOI 10.1016/j.ijcard.2013.09.001; Wei Y, 2006, J CLIN ACUPUNCTURE M, V22, P4; Wu QM, 2003, NEW J TRADIT CHIN ME, V35, P45; Yang Dian-Hui, 2010, Zhongguo Zhen Jiu, V30, P547; Yang Yue, 2010, ACTA CHIN MED PHARM, V38, P106; Yin C, 2007, NEUROL RES, V29, pS98, DOI 10.1179/016164107X172220; [张朝晖 Zhang Zhaohui], 2004, [中国针灸, Chinese Acupuncture and Moxibustion], V24, P539; Zhang ZR, 1954, J JIANGXI TRADI CHIN, V5, P53; [赵东杰 Zhao Dongjie], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P165; Zhao R., 2011, CLIN J ACUPUNCT MOXI, V27, P46	40	54	57	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0127019	10.1371/journal.pone.0127019	http://dx.doi.org/10.1371/journal.pone.0127019			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207806	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000001
J	Antonelli, R; Viera, AJ				Antonelli, Ray; Viera, Anthony J.			Potential Effect of Physical Activity Calorie Equivalent (PACE) Labeling on Adult Fast Food Ordering and Exercise	PLOS ONE			English	Article							OBESITY; CHOICES	Introduction Numeric calorie content labels show limited efficacy in reducing the number of calories ordered from fast food meals. Physical activity calorie equivalent (PACE) labels are an alternative that may reduce the number of calories ordered in fast food meals while encouraging patrons to exercise. Methods A total of 1000 adults from 47 US states were randomly assigned via internet survey to one of four generic fast food menus: no label, calories only, calories + minutes, or calories + miles necessary to walk to burn off the calories. After completing hypothetical orders participants were asked to rate the likelihood of calorie-only and PACE labels to influence (1) food choice and (2) physical activity. Results Respondents (n = 823) ordered a median of 1580 calories from the no-label menu, 1200 from the calories-only menu, 1140 from the calories + minutes menu, and 1210 from the calories + miles menu (p = 0.0001). 40% of respondents reported that PACE labels were "very likely" to influence food item choice vs. 28% for calorie-only labels (p<0.0001). 64% of participants reported that PACE labels were "somewhat likely" or "very likely" to influence their level of physical activity vs. 49% for calorie-only labels (p<0.0001). Conclusions PACE labels may be helpful in reducing the number of calories ordered in fast food meals and may have the added benefit of encouraging exercise.	[Antonelli, Ray] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Viera, Anthony J.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Viera, AJ (corresponding author), Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA.	anthony_viera@med.unc.edu			National Institutes of Health [T35-DK007386]; MD '06 Distinguished Professorship of Family Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD '06 Distinguished Professorship of Family Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the endowed Charles B Wilkerson, MD '06 Distinguished Professorship of Family Medicine and by grant number T35-DK007386 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NCHS DATA BRIEF; BLAIR SN, 2001, ACTIVE LIVING EVERY; Block JP, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2907; Dowray S, 2013, APPETITE, V62, P173, DOI 10.1016/j.appet.2012.11.013; Elbel B, 2013, OBESITY, V21, P2172, DOI 10.1002/oby.20550; Ellison B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-21; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099; Platkin Charles, 2014, BMC Obes, V1, P21, DOI 10.1186/s40608-014-0021-5; Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226; Sinclair SE, 2014, J ACAD NUTR DIET, DOI S2212-2672(14)00599-1[pii]; Swartz JJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-72; Swartz JJ, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-135; Temple NJ, 2014, NUTRITION, V30, P257, DOI 10.1016/j.nut.2013.06.012; United States Census Bureau Geography Division, 2014, CENS REG DIV US; US Food and Drug Administration, 2011, FOOD LAB NUTR LAB ST, V76; Varlyam J. H., 2005, ERR4 EC RES, P28; Viera AJ, 2015, PEDIATRICS, V135, pE376, DOI 10.1542/peds.2014-2902; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; ZARKIN GA, 1993, AM J PUBLIC HEALTH, V83, P717, DOI 10.2105/AJPH.83.5.717	21	15	16	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134289	10.1371/journal.pone.0134289	http://dx.doi.org/10.1371/journal.pone.0134289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222056	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800123
J	Muneer, S; Jeong, BR				Muneer, Sowbiya; Jeong, Byoung Ryong			Proteomic Analysis Provides New Insights in Phosphorus Homeostasis Subjected to Pi (Inorganic Phosphate) Starvation in Tomato Plants (Solanum lycopersicum L.)	PLOS ONE			English	Article							TRANSLATION INITIATION; OXIDATIVE STRESS; USE EFFICIENCY; ARABIDOPSIS; DEFICIENCY; TOLERANCE; RESPONSES; RICE; TRANSPORTERS; ACQUISITION	Phosphorus is a major nutrient acquired by plants via high-affinity inorganic phosphate (Pi) transporters. To determine the adaptation and homeostasis strategy to Pi starvation, we compared the proteome analysis of tomato leaves that were treated with and without Pi (as KH2PO4) for 10 days. Among 600 reproducible proteins on 2-DE gels 46 of them were differentially expressed. These proteins were involved in major metabolic pathways, including photosynthesis, transcriptional/translational regulations, carbohydrate/energy metabolism, protein synthesis, defense response, and other secondary metabolism. The results also showed that the reduction in photosynthetic pigments lowered P content under -Pi treatments. Furthermore, high-affinity Pi transporters (lePT1 and lePT2) expressed in higher amounts under -Pi treatments. Also, the accumulation of Pi transporters was observed highly in the epidermis and palisade parenchyma under +Pi treatments compared to -Pi treatments. Our data suggested that tomato plants developed reactive oxygen species (ROS) scavenging mechanisms to cope with low Pi content, including the up-regulation of proteins mostly involved in important metabolic pathways. Moreover, Pi-starved tomato plants increased their internal Pi utilization efficiency by increasing the Pi transporter genes and their rational localization. These results thus provide imperative information about how tomato plants respond to Pi starvation and its homeostasis.	[Muneer, Sowbiya; Jeong, Byoung Ryong] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21 Plus, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju 660701, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University	Jeong, BR (corresponding author), Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21 Plus, Jinju 660701, South Korea.	brjeong@gnu.ac.kr	Jeong, Byoung Ryong/D-7667-2014; Muneer, Sowbiya/S-5382-2019	Jeong, Byoung Ryong/0000-0002-4146-7278; Muneer, Sowbiya/0000-0003-0230-772X	BK21 Plus program (Brain Korea 21), Ministry of Education, South Korea	BK21 Plus program (Brain Korea 21), Ministry of Education, South Korea	This study was supported from the grants of BK21 Plus program (Brain Korea 21), Ministry of Education, South Korea. Authors would like to thank Mr. Prabhakaran Soundarajan, Division of Applied Life Science, Gyeongsang National University, for assistance in section cutting under microtome.	Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chen YF, 2008, J INTEGR PLANT BIOL, V50, P835, DOI 10.1111/j.1744-7909.2008.00707.x; Chen ZJ, 2011, PROTEOMICS, V11, P4648, DOI 10.1002/pmic.201100231; Cubero B, 2009, MOL PLANT, V2, P535, DOI 10.1093/mp/ssp013; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Echevarria-Zomeno S, 2013, INT J MOL SCI, V14, P4670, DOI 10.3390/ijms14034670; FOYER C, 1986, PLANTA, V167, P369, DOI 10.1007/BF00391341; FREDEEN AL, 1989, PLANT PHYSIOL, V89, P225, DOI 10.1104/pp.89.1.225; Guo B, 2008, NEW PHYTOL, V177, P889, DOI 10.1111/j.1469-8137.2007.02331.x; Hammond JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024606; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Ivanov R, 2012, MOL PLANT, V5, P27, DOI 10.1093/mp/ssr065; JACOB J, 1992, PLANT PHYSIOL, V98, P801, DOI 10.1104/pp.98.3.801; Jennings MD, 2013, GENE DEV, V27, P2696, DOI 10.1101/gad.231514.113; Jia HF, 2011, PLANT PHYSIOL, V156, P1164, DOI 10.1104/pp.111.175240; Karthikeyan AS, 2002, PLANT PHYSIOL, V130, P221, DOI 10.1104/pp.020007; Kim SG, 2011, J KOREAN SOC APPL BI, V54, P667, DOI 10.3839/jksabc.2011.102; Lee BR, 2007, J EXP BOT, V58, P1271, DOI 10.1093/jxb/erl280; Li KP, 2008, PLANT J, V55, P927, DOI 10.1111/j.1365-313X.2008.03561.x; Li KP, 2007, PLANT SCI, V172, P255, DOI 10.1016/j.plantsci.2006.09.004; Liu CM, 1998, PLANT PHYSIOL, V116, P91, DOI 10.1104/pp.116.1.91; Liu P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-18; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Morita S, 1999, PLANT CELL PHYSIOL, V40, P417, DOI 10.1093/oxfordjournals.pcp.a029557; Mostek A, 2015, J PLANT PHYSIOL, V174, P166, DOI 10.1016/j.jplph.2014.08.020; Muneer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120899; Muneer S, 2014, INT J MOL SCI, V15, P21803, DOI 10.3390/ijms151221803; Muneer S, 2012, PLANT OMICS, V5, P167; Paolacci AR, 2014, J INTEGR PLANT BIOL, V56, P88, DOI 10.1111/jipb.12110; POIRIER Y, ARABIDOPSIS BOOK; PREISS J, 1984, TRENDS BIOCHEM SCI, V9, P24, DOI 10.1016/0968-0004(84)90043-4; Qureshi MI, 2010, ADV BOT RES, V56, P1, DOI 10.1016/S0065-2296(10)56001-4; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Rolfe BG, 2003, COMP FUNCT GENOM, V4, P225, DOI 10.1002/cfg.263; Rouached H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-19; Rouached H, 2010, MOL PLANT, V3, P288, DOI 10.1093/mp/ssp120; Sanan-Mishra N, 2005, P NATL ACAD SCI USA, V102, P509, DOI 10.1073/pnas.0406485102; Shenoy VV, 2005, BIOTECHNOL ADV, V23, P501, DOI 10.1016/j.biotechadv.2005.01.004; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Stefanovic A, 2007, PLANT J, V50, P982, DOI 10.1111/j.1365-313X.2007.03108.x; Torabi S, 2009, PROTEOMICS, V9, P159, DOI 10.1002/pmic.200800350; Tran HT, 2008, PROTEOMICS, V8, P4317, DOI 10.1002/pmic.200800292; Tyburski J, 2009, PLANT GROWTH REGUL, V59, P27, DOI 10.1007/s10725-009-9385-9; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.010331; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang Z, 2005, FEBS LETT, V579, P1683, DOI 10.1016/j.febslet.2005.02.024; Wissuwa M, 2005, PLANT SOIL, V269, P57, DOI 10.1007/s11104-004-2026-1; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Yao YA, 2011, PLANTA, V233, P523, DOI 10.1007/s00425-010-1311-x; Zhang HW, 2009, PLANT SOIL, V320, P91, DOI 10.1007/s11104-008-9873-0; Zhang KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098215; Zimmerli C, 2012, PLANT J, V72, P199, DOI 10.1111/j.1365-313X.2012.05058.x	60	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134103	10.1371/journal.pone.0134103	http://dx.doi.org/10.1371/journal.pone.0134103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222137	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800104
J	Deudero, S; Vazquez-Luis, M; Alvarez, E				Deudero, Salud; Vazquez-Luis, Maite; Alvarez, Elvira			Human Stressors Are Driving Coastal Benthic Long-Lived Sessile Fan Mussel Pinna nobilis Population Structure More than Environmental Stressors	PLOS ONE			English	Article							SHELL; BIVALVE; IMPACTS; DENSITY; GULF; SEAGRASSES; MOLLUSCA; FORCES; GROWTH; SIZE	Coastal degradation and habitat disruption are severely compromising sessile marine species. The fan shell Pinna nobilis is an endemic, vulnerable species and the largest bivalve in the Mediterranean basin. In spite of species legal protection, fan shell populations are declining. Models analyzed the contributions of environmental (mean depth, wave height, maximum wave height, period of waves with high energy and mean direction of wave source) versus human-derived stressors (anchoring, protection status, sewage effluents, fishing activity and diving) as explanatory variables depicting Pinna nobilis populations at a mesoscale level. Human stressors were explaining most of the variability in density spatial distribution of fan shell, significantly disturbing benthic communities. Habitat protection affected P. nobilis structure and physical aggression by anchoring reveals a high impact on densities. Environmental variables instead played a secondary role, indicating that global change processes are not so relevant in coastal benthic communities as human-derived impacts.	[Deudero, Salud; Vazquez-Luis, Maite] Ctr Oceanog Baleares, IEO, Palma De Mallorca, Spain; [Alvarez, Elvira] Govern Illes Balears, Direccio Gen Medi Rural & Mari, Palma De Mallorca, Spain	Spanish Institute of Oceanography	Deudero, S (corresponding author), Ctr Oceanog Baleares, IEO, Palma De Mallorca, Spain.	salud.deudero@ba.ieo.es	Luis, Maite Vázquez/R-5189-2018; Deudero, Salud/I-1883-2015	Deudero, Salud/0000-0001-5584-2801; Vazquez-Luis, M. (Maite)/0000-0002-2733-2801	Organismo Autonomo Parques Nacionales, Ministerio de Medio Ambiente for the project "Estado de conservacion del bivalvo amenazado Pinna nobilis en el Parque Nacional del Archipielago de Cabrera" [024/2010]; European Community [287844]	Organismo Autonomo Parques Nacionales, Ministerio de Medio Ambiente for the project "Estado de conservacion del bivalvo amenazado Pinna nobilis en el Parque Nacional del Archipielago de Cabrera"; European Community(European Commission)	Funding was from Organismo Autonomo Parques Nacionales, Ministerio de Medio Ambiente for the project "Estado de conservacion del bivalvo amenazado Pinna nobilis en el Parque Nacional del Archipielago de Cabrera" (024/2010)", and partly funded from European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 287844 project 'Towards Coast to COast NETworks of marine protected areas (from the shore to the high and deep sea), coupled with sea-based wind energy potential' (COCONET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis P, 2009, SCI MAR, V73, P143, DOI 10.3989/scimar.2009.73n1143; Alomar C, 2015, J EXP MAR BIOL ECOL, V467, P77, DOI 10.1016/j.jembe.2015.03.006; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson M.J., 2004, PERMANOVA 2 FACTOR F; [Anonymous], WANA PROV TEMP SER N; Balaguer P, 2011, OCEAN COAST MANAGE, V54, P241, DOI 10.1016/j.ocecoaman.2010.12.002; Basso L, 2015, ADV MARINE IN PRESS; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Butler Alan, 1994, Marine Life, V3, P37; Cabanellas-Reboredo Miguel, 2009, Marine Biodiversity Records, V2, pe126, DOI 10.1017/S1755267209001274; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Coppa S, 2010, J MAR BIOL ASSOC UK, V90, P885, DOI 10.1017/S002531540999141X; Coppa S, 2013, J SEA RES, V76, P201, DOI 10.1016/j.seares.2012.09.007; Deudero S, 2011, ATLAS BIODIVERSIDAD; Fraschetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081838; Garcia-March JR, 2007, J EXP MAR BIOL ECOL, V342, P202, DOI 10.1016/j.jembe.2006.09.007; Gorley C.K., 2006, GETTING STARTED PRIM; Hendriks IE, 2013, BIOL CONSERV, V160, P105, DOI 10.1016/j.biocon.2013.01.012; Hendriks IE, 2011, ESTUAR COAST, V34, P60, DOI 10.1007/s12237-010-9309-y; Katsanevakis S, 2011, MEDITERR MAR SCI, V12, P429, DOI 10.12681/mms.42; Katsanevakis S, 2007, MAR BIOL, V152, P1319, DOI 10.1007/s00227-007-0781-2; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lemer S, 2014, MOL PHYLOGENET EVOL, V75, P11, DOI 10.1016/j.ympev.2014.02.008; Luna B, 2009, ICES J MAR SCI, V66, P517, DOI 10.1093/icesjms/fsp020; Marba N, 2005, ESTUARIES, V28, P53, DOI 10.1007/BF02732753; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; Prado P, 2014, SCI MAR, V78, P555, DOI 10.3989/scimar.04087.03A; Procaccini G., 2003, WORLD ATLAS SEAGRASS, P48; Rabaoui L, 2010, J MOLLUS STUD, V76, P340, DOI 10.1093/mollus/eyq023; Richardson CA, 2004, J EXP MAR BIOL ECOL, V299, P1, DOI 10.1016/j.jembe.2003.08.012; Schultz Peter W.W., 2013, Acta Conchyliorum, V13, P1; SPA/BD Protocol, 1995, ANN 2 SPA BIOD PROT; Vazquez-Luis M, 2014, MEDITERR MAR SCI, V15, P626, DOI 10.12681/mms.796; Vazquez-Luis M, 2015, INFLUENCE BOAT ANCHO, DOI [10.1071/MF14285, DOI 10.1071/MF14285]; VICENTE N, 1991, ESPECES MARINES PROT, P159; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zavodnik Dusan, 1991, P169	39	26	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134530	10.1371/journal.pone.0134530	http://dx.doi.org/10.1371/journal.pone.0134530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218134	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900123
J	Herweijer, E; Feldman, AL; Ploner, A; Arnheim-Dahlstrom, L; Uhnoo, I; Netterlid, E; Dillner, J; Sparen, P; Sundstrom, K				Herweijer, Eva; Feldman, Adina L.; Ploner, Alexander; Arnheim-Dahlstrom, Lisen; Uhnoo, Ingrid; Netterlid, Eva; Dillner, Joakim; Sparen, Par; Sundstrom, Karin			The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; YOUNG-WOMEN; CANCER; ASSOCIATION; BEHAVIOR; MODEL	Background Concerns have been raised that HPV-vaccination might affect women's cervical screening behavior. We therefore investigated the association between opportunistic HPV-vaccination and attendance after invitation to cervical screening. Methods A cohort of all women resident in Sweden, born 1977-1987 (N=629,703), and invited to cervical screening, was followed October 2006 - December 2012. Invitations to screening were identified via the National Quality Register for Cervical Cancer Prevention, as was the primary outcome of a registered smear. Vaccination status was obtained from two nationwide health data registers. Hazard ratios (HR) were estimated using Cox regression adjusted for age, education level and income (HRadj). Women were individually followed for up to 6 years, of which the first and second screening rounds were analyzed separately. Results Screening attendance after three years of follow-up was 86% in vaccinated women (N=4,897) and 75% in unvaccinated women (N=625,804). The crude HR of screening attendance in vaccinated vs. unvaccinated women was 1.31 (95% CI 1.27-1.35) in the first screening round. Adjustment for education and income reduced but did not erase this difference (HRadj=1.09, 95% CI 1.05-1.13). In the second screening round, attendance was likewise higher in HPV-vaccinated women (crude HR=1.26, 95% CI 1.21-1.32; HRadj=1.15, 95% CI 1.10-1.20). Conclusions HPV-vaccination is so far associated with equal or higher attendance to cervical screening in Sweden in a cohort of opportunistically vaccinated young women. Most but not all of the difference in attendance was explained by socioeconomic differences between vaccinated and unvaccinated women. HPV vaccine effectiveness studies should consider screening attendance of HPV-vaccinated women when assessing incidence of screen-detected cervical lesions.	[Herweijer, Eva; Feldman, Adina L.; Ploner, Alexander; Arnheim-Dahlstrom, Lisen; Dillner, Joakim; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Feldman, Adina L.] Univ Cambridge, Epidemiol Unit, MRC, Cambridge, England; [Uhnoo, Ingrid; Netterlid, Eva] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Netterlid, Eva] Lund Univ, Fac Med, Dept Clin Sci, Malmo, Sweden; [Netterlid, Eva] Skane Univ Hosp, Dept Occupat & Environm Dermatol, Malmo, Sweden; [Dillner, Joakim; Sundstrom, Karin] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; University of Cambridge; Public Health Agency of Sweden; Lund University; Lund University; Skane University Hospital; Karolinska Institutet	Sundstrom, K (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	karin.sundstrom@ki.se	Sundström, Karin/V-5714-2017	Sundström, Karin/0000-0002-6865-0224; Sparen, Par/0000-0002-5184-8971; Ploner, Alexander/0000-0002-5042-8326	Swedish Foundation for Strategic Research; MRC [MC_UU_12015/4, MC_U106179474] Funding Source: UKRI; Medical Research Council [MC_U106179474, MC_UU_12015/4] Funding Source: researchfish	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Swedish Foundation for Strategic Research. All research was conducted entirely independent of the study funder. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrae B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e900; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Beer H, 2014, VACCINE, V32, P1828, DOI 10.1016/j.vaccine.2014.01.087; Bowyer HL, 2014, VACCINE, V32, P4310, DOI 10.1016/j.vaccine.2014.06.011; Bowyer HL, 2013, VACCINE, V31, P1051, DOI 10.1016/j.vaccine.2012.12.038; Budd AC, 2014, MED J AUSTRALIA, V201, P279, DOI 10.5694/mja14.00021; Elfstrom KM, 2014, CURR OPIN ONCOL, V26, P120, DOI 10.1097/CCO.0000000000000034; Folkhalsomyndigheten. [Public Health Agency of Sweden: Description of the Swedish Vaccination Register (SVEVAC)], 2014, PUBL HLTH AG SWED DE; Haupt RM, 2011, INT J CANCER, V129, P2632, DOI 10.1002/ijc.25940; Herweijer E, 2014, JAMA-J AM MED ASSOC, V311, P597, DOI 10.1001/jama.2014.95; Juraskova I, 2011, WOMEN HEALTH ISS, V21, P71, DOI 10.1016/j.whi.2010.08.004; Kulasingam SL, 2007, VACCINE, V25, P8110, DOI 10.1016/j.vaccine.2007.09.035; Leval A, 2013, JNCI-J NATL CANCER I, V105, P469, DOI 10.1093/jnci/djt032; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mather T, 2012, VACCINE, V30, P3196, DOI 10.1016/j.vaccine.2012.02.081; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Robbins SCC, 2010, VACCINE, V28, P3398, DOI 10.1016/j.vaccine.2010.02.078; Sauer AG, 2015, CANCER EPIDEMIOL, V39, P650, DOI 10.1016/j.canep.2015.05.002; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sundstrom K, 2010, VACCINE, V28, P7492, DOI 10.1016/j.vaccine.2010.09.007; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	22	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134185	10.1371/journal.pone.0134185	http://dx.doi.org/10.1371/journal.pone.0134185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218492	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900093
J	Liu, CY; Chou, YC; Chao, JCJ; Hsu, CY; Cha, TL; Tsao, CW				Liu, Chin-Yu; Chou, Yu-Ching; Chao, Jane C. -J.; Hsu, Chien-Yeh; Cha, Tai-Lung; Tsao, Chih-Wei			The Association between Dietary Patterns and Semen Quality in a General Asian Population of 7282 Males	PLOS ONE			English	Article							REPRODUCTIVE HORMONE-LEVELS; OXIDATIVE STRESS; FOOD-INTAKE; MEN; DETERIORATION; INFERTILITY; DECLINE; FAT	Objective To explore the associations between different dietary patterns and semen quality in a general Asian male population. Methods Cross-sectional study. Healthy Taiwanese men aged 18 years or older who participated in a standard medical screening program from 2008-2013 run by a private firm were included in this study. Semen parameters including sperm concentration (SC), total sperm motility (TSM), progressive motility (PRM) and normal sperm morphology (NSM) were recorded. A dietary questionnaire was used to categorize the participants into 5 groups: "Healthy diet", "Western diet", "High-carbohydrate diet", "High sweet snacks & sugar-sweetened drinks" and "High-sodium diet". Results A total of 7282 men completed the questionnaire regarding dietary pattern, and examination of anthropometric indexes was performed and laboratory data were obtained. A high intake of a "Western diet" resulted in statistically linear declines of SC and NSM (P < 0.001 and P < 0.001). Similarly, a greater intake of "High sweet snacks & sugar-sweetened drinks" was associated with a lower SC (P = 0.001). Increased intake of a "High-carbohydrate diet" was related to higher prevalences of abnormal TSM and PRM (P = 0.012 and P = 0.025). Similarly, a greater intake of a "High-sodium diet" was correlated with an elevated prevalence of abnormal NSM (P = 0.035). Conclusions This study showed that a greater intake of a "Western diet" is associated with poorer SC and NSM, a "High sweet snacks and sugar-sweetened drinks" intake is correlated with a lower SC, and high-carbohydrate food is related to elevated prevalences of abnormal TSM and PRM.	[Liu, Chin-Yu] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei City, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chao, Jane C. -J.] Taipei Med Univ, Sch Nutr & Hlth Sci, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Chao, Jane C. -J.; Hsu, Chien-Yeh] Taipei Med Univ, Master Program Global Hlth & Dev, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Chao, Jane C. -J.] Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan; [Hsu, Chien-Yeh] Natl Taipei Univ Nursing & Hlth Sci, Dept Informat Management, Taipei, Taiwan; [Cha, Tai-Lung; Tsao, Chih-Wei] Triserv Gen Hosp, Natl Def Med Ctr, Div Urol, Dept Surg, Taipei, Taiwan	Fu Jen Catholic University; National Defense Medical Center; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Taipei University of Nursing & Health Science (NTUNHS); National Defense Medical Center; Tri-Service General Hospital	Tsao, CW (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Div Urol, Dept Surg, Taipei, Taiwan.	weisurger@gmail.com		Tsao, Chih-Wei/0000-0001-7214-8766				Afeiche M, 2013, HUM REPROD, V28, P2265, DOI 10.1093/humrep/det133; Afeiche MC, 2014, FERTIL STERIL, V101, P1280, DOI 10.1016/j.fertnstert.2014.02.003; Akmal M, 2006, J MED FOOD, V9, P440, DOI 10.1089/jmf.2006.9.440; Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Chavarro JE, 2008, HUM REPROD, V23, P2584, DOI 10.1093/humrep/den243; Chavarro JE, 2014, HUM REPROD, V29, P429, DOI 10.1093/humrep/det464; Chen SJ, 2013, ARCH GYNECOL OBSTET, V288, P191, DOI 10.1007/s00404-013-2801-4; Chiu YH, 2014, HUM REPROD, V29, P1575, DOI 10.1093/humrep/deu102; Choy CMY, 2002, BJOG-INT J OBSTET GY, V109, P1121, DOI 10.1111/j.1471-0528.2002.02084.x; Eisenberg ML, 2014, HUM REPROD, V29, P193, DOI 10.1093/humrep/det428; Eskenazi B, 2005, HUM REPROD, V20, P1006, DOI 10.1093/humrep/deh725; Eslamian G, 2016, J AM COLL NUTR, V35, P50, DOI 10.1080/07315724.2014.936983; Eslamian G, 2012, HUM REPROD, V27, P3328, DOI 10.1093/humrep/des311; Fisch H, 1996, FERTIL STERIL, V65, P1009, DOI 10.1016/S0015-0282(16)58278-8; Gaskins AJ, 2012, HUM REPROD, V27, P2899, DOI 10.1093/humrep/des298; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; Jensen TK, 2013, AM J CLIN NUTR, V97, P411, DOI 10.3945/ajcn.112.042432; Jensen TK, 2010, AM J EPIDEMIOL, V171, P883, DOI 10.1093/aje/kwq007; Keskes-Ammar L, 2003, ARCH ANDROLOGY, V49, P83, DOI 10.1080/713828100; Kondaki K, 2013, PUBLIC HEALTH NUTR, V16, P479, DOI 10.1017/S1368980012002613; Meeker JD, 2008, ENVIRON HEALTH PERSP, V116, P1473, DOI 10.1289/ehp.11490; Meeker JD, 2010, SYST BIOL REPROD MED, V56, P122, DOI 10.3109/19396360903443658; Mendiola J, 2010, FERTIL STERIL, V93, P1128, DOI 10.1016/j.fertnstert.2008.10.075; Mendiola J, 2009, FERTIL STERIL, V91, P812, DOI 10.1016/j.fertnstert.2008.01.020; Park K, 2009, DIABETES CARE, V32, P1302, DOI 10.2337/dc09-0259; Paulsen CA, 1996, FERTIL STERIL, V65, P1015; Robbins WA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101634; Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415; Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3; Safarinejad MR, 2012, ASIAN J ANDROL, V14, P514, DOI 10.1038/aja.2012.46; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; Vujkovic M, 2009, HUM REPROD, V24, P1304, DOI 10.1093/humrep/dep024; Wong WY, 2000, FERTIL STERIL, V73, P435, DOI 10.1016/S0015-0282(99)00551-8; Zou ZK, 2011, FERTIL STERIL, V95, P2018, DOI 10.1016/j.fertnstert.2011.02.052	35	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134224	10.1371/journal.pone.0134224	http://dx.doi.org/10.1371/journal.pone.0134224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218796	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900097
J	Morgan, D; Warburton, B; Nugent, G				Morgan, David; Warburton, Bruce; Nugent, Graham			Aerial Prefeeding Followed by Ground Based Toxic Baiting for More Efficient and Acceptable Poisoning of Invasive Small Mammalian Pests	PLOS ONE			English	Article							POSSUMS TRICHOSURUS-VULPECULA; NEW-ZEALAND	Introduced brushtail possums (Trichosurus vulpecula) and rat species (Rattus spp.) are major vertebrate pests in New Zealand, with impacts on conservation and agriculture being managed largely through poisoning operations. Aerial distribution of baits containing sodium fluoroacetate (1080) has been refined to maximise cost effectiveness and minimise environmental impact, but this method is strongly opposed by some as it is perceived as being indiscriminate. Although ground based control enables precise placement of baits, operations are often more than twice as costly as aerial control, mainly due to the high labour costs. We investigated a new approach to ground based control that combined aerial distribution of non.toxic 'prefeed' baits followed by sparse distribution of toxic baits at regular intervals along the GPS tracked prefeeding flight paths. This approach was tested in two field trials in which both 1080 baits and cholecalciferol baits were used in separate areas. Effectiveness of the approach, assessed primarily using 'chewcards', was compared with that of scheduled aerial 1080 operations that were conducted in outlying areas of both trials. Contractors carrying out ground based control were able to follow the GPS tracks of aerial prefeeding flight lines very accurately, and with 1080 baits achieved very high levels of kill of possums and rats similar to those achieved by aerial 1080 baiting. Cholecalciferol was less effective in the first trial, but by doubling the amount of cholecalciferol bait used in the second trial, few possums or rats survived. By measuring the time taken to complete ground baiting from GPS tracks, we predicted that the method (using 1080 baits) would be similarly cost effective to aerial 1080 operations for controlling possums and rats, and considerably less expensive than typical current costs of ground based control. The main limitations to the use of the method will be access to, and size of, the operational site, along with topography and vegetation density.	[Morgan, David; Warburton, Bruce; Nugent, Graham] Landcare Res, Dept Wildlife Ecol & Management, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Morgan, D (corresponding author), Landcare Res, Dept Wildlife Ecol & Management, POB 40, Lincoln 7640, New Zealand.	morgand@landcareresearch.co.nz		Nugent, Graham/0000-0001-6223-8450	TBfree New Zealand (AHB project) [R-10721]	TBfree New Zealand (AHB project)	This study was supported by a research project grant from TBfree New Zealand (AHB project number R-10721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, BRUSHTAIL POSSUM BIO; Caughley G., 1977, ANAL VERTEBRATE POPU; Eason CT, 2001, DEP CONSERVATION TEC, V23; ERMA, 2009, COMM GUID AER 1080 O; Fox K., 2013, VETERANS DAY SOLAR F; Green W, 2012, J ROY SOC NEW ZEAL, V42, P185, DOI 10.1080/03036758.2011.556130; Innes J., 1990, HDB NZ MAMMALS; Innes J.G., 1990, P206; Morgan DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070683; Morgan DR, 1990, NZ J ECOL, V9, P167; Morgan DR, 2000, POSSUMS NZ BIOL IMPA, P143; MORGAN DR, 2004, THESIS LINCOLN U NZ; NPCA, 2011, AER 1080 PEST CONTR; NPCA (National Pest Control Agencies), 2011, POSS POP MON US TRAP; Nugent G, 2011, INT J PEST MANAGE, V57, P51, DOI 10.1080/09670874.2010.522265; Nugent G, 2009, NEW ZEAL J ZOOL, V36, P473, DOI 10.1080/03014223.2009.9651479; Nugent G, 2010, LC0910174 LANDC RES; Nugent G, 2013, NEW ZEAL J ECOL, V37, P246; Nugent G, 2012, PEST MANAG SCI, V68, P1374, DOI 10.1002/ps.3315; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; SPURR E, 1997, SCI CONSERVATION, V62, P20; Sweetapple P, 2011, NEW ZEAL J ECOL, V35, P153; Thompson J., 2013, DANGERS SOLAR STORMS; Warburton B, 2015, NEW ZEAL VET J, V63, P77, DOI 10.1080/00480169.2014.981315; Warburton B, 2009, WILDLIFE RES, V36, P659, DOI 10.1071/WR09047	25	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134032	10.1371/journal.pone.0134032	http://dx.doi.org/10.1371/journal.pone.0134032			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218095	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900068
J	Hansen, K; Schussel, K; Kieble, M; Werning, J; Schulz, M; Friis, R; Pohlau, D; Schmitz, N; Kugler, J				Hansen, Kerstin; Schuessel, Katrin; Kieble, Marita; Werning, Johanna; Schulz, Martin; Friis, Robert; Poehlau, Dieter; Schmitz, Norbert; Kugler, Joachim			Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study	PLOS ONE			English	Article							INTERFERON-BETA TREATMENT; LONG-TERM ADHERENCE; MEDICATION ADHERENCE; CLINICAL-TRIAL; RRMS PATIENTS; PERSISTENCE; THERAPY; PRESCRIPTION	Background Long-term therapies such as disease modifying therapy for Multiple Sclerosis (MS) demand high levels of medication adherence in order to reach acceptable outcomes. The objective of this study was to describe adherence to four disease modifying drugs (DMDs) among statutorily insured patients within two years following treatment initiation. These drugs were interferon beta-1a i.m. (Avonex), interferon beta-1a s.c. (Rebif), interferon beta-1b s.c. (Betaferon) and glatiramer acetate s.c. (Copaxone). Methods This retrospective cohort study used pharmacy claims data from the data warehouse of the German Institute for Drug Use Evaluation (DAPI) from 2001 through 2009. New or renewed DMD prescriptions in the years 2002 to 2006 were identified and adherence was estimated during 730 days of follow-up by analyzing the medication possession ratio (MPR) as proxy for compliance and persistence defined as number of days from initiation of DMD therapy until discontinuation or interruption. Findings A total of 52,516 medication profiles or therapy cycles (11,891 Avonex, 14,060 Betaferon, 12,353 Copaxone and 14,212 Rebif) from 50,057 patients were included into the analysis. Among the 4 cohorts, no clinically relevant differences were found in available covariates. The Medication Possession Ratio (MPR) measured overall compliance, which was 39.9% with a threshold MPR >= 0.8. There were small differences in the proportion of therapy cycles during which a patient was compliant for the following medications: Avonex (42.8%), Betaferon (40.6%), Rebif (39.2%), and Copaxone (37%). Overall persistence was 32.3% at the end of the 24 months observation period, i.e. during only one third of all included therapy cycles patients did not discontinue or interrupt DMD therapy. There were also small differences in the proportion of therapy cycles during which a patient was persistent as follows: Avonex (34.2%), Betaferon (33.4%), Rebif (31.7%) and Copaxone (29.8%). Conclusions Two years after initiating MS-modifying therapy, only 30-40% of patients were adherent to DMDs.	[Hansen, Kerstin; Kugler, Joachim] Tech Univ Dresden, Fak Med, Lehrstuhl Gesundheitswissensch Publ Hlth, Dresden, Germany; [Schuessel, Katrin; Kieble, Marita; Werning, Johanna; Schulz, Martin] Deutsch Arzneiprufungsinst eV DAPI, Berlin, Germany; [Friis, Robert] Calif State Univ Long Beach, Dept Hlth Sci, Long Beach, CA 90840 USA; [Poehlau, Dieter] Kamillus Klin, Asbach, Germany; [Schmitz, Norbert] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Hansen, Kerstin] Tech Univ Dresden, Fak Med, Bereich Allgemeinmed, Dresden, Germany	Technische Universitat Dresden; California State University System; California State University Long Beach; Technische Universitat Dresden	Kugler, J (corresponding author), Tech Univ Dresden, Fak Med, Lehrstuhl Gesundheitswissensch Publ Hlth, Dresden, Germany.	Joachim.Kugler@tu-dresden.de	Schmitz, Norbert/A-5177-2010; Schulz, Martin/HHT-0997-2022; Schmitz, Norbert/AAH-3624-2020; Schulz, Martin/AAA-6157-2020	Schmitz, Norbert/0000-0001-7777-6323; Schulz, Martin/0000-0002-5876-7322; Schuessel, Katrin/0000-0002-8377-2254				ABDATA Pharma Daten Service, 2001, ABDA DATABASE AND AB; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V.(AWMF), 2012, GUIDELINE ON MULTIPL; Arroyo E, 2011, EUR NEUROL, V65, P59, DOI 10.1159/000323216; Bruce JM, 2010, MULT SCLER, V16, P112, DOI 10.1177/1352458509351897; Bundesministerium fur Gesundheit und Soziale Sicherung, 2010, STATUTORY HEALTH INS; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; de Seze J, 2012, PATIENT PREFER ADHER, V6, P263, DOI 10.2147/PPA.S27038; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Enting RH, 2007, J PAIN SYMPTOM MANAG, V34, P523, DOI 10.1016/j.jpainsymman.2007.01.007; Evans C, 2012, CLIN THER, V34, P341, DOI 10.1016/j.clinthera.2012.01.006; Giovannoni G, 2012, MULT SCLER J, V18, P932, DOI 10.1177/1352458511433302; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Grimmsmann T, 2014, EUR J CLIN PHARMACOL, V70, P295, DOI 10.1007/s00228-013-1607-4; Grymonpre R, 2006, MED CARE, V44, P471, DOI 10.1097/01.mlr.0000207817.32496.cb; Haas J, 2005, EUR J NEUROL, V12, P425, DOI 10.1111/j.1468-1331.2005.00936.x; Halpern R, 2011, ADV THER, V28, P761, DOI 10.1007/s12325-011-0054-9; Hasford J, 2007, EUR J CLIN PHARMACOL, V63, P1055, DOI 10.1007/s00228-007-0340-2; Hein T, 2000, NERVENARZT, V71, P288, DOI 10.1007/s001150050559; Kleinman Nathan L, 2010, J Med Econ, V13, P633, DOI 10.3111/13696998.2010.527588; Lafata JE, 2008, J AM PHARM ASSOC, V48, P752, DOI 10.1331/JAPhA.2008.07116; Lopez-Mendez P, 2013, REV NEUROLOGIA, V56, P8, DOI 10.33588/rn.5601.2012593; Menning M, 2011, GESUNDHEITSWESEN, V73, pE84, DOI 10.1055/s-0030-1255055; Mesaros S, 2012, CLIN NEUROL NEUROSUR, V114, P1145, DOI 10.1016/j.clineuro.2012.02.043; Milanese C, 2005, NEUROL SCI, V26, pS171, DOI 10.1007/s10072-005-0509-3; Mohr DC, 1999, MULT SCLER, V5, P192, DOI 10.1191/135245899678846069; O'Rourke KET, 2005, MULT SCLER J, V11, P46, DOI 10.1191/1352458505ms1131oa; Portaccio E, 2008, EUR NEUROL, V59, P131, DOI 10.1159/000111875; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Ruggieri RM, 2003, NEUROL SCI, V24, P361, DOI 10.1007/s10072-003-0190-3; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Swart E, 2005, GESUNDHEITSWESEN, V67, P416, DOI 10.1055/s-2005-858356; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; Twork S, 2007, CURR MED RES OPIN, V23, P1209, DOI 10.1185/030079907X188125; Vicente Iturbe C, 2012, Farm Hosp, V36, P77, DOI 10.1016/j.farma.2010.12.006; World Health Organisation, 2003, ADHERENCE TO LONG TE	37	58	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133279	10.1371/journal.pone.0133279	http://dx.doi.org/10.1371/journal.pone.0133279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214805	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300018
J	Dominguez, E; Raoul, W; Calippe, B; Sahel, JA; Guillonneau, X; Paques, M; Sennlaub, F				Dominguez, Elisa; Raoul, William; Calippe, Bertrand; Sahel, Jose-Alain; Guillonneau, Xavier; Paques, Michel; Sennlaub, Florian			Experimental Branch Retinal Vein Occlusion Induces Upstream Pericyte Loss and Vascular Destabilization	PLOS ONE			English	Article							MULLER CELL RESPONSES; GENE-EXPRESSION; RAT MODEL; ANGIOGENESIS; RETINOPATHY; APOPTOSIS; DISEASE; HEALTH	Aims Branch retinal vein occlusion (BRVO) leads to extensive vascular remodeling and is important cause of visual impairment. Although the vascular morphological changes following experimental vein occlusion have been described in a variety of models using angiography, the underlying cellular events are ill defined. Methods and Results We here show that laser-induced experimental BRVO in mice leads to a wave of TUNEL-positive endothelial cell (EC) apoptosis in the upstream vascular network associated with a transient edema and hemorrhages. Subsequently, we observe an induction of EC proliferation within the dilated vein and capillaries, detected by EdU incorporation, and the edema resolves. However, the pericytes of the upstream capillaries are severely reduced, which was associated with continuing EC apoptosis and proliferation. The vascular remodeling was associated with increased expression of TGF beta, TSP-1, but also FGF2 expression. Exposure of the experimental animals to hypoxia, when pericyte (PC) dropout had occurred, led to a dramatic increase in endothelial cell proliferation, confirming the vascular instability induced by the experimental BRVO. Conclusion Experimental BRVO leads to acute endothelial cells apoptosis and increased permeability. Subsequently the upstream vascular network remains destabilized, characterized by pericyte dropout, un-physiologically high endothelial cells turnover and sensitivity to hypoxia. These early changes might pave the way for capillary loss and subsequent chronic ischemia and edema that characterize the late stage disease.	[Dominguez, Elisa; Calippe, Bertrand; Sahel, Jose-Alain; Guillonneau, Xavier; Paques, Michel; Sennlaub, Florian] INSERM, U968, F-75012 Paris, France; [Dominguez, Elisa; Calippe, Bertrand; Sahel, Jose-Alain; Guillonneau, Xavier; Paques, Michel; Sennlaub, Florian] Univ Paris 04, Univ Paris 06, UMR S 968, Inst Vis, F-75012 Paris, France; [Dominguez, Elisa; Calippe, Bertrand; Sahel, Jose-Alain; Guillonneau, Xavier; Paques, Michel; Sennlaub, Florian] CNRS, UMR 7210, F-75012 Paris, France; [Raoul, William] Univ Tours, CNRS, GICC UMR 7292, Tours, France; [Sahel, Jose-Alain; Paques, Michel] Ctr Hosp Natl Ophtalmol Quinze Vingts, DHU ViewMaintain, INSERM DHOS CIC 1423, F-75012 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Sennlaub, F (corresponding author), INSERM, U968, F-75012 Paris, France.	florian.sennlaub@inserm.fr	Raoul, William/H-2118-2018; Guillonneau, xavier/E-3995-2017; guillonneau, xavier/AAF-9495-2021; Sennlaub, Florian/F-2756-2017; Sahel, Jose-Alain/F-3172-2017	Raoul, William/0000-0002-5040-3372; Guillonneau, xavier/0000-0001-7379-3935; guillonneau, xavier/0000-0001-7379-3935; Sennlaub, Florian/0000-0003-4412-1341; Sahel, Jose-Alain/0000-0002-4831-1153	INSERM; Labex Lifesenses; Carnot; ERC starting Grant [ERC-2007 St.G. 210345]; Association de Prevoyance Sante de ALLIANZ; Berthe-Fouassier Foundation	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Labex Lifesenses; Carnot; ERC starting Grant(European Research Council (ERC)); Association de Prevoyance Sante de ALLIANZ; Berthe-Fouassier Foundation	This work was supported by grants from INSERM (http://www.inserm.fr/), Labex Lifesenses (http://cache.media.enseignementsup-recherche.gouv.fr/file/Fiches_Labex/91/3/LIFESENSES_171913.pdf), Carnot (http://www.instituts-carnot.eu/), and ERC starting Grant (ERC-2007 St.G. 210345) and by the Association de Prevoyance Sante de ALLIANZ. ED was a beneficiary of a scholarship from the Berthe-Fouassier Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Chatziralli IP, 2013, SEMIN OPHTHALMOL; Coscas G, 2011, OPHTHALMOLOGICA, V226, P4, DOI 10.1159/000327391; DANIS RP, 1987, OPHTHALMOLOGY, V94, P1213; Donati G, 2008, ACTA OPHTHALMOL, V86, P302, DOI [10.1111/j.1600-0420.2007.01044.x, 10.1111/j.600-0420.2007.01044.x]; Ehlers JP, 2011, SURV OPHTHALMOL, V56, P281, DOI 10.1016/j.survophthal.2010.11.006; Feenstra Derrick J, 2013, J Clin Exp Ophthalmol, V4, P298; Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706; Genevois O, 2004, INVEST OPHTH VIS SCI, V45, P594, DOI 10.1167/iovs.03-0764; Hardy P, 2005, PHARMACOL REP, V57, P169; Im Chan Young, 2002, Korean J Ophthalmol, V16, P82; Jonas J, 2010, DEV OPHTHALMOL, V47, P111, DOI 10.1159/000320076; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Koferl P, 2014, GRAEF ARCH CLIN EXP, V252, P257, DOI 10.1007/s00417-013-2532-z; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Paques M, 2003, INVEST OPHTH VIS SCI, V44, P4960, DOI 10.1167/iovs.02-0738; Petrella RJ, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/723169; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Rehak M, 2009, INVEST OPHTH VIS SCI, V50, P2359, DOI 10.1167/iovs.08-2332; Sennlaub F, 2003, CIRCULATION, V108, P198, DOI 10.1161/01.CIR.0000080735.93327.00; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; SLAVIN J, 1995, CELL BIOL INT, V19, P431, DOI 10.1006/cbir.1995.1087; Sun C, 2013, EXP EYE RES, V113, P105, DOI 10.1016/j.exer.2013.05.018; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	27	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132644	10.1371/journal.pone.0132644	http://dx.doi.org/10.1371/journal.pone.0132644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208283	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000036
J	Fan, XB; Macleod, K; Mustafi, D; Conzen, SD; Markiewicz, E; Zamora, M; Vosicky, J; Mueller, J; Karczmar, GS				Fan, Xiaobing; Macleod, Kay; Mustafi, Devkumar; Conzen, Suzanne D.; Markiewicz, Erica; Zamora, Marta; Vosicky, James; Mueller, Jeffrey; Karczmar, Gregory S.			Correlation of In Vivo and Ex Vivo ADC and T2 of In Situ and Invasive Murine Mammary Cancers	PLOS ONE			English	Article							BREAST-CONSERVING SURGERY; TRANSGENIC MOUSE MODEL; DIFFUSION-WEIGHTED MRI; MARGIN ASSESSMENT; TUMORS; LESIONS; VALUES	Ex vivo MRI may aid in the evaluation of surgical specimens, and provide valuable information regarding the micro-anatomy of mammary/breast cancer. The use of ex vivo MRI to study mouse mammary cancer would be enhanced if there is a strong correlation between parameters derived from in vivo and ex vivo scans. Here, we report the correlation between apparent diffusion coefficient (ADC) and T-2 values measured in vivo and ex vivo in mouse mammary glands with in situ cancers (mammary intraepithelial neoplasia (MIN)) and invasive cancers (those which spread outside the ducts into surrounding tissue). MRI experiments were performed on the Polyoma middle T oncoprotein breast cancer mouse model (n = 15) in a 9.4T scanner. For in vivo experiments, T-2-weighted (T2W) images were acquired to identify abnormal regions, then ADC and T-2 values were measured for nine selected slices. For ex vivo experiments, a midline incision was made along the spine, and then skin, glands, and tumors were gently peeled from the body. Tissue was fixed in formalin, placed around a mouse-sized sponge, and sutured together mimicking the geometry of the gland when attached to the mouse. The same pulse sequences used for in vivo experiments were repeated for ex vivo scans at room temperature. Regions of interest were manually traced on T2W images defining features that could be identified on in vivo and ex vivo images. The results demonstrate a strong positive correlations between in vivo and ex vivo invasive cancers for ADC (r = 0.89, p < 0.0001) and T-2 (r = 0.89, p < 0.0001) values; and weak to moderate positive correlations between in vivo and ex vivo in situ cancers for ADC (r = 0.61, p < 0.0001) and T-2 (r = 0.79, p < 0.0001) values. The average ex vivo ADC value was about 54% of the in vivo value; and the average ex vivo T-2 was similar to the in vivo value for cancers. Although motion, fixation, and temperature differences affect ADC and T-2, these results show a reliable relationship between ADC and T-2 in vivo and ex vivo. As result ex vivo images can provide valuable information with clinical and research applications.	[Fan, Xiaobing; Mustafi, Devkumar; Markiewicz, Erica; Zamora, Marta; Vosicky, James; Karczmar, Gregory S.] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; [Macleod, Kay] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Conzen, Suzanne D.] Univ Chicago, Med Hematol Oncol, Chicago, IL 60637 USA; [Mueller, Jeffrey] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Karczmar, GS (corresponding author), Univ Chicago, Dept Radiol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	gskarczm@uchicago.edu			National Institutes of Health grant [1R01CA133490-01A2]; University of Chicago Cancer Center; NATIONAL CANCER INSTITUTE [R01CA162405, R01CA131188, R01CA089208, R01CA133490] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Cancer Center(University of Chicago); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health grant (1R01CA133490-01A2) and by a core facilities grant from the University of Chicago Cancer Center.	Chagpar A, 2003, AM J SURG, V186, P371, DOI 10.1016/S0002-9610(03)00264-2; Chenevert TL, 2011, J MAGN RESON IMAGING, V34, P983, DOI 10.1002/jmri.22363; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ihrai T, 2014, EJSO-EUR J SURG ONC, V40, P449, DOI 10.1016/j.ejso.2014.01.002; Jansen SA, 2008, PHYS MED BIOL, V53, P5481, DOI 10.1088/0031-9155/53/19/014; Jansen SA, 2011, NMR BIOMED, V24, P880, DOI 10.1002/nbm.1643; Jansen SA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2357; Kim SE, 2011, J MAGN RESON IMAGING, V34, P1167, DOI 10.1002/jmri.22736; Lee JH, 2003, MAGNET RESON MED, V49, P450, DOI 10.1002/mrm.10402; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Nilsen LB, 2013, EUR RADIOL, V23, P1027, DOI 10.1007/s00330-012-2687-8; Park MJ, 2007, KOREAN J RADIOL, V8, P390, DOI 10.3348/kjr.2007.8.5.390; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P562, DOI 10.1002/jmri.22078; Pfefferbaum A, 2004, NEUROIMAGE, V21, P1585, DOI 10.1016/j.neuroimage.2003.11.024; Santamaria G, 2010, RADIOGRAPHICS, V30, P533, DOI 10.1148/rg.302095044; Sun XH, 2009, J MAGN RESON IMAGING, V29, P621, DOI 10.1002/jmri.21675; Takano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052904; Tamura T, 2012, MAGN RESON MED, V68, P890, DOI 10.1002/mrm.23277; Westra C, 2014, AM J ROENTGENOL, V202, pW183, DOI 10.2214/AJR.13.11266; Xu JQ, 2009, MAGN RESON MED, V61, P842, DOI 10.1002/mrm.21896	21	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0129212	10.1371/journal.pone.0129212	http://dx.doi.org/10.1371/journal.pone.0129212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208092	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000004
J	Lao, Z; Kelly, CJ; Yang, XY; Jenkins, WT; Toorens, E; Ganguly, T; Evans, SM; Koch, CJ				Lao, Zheng; Kelly, Catherine J.; Yang, Xiang-Yang; Jenkins, W. Timothy; Toorens, Erik; Ganguly, Tapan; Evans, Sydney M.; Koch, Cameron J.			Improved Methods to Generate Spheroid Cultures from Tumor Cells, Tumor Cells & Fibroblasts or Tumor-Fragments: Microenvironment, Microvesicles and MiRNA	PLOS ONE			English	Article							CANCER STEM-CELLS; IN-VITRO; MAMMALIAN-CELLS; 2-NITROIMIDAZOLE EF5; POTENTIALLY LETHAL; GLIOMA SPHEROIDS; RADIATION-DAMAGE; SOLID TUMORS; OXYGEN; MODEL	Diagnostic and prognostic indicators are key components to achieve the goal of personalized cancer therapy. Two distinct approaches to this goal include predicting response by genetic analysis and direct testing of possible therapies using cultures derived from biopsy specimens. Optimally, the latter method requires a rapid assessment, but growing xenograft tumors or developing patient-derived cell lines can involve a great deal of time and expense. Furthermore, tumor cells have much different responses when grown in 2D versus 3D tissue environments. Using a modification of existing methods, we show that it is possible to make tumor-fragment (TF) spheroids in only 2-3 days. TF spheroids appear to closely model characteristics of the original tumor and may be used to assess critical therapy-modulating features of the microenvironment such as hypoxia. A similar method allows the reproducible development of spheroids from mixed tumor cells and fibroblasts (mixed-cell spheroids). Prior literature reports have shown highly variable development and properties of mixed-cell spheroids and this has hampered the detailed study of how individual tumor-cell components interact. In this study, we illustrate this approach and describe similarities and differences using two tumor models (U87 glioma and SQ20B squamous-cell carcinoma) with supporting data from additional cell lines. We show that U87 and SQ20B spheroids predict a key microenvironmental factor in tumors (hypoxia) and that SQ20B cells and spheroids generate similar numbers of microvesicles. We also present pilot data for miRNA expression under conditions of cells, tumors, and TF spheroids.	[Lao, Zheng; Yang, Xiang-Yang; Jenkins, W. Timothy; Evans, Sydney M.; Koch, Cameron J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Lao, Zheng] Fudan Univ, Eye & ENT Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Kelly, Catherine J.] Univ Oxford, Gray Inst Radiat Oncol, Oxford, England; [Toorens, Erik; Ganguly, Tapan] Univ Penn, Perelman Sch Med, Penn Genom Anal Core, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Fudan University; University of Oxford; University of Pennsylvania; Pennsylvania Medicine	Koch, CJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	kochc@mail.med.upenn.edu		Evans, Sydney M/0000-0002-0216-1014	Commonwealth of Pennsylvania, Health Research Formula Fund [4100062223]; Cancer Research UK [C48264/A16614]; visiting PhD student grant (program of China Scholarship Council) from the Science and Technology Commission of Shanghai [12JC1402102]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania, Health Research Formula Fund; Cancer Research UK(Cancer Research UK); visiting PhD student grant (program of China Scholarship Council) from the Science and Technology Commission of Shanghai; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported by a grant from the Commonwealth of Pennsylvania, 2013 Health Research Formula Fund (#4100062223). Dr. Kelly was supported by a visiting scholar travel-research grant from Cancer Research UK: C48264/A16614. ZL was supported by a visiting PhD student grant (program of China Scholarship Council) from the Science and Technology Commission of Shanghai (12JC1402102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; CARLSSON J, 1988, INT J CANCER, V42, P715, DOI 10.1002/ijc.2910420515; Cowan DSM, 1996, BRIT J CANCER, V74, pS28; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Durand RE, 2001, METHOD CELL BIOL, V64, P211; Evans SM, 1996, CANCER RES, V56, P405; FRANKO AJ, 1983, RADIAT RES, V96, P497, DOI 10.2307/3576116; FRANKO AJ, 1984, INT J RADIAT ONCOL, V10, P1333, DOI 10.1016/0360-3016(84)90343-2; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hamer PCDW, 2009, CYTOM PART A, V75A, P528, DOI 10.1002/cyto.a.20716; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Horan AD, 2001, RADIAT RES, V156, P388, DOI 10.1667/0033-7587(2001)156[0388:TKMFRO]2.0.CO;2; Hovinga KE, 2005, J NEURO-ONCOL, V74, P99, DOI 10.1007/s11060-004-4204-7; IonTorrent, ION TORR WHIT PAP ME; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kelly CJ, 2014, RADIOTHER ONCOL, V111, P72, DOI 10.1016/j.radonc.2014.02.007; Koch CJ, 2008, RADIAT RES, V169, P677, DOI 10.1667/RR1305.1; Koch CJ, 2014, TRANSL ONCOL, V7, P752, DOI 10.1016/j.tranon.2014.10.004; Koch CJ, 2002, METHOD ENZYMOL, V352, P3; KOCH CJ, 1984, RADIAT RES, V97, P434, DOI 10.2307/3576294; KOCH CJ, 1977, RADIAT RES, V70, P542, DOI 10.2307/3574644; KOCH CJ, 1978, BRIT J CANCER, V37, P163; Koch CJ, 2012, TUMOR MICROENVIRON T, V1, P1, DOI DOI 10.2478/TUMOR-2012-001; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Kross KW, 2008, SCAND J IMMUNOL, V67, P392, DOI 10.1111/j.1365-3083.2008.02072.x; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LITTLE JB, 1973, RADIOLOGY, V106, P689, DOI 10.1148/106.3.689; Machida H, 2005, CANCER SCI, V96, P911, DOI 10.1111/j.1349-7006.2005.00125.x; Marotta D, 2011, CANCER RES, V71, P779, DOI 10.1158/0008-5472.CAN-10-3061; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Sundlisaester E, 2006, NEUROPATH APPL NEURO, V32, P419, DOI 10.1111/j.1365-2990.2006.00744.x; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SUTHERLAND RM, 1974, CANCER RES, V34, P3501; SUTHERLAND RM, 1970, INT J RADIAT BIOL RE, V18, P491, DOI 10.1080/09553007014551401; WEICHSELBAUM RR, 1984, RADIOTHER ONCOL, V2, P41, DOI 10.1016/S0167-8140(84)80037-7; Yeon SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073345	44	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133895	10.1371/journal.pone.0133895	http://dx.doi.org/10.1371/journal.pone.0133895			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208323	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000167
J	Reardon, C; Tobin, DP; Delahunt, E				Reardon, Cillian; Tobin, Daniel P.; Delahunt, Eamonn			Application of Individualized Speed Thresholds to Interpret Position Specific Running Demands in Elite Professional Rugby Union: A GPS Study	PLOS ONE			English	Article							PHYSICAL DEMANDS; MOTION ANALYSIS; PERFORMANCE; ACCELERATION; RELIABILITY; VALIDITY; PLAYERS; TIME	A number of studies have used GPS technology to categorise rugby union locomotive demands. However, the utility of the results of these studies is confounded by small sample sizes, sub-elite player status and the global application of absolute speed thresholds to all player positions. Furthermore, many of these studies have used GPS units with low sampling frequencies. The aim of the present study was to compare and contrast the high speed running (HSR) demands of professional rugby union when utilizing micro-technology units sampling at 10 Hz and applying relative or individualised speed zones. The results of this study indicate that application of individualised speed zones results in a significant shift in the interpretation of the HSR demands of both forwards and backs and positional sub-categories therein. When considering the use of an absolute in comparison to an individualised HSR threshold, there was a significant underestimation for forwards of HSR distance (HSRD) (absolute = 269 +/- 172.02, individualised = 354.72 +/- 99.22, p < 0.001), HSR% (absolute = 5.15 +/- 3.18, individualised = 7.06 +/- 2.48, p < 0.001) and HSR efforts (HSRE) (absolute = 18.81 +/- 12.25; individualised = 24.78 +/- 8.30, p < 0.001). In contrast, there was a significant overestimation of the same HSR metrics for backs with the use of an absolute threshold (HSRD absolute = 697.79 +/- 198.11, individualised = 570.02 +/- 171.14, p < 0.001; HSR% absolute = 10.85 +/- 2.82, individualised = 8.95 +/- 2.76, p < 0.001; HSRE absolute = 41.55 +/- 11.25; individualised = 34.54 +/- 9.24, p < 0.001). This under-or overestimation associated with an absolute speed zone applies to varying degrees across the ten positional sub-categories analyzed and also to individuals within the same positional sub-category. The results of the present study indicated that although use of an individulised HSR threshold improves the interpretation of the HSR demands on a positional basis, inter-individual variability in maximum velocity within positional sub-categories means that players need to be considered on an individual basis to accurately gauge the HSR demands of rugby union.	[Reardon, Cillian; Tobin, Daniel P.] Leinster Rugby, Dublin, Ireland; [Reardon, Cillian; Delahunt, Eamonn] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [Delahunt, Eamonn] Univ Coll Dublin, Inst Sport & Hlth, Dublin 2, Ireland	University College Dublin; University College Dublin	Reardon, C (corresponding author), Leinster Rugby, Dublin, Ireland.	cillian.reardon@leinsterrugby.ie		Delahunt, Eamonn/0000-0001-5449-5932	Leinster Rugby	Leinster Rugby	There are no current funding sources for this study; Co-authors CR & DPT are employed by Leinster Rugby. Leinster Rugby provided support in the form of salaries for CR and DPT, but did not have any additional role in the study design, data collection & analysis, decision to publish or preparation of the manuscript. The specific role of each author is outlined in the "Author Contributions," section.	Akenhead R, 2013, J SCI MED SPORT, P925; Austin D, 2011, J SPORT SCI, V29, P1105, DOI 10.1080/02640414.2011.582508; Austin D, 2011, J SCI MED SPORT, V14, P259, DOI 10.1016/j.jsams.2011.01.003; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Coughlan GF, 2011, J ORTHOP SPORT PHYS, V41, P600, DOI 10.2519/jospt.2011.3508; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Cronin J, 2006, STRENGTH COND J, V28, P42, DOI 10.1519/1533-4295(2006)028[0042:RSTFTA]2.0.CO;2; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Duthie GM, 2006, J STRENGTH COND RES, V20, P208, DOI 10.1519/R-16784.1; Gabbett TJ, 2013, J STRENGTH COND RES, V27, P2319, DOI 10.1519/JSC.0b013e318277fd21; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Jones MR, 2015, QUANTIFYING POSITION; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Spinks CD, 2007, J STRENGTH COND RES, V21, P77, DOI 10.1519/00124278-200702000-00015; Suarez-Arrones LJ, 2012, ISOKINET EXERC SCI, V20, P77, DOI 10.3233/IES-2012-0444; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Waldron M, 2011, J SPORT SCI, V29, P1223, DOI 10.1080/02640414.2011.587445	22	50	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133410	10.1371/journal.pone.0133410	http://dx.doi.org/10.1371/journal.pone.0133410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208315	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000087
J	Vijayan, A; Garcia-Arriaza, J; Raman, SC; Conesa, JJ; Chichon, FJ; Santiago, C; Sorzano, COS; Carrascosa, JL; Esteban, M				Vijayan, Aneesh; Garcia-Arriaza, Juan; Raman, Suresh C.; Javier Conesa, Jose; Javier Chichon, Francisco; Santiago, Cesar; Sorzano, Carlos Oscar S.; Carrascosa, Jose L.; Esteban, Mariano			A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen	PLOS ONE			English	Article							T-CELL RESPONSES; NEUTRALIZING ANTIBODY-RESPONSE; HUMAN MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEINS; CD4-BINDING SITE; DENDRITIC CELLS; CENTRAL MEMORY; MVA-B; TYPE-1; EFFECTOR	In the HIV vaccine field, there is a need to produce highly immunogenic forms of the Env protein with the capacity to trigger broad B and T-cell responses. Here, we report the generation and characterization of a chimeric HIV-1 gp120 protein (termed gp120-14K) by fusing gp120 from clade B with the vaccinia virus (VACV) 14K oligomeric protein (derived from A27L gene). Stable CHO cell lines expressing HIV-1 gp120-14K protein were generated and the protein purified was characterized by size exclusion chromatography, electron microscopy and binding to anti-Env antibodies. These approaches indicate that gp120-14K protein is oligomeric and reacts with a wide spectrum of HIV-1 neutralizing antibodies. Furthermore, in human monocyte-derived dendritic cells (moDCs), gp120-14K protein upregulates the levels of several proinflammatory cytokines and chemokines associated with Th1 innate immune responses (IL-1 beta, IFN-gamma, IL-6, IL-8, IL-12, RANTES). Moreover, we showed in a murine model, that a heterologous prime/boost immunization protocol consisting of a DNA prime with a plasmid expressing gp120-14K protein followed by a boost with MVA-B [a recombinant modified vaccinia virus Ankara (MVA) expressing HIV-1 gp120, Gag, Pol and Nef antigens from clade B], generates stronger, more polyfunctional, and greater effector memory HIV-1-specific CD4(+) and CD8(+) T-cell immune responses, than immunization with DNA-gp120/MVA-B. The DNA/MVA protocol was superior to immunization with the combination of protein/MVA and the latter was superior to a prime/boost of MVA/MVA or protein/protein. In addition, these immunization protocols enhanced antibody responses against gp120 of the class IgG2a and IgG3, together favoring a Th1 humoral immune response. These results demonstrate that fusing HIV-1 gp120 with VACV 14K forms an oligomeric protein which is highly antigenic as it activates a Th1 innate immune response in human moDCs, and in vaccinated mice triggers polyfunctional HIV-1-specific adaptive and memory T-cell immune responses, as well as humoral responses. This novel HIV-1 gp120-14K immunogen might be considered as an HIV vaccine candidate for broad T and B-cell immune responses.	[Vijayan, Aneesh; Garcia-Arriaza, Juan; Raman, Suresh C.; Esteban, Mariano] CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Javier Conesa, Jose; Javier Chichon, Francisco; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Dept Struct Macromol, Madrid, Spain; [Santiago, Cesar] CSIC, Ctr Nacl Biotecnol, Xray Crystallizat Unit, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Esteban, M (corresponding author), CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain.	mesteban@cnb.csic.es	VIJAYAN, ANEESH/K-1961-2014; GARCIA-ARRIAZA, JUAN/Q-6243-2017; S. Sorzano, Carlos Oscar/ABE-4884-2021; Sorzano, Carlos Oscar S S./F-2639-2016; Santiago, César/K-4240-2014; García, Francisco Javier Chichón/R-2167-2019; Conesa, Jose Javier/J-5878-2017; Esteban, Mariano/ABG-5375-2020; Vijayan, Aneesh/AAH-5640-2019; Chichón García, Francisco Javier/B-6029-2011	VIJAYAN, ANEESH/0000-0002-2828-5285; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Santiago, César/0000-0002-5149-1722; García, Francisco Javier Chichón/0000-0003-2766-0327; Conesa, Jose Javier/0000-0002-8440-5691; Esteban, Mariano/0000-0003-0846-2827; Vijayan, Aneesh/0000-0002-2828-5285; Chichón García, Francisco Javier/0000-0003-2766-0327	Spanish grants [SAF-2008-02036, SAF-2013-45232-R, RD12/0017/0038, BFU2011-29038]; La CAIXA fellowships	Spanish grants(Spanish Government); La CAIXA fellowships	This investigation was supported by Spanish grants, SAF-2008-02036, SAF-2013-45232-R, RD12/0017/0038 to ME and BFU2011-29038 to JLC. AV and SCR were supported by La CAIXA fellowships.	Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Buckheit RW, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-68; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chang TH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003563; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Daly LM, 2005, VACCINE, V23, P963, DOI 10.1016/j.vaccine.2004.03.072; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Fantuzzi L, 2004, J VIROL, V78, P9763, DOI 10.1128/JVI.78.18.9763-9772.2004; Fonseca SG, 2011, CURR OPIN HIV AIDS, V6, P188, DOI 10.1097/COH.0b013e32834589a1; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13; Garcia-Arriaza J, 2014, J VIROL, V88, P3392, DOI 10.1128/JVI.02723-13; Garcia-Arriaza J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066894; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; GORNY MK, 1993, J IMMUNOL, V150, P635; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Huang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093804; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; JEFFERIS R, 1994, ANN BIOL CLIN-PARIS, V52, P57; Jones NG, 2009, VACCINE, V27, P1136, DOI 10.1016/j.vaccine.2008.11.071; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; LAI CF, 1990, J BIOL CHEM, V265, P22174; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; MADASSERY JV, 1988, CLIN CHEM, V34, P1407; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; McFarland EJ, 2001, J INFECT DIS, V184, P1331, DOI 10.1086/323994; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McMichael AJ, 2014, NAT IMMUNOL, V15, P319, DOI 10.1038/ni.2844; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; PAGANIN C, 1995, J CLIN INVEST, V96, P1677, DOI 10.1172/JCI118209; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pennings PS, 2013, INFECT DIS REP, V5, P21, DOI 10.4081/idr.2013.s1.e5; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rao M, 2004, IMMUNOL CELL BIOL, V82, P523, DOI 10.1111/j.0818-9641.2004.01283.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sandgren KJ, 2013, J IMMUNOL, V191, P60, DOI 10.4049/jimmunol.1202489; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Vazquez MI, 1999, J VIROL, V73, P9098; Vazquez MI, 1998, J VIROL, V72, P10126; Vijayan A, 2012, J IMMUNOL, V188, P6407, DOI 10.4049/jimmunol.1102492; Visciano ML, 2008, VIROLOGY, V372, P409, DOI 10.1016/j.virol.2007.10.044; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, J VIROL, V85, P12811, DOI 10.1128/JVI.05994-11; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	94	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133595	10.1371/journal.pone.0133595	http://dx.doi.org/10.1371/journal.pone.0133595			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208356	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000107
J	Busse, H; Riedel, T; Garnov, N; Thormer, G; Kahn, T; Moche, M				Busse, Harald; Riedel, Tim; Garnov, Nikita; Thoermer, Gregor; Kahn, Thomas; Moche, Michael			Targeting Accuracy, Procedure Times and User Experience of 240 Experimental MRI Biopsies Guided by a Clinical Add-On Navigation System	PLOS ONE			English	Article							FIELD ORIENTATION; VISIBLE MARKERS; NEEDLE-BIOPSY; FEASIBILITY; INTERVENTIONS; SCANNER; LOCALIZATION; PUNCTURES; MAGNET	Objectives MRI is of great clinical utility for the guidance of special diagnostic and therapeutic interventions. The majority of such procedures are performed iteratively ("in-and-out") in standard, closed-bore MRI systems with control imaging inside the bore and needle adjustments outside the bore. The fundamental limitations of such an approach have led to the development of various assistance techniques, from simple guidance tools to advanced navigation systems. The purpose of this work was to thoroughly assess the targeting accuracy, workflow and usability of a clinical add-on navigation solution on 240 simulated biopsies by different medical operators. Methods Navigation relied on a virtual 3D MRI scene with real-time overlay of the optically tracked biopsy needle. Smart reference markers on a freely adjustable arm ensured proper registration. Twenty-four operators - attending (AR) and resident radiologists (RR) as well as medical students (MS) - performed well-controlled biopsies of 10 embedded model targets (mean diameter: 8.5 mm, insertion depths: 17-76 mm). Targeting accuracy, procedure times and 13 Likert scores on system performance were determined (strong agreement: 5.0). Results Differences in diagnostic success rates (AR: 93%, RR: 88%, MS: 81%) were not significant. In contrast, between-group differences in biopsy times (AR: 4: 15, RR: 4: 40, MS: 5: 06 min: sec) differed significantly (p<0.01). Mean overall rating was 4.2. The average operator would use the system again (4.8) and stated that the outcome justifies the extra effort (4.4). Lowest agreement was reported for the robustness against external perturbations (2.8). Conclusions The described combination of optical tracking technology with an automatic MRI registration appears to be sufficiently accurate for instrument guidance in a standard (closed-bore) MRI environment. High targeting accuracy and usability was demonstrated on a relatively large number of procedures and operators. Between groups with different expertise there were significant differences in experimental procedure times but not in the number of successful biopsies.	[Busse, Harald; Riedel, Tim; Garnov, Nikita; Thoermer, Gregor; Kahn, Thomas; Moche, Michael] Leipzig Univ Hosp, Dept Diagnost & Intervent Radiol, Leipzig, Germany	Leipzig University	Busse, H (corresponding author), Leipzig Univ Hosp, Dept Diagnost & Intervent Radiol, Leipzig, Germany.	harald.busse@medizin.uni-leipzig.de			German Research Foundation (DFG); Universitat Leipzig	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing.	Busse H, 2007, J MAGN RESON IMAGING, V26, P1087, DOI 10.1002/jmri.21129; Busse Harald, 2011, Top Magn Reson Imaging, V22, P179, DOI 10.1097/RMR.0b013e31827c2d13; Busse H, 2010, MAGN RESON MED, V64, P922, DOI 10.1002/mrm.22464; Das CJ, 2010, ABDOM IMAGING, V35, P218, DOI 10.1007/s00261-009-9504-0; Fischbach F, 2011, CARDIOVASC INTER RAD, V34, P188, DOI 10.1007/s00270-010-9836-8; Fritz J, 2008, AM J ROENTGENOL, V191, P1717, DOI 10.2214/AJR.08.1075; Garnov N, 2011, MED PHYS, V38, P6327, DOI 10.1118/1.3655027; Hata N, 2008, J MAGN RESON IMAGING, V27, P1130, DOI 10.1002/jmri.21314; Hoffmann R, 2012, EUR RADIOL, V22, P663, DOI 10.1007/s00330-011-2297-x; Konig CW, 2004, ABDOM IMAGING, V29, P71, DOI 10.1007/s00261-003-0060-8; Kuhn JP, 2010, EUR RADIOL, V20, P2414, DOI 10.1007/s00330-010-1809-4; Lewin JS, 1996, AM J ROENTGENOL, V166, P1337, DOI 10.2214/ajr.166.6.8633445; Meyer BC, 2013, RADIOLOGY, V266, P912, DOI 10.1148/radiol.12120117; Moche M, 2008, J MAGN RESON IMAGING, V27, P276, DOI 10.1002/jmri.21262; Moche M, 2010, J MAGN RESON IMAGING, V31, P964, DOI 10.1002/jmri.21990; Noroozian M, 2010, AM J ROENTGENOL, V194, pW150, DOI 10.2214/AJR.09.2366; Ricke J, 2010, EUR RADIOL, V20, P1985, DOI 10.1007/s00330-010-1751-5; Rothgang E, 2013, J MAGN RESON IMAGING, V37, P1202, DOI 10.1002/jmri.23894; Salomonowitz E, 2001, AM J ROENTGENOL, V177, P159, DOI 10.2214/ajr.177.1.1770159; Stattaus J, 2008, J MAGN RESON IMAGING, V27, P1181, DOI 10.1002/jmri.21075; Streitparth F, 2010, EUR RADIOL, V20, P395, DOI 10.1007/s00330-009-1567-3; Tatli S, 2007, TECH VASC INTERV RAD, V10, P159, DOI 10.1053/j.tvir.2007.09.008; Wacker FK, 2006, RADIOLOGY, V238, P497, DOI 10.1148/radiol.2382041441; Zangos S, 2011, RADIOLOGY, V259, P903, DOI 10.1148/radiol.11101559	24	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134370	10.1371/journal.pone.0134370	http://dx.doi.org/10.1371/journal.pone.0134370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222443	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800136
J	Chao, A; Tsai, CL; Jung, SM; Chuang, WC; Kao, C; Hsu, A; Chen, SH; Lin, CY; Lee, YC; Lee, YS; Wang, TH; Wang, HS; Lai, CH				Chao, Angel; Tsai, Chia-Lung; Jung, Shih-Ming; Chuang, Wei-Chi; Kao, Chieh; Hsu, An; Chen, Shun-Hua; Lin, Chiao-Yun; Lee, Yi-Chao; Lee, Yun-Shien; Wang, Tzu-Hao; Wang, Hsin-Shih; Lai, Chyong-Huey			BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; IRTKS; METABOLISM; MEMBRANE; PROGRESS; IRSP53; CELLS; TIR	Brain-specific angiogenesis inhibitor 1 (BAI1)-associated protein 2-like 1 (BAIAP2L1), also known as insulin receptor tyrosine kinase substrate (IRTKS), is involved in plasma membrane protrusion and actin formation during cell morphogenesis and migration. BAIAP2L1 is recently reported to promote cell proliferation through activation of the EGFR-ERK pathway in hepatocellular carcinoma. In this study, we report the first comprehensive study of BAIAP2L1 upregulation in human ovarian cancer. Upregulation of BAIAP2L1 in ovarian tumors was first found during RNA screening and confirmed by immunohistochemical studies on ovarian cancers and other cancer types. Significant upregulation of BAIAP2L1 in ovarian cancer was validated by analyzing multiple independent cohorts in publicly available data sets. Furthermore, BAIAP2L1 protein expression in metastatic lesions was higher than the corresponding primary tumors. Functional assays in ovarian cancer cells revealed that BAIAP2L1 is involved in promoting cell proliferation and avoiding apoptosis. In conclusion, results of this study not only indicate that BAIAP2L1 can be used as a biomarker for human ovarian cancer but also reveal its role in cancer biology. Further elucidation of the role of BAIAP2L1 in context of the insulin receptor signaling pathways of cancer cells is warranted for developing cancer therapeutics by targeting cancer-specific metabolism.	[Chao, Angel; Lin, Chiao-Yun; Wang, Tzu-Hao; Wang, Hsin-Shih; Lai, Chyong-Huey] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Chao, Angel; Jung, Shih-Ming; Lin, Chiao-Yun; Wang, Tzu-Hao; Wang, Hsin-Shih; Lai, Chyong-Huey] Chang Gung Univ, Taoyuan, Taiwan; [Tsai, Chia-Lung; Lee, Yun-Shien; Wang, Tzu-Hao] Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan; [Jung, Shih-Ming] Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan; [Chuang, Wei-Chi; Kao, Chieh; Hsu, An; Chen, Shun-Hua] Chang Gung Univ, Sch Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Lee, Yi-Chao] Taipei Med Univ, Coll Med Sci & Technol, Taipei, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Wang, Tzu-Hao] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Ming Chuan University; Chang Gung University	Lee, YS (corresponding author), Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan.	bojack@mail.mcu.edu.tw; knoxtn@cgmh.org.tw	Lai, Chyong-Huey/AAE-5731-2022	Lai, Chyong-Huey/0000-0002-9977-9645; Lee, Yi-Chao/0000-0003-3451-183X	Chang Gung Medical Foundation [CMRPG3E0391, CMRPG3C1621-2, CMRPG3C0281-3, CMRPG3C0941-2, CRRPG3D0031]	Chang Gung Medical Foundation	This work was funded by Chang Gung Medical Foundation: CMRPG3E0391 (Chao A), CMRPG3C1621-2 (Tsai CL), CMRPG3C0281-3, CMRPG3C0941-2 and CRRPG3D0031 (Wang TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitio O, 2010, P NATL ACAD SCI US; Aitio O, 2012, STRUCTURE, V20, P1692, DOI 10.1016/j.str.2012.07.015; [Anonymous], 2007, CANC REG ANN REP TAI; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bowen NJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-71; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chan JK, 2006, OBSTET GYNECOL, V108, P521, DOI 10.1097/01.AOG.0000231680.58221.a7; Chao A, 2008, RADIAT RES, V169, P76, DOI 10.1667/RR1045.1; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Chao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057084; Chen G, 2011, FEBS LETT, V585, P2972, DOI 10.1016/j.febslet.2011.08.005; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; D'Amours D, 2001, J CELL SCI, V114, P3771; de Groot JC, 2011, STRUCTURE, V19, P1294, DOI 10.1016/j.str.2011.06.015; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Engel J, 2002, EUR J CANCER, V38, P2435, DOI 10.1016/S0959-8049(02)00495-1; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Galligan CL, 2007, GENES IMMUN, V8, P480, DOI 10.1038/sj.gene.6364400; Hu RM, 2000, P NATL ACAD SCI USA, V97, P9543, DOI 10.1073/pnas.160270997; Huang LY, 2013, CELL RES, V23, P1310, DOI 10.1038/cr.2013.99; JACOBS I, 1989, HUM REPROD, V4, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Nakanishi Y, 2015, MOL CANCER THER, V14, P704, DOI 10.1158/1535-7163.MCT-14-0927-T; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Saito K, 2011, NAT REV UROL, V8, P659, DOI 10.1038/nrurol.2011.145; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Van Calster B, 2007, JNCI-J NATL CANCER I, V99, P1706, DOI 10.1093/jnci/djm199; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Wang KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023571; Wang TH, 2010, MOL CELL PROTEOMICS, V9, P1873, DOI 10.1074/mcp.M110.000802; Wang YP, 2013, CANCER LETT, V337, P96, DOI 10.1016/j.canlet.2013.05.019; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yi CR, 2009, P NATL ACAD SCI USA, V106, P6431, DOI 10.1073/pnas.0902773106; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	40	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133081	10.1371/journal.pone.0133081	http://dx.doi.org/10.1371/journal.pone.0133081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222696	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800039
J	Jiang, ZX; Hennein, L; Tao, YL; Tao, LM				Jiang, Zhengxuan; Hennein, Lauren; Tao, Yulin; Tao, Liming			Interleukin-23 Receptor Gene Polymorphism May Enhance Expression of the IL-23 Receptor, IL-17, TNF-alpha and IL-6 in Behcet's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IL23R-IL12RB2; UVEITIS; IL10; DIFFERENTIATION; SUSCEPTIBILITY; HLA-B51	Purpose Recent studies identified an association between Behcet's disease (BD) and the IL-23R gene polymorphism (rs17375018) in different populations. This study examined whether this IL-23R gene polymorphism is associated with enhanced inflammatory responses. Methods We recruited 27 BD patients and 32 controls with three genotypes. Peripheral blood mononuclear cells (PBMCs) were seeded with or without anti-CD3 and CD28. Cells were incubated for 24 hours, and then supernatants were collected and stored at -20 degrees C until analyzed. Levels of interferon (IFN)-gamma, tissue necrosis factor (TNF)-alpha, interleukin (IL)-17 and IL-6 were detected by ELISA. IL-23R expression was assessed by quantitative real-time polymerase chain reaction (RT-PCR). Results The expression of IL-23R was significantly higher in both BD patients and healthy controls with the GG genotype compared to the AG and AA genotype with anti-CD3 and CD28 stimulation (all P-value < 0.05). Among the PBMCs cultured with anti-CD3 and CD28 stimulation, there was an elevated secretion of TNF-alpha, IL-6 and IL-17 in BD patients and healthy controls with the GG genotype. However, there was no significant change in secretion of IFN-gamma in BD patients and healthy controls among the genotype of this IL-23R gene polymorphism. Conclusions The results suggest that the GG genotype of the rs17375018 variant in the IL-23R gene enhances pro-inflammatory cytokine responses.	[Jiang, Zhengxuan; Tao, Yulin; Tao, Liming] Anhui Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Hefei, Anhui, Peoples R China; [Hennein, Lauren] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Hennein, Lauren] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Anhui Medical University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jiang, ZX (corresponding author), Anhui Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Hefei, Anhui, Peoples R China.	jzx1287@163.com	TAO, Li/HIR-4254-2022		National Natural Science Foundation Project of China [81300755]; Natural Science Foundation of the Higher Educational Bureau of Anhui Province [KJ2013A147]; Second Affiliated Hospital of Anhui Medical University [2014BKJ047]	National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Higher Educational Bureau of Anhui Province; Second Affiliated Hospital of Anhui Medical University	This work was supported by the National Natural Science Foundation Project of China (81300755), the key project of the Natural Science Foundation of the Higher Educational Bureau of Anhui Province (KJ2013A147), and the Grant of Second Affiliated Hospital of Anhui Medical University (2014BKJ047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Bhakta BB, 1999, RHEUMATOLOGY, V38, P728, DOI 10.1093/rheumatology/38.8.728; Cavus F, 2014, IMMUNOL LETT, V160, P96, DOI 10.1016/j.imlet.2014.01.001; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Criteria for diagnosis of Behcet's disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-6736(90)92643-V; Gheita TA, 2015, JOINT BONE SPINE, V82, P213, DOI 10.1016/j.jbspin.2014.10.008; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Na SY, 2013, CLIN EXP RHEUMATOL, V31, pS32; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; TAKENO M, 1995, ARTHRITIS RHEUM, V38, P426, DOI 10.1002/art.1780380321; Touzot M, 2014, AUTOIMMUN REV; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Xavier JM, 2012, ARTHRITIS RHEUM-US, V64, P2761, DOI 10.1002/art.34437; Yu RY, 2015, J IMMUNOL, V194, P1062, DOI 10.4049/jimmunol.1401850; Zhou ZY, 2012, AUTOIMMUN REV, V11, P699, DOI 10.1016/j.autrev.2011.12.005	20	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134632	10.1371/journal.pone.0134632	http://dx.doi.org/10.1371/journal.pone.0134632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222305	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800155
J	Khurana, H; Meena, VK; Prakash, S; Chuttani, K; Chadha, N; Jaswal, A; Dhawan, DK; Mishra, AK; Hazari, PP				Khurana, Harleen; Meena, Virendra Kumar; Prakash, Surbhi; Chuttani, Krishna; Chadha, Nidhi; Jaswal, Ambika; Dhawan, Devinder Kumar; Mishra, Anil Kumar; Hazari, Puja Panwar			Preclinical Evaluation of a Potential GSH Ester Based PET/SPECT Imaging Probe DT (GSHMe)(2) to Detect Gamma Glutamyl Transferase Over Expressing Tumors	PLOS ONE			English	Article							HUMAN LYMPHOID-CELLS; CANCER-CELLS; TRANSPEPTIDASE; GLUTATHIONE; GROWTH; RADIOPROTECTION; METABOLISM; RESISTANCE; INCREASES	Gamma Glutamyl Transferase (GGT) is an important biomarker in malignant cancers. The redox processes ensuing from GGT-mediated metabolism of extracellular GSH are implicated in critical aspects of tumor cell biology. Reportedly, Glutathione monoethyl ester (GSHMe) is a substrate of GGT, which has been used for its rapid transport over glutathione. Exploring GGT to be an important target, a homobivalent peptide system, DT (GSHMe)(2) was designed to target GGT-over expressing tumors for diagnostic purposes. DT(GSHMe)(2) was synthesized, characterized and preclinically evaluated in vitro using toxicity, cell binding assays and time dependent experiments. Stable and defined radiochemistry with Tc-99m and Ga-68 was optimized for high radiochemical yield. In vivo biodistribution studies were conducted for different time points along with scintigraphic studies of radiolabeled DT(GSHMe)(2) on xenografted tumor models. For further validation, in silico docking studies were performed on GGT (hGGT1, P19440). Preclinical in vitro evaluations on cell lines suggested minimal toxicity of DT(GSHMe)(2) at 100 mu M concentration. Kinetic analysis revealed transport of Tc-99m-DT(GSHMe)(2) occurs via a saturable high-affinity carrier with Michaelis constant (Km) of 2.25 mu M and maximal transport rate velocity (Vmax) of 0.478 mu M/min. Quantitative estimation of GGT expression from western blot experiments showed substantial expression with 41.6 +/- 7.07 % IDV for tumor. Small animal micro PET (Positron Emission Tomography)/CT(Computed Tomography) coregistered images depicted significantly high uptake of DT(GSHMe)(2) at the BMG-1 tumor site. ROI analysis showed high tumor to contra lateral muscle ratio of 9.33 in PET imaging studies. Avid accumulation of radiotracer was observed at tumor versus inflammation site at 2 h post i.v. injection in an Ehrlich Ascites tumor (EAT) mice model, showing evident specificity for tumor. We propose DT(GSHMe)(2) to be an excellent candidate for prognostication and tumor imaging using PET/SPECT.	[Khurana, Harleen; Meena, Virendra Kumar; Prakash, Surbhi; Chuttani, Krishna; Chadha, Nidhi; Jaswal, Ambika; Mishra, Anil Kumar; Hazari, Puja Panwar] Inst Nucl Med & Allied Sci, Div Cyclotron & Radiopharmaceut Sci, Delhi, India; [Khurana, Harleen; Dhawan, Devinder Kumar] Panjab Univ, Dept Biophys, Chandigarh 160014, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Panjab University	Mishra, AK (corresponding author), Inst Nucl Med & Allied Sci, Div Cyclotron & Radiopharmaceut Sci, Delhi, India.	akmishra63@gmail.com; puja.hazari@gmail.com	Meena, Dr. Virendra Kumar/ABA-7698-2021	Meena, Dr. Virendra Kumar/0000-0002-2083-7188	INMAS DRDO project [INM311 (3.1)]; Council of scientific and Industrial Research (CSIR)	INMAS DRDO project; Council of scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by INMAS DRDO project INM311 (3.1), and the research fellowship was provided by Council of scientific and Industrial Research (CSIR).	Cacciatore I, 2010, MOLECULES, V15, P1242, DOI 10.3390/molecules15031242; Campbell EB, 1992, United States patent No, Patent No. [US 5093458, 5093458]; Corti A, 2010, ANTICANCER RES, V30, P1169; Dilworth JR, 1998, CHEM SOC REV, V27, P43; DWARKANATH BS, 1989, INT J RADIAT ONCOL, V17, P1033, DOI 10.1016/0360-3016(89)90152-1; Fani M, 2012, THERANOSTICS, V2, P481, DOI 10.7150/thno.4024; Fani M, 2012, EUR J NUCL MED MOL I, V39, P11, DOI 10.1007/s00259-011-2001-z; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Hanada K, 1997, J INVEST DERMATOL, V108, P727, DOI 10.1111/1523-1747.ep12292108; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; Hanigan MH, 1999, BRIT J CANCER, V81, P75, DOI 10.1038/sj.bjc.6690653; Hanigan MH, 1999, HUM PATHOL, V30, P300, DOI 10.1016/S0046-8177(99)90009-6; Hazari PP, 2014, CURR CANCER DRUG TAR, V14, P817; Hazari PP, 2010, BIOCONJUGATE CHEM, V21, P229, DOI 10.1021/bc900197n; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; JENSEN GL, 1983, P NATL ACAD SCI-BIOL, V80, P4714, DOI 10.1073/pnas.80.15.4714; JHA B, 1992, INT J RADIAT BIOL, V62, P409, DOI 10.1080/09553009214552291; Jong M, 2003, EUR J NUCL MED MOL I, V30, P463, DOI 10.1007/s00259-002-1107-8; Laverman P, 2012, EUR J NUCL MED MOL I, V39, P78, DOI 10.1007/s00259-011-2014-7; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Liu S, 2008, ADV DRUG DELIVER REV, V60, P1347, DOI 10.1016/j.addr.2008.04.006; Maecke HR, 2005, J NUCL MED, V46, p172S; Mansi L, 2011, EUR J NUCL MED MOL I, V38, P605, DOI 10.1007/s00259-011-1762-8; NY SL, 2014, PROTEIN PREPWIZARD L; Obrador E, 2002, HEPATOLOGY, V35, P74, DOI 10.1053/jhep.2002.30277; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; Pompella A, 2007, CURR OPIN PHARMACOL, V7, P360, DOI 10.1016/j.coph.2007.04.004; Roomi MW, 2006, EXP MOL PATHOL, V81, P8, DOI 10.1016/j.yexmp.2006.02.006; Van Dort ME, 2008, CURR COMPUT-AID DRUG, V4, P46, DOI 10.2174/157340908783769265; Wang W, 1998, PHARMACOL REV, V50, P335; WELLNER VP, 1984, P NATL ACAD SCI-BIOL, V81, P4732, DOI 10.1073/pnas.81.15.4732; West MB, 2013, J BIOL CHEM, V288, P31902, DOI 10.1074/jbc.M113.498139; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	35	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134281	10.1371/journal.pone.0134281	http://dx.doi.org/10.1371/journal.pone.0134281			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221728	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800121
J	Ringe, KI; Lutat, C; Rieder, C; Schenk, A; Wacker, F; Raatschen, HJ				Ringe, Kristina I.; Lutat, Carolin; Rieder, Christian; Schenk, Andrea; Wacker, Frank; Raatschen, Hans-Juergen			Experimental Evaluation of the Heat Sink Effect in Hepatic Microwave Ablation	PLOS ONE			English	Article							PERCUTANEOUS RADIOFREQUENCY ABLATION; VENOUS-BLOOD FLOW; LIVER; THERMOTHERAPY; VESSELS; TUMORS; LASER	Purpose To demonstrate and quantify the heat sink effect in hepatic microwave ablation (MWA) in a standardized ex vivo model, and to analyze the influence of vessel distance and blood flow on lesion volume and shape. Materials and Methods 108 ex vivo MWA procedures were performed in freshly harvested pig livers. Antennas were inserted parallel to non-perfused and perfused (700,1400 ml/min) glass tubes (diameter 5mm) at different distances (10, 15, 20mm). Ablation zones (radius, area) were analyzed and compared (Kruskal-Wallis Test, Dunn's multiple comparison Test). Temperature changes adjacent to the tubes were measured throughout the ablation cycle. Results Maximum temperature decreased significantly with increasing flow and distance (p<0.05). Compared to non-perfused tubes, ablation zones were significantly deformed by perfused tubes within 15mm distance to the antenna (p<0.05). At a flow rate of 700ml/min ablation zone radius was reduced to 37.2% and 80.1% at 10 and 15mm tube distance, respectively; ablation zone area was reduced to 50.5% and 89.7%, respectively. Conclusion Significant changes of ablation zones were demonstrated in a pig liver model. Considerable heat sink effect was observed within a diameter of 15mm around simulated vessels, dependent on flow rate. This has to be taken into account when ablating liver lesions close to vessels.	[Ringe, Kristina I.; Lutat, Carolin; Wacker, Frank; Raatschen, Hans-Juergen] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany; [Rieder, Christian; Schenk, Andrea] Fraunhofer MEVIS, Inst Med Image Comp, Bremen, Germany	Hannover Medical School	Ringe, KI (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.	ringe.kristina@mh-hannover.de	Schenk, Andrea/AAF-1323-2021	Schenk, Andrea/0000-0003-1806-8380	BMBF, German Center for Lung Research (DZL); BMBF Forschungscampus STIMULATE; DFG Rebirth-Cluster of Excellence; Promedicus Ltd; Siemens Healthcare	BMBF, German Center for Lung Research (DZL); BMBF Forschungscampus STIMULATE; DFG Rebirth-Cluster of Excellence(German Research Foundation (DFG)); Promedicus Ltd; Siemens Healthcare(Siemens AG)	Frank Wacker reports grants from the BMBF, German Center for Lung Research (DZL); BMBF Forschungscampus STIMULATE; DFG Rebirth-Cluster of Excellence; Promedicus Ltd and Siemens Healthcare, outside the submitted work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Al-Alem I, 2014, SURG INNOV, V21, P269, DOI 10.1177/1553350613505713; Awad Michael M, 2007, HPB (Oxford), V9, P357, DOI 10.1080/13651820701646222; Bhardwaj N, 2010, EJSO-EUR J SURG ONC, V36, P264, DOI 10.1016/j.ejso.2009.10.006; Brannan JD, 2009, IEEE ENG MED BIO, P5989, DOI 10.1109/IEMBS.2009.5334699; BROWN HS, 1989, GUT, V30, P503, DOI 10.1136/gut.30.4.503; Carrafiello Gianpaolo, 2008, Int J Surg, V6 Suppl 1, pS65, DOI 10.1016/j.ijsu.2008.12.028; Chinn SB, 2001, AM J ROENTGENOL, V176, P789, DOI 10.2214/ajr.176.3.1760789; de Baere T, 2002, AM J ROENTGENOL, V178, P53, DOI 10.2214/ajr.178.1.1780053; Dodd GD, 2013, RADIOLOGY, V267, P129, DOI 10.1148/radiol.12120486; Dupuy DE, 2001, J VASC INTERV RADIOL, V12, P1135, DOI 10.1016/S1051-0443(07)61670-4; Hong K, 2011, PERCUTANEOUS TUMOR A, P2; Kim Y, 2006, EUR J RADIOL, V59, P432, DOI 10.1016/j.ejrad.2006.03.007; Kobayashi A, 2008, ANN SURG ONCOL, V15, P1549, DOI 10.1245/s10434-007-9773-1; Lehmann KS, 2009, LANGENBECK ARCH SURG, V394, P475, DOI 10.1007/s00423-009-0480-1; Lu DSK, 2003, J VASC INTERV RADIOL, V14, P1267, DOI 10.1097/01.RVI.0000092666.72261.6B; Ritz JP, 2006, J SURG RES, V133, P176, DOI 10.1016/j.jss.2005.09.028; Schramm Wolfgang, 2007, Open Biomed Eng J, V1, P47, DOI 10.2174/1874120700701010047; Skinner MG, 1998, PHYS MED BIOL, V43, P3535, DOI 10.1088/0031-9155/43/12/011; Wacker FK, 2001, J MAGN RESON IMAGING, V13, P31, DOI 10.1002/1522-2586(200101)13:1<31::AID-JMRI1005>3.3.CO;2-9; Wright AS, 2005, RADIOLOGY, V236, P132, DOI 10.1148/radiol.2361031249; Yu NC, 2008, J VASC INTERV RADIOL, V19, P1087, DOI 10.1016/j.jvir.2008.03.023	22	50	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134301	10.1371/journal.pone.0134301	http://dx.doi.org/10.1371/journal.pone.0134301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222431	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800126
J	Shao, MW; Lu, YH; Miao, S; Zhang, Y; Chen, TT; Zhang, YL				Shao, Ming-Wei; Lu, Yi-Hui; Miao, Shuang; Zhang, Yun; Chen, Ting-Ting; Zhang, Ying-Lao			Diversity, Bacterial Symbionts and Antibacterial Potential of Gut-Associated Fungi Isolated from the Pantala flavescens Larvae in China	PLOS ONE			English	Article							METABOLITES	The diversity of fungi associated with the gut of Pantala flavescens larvae was investigated using a culture-dependent method and molecular identification based on an analysis of the internally transcribed spacer sequence. In total, 48 fungal isolates were obtained from P. flavescens larvae. Based on phylogenetic analyses, the fungal isolates were grouped in 5 classes and 12 different genera. Fourteen bacterial 16S rDNA sequences derived from total genomic DNA extractions of fungal mycelia were obtained. The majority of the sequences were associated with Proteobacteria (13/14), and one Bacillaceae (1/14) was included. Leclercia sp., Oceanobacillus oncorhynchi and Methylobacterium extorquens, were reported for the first time as bacterial endosymbionts in fungi. High-performance liquid chromatography (HPLC) analysis indicated that bacterial symbionts produced specific metabolites and also exerted an inhibitory effect on fungal metabolites. The biological activity of the fungal culture extracts against the pathogenic bacteria Staphylococcus aureus (ATCC 6538), Bacillus subtilis (ATCC 6633) and Escherichia coli (ATCC 8739) was investigated, and 20 extracts (42%) exhibited antibacterial activity against at least one of the tested bacterial strains. This study is the first report on the diversity and antibacterial activity of symbiotic fungi residing in the gut of P. flavescens larvae, and the results show that these fungi are highly diverse and could be exploited as a potential source of bioactive compounds.	[Shao, Ming-Wei; Lu, Yi-Hui; Miao, Shuang; Zhang, Yun; Chen, Ting-Ting; Zhang, Ying-Lao] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Peoples R China; [Zhang, Ying-Lao] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	Zhejiang Normal University; Nanjing University	Zhang, YL (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua 321004, Peoples R China.	ylzhang@zjnu.cn	Zhang, Yinglao/AAR-9281-2021		National Natural Science Foundation of China (NSFC) [21002092, 21272215]; State Key Laboratory of Pharmaceutical Biotechnology in Nanjing University [01KF-201104]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pharmaceutical Biotechnology in Nanjing University	This work was co-financed by the National Natural Science Foundation of China (NSFC) (21002092 and 21272215), and Open Project of State Key Laboratory of Pharmaceutical Biotechnology in Nanjing University (01KF-201104).	Angela ED, 2015, ANNU REV ENTOMOL, V60, P17, DOI [10.1146/annurev-ento-010814-020822, DOI 10.1146/ANNUREV-ENT0-010814-020822]; Bhadury P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026445; Camara MPS, 2001, MYCOL RES, V105, P41, DOI 10.1017/S0953756200003233; Cazemier AE, 1997, MICROB ECOL, V33, P189, DOI 10.1007/s002489900021; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Hoffman MT, 2010, APPL ENVIRON MICROB, V76, P4063, DOI 10.1128/AEM.02928-09; Hollister EB, 2010, SOIL BIOL BIOCHEM, V42, P1816, DOI 10.1016/j.soilbio.2010.06.022; HUGHES GM, 1958, J EXP BIOL, V35, P567; Judith K, 2007, TERMITES CURR BIOL, V17, P995; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Lackner G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002096; Leone MR, 2010, ANGEW CHEM, V122, P7638; Li S, 2014, J AGR FOOD CHEM, V62, P8997, DOI 10.1021/jf502484n; Lin ZJ, 2014, J ANTIBIOT, V67, P121, DOI 10.1038/ja.2013.115; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; McFrederick QS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2653; Minerdi D, 2008, ENVIRON MICROBIOL, V10, P1725, DOI 10.1111/j.1462-2920.2008.01594.x; Mueller UG, 2012, CURR OPIN MICROBIOL, V15, P269, DOI 10.1016/j.mib.2012.03.001; Nancy AM, 2006, SYMBIOSIS CURR BIOL, V16, P866; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; Salvioli A., ENV MICROB, V12, P2083; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schaaf O, 1997, MICROBIOL RES, V152, P57; Scherlach K, 2012, ANGEW CHEM, V124, P9753, DOI DOI 10.1002/ANGE.201204540; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Steinhaus EA, 1941, J BACTERIOL, V42, P757, DOI 10.1128/JB.42.6.757-790.1941; Sulemankhil I, 2012, ANTIMICROB AGENTS CH, V56, P6095, DOI 10.1128/AAC.01173-12; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Wagenaar MM, 2001, J NAT PROD, V64, P1006, DOI 10.1021/np010020u; White MM, 2004, MYCOLOGIA, V96, P891, DOI 10.2307/3762122; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zhang Y., 2008, ANGEW CHEM, V120, P5907, DOI DOI 10.1002/ANGE.200801284; Zhang YL, 2011, J AM CHEM SOC, V133, P5931, DOI 10.1021/ja110932p; Zhang YL, 2008, CHEM BIODIVERS, V5, P2402, DOI 10.1002/cbdv.200890204; Zhang YL, 2011, BIORESOURCE TECHNOL, V102, P3575, DOI 10.1016/j.biortech.2010.10.028	38	16	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134542	10.1371/journal.pone.0134542	http://dx.doi.org/10.1371/journal.pone.0134542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221957	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800152
J	Yeo, JHC; Skinner, JPJ; Bird, MJ; Formosa, LE; Zhang, JG; Kluck, RM; Belz, GT; Chong, MMW				Yeo, Janet H. C.; Skinner, Jarrod P. J.; Bird, Matthew J.; Formosa, Luke E.; Zhang, Jian-Guo; Kluck, Ruth M.; Belz, Gabrielle T.; Chong, Mark M. W.			A Role for the Mitochondrial Protein Mrpl44 in Maintaining OXPHOS Capacity	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; MOLECULAR DIAGNOSIS; RNA-POLYMERASE; LARGE SUBUNIT; TRANSLATION; RIBOSOME; MUTATIONS; GENOME; DISORDERS; SPECTRUM	We identified Mrpl44 in a search for mammalian proteins that contain RNase III domains. This protein was previously found in association with the mitochondrial ribosome of bovine liver extracts. However, the precise Mrpl44 localization had been unclear. Here, we show by immunofluorescence microscopy and subcellular fractionation that Mrpl44 is localized to the matrix of the mitochondria. We found that it can form multimers, and confirm that it is part of the large subunit of the mitochondrial ribosome. By manipulating its expression, we show that Mrpl44 may be important for regulating the expression of mtDNA-encoded genes. This was at the level of RNA expression and protein translation. This ultimately impacted ATP synthesis capability and respiratory capacity of cells. These findings indicate that Mrpl44 plays an important role in the regulation of the mitochondrial OXPHOS capacity.	[Yeo, Janet H. C.; Zhang, Jian-Guo; Kluck, Ruth M.; Belz, Gabrielle T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Yeo, Janet H. C.; Zhang, Jian-Guo; Kluck, Ruth M.; Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Yeo, Janet H. C.; Skinner, Jarrod P. J.; Chong, Mark M. W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Bird, Matthew J.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bird, Matthew J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Formosa, Luke E.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; [Chong, Mark M. W.] Univ Melbourne, Dept Med St Vincents, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; St. Vincent's Institute of Medical Research; Murdoch Children's Research Institute; University of Melbourne; La Trobe University; University of Melbourne	Chong, MMW (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	mchong@svi.edu.au	Kluck, Ruth M/C-8413-2013; Belz, Gabrielle T/C-9350-2013; Chong, Mark/H-6684-2016	Kluck, Ruth M/0000-0002-7101-1925; Belz, Gabrielle T/0000-0002-9660-9587; Chong, Mark/0000-0002-3701-7397; Formosa, Luke/0000-0002-7740-6151; Bird, Matthew/0000-0003-3185-0780	National Health and Medical Research Council, Australia [1004541, 1042211, 1042582, 1016647]; Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	This work was funded by grants from the National Health and Medical Research Council, Australia (#1004541 and #1042211 to MMWC; #1042582 to GTB; #1016647 to JGZ), MMWC is an Australian Research Council QEII Fellow, GTB is an Australian Research Council Future Fellow, JHCY was supported by the Melbourne International Research Scholarship and Melbourne International Fee Remission Scholarship. This work was made possible through Victorian State Government Operational Infrastructure Support, Australian National Health and Medical Research Council Research Institute Infrastructure Support Scheme and the Australian Mitochondrial Disease Foundation.	Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Calin-Jageman I, 2003, NUCLEIC ACIDS RES, V31, P2381, DOI 10.1093/nar/gkg329; Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144; Dames S, 2013, J MOL DIAGN, V15, P526, DOI 10.1016/j.jmoldx.2013.03.005; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinwiddie DL, 2013, GENOMICS, V102, P148, DOI 10.1016/j.ygeno.2013.04.013; Gan J, 2008, MOL MICROBIOL, V67, P143, DOI 10.1111/j.1365-2958.2007.06032.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Greber BJ, 2014, NATURE; Hahn SH, 2012, GENOME MED, V4, DOI 10.1186/gm321; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Kotani T, 2013, NUCLEIC ACIDS RES, V41, P3713, DOI 10.1093/nar/gkt079; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Macias S, 2013, BIOCHEM SOC T, V41, P838, DOI 10.1042/BST20130011; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14; Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Valente L, 2007, AM J HUM GENET, V80, P44, DOI 10.1086/510559; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P219, DOI 10.1016/0925-4439(93)90024-U; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Wanschers BFJ, 2012, NUCLEIC ACIDS RES, V40, P4040, DOI 10.1093/nar/gkr1271; Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001; Yeo JHC, 2011, IUBMB LIFE, V63, P972, DOI 10.1002/iub.524; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134326	10.1371/journal.pone.0134326	http://dx.doi.org/10.1371/journal.pone.0134326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221731	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800131
J	Chiang, CY; Lee, CC; Lo, SY; Wang, AHJ; Tsai, HJ				Chiang, Cheng-Yi; Lee, Cheng-Chung; Lo, Shin-Yi; Wang, Andrew H. -J.; Tsai, Huai-Jen			Chromophore Deprotonation State Alters the Optical Properties of Blue Chromoprotein	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; SEA-ANEMONE; STRUCTURAL BASIS; VARIANTS; HOMOLOG; CORAL	Chromoproteins (CPs) have unique colors and can be used in biological applications. In this work, a novel blue CP with a maximum absorption peak (lambda(max)) at 608 nm was identified from the carpet anemone Stichodactyla gigantea (sgBP). In vivo expression of sgBP in zebrafish would change the appearance of the fishes to have a blue color, indicating the potential biomarker function. To enhance the color properties, the crystal structure of sgBP at 2.25 angstrom resolution was determined to allow structure - based protein engineering. Among the mutations conducted in the Gln-Tyr-Gly chromophore and chromophore environment, a S157C mutation shifted the lambda(max) to 604 nm with an extinction coefficient (epsilon) of 58,029 M-1.cm(-1) and darkened the blue color expression. The S157C mutation in the sgBP chromophore environment could affect the color expression by altering the deprotonation state of the phenolic group in the chromophore. Our results provide a structural basis for the blue color enhancement of the biomarker development.	[Chiang, Cheng-Yi] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Lee, Cheng-Chung; Lo, Shin-Yi; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lee, Cheng-Chung; Lo, Shin-Yi; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei, Taiwan; [Tsai, Huai-Jen] MacKay Med Coll, Inst Biomed Sci, New Taipei City, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Mackay Medical College	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw; hjtsai@ntu.edu.tw			National Science Council, Taiwan [NSC103-2313-B-002-048-MY2]; Academia Sinica from the National Science Council of Taiwan [NSC102-2319-B-001-003]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica from the National Science Council of Taiwan	This work was supported by the National Science Council, Taiwan (NSC103-2313-B-002-048-MY2). This work was also supported by Academia Sinica with grants from the National Science Council of Taiwan (NSC102-2319-B-001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Bulina ME, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-7; Chan MCY, 2006, J BIOL CHEM, V281, P37813, DOI 10.1074/jbc.M606921200; Chiang CY, 2014, MAR BIOTECHNOL, V16, P436, DOI 10.1007/s10126-014-9563-2; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2003, J BIOL CHEM, V278, P7215, DOI 10.1074/jbc.M211988200; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Dove SG, 1995, BIOL BULL, V189, P288, DOI 10.2307/1542146; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Molich A, 2005, J EXP BIOL, V208, P4137, DOI 10.1242/jeb.01878; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pakhomov AA, 2006, BIOCHEMISTRY-US, V45, P7256, DOI 10.1021/bi060207q; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pletnev S, 2012, J MOL BIOL, V417, P144, DOI 10.1016/j.jmb.2012.01.044; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shkrob MA, 2005, BIOCHEM J, V392, P649, DOI 10.1042/BJ20051314; Sniegowski JA, 2005, BIOCHEM BIOPH RES CO, V332, P657, DOI 10.1016/j.bbrc.2005.04.166; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; STORER AC, 1994, METHOD ENZYMOL, V244, P486; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	37	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134108	10.1371/journal.pone.0134108	http://dx.doi.org/10.1371/journal.pone.0134108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218063	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900078
J	Rakoczy, H; Behne, T; Cluver, A; Dallmann, S; Weidner, S; Waldmann, MR				Rakoczy, Hannes; Behne, Tanya; Cluever, Annette; Dallmann, Stephanie; Weidner, Sarah; Waldmann, Michael R.			The Side-Effect Effect in Children Is Robust and Not Specific to the Moral Status of Action Effects	PLOS ONE			English	Article							INTENTIONAL ACTION; ORDINARY LANGUAGE; YOUNG-CHILDREN; JUDGMENT; AUTISM; MIND; KNOWLEDGE; NORMS; TASK	Adults' intentionality judgments regarding an action are influenced by their moral evaluation of this action. This is clearly indicated in the so-called side-effect effect: when told about an action (e.g. implementing a business plan) with an intended primary effect (e.g. raise profits) and a foreseen side effect (e.g. harming/helping the environment), subjects tend to interpret the bringing about of the side effect more often as intentional when it is negative (harming the environment) than when it is positive (helping the environment). From a cognitive point of view, it is unclear whether the side-effect effect is driven by the moral status of the side effects specifically, or rather more generally by its normative status. And from a developmental point of view, little is known about the ontogenetic origins of the effect. The present study therefore explored the cognitive foundations and the ontogenetic origins of the side-effect effect by testing 4-to 5-year-old children with scenarios in which a side effect was in accordance with/violated a norm. Crucially, the status of the norm was varied to be conventional or moral. Children rated the bringing about of side-effects as more intentional when it broke a norm than when it accorded with a norm irrespective of the type of norm. The side-effect effect is thus an early-developing, more general and pervasive phenomenon, not restricted to morally relevant side effects.	[Rakoczy, Hannes] Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany; Univ Gottingen, Courant Res Ctr, Evolut Social Behav, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Rakoczy, H (corresponding author), Univ Gottingen, Inst Psychol, Waldweg 26, D-37073 Gottingen, Germany.	hannes.rakoczy@psych.uni-goettingen.de		rakoczy, hannes/0000-0003-3296-0551				Adams F, 2004, ANALYSIS-UK, V64, P173, DOI 10.1111/j.1467-8284.2004.00480.x; Astington JW, 2004, NEW DIR CHILD ADOLES, V103, P63, DOI 10.1002/cd.98; ASTINGTON JW, 2001, INTENTIONS INTENTION, P85; Baird JA, 2004, CONNECTIONS THEORY M; Chandler M. J., 2001, INTENTIONS INTENTION, P345; Chandler MJ, 2000, CHILD DEV, V71, P91, DOI 10.1111/1467-8624.00122; Harris PL, 1996, CHILD DEV, V67, P1572, DOI 10.2307/1131719; Holton R, 2010, ANALYSIS-UK, V70, P417, DOI 10.1093/analys/anq037; Killen M, 2011, COGNITION, V119, P197, DOI 10.1016/j.cognition.2011.01.006; Knobe J, 2003, PHILOS PSYCHOL, V16, P309, DOI 10.1080/09515080307771; Knobe J, 2003, ANALYSIS, V63, P190, DOI 10.1111/1467-8284.00419; Knobe J., 2004, J THEORETICAL PHILOS, V24, P270, DOI DOI 10.1037/H0091246; Knobe J, 2006, J COGN CULT, V6, P113, DOI 10.1163/156853706776931222; Knobe J, 2010, BEHAV BRAIN SCI, V33, P315, DOI 10.1017/S0140525X10000907; Leslie AM, 2006, PSYCHOL SCI, V17, P421, DOI 10.1111/j.1467-9280.2006.01722.x; Lombrozo T, 2010, BEHAV BRAIN SCI, V33, P344, DOI 10.1017/S0140525X10001810; Michelin C, 2010, EUR J DEV PSYCHOL, V7, P641, DOI 10.1080/17405620902969989; MOSES LJ, 1993, COGNITIVE DEV, V8, P1, DOI 10.1016/0885-2014(93)90002-M; Nadelhoffer T., 2006, PHILOS EXPLOR, V9, P203, DOI DOI 10.1080/13869790600641905; Nobes G, 2009, J EXP CHILD PSYCHOL, V104, P382, DOI 10.1016/j.jecp.2009.08.001; Noveck IA, 2001, COGNITION, V78, P165, DOI 10.1016/S0010-0277(00)00114-1; Nunez M, 1998, MIND LANG, V13, P153, DOI 10.1111/1468-0017.00071; Pellizzoni S, 2009, DEV PSYCHOL, V45, P289, DOI 10.1037/a0014165; Perner J, 1991, UNDERSTANDING REPRES; Pettit D, 2009, MIND LANG, V24, P586, DOI 10.1111/j.1468-0017.2009.01375.x; Phillips W, 1998, BRIT J DEV PSYCHOL, V16, P337, DOI 10.1111/j.2044-835X.1998.tb00756.x; Russell J, 2001, COGNITIVE DEV, V16, P775, DOI 10.1016/S0885-2014(01)00057-0; Russell J, 2001, J CHILD PSYCHOL PSYC, V42, P317, DOI 10.1111/1469-7610.00725; SHULTZ TR, 1980, BRIT J SOC CLIN PSYC, V19, P301, DOI 10.1111/j.2044-8260.1980.tb00357.x; Uttich K, 2010, COGNITION, V116, P87, DOI 10.1016/j.cognition.2010.04.003; Wainryb C, 2006, ADV CHILD DEV BEHAV, V34, P131, DOI 10.1016/S0065-2407(06)80006-6; Wellman HM, 2008, HUM DEV, V51, P105, DOI 10.1159/000115958; Williams D, 2010, DEVELOPMENTAL SCI, V13, P307, DOI 10.1111/j.1467-7687.2009.00885.x; YUILL N, 1988, DEV PSYCHOL, V24, P358, DOI 10.1037/0012-1649.24.3.358; Zelazo PD, 1996, CHILD DEV, V67, P2478, DOI 10.2307/1131635	35	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132933	10.1371/journal.pone.0132933	http://dx.doi.org/10.1371/journal.pone.0132933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218422	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900015
J	Chen, Q				Chen, Qun			An Optimization Model for the Selection of Bus-Only Lanes in a City	PLOS ONE			English	Article							NETWORK DESIGN PROBLEM; POWER MANAGEMENT; HYBRID BUS; ALGORITHM	The planning of urban bus-only lane networks is an important measure to improve bus service and bus priority. To determine the effective arrangement of bus-only lanes, a bi-level programming model for urban bus lane layout is developed in this study that considers accessibility and budget constraints. The goal of the upper-level model is to minimize the total travel time, and the lower-level model is a capacity-constrained traffic assignment model that describes the passenger flow assignment on bus lines, in which the priority sequence of the transfer times is reflected in the passengers' route-choice behaviors. Using the proposed bi-level programming model, optimal bus lines are selected from a set of candidate bus lines; thus, the corresponding bus lane network on which the selected bus lines run is determined. The solution method using a genetic algorithm in the bi-level programming model is developed, and two numerical examples are investigated to demonstrate the efficacy of the proposed model.	Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China	Central South University	Chen, Q (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	chenqun631@csu.edu.cn						Bagloee SA, 2011, TRANSPORT RES B-METH, V45, P1787, DOI 10.1016/j.trb.2011.07.005; Chiabaut N, 2012, TRANSPORT RES REC, P182, DOI 10.3141/2315-19; DAVIS GA, 1994, TRANSPORT RES B-METH, V28, P61, DOI 10.1016/0191-2615(94)90031-0; Fan W, 2006, J TRANSP ENG-ASCE, V132, P122, DOI 10.1061/(ASCE)0733-947X(2006)132:2(122); Gao ZY, 2005, TRANSPORT RES B-METH, V39, P479, DOI 10.1016/j.trb.2004.06.004; Herbert SL, 1998, TRANSP RES BOARD ANN; Hu XS, 2015, IEEE-ASME T MECH, V20, P457, DOI 10.1109/TMECH.2014.2336264; Hu XS, 2015, APPL ENERG, V137, P913, DOI 10.1016/j.apenergy.2014.05.013; Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675; Khoo HL, 2014, ENG OPTIMIZ, V46, P987, DOI 10.1080/0305215X.2013.812728; Li SG, 2009, IEEE T INTELL TRANSP, V10, P236, DOI 10.1109/TITS.2009.2018326; Liu HX, 2015, TRANSPORT RES B-METH, V72, P20, DOI 10.1016/j.trb.2014.10.009; Luathep P, 2011, TRANSPORT RES B-METH, V45, P808, DOI 10.1016/j.trb.2011.02.002; Mauttone A, 2009, COMPUT OPER RES, V36, P2440, DOI 10.1016/j.cor.2008.09.014; Nayeem MA, 2014, TRANSPORT RES C-EMER, V46, P30, DOI 10.1016/j.trc.2014.05.002; Patankar VM, 2007, J URBAN PLAN D-ASCE, V133, P99, DOI 10.1061/(ASCE)0733-9488(2007)133:2(99); Sakamoto K, 2007, TRANSP RES RECORD, P103, DOI 10.3141/2034-12; Surprenant-Legault J, 2011, TRANSPORT RES REC, P10, DOI 10.3141/2218-02; Tse LY, 2014, TRANSPORTMETRICA A, V10, P140, DOI 10.1080/18128602.2012.724470; Uchida K, 2007, NETW SPAT ECON, V7, P213, DOI 10.1007/s11067-006-9010-7; Vijay KM, 1999, TRAFFIC CONGEST TRAF, V3, P319; Wang DZW, 2015, TRANSPORT RES E-LOG, V79, P213, DOI 10.1016/j.tre.2015.04.005; Wang DZW, 2010, TRANSPORT RES B-METH, V44, P482, DOI 10.1016/j.trb.2009.10.003; Wang SA, 2013, TRANSPORT RES B-METH, V50, P42, DOI 10.1016/j.trb.2013.01.006; Wang W, 2002, PLANNING METHOD MANA; Yang H, 1998, TRANSPORT REV, V18, P257, DOI 10.1080/01441649808717016; Yao BZ, 2014, TRANSPORT RES C-EMER, V43, P233, DOI 10.1016/j.trc.2013.12.005; Yao J, 2012, J TRANSP ENG-ASCE, V138, P1422, DOI 10.1061/(ASCE)TE.1943-5436.0000475; Zhu L, 2012, J PUBLIC TRANSPORT, V15, P111, DOI 10.5038/2375-0901.15.4.6	29	9	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133951	10.1371/journal.pone.0133951	http://dx.doi.org/10.1371/journal.pone.0133951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214001	Green Submitted, gold, Green Published			2022-12-27	WOS:000358594300041
J	Esteve-Turrillas, FA; Mercader, JV; Parra, J; Agullo, C; Abad-Somovilla, A; Abad-Fuentes, A				Esteve-Turrillas, Francesc A.; Mercader, Josep V.; Parra, Javier; Agullo, Consuelo; Abad-Somovilla, Antonio; Abad-Fuentes, Antonio			Ready Access to Proquinazid Haptens via Cross-Coupling Chemistry for Antibody Generation and Immunoassay Development	PLOS ONE			English	Article							COMPETITIVE IMMUNOASSAYS; REGIOISOMERIC HAPTENS; PICOXYSTROBIN; RESIDUES; AFFINITY; DESIGN	Bioconjugate preparation is a fundamental step for antibody generation and immunoassay development to small chemical compounds. For analytical targets holding in their structure an aryl halogen atom, cross-coupling reactions may be a simple and efficient way to obtain functionalized derivatives; thus offering great potential to elicit robust and selective immune responses after being coupled to immunogenic carrier proteins. However, substitution of the halogen atom by an aliphatic chain might eventually compromise the affinity and specificity of the resulting antibodies. In order to address this issue, proquinazid, a new-generation fungicide with outstanding performance, was chosen as model analyte. Two functionalized derivatives differing in spacer arm rigidity were synthesized by Sonogashira cross-coupling chemistry. These haptens were covalently coupled to bovine serum albumin and the resulting immunoconjugates were employed for rabbit vaccination. Antibodies were tested for proquinazid recognition by direct and indirect competitive immunoassay, and IC50 values in the low nanomolar range were found, thus demonstrating the suitability of this straightforward synthetic strategy for the generation of immunoreagents to compounds bearing an aryl halide. Following antibody characterization, competitive immunoassays were developed and employed to determine proquinazid residues in grape musts, and their analytical performance was satisfactorily validated by comparison with GC-MS. Besides having described the development of the first immunochemical method for proquinazid analysis, an efficient functionalization approach for analytes comprising aryl halides is reported.	[Esteve-Turrillas, Francesc A.; Mercader, Josep V.; Parra, Javier; Abad-Fuentes, Antonio] IATA CSIC, Dept Biotechnol, Valencia 46980, Spain; [Agullo, Consuelo; Abad-Somovilla, Antonio] Univ Valencia, Dept Organ Chem, E-46100 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia	Abad-Somovilla, A (corresponding author), Univ Valencia, Dept Organ Chem, Doctor Moliner 50, E-46100 Valencia, Spain.	antonio.abad@uv.es; aabad@iata.csic.es	Abad-Fuentes, Antonio/ABC-1805-2021; Esteve-Turrillas, Francesc/N-2976-2013; Agulló, Consuelo/F-9385-2015; Abad-Fuentes, Antonio/B-5716-2011; Somovilla, Antonio Abad/F-9217-2015; Mercader, Josep Vicent/H-2849-2012	Abad-Fuentes, Antonio/0000-0001-5672-1438; Esteve-Turrillas, Francesc/0000-0003-1543-1877; Agulló, Consuelo/0000-0001-6056-5087; Abad-Fuentes, Antonio/0000-0001-5672-1438; Somovilla, Antonio Abad/0000-0002-5599-3682; Mercader, Josep Vicent/0000-0002-1838-2647	Ministerio de Economia y Competitividad [AGL2012-39965-C02-01/02/ALI]; FEDER funds; Ministerio de Ciencia e Innovacion; European Social Fund	Ministerio de Economia y Competitividad(Spanish Government); FEDER funds(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Social Fund(European Social Fund (ESF))	The work was supported by Ministerio de Economia y Competitividad (AGL2012-39965-C02-01/02/ALI) and cofinanced by FEDER funds. FAET: JAE postdoctoral contract from Ministerio de Ciencia e Innovacion and the European Social Fund. JVM: Ramon y Cajal postdoctoral contract from Ministerio de Ciencia e Innovacion and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Fuentes A, 2012, FOOD CHEM, V135, P276, DOI 10.1016/j.foodchem.2012.04.090; APVMA, PUBL REL SUMM EV NEW; Bereznak JF, 1997, US Pat, Patent No. [6166208A, 6166208]; Ceballos-Alcantarilla E, 2014, ANALYST, V139, P5358, DOI 10.1039/c4an00828f; Chinchilla R, 2011, CHEM SOC REV, V40, P5084, DOI 10.1039/c1cs15071e; EFSA, 2009, EFSA J, V7, DOI [10.2903/j.efsa.2009.1350, DOI 10.2903/J.EFSA.2009.1350]; Esteve-Turrillas FA, 2014, ANALYST, V139, P3636, DOI 10.1039/c3an01104f; Esteve-Turrillas FA, 2013, ANALYST, V138, P3360, DOI 10.1039/c3an00228d; Esteve-Turrillas FA, 2010, ANAL CHIM ACTA, V682, P93, DOI 10.1016/j.aca.2010.09.042; Genet JL, 2009, PEST MANAG SCI, V65, P878, DOI 10.1002/ps.1768; Jeschke P., 2013, MODERN METHODS CROP, P73, DOI [DOI 10.1002/9783527655908.CH4, 10.1002/9783527655908]; Lehotay SJ, 2010, J CHROMATOGR A, V1217, P2548, DOI 10.1016/j.chroma.2010.01.044; Lopez-Moreno R, 2014, FOOD CHEM, V152, P230, DOI 10.1016/j.foodchem.2013.11.150; Lopez-Moreno R, 2013, ORG BIOMOL CHEM, V11, P7361, DOI 10.1039/c3ob41570h; Mercader JV, 2012, FOOD CONTROL, V26, P162, DOI 10.1016/j.foodcont.2012.01.021; Mercader JV, 2011, ORG BIOMOL CHEM, V9, P1443, DOI 10.1039/c0ob00686f; Parra J, 2011, TETRAHEDRON, V67, P624, DOI 10.1016/j.tet.2010.11.054; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Selby Thomas P., 2007, V948, P209; Suarez-Pantaleon C, 2010, J AGR FOOD CHEM, V58, P8502, DOI 10.1021/jf101660z	20	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134042	10.1371/journal.pone.0134042	http://dx.doi.org/10.1371/journal.pone.0134042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214507	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300044
J	Gruschus, JM				Gruschus, James M.			Did alpha-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease	PLOS ONE			English	Article							LONG-RANGE INTERACTIONS; CORRELATED MUTATIONS; GAUCHER-DISEASE; X-RAY; INFORMATION; COEVOLUTION; INTERACTS; SEQUENCE; PHOSPHORYLATION; AGGREGATION	Mutations in the GBA1 gene are associated with increased risk of Parkinson's disease, and the protein produced by the gene, glucocerebrosidase, interacts with alpha-synuclein, the protein at the center of the disease etiology. One possibility is that the mutations disrupt a beneficial interaction between the proteins, and a beneficial interaction would imply that the proteins have coevolved. To explore this possibility, a correlated mutation analysis has been performed for all 72 vertebrate species where complete sequences of alpha-synuclein and glucocerebrosidase are known. The most highly correlated pair of residue variations is alpha-synuclein A53T and glucocerebrosidase G115E. Intriguingly, the A53T mutation is a Parkinson's disease risk factor in humans, suggesting the pathology associated with this mutation and interaction with glucocerebrosidase might be connected. Correlations with beta-synuclein are also evaluated. To assess the impact of lowered species number on accuracy, intra and inter-chain correlations are also calculated for hemoglobin, using mutual information Z-value and direct coupling analyses.	NHLBI, Lab Struct Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gruschus, JM (corresponding author), NHLBI, Lab Struct Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA.	gruschuj@helix.nih.gov			Intramural Research Program at the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)	Intramural Research Program at the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI)	This work was supported by the Intramural Research Program at the National Institutes of Health, National Heart, Lung, and Blood Institute (NHLBI).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Ashenberg O, 2013, METHOD ENZYMOL, V523, P191, DOI 10.1016/B978-0-12-394292-0.00009-6; Ashkenazy H, 2010, PROTEIN ENG DES SEL, V23, P321, DOI 10.1093/protein/gzp078; Bellani Serena, 2010, Commun Integr Biol, V3, P106; Beutler E, 1996, P ASSOC AM PHYSICIAN, V108, P179; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Brighina L, 2007, NEUROSCI LETT, V420, P229, DOI 10.1016/j.neulet.2007.05.021; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Cho MK, 2009, PROTEIN SCI, V18, P1840, DOI 10.1002/pro.194; Choi P, 2001, NEUROREPORT, V12, P2839, DOI 10.1097/00001756-200109170-00017; Cookson MR, 2012, CURR BIOL, V22, pR753, DOI 10.1016/j.cub.2012.07.008; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Di Lena P, 2012, BIOINFORMATICS, V28, P2449, DOI 10.1093/bioinformatics/bts475; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; El-Agnaf OMA, 1998, EUR J BIOCHEM, V258, P157, DOI 10.1046/j.1432-1327.1998.2580157.x; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Gruschus JM, 2015, BIOCHEM BIOPH RES CO, V457, P561, DOI 10.1016/j.bbrc.2015.01.024; Gruschus JM, 2013, BIOCHEMISTRY-US, V52, P3436, DOI 10.1021/bi400199p; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Jeong CS, 2012, PROTEIN ENG DES SEL, V25, P705, DOI 10.1093/protein/gzs081; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Knaggs MH, 2007, BIOPHYS J, V92, P2062, DOI 10.1529/biophysj.106.081950; Kosciolek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092197; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Lee BC, 2009, BIOINFORMATICS, V25, P2506, DOI 10.1093/bioinformatics/btp455; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Neystat M, 2002, NEUROSCI LETT, V325, P119, DOI 10.1016/S0304-3940(02)00253-7; Noivirt-Brik O, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-4; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pele J, 2014, PROTEINS, V82, P2141, DOI 10.1002/prot.24570; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Sybertz E, 2014, J LIPID RES, V55, P1996, DOI 10.1194/jlr.R047381; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uemura N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005065; Vargas KJ, 2014, J NEUROSCI, V34, P9364, DOI 10.1523/JNEUROSCI.4787-13.2014; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Wei RR, 2011, J BIOL CHEM, V286, P299, DOI 10.1074/jbc.M110.150433; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Yap TL, 2013, BIOCHEMISTRY-US, V52, P7161, DOI 10.1021/bi401191v; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	70	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133863	10.1371/journal.pone.0133863	http://dx.doi.org/10.1371/journal.pone.0133863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214314	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300036
J	Saleh, A; Lopez-Campos, JL; Hartl, S; Pozo-Rodriguez, F; Roberts, CM				Saleh, Aarash; Luis Lopez-Campos, Jose; Hartl, Sylvia; Pozo-Rodriguez, Francisco; Roberts, C. Michael		European COPD Audit Team	The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INHALED CORTICOSTEROIDS; PNEUMONIA; PROPIONATE; PLACEBO; RISK	Objective There is controversy regarding the significance of radiological consolidation in the context of COPD exacerbation (eCOPD). While some studies into eCOPD exclude these cases, consolidation is a common feature of eCOPD admissions in real practice. This study aims to address the question of whether consolidation in eCOPD is a distinct clinical phenotype with implications for management decisions and outcomes. Patients and Methods The European COPD Audit was carried out in 384 hospitals from 13 European countries between 2010 and 2011 to analyze guideline adherence in eCOPD. In this analysis, admissions were split according to the presence or not of consolidation on the admission chest radiograph. Groups were compared in terms of clinical and epidemiological features, existing treatment, clinical care utilized and mortality. Results 14,111 cases were included comprising 2,714 (19.2%) with consolidation and 11,397 (80.8%) without. The risk of radiographic consolidation increased with age, female gender, cardiovascular diseases, having had two or more admissions in the previous year, and sputum color change. Previous treatment with inhaled steroids was not associated. Patients with radiographic consolidation were significantly more likely to receive antibiotics, oxygen and non-invasive ventilation during the admission and had a lower survival from admission to 90-day follow-up. Conclusions Patients admitted for COPD exacerbation who have radiological consolidation have a more severe illness course, are treated more intensively by clinicians and have a poorer prognosis. We recommend that these patients be considered a distinct subset in COPD exacerbation.	[Saleh, Aarash] UCL, UCL Resp Med, London, England; [Luis Lopez-Campos, Jose] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain; [Luis Lopez-Campos, Jose] Inst Salud Carlos III, Ctr Invest Red Enfermedades Resp CIBERES, Madrid, Spain; [Hartl, Sylvia] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria; [Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Inst Invest i 12, E-28041 Madrid, Spain; [Roberts, C. Michael] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Ludwig Boltzmann Institute; Hospital Universitario 12 de Octubre; University of London; Queen Mary University London	Lopez-Campos, JL (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain.	lcampos@separ.es	Alcázar-Navarrete, Bernardino/X-8947-2018; Represas-Represas, Cristina/AAA-7143-2019; Özgür, Eylem Sercan/I-1921-2015; POLATLI, MEHMET/A-3516-2017; López-Quílez, Antonio/H-5945-2011; Majewski, Sebastian/S-9487-2016; Bodineau, José Luis López-Campos/AAG-5203-2019; Castro-Acosta, Ady Angelica/H-4163-2011; Guardia, Sergi Pascual/L-7652-2014; Kirkil, Gamze/W-6737-2018; Arghir, Oana C/F-8515-2015; LOPEZ-ALBERCA, CRISTINA ROMERO/R-3428-2016; Ciebiada, Maciej Ireneusz/S-9324-2016; Nayci, Sibel/A-6015-2016; Alfageme, Inmaculada/K-2092-2014	Alcázar-Navarrete, Bernardino/0000-0003-2356-9366; Represas-Represas, Cristina/0000-0002-5908-6684; Özgür, Eylem Sercan/0000-0003-4459-232X; POLATLI, MEHMET/0000-0001-7917-4297; López-Quílez, Antonio/0000-0002-7022-9260; Majewski, Sebastian/0000-0002-7210-5552; Bodineau, José Luis López-Campos/0000-0003-1703-1367; Castro-Acosta, Ady Angelica/0000-0001-7591-6011; Guardia, Sergi Pascual/0000-0002-6567-0916; Arghir, Oana C/0000-0001-9844-8521; LOPEZ-ALBERCA, CRISTINA ROMERO/0000-0001-5856-8668; Ciebiada, Maciej Ireneusz/0000-0003-3391-264X; CETINKAYA, ERDOGAN/0000-0002-0891-0020; Perlikos, Fotis/0000-0002-2579-6522; Gaga, Mina/0000-0002-9949-6012; Diar Bakerly, Nawar/0000-0003-2102-1997; Czajkowska-Malinowska, Malgorzata/0000-0001-5661-3816; Janssens, Wim/0000-0003-1830-2982; Borderias, Luis/0000-0003-3296-9644; Kouranos, Vasileios/0000-0002-2723-0928; Stolz, Daiana/0000-0003-0099-882X; CORBACHO, DOLORES/0000-0003-1239-5276; roberts, christopher/0000-0001-8212-1460; Canon-Barroso, Lourdes/0000-0002-9164-8915; Moloney, Eddie/0000-0001-5768-3760; Villanueva, Manuel Angel/0000-0003-3256-9579; Kaltsakas, Georgios/0000-0002-6852-1553; Nadarajan, Parthiban/0000-0002-1685-1876; Brutsche, Martin/0000-0002-1612-3609; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249; ESTEBAN, CRISTOBAL/0000-0001-9878-7806; Cenjor Espanol, Carlos/0000-0002-2595-7058; burghuber, otto/0000-0002-8419-621X; Nayci, Sibel/0000-0002-8415-5717; Saleh, Aarash/0000-0001-5076-770X; MacNee, William/0000-0002-3692-1448; Schindler, Otmar/0000-0002-1838-7384; Ryan, Silke/0000-0003-0963-255X; Alfageme, Inmaculada/0000-0002-5106-1669	European Respiratory Society	European Respiratory Society	The study has been funded by the European Respiratory Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bustamante-Fermosel A, 2007, AM J EMERG MED, V25, P515, DOI 10.1016/j.ajem.2006.09.014; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Davies L, 1999, LANCET, V354, P456, DOI 10.1016/S0140-6736(98)11326-0; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Garcia-Aymerich J, 2011, THORAX, V66, P585, DOI 10.1136/thx.2010.152876; Huerta A, 2013, CHEST, V144, P1134, DOI 10.1378/chest.13-0488; Lieberman D, 2002, CHEST, V122, P1264, DOI 10.1378/chest.122.4.1264; Lopez-Campos JL, 2013, EUR RESPIR J, V41, P270, DOI 10.1183/09031936.00021812; Maltais F, 2002, AM J RESP CRIT CARE, V165, P698, DOI 10.1164/ajrccm.165.5.2109093; Myint PK, 2011, RESPIRATION, V82, P320, DOI 10.1159/000327203; Pifarre R, 2007, RESP MED, V101, P2139, DOI 10.1016/j.rmed.2007.05.011; Press CU, 2009, DATA ANALYSIS USING; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI, V2nd; Roberts CM, 2013, THORAX, V68, P1169, DOI 10.1136/thoraxjnl-2013-203465; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; Suzuki M, 2014, EUR RESPIR J, V43, P1289, DOI 10.1183/09031936.00110213; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Yang IA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub3	21	21	22	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134004	10.1371/journal.pone.0134004	http://dx.doi.org/10.1371/journal.pone.0134004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214175	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300042
J	Tachi, Y; Hirai, T; Toyoda, H; Tada, T; Hayashi, K; Honda, T; Ishigami, M; Goto, H; Kumada, T				Tachi, Yoshihiko; Hirai, Takanori; Toyoda, Hidenori; Tada, Toshifumi; Hayashi, Kazuhiko; Honda, Takashi; Ishigami, Masatoshi; Goto, Hidemi; Kumada, Takashi			Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; SIMPLE NONINVASIVE INDEX; HEPATOCELLULAR-CARCINOMA; INTERFERON THERAPY; RISK-FACTORS; LONG-TERM; HISTOLOGIC IMPROVEMENT; CIRRHOSIS; MORBIDITY; MORTALITY	Liver fibrosis remains an important risk factor for hepatocarcinogenesis in patients with chronic hepatitis C even after the eradication of hepatitis C virus (HCV). However, it is difficult to estimate liver fibrosis based on liver biopsy after the eradication of HCV. We investigated the ability of laboratory indices to predict liver fibrosis in patients with sustained virologic response (SVR) to antiviral therapy. Three laboratory liver fibrosis indices (aspartate aminotransferase-platelet ratio index (APRI), FIB-4 index, and Forns index) were calculated based on data at the time of initial pretreatment liver biopsy and at second liver biopsy performed approximately 5 years after SVR in 115 patients who underwent serial liver biopsies. The indices at the time of initial biopsy were compared to histological degree of liver fibrosis in initial biopsy, and laboratory indices at the time of second liver biopsy were compared to the degree of fibrosis in second biopsy. In both comparisons, there were significant increases in all 3 indices with the increase of liver fibrosis grade as assessed in liver biopsy specimens. All 3 indices at the time of second biopsy were able to predict moderate to advanced (METAVIR score F2-4) and advanced (F3-4) fibrosis on liver biopsy, with the area under the receiver-operating characteristics curve >0.8 and the accuracy >70%. All 3 laboratory indices of fibrosis accurately reflected liver fibrosis in patients with SVR for 5 years despite the normalization of serum liver transaminase activity and the lack of liver inflammation.	[Tachi, Yoshihiko; Hirai, Takanori] Komaki City Hosp, Dept Gastroenterol, Komaki, Japan; [Toyoda, Hidenori; Tada, Toshifumi; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan; [Hayashi, Kazuhiko; Honda, Takashi; Ishigami, Masatoshi; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan	Ogaki Municipal Hospital; Nagoya University	Toyoda, H (corresponding author), Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan.	tkumada@he.mirai.ne.jp	Honda, Takashi/I-7268-2014; Hayashi, Kazuhiko/I-7382-2014	Hayashi, Kazuhiko/0000-0002-7919-6071				Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Degasperi E, 2014, J HEPATOL, V60, pS418, DOI 10.1016/S0168-8278(14)61192-2; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Guzelbulut F, 2011, TURK J GASTROENTEROL, V22, P279, DOI 10.4318/tjg.2011.0213; Halfon Philippe, 2002, Comp Hepatol, V1, P3, DOI 10.1186/1476-5926-1-3; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; Iwasaki Y, 2004, LIVER INT, V24, P603, DOI 10.1111/j.1478-3231.2004.0956.x; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Shiffman ML, 1997, HEPATOLOGY, V26, P780, DOI 10.1002/hep.510260335; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tachi Y, 2015, HEPATOL RES, V45, P238, DOI 10.1111/hepr.12331; Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1440-1746.2005.03800.x; Toyoda H, J GASTROENTEROL HEPA; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	37	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133515	10.1371/journal.pone.0133515	http://dx.doi.org/10.1371/journal.pone.0133515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214180	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300021
J	Yasuda, S; Kachi, S; Kondo, M; Ueno, S; Kaneko, H; Terasaki, H				Yasuda, Shunsuke; Kachi, Shu; Kondo, Mineo; Ueno, Shinji; Kaneko, Hiroki; Terasaki, Hiroko			Significant Correlation between Retinal Venous Tortuosity and Aqueous Vascular Endothelial Growth Factor Concentration in Eyes with Central Retinal Vein Occlusion	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; NATURAL-HISTORY; HUMOR; PREMATURITY; BEVACIZUMAB; THICKNESS	Purpose To determine whether the degree of venous tortuosity is significantly correlated with the aqueous vascular endothelial growth factor (VEGF) concentration in eyes with a central retinal vein occlusion (CRVO). Methods We reviewed the medical records of 32 eyes of 32 patients who had macular edema due to a CRVO. All of the patients were examined at the Nagoya University Hospital and were scheduled to receive an intravitreal injection of bevacizumab (IVB) or ranibizumab (IVR) within 12 weeks of the onset of the CRVO to treat the macular edema. Aqueous humor was collected just before the IVB or IVR, and the VEGF concentration was determined by enzyme-linked immunosorbent assay (ELISA). The venous tortuosity index was calculated by dividing the length of the retinal veins by the chord length of the same segment. The correlation between the mean tortuosity index of the inferotemporal and supratemporal branches of the retinal vein and the aqueous VEGF concentration was determined. Results The mean aqueous VEGF concentration was 384 +/- 312 pg/ml with a range of 90 to 1077 pg/ml. The degree of venous tortuosity was significantly correlated with the VEGF concentration in the aqueous. (r = 0.49, P = 0.004), with the foveal thickness (r = 0.40, P = 0.02), and with the best-corrected visual acuity (r = 0.38, P = 0.03). Conclusions The significant correlation between the aqueous VEGF concentration and the venous tortuosity indicates that the degree of retinal venous tortuosity can be used to identify eyes that are at a high risk of developing neovascularization.	[Yasuda, Shunsuke; Kachi, Shu; Ueno, Shinji; Kaneko, Hiroki; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kondo, Mineo] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 5148507, Japan	Nagoya University; Mie University	Yasuda, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	s.yasuda@med.nagoya-u.ac.jp	Kaneko, Hiroki/AHA-2461-2022; Kaneko, Hiroki/O-7695-2015; Ueno, Shinji/M-5063-2014; Yasuda, Shunsuke/M-5080-2014; Terasaki, Hiroko/M-5054-2014	Kaneko, Hiroki/0000-0003-0731-6465; Kaneko, Hiroki/0000-0003-0731-6465; 	Ministry of Education, Culture, Sports, Science and Technology [26861444, 25462709, 25670230, 25713056]; Grants-in-Aid for Scientific Research [25713056] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by Grant-in-Aid (No. 26861444[SY]), (No. 25462709[SU]), (No. 25670230, and 25713056[HK]) from the Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/).	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Bhuiyan A, 2012, J MED SYST, V36, P689, DOI 10.1007/s10916-010-9536-6; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486; Costa RA, 2004, INVEST OPHTH VIS SCI, V45, P2399, DOI 10.1167/iovs.04-0155; Ferrara DC, 2007, AM J OPHTHALMOL, V144, P864, DOI 10.1016/j.ajo.2007.07.038; Ha SO, 2014, INTERN EMERG MED, V9, P325, DOI 10.1007/s11739-013-1019-6; Hart WE, 1999, INT J MED INFORM, V53, P239, DOI 10.1016/S1386-5056(98)00163-4; Hayreh SS, 2011, OPHTHALMOLOGY, V118, P119, DOI 10.1016/j.ophtha.2010.04.019; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P488; Kakinoki M, 2009, OPHTHAL SURG LAS IM, V40, P135, DOI 10.3928/15428877-20090301-09; Keck KM, 2013, RETINA-J RET VIT DIS, V33, P1700, DOI 10.1097/IAE.0b013e3182845c39; Mohsenin A, 2013, CLIN OPHTHALMOL, V7, P787, DOI 10.2147/OPTH.S41795; Muraoka Y, 2014, INVEST OPHTH VIS SCI, V55, P134, DOI 10.1167/iovs.13-13201; Noma H, 2010, ACTA OPHTHALMOL, V88, P646, DOI 10.1111/j.1755-3768.2009.01524.x; Nonobe NI, 2009, RETINA-J RET VIT DIS, V29, P579, DOI 10.1097/IAE.0b013e3181a3b848; Pe'er J, 1998, OPHTHALMOLOGY, V105, P412, DOI 10.1016/S0161-6420(98)93020-2; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Sasongko MB, 2011, DIABETOLOGIA, V54, P2409, DOI 10.1007/s00125-011-2200-y; Thyparampil PJ, 2010, AM J OPHTHALMOL, V150, P468, DOI 10.1016/j.ajo.2010.04.027; Tripathi RC, 1998, OPHTHALMOLOGY, V105, P232, DOI 10.1016/S0161-6420(98)92782-8; Wilson CM, 2008, INVEST OPHTH VIS SCI, V49, P3577, DOI 10.1167/iovs.07-1353; Yasuda S, 2011, INVEST OPHTH VIS SCI, V52, P5737, DOI 10.1167/iovs.10-6923	23	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134267	10.1371/journal.pone.0134267	http://dx.doi.org/10.1371/journal.pone.0134267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214803	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300060
J	Beltran-Pardo, E; Jonsson, KI; Harms-Ringdahl, M; Haghdoost, S; Wojcik, A				Beltran-Pardo, Eliana; Jonsson, K. Ingemar; Harms-Ringdahl, Mats; Haghdoost, Siamak; Wojcik, Andrzej			Tolerance to Gamma Radiation in the Tardigrade Hypsibius dujardini from Embryo to Adult Correlate Inversely with Cellular Proliferation	PLOS ONE			English	Article							DNA-DAMAGE; IONIZING-RADIATION; RESISTANCE; INDUCTION; DESICCATION; REPAIR; SPACE; CELLS; MODEL	Tardigrades are highly tolerant to desiccation and ionizing radiation but the mechanisms of this tolerance are not well understood. In this paper, we report studies on dose responses of adults and eggs of the tardigrade Hypsibius dujardini exposed to gamma radiation. In adults the LD50/48h for survival was estimated at similar to 4200 Gy, and doses higher than 100 Gy reduced both fertility and hatchability of laid eggs drastically. We also evaluated the effect of radiation (doses 50 Gy, 200 Gy, 500 Gy) on eggs in the early and late embryonic stage of development, and observed a reduced hatchability in the early stage, while no effect was found in the late stage of development. Survival of juveniles from irradiated eggs was highly affected by a 500 Gy dose, both in the early and the late stage. Juveniles hatched from eggs irradiated at 50 Gy and 200 Gy developed into adults and produced offspring, but their fertility was reduced compared to the controls. Finally we measured the effect of low temperature during irradiation at 4000 Gy and 4500 Gy on survival in adult tardigrades, and observed a slight delay in the expressed mortality when tardigrades were irradiated on ice. Since H. dujardini is a freshwater tardigrade with lower tolerance to desiccation compared to limno-terrestrial tardigrades, the high radiation tolerance in adults, similar to limno-terrestrial tardigrades, is unexpected and seems to challenge the idea that desiccation and radiation tolerance rely on the same molecular mechanisms. We suggest that the higher radiation tolerance in adults and late stage embryos of H. dujardini (and in other studied tardigrades) compared to early stage embryos may partly be due to limited mitotic activity, since tardigrades have a low degree of somatic cell division (eutely), and dividing cells are known to be more sensitive to radiation.	[Beltran-Pardo, Eliana; Jonsson, K. Ingemar; Harms-Ringdahl, Mats; Haghdoost, Siamak; Wojcik, Andrzej] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Jonsson, K. Ingemar] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden	Stockholm University; Kristianstad University	Beltran-Pardo, E (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	elianabeltran@yahoo.com		Levine, Eliana/0000-0002-0609-3944	Swedish National Space Board [87/11]	Swedish National Space Board	This study was funded by the Swedish National Space Board (http://www.rymdstyrelsen.se/en/Home/Home/), from grant 87/11 to AW.	ALEXANDER ML, 1955, P NATL ACAD SCI USA, V41, P1046, DOI 10.1073/pnas.41.12.1046; Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; Beltran-Pardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072098; Beltran-Pardo EA, 2013, J LIMNOL, V72, P80, DOI 10.4081/jlimnol.2013.s1.e10; Bergonie J, 1906, CR HEBD ACAD SCI, V143, P983; BERTOLAN.R, 1970, ATTI ACCAD NAZ LIN, V48, P739; Dartnell LR, 2010, ASTROBIOLOGY, V10, P717, DOI 10.1089/ast.2009.0439; de Carvalho RC, 2012, ANN BOT-LONDON, V110, P1007, DOI 10.1093/aob/mcs180; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Erkut C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082473; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gobbel GT, 1998, J NEUROSCI, V18, P147; Gusev O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014008; Hejnol A, 2005, DEVELOPMENT, V132, P1349, DOI 10.1242/dev.01701; Holway AH, 2006, J CELL BIOL, V172, P999, DOI 10.1083/jcb.200512136; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Horikawa DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064793; Horikawa DD, 2012, ASTROBIOLOGY, V12, P283, DOI 10.1089/ast.2011.0669; Jonsson I, 2013, J LIMNOL, V72, P73, DOI 10.4081/jlimnol.2013.s1.e9; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, ASTROBIOLOGY, V7, P757, DOI 10.1089/ast.2006.0088; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Jonsson KI, 2003, PHYSIOL BIOCHEM ZOOL, V76, P429; Kappas NC, 2000, MOL BIOL CELL, V11, P3101, DOI 10.1091/mbc.11.9.3101; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Krisko A, 2012, P NATL ACAD SCI USA, V109, P2354, DOI 10.1073/pnas.1119762109; Lisowska H, 2014, INT J RADIAT BIOL, V90, P318, DOI 10.3109/09553002.2014.887233; McLennan AG, 2009, J EXP BIOL, V212, P785, DOI 10.1242/jeb.023663; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; Nilsson EJC, 2010, INT J RADIAT BIOL, V86, P420, DOI 10.3109/09553000903568001; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Santos-Ahmed J, 2011, REPROD TOXICOL, V31, P17, DOI 10.1016/j.reprotox.2010.09.012; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092663; Widel M, 2014, FREE RADICAL BIO MED, V68, P278, DOI 10.1016/j.freeradbiomed.2013.12.021; WRIGHT JC, 1989, J EXP BIOL, V142, P267	38	27	27	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133658	10.1371/journal.pone.0133658	http://dx.doi.org/10.1371/journal.pone.0133658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208275	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000116
J	Hu, QY; Yang, CX; Wang, Q; Zeng, HY; Qin, WZ				Hu, Qiongyi; Yang, Chunxin; Wang, Qiang; Zeng, Haiying; Qin, Wanzhang			Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-kappa B Pathway	PLOS ONE			English	Article							WILFORDII HOOK-F; DNA ANTIBODIES; RHEUMATOID-ARTHRITIS; NLRP3 INFLAMMASOME; RENAL MACROPHAGES; MURINE; DISEASE; MECHANISMS; TRIPTOLIDE; RESPONSES	Background Inflammation plays a vital role in the pathogenesis in lupus nephritis (LN), which is largely attributable to the activation of nuclear factor kappa B (NF-kappa B) signal pathway. NF-kappa B upregulates pro-inflammatory mediators, such as TNF-alpha, cyclo-oxygenase-2 (COX-2) and ICAM-1, and promotes macrophage infiltration into renal tissue, further inducing the progression of LN. Over the past 30 years, research has demonstrated that Tripterygium wilfordii Hook F (TWHF) possesses potent anti-inflammatory and immunosuppressive activities, and that demethylzeylasteral (T-96), an extract of TWHF, may be one of the responsible compounds. Here, we investigate the pharmacodynamic role and therapeutic mechanism by which T-96 suppresses inflammation and reduces renal pathology in the lupus-prone MRL/lpr mice. Methods Forty-eight MRL/lpr mice were equally randomly divided into 6 groups (1.2, 0.6 or 0.3 mg/10g T-96, 0.022 pills/10g kang lang chuang san (one of Traditional Chinese herb as positive control), 0.125 mg/10g prednisone and 0.1 ml/10g normal saline as the LN disease control group). Also, eight WT C57BL/6 mice were used as normal control. After treatment by gavage with 0.10 ml/10g/day volumes for 8 weeks, all mice were sacrificed and renal tissues were collected. The amount of 24 h proteinuria and the levels of anti-dsDNA antibody in serum were assessed respectively at weeks 0, 4 and 8. Inflammation, cytokines and NF-kappa B levels were assessed by histological examinations, immunohistochemical analyses and Western blot analyses. Results In comparison with untreated MRL/lpr mice, mice treated with 1.2 and 0.6 mg/10g of T-96 showed a significant improvement in 24 h proteinuria and the levels of anti-dsDNA antibody in serum. In addition, T-96 reduced the secretion of pro-inflammatory mediators such as TNF-alpha, COX-2 and ICAM-1, and the infiltration of macrophages in renal tissue. Moreover, T-96 significantly suppressed phosphorylations of cytoplasmic IKK and nuclear p65. Conclusion This study suggests that T-96 exhibits reno-protective effects in LN accompanied by inhibiting the activation of NF-kappa B, reducing the downstream pro-inflammatory mediators and thus restricting macrophage infiltration. Because of these potent properties, T-96 should be considered as a promising therapeutic drug for LN.	[Hu, Qiongyi; Wang, Qiang; Qin, Wanzhang] Fudan Univ, Zhongshan Hosp, Dept Dermatol, Shanghai 200032, Peoples R China; [Yang, Chunxin] Fudan Univ, Zhongshan Hosp, Dept Pharmaceut Chem, Shanghai 200032, Peoples R China; [Zeng, Haiying] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Yang, CX (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Pharmaceut Chem, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	yang.chunxin@zs-hospital.sh.cn; wang.qiang@zs-hospital.sh.cn	Hu, Anna/AAD-3585-2019					Abd-Elkareem MI, 2010, CLIN EXP NEPHROL, V14, P548, DOI 10.1007/s10157-010-0322-z; Berthier CC, 2012, J IMMUNOL, V189, P988, DOI 10.4049/jimmunol.1103031; Bethunaickan R, 2012, ARTHRITIS RHEUM-US, V64, P3399, DOI 10.1002/art.34553; Bethunaickan R, 2011, J IMMUNOL, V186, P4994, DOI 10.4049/jimmunol.1003010; Brinker AM, 2007, PHYTOCHEMISTRY, V68, P732, DOI 10.1016/j.phytochem.2006.11.029; Cai YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062465; Davidson A, 2006, CURR OPIN RHEUMATOL, V18, P468; EHRENSTEIN MR, 1995, KIDNEY INT, V48, P705, DOI 10.1038/ki.1995.341; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Goldbach-Mansky R, 2009, ANN INTERN MED, V151, P229, DOI 10.7326/0003-4819-151-4-200908180-00005; Han R, 2012, BRIT J CLIN PHARMACO, V74, P424, DOI 10.1111/j.1365-2125.2012.04221.x; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Ho LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-294; Holdsworth SR, 2007, SEMIN IMMUNOPATHOL, V29, P355, DOI 10.1007/s00281-007-0097-9; Isenberg DA, 2007, RHEUMATOLOGY, V46, P1052, DOI 10.1093/rheumatology/kem112; Ji W, 2010, CLIN RHEUMATOL, V29, P1067, DOI 10.1007/s10067-010-1497-0; Jiang T, 2014, KIDNEY INT, V85, P333, DOI 10.1038/ki.2013.343; Kalergis AM, 2009, IMMUNOLOGY, V128, pe306, DOI 10.1111/j.1365-2567.2008.02964.x; Kang HK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2682; Lee SW, 2012, RHEUMATOLOGY, V51, P2131, DOI 10.1093/rheumatology/kes227; Liu HN, 2011, RHEUMATOL INT, V31, P1459, DOI 10.1007/s00296-010-1499-x; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Menke J, 2009, J AM SOC NEPHROL, V20, P2581, DOI 10.1681/ASN.2009050499; Mok CC, 2013, ARTHRITIS RHEUM-US, V65, P2154, DOI 10.1002/art.38006; Neumann I, 2005, NEPHROL DIAL TRANSPL, V20, P96, DOI 10.1093/ndt/gfh563; Okamoto A, 2008, J IMMUNOL, V181, P5264, DOI 10.4049/jimmunol.181.8.5264; OKAMURA M, 1993, ANN RHEUM DIS, V52, P14, DOI 10.1136/ard.52.1.14; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; RAZ E, 1989, J IMMUNOL, V142, P3076; Sahu R, 2014, ARTHRITIS RHEUMATOL, V66, P1596, DOI 10.1002/art.38410; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Shi X, 1989, MED LAB ANIMAL SCI; Tao XL, 2002, ARTHRITIS RHEUM, V46, P1735, DOI 10.1002/art.10411; Tao X, 2008, ARTHRITIS RHEUM-US, V58, P1774, DOI 10.1002/art.23513; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Xu WP, 2009, INT IMMUNOPHARMACOL, V9, P996, DOI 10.1016/j.intimp.2009.04.007; Yung S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/317682; Zhang L, 2011, LUPUS, V20, P667, DOI 10.1177/0961203310393262; Zhang L, 2007, ARTHRITIS RHEUM-US, V56, P4132, DOI 10.1002/art.23054; Zhang L, 2015, LAB INVEST, V95, P65, DOI 10.1038/labinvest.2014.135; Zhao JJ, 2013, INT IMMUNOPHARMACOL, V17, P116, DOI 10.1016/j.intimp.2013.05.027; Zheng L, 2006, VIRCHOWS ARCH, V448, P172, DOI 10.1007/s00428-005-0061-9; Zheng L, 2008, J HISTOCHEM CYTOCHEM, V56, P517, DOI 10.1369/jhc.7A7368.2008; Zhou ZL, 2012, NAT PROD REP, V29, P457, DOI 10.1039/c2np00088a; Zhu JK, 2005, J CLIN INVEST, V115, P1869, DOI 10.1172/JCI23049	49	30	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133724	10.1371/journal.pone.0133724	http://dx.doi.org/10.1371/journal.pone.0133724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208003	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000123
J	Hwang, S; Aronov, A; Bar-Peled, M				Hwang, Soyoun; Aronov, Avi; Bar-Peled, Maor			The Biosynthesis of UDP-D-QuiNAc in Bacillus cereus ATCC 14579	PLOS ONE			English	Article							O-ANTIGENIC POLYSACCHARIDE; IN-VITRO BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL-CHARACTERIZATION; RHIZOBIUM-PHASEOLI; H-1-NMR SPECTRA; D-QUINOVOSAMINE; LIPOPOLYSACCHARIDE; 4,6-DEHYDRATASE; IDENTIFICATION	N-acetylquinovosamine (2-acetamido-2,6-di-deoxy-D-glucose, QuiNAc) is a relatively rare amino sugar residue found in glycans of few pathogenic gram-negative bacteria where it can play a role in infection. However, little is known about QuiNAc-related polysaccharides in gram-positive bacteria. In a routine screen for bacillus glycan grown at defined medium, it was surprising to identify a QuiNAc residue in polysaccharides isolated from this gram-positive bacterium. To gain insight into the biosynthesis of these glycans, we report the identification of an operon in Bacillus cereus ATCC 14579 that contains two genes encoding activities not previously described in gram-positive bacteria. One gene encodes a UDP-N-acetylglucosamine C4,6-dehydratase, (abbreviated Pdeg) that converts UDP-GlcNAc to UDP-4-keto-4,6-D-deoxy-GlcNAc (UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-4-hexulose); and the second encodes a UDP-4-reductase (abbr. Preq) that converts UDP-4-keto-4,6-D-deoxy-GlcNAc to UDP-N-acetyl-quinovosamine in the presence of NADPH. Biochemical studies established that the sequential Pdeg and Preq reaction product is UDP-D-QuiNAc as determined by mass spectrometry and one- and two-dimensional NMR experiments. Also, unambiguous evidence for the conversions of the dehydratase product, UDP-alpha-D-4-keto-4,6-deoxy-GlcNAc, to UDP-alpha-D-QuiNAc was obtained using real-time H-1-NMR spectroscopy and mass spectrometry. The two genes overlap by 4 nucleotides and similar operon organization and identical gene sequences were also identified in a few other Bacillus species suggesting they may have similar roles in the lifecycle of this class of bacteria important to human health. Our results provide new information about the ability of Bacilli to form UDP-QuiNAc and will provide insight to evaluate their role in the biology of Bacillus.	[Hwang, Soyoun; Aronov, Avi; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu		Aronov, Avi/0000-0003-1781-6068	US Department of Energy [UG1021RR549475]	US Department of Energy(United States Department of Energy (DOE))	This works was supported by UG1021RR549475, US Department of Energy, (http://energy.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard STM, 2000, ACTA CRYSTALLOGR D, V56, P222, DOI 10.1107/S0907444999016200; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BOWSER DV, 1974, INFECT IMMUN, V9, P772, DOI 10.1128/IAI.9.4.772-774.1974; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Bretthauer RK, 2009, CURR DRUG TARGETS, V10, P477, DOI 10.2174/138945009788488369; Bubb WA, 2003, CONCEPT MAGN RESON A, V19A, P1, DOI 10.1002/cmr.a.10080; CARLSON RW, 1987, J BACTERIOL, V169, P4923, DOI 10.1128/jb.169.11.4923-4928.1987; CAVA JR, 1989, J BACTERIOL, V171, P8, DOI 10.1128/jb.171.1.8-15.1989; De Castro C, 2013, P NATL ACAD SCI USA, V110, P13956, DOI 10.1073/pnas.1313005110; Forsberg LS, 2003, J BIOL CHEM, V278, P51347, DOI 10.1074/jbc.M309016200; Forsberg LS, 2000, J BIOL CHEM, V275, P18851, DOI 10.1074/jbc.M001090200; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Hartley MD, 2011, BIOCHEMISTRY-US, V50, P4936, DOI 10.1021/bi2003372; HRABAK EM, 1981, J BACTERIOL, V148, P697, DOI 10.1128/JB.148.2.697-711.1981; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; ITO M, 1993, CARBOHYD RES, V242, P173, DOI 10.1016/0008-6215(93)80032-A; King JD, 2009, FEBS J, V276, P2686, DOI 10.1111/j.1742-4658.2009.06993.x; Li TZ, 2014, J BIOL CHEM, V289, P18110, DOI 10.1074/jbc.M114.555862; Li Z, 2015, J BIOL CHEM, V290, P691, DOI 10.1074/jbc.M114.612747; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; Miyafusa T, 2013, BIOSCIENCE REP, V33; Morrison MJ, 2014, BIOCHEMISTRY-US, V53, P624, DOI 10.1021/bi401546r; Morrison MJ, 2013, ARCH BIOCHEM BIOPHYS, V536, P72, DOI 10.1016/j.abb.2013.05.011; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; Osipiuk J, PDB 3PVZ UNPUB; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SHARON N, 1964, BIOCHEM J, V93, P210, DOI 10.1042/bj0930210; SONESSON A, 1989, ARCH MICROBIOL, V153, P72, DOI 10.1007/BF00277544; Stanley P SH, 2009, ESSENTIALS GLYCOBIOL	37	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133790	10.1371/journal.pone.0133790	http://dx.doi.org/10.1371/journal.pone.0133790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207987	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000143
J	Rubtsova, SN; Zhitnyak, IY; Gloushankova, NA				Rubtsova, Svetlana N.; Zhitnyak, Irina Y.; Gloushankova, Natalya A.			A Novel Role of E-Cadherin-Based Adherens Junctions in Neoplastic Cell Dissemination	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL BARRIER; BREAST-CANCER; ACTIN CYTOSKELETON; ALPHA-CATENIN; BETA-CATENIN; EXPRESSION; CARCINOMA; INVASION; METASTASIS	Using confocal microscopy, we analyzed the behavior of IAR-6-1, IAR1170, and IAR1162 transformed epithelial cells seeded onto the confluent monolayer of normal IAR-2 epithelial cells. Live-cell imaging of neoplastic cells stably expressing EGFP and of normal epithelial cells stably expressing mKate2 showed that transformed cells retaining expression of E-cadherin were able to migrate over the IAR-2 epithelial monolayer and invade the monolayer. Transformed IAR cells invaded the IAR-2 monolayer at the boundaries between normal cells. Studying interactions of IAR-6-1 transformed cells stably expressing GFP-E-cadherin with the IAR-2 epithelial monolayer, we found that IAR-6-1 cells established E-cadherin-based adhesions with normal epithelial cells: dot-like dynamic E-cadherin-based adhesions in protrusions and large adherens junctions at the cell sides and rear. A comparative study of a panel of transformed IAR cells that differ by their ability to form E-cadherin-based AJs, either through loss of E-cadherin expression or through expression of a dominant negative E-cadherin mutant, demonstrated that E-cadherin-based AJs are key mediators of the interactions between neoplastic and normal epithelial cells. IAR-6-1DNE cells expressing a dominant-negative mutant form of E-cadherin with the mutation in the first extracellular domain practically lost the ability to adhere to IAR-2 cells and invade the IAR-2 epithelial monolayer. The ability of cancer cells to form E-cadherin-based AJs with the surrounding normal epithelial cells may play an important role in driving cancer cell dissemination in the body.	[Rubtsova, Svetlana N.; Zhitnyak, Irina Y.; Gloushankova, Natalya A.] NN Blokhin Russian Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia	N.N. Blokhin Russian Cancer Research Center	Gloushankova, NA (corresponding author), NN Blokhin Russian Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia.	natglu@hotmail.com	Zhitnyak, Irina Y/I-2967-2015; Rubtsova, Svetlana/R-7178-2019; Gloushankova, Natalya/S-2577-2019	Zhitnyak, Irina Y/0000-0002-6717-3745; Rubtsova, Svetlana/0000-0003-4620-7851; Gloushankova, Natalya/0000-0002-2044-2063	Russian Foundation for Basic Research [13-04-01423a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Foundation for Basic Research grant #13-04-01423a to NAG (http://www.rfbr.ru/rffi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayollo DV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008027; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bukholm IK, 2000, J PATHOL, V190, P15; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Garcia-Roman J, 2013, CANCER LETT, V335, P259, DOI 10.1016/j.canlet.2013.03.005; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Hashizume R, 1996, HISTOPATHOLOGY, V29, P139, DOI 10.1046/j.1365-2559.1996.d01-499.x; Heyder C, 2002, J CANCER RES CLIN, V128, P533, DOI 10.1007/s00432-002-0377-7; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kartenbeck J, 2005, EUR J CELL BIOL, V84, P417, DOI 10.1016/j.ejcb.2005.01.005; Kenny HA, 2009, CANCER TREAT RES, V149, P335, DOI 10.1007/978-0-387-98094-2_16; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Mazurov D, 2012, J VIROL, V86, P2447, DOI 10.1128/JVI.06993-11; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; MONTESANO R, 1975, INT J CANCER, V16, P550, DOI 10.1002/ijc.2910160405; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; Oldenburg J, 2014, CELL TISSUE RES, V355, P545, DOI 10.1007/s00441-013-1792-6; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rakha EA, 2013, HISTOPATHOLOGY, V62, P695, DOI 10.1111/his.12066; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16; Vered M, 2012, HISTOL HISTOPATHOL, V27, P141, DOI 10.14670/HH-27.141; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Voura EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078413; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wu C, 2008, DIFFERENTIATION, V76, P193, DOI 10.1111/j.1432-0436.2007.00193.x; Zhitnyak IY, 2011, RUSS J DEV BIOL+, V42, P402, DOI 10.1134/S1062360411050110	44	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133578	10.1371/journal.pone.0133578	http://dx.doi.org/10.1371/journal.pone.0133578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207916	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000102
J	Ryo, M; Iwasaki, Y; Yoshimura, C; Oliver, VOC				Ryo, Masahiro; Iwasaki, Yuichi; Yoshimura, Chihiro; Saavedra, Oliver C., V			Evaluation of Spatial Pattern of Altered Flow Regimes on a River Network Using a Distributed Hydrological Model	PLOS ONE			English	Article							MANAGEMENT; FRAMEWORK; CRITERIA; SCIENCE; DAMS	Alteration of the spatial variability of natural flow regimes has been less studied than that of the temporal variability, despite its ecological importance for river ecosystems. Here, we aimed to quantify the spatial patterns of flow regime alterations along a river network in the Sagami River, Japan, by estimating river discharge under natural and altered flow conditions. We used a distributed hydrological model, which simulates hydrological processes spatiotemporally, to estimate 20-year daily river discharge along the river network. Then, 33 hydrologic indices (i.e., Indicators of Hydrologic Alteration) were calculated from the simulated discharge to estimate the spatial patterns of their alterations. Some hydrologic indices were relatively well estimated such as the magnitude and timing of maximum flows, monthly median flows, and the frequency of low and high flow pulses. The accuracy was evaluated with correlation analysis (r > 0.4) and the Kolmogorov-Smirnov test (alpha = 0.05) by comparing these indices calculated from both observed and simulated discharge. The spatial patterns of the flow regime alterations varied depending on the hydrologic indices. For example, both the median flow in August and the frequency of high flow pulses were reduced by the maximum of approximately 70%, but these strongest alterations were detected at different locations (i.e., on the mainstream and the tributary, respectively). These results are likely caused by different operational purposes of multiple water control facilities. The results imply that the evaluation only at discharge gauges is insufficient to capture the alteration of the flow regime. Our findings clearly emphasize the importance of evaluating the spatial pattern of flow regime alteration on a river network where its discharge is affected by multiple water control facilities.	[Ryo, Masahiro; Yoshimura, Chihiro; Saavedra, Oliver C., V] Tokyo Inst Technol, Dept Civil Engn, Meguro Ku, Tokyo 152, Japan; [Iwasaki, Yuichi] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	Tokyo Institute of Technology; Colorado State University	Ryo, M (corresponding author), Eawag, Dept Aquat Ecol, Dubendorf, Switzerland.	masahiroryo@gmail.com	Iwasaki, Yuichi/A-4634-2009; Ryo, Masahiro/AAL-7294-2020	Iwasaki, Yuichi/0000-0001-7006-8113; Ryo, Masahiro/0000-0002-5271-3446; Saavedra, Oliver/0000-0002-1674-7737	Japan Society for the Promotion of Science [26.11771]; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Japan Society for the Promotion of Science, grant Number 26.11771 (http://www.jsps.go.jp/english/index.html) to MR, and Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, grant Number not allocated (http://www.jst.go.jp/kisoken/crest/en/index.html) to CY.	[Anonymous], 2014, R LANG ENV STAT COMP; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Brocca L, 2010, HYDROL EARTH SYST SC, V14, P1881, DOI 10.5194/hess-14-1881-2010; Brutsaert W., 1982, EVAPORATION ATMOSPHE, P302, DOI [10.1007/978-94-017-1497-6, DOI 10.1007/978-94-017-1497-6]; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carlisle DM, 2010, RIVER RES APPL, V26, P118, DOI 10.1002/rra.1247; Commission on Dams in Kanto region, 2011, REG REP EV MIYAG; DUAN QY, 1994, J HYDROL, V158, P265, DOI 10.1016/0022-1694(94)90057-4; Gan TY, 1997, J HYDROL, V192, P81, DOI 10.1016/S0022-1694(96)03114-9; Graf WL, 2006, GEOMORPHOLOGY, V79, P336, DOI 10.1016/j.geomorph.2006.06.022; Ishidaira H, 2000, P JAP SOC CIV ENG AN, P11; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Kiffney PM, 2006, CAN J FISH AQUAT SCI, V63, P2518, DOI 10.1139/F06-138; Larned ST, 2010, J AM WATER RESOUR AS, V46, P541, DOI 10.1111/j.1752-1688.2010.00433.x; Larned ST, 2011, ECOHYDROLOGY, V4, P532, DOI 10.1002/eco.126; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Magilligan FJ, 2005, GEOMORPHOLOGY, V71, P61, DOI 10.1016/j.geomorph.2004.08.017; Maidment D.R., 1993, HDB HYDROLOGY; Murphy JC, 2013, RIVER RES APPL, V29, P660, DOI 10.1002/rra.2570; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; Postel S, 2003, RIVERS LIFE MANAGING; Pushpalatha R, 2012, J HYDROL, V420, P171, DOI 10.1016/j.jhydrol.2011.11.055; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Richter BD, 1998, REGUL RIVER, V14, P329; Richter BD, 1997, FRESHWATER BIOL, V37, P231, DOI 10.1046/j.1365-2427.1997.00153.x; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Robinson JS, 1996, HYDROL PROCESS, V10, P845, DOI 10.1002/(SICI)1099-1085(199606)10:6&lt;845::AID-HYP375&gt;3.0.CO;2-7; Ryo M, 2011, ANN J HYDRAUL ENG, V55, P1459; Ryo M, 2014, J HYDROMETEOROL, V15, P563, DOI 10.1175/JHM-D-13-052.1; Shrestha RR, 2014, HYDROL PROCESS, V28, P4294, DOI 10.1002/hyp.9997; Snelder TH, 2009, J HYDROL, V373, P57, DOI 10.1016/j.jhydrol.2009.04.011; Stanford JA, 2001, REGUL RIVER, V17, P303, DOI 10.1002/rrr.659; Suen JP, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004314; The Nature Conservancy, 2009, IND HYDR ALT VERS 7; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Verdin KL, 1999, J HYDROL, V218, P1, DOI 10.1016/S0022-1694(99)00011-6; Wohling T, 2013, ENVIRON EARTH SCI, V69, P453, DOI 10.1007/s12665-013-2306-2; Yang D, 2002, HYDROLOG SCI J, V47, P49, DOI 10.1080/02626660209492907; Yang D, 2000, HYDROL PROCESS, V14, P403, DOI 10.1002/(SICI)1099-1085(20000228)14:3&lt;403::AID-HYP945&gt;3.0.CO;2-3	44	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133833	10.1371/journal.pone.0133833	http://dx.doi.org/10.1371/journal.pone.0133833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207997	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000153
J	Semmler, V; Biermann, J; Haller, B; Jilek, C; Sarafoff, N; Lennerz, C; Vrazic, H; Zrenner, B; Asbach, S; Kolb, C				Semmler, Verena; Biermann, Juergen; Haller, Bernhard; Jilek, Clemens; Sarafoff, Nikolaus; Lennerz, Carsten; Vrazic, Hrvoje; Zrenner, Bernhard; Asbach, Stefan; Kolb, Christof			ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing-The Prospective, Randomized, Multicentre TropShock-Trial	PLOS ONE			English	Article							CARDIOVERTER-DEFIBRILLATORS; UPPER LIMIT; MYOCARDIAL INJURY; IMPLANTATION; VULNERABILITY	Background The placement of an implantable cardioverter defibrillator (ICD) has become routine practice to protect high risk patients from sudden cardiac death. However, implantation-related myocardial micro-damage and its relation to different implantation strategies are poorly characterized. Methods A total of 194 ICD recipients (64 +/- 12 years, 83% male, 95% primary prevention of sudden cardiac death, 35% cardiac resynchronization therapy) were randomly assigned to one of three implantation strategies: (1) ICD implantation without any defibrillation threshold (DFT) testing, (2) estimation of the DFT without arrhythmia induction (modified "upper limit of vulnerability (ULV) testing") or (3) traditional safety margin testing including ventricular arrhythmia induction. High-sensitive Troponin T (hsTnT) levels were determined prior to the implantation and 6 hours after. Results All three groups showed a postoperative increase of hsTnT. The mean delta was 0.031 +/- 0.032 ng/ml for patients without DFT testing, 0.080 +/- 0.067 ng/ml for the modified ULV-testing and 0.064 +/- 0.056 ng/ml for patients with traditional safety margin testing. Delta hsTnT was significantly larger in both of the groups with intraoperative ICD testing compared to the non-testing strategy (p<0.001 each). There was no statistical difference in delta hsTnT between the two groups with intraoperative ICD testing (p = 0.179). Conclusion High-sensitive Troponin T release during ICD implantation is significantly higher in patients with intraoperative ICD testing using shock applications compared to those without testing. Shock applications, with or without arrhythmia induction, did not result in a significantly different delta hsTnT. Hence, the ICD shock itself and not ventricular fibrillation seems to cause myocardial micro-damage.	[Semmler, Verena; Jilek, Clemens; Sarafoff, Nikolaus; Lennerz, Carsten; Vrazic, Hrvoje; Kolb, Christof] Tech Univ Munich, Deutsch Herzzentrum Munchen, Klin Herz & Kreislauferkrankungen, Abt Elektrophysiol,Fac Med, D-80290 Munich, Germany; [Biermann, Juergen; Asbach, Stefan] Univ Freiburg, Cardiol & Angiol 1, Ctr Heart, D-79106 Freiburg, Germany; [Haller, Bernhard] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Jilek, Clemens] Schon Klin Starnberger See, Kardiol, Starnberg, Germany; [Sarafoff, Nikolaus] Klinikum Ludwig Maximilians Univ, Med Klin & Poliklin 1, Munich, Germany; [Vrazic, Hrvoje] Univ Hosp Dubrava, Div Cardiol, Dept Internal Med, Zagreb, Croatia; [Zrenner, Bernhard] Krankenhaus Landshut Achdorf, Med Klin 1, Kardiol, Landshut, Germany	German Heart Centre Munich; Technical University of Munich; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; University of Munich	Semmler, V (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, Klin Herz & Kreislauferkrankungen, Abt Elektrophysiol,Fac Med, D-80290 Munich, Germany.	semmler@dhm.mhn.de	Haller, Bernhard/I-1943-2019	Haller, Bernhard/0000-0002-9723-393X; Jilek, Clemens/0000-0001-9558-6240	European Heart Rhythm Association; Sorin; Biotronik; Boston Scientific; Medtronic; St. Jude Medical	European Heart Rhythm Association; Sorin; Biotronik; Boston Scientific(Boston Scientific); Medtronic(Medtronic); St. Jude Medical(St. Jude Medical)	Hrvoje Vrazic was supported by a training fellowship provided by the European Heart Rhythm Association. Sorin, Biotronik, Boston Scientific, Medtronic and St. Jude Medical provided support in the form of lecture fees, travel support, consultancy or study compensation for authors VS, JB, CL, NS, CL, HV, BZ, SA and CK concerning material unrelated to the presented study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Sham'a R, 2014, PACE, V37, P237, DOI 10.1111/pace.12263; Bansch D, 2014, EUROPACE; Birnie D, 2008, HEART RHYTHM, V5, P387, DOI 10.1016/j.hrthm.2007.11.018; Blatt JA, 2008, J AM COLL CARDIOL, V52, P551, DOI 10.1016/j.jacc.2008.04.051; Blendea D, 2009, HEART, V95, P1153, DOI 10.1136/hrt.2008.162677; Brignole M, 2012, J AM COLL CARDIOL, V60, P981, DOI 10.1016/j.jacc.2012.05.014; Calvi V, 2010, AM HEART J, V159, P98, DOI 10.1016/j.ahj.2009.10.031; Dosdall DJ, 2010, ANNU REV BIOMED ENG, V12, P233, DOI [10.1146/annurev-bioeng-070909-105305, 10.1146/armurev-bioeng-070909-105305]; Francis CK, 2012, PACE, V35, P314, DOI 10.1111/j.1540-8159.2011.03275.x; Furniss G, 2014, EUROPACE; Glikson M, 2004, AM J CARDIOL, V94, P1445, DOI 10.1016/j.amjcard.2004.07.151; Hasdemir C, 2002, J CARDIOVASC ELECTR, V13, P144, DOI 10.1046/j.1540-8167.2002.00144.x; Healey JS, 2012, AM HEART J, V164, P146, DOI 10.1016/j.ahj.2012.05.007; Healey JS, 2015, LANCET; Hurst TM, 1999, J AM COLL CARDIOL, V34, P402, DOI 10.1016/S0735-1097(99)00194-1; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Kolb C, 2009, PACE, V32, P570, DOI 10.1111/j.1540-8159.2009.02328.x; Lemke B, 2008, EUROPACE, V10, P907, DOI 10.1093/europace/eun136; Matassini Maria Vittoria, 2013, Curr Treat Options Cardiovasc Med, V15, P497, DOI 10.1007/s11936-013-0244-7; Nikolski VP, 2005, EUROPACE, V7, pS146, DOI 10.1016/j.eupc.2005.04.011; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Schluter T, 2001, CLIN CHEM, V47, P459; Sonel AF, 2007, PACE, V30, P839, DOI 10.1111/j.1540-8159.2007.00770.x; Swerdlow CD, 1997, CIRCULATION, V95, P1497; Swerdlow CD, 2001, CIRCULATION, V103, P2159; van Waes JAR, 2013, CIRCULATION, V127, P2264, DOI 10.1161/CIRCULATIONAHA.113.002128; Zangrillo A, 2005, CAN J ANAESTH, V52, P336, DOI 10.1007/BF03016076	28	27	27	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0131570	10.1371/journal.pone.0131570	http://dx.doi.org/10.1371/journal.pone.0131570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208329	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000017
J	Tsang, SY; Mei, LL; Wan, WQ; Li, J; Li, Y; Zhao, CY; Ding, XF; Pun, FW; Hu, XX; Wang, JM; Zhang, JY; Luo, RC; Cheung, ST; Leung, GKK; Poon, WS; Ng, HK; Zhang, LW; Xue, H				Tsang, Shui-Ying; Mei, Lingling; Wan, Weiqing; Li, Jun; Li, Yi; Zhao, Cunyou; Ding, Xiaofan; Pun, Frank W.; Hu, Xiaoxia; Wang, Jianmin; Zhang, Junyi; Luo, Rongcheng; Cheung, Siu-Tim; Leung, Gilberto K. K.; Poon, Wai-Sang; Ng, Ho-Keung; Zhang, Liwei; Xue, Hong			Glioma Association and Balancing Selection of ZFPM2	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENE; FOG-2; POLYMORPHISMS; EXPRESSION; COFACTOR; HEART; MICE; EPIDEMIOLOGY; RESISTANCE	ZFPM2, encoding a zinc finger protein and abundantly expressed in the brain, uterus and smooth muscles, plays important roles in cardiac and gonadal development. Abnormal expression of ZFPM2 in ovarian tumors and neuroblastoma has been reported but hitherto its genetic association with cancer and effects on gliomas have not been studied. In the present study, the hexamer insertion-deletion polymorphism rs71305152, located within a large haplotype block spanning intron 1 to intron 3 of ZFPM2, was genotyped in Chinese cohorts of glioma (n = 350), non-glioma cancer (n = 354) and healthy control (n = 463) by direct sequencing and length polymorphism in gel electrophoresis, and ZFPM2 expression in glioma tissues (n = 69) of different grades was quantified by real-time RT-PCR. Moreover, potential natural selection pressure acting on the gene was investigated. Disease-association analysis showed that the overall genotype of rs71305152 was significantly associated with gliomas (P = 0.016), and the heterozygous genotype compared to the combined homozygous genotypes was less frequent in gliomas than in controls (P = 0.005) or non-glioma cancers (P = 0.020). ZFPM2 mRNA expression was negatively correlated with the grades of gliomas (P = 0.002), with higher expression levels in the low-grade gliomas. In the astrocytoma subtype, higher ZFPM2 expression was also correlated with the rs71305152 heterozygous genotype (P = 0.028). In addition, summary statistics tests gave highly positive values, demonstrating that the gene is under the influence of balancing selection. These findings suggest that ZFPM2 is a glioma susceptibility gene, its genotype and expression showing associations with incidence and severity, respectively. Moreover, the balancing selection acting on ZFPM2 may be related to the important roles it has to play in multiple organ development or associated disease etiology.	[Tsang, Shui-Ying; Mei, Lingling; Zhao, Cunyou; Ding, Xiaofan; Pun, Frank W.; Xue, Hong] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Tsang, Shui-Ying; Mei, Lingling; Zhao, Cunyou; Ding, Xiaofan; Pun, Frank W.; Xue, Hong] Hong Kong Univ Sci & Technol, Appl Genom Ctr, Clear Water Bay, Hong Kong, Peoples R China; [Wan, Weiqing; Zhang, Liwei] Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Beijing, Peoples R China; [Li, Jun; Li, Yi; Poon, Wai-Sang] Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Hu, Xiaoxia; Wang, Jianmin] Second Mil Med Univ, Dept Hematol, Inst Hematol, PLA,Changhai Hosp, Shanghai, Peoples R China; [Zhang, Junyi; Luo, Rongcheng] Southern Med Univ, Nanfang Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Cheung, Siu-Tim; Leung, Gilberto K. K.] Univ Hong Kong, Div Neurosurg, Dept Surg, Li Ka Shing Fac Med,Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Ng, Ho-Keung] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Capital Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Naval Medical University; Southern Medical University - China; University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Zhang, LW (corresponding author), Capital Med Univ, Dept Neurosurg, Beijing Tiantan Hosp, Beijing, Peoples R China.	zlwtt@yahoo.com.cn; hxue@ust.hk	DING, Xiaofan/GLS-2274-2022; Poon, Wai Sang/F-1558-2011; Cheung, Siu-Tim/C-4238-2009; Poon, Wai S/HGD-3084-2022; ZHAO, Cunyou/Q-5076-2016; Ng, Ho Keung/I-3952-2015; wang, jian/GVS-0711-2022; Leung, Gilberto Ka Kit/C-4337-2009	Cheung, Siu-Tim/0000-0003-2147-315X; ZHAO, Cunyou/0000-0001-6116-4584; Leung, Gilberto Ka Kit/0000-0003-3147-3057; DING, Xiaofan/0000-0003-2565-7757; Xue, Hong/0000-0002-8133-9828	University Grants Council of Hong Kong SAR [VPRDO09/10.SC08, VPRDO14SC01, DG14SC02, SRFI11SC06, SRFI11SC06PG]; 863 Program, Ministry of Science and Technology, China [2012AA02A201]	University Grants Council of Hong Kong SAR; 863 Program, Ministry of Science and Technology, China(National High Technology Research and Development Program of China)	The study was supported by grants to HX from the University Grants Council of Hong Kong SAR (VPRDO09/10.SC08, VPRDO14SC01, DG14SC02, SRFI11SC06 and SRFI11SC06PG) and a grant to LZ from 863 Program, Ministry of Science and Technology, China (2012AA02A201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Andersson U, 2010, ACTA ONCOL, V49, P767, DOI 10.3109/0284186X.2010.480980; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Chakrabarti I, 2005, CANCER-AM CANCER SOC, V104, P2798, DOI 10.1002/cncr.21539; Chen HY, 2011, AM J EPIDEMIOL, V173, P915, DOI 10.1093/aje/kwq457; Chen ZJ, 2013, TECHNOL CANCER RES T, V12, P91, DOI 10.7785/tcrt.2012.500250; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dobbins SE, 2011, INT J CANCER, V128, P1736, DOI 10.1002/ijc.25483; Dubrow R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-325; Fan WW, 2011, J NEURO-ONCOL, V105, P211, DOI 10.1007/s11060-011-0586-5; Fazeny-Dorner B, 2003, ANTI-CANCER DRUG, V14, P305, DOI 10.1097/00001813-200304000-00008; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Finelli P, 2007, CLIN GENET, V71, P195, DOI 10.1111/j.1399-0004.2007.00752.x; FU YX, 1993, GENETICS, V133, P693; Garnatz AS, 2014, DEV BIOL, V395, P50, DOI 10.1016/j.ydbio.2014.08.030; Hamm D, 2007, AM J HUM GENET, V81, P44, DOI 10.1086/518695; Hedrick P.W., 2011, GENETICS POPULATIONS; Hoene V, 2009, BRIT J CANCER, V101, P1481, DOI 10.1038/sj.bjc.6605276; Hou WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037531; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kabat GC, 2010, CANCER EPIDEM BIOMAR, V19, P2421, DOI 10.1158/1055-9965.EPI-10-0658; Key FM, 2014, CURR OPIN GENET DEV, V29, P45, DOI 10.1016/j.gde.2014.08.001; Koika V, 2012, EUR J ENDOCRINOL, V166, P695, DOI 10.1530/EJE-11-0894; Laitinen MPE, 2000, J CLIN ENDOCR METAB, V85, P3476, DOI 10.1210/jc.85.9.3476; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li G, 2012, CANCER EPIDEMIOL, V36, P525, DOI 10.1016/j.canep.2012.06.008; Li R, 2011, INT J CANCER, V128, P166, DOI 10.1002/ijc.25306; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu WD, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-76; Lopez C, 2010, GENE, V467, P1, DOI 10.1016/j.gene.2010.07.008; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Manuylov NL, 2007, ONCOGENE, V26, P5204, DOI 10.1038/sj.onc.1210333; Mei LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-564; Ng SK, 2010, PLOS ONE, V5, pA18, DOI 10.1371/journal.pone.0009547; Ng SK, 2006, GENE, V368, P110, DOI 10.1016/j.gene.2005.10.034; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Schulz S, 2010, J PERIODONTAL RES, V45, P396, DOI 10.1111/j.1600-0765.2009.01251.x; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Sipos L, 1998, Pathol Oncol Res, V4, P267; Song X, 2012, CARCINOGENESIS, V33, P1065, DOI 10.1093/carcin/bgs117; Sun C, 2011, HUM GENET, V130, P767, DOI 10.1007/s00439-011-1025-6; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; TAJIMA F, 1989, GENETICS, V123, P585; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Wang J, 2008, AM J HUM GENET, V83, P53, DOI 10.1016/j.ajhg.2008.06.010; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhao YJ, 2012, INT J CANCER, V131, P1569, DOI 10.1002/ijc.27417	50	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133003	10.1371/journal.pone.0133003	http://dx.doi.org/10.1371/journal.pone.0133003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207917	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000052
J	Bartels, S; Schipper, E; Kreipe, HH; Lehmann, U				Bartels, Stephan; Schipper, Elisa; Kreipe, Hans Heinrich; Lehmann, Ulrich			Comprehensive Molecular Profiling of Archival Bone Marrow Trephines Using a Commercially Available Leukemia Panel and Semiconductor-Based Targeted Resequencing	PLOS ONE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; SEQUENCE ARTIFACTS; MUTATIONS; ASXL1; DNA; APPLICABILITY; FEASIBILITY; DIAGNOSTICS; SPECIMENS; GENE	Comprehensive mutation profiling becomes more and more important in hematopathology complementing morphological and immunohistochemical evaluation of fixed, decalcified and embedded bone marrow biopsies for diagnostic, prognostic and also predictive purposes. However, the number and the size of relevant genes leave conventional Sanger sequencing impracticable in terms of costs, required input DNA, and turnaround time. Since most published protocols and commercially available reagents for targeted resequencing of gene panels are established and validated for the analysis of fresh bone marrow aspirate or peripheral blood it remains to be proven whether the available technology can be transferred to the analysis of archival trephines. Therefore, the performance of the recently available Ion AmpliSeq AML Research panel (LifeTechnologies) was evaluated for the analysis of fragmented DNA extracted from archival bone marrow trephines. Taking fresh aspirate as gold standard all clinically relevant mutations (n = 17) as well as 25 well-annotated SNPs could be identified reliably with high quality in the corresponding archival trephines of the training set (n = 10). Pre-treatment of the extracted DNA with Uracil-DNA-Glycosylase reduced the number of low level artificial sequence variants by more than 60%, vastly reducing time required for proper evaluation of the sequencing results. Subsequently, randomly picked FFPE samples (n = 41) were analyzed to evaluate sequencing performance under routine conditions. Thereby all known mutations (n = 43) could be verified and 36 additional mutations in genes not yet covered by the routine work-up (e.g., TET2, ASXL1, DNMT3A), demonstrating the feasibility of this approach and the gain of diagnostically relevant information. The dramatically reduced amount of input DNA, the increase in sensitivity as well as calculated cost-effectiveness, low hands on, and turn-around-time, necessary for the analysis of 237 amplicons strongly argue for replacing Sanger sequencing by this semiconductor-based targeted resequencing approach.	[Bartels, Stephan; Schipper, Elisa; Kreipe, Hans Heinrich; Lehmann, Ulrich] Hannover Med Sch, Inst Pathol, Hannover, Germany	Hannover Medical School	Lehmann, U (corresponding author), Hannover Med Sch, Inst Pathol, Hannover, Germany.	Lehmann.Ulrich@MH-Hannover.de		Bartels, Stephan/0000-0002-8903-2345	Deutsche Krebshilfe [1097154]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe (grant number 1097154, TP A,D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2013, J CLIN PATHOL, V66, P803, DOI 10.1136/jclinpath-2013-201549; Bernard V, 2014, INT J CLIN EXP PATHO, V7, P1667; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Do HD, 2012, ONCOTARGET, V3, P546; Endris V, 2013, J MOL DIAGN, V15, P765, DOI 10.1016/j.jmoldx.2013.06.002; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Hasemeier B, 2013, HAEMATOLOGICA, V98, pE115, DOI 10.3324/haematol.2013.091652; JACKSON DP, 1990, J CLIN PATHOL, V43, P499, DOI 10.1136/jcp.43.6.499; Kohlmann A, 2013, BRIT J HAEMATOL, V160, P736, DOI 10.1111/bjh.12194; Luthra R, 2014, HAEMATOLOGICA, V99, P465, DOI 10.3324/haematol.2013.093765; Malapelle U, 2015, J CLIN PATHOL, V68, P64, DOI 10.1136/jclinpath-2014-202691; Malcovati L, 2014, BLOOD, V124, P1513, DOI 10.1182/blood-2014-03-560227; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Patnaik MM, 2014, LEUKEMIA, V28, P2206, DOI 10.1038/leu.2014.125; Schnittger S, 2013, LEUKEMIA, V27, P82, DOI 10.1038/leu.2012.262; Thol F, 2011, J CLIN ONCOL, V29, P2499, DOI 10.1200/JCO.2010.33.4938; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23; Zhang LX, 2014, ONCOLOGIST, V19, P336, DOI 10.1634/theoncologist.2013-0180	20	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133930	10.1371/journal.pone.0133930	http://dx.doi.org/10.1371/journal.pone.0133930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222071	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800083
J	Guillotte, M; Juillerat, A; Igonet, S; Hessel, A; Petres, S; Crublet, E; Le Scanf, C; Lewit-Bentley, A; Bentley, GA; Vigan-Womas, I; Mercereau-Puijalon, O				Guillotte, Micheline; Juillerat, Alexandre; Igonet, Sebastien; Hessel, Audrey; Petres, Stephane; Crublet, Elodie; Le Scanf, Cecile; Lewit-Bentley, Anita; Bentley, Graham A.; Vigan-Womas, Ines; Mercereau-Puijalon, Odile			Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MALARIA; CHONDROITIN-SULFATE-A; PLACENTAL MALARIA; INHIBITORY ANTIBODIES; BLOCKING ANTIBODIES; VAR GENES; IN-VITRO; VAR2CSA; DOMAIN; VARIANT	Adhesion of Plasmodium falciparum-infected red blood cells (iRBC) to human erythrocytes (i.e. rosetting) is associated with severe malaria. Rosetting results from interactions between a subset of variant PfEMP1 (Plasmodium falciparum erythrocyte membrane protein 1) adhesins and specific erythrocyte receptors. Interfering with such interactions is considered a promising intervention against severe malaria. To evaluate the feasibility of a vaccine strategy targetting rosetting, we have used here the Palo Alto 89F5 VarO rosetting model. PfEMP1-VarO consists of five Duffy-Binding Like domains (DBL1-5) and one Cysteine-rich Interdomain Region (CIDR1). The binding domain has been mapped to DBL1 and the ABO blood group was identified as the erythrocyte receptor. Here, we study the immunogenicity of all six recombinant PfEMP1-VarO domains and the DBL1-CIDR1 Head domain in BALB/c and outbred OF1 mice. Five readouts of antibody responses are explored: ELISA titres on the recombinant antigen, VarO-iRBC immunoblot reactivity, VarO-iRBC surface-reactivity, capacity to disrupt VarO rosettes and the capacity to prevent VarO rosette formation. For three domains, we explore influence of the expression system on antigenicity and immunogenicity. We show that correctly folded PfEMP1 domains elicit high antibody titres and induce a homogeneous response in outbred and BALB/c mice after three injections. High levels of rosette-disrupting and rosette-preventing antibodies are induced by DBL1 and the Head domain. Reduced-alkylated or denatured proteins fail to induce surface-reacting and rosette-disrupting antibodies, indicating that surface epitopes are conformational. We also report limited cross-reactivity between some PfEMP1 VarO domains. These results highlight the high immunogenicity of the individual domains in outbred animals and provide a strong basis for a rational vaccination strategy targeting rosetting.	[Guillotte, Micheline; Hessel, Audrey; Vigan-Womas, Ines; Mercereau-Puijalon, Odile] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Guillotte, Micheline; Vigan-Womas, Ines; Mercereau-Puijalon, Odile] CNRS, Unite Rech Associee 2581, Paris, France; [Juillerat, Alexandre; Igonet, Sebastien; Hessel, Audrey; Lewit-Bentley, Anita; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, Paris, France; [Juillerat, Alexandre; Igonet, Sebastien; Lewit-Bentley, Anita; Bentley, Graham A.] CNRS, Unite Rech Associee 2185, Paris, France; [Petres, Stephane; Crublet, Elodie] Inst Pasteur, PFPR, Paris, France; [Le Scanf, Cecile] CHU Bordeaux, Grp Hosp Pellegrin, Bordeaux Biotheques Sante, Bordeaux, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Bordeaux	Mercereau-Puijalon, O (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, Paris, France.	odile.puijalon@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020; Ines, VIGAN-WOMAS/I-8604-2012; Ines, VIGAN-WOMAS/A-7846-2017	Ines, VIGAN-WOMAS/0000-0001-7848-9297; Ines, VIGAN-WOMAS/0000-0001-7848-9297; petres, stephane/0000-0002-4716-565X	French National Research Agency (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes) [ANR-07-MIME-021-0]; European Community's Seventh Framework Programme (FP7) [Evimalar 242095]	French National Research Agency (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes)(French National Research Agency (ANR)); European Community's Seventh Framework Programme (FP7)	This work was supported by the French National Research Agency (www.agence-nationale-recherche.fr/) (Agence Nationale de la Recherche, Programme Microbiologie, Immunologie et Maladies Emergentes, grant ANR-07-MIME-021-0, Project Rosettes, PIs OMP and GAB), which supported a fellowship to A. J. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No Evimalar 242095. OMP is a member of the Evimalar Network of Excellence (www.evimalar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Y, 2014, INFECT IMMUN, V82, P949, DOI 10.1128/IAI.01233-13; Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; Barragan A, 1999, EXP PARASITOL, V91, P133, DOI 10.1006/expr.1998.4349; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Blomqvist K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052679; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 2013, INFECT IMMUN, V81, P487, DOI 10.1128/IAI.01106-12; Gamain B, 2004, MOL MICROBIOL, V53, P445, DOI 10.1111/j.1365-2958.2004.04145.x; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Ghumra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016414; Guillotte M, 2013, BIOPROTOCOLS, V3; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Le Scanf C, 2008, MICROBES INFECT, V10, P447, DOI 10.1016/j.micinf.2007.12.012; leScanf C, 1997, EXP PARASITOL, V85, P135, DOI 10.1006/expr.1996.4121; Mercereau-Puijalon O, 2008, TRANSFUS CLIN BIOL, V15, P62, DOI 10.1016/j.tracli.2008.04.003; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Obiakor H, 2013, CLIN VACCINE IMMUNOL, V20, P433, DOI 10.1128/CVI.00638-12; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Pinto VV, 2012, VACCINE, V30, P572, DOI 10.1016/j.vaccine.2011.11.068; Pinto VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017942; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Saveria T, 2013, INFECT IMMUN, V81, P1031, DOI 10.1128/IAI.00978-12; Schofield L, 2007, IMMUNOL CELL BIOL, V85, P130, DOI 10.1038/sj.icb.7100040; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Smith JD, 2014, MOL BIOCHEM PARASIT, V195, P82, DOI 10.1016/j.molbiopara.2014.07.006; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2013, BIOPROTOCOLS, V3; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Vigan-Womas I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-267	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134292	10.1371/journal.pone.0134292	http://dx.doi.org/10.1371/journal.pone.0134292			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222304	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800125
J	Tasoff, J; Mee, MT; Wang, HH				Tasoff, Joshua; Mee, Michael T.; Wang, Harris H.			An Economic Framework of Microbial Trade	PLOS ONE			English	Article							ESCHERICHIA-COLI; COMPARATIVE-ADVANTAGE; EVOLUTION; DYNAMICS; COOPERATION; MODEL; POPULATIONS; MICROORGANISMS; COMMUNITIES; METABOLISM	A large fraction of microbial life on earth exists in complex communities where metabolic exchange is vital. Microbes trade essential resources to promote their own growth in an analogous way to countries that exchange goods in modern economic markets. Inspired by these similarities, we developed a framework based on general equilibrium theory (GET) from economics to predict the population dynamics of trading microbial communities. Our biotic GET (BGET) model provides an a priori theory of the growth benefits of microbial trade, yielding several novel insights relevant to understanding microbial ecology and engineering synthetic communities. We find that the economic concept of comparative advantage is a necessary condition for mutualistic trade. Our model suggests that microbial communities can grow faster when species are unable to produce essential resources that are obtained through trade, thereby promoting metabolic specialization and increased intercellular exchange. Furthermore, we find that species engaged in trade exhibit a fundamental tradeoff between growth rate and relative population abundance, and that different environments that put greater pressure on group selection versus individual selection will promote varying strategies along this growth-abundance spectrum. We experimentally tested this tradeoff using a synthetic consortium of Escherichia coli cells and found the results match the predictions of the model. This framework provides a foundation to study natural and engineered microbial communities through a new lens based on economic theories developed over the past century.	[Tasoff, Joshua] Claremont Grad Univ, Dept Econ, Claremont, CA 91711 USA; [Mee, Michael T.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Wang, Harris H.] Columbia Univ, Dept Syst Biol, New York, NY USA	Claremont Colleges; Claremont Graduate School; Boston University; Columbia University	Tasoff, J (corresponding author), Claremont Grad Univ, Dept Econ, Claremont, CA 91711 USA.	joshua.tasoff@cgu.edu; hw2429@columbia.edu			National Institute of Health Director's Early Independence Award [7DP5OD009172-03]; Canadian Institutes of Health Research; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009172] Funding Source: NIH RePORTER	National Institute of Health Director's Early Independence Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by HHW received a National Institute of Health Director's Early Independence Award (7DP5OD009172-03) [http://www.nih.gov/]. MTM received a Doctoral Study Award from the Canadian Institutes of Health Research [http://www.cihr-irsc.gc.ca/e/193.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein HC, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210017; Boucher DH, 1985, THE BIOLOGY OF MUTUA, px; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bull JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004115; Chiu HC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003695; Cremer J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00281; D'Souza G, 2014, EVOLUTION, V68, P2559, DOI 10.1111/evo.12468; Doebeli M, 2002, POPUL ECOL, V44, P59, DOI 10.1007/s101440200008; Doroshenko V, 2007, FEMS MICROBIOL LETT, V275, P312, DOI 10.1111/j.1574-6968.2007.00894.x; DYKHUIZEN D, 1978, EVOLUTION, V32, P125, DOI 10.1111/j.1558-5646.1978.tb01103.x; Enyeart PJ, 2015, J THEOR BIOL, V364, P326, DOI 10.1016/j.jtbi.2014.09.030; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Foster KR, 2006, J EVOLUTION BIOL, V19, P1283, DOI 10.1111/j.1420-9101.2005.01073.x; Gartner B, 2007, UNDERSTANDING AND US, pviii; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Hammerstein P, 2003, GENETIC AND CULTURAL, pxiv; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; Henson MA, 2014, IET SYST BIOL, V8, P214, DOI 10.1049/iet-syb.2013.0021; Hoeksema JD, 2003, P ROY SOC B-BIOL SCI, V270, P913, DOI 10.1098/rspb.2002.2312; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Mas-Colell A, 1995, MICROECONOMIC THEORY, pxvii; McInerney MJ, 2008, ANN NY ACAD SCI, V1125, P58, DOI 10.1196/annals.1419.005; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Mee MT, 2012, MOL BIOSYST, V8, P2470, DOI 10.1039/c2mb25133g; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Nandineni MR, 2004, J BACTERIOL, V186, P3539, DOI 10.1128/JB.186.11.3539-3546.2004; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pande S, 2014, ISME J, V8, P953, DOI 10.1038/ismej.2013.211; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739; Ricardo D, 1821, ON THE PRINCIPLES OF, pxii; Schwartz MW, 1998, ECOLOGY, V79, P1029, DOI 10.1890/0012-9658(1998)079[1029:SARTBM]2.0.CO;2; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Seth EC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00350; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Waite AJ, 2012, P NATL ACAD SCI USA, V109, P19079, DOI 10.1073/pnas.1210190109; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Werner GDA, 2014, P NATL ACAD SCI USA, V111, P1237, DOI 10.1073/pnas.1315980111; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Yu TC, 2012, CURR OPIN BIOTECH, V23, P791, DOI 10.1016/j.copbio.2012.01.006; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108297	45	25	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132907	10.1371/journal.pone.0132907	http://dx.doi.org/10.1371/journal.pone.0132907			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222307	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800035
J	Nguyen, TMD; Seigneurin, F; Froment, P; Combarnous, Y; Blesbois, E				Thi Mong Diep Nguyen; Seigneurin, Francois; Froment, Pascal; Combarnous, Yves; Blesbois, Elisabeth			The 5 '-AMP-Activated Protein Kinase (AMPK) Is Involved in the Augmentation of Antioxidant Defenses in Cryopreserved Chicken Sperm	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; SEMEN CRYOPRESERVATION; LIQUID-NITROGEN; FREE-RADICALS; FOWL SEMEN; METFORMIN; ACTIVATION	Semen cryopreservation is a unique tool for the management of animal genetic diversity. However, the freeze-thaw process causes biochemical and physical alterations which make difficult the restoration of sperm energy-dependent functions needed for fertilization. 5'-AMP activated protein kinase (AMPK) is a key sensor and regulator of intracellular energy metabolism. Mitochondria functions are known to be severely affected during sperm cryopreservation with deleterious oxidative and peroxidative effects leading to cell integrity and functions damages. The aim of this study was thus to examine the role of AMPK on the peroxidation/antioxidant enzymes defense system in frozen-thawed sperm and its consequences on sperm functions. Chicken semen was diluted in media supplemented with or without AMPK activators (AICAR or Metformin [MET]) or inhibitor (Compound C [CC]) and then cryopreserved. AMPK alpha phosphorylation, antioxidant enzymes activities, mitochondrial potential, ATP, citrate, viability, acrosome reaction ability (AR) and various motility parameters were negatively affected by the freeze-thaw process while reactive oxygen species (ROS) production, lipid peroxidation (LPO) and lactate concentration were dramatically increased. AICAR partially restored superoxide dismutase (SOD), Glutathione Peroxidase (GPx) and Glutathione Reductase (GR), increased ATP, citrate, and lactate concentration and subsequently decreased the ROS and LPO (malondialdehyde) in frozen-thawed semen. Motility parameters were increased (i.e., +23% for motility, +34% for rapid sperm) as well as AR (+100%). MET had similar effects as AICAR except that catalase activity was restored and that ATP and mitochondrial potential were further decreased. CC showed effects opposite to AICAR on SOD, ROS, LPO and AR and motility parameters. Taken together, our results strongly suggest that, upon freeze-thaw process, AMPK stimulated intracellular anti-oxidative defense enzymes through ATP regulation, thus reducing ROS and lipid peroxidation, and consequently partially restoring several essential sperm functions and leading to a better quality of cryopreserved sperm.	[Thi Mong Diep Nguyen; Froment, Pascal; Combarnous, Yves; Blesbois, Elisabeth] INRA CNRS, Unite Mixte Rech Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Thi Mong Diep Nguyen] Univ Tours, Tours, France; [Seigneurin, Francois] SYSAAF, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Universite de Tours	Blesbois, E (corresponding author), INRA CNRS, Unite Mixte Rech Physiol Reprod & Comportements, F-37380 Nouzilly, France.	Elisabeth.Blesbois@tours.inra.fr	Nguyen, Thi Mong Diep/AAB-3939-2020; Combarnous, Yves/K-4161-2019	Nguyen, Thi Mong Diep/0000-0001-6534-9041; Combarnous, Yves/0000-0002-0574-2025	French Agence Nationale de la Recherche; French National Science Infrastructure CRB-Anim; Vietnam Education Ministry; non-profit SYSAAF	French Agence Nationale de la Recherche(French National Research Agency (ANR)); French National Science Infrastructure CRB-Anim; Vietnam Education Ministry; non-profit SYSAAF	This study was performed with the financial support of the French Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/), and the French National Science Infrastructure CRB-Anim. Thi Mong Diep Nguyen is a PhD student supported by a grant from the Vietnam Education Ministry (http://www.moet.gov.vn/). Francois Seigneurin received funding in the form of salary from the non-profit SYSAAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1996, FREE RADICAL BIO MED, V21, P495, DOI 10.1016/0891-5849(96)00119-0; Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Bertoldo MJ, 2014, CRYOBIOLOGY, V68, P262, DOI 10.1016/j.cryobiol.2014.02.006; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; Blesbois E, 2007, ANIMAL, V1, P1472, DOI 10.1017/S175173110700081X; Blesbois E, 2008, THERIOGENOLOGY, V69, P252, DOI 10.1016/j.theriogenology.2007.09.019; Blesbois E., 2003, PHOSPHOLIPIDS MALE F, P73; Blesbois E, 2012, J POULT SCI, V49, P141, DOI 10.2141/jpsa.011120; Blesbois E, 2011, AVIAN BIOL RES, V4, P52, DOI 10.3184/175815511X13069413108523; Buldak L, 2014, PHARMACOL REP, V66, P418, DOI 10.1016/j.pharep.2013.11.008; Burk RF, 1976, BIOCHEM BIOPH RES CO, V425, P503; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chalah T, 1998, THERIOGENOLOGY, V50, P487, DOI 10.1016/S0093-691X(98)00155-1; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Cordova A, 2014, CRYOBIOLOGY, V69, P473, DOI 10.1016/j.cryobiol.2014.10.008; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dai J, 2014, CHEM-BIOL INTERACT, V216, P34, DOI 10.1016/j.cbi.2014.03.013; Dandekar S P, 2002, J Postgrad Med, V48, P186; DELAMIRANDE E, 1993, INT J ANDROL, V16, P21; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Esfandiari N, 2003, J ANDROL, V24, P862; Esteghamati A, 2013, CLIN NUTR, V32, P179, DOI 10.1016/j.clnu.2012.08.006; Froman DP, 2011, J ANIM SCI, V89, P1330, DOI 10.2527/jas.2010-3367; Gadea J, 2004, THERIOGENOLOGY, V62, P690, DOI 10.1016/j.theriogenology.2003.11.013; Gaskin FS, 2009, MICROCIRCULATION, V16, P167, DOI 10.1080/10739680802355897; Goth L, 1986, CLINICACHIMICAACTA, V196, P143; GRIVEAU JF, 1995, J REPROD FERTIL, V103, P17; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; Horrocks AJ, 2000, BIOCHEM BIOPH RES CO, V278, P84, DOI 10.1006/bbrc.2000.3766; Hu L, 2014, INT J CLIN EXP PATHO, V7, P7378; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; LAKE PE, 1978, BRIT POULTRY SCI, V19, P187, DOI 10.1080/00071667808416462; LAKE PE, 1981, BRIT POULTRY SCI, V22, P71, DOI 10.1080/00071688108447865; Lake PE, 1968, INTREPRODANIMINSEMAR, V2, P1633; LASSO JL, 1994, J ANDROL, V15, P255; Lemoine M, 2008, REPRODUCTION, V136, P391, DOI 10.1530/REP-08-0094; Lemoine M, 2009, BIOL REPROD, V81, P657, DOI 10.1095/biolreprod.108.072660; Long JA, 2006, POULTRY SCI, V85, P232, DOI 10.1093/ps/85.2.232; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Martin-Hidalgo D, 2013, THERIOGENOLOGY, V80, P285, DOI 10.1016/j.theriogenology.2013.02.015; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Moce E, 2010, ANIM REPROD SCI, V122, P359, DOI 10.1016/j.anireprosci.2010.10.010; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ouslimani N, 2005, METABOLISM, V54, P829, DOI 10.1016/j.metabol.2005.01.029; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Partyka A, 2012, THERIOGENOLOGY, V77, P1497, DOI 10.1016/j.theriogenology.2011.11.006; Partyka A, 2010, THERIOGENOLOGY, V74, P1019, DOI 10.1016/j.theriogenology.2010.04.032; Peron A, 2006, POULTRY SCI, V85, P462, DOI 10.1093/ps/85.3.462; PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109; Piwkowska A, 2010, BIOCHEM BIOPH RES CO, V393, P268, DOI 10.1016/j.bbrc.2010.01.119; Richardson MC, 2009, J CLIN ENDOCR METAB, V94, P670, DOI 10.1210/jc.2008-2025; Rubin LJ, 2005, J APPL PHYSIOL, V98, P296, DOI 10.1152/japplphysiol.00075.2004; SEIGNEURIN F, 1995, THERIOGENOLOGY, V43, P1351, DOI 10.1016/0093-691X(95)00119-S; SEXTON TJ, 1977, POULTRY SCI, V56, P1443, DOI 10.3382/ps.0561443; Surai PF, 1998, COMP BIOCHEM PHYS B, V120, P527, DOI 10.1016/S0305-0491(98)10039-1; Surai PF, 1998, POULT AVIAN BIOL REV, V9, P11; Surai PF, 2001, ASIAN AUSTRAL J ANIM, V14, P1024, DOI 10.5713/ajas.2001.1024; Tchir J, 2010, CRYOBIOLOGY, V61, P100, DOI 10.1016/j.cryobiol.2010.05.007; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Wang XR, 2011, AM J PHYSIOL-ENDOC M, V300, pE1135, DOI 10.1152/ajpendo.00001.2011; Weber G, 1966, Adv Enzyme Regul, V4, P59, DOI 10.1016/0065-2571(66)90007-0; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017	72	57	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134420	10.1371/journal.pone.0134420	http://dx.doi.org/10.1371/journal.pone.0134420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222070	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800143
J	Gerzova, L; Babak, V; Sedlar, K; Faldynova, M; Videnska, P; Cejkova, D; Jensen, AN; Denis, M; Kerouanton, A; Ricci, A; Cibin, V; Osterberg, J; Rychlik, I				Gerzova, Lenka; Babak, Vladimir; Sedlar, Karel; Faldynova, Marcela; Videnska, Petra; Cejkova, Darina; Jensen, Annette Nygaard; Denis, Martine; Kerouanton, Annaelle; Ricci, Antonia; Cibin, Veronica; Osterberg, Julia; Rychlik, Ivan			Characterization of Antibiotic Resistance Gene Abundance and Microbiota Composition in Feces of Organic and Conventional Pigs from Four EU Countries	PLOS ONE			English	Article							REAL-TIME PCR; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; TETRACYCLINE RESISTANCE; EUROPEAN COUNTRIES; FOOD ANIMALS; PREVALENCE; POULTRY; FARMS; SALMONELLA	One of the recent trends in animal production is the revival of interest in organic farming. The increased consumer interest in organic animal farming is mainly due to concerns about animal welfare and the use of antibiotics in conventional farming. On the other hand, providing animals with a more natural lifestyle implies their increased exposure to environmental sources of different microorganisms including pathogens. To address these concerns, we determined the abundance of antibiotic resistance and diversity within fecal microbiota in pigs kept under conventional and organic farming systems in Sweden, Denmark, France and Italy. The abundance of sul1, sul2, strA, tet(A), tet(B) and cat antibiotic resistance genes was determined in 468 samples by real-time PCR and the fecal microbiota diversity was characterized in 48 selected samples by pyrosequencing of V3/V4 regions of 16S rRNA. Contrary to our expectations, there were no extensive differences between the abundance of tested antibiotic resistance genes in microbiota originating from organic or conventionally housed pigs within individual countries. There were also no differences in the microbiota composition of organic and conventional pigs. The only significant difference was the difference in the abundance of antibiotic resistance genes in the samples from different countries. Fecal microbiota in the samples originating from southern European countries (Italy, France) exhibited significantly higher antibiotic resistance gene abundance than those from northern parts of Europe (Denmark, Sweden). Therefore, the geographical location of the herd influenced the antibiotic resistance in the fecal microbiota more than farm's status as organic or conventional.	[Gerzova, Lenka; Babak, Vladimir; Faldynova, Marcela; Videnska, Petra; Cejkova, Darina; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic; [Sedlar, Karel] Brno Univ Technol, CS-61090 Brno, Czech Republic; [Jensen, Annette Nygaard] Tech Univ Denmark, Natl Food Inst, Copenhagen, Denmark; [Denis, Martine; Kerouanton, Annaelle] Anses, Hyg & Qual Poultry & Pig Prod Unit, Ploufragan, France; [Ricci, Antonia; Cibin, Veronica] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy; [Osterberg, Julia] Natl Vet Inst SVA, Uppsala, Sweden	Czech Veterinary Research Institute; Brno University of Technology; Technical University of Denmark; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); IZS delle Venezie; National Veterinary Institute SVA	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	Cejkova, Darina/AAA-5820-2022; Sedlar, Karel/K-1120-2014; , Ivan/GPS-9674-2022; Ricci, Antonia/AAA-9473-2019	Cejkova, Darina/0000-0002-6989-6330; Sedlar, Karel/0000-0002-8269-4020; , Ivan/0000-0001-7995-6483; Ricci, Antonia/0000-0002-4774-9655; Jensen, Annette Nygaard/0000-0001-9681-7258	Ministry of Agriculture of the Czech Republic [CZ1.05/2.1.00/01.0006-ED 0006/01/01, MZE0002716202]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work has been supported by the SafeOrganic project, AdmireVet CZ1.05/2.1.00/01.0006-ED 0006/01/01 project and MZE0002716202 project from the Ministry of Agriculture of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez E, 2012, J FOOD PROTECT, V75, P847, DOI 10.4315/0362-028X.JFP-11-182; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Christensen Ellen Gerd, 2014, BMC Res Notes, V7, P660, DOI 10.1186/1756-0500-7-660; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; Dransfield E, 2005, MEAT SCI, V69, P61, DOI 10.1016/j.meatsci.2004.06.006; European Medicines Agency, 2014, EMA3339212014; Faldynova M, 2013, VET MED-CZECH, V58, P298, DOI 10.17221/6865-VETMED; Gerzova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103865; Grave K, 2014, J ANTIMICROB CHEMOTH, V69, P2284, DOI 10.1093/jac/dku106; Grsboll K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100458; Hellweger FL, 2013, FEMS MICROBIOL ECOL, V83, P622, DOI 10.1111/1574-6941.12019; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Miranda JN, 2008, J FOOD PROTECT, V71, P2537, DOI 10.4315/0362-028X-71.12.2537; Mollenkopf DF, 2014, FOODBORNE PATHOG DIS, V11, P920, DOI 10.1089/fpd.2014.1808; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Ngapo TM, 2004, MEAT SCI, V66, P125, DOI 10.1016/S0309-1740(03)00076-7; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Roesch M, 2006, J DAIRY SCI, V89, P989, DOI 10.3168/jds.S0022-0302(06)72164-6; Sapkota AR, 2014, SCI TOTAL ENVIRON, V476, P387, DOI 10.1016/j.scitotenv.2013.12.005; Sato K, 2004, APPL ENVIRON MICROB, V70, P1442, DOI 10.1128/AEM.70.3.1442-1447.2004; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Soonthornchaikul N, 2006, INT J ANTIMICROB AG, V27, P125, DOI 10.1016/j.ijantimicag.2005.09.020; Szmolka A, 2012, VET MICROBIOL, V156, P110, DOI 10.1016/j.vetmic.2011.09.030; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Videnska P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115142; Videnska P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110076; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005; Zheng DM, 2007, LIVEST SCI, V106, P189, DOI 10.1016/j.livsci.2006.08.003; Zhou XL, 2012, J ANIM SCI, V90, P37, DOI 10.2527/jas.50269	35	31	31	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132892	10.1371/journal.pone.0132892	http://dx.doi.org/10.1371/journal.pone.0132892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218075	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900012
J	Messerli, P; Bader, C; Hett, C; Epprecht, M; Heinimann, A				Messerli, Peter; Bader, Christoph; Hett, Cornelia; Epprecht, Michael; Heinimann, Andreas			Towards a Spatial Understanding of Trade-Offs in Sustainable Development: A Meso-Scale Analysis of the Nexus between Land Use, Poverty, and Environment in the Lao PDR	PLOS ONE			English	Article							SYSTEM SCIENCE; LIVELIHOODS; CHALLENGES; FORESTS; PEOPLE; POLICY	In land systems, equitably managing trade-offs between planetary boundaries and human development needs represents a grand challenge in sustainability oriented initiatives. Informing such initiatives requires knowledge about the nexus between land use, poverty, and environment. This paper presents results from Lao PDR, where we combined nationwide spatial data on land use types and the environmental state of landscapes with village-level poverty indicators. Our analysis reveals two general but contrasting trends. First, landscapes with paddy or permanent agriculture allow a greater number of people to live in less poverty but come at the price of a decrease in natural vegetation cover. Second, people practising extensive swidden agriculture and living in intact environments are often better off than people in degraded paddy or permanent agriculture. As poverty rates within different landscape types vary more than between landscape types, we cannot stipulate a land use-poverty-environment nexus. However, the distinct spatial patterns or configurations of these rates point to other important factors at play. Drawing on ethnicity as a proximate factor for endogenous development potentials and accessibility as a proximate factor for external influences, we further explore these linkages. Ethnicity is strongly related to poverty in all land use types almost independently of accessibility, implying that social distance outweighs geographic or physical distance. In turn, accessibility, almost a precondition for poverty alleviation, is mainly beneficial to ethnic majority groups and people living in paddy or permanent agriculture. These groups are able to translate improved accessibility into poverty alleviation. Our results show that the concurrence of external influences with local-highly contextual-development potentials is key to shaping outcomes of the land use-poverty- environment nexus. By addressing such leverage points, these findings help guide more effective development interventions. At the same time, they point to the need in land change science to better integrate the understanding of place-based land indicators with process-based drivers of land use change.	[Messerli, Peter; Bader, Christoph; Heinimann, Andreas] Univ Bern, Ctr Dev & Environm, Bern, Switzerland; [Bader, Christoph; Heinimann, Andreas] Univ Bern, Inst Geog, Bern, Switzerland; [Hett, Cornelia; Epprecht, Michael] Ctr Dev & Environm, Lao Country Off, Viangchan, Laos	University of Bern; University of Bern	Messerli, P (corresponding author), Univ Bern, Ctr Dev & Environm, Bern, Switzerland.	peter.messerli@cde.unibe.ch	Bader, Christoph/AAG-8312-2020	Bader, Christoph/0000-0002-8991-353X; Messerli, Peter/0000-0002-0286-6348; Heinimann, Andreas/0000-0001-8905-8169	Centre for Development and Environment (CDE); Institute of Geography, University of Bern, Switzerland; National Centre of Competence in Research (NCCR) North-South, Switzerland; Swiss Programme for Research on Global Issues for Development (r4d programme) - Swiss National Science Foundation (SNSF); Swiss Agency for Development and Cooperation (SDC) [400440 152167]	Centre for Development and Environment (CDE); Institute of Geography, University of Bern, Switzerland; National Centre of Competence in Research (NCCR) North-South, Switzerland; Swiss Programme for Research on Global Issues for Development (r4d programme) - Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Agency for Development and Cooperation (SDC)	This research was supported by the Centre for Development and Environment (CDE), and the Institute of Geography, University of Bern, Switzerland, the National Centre of Competence in Research (NCCR) North-South, Switzerland, as well as the Swiss Programme for Research on Global Issues for Development (r4d programme) supported by the Swiss National Science Foundation (SNSF) and Swiss Agency for Development and Cooperation (SDC), grant number 400440 152167.	[Anonymous], 2012, OXFAM POLICY PRACTIC; Baird IG, 2011, NEW PROPOS, V5, P10; Castella J-C, 2012, AGRARIAN TRANSITION; Castella JC, 2013, HUM ECOL, V41, P63, DOI 10.1007/s10745-012-9538-8; Cleaver K. M., 1994, Reversing the spiral: the population, agriculture, and environment nexus in sub-Saharan Africa.; Cumming GS, 2013, LANDSCAPE ECOL, V28, P1139, DOI 10.1007/s10980-012-9725-4; Dasgupta S, 2005, WORLD DEV, V33, P617, DOI 10.1016/j.worlddev.2004.10.003; de Blecourt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069357; De Koninck R., 2004, LABOUR CAPITAL SOC, V37, P285; Ducourtieux O, 2005, DEV CHANGE, V36, P499, DOI 10.1111/j.0012-155X.2005.00421.x; Dyer GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052478; Epprecht M, 2010, GLOBAL CHANGE SUSTAI, P371; Evans G, 1999, LAOS CULTURE SOC; Folke C, 2007, ECOL RES, V22, P14, DOI 10.1007/s11284-006-0074-0; Future Earth, 2013, FUT EARTH IN DES REP; Government of Lao PDR, 2005, REP ASS FOR COV LAND; Government of Laos PDR, 2006, RES POP HOUS CENS 20; Gray LC, 2005, GEOGR J, V171, P9, DOI 10.1111/j.1475-4959.2005.00146.x; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Hall D., 2011, POWERS EXCLUSION; Heinimann A, 2006, THESIS U BERN BERN; Heinimann A, 2013, HUM ECOL, V41, P51, DOI 10.1007/s10745-013-9564-1; Hett C, 2012, MT RES DEV, V32, P390, DOI 10.1659/MRD-JOURNAL-D-12-00065.1; Hett C, 2012, APPL GEOGR, V32, P608, DOI 10.1016/j.apgeog.2011.07.011; Kaplinsky R., 2022, SUSTAINABLE FUTURES; Kerns T., 2008, ANAL HOSPITALISED MO; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Leach M, 1999, WORLD DEV, V27, P225, DOI 10.1016/S0305-750X(98)00141-7; Lestrelin G, 2012, J CONTEMP ASIA, V42, P581, DOI 10.1080/00472336.2012.706745; Lufumpa CL, 2005, AFR DEV REV, V17, P366, DOI 10.1111/j.1017-6772.2006.00120.x; Magliocca NR, 2015, REG ENVIRON CHANGE, V15, P211, DOI 10.1007/s10113-014-0626-8; Magliocca NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086179; McConnell WJ, 2000, LUCC REPORT SERIES, V5; Messerli P, 2013, CURR OPIN ENV SUST, V5, P528, DOI 10.1016/j.cosust.2013.03.004; Messerli P, 2009, HUM ECOL, V37, P291, DOI 10.1007/s10745-009-9238-1; Messerli Peter, 2008, GEOGRAPHY POVERTY IN; Michaud J, 2009, ASIAN ETHN, V10, P25, DOI 10.1080/14631360802628442; Nelson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014327; Organisation for Economic Cooperation and Development OECD, 2011, OECD ENV OUTL 2050 C, DOI DOI 10.1787/9789264122246-EN; Ostrom E, 2006, P NATL ACAD SCI USA, V103, P19224, DOI 10.1073/pnas.0607962103; Reardon T, 1997, POVERTY ENV LINKS RU; Reenberg A, 2009, J LAND USE SCI, V4, P1, DOI 10.1080/17474230802645618; Ribot JC, 2003, RURAL SOCIOL, V68, P153, DOI 10.1111/j.1549-0831.2003.tb00133.x; Rigg J, 2006, WORLD DEV, V34, P180, DOI 10.1016/j.worlddev.2005.07.015; Rigg J., 2005, LIVING TRANSITION LA, DOI [10.4324/9780203002032, DOI 10.4324/9780203002032]; Rindfuss RR, 2008, J LAND USE SCI, V3, P1, DOI 10.1080/17474230802047955; Rindfuss RR, 2004, P NATL ACAD SCI USA, V101, P13976, DOI 10.1073/pnas.0401545101; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sch?nweger O., 2012, CONCESSIONS LEASES L; Scherr SJ, 2000, FOOD POLICY, V25, P479, DOI 10.1016/S0306-9192(00)00022-1; Sneddon CS, 2000, PROG HUM GEOG, V24, P521, DOI 10.1191/030913200100189076; Thanichanon P, 2013, SOC NATUR RESOUR, V26, P1283, DOI 10.1080/08941920.2013.788429; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; Turner BL, 2010, P NATL ACAD SCI USA, V107, P21963, DOI 10.1073/pnas.1013972108; Verburg PH, 2013, CURR OPIN ENV SUST, V5, P433, DOI 10.1016/j.cosust.2013.08.001; Woodcock CE, 2004, TRENDS LAND COVER MA; World Bank, 2014, MAN RISKS MACR STAB; World Wildlife Fund (WWF), 2012, LIV PLAN REP 2012 BI; Young O, 2006, ECOL SOC, V11	59	20	22	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133418	10.1371/journal.pone.0133418	http://dx.doi.org/10.1371/journal.pone.0133418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218646	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900030
J	Kidd, AR; Muniz-Medina, V; Der, CJ; Cox, AD; Reiner, DJ				Kidd, Ambrose R., III; Muniz-Medina, Vanessa; Der, Channing J.; Cox, Adrienne D.; Reiner, David J.			The C-elegans Chp/Wrch Ortholog CHW-1 Contributes to LIN-18/Ryk and LIN-17/Frizzled Signaling in Cell Polarity	PLOS ONE			English	Article							FAMILY SMALL GTPASE; CAENORHABDITIS-ELEGANS; TISSUE POLARITY; RHO-GTPASES; VULVAL DEVELOPMENT; PLANAR POLARITY; WNT; PATHWAYS; MIGRATION; WRCH-1	Wnt signaling controls various aspects of developmental and cell biology, as well as contributing to certain cancers. Expression of the human Rho family small GTPase Wrch/RhoU is regulated by Wnt signaling, and Wrch and its paralog Chp/RhoV are both implicated in oncogenic transformation and regulation of cytoskeletal dynamics. We performed developmental genetic analysis of the single Caenorhabditis elegans ortholog of Chp and Wrch, CHW-1. Using a transgenic assay of the distal tip cell migration, we found that wild-type CHW-1 is likely to be partially constitutively active and that we can alter ectopic CHW-1-dependent migration phenotypes with mutations predicted to increase or decrease intrinsic GTP hydrolysis rate. The vulval P7.p polarity decision balances multiple antagonistic Wnt signals, and also uses different types of Wnt signaling. Previously described cooperative Wnt receptors LIN-17/Frizzled and LIN-18/Ryk orient P7.p posteriorly, with LIN-17/Fz contributing approximately two-thirds of polarizing activity. CHW-1 deletion appears to equalize the contributions of these two receptors. We hypothesize that CHW-1 increases LIN-17/Fz activity at the expense of LIN-18/Ryk, thus making the contribution of these signals unequal. For P7.p to polarize correctly and form a proper vulva, LIN-17/Fz and LIN-18/Ryk antagonize other Wnt transmembrane systems VANG-1/VanGogh and CAM-1/Ror. Our genetic data suggest that LIN-17/Fz represses both VANG-1/VanGogh and CAM-1/Ror, while LIN-18/Ryk represses only VANG-1. These data expand our knowledge of a sophisticated signaling network to control P7.p polarity, and suggests that CHW-1 can alter ligand gradients or receptor priorities in the system.	[Kidd, Ambrose R., III; Muniz-Medina, Vanessa; Der, Channing J.; Cox, Adrienne D.; Reiner, David J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Der, Channing J.; Cox, Adrienne D.; Reiner, David J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA; [Reiner, David J.] Texas A&M Hlth Sci Ctr & Coll Med, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Reiner, DJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	dreiner@ibt.tamhsc.edu		Cox, Adrienne D./0000-0002-4901-2454; Der, Channing/0000-0002-7751-2747; Reiner, David/0000-0002-0344-7161	NRSA postdoctoral fellowship [5F32CA138142]; National Institutes of Health [R01 GM085309]; NATIONAL CANCER INSTITUTE [F32CA138142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085309] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NRSA postdoctoral fellowship 5F32CA138142 to A. R. K. and National Institutes of Health grant R01 GM085309 (D. J. R.). http://www.nigms.nih.gov/, http://grants.nih.gov/training/nrsa.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley BD, 2014, DEV NEUROBIOL, V74, P781, DOI 10.1002/dneu.22146; Alan JK, 2010, MOL CELL BIOL, V30, P4324, DOI 10.1128/MCB.01646-09; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Berzat AC, 2005, J BIOL CHEM, V280, P33055, DOI 10.1074/jbc.M507362200; Bhavsar PJ, 2013, ONCOGENE, V32, P198, DOI 10.1038/onc.2012.42; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brady DC, 2009, MOL CELL BIOL, V29, P1035, DOI 10.1128/MCB.00336-08; BRENNER S, 1974, GENETICS, V77, P71; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Fujisawa K, 2007, SCIENCE, V317, P1934, DOI 10.1126/science.1144874; GAO DL, 1995, P NATL ACAD SCI USA, V92, P9839, DOI 10.1073/pnas.92.21.9839; Gleason JE, 2006, DEV BIOL, V298, P442, DOI 10.1016/j.ydbio.2006.06.050; Goh KY, 2012, P NATL ACAD SCI USA, V109, P15853, DOI 10.1073/pnas.1120795109; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Hoffmann M, 2010, DEV BIOL, V339, P268, DOI 10.1016/j.ydbio.2009.12.002; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; MacNeil LT, 2009, NAT NEUROSCI, V12, P150, DOI 10.1038/nn.2256; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Minor PJ, 2013, DEVELOPMENT, V140, P3882, DOI 10.1242/dev.095687; Modzelewska K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001465; Myers TR, 2007, P NATL ACAD SCI USA, V104, P20368, DOI 10.1073/pnas.0709989104; Najarro EH, 2013, DEV BIOL, V377, P224, DOI 10.1016/j.ydbio.2013.01.014; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Nishiwaki K, 1999, GENETICS, V152, P985; Peters EC, 2013, G3-GENES GENOM GENET, V3, P181, DOI 10.1534/g3.112.004416; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Schiavone D, 2009, BIOCHEM J, V421, P283, DOI 10.1042/BJ20090061; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shutes A, 2004, CURR BIOL, V14, P2052, DOI 10.1016/j.cub.2004.11.011; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Tay HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010125; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Zand TP, 2011, DEV CELL, V20, P84, DOI 10.1016/j.devcel.2010.12.004	57	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133226	10.1371/journal.pone.0133226	http://dx.doi.org/10.1371/journal.pone.0133226			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208319	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000067
J	Wang, XQ; Wei, DP; Ma, YB; McLaughlin, MJ				Wang, Xiaoqing; Wei, Dongpu; Ma, Yibing; McLaughlin, Mike J.			Derivation of Soil Ecological Criteria for Copper in Chinese Soils	PLOS ONE			English	Article							SPECIES SENSITIVITY DISTRIBUTIONS; RISK-ASSESSMENT; TOXICITY; NICKEL; PLANTS; METALS; ZINC; BIOAVAILABILITY; ACCUMULATION; WHEAT	Considerable information on copper (Cu) ecotoxicity as affected by biological species and abiotic properties of soils has been collected from the last decade in the present study. The information on bioavailability/ecotoxicity, species sensitivity and differences in laboratory and field ecotoxicity of Cu in different soils was collated and integrated to derive soil ecological criteria for Cu in Chinese soils, which were expressed as predicted no effect concentrations (PNEC). First, all ecotoxicity data of Cu from bioassays based on Chinese soils were collected and screened with given criteria to compile a database. Second, the compiled data were corrected with leaching and aging factors to minimize the differences between laboratory and field conditions. Before Cu ecotoxicity data were entered into a species sensitivity distribution (SSD), they were normalized with Cu ecotoxicity predictive models to modify the effects of soil properties on Cu ecotoxicity. The PNEC value was set equal to the hazardous concentration for x% of the species (HCx), which could be calculated from the SSD curves, without an additional assessment factor. Finally, predictive models for HCx based on soil properties were developed. The soil properties had a significant effect on the magnitude of HCx, with HC5 varying from 13.1 mg/kg in acidic soils to 51.9 mg/kg in alkaline non-calcareous soils. The two-factor predictive models based on soil pH and cation exchange capacity could predict HCx with determination coefficients (R-2) of 0.82-0.91. The three-factor predictive models - that took into account the effect of soil organic carbon were more accurate than two-factor models, with R-2 of 0.85-0.99. The predictive models obtained here could be used to calculate soil-specific criteria. All results obtained here could provide a scientific basis for revision of current Chinese soil environmental quality standards, and the approach adopted in this study could be used as a pragmatic framework for developing soil ecological criteria for other trace elements in soils.	[Wang, Xiaoqing] Luoyang Inst Sci & Technol, Dept Environm Engn & Chem, Luoyang, Peoples R China; [Wang, Xiaoqing; Wei, Dongpu; Ma, Yibing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China; [Ma, Yibing] Univ Jinan, Sch Resources & Environm, Jinan, Peoples R China; [McLaughlin, Mike J.] CSIRO Land & Water, Ctr Environm Contaminant Res, Adelaide, SA, Australia; [McLaughlin, Mike J.] Univ Adelaide, Sch Agr Food & Wine, Waite Res Inst, Soil Sci, Adelaide, SA, Australia	Luoyang Institute of Science & Technology; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; University of Jinan; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide	Ma, YB (corresponding author), 12 Southern St Zhongguancun, Beijing 100081, Peoples R China.	mayibing@caas.cn	McLaughlin, Mike J/F-2931-2010; McLaughlin, Michael J/N-5888-2017	McLaughlin, Mike J/0000-0001-6796-4144; McLaughlin, Michael J/0000-0001-6796-4144; Ma, Yibing/0000-0002-9340-8181	Special Fund for Environmental Protection Scientific Research in the Public Interest [201509032]; International Copper Association; Rio Tinto Pty Ltd	Special Fund for Environmental Protection Scientific Research in the Public Interest; International Copper Association; Rio Tinto Pty Ltd	The authors are thankful for the financial support provided by the Special Fund for Environmental Protection Scientific Research in the Public Interest (Project no. 201509032), the International Copper Association and Rio Tinto Pty Ltd. There are no patents, products in development or marketed products to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva AK, 2000, SOIL SCI SOC AM J, V64, P955, DOI 10.2136/sssaj2000.643955x; [Anonymous], [No title captured]; BCMOE (British Columbia Ministry of Environment), 2005, BACKGROUND SOIL QUAL, V17; Bongers M, 2004, ENVIRON TOXICOL CHEM, V23, P195, DOI 10.1897/02-508; Chang A. C., 2000, California Agriculture, V54, P49, DOI 10.3733/ca.v054n02p49; Conesa HM, 2007, ENVIRON POLLUT, V145, P700, DOI 10.1016/j.envpol.2006.06.002; Crommentuijn T, 2000, ENVIRON TOXICOL CHEM, V19, P1692, DOI 10.1002/etc.5620190628; CSIRO (Australia's Commonwealth Scientific and Industrial Research Organisation), 2008, FLEX APPR SPEC PROT; Daoust CM, 2006, J ENVIRON QUAL, V35, P558, DOI 10.2134/jeq2005.0107; Department for Environment Food and Rural Affairs and the Environment Agency, 2002, CONT LAND EXP ASS CL; Domene X, 2008, ENVIRON POLLUT, V155, P227, DOI 10.1016/j.envpol.2007.12.001; Duboudin C, 2004, ENVIRON TOXICOL CHEM, V23, P1774, DOI [10.1897/1551-5028(2004)023&lt;1774:ASSDE&gt;2.0.CO;2, 10.1002/etc.5620230723]; European Chemicals Agency, 2008, GUID INF REQ CHEM SA; European Union (EU), 2006, DRAFT RISK ASS REP N; Goldhaber SB, 2003, REGUL TOXICOL PHARM, V38, P232, DOI 10.1016/S0273-2300(02)00020-X; Grist EPM, 2006, ENVIRON SCI TECHNOL, V40, P395, DOI 10.1021/es050871e; Guo XY, 2010, PLANT SOIL, V333, P365, DOI 10.1007/s11104-010-0351-0; HAANSTRA L, 1985, PLANT SOIL, V84, P293, DOI 10.1007/BF02143194; Huang J., 2012, THESIS CHINESE ACAD; Huang Jin-sun, 2012, Huanjing Kexue, V33, P1369; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Kabata P.A, 2001, TRACE ELEMENTS SOILS, V3rd; KOOIJMAN SALM, 1987, WATER RES, V21, P269, DOI 10.1016/0043-1354(87)90205-3; Li B, 2010, THESIS CHINESE ACAD; Li B, 2013, ENVIRON TOXICOL CHEM, V32, P2372, DOI 10.1002/etc.2312; Li B, 2010, ENVIRON TOXICOL CHEM, V29, P835, DOI 10.1002/etc.108; Li X., 2009, THESIS CHINESE ACAD; Li XF, 2010, ENVIRON TOXICOL CHEM, V29, P294, DOI 10.1002/etc.51; Lock K, 2003, ENVIRON TOXICOL CHEM, V22, P1162, DOI [10.1897/1551-5028(2003)022&lt;1162:IOAOCB&gt;2.0.CO;2, 10.1002/etc.5620220527]; Ma YB, 2006, ENVIRON SCI TECHNOL, V40, P6310, DOI 10.1021/es060306r; National Environmental Protection Council, 2011, GUID SOIL QUAL GUID; Oorts K, 2006, ENVIRON TOXICOL CHEM, V25, P845, DOI 10.1897/04-673R.1; Oorts K, 2007, ENVIRON TOXICOL CHEM, V26, P1130, DOI 10.1897/06-533R.1; Pedersen MB, 2000, ARCH ENVIRON CON TOX, V39, P431, DOI 10.1007/s002440010124; Posthuma L., 2002, SPECIES SENSITIVITY; Rooney CP, 2006, ENVIRON TOXICOL CHEM, V25, P726, DOI 10.1897/04-602R.1; Schlekat CE, 2010, SCI TOTAL ENVIRON, V408, P6148, DOI 10.1016/j.scitotenv.2010.09.012; Scott-Fordsmand Janeck J., 2000, Environmental Toxicology and Chemistry, V19, P1774, DOI 10.1897/1551-5028(2000)019&lt;1774:IOCHFU&gt;2.3.CO;2; Scott-Fordsmand JJ, 2000, ENVIRON TOXICOL CHEM, V19, P1297, DOI [10.1897/1551-5028(2000)019&lt;1297:ROFFCI&gt;2.3.CO;2, 10.1002/etc.5620190511]; Smolders E, 2009, ENVIRON TOXICOL CHEM, V28, P1633, DOI 10.1897/08-592.1; Stevens DP, 2003, ENVIRON TOXICOL CHEM, V22, P3017, DOI 10.1897/02-290; Struijs J, 1997, ECOTOX ENVIRON SAFE, V37, P112, DOI 10.1006/eesa.1997.1534; Van Sprang PA, 2009, SCI TOTAL ENVIRON, V407, P5373, DOI 10.1016/j.scitotenv.2009.06.029; [王小庆 Wang Xiaoqing], 2012, [农业环境科学学报, Journal of Agro-Environment Science], V31, P92; Warne MSJ, 2008, ENVIRON TOXICOL CHEM, V27, P786, DOI 10.1897/07-294.1; Wei DP, 2010, THESIS CHINESE ACAD; Wheeler JR, 2002, MAR POLLUT BULL, V45, P192, DOI 10.1016/S0025-326X(01)00327-7; Xiong Y, 1987, THE SOILS OF CHINA; Zhou Juan, 2008, Asian Journal of Ecotoxicology, V3, P394	49	11	13	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133941	10.1371/journal.pone.0133941	http://dx.doi.org/10.1371/journal.pone.0133941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207783	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000180
J	Flinner, N; Schleiff, E				Flinner, Nadine; Schleiff, Enrico			Dynamics of the Glycophorin A Dimer in Membranes of Native-Like Composition Uncovered by Coarse-Grained Molecular Dynamics Simulations	PLOS ONE			English	Article							TRANSMEMBRANE HELICES; PREFERENTIAL INTERACTION; HYDROPHOBIC MISMATCH; LIPID RAFTS; MODEL; CHOLESTEROL; DOMAINS; BILAYER; NMR; PHOSPHOLIPIDS	Membranes are central for cells as borders to the environment or intracellular organelle definition. They are composed of and harbor different molecules like various lipid species and sterols, and they are generally crowded with proteins. The membrane system is very dynamic and components show lateral, rotational and translational diffusion. The consequence of the latter is that phase separation can occur in membranes in vivo and in vitro. It was documented that molecular dynamics simulations of an idealized plasma membrane model result in formation of membrane areas where either saturated lipids and cholesterol (liquid-ordered character, L-o) or unsaturated lipids (liquid-disordered character, L-d) were enriched. Furthermore, current discussions favor the idea that proteins are sorted into the liquid-disordered phase of model membranes, but experimental support for the behavior of isolated proteins in native membranes is sparse. To gain insight into the protein behavior we built a model of the red blood cell membrane with integrated glycophorin A dimer. The sorting and the dynamics of the dimer were subsequently explored by coarse-grained molecular dynamics simulations. In addition, we inspected the impact of lipid head groups and the presence of cholesterol within the membrane on the dynamics of the dimer within the membrane. We observed that cholesterol is important for the formation of membrane areas with L-o and L-d character. Moreover, it is an important factor for the reproduction of the dynamic behavior of the protein found in its native environment. The protein dimer was exclusively sorted into the domain of L-d character in the model red blood cell plasma membrane. Therefore, we present structural information on the glycophorin A dimer distribution in the plasma membrane in the absence of other factors like e.g. lipid anchors in a coarse grain resolution.	[Flinner, Nadine; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Cluster Excellence Frankfurt, D-60438 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, D-60438 Frankfurt, Germany; [Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, Max Von Laue Str 9, D-60438 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Flinner, Nadine/AAZ-5668-2020; Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489	Cluster of Excellence Frankfurt "Macromolecular Complexes"; graduate program TRAM; Deutsche Forschungsgemeinschaft;  [SFB 807 P17]	Cluster of Excellence Frankfurt "Macromolecular Complexes"; graduate program TRAM; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This project was funded by the Cluster of Excellence Frankfurt "Macromolecular Complexes" (ES), the SFB 807 P17 (ES), the graduate program TRAM (NF), and the Deutsche Forschungsgemeinschaft (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027; BRULET P, 1976, BIOCHEM BIOPH RES CO, V68, P363, DOI 10.1016/0006-291X(76)91153-0; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; de Jong DH, 2013, FARADAY DISCUSS, V161, P347, DOI 10.1039/c2fd20086d; de Planque MRR, 1998, BIOCHEMISTRY-US, V37, P9333, DOI 10.1021/bi980233r; Domanski J, 2012, BBA-BIOMEMBRANES, V1818, P984, DOI 10.1016/j.bbamem.2011.08.021; Duque D, 2002, J CHEM PHYS, V116, P10478, DOI 10.1063/1.1477927; EDIDIN M, 1974, ANNU REV BIOPHYS BIO, V3, P179, DOI 10.1146/annurev.bb.03.060174.001143; Efremov RG, 2006, J COMPUT AID MOL DES, V20, P27, DOI 10.1007/s10822-006-9034-6; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; FATTAL DR, 1993, BIOPHYS J, V65, P1795, DOI 10.1016/S0006-3495(93)81249-9; Flinner N, 2014, INT J MOL SCI, V15, P14247, DOI 10.3390/ijms150814247; GRANT CWM, 1974, P NATL ACAD SCI USA, V71, P4653, DOI 10.1073/pnas.71.12.4653; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Los DA, 2004, BBA-BIOMEMBRANES, V1666, P142, DOI 10.1016/j.bbamem.2004.08.002; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marrink SJ, 2008, J AM CHEM SOC, V130, P10, DOI 10.1021/ja076641c; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; MCCAUGHAN L, 1980, SCIENCE, V207, P1481, DOI 10.1126/science.7361101; Mineev KS, 2011, ACTA NATURAE, V3, P90, DOI 10.32607/20758251-2011-3-2-90-98; MULLER P, 1993, BIOCHIM BIOPHYS ACTA, V1151, P7, DOI 10.1016/0005-2736(93)90064-7; ONG RL, 1984, J MEMBRANE BIOL, V78, P1, DOI 10.1007/BF01872526; ONG RL, 1982, BIOCHIM BIOPHYS ACTA, V692, P252, DOI 10.1016/0005-2736(82)90529-6; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pan JJ, 2012, J PHYS CHEM B, V116, P14829, DOI 10.1021/jp310345j; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Polyansky AA, 2012, J AM CHEM SOC, V134, P14390, DOI 10.1021/ja303483k; Poole J, 2000, BLOOD REV, V14, P31, DOI 10.1054/blre.1999.0124; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schafer LV, 2011, P NATL ACAD SCI USA, V108, P1343, DOI 10.1073/pnas.1009362108; SHAN X, 1994, BBA-BIOMEMBRANES, V1193, P127, DOI 10.1016/0005-2736(94)90341-7; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smondyrev AM, 1999, BIOPHYS J, V77, P2075, DOI 10.1016/S0006-3495(99)77049-9; Sparr E, 2005, J BIOL CHEM, V280, P39324, DOI 10.1074/jbc.M502810200; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402; TAMPE R, 1991, BIOCHEMISTRY-US, V30, P4909, DOI 10.1021/bi00234a011; TAMPE R, 1989, BIOCHIM BIOPHYS ACTA, V982, P41, DOI 10.1016/0005-2736(89)90171-5; TANNER MJA, 1993, BAILLIERE CLIN HAEM, V6, P333, DOI 10.1016/S0950-3536(05)80149-0; VANZOELEN EJJ, 1977, BIOCHIM BIOPHYS ACTA, V464, P482, DOI 10.1016/0005-2736(77)90024-4; Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8; ZACHOWSKI A, 1990, EXPERIENTIA, V46, P644, DOI 10.1007/BF01939703	54	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133999	10.1371/journal.pone.0133999	http://dx.doi.org/10.1371/journal.pone.0133999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222139	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800094
J	Franciscovich, A; Vaidya, D; Doyle, J; Bolinger, J; Capdevila, M; Rice, M; Hancock, L; Mahr, T; Mogul, DB				Franciscovich, Amy; Vaidya, Dhananjay; Doyle, Joe; Bolinger, Josh; Capdevila, Montserrat; Rice, Marcus; Hancock, Leslie; Mahr, Tanya; Mogul, Douglas B.			PoopMD, a Mobile Health Application, Accurately Identifies Infant Acholic Stools	PLOS ONE			English	Article							BILIARY ATRESIA; COLOR CARD	Biliary atresia (BA) is the leading cause of pediatric end-stage liver disease in the United States. Education of parents in the perinatal period with stool cards depicting acholic and normal stools has been associated with improved time-to-diagnosis and survival in BA. PoopMD is a mobile application that utilizes a smartphone's camera and color recognition software to analyze an infant's stool and determine if additional follow-up is indicated. PoopMD was developed using custom HTML5/CSS3 and wrapped to work on iOS and Android platforms. In order to define the gold standard regarding stool color, seven pediatricians were asked to review 45 photographs of infant stool and rate them as acholic, normal, or indeterminate. Samples for which 6+ pediatricians demonstrated agreement defined the gold standard, and only these samples were included in the analysis. Accuracy of PoopMD was assessed using an iPhone 5s with incandescent lighting. Variability in analysis of stool photographs as acholic versus normal with intermediate rating weighted as 50% agreement (kappa) was compared between three laypeople and one expert user. Variability in output was also assessed between an iPhone 5s and a Samsung Galaxy S4, as well as between incandescent lighting and compact fluorescent lighting. Six-plus pediatricians agreed on 27 normal and 7 acholic photographs; no photographs were defined as indeterminate. The sensitivity was 7/7 (100%). The specificity was 24/27 (89%) with 3/27 labeled as indeterminate; no photos of normal stool were labeled as acholic. The Laplace-smoothed positive likelihood ratio was 6.44 (95% CI 2.52 to 16.48) and the negative likelihood ratio was 0.13 (95% CI 0.02 to 0.83). kappa(user) was 0.68, kappa(phone) was 0.88, and kappa(light) was 0.81. Therefore, in this pilot study, PoopMD accurately differentiates acholic from normal color with substantial agreement across users, and almost perfect agreement across two popular smartphones and ambient light settings. PoopMD may be a valuable tool to help parents identify acholic stools in the perinatal period, and provide guidance as to whether additional evaluation with their pediatrician is indicated. PoopMD may improve outcomes for children with BA.	[Franciscovich, Amy; Mogul, Douglas B.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Vaidya, Dhananjay] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Doyle, Joe; Bolinger, Josh; Rice, Marcus; Hancock, Leslie; Mahr, Tanya] HCB Hlth, Austin, TX USA; [Capdevila, Montserrat] Johns Hopkins Univ, Off Technol Transfer, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Mogul, DB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	dmogul1@jhmi.edu	Vaidya, Dhananjay/AAL-5684-2020	Vaidya, Dhananjay/0000-0002-7164-1601	HCB Health	HCB Health	There were no grants or external funding for this study. HCB Health performed this work "pro bono." HCB Health provided support in the form of salaries for authors JD, JB, MR, LH, TM and had a role in the preparation of the manuscript, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], SMARTPHONE OWNERSHIP; [Anonymous], 2015, INTEGRATED PUBLIC AL; Bakshi B, 2012, ARCH DIS CHILD-FETAL, V97, pF385, DOI 10.1136/fetalneonatal-2010-209700; Chen SM, 2006, PEDIATRICS, V117, P1147, DOI 10.1542/peds.2005-1267; de Vries W, 2012, J PEDIATR-US, V160, P638, DOI 10.1016/j.jpeds.2011.09.061; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Fox S and Duggan M. Mobile health, 2012, MOBILE HEALTH 2012; Hsiao CH, 2008, HEPATOLOGY, V47, P1233, DOI 10.1002/hep.22182; Hung PY, 2006, J PEDIATR GASTR NUTR, V42, P190, DOI 10.1097/01.mpg.0000189339.92891.64; Lien TH, 2011, HEPATOLOGY, V53, P202, DOI 10.1002/hep.24023; Mogul D, 2015, J PEDIATR GASTR NUTR, V60, P91, DOI 10.1097/MPG.0000000000000569; Pringle Beverly, 2012, NCHS Data Brief, P1; Schreiber RA, 2014, J MED SCREEN, V21, P126, DOI 10.1177/0969141314542115; Schwarz KB, 2013, HEPATOLOGY, V58, P1724, DOI 10.1002/hep.26512; Sokol RJ, 2003, J PEDIATR GASTR NUTR, V37, P4, DOI 10.1097/00005176-200307000-00003; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Tiao MM, 2008, J GASTROEN HEPATOL, V23, P62, DOI 10.1111/j.1440-1746.2007.05114.x; Wengrovitz Anne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Yoon PW, 1997, PEDIATRICS, V99, P376, DOI 10.1542/peds.99.3.376	19	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132270	10.1371/journal.pone.0132270	http://dx.doi.org/10.1371/journal.pone.0132270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221719	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800021
J	Gu, Y; Razlighi, QR; Zahodne, LB; Janicki, SC; Ichise, M; Manly, JJ; Devanand, DP; Brickman, AM; Schupf, N; Mayeux, R; Stern, Y				Gu, Yian; Razlighi, Qolamreza R.; Zahodne, Laura B.; Janicki, Sarah C.; Ichise, Masanori; Manly, Jennifer J.; Devanand, D. P.; Brickman, Adam M.; Schupf, Nicole; Mayeux, Richard; Stern, Yaakov			Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population	PLOS ONE			English	Article							A-BETA; ALZHEIMERS-DISEASE; CARIBBEAN HISPANICS; HYPOTHETICAL MODEL; AFRICAN-AMERICANS; VISUAL ASSESSMENT; APOE GENOTYPE; IMPAIRMENT; PET; F-18-FLORBETABEN	Objective We aimed to whether the abnormally high amyloid-beta (A beta) level in the brain among apparently healthy elders is related with subtle cognitive deficits and/or accelerated cognitive decline. Methods A total of 116 dementia-free participants (mean age 84.5 years) of the Washington Heights Inwood Columbia Aging Project completed 18F-Florbetaben PET imaging. Positive or negative cerebral A beta deposition was assessed visually. Quantitative cerebral A beta burden was calculated as the standardized uptake value ratio in pre-established regions of interest using cerebellar cortex as the reference region. Cognition was determined using a neuropsychological battery and selected tests scores were combined into four composite scores (memory, language, executive/speed, and visuospatial) using exploratory factor analysis. We examined the relationship between cerebral A beta level and longitudinal cognition change up to 20 years before the PET scan using latent growth curve models, controlling for age, education, ethnicity, and Apolipoprotein E (APOE) genotype. Results Positive reading of A beta was found in 41 of 116 (35%) individuals. Cognitive scores at scan time was not related with A beta. All cognitive scores declined over time. A beta positive reading (B = -0.034, p = 0.02) and higher A beta burden in temporal region (B = -0.080, p = 0.02) were associated with faster decline in executive/speed. Stratified analyses showed that higher A beta deposition was associated with faster longitudinal declines in mean cognition, language, and executive/speed in African-Americans or in APOE epsilon 4 carriers, and with faster memory decline in APOE epsilon 4 carriers. The associations remained significant after excluding mild cognitive impairment participants. Conclusions High A beta deposition in healthy elders was associated with decline in executive/speed in the decade before neuroimaging, and the association was observed primarily in African-Americans and APOE epsilon 4 carriers. Our results suggest that measuring cerebral A beta may give us important insights into the cognitive profile in the years prior to the scan in cognitively normal elders.	[Gu, Yian; Zahodne, Laura B.; Manly, Jennifer J.; Brickman, Adam M.; Schupf, Nicole; Mayeux, Richard; Stern, Yaakov] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Razlighi, Qolamreza R.; Manly, Jennifer J.; Brickman, Adam M.; Schupf, Nicole; Mayeux, Richard; Stern, Yaakov] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Janicki, Sarah C.; Manly, Jennifer J.; Brickman, Adam M.; Mayeux, Richard; Stern, Yaakov] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Ichise, Masanori] Columbia Univ, Coll Med, Dept Radiol, New York, NY 10027 USA; [Devanand, D. P.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; [Schupf, Nicole; Mayeux, Richard] Columbia Univ, Joseph P Mailman Sch Publ Hlth, Div Epidemiol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Gu, Y (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	yg2121@columbia.edu	Gu, Yian/AAD-8343-2020	Gu, Yian/0000-0002-4297-1548; Stern, Yaakov/0000-0001-7542-3241	NIH [AG037212, AG007370, AG034189, AG042483]; Piramal; NATIONAL INSTITUTE ON AGING [R01AG007370, R01AG033546, R01AG038465, R01AG034189, R00AG042483, K99AG042483, R01AG037212, K01AG044467, R56AG034189, R01AG026158] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Piramal; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by NIH grants AG037212, AG007370, AG034189, and AG042483. Radioligand was provided through a grant from Piramal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; American Psychiatric Association, 1987, DIAGNOSTIC AND STATI; Barthel H, 2011, LANCET NEUROL, V10, P424, DOI 10.1016/S1474-4422(11)70077-1; Becker GA, 2013, J NUCL MED, V54, P723, DOI 10.2967/jnumed.112.107185; Benedetti B, 2006, NEUROLOGY, V66, P535, DOI 10.1212/01.wnl.0000198510.73363.c6; Benton AL, 1955, THE VISUAL RETENTION; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brickman AM, 2008, ARCH NEUROL-CHICAGO, V65, P1053, DOI 10.1001/archneur.65.8.1053; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; DElia L., 1994, COLOR TRAILS TEST PR; Doraiswamy PM, 2012, NEUROLOGY, V79, P1636, DOI 10.1212/WNL.0b013e3182661f74; Ellis KA, 2013, J ALZHEIMERS DIS, V34, P861, DOI 10.3233/JAD-122170; Ewers M, 2012, CEREB CORTEX, V22, P1993, DOI 10.1093/cercor/bhr271; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fleiss JL, 1981, STAT METHODS RATES P; Goodglass H., 1983, BOSTON NAMING TEST; Hedden T, 2013, NEUROLOGY, V80, P1341, DOI 10.1212/WNL.0b013e31828ab35d; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kantarci K, 2012, NEUROLOGY, V78, P232, DOI 10.1212/WNL.0b013e31824365ab; Kaplan E., 1983, THE ASSESSMENT OF AP; Kawas CH, 2013, ALZHEIMERS DEMENT, V9, P199, DOI 10.1016/j.jalz.2012.06.005; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; Lim YY, 2013, ALZHEIMERS DEMENT, V9, P538, DOI 10.1016/j.jalz.2012.07.004; Lim YY, 2012, NEUROLOGY, V79, P1645, DOI 10.1212/WNL.0b013e31826e9ae6; Manly JJ, 2005, ARCH NEUROL-CHICAGO, V62, P1739, DOI 10.1001/archneur.62.11.1739; Mattis S, 1988, DEMENTIA RATING SCAL; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Ng S, 2007, J NUCL MED, V48, P547, DOI 10.2967/jnumed.106.037762; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pike KE, 2011, NEUROPSYCHOLOGIA, V49, P2384, DOI 10.1016/j.neuropsychologia.2011.04.012; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Resnick SM, 2010, NEUROLOGY, V74, P807, DOI 10.1212/WNL.0b013e3181d3e3e9; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Rosen W, 1981, THE ROSEN DRAWING TE; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Shimada H, 2011, J GERIATR PSYCH NEUR, V24, P123, DOI 10.1177/0891988711409410; Snitz BE, 2013, NEUROLOGY, V80, P1378, DOI 10.1212/WNL.0b013e31828c2fc8; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Storandt M, 2009, ARCH NEUROL-CHICAGO, V66, P1476, DOI 10.1001/archneurol.2009.272; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Suotunen T, 2010, EUR J NUCL MED MOL I, V37, P1141, DOI 10.1007/s00259-010-1382-8; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; Tolboom N, 2010, J NEUROL NEUROSUR PS, V81, P882, DOI 10.1136/jnnp.2009.194779; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Wechsler D, 1987, WECHSLER ADULT INTEL; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102	56	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0123743	10.1371/journal.pone.0123743	http://dx.doi.org/10.1371/journal.pone.0123743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221954	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800002
J	Hahn, P; Oezdemir, S; Komp, M; Giannakopoulos, A; Heikenfeld, R; Kasch, R; Merk, H; Godolias, G; Ruetten, S				Hahn, Patrick; Oezdemir, Semih; Komp, Martin; Giannakopoulos, Athanasios; Heikenfeld, Roderich; Kasch, Richard; Merk, Harry; Godolias, Georgios; Ruetten, Sebastian			A New Electromagnetic Navigation System for Pedicle Screws Placement: A Human Cadaver Study at the Lumbar Spine	PLOS ONE			English	Article							COMPLICATIONS	Introduction Technical developments for improving the safety and accuracy of pedicle screw placement play an increasingly important role in spine surgery. In addition to the standard techniques of free-hand placement and fluoroscopic navigation, the rate of complications is reduced by 3D fluoroscopy, cone-beam CT, intraoperative CT/MRI, and various other navigation techniques. Another important aspect that should be emphasized is the reduction of intraoperative radiation exposure for personnel and patient. The aim of this study was to investigate the accuracy of a new navigation system for the spine based on an electromagnetic field. Material and Method Twenty pedicle screws were placed in the lumbar spine of human cadavers using EMF navigation. Navigation was based on data from a preoperative thin-slice CT scan. The cadavers were positioned on a special field generator and the system was matched using a patient tracker on the spinous process. Navigation was conducted using especially developed instruments that can be tracked in the electromagnetic field. Another thin-slice CT scan was made postoperatively to assess the result. The evaluation included the position of the screws in the direction of trajectory and any injury to the surrounding cortical bone. The results were classified in 5 groups: grade 1: ideal screw position in the center of the pedicle with no cortical bone injury; grade 2: acceptable screw position, cortical bone injury with cortical penetration <= 2 mm; grade 3: cortical bone injury with cortical penetration 2,1-4 mm, grad 4: cortical bone injury with cortical penetration 4,1-6 mm, grade 5: cortical bone injury with cortical penetration > 6 mm. Results The initial evaluation of the system showed good accuracy for the lumbar spine (65% grade 1, 20% grade 2, 15% grade 3, 0% grade 4, 0% grade 5). A comparison of the initial results with other navigation techniques in literature (CT navigation, 2D fluoroscopic navigation) shows that the accuracy of this system is comparable. Conclusion EMF navigation offers a high accuracy in Pedicle screw placement with additional advantages compared to other techniques. The short set-up time and easy handling of EMF navigation should be emphasized. Additional advantages are the absence of intraoperative radiation exposure for the operator and surgical team in the current set-up and the operator's free mobility without interfering with navigation. Further studies with navigation at higher levels of the spine, larger numbers of cases and studies with control group are planned.	[Hahn, Patrick; Oezdemir, Semih; Komp, Martin; Giannakopoulos, Athanasios; Ruetten, Sebastian] Univ Hosp, Marien Hosp Witten,Ctr Spine Surg & Pain Theraphy, Marienhosp Herne,Ctr Orthopaed & Traumatol, St Anna Hosp Herne,Catholic Hosp Rhein Ruhr,St El, Herne, Germany; [Kasch, Richard; Merk, Harry] Univ Med Greifswald, Clin Orthopaed & Orthopaed Surg, Greifswald, Germany; [Heikenfeld, Roderich; Godolias, Georgios] Univ Hosp, Marienhosp Herne,Ctr Orthopaed & Traumatol, St Anna Hosp Herne,Catholic Hosp Rhein Ruhr, Marien Hosp,St Elisabeth Grp, Herne, Germany	Ruhr University Bochum; Saint Anna Hospital; St. Marien Hospital; Greifswald Medical School; Ruhr University Bochum; Saint Anna Hospital; St. Marien Hospital	Hahn, P (corresponding author), Univ Hosp, Marien Hosp Witten,Ctr Spine Surg & Pain Theraphy, Marienhosp Herne,Ctr Orthopaed & Traumatol, St Anna Hosp Herne,Catholic Hosp Rhein Ruhr,St El, Herne, Germany.	Patrick-hahn@gmx.de						Acosta Frank L Jr, 2005, Spine J, V5, P339, DOI 10.1016/j.spinee.2004.09.012; Amiot LP, 2000, SPINE, V25, P606, DOI 10.1097/00007632-200003010-00012; Ammirati M, 2013, NEUROSURG REV, V36, P157, DOI 10.1007/s10143-012-0421-2; Bandela JR, 2013, WORLD NEUROSURG, V79, P390, DOI 10.1016/j.wneu.2011.05.019; Barber JW, 1998, J SPINAL DISORD, V11, P215; Brown CA, 1998, SPINE, V23, P1566, DOI 10.1097/00007632-199807150-00012; Bruners P, 2009, EUR RADIOL, V19, P990, DOI 10.1007/s00330-008-1227-z; Costa F, 2011, SPINE, V36, P2094, DOI 10.1097/BRS.0b013e318201129d; Fu TS, 2008, INT ORTHOP, V32, P517, DOI 10.1007/s00264-007-0358-1; Gebhard F, 2000, UNFALLCHIRURG, V103, P696, DOI 10.1007/s001130050605; Gebhard F, 2003, UNFALLCHIRURG, V106, P492, DOI 10.1007/s00113-003-0606-9; Gebhard FT, 2006, SPINE, V31, P2024, DOI 10.1097/01.brs.0000229250.69369.ac; Geerling J, 2008, COMPUT AIDED SURG, V13, P157, DOI 10.3109/10929080802102110; Gelalis ID, 2012, EUR SPINE J, V21, P247, DOI 10.1007/s00586-011-2011-3; Hamill CL, 1996, SPINE, V21, P1241, DOI 10.1097/00007632-199605150-00020; HARRINGTON PR, 1969, SOUTH MED J, V62, P1, DOI 10.1097/00007611-196901000-00001; Hayhurst C, 2009, J NEUROSURG, V111, P1179, DOI 10.3171/2008.12.JNS08628; Hojo Y, 2014, EUR SPINE J, V22; Holly LT, 2007, ORTHOP CLIN N AM, V38, P451, DOI 10.1016/j.ocl.2007.04.001; Komp M, 2014, SURG INNOV, V21, P605, DOI 10.1177/1553350614525668; Komp M, 2011, J SPINAL DISORD TECH, V24, P281, DOI 10.1097/BSD.0b013e3181f9f55e; Kosmopoulos V, 2007, SPINE, V32, pE111, DOI 10.1097/01.brs.0000254048.79024.8b; Kraus MD, 2012, ARCH ORTHOP TRAUM SU, V132, P741, DOI 10.1007/s00402-012-1471-1; Lonstein JE, 1999, J BONE JOINT SURG AM, V81A, P1519, DOI 10.2106/00004623-199911000-00003; Mezger U, 2013, LANGENBECK ARCH SURG, V398, P501, DOI 10.1007/s00423-013-1059-4; Rahmathulla G, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13516; Ringel Florian, 2014, Adv Tech Stand Neurosurg, V41, P3, DOI 10.1007/978-3-319-01830-0_1; Roser F, 1227, NEUROSURGERY, V1, P12; Sagi HC, 2003, SPINE, V28, P2013, DOI 10.1097/01.BRS.0000087851.51547.00; Sagi HC, 2003, SPINE, V28, pE351, DOI 10.1097/01.BRS.0000086822.76638.76; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; Schnake KJ, 2004, UNFALLCHIRURG, V107, P104, DOI 10.1007/s00113-003-0720-8; Tabaraee E, 2013, SPINE, V38, P1953, DOI 10.1097/BRS.0b013e3182a51d1e; Tang J, J BIOMED RES, V28, P228; Tian NF, 2009, INT ORTHOP, V33, P895, DOI 10.1007/s00264-009-0792-3	35	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133708	10.1371/journal.pone.0133708	http://dx.doi.org/10.1371/journal.pone.0133708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221733	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800061
J	Merino, B; Quesada, I; Hernandez-Cascales, J				Merino, Beatriz; Quesada, Ivan; Hernandez-Cascales, Jesus			Glucagon Increases Beating Rate but Not Contractility in Rat Right Atrium. Comparison with Isoproterenol	PLOS ONE			English	Article							PROTEIN-KINASE-C; SINOATRIAL NODE; GUINEA-PIG; I-F; SYMPTOMATIC BRADYCARDIA; VENTRICULAR MYOCARDIUM; PACEMAKER ACTIVITY; HEART-FAILURE; CAMP SIGNALS; CLINICAL-USE	This study evaluated the chronotropic and inotropic responses to glucagon in spontaneously beating isolated right atria of rat heart. For comparison, we also investigated the effects resulting from stimulating beta-adrenoceptors with isoproterenol in this tissue. Isoproterenol increased both atrial frequency and contractility but glucagon only enhanced atrial rate. The transcript levels of glucagon receptors were about three times higher in sinoatrial node than in the atrial myocardium. Chronotropic responses to glucagon and isoproterenol were blunted by the funny current (If) inhibitor ZD 7288. Inhibitors of protein kinase A, H-89 and KT-5720 reduced the chronotropic response to glucagon but not to isoproterenol. Inhibition of ryanodine receptors and calcium/calmodulin dependent protein kinase II (important regulators of sarcoplasmic reticulum Ca2(+) release), with ruthenium red and KN-62 respectively, failed to alter chronotropic responses of either glucagon or isoproterenol. Non selective inhibition of phosphodiesterase (PDE) with 3-isobutylmethylxantine or selective inhibition of PDE3 or PDE4 with cilostamide or rolipram respectively did not affect chronotropic effects of glucagon or isoproterenol. Our results indicate that glucagon increases beating rate but not contractility in rat right atria which could be a consequence of lower levels of glucagon receptors in atrial myocardium than in sinoatrial node. Chronotropic responses to glucagon or isoproterenol are mediated by If current but not by sarcoplasmic reticulum Ca2(+) release, neither are regulated by PDE activity.	[Merino, Beatriz; Quesada, Ivan] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain; [Merino, Beatriz; Quesada, Ivan] CIBER Diabet Enfermedades Metabol Asociadas CIBER, Elche, Spain; [Hernandez-Cascales, Jesus] Univ Murcia, Fac Med, Dept Farmacol, Murcia, Spain	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Murcia	Hernandez-Cascales, J (corresponding author), Univ Murcia, Fac Med, Dept Farmacol, Murcia, Spain.	jehernca@um.es	Ivan, Quesada/P-6541-2014; MERINO, BEATRIZ/V-4121-2017	Ivan, Quesada/0000-0002-9808-514X; MERINO, BEATRIZ/0000-0002-4761-3977				ANTONACCIO MJ, 1974, ARCH INT PHARMACOD T, V209, P273; Asada M, 2001, ANESTHESIOLOGY, V95, P437, DOI 10.1097/00000542-200108000-00028; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bindon MJ, 2009, RESUSCITATION, V80, P1327, DOI 10.1016/j.resuscitation.2009.08.002; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Brodde OE, 1999, PHARMACOL REV, V51, P651; DeWitt Christopher R, 2004, Toxicol Rev, V23, P223, DOI 10.2165/00139709-200423040-00003; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Du XJ, 2004, BRIT J PHARMACOL, V142, P107, DOI 10.1038/sj.bjp.0705696; FURUKAWA Y, 1986, JPN HEART J, V27, P215; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gonzalez-Munoz C, 2008, EUR J PHARMACOL, V587, P243, DOI 10.1016/j.ejphar.2008.04.001; GUTH BD, 1995, BASIC RES CARDIOL, V90, P192, DOI 10.1007/BF00805662; Hardouin S, 1998, MECH AGEING DEV, V100, P277, DOI 10.1016/S0047-6374(97)00142-5; JESSE R, 1975, BASIC RES CARDIOL, V70, P217, DOI 10.1007/BF01905622; Juan-Fita MJ, 2005, EUR J PHARMACOL, V512, P207, DOI 10.1016/j.ejphar.2005.01.056; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Liao ZD, 2010, J GEN PHYSIOL, V136, P247, DOI 10.1085/jgp.201010488; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; London JA, 2006, SURG CLIN N AM, V86, P1503, DOI 10.1016/j.suc.2006.08.003; Love JN, 1997, ANN EMERG MED, V29, P181, DOI 10.1016/S0196-0644(97)70327-5; Love JN, 1998, CHEST, V114, P323, DOI 10.1378/chest.114.1.323; MA JJ, 1993, J GEN PHYSIOL, V102, P1031, DOI 10.1085/jgp.102.6.1031; MACLEOD KM, 1981, J PHARMACOL EXP THER, V217, P798; Matsuda Y, 1983, CIRCULATION, V67, P565; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; NORD HJ, 1970, ANN INTERN MED, V72, P649, DOI 10.7326/0003-4819-72-5-649; Ozcan L, 2012, CELL METAB, V15, P739, DOI 10.1016/j.cmet.2012.03.002; PRASAD K, 1975, CLIN PHARMACOL THER, V18, P22; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Rodgers RL, 2012, CURR DIABETES REV, V8, P362, DOI 10.2174/157339912802083540; SHAHID M, 1989, BRIT J PHARMACOL, V98, P291, DOI 10.1111/j.1476-5381.1989.tb16894.x; Song GL, 2002, CELL RES, V12, P385, DOI 10.1038/sj.cr.7290140; Stevenson LW, 2003, CIRCULATION, V108, P367, DOI 10.1161/01.CIR.0000078348.44634.BA; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Vinogradova TM, 2009, J MOL CELL CARDIOL, V47, P456, DOI 10.1016/j.yjmcc.2009.06.014; Wahl-Schott C, 2014, CURR OPIN PHARMACOL, V15, P83, DOI 10.1016/j.coph.2013.12.005; White CM, 1999, J CLIN PHARMACOL, V39, P442	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132884	10.1371/journal.pone.0132884	http://dx.doi.org/10.1371/journal.pone.0132884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222156	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800034
J	Vergara, M; Basto, MP; Madeira, MJ; Gomez-Moliner, BJ; Santos-Reis, M; Fernandes, C; Ruiz-Gonzalez, A				Vergara, Maria; Basto, Mafalda P.; Jose Madeira, Maria; Gomez-Moliner, Benjamin J.; Santos-Reis, Margarida; Fernandes, Carlos; Ruiz-Gonzalez, Aritz			Inferring Population Genetic Structure in Widely and Continuously Distributed Carnivores: The Stone Marten (Martes foina) as a Case Study	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MINK MUSTELA-VISON; MICROSATELLITE LOCI; COMPUTER-PROGRAM; SOFTWARE; BARRIERS; INFERENCE; MARKERS; FLOW; DIFFERENTIATION	The stone marten is a widely distributed mustelid in the Palaearctic region that exhibits variable habitat preferences in different parts of its range. The species is a Holocene immigrant from southwest Asia which, according to fossil remains, followed the expansion of the Neolithic farming cultures into Europe and possibly colonized the Iberian Peninsula during the Early Neolithic (ca. 7,000 years BP). However, the population genetic structure and historical biogeography of this generalist carnivore remains essentially unknown. In this study we have combined mitochondrial DNA (mtDNA) sequencing (621 bp) and microsatellite genotyping (23 polymorphic markers) to infer the population genetic structure of the stone marten within the Iberian Peninsula. The mtDNA data revealed low haplotype and nucleotide diversities and a lack of phylogeographic structure, most likely due to a recent colonization of the Iberian Peninsula by a few mtDNA lineages during the Early Neolithic. The microsatellite data set was analysed with a) spatial and non-spatial Bayesian individual-based clustering (IBC) approaches (STRUCTURE, TESS, BAPS and GENELAND), and b) multivariate methods [discriminant analysis of principal components (DAPC) and spatial principal component analysis (sPCA)]. Additionally, because isolation by distance (IBD) is a common spatial genetic pattern in mobile and continuously distributed species and it may represent a challenge to the performance of the above methods, the microsatellite data set was tested for its presence. Overall, the genetic structure of the stone marten in the Iberian Peninsula was characterized by a NE-SW spatial pattern of IBD, and this may explain the observed disagreement between clustering solutions obtained by the different IBC methods. However, there was significant indication for contemporary genetic structuring, albeit weak, into at least three different subpopulations. The detected subdivision could be attributed to the influence of the rivers Ebro, Tagus and Guadiana, suggesting that main watercourses in the Iberian Peninsula may act as semi-permeable barriers to gene flow in stone martens. To our knowledge, this is the first phylogeographic and population genetic study of the species at a broad regional scale. We also wanted to make the case for the importance and benefits of using and comparing multiple different clustering and multivariate methods in spatial genetic analyses of mobile and continuously distributed species.	[Vergara, Maria; Jose Madeira, Maria; Gomez-Moliner, Benjamin J.; Ruiz-Gonzalez, Aritz] Univ Basque Country UPV EHU, Zool Lab, Dept Zool & Anim Cell Biol, Vitoria, Spain; [Vergara, Maria; Jose Madeira, Maria; Gomez-Moliner, Benjamin J.; Ruiz-Gonzalez, Aritz] Univ Basque Country UPV EHU, Lascaray Res Ctr, Systemat Biogeog & Populat Dynam Res Grp, Vitoria, Spain; [Basto, Mafalda P.; Santos-Reis, Margarida; Fernandes, Carlos] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, Lisbon, Portugal	University of Basque Country; University of Basque Country; Universidade de Lisboa	Vergara, M (corresponding author), Univ Basque Country UPV EHU, Zool Lab, Dept Zool & Anim Cell Biol, Vitoria, Spain.	maria.vergara@ehu.es	Fernandes, Carlos/AAB-5256-2019; Gomez, Benjamin/AAA-4119-2019; MADEIRA, MARÍA JOSÉ/L-7556-2014; Fernandes, Carlos/J-3045-2013; Ruiz-Gonzalez, Aritz/A-1613-2013; GONZALEZ, ARITZ RUIZ/P-3384-2019; Santos-Reis, Margarida/H-4064-2011	Fernandes, Carlos/0000-0002-1386-8103; MADEIRA, MARÍA JOSÉ/0000-0002-7357-7228; Fernandes, Carlos/0000-0002-1386-8103; GONZALEZ, ARITZ RUIZ/0000-0001-7409-4634; Santos-Reis, Margarida/0000-0002-0337-963X; GOMEZ MOLINER, BENJAMIN JUAN/0000-0002-3054-8806	Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics'' [IT317-10, GIC10/76, IT575-13]; Dept. of Education, Universities and Research of the Basque Government [RBFI-2012-446, DKR-2012-64]; Fundacao para a Ciencia e Tecnologia [SFRH/BD/38410/2007];  [C2007-UL-342-CBA1];  [PTDC/BIA-BEC/101511/2008]	Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics''; Dept. of Education, Universities and Research of the Basque Government; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); ; 	This study has been partially funded by the Basque Government through the Research group on "Systematics, Biogeography and Population Dynamics'' (Ref. IT317-10; GIC10/76; IT575-13). MV (Ref: RBFI-2012-446) and ARG (Ref: DKR-2012-64) were supported by a PhD and post-doctoral fellowships awarded by the Dept. of Education, Universities and Research of the Basque Government. MPB and CF acknowledge financial support from Fundacao para a Ciencia e Tecnologia through the PhD fellowship SFRH/BD/38410/2007, the Ciencia 2007 contract C2007-UL-342-CBA1, and the research project PTDC/BIA-BEC/101511/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E., 1970, Acta Zoologica Fennica, VNo.130,1970, P1; Aurelle D, 2013, CONSERV GENET, V14, P705, DOI 10.1007/s10592-013-0464-0; Balestrieri A, 2008, HYSTRIX, V19, P77; Ball MC, 2010, CONSERV GENET, V11, P2131, DOI 10.1007/s10592-010-0099-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basto MP, 2010, CONSERV GENET RESOUR, V2, P317, DOI 10.1007/s12686-010-9217-2; Basto MP, 2014, THESIS U LISBON PORT; Belkhir K, 2000, GENETIX V 4 02 LOGIC; Bijlsma R, 2000, MOL ECOL, V9, P2216; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Cabria MT, 2007, MOL ECOL NOTES, V7, P1185, DOI 10.1111/j.1471-8286.2007.01825.x; Cercueil A, 2007, THEOR POPUL BIOL, V71, P332, DOI 10.1016/j.tpb.2007.01.007; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Dallas JF, 1998, MOL ECOL, V7, P1248; Dallas JF, 2003, MOL ECOL, V12, P275, DOI 10.1046/j.1365-294X.2003.01712.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis CS, 1998, MOL ECOL, V7, P1776, DOI 10.1046/j.1365-294x.1998.00515.x; Delibes M., 1983, Acta Zoologica Fennica, P229; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; EDWARDS AWF, 1971, BIOMETRICS, V27, P873, DOI 10.2307/2528824; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandes CA, 2008, CONSERV GENET, V9, P681, DOI 10.1007/s10592-007-9364-5; Fleming MA, 1999, MOL ECOL, V8, P1352, DOI 10.1046/j.1365-294X.1999.00701_2.x; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Fu YX, 1997, GENETICS, V147, P915; Goldberg CS, 2010, MOL ECOL RESOUR, V10, P304, DOI 10.1111/j.1755-0998.2009.02755.x; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hapeman P, 2011, J HERED, V102, P251, DOI 10.1093/jhered/esr001; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hartmann SA, 2013, CONSERV GENET, V14, P413, DOI 10.1007/s10592-013-0468-9; Herr J, 2008, THESIS U SUSSEX ENGL, P226; Hobbs GI, 2011, J APPL ECOL, V48, P1206, DOI 10.1111/j.1365-2664.2011.02028.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jordan MJ, 2007, MOL ECOL NOTES, V7, P797, DOI 10.1111/j.1471-8286.2007.01708.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Kyle CJ, 2003, CONSERV GENET, V4, P179, DOI 10.1023/A:1023334521996; Landguth EL, 2012, MOL ECOL RESOUR, V12, P363, DOI 10.1111/j.1755-0998.2011.03075.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2014, CONSERV GENET, V15, P981, DOI 10.1007/s10592-014-0593-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latch EK, 2014, MOL ECOL, V23, P3171, DOI 10.1111/mec.12803; Li B, 2014, MOL PHYLOGENET EVOL, V80, P156, DOI 10.1016/j.ympev.2014.08.002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Llorente L, 2011, ACT 31 RENC INT ARCH, P189; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Mucci N, 2010, CONSERV GENET, V11, P583, DOI 10.1007/s10592-010-0054-3; Nagai T, 2012, MAMM STUDY, V37, P353, DOI 10.3106/041.037.0410; Nei M., 1987, MOL EVOLUTIONARY GEN; OConnell M, 1996, MOL ECOL, V5, P311, DOI 10.1111/j.1365-294X.1996.tb00320.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Reig S, 2002, ATLAS MAMIFEROS TERR, P270; Reig S, 2007, ATLAS LIBRO ROJO MAM, P305; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruiz-Gonzalez A, 2013, BIOL J LINN SOC, V109, P1, DOI 10.1111/bij.12046; Rutledge LY, 2010, HEREDITY, V105, P520, DOI 10.1038/hdy.2010.6; Sacks BN, 2004, MOL ECOL, V13, P1265, DOI 10.1111/j.1365-294X.2004.02110.x; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Santos MJ, 2010, EUR J WILDLIFE RES, V56, P275, DOI 10.1007/s10344-009-0317-9; Schwartz M, 2012, BIOL CONSERVATION MA; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Sommer R, 2004, MAMMAL REV, V34, P249, DOI 10.1111/j.1365-2907.2004.00043.x; TAJIMA F, 1989, GENETICS, V123, P585; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tikhonov A, 2008, IUCN RED LIST THREAT; Tucker JM, 2014, CONSERV GENET, V15, P123, DOI 10.1007/s10592-013-0525-4; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Virgos E, 2002, ACTA OECOL, V23, P231, DOI 10.1016/S1146-609X(02)01142-6; Virgos E, 2012, BIOL CONSERVATION MA, P255; Virgos E, 2010, ANIM BIOL, V60, P423, DOI 10.1163/157075610X523297; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1946, GENETICS, V31, P39	103	27	27	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134257	10.1371/journal.pone.0134257	http://dx.doi.org/10.1371/journal.pone.0134257			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222680	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800118
J	Zhang, G; He, LS; Wong, YH; Xu, Y; Zhang, Y; Qian, PY				Zhang, Gen; He, Li-sheng; Wong, Yue-Him; Xu, Ying; Zhang, Yu; Qian, Pei-yuan			Chemical Component and Proteomic Study of the Amphibalanus (= Balanus) amphitrite Shell	PLOS ONE			English	Article							PROTEIN COMPLEX SIPC; C-TYPE-LECTIN; WHEY ACIDIC PROTEIN; BARNACLE CEMENT; ACORN BARNACLE; CARBONIC-ANHYDRASE; MATRIX PROTEIN; PURIFICATION; INVOLVEMENT; CLONING	As typical biofoulers, barnacles possess hard shells and cause serious biofouling problems. In this study, we analyzed the protein component of the barnacle Amphibalanus (= Balanus) amphitrite shell using gel-based proteomics. The results revealed 52 proteins in the A. Amphitrite shell. Among them, 40 proteins were categorized into 11 functional groups based on KOG database, and the remaining 12 proteins were unknown. Besides the known proteins in barnacle shell (SIPC, carbonic anhydrase and acidic acid matrix protein), we also identified chorion peroxidase, C-type lectin-like domains, serine proteases and proteinase inhibitor proteins in the A. Amphitrite shell. The sequences of these proteins were characterized and their potential functions were discussed. Histology and DAPI staining revealed living cells in the shell, which might secrete the shell proteins identified in this study.	[Zhang, Gen; Wong, Yue-Him; Qian, Pei-yuan] Hong Kong Univ Sci & Technol, Sch Sci, Environm Sci Programs, Kowloon, Hong Kong, Peoples R China; [Zhang, Gen; Wong, Yue-Him; Qian, Pei-yuan] Hong Kong Univ Sci & Technol, Sch Sci, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [He, Li-sheng] Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya City 572000, Hainan Province, Peoples R China; [Xu, Ying; Zhang, Yu] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen 518060, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Shenzhen University	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Sch Sci, Environm Sci Programs, Kowloon, Hong Kong, Peoples R China.	boqianpy@ust.hk	Xu, Ying/E-2072-2018; Zhang, Yu/K-4912-2012; Zhang/L-6428-2017	Xu, Ying/0000-0003-4658-3283; Zhang/0000-0001-8619-3285; Qian, Pei-Yuan/0000-0003-4074-9078	China Ocean Mineral Resources Research and Development Association [DY125-15-T-02]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Research Grants Council of the Hong Kong Special Administrative Region [GRF661611, GRF662413]; National Natural Science Foundation of China [31460092]	China Ocean Mineral Resources Research and Development Association; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (DY125-15-T-02) from the China Ocean Mineral Resources Research and Development Association, an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016) and grants (GRF661611, GRF662413) from the Research Grants Council of the Hong Kong Special Administrative Region to PYQ as well as a grant from the National Natural Science Foundation of China (31460092) to LSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; Bedouet L, 2007, MAR BIOTECHNOL, V9, P437, DOI 10.1007/s10126-007-7120-y; Bobelmann F, 2007, THERMOCHIM ACTA, V463, P65, DOI 10.1016/j.tca.2007.07.018; BOURGET E, 1974, MAR BIOL, V28, P27; Chen ZF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094493, 10.1371/journal.pone.0088744]; CRISP DJ, 1985, ADV MAR BIOL, V22, P199, DOI 10.1016/S0065-2881(08)60052-8; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dickinson GH, 2009, J EXP BIOL, V212, P3499, DOI 10.1242/jeb.029884; Dreanno C, 2007, J EXP MAR BIOL ECOL, V351, P276, DOI 10.1016/j.jembe.2007.07.003; Dreanno C, 2006, P ROY SOC B-BIOL SCI, V273, P2721, DOI 10.1098/rspb.2006.3649; Fernandez MS, 2002, MATER RES SOC SYMP P, V724, P3; FUKUZAWA H, 1990, P NATL ACAD SCI USA, V87, P4383, DOI 10.1073/pnas.87.11.4383; Glazer L, 2012, INVERTEBR REPROD DEV, V56, P57, DOI 10.1080/07924259.2011.588010; Gohad NV, 2009, J EXP MAR BIOL ECOL, V380, P88, DOI 10.1016/j.jembe.2009.09.008; GORDON CM, 1970, LIMNOL OCEANOGR, V15, P461, DOI 10.4319/lo.1970.15.3.0461; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Han Q, 2000, ARCH BIOCHEM BIOPHYS, V378, P107, DOI 10.1006/abbi.2000.1821; Han Z, 2013, J PROTEOME RES, V12, P2090, DOI 10.1021/pr301083e; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 1996, BIOL BULL, V190, P403, DOI 10.2307/1543033; Kamiya H, 2002, MAR BIOL, V140, P1235, DOI 10.1007/s00227-002-0789-6; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Khalifa GM, 2011, CRYST GROWTH DES, V11, P5122, DOI 10.1021/cg2010216; Khandeparker L, 2011, J ZOOL, V284, P206, DOI 10.1111/j.1469-7998.2011.00794.x; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Li M, 2014, DEV COMP IMMUNOL, V46, P231, DOI 10.1016/j.dci.2014.04.014; Liu XF, 2014, J PROTEOME RES, V13, P1223, DOI 10.1021/pr400669d; Mann K, 2006, COMP BIOCHEM PHYS B, V143, P160, DOI 10.1016/j.cbpb.2005.11.003; Marie B, 2008, CHEMBIOCHEM, V9, P2515, DOI 10.1002/cbic.200800159; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marie B, 2011, MAR BIOTECHNOL, V13, P955, DOI 10.1007/s10126-010-9357-0; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Matsubara H, 2008, FISHERIES SCI, V74, P418, DOI 10.1111/j.1444-2906.2008.01539.x; Matsumura K, 1998, P ROY SOC B-BIOL SCI, V265, P1825, DOI 10.1098/rspb.1998.0508; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; Robinson CM, 2013, MBIO, V4, DOI 10.1128/mBio.00595-12; Rodde RH, 2008, CARBOHYD POLYM, V71, P388, DOI 10.1016/j.carbpol.2007.06.006; Shafer TH, 2006, INTEGR COMP BIOL, V46, P978, DOI 10.1093/icb/icl022; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x; Wade N, 2005, COMP BIOCHEM PHYS B, V141, P307, DOI 10.1016/j.cbpc.2005.04.004; Wu CL, 2013, IMMUNOBIOLOGY, V218, P159, DOI 10.1016/j.imbio.2012.02.011; Yoon GL, 2003, WASTE MANAGE, V23, P825, DOI 10.1016/S0956-053X(02)00159-9; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang Y, 2010, J PROTEOME RES, V9, P3146, DOI 10.1021/pr1000384	53	14	14	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133866	10.1371/journal.pone.0133866	http://dx.doi.org/10.1371/journal.pone.0133866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222041	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800073
J	Cai, HY; Li, Y; Zhao, MJ; Fu, GW; Lai, J; Feng, FQ				Cai, Haiying; Li, Yang; Zhao, Minjie; Fu, Guanwen; Lai, Jia; Feng, Fengqin			Immobilization, Regiospecificity Characterization and Application of Aspergillus oryzae Lipase in the Enzymatic Synthesis of the Structured Lipid 1,3-Dioleoyl-2-Palmitoylglycerol	PLOS ONE			English	Article							MILK FAT SUBSTITUTES; CANDIDA-RUGOSA LIPASE; SOLVENT-FREE SYSTEM; HYDROPHOBIC SUPPORTS; ORGANIC-SOLVENTS; RHIZOPUS-ORYZAE; CEPACIA LIPASE; BIOCATALYTIC SYNTHESIS; PSEUDOMONAS-CEPACIA; MICROBIAL LIPASES	The enzymatic synthesis of 1,3-dioleoyl-2-palmitoylglycerol (OPO), one of the main components of human milk fats, has been hindered by the relatively high cost of sn-1,3-specific lipases and the deficiency in biocatalyst stability. The sn-1,3-specific lipase from Aspergillus oryzae (AOL) is highly and efficiently immobilized with the polystyrene-based hydrophobic resin D3520, with a significant 49.54-fold increase in specific lipase activity compared with the AOL powder in catalyzing the synthesis of OPO through the acidolysis between palm stearin and oleic acid (OA). The optimal immobilization conditions were investigated, including time course, initial protein concentration and solution pH. The sn-1,3 specificity of lipases under different immobilization conditions was evaluated and identified as positively associated with the lipase activity, and the pH of the immobilization solution influenced the regiospecificity and synthetic activity of these lipases. Immobilized AOL D3520, as the biocatalyst, was used for the enzymatic synthesis of the structured lipid OPO through the acidolysis between palm stearin and OA. The following conditions were optimized for the synthesis of structured lipid OPO: 65 degrees C temperature; 1:8 substrate molar ratio between palm stearin and OA; 8% (w/w) enzyme load; 3.5% water content of the immobilized lipase; and 1 h reaction time. Under these conditions, highly efficient C52 production (45.65%) was achieved, with a tripalmitin content of 2.75% and a sn-2 palmitic acid (PA) proportion of 55.08% in the system.	[Cai, Haiying; Li, Yang; Zhao, Minjie; Lai, Jia; Feng, Fengqin] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Cai, Haiying; Li, Yang; Zhao, Minjie; Lai, Jia; Feng, Fengqin] Zhejiang Univ, Zhejiang Key Lab Agrofood Proc, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Guanwen] Hangzhou Kangyuan Food Technol Co Ltd, Hangzhou, Zhejiang, Peoples R China; [Feng, Fengqin] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Feng, FQ (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fengfq@zju.edu.cn	Cai, Haiying/AAQ-6456-2021		Key Science and Technology Programs in Zhejiang Province [2012C12005-2]; Hangzhou Kangyuan Food Technology Co., Ltd	Key Science and Technology Programs in Zhejiang Province; Hangzhou Kangyuan Food Technology Co., Ltd	This work was supported by the Key Science and Technology Programs in Zhejiang Province (No. 2012C12005-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hangzhou Kangyuan Food Technology Co., Ltd provided support in the form of salaries for author Guanwen Fu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adlercreutz P, 2013, CHEM SOC REV, V42, P6406, DOI 10.1039/c3cs35446f; Aggett P, 2003, NUTRITION, V19, P375, DOI 10.1016/S0899-9007(02)00999-1; Alles M. S., 2004, CURRENT PAEDIAT, V14, P51; Bastida A, 1998, BIOTECHNOL BIOENG, V58, P486, DOI 10.1002/(SICI)1097-0290(19980605)58:5<486::AID-BIT4>3.0.CO;2-9; Blanco RM, 2007, J MOL CATAL B-ENZYM, V47, P13, DOI 10.1016/j.molcatb.2007.03.003; Cao XW, 2009, PROCESS BIOCHEM, V44, P177, DOI 10.1016/j.procbio.2008.10.003; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Contesini FJ, 2010, J MOL CATAL B-ENZYM, V67, P163, DOI 10.1016/j.molcatb.2010.07.021; Esteban L, 2011, BIOCHEM ENG J, V54, P62, DOI 10.1016/j.bej.2011.01.009; Fernandez-Lorente G, 2007, ENZYME MICROB TECH, V41, P565, DOI 10.1016/j.enzmictec.2007.05.004; Gustafsson H, 2012, COLLOID SURFACE B, V100, P22, DOI 10.1016/j.colsurfb.2012.04.042; Herbst D, 2012, J BIOTECHNOL, V162, P398, DOI 10.1016/j.jbiotec.2012.03.011; Hou C, 2014, PROCESS BIOCHEM, V49, P244, DOI 10.1016/j.procbio.2013.10.019; Jegannathan KR, 2008, CRIT REV BIOTECHNOL, V28, P253, DOI [10.1080/07388550802428392, 10.1080/07388550802428392 ]; Jensen RG, 1999, LIPIDS, V34, P1243, DOI 10.1007/s11745-999-0477-2; JENSEN RG, 1992, J PEDIATR GASTR NUTR, V15, P232, DOI 10.1097/00005176-199210000-00002; Kim BH, 2005, J AGR FOOD CHEM, V53, P8033, DOI 10.1021/jf0509761; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Koseki T, 2013, APPL MICROBIOL BIOT, V97, P5351, DOI 10.1007/s00253-012-4391-7; Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4; Lam MK, 2010, BIOTECHNOL ADV, V28, P500, DOI 10.1016/j.biotechadv.2010.03.002; Lang DA, 1998, EUR J BIOCHEM, V254, P333, DOI 10.1046/j.1432-1327.1998.2540333.x; Liu T, 2011, J MOL CATAL B-ENZYM, V71, P45, DOI 10.1016/j.molcatb.2011.03.007; Manoel EA, 2015, ENZYME MICROB TECH, V71, P53, DOI 10.1016/j.enzmictec.2015.02.001; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Nishizawa K., 1997, J CHEM SOC P2, V26, P1293; No DS, 2013, J AGR FOOD CHEM, V61, P8934, DOI 10.1021/jf402953n; Okobira T, 2015, J BIOSCI BIOENG, V9; Pahujani S, 2008, BIORESOURCE TECHNOL, V99, P2566, DOI 10.1016/j.biortech.2007.04.042; Pencreach G, 1997, BIOTECHNOL BIOENG, V56, P181, DOI 10.1002/(SICI)1097-0290(19971020)56:2<181::AID-BIT7>3.0.CO;2-L; Perignon M, 2013, J AM OIL CHEM SOC, V90, P1151, DOI 10.1007/s11746-013-2256-6; Pleiss J, 2000, BIOCHIMIE, V82, P1043, DOI 10.1016/S0300-9084(00)01181-0; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Simoes T, 2014, J AM OIL CHEM SOC, V91, P411, DOI 10.1007/s11746-013-2379-9; STADLER P, 1995, EUR J BIOCHEM, V227, P335, DOI 10.1111/j.1432-1033.1995.tb20394.x; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Tecelao C, 2012, BIOCHEM ENG J, V67, P104, DOI 10.1016/j.bej.2012.06.001; Toida J, 1998, BIOSCI BIOTECH BIOCH, V62, P759, DOI 10.1271/bbb.62.759; Wei W, 2015, LWT-FOOD SCI TECHNOL, V60, P1187, DOI 10.1016/j.lwt.2014.09.013; Wu XY, 1996, ENZYME MICROB TECH, V19, P226, DOI 10.1016/0141-0229(95)00239-1; Xu XB, 2000, EUR J LIPID SCI TECH, V102, P287; Yadav GD, 2004, CHEM ENG SCI, V59, P373, DOI 10.1016/j.ces.2003.09.034; Yan HD, 2014, CATAL COMMUN, V45, P59, DOI 10.1016/j.catcom.2013.10.018; Yang TK, 2003, J AM OIL CHEM SOC, V80, P881, DOI 10.1007/s11746-003-0789-7; ZAKS A, 1985, P NATL ACAD SCI USA, V82, P3192, DOI 10.1073/pnas.82.10.3192; Zhang YHP, 2011, J MATER CHEM, V21, P18877, DOI 10.1039/c1jm12078f; Zheng MM, 2012, BIORESOURCE TECHNOL, V115, P141, DOI 10.1016/j.biortech.2011.11.128; Zou XQ, 2011, J AGR FOOD CHEM, V59, P6055, DOI 10.1021/jf200619v	48	29	32	15	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133857	10.1371/journal.pone.0133857	http://dx.doi.org/10.1371/journal.pone.0133857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218640	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900051
J	Hiraoka, T; Hoshi, S; Okamoto, Y; Okamoto, F; Oshika, T				Hiraoka, Takahiro; Hoshi, Sujin; Okamoto, Yoshifumi; Okamoto, Fumiki; Oshika, Tetsuro			Mesopic Functional Visual Acuity in Normal Subjects	PLOS ONE			English	Article							LASER PHOTOREFRACTIVE KERATECTOMY; IN-SITU KERATOMILEUSIS; DRY EYE PATIENTS; CONTRAST SENSITIVITY; TONIC ACCOMMODATION; MEASUREMENT SYSTEM; REACTION-TIMES; HIGH MYOPIA; VISION; LUMINANCE	To evaluate mesopic functional visual acuity (FVA) with a newly developed system in normal subjects and to compare the results with photopic FVA, sixty-eight healthy volunteers (24.03 +/- 4.42 [mean +/- standard deviation] years) were enrolled in this study. A commercially available FVA measurement system (AS-28; Kowa, Aichi, Japan) was modified to measure FVA under mesopic conditions as well as photopic conditions. Measurements were performed monocularly in photopic conditions during 60 seconds. After dark adaptation for 15 minutes, the same measurements were repeated in mesopic conditions. Outcomes included starting visual acuity (VA), FVA (the average of VAs), visual maintenance ratio (VMR), maximum VA, minimum VA, and numbers of blinks during the 60-second measurement session, and were compared between mesopic and photopic conditions. Starting VA was -0.11 +/- 0.08 and 0.39 +/- 0.12 logarithm of the minimum angle of resolution (logMAR) in photopic and mesopic conditions, respectively. FVA was -0.06 +/- 0.09 and 0.52 +/- 0.14 logMAR, VMR was 0.98 +/- 0.02 and 0.94 +/- 0.04, maximum VA was -0.15 +/- 0.06 and 0.33 +/- 0.12 logMAR, the minimum VA was 0.05 +/- 0.12 and 0.78 +/- 0.20 logMAR, and the number of blinks was 8.23 +/- 7.54 and 7.23 +/- 6.20, respectively. All these parameters except the number of blinks were significantly different between the two conditions (P < 0.001). Besides, the difference between maximum and minimum VAs and standard deviation of VA were significantly larger in mesopic than in photopic conditions (P < 0.001). This study revealed that not only overall visual function decline but also instability of vision under mesopic conditions even in healthy subjects.	[Hiraoka, Takahiro; Hoshi, Sujin; Okamoto, Yoshifumi; Okamoto, Fumiki; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan	University of Tsukuba	Hiraoka, T (corresponding author), Univ Tsukuba, Fac Med, Dept Ophthalmol, Ibaraki, Japan.	thiraoka@md.tsukuba.ac.jp			JSPS KAKENHI grant [24592619]	JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant number 24592619. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERN M, 1958, J OPT SOC AM, V48, P193, DOI 10.1364/JOSA.48.000193; Arumi P, 1997, OPHTHAL PHYSL OPT, V17, P291, DOI 10.1111/j.1475-1313.1997.tb00060.x; Bella F, 2014, J SAFETY RES, V49, P45, DOI 10.1016/j.jsr.2014.02.007; Brunette I, 2000, OPHTHALMOLOGY, V107, P1790, DOI 10.1016/S0161-6420(00)00267-0; CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; CAMPBELL FW, 1958, J OPT SOC AM, V48, P669, DOI 10.1364/JOSA.48.000669; CHARMAN WN, 1988, OPHTHAL PHYSL OPT, V8, P153, DOI 10.1111/j.1475-1313.1988.tb01031.x; Charman WN, 1997, OPHTHAL PHYSL OPT, V17, P371, DOI 10.1111/j.1475-1313.1997.tb00070.x; CHARMAN WN, 1978, AM J OPTOM PHYS OPT, V55, P84; Collins G., 1937, BR J PHYSL OPT, V11, P30, DOI [10.1111/j.1444-0938.1939.tb01569.x, DOI 10.1111/J.1444-0938.1939.TB01569.X]; Community Road Accident Database, ANN STAT REP 2011; DAVISON PA, 1985, OPHTHAL PHYSL OPT, V5, P195, DOI 10.1111/j.1475-1313.1985.tb00656.x; DOMA H, 1988, VISION RES, V28, P915, DOI 10.1016/0042-6989(88)90100-9; FENDER DH, 1964, SCI AM, V211, P24, DOI 10.1038/scientificamerican0764-24; Goto E, 2003, AM J OPHTHALMOL, V135, P704, DOI 10.1016/S0002-9394(02)02147-5; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; GRAY LS, 1993, OPHTHAL PHYSL OPT, V13, P258, DOI 10.1111/j.1475-1313.1993.tb00468.x; HALLIDAY BL, 1995, BRIT J OPHTHALMOL, V79, P881, DOI 10.1136/bjo.79.10.881; Hamberg-Nystrom H, 1995, J Refract Surg, V11, pS335; Hiraoka T, 2013, J OCUL PHARMACOL TH, V29, P770, DOI 10.1089/jop.2013.0024; Hofstetter H W, 1976, J Am Optom Assoc, V47, P887; HUMPHRISS D, 1987, OPHTHAL PHYSL OPT, V7, P73, DOI 10.1016/0275-5408(87)90183-9; International Road Traffic and Accident Database, ROAD SAF ANN REP 201; Ishida R, 2005, AM J OPHTHALMOL, V139, P253, DOI 10.1016/j.ajo.2004.08.075; Ishioka M, 2009, ACTA OPHTHALMOL, V87, P574, DOI 10.1111/j.1755-3768.2008.01230.x; Johnson CA, 2005, OPTOMETRY VISION SCI, V82, P779, DOI 10.1097/01.opx.0000174767.13915.40; JOHNSON CA, 1976, J OPT SOC AM, V66, P138, DOI 10.1364/JOSA.66.000138; Kaido M, 2008, OPTOMETRY VISION SCI, V85, P758, DOI 10.1097/OPX.0b013e3181819f0a; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2014, INVEST OPHTH VIS SCI, V55, P3275, DOI 10.1167/iovs.13-13000; Kaido M, 2011, JPN J OPHTHALMOL, V55, P183, DOI 10.1007/s10384-011-0026-2; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Lee HK, 2006, J REFRACT SURG, V22, P647; LEIBOWITZ HW, 1978, DOC OPHTHALMOL, V46, P133; MCBRIEN NA, 1987, INVEST OPHTH VIS SCI, V28, P997; McGhee CNJ, 2000, J CATARACT REFR SURG, V26, P497, DOI 10.1016/S0886-3350(00)00312-6; Nishi Y, 2013, ACTA OPHTHALMOL, V91, pE353, DOI 10.1111/aos.12060; Owens DA, 1996, HUM FACTORS, V38, P680, DOI 10.1518/001872096778827233; OWENS DA, 1996, IATSS RES, V20, P57; Owsley C, 1999, SURV OPHTHALMOL, V43, P535, DOI 10.1016/S0039-6257(99)00035-1; OWSLEY C, 1994, OPTOMETRY VISION SCI, V71, P727, DOI 10.1097/00006324-199412000-00002; Piovella M, 1997, OPHTHALMOLOGY, V104, P1554, DOI 10.1016/S0161-6420(97)30096-7; Plainis S, 2000, NEUROPSYCHOLOGIA, V38, P1555, DOI 10.1016/S0028-3932(00)00100-7; Plainis S, 2002, OPHTHAL PHYSL OPT, V22, P409, DOI 10.1046/j.1475-1313.2002.00076.x; Puell MC, 2004, J REFRACT SURG, V20, P484, DOI 10.3928/1081-597X-20040901-12; Rassow B, 1999, KLIN MONATSBL AUGENH, V214, P401, DOI 10.1055/s-2008-1034820; RICHARDS OW, 1966, AMER J OPT ARCH AM A, V43, P313; Rubin GS, 2007, INVEST OPHTH VIS SCI, V48, P1483, DOI 10.1167/iovs.06-0474; Schlote T, 1997, J CATARACT REFR SURG, V23, P718, DOI 10.1016/S0886-3350(97)80280-5; SCHOR CM, 1984, OPHTHAL PHYSL OPT, V4, P133, DOI 10.1111/j.1475-1313.1984.tb00346.x; Subzwari S, 2009, COCHRANE DB SYST REV, V21; Tanaka M, 2004, J CATARACT REFR SURG, V30, P2311, DOI 10.1016/j.jcrs.2004.02.086; Wakamatsu TH, 2011, J CATARACT REFR SURG, V37, P258, DOI 10.1016/j.jcrs.2010.08.048; Watanabe K, 2014, CONTACT LENS ANTERIO, V37, P203, DOI 10.1016/j.clae.2013.11.009; Williams AF, 2003, J SAFETY RES, V34, P5, DOI 10.1016/S0022-4375(02)00075-0; WINN B, 1992, OPHTHAL PHYSL OPT, V12, P252; Yamaguchi T, 2009, J REFRACT SURG, V25, P410, DOI 10.3928/1081597X-20090422-02	57	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134505	10.1371/journal.pone.0134505	http://dx.doi.org/10.1371/journal.pone.0134505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218066	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900122
J	Jovicic, N; Jeftic, I; Jovanovic, I; Radosavljevic, G; Arsenijevic, N; Lukic, ML; Pejnovic, N				Jovicic, Nemanja; Jeftic, Ilija; Jovanovic, Ivan; Radosavljevic, Gordana; Arsenijevic, Nebojsa; Lukic, Miodrag L.; Pejnovic, Nada			Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding	PLOS ONE			English	Article							DIET-INDUCED OBESITY; LIVER-DISEASE; ADIPOSE-TISSUE; WIDE ASSOCIATION; INTERFERON-GAMMA; C57BL/6J MICE; FIBROSIS; INFLAMMATION; SUSCEPTIBILITY; EXPRESSION	Immune reactivity plays an important role in obesity-associated metabolic disorders. We investigated immunometabolic phenotype of C57Bl/6 and BALB/c mice, prototypical Th1 and Th2-type strains, fed chow or high-fat diet (HFD) for 24 weeks. In comparison to C57Bl/ 6 mice, chow-fed BALB/c mice had higher body weight and weight gain, lower glycemia, more pronounced liver steatosis, but less inflammation and collagen deposition in liver. In response to HFD C57Bl/6 mice exhibited higher weight gain, higher glycemia, HbA1c and liver glycogen content, increased amount of visceral adipose tissue (VAT) and number of VAT associated CD3(+) CXCR3(+) T cells, CD11c(+) dendritic cells (DCs) and F4/80(+) macrophages than BALB/c mice. More numerous CD3(+) and CD8(+) T lymphocytes, myeloid DCs, proinflammatory macrophages (F4/80(+) CD11b(+) CD11(+) and F4/80(+) IL-1 beta(+)) and CD11b(+) Ly6C(high) monocytes and higher levels of proinflammatory IL-6, TNF-alpha and IFN-gamma were present in liver in HFD-fed C57Bl/6 mice compared with diet-matched BALB/c mice. As opposed to C57Bl/6 mice, HFD induced marked liver steatosis and upregulated the hepatic LXRa alpha and PPAR. genes in BALB/c mice. C57Bl/6 mice fed HFD developed liver fibrosis and increased hepatic procollagen and TGF-alpha mRNA expression, and IL-33, IL-13 and TGF-beta levels in liver homogenates, while BALB/c mice fed HFD had scarce collagen deposition in liver. The obtained results suggest inherent immunometabolic differences in C57Bl/6 and BALB/c mice. Moreover, HFD Th1-type mice on high fat diet regimen are more susceptible to adiposity, liver inflammation and fibrosis, while Th2-type mice to liver steatosis, which is associated with differential immune cell composition in metabolic tissues. Strain-dependent differences in immunometabolic phenotype may be relevant for studies of obesity-associated metabolic diseases in humans.	[Jovicic, Nemanja; Jeftic, Ilija; Jovanovic, Ivan; Radosavljevic, Gordana; Arsenijevic, Nebojsa; Lukic, Miodrag L.; Pejnovic, Nada] Univ Kragujevac, Fac Med Sci, Ctr Mol Med, Kragujevac, Serbia; [Jovicic, Nemanja] Univ Kragujevac, Fac Med Sci, Inst Histol, Kragujevac, Serbia; [Jeftic, Ilija; Pejnovic, Nada] Univ Kragujevac, Fac Med Sci, Inst Pathophysiol, Kragujevac, Serbia	University of Kragujevac; University of Kragujevac; University of Kragujevac	Lukic, ML (corresponding author), Univ Kragujevac, Fac Med Sci, Ctr Mol Med, Kragujevac, Serbia.	miodrag.lukic@medf.kg.ac.rs; nadap@ikomline.net	Jovicic, Nemanja U/Q-9078-2016; Lukic, Miodrag/U-8848-2019; Jovicic, Nemanja/HGF-1384-2022	Arsenijevic, Nebojsa/0000-0002-2107-3490; Radosavljevic, Gordana/0000-0001-6016-0725; Pejnovic, Nada/0000-0002-2279-9197; Jeftic, Ilija/0000-0002-3328-7293; Jovanovic, Ivan/0000-0002-1169-2378; Lukic, Miodrag/0000-0002-3563-632X; Jovicic, Nemanja/0000-0003-1697-8380	Serbian Ministry of Science and Technological Development (Belgrade, Serbia) [175071, 175069]; SCOPES [IZ73Z0_152407]; Faculty of Medical Sciences (Kragujevac, Serbia) [JP 02-14, JP 03-14]	Serbian Ministry of Science and Technological Development (Belgrade, Serbia)(Ministry of Education, Science & Technological Development, Serbia); SCOPES; Faculty of Medical Sciences (Kragujevac, Serbia)	This work was supported by grants from the Serbian Ministry of Science and Technological Development (175071 and 175069) (Belgrade, Serbia), Joint research project (SCOPES, IZ73Z0_152407) and Internal projects of Faculty of Medical Sciences (JP 02-14, JP 03-14) (Kragujevac, Serbia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Bonniaud P, 2004, AM J RESP CELL MOL, V31, P510, DOI 10.1165/rcmb.2004-0158OC; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; Choi S, 2005, CURR OPIN GASTROEN, V21, P702, DOI 10.1097/01.mog.0000182863.96421.47; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; De Minicis S, 2011, EXPERT REV GASTROENT, V5, P179, DOI [10.1586/EGH.11.28, 10.1586/egh.11.28]; Deutsch MJ, 2014, ANAL BIOCHEM, V445, P87, DOI 10.1016/j.ab.2013.10.001; Farrell GC, 2014, LIVER INT, V34, P1084, DOI 10.1111/liv.12335; Fernandez I, 2010, J AM ASSOC LAB ANIM, V49, P202; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Grarup N, 2014, DIABETOLOGIA, V57, P1528, DOI 10.1007/s00125-014-3270-4; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hadi AM, 2010, ANAL CELL PATHOL, V33, P257, DOI [10.1155/2010/858356, 10.3233/ACP-CLO-2010-0548]; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hayashi H, 2011, AM J PHYSIOL-GASTR L, V300, pG729, DOI 10.1152/ajpgi.00013.2011; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; HERBERG L, 1974, J LIPID RES, V15, P580; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Juluri R, 2011, J CLIN GASTROENTEROL, V45, P55, DOI 10.1097/MCG.0b013e3181dd1348; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Lin XB, 2005, AM J PHYSIOL-GASTR L, V288, pG1179, DOI 10.1152/ajpgi.00411.2004; Lin YC, 2014, AM J CLIN NUTR, V99, P869, DOI 10.3945/ajcn.113.079749; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Milovanovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045225; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248; Nishikawa S, 2008, TOXICOL PATHOL, V36, P850, DOI 10.1177/0192623308323920; Nishikawa S, 2007, EXP ANIM TOKYO, V56, P263, DOI 10.1538/expanim.56.263; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Pejnovic NN, 2013, DIABETES, V62, P1932, DOI 10.2337/db12-0222; Pinchuk Lesya M, 2008, Immun Ageing, V5, P1, DOI 10.1186/1742-4933-5-1; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Saksida T, 2013, J CELL PHYSIOL, V228, P1568, DOI 10.1002/jcp.24318; Stefanovic-Racic M, 2012, DIABETES, V61, P2330, DOI 10.2337/db11-1523; Stewart D, 2002, SHOCK, V18, P342, DOI 10.1097/00024382-200210000-00009; Stolarczyk E, 2014, IMMUNE CELL TRANSCRI, V3, P58, DOI [10.4161/adip.26220, DOI 10.4161/ADIP.26220]; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zdravkovic N, 2009, MOL IMMUNOL, V47, P28, DOI 10.1016/j.molimm.2008.12.023	56	63	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134089	10.1371/journal.pone.0134089	http://dx.doi.org/10.1371/journal.pone.0134089			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218873	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900076
J	Liu, W; Peng, LP; Liu, HM; Hua, SC				Liu, Wei; Peng, Liping; Liu, Hongmei; Hua, Shucheng			Pulmonary Function and Clinical Manifestations of Patients Infected with Mild Influenza A Virus Subtype H1N1: A One-Year Follow-Up	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; EXERCISE CAPACITY; LUNG-FUNCTION; SURVIVORS; HUMANS	Objective To investigate the long-term effects of mild H1N1 influenza infection on the pulmonary function of a cohort of patients. Methods Forty-eight patients, all diagnosed with influenza A virus subtype H1N1 in 2009, were retrospectively included in this study. Each patient in the study was monitored for 11-13 months by standard pulmonary function examination. The examination included monitoring respiratory tract infection symptoms (cough, expectoration or gasping) and vital signs. Long-term changes in symptoms and changes in vital signs were correlated back to and compared with the severity of the initial H1N1 influenza infection. Results One year post discharge, mild to moderate pulmonary dysfunction was observed in the majority of patients. Further, 54.2% of patients had signs of severe abnormal pulmonary function, including diffusion disorder (33.3%) and small airway dysfunction (33.3%). Fourteen patients presented with respiratory tract infection symptoms; 12 with abnormal pulmonary function and two with normal pulmonary function. Our results indicated that the change in pulmonary function at one year post discharge was not significantly correlated with the severity of H1N1 influenza. Conclusion Signs and symptoms of abnormal pulmonary function accompanied by respiratory tract infection symptoms remain for some patients after one year following discharge from the hospital for mild influenza A virus subtype H1N1 infection. These patients should continue to be monitored for any changes in condition and symptoms and rehabilitation treatment should be provided when necessary.	[Liu, Wei; Peng, Liping; Liu, Hongmei; Hua, Shucheng] Jilin Univ, Hosp 1, Dept Resp Med, Changchun 130021, Jilin Province, Peoples R China	Jilin University	Hua, SC (corresponding author), Jilin Univ, Hosp 1, Dept Resp Med, Changchun 130021, Jilin Province, Peoples R China.	shuchenghua@eyou.com						Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Goka EA, 2014, ARCH VIROL, V159, P3167, DOI 10.1007/s00705-014-2179-z; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Luyt CE, 2012, CHEST, V142, P583, DOI 10.1378/chest.11-2196; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McMullen SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040190; Neff TA, 2003, CHEST, V123, P845, DOI 10.1378/chest.123.3.845; Ngai JC, 2010, RESPIROLOGY, V15, P543, DOI 10.1111/j.1440-1843.2010.01720.x; PETERS JI, 1989, AM REV RESPIR DIS, V139, P1163, DOI 10.1164/ajrccm/139.5.1163; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rios FG, 2011, CRIT CARE, V15, DOI 10.1186/cc10369; Schmidt R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-55; Su MC, 2007, RESPIRATION, V74, P511, DOI 10.1159/000095673; SUCHYTA MR, 1993, RESPIRATION, V60, P103	15	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133698	10.1371/journal.pone.0133698	http://dx.doi.org/10.1371/journal.pone.0133698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218647	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900041
J	Nakajima, M; Arimatsu, K; Kato, T; Matsuda, Y; Minagawa, T; Takahashi, N; Ohno, H; Yamazaki, K				Nakajima, Mayuka; Arimatsu, Kei; Kato, Tamotsu; Matsuda, Yumi; Minagawa, Takayoshi; Takahashi, Naoki; Ohno, Hiroshi; Yamazaki, Kazuhisa			Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERIODONTAL-DISEASE; DIABETES-MELLITUS; INFLAMMATION; HEALTH; METAANALYSIS; PATHOGENS; OBESITY; MICE	Although periodontitis has been implicated as a risk factor for various systemic diseases, the precise mechanisms by which periodontitis induces systemic disease remain to be elucidated. We have previously revealed that repeated oral administration of Porphyromonas gingivalis elicits endotoxemia via changes in the gut microbiota of the ileum, and thereby induces systemic inflammation and insulin resistance. However, it is not clear to what extent a single administration of P. gingivalis could affect gut microbiota composition, gut barrier function, and subsequent influx of gut microbiota into the liver. Therefore, in the present study, C57BL/6 mice were orally administered P. gingivalis (strain W83) once and compared to sham-inoculated mice. The phylogenetic structure and diversity of microbial communities in the gut and liver were analyzed by pyrosequencing the 16S ribosomal RNA genes. Serum endotoxin activity was determined by a Limulus amebocyte lysate test. Gene expression in the intestine and expression of 16S rRNA genes in the blood and liver were examined by quantitative polymerase chain reaction. Administration of P. gingivalis significantly altered gut microbiota, with an increased proportion of phylum Bacteroidetes, a decreased proportion of phylum Firmicutes, and increased serum endotoxin levels. In the intestinal tissues, gene expression of tjp-1 and occludin, which are involved in intestinal permeability, were downregulated. Higher amounts of bacterial DNA were detected in the liver of infected mice. Importantly, changes in gut microbiota preceded systemic inflammatory changes. These results further support the idea that disturbance of the gut microbiota composition by orally derived periodontopathic bacteria may be a causal mechanism linking periodontitis and systemic disease.	[Nakajima, Mayuka; Arimatsu, Kei; Matsuda, Yumi; Minagawa, Takayoshi; Takahashi, Naoki; Yamazaki, Kazuhisa] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Lab Periodontol & Immunol, Niigata, Japan; [Nakajima, Mayuka; Arimatsu, Kei; Matsuda, Yumi; Minagawa, Takayoshi; Takahashi, Naoki] Niigata Univ, Div Periodontol, Dept Oral Biol Sci, Grad Sch Med & Dent Sci, Niigata, Japan; [Kato, Tamotsu; Ohno, Hiroshi] RIKEN, Lab Intestinal Ecosyst, Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan; [Ohno, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Niigata University; Niigata University; RIKEN; Japan Science & Technology Agency (JST)	Yamazaki, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Lab Periodontol & Immunol, Niigata, Japan.	kaz@dent.niigata-u.ac.jp	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661; Kato, Tamotsu/0000-0002-8407-4327; Nakajima, Mayuka/0000-0002-2875-2111	Japan Society for the Promotion of Science KAKENHI [23390476, 25670882, 15H02578]; Japan Science and Technology Agency; Sunstar Inc.	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Sunstar Inc.	This work was supported by the Japan Society for the Promotion of Science KAKENHI 23390476, 25670882, and 15H02578 (KY); The Japan Science and Technology Agency (HO); and Sunstar Inc. (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Armingohar Z, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23408; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Boutaga K, 2007, J PERIODONTOL, V78, P79, DOI 10.1902/jop.2007.060078; Brinkman BM, 2013, INFLAMM BOWEL DIS, V19, P2560, DOI 10.1097/MIB.0b013e3182a8759a; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cullinan MP, 2013, PERIODONTOL 2000, V62, P271, DOI 10.1111/prd.12007; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fukuda S, 2014, SEMIN IMMUNOPATHOL, V36, P103, DOI 10.1007/s00281-013-0399-z; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Kato T, 2014, DNA RES, V21, P469, DOI 10.1093/dnares/dsu013; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Chavarry NGM, 2009, ORAL HLTH PREV DENT, V7, P107; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salvi GE, 2008, J CLIN PERIODONTOL, V35, P398, DOI 10.1111/j.1600-051X.2008.01282.x; Saygun I, 2011, J PERIODONTAL RES, V46, P235, DOI 10.1111/j.1600-0765.2010.01335.x; Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336; Vaziri ND, 2012, NEPHROL DIAL TRANSPL, V27, P2686, DOI 10.1093/ndt/gfr624; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; vonTroilLinden B, 1995, J DENT RES, V74, P1789, DOI 10.1177/00220345950740111201; Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843	36	170	185	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134234	10.1371/journal.pone.0134234	http://dx.doi.org/10.1371/journal.pone.0134234			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218067	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900100
J	Olah, G; Szczesny, B; Brunyanszki, A; Lopez-Garcia, IA; Gero, D; Radak, Z; Szabo, C				Olah, Gabor; Szczesny, Bartosz; Brunyanszki, Attila; Lopez-Garcia, Isabel A.; Geroe, Domokos; Radak, Zsolt; Szabo, Csaba			Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; SATELLITE CELLS; POTENTIAL ROLE; DNA-DAMAGE; MITOCHONDRIAL; INHIBITION; EXERCISE; METABOLISM; REPAIR; MODULATION	Poly(ADP-ribose) polymerase 1 (PARP-1), the major isoform of the poly (ADP-ribose) polymerase family, is a constitutive nuclear and mitochondrial protein with well-recognized roles in various essential cellular functions such as DNA repair, signal transduction, apoptosis, as well as in a variety of pathophysiological conditions including sepsis, diabetes and cancer. Activation of PARP-1 in response to oxidative stress catalyzes the covalent attachment of the poly (ADP-ribose) (PAR) groups on itself and other acceptor proteins, utilizing NAD(+) as a substrate. Overactivation of PARP-1 depletes intracellular NAD(+) influencing mitochondrial electron transport, cellular ATP generation and, if persistent, can result in necrotic cell death. Due to their high metabolic activity, skeletal muscle cells are particularly exposed to constant oxidative stress insults. In this study, we investigated the role of PARP-1 in a well-defined model of murine skeletal muscle differentiation (C2C12) and compare the responses to oxidative stress of undifferentiated myoblasts and differentiated myotubes. We observed a marked reduction of PARP-1 expression as myoblasts differentiated into myotubes. This alteration correlated with an increased resistance to oxidative stress of the myotubes, as measured by MTT and LDH assays. Mitochondrial function, assessed by measuring mitochondrial membrane potential, was preserved under oxidative stress in myotubes compared to myoblasts. Moreover, basal respiration, ATP synthesis, and the maximal respiratory capacity of mitochondria were higher in myotubes than in myoblasts. Inhibition of the catalytic activity of PARP-1 by PJ34 (a phenanthridinone PARP inhibitor) exerted greater protective effects in undifferentiated myoblasts than in differentiated myotubes. The above observations in C2C12 cells were also confirmed in a rat-derived skeletal muscle cell line (L6). Forced overexpression of PARP1 in C2C12 myotubes sensitized the cells to oxidant-induced injury. Taken together, our data indicate that the reduction of PARP-1 expression during the process of the skeletal muscle differentiation serves as a protective mechanism to maintain the cellular functions of skeletal muscle during oxidative stress.	[Olah, Gabor; Szczesny, Bartosz; Brunyanszki, Attila; Lopez-Garcia, Isabel A.; Geroe, Domokos; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Radak, Zsolt] Semmelweis Univ, Fac Phys Educ & Sport Sci, H-1085 Budapest, Hungary; [Szczesny, Bartosz; Szabo, Csaba] Shriners Hosp Children, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; Semmelweis University; University of Physical Education	Szabo, C (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	szabocsaba@aol.com	Gero, Domokos/F-7853-2017; Szabo, Csaba/ABG-2644-2021	Gero, Domokos/0000-0002-3132-3465; Radak, Zsolt/0000-0003-1297-6804	US National Institutes of Health [2P50 GM060338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM060338] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health 2P50 GM060338 to C.S.	Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Aoi W, 2014, SUBCELL BIOCHEM, V77, P175, DOI 10.1007/978-94-007-7920-4_15; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brunyanszki A, 2014, MOL PHARMACOL, V86, P450, DOI 10.1124/mol.114.094318; Chen M, 2004, CARDIOVASC RES, V63, P682, DOI 10.1016/j.cardiores.2004.04.018; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Diaz EC, 2015, BURNS, V41, P649, DOI 10.1016/j.burns.2014.10.010; Ding YC, 2001, BRAIN RES, V915, P210, DOI 10.1016/S0006-8993(01)02852-9; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Erdelyi K, 2009, FASEB J, V23, P3553, DOI 10.1096/fj.09-133264; Ferri P, 2009, J CELL BIOCHEM, V108, P1302, DOI 10.1002/jcb.22360; Frederick DW, 2015, J BIOL CHEM, V290, P1546, DOI 10.1074/jbc.M114.579565; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gero D, 2014, MOL MED, V20, P313, DOI 10.2119/molmed.2014.00102; Gero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065994; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HELLER B, 1995, J BIOL CHEM, V270, P11176, DOI 10.1074/jbc.270.19.11176; Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jagtap P, 2002, CRIT CARE MED, V30, P1071, DOI 10.1097/00003246-200205000-00019; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Modis K, 2013, BIOCHEM PHARMACOL, V86, P1311, DOI 10.1016/j.bcp.2013.08.064; Modis K, 2012, BIOCHEM PHARMACOL, V83, P633, DOI 10.1016/j.bcp.2011.12.014; Mohamed JS, 2014, DIABETES, V63, P1546, DOI 10.2337/db13-1364; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Pieper AA, 2000, MOL MED, V6, P271, DOI 10.1007/BF03401936; Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002; Radak Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Radak Z, 2011, FREE RADICAL BIO MED, V51, P417, DOI 10.1016/j.freeradbiomed.2011.04.018; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Sakellariou GK, 2014, FREE RADICAL RES, V48, P12, DOI 10.3109/10715762.2013.830718; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; Szczesny B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075201; Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009; Thibault R, 2011, CURR OPIN CLIN NUTR, V14, P261, DOI 10.1097/MCO.0b013e3283455d60; Wang YX, 2014, J CELL SCI, V127, P4543, DOI 10.1242/jcs.151209; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	54	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134227	10.1371/journal.pone.0134227	http://dx.doi.org/10.1371/journal.pone.0134227			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218895	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900098
J	Wu, JN; Li, SR; Jia, WJ; Deng, HR; Chen, K; Zhu, LL; Yu, FY; Su, FX				Wu, Jiannan; Li, Shunrong; Jia, Weijuan; Deng, Heran; Chen, Kai; Zhu, Liling; Yu, Fengyan; Su, Fengxi			Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; TUMOR; CHEMOTHERAPY; DOXORUBICIN; MICRORNAS	Chemotherapy resistance remains an important problem in the breast cancer clinic. The ability to predict the patients who would respond to a distinct therapy would help to optimize tailored treatment options. miRNAs can mediate a number of genes in response to druginduced acute cellular stress. Several studies suggest that let-7 miRNA may be involved in the chemosensitivity of cancer cell lines in vitro. However, it is not known whether this phenomenon occurs in clinical breast tumors. The present study showed that lower let-7a expression was associated with epirubicin resistance in primary breast tumors. Moreover, upregulation of let-7a expression sensitized resistant breast tumor cell lines to epirubicin by enhancing cellular apoptosis in vitro. Collectively, these findings indicate that lower expression of let-7a miRNA can induce chemoresistance in breast cancer by enhancing cellular apoptosis and suggest that let-7a may be used as a therapeutic target to modulate epirubicin-based chemotherapy resistance.	[Wu, Jiannan; Yu, Fengyan; Su, Fengxi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Wu, Jiannan; Li, Shunrong; Jia, Weijuan; Deng, Heran; Chen, Kai; Zhu, Liling; Yu, Fengyan; Su, Fengxi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yu, FY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China.	fengyanyu_summer@163.com; fengxisu@vip.163.com	Wu, Jiannan/AAD-9358-2019		National Natural Science Foundation of China [81472731]; Guangdong Natural Science Funds for Distinguished Young Scholars [S20120011199]; Program for New Century Excellent Talents in University of the Ministry of Education of China; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD); Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013] 163]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes [KLB09001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholars; Program for New Century Excellent Talents in University of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China); Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes	This work was supported by the National Natural Science Foundation of China (81472731), the Guangdong Natural Science Funds for Distinguished Young Scholars (S20120011199), the Program for New Century Excellent Talents in University of the Ministry of Education of China and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD). This work was also supported by Grant [2013] 163 from the Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology and Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes.	Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Helleman J, 2010, INT J BIOCHEM CELL B, V42, P25, DOI 10.1016/j.biocel.2009.10.016; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaufmann M, 2007, ANN ONCOL, V18, P1927, DOI 10.1093/annonc/mdm201; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Serguienko A, 2015, ONCOTARGET, V6, P2451, DOI 10.18632/oncotarget.3235; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; van Jaarsveld MTM, 2010, INT J BIOCHEM CELL B, V42, P1282, DOI 10.1016/j.biocel.2010.01.014; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	16	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133643	10.1371/journal.pone.0133643	http://dx.doi.org/10.1371/journal.pone.0133643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218285	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900037
J	Isosaka, M; Niinuma, T; Nojima, M; Kai, M; Yamamoto, E; Maruyama, R; Nobuoka, T; Nishida, T; Kanda, T; Taguchi, T; Hasegawa, T; Tokino, T; Hirata, K; Suzuki, H; Shinomura, Y				Isosaka, Mai; Niinuma, Takeshi; Nojima, Masanori; Kai, Masahiro; Yamamoto, Eiichiro; Maruyama, Reo; Nobuoka, Takayuki; Nishida, Toshirou; Kanda, Tatsuo; Taguchi, Takahiro; Hasegawa, Tadashi; Tokino, Takashi; Hirata, Koichi; Suzuki, Hiromu; Shinomura, Yasuhisa			A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							TARGETING BCL-W; HEPATOCELLULAR-CARCINOMA; INHIBITS MIGRATION; COLORECTAL-CANCER; PANCREATIC-CANCER; DNA METHYLATION; GASTRIC-CANCER; OVARIAN-CANCER; ANATOMIC SITE; BREAST-CANCER	Background Dysregulation of microRNA (miRNA) has been implicated in gastrointestinal stromal tumors (GISTs) but the mechanism is not fully understood. In this study, we aimed to explore the involvement of epigenetic alteration of miRNA genes in GISTs. Methods GIST-T1 cells were treated with 5-aza-2'-deoxycytidine (5-aza-dC) and 4-phenylbutyric acid (PBA), after which miRNA expression profiles were analyzed using TaqMan miRNA arrays. DNA methylation was then analyzed using bisulfite pyrosequencing. The functions of miRNAs were examined using MTT assays, wound-healing assays, Boyden chamber assays and Matrigel invasion assays. Gene expression microarrays were analyzed to assess effect of ectopic miRNA expression in GIST-T1 cells. Results Of the 754 miRNAs analyzed, 61 were significantly upregulated in GIST-T1 cells treated with 5-aza-dC plus PBA. Among those, 21 miRNA genes were associated with an upstream CpG island (CGI), and the CGIs of miR-34a and miR-335 were frequently methylated in GIST-T1 cells and primary GIST specimens. Transfection of miR-34a or miR-335 mimic molecules into GIST-T1 cells suppressed cell proliferation, and miR-34a also inhibited migration and invasion by GIST-T1 cells. Moreover, miR-34a downregulated a number of predicted target genes, including PDGFRA. RNA interference-mediated knockdown of PDGFRA in GIST-T1 cells suppressed cell proliferation, suggesting the tumor suppressive effect of miR-34a is mediated, at least in part, through targeting PDGFRA. Conclusions Our results suggest that miR-34a and miR-335 are candidate tumor suppressive miRNAs in GISTs, and that they are frequent targets of epigenetic silencing in GISTs.	[Isosaka, Mai; Yamamoto, Eiichiro; Maruyama, Reo; Shinomura, Yasuhisa] Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan; [Niinuma, Takeshi; Kai, Masahiro; Yamamoto, Eiichiro; Suzuki, Hiromu] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Nojima, Masanori] Univ Tokyo, Inst Med Sci, Ctr Translat Res, Tokyo, Japan; [Nobuoka, Takayuki; Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan; [Nishida, Toshirou] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan; [Kanda, Tatsuo] Sanjo Gen Hosp, Dept Surg, Sanjo City, Niigata, Japan; [Taguchi, Takahiro] Kochi Univ, Grad Sch Kuroshio Sci, Div Human Hlth & Med Sci, Nankoku, Kochi, Japan; [Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan; [Tokino, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Med Genome Sci, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; University of Tokyo; Sapporo Medical University; National Cancer Center - Japan; Kochi University; Sapporo Medical University; Sapporo Medical University	Suzuki, H (corresponding author), Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan.	hsuzuki@sapmed.ac.jp	ravegnini, gloria/K-1330-2016; Tokino, Takashi/AAI-9887-2021; Nojima, Masanori/ABE-2237-2020	ravegnini, gloria/0000-0002-7774-402X; Nojima, Masanori/0000-0002-8788-2522	Japan Society for Promotion of Science [25670371, 26860514]; Takeda Science Foundation [2011]; Project for Developing Innovative Research on Cancer Therapeutics (P-DIRECT) [11093014]; Grants-in-Aid for Scientific Research [25430115] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Project for Developing Innovative Research on Cancer Therapeutics (P-DIRECT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-Aid for Challenging Exploratory Research from the Japan Society for Promotion of Science (No 25670371), Grant-in-Aid for Young Scientists (B) from the Japan Society for Promotion of Science (No 26860514), the Takeda Science Foundation (No 2011), and the Project for Developing Innovative Research on Cancer Therapeutics (P-DIRECT) (No 11093014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; Assamaki R, 2007, GENE CHROMOSOME CANC, V46, P564, DOI 10.1002/gcc.20439; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Cao J, 2013, ONCOL REP, V30, P701, DOI 10.3892/or.2013.2482; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chim CS, 2010, CARCINOGENESIS, V31, P745, DOI 10.1093/carcin/bgq033; Choi HJ, 2010, INT J CANCER, V126, P1640, DOI 10.1002/ijc.24897; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; de la Rosa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3268; Dohi O, 2013, INT J ONCOL, V42, P411, DOI 10.3892/ijo.2012.1724; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan R, 2014, TUMOR BIOL, V35, P4209, DOI 10.1007/s13277-013-1551-z; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Gao L, 2014, TUMOR BIOL, V35, P8309, DOI 10.1007/s13277-014-2092-9; Gao Y, 2015, TUMOR BIOL, V36, P2875, DOI 10.1007/s13277-014-2917-6; Garofalo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067581; Gong M, 2014, MOL CANCER RES, V12, P101, DOI 10.1158/1541-7786.MCR-13-0136; Guan XY, 2001, CANCER RES, V61, P3806; Haller F, 2010, J PATHOL, V220, P71, DOI 10.1002/path.2610; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He LR, 2011, INT J CANCER, V129, P143, DOI 10.1002/ijc.25669; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heyn H, 2011, INT J CANCER, V129, P2797, DOI 10.1002/ijc.25962; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S0016-5085(03)01046-1; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jiang J, 2012, MED ONCOL, V29, P3472, DOI 10.1007/s12032-012-0259-z; Joensuu H, 2013, LANCET, V382, P973, DOI 10.1016/S0140-6736(13)60106-3; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li Y, 2014, GASTROENTEROLOGY, V146, P1701, DOI 10.1053/j.gastro.2014.02.029; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu S, 2014, TUMOR BIOL, V35, P9131, DOI 10.1007/s13277-014-2177-5; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lynch J, 2012, CARCINOGENESIS, V33, P976, DOI 10.1093/carcin/bgs114; Nakatani H, 2005, CANCER SCI, V96, P116, DOI 10.1111/j.1349-7006.2005.00018.x; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Okamoto Y, 2012, GUT, V61, P392, DOI 10.1136/gut.2011.241034; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Peng Y, 2014, BIOSCIENCE REP, V34, P247, DOI 10.1042/BSR20140020; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Shimizu T, 2013, EUR UROL, V63, P1091, DOI 10.1016/j.eururo.2012.11.030; Shu MF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-59; Silber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033844; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Wang HQ, 2013, TUMOR BIOL, V34, P3101, DOI 10.1007/s13277-013-0878-9; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wozniak A, 2007, GENE CHROMOSOME CANC, V46, P261, DOI 10.1002/gcc.20408; Xu Y, 2012, ONCOGENE, V31, P1398, DOI 10.1038/onc.2011.340; Yan Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040037; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	60	16	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133754	10.1371/journal.pone.0133754	http://dx.doi.org/10.1371/journal.pone.0133754			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214687	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300031
J	Gnambs, T; Appel, M; Oeberst, A				Gnambs, Timo; Appel, Markus; Oeberst, Aileen			Red Color and Risk-Taking Behavior in Online Environments	PLOS ONE			English	Article							ENHANCES MENS ATTRACTION; DECISION-MAKING; TASK BART; NEED; ASSOCIATIONS; WILLINGNESS; PERFORMANCE; PERSUASION; COGNITION; CONTEXT	In many situations red is associated with hazard and danger. As a consequence, it was expected that task-irrelevant color cues in online environments would affect risk-taking behaviors. This assumption was tested in two web-based experiments. The first study (N = 383) demonstrated that in risky choice dilemmas respondents preferred the less risky option when the displayed university logo was in red (versus gray); but only when both choice alternatives were at least moderately risky. The second study (N = 144) replicated these results with a behavioral outcome: Respondents showed more cautious behavior in a web-based game when the focal stimuli were colored red (versus blue). Together, these findings demonstrate that variations in the color design of a computerized environment affect risk taking: Red color leads to more conservative choices and behaviors.	[Gnambs, Timo] Univ Osnabruck, Inst Psychol, Osnabruck, Germany; [Appel, Markus] Univ Koblenz Landau, Dept Psychol, Landau, Germany; [Oeberst, Aileen] Leibniz Inst Wissensmedien, Tubingen, Germany	University Osnabruck; University of Koblenz & Landau; Leibniz Institut fur Wissensmedien	Gnambs, T (corresponding author), Univ Osnabruck, Inst Psychol, Osnabruck, Germany.	timo.gnambs@uni-osnabrueck.de	Oeberst, Aileen/AAQ-7372-2021; Gnambs, Timo/I-8353-2014; Appel, Markus/ABF-1999-2020	Oeberst, Aileen/0000-0002-1094-9610; Gnambs, Timo/0000-0002-6984-1276; 				Appel M, 2012, J PERS ASSESS, V94, P418, DOI 10.1080/00223891.2012.666921; Appel M, 2010, MEDIA PSYCHOL, V13, P101, DOI 10.1080/15213261003799847; Bagchi R, 2013, J CONSUM RES, V39, P947, DOI 10.1086/666466; Bakhshi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117148; Bolton RN, 2013, J SERV MANAGE, V24, P245, DOI 10.1108/09564231311326987; Bruno N, 2013, APPETITE, V71, P307, DOI 10.1016/j.appet.2013.08.012; Carnevale JJ, 2011, PERS INDIV DIFFER, V51, P274, DOI 10.1016/j.paid.2010.07.002; Chan AHS, 2001, INT J IND ERGONOM, V28, P165, DOI 10.1016/S0169-8141(01)00029-4; Chien YH, 2011, SOC BEHAV PERSONAL, V39, P1063, DOI 10.2224/sbp.2011.39.8.1063; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00368; Elliot AJ, 2014, ANNU REV PSYCHOL, V65, P95, DOI 10.1146/annurev-psych-010213-115035; Elliot AJ, 2013, J EXP SOC PSYCHOL, V49, P599, DOI 10.1016/j.jesp.2012.10.001; Elliot AJ, 2012, ADV EXP SOC PSYCHOL, V45, P61, DOI 10.1016/B978-0-12-394286-9.00002-0; Elliot AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034607; Elliot AJ, 2011, PSYCHOPHYSIOLOGY, V48, P1340, DOI 10.1111/j.1469-8986.2011.01216.x; Feltman R, 2011, J SPORT EXERCISE PSY, V33, P308, DOI 10.1123/jsep.33.2.308; Fernie G, 2010, DRUG ALCOHOL DEPEN, V112, P54, DOI 10.1016/j.drugalcdep.2010.05.011; Figner B, 2011, CURR DIR PSYCHOL SCI, V20, P211, DOI 10.1177/0963721411415790; Gerend MA, 2009, J EXP SOC PSYCHOL, V45, P999, DOI 10.1016/j.jesp.2009.04.002; Gerpott TJ, 2014, TELECOMMUN POLICY, V38, P293, DOI 10.1016/j.telpol.2013.10.003; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Gnambs T, 2015, BEHAV RES METHODS, V47, P1237, DOI 10.3758/s13428-014-0533-4; Gnambs T, 2010, COMPUT HUM BEHAV, V26, P1625, DOI 10.1016/j.chb.2010.06.010; Gueguen N, 2014, J HOSP TOUR RES, V38, P275, DOI 10.1177/1096348012442546; Gueguen N, 2013, COLOR RES APPL, V38, P309, DOI 10.1002/col.21718; Gueguen N, 2012, INT J HOSP MANAG, V31, P1333, DOI 10.1016/j.ijhm.2012.03.012; Gueguen N, 2012, AGGRESSIVE BEHAV, V38, P166, DOI 10.1002/ab.21416; Gueguen Nicolas, 2012, INT J PSYCHOL STUD, V4, P206, DOI DOI 10.5539/IJPS.V4N2P206; Haddock G, 2008, PERS SOC PSYCHOL B, V34, P769, DOI 10.1177/0146167208314871; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Ilie A, 2008, CYBERPSYCHOL BEHAV, V11, P375, DOI 10.1089/cpb.2007.0122; Ishihara S, 1985, ISHIHARAS TEST COLOU; Jadin T, 2013, COMPUT HUM BEHAV, V29, P210, DOI 10.1016/j.chb.2012.08.007; Jiang F, 2014, J BEHAV DECIS MAKING, V27, P226, DOI 10.1002/bdm.1800; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kliger D, 2012, J SOCIO-ECON, V41, P738, DOI 10.1016/j.socec.2012.07.003; Lantz B, 2013, BRIT J MATH STAT PSY, V66, P224, DOI 10.1111/j.2044-8317.2012.02047.x; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lin HY, 2014, DISPLAYS, V35, P202, DOI 10.1016/j.displa.2014.05.009; Maier MA, 2008, PERS SOC PSYCHOL B, V34, P1530, DOI 10.1177/0146167208323104; Meier BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040333; Mousavi S, 2014, J BUS RES, V67, P1671, DOI 10.1016/j.jbusres.2014.02.013; Oeberst A, 2015, COMPUT HUM BEHAV, V44, P250, DOI 10.1016/j.chb.2014.10.060; Or CKL, 2014, COLOR RES APPL, V39, P630, DOI 10.1002/col.21832; Pravossoudovitch K, 2014, ERGONOMICS, V57, P503, DOI 10.1080/00140139.2014.889220; Shi JX, 2015, INT J PSYCHOL, V50, P81, DOI 10.1002/ijop.12076; Sokolik K., 2014, J INTERACT ADVERT, V14, P31, DOI [10.1080/15252019.2014.907757, DOI 10.1080/15252019.2014.907757, https://doi.org/10.1080/15252019.2014.907757]; Ten Velden FS, 2012, J EXP SOC PSYCHOL, V48, P1205, DOI 10.1016/j.jesp.2012.04.004; Zhang TX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089193	51	23	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134033	10.1371/journal.pone.0134033	http://dx.doi.org/10.1371/journal.pone.0134033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26207983	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000193
J	Musilova, I; Kutova, R; Pliskova, L; Stepan, M; Menon, R; Jacobsson, B; Kacerovsky, M				Musilova, Ivana; Kutova, Radka; Pliskova, Lenka; Stepan, Martin; Menon, Ramkumar; Jacobsson, Bo; Kacerovsky, Marian			Intraamniotic Inflammation in Women with Preterm Prelabor Rupture of Membranes	PLOS ONE			English	Article							AMNIOTIC-FLUID INTERLEUKIN-6; PREMATURE RUPTURE; MICROBIAL INVASION; DIAGNOSTIC PERFORMANCE; OXIDATIVE STRESS; RACIAL DISPARITY; BACTERIA; LATENCY; CAVITY; DAMAGE	Objective To characterize subgroups of preterm prelabor rupture of membranes (PPROM) and short-term neonatal outcomes based on the presence and absence of intraamniotic inflammation (IAI) and/or microbial invasion of the amniotic cavity (MIAC). Methods One hundred and sixty-six Caucasian women with singleton pregnancies were included in this study. Amniotic fluid samples were obtained by transabdominal amniocentesis (n=166) and were assayed for interleukin-6 levels by a lateral flow immunoassay. The presence of Ureaplasma species, Mycoplasma hominis, Chlamydia trachomatis, and 16S rRNA was evaluated in the amniotic fluid. IAI was defined as amniotic fluid IL-6 values, measured by a point of care test, higher than 745 pg/mL. Results Microbial-associated IAI (IAI with MIAC) and sterile intraamniotic inflammation (IAI alone) were found in 21% and 4%, respectively, of women with PPROM. Women with microbial-associated IAI had higher microbial loads of Ureaplasma species in the amniotic fluid than women with MIAC alone. No differences in the short-term neonatal morbidity with respect to the presence of microbial-associated IAI, sterile IAI and MIAC alone were found after adjusting for the gestational age at delivery in women with PPROM. Conclusions Microbial-associated but not sterile intraamniotic inflammation is common in Caucasian women with PPROM. The gestational age at delivery but not the presence of inflammation affects the short-term neonatal morbidity of newborns from PPROM pregnancies.	[Musilova, Ivana; Stepan, Martin; Kacerovsky, Marian] Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Charles Univ Prague, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Kutova, Radka; Pliskova, Lenka] Univ Hosp Hradec Kralove, Inst Clin Biochem, Hradec Kralove, Czech Republic; [Menon, Ramkumar] Sahlgrens Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Norwegian Inst Publ Hlth, Dept Genes & Environm, Div Epidemiol, Oslo, Norway; [Jacobsson, Bo] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; University of Gothenburg; Norwegian Institute of Public Health (NIPH); University of Texas System; University of Texas Medical Branch Galveston; University Hospital Hradec Kralove	Kacerovsky, M (corresponding author), Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Charles Univ Prague, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic.	kacermar@fnhk.cz	Kacerovsky, Marian/ABE-3437-2020; Musilová, Ivana Kacerovská/I-6204-2017; Jacobsson, Bo/O-8007-2014; Kacerovsky, Marian/A-7586-2011	Musilová, Ivana Kacerovská/0000-0002-6960-8319; Jacobsson, Bo/0000-0001-5079-2374; Kacerovsky, Marian/0000-0001-9858-7900	Ministry of Health of the Czech Republic [NS 13461-4/2012]; Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK" [P37/10]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK"	This work was supported by 1) a grant from the Ministry of Health of the Czech Republic (NS 13461-4/2012), and 2) Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK" P37/10.	Bredeson S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113799; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P349, DOI 10.3109/14767058.2015.1006620; Chaemsaithong P, 2015, J MATERN-FETAL NEO M, V28, P1510, DOI 10.3109/14767058.2014.961417; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Fortunato SJ, 2004, AM J OBSTET GYNECOL, V190, P1557, DOI 10.1016/j.ajog.2004.03.053; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; Frenette P, 2013, J OBSTET GYNAECOL CA, V35, P710, DOI 10.1016/S1701-2163(15)30861-6; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Jacobsson B, 2009, ACTA OBSTET GYN SCAN, V88, P63, DOI 10.1080/00016340802572646; Kacerovsky M, 2015, AM J OBSTET GYNECOL, V213, P435, DOI 10.1016/j.ajog.2015.05.039; Kacerovsky M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.069; Kacerovsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060399; Kacerovsky M, 2012, J MATERN-FETAL NEO M, V25, P2014, DOI 10.3109/14767058.2012.671873; Kacerovsky M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.004; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Menon R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00567; Menon R, 2014, AM J REPROD IMMUNOL, V72, P75, DOI 10.1111/aji.12220; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Nayot D, 2012, J PERINATOL, V32, P970, DOI 10.1038/jp.2012.15; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; ROMERO R, 1991, CLIN OBSTET GYNECOL, V34, P769, DOI 10.1097/00003081-199112000-00013; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; ROMERO R, 1993, AM J REPROD IMMUNOL, V30, P167, DOI 10.1111/j.1600-0897.1993.tb00618.x; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Romero R, 2014, J MATERN-FETAL NEO M, V27, P757, DOI 10.3109/14767058.2013.844123; Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383	34	70	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133929	10.1371/journal.pone.0133929	http://dx.doi.org/10.1371/journal.pone.0133929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208287	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000176
J	Tokuhisa, M; Ichikawa, Y; Kosaka, N; Ochiya, T; Yashiro, M; Hirakawa, K; Kosaka, T; Makino, H; Akiyama, H; Kunisaki, C; Endo, I				Tokuhisa, Motohiko; Ichikawa, Yasushi; Kosaka, Nobuyoshi; Ochiya, Takahiro; Yashiro, Masakazu; Hirakawa, Kosei; Kosaka, Takashi; Makino, Hirochika; Akiyama, Hirotoshi; Kunisaki, Chikara; Endo, Itaru			Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer	PLOS ONE			English	Article							MICRORNA; CELLS; PROFILES; SERUM	Peritoneal metastasis is the most frequent type of recurrence in patients with gastric cancer (GC) and is associated with poor prognosis. Peritoneal lavage cytology, used to evaluate the risk of peritoneal metastasis, has low sensitivity. Here, we assessed the diagnostic potential of exosomal miRNA profiles in peritoneal fluid for the prediction of peritoneal dissemination in GC. Total RNA was extracted from exosomes isolated from six gastric malignant ascites (MA) samples, 24 peritoneal lavage fluid (PLF) samples, and culture supernatants (CM) of two human gastric carcinoma cell lines that differ in their potential for peritoneal metastasis. Expression of exosomal miRNAs was evaluated with Agilent Human miRNA microarrays and quantitative reverse transcription polymerase chain reaction (qRT-PCR). The microarray analysis indicated a low variability in the number and signal intensity of miRNAs detected among the samples. In the six MA fluids, miR-21 showed the highest signal intensity. We identified five miRNAs (miR-1225-5p, miR-320c, miR-1202, miR-1207-5p, and miR-4270) with high expression in MA samples, the PLF of serosa-invasive GC, and the CM of a highly metastatic GC cell line; these candidate miRNA species appear to be related to peritoneal dissemination. Differential expression of miR-21, miR-320c, and miR-1225-5p was validated in the PLF of serosa-invasive and non-invasive GC by qRT-PCR and miR-21 and miR-1225-5p were confirmed to be associated with serosal invasion in GC. PLF can be used to profile the expression of exosomal miRNAs. Our findings suggest that miR-21 and miR-1225-5p may serve as biomarkers of peritoneal recurrence after curative GC resection, thus providing a novel approach to early diagnosis of peritoneal dissemination of GC.	[Tokuhisa, Motohiko; Kosaka, Takashi; Makino, Hirochika; Akiyama, Hirotoshi; Kunisaki, Chikara; Endo, Itaru] Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Ichikawa, Yasushi] Yokohama City Univ, Dept Clin Oncol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Kosaka, Nobuyoshi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo 104, Japan; [Yashiro, Masakazu; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan	Yokohama City University; Yokohama City University; National Cancer Center - Japan; Osaka Metropolitan University	Tokuhisa, M (corresponding author), Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	tokuhisa@yokohama-cu.ac.jp	Ochiya, Takahiro/AAH-7585-2019					Bando E, 1999, AM J SURG, V178, P256, DOI 10.1016/S0002-9610(99)00162-2; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kim DW, 2011, J KOREAN MED SCI, V26, P875, DOI 10.3346/jkms.2011.26.7.875; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Li QL, 2008, CLIN MED INSIGHTS-ON, V2, P461; Li Z, 2012, MOL MED REP, V6, P558, DOI 10.3892/mmr.2012.951; Lim JS, 2006, RADIOGRAPHICS, V26, P143, DOI 10.1148/rg.261055078; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Liu J, 2014, INT J MOL SCI, V15, P758, DOI 10.3390/ijms15010758; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maehara Y, 1999, ONCOLOGY-BASEL, V56, P322, DOI 10.1159/000011986; Olszewski WL, 2007, SURGERY, V141, P212, DOI 10.1016/j.surg.2006.06.031; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Sanyukta R, 2013, NEOPLASIA, V15, P281; Tamura S, 2014, J SURG ONCOL, V109, P75, DOI 10.1002/jso.23472; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685	33	118	126	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130472	10.1371/journal.pone.0130472	http://dx.doi.org/10.1371/journal.pone.0130472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208314	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000007
J	Wang, J; Zhao, XM; Yuan, P; Fang, TF; Ouyang, NY; Li, RQ; Ou, SB; Wang, WJ				Wang, Jing; Zhao, Xiaomiao; Yuan, Ping; Fang, Tingfeng; Ouyang, Nengyong; Li, Ruiqi; Ou, Songbang; Wang, Wenjun			Clinical Outcomes of In Vitro Fertilization among Chinese Infertile Couples Treated for Syphilis Infection	PLOS ONE			English	Article							TREPONEMA-PALLIDUM; PREGNANCY OUTCOMES; RELIABILITY; DIAGNOSIS; WOMEN	To compare the clinical outcomes of infertile patients with and without syphilis after in vitro fertilization and embryo transfer (IVF-ET), in this case-control study, 320 infertile couples were enrolled and divided into syphilis (n = 160) and control groups (n = 160). The primary IVF outcomes were the clinical pregnancy rate and the birth of a healthy baby. All syphilis patients received the standard anti-syphilis treatment before undergoing IVF/ICSI. Our results showed that the endometrial thickness of the syphilis group was greater than that of the control group following hCG injection (16.9 +/- 5.4 vs. 13.0 +/- 4.7 mm, P<0.001). The numbers of normally fertilized eggs and normally cleaved fertilized eggs and the implantation rate were 6.8 +/- 4.8, 6.3 +/- 4.7 and 24.2%, respectively, for the syphilis group and 8.3 +/- 4.6, 8.1 +/- 4.6 and 34.4%, respectively, for the control group, and these values were significantly different between the groups. The clinical pregnancy rate was lower in the syphilis group compared with that in the control group (43.8% vs. 55.6%, P = 0.03). Lower offspring birth weight was observed in the infected male group compared with those in the infected female (2.7 +/- 0.4 vs. 3.0 +/- 0.4 kg, P = 0.01) and infected couple groups (2.7 +/- 0.4 vs. 3.1 +/- 0.5 kg, P = 0.007). Therefore, syphilis infection reduces the clinical pregnancy rate after IVF/ICSI.	[Wang, Jing; Zhao, Xiaomiao; Yuan, Ping; Fang, Tingfeng; Ouyang, Nengyong; Li, Ruiqi; Ou, Songbang; Wang, Wenjun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Reprod Med Ctr, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University	Wang, WJ (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Reprod Med Ctr, 107 Yanjiang Xi Rd, Guangzhou 510120, Guangdong, Peoples R China.	wenjungzcn@163.com			National Science Technology Research Projects of China [81100402]; Specialized Research Funds for New Teachers Program of the Chinese Ministry of Education [20110171120083]	National Science Technology Research Projects of China; Specialized Research Funds for New Teachers Program of the Chinese Ministry of Education	This study was funded by The National Science Technology Research Projects of China (81100402) and The Specialized Research Funds for New Teachers Program of the Chinese Ministry of Education(20110171120083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almobarak AO, 2013, J CYTOL, V30, P100, DOI 10.4103/0970-9371.112651; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Arroll TW, 1999, INFECT IMMUN, V67, P4757, DOI 10.1128/IAI.67.9.4757-4763.1999; Askienazy-Elbhar M, 2005, Gynecol Obstet Fertil, V33, P691, DOI 10.1016/j.gyobfe.2005.07.008; Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082249; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Borkhardt HL, 1997, J MED MICROBIOL, V46, P965, DOI 10.1099/00222615-46-11-965; Calonge N, 2009, ANN INTERN MED, V150, P705; Casper RF, 2011, FERTIL STERIL, V96, P519, DOI 10.1016/j.fertnstert.2011.07.1096; Chen H, 2011, J ASSIST REPROD GEN, V28, P797, DOI 10.1007/s10815-011-9600-2; Chen XS, 2013, CHINESE MED J-PEKING, V126, P2774, DOI 10.3760/cma.j.issn.0366-6999.20123559; Chen XS, 2011, FUTURE MICROBIOL, V6, P1131, DOI [10.2217/fmb.11.99, 10.2217/FMB.11.99]; Cicinelli E, 2009, GYNECOL OBSTET INVES, V68, P108, DOI 10.1159/000223819; Deiss RG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-426; Di Simone N, 2000, ARTHRITIS RHEUM-US, V43, P140, DOI 10.1002/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P; Fang J, 2007, STAT METHODS BIOMEDI, P266; Hammadeh ME, 2002, AM J REPROD IMMUNOL, V47, P82, DOI 10.1034/j.1600-0897.2002.1o024.x; Jiang CH, 2013, CLIN VACCINE IMMUNOL, V20, P1563, DOI 10.1128/CVI.00122-13; Jin X, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/179098; Karimzade MA, 2010, ARCH GYNECOL OBSTET, V281, P499, DOI 10.1007/s00404-009-1166-1; Kasius JC, 2012, HUM REPROD, V27, P153, DOI 10.1093/humrep/der341; Kiguli-Malwadde Elsie, 2004, Afr Health Sci, V4, P178; Knudsen A, 2009, SEX TRANSM DIS, V36, P300, DOI 10.1097/OLQ.0b013e318193ca26; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Lam PM, 2010, FERTIL STERIL, V93, P480, DOI 10.1016/j.fertnstert.2009.01.137; Lee SH, 2014, ACTA DERM-VENEREOL, V94, P321, DOI 10.2340/00015555-1703; Lee V, 2008, CLIN MED, V8, P330, DOI 10.7861/clinmedicine.8-3-330; Munkhzul B, 2012, WEST PAC SURVEILL RE, V3, P48, DOI [10.5365/WPSAR.2012.3.4.003, 10.5365/wpsar.2012.3.4.003]; Okohue J E, 2009, Afr J Reprod Health, V13, P113; Quentin R, 2012, J GYNECOL OBST BIO R, V41, P850, DOI 10.1016/j.jgyn.2012.09.015; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; Smit PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075327; Tong ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070102; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; Wang BX, 2014, INT J STD AIDS, V25, P550, DOI 10.1177/0956462413515444; Wilkinson D, 1997, GENITOURIN MED, V73, P558; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, 2010, WHO LAB MAN EX PROC, V5th, P224; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Xiao Z, 2013, SHANGDONG MED J, V17, P18; Yang LG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-793; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084950; Zhao J, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-100; Zhao WH, 2014, GYNECOL OBSTET INVES, V77, P169, DOI 10.1159/000358393	44	2	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133726	10.1371/journal.pone.0133726	http://dx.doi.org/10.1371/journal.pone.0133726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208116	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000124
J	Chu, J; Nadarajah, S; Chan, S				Chu, Jeffrey; Nadarajah, Saralees; Chan, Stephen			Statistical Analysis of the Exchange Rate of Bitcoin	PLOS ONE			English	Article							BID-ASK SPREAD; MODEL SELECTION; DISTRIBUTIONS; VOLATILITY; COMPONENTS; REGRESSION	Bitcoin, the first electronic payment system, is becoming a popular currency. We provide a statistical analysis of the log-returns of the exchange rate of Bitcoin versus the United States Dollar. Fifteen of the most popular parametric distributions in finance are fitted to the log-returns. The generalized hyperbolic distribution is shown to give the best fit. Predictions are given for future values of the exchange rate.	[Chu, Jeffrey; Nadarajah, Saralees; Chan, Stephen] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England	University of Manchester	Nadarajah, S (corresponding author), Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England.	mbbsssn2@manchester.ac.uk	Chan, Stephen/AAE-2466-2020	Chan, Stephen/0000-0002-2312-2137	Engineering and Physical Sciences Research Council [1240734] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander C, 2006, J APPL ECONOMET, V21, P307, DOI 10.1002/jae.849; AMIHUD Y, 1986, J FINANC ECON, V17, P223, DOI 10.1016/0304-405X(86)90065-6; ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; [Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 2014, LANG ENV STAT COMP; [Anonymous], 1986, FINANC ANAL J, DOI DOI 10.2469/FAJ.V42.N3.43; AZZALINI A, 1985, SCAND J STAT, V12, P171; Azzalini A, 2003, J R STAT SOC B, V65, P367, DOI 10.1111/1467-9868.00391; Badev A, 2014, FINANCE AND ECONOMIC; BARNDORFFNIELSEN O, 1977, P ROY SOC LOND A MAT, V353, P401, DOI 10.1098/rspa.1977.0041; BARTELS R, 1982, J AM STAT ASSOC, V77, P40, DOI 10.2307/2287767; Bauer C, 2000, J ECON BUS, V52, P455, DOI [10.1016/S0148-6195(00)00026-6, DOI 10.1016/S0148-6195(00)00026-6]; Box G. E., 1970, J AM STAT ASSOC, V65, P1509, DOI [10.1080/01621459.1970.10481180, DOI 10.1080/01621459.1970.10481180]; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; BREUSCH TS, 1978, AUST ECON PAP, V17, P334, DOI 10.1111/j.1467-8454.1978.tb00635.x; Briere M, 2015, JOURNAL OF ASSET MAN; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cheung A, 2015, APPL ECON, V47, P2348, DOI 10.1080/00036846.2015.1005827; COPPES RC, 1995, ECON LETT, V47, P117, DOI 10.1016/0165-1765(94)00571-I; Corlu CG, 2015, QUANTITATIVE FINANCE; COX DR, 1955, BIOMETRIKA, V42, P80, DOI 10.1093/biomet/42.1-2.80; Cox DR, 1974, THEORETICAL STATISTI; de Moivre A, 1738, THE DOCTRINE OF CHAN; DURBIN J, 1971, BIOMETRIKA, V58, P1; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Embrechts P, 2005, COMPUT OPTIM APPL, V32, P61, DOI 10.1007/s10589-005-2054-7; Fang Y., 2011, J DATA SCI, V9, P15, DOI DOI 10.6339/JDS.201101_09(1)0.0002; Garcia D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0623; Gauss C.F., 1809, THEORIA MOTVS CORPOR; Glaser F, 2014, PROCEEDINGS OF THE T; GODFREY LG, 1978, ECONOMETRICA, V46, P1293, DOI 10.2307/1913829; Grinberg R., 2011, HASTINGS SCI TECHNOL, V4, P159; Gurrola P., 2007, J RISK, V10, P73; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; Hencic A, 2014, PROCEEDINGS OF THE 7; Huang RD, 1997, REV FINANC STUD, V10, P995, DOI 10.1093/rfs/10.4.995; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kilic R, 2007, STUD NONLINEAR DYN E, V11; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kondor D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086197; Kristoufek L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123923; Kristoufek L, 2013, SCI REP-UK, V3, DOI [10.1038/srep03415, 10.1038/srep02857]; Laplace PS., 1774, MEMOIRES ACAD ROYALE, V6, P621; Linden M, 2005, PHYSICA A, V352, P573, DOI 10.1016/j.physa.2004.12.024; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Herrera FL, 2011, INVEST ECON-MEX, V70, P19; Ly K. M., 2014, HARV J LAW TECHNOL, V27, P587; MacDonell A, 2014, WORKING PAPER; MCDONALD JB, 1988, ECONOMET THEOR, V4, P428, DOI 10.1017/S0266466600013384; MOORE T, 2013, LECT NOTES COMPUTER, V7859; Nadarajah S, 2015, QUANTITATIVE FINANCE; Nakajima J, 2013, STUD NONLINEAR DYN E, V17, P499, DOI 10.1515/snde-2012-0021; Nakamoto Satoshi., 2009, BITCOIN A PEER TO PE; Pipien M., 2004, FOLIA OECONOMICA CRA, V45, P45; Sapuric S, 2014, LECT NOTES BUS INF P, V183, P255, DOI 10.1007/978-3-319-11460-6_22; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; STOLL HR, 1989, J FINANC, V44, P115, DOI 10.2307/2328278; Subbotin M.T., 1923, MAT SBORNIK, V31, P296; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; WENDEL JG, 1961, ANN MATH STAT, V32, P338, DOI 10.1214/aoms/1177705164; Yermack D., 2014, WORKING PAPER; Zhu DM, 2010, J ECONOMETRICS, V157, P297, DOI 10.1016/j.jeconom.2010.01.013; Zhu DM, 2009, J ECONOMETRICS, V148, P86, DOI 10.1016/j.jeconom.2008.09.038	67	80	81	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133678	10.1371/journal.pone.0133678	http://dx.doi.org/10.1371/journal.pone.0133678			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222702	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800059
J	Fischer, DL; Collier, TJ; Cole-Strauss, A; Wohlgenant, SL; Lipton, JW; Steece-Collier, K; Manfredsson, FP; Kemp, CJ; Sortwell, CE				Fischer, D. Luke; Collier, Timothy J.; Cole-Strauss, Allyson; Wohlgenant, Susan L.; Lipton, Jack W.; Steece-Collier, Kathy; Manfredsson, Fredric P.; Kemp, Christopher J.; Sortwell, Caryl E.			High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; NIGRA PARS RETICULATA; STAGE PARKINSONS-DISEASE; REACTION-TIME-TASK; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; SUBSTANTIA-NIGRA; GLOBUS-PALLIDUS; NIGROSTRIATAL SYSTEM; ELECTRICAL-STIMULATION	Deep brain stimulation (DBS) is the most common neurosurgical treatment for Parkinson's disease (PD). Whereas the globus pallidus interna (GPi) has been less commonly targeted than the subthalamic nucleus (STN), a recent clinical trial suggests that GPi DBS may provide better outcomes for patients with psychiatric comorbidities. Several laboratories have demonstrated that DBS of the STN provides neuroprotection of substantia nigra pars compacta (SNpc) dopamine neurons in preclinical neurotoxin models of PD and increases brain-derived neurotrophic factor (BDNF). However, whether DBS of the entopeduncular nucleus (EP), the homologous structure to the GPi in the rat, has similar neuroprotective potential in preclinical models has not been investigated. We investigated the impact of EP DBS on forelimb use asymmetry and SNpc degeneration induced by 6-hydroxydopamine (6-OHDA) and on BDNF levels. EP DBS in male rats received unilateral, intrastriatal 6-OHDA and ACTIVE or INACTIVE stimulation continuously for two weeks. Outcome measures included quantification of contralateral forelimb use, stereological assessment of SNpc neurons and BDNF levels. EP DBS 1) did not ameliorate forelimb impairments induced by 6-OHDA, 2) did not provide neuroprotection for SNpc neurons and 3) did not significantly increase BDNF levels in any of the structures examined. These results are in sharp contrast to the functional improvement, neuroprotection and BDNF-enhancing effects of STN DBS under identical experimental parameters in the rat. The lack of functional response to EP DBS suggests that stimulation of the rat EP may not represent an accurate model of clinical GPi stimulation.	[Fischer, D. Luke; Collier, Timothy J.; Cole-Strauss, Allyson; Wohlgenant, Susan L.; Lipton, Jack W.; Steece-Collier, Kathy; Manfredsson, Fredric P.; Kemp, Christopher J.; Sortwell, Caryl E.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA; [Fischer, D. Luke] Michigan State Univ, Coll Human Med, MD PhD Program, Grand Rapids, MI USA; [Fischer, D. Luke] Michigan State Univ, Coll Human Med, Neurosci Grad Program, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine	Sortwell, CE (corresponding author), Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA.	caryl.sortwell@hc.msu.edu	Fischer, David/AAH-1934-2019; Lipton, Jack/L-3631-2019; Manfredsson, Fredric/GMI-5876-2022	Fischer, David/0000-0002-5245-3832; Lipton, Jack/0000-0003-0991-8275; Manfredsson, Fredric/0000-0001-5802-5487	Spectrum Health; Mercy Health Saint Mary's; Morris K. Udall Center of Excellence for Parkinson's Disease Research at Michigan State University [NS058830]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS058830] Funding Source: NIH RePORTER	Spectrum Health; Mercy Health Saint Mary's; Morris K. Udall Center of Excellence for Parkinson's Disease Research at Michigan State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support provided by Spectrum Health (DLF), Mercy Health Saint Mary's (FPM) and the Morris K. Udall Center of Excellence for Parkinson's Disease Research at Michigan State University NS058830 (CES, TJC, KSC, CJK, JWL, ACS, SLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2010, BRAIN RES, V1306, P159, DOI 10.1016/j.brainres.2009.09.040; Aminoff MJ, 2001, NEUROL CLIN, V19, P119, DOI 10.1016/S0733-8619(05)70008-6; Andrade P, 2009, J CLIN NEUROSCI, V16, P877, DOI 10.1016/j.jocn.2008.11.006; ARBUTHNOTT GW, 1975, EXP NEUROL, V47, P162, DOI 10.1016/0014-4886(75)90244-7; Benhamou L, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00007; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; CARPENTER MB, 1976, J COMP NEUROL, V165, P401, DOI 10.1002/cne.901650402; Chang JY, 2003, BRAIN RES, V983, P174, DOI 10.1016/S0006-8993(03)03053-1; Charles D, 2014, PARKINSONISM RELAT D, V20, P731, DOI 10.1016/j.parkreldis.2014.03.019; Charles PD, 2012, PARKINSONISM RELAT D, V18, P268, DOI 10.1016/j.parkreldis.2011.11.001; Charles PD, 2008, NAT CLIN PRACT NEURO, V4, P424, DOI 10.1038/ncpneuro0848; Charles PDea, SAFETY TOLERABILITY; Collier TJ, 1999, DRUG AGING, V14, P261, DOI 10.2165/00002512-199914040-00003; Creed MC, 2013, BRAIN STIMUL, V6, P506, DOI 10.1016/j.brs.2012.09.012; Daniels C, 2010, MOVEMENT DISORD, V25, P1583, DOI 10.1002/mds.23078; Darbaky Y, 2003, EUR J NEUROSCI, V18, P951, DOI 10.1046/j.1460-9568.2003.02803.x; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Deniau JM, 1996, NEUROSCIENCE, V73, P761, DOI 10.1016/0306-4522(96)00088-7; Fang X, 2006, BRAIN RES, V1120, P202, DOI 10.1016/j.brainres.2006.08.073; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; FRANCOIS C, 1984, NEUROSCIENCE, V13, P61, DOI 10.1016/0306-4522(84)90259-8; Gill CE, 2011, NEUROMODULATION, V14, P515, DOI 10.1111/j.1525-1403.2011.00391.x; Gombash SE, 2012, MOL THER, V20, P544, DOI 10.1038/mt.2011.216; Gombash SE, 2014, GENE THERAP IN PRESS; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Gulcebi MI, 2012, BRAIN RES BULL, V87, P312, DOI 10.1016/j.brainresbull.2011.11.005; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; Harnack D, 2010, NEUROMODULATION, V13, P160, DOI 10.1111/j.1525-1403.2010.00282.x; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; ILINSKY IA, 1985, J COMP NEUROL, V236, P315, DOI 10.1002/cne.902360304; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kahn E, 2012, J NEUROL NEUROSUR PS, V83, P164, DOI 10.1136/jnnp-2011-300008; Kha HT, 2000, J COMP NEUROL, V426, P366; KINCAID AE, 1991, NEUROSCI LETT, V128, P121, DOI 10.1016/0304-3940(91)90774-N; KINCAID AE, 1992, NEUROSCIENCE, V51, P705, DOI 10.1016/0306-4522(92)90309-P; KITA H, 1987, J COMP NEUROL, V260, P435, DOI 10.1002/cne.902600309; KITA H, 1983, J COMP NEUROL, V215, P245, DOI 10.1002/cne.902150302; Kita H, 2006, THE BASAL GANGLIA, P357; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Kondziolka D, 2004, STEREOT FUNCT NEUROS, V82, P127, DOI 10.1159/000079844; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Li XH, 2010, J NEUROSCI RES, V88, P1510, DOI 10.1002/jnr.22313; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Meissner W, 2002, NEUROSCI LETT, V328, P105, DOI 10.1016/S0304-3940(02)00463-9; MINK JW, 1991, J NEUROPHYSIOL, V65, P273, DOI 10.1152/jn.1991.65.2.273; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Oertel W H, 1984, Adv Neurol, V40, P91; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Olds ME, 2001, SYNAPSE, V40, P215, DOI 10.1002/syn.1044; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penney J B Jr, 1986, Mov Disord, V1, P3, DOI 10.1002/mds.870010102; RAJAKUMAR N, 1994, J COMP NEUROL, V350, P324, DOI 10.1002/cne.903500214; RAJAKUMAR N, 1994, J COMP NEUROL, V346, P337, DOI 10.1002/cne.903460303; Sato F, 2000, J COMP NEUROL, V424, P142, DOI 10.1002/1096-9861(20000814)424:1<142::AID-CNE10>3.0.CO;2-8; Schallert T, 2000, CONT NEUROS, P131; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Shi LH, 2006, SYNAPSE, V59, P445, DOI 10.1002/syn.20261; Shi LH, 2004, BRAIN RES, V1013, P98, DOI 10.1016/j.brainres.2004.03.053; SHINK E, 1995, J COMP NEUROL, V358, P119, DOI 10.1002/cne.903580108; SMITH Y, 1994, J COMP NEUROL, V343, P297, DOI 10.1002/cne.903430209; SMITH Y, 1988, BRAIN RES, V453, P353, DOI 10.1016/0006-8993(88)90177-1; SPANN BM, 1991, J COMP NEUROL, V311, P375, DOI 10.1002/cne.903110308; Spieles-Engemann AL, 2010, EUR J NEUROSCI, V32, P1092, DOI 10.1111/j.1460-9568.2010.07416.x; Spieles-Engemann AL, 2010, NEUROBIOL DIS, V39, P105, DOI 10.1016/j.nbd.2010.03.009; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; STEININGER TL, 1992, J COMP NEUROL, V321, P515, DOI 10.1002/cne.903210403; Summerson SR, 2014, IEEE T NEUR SYS REH, V22, P1218, DOI 10.1109/TNSRE.2014.2330515; Summerson SR, 2013, IEEE ENG MED BIO, P783, DOI 10.1109/EMBC.2013.6609617; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Sutton AC, 2013, J NEUROPHYSIOL, V109, P363, DOI 10.1152/jn.00311.2012; Tachibana Y, 2008, EUR J NEUROSCI, V27, P238, DOI 10.1111/j.1460-9568.2007.05990.x; Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X; Temel Y, 2005, EXP NEUROL, V193, P43, DOI 10.1016/j.expneurol.2004.12.025; Temel Y, 2006, BRAIN RES, V1120, P100, DOI 10.1016/j.brainres.2006.08.082; VANDERKOOY D, 1981, BRAIN RES, V211, P15, DOI 10.1016/0006-8993(81)90064-0; Vlamings R, 2007, NEUROSCIENCE, V148, P815, DOI 10.1016/j.neuroscience.2007.06.043; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; WATANABE H, 1983, FOLIA PHARMACOL JPN, V82, P247, DOI 10.1254/fpj.82.247; Yurek DM, 2001, BRAIN RES, V891, P228, DOI 10.1016/S0006-8993(00)03217-0; Zhang XQ, 2006, BRAIN RES, V1095, P207, DOI 10.1016/j.brainres.2006.04.019; Zhou FM, 2011, NEUROSCIENCE, V198, P69, DOI 10.1016/j.neuroscience.2011.07.061	89	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133957	10.1371/journal.pone.0133957	http://dx.doi.org/10.1371/journal.pone.0133957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222442	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800086
J	Guo, ZG; Zhang, Y; Zou, LL; Wang, DQ; Shao, C; Wang, YJ; Sun, W; Zhang, LW				Guo, Zhengguang; Zhang, Yang; Zou, Lili; Wang, Danqi; Shao, Chen; Wang, Yajie; Sun, Wei; Zhang, Liwei			A Proteomic Analysis of Individual and Gender Variations in Normal Human Urine and Cerebrospinal Fluid Using iTRAQ Quantification	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BIOMARKER; PROTEIN	Urine and cerebrospinal fluid (CSF) are two important biofluids used for disease biomarker discovery. For differential proteomic analysis, it is essential to evaluate individual and gender variations. In this study, we characterized urinary and CSF proteomes of 14 healthy volunteers with regard to individual and gender variations using 2DLC-MS/MS analysis and 8-plex iTRAQ quantification. A total of 968/512 urinary/CSF proteins were identified, with 406/280 quantified in all individuals. The median inter-individual coefficients of variation (CVs) were 0.262 and 0.183 for urinary and CSF proteomes, respectively. Cluster analysis showed that male and female urinary proteomes exhibited different patterns, though CSF proteome showed no remarkable gender differences. In comparison with CSF proteome, urinary proteome showed higher individual variation. Further analysis revealed that individual variation was not correlated with protein abundance. The minimum sample size for proteomic analysis with a 2-fold change was 10 (4/5 for males/females using iTRAQ quantification) for urinary or 8 for CSF proteome. Intracellular proteins leaked from exfoliative cells tended to have higher CVs, and extracellular proteins secreted from urinary tract or originating from plasma tended to have lower CVs. The above results might be beneficial for differential proteomic analysis and biomarker discovery.	[Guo, Zhengguang; Zou, Lili; Wang, Danqi; Sun, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Core Facil Instrument,Sch Basic Med, Beijing 100005, Peoples R China; [Zhang, Yang; Zhang, Liwei] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Dept Neurosurg, Beijing 100050, Peoples R China; [Shao, Chen] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Dept Physiol & Pathophysiol, Inst Basic Med Sci,Sch Basic Med,Peking Union Med, Beijing 100005, Peoples R China; [Wang, Yajie] Capital Med Univ, Beijing Tiantan Hosp, Core Lab Clin Med Res, Beijing 100050, Peoples R China; [Wang, Yajie] Capital Med Univ, Dept Clin Lab Diag, Beijing Tiantan Hosp, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Capital Medical University; Capital Medical University	Sun, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Peking Union Med Coll, Core Facil Instrument,Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	sunwei1018@hotmail.com; zlw.tth@hotmail.com			National Basic Research Program of China [2013CB530805, 2014CBA02005]; Key Basic Research Program of the Ministry of Science and Technology of China [2013FY114100]; Science and Technology Yuanjiang project of Xinjiang Uygur Autonomous Region [2013911114]; National Natural Science Foundation of China [31400669]	National Basic Research Program of China(National Basic Research Program of China); Key Basic Research Program of the Ministry of Science and Technology of China; Science and Technology Yuanjiang project of Xinjiang Uygur Autonomous Region; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (No. 2013CB530805, No. 2014CBA02005), Key Basic Research Program of the Ministry of Science and Technology of China (No. 2013FY114100), Science and Technology Yuanjiang project of Xinjiang Uygur Autonomous Region (2013911114) and the National Natural Science Foundation of China (31400669).	Choi YS, 2013, J CHROMATOGR B, V930, P129, DOI 10.1016/j.jchromb.2013.05.003; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; Havanapan PO, 2009, J PROTEOME RES, V8, P3109, DOI 10.1021/pr900015q; Higgs Richard E, 2013, Int J Proteomics, V2013, P674282, DOI 10.1155/2013/674282; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Jia LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066911; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Lehnert S, 2012, EXP NEUROL, V234, P499, DOI 10.1016/j.expneurol.2012.01.024; Lim SC, 2012, DIABETIC MED, V29, P945, DOI 10.1111/j.1464-5491.2011.03564.x; Liu XJ, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-70; Mertins P, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014423; Nagaraj N, 2011, J PROTEOME RES, V10, P637, DOI 10.1021/pr100835s; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Perrin RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064314; Rajagopal MU, 2011, PROTEOMICS, V11, P935, DOI 10.1002/pmic.201000198; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Stoop MP, 2010, MOL CELL PROTEOMICS, V9, P2063, DOI 10.1074/mcp.M900877-MCP200; Thongboonkerd V, 2006, J PROTEOME RES, V5, P183, DOI 10.1021/pr0502525; Vafadar-Isfahani B, 2012, J ALZHEIMERS DIS, V28, P625, DOI 10.3233/JAD-2011-111505; Vivekanandan-Giri Anuradha, 2011, Int J Proteomics, V2011, P214715, DOI 10.1155/2011/214715; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang N, 2011, CLIN CANCER RES, V17, P3349, DOI 10.1158/1078-0432.CCR-10-3121	23	31	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133270	10.1371/journal.pone.0133270	http://dx.doi.org/10.1371/journal.pone.0133270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222143	Green Published, gold			2022-12-27	WOS:000358836800044
J	Lan, T; Kisseleva, T; Brenner, DA				Lan, Tian; Kisseleva, Tatiana; Brenner, David A.			Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation	PLOS ONE			English	Article							NADPH OXIDASE; OXIDATIVE STRESS; HEPATOCYTE APOPTOSIS; SIGNALING PATHWAYS; HEDGEHOG PATHWAY; NAD(P)H OXIDASES; TRANSFORMATION; PROLIFERATION; INVOLVEMENT; EXPRESSION	Reactive oxygen species (ROS) produced by nicotinamide adenine dinucleotide phosphate oxidase (NOX) play a key role in liver injury and fibrosis. Previous studies demonstrated that GKT137831, a dual NOX1/4 inhibitor, attenuated liver fibrosis in mice as well as pro-fibrotic genes in hepatic stellate cells (HSCs) as well as hepatocyte apoptosis. The effect of NOX1 and NOX4 deficiency in liver fibrosis is unclear, and has never been directly compared. HSCs are the primary myofibroblasts in the pathogenesis of liver fibrosis. Therefore, we aimed to determine the role of NOX1 and NOX4 in liver fibrosis, and investigated whether NOX1 and NOX4 signaling mediates liver fibrosis by regulating HSC activation. Mice were treated with carbon tetrachloride (CCl4) to induce liver fibrosis. Deficiency of either NOX1 or NOX4 attenuates liver injury, inflammation, and fibrosis after CCl4 compared to wild-type mice. NOX1 or NOX4 deficiency reduced lipid peroxidation and ROS production in mice with liver fibrosis. NOX1 and NOX4 deficiency are approximately equally effective in preventing liver injury in the mice. The NOX1/4 dual inhibitor GKT137831 suppressed ROS production as well as inflammatory and proliferative genes induced by lipopolysaccharide (LPS), platelet-derived growth factor (PDGF), or sonic hedgehog (Shh) in primary mouse HSCs. Furthermore, the mRNAs of proliferative and pro-fibrotic genes were downregulated in NOX1 and NOX4 knock-out activated HSCs (cultured on plastic for 5 days). Finally, NOX1 and NOX4 protein levels were increased in human livers with cirrhosis compared with normal controls. Thus, NOX1 and NOX4 signaling mediates the pathogenesis of liver fibrosis, including the direct activation of HSC.	[Lan, Tian; Kisseleva, Tatiana; Brenner, David A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lan, Tian] Guangdong Pharmaceut Univ, Vasc Biol Res Inst, Guangzhou, Guangdong, Peoples R China	University of California System; University of California San Diego; Guangdong Pharmaceutical University	Brenner, DA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	dbrenner@ucsd.edu		Brenner, David/0000-0003-2573-525X	Natural Science Foundation of China [81200308]; Zhujiang Technology New Star of Guangzhou City [2013J2200025]; National Institutes of Health [R01 GM041804-26, P50 AA011999-16, P42 ES010337-13, U01 AA021856-02, R01 DK101737-01A1, U01 AA022614-01A1, R01 DK099205-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099205, R01DK101737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, U01AA021856, U01AA022614] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhujiang Technology New Star of Guangzhou City; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Natural Science Foundation of China (No. 81200308) and the Zhujiang Technology New Star of Guangzhou City (2013J2200025) (to Tian Lan), and by the National Institutes of Health (R01 GM041804-26, P50 AA011999-16, P42 ES010337-13, U01 AA021856-02, R01 DK101737-01A1, U01 AA022614-01A1, R01 DK099205-01A1).	Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Aoyama T, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/192543; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Bai T, 2013, INT IMMUNOPHARMACOL, V15, P275, DOI 10.1016/j.intimp.2012.12.020; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Burt AD, 1999, J GASTROENTEROL, V34, P299, DOI 10.1007/s005350050264; Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Colmenero J, 2007, GASTROENTEROLOGY, V132, P687, DOI 10.1053/j.gastro.2006.12.036; Colmenero J, 2009, AM J PHYSIOL-GASTR L, V297, pG726, DOI 10.1152/ajpgi.00162.2009; Cui WH, 2011, HEPATOLOGY, V54, P949, DOI 10.1002/hep.24465; De Bleser PJ, 1999, J BIOL CHEM, V274, P33881, DOI 10.1074/jbc.274.48.33881; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Foo NP, 2011, TOXICOLOGY, V282, P39, DOI 10.1016/j.tox.2011.01.009; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gaggini F, 2011, BIOORGAN MED CHEM, V19, P6989, DOI 10.1016/j.bmc.2011.10.016; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Jung YM, 2010, GUT, V59, P655, DOI 10.1136/gut.2009.204354; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Li A, 2015, EUR J PHARMACOL, V747, P71, DOI 10.1016/j.ejphar.2014.11.040; Li T, 2014, HEPATOLOGY, V59, P2383, DOI 10.1002/hep.27049; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Nieto N, 2002, J BIOL CHEM, V277, P9853, DOI 10.1074/jbc.M110506200; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Peng Y, 2013, EUR J CLIN INVEST, V43, P358, DOI 10.1111/eci.12053; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369	41	130	132	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0129743	10.1371/journal.pone.0129743	http://dx.doi.org/10.1371/journal.pone.0129743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222337	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800005
J	Lorent, N; Choun, K; Malhotra, S; Koeut, P; Thai, S; Khun, KE; Colebunders, R; Lynen, L				Lorent, Natalie; Choun, Kimcheng; Malhotra, Shelly; Koeut, Pichenda; Thai, Sopheak; Khun, Kim Eam; Colebunders, Robert; Lynen, Lut			Challenges from Tuberculosis Diagnosis to Care in Community-Based Active Case Finding among the Urban Poor in Cambodia: A Mixed-Methods Study	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; COST-EFFECTIVENESS; FACILITY INVOLVEMENT; INITIAL DEFAULT; BARRIERS; DISTRICT; PROGRAM; ETHIOPIA; BURDEN	Background While community-based active case finding (ACF) for tuberculosis (TB) holds promise for increasing early case detection among hard-to-reach populations, limited data exist on the acceptability of active screening. We aimed to identify barriers and explore facilitators on the pathway from diagnosis to care among TB patients and health providers. Methods Mixed-methods study. We administered a survey questionnaire to, and performed in-depth interviews with, TB patients identified through ACF from poor urban settlements in Phnom Penh, Cambodia. Additionally, we conducted focus group discussions and in-depth interviews with community and public health providers involved in ACF, respectively. Results Acceptance of home TB screening was strong among key stakeholders due to perceived reductions in access barriers and in direct and indirect patient costs. Privacy and stigma were not an issue. To build trust and facilitate communication, the participation of community representatives alongside health workers was preferred. Most health providers saw ACF as complementary to existing TB services; however, additional workload as a result of ACF was perceived as straining operating capacity at public sector sites. Proximity to a health facility and disease severity were the strongest determinants of prompt care-seeking. The main reasons reported for delays in treatment-seeking were non-acceptance of diagnosis, high indirect costs related to lost income/productivity and transportation expenses, and anticipated side-effects from TB drugs. Conclusions TB patients and health providers considered home-based ACF complementary to facility-based TB screening. Strong engagement with community representatives was believed critical in gaining access to high risk communities. The main barriers to prompt treatment uptake in ACF were refusal of diagnosis, high indirect costs, and anticipated treatment side-effects. A patient-centred approach and community involvement were essential in mitigating barriers to care in marginalised communities.	[Lorent, Natalie; Choun, Kimcheng; Thai, Sopheak] Sihanouk Hosp Ctr HOPE, Dept Infect Dis, Phnom Penh, Cambodia; [Lorent, Natalie; Colebunders, Robert; Lynen, Lut] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Malhotra, Shelly] Global Alliance TB Drug Dev, New York, NY USA; [Koeut, Pichenda; Khun, Kim Eam] CENAT, Natl TB & Leprosy Control Programme, Phnom Penh, Cambodia; [Colebunders, Robert] Univ Antwerp, Epidemiol & Social Med Dept, B-2020 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp	Lorent, N (corresponding author), Univ Hosp Leuven, Dept Pulm Med, Leuven, Belgium.	natalie.lorent@uzleuven.be	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; Colebunders, Robert/0000-0002-1919-1340	Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium; Research Foundation - Flanders; World Health Organisation - Western Pacific Regional Office	Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium; Research Foundation - Flanders(FWO); World Health Organisation - Western Pacific Regional Office	The study was funded by an operational research grant from the World Health Organisation - Western Pacific Regional Office. NL was supported by the Directorate General for Development Cooperation, Belgium, through the Institute of Tropical Medicine, Belgium and the Research Foundation - Flanders. KC was supported by the Operational research grant from the World Health Organisation - Western Pacific Regional Office. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Afutu FK, 2012, T ROY SOC TROP MED H, V106, P511, DOI 10.1016/j.trstmh.2012.05.002; Asefa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102884; Ayisi JG, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-515; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Buu TN, 2003, INT J TUBERC LUNG D, V7, P735; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Deery CB, 2014, INT J TUBERC LUNG D, V18, P534, DOI 10.5588/ijtld.13.0587; DELIMA YV, 2013, PLOS ONE, V0008; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29; Gele Abdi A, 2010, BMC Res Notes, V3, P86, DOI 10.1186/1756-0500-3-86; GILSON L, 1989, Journal of Public Health Policy, V10, P518, DOI 10.2307/3342522; Koole O, 2014, INT J TUBERC LUNG D, V18, P843, DOI 10.5588/ijtld.13.0811; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; Lorent N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092754; Mao TE, 2014, B WORLD HEALTH ORGAN, V92, P573, DOI 10.2471/BLT.13.131581; Mauch V, 2013, INT J TUBERC LUNG D, V17, P381, DOI 10.5588/ijtld.12.0368; National Institute of Statistics DGfHaIM2, 2013, CAMB DEM HLTH SURV 2; Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14; Okello D, 2003, INT J TUBERC LUNG D, V7, pS72; Pichenda K, 2012, INT J TUBERC LUNG D, V16, P828, DOI 10.5588/ijtld.11.0688; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Stop TB Partnership, 2014, GLOB PLAN STOP TB 20; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; WHO, 2013, WHOHTMTB201304; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2014, WHOHTMTB201311; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	36	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0130179	10.1371/journal.pone.0130179	http://dx.doi.org/10.1371/journal.pone.0130179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222545	gold, Green Published			2022-12-27	WOS:000358836800007
J	Schoeni, A; Roser, K; Roosli, M				Schoeni, Anna; Roser, Katharina; Roeoesli, Martin			Symptoms and Cognitive Functions in Adolescents in Relation to Mobile Phone Use during Night	PLOS ONE			English	Article							SLEEP-DEPRIVATION; JAPANESE ADOLESCENTS; PROSPECTIVE COHORT; PERFORMANCE; ATTENTION; DURATION; MEMORY; WELL; DISTURBANCES; ASSOCIATION	Many adolescents tend to leave their mobile phones turned on during night, accepting that they may be awakened by an incoming text message or call. Using self-reported and objective operator recorded mobile phone use data, we thus aimed to analyze how being awakened during night by mobile phone affects adolescents' perceived health and cognitive functions. In this cross-sectional study, 439 adolescents completed questionnaires about their mobile phone use during night, health related quality of life and possible confounding factors. Standardized computerized cognitive tests were performed to assess memory and concentration capacity. Objective operator recorded mobile phone use data was further collected for 233 study participants. Data were analyzed by multivariable regression models adjusted for relevant confounders including amount of mobile phone use. For adolescents reporting to be awakened by a mobile phone during night at least once a month the odds ratio for daytime tiredness and rapid exhaustibility were 1.86 (95% CI: 1.02-3.39) and 2.28 (95% CI: 0.97-5.34), respectively. Similar results were found when analyzing objective operator recorded mobile phone use data (tiredness: 1.63, 95% CI: 0.94-2.82 and rapid exhaustibility: 2.32, 95% CI: 1.01-5.36). The cognitive tests on memory and concentration capacity were not related to mobile phone use during night. Overall, being awakened during night by mobile phone was associated with an increase in health symptom reports such as tiredness, rapid exhaustibility, headache and physical ill-being, but not with memory and concentration capacity. Prevention strategies should focus on helping adolescents set limits for their accessibility by mobile phone, especially during night.	[Schoeni, Anna; Roser, Katharina; Roeoesli, Martin] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schoeni, Anna; Roser, Katharina; Roeoesli, Martin] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Roosli, M (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	martin.roosli@unibas.ch	Röösli, Martin/A-2658-2008; Roser, Katharina/AAI-1429-2020	Röösli, Martin/0000-0002-7475-1531; Roser, Katharina/0000-0001-5253-3333; Schoeni, Anna/0000-0002-2421-5925	Swiss National Science Foundation [138190]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by the Swiss National Science Foundation (Project Number 138190, www.snf.ch); MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson MJ, 2009, BIOELECTROMAGNETICS, V30, P678, DOI 10.1002/bem.20534; Aydin D, 2011, PROG BIOPHYS MOL BIO, V107, P356, DOI 10.1016/j.pbiomolbio.2011.08.013; Beebe DW, 2010, J ADOLESCENT HEALTH, V47, P523, DOI 10.1016/j.jadohealth.2010.03.005; Byun Yoon-Hwan, 2013, Environ Health Toxicol, V28, pe2013018, DOI 10.5620/eht.2013.28.e2013018; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Chiu C.T., 2014, J FORMOS MED ASS; Choo WC, 2005, NEUROIMAGE, V25, P579, DOI 10.1016/j.neuroimage.2004.11.029; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dinges DF, 1997, SLEEP, V20, P267; Dodick DW, 2003, HEADACHE, V43, P282, DOI 10.1046/j.1526-4610.2003.03055.x; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; FAKT II, 2007, FRANKFURTER ADAPTIVE; Fallone G, 2002, SLEEP MED REV, V6, P287, DOI 10.1053/smrv.2001.0192; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Harvard School of Public Health, CAUS INF BOOK; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Iber C, 2005, NEUROL CLIN, V23, P1045, DOI 10.1016/j.ncl.2005.08.001; Ikeda K, 2014, ENVIRON HEALTH PREV, V19, P187, DOI 10.1007/s12199-013-0373-3; Inyang I, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-36; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Kalak N, 2014, NEUROPSYCH DIS TREAT, V10, P1199, DOI 10.2147/NDT.S62533; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Liepmann D., 2006, I S T 2000R; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Nuutinen T, 2014, INT J PUBLIC HEALTH, V59, P619, DOI 10.1007/s00038-014-0561-y; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Punamaki RL, 2007, J ADOLESCENCE, V30, P569, DOI 10.1016/j.adolescence.2006.07.004; Rains JC, 2008, CURR NEUROL NEUROSCI, V8, P167, DOI 10.1007/s11910-008-0027-9; Ravens-Sieberer Ulrike, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P353, DOI 10.1586/14737167.5.3.353; Redmayne M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-90; The Kidscreen Group Europe, 2006, HDB KIDSCREEN QUEST; Thomas S, 2010, OCCUP ENVIRON MED, V67, P861, DOI 10.1136/oem.2009.054080; Thomee S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-66; Van den Bulck J, 2003, J SLEEP RES, V12, P263, DOI 10.1046/j.1365-2869.2003.00362.x; Van den Bulck J, 2007, SLEEP, V30, P1220, DOI 10.1093/sleep/30.9.1220; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; Vrijheid M, 2009, J EXPO SCI ENV EPID, V19, P369, DOI 10.1038/jes.2008.27	39	31	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133528	10.1371/journal.pone.0133528	http://dx.doi.org/10.1371/journal.pone.0133528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222312	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800055
J	Yu, XY; Liang, XY; Liu, KX; Dong, WX; Wang, JX; Zhou, MG				Yu, Xiaoyue; Liang, Xiaoyu; Liu, Kexue; Dong, Wenxia; Wang, Jianxin; Zhou, Ming-guo			The thiG Gene Is Required for Full Virulence of Xanthomonas oryzae pv. oryzae by Preventing Cell Aggregation	PLOS ONE			English	Article							THIAMIN BIOSYNTHESIS; OXIDATIVE STRESS; RESISTANCE; DEFICIENT; VECTORS; MUTANTS; DNA	Bacterial blight of rice is an important serious bacterial diseases of rice in many rice-growing regions, caused by Xanthomonas oryzae pv. oryzae (Xoo). The thiG gene from Xoo strain ZJ173, which is involved with thiazole moiety production in the thiamine biosynthesis pathway, is highly conserved among the members of Xanthomonas. The thiG deletion mutant displayed impaired virulence and growth in thiamine-free medium but maintained its normal growth rate in the rice tissues, indicating that the thiG gene is involved in Xoo virulence. Compared to the wild type strain, the formation of cell-cell aggregates was affected in thiG deletion mutants. Although biofilm formation was promoted, motility and migration in rice leaves were repressed in the thiG mutants, and therefore limited the expansion of pathogen infection in rice. Quorum sensing and extracellular substance are two key factors that contribute to the formation of cell-cell aggregates. Our study found that in the thiG mutant the expression of two genes, rpfC and rpfG, which form a two-component regulatory signal system involved in the regulation of biofilm formation by a second messenger cyclic di-GMP is down-regulated. In addition, our study showed that xanthan production was not affected but the expression of some genes associated with xanthan biosynthesis, like gumD, gumE, gumH and gumM, were up-regulated in thiG mutants. Taken together, these findings are the first to demonstrate the role of the thiazole biosynthsis gene, thiG, in virulence and the formation of aggregates in Xanthomonas oryzae pv. oryzae.	[Yu, Xiaoyue; Liang, Xiaoyu; Liu, Kexue; Dong, Wenxia; Wang, Jianxin; Zhou, Ming-guo] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, MG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	mgzhou@njau.edu.cn			National Science and Technology Support Program [2012BAD19B01]	National Science and Technology Support Program	This work was supported by the National Science and Technology Support Program (2012BAD19B01) to MZ. The funders had the role in the study design and data analysis, decision to publish.	Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Bradbury JF, 1984, BERGEYS MANUAL SYSTE, V1; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Chatterjee S, 2002, MOL PLANT MICROBE IN, V15, P463, DOI 10.1094/MPMI.2002.15.5.463; Chesnokova O, 1997, MOL MICROBIOL, V23, P579, DOI 10.1046/j.1365-2958.1997.d01-1875.x; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DEFEYTER R, 1990, GENE, V88, P65, DOI 10.1016/0378-1119(90)90060-5; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Hoppenau CE, 2014, ENVIRON EXP BOT, V108, P14, DOI 10.1016/j.envexpbot.2013.12.015; Jenkinson HF, 1997, CRIT REV ORAL BIOL M, V8, P175, DOI 10.1177/10454411970080020601; Katzen F, 1998, J BACTERIOL, V180, P1607, DOI 10.1128/JB.180.7.1607-1617.1998; Kauffman H, 1973, PLANT DIS REPORTER; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Machado CR, 1997, J MOL BIOL, V273, P114, DOI 10.1006/jmbi.1997.1302; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; Monier JM, 2003, P NATL ACAD SCI USA, V100, P15977, DOI 10.1073/pnas.2436560100; Nosaka K, 2006, APPL MICROBIOL BIOT, V72, P30, DOI 10.1007/s00253-006-0464-9; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ou S.H., 1985, RICE DIS IRRI; Qian GL, 2013, MOL PLANT PATHOL, V14, P145, DOI 10.1111/j.1364-3703.2012.00838.x; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Ruiz-Roldan C, 2008, FUNGAL GENET BIOL, V45, P6, DOI 10.1016/j.fgb.2007.09.003; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schauer K, 2009, J BACTERIOL, V191, P2218, DOI 10.1128/JB.01636-08; Solano C, 2014, CURR OPIN MICROBIOL, V18, P96, DOI 10.1016/j.mib.2014.02.008; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013; Wang GN, 2006, PLANT MOL BIOL, V60, P437, DOI 10.1007/s11103-005-4770-x; Webb E, 1998, J BIOL CHEM, V273, P8946, DOI 10.1074/jbc.273.15.8946; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; Yuan ZH, 2013, J GENET GENOMICS, V40, P473, DOI 10.1016/j.jgg.2013.05.003; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao YC, 2011, MICROB PATHOGENESIS, V50, P48, DOI 10.1016/j.micpath.2010.09.002; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	42	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134237	10.1371/journal.pone.0134237	http://dx.doi.org/10.1371/journal.pone.0134237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222282	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800115
J	Chen, G; Yang, LH; Jin, MJ; Du, PF; Zhang, C; Wang, J; Shao, H; Jin, F; Zheng, LF; Wang, SS; She, YX; Wang, J				Chen, Ge; Yang, Lihua; Jin, Maojun; Du, Pengfei; Zhang, Chan; Wang, Jian; Shao, Hua; Jin, Fen; Zheng, Lufei; Wang, Shanshan; She, Yongxin; Wang, Jing			The Rapid Screening of Triazophos Residues in Agricultural Products by Chemiluminescent Enzyme Immunoassay	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY PRODUCTION; LINKED-IMMUNOSORBENT-ASSAY; HAPTEN SYNTHESIS; SPECTROMETRY	A highly sensitive chemiluminescent enzyme immunoassay (CLEIA) method was developed in this study for efficient screening of triazophos residues in a large number of samples. Based on the maximum residue limits (MRLs) set by China and CAC for triazophos in different agro-products, the representative apple, orange, cabbage, zucchini, and rice samples were selected as spiked samples, and the triazophos at the concentrations of the MRL values were spiked to blank samples. Subsequently, the five samples with the spiked triazophos standard were measured by CLEIA 100 times, and the detection results indicated that the correction factors of the apple, orange, cabbage, zucchini, and rice were determined as 0.79, 0.66, 0.85, 0.76, and 0.91, respectively. In this experiment, 1500 real samples were detected by both the CLEIA and the GC-MS methods. With the GC-MS method, 1462 samples were identified as negative samples and 38 samples as positive samples. Based on the correction factors, the false positive rate of the CLEIA method was 0.13%, and false negative rate was 0. The results showed that the established CLEIA method could be used to screen a large number of real samples.	[Chen, Ge; Yang, Lihua; Jin, Maojun; Du, Pengfei; Zhang, Chan; Wang, Jian; Shao, Hua; Jin, Fen; Zheng, Lufei; Wang, Shanshan; She, Yongxin; Wang, Jing] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Jin, MJ (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Key Lab Agroprod Qual & Safety, Beijing 100081, Peoples R China.	katonking@163.com; w_jing2001@126.com		Jin, Maojun/0000-0002-9102-8572	National Natural Science Foundation of China [31201371]; National key foundation for exploring scientific instrument [2013YQ140371]; Chinese Public Interest Industrial Science & Technology Project [201203094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key foundation for exploring scientific instrument; Chinese Public Interest Industrial Science & Technology Project	This study was supported by the National Natural Science Foundation of China (31201371), National key foundation for exploring scientific instrument (2013YQ140371), Chinese Public Interest Industrial Science & Technology Project (201203094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2015, FOOD AGR IMMUNOL, V26, P1, DOI 10.1080/09540105.2013.858663; [楚金申 CHU Jinshen], 2011, [食品科学, Food Science], V32, P124; [龚云飞 Gong Yunfei], 2014, [食品工业科技, Science & Technology of Food Industry], V35, P66; He ZY, 2015, FOOD CHEM, V169, P372, DOI 10.1016/j.foodchem.2014.07.102; Jiang JQ, 2012, J FOOD SCI, V77, pT63, DOI 10.1111/j.1750-3841.2011.02578.x; Jin MaoJun, 2014, Journal of Food Safety and Quality, V5, P840; Jin MJ, 2013, FOOD AGR IMMUNOL, V24, P345, DOI 10.1080/09540105.2012.694096; Jin MJ, 2012, J FOOD SCI, V77, pT99, DOI 10.1111/j.1750-3841.2012.02659.x; Jin RenYao, 2006, Journal of Zhejiang University (Agriculture and Life Sciences), V32, P591; Kim BM, 2007, B KOREAN CHEM SOC, V28, P929; Li PL, 2013, CHIN RES PERSP SOC, V1, P1; [李培武 Li Peiwu], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3618; Liang CZ, 2013, FOOD AGR IMMUNOL, V24, P9, DOI 10.1080/09540105.2011.639065; Liu YH, 2013, J FOOD SCI, V78, pT372, DOI 10.1111/1750-3841.12017; Ruan ED, 2014, RAPID COMMUN MASS SP, V28, P2723, DOI 10.1002/rcm.7058; STARRATT AN, 1977, CAN J CHEM, V55, P4238, DOI 10.1139/v77-601; Tao XQ, 2014, LUMINESCENCE, V29, P301, DOI 10.1002/bio.2544; Tian Jie, 2013, Journal of Zhejiang University (Agriculture and Life Sciences), V39, P513; Torres OB, 2014, ANAL BIOANAL CHEM, V406, P5927, DOI 10.1007/s00216-014-8035-x; Wang ZH, 2015, FOOD CHEM, V171, P98, DOI 10.1016/j.foodchem.2014.08.104; Wijaya W, 2014, J FOOD SCI, V79, pT743, DOI 10.1111/1750-3841.12391; Wu J, 2014, J AGR FOOD CHEM, V62, P7078, DOI 10.1021/jf5015395; Wu YJ, 2011, SPECTROCHIM ACTA A, V81, P544, DOI 10.1016/j.saa.2011.06.047; [杨丽华 Yang Lihua], 2014, [分析测试学报, Journal of Instrumental Analysis], V33, P758; Yu F, 2014, FOOD CHEM, V149, P71, DOI 10.1016/j.foodchem.2013.10.024; Zhao JY, 2014, FOOD AGR IMMUNOL, V25, P350, DOI 10.1080/09540105.2013.797385	26	14	14	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133839	10.1371/journal.pone.0133839	http://dx.doi.org/10.1371/journal.pone.0133839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218576	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900050
J	Ladur, AN; Colvin, CJ; Stinson, K				Ladur, Alice Norah; Colvin, Christopher J.; Stinson, Kathryn			Perceptions of Community Members and Healthcare Workers on Male Involvement in Prevention of Mother-To-Child Transmission Services in Khayelitsha, Cape Town, South Africa	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; FOLLOW-UP; HIV; PROGRAMS; WOMEN	Involving male partners of pregnant women accessing PMTCT programs has the potential to improve health outcomes for women and children. This study explored community members' (men and women) and healthcare workers' perceptions of male involvement in the prevention of mother-to-child transmission of HIV in Khayelitsha, South Africa. Two focus group discussions were held with 25 men of unknown HIV status and one focus group discussion held with 12 HIV-positive women in the community. In depth interviews were conducted with four HIV-positive couples and five service providers purposely sampled from the community and a health facility, respectively. Both men and women interviewed in this study were receptive towards male involvement in PMTCT. However, men were reluctant to engage with health services due to stigma and negative attitudes from nurses. This study also found HIV testing, disclosure and direct health worker engagement with men increases male involvement in PMTCT. Using men in the media and community to reach out to fellow men with prevention messages tailored to suit specific audiences may reduce perceptions of antenatal care as being a woman's domain.	[Ladur, Alice Norah; Colvin, Christopher J.; Stinson, Kathryn] Univ Cape Town, CIDER, ZA-7925 Cape Town, South Africa; [Ladur, Alice Norah] Africa Renewal Univ, Dept Community Hlth, Kampala, Uganda	University of Cape Town	Ladur, AN (corresponding author), Univ Cape Town, CIDER, ZA-7925 Cape Town, South Africa.	aliceladur@gmail.com	Colvin, Christopher/AAQ-1607-2021; Colvin, Christopher/AAB-8276-2019	Colvin, Christopher/0000-0002-8930-7863				Abrams EJ, 2007, AM J OBSTET GYNECOL, V197, pS101, DOI 10.1016/j.ajog.2007.03.068; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; [Anonymous], 2011, MED SANS FRONTIERES; [Anonymous], 2013, 2012 NAT ANT SENT HI; Bolu O, 2007, AM J OBSTET GYNECOL, V197, pS17, DOI 10.1016/j.ajog.2007.03.082; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Dawson S, 1993, FOCUS GROUPS MANUAL; Ditekemena J, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-32; Dorrington R, 2002, POPULATION PROJECTIO; Falnes EF, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-21; Garson P., 2005, MEN THINK WE BRING D; Goga A, 2010, EVALUATION EFFECTIVE; Greenwood N, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-107; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Homsy J, 2006, JAIDS-J ACQ IMM DEF, V42, P149, DOI 10.1097/01.qai.0000225032.52766.c2; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Larsson EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037590; Larsson EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-769; Montgomery CM, 2006, SOC SCI MED, V62, P2411, DOI 10.1016/j.socscimed.2005.10.026; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Msuya Sia E, 2006, AIDS Res Ther, V3, P27, DOI 10.1186/1742-6405-3-27; National Department of Health of South Africa, 2014, NAT CONS GUID PREV M; National Department of Health [South Africa], 2008, POL GUID IMPL PMTCT; Peacock D., 2004, International Journal of Men's Health, V3, P173, DOI 10.3149/jmh.0303.173; Peacock D, 2003, JOINT UN PROGR HIV A; Peacock D., 2008, MEN CARE CONTEXT HIV; Peltzer K, 2008, J ASSOC NURSE AIDS C, V19, P450, DOI 10.1016/j.jana.2008.05.006; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Technau KG, 2014, JAIDS-J ACQ IMM DEF, V65, pE170, DOI 10.1097/QAI.0000000000000068; Theuring S, 2009, AIDS CARE, P1562; Traore AT, 2009, SOC SCI MED, V69, P830, DOI 10.1016/j.socscimed.2009.06.001; Trieu Nguyen Ngoc, 2010, MALE INVOLVEMENT PMT; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; Van Rossem R, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-352; Yin R.K., 2017, APPL CASE STUDY RES	37	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133239	10.1371/journal.pone.0133239	http://dx.doi.org/10.1371/journal.pone.0133239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7ED	26218065	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900023
J	Siu, MKY; Kong, DSH; Ngai, SYP; Chan, HY; Jiang, LL; Wong, ESY; Liu, SS; Chan, KKL; Ngan, HYS; Cheung, ANY				Siu, Michelle K. Y.; Kong, Daniel S. H.; Ngai, Sheila Y. P.; Chan, Hoi Yan; Jiang, Lili; Wong, Esther S. Y.; Liu, Stephanie S.; Chan, Karen K. L.; Ngan, Hextan Y. S.; Cheung, Annie N. Y.			p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GROUP-II PAKS; CYCLIN D1; PHOSPHORYLATION; EXPRESSION; ACTIVATION; CARCINOMA; MIGRATION; INVASION; CONTRIBUTES	p21-activated kinases (Paks) are serine/threonine protein kinases involved in biological events linked to malignant tumor progression. In this study, expression of Pak1, p-Pak2 Ser(20), Pak4, pPak4 Ser(474) in 21 normal endometrium, 16 hyperplastic endometrium without atypia, 17 atypical complex hyperplasia and 67 endometrial cancers was assessed by immunohistochemistry and correlated with clinicopathological parameters. We also accessed the proliferative role and downstream targets of Pak1 in endometrial cancer. Pak1 was expressed in cytoplasm whereas Pak4 and p-Pak4 were expressed in both cytoplasm and nucleus of endometrial tissues. In normal endometrium, significantly higher Pak1 (P = 0.028) and cytoplasmic p-Pak2 (P = 0.048) expression was detected in proliferative endometrium than secretory endometrium. Pak1, cytoplasmic and nuclear Pak4 and nuclear p-Pak4 was significantly overexpressed in endometrial cancer when compared to atrophic endometrium (all P<0.05). Moreover, type I endometrioid carcinomas showed significantly higher Pak1 expression than type II non-endometrioid carcinomas (P<0.001). On the other hand, Pak1, Pak4 and p-Pak4 expression negatively correlated with histological grade (all P<0.05) while p-Pak2 and cytoplasmic Pak4 expression inversely correlated with myometrial invasion (all P<0.05). Furthermore, patients with endometrial cancers with lower cytoplasmic Pak4 expression showed poorer survival (P = 0.026). Multivariate analysis showed cytoplasmic Pak4 is an independent prognostic factor. Functionally, knockdown of Pak1, but not Pak4, in endometrial cancer cell line led to reduced cell proliferation along with reduced cyclin D1, estrogen receptor (ER alpha) and progestogen receptor (PR) expression. Significant correlation between Pak1 and PR expression was also detected in clinical samples. Our findings suggest that Pak1 and cytoplasmic p-Pak2 may promote cell proliferation in normal endometrium during menstral cycle. Pak1, cytoplasmic and nuclear Pak4 and nuclear p-Pak4 are involved in the pathogenesis of endometrial cancer especially in postmenopausal women. Pak1 promote endometrial cancer cell proliferation, particular in type I endometrioid carcinoma. Cytoplasmic Pak4 can be potential prognostic marker in endometrial cancer.	[Siu, Michelle K. Y.; Kong, Daniel S. H.; Ngai, Sheila Y. P.; Chan, Hoi Yan; Jiang, Lili; Wong, Esther S. Y.; Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Siu, Michelle K. Y.; Liu, Stephanie S.; Chan, Karen K. L.; Ngan, Hextan Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Siu, MKY (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	mkysiu@hkucc.hku.hk; anycheun@hkucc.hku.hk	Cheung, Annie Nga Yin/C-4231-2009	Cheung, Annie Nga Yin/0000-0002-1584-7568; Ngan, Hextan Y S/0000-0003-3945-159X	Hong Kong Anti-Cancer Society Grant; University of Hong Kong Small Project Funding; Conference and Research Council Grant	Hong Kong Anti-Cancer Society Grant; University of Hong Kong Small Project Funding; Conference and Research Council Grant	This study was supported by the Hong Kong Anti-Cancer Society Grant, the University of Hong Kong Small Project Funding and the Conference and Research Council Grant.	Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; Balasenthil S, 2004, FEBS LETT, V567, P243, DOI 10.1016/j.febslet.2004.04.071; Begum A, 2009, CANCER SCI, V100, P1908, DOI 10.1111/j.1349-7006.2009.01252.x; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; Kamelle S, 2002, FERTIL STERIL, V78, P596, DOI 10.1016/S0015-0282(02)03302-2; Kim SH, 2009, HUM REPROD, V24, P1133, DOI 10.1093/humrep/den484; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Liao XY, 2009, MODERN PATHOL, V22, P839, DOI 10.1038/modpathol.2009.45; Mazumdar A, 2003, FEBS LETT, V535, P6, DOI 10.1016/S0014-5793(02)03846-2; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Nikaido T, 1996, CANCER, V78, P1248, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1248::AID-CNCR12>3.3.CO;2-U; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Shabani N, 2007, EUR J CANCER, V43, P2434, DOI 10.1016/j.ejca.2007.08.014; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Siu MKY, 2013, ONCOGENE, V32, P3500, DOI 10.1038/onc.2012.363; Siu MKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047201; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Siu MKY, 2010, AM J PATHOL, V176, P3015, DOI 10.2353/ajpath.2010.091263; Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005; Tao J, 2011, MOL ENDOCRINOL, V25, P1565, DOI 10.1210/me.2011-0062; Thiel DA, 2002, CURR BIOL, V12, P1227, DOI 10.1016/S0960-9822(02)00931-4; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wong OG, 2010, OBSTET GYNECOL INT, DOI [10.1155/2010/682504, DOI 10.1155/2010/682504]; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	36	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133467	10.1371/journal.pone.0133467	http://dx.doi.org/10.1371/journal.pone.0133467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218748	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900031
J	Zhang, TW; Zhang, L; Fan, SQ; Zhang, MZ; Fu, HH; Liu, YJ; Yin, XL; Chen, H; Xie, L; Zhang, JC; Gavine, PR; Gu, Y; Ni, XZ; Su, XY				Zhang, Tianwei; Zhang, Lin; Fan, Shuqiong; Zhang, Meizhuo; Fu, Haihua; Liu, Yuanjie; Yin, Xiaolu; Chen, Hao; Xie, Liang; Zhang, Jingchuan; Gavine, Paul R.; Gu, Yi; Ni, Xingzhi; Su, Xinying			Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity	PLOS ONE			English	Article							CELL LUNG-CANCER; POTENTIAL THERAPEUTIC TARGET; FGFR2 GENE AMPLIFICATION; GROWTH-FACTOR RECEPTORS; C-MET INHIBITOR; JUNCTION ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; ESTABLISHMENT; HER2; EXPRESSION	Patient-derived cancer xenografts (PDCX) generally represent more reliable models of human disease in which to evaluate a potential drugs preclinical efficacy. However to date, only a few patient-derived gastric cancer xenograft (PDGCX) models have been reported. In this study, we aimed to establish additional PDGCX models and to evaluate whether these models accurately reflected the histological and genetic diversities of the corresponding patient tumors. By engrafting fresh patient gastric cancer (GC) tissues into immune-compromised mice (SCID and/or nude mice), thirty two PDGCX models were established. Histological features were assessed by a qualified pathologist based on H&E staining. Genomic comparison was performed for several biomarkers including ERBB1, ERBB2, ERBB3, FGFR2, MET and PTEN. These biomarkers were profiled to assess gene copy number by fluorescent in situ hybridization (FISH) and/or protein expression by immunohistochemistry (IHC). All 32 PDGCX models retained the histological features of the corresponding human tumors. Furthermore, among the 32 models, 78% (25/32) highly expressed ERBB1 (EGFR), 22% (7/32) were ERBB2 (HER2) positive, 78% (25/32) showed ERBB3 (HER3) high expression, 66% (21/32) lost PTEN expression, 3% (1/32) harbored FGFR2 amplification, 41% (13/32) were positive for MET expression and 16% (5/32) were MET gene amplified. Between the PDGCX models and their parental tumors, a high degree of similarity was observed for FGFR2 and MET gene amplification, and also for ERBB2 status (agreement rate = 94 similar to 100%; kappa value = 0.81 similar to 1). Protein expression of PTEN and MET also showed moderate agreement (agreement rate = 78%; kappa value = 0.46 similar to 0.56), while ERBB1 and ERBB3 expression showed slight agreement (agreement rate = 59 similar to 75%; kappa value = 0.18 similar to 0.19). ERBB2 positivity, FGFR2 or MET gene amplification was all maintained until passage 12 in mice. The stability of the molecular profiles observed across subsequent passages within the individual models provides confidence in the utility and translational significance of these models for in vivo testing of personalized therapies.	[Zhang, Tianwei; Zhang, Lin; Fan, Shuqiong; Fu, Haihua; Liu, Yuanjie; Yin, Xiaolu; Xie, Liang; Zhang, Jingchuan; Gavine, Paul R.; Gu, Yi; Su, Xinying] AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China; [Zhang, Meizhuo] AstraZeneca R&D, Res & Dev Informat, Shanghai, Peoples R China; [Chen, Hao; Ni, Xingzhi] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China	AstraZeneca; AstraZeneca; Shanghai Jiao Tong University	Ni, XZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200030, Peoples R China.	georgeniwjc@163.com; Xinying.Su@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	This study is fully funded by AstraZeneca. To clarify, AstraZeneca authors were fully involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CANCER DISCOV, V4, P752, DOI 10.1158/2159-8290.CD-NB2014-069; Asaoka Y, 2011, EXPERT OPIN INV DRUG, V20, P595, DOI 10.1517/13543784.2011.566863; Bang YJ, 2010, LANCET, V376, P1302; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Burgenske DM, 2014, AM J CANCER RES, V4, P824; Carneiro F, 2000, CANCER, V88, P238, DOI 10.1002/(SICI)1097-0142(20000101)88:1<238::AID-CNCR31>3.0.CO;2-F; Chen H, 2015, PATHOL ONCO IN PRESS; Cho EY, 2013, MODERN PATHOL, V26, P677, DOI 10.1038/modpathol.2012.205; Cho YB, 2014, J SURG RES, V187, P502, DOI 10.1016/j.jss.2013.11.010; Chong ML, 2014, INT J CANCER, V134, P1232, DOI 10.1002/ijc.28444; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; de Mello RA, 2013, WORLD J GASTROENTERO, V19, P6165, DOI 10.3748/wjg.v19.i37.6165; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Gavine PR, 2015, MOL ONCOL, V9, P323, DOI 10.1016/j.molonc.2014.08.015; Ha SY, 2013, MODERN PATHOL, V26, P1632, DOI 10.1038/modpathol.2013.108; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Hong L, 2013, EXPERT REV GASTROENT, V7, P759, DOI 10.1586/17474124.2013.837804; Ilie M, 2014, CANC MED IN PRESS; Iveson T, 2014, LANCET ONCOL, V15, P1007, DOI 10.1016/S1470-2045(14)70023-3; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Jin KT, 2012, ONCOL LETT, V3, P1052, DOI 10.3892/ol.2012.603; Jin KT, 2011, HEPATO-GASTROENTEROL, V58, P1814, DOI 10.5754/hge11136; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kang YK, 2014, INVEST NEW DRUG, V32, P355, DOI 10.1007/s10637-013-0057-2; Kawakami H, 2013, ONCOTARGET, V4, P9, DOI 10.18632/oncotarget.718; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018; Li J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-241; Lin D, 2014, ASIAN J ANDROL, V16, P407, DOI 10.4103/1008-682X.125394; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; Lu J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0398-z; Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603; Mattie Mike, 2013, Neoplasia, V15, P1138; Milne ANA, 2007, HUM PATHOL, V38, P903, DOI 10.1016/j.humpath.2006.12.010; Okamoto W, 2012, MOL CANCER THER, V11, P1557, DOI 10.1158/1535-7163.MCT-11-0934; Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005; Salgia R, 2014, CLIN CANCER RES, V20, P1666, DOI 10.1158/1078-0432.CCR-13-2070; Scott CL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00295; Stahl P, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0231-4; Su X, 2014, BRIT J CANCER, V110, P967, DOI 10.1038/bjc.2013.802; Tajiri R, 2014, HUM PATHOL, V45, P725, DOI 10.1016/j.humpath.2013.11.004; Teng LS, 2013, INT J MOL MED, V32, P1247, DOI 10.3892/ijmm.2013.1531; Terashima M, 2012, CLIN CANCER RES, V18, P5992, DOI 10.1158/1078-0432.CCR-12-1318; Tran TN, 2013, J SURG ONCOL, V108, P113, DOI 10.1002/jso.23357; Wu XH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-180; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Yang JY, 2012, CELL BIOCHEM BIOPHYS, V62, P221, DOI 10.1007/s12013-011-9286-1; Zhang HY, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3640; Zhang JC, 2014, LAB INVEST, V94, P917, DOI 10.1038/labinvest.2014.77; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694; Zhang XC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-168; Zhu M, 2015, BRIT J CANCER, V112, P429, DOI 10.1038/bjc.2014.649; Zhu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08542	59	24	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134493	10.1371/journal.pone.0134493	http://dx.doi.org/10.1371/journal.pone.0134493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217940	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900121
J	Bruxvoort, K; Festo, C; Cairns, M; Kalolella, A; Mayaya, F; Kachur, SP; Schellenberg, D; Goodman, C				Bruxvoort, Katia; Festo, Charles; Cairns, Matthew; Kalolella, Admirabilis; Mayaya, Frank; Kachur, S. Patrick; Schellenberg, David; Goodman, Catherine			Measuring Patient Adherence to Malaria Treatment: A Comparison of Results from Self-Report and a Customised Electronic Monitoring Device	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; 6-DOSE ARTEMETHER-LUMEFANTRINE; COMBINATION THERAPY; RANDOMIZED-TRIAL; POPULATION PHARMACOKINETICS; SULFADOXINE-PYRIMETHAMINE; ANTIMALARIAL-DRUGS; RURAL TANZANIA; MEDICATION; BENFLUMETOL	Background Self-report is the most common and feasible method for assessing patient adherence to medication, but can be prone to recall bias and social desirability bias. Most studies assessing adherence to artemisinin-based combination therapies (ACTs) have relied on self-report. In this study, we use a novel customised electronic monitoring device-termed smart blister packs-to examine the validity of self-reported adherence to artemether-lumefantrine (AL) in southern Tanzania. Methods Smart blister packs were designed to look identical to locally available AL blister packs and to record the date and time each tablet was removed from packaging. Patients obtaining AL at randomly selected health facilities and drug stores were followed up at home three days later and interviewed about each dose of AL taken. Blister packs were requested for pill count and extraction of smart blister pack data. Results Data on adherence from both self-report verified by pill count and smart blister packs were available for 696 of 1,204 patients. There was no difference between methods in the proportion of patients assessed to have completed treatment (64% and 67%, respectively). However, the percentage taking the correct number of pills for each dose at the correct times (timely completion) was higher by self-report than smart blister packs (37% vs. 24%; p<0.0001). By smart blister packs, 64% of patients completing treatment did not take the correct number of pills per dose or did not take each dose at the correct time interval. Conclusion Smart blister packs resulted in lower estimates of timely completion of AL and may be less prone to recall and social desirability bias. They may be useful when data on patterns of adherence are desirable to evaluate treatment outcomes. Improved methods of collecting self-reported data are needed to minimise bias and maximise comparability between studies.	[Bruxvoort, Katia; Goodman, Catherine] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Bruxvoort, Katia; Festo, Charles; Kalolella, Admirabilis; Mayaya, Frank] Ifakara Hlth Inst, Impact Evaluat Themat Grp, Dar Es Salaam, Tanzania; [Cairns, Matthew] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Kachur, S. Patrick] US Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [Schellenberg, David] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine	Bruxvoort, K (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	katia.bruxvoort@lshtm.ac.uk	Kachur, Patrick/ABE-7220-2021	Bruxvoort, Katia/0000-0001-8277-2431; Schellenberg, David/0000-0001-8222-0186; Goodman, Catherine/0000-0002-2241-3485	Bill and Melinda Gates Foundation; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council [MR/J012394/1, MR/K012126/1] Funding Source: researchfish; MRC [MR/J012394/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Bill and Melinda Gates Foundation, through a grant to the ACT Consortium. MC is supported by a fellowship jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement. KB, MC, DS, and CG are members of the LSHTM Malaria Centre.	AMFm Independent Evaluation Team, 2012, MULTI COUNTRY INDEPE; [Anonymous], TANZANIA DEMOGRAPHIC; Banek K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-7; Barnes KI, 2008, TRENDS PARASITOL, V24, P127, DOI 10.1016/j.pt.2007.11.008; Bell DJ, 2007, JAIDS-J ACQ IMM DEF, V45, P560, DOI 10.1097/QAI.0b013e3180decadb; Bell DJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-204; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Bruxvoort K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0602-x; Bruxvoort K, 2014, AM J TROP MED HYG, V91, P844, DOI 10.4269/ajtmh.14-0126; Bruxvoort K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084555; Checchi F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-59; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Farmer KC, 1999, CLIN THER, V21, P1074, DOI 10.1016/S0149-2918(99)80026-5; Faucher JF, 2009, J INFECT DIS, V200, P57, DOI 10.1086/599378; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Fuangchan A, 2014, AM J TROP MED HYG, V90, P11, DOI 10.4269/ajtmh.12-0598; Garber MC, 2004, MED CARE, V42, P649, DOI 10.1097/01.mlr.0000129496.05898.02; Jones SR, 2003, EMERG MED J, V20, P453, DOI 10.1136/emj.20.5.453; Lefevre G, 2001, AM J TROP MED HYG, V64, P247, DOI 10.4269/ajtmh.2001.64.247; Ngasala BE, 2011, CLIN INFECT DIS, V52, P873, DOI 10.1093/cid/cir066; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Rahman MM, 2008, T ROY SOC TROP MED H, V102, P861, DOI 10.1016/j.trstmh.2008.05.022; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; Rutta Edmund, 2009, Prog Community Health Partnersh, V3, P145, DOI 10.1353/cpr.0.0063; Simba DO, 2012, T ROY SOC TROP MED H, V106, P3, DOI 10.1016/j.trstmh.2011.09.006; Souares A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-257; Taneja I, 2013, BIOANALYSIS, V5, P2171, DOI [10.4155/BIO.13.180, 10.4155/bio.13.180]; Tanzania Commission for AIDS (TACAIDS) ZACZ, 2012, TANZANIA HIV AIDS AN; Tarning J, 2009, ANTIMICROB AGENTS CH, V53, P3837, DOI 10.1128/AAC.00195-09; Twagirumukiza M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-206; United Republic of Tanzania Ministry of Health and Social Welfare, 2011, NATIONAL GUIDELINES; van den Boogaard J, 2011, B WORLD HEALTH ORGAN, V89, P632, DOI 10.2471/BLT.11.086462; van Vugt M, 1999, AM J TROP MED HYG, V60, P936, DOI 10.4269/ajtmh.1999.60.936; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	38	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134275	10.1371/journal.pone.0134275	http://dx.doi.org/10.1371/journal.pone.0134275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214848	Green Accepted, gold, Green Published			2022-12-27	WOS:000358594300061
J	Delio, M; Patel, K; Maslov, A; Marion, RW; McDonald, TV; Cadoff, EM; Golden, A; Greally, JM; Vijg, J; Morrow, B; Montagna, C				Delio, Maria; Patel, Kunjan; Maslov, Alex; Marion, Robert W.; McDonald, Thomas V.; Cadoff, Evan M.; Golden, Aaron; Greally, John M.; Vijg, Jan; Morrow, Bernice; Montagna, Cristina			Development of a Targeted Multi-Disorder High-Throughput Sequencing Assay for the Effective Identification of Disease-Causing Variants	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; ALPHA-T-CATENIN; DILATED CARDIOMYOPATHY; GENETIC-VARIANTS; READ ALIGNMENT; CAPTURE; DIAGNOSTICS; ENVIRONMENT; MUTATIONS	Background While next generation sequencing (NGS) is a useful tool for the identification of genetic variants to aid diagnosis and support therapy decision, high sequencing costs have limited its application within routine clinical care, especially in economically depressed areas. To investigate the utility of a multi-disease NGS based genetic test, we designed a custom sequencing assay targeting over thirty disease-associated areas including cardiac disorders, intellectual disabilities, hearing loss, collagenopathies, muscular dystrophy, Ashkenazi Jewish genetic disorders, and complex Mendelian disorders. We focused on these specific areas based on the interest of our collaborative clinical team, suggesting these diseases being the ones in need for the development of a sequencing-screening assay. Results We targeted all coding, untranslated regions (UTR) and flanking intronic regions of 650 known disease-associated genes using the Roche-NimbleGen EZ SeqCapV3 capture system and sequenced on the Illumina HiSeq 2500 Rapid Run platform. Eight controls with known variants and one HapMap sample were first sequenced to assess the performance of the panel. Subsequently, as a proof of principle and to explore the possible utility of our test, we analyzed test disease subjects (n = 16). Eight had known Mendelian disorders and eight had complex pediatric diseases. In addition to assess whether copy number variation may be of utility as a companion assay relative to these specific disease areas, we used the Affymetrix Genome-Wide SNP Array 6.0 to analyze the same samples. Conclusion We identified potentially disease-associated variants: 22 missense, 4 nonsense, 1 frameshift, and 1 splice variants (16 previously identified, 12 novel among dbSNP and 15 novel among NHLBI Exome Variant Server). We found multi-disease targeted high-throughput sequencing to be a cost efficient approach in detecting disease-associated variants to aid diagnosis.	[Delio, Maria; Patel, Kunjan; Maslov, Alex; Golden, Aaron; Greally, John M.; Vijg, Jan; Morrow, Bernice; Montagna, Cristina] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Marion, Robert W.] Childrens Hosp Montefiore, Div Dev Med & Genet, Bronx, NY USA; [McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA; [Cadoff, Evan M.; Montagna, Cristina] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Montagna, C (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	Cristina.Montagna@einstein.yu.edu	Greally, John/AAF-9540-2019	Greally, John/0000-0001-6069-7960; Morrow, Bernice/0000-0002-8076-4726	 [RSG-11-021-01-CNE]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by RSG-11-021-01-CNE from http://www.cancer.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; [Anonymous], 2014, EX VAR SERV; Auton A, 2012, METHODS MOL BIOL, V856, P217, DOI 10.1007/978-1-61779-585-5_9; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Gabe T., 2013, POVERTY US 2012; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Janssens B, 2003, HUM GENET, V112, P227, DOI 10.1007/s00439-002-0857-5; Kenna KP, 2013, J MED GENET, V50, P776, DOI 10.1136/jmedgenet-2013-101795; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JF, 2012, J CELL SCI, V125, P1058, DOI 10.1242/jcs.098640; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLellan AS, 2012, GENOMICS, V100, P345, DOI 10.1016/j.ygeno.2012.08.005; Mook ORF, 2013, J MED GENET, V50, P614, DOI 10.1136/jmedgenet-2012-101231; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Rozen S, 1998, PRIMER3; School HM Partners HealthCare Center for Personalized Genetic Medicine (PCPGM), PRIC CPT COD; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; The International Standards for Cytogenomic Arrays Consortium, 2012, DAT THIS MAN WER OBT; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trujillano D, 2013, J MED GENET, V50, P455, DOI 10.1136/jmedgenet-2013-101602; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willard NM, 2007, THOMPSON THOMPSON GE; Wong SQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03494	30	12	13	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133742	10.1371/journal.pone.0133742	http://dx.doi.org/10.1371/journal.pone.0133742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214305	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300029
J	Labedz-Maslowska, A; Lipert, B; Berdecka, D; Kedracka-Krok, S; Jankowska, U; Kamycka, E; Sekula, M; Madeja, Z; Dawn, B; Jura, J; Zuba-Surma, EK				Labedz-Maslowska, Anna; Lipert, Barbara; Berdecka, Dominika; Kedracka-Krok, Sylwia; Jankowska, Urszula; Kamycka, Elzbieta; Sekula, Malgorzata; Madeja, Zbigniew; Dawn, Buddhadeb; Jura, Jolanta; Zuba-Surma, Ewa K.			Monocyte Chemoattractant Protein-Induced Protein 1 (MCPIP1) Enhances Angiogenic and Cardiomyogenic Potential of Murine Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							INHIBITORS DECREASE PROLIFERATION; ZINC-FINGER PROTEIN; OXIDATIVE STRESS; MYOCARDIAL DYSFUNCTION; PROMOTES ANGIOGENESIS; ENDOTHELIAL-CELLS; SDF-1-CXCR4 AXIS; GENE-TRANSFER; NITRIC-OXIDE; IN-VITRO	The current evidence suggests that beneficial effects of mesenchymal stem cells (MSCs) toward myocardial repair are largely due to paracrine actions of several factors. Although Monocyte chemoattractant protein-induced protein 1 (MCPIP1) is involved in the regulation of inflammatory response, apoptosis and angiogenesis, whether MCPIP1 plays any role in stem cell-induced cardiac repair has never been examined. By employing retroviral (RV)transduced overexpression of MCPIP1, we investigated the impact of MCPIP1 on viability, apoptosis, proliferation, metabolic activity, proteome, secretome and differentiation capacity of murine bone marrow (BM) - derived MSCs. MCPIP1 overexpression enhanced angiogenic and cardiac differentiation of MSCs compared with controls as indicated by elevated expression of genes accompanying angiogenesis and cardiomyogenesis in vitro. The proangiogenic activity of MCPIP1-overexpressing MSCs (MCPIP1-MSCs) was also confirmed by increased capillary-like structure formation under several culture conditions. This increase in differentiation capacity was associated with decreased proliferation of MCPIP1-MSCs when compared with controls. MCPIP1-MSCs also expressed increased levels of proteins involved in angiogenesis, autophagy, and induction of differentiation, but not adverse inflammatory agents. We conclude that MCPIP1 enhances endothelial and cardiac differentiation of MSCs. Thus, modulating MCPIP1 expression may be a novel approach useful for enhancing the immune-regulatory, anti-apoptotic, anti-inflammatory and regenerative capacity of BM-derived MSCs for myocardial repair and regeneration of ischemic tissues.	[Labedz-Maslowska, Anna; Berdecka, Dominika; Kamycka, Elzbieta; Sekula, Malgorzata; Madeja, Zbigniew; Zuba-Surma, Ewa K.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Krakow, Poland; [Lipert, Barbara; Jura, Jolanta] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Gen Biochem, Krakow, Poland; [Kedracka-Krok, Sylwia; Jankowska, Urszula] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland; [Kedracka-Krok, Sylwia; Jankowska, Urszula; Sekula, Malgorzata] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland; [Dawn, Buddhadeb] Univ Kansas, Med Ctr, Cardiovasc Res Inst, Div Cardiovasc Dis, Kansas City, KS 66103 USA	Jagiellonian University; Jagiellonian University; Jagiellonian University; Jagiellonian University; University of Kansas; University of Kansas Medical Center	Zuba-Surma, EK (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Krakow, Poland.	ewa.zuba-surma@uj.edu.pl	Jankowska, Urszula/C-4898-2015; Jura, Jolanta/F-8889-2015; Zuba-Surma, Ewa/GZM-7140-2022; Sekuła, Małgorzata/AAA-8305-2021; Berdecka, Dominika/A-2391-2017; Berdecka, Dominika/AAP-5200-2020	Jankowska, Urszula/0000-0002-7165-8964; Jura, Jolanta/0000-0002-0816-3475; Berdecka, Dominika/0000-0003-1035-2520; Berdecka, Dominika/0000-0003-1035-2520; Labedz-Maslowska, Anna/0000-0002-8088-6221; Madeja, Zbigniew/0000-0002-5523-1215; Zuba-Surma, Ewa/0000-0001-6814-6127	National Science Centre (NCN) [N N302 177338]; Foundation for Polish Science (FNP) [TEAM-2012/9-6]; Ministry of Science and Higher Education [POIG.01.01.02-00-109/09]	National Science Centre (NCN)(National Science Centre, Poland); Foundation for Polish Science (FNP)(Foundation for Polish Science); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by 1) Grant no. N N302 177338 from National Science Centre (NCN; https://www.ncn.gov.pl) to EZS, 2) Grant no. TEAM-2012/9-6 from Foundation for Polish Science (FNP; http://www.fnp.org.pl) to EZS, and 3) Grant no. POIG.01.01.02-00-109/09 from Ministry of Science and Higher Education (http://www.nauka.gov.pl) to EZS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008576; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Baumgarten G, 2006, SHOCK, V25, P43, DOI 10.1097/01.shk.0000196498.57306.a6; Cho J, 2011, CIRC RES, V108, P478, DOI 10.1161/CIRCRESAHA.110.229658; Chugh A R, 2009, Minerva Cardioangiol, V57, P185; Davis T, 2000, CLIN CANCER RES, V6, P4334; Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680; Fan L, 2009, EUR J HEART FAIL, V11, P1023, DOI 10.1093/eurjhf/hfp135; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hattan N, 2005, CARDIOVASC RES, V65, P334, DOI 10.1016/j.cardiores.2004.10.004; Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Huang F, 2013, CARDIOLOGY, V125, P18, DOI 10.1159/000347081; Huang F, 2013, INT J MOL MED, V31, P484, DOI 10.3892/ijmm.2012.1200; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ikezoe T, 2000, BLOOD, V96, P3553; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kawai T, 2015, CYTOTHERAPY, V17, P369, DOI 10.1016/j.jcyt.2014.11.009; Khadour FH, 2002, AM J PHYSIOL-HEART C, V283, pH1108, DOI 10.1152/ajpheart.00549.2001; Kim JH, 2014, KOREAN J UROL, V55, P228, DOI 10.4111/kju.2014.55.4.228; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Lipert B, 2014, BBA-MOL CELL RES, V1843, P780, DOI 10.1016/j.bbamcr.2014.01.001; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; McGinley LM, 2013, HUM GENE THER, V24, P840, DOI 10.1089/hum.2011.009; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mizgalska D, 2009, FEBS J, V276, P7386, DOI 10.1111/j.1742-4658.2009.07452.x; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Morimoto H, 2008, CARDIOVASC RES, V78, P554, DOI 10.1093/cvr/cvn035; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Murphy MK, 2015, STEM CELLS, V33, P762, DOI 10.1002/stem.1890; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Niu JL, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0483-8; Niu JL, 2013, J PHARMACOL EXP THER, V347, P288, DOI 10.1124/jpet.113.207316; Niu JL, 2011, J MOL CELL CARDIOL, V51, P177, DOI 10.1016/j.yjmcc.2011.04.018; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Piao WH, 2010, ANGIOGENESIS, V13, P203, DOI 10.1007/s10456-010-9169-x; Qi DF, 2011, J BIOL CHEM, V286, P41692, DOI 10.1074/jbc.M111.276006; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Ratajczak MZ, 2006, EXP HEMATOL, V34, P986, DOI 10.1016/j.exphem.2006.03.015; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Roy A, 2012, CELL SIGNAL, V24, P2123, DOI 10.1016/j.cellsig.2012.07.014; Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200; Shi B, 2014, EXP BIOL MED, V239, P356, DOI 10.1177/1535370213517619; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Solchaga LA, 2011, METHODS MOL BIOL, V698, P253, DOI 10.1007/978-1-60761-999-4_20; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tatsumi T, 2004, J MOL CELL CARDIOL, V37, P775, DOI 10.1016/j.yjmcc.2004.06.014; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu JW, 2012, NUCLEIC ACIDS RES, V40, P6957, DOI 10.1093/nar/gks359; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111246; Zhang W, 2013, CORONARY ARTERY DIS, V24, P549, DOI 10.1097/MCA.0b013e3283640f00; Zuba-Surma EK, 2012, CIRCULATION, V126	68	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133746	10.1371/journal.pone.0133746	http://dx.doi.org/10.1371/journal.pone.0133746			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214508	gold, Green Submitted, Green Published			2022-12-27	WOS:000358594300030
J	Sauliene, I; Greiciuviene, J; Sukiene, L; Juskeviciute, N; Benner, C; Zinkeviciene, A; Ripatti, S; Donner, K; Kainov, D				Sauliene, Ingrida; Greiciuviene, Jurate; Sukiene, Laura; Juskeviciute, Neringa; Benner, Christian; Zinkeviciene, Aukse; Ripatti, Samuli; Donner, Kati; Kainov, Denis			Genetic Loci Associated with Allergic Sensitization in Lithuanians	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RHINITIS; ASTHMA; METAANALYSIS; POPULATION; REPLICATION; PREVALENCE	Allergic rhinitis (AR) is a common and complex disease. It is associated with environmental as well as genetic factors. Three recent genome-wide association studies (GWAS) reported altogether 47 single nucleotide polymorphisms (SNPs) associated with AR or allergic sensitization (AS) in Europeans and North Americans. Two follow up studies in Swedish and Chinese replicated 15 associations. In these studies individuals were selected based on the self-reported AR, or AR/AS diagnosed using blood IgE test or skin prick test (SPT), which were performed often without restriction to specific allergens. Here we performed third replication study in Lithuanians. We used SPT and carefully selected set of allergens prevalent in Lithuania, as well as Illumina Core Exome chip for SNP detection. We genotyped 270 SPT-positive individuals (137 Betulaceae -, 174 Poaceae-, 199 Artemisia-, 70 Helianthus-, 22 Alternaria-, 22 Cladosporium-, 140 mites-, 95 cat-and 97 dog dander-sensitive cases) and 162 SPT-negative controls. We found altogether 13 known SNPs associated with AS (p <= 0.05). Three SNPs were found in Lithuanians sensitive to several allergens, and 10 SNPs were found in Lithuanians sensitive to a certain allergen. For the first time, SNP rs7775228:C was associated with patient sensitivity to dog allergens (F_A=0,269, F_U=0.180, P=0.008). Thus, careful assessment of AS allowed us to detect known genetic variants associated with AS/AR in relatively small cohort of Lithuanians.	[Sauliene, Ingrida; Greiciuviene, Jurate; Sukiene, Laura; Juskeviciute, Neringa; Kainov, Denis] Siauliai Univ, Deptartment Environm Res, Shiauliai, Lithuania; [Zinkeviciene, Aukse] Ctr Innovat Med, State Res Inst, Dept Immunol, Vilnius, Lithuania; [Benner, Christian; Ripatti, Samuli; Donner, Kati; Kainov, Denis] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ripatti, Samuli] Univ Helsinki, Publ Hlth, Helsinki, Finland; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Hinxton, England	Siauliai University; State Research Institute Centre for Innovative Medicine; University of Helsinki; University of Helsinki; Wellcome Trust Sanger Institute	Kainov, D (corresponding author), Siauliai Univ, Deptartment Environm Res, Shiauliai, Lithuania.	denis.kainov@helsinki.fi	Ripatti, Samuli/H-9446-2014; Sauliene, Ingrida/J-9320-2019; Šaulienė, Ingrida/M-9325-2015; Šukiene, Laura/M-3728-2015; kainov, denis/I-5526-2019; Šukienė, Laura/AAJ-1261-2021	Ripatti, Samuli/0000-0002-0504-1202; Sauliene, Ingrida/0000-0003-0250-1127; Šaulienė, Ingrida/0000-0003-0250-1127; Šukiene, Laura/0000-0002-8273-7182; kainov, denis/0000-0001-7716-6955; Šukienė, Laura/0000-0002-8273-7182; Zinkeviciene, Aukse/0000-0002-0190-6360	Research Council of Lithuania [VP1-3.1-SMM-07-K-03-069]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This study was funded by grant No. VP1-3.1-SMM-07-K-03-069 from the Research Council of Lithuania (http://www.lmt.lt/en/about.html).	Andiappan AK, 2013, J ALLERGY CLIN IMMUN, V131, P1431, DOI 10.1016/j.jaci.2012.11.001; [Anonymous], 2008, LANCET, V371, P1551, DOI DOI 10.1016/S0140-6736; Arshad SH, 2001, J INVEST ALLERG CLIN, V11, P94; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2012, ALLERGY, V67, P18, DOI 10.1111/j.1398-9995.2011.02728.x; Davila I, 2009, J INVEST ALLERG CLIN, V19, P25; Eriksson NE, 2004, J INVEST ALLERG CLIN, V14, P70; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304; Kudzyte J, 2008, MEDICINA-LITHUANIA, V44, P944, DOI 10.3390/medicina44120118; Nilsson D, 2014, ALLERGY, V69, P1506, DOI 10.1111/all.12495; Ozdoganoglu T, 2012, THER ADV RESPIR DIS, V6, P11, DOI 10.1177/1753465811431975; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; Portnoy JM, 2008, LANCET, V372, P1037, DOI 10.1016/S0140-6736(08)61441-5; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Sauliene I, 2016, AEROBIOLOGIA, V32, P157, DOI 10.1007/s10453-015-9387-1; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4	20	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134188	10.1371/journal.pone.0134188	http://dx.doi.org/10.1371/journal.pone.0134188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214689	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300059
J	Ahn, SY; Chang, YS; Sung, DK; Sung, SI; Yoo, HS; Im, GH; Choi, SJ; Park, WS				Ahn, So Yoon; Chang, Yun Sil; Sung, Dong Kyung; Sung, Se In; Yoo, Hye Soo; Im, Geun Ho; Choi, Soo Jin; Park, Won Soon			Optimal Route for Mesenchymal Stem Cells Transplantation after Severe Intraventricular Hemorrhage in Newborn Rats	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; MARROW STROMAL CELLS; TRAUMATIC BRAIN INJURY; BONE-MARROW; AGE; HYDROCEPHALUS; RECOVERY; OUTCOMES; THERAPY; INFANTS	Recently, we showed that intracerebroventricular (IC) transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) significantly attenuates post-hemorrhagic hydrocephalus (PHH) and brain damage after severe IVH in newborn rats. This study was performed to determine the optimal route for transplanting MSCs for severe IVH by comparing IC transplantation, intravenous (IV) transplantation, and IV transplantation plus mannitol infusion. Severe IVH was induced by injecting 100 uL of blood into each ventricle of Sprague-Dawley rats on postnatal day 4 (P4). After confirming severe IVH with brain magnetic resonance imaging (MRI) at P5, human UCB-derived MSCs were transplanted at P6 by an IC route (1x10(5)), an IV route (5x10(5)), or an IV route with mannitol infused. Follow-up brain MRIs and rotarod tests were performed. At P32, brain tissue samples were obtained for biochemical and histological analyses. Although more MSCs localized to the brain after IC than after IV delivery, both methods were equally effective in preventing PHH; attenuating impaired rotarod test; increasing the number of TUNEL-positive cells, inflammatory cytokines, and astrogliosis; and reducing corpus callosal thickness and myelin basic protein expression after severe IVH regardless of mannitol co-infusion. Despite the superior delivery efficacy with IC than with the IV route, both IC and IV transplantation of MSCs had equal therapeutic efficacy in protecting against severe IVH. These findings suggest that the less invasive IV route might be a good alternative for clinically unstable, very preterm infants that cannot tolerate a more invasive IC delivery of MSCs.	[Ahn, So Yoon; Chang, Yun Sil; Sung, Dong Kyung; Sung, Se In; Yoo, Hye Soo; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Im, Geun Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Soo Jin] MEDIPOST Co Ltd, Biomed Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; MEDIPOST	Park, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea.	ws123.park@samsung.com			Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A110445]; Samsung Biomedical Research Institute grant [SMX1131761, SMX1132321]	Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Samsung Biomedical Research Institute grant(Samsung)	This work was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Number; A110445, Author; Won Soon Park) (https://www.htdream.kr/) and by a Samsung Biomedical Research Institute grant (Number; SMX1131761, Author; Won Soon Park, SMX1132321, Author; So Yoon Ahn) (http://www.skkusm.ac.kr/academics/ri.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and do not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Ahn SY, 2013, STROKE, V44, P497, DOI 10.1161/STROKEAHA.112.679092; AMTORP O, 1974, J PHYSIOL-LONDON, V243, P387, DOI 10.1113/jphysiol.1974.sp010759; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; BRAUN LD, 1980, J NEUROCHEM, V34, P147, DOI 10.1111/j.1471-4159.1980.tb04633.x; Chang YS, 2014, J PEDIATR-US, V164, P966, DOI 10.1016/j.jpeds.2013.12.011; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Choi YJ, 2010, J NEUROL SCI, V298, P28, DOI 10.1016/j.jns.2010.09.003; Delo DM, 2008, STEM CELLS DEV, V17, P1185, DOI 10.1089/scd.2008.0028; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hudgins RJ, 1997, PEDIATR NEUROSURG, V26, P281, DOI 10.1159/000121207; Jang YK, 2006, ANN HEMATOL, V85, P212, DOI 10.1007/s00277-005-0047-3; Kawabori M, 2012, NEUROPATHOLOGY, V32, P217, DOI 10.1111/j.1440-1789.2011.01260.x; Kennedy C, 1998, LANCET, V352, P433; Kim ES, 2012, PEDIATR RES, V72, P277, DOI 10.1038/pr.2012.71; Kingham PJ, 2014, STEM CELLS DEV, V23, P741, DOI 10.1089/scd.2013.0396; Kuchroo P, 2015, STEM CELLS DEV, V24, P437, DOI 10.1089/scd.2014.0184; LARROCHE JC, 1972, BIOL NEONATE, V20, P287; Lee JK, 2007, CELL TRANSPLANT, V16, P849, DOI 10.3727/000000007783465271; LEVENE MI, 1982, ARCH DIS CHILD, V57, P410, DOI 10.1136/adc.57.6.410; Liu R, 2013, STEM CELLS DEV, V22, P1053, DOI 10.1089/scd.2012.0463; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; MUJSCE DJ, 1990, STROKE, V21, P1210, DOI 10.1161/01.STR.21.8.1210; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Payne AH, 2013, JAMA PEDIATR, V167, P451, DOI 10.1001/jamapediatrics.2013.866; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Thorp JA, 2001, AM J OBSTET GYNECOL, V185, P859, DOI 10.1067/mob.2001.117355; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; van Velthoven CTJ, 2009, BRAIN RES REV, V61, P1, DOI 10.1016/j.brainresrev.2009.03.003; Vinukonda G, 2010, BRAIN, V133, P2264, DOI 10.1093/brain/awq107; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x; Zawadzka M, 2009, ACTA NEUROBIOL EXP, V69, P46; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; 1990, ARCH DIS CHILDHOOD, V65, P3	40	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132919	10.1371/journal.pone.0132919	http://dx.doi.org/10.1371/journal.pone.0132919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208299	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000046
J	Byabagambi, J; Marks, P; Megere, H; Karamagi, E; Byakika, S; Opio, A; Calnan, J; Njeuhmeli, E				Byabagambi, John; Marks, Pamela; Megere, Humphrey; Karamagi, Esther; Byakika, Sarah; Opio, Alex; Calnan, Jacqueline; Njeuhmeli, Emmanuel			Improving the Quality of Voluntary Medical Male Circumcision through Use of the Continuous Quality Improvement Approach: A Pilot in 30 PEPFAR-Supported Sites in Uganda	PLOS ONE			English	Article							HEALTH-CARE; SAFETY	Background Uganda adopted voluntary medical male circumcision (VMMC) (also called Safe Male Circumcision in Uganda), as part of its HIV prevention strategy in 2010. Since then, the Ministry of Health (MOH) has implemented VMMC mostly with support from the United States President's Emergency Plan for AIDS Relief (PEPFAR) through its partners. In 2012, two PEPFAR-led external quality assessments evaluated compliance of service delivery sites with minimum quality standards. Quality gaps were identified, including lack of standardized forms or registers, lack of documentation of client consent, poor preparedness for emergencies and use of untrained service providers. In response, PEPFAR, through a USAID-supported technical assistance project, provided support in quality improvement to the MOH and implementing partners to improve quality and safety in VMMC services and build capacity of MOH staff to continuously improve VMMC service quality. Methods and Findings Sites were supported to identify barriers in achieving national standards, identify possible solutions to overcome the barriers and carry out improvement plans to test these changes, while collecting performance data to objectively measure whether they had bridged gaps. A 53-indicator quality assessment tool was used by teams as a management tool to measure progress; teams also measured client-level indicators through self-assessment of client records. At baseline (February-March 2013), less than 20 percent of sites scored in the "good" range (>80%) for supplies and equipment, patient counseling and surgical procedure; by November 2013, the proportion of sites scoring "good" rose to 67 percent, 93 percent and 90 percent, respectively. Significant improvement was noted in post-operative follow-up at 48 hours, sexually transmitted infection assessment, informed consent and use of local anesthesia but not rate of adverse events. Conclusion Public sector providers can be engaged to address the quality of VMMC using a continuous quality improvement approach.	[Byabagambi, John; Megere, Humphrey; Karamagi, Esther] Univ Res Co LLC URC, USAID Applying Sci Strengthen & Improve Syst ASSI, Kampala, Uganda; [Marks, Pamela] Univ Res Co LLC URC, USAID Applying Sci Strengthen & Improve Syst ASSI, Bethesda, MD USA; [Byakika, Sarah; Opio, Alex] Minist Hlth, Kampala, Uganda; [Calnan, Jacqueline] US Agcy Int Dev, Hlth Team, Kampala, Uganda; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Off HIV AIDS, Global Hlth Bur, Washington, DC 20523 USA	United States Agency for International Development (USAID); United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Njeuhmeli, E (corresponding author), US Agcy Int Dev, Off HIV AIDS, Global Hlth Bur, Washington, DC 20523 USA.	enjeuhmeli@usaid.gov	Byabagambi, MD, MPH, MMS, FISQua, John/GWC-7323-2022; Byabagambi, John/GVU-6682-2022	Byabagambi, John/0000-0002-1456-3387	American people through the United States Agency for International Development (USAID); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The work described in this article was supported by the American people through the United States Agency for International Development (USAID) with funding support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). It was implemented under the USAID Applying Science to Strengthen and Improve Systems (ASSIST) Project, managed by URC under the terms of Cooperative Agreement Number AIDOAAA1200101. Donor staff played an important role in the study design, data analysis, decision to publish and review of the manuscript.	Bertrand JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082518; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Franco LM, 2011, BMJ QUAL SAF, V20, P658, DOI 10.1136/bmjqs.2010.044388; Heiby JR, 2014, BJOG-INT J OBSTET GY, V121, P4, DOI 10.1111/1471-0528.12903; Herman-Roloff A, 2012, B WORLD HEALTH ORGAN, V90, P773, DOI 10.2471/BLT.12.106112; Institute for Healthcare Improvement, 2003, I HEALTHC IMPR INN S; Jennings L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079524; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Ministry of Health, 2011, MIN STAND PROC SAF M; Ministry of Health, 2011, HLTH SECT QUAL IMPR; Ministry of Health (MOH) [Uganda] and ORC Macro, 2006, UG HIV AIDS SER BEH; Ministry of Health Uganda, 2010, SAF MAL CIRC POL; Muula Adamson S, 2007, BMC Urol, V7, P4, DOI 10.1186/1471-2490-7-4; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Perla RJ, 2011, BMJ QUAL SAF, V20, P46, DOI 10.1136/bmjqs.2009.037895; Presidential Emergency Plan For AIDS Relief (PEPFAR), 2012, PREL FIND EXT QUAL A; Rech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084271; Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862; Uganda Ministry of Health and ICF International, 2012, 2011 UG AIDS IND SUR; WHO/UNAIDS Technical Consultation, 2007, MAL CIRC HIV PREV RE; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85; World Health Organization, 2009, MAL CIRC SERV QUAL A	22	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133369	10.1371/journal.pone.0133369	http://dx.doi.org/10.1371/journal.pone.0133369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207986	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000083
J	Kang, HR; Lee, YA; Kim, YH; Lee, DG; Kim, BJ; Kim, KJ; Kim, BG; Oh, MG; Han, CK; Lee, S; Ryu, BY				Kang, Hye-Ryun; Lee, Yong-An; Kim, Yong-Hee; Lee, Dong Gu; Kim, Bang-Jin; Kim, Ki-Jung; Kim, Byung-Gak; Oh, Myeong-Geun; Han, Chan Kyu; Lee, Sanghyun; Ryu, Buom-Yong			Petasites japonicus Stimulates the Proliferation of Mouse Spermatogonial Stem Cells	PLOS ONE			English	Article							JAPANESE HERBAL MEDICINE; FUNCTIONAL-CHARACTERISTICS; SELF-RENEWAL; EXTRACTS	Oriental natural plants have been used as medical herbs for the treatment of various diseases for over 2,000 years. In this study, we evaluated the effect of several natural plants on the preservation of male fertility by assessing the ability of plant extracts to stimulate spermatogonial stem cell (SSC) proliferation by using a serum-free culture method. In vitro assays showed that Petasites japonicus extracts, especially the butanol fraction, have a significant effect on germ cells proliferation including SSCs. The activity of SSCs cultured in the presence of the Petasites japonicus butanol fraction was confirmed by normal colony formation and spermatogenesis following germ cell transplantation of the treated SSCs. Our findings could lead to the discovery of novel factors that activate SSCs and could be useful for the development of technologies for the prevention of male infertility.	[Kang, Hye-Ryun; Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Kim, Ki-Jung; Oh, Myeong-Geun; Ryu, Buom-Yong] Chung Ang Univ, Dept Anim Sci & Technol, Ansong, South Korea; [Lee, Dong Gu; Lee, Sanghyun] Chung Ang Univ, Dept Integrat Plant Sci, Ansong, South Korea; [Kim, Byung-Gak] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Van Andel Inst, Grand Rapids, MI USA; [Han, Chan Kyu] Korea Food Res Inst, Songnam, South Korea	Chung Ang University; Chung Ang University; Michigan State University; Van Andel Institute; Korea Food Research Institute (KFRI)	Ryu, BY (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Ansong, South Korea.	byryu@cau.ac.kr		Lee, Yong-An/0000-0001-7253-2397	Korea Food Research Institute, Republic of Korea [ER142023887]; Excellent Student Scholarship (CAU) from Chung-Ang University, Republic of Korea	Korea Food Research Institute, Republic of Korea; Excellent Student Scholarship (CAU) from Chung-Ang University, Republic of Korea	This work was supported by the fund of Korea Food Research Institute (ER142023887), Republic of Korea. HRK YAL YHK DGL BJK KJK BGK MGO CKH SL BYR received the funding above for this work. MGO was supported by the Excellent Student Scholarship 2015 (CAU2015) from Chung-Ang University, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte PM, 2005, APMIS, V113, P727, DOI 10.1111/j.1600-0463.2005.apm_302.x; Bickford PC, 2006, STEM CELLS DEV, V15, P118, DOI 10.1089/scd.2006.15.118; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chignell CF, 2007, PHOTOCHEM PHOTOBIOL, V83, P938, DOI 10.1111/j.1751-1097.2007.00086.x; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cui HS, 2005, J AGR FOOD CHEM, V53, P8526, DOI 10.1021/jf051595q; de Kretser DM, 1998, HUM REPROD, V13, P1; Debrunner B, 1998, Pharm Acta Helv, V72, P359, DOI 10.1016/S0031-6865(97)00027-7; Deters AM, 2012, J ETHNOPHARMACOL, V142, P438, DOI 10.1016/j.jep.2012.05.014; Engel N, 2011, J ETHNOPHARMACOL, V137, P1003, DOI 10.1016/j.jep.2011.07.023; Grabowska-Joachimiak A, 2011, CYTOGENET GENOME RES, V132, P203, DOI 10.1159/000321584; Hisha H, 1997, BLOOD, V90, P1022, DOI 10.1182/blood.V90.3.1022.1022_1022_1030; Hisha H, 2002, STEM CELLS, V20, P311, DOI 10.1634/stemcells.20-4-311; Holehouse EL, 1998, BBA-LIPID LIPID MET, V1390, P52, DOI 10.1016/S0005-2760(97)00176-8; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lee DY, 2009, J ETHNOPHARMACOL, V123, P149, DOI 10.1016/j.jep.2009.02.009; Lee JS, 2011, J ETHNOPHARMACOL, V133, P551, DOI 10.1016/j.jep.2010.10.038; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nembo EN, 2014, J ETHNOPHARMACOL, V156, P73, DOI 10.1016/j.jep.2014.07.046; Ng TB, 2003, COMP BIOCHEM PHYS C, V136, P109, DOI 10.1016/S1532-0456(03)00170-4; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Paul C, 2013, NAT REV UROL, V10, P227, DOI 10.1038/nrurol.2013.18; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Schmidt S, 2013, J ETHNOPHARMACOL, V150, P85, DOI 10.1016/j.jep.2013.08.013; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132; vanPelt AMM, 1996, BIOL REPROD, V55, P439, DOI 10.1095/biolreprod55.2.439; Wang SN, 2013, FOOD CHEM, V141, P2075, DOI 10.1016/j.foodchem.2013.04.116; Yeap SK, 2007, J ETHNOPHARMACOL, V114, P406, DOI 10.1016/j.jep.2007.08.020	36	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133077	10.1371/journal.pone.0133077	http://dx.doi.org/10.1371/journal.pone.0133077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207817	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000061
J	Kwon, J; Ogawa, KI; Ono, E; Miyake, Y				Kwon, Jinhwan; Ogawa, Ken-ichiro; Ono, Eisuke; Miyake, Yoshihiro			Detection of Nonverbal Synchronization through Phase Difference in Human Communication	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENTS; FACE-TO-FACE; CONVERSATION; JAPANESE; MOVEMENT; COORDINATION; AFFILIATION; RESPONSES; REFLECTS; RAPPORT	Nonverbal communication is an important factor in human communication, and body movement synchronization in particular is an important part of nonverbal communication. Some researchers have analyzed body movement synchronization by focusing on changes in the amplitude of body movements. However, the definition of "body movement synchronization" is still unclear. From a theoretical viewpoint, phase difference is the most important factor in synchronization analysis. Therefore, there is a need to measure the synchronization of body movements using phase difference. The purpose of this study was to provide a quantitative definition of the phase difference distribution for detecting body movement synchronization in human communication. The phase difference distribution was characterized using four statistical measurements: density, mean phase difference, standard deviation (SD) and kurtosis. To confirm the effectiveness of our definition, we applied it to human communication in which the roles of speaker and listener were defined. Specifically, we examined the difference in the phase difference distribution between two different communication situations: face-to-face communication with visual interaction and remote communication with unidirectional visual perception. Participant pairs performed a task supposing lecture in the face-to-face communication condition and in the remote communication condition via television. Throughout the lecture task, we extracted a set of phase differences from the time-series data of the acceleration norm of head nodding motions between two participants. Statistical analyses of the phase difference distribution revealed the characteristics of head nodding synchronization. Although the mean phase differences in synchronized head nods did not differ significantly between the conditions, there were significant differences in the densities, the SDs and the kurtoses of the phase difference distributions of synchronized head nods. These results show the difference in nonverbal synchronization between different communication types. Our study indicates that the phase difference distribution is useful in detecting nonverbal synchronization in various human communication situations.	[Kwon, Jinhwan; Ogawa, Ken-ichiro; Ono, Eisuke; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology	Kwon, J (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	kwon@myk.dis.titech.ac.jp						Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Altmann U, 2007, LECT NOTES COMPUT SC, V4775, P37; Angles J, 2000, LANG COMMUN, V20, P55, DOI 10.1016/S0271-5309(99)00018-X; Bavelas JB, 2002, J COMMUN, V52, P566, DOI 10.1111/j.1460-2466.2002.tb02562.x; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Bernieri FJ, 1996, J PERS SOC PSYCHOL, V71, P110, DOI 10.1037/0022-3514.71.1.110; CONDON WS, 1974, CHILD DEV, V45, P456; Darwin C., 1998, EXPRESS EMOT MAN, V3rd; HADAR U, 1984, HUM MOVEMENT SCI, V3, P237, DOI 10.1016/0167-9457(84)90018-6; HODGINS HS, 1990, J NONVERBAL BEHAV, V14, P155, DOI 10.1007/BF00996224; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; JASKOWSKI P, 1990, PSYCHOL RES-PSYCH FO, V52, P35, DOI 10.1007/BF00867209; Kanabus M, 2002, ACTA NEUROBIOL EXP, V62, P263; Keetels M, 2005, EXP BRAIN RES, V167, P635, DOI 10.1007/s00221-005-0067-1; Kita S, 2007, J PRAGMATICS, V39, P1242, DOI 10.1016/j.pragma.2007.02.009; Kwon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110224; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; MAYNARD SK, 1987, J PRAGMATICS, V11, P589, DOI 10.1016/0378-2166(87)90181-0; MAYNARD SK, 1990, J PRAGMATICS, V14, P397, DOI 10.1016/0378-2166(90)90097-W; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Nagaoka C, 2010, JAPANESE J COGNITIVE, V8, P1; Nagaoka C, 2008, IEICE T INF SYST, VE91D, P1634, DOI 10.1093/ietisy/e91-d.6.1634; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Richmond V. P., 2012, NONVERBAL BEHAV INTE, V7th; Saiga H, 2010, INFORM PROCESSING SO, V26, P1; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Stivers T, 2008, RES LANG SOC INTERAC, V41, P31, DOI 10.1080/08351810701691123; Tickle-Degnen L, 1990, PSYCHOL INQ, V1, P285, DOI [DOI 10.1207/S15327965PLI0104_, 10.1207/s15327965pli0104_1, DOI 10.1207/S15327965PLI0104_1]; van der Kleij R, 2005, INT J HUM-COMPUT ST, V62, P521, DOI 10.1016/j.ijhcs.2005.01.003; van der Kleij R, 2009, SMALL GR RES, V40, P355, DOI 10.1177/1046496409333724; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WHITE S, 1989, LANG SOC, V18, P59, DOI 10.1017/S0047404500013270; Yngve V.H., 1970, 6 REG M CHIC LING SO, P567; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2003, EXP BRAIN RES, V152, P198, DOI 10.1007/s00221-003-1536-z	41	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133881	10.1371/journal.pone.0133881	http://dx.doi.org/10.1371/journal.pone.0133881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208100	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000164
J	Reed, MD; Wilder, JA; Mega, WM; Hutt, JA; Kuehl, PJ; Valderas, MW; Chew, LL; Liang, BC; Squires, CH				Reed, Matthew D.; Wilder, Julie A.; Mega, William M.; Hutt, Julie A.; Kuehl, Philip J.; Valderas, Michelle W.; Chew, Lawrence L.; Liang, Bertrand C.; Squires, Charles H.			Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; VACCINE; IMMUNOGENICITY; TOXIN; ANTIBODIES; THERAPY; ASSAY; MODEL	Protective antigen (PA), one of the components of the anthrax toxin, is the major component of human anthrax vaccine (Biothrax). Human anthrax vaccines approved in the United States and Europe consist of an alum-adsorbed or precipitated (respectively) supernatant material derived from cultures of toxigenic, non-encapsulated strains of Bacillus anthracis. Approved vaccination schedules in humans with either of these vaccines requires several booster shots and occasionally causes adverse injection site reactions. Mutant derivatives of the protective antigen that will not form the anthrax toxins have been described. We have cloned and expressed both mutant (PA SNKE167-Delta FF-315-E308D) and native PA molecules recombinantly and purified them. In this study, both the mutant and native PA molecules, formulated with alum (Alhydrogel), elicited high titers of anthrax toxin neutralizing anti-PA antibodies in New Zealand White rabbits. Both mutant and native PA vaccine preparations protected rabbits from lethal, aerosolized, B. anthracis spore challenge subsequent to two immunizations at doses of less than 1 mu g.	[Reed, Matthew D.; Wilder, Julie A.; Mega, William M.; Hutt, Julie A.; Kuehl, Philip J.; Valderas, Michelle W.] Lovelace Biomed & Environm Res Inst, Preclin Drug Dev, Albuquerque, NM USA; [Chew, Lawrence L.; Liang, Bertrand C.; Squires, Charles H.] Pfenex Inc, San Diego, CA 92121 USA	Lovelace Respiratory Research Institute	Liang, BC (corresponding author), Pfenex Inc, 10790 Roselle St, San Diego, CA 92121 USA.	bl@pfenex.com		Kuehl, Philip/0000-0002-7567-3002	BARDA contract [HHS0100201000045C]; Pfenex Inc.; United States Government's (USG) Health and Human Services Biomedical Advanced Research and Development Authority	BARDA contract; Pfenex Inc.; United States Government's (USG) Health and Human Services Biomedical Advanced Research and Development Authority	Funding was provided by BARDA contract HHS0100201000045C (http://www.phe.gov/about/barda/Pages/default.aspx). Pfenex Inc. provided support in the form of salaries for authors LLC, BCL and CHS. The specific technology focus of this U.S. Government contract necessitated scientific input from the technology provider, Pfenex Inc. The specific roles of these authors are articulated in the 'author contributions' section. Pfenex was provided funding under a technology-focused contract from the United States Government's (USG) Health and Human Services Biomedical Advanced Research and Development Authority.	Aulinger BA, 2005, INFECT IMMUN, V73, P3408, DOI 10.1128/IAI.73.6.3408-3414.2005; Bellanti JA, 2012, CLIN VACCINE IMMUNOL, V19, P140, DOI 10.1128/CVI.05556-11; Brown BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013849; Campbell JD, 2007, HUM VACCINES, V3, P205, DOI 10.4161/hv.3.5.4459; Cote CK, 2005, MICROB PATHOGENESIS, V38, P209, DOI 10.1016/j.micpath.2005.02.001; Cybulski RJ, 2009, MOL ASPECTS MED, V30, P490, DOI 10.1016/j.mam.2009.08.006; Gorse GJ, 2006, VACCINE, V24, P5950, DOI 10.1016/j.vaccine.2006.05.044; Gutting BW, 2013, J THEOR BIOL, V329, P20, DOI 10.1016/j.jtbi.2013.03.020; Gutting BW, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00087; Hering D, 2004, BIOLOGICALS, V32, P17, DOI 10.1016/j.biologicals.2003.09.003; Little SF, 2007, VACCINE, V25, P2771, DOI 10.1016/j.vaccine.2006.12.043; Little SF, 2004, VACCINE, V22, P2843, DOI 10.1016/j.vaccine.2003.12.027; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Pitt MLM, 2001, VACCINE, V19, P4768, DOI 10.1016/S0264-410X(01)00234-1; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; Retallack DM, 2012, PROTEIN EXPRES PURIF, V81, P157, DOI 10.1016/j.pep.2011.09.010; Rhie GE, 2005, FEMS IMMUNOL MED MIC, V45, P341, DOI 10.1016/j.femsim.2005.05.009; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Taft SC, 2008, CLIN VACCINE IMMUNOL, V15, P71, DOI 10.1128/CVI.00321-07; Verma A, 2013, INFECT IMMUN, V81, P278, DOI 10.1128/IAI.00863-12; Yan M, 2008, VACCINE, V26, P947, DOI 10.1016/j.vaccine.2007.11.087; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	24	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130952	10.1371/journal.pone.0130952	http://dx.doi.org/10.1371/journal.pone.0130952			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207820	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000011
J	Shi, WJ; Xu, XH; Zhang, Y; Guo, S; Wang, J; Wang, J				Shi, Wenjun; Xu, Xiaohang; Zhang, Yi; Guo, Sa; Wang, Jing; Wang, Jianjun			Epidemiology and Risk Factors of Functional Constipation in Pregnant Women	PLOS ONE			English	Article							QUALITY-OF-LIFE; UNITED-STATES; POPULATION; PREVALENCE; DEPRESSION; DEFECATION; DISORDERS; SYMPTOMS	Aim To understand the prevalence of functional constipation in pregnant women and to analyze the impact of its risk factors. Methods We searched hospital databases for women who were 37-41 weeks pregnant (1698 cases) from July 2012 to January 2014 in four hospitals in Shanghai. We reviewed factors including general data, living and eating habits, psychological history, past history of defecation in the 6 months before pregnancy and defecation after pregnancy. Data were analyzed using SPSS software. Results Pregnant women who were more than 35 years old, with a pre-pregnancy body mass index >24, who were highly educated and employed in a sedentary occupation, showed a higher prevalence of functional constipation. Multivariate logistic regression analysis indicated that the prevalence of functional constipation among pregnant women was related to age, pre-pregnancy body mass index, diet, exercise, occupation, psychological factors, threatened abortion in early pregnancy and constipation history. Conclusion The prevalence rate of functional constipation in pregnant women was significantly higher than in the general population.	[Shi, Wenjun; Xu, Xiaohang] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Shi, Wenjun] Huangpu Dist Matern & Infant Hosp, Shanghai, Peoples R China; [Xu, Xiaohang; Zhang, Yi; Guo, Sa; Wang, Jing; Wang, Jianjun] Tongji Univ, Tongji Hosp, Dept Obstet & Gynaecol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wang, J (corresponding author), Tongji Univ, Tongji Hosp, Dept Obstet & Gynaecol, Shanghai 200092, Peoples R China.	18918513937@163.com; jjwang0524@sina.com	Zhang, Yi/ABD-4822-2020					American Gastroenterological Association, 2013, Gastroenterology, V144, P211, DOI 10.1053/j.gastro.2012.10.029; Barbezat Gil, 2002, N Z Med J, V115, pU220; Bradley CS, 2007, OBSTET GYNECOL, V110, P1351, DOI 10.1097/01.AOG.0000295723.94624.b1; Chen L. Y., 2000, SMJ, V41, P255; Cheng C, 2003, ALIMENT PHARM THERAP, V18, P319, DOI 10.1046/j.1365-2036.2003.01663.x; Dennison C, 2005, PHARMACOECONOMICS, V23, P461, DOI 10.2165/00019053-200523050-00006; Devanarayana NM, 2010, J TROP PEDIATRICS, V56, P144, DOI 10.1093/tropej/fmp077; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Fishman L, 2004, J PEDIATR-US, V145, P253, DOI 10.1016/j.jpeds.2004.04.022; [付朝伟 FU Chaowei], 2006, [中华消化杂志, Chinese Journal of Digestion], V26, P151; Garrigues V, 2004, AM J EPIDEMIOL, V159, P520, DOI 10.1093/aje/kwh072; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Jin J. J., 2009, CHINA PRACTICAL MED, V4, P106; Jun DW, 2006, DIGEST DIS SCI, V51, P1471, DOI 10.1007/s10620-006-9087-3; Jung Hye-Kyung, 2003, Korean J Intern Med, V18, P181; Kil SY, 2010, J CLIN NURS, V19, P1307, DOI 10.1111/j.1365-2702.2009.03053.x; Li Z. J., 2000, CHINA J CENTR S FOR, V20, P1; Liu W, 2010, CHIN J GASTROENTEROL, V15, P95; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Nakaji S, 2002, EUR J NUTR, V41, P244, DOI 10.1007/s00394-002-0380-4; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Peppas G, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-5; SANDLER RS, 1990, AM J PUBLIC HEALTH, V80, P185, DOI 10.2105/AJPH.80.2.185; Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8; Stewart WF, 1999, AM J GASTROENTEROL, V94, P3530, DOI 10.1111/j.1572-0241.1999.01642.x; Tuteja AK, 2005, AM J GASTROENTEROL, V100, P124, DOI 10.1111/j.1572-0241.2005.40516.x; Wei XQ, 2001, CHIN J GASTROENTEROL, V10, P150; Wu Jia-Xuan, 2009, Zhonghua Yi Xue Za Zhi, V89, P1255; Wuhan J, 2013, CHIN J DIG, V33, P291; [阚志超 Xian Zhichao], 2004, [中华消化杂志, Chinese Journal of Digestion], V24, P612; Xin HW, 2012, CHIN J GASTROENTEROL, V17, P87; You JS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S41; Zhao YF, 2011, ALIMENT PHARM THER, V34, P1020, DOI 10.1111/j.1365-2036.2011.04809.x; 郭晓峰, 2002, [中华消化杂志, Chinese Journal of Digestion], V22, P637; 刘智勇, 2004, [中华消化杂志, Chinese Journal of Digestion], V24, P435	36	14	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133521	10.1371/journal.pone.0133521	http://dx.doi.org/10.1371/journal.pone.0133521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208169	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000095
J	Catarino, R; Vassilakos, P; Scaringella, S; Undurraga-Malinverno, M; Meyer-Hamme, U; Ricard-Gauthier, D; Matute, JC; Petignat, P				Catarino, Rosa; Vassilakos, Pierre; Scaringella, Stefano; Undurraga-Malinverno, Manuela; Meyer-Hamme, Ulrike; Ricard-Gauthier, Dominique; Matute, Juan Carlos; Petignat, Patrick			Smartphone Use for Cervical Cancer Screening in Low-Resource Countries: A Pilot Study Conducted in Madagascar	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; VISUAL INSPECTION; POOLED ANALYSIS; KNOWLEDGE; AFRICA	Background Visual inspection of the cervix after application of 5% acetic acid (VIA) is a screening technique for cervical cancer used widely in low and middle-income countries (LMIC). To improve VIA screening performance, digital images after acid acetic application (D-VIA) are taken. The aim of this study was to evaluate the use of a smartphone for on- and off-site D-VIA diagnosis. Materials and Methods Women aged 30-65 years, living in the city of Ambanja, Madagascar, were recruited through a cervical cancer screening campaign. Each performed a human papillomavirus (HPV) self-sample as a primary screen. Women testing positive for HPV were referred for VIA followed by D-VIA, cervical biopsy and endocervical curettage according to routine protocol. In addition, the same day, the D-VIA was emailed to a tertiary care center for immediate assessment. Results were scored as either D-VIA normal or D-VIA abnormal, requiring immediate therapy or referral to a tertiary center. Each of the three off-site physicians were blinded to the result reported by the one on-site physician and each gave their individual assessment followed by a consensus diagnosis. Statistical analyses were conducted using STATA software. Results Of the 332 women recruited, 137 (41.2%) were HPV-positive and recalled for VIA triage; compliance with this invitation was 69.3% (n = 95). Cervical intraepithelial neoplasia was detected in 17.7% and 21.7% of digital images by on-site and off-site physicians, respectively. The on-site physician had a sensitivity of 66.7% (95% CI: 30.0-90.3) and a specificity of 85.7% (95% CI: 76.7-91.6); the off-site physician consensus sensitivity was 66.7% (95% CI: 30.0-90.3) with a specificity of 82.3%(95% CI: 72.4-89.1). Conclusion This pilot study supports the use of telemedicine for off-site diagnosis of cervical intraepithelial neoplasia, with diagnostic performance similar to those achieved on-site. Further studies need to determine if smartphones can improve cervical cancer screening efficiency in LMIC.	[Catarino, Rosa; Undurraga-Malinverno, Manuela; Meyer-Hamme, Ulrike; Ricard-Gauthier, Dominique; Matute, Juan Carlos; Petignat, Patrick] Univ Hosp Geneva, Dept Gynecol & Obstet, Geneva, Switzerland; [Vassilakos, Pierre] Geneva Fdn Med Educ & Res, Geneva, Switzerland; [Scaringella, Stefano] St Damien Hlth Care Ctr, Ambanja, Madagascar	University of Geneva	Catarino, R (corresponding author), Univ Hosp Geneva, Dept Gynecol & Obstet, Geneva, Switzerland.	rosapintocatarino@gmail.com		Ricard-Gauthier, Dominique/0000-0002-7796-9587; Catarino, Rosa/0000-0002-5317-7710; Petignat, Patrick/0000-0002-6835-533X	Action Madagascar Foundation; University Hospitals of Geneva, Switzerland	Action Madagascar Foundation; University Hospitals of Geneva, Switzerland	This study was supported by the Action Madagascar Foundation and the University Hospitals of Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Bediang G, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00180; Bigoni J, 2015, INT J CANCER, V137, P127, DOI 10.1002/ijc.29353; Blumenthal PD, 2005, INT J GYNECOL OBSTET, V89, pS30, DOI 10.1016/j.ijgo.2005.01.012; Bruni L, ICO INFORM CTR HPV C; Crofts V, 2015, INT J WOMENS HEALTH, V7, P149, DOI 10.2147/IJWH.S56307; Ebu NI, 2015, INT J WOMENS HEALTH, V7, P31, DOI 10.2147/IJWH.S71797; Ferris DG, 2002, OBSTET GYNECOL, V99, P248, DOI 10.1016/S0029-7844(01)01671-4; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Hitt WC, 2013, TELEMED E-HEALTH, V19, P403, DOI 10.1089/tmj.2012.0148; Makwe CC, 2012, J EPIDEMIOL GLOB HEA, V2, P199, DOI 10.1016/j.jegh.2012.11.001; Mwaka AD, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-84; Parham GP, 2010, J LOW GENIT TRACT DI, V14, P167, DOI 10.1097/LGT.0b013e3181cd6d5e; Pinco J, 2009, ARCH PATHOL LAB MED, V133, P57, DOI 10.1043/1543-2165-133.1.57; Quinley KE, 2011, J TELEMED TELECARE, V17, P203, DOI 10.1258/jtt.2011.101008; Rosser JI, 2015, PATIENT EDUC COUNS, V98, P884, DOI 10.1016/j.pec.2015.03.017; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Schadel D, 2005, J TELEMED TELECARE, V11, P103, DOI 10.1258/1357633053499831; WHO, 2013, WHO GUID SCREEN TREA; WHO Library Cataloguing-in-Publication Data, 2002, WHO LIB CAT IN PUBL; Zhao FH, 2012, INT J CANCER, V131, P2929, DOI 10.1002/ijc.27571	21	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134309	10.1371/journal.pone.0134309	http://dx.doi.org/10.1371/journal.pone.0134309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222772	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800129
J	Chen, ZZ; Luo, YJ; Yang, WL; Ding, LW; Wang, JP; Tu, J; Geng, B; Cui, QH; Yang, JC				Chen, Zhenzhen; Luo, Yanjin; Yang, Weili; Ding, Liwei; Wang, Junpei; Tu, Jian; Geng, Bin; Cui, Qinghua; Yang, Jichun			Comparison Analysis of Dysregulated LncRNA Profile in Mouse Plasma and Liver after Hepatic Ischemia/Reperfusion Injury	PLOS ONE			English	Article							LONG NONCODING RNAS; EXPRESSION; ISCHEMIA; HEART	Long noncoding RNAs (LncRNAs) have been believed to be the major transcripts in various tissues and organs, and may play important roles in regulation of many biological processes. The current study determined the LncRNA profile in mouse plasma after liver ischemia/reperfusion injury (IRI) using microarray technology. Microarray assays revealed that 64 LncRNAs were upregulated, and 244 LncRNAs were downregulated in the plasma of liver IRI mouse. Among these dysregulated plasma LncRNAs, 59-61% were intergenic, 22-25% were antisense overlap, 8-12% were sense overlap and 6-7% were bidirectional. Ten dysregulated plasma LncRNAs were validated by quantitative PCR assays, confirming the accuracy of microarray analysis result. Comparison analysis between dysregulated plasma and liver LncRNA profile after liver IRI revealed that among the 308 dysregulated plasma LncRNAs, 245 LncRNAs were present in the liver, but remained unchanged. In contrast, among the 98 dysregulated liver LncRNAs after IRI, only 19 were present in the plasma, but remained unchanged. LncRNA AK139328 had been previously reported to be upregulated in the liver after IRI, and silencing of hepatic AK139328 ameliorated liver IRI. Both microarray and RTPCR analyses failed to detect the presence of AK139328 in mouse plasma. In summary, the current study compared the difference between dysregulated LncRNA profile in mouse plasma and liver after liver IRI, and suggested that a group of dysregulated plasma LncRNAs have the potential of becoming novel biomarkers for evaluation of ischemic liver injury.	[Chen, Zhenzhen; Luo, Yanjin; Yang, Weili; Ding, Liwei; Wang, Junpei; Tu, Jian; Geng, Bin; Cui, Qinghua; Yang, Jichun] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Wang, Junpei; Tu, Jian; Cui, Qinghua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100191, Peoples R China; [Cui, Qinghua] Peking Univ, Inst Syst Biomed, Beijing 100191, Peoples R China; [Chen, Zhenzhen; Luo, Yanjin; Yang, Weili; Ding, Liwei; Geng, Bin; Cui, Qinghua; Yang, Jichun] Peking Univ, MOE Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China; [Geng, Bin; Cui, Qinghua; Yang, Jichun] Peking Univ, Ctr Noncoding RNA Med, Hlth Sci Ctr, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Cui, QH (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangj@hsc.pku.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710; Chen, Zhenzhen/0000-0001-9919-3997	Ministry of Science and Technology [2012CB517504, 2012CB517806]; Natural Science Foundation of China [81471035/91339106/81170791/81322011/81422006]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from by the Ministry of Science and Technology (2012CB517504 and 2012CB517806) and the Natural Science Foundation of China (81471035/91339106/81170791/81322011/81422006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita T, 2013, ANTICANCER RES, V33, P3185; Bai Y, 2014, STROKE, V45, P383, DOI 10.1161/STROKEAHA.113.003393; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Chen ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080817; Dharap A, 2013, ASN NEURO, V5, P283, DOI 10.1042/AN20130029; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Guo XL, 2016, BRIEF FUNCT GENOMICS, V15, P38, DOI 10.1093/bfgp/elv022; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; Isin M, 2014, CLIN CHIM ACTA, V431, P255, DOI 10.1016/j.cca.2014.02.010; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077938; Li Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/368975; Liu YB, 2014, GENE, V543, P15, DOI 10.1016/j.gene.2014.04.016; Lorenzen JM, 2015, CLIN CHEM, V61, P191, DOI 10.1373/clinchem.2014.230359; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Saidi RF, 2014, J INVEST SURG, V27, P366, DOI 10.3109/08941939.2014.932473; Schilling D, 2010, BJU INT, V105, P452, DOI 10.1111/j.1464-410X.2009.09085.x; St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007; Suzuki S, 2008, CURR OPIN ORGAN TRAN, V13, P142, DOI 10.1097/MOT.0b013e3282f6a164; Thum T, 2015, CIRC RES, V116, P751, DOI 10.1161/CIRCRESAHA.116.303549	23	29	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133462	10.1371/journal.pone.0133462	http://dx.doi.org/10.1371/journal.pone.0133462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221732	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800051
J	Kandori, I; Tsuchihara, K; Suzuki, TA; Yokoi, T; Papaj, DR				Kandori, Ikuo; Tsuchihara, Kazuko; Suzuki, Taichi A.; Yokoi, Tomoyuki; Papaj, Daniel R.			Long Frontal Projections Help Battus philenor (Lepidoptera: Papilionidae) Larvae Find Host Plants	PLOS ONE			English	Article							PIPEVINE SWALLOWTAIL; SEXUAL SELECTION; PHENOTYPIC PLASTICITY; FORAGING BEHAVIOR; PREDATORY WASPS; CATERPILLARS; ALLOMETRY; EVOLUTION; BEETLE; PATTERNS	Animals sometimes develop conspicuous projections on or near their heads as, e.g., weaponry, burrowing or digging tools, and probes to search for resources. The frontal projections that insects generally use to locate and assess resources are segmented appendages, including antennae, maxillary palps, and labial palps. There is no evidence to date that arthropods, including insects, use projections other than true segmental appendages to locate food. In this regard, it is noteworthy that some butterfly larvae possess a pair of long antenna-like projections on or near their heads. To date, the function of these projections has not been established. Larvae of pipevine swallowtail butterflies Battus philenor (Papilionidae) have a pair of long frontal fleshy projections that, like insect antennae generally, can be actively moved. In this study, we evaluated the possible function of this pair of long moveable frontal projections. In laboratory assays, both frontal projections and lateral ocelli were shown to increase the frequency with which search larvae found plants. The frontal projections increased finding of host and non-host plants equally, suggesting that frontal projections do not detect host-specific chemical cues. Detailed SEM study showed that putative mechanosensillae are distributed all around the frontal as well as other projections. Taken together, our findings suggest that the frontal projections and associated mechanosensillae act as vertical object detectors to obtain tactile information that, together with visual information from lateral ocelli and presumably chemical information from antennae and mouthparts, help larvae to find host plants. Field observations indicate that host plants are small and scattered in southern Arizona locations. Larvae must therefore find multiple host plants to complete development and face significant challenges in doing so. The frontal projections may thus be an adaptation for finding a scarce resource before starving to death. This is the first evidence that arthropods use projections other than true segmental appendages such as antennae, mouthparts and legs, to locate food resources.	[Kandori, Ikuo] Kinki Univ, Fac Agr, Entomol Lab, Nara 631, Japan; [Tsuchihara, Kazuko] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Suzuki, Taichi A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Yokoi, Tomoyuki] Univ Tsukuba, Fac Life & Environm Sci, Lab Conservat Ecol, Tsukuba, Ibaraki, Japan; [Papaj, Daniel R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Kindai University (Kinki University); Forestry & Forest Products Research Institute - Japan; University of California System; University of California Berkeley; University of Tsukuba; University of Arizona	Kandori, I (corresponding author), Kinki Univ, Fac Agr, Entomol Lab, Nara 631, Japan.	kandori@nara.kindai.ac.jp						Baker RH, 2001, EVOLUTION, V55, P1373; Bennett VA, 2003, CRYOLETTERS, V24, P191; Bergmann PJ, 2012, EVOL BIOL, V39, P311, DOI 10.1007/s11692-011-9147-2; Bierzychudek P, 2009, ECOL ENTOMOL, V34, P632, DOI 10.1111/j.1365-2311.2009.01112.x; Bro-Jorgensen J, 2007, EVOLUTION, V61, P1316, DOI 10.1111/j.1558-5646.2007.00111.x; Cain ML, 1983, ECOL ENTOMOL, V10, P1; Crespo JG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.6201; Cunningham JP, 1998, ANIM BEHAV, V55, P227, DOI 10.1006/anbe.1997.0600; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Dethier VG, 1937, BIOL BULL-US, V72, P7, DOI 10.2307/1537535; DETHIER VG, 1989, ECOL ENTOMOL, V14, P375, DOI 10.1111/j.1365-2311.1989.tb00939.x; Dweck HKM, 2009, MICRON, V40, P769, DOI 10.1016/j.micron.2009.07.012; Emlen DJ, 2005, EVOLUTION, V59, P1060; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Fordyce JA, 2003, EVOLUTION, V57, P1089, DOI 10.1111/j.0014-3820.2003.tb00318.x; Fox H, 1999, HYDROBIOLOGIA, V403, P153, DOI 10.1023/A:1003778125517; GABEL B, 1992, J CHEM ECOL, V18, P693, DOI 10.1007/BF00994607; Gripenberg S, 2007, J ANIM ECOL, V76, P854, DOI 10.1111/j.1365-2656.2007.01261.x; Hashimoto K, 2012, ENTOMOL SCI, V15, P274, DOI 10.1111/j.1479-8298.2012.00517.x; Honda K, 2001, PHYSIOL ENTOMOL, V26, P6, DOI 10.1046/j.1365-3032.2001.00208.x; Honda K, 2011, J CHEM ECOL, V37, P575, DOI 10.1007/s10886-011-9965-9; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; IBM SPSS, 2013, IBM SPSS STAT 22; Juma G, 2008, ENTOMOL EXP APPL, V128, P93, DOI 10.1111/j.1570-7458.2008.00673.x; Kalkowski K, 1958, FOLIA BIOL, V6, P79; Layne JR, 1999, AM MIDL NAT, V141, P293, DOI 10.1674/0003-0031(1999)141[0293:CHOTWB]2.0.CO;2; Lincoln G.A., 1994, P131; Liu Z, 2011, MICRON, V42, P478, DOI 10.1016/j.micron.2011.01.006; Lundrigan B, 1996, J MAMMAL, V77, P462, DOI 10.2307/1382822; Mason PA, 2014, J EXP BIOL, V217, P2250, DOI 10.1242/jeb.093716; McCullough EL, 2012, BEHAV ECOL, V23, P1042, DOI 10.1093/beheco/ars069; Murphy SM, 2010, BEHAV ECOL, V21, P153, DOI 10.1093/beheco/arp166; Nice CC, 2006, OECOLOGIA, V146, P541, DOI 10.1007/s00442-005-0229-7; Nielsen ME, 2014, OECOLOGIA; OHSUGI T, 1991, APPL ENTOMOL ZOOL, V26, P29, DOI 10.1303/aez.26.29; Okada K, 2004, ANN ENTOMOL SOC AM, V97, P1342, DOI 10.1603/0013-8746(2004)097[1342:SDIMAM]2.0.CO;2; Papaj DR, 2007, OECOLOGIA, V152, P365, DOI 10.1007/s00442-007-0658-6; Papaj DR, 2005, P ROY SOC B-BIOL SCI, V272, P2519, DOI 10.1098/rspb.2005.3186; Plard F, 2011, OIKOS, V120, P601, DOI 10.1111/j.1600-0706.2010.18934.x; Plepys D, 2002, OIKOS, V99, P75, DOI 10.1034/j.1600-0706.2002.990108.x; Pomfret JC, 2006, ANIM BEHAV, V71, P567, DOI 10.1016/j.anbehav.2005.05.023; Pratt GF, 2010, J INSECT CONSERV, V14, P107, DOI 10.1007/s10841-009-9229-y; SAXENA KN, 1977, J INSECT PHYSIOL, V23, P1421, DOI 10.1016/0022-1910(77)90167-6; SAXENA KN, 1977, EXPERIENTIA, V33, P1312, DOI 10.1007/BF01920152; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Smilanich AM, 2011, OECOLOGIA, V165, P995, DOI 10.1007/s00442-010-1803-1; Snell-Rood EC, 2009, AM NAT, V173, P615, DOI 10.1086/597609; STAMP NE, 1992, OECOLOGIA, V92, P596, DOI 10.1007/BF00317854; Stamp NE, 1997, OIKOS, V79, P147, DOI 10.2307/3546099; STAMP NE, 1993, OECOLOGIA, V95, P376, DOI 10.1007/BF00320992; STAMP NE, 1988, OECOLOGIA, V75, P619, DOI 10.1007/BF00776428; Stankowich T, 2012, ADAPT BEHAV, V20, P32, DOI 10.1177/1059712311426798; Stankowich T, 2009, P ROY SOC B-BIOL SCI, V276, P4329, DOI 10.1098/rspb.2009.1256; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stoffolano JG, 2013, CAN ENTOMOL, V145, P265, DOI 10.4039/tce.2012.103; Tamura M, 1966, P KANTO TOSAN PLAN T, V13, P118; Warren AD, 2014, BUTTERFLIES AM	57	4	4	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131596	10.1371/journal.pone.0131596	http://dx.doi.org/10.1371/journal.pone.0131596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222554	Green Published, gold			2022-12-27	WOS:000358836800017
J	Khaw, MW; Grab, DA; Livermore, MA; Vossler, CA; Glimcher, PW				Khaw, Mel W.; Grab, Denise A.; Livermore, Michael A.; Vossler, Christian A.; Glimcher, Paul W.			The Measurement of Subjective Value and Its Relation to Contingent Valuation and Environmental Public Goods	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; DECISION-MAKING; ORBITOFRONTAL CORTEX; NEURAL RESPONSES; CHOICE; PREFERENCES; REPRESENTATION; ACTIVATION; MECHANISMS; VALIDITY	Environmental public goods-including national parks, clean air/water, and ecosystem services-provide substantial benefits on a global scale. These goods have unique characteristics in that they are typically "nonmarket" goods, with values from both use and passive use that accrue to a large number of individuals both in current and future generations. In this study, we test the hypothesis that neural signals in areas correlated with subjective valuations for essentially all other previously studied categories of goods (ventromedial prefrontal cortex and ventral striatum) also correlate with environmental valuations. We use contingent valuation (CV) as our behavioral tool for measuring valuations of environmental public goods. CV is a standard stated preference approach that presents survey respondents with information on an issue and asks questions that help policymakers determine how much citizens are willing to pay for a public good or policy. We scanned human subjects while they viewed environmental proposals, along with three other classes of goods. The presentation of all four classes of goods yielded robust and similar patterns of temporally synchronized brain activation within attentionalnetworks. The activations associated with the traditional classes of goods replicate previous correlations between neural activity in valuation areas and behavioral preferences. In contrast, CV-elicited values for environmental proposals did not correlate with brain activity at either the individual or population level. For a sub-population of participants, CV-elicited values were correlated with activity within the dorsomedial prefrontal cortex, a region associated with cognitive control and shifting decision strategies. The results show that neural activity associated with the subjective valuation of environmental proposals differs profoundly from the neural activity associated with previously examined goods and preference measures.	[Khaw, Mel W.; Glimcher, Paul W.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Grab, Denise A.] NYU, Sch Law, Inst Policy Integr, New York, NY 10003 USA; [Livermore, Michael A.] Univ Virginia, Sch Law, Charlottesville, VA 22903 USA; [Vossler, Christian A.] Univ Tennessee, Dept Econ, Knoxville, TN USA; [Vossler, Christian A.] Univ Tennessee, Howard H Baker Jr Ctr Publ Policy, Knoxville, TN USA	New York University; New York University; University of Virginia; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Khaw, MW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	mwk247@nyu.edu	Vossler, Christian A/A-5453-2010	Khaw, Mel Win/0000-0002-6601-3715	National Institutes of Health [5R01AG033406]; NATIONAL INSTITUTE ON AGING [R01AG033406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by grants from the National Institutes of Health (no. 5R01AG033406), http://grants.nih.gov/grants/oer.htm, received by PWG.	Adamowicz W, 1998, AM J AGR ECON, V80, P64, DOI 10.2307/3180269; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Carson RT, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.4.27; Carson RT, 2001, ENVIRON RESOUR ECON, V19, P173, DOI 10.1023/A:1011128332243; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Cooper JC, 2010, NEURON, V67, P511, DOI 10.1016/j.neuron.2010.06.030; Corso PS, 2001, J RISK UNCERTAINTY, V23, P165, DOI 10.1023/A:1011184119153; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fehr E, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.4.3; Gross J, 2014, J NEUROSCI, V34, P7580, DOI 10.1523/JNEUROSCI.5082-13.2014; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hausman J, 2012, J ECON PERSPECT, V26, P43, DOI 10.1257/jep.26.4.43; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Hsu M, 2008, SCIENCE, V320, P1092, DOI 10.1126/science.1153651; Kang MJ, 2011, J NEUROSCI, V31, P461, DOI 10.1523/JNEUROSCI.1583-10.2011; Kling CL, 2012, J ECON PERSPECT, V26, P3, DOI 10.1257/jep.26.4.3; Krajbich I, 2009, SCIENCE, V326, P596, DOI 10.1126/science.1177302; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Vossler CA, 2006, ENVIRON RESOUR ECON, V35, P137, DOI 10.1007/s10640-006-9011-5; Vossler CA, 2013, J ECON BEHAV ORGAN, V86, P137, DOI 10.1016/j.jebo.2012.12.007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334	33	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132842	10.1371/journal.pone.0132842	http://dx.doi.org/10.1371/journal.pone.0132842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26221734	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800031
J	Masum, AKM; Azad, MA; Hoque, KE; Beh, LS				Masum, Abdul Kadar Muhammad; Azad, Md. Abul Kalam; Hoque, Kazi Enamul; Beh, Loo-See			Domestic Banks in Bangladesh Could Ensure Efficiency by Improving Human Resource Management Practices	PLOS ONE			English	Article							FIRM PERFORMANCE; ORGANIZATIONAL PERFORMANCE; PRODUCTIVITY; QUALITY; CONTINGENCY; TURNOVER; STRATEGY; IMPACT; TESTS	The paper aims to examine the influence of human resource management (HRM) practices on bank efficiency using Malmquist index of total factor productivity. The model comprises HRM index that represents the quality of HRM practices. The results are decomposed into three efficiency scores, namely, technical efficiency, pure efficiency, and scale efficiency. In this study, panel data for 44 banks in Bangladesh are used for the period 2008-2013. This paper reveals that foreign banks are ahead in converting the influence of HRM practices into efficiency scores (0.946>0.833). On the other hand, domestic banks performed better than foreign banks in terms of pure efficiency and scale efficiency. But, in terms of technical efficiency, the domestic banks are regressed by 6.7% annually whereas foreign banks are progressed with a yearly value of 5.8%. The results are robust, because the Mann-Whitney test and Kruskall-Wallis test (non-parametric tests) also confirm the same results. This study emphasizes HRM practices in the banking industry to ensure efficiency in the long-term scenario. Domestic banks are suggested to ensure continuous development in HRM practices in order to compete with foreign banks.	[Masum, Abdul Kadar Muhammad; Beh, Loo-See] Univ Malaya, Fac Econ & Adm, Dept Adm Studies & Polit, Kuala Lumpur, Malaysia; [Azad, Md. Abul Kalam] Univ Malaya, Fac Econ & Adm, Dept Appl Stat, Kuala Lumpur, Malaysia; [Hoque, Kazi Enamul] Univ Malaya, Fac Educ, Dept Educ Management Planning & Policy, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Masum, AKM (corresponding author), Univ Malaya, Fac Econ & Adm, Dept Adm Studies & Polit, Kuala Lumpur, Malaysia.	akmmasum@yahoo.com	Beh, Loo-See/B-4549-2009; Hoque, Kazi E/N-1170-2017; Azad, Abul Kalam/E-2814-2016; Hoque, Kazi Enamul/B-8758-2010	Beh, Loo-See/0000-0001-7061-9317; Azad, Abul Kalam/0000-0003-3463-2738; 	Bright Spark Scheme of the University of Malaya, Malaysia; UMRG-Frontier Science Cluster, University of Malaya, Kuala Lumpur, Malaysia [RG300-14AFR]	Bright Spark Scheme of the University of Malaya, Malaysia; UMRG-Frontier Science Cluster, University of Malaya, Kuala Lumpur, Malaysia	This research was funded by grants awarded by Bright Spark Scheme of the University of Malaya, Malaysia. This work was also partially supported by UMRG-Frontier Science Cluster (Project No- RG300-14AFR), University of Malaya, Kuala Lumpur, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Aziz AR., 2012, INT J BUS SOC RES, V2, P35; Akther S, 2013, OMEGA-INT J MANAGE S, V41, P88, DOI 10.1016/j.omega.2011.02.009; Alpern R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079053; Anik L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075509; Asuinura EL, 2011, INT BUSINESS RES, V4, P266; Attig N., 2014, J BUS ETHICS, V31, P1; Bakshi S, 2014, ABHINAV INT MONTHLY, V3, P86; Brown M, 2004, SERV IND J, V24, P41, DOI 10.1080/0264206042000275181; Buller PF, 2012, HUM RESOUR MANAGE R, V22, P43, DOI 10.1016/j.hrmr.2011.11.002; Carlson DS, 2006, J VOCAT BEHAV, V68, P131, DOI 10.1016/j.jvb.2005.02.002; CAVES DW, 1982, ECONOMETRICA, V50, P1393, DOI 10.2307/1913388; Chang WJA, 2005, INT J MANPOWER, V26, P434, DOI 10.1108/01437720510615125; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Cho S. H., 2006, International Journal of Hospitality Management, V25, P262, DOI 10.1016/j.ijhm.2005.04.001; Cho S. H., 2006, Journal of Human Resources in Hospitality & Tourism, V5, P55, DOI 10.1300/J171v05n02_04; Chou YC, 2012, DECIS SUPPORT SYST, V54, P173, DOI 10.1016/j.dss.2012.05.003; Chou YC, 2008, 14TH ISSAT INTERNATIONAL CONFERENCE ON RELIABILITY AND QUALITY IN DESIGN, PROCEEDINGS, P224; Coakes S.J., 2003, SPSS ANAL ANGUISH VE; Coelli T. J., 2005, MEDICINE; Cooper W., 2011, HDB DATA ENVELOPMENT; Souza GDE, 2015, EUR J OPER RES, V240, P819, DOI 10.1016/j.ejor.2014.07.027; de Moraes VY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050251; De Nicola A, 2013, TRANSPORT RES E-LOG, V58, P67, DOI 10.1016/j.tre.2013.07.001; Dekle R, 2015, J INT MONEY FINANC, V50, P16, DOI 10.1016/j.jimonfin.2014.08.005; Delery JE, 1996, ACAD MANAGE J, V39, P802, DOI 10.2307/256713; Dessler G., 2011, HUMAN RESOURCE MANAG; Dougherty TW, 2005, HUMAN RESOURCE STRAT; Dumas A, 2010, INT J MANPOWER, V31, P585, DOI 10.1108/01437721011066371; Dyer L., 1995, INT J HUM RESOUR MAN, V6, P656, DOI [DOI 10.1080/09585199500000041, 10.1080/09585199500000041]; Edwards J.E., 2007, EVALUATING HUMAN RES; FARE R, 1995, INT J PROD ECON, V39, P137, DOI 10.1016/0925-5273(94)00063-G; FARE R, 1995, J ECONOMETRICS, V69, P415, DOI 10.1016/0304-4076(94)01677-R; Gittell JH, 2004, IND LABOR RELAT REV, V57, P163, DOI 10.2307/4126615; Gunter BG, 2013, BRIDG POL ACT DIV CH; Gupta R., 2014, INTERMONTHLY REFER J, V3, P74; Haines VY, 2012, INT J HUM RESOUR MAN, V23, P1158, DOI 10.1080/09585192.2011.561230; Haines VY, 2010, IND LABOR RELAT REV, V63, P228, DOI 10.1177/001979391006300203; HUSELID MA, 1995, ACAD MANAGE J, V38, P635, DOI 10.2307/256741; Isik Ihsan, 2002, FINANC REV, V37, P257, DOI DOI 10.1111/1540-6288.00014; Katou A.A., 2009, J BEHAV APPL MANAGEM, V10, P335; Katou AA, 2007, THUNDERBIRD INT BUS, V49, P1, DOI 10.1002/tie.20129; Khezrimotlagh D, 2013, J OPERATIONAL RES SO, V65, P694; King-Kauanui S, 2006, J DEV ENTREP, V11, P79, DOI 10.1142/S1084946706000271; Lee FH, 2010, INT J HUM RESOUR MAN, V21, P1351, DOI 10.1080/09585192.2010.488428; Li WQ, 2012, ADV INTEL SOFT COMPU, V148, P455; Malmquist S, 1953, TRABAJOS ESTATISTICA, V4, P1209, DOI [DOI 10.1007/BF03006863, 10.1007/BF03006863]; Masum AKM, 2015, TOTAL QUAL MANAGE; McAuliffe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058415; Mehbob A, 2008, BUS REV, V10, P185; Nguyen C, 2011, CURRENT STATE FINANC; Otsuki T, 2013, EMPIR ECON, V44, P1455, DOI 10.1007/s00181-012-0582-4; Peng JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084193, 10.1371/journal.pone.0082465]; Lopez SP, 2005, LEARN ORGAN, V12, P227, DOI 10.1108/09696470510592494; RUSSELL JS, 1985, PERS PSYCHOL, V38, P849, DOI 10.1111/j.1744-6570.1985.tb00570.x; SENGUPTA JK, 1988, APPL ECON, V20, P285, DOI 10.1080/00036848800000042; Shepard R.W., 1970, THEORY COST PRODUCTI; Somarriba N, 2009, SOC INDIC RES, V94, P115, DOI 10.1007/s11205-008-9356-y; Sufian F., 2012, J BUSINESS PERSPECTI, V16, P1, DOI DOI 10.1177/097226291201600101; Sung SY, 2014, J ORGAN BEHAV, V35, P851, DOI 10.1002/job.1933; Suzuki Y, 2010, CONTEMP SOUTH ASIA, V18, P155, DOI 10.1080/09584930903275900; Szamosi LT, 2006, EDUC TRAIN, V48, P654, DOI 10.1108/00400910610710074; Tasnim F, 2014, J DEV STUD, V50, P463, DOI 10.1080/00220388.2014.893678; TERPSTRA DE, 1993, PERS PSYCHOL, V46, P27; Thwala D. W., 2012, J BASIC APPL SOCIAL, V2, P7414, DOI DOI 10.18045/zbefri.2018.1.337; Tzafrir SS, 2005, INT J HUM RESOUR MAN, V16, P1600, DOI 10.1080/09585190500239135; Umene-Nakano W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055189; United Nations, 2014, BANGL POP LIV; Vemic-Durkovic J. J. J.M. R., 2013, INDUSTRIJA, P91, DOI [DOI 10.5937/INDUSTRIJA41-4487, 10.5937/industrija41-4487]; Wanke PF, 2012, INT J PROD RES, V50, P2423, DOI 10.1080/00207543.2011.581005; Wright PM, 2005, PERS PSYCHOL, V58, P409, DOI 10.1111/j.1744-6570.2005.00487.x; Zheng C, 2010, ASIA PAC J MANAG, V27, P423, DOI 10.1007/s10490-009-9159-y	71	4	4	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0121017	10.1371/journal.pone.0121017	http://dx.doi.org/10.1371/journal.pone.0121017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26221727	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800001
J	Voorwald, FA; Marchi, FA; Villacis, RAR; Alves, CEF; Toniollo, GH; Amorim, RL; Drigo, SA; Rogatto, SR				Voorwald, Fabiana Azevedo; Marchi, Fabio Albuquerque; Rios Villacis, Rolando Andre; Fonseca Alves, Carlos Eduardo; Toniollo, Gilson Helio; Amorim, Renee Laufer; Drigo, Sandra Aparecida; Rogatto, Silvia Regina			Molecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; HYPERPLASIA-PYOMETRA COMPLEX; DOGS; BITCH; INFECTION; MUCOMETRA; MARKERS; TRACT	Cystic endometrial hyperplasia (CEH), mucometra, and pyometra are common uterine diseases in intact dogs, with pyometra being a life threatening disease. This study aimed to determine the gene expression profile of these lesions and potential biomarkers for closed-cervix pyometra, the most severe condition. Total RNA was extracted from 69 fresh endometrium samples collected from 21 healthy female dogs during diestrus, 16 CEH, 15 mucometra and 17 pyometra (eight open and nine closed-cervixes). Global gene expression was detected using the Affymetrix Canine Gene 1.0 ST Array. Unsupervised analysis revealed two clusters, one mainly composed of diestrus and CEH samples and the other by 12/15 mucometra and all pyometra samples. When comparing pyometra with other groups, 189 differentially expressed genes were detected. SLPI, PTGS2/COX2, MMP1, S100A8, S100A9 and IL8 were among the top up-regulated genes detected in pyometra, further confirmed by external expression data. Notably, a particular molecular profile in pyometra from animals previously treated with exogenous progesterone compounds was observed in comparison with pyometra from untreated dogs as well as with other groups irrespective of exogenous hormone treatment status. In addition to S100A8 and S100A9 genes, overexpression of the inflammatory cytokines IL1B, TNF and IL6 as well as LTF were detected in the pyometra from treated animals. Interestingly, closed pyometra was more frequently detected in treated dogs (64% versus 33%), with IL1B, TNF, LBP and CXCL10 among the most relevant overexpressed genes. This molecular signature associated with potential biomarkers and therapeutic targets, such as CXCL10 and COX2, should guide future clinical studies. Based on the gene expression profile we suggested that pyometra from progesterone treated dogs is a distinct molecular entity.	[Voorwald, Fabiana Azevedo; Toniollo, Gilson Helio] Sao Paulo State Univ UNESP, Vet Clin, Jaboticabal, SP, Brazil; [Voorwald, Fabiana Azevedo; Toniollo, Gilson Helio] Sao Paulo State Univ UNESP, Dept Surg, Jaboticabal, SP, Brazil; [Marchi, Fabio Albuquerque; Rios Villacis, Rolando Andre; Rogatto, Silvia Regina] AC Camargo Canc Ctr, Int Res Ctr CIPE, Sao Paulo, Brazil; [Fonseca Alves, Carlos Eduardo; Amorim, Renee Laufer] Sao Paulo State Univ UNESP, Vet Clin Dept, Botucatu, SP, Brazil; [Drigo, Sandra Aparecida; Rogatto, Silvia Regina] Sao Paulo State Univ UNESP, Fac Med, Dept Urol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; A.C.Camargo Cancer Center; Universidade Estadual Paulista; Universidade Estadual Paulista	Rogatto, SR (corresponding author), AC Camargo Canc Ctr, Int Res Ctr CIPE, Sao Paulo, Brazil.	rogatto@fmb.unesp.br	Drigo, Sandra A/I-6514-2012; Voorwald, Fabiana A/G-6893-2013; Fonseca-Alves, Carlos Eduardo/G-7554-2012; Marchi, Fabio A/N-9288-2018; Rogatto, Silvia R/E-6535-2012; LINDE, SANDRA/S-3128-2019; AMORIM, RENEE LAUFER/AAV-2951-2020	Drigo, Sandra A/0000-0001-6747-6642; Fonseca-Alves, Carlos Eduardo/0000-0002-6702-6139; Marchi, Fabio A/0000-0001-5815-8423; LINDE, SANDRA/0000-0001-6747-6642; AMORIM, RENEE LAUFER/0000-0002-8653-7938; Rogatto, Silvia/0000-0003-4637-5687; Villacis, Rolando/0000-0003-3851-2696	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); FAPESP [2011/51976-2]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). SRR received research grants from FAPESP (2011/51976-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branescu C, 2012, J Med Life, V5, P342; De Bosschere H, 2001, THERIOGENOLOGY, V55, P1509, DOI 10.1016/S0093-691X(01)00498-8; Egenvall A, 2001, J VET INTERN MED, V15, P530, DOI 10.1892/0891-6640(2001)015&lt;0530:BROPII&gt;2.3.CO;2; Drago-Serrano ME, 2012, INT IMMUNOPHARMACOL, V12, P1, DOI 10.1016/j.intimp.2011.11.002; Fieni F, 2014, REPROD DOMEST ANIM, V49, P28, DOI 10.1111/rda.12302; Floras ANK, 2014, J VET INTERN MED, V28, P1447, DOI 10.1111/jvim.12409; Hagman R, 2014, REPROD DOMEST ANIM, V49, P16, DOI 10.1111/rda.12331; Hagman R, 2012, REPROD DOMEST ANIM, V47, P323, DOI 10.1111/rda.12031; Hagman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008039; Hara T, 2012, J BIOCHEM, V151, P469, DOI 10.1093/jb/mvs030; Harvey MJA, 1997, J SMALL ANIM PRACT, V38, P336, DOI 10.1111/j.1748-5827.1997.tb03480.x; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Johnston SD, 2001, CANINE FELINE THERIO, P206; Karlsson I, 2012, REPROD DOMEST ANIM, V47, P337, DOI 10.1111/rda.12034; Kida K, 2006, THERIOGENOLOGY, V66, P1325, DOI 10.1016/j.theriogenology.2006.04.028; Pretzer SD, 2008, THERIOGENOLOGY, V70, P359, DOI 10.1016/j.theriogenology.2008.04.028; Sangiuliano B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/821043; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Serrano M, 2013, ATHEROSCLEROSIS, V230, P223, DOI 10.1016/j.atherosclerosis.2013.07.004; Silva E, 2010, J REPROD IMMUNOL, V84, P66, DOI 10.1016/j.jri.2009.10.004; Smith FO, 2006, THERIOGENOLOGY, V66, P610, DOI 10.1016/j.theriogenology.2006.04.023; Sorribas CE, 2006, ATLAS REPROD CANINA; Tahir MZ, 2013, DOMEST ANIM ENDOCRIN, V45, P141, DOI 10.1016/j.domaniend.2013.07.002; Tsalkidou EA, 2013, PEDIATR NEPHROL, V28, P1091, DOI 10.1007/s00467-013-2432-9; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Verstegen J, 2008, THERIOGENOLOGY, V70, P364, DOI 10.1016/j.theriogenology.2008.04.036	28	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133894	10.1371/journal.pone.0133894	http://dx.doi.org/10.1371/journal.pone.0133894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222498	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800077
J	Fleury, M; Marcelo, W; Vasquez, RA; Gonzalez, LA; Bustamante, RO				Fleury, Marina; Marcelo, Wara; Vasquez, Rodrigo A.; Alberto Gonzalez, Luis; Bustamante, Ramiro O.			Recruitment Dynamics of the Relict Palm, Jubaea chilensis: Intricate and Pervasive Effects of Invasive Herbivores and Nurse Shrubs in Central Chile	PLOS ONE			English	Article							ORYCTOLAGUS-CUNICULUS; SPATIAL-DISTRIBUTION; EUROPEAN RABBITS; TREE SAPLINGS; BIOTIC STRESS; FACILITATION; VEGETATION; PLANTS; PATTERNS; PREDATOR	Shrubs can have a net positive effect on the recruitment of other species, especially relict species in dry-stressful conditions. We tested the effects of nurse shrubs and herbivory defoliation on performance (survival and growth) of nursery-grown seedlings of the largest living palm, the relict wine palm Jubaea chilensis. During an 18-month period, a total of more than 300 seedlings were exposed to of four possible scenarios produced by independently weakening the effects of nurse shrubs and browsers. The experiment followed a two-way fully factorial design. We found consistent differences in survival between protected and unprotected seedlings (27.5% and 0.7%, respectively), and herbivory had a dramatic and overwhelmingly negative effect on seedling survival. The invasive rabbit (Oryctolagus cuniculus) is clearly creating a critical bottleneck in the regeneration process and might, therefore, partially explain the general lack of natural regeneration of wine palms under natural conditions. Apparently biotic filters mediated by ecological interactions are more relevant in the early stages of recruitment than abiotic, at least in invaded sites of central Chile. Our data reveal that plant-plant facilitation relationship may be modulated by plant-animal interactions, specifically by herbivory, a common and widespread ecological interaction in arid and semi-arid environments whose role has been frequently neglected. Treatments that protect young wine palm seedlings are mandatory to enable the seedlings to attain a height at which shoots are no longer vulnerable to browsing. Such protection is an essential first step toward the conservation and reintroduction of this emblematic and threatened species.	[Fleury, Marina; Alberto Gonzalez, Luis] Univ Chile, Fac Ciencias Forest & Conservac Nat, Santiago, Chile; [Fleury, Marina; Marcelo, Wara; Vasquez, Rodrigo A.; Bustamante, Ramiro O.] Univ Chile, Dept Ciencias Ecol, Inst Ecol & Biodiversidad, Santiago, Chile	Universidad de Chile; Universidad de Chile	Fleury, M (corresponding author), Univ Chile, Fac Ciencias Forest & Conservac Nat, Santiago, Chile.	marina.fleury@mac.com	BUSTAMANTE, RAMIRO/I-7353-2019		Fondecyt [1140548]; CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) [PFB-23]; Millennium Scientific Initiative [ICM-P05-002]; International Palm Society; CNPq; CONICYT-ICM	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Millennium Scientific Initiative; International Palm Society; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONICYT-ICM	The authors thank Fondecyt (1140548), CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) (PFB-23), the Millennium Scientific Initiative (ICM-P05-002), and the International Palm Society for financial support. MF received a fellowship from CNPq, and WM, RV and RB received fellowships from CONICYT-ICM. In addition, MF would like to thank the Institutional Excellence Incentive/PEEI, Universidad de Chile. The sources of funding agencies have not affected the research design, the collection and interpretation of data, or the writing of the manuscript in any way.	Alberto Gonzalez Luis, 2009, Palms, V53, P68; Allcock KG, 2004, OECOLOGIA, V138, P231, DOI 10.1007/s00442-003-1420-3; Armesto J.J., 2007, PHYS GEOGRAPHY S AM, P184, DOI DOI 10.1093/OSO/9780195313413.003.0019; ARMESTO JJ, 1978, J ECOL, V66, P881, DOI 10.2307/2259301; Armesto JJ., 1995, ECOLOGY BIOGEOGRAPHY, P418; Arroyo MTK, 1995, ECOL STU AN, P43, DOI DOI 10.1007/978-1-4612-2490-7_; Baraza E, 2006, OIKOS, V113, P148, DOI 10.1111/j.0030-1299.2006.14265.x; Barrett MA, 2006, BIOL CONSERV, V129, P100, DOI 10.1016/j.biocon.2005.10.026; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bozinovic F, 1997, COMP BIOCHEM PHYS A, V118, P625, DOI 10.1016/S0300-9629(96)00480-X; Bustamante RO, 2000, PLANT ECOL, V147, P173, DOI 10.1023/A:1009852400814; Castro J, 2002, RESTOR ECOL, V10, P297, DOI 10.1046/j.1526-100X.2002.01022.x; Collett, 2003, MODELLING SURVIVAL D; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; COX DR, 1972, J R STAT SOC B, V34, P187; Davey C, 2006, ECOSYSTEMS, V9, P992, DOI 10.1007/s10021-004-0173-0; ElOrtegui S, 2002, CAMPANA NATL PARK OR; Fleury M, 2015, BASIC APPL ECOL, V16, P141, DOI 10.1016/j.baae.2014.11.006; FrancoPizana JG, 1996, J VEG SCI, V7, P257, DOI 10.2307/3236326; FUENTES ER, 1986, OECOLOGIA, V68, P358, DOI 10.1007/BF01036739; FUENTES ER, 1984, OECOLOGIA, V62, P405, DOI 10.1007/BF00384275; FUENTES ER, 1983, OECOLOGIA, V58, P411, DOI 10.1007/BF00385244; Garcia D, 2005, ECOSCIENCE, V12, P223, DOI 10.2980/i1195-6860-12-2-223.1; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Gomez JM, 2005, ECOL MONOGR, V75, P231, DOI 10.1890/04-0722; Gomez JM, 2003, FOREST ECOL MANAG, V180, P125, DOI 10.1016/S0378-1127(02)00608-4; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gomez-Aparicio L, 2008, J VEG SCI, V19, P161, DOI 10.3170/2008-8-18347; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Graff P, 2011, OIKOS, V120, P1023, DOI 10.1111/j.1600-0706.2010.19059.x; Hastwell GT, 2003, J ECOL, V91, P941, DOI 10.1046/j.1365-2745.2003.00832.x; Henriquez CA, 2001, BIOL CONSERV, V98, P69, DOI 10.1016/S0006-3207(00)00143-9; Holmgren M, 2000, PLANT ECOL, V147, P49, DOI 10.1023/A:1009804726307; Holmgren Milena, 2002, Biological Invasions, V4, P25, DOI 10.1023/A:1020535628776; JAKSIC FM, 1979, J MAMMAL, V60, P207, DOI 10.2307/1379775; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kissling WD, 2012, P NATL ACAD SCI USA, V109, P7379, DOI 10.1073/pnas.1120467109; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MACDONALD IAW, 1988, BIOL CONSERV, V44, P37, DOI 10.1016/0006-3207(88)90004-3; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; Maher CT, 2015, FOREST ECOL MANAG, V342, P76, DOI 10.1016/j.foreco.2015.01.015; Marcelo W., 2007, JUBAEA CHILENSIS MOL; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Perea R, 2014, EUR J FOREST RES, V133, P525, DOI 10.1007/s10342-014-0782-x; Perea R, 2014, FOREST ECOL MANAG, V312, P47, DOI 10.1016/j.foreco.2013.10.022; Pias B, 2014, FOREST ECOL MANAG, V329, P186, DOI 10.1016/j.foreco.2014.06.021; Pliscoff P, 2011, ENVIRON CONSERV, V38, P303, DOI 10.1017/S0376892911000208; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saiz H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040551; Schenk HJ, 2003, J ECOL, V91, P383, DOI 10.1046/j.1365-2745.2003.00782.x; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; SIMONETTI JA, 1982, OECOLOGIA, V54, P55, DOI 10.1007/BF00541107; Smit C, 2007, OECOLOGIA, V152, P265, DOI 10.1007/s00442-006-0650-6; Smit C, 2009, J ECOL, V97, P1215, DOI 10.1111/j.1365-2745.2009.01555.x; Spinoni J, 2014, INT J CLIMATOL, V34, P2792, DOI 10.1002/joc.3875; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; Terborgh J, 2006, J ECOL, V94, P253, DOI 10.1111/j.1365-2745.2006.01106.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Valiente-Banuet A, 2006, P NATL ACAD SCI USA, V103, P16812, DOI 10.1073/pnas.0604933103; Van Staalduinen MA, 2007, APPL VEG SCI, V10, P299, DOI 10.1111/j.1654-109X.2007.tb00428.x; Villasenor R, 1980, ATTI I BOT LAB CRITT, V6, P69	63	10	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133559	10.1371/journal.pone.0133559	http://dx.doi.org/10.1371/journal.pone.0133559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218100	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900035
J	Lei, Y; Shao, YC; Wang, LB; Zhai, TY; Zou, F; Ye, EM; Jin, X; Li, WJ; Qi, JL; Yang, Z				Lei, Yu; Shao, Yongcong; Wang, Lubin; Zhai, Tianye; Zou, Feng; Ye, Enmao; Jin, Xiao; Li, Wuju; Qi, Jianlin; Yang, Zheng			Large-Scale Brain Network Coupling Predicts Total Sleep Deprivation Effects on Cognitive Capacity	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; NEUROCOGNITIVE CONSEQUENCES; NEURAL BASIS; CONNECTIVITY; PERFORMANCE; CORTEX	Interactions between large-scale brain networks have received most attention in the study of cognitive dysfunction of human brain. In this paper, we aimed to test the hypothesis that the coupling strength of large-scale brain networks will reflect the pressure for sleep and will predict cognitive performance, referred to as sleep pressure index (SPI). Fourteen healthy subjects underwent this within-subject functional magnetic resonance imaging (fMRI) study during rested wakefulness (RW) and after 36 h of total sleep deprivation (TSD). Self-reported scores of sleepiness were higher for TSD than for RW. A subsequent working memory (WM) task showed that WM performance was lower after 36 h of TSD. Moreover, SPI was developed based on the coupling strength of salience network (SN) and default mode network (DMN). Significant increase of SPI was observed after 36 h of TSD, suggesting stronger pressure for sleep. In addition, SPI was significantly correlated with both the visual analogue scale score of sleepiness and the WM performance. These results showed that alterations in SN-DMN coupling might be critical in cognitive alterations that underlie the lapse after TSD. Further studies may validate the SPI as a potential clinical biomarker to assess the impact of sleep deprivation.	[Lei, Yu; Shao, Yongcong; Wang, Lubin; Zhai, Tianye; Zou, Feng; Ye, Enmao; Jin, Xiao; Li, Wuju; Yang, Zheng] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Lei, Yu; Shao, Yongcong; Wang, Lubin; Zhai, Tianye; Zou, Feng; Ye, Enmao; Jin, Xiao; Yang, Zheng] Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China; [Qi, Jianlin] Air Force Gen Hosp, Dept Clin Psychol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Air Force General Hospital PLA	Li, WJ (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	liwj@nic.bmi.ac.cn; qjldln@163.com; yangzhengchina@aliyun.com	Li, Wu/AHA-4320-2022		National Military Science Foundation of China [BWS11J045, 06z066, AWS11Z005-2, AWS12J003, 2013BAHD2806]	National Military Science Foundation of China	Financial support for this work was provided by National Military Science Foundation of China, grant number BWS11J045 (Y S), 06z066 (Y S), AWS11Z005-2 (Y S), AWS12J003 (Y S), and 2013BAHD2806 (Y S). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2005, SLEEP, V28, P1059; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Garcia-Garcia I, 2013, HUM BRAIN MAPP, V34, P2786, DOI 10.1002/hbm.22104; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Lerman C, 2014, JAMA PSYCHIAT, V71, P523, DOI 10.1001/jamapsychiatry.2013.4091; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mu QW, 2005, SLEEP, V28, P55, DOI 10.1093/sleep/28.1.55; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Samann PG, 2010, MAGN RESON MATER PHY, V23, P375, DOI 10.1007/s10334-010-0213-z; Schmidt MH, 2014, NEUROSCI BIOBEHAV R, V47, P122, DOI 10.1016/j.neubiorev.2014.08.001; Scott JPR, 2006, PHYSIOL BEHAV, V87, P396, DOI 10.1016/j.physbeh.2005.11.009; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Uddin LQ, 2009, NEUROSCI BIOBEHAV R, V33, P1198, DOI 10.1016/j.neubiorev.2009.06.002; Vanhaudenhuyse A, 2009, BRAIN; Walter M, 2009, ARCH GEN PSYCHIAT, V66, P478, DOI 10.1001/archgenpsychiatry.2009.39; Zhou J, 2010, BRAIN; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	37	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133959	10.1371/journal.pone.0133959	http://dx.doi.org/10.1371/journal.pone.0133959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218521	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900060
J	Hoffmann, W; Bahr, J; Weitmann, K; Herold, R; Kohlmann, T; van den Berg, N				Hoffmann, Wolfgang; Bahr, Jeanette; Weitmann, Kerstin; Herold, Robert; Kohlmann, Thomas; van den Berg, Neeltje			Not Just the Demographic Change - The Impact of Trends in Risk Factor Prevalences on the Prediction of Future Cases of Myocardial Infarction	PLOS ONE			English	Article							HEALTH; POPULATION; MORTALITY; NUMBERS; EVENTS; REGION; CARE	Background Previous predictions of population morbidity consider demographic changes only. To model future morbidity, however, changes in prevalences of risk factors should be considered. We calculated the number of incident cases of first myocardial infarction (MI) in Mecklenburg-Western Pomerania in 2017 considering the effects of demographic changes and trends in the prevalences of major risk factors simultaneously. Methods Data basis of the analysis were two population-based cohorts of the German Study of Health in Pomerania (SHIP-baseline [1997-2001] and the 5-year follow-up and SHIP-Trend- baseline [2008-2011] respectively). SHIP-baseline data were used to calculate the initial coefficients for major risk factors for MI with a Poisson regression model. The dependent variable was the number of incident cases of MI between SHIP-baseline and SHIP-5-year follow-up. Explanatory variables were sex, age, a validated diagnosis of hypertension and/or diabetes, smoking, waist circumference (WC), increased blood levels of triglycerides (TG) and low-density-lipoprotein cholesterol (LDL), and low blood levels of high-density-lipoprotein cholesterol (HDL). Applying the coefficients determined for SHIP baseline to risk factor prevalences, derived from the new cohort SHIP-Trend together with population forecast data, we calculated the projected number of incident cases of MI in 2017. Results Except for WC and smoking in females, prevalences of risk factors in SHIP-Trend-baseline were lower compared to SHIP-baseline. Based on demographic changes only, the calculated incidence of MI for 2017 compared to the reference year 2006 yields an increase of MI (males: + 11.5%, females: + 8.0%). However, a decrease of MI (males: - 23.7%, females: -17.1%) is shown considering the changes in the prevalences of risk factors in the projection. Conclusions The predicted number of incident cases of MI shows large differences between models with and without considering changes in the prevalences of major risk factors. Hence, the prediction of incident MI should preferably not only be based on demographic changes.	[Hoffmann, Wolfgang; Bahr, Jeanette; Weitmann, Kerstin; Herold, Robert; Kohlmann, Thomas; van den Berg, Neeltje] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Hoffmann, Wolfgang; Weitmann, Kerstin; van den Berg, Neeltje] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany	Greifswald Medical School; German Centre for Cardiovascular Research	Hoffmann, W (corresponding author), Univ Med Greifswald, Inst Community Med, Greifswald, Germany.	wolfgang.hoffmann@uni-greifswald.de						[Anonymous], 2008, DEM WAND DEUTSCHL AU; Boateng S, 2013, DM-DIS MON, V59, P83, DOI 10.1016/j.disamonth.2012.12.004; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cassar A, 2009, MAYO CLIN PROC, V84, P1130, DOI 10.4065/mcp.2009.0391; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Fendrich K, 2007, J PUBLIC HEALTH-HEID, V15, P345, DOI 10.1007/s10389-007-0142-0; Foerch C, 2008, DTSCH ARZTEBL INT, V105, P467, DOI 10.3238/arztebl.2008.0467; Germano G, 2012, EUR HEART J, V33, P137; Guo J, 2013, CHINESE MED J-PEKING, V126, P464, DOI 10.3760/cma.j.issn.0366-6999.20113076; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS31, DOI 10.1055/s-2005-858241; Neumann T, 2009, DTSCH ARZTEBL INT, V106, P269, DOI 10.3238/arztebl.2009.0269; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Schulz E, 2004, HEALTH POLICY, V67, P57, DOI 10.1016/S0168-8510(03)00083-6; Schunkert H, 2010, EUR HEART J, V31, P918, DOI 10.1093/eurheartj/ehq038; Siewert U, 2010, DTSCH ARZTEBL INT, V107, P328, DOI 10.3238/arztebl.2010.0328; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Verschuren JJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056262; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0131256	10.1371/journal.pone.0131256	http://dx.doi.org/10.1371/journal.pone.0131256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214851	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300005
J	Legros, A; Modolo, J; Brown, S; Roberston, J; Thomas, AW				Legros, Alexandre; Modolo, Julien; Brown, Samantha; Roberston, John; Thomas, Alex W.			Effects of a 60 Hz Magnetic Field Exposure Up to 3000 mu T on Human Brain Activation as Measured by Functional Magnetic Resonance Imaging	PLOS ONE			English	Article							FREQUENCY-DEPENDENT CHANGES; CONSCIOUS RESTING STATE; CEREBRAL-BLOOD-FLOW; MENTAL ROTATION; ELECTROMAGNETIC-FIELDS; SYNAPTIC PLASTICITY; COGNITIVE FUNCTION; HEART-RATE; POWER; MEMORY	Several aspects of the human nervous system and associated motor and cognitive processes have been reported to be modulated by extremely low-frequency (ELF, < 300 Hz) time-varying Magnetic Fields (MF). Due do their worldwide prevalence; power-line frequencies (60 Hz in North America) are of particular interest. Despite intense research efforts over the last few decades, the potential effects of 60 Hz MF still need to be elucidated, and the underlying mechanisms to be understood. In this study, we have used functional Magnetic Resonance Imaging (fMRI) to characterize potential changes in functional brain activation following human exposure to a 60 Hz MF through motor and cognitive tasks. First, pilot results acquired in a first set of subjects (N=9) were used to demonstrate the technical feasibility of using fMRI to detect subtle changes in functional brain activation with 60 Hz MF exposure at 1800 mu T. Second, a full study involving a larger cohort of subjects tested brain activation during 1) a finger tapping task (N=20), and 2) a mental rotation task (N=21); before and after a one-hour, 60 Hz, 3000 mu T MF exposure. The results indicate significant changes in task-induced functional brain activation as a consequence of MF exposure. However, no impact on task performance was found. These results illustrate the potential of using fMRI to identify MF-induced changes in functional brain activation, suggesting that a one-hour 60 Hz, 3000 mu T MF exposure can modulate activity in specific brain regions after the end of the exposure period (i.e., residual effects). We discuss the possibility that MF exposure at 60 Hz, 3000 mu T may be capable of modulating cortical excitability via a modulation of synaptic plasticity processes.	[Legros, Alexandre; Modolo, Julien; Brown, Samantha; Roberston, John; Thomas, Alex W.] Lawson Hlth Res Inst, Human Threshold Res Grp, London, ON, Canada; [Legros, Alexandre; Modolo, Julien; Roberston, John; Thomas, Alex W.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Legros, Alexandre; Modolo, Julien; Thomas, Alex W.] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Legros, Alexandre] Univ Western Ontario, Sch Kinesiol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Legros, A (corresponding author), Lawson Hlth Res Inst, Human Threshold Res Grp, London, ON, Canada.	alegros@lawsonimaging.ca	Modolo, Julien G/B-5714-2015; Modolo, Julien/M-5120-2018	Modolo, Julien G/0000-0002-5973-7571; Modolo, Julien/0000-0002-5973-7571; Legros, Alexandre/0000-0003-2532-6624	HydroQuebec (Canada); EDF-RTE (France); CIHR (Canada) [187204]; CFI/ORF (Canada, Biomedical Multimodality Hybrid Imaging) [11358]; Lawson Health Research Institute	HydroQuebec (Canada); EDF-RTE (France); CIHR (Canada)(Canadian Institutes of Health Research (CIHR)); CFI/ORF (Canada, Biomedical Multimodality Hybrid Imaging); Lawson Health Research Institute	This project was sponsored by: HydroQuebec (Canada) (http://www.hydroquebec.com/en/); EDF-RTE (France) (http://www.edf.com/the-edf-group-42667.html) (http://www.rte-france.com/fr/); CIHR (Canada, grant #187204) (http://www.cihr-irsc.gc.ca/e/193.html); CFI/ORF (Canada, Biomedical Multimodality Hybrid Imaging - grant #11358) (http://www.innovation.ca/en); and the Lawson Health Research Institute (http://www.lhrionhealth.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; [Anonymous], C956 IEEE; Beuter A, 2009, CHAOS, V19, DOI 10.1063/1.3127585; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; Cash RF, 2014, CEREB CORTEX; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Cook CM, 2005, BIOELECTROMAGNETICS, V26, P367, DOI 10.1002/bem.20113; Cook CM, 2004, BIOELECTROMAGNETICS, V25, P196, DOI 10.1002/bem.10188; COOK MR, 1992, BIOELECTROMAGNETICS, V13, P261, DOI 10.1002/bem.2250130403; Corbacio M, 2011, BIOELECTROMAGNETICS, V32, P620, DOI 10.1002/bem.20676; Corballis MC, 1997, BRAIN LANG, V57, P100, DOI 10.1006/brln.1997.1835; Crasson M, 2003, RADIAT PROT DOSIM, V106, P333, DOI 10.1093/oxfordjournals.rpd.a006369; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Ghione S, 2005, NEUROSCI LETT, V382, P112, DOI 10.1016/j.neulet.2005.02.072; Ghione S, 2004, BIOELECTROMAGNETICS, V25, P167, DOI 10.1002/bem.10180; Gianni M, 2006, BIOL CYBERN, V94, P118, DOI 10.1007/s00422-005-0029-5; Graham C, 2000, BIOELECTROMAGNETICS, V21, P413, DOI 10.1002/1521-186X(200009)21:6<413::AID-BEM1>3.0.CO;2-1; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Heusser K, 1997, NEUROSCI LETT, V239, P57, DOI 10.1016/S0304-3940(97)00881-1; Horowitz AL, 1995, MRI PHYS RADIOLOGIST; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Johansen-Berg H, 2000, NEUROREPORT, V11, P1237, DOI 10.1097/00001756-200004270-00019; JOHNSON AM, 1990, PERCEPT MOTOR SKILL, V71, P803, DOI 10.2466/PMS.71.7.803-806; JONES B, 1982, CORTEX, V18, P501, DOI 10.1016/S0010-9452(82)80049-X; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Legros A, 2005, BIOELECTROMAGNETICS, V26, P657, DOI 10.1002/bem.20161; Legros A, 2010, REV ELECT ELECT REE, V5, P44; Legros A, 2011, EUR J APPL PHYSL; Legros A, 2006, MED ENG PHYS, V28, P827, DOI 10.1016/j.medengphy.2005.11.003; Legros A, 2006, NEUROTOXICOLOGY, V27, P534, DOI 10.1016/j.neuro.2006.02.007; LOVSUND P, 1980, MED BIOL ENG COMPUT, V18, P326, DOI 10.1007/BF02443387; LOVSUND P, 1979, ACTA OPHTHALMOL, V57, P812; Lyskov E, 2001, BIOELECTROMAGNETICS, V22, P457, DOI 10.1002/bem.73; LYSKOV E, 1993, INT J PSYCHOPHYSIOL, V14, P227, DOI 10.1016/0167-8760(93)90036-O; LYSKOV EB, 1993, BIOELECTROMAGNETICS, V14, P87, DOI 10.1002/bem.2250140202; Marino AA, 2004, CLIN NEUROPHYSIOL, V115, P1195, DOI 10.1016/j.clinph.2003.12.023; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Modolo J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00034; Modolo J, 2010, IEEE 5 INT C BIOINSP, P2010; Modolo J, 2013, ELECTROMAGN BIOL MED, V32, P137, DOI 10.3109/15368378.2013.776341; Mourao-Miranda J, 2009, J COGNITIVE NEUROSCI, V21, P890, DOI 10.1162/jocn.2009.21078; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Preece AW, 1998, INT J RADIAT BIOL, V74, P463, DOI 10.1080/095530098141339; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Richter W, 2000, J COGNITIVE NEUROSCI, V12, P310, DOI 10.1162/089892900562129; Riecker A, 2003, NEUROIMAGE, V18, P731, DOI 10.1016/S1053-8119(03)00003-X; Robertson JA, 2010, J R SOC INTERFACE, V7, P467, DOI 10.1098/rsif.2009.0205; Sadato N, 1997, J CEREBR BLOOD F MET, V17, P670; Sadato N, 1996, J CEREBR BLOOD F MET, V16, P23, DOI 10.1097/00004647-199601000-00003; Sait ML, 1999, MED ENG PHYS, V21, P361, DOI 10.1016/S1350-4533(99)00062-4; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sastre A, 2000, CLIN NEUROPHYSIOL, V111, P1942, DOI 10.1016/S1388-2457(00)00438-7; Sastre A, 1998, BIOELECTROMAGNETICS, V19, P98, DOI 10.1002/(SICI)1521-186X(1998)19:2<98::AID-BEM7>3.0.CO;2-Z; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Stodilka RZ, 2011, NEUROCOMPUTING, V74, P2164, DOI 10.1016/j.neucom.2011.01.025; Stuchly MA, 2002, HEALTH PHYS, V83, P333, DOI 10.1097/00004032-200209000-00003; Tabor Z, 2004, BIOELECTROMAGNETICS, V25, P474, DOI 10.1002/bem.20039; Thomas AW, 2001, NEUROSCI LETT, V297, P121, DOI 10.1016/S0304-3940(00)01688-8; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Toma Keiichiro, 2002, Magn Reson Med Sci, V1, P109, DOI 10.2463/mrms.1.109; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; Wexler BE, 1997, MAGN RESON IMAGING, V15, P385, DOI 10.1016/S0730-725X(96)00232-9; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766	73	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132024	10.1371/journal.pone.0132024	http://dx.doi.org/10.1371/journal.pone.0132024			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214312	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300008
J	Bidmos, FA; Chan, H; Praekelt, U; Tauseef, I; Ali, YM; Kaczmarski, EB; Feavers, I; Bayliss, CD				Bidmos, Fadil A.; Chan, Hannah; Praekelt, Uta; Tauseef, Isfahan; Ali, Youssif M.; Kaczmarski, Edward B.; Feavers, Ian; Bayliss, Christopher D.			Investigation into the Antigenic Properties and Contributions to Growth in Blood of the Meningococcal Haemoglobin Receptors, HpuAB and HmbR	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; TRANSFERRIN-BINDING PROTEINS; NEISSERIA-MENINGITIDIS; GROUP-B; PHASE VARIATION; BACTERICIDAL ANTIBODIES; IRON-METABOLISM; STRAIN COVERAGE; IGG SUBCLASS; WHOLE-BLOOD	Acquisition of iron from host complexes is mediated by four surface-located receptors of Neisseria meningitidis. The HmbR protein and heterodimeric HpuAB complex bind to haemoglobin whilst TbpBA and LbpBA bind iron-loaded transferrin and lactoferrin complexes, respectively. The haemoglobin receptors are unevenly distributed; disease-causing meningococcal isolates encode HmbR or both receptors while strains with only HpuAB are rarely-associated with disease. Both these receptors are subject to phase variation and 70-90% of disease isolates have one or both of these receptors in an ON expression state. The surface- expression, ubiquity and association with disease indicate that these receptors could be potential virulence factors and vaccine targets. To test for a requirement during disease, an hmbR deletion mutant was constructed in a strain (MC58) lacking HpuAB and in both a wild-type and TbpBA deletion background. The hmbR mutant exhibited an identical growth pattern to wild-type in whole blood from healthy human donors whereas growth of the tbpBA mutant was impaired. These results suggest that transferrin is the major source of iron for N. meningitidis during replication in healthy human blood. To examine immune responses, polyclonal antisera were raised against His-tagged purified-recombinant variants of HmbR, HpuA and HpuB in mice using monolipopolysaccharide as an adjuvant. Additionally, monoclonal antibodies were raised against outer membrane loops of HmbR presented on the surface of EspA, an E. coli fimbrial protein. All antisera exhibited specific reactivity in Western blots but HmbR and HpuA polyclonal sera were reactive against intactmeningococcal cells. None of the sera exhibited bactericidal activity against iron-induced wild-type meningococci. These findings suggest that the HmbR protein is not required during the early stages of disease and that immune responses against these receptors may not be protective.	[Bidmos, Fadil A.; Praekelt, Uta; Tauseef, Isfahan; Bayliss, Christopher D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Chan, Hannah; Feavers, Ian] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Ali, Youssif M.] Univ Leicester, Dept Infect Inflammat & Immun, Leicester, Leics, England; [Kaczmarski, Edward B.] Publ Hlth England, Meningococcal Reference Unit, Manchester, Lancs, England; [Ali, Youssif M.] Mansoura Univ, Fac Pharm, Dept Microbiol, Mansoura, Egypt	University of Leicester; National Institute for Biological Standards & Control; University of Leicester; Public Health England; Egyptian Knowledge Bank (EKB); Mansoura University	Bayliss, CD (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	cdb12@le.ac.uk	Bidmos, Fadil/AAD-8401-2020; Ali, Youssif M./P-9593-2018	Bidmos, Fadil/0000-0003-2843-409X; Ali, Youssif M./0000-0003-3124-9848; Bayliss, Christopher/0000-0002-5564-2145	Meningitis Research Foundation;  [1002.0]	Meningitis Research Foundation(Meningitis Research Foundation (MRF)); 	This work was funded by the Meningitis Research Foundation (http://www.meningitis.org/). Grant number 1002.0 entitled "Examination of meningococcal haemoglobin receptors as potential vaccine targets" was awarded to HC, EK, IF, and CDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase A, 1998, SCAND J IMMUNOL, V47, P388; Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Alamro M, 2014, INFECT IMMUN, V82, P2472, DOI 10.1128/IAI.01521-14; Bidmos FA, 2011, J CLIN MICROBIOL, V49, P506, DOI 10.1128/JCM.01322-10; BOSLEGO J, 1995, VACCINE, V13, P821, DOI 10.1016/0264-410X(94)00037-N; Bridges KR, 1995, BLOOD PRINCIPLES PRA; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chen CJ, 2002, J BACTERIOL, V184, P420, DOI 10.1128/JB.184.2.420-426.2002; DANVE B, 1993, VACCINE, V11, P1214, DOI 10.1016/0264-410X(93)90045-Y; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Evans NJ, 2010, MICROBIOL-SGM, V156, P1384, DOI 10.1099/mic.0.036475-0; FINNE J, 1983, LANCET, V2, P355; Frosi G, 2013, VACCINE, V31, P4968, DOI 10.1016/j.vaccine.2013.08.006; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Giuntini S, 2012, INFECT IMMUN, V80, P187, DOI 10.1128/IAI.05956-11; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; GORRINGE AR, 1995, VACCINE, V13, P1207, DOI 10.1016/0264-410X(95)00055-6; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison OB, 2013, MICROBIOL-SGM, V159, P1920, DOI 10.1099/mic.0.068874-0; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; ISON CA, 1995, MICROB PATHOGENESIS, V18, P97, DOI 10.1016/S0882-4010(95)90093-4; Jack DL, 2005, J LEUKOCYTE BIOL, V77, P328, DOI 10.1189/jlb.0604342; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; LETENDRE ED, 1987, CANCER METAST REV, V6, P41, DOI 10.1007/BF00047608; Lewis LA, 1998, J BACTERIOL, V180, P6043, DOI 10.1128/JB.180.22.6043-6047.1998; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; Lewis LA, 1999, MOL MICROBIOL, V32, P977, DOI 10.1046/j.1365-2958.1999.01409.x; LONNERDAL B, 1995, ANNU REV NUTR, V15, P93, DOI 10.1146/annurev.nu.15.070195.000521; Lucidarme J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076932; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Na N, 2005, CLIN CHEM, V51, P1754, DOI 10.1373/clinchem.2005.055657; Omer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017145; Pelicic V, 2000, J BACTERIOL, V182, P5391, DOI 10.1128/JB.182.19.5391-5398.2000; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Perkins-Balding D, 2003, MICROBIOL-SGM, V149, P3423, DOI 10.1099/mic.0.26448-0; Piet JR, 2011, J BACTERIOL, V193, P2371, DOI 10.1128/JB.01331-10; Praekelt U, 2014, J MED MICROBIOL, V63, P1595, DOI 10.1099/jmm.0.076323-0; Richardson AR, 1999, J BACTERIOL, V181, P2067, DOI 10.1128/JB.181.7.2067-2074.1999; Rohde KH, 2002, MOL MICROBIOL, V43, P335, DOI 10.1046/j.1365-2958.2002.02745.x; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; Rokbi B, 1997, INFECT IMMUN, V65, P55, DOI 10.1128/IAI.65.1.55-63.1997; ROSENQVIST E, 1995, INFECT IMMUN, V63, P4642, DOI 10.1128/IAI.63.12.4642-4652.1995; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; SCHRYVERS AB, 1990, CAN J MICROBIOL, V36, P145, DOI 10.1139/m90-026; SCHRYVERS AB, 1989, INFECT IMMUN, V57, P2425, DOI 10.1128/IAI.57.8.2425-2429.1989; Seib KL, 2009, INFECT IMMUN, V77, P292, DOI 10.1128/IAI.01071-08; Stojiljkovic I, 1996, J BACTERIOL, V178, P4670, DOI 10.1128/jb.178.15.4670-4678.1996; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Tauseef I, THESIS; Tauseef I, 2013, INFECT IMMUN, V81, P1374, DOI 10.1128/IAI.01358-12; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Turner PC, 1998, INFECT IMMUN, V66, P5215, DOI 10.1128/IAI.66.11.5215-5223.1998; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Welsch JA, 2007, CLIN VACCINE IMMUNOL, V14, P1596, DOI 10.1128/CVI.00341-07; West D, 2001, INFECT IMMUN, V69, P1561, DOI 10.1128/IAI.69.3.1561-1567.2001; Wyngaarden JB, 1985, CECIL TEXTBOOK OF ME; Zarantonelli ML, 2007, INFECT IMMUN, V75, P5609, DOI 10.1128/IAI.00781-07; Zhao SM, 2010, INFECT IMMUN, V78, P1109, DOI 10.1128/IAI.00363-09; Zhu WM, 2000, J BACTERIOL, V182, P439, DOI 10.1128/JB.182.2.439-447.2000	63	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133855	10.1371/journal.pone.0133855	http://dx.doi.org/10.1371/journal.pone.0133855			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208277	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000156
J	van Lelyveld, SFL; Drylewicz, J; Krikke, M; Veel, EM; Otto, SA; Richter, C; Soetekouw, R; Prins, JM; Brinkman, K; Mulder, JW; Kroon, F; Middel, A; Symons, J; Wensing, AMJ; Nijhuis, M; Borghans, JAM; Tesselaar, K; Hoepelman, AIM				van Lelyveld, Steven F. L.; Drylewicz, Julia; Krikke, Maaike; Veel, Ellen M.; Otto, Sigrid A.; Richter, Clemens; Soetekouw, Robin; Prins, Jan M.; Brinkman, Kees; Mulder, Jan Willem; Kroon, Frank; Middel, Ananja; Symons, Jori; Wensing, Annemarie M. J.; Nijhuis, Monique; Borghans, Jose A. M.; Tesselaar, Kiki; Hoepelman, Andy I. M.		MIRS Study Grp	Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED INDIVIDUALS; T-CELL RECOVERY; IMMUNE ACTIVATION; VIROLOGICAL SUPPRESSION; VIRAL SUPPRESSION; ADDING MARAVIROC; CCR5 EXPRESSION; APOPTOSIS; INCREASES	Objective The immunomodulatory effects of the CCR5-antagonist maraviroc might be beneficial in patients with a suboptimal immunological response, but results of different cART (combination antiretroviral therapy) intensification studies are conflicting. Therefore, we performed a 48-week placebo-controlled trial to determine the effect of maraviroc intensification on CD4(+) T-cell counts and immune activation in these patients. Design Double-blind, placebo-controlled, randomized trial. Methods Major inclusion criteria were 1. CD4(+) T-cell count <350 cells/mu L while at least two years on cART or CD4(+) T-cell count <200 cells/mu L while at least one year on cART, and 2. viral suppression for at least the previous 6 months. HIV-infected patients were randomized to add maraviroc (41 patients) or placebo (44 patients) to their cART regimen for 48 weeks. Changes in CD4(+) T-cell counts (primary endpoint) and other immunological parameters were modeled using linear mixed effects models. Results No significant differences for the modelled increase in CD4(+) T-cell count (placebo 15.3 CD4(+) T cells/mu L (95% confidence interval (CI) [1.0, 29.5] versus maraviroc arm 22.9 CD4(+) T cells/mu L (95% CI [7.4, 38.5] p = 0.51) or alterations in the expression of markers for T-cell activation, proliferation and microbial translocation were found between the arms. However, maraviroc intensification did increase the percentage of CCR5 expressing CD4(+) and CD8(+) T-cells, and the plasma levels of the CCR5 ligand MIP-1 beta. In contrast, the percentage of ex-vivo apoptotic CD8(+) and CD4(+) T-cells decreased in the maraviroc arm. Conclusions Maraviroc intensification of cART did not increase CD4(+) T-cell restoration or decrease immune activation as compared to placebo. However, ex-vivo T-cell apoptosis was decreased in the maraviroc arm.	[van Lelyveld, Steven F. L.; Krikke, Maaike; Middel, Ananja; Hoepelman, Andy I. M.] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Drylewicz, Julia; Veel, Ellen M.; Otto, Sigrid A.; Borghans, Jose A. M.; Tesselaar, Kiki] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [Richter, Clemens] Rijnstate Hosp, Dept Internal Med, Arnhem, Netherlands; [van Lelyveld, Steven F. L.; Soetekouw, Robin] Spaarne Gasthuis, Dept Internal Med & Gastroenterol, Haarlem, Netherlands; [Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis,Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands; [Brinkman, Kees] Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands; [Mulder, Jan Willem] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands; [Kroon, Frank] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Symons, Jori; Wensing, Annemarie M. J.; Nijhuis, Monique] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Rijnstate Hospital; Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Slotervaart Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Tesselaar, K (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands.	k.tesselaar@umcutrecht.nl	Drylewicz, Julia/I-4703-2019; Prins, Jan M./AAF-4945-2020	Drylewicz, Julia/0000-0002-9434-8459; Symons, Jori/0000-0001-6560-1577; Prins, Jan/0000-0002-5415-8933; Tesselaar, Kiki/0000-0002-9847-0814; Symons, Joir/0000-0003-0252-3887	Pfizer Inc. USA; VIDI grant from the Netherlands Organisation for Scientific Research (NWO) [917.96.350]; Aids Fonds Netherlands [2007040]	Pfizer Inc. USA(Pfizer); VIDI grant from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Aids Fonds Netherlands	This work was supported by a grant from Pfizer Inc. USA, a VIDI grant from the Netherlands Organisation for Scientific Research (NWO, grant 917.96.350) and a grant from the Aids Fonds Netherlands (grant 2007040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Algeciras-Schimnich A, 2002, AIDS, V16, P1467, DOI 10.1097/00002030-200207260-00003; Arberas H, 2013, J ANTIMICROB CHEMOTH, V68, P577, DOI 10.1093/jac/dks432; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Berson JF, 1996, J VIROL, V70, P6288, DOI 10.1128/JVI.70.9.6288-6295.1996; Bloemers BLP, 2011, J IMMUNOL, V186, P4500, DOI 10.4049/jimmunol.1001700; Camargo JF, 2009, J IMMUNOL, V182, P171, DOI 10.4049/jimmunol.182.1.171; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Cuzin L, 2012, J ACQUIR IMMUNE DEFI; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gutierrez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027864; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hunt PW, 2013, BLOOD, V121, P4635, DOI 10.1182/blood-2012-06-436345; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Lin YL, 2008, AIDS, V22, P430, DOI 10.1097/QAD.0b013e3282f46a6f; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Murooka TT, 2006, J BIOL CHEM, V281, P25184, DOI 10.1074/jbc.M603912200; Pett SL, 2010, AIDS RES HUM RETROV, V26, P653, DOI 10.1089/aid.2009.0278; Portales P, 2012, IMMUNOLOGY, V137, P89, DOI 10.1111/j.1365-2567.2012.03609.x; Pozo-Balado MM, 2014, J INFECT DIS; Psomas C, 2013, BLOOD, V122, P2282, DOI 10.1182/blood-2013-06-507012; Reshef R, 2012, NEW ENGL J MED, V367, P135, DOI 10.1056/NEJMoa1201248; Rusconi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080157; Stepanyuk O, 2009, AIDS, V23, P1911, DOI 10.1097/QAD.0b013e32832f3c65; Symons J, 2012, CLIN MICROBIOL INFEC, V18, P606, DOI 10.1111/j.1469-0691.2011.03631.x; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Tilling R, 2002, AIDS, V16, P589, DOI 10.1097/00002030-200203080-00010; van Lelyveld SFL, 2012, AIDS, V26, P465, DOI 10.1097/QAD.0b013e32834f32f8; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Westrop SJ, 2012, MOL MED, V18, P1240, DOI 10.2119/molmed.2012.00206; Wilkin TJ, 2012, J INFECT DIS, V206, P534, DOI 10.1093/infdis/jis376; Wilkin TJ, 2010, HIV CLIN TRIALS, V11, P351, DOI 10.1310/hct1106-351; Zaunders JJ, 2003, J INFECT DIS, V187, P1735, DOI 10.1086/375030	40	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132430	10.1371/journal.pone.0132430	http://dx.doi.org/10.1371/journal.pone.0132430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208341	Green Published, gold			2022-12-27	WOS:000358622000027
J	Amukele, TK; Sokoll, LJ; Pepper, D; Howard, DP; Street, J				Amukele, Timothy K.; Sokoll, Lori J.; Pepper, Daniel; Howard, Dana P.; Street, Jeff			Can Unmanned Aerial Systems (Drones) Be Used for the Routine Transport of Chemistry, Hematology, and Coagulation Laboratory Specimens?	PLOS ONE			English	Article							PNEUMATIC-TUBE SYSTEM; BLOOD SPECIMENS; VARIABILITY; PERFORMANCE; DELIVERY; CRITERIA; TESTS	Background Unmanned Aerial Systems (UAS or drones) could potentially be used for the routine transport of small goods such as diagnostic clinical laboratory specimens. To the best of our knowledge, there is no published study of the impact of UAS transportation on laboratory tests. Methods Three paired samples were obtained from each one of 56 adult volunteers in a single phlebotomy event (336 samples total): two tubes each for chemistry, hematology, and coagulation testing respectively. 168 samples were driven to the flight field and held stationary. The other 168 samples were flown in the UAS for a range of times, from 6 to 38 minutes. After the flight, 33 of the most common chemistry, hematology, and coagulation tests were performed. Statistical methods as well as performance criteria from four distinct clinical, academic, and regulatory bodies were used to evaluate the results. Results Results from flown and stationary sample pairs were similar for all 33 analytes. Bias and intercepts were <10% and <13% respectively for all analytes. Bland-Altman comparisons showed a mean difference of 3.2% for Glucose and <1% for other analytes. Only bicarbonate did not meet the strictest (Royal College of Pathologists of Australasia Quality Assurance Program) performance criteria. This was due to poor precision rather than bias. There were no systematic differences between laboratory-derived (analytic) CV's and the CV's of our flown versus terrestrial sample pairs however CV's from the sample pairs tended to be slightly higher than analytic CV's. The overall concordance, based on clinical stratification (normal versus abnormal), was 97%. Length of flight had no impact on the results. Conclusions Transportation of laboratory specimens via small UASs does not affect the accuracy of routine chemistry, hematology, and coagulation tests results from selfsame samples. However it results in slightly poorer precision for some analytes.	[Amukele, Timothy K.; Sokoll, Lori J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Amukele, Timothy K.] Johns Hopkins Univ, Makerere Univ, Infect Dis Inst, Clin Core Lab, Kampala, Uganda; [Pepper, Daniel] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Howard, Dana P.; Street, Jeff] NextGen Aeronaut, Torrance, CA USA	Johns Hopkins University; Makerere University; University of Michigan System; University of Michigan	Amukele, TK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 600 N Wolfe Street Carnegie 417, Baltimore, MD 21287 USA.	tamukel1@jhmi.edu			Vayu, Incorporated	Vayu, Incorporated	The author(s) received no specific funding for this work. Vayu, Incorporated provided support in the form of salaries for one author [DP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This author's affiliation with Vayu Incorporated, as well as the amended statements of Competing Interests and Financial disclosure does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Amukele TK, 2015, AM J CLIN PATHOL, V143, P50, DOI 10.1309/AJCPCYA54DWZQPQT; Anderson BE, 1996, J GEOPHYS RES-ATMOS, V101, P1985, DOI 10.1029/95JD00413; [Anonymous], THE LIBERIAN OBSERVE; [Anonymous], ATM PRESS; Arcury TA, 2005, HEALTH SERV RES, V40, P135, DOI 10.1111/j.1475-6773.2005.00346.x; BRUNER KW, 1980, AM J CLIN PATHOL, V73, P593; Brunt D., 1933, Q J ROY METEOR SOC, V59, P351, DOI [10.1002/qj.49705925204, DOI 10.1002/QJ.49705925204]; Elbireer AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064661; Gerbig C, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003770; Guyot A, 1858, TABLES METEOROLOGICA; Jones Graham Rd, 2012, Clin Biochem Rev, V33, P133; KESHGEGIAN AA, 1992, AM J CLIN PATHOL, V97, P535, DOI 10.1093/ajcp/97.4.535; Ladenson JH, 2003, CLIN CHEM, V49, P162, DOI 10.1373/49.1.162; LaPlace P-S, 1835, MESURE HAUTEURS OBSE; *LEW GROUP, LAB MED NAT STAT REP; POZNANSKI W, 1978, AM J CLIN PATHOL, V70, P291; SKENDZEL LP, 1985, AM J CLIN PATHOL, V83, P200, DOI 10.1093/ajcp/83.2.200; Sodi R, 2004, ANN CLIN BIOCHEM, V41, P237, DOI 10.1258/000456304323019631; SOKAL RR, 1980, SYST ZOOL, V29, P50, DOI 10.2307/2412626; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; Unmanned aerial vehicle, 2014, UNM AER VEH INT; Vreeman Daniel J, 2007, AMIA Annu Symp Proc, P771; WEAVER DK, 1978, AM J CLIN PATHOL, V70, P400; WESTGARD JO, 1992, CLIN CHEM, V38, P1226; Wilson ML, 1996, CLIN INFECT DIS, V22, P766, DOI 10.1093/clinids/22.5.766	25	74	76	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134020	10.1371/journal.pone.0134020	http://dx.doi.org/10.1371/journal.pone.0134020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222261	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800095
J	Zhu, L; McDavid, S; Currie, KPM				Zhu, Lei; McDavid, Sarah; Currie, Kevin P. M.			"Slow" Voltage-Dependent Inactivation of CaV2.2 Calcium Channels Is Modulated by the PKC Activator Phorbol 12-Myristate 13-Acetate (PMA)	PLOS ONE			English	Article							PROTEIN-KINASE-C; GATED CA2+ CHANNELS; ADRENAL CHROMAFFIN CELLS; METABOTROPIC GLUTAMATE RECEPTORS; RAT SYMPATHETIC NEURONS; N-TYPE; MOLECULAR DETERMINANTS; BETA-SUBUNITS; CUMULATIVE INACTIVATION; CA(V)2.2 CHANNELS	Ca(V)2.2 (N-type) voltage-gated calcium channels (Ca2+ channels) play key roles in neurons and neuroendocrine cells including the control of cellular excitability, neurotransmitter / hormone secretion, and gene expression. Calcium entry is precisely controlled by channel gating properties including multiple forms of inactivation. "Fast" voltage-dependent inactivation is relatively well-characterized and occurs over the tens-to- hundreds of milliseconds timeframe. Superimposed on this is the molecularly distinct, but poorly understood process of "slow" voltage-dependent inactivation, which develops / recovers over seconds-to-minutes. Protein kinases can modulate "slow" inactivation of sodium channels, but little is known about if/how second messengers control "slow" inactivation of Ca2+ channels. We investigated this using recombinant Ca(V)2.2 channels expressed in HEK293 cells and native Ca(V)2 channels endogenously expressed in adrenal chromaffin cells. The PKC activator phorbol 12-myristate 13-acetate (PMA) dramatically prolonged recovery from "slow" inactivation, but an inactive control (4 alpha-PMA) had no effect. This effect of PMA was prevented by calphostin C, which targets the C1-domain on PKC, but only partially reduced by inhibitors that target the catalytic domain of PKC. The subtype of the channel beta-subunit altered the kinetics of inactivation but not the magnitude of slowing produced by PMA. Intracellular GDP-beta-S reduced the effect of PMA suggesting a role for G proteins in modulating "slow" inactivation. We postulate that the kinetics of recovery from "slow" inactivation could provide a molecular memory of recent cellular activity and help control Ca(V)2 channel availability, electrical excitability, and neurotransmission in the seconds-to-minutes timeframe.	[Zhu, Lei; McDavid, Sarah; Currie, Kevin P. M.] Vanderbilt Univ, Dept Anesthesiol, Nashville, TN 37235 USA; [Currie, Kevin P. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Currie, Kevin P. M.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Currie, KPM (corresponding author), Vanderbilt Univ, Dept Anesthesiol, 221 Kirkland Hall, Nashville, TN 37235 USA.	kevin.currie@vanderbilt.edu	Currie, Kevin P/J-9561-2019	Currie, Kevin P/0000-0002-0861-423X	National Institutes of Health [R01 NS052446, R21 NS081492]; Vanderbilt University Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081492, R01NS052446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health [Grant R01 NS052446 and Grant R21 NS081492] to KC and by a Discovery grant from Vanderbilt University Medical Center to KC. The authors declare no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CF, 2000, J GEN PHYSIOL, V115, P277, DOI 10.1085/jgp.115.3.277; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Blair NT, 2003, J NEUROSCI, V23, P10338; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028; Cahill AL, 2000, J NEUROSCI, V20, P1685; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Catterall WA, 2013, J BIOL CHEM, V288, P10742, DOI 10.1074/jbc.R112.411645; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Choi JS, 2007, J NEUROPHYSIOL, V97, P1258, DOI 10.1152/jn.01033.2006; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Currie KPM, 2010, CHANNELS, V4, P497, DOI 10.4161/chan.4.6.12871; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Degtiar VE, 2000, J NEUROSCI, V20, P4355, DOI 10.1523/JNEUROSCI.20-12-04355.2000; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Diaz-Cardenas AF, 2008, ARCH BIOCHEM BIOPHYS, V473, P1, DOI 10.1016/j.abb.2008.01.030; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Fang HY, 2006, J BIOL CHEM, V281, P20011, DOI 10.1074/jbc.M601776200; Gandini MA, 2014, PFLUG ARCH EUR J PHY, V466, P2113, DOI 10.1007/s00424-014-1476-4; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Hamid J, 1999, J BIOL CHEM, V274, P6195, DOI 10.1074/jbc.274.10.6195; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Herlitze S, 2001, P NATL ACAD SCI USA, V98, P4699, DOI 10.1073/pnas.051628998; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Hurley JF, 2000, P NATL ACAD SCI USA, V97, P9293, DOI 10.1073/pnas.160589697; Jewell M.L., 2013, MODULATION PRESYNAPT, P01; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; Kanda VA, 2011, HEART RHYTHM, V8, P1641, DOI 10.1016/j.hrthm.2011.04.034; Khanna R, 2007, EUR J NEUROSCI, V26, P547, DOI 10.1111/j.1460-9568.2007.05680.x; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Ko B, 2010, AM J PHYSIOL-RENAL, V299, pF300, DOI 10.1152/ajprenal.00441.2009; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; McCool BA, 1996, MOL PHARMACOL, V50, P912; McCool BA, 1998, J NEUROPHYSIOL, V79, P379, DOI 10.1152/jn.1998.79.1.379; McDavid S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109203; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Mykoniatis A, 2010, AM J PHYSIOL-CELL PH, V298, pC85, DOI 10.1152/ajpcell.00118.2009; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; Perez-Burgos A, 2008, NEUROSCIENCE, V155, P1079, DOI 10.1016/j.neuroscience.2008.06.047; Rajagopal S, 2014, NEUROSCIENCE, V280, P1, DOI 10.1016/j.neuroscience.2014.08.049; Rajagopal S, 2009, NEUROSCIENCE, V159, P618, DOI 10.1016/j.neuroscience.2008.12.047; Roberts-Crowley ML, 2009, CELL CALCIUM, V45, P589, DOI 10.1016/j.ceca.2009.03.015; Sculptoreanu A, 2003, J NEUROPHYSIOL, V90, P21, DOI 10.1152/jn.00108.2003; Silva Jonathan, 2014, Handb Exp Pharmacol, V221, P33, DOI 10.1007/978-3-642-41588-3_3; Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y; Sokolov S, 2000, J PHYSIOL-LONDON, V527, P445, DOI 10.1111/j.1469-7793.2000.t01-1-00445.x; Stephens GJ, 2009, TRENDS PHARMACOL SCI, V30, P421, DOI 10.1016/j.tips.2009.05.008; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; Thaler C, 2004, P NATL ACAD SCI USA, V101, P5675, DOI 10.1073/pnas.0303402101; Todd RD, 2012, ANESTHESIOLOGY, V116, P1013, DOI 10.1097/ALN.0b013e31825153ea; Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010; Wykes RCE, 2007, J NEUROSCI, V27, P5236, DOI 10.1523/JNEUROSCI.3545-06.2007; Yan JL, 2003, ANAL CHEM, V75, P5406, DOI 10.1021/ac034017m; Zamponi GW, 2013, BBA-BIOMEMBRANES, V1828, P1629, DOI 10.1016/j.bbamem.2012.10.004; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; ZHU Y, 1994, J NEUROPHYSIOL, V72, P1549, DOI 10.1152/jn.1994.72.4.1549	68	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134117	10.1371/journal.pone.0134117	http://dx.doi.org/10.1371/journal.pone.0134117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222492	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800107
J	Vinn, O; Wilson, MA; Toom, U				Vinn, Olev; Wilson, Mark A.; Toom, Ursula			Bioerosion of Inorganic Hard Substrates in the Ordovician of Estonia (Baltica)	PLOS ONE			English	Article							PALEOECOLOGY; HARDGROUNDS; MORPHOLOGY; ARAGONITE	The earliest bioeroded inorganic hard substrates in the Ordovician of Estonia appear in the Dapingian. Hardgrounds are also known from the Sandbian and Katian. Most of the bioerosion of inorganic hard substrates occurs as the boring Trypanites Magdefrau, 1932 along with some possible Gastrochaenolites borings. North American hardground borings are more diverse than those in Baltica. In contrast to a worldwide trend of increasing boring intensity, the Estonian record seems to show no increase in boring intensities during the Middle and Late Ordovician. Hardgrounds seem to be more common during the temperate climate interval of the Ordovician calcite sea in Estonia (seven hardgrounds during 15 my) than in the part with a tropical climate (four hardgrounds during 12 my). Bioerosion is mostly associated with carbonate hardgrounds, but cobbles and pebbles broken from the hardgrounds are also often penetrated by Trypanites borings. The general diversity of boring ichnotaxa in Baltica increased from one ichnospecies in the Cambrian to seven by the end of Ordovician, showing the effect of the GOBE on bioeroding ichnotaxa. The diversity of inorganic hard substrate borers increased by only two times. This difference can be explained by the wider environmental distribution of organic as compared to inorganic substrates in the Ordovician seas of Baltica, and their more continuous temporal availability, which may have caused increased specialization of several borers. The inorganic substrates may have been bioreroded only by the generalists among boring organisms.	[Vinn, Olev] Univ Tartu, Dept Geol, Tartu, Estonia; [Wilson, Mark A.] Coll Wooster, Dept Geol, Wooster, OH 44691 USA; [Toom, Ursula] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	University of Tartu; College of Wooster; Tallinn University of Technology	Vinn, O (corresponding author), Univ Tartu, Dept Geol, Tartu, Estonia.	olev.vinn@ut.ee	Vinn, Olev/AAG-6806-2020	Vinn, Olev/0000-0002-2889-2544; Toom, Ursula/0000-0002-7782-6615	Palaeontological Association Research Grant; Estonian Research Council [ETF9064, IUT20-34]	Palaeontological Association Research Grant; Estonian Research Council	Financial support to O.V. was provided by the Palaeontological Association Research Grant, Estonian Research Council projects ETF9064 and IUT20-34.	Ainsaar L, 2004, PALAEOGEOGR PALAEOCL, V210, P119, DOI 10.1016/j.palaeo.2004.02.046; [Anonymous], 1997, GEOLOGY MINERAL RESO; Balthasar U, 2015, GEOLOGY, V43, P99, DOI 10.1130/G36293.1; BRETT CE, 1984, PALAEOGEOGR PALAEOCL, V46, P233, DOI 10.1016/0031-0182(84)90001-4; BRETT CE, 1978, PALEOBIOLOGY, V4, P329, DOI 10.1017/S0094837300006035; Dronov A., 2000, P EST ACAD SCI, V49, P3; Ekdale AA, 2001, LETHAIA, V34, P1; Hecker RF, 1960, T I GEOL AN ESTSSR, V5, P199; Hints L, 2008, EST J EARTH SCI, V57, P11, DOI 10.3176/earth.2008.1.02; Jackson PNW, 2007, LETHAIA, V40, P237, DOI 10.1111/j.1502-3931.2007.00021.x; Motus M-A, 2007, 10 INT S FOSS CNID P, P54; Nestor H., 1977, FACIES FAUNA SILURIA, P89; NORDLUND U, 1989, GEOL FORENING STOCK, V111, P161; Orviku K, 1940, LITHOLOGIE TALLINNA, VI, P1; Orviku K, 1961, GEOLOOGILINE KOGUMIK, P16; Orviku K, 1960, AK NAUK EST SSR GEOL, V5, P45; Orviku K, 1962, AKAD NAUK EST SSR GE, V10, P187; PALMER T, 1982, LETHAIA, V15, P309, DOI 10.1111/j.1502-3931.1982.tb01696.x; PALMER TJ, 1977, LETHAIA, V10, P179, DOI 10.1111/j.1502-3931.1977.tb00608.x; Palmer TJ, 2004, LETHAIA, V37, P417, DOI 10.1080/00241160410002135; Tapanila L, 2004, PALAIOS, V19, P292, DOI 10.1669/0883-1351(2004)019<0292:EASCOP>2.0.CO;2; Taylor PD, 2003, EARTH-SCI REV, V62, P1, DOI 10.1016/S0012-8252(02)00131-9; Vinn O., 2005, CARNETS GEOL, VCG2005, pA03; Vinn O, ESTONIAN J IN PRESS; Vinn O, CARNETS GEO IN PRESS; Vinn Olev, 2004, Proceedings of the Estonian Academy of Sciences Geology, V53, P257; Vinn O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099455; Vinn O, 2010, CARNETS GEOL; WILSON MA, 1988, J PALEONTOL, V62, P306, DOI 10.1017/S0022336000029978; WILSON MA, 1992, I EARTH STUDIES PUBL, V9, P1; Wilson Mark A., 2006, Ichnos, V13, P109, DOI 10.1080/10420940600850505	31	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134279	10.1371/journal.pone.0134279	http://dx.doi.org/10.1371/journal.pone.0134279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218582	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900106
J	Wu, FC; Zhang, M; Wang, GH; Hu, ZY				Wu, Fuchao; Zhang, Ming; Wang, Guanghui; Hu, Zhanyi			Algebraic Error Based Triangulation and Metric of Lines	PLOS ONE			English	Article							CAMERA	Line triangulation, a classical geometric problem in computer vision, is to determine the 3D coordinates of a line based on its 2D image projections from more than two views of cameras with known projection matrices. Compared to point features, line segments are more robust to matching errors, occlusions, and image uncertainties. In addition to line triangulation, a better metric is needed to evaluate 3D errors of line triangulation. In this paper, the line triangulation problem is investigated by using the Lagrange multipliers theory. The main contributions include: (i) Based on the Lagrange multipliers theory, a formula to compute the Plucker correction is provided, and from the formula, a new linear algorithm, LINa, is proposed for line triangulation; (ii) two optimal algorithms, OPTa-I and OPTa-II, are proposed by minimizing the algebraic error; and (iii) two metrics on 3D line space, the orthogonal metric and the quasi-Riemannian metric, are introduced for the evaluation of line triangulations. Extensive experiments on synthetic data and real images are carried out to validate and demonstrate the effectiveness of the proposed algorithms.	[Wu, Fuchao; Zhang, Ming; Hu, Zhanyi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing 100190, Peoples R China; [Wang, Guanghui] Univ Kansas, Dept Elect Engn & Comp Sci, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Institute of Automation, CAS; University of Kansas	Zhang, M (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, POB 2728, Beijing 100190, Peoples R China.	zhangming@nlpr.ia.ac.cn			National Natural Science Foundation of China (NSFC) [61375043]; National Natural Science Foundation of China [61273282]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (NSFC) under the grant 61375043. The funding is received by FCW. This work is also supported by the National Natural Science Foundation of China under the grant 61273282. The funding is received by GHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoli A, 2005, COMPUT VIS IMAGE UND, V100, P416, DOI 10.1016/j.cviu.2005.06.001; Bartoli A, 2004, INT J COMPUT VISION, V57, P159, DOI 10.1023/B:VISI.0000013092.07433.82; CHOW SN, 1978, MATH COMPUT, V32, P887, DOI 10.1090/S0025-5718-1978-0492046-9; FAUGERAS O, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P951, DOI 10.1109/ICCV.1995.466832; Freund RW, 2001, J GLOBAL OPTIM, V19, P83, DOI 10.1023/A:1008316327038; Hartley R., 2000, MULTIPLE VIEW GEOMET, V2; Josephson K, 2008, J MATH IMAGING VIS, V32, P215, DOI 10.1007/s10851-008-0097-y; Lasdon L.S., 2002, OPTIMIZATION THEORY; MAYBANK SJ, 1992, INT J COMPUT VISION, V8, P123, DOI 10.1007/BF00127171; MORGAN A, 1987, APPL MATH COMPUT, V24, P115, DOI 10.1016/0096-3003(87)90064-6; Morgan A. P., 1987, SOLVING POLYNOMIAL S; Petersen P., 1998, RIEMANNIAN GEOMETRY; Ronda JI, 2008, J MATH IMAGING VIS, V32, P193, DOI 10.1007/s10851-008-0095-0; Yorke J.A., 1979, LECT NOTES MATH, P77; Zhang Q, 2014, J MATH IMAGING VIS, V49, P611, DOI 10.1007/s10851-013-0491-y	15	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132354	10.1371/journal.pone.0132354	http://dx.doi.org/10.1371/journal.pone.0132354			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218615	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900007
J	Rossi, L; Stevens, D; Pierga, JY; Lerebours, F; Reyal, F; Robain, M; Asselain, B; Rouzier, R				Rossi, Lea; Stevens, Denise; Pierga, Jean-Yves; Lerebours, Florence; Reyal, Fabien; Robain, Mathieu; Asselain, Bernard; Rouzier, Roman			Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population	PLOS ONE			English	Article							OLDER WOMEN; EPIDEMIOLOGY; MORTALITY; THERAPY	Background The impact of adjuvant chemotherapy on breast cancer prognosis has been demonstrated in randomized trials, but its impact is unknown in real-world populations. The aim of this study was to evaluate the effect of adjuvant chemotherapy on the survival of breast cancer patients in an unselected population. Methods This prospective cohort study included 32,502 women treated at the Institut Curie between 1981 and 2008 for a first invasive breast cancer without metastasis. The patients were matched based on their propensity score to receive adjuvant chemotherapy. Results The matching generated a subsample of 9,180 patients with an overlapping propensity score. In the group without chemotherapy, the overall survival (OS) rates at 5 and 10 years of follow-up were 87.6% (95% CI [86.7-88.6]) and 75.0% (95% CI [73.6-76.5]), respectively, versus 92.1% (95% CI [91.3-92.9]) and 81.9% (95% CI [80.6-83.2]), respectively, in the chemotherapy group. Distant disease-free survival (DDFS) was significantly improved in the five first years (absolute benefit of 3.5%). In a multivariate analysis, adjuvant chemotherapy was associated with better OS (HR = 0.75, 95% CI [0.69-0.83], p<0.0001) and DDFS (HR = 0.82, 95% CI [0.75-0.90], p<0.0001). Conclusion Adjuvant chemotherapy significantly improves OS and DDFS rates in an unselected population, in accordance with previous results reported by randomized trials.	[Rossi, Lea; Stevens, Denise; Pierga, Jean-Yves; Lerebours, Florence; Reyal, Fabien; Robain, Mathieu; Asselain, Bernard; Rouzier, Roman] Inst Curie, Paris, France; [Rossi, Lea; Rouzier, Roman] Univ Versailles St Quentin, Risk & Safety Clin Med Women & Perinatal Hlth, Equipe Accueil 7285, Montigny Le Bretonneux, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay	Rouzier, R (corresponding author), Inst Curie, Paris, France.	roman.rouzier@curie.fr	Rouzier, Roman/G-2953-2018	Rouzier, Roman/0000-0002-8167-6808	Fondation Curie; Fonds d'etude et de recherche du corps medical (FERCM)	Fondation Curie; Fonds d'etude et de recherche du corps medical (FERCM)	This work was supported by Fondation Curie and Fonds d'etude et de recherche du corps medical (FERCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Ban KA, 2014, SURG ONCOL CLIN N AM, V23, P409, DOI 10.1016/j.soc.2014.03.011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Brookhart M Alan, 2007, Int J Biostat, V3, P14; DRAKE C, 1995, INT J EPIDEMIOL, V24, P183, DOI 10.1093/ije/24.1.183; Elkin EB, 2006, J CLIN ONCOL, V24, P2757, DOI 10.1200/JCO.2005.03.6053; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Hassan MSU, 2010, ONCOL REP, V24, P1121, DOI 10.3892/or_00000963; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hery C, 2008, ANN ONCOL, V19, P1009, DOI 10.1093/annonc/mdm593; Kemeny MM, 2003, J CLIN ONCOL, V21, P2268, DOI 10.1200/JCO.2003.09.124; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Olszewski AJ, 2013, BREAST CANCER RES TR, V138, P215, DOI 10.1007/s10549-013-2423-3; Poole CJ, 2006, NEW ENGL J MED, V355, P1851, DOI 10.1056/NEJMoa052084; Schneider M, 2011, J AM GERIATR SOC, V59, P637, DOI 10.1111/j.1532-5415.2011.03351.x; Sorensen HT, 2006, HEPATOLOGY, V44, P1075, DOI 10.1002/hep.21404; Webb PM, 2004, BREAST, V13, P7, DOI 10.1016/S0960-9776(03)00129-2; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	22	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0132853	10.1371/journal.pone.0132853	http://dx.doi.org/10.1371/journal.pone.0132853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214853	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300012
J	Alonso, P; Cuadras, D; Gabriels, L; Denys, D; Goodman, W; Greenberg, BD; Jimenez-Ponce, F; Kuhn, J; Lenartz, D; Mallet, L; Nuttin, B; Real, E; Segalas, C; Schuurman, R; du Montcel, ST; Menchon, JM				Alonso, Pino; Cuadras, Daniel; Gabriels, Loes; Denys, Damiaan; Goodman, Wayne; Greenberg, Ben D.; Jimenez-Ponce, Fiacro; Kuhn, Jens; Lenartz, Doris; Mallet, Luc; Nuttin, Bart; Real, Eva; Segalas, Cinto; Schuurman, Rick; du Montcel, Sophie Tezenas; Menchon, Jose M.			Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS STIMULATION; ANTERIOR CAPSULAR STIMULATION; ELECTRICAL-STIMULATION; MAJOR DEPRESSION; ACCUMBENS; DISEASE; PATIENT	Background Deep brain stimulation (DBS) has been proposed as an alternative to ablative neurosurgery for severe treatment-resistant Obsessive-Compulsive Disorder (OCD), although with partially discrepant results probably related to differences in anatomical targetting and stimulation conditions. We sought to determine the efficacy and tolerability of DBS in OCD and the existence of clinical predictors of response using meta-analysis. Methods We searched the literature on DBS for OCD from 1999 through January 2014 using PubMed/MEDLINE and PsycINFO. We performed fixed and random-effect meta-analysis with score changes (pre-post DBS) on the Yale-Brown Obsessive Compulsive Scale Y-BOCS) as the primary-outcome measure, and the number of responders to treatment, quality of life and acceptability as secondary measures. Findings Thirty-one studies involving 116 subjects were identified. Eighty-three subjects were implanted in striatal areas-anterior limb of the internal capsule, ventral capsule and ventral striatum, nucleus accumbens and ventral caudate-27 in the subthalamic nucleus and six in the inferior thalamic peduncle. Global percentage of Y-BOCS reduction was estimated at 45.1% and global percentage of responders at 60.0%. Better response was associated with older age at OCD onset and presence of sexual/religious obsessions and compulsions. No significant differences were detected in efficacy between targets. Five patients dropped out, but adverse effects were generally reported as mild, transient and reversible. Conclusions Our analysis confirms that DBS constitutes a valid alternative to lesional surgery for severe, therapy-refractory OCD patients. Well-controlled, randomized studies with larger samples are needed to establish the optimal targeting and stimulation conditions and to extend the analysis of clinical predictors of outcome.	[Alonso, Pino; Real, Eva; Segalas, Cinto; Menchon, Jose M.] Bellvitge Hosp, Dept Psychiat, OCD Clin & Res Unit, Barcelona, Spain; [Alonso, Pino; Real, Eva; Segalas, Cinto; Menchon, Jose M.] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain; [Alonso, Pino; Real, Eva; Segalas, Cinto; Menchon, Jose M.] Carlos III Hlth Inst, CIBERSAM Ctr Invest Red Salud Mental, Barcelona, Spain; [Alonso, Pino; Menchon, Jose M.] Univ Barcelona, Dept Clin Sci, Barcelona, Spain; [Cuadras, Daniel] Fundacio Sant Joan de Deu, Methodol & Stat Assessment Unit, Barcelona, Spain; [Gabriels, Loes] UPC KULeuven, Dept Psychiat, Univ Ctr OCD, Leuven, Belgium; [Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Denys, Damiaan] Acad Arts & Sci, Inst Royal Netherlands, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Goodman, Wayne] Icahn Sch Med Mt Sinai, Dept Psychiat & Behav Hlth Syst, New York, NY 10029 USA; [Greenberg, Ben D.] Brown Univ, Dept Psychiat & Human Behav, Butler Hosp, Alpert Med Sch, Providence, RI 02912 USA; [Jimenez-Ponce, Fiacro] Gen Hosp Mexico, Unit Stereotact Funct Neurosurg & Radiosurg, Mexico City, DF, Mexico; [Kuhn, Jens; Lenartz, Doris] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany; [Mallet, Luc] UPMC, CNRS, INSERM, U1127,UMR7225,ICM Brain & Spine Inst, Paris, France; [Nuttin, Bart] Katholieke Univ Leuven, UZ Leuven, Dept Neurosurg, Leuven, Belgium; [Schuurman, Rick] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1105 AZ Amsterdam, Netherlands; [du Montcel, Sophie Tezenas] Univ Paris 06, ER4, Modelling Clin Res, Paris, France; [du Montcel, Sophie Tezenas] Hopitaux Univ Pitie Salpetriere Charles Foix, AP HP, Dept Biostat & Med Informat, Paris, France	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; KU Leuven; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Icahn School of Medicine at Mount Sinai; Brown University; Butler Hospital Rhode Island; University of Cologne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; KU Leuven; University Hospital Leuven; University of Amsterdam; Academic Medical Center Amsterdam; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Alonso, P (corresponding author), Bellvitge Hosp, Dept Psychiat, OCD Clin & Res Unit, Barcelona, Spain.	mpalonso@bellvitgehospital.cat	Alonso, Pino/AAI-3439-2020; Schuurman, Rick/ABE-9100-2021; Tezenas du Montcel, Sophie/A-6207-2012; Mallet, Luc/F-7156-2013; Menchon, Jose/A-5242-2009	Tezenas du Montcel, Sophie/0000-0002-2866-4330; Mallet, Luc/0000-0001-8061-1167; Cuadras, Daniel/0000-0001-8780-1764; Segalas, Cinto/0000-0002-0959-0356; Alonso, Pino/0000-0002-5779-9111; Menchon, Jose/0000-0002-6231-6524	Carlos III Health Institute, Ministry of Economy and Competitivity, Spanish Government [FIS PI13/00918, FIS PI 14/00413]; Deutsche Forschungsgemeinschaft [KFO-219]	Carlos III Health Institute, Ministry of Economy and Competitivity, Spanish Government; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Carlos III Health Institute, Ministry of Economy and Competitivity, Spanish Government -FIS PI13/00918 and FIS PI 14/00413- and the Deutsche Forschungsgemeinschaft (KFO-219 grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Anderson D, 2003, J NEUROSURG, V98, P1104, DOI 10.3171/jns.2003.98.5.1104; Anholt GE, 2013, PSYCHOL MED, V21, P1, DOI DOI 10.1017/S0033291713000470; Aouizerate B, 2005, AM J PSYCHIAT, V162, P2192, DOI 10.1176/appi.ajp.162.11.2192; Aouizerate B, 2004, J NEUROSURG, V101, P682, DOI 10.3171/jns.2004.101.4.0682; Aouizerate B, 2009, J NEUROSURG, V111, P775, DOI 10.3171/2009.2.JNS0881; BALLANTINE HT, 1987, BIOL PSYCHIAT, V22, P807, DOI 10.1016/0006-3223(87)90080-1; Blomstedt P, 2013, WORLD NEUROSURG, V80, pE245, DOI 10.1016/j.wneu.2012.10.006; Borenstein M., 2009, INTRO META ANAL; Burdick A, 2010, NEUROCASE, V16, P321, DOI 10.1080/13554790903560422; Chabardes S, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.03.010; Cooper H, 2009, THE HANDBOOK OF RESE; Correia S, 2010, BRAIN IMAGING BEHAV, V4, P35, DOI 10.1007/s11682-009-9083-2; D'Astous M, 2013, J NEUROL NEUROSUR PS, V84, P1208, DOI 10.1136/jnnp-2012-303826; Denys D, 2006, PSYCHIAT CLIN N AM, V29, P553, DOI 10.1016/j.psc.2006.02.013; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; do Rosario-Campos MC, 2001, AM J PSYCHIAT, V158, P1899, DOI 10.1176/appi.ajp.158.11.1899; Figee M, 2013, NAT NEUROSCI, V16, P386, DOI 10.1038/nn.3344; Fontaine D, 2004, J NEUROSURG, V100, P1084, DOI 10.3171/jns.2004.100.6.1084; Franzini A, 2010, NEUROL SCI, V31, P353, DOI 10.1007/s10072-009-0214-8; Gabriels L, 2003, ACTA PSYCHIAT SCAND, V107, P275, DOI 10.1034/j.1600-0447.2003.00066.x; Goodman WK, 2010, BIOL PSYCHIAT, V67, P535, DOI 10.1016/j.biopsych.2009.11.028; Grant JE, 2011, AM J PSYCHIAT, V168, P1338, DOI 10.1176/appi.ajp.2011.11071108; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Guehl D, 2008, BIOL PSYCHIAT, V63, P557, DOI 10.1016/j.biopsych.2007.06.023; Harrison BJ, 2013, BIOL PSYCHIAT, V73, P321, DOI 10.1016/j.biopsych.2012.10.006; Haynes WIA, 2010, EUR J NEUROSCI, V32, P1118, DOI 10.1111/j.1460-9568.2010.07418.x; Huff W, 2010, CLIN NEUROL NEUROSUR, V112, P137, DOI 10.1016/j.clineuro.2009.11.006; Jimenez F, 2007, ACTA NEUROCHIR SUPPL, V97, P393; Jimenez-Ponce F, 2013, WORLD NEUROSURG, V80; Jimenez-Ponce F, 2009, NEUROSURGERY, V65, P203, DOI 10.1227/01.NEU.0000345938.39199.90; Kuhn J, 2007, J NEUROL, V254, P963, DOI 10.1007/s00415-006-0404-8; Le Jeune F, 2010, BIOL PSYCHIAT, V68, P1016, DOI 10.1016/j.biopsych.2010.06.033; Lujan JL, 2008, FRONT BIOSCI-LANDMRK, V13, P5892, DOI 10.2741/3124; Mallet L, 2002, LANCET, V360, P1302, DOI 10.1016/S0140-6736(02)11339-0; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; McLaughlin NCR, 2013, BIOL PSYCHIAT, V73, pE29, DOI 10.1016/j.biopsych.2012.09.015; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; MINDUS P, 1994, J NEUROPSYCH CLIN N, V6, P467; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Nuttin BJ, 2003, NEUROSURGERY, V52, P1263, DOI 10.1227/01.NEU.0000064565.49299.9A; Ooms P, 2014, J NEUROL NEUROSUR PS, V85, P153, DOI 10.1136/jnnp-2012-302550; Piallat B, 2011, ANN NEUROL, V69, P793, DOI 10.1002/ana.22222; Plewnia C, 2008, INT J NEUROPSYCHOPH, V11, P1181, DOI 10.1017/S1461145708009188; R Core Team, 2013, R A LANGUAGE AND ENV; Roh D, 2012, PSYCHIAT RES, V200, P1067, DOI 10.1016/j.psychres.2012.06.018; Rosenberg DR, 1997, ARCH GEN PSYCHIAT, V54, P824; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Sachdev Perminder Singh, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-006579; Schwarzer G, 2013, META META ANALYSIS W; Servello D, 2009, J NEUROL, V256, P1533, DOI 10.1007/s00415-009-5159-6; Sturm V, 2003, J CHEM NEUROANAT, V26, P293, DOI 10.1016/j.jchemneu.2003.09.003; Tsai HC, 2012, PSYCHIAT CLIN NEUROS, V66, P303, DOI 10.1111/j.1440-1819.2012.02352.x; Van Laere K, 2006, J NUCL MED, V47, P740; World Health Organization, 1992, ICD 10 CLASS MENT BE	58	177	183	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133591	10.1371/journal.pone.0133591	http://dx.doi.org/10.1371/journal.pone.0133591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208305	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000106
J	Chen, PC; Lee, JC; Wang, JD				Chen, Po-Chuan; Lee, Jenq-Chang; Wang, Jung-Der			Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan	PLOS ONE			English	Article							QUALITY-OF-LIFE; EXPECTED YEARS; FOLLOW-UP; SURVIVAL; CANCER; EXTRAPOLATION; HEALTH	Backgrounds and aims Life-expectancy of colon cancer patients cannot be accurately answered due to the lack of both large datasets and long-term follow-ups, which impedes accurate estimation of lifetime cost to treat colon cancer patients. In this study, we applied a method to estimate life-expectancy of colon cancer patients in Taiwan and calculate the lifetime costs by different stages and age groups. Methods A total of 17,526 cases with pathologically verified colon adenocarcinoma between 2002 and 2009 were extracted from Taiwan Cancer Registry database for analysis. All patients were followed-up until the end of 2011. Life-expectancy, expected-years-of-life-lost and lifetime costs were estimated, using a semi-parametric survival extrapolation method and borrowing information from life tables of vital statistics. Results Patients with more advanced stages of colon cancer were generally younger and less comorbid with major chronic diseases than those with stages I and II. The LE of stage I was not significantly different from that of the age- and sex-matched general population, whereas those of stages II, III, and IV colon cancer patients after diagnosis were 16.57 +/- 0.07, 13.35 +/- 0.07, and 4.05 +/- 0.05 years, respectively; the corresponding expected-years-of-life-lost were 1.28 +/- 0.07, 5.93 +/- 0.07 and 16.42 +/- 0.06 years, significantly shorter than the general population after accounting for lead time bias. Besides, the lifetime cost of managing stage II colon cancer patients would be US $8,416 +/- 1939, 14,334 +/- 1,755, and 21,837 +/- 1,698, respectively, indicating a big saving for early diagnosis and treatment after stratification for age and sex. Conclusions Treating colon cancer at younger age and earlier stage saves more life-years and health-care costs. Future studies are indicated to apply these quantitative results into the cost-effectiveness evaluation of screening program for colon cancers.	[Chen, Po-Chuan; Lee, Jenq-Chang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Colorectal Surg & Gen Surg,Dept Surg, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Wang, JD (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan.	jdwang121@gmail.com			National Science Council [NSC 102-2314-B-006-029-MY2]; Ministry of Health and Welfare of Taiwan [DOH 102-TD-C-111-003]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare of Taiwan	This research was supported, in part, by grants from the National Science Council (NSC 102-2314-B-006-029-MY2; http://www.most.gov.tw/mp.aspx?mp=7) and the Ministry of Health and Welfare of Taiwan (DOH 102-TD-C-111-003; http://www.mohw.gov.tw/EN/Ministry/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson TML, 2013, STAT MED, V32, P5286, DOI 10.1002/sim.5943; BECK JR, 1982, AM J MED, V73, P883, DOI 10.1016/0002-9343(82)90786-0; Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; Chu PC, 2008, VALUE HEALTH, V11, P1102, DOI 10.1111/j.1524-4733.2008.00350.x; Dal Maso L, 2014, ANN ONCOL, V25, P2251, DOI 10.1093/annonc/mdu383; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Gaitatzis A, 2004, BRAIN, V127, P2427, DOI 10.1093/brain/awh267; Haybittle J L, 1998, Clin Oncol (R Coll Radiol), V10, P92, DOI 10.1016/S0936-6555(05)80485-6; Ho JJ, 2006, ACCIDENT ANAL PREV, V38, P961, DOI 10.1016/j.aap.2006.03.007; Ho JJ, 2006, SCAND J WORK ENV HEA, V32, P91, DOI 10.5271/sjweh.984; Hwang JS, 2004, QUAL LIFE RES, V13, P1, DOI 10.1023/B:QURE.0000015299.45623.38; Hwang JS, 1999, STAT MED, V18, P1627, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.3.CO;2-4; Janssen-Heijnen MLG., 2005, RESULTS 50 YEARS CAN; Kao TW, 2010, J NEPHROL, V23, P677; Lee LJH, 2012, OCCUP ENVIRON MED, V69, P582, DOI 10.1136/oemed-2011-100462; Messori A, 1997, COMPUT METH PROG BIO, V52, P157, DOI 10.1016/S0169-2607(96)01788-9; Soerjomataram I, 2012, CANCER CAUSE CONTROL, V23, P1421, DOI 10.1007/s10552-012-0010-2	17	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133755	10.1371/journal.pone.0133755	http://dx.doi.org/10.1371/journal.pone.0133755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26207912	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000132
J	Geaney, F; Scutaru, C; Kelly, C; Glynn, RW; Perry, IJ				Geaney, Fiona; Scutaru, Cristian; Kelly, Clare; Glynn, Ronan W.; Perry, Ivan J.			Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis and Density-Equalizing Mapping	PLOS ONE			English	Article							PUBLIC-HEALTH RESEARCH; INFECTIOUS-DISEASES; UNITED-KINGDOM; TRENDS; OUTPUT; RISK	The objective of this paper is to provide a detailed evaluation of type 2 diabetes mellitus research output from 1951-2012, using large-scale data analysis, bibliometric indicators and density-equalizing mapping. Data were retrieved from the Science Citation Index Expanded database, one of the seven curated databases within Web of Science. Using Boolean operators "OR", "AND" and "NOT", a search strategy was developed to estimate the total number of published items. Only studies with an English abstract were eligible. Type 1 diabetes and gestational diabetes items were excluded. Specific software developed for the database analysed the data. Information including titles, authors' affiliations and publication years were extracted from all files and exported to excel. Density-equalizing mapping was conducted as described by Groenberg-Kloft et al, 2008. A total of 24,783 items were published and cited 476,002 times. The greatest number of outputs were published in 2010 (n=2,139). The United States contributed 28.8% to the overall output, followed by the United Kingdom (8.2%) and Japan (7.7%). Bilateral cooperation was most common between the United States and United Kingdom (n=237). Harvard University produced 2% of all publications, followed by the University of California (1.1%). The leading journals were Diabetes, Diabetologia and Diabetes Care and they contributed 9.3%, 7.3% and 4.0% of the research yield, respectively. In conclusion, the volume of research is rising in parallel with the increasing global burden of disease due to type 2 diabetes mellitus. Bibliometrics analysis provides useful information to scientists and funding agencies involved in the development and implementation of research strategies to address global health issues.	[Geaney, Fiona; Kelly, Clare; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Scutaru, Cristian] Free Univ Berlin, Charite Univ Med Berlin, Berlin, Germany; [Scutaru, Cristian] Humboldt Univ, D-10099 Berlin, Germany; [Glynn, Ronan W.] Dr Steevens Hosp, HSE Eastern Reg, Dept Publ Hlth, Dublin 8, Ireland	University College Cork; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Geaney, F (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland.	f.geaney@ucc.ie	Scutaru, Cristian/AAD-4098-2020	Scutaru, Cristian/0000-0003-0753-9730; Perry, Ivan/0000-0002-4965-9792	HRB Centre for Health & Diet Research grant [HRC2007/13]; Irish Health Research Board; Department of Agriculture, Fisheries and Food	HRB Centre for Health & Diet Research grant; Irish Health Research Board; Department of Agriculture, Fisheries and Food	This work was supported by the HRB Centre for Health & Diet Research grant (HRC2007/13) which is funded by the Irish Health Research Board and by the Department of Agriculture, Fisheries and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J LIB INFORM SCI; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Borger Julia-Annik, 2008, J Occup Med Toxicol, V3 Suppl 1, pS7, DOI 10.1186/1745-6673-3-S1-S7; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cimmino MA, 2005, OTOLARYNG HEAD NECK, V132, P295, DOI 10.1016/j.otohns.2004.09.026; Clarke A, 2007, EUR J PUBLIC HEALTH, V17, P43, DOI 10.1093/eurpub/ckm063; Durando P, 2007, EUR J PUBLIC HEALTH, V17, P19, DOI 10.1093/eurpub/ckm066; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Glynn RW, 2012, LARYNGOSCOPE, V122, P1967, DOI 10.1002/lary.23401; Glynn RW, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2795; Groneberg-Kloft B, 2009, J INVEST ALLERG CLIN, V19, P266; Groneberg-Kloft Beatrix, 2008, Health Res Policy Syst, V6, P6, DOI 10.1186/1478-4505-6-6; Hannaford P, 2009, ANN FAM MED, V7, P277, DOI 10.1370/afm.1009; Harande YI, 2011, AFR J DIABETES MED, V19, P8; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; Krishnamoorthy G, 2009, ANN LIB INFORM STUDI, V56, P150; Lewison G, 1998, GUT, V43, P288, DOI 10.1136/gut.43.2.288; Michalopoulos A, 2005, CHEST, V128, P3993, DOI 10.1378/chest.128.6.3993; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Ramos JM, 2004, EUR J CLIN MICROBIOL, V23, P180, DOI 10.1007/s10096-003-1074-4; Sharma B, 2013, SURGERY, V153, P493, DOI 10.1016/j.surg.2012.09.006; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Vergidis PI, 2005, EUR J CLIN MICROBIOL, V24, P342, DOI 10.1007/s10096-005-1306-x; Vioque J, 2010, OBES REV, V11, P603, DOI 10.1111/j.1467-789X.2009.00647.x; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zacca-Gonzalez G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-632; Zhang Y, 2011, CHINESE J DRUG DEPEN, V1, P19; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	30	54	54	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133009	10.1371/journal.pone.0133009	http://dx.doi.org/10.1371/journal.pone.0133009			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208117	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000054
J	Inobe, T; Genmei, R				Inobe, Tomonao; Genmei, Reiko			N-Terminal Coiled-Coil Structure of ATPase Subunits of 26S Proteasome Is Crucial for Proteasome Function	PLOS ONE			English	Article							19 S REGULATOR; PROTEIN-DEGRADATION; MOLECULAR ARCHITECTURE; EUKARYOTIC PROTEASOME; SUBSTRATE ENTRY; CORE PARTICLE; AAA SUBUNITS; ROLES; YEAST; TRANSLOCATION	The proteasome is an essential proteolytic machine in eukaryotic cells, where it removes damaged proteins and regulates many cellular activities by degrading ubiquitinated proteins. Its heterohexameric AAA+ ATPase Rpt subunits play a central role in proteasome activity by the engagement of substrate unfolding and translocation for degradation; however, its detailed mechanism remains poorly understood. In contrast to AAA+ ATPase domains, their N-terminal regions of Rpt subunits substantially differ from each other. Here, to investigate the requirements and roles of the N-terminal regions of six Rpt subunits derived from Saccharomyces cerevisiae, we performed systematic mutational analysis using conditional knockdown yeast strains for each Rpt subunit and bacterial heterologous expression system of the base subcomplex. We showed that the formation of the coiled-coil structure was the most important for the N-terminal region of Rpt subunits. The primary role of coiled-coil structure would be the maintenance of the ring structure with the defined order. However, the coiled-coil region would be also be involved in substrate recognition and an interaction between lid and base subcomplexes.	[Inobe, Tomonao; Genmei, Reiko] Toyama Univ, Frontier Res Core Life Sci, Toyama 9308555, Japan	University of Toyama	Inobe, T (corresponding author), Toyama Univ, Frontier Res Core Life Sci, 3190 Gofuku, Toyama 9308555, Japan.	inobe@ctg.u-toyama.ac.jp		Inobe, Tomonao/0000-0002-5864-6889	KAKENHI [26870216, 15H01531]; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [15H01531] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (grant 26870216 and 15H01531 (T.I.)); and the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science and Technology (T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Erales J, 2012, J BIOL CHEM, V287, P18535, DOI 10.1074/jbc.M112.357327; Farrell CM, 2007, MOL CELL, V25, P161, DOI 10.1016/j.molcel.2006.11.018; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Gautam AKS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034864; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kimura Y, 2013, PROTEOMICS, V13, P3167, DOI 10.1002/pmic.201300207; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134056	10.1371/journal.pone.0134056	http://dx.doi.org/10.1371/journal.pone.0134056			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208326	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000197
J	Ou, JP; Xing, WJ; Li, YB; Xu, YW; Zhou, CQ				Ou, Jianping; Xing, Weijie; Li, Yubin; Xu, Yanwen; Zhou, Canquan			Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; POOR RESPONDERS; INVITRO FERTILIZATION; EMBRYO QUALITY; AGONIST; STIMULATION; INDUCTION; OVULATION; IVF	Objective To compare the two GnRH-a protocols (long GnRH-a protocol and short GnRH-a protocol) for ovarian stimulation in IVF/ICSI cycles in patients of various age ranges. Methods A total of 5662 IVF-ET/ICSI cycles from 2010 to 2013 were retrospectively identified. The cycles were divided into two groups: a long protocol group and short protocol group. In each group, the patients were divided into four age ranges: <31 years, 31 to 35 years, 36 to 40 years, and >40 years. The duration of stimulation, total dose of Gn, implantation rate and pregnancy rate were compared. Results The total dose of Gn was significantly higher, and the duration of stimulation was significantly longer, in the long protocol group than in the short protocol group for all age ranges (P<0.05). If the patients were of the same age range, the number of oocytes retrieved, MII oocytes, and high-quality embryos in the long protocol group were all significantly greater than those in the short protocol group (P<0.05). In the long protocol group, the clinical pregnancy rates of the four age ranges were 52.76%, 44.33%, 36.15% and 13.33%, respectively, which were significantly higher than those in the short protocol group (33.33%, 24.58%, 22.49% and 8.72%, respectively; P<0.05). The same trend was also found in the implantation rates of the four age ranges. As the age increased, the clinical pregnancy and implantation rates, as well as the number of oocytes retrieved, MII oocytes, and high-quality embryos, of the long protocol group significantly decreased (P<0.05). Conclusions Our study demonstrated that regardless of patient age, the long protocol was superior to the short protocol in terms of the number of retrieved oocytes, as well as the implantation and pregnancy rates.	[Ou, Jianping; Xing, Weijie] Sun Yat Sen Univ, Affiliated Hosp 3, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yubin; Xu, Yanwen; Zhou, Canquan] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, CQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Reprod Med, Guangzhou 510275, Guangdong, Peoples R China.	zhoucanquan@hotmail.com						Berin I, 2010, FERTIL STERIL, V93, P360, DOI 10.1016/j.fertnstert.2008.11.007; Daya S, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001299, 10.1002/14641858.CD001299]; Dong XY, 2013, INT J CLIN EXP PATHO, V6, P1911; GARCIA JE, 1990, FERTIL STERIL, V53, P302; HUGHES EG, 1992, FERTIL STERIL, V58, P888; Kahraman K, 2009, FERTIL STERIL, V91, P2437, DOI 10.1016/j.fertnstert.2008.03.057; Maldonado LG, 2013, FERTIL STERIL, V99, P1615, DOI 10.1016/j.fertnstert.2013.01.095; Madani T, 2012, GYNECOL ENDOCRINOL, V28, P102, DOI 10.3109/09513590.2011.579206; Mahutte NG, 2002, CURR OPIN OBSTET GYN, V14, P275, DOI 10.1097/00001703-200206000-00005; Mao GH, 2014, ARCH MED SCI, V10, P161, DOI 10.5114/aoms.2014.40743; PORTER RN, 1984, LANCET, V2, P1284, DOI 10.1016/S0140-6736(84)92840-X; Shanbhag S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004379.pub2; Sunkara SK, 2014, FERTIL STERIL, V101, P147, DOI 10.1016/j.fertnstert.2013.09.035; Tarlatzis BC, 2003, HUM REPROD UPDATE, V9, P61, DOI 10.1093/humupd/dmg007; Tesarik Jan, 2003, Reprod Biomed Online, V7, P59; Toner JP, 2003, FERTIL STERIL, V79, P491, DOI 10.1016/S0015-0282(02)04840-9; van Rooij IAJ, 2003, FERTIL STERIL, V79, P482, DOI 10.1016/S0015-0282(02)04839-2	17	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133887	10.1371/journal.pone.0133887	http://dx.doi.org/10.1371/journal.pone.0133887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208150	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000165
J	Stewart, JE; Brooks, K; Brannen, PM; Cline, WO; Brewer, MT				Stewart, Jane E.; Brooks, Kyle; Brannen, Phillip M.; Cline, William O.; Brewer, Marin T.			Elevated Genetic Diversity in the Emerging Blueberry Pathogen Exobasidium maculosum	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; INTERNAL TRANSCRIBED SPACER; POPULATION EXPANSION; DNA; FUNGAL; PLANT; SEQUENCE; REVEALS; NUMBER; PHYLOGEOGRAPHY	Emerging diseases caused by fungi are increasing at an alarming rate. Exobasidium leaf and fruit spot of blueberry, caused by the fungus Exobasidium maculosum, is an emerging disease that has rapidly increased in prevalence throughout the southeastern USA, severely reducing fruit quality in some plantings. The objectives of this study were to determine the genetic diversity of E. maculosum in the southeastern USA to elucidate the basis of disease emergence and to investigate if populations of E. maculosum are structured by geography, host species, or tissue type. We sequenced three conserved loci from 82 isolates collected from leaves and fruit of rabbiteye blueberry (Vaccinium virgatum), highbush blueberry (V. corymbosum), and southern highbush blueberry (V. corymbosum hybrids) from commercial fields in Georgia and North Carolina, USA, and 6 isolates from lowbush blueberry (V. angustifolium) from Maine, USA, and Nova Scotia, Canada. Populations of E. maculosum from the southeastern USA and from lowbush blueberry in Maine and Nova Scotia are distinct, but do not represent unique species. No difference in genetic structure was detected between different host tissues or among different host species within the southeastern USA; however, differentiation was detected between populations in Georgia and North Carolina. Overall, E. maculosum showed extreme genetic diversity within the conserved loci with 286 segregating sites among the 1,775 sequenced nucleotides and each isolate representing a unique multilocus haplotype. However, 94% of the nucleotide substitutions were silent, so despite the high number of mutations, selective constraints have limited changes to the amino acid sequences of the housekeeping genes. Overall, these results suggest that the emergence of Exobasidium leaf and fruit spot is not due to a recent introduction or host shift, or the recent evolution of aggressive genotypes of E. maculosum, but more likely as a result of an increasing host population or an environmental change.	[Stewart, Jane E.; Brooks, Kyle; Brannen, Phillip M.; Brewer, Marin T.] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [Cline, William O.] N Carolina State Univ, Hort Crops Res Stn, Dept Plant Pathol, Castle Hayne, NC USA	University System of Georgia; University of Georgia; University of North Carolina; North Carolina State University	Brewer, MT (corresponding author), Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA.	mtbrewer@uga.edu			Georgia Blueberry Commission; U. S. Department of Agriculture, Specialty Crop Research Initiative grant [2008-51180-19579]; Southern Region Small Fruit Consortium grant [2012-01]	Georgia Blueberry Commission; U. S. Department of Agriculture, Specialty Crop Research Initiative grant; Southern Region Small Fruit Consortium grant	The study was supported by a grant to MTB and PMB from the Georgia Blueberry Commission, from the U. S. Department of Agriculture, Specialty Crop Research Initiative grant no. 2008-51180-19579 and by Southern Region Small Fruit Consortium grant 2012-01 to PMB.	Alexandrino J, 2002, HEREDITY, V88, P66, DOI 10.1038/sj.hdy.6800010; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Begerow D, 2014, MYCOTA A, V7; Begerow Dominik, 2002, Mycological Progress, V1, P187, DOI 10.1007/s11557-006-0018-7; Bell DJ, 2008, J AM SOC HORTIC SCI, V133, P701, DOI 10.21273/JASHS.133.5.701; Billiard S, 2012, J EVOLUTION BIOL, V25, P1020, DOI 10.1111/j.1420-9101.2012.02495.x; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Brewer MT, 2014, MYCOLOGIA, V106, P415, DOI 10.3852/13-202; Brewer MT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-268; Burt EA, 1915, ANN MISSOURI BOT GAR, V2, P627, DOI DOI 10.2307/2990117; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cline W. O., 1998, Plant Disease, V82, P1064, DOI 10.1094/PDIS.1998.82.9.1064B; Eaton CJ, 2011, PLANT SCI, V180, P190, DOI 10.1016/j.plantsci.2010.10.002; Fontaine MC, 2013, MOL ECOL, V22, P2771, DOI 10.1111/mec.12293; Fry W, 2015, REEMERGING PHYTOPHTH; FU YX, 1993, GENETICS, V133, P693; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Gattepaille LM, 2013, HEREDITY, V110, P409, DOI 10.1038/hdy.2012.120; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gladieux P, 2015, MOL ECOL, V24, P1969, DOI 10.1111/mec.13028; GRAAFLAND W., 1960, ACTA BOT NEERLAND, V9, P347; Grunwald NJ, 2011, ANNU REV PHYTOPATHOL, V49, P249, DOI 10.1146/annurev-phyto-072910-095246; Harder CB, 2013, FUNGAL BIOL-UK, V117, P764, DOI 10.1016/j.funbio.2013.09.004; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Kauserud H, 2006, MOL ECOL, V15, P421, DOI 10.1111/j.1365-294X.2005.02768.x; Levi A, 1997, J AM SOC HORTIC SCI, V122, P74, DOI 10.21273/JASHS.122.1.74; Lucas JA, 2015, ADV APPL MICROBIOL, V90, P29, DOI 10.1016/bs.aambs.2014.09.001; Mahuku GS, 2004, PLANT MOL BIOL REP, V22, P71, DOI 10.1007/BF02773351; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Mikaberidze A, 2014, PHYTOPATHOLOGY, V104, P324, DOI 10.1094/PHYTO-07-13-0204-R; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; MIMS CW, 1987, BOT GAZ, V148, P228, DOI 10.1086/337651; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Mouli B. C., 2003, Annual Review of Plant Pathology, V2, P145; Nagao Hideyuki, 2006, Mycoscience, V47, P277, DOI 10.1007/s10267-006-0307-7; Nannfeldt J.A., 1981, SYMB BOT UPSAL, V23, P1; NEI M, 1981, GENETICS, V97, P145; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nei M., 1987, MOL EVOLUTIONARY GEN; Nickerson NL, 1997, CAN J PLANT PATHOL, V19, P66, DOI 10.1080/07060669709500575; Pelczar Jr MJ, 1958, LAB EXERCISES MICROB, P45; Piatek M, 2012, MYCOL PROG, V11, P361, DOI 10.1007/s11557-011-0751-4; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shen Q, 2002, MYCOLOGIA, V94, P472, DOI 10.2307/3761781; Smith B, 2012, MISSISSIPPI VACCINIU, V1, P10; Smith K., 2009, Outlooks on Pest Management, V20, P148, DOI 10.1564/20aug02; Stukenbrock EH, 2014, FUNGAL BIOL REV, V28, P1, DOI 10.1016/j.fbr.2014.02.001; SUNDSTROM K. R., 1964, Symbolae botanicae upsalienses, V18; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Symington LS, 2014, NATURE, V514, P39, DOI 10.1038/nature13751; TAJIMA F, 1989, GENETICS, V123, P597; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Van Kan JAL, 2014, MOL PLANT PATHOL, V15, P957, DOI 10.1111/mpp.12148; Vialle A, 2013, MOL PHYLOGENET EVOL, V66, P628, DOI 10.1016/j.ympev.2012.10.021; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	76	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132545	10.1371/journal.pone.0132545	http://dx.doi.org/10.1371/journal.pone.0132545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207812	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000031
J	Zheng, CB; Zhou, WB; Wang, TT; You, PP; Zhao, YL; Yang, YQ; Wang, X; Luo, J; Chen, YH; Liu, MY; Chen, HQ				Zheng, Chunbing; Zhou, Wenbo; Wang, Tongtong; You, Panpan; Zhao, Yongliang; Yang, Yiqing; Wang, Xin; Luo, Jian; Chen, Yihua; Liu, Mingyao; Chen, Huaqing			A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic beta-Cells in Type 2 Diabetic Mice	PLOS ONE			English	Article							BILE-ACID RECEPTOR; FASTING BLOOD-GLUCOSE; INSULIN-RESISTANCE; IN-VITRO; AGONISTS; POTENT; MASS; SITAGLIPTIN; DERIVATIVES; MELLITUS	The G protein-coupled receptor TGR5 is a membrane receptor for bile acids. Its agonism increases energy expenditure and controls blood glucose through secretion of glucagon-like peptide-1 in enteroendocrine cells. In this study, we explored the therapeutic potential of WB403, a small compound activating TGR5 which was identified by combining TGR5 targeted luciferase assay and active GLP-1 assay, in treating type 2 diabetes. After confirmation of TGR5 and GLP-1 stimulating activities in various cell systems, WB403 was examined in oral glucose tolerance test, and tested on different mouse models of type 2 diabetes for glycemic control and pancreatic beta-cell protection effect. As a result, WB403 exhibited a moderate TGR5 activation effect while promoting GLP-1 secretion efficiently. Interestingly, gallbladder filling effect, which was reported for some known TGR5 agonists, was not detected in this novel compound. In vivo results showed that WB403 significantly improved glucose tolerance and decreased fasting blood glucose, postprandial blood glucose and HbA1c in type 2 diabetic mice. Further analysis revealed that WB403 increased pancreatic beta-cells and restored the normal distribution pattern of alpha-cell and beta-cell in islets. These findings demonstrated that TGR5 activator WB403 effectively promoted GLP-1 release, improved hyperglycemia and preserved the mass and function of pancreatic beta-cells, whereas it did not show a significant side effect on gallbladder. It may represent a promising approach for future type 2 diabetes mellitus drug development.	[Zheng, Chunbing; Zhou, Wenbo; Wang, Tongtong; You, Panpan; Zhao, Yongliang; Yang, Yiqing; Wang, Xin; Luo, Jian; Chen, Yihua; Liu, Mingyao; Chen, Huaqing] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Zheng, Chunbing; Zhou, Wenbo; Wang, Tongtong; You, Panpan; Zhao, Yongliang; Yang, Yiqing; Wang, Xin; Luo, Jian; Chen, Yihua; Liu, Mingyao; Chen, Huaqing] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX USA	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Liu, MY (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200062, Peoples R China.	myliu@bio.ecnu.edu.cn; hqchen@bio.ecnu.edu.cn	Chen, Yihua/A-4323-2013; Wang, Xin/B-6572-2011; Chen, Yihua/O-2743-2019; Luo, Jian/H-3362-2016	Chen, Yihua/0000-0003-1733-7980; Wang, Xin/0000-0001-8079-8638; Chen, Yihua/0000-0003-1733-7980; Liu, Mingyao/0000-0001-7339-5048; Luo, Jian/0000-0003-3583-0154	Ministry of Science and Technology of China [2013ZX09507001]; National Natural Science Foundation of China [31271468]; Science and Technology Commission of Shanghai Municipality [12ZR1408700]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grant funding from the Ministry of Science and Technology of China (http://www.most.gov.cn. 2013ZX09507001) to ML; the National Natural Science Foundation of China (http://isisn.nsfc.gov.cn. 31271468) to HC; and the Science and Technology Commission of Shanghai Municipality (http://www.stcsm.gov.cn. 12ZR1408700) to HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2001, Diabetes Care, V24, P775; Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Christiansen E, 2011, J MED CHEM, V54, P6691, DOI 10.1021/jm2005699; Duan HL, 2012, J MED CHEM, V55, P10475, DOI 10.1021/jm301071h; Evans KA, 2009, J MED CHEM, V52, P7962, DOI 10.1021/jm901434t; Eyre H, 2004, CIRCULATION, V109, P3244, DOI 10.1161/01.CIR.0000133321.00456.00; Gadsby Roger, 2007, Prim Care Diabetes, V1, P209, DOI 10.1016/j.pcd.2007.10.004; Gerich JE, 1999, DIABETES OBES METAB, V1, P257, DOI 10.1046/j.1463-1326.1999.00027.x; Goke B, 2008, INT J CLIN PRACT, V62, P2, DOI 10.1111/j.1742-1241.2007.01686.x; Hansen HS, 2012, TRENDS PHARMACOL SCI, V33, P374, DOI 10.1016/j.tips.2012.03.014; Herbert MR, 2010, BIOORG MED CHEM LETT, V20, P5718, DOI 10.1016/j.bmcl.2010.08.014; Holst JJ, 2012, CLIN DRUG INVEST, V32, P1, DOI 10.2165/11595370-000000000-00000; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Knop FK, 2010, AM J PHYSIOL-ENDOC M, V299, pE10, DOI 10.1152/ajpendo.00137.2010; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Li TT, 2011, MOL ENDOCRINOL, V25, P1066, DOI 10.1210/me.2010-0460; Maedler K, 2005, J CLIN ENDOCR METAB, V90, P501, DOI 10.1210/jc.2004-0699; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Masur K, 2005, MOL ENDOCRINOL, V19, P1373, DOI 10.1210/me.2004-0350; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moran BM, 2014, DIABETES OBES METAB, V16, P1128, DOI 10.1111/dom.12330; Motta M, 2010, ARCH GERONTOL GERIAT, V50, P60, DOI 10.1016/j.archger.2009.01.012; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Murakami M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-20; Nakashima K, 2012, MOL CELL ENDOCRINOL, V349, P281, DOI 10.1016/j.mce.2011.11.008; Poucher SM, 2012, DIABETES OBES METAB, V14, P918, DOI 10.1111/j.1463-1326.2012.01619.x; Qian J, 2014, CELL SIGNAL, V26, P2412, DOI 10.1016/j.cellsig.2014.07.019; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Renehan AG, 2005, LANCET, V365, P1449, DOI 10.1016/S0140-6736(05)66399-4; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Shah P, 2013, J CLIN ENDOCR METAB, V98, pE1163, DOI 10.1210/jc.2013-1029; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Stumvoll M, 2001, CLIN LAB MED, V21, P31; Tanaka H, 2014, LIFE SCI, V94, P115, DOI 10.1016/j.lfs.2013.11.010; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Valentine WJ, 2006, INT J CLIN PRACT, V60, P1138, DOI 10.1111/j.1742-1241.2006.01102.x; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhu JJ, 2013, EUR J MED CHEM, V69, P55, DOI 10.1016/j.ejmech.2013.07.050	45	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134051	10.1371/journal.pone.0134051	http://dx.doi.org/10.1371/journal.pone.0134051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208278	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000196
J	Chung, MG; Kang, H; Choi, SU				Chung, Min Gon; Kang, Hojeong; Choi, Sung-Uk			Assessment of Coastal Ecosystem Services for Conservation Strategies in South Korea	PLOS ONE			English	Article							COUPLED HUMAN; TRADEOFFS; IMPACTS	Despite the fact that scientific and political consideration for ecosystem services has dramatically increased over the past decade, few studies have focused on marine and coastal ecosystem services for conservation strategies. We used an ecosystem services approach to assess spatial distributions of habitat risks and four ecosystem services (coastal protection, carbon storage, recreation, and aesthetic quality), and explored the tradeoffs among them in coastal areas of South Korea. Additionally, we analyzed how the social and ecological characteristics in coastal areas interact with conservation and development policies by using this approach. We found strong negative associations between the habitat risks and ecosystem services (aquaculture, carbon storage, recreation, and aesthetic quality) across the coastal counties. Our results showed that the intensity of the habitat risks and the provision of ecosystem services were significantly different between reclamation-dominated and conservation-dominated counties, except for coastal vulnerability. A generalized linear model suggested that reclamation projects were dependent on economic efficiency, whereas demographic pressures and habitat conditions influenced the designation of protected areas at a county level. The ecosystem services approach provided guidelines to achieve both sustainable development and environment conservation. By using the approach, we can select the priority areas for developments while we can minimize the degradation of biodiversity and ecosystem services. As cultural ecosystem services are evenly distributed throughout coastal areas of South Korea, decision makers may employ them to improve the conditions of coastal wetlands outside of protected areas.	[Chung, Min Gon; Kang, Hojeong; Choi, Sung-Uk] Yonsei Univ, Sch Civil & Environm Engn, Seoul 120749, South Korea	Yonsei University	Kang, H (corresponding author), Yonsei Univ, Sch Civil & Environm Engn, Seoul 120749, South Korea.	hj_kang@yonsei.ac.kr	Kang, Hojeong/C-7208-2011; Chung, Min Gon/AAF-7277-2021	Chung, Min Gon/0000-0002-7177-7189; Choi, Sung-Uk/0000-0002-0802-7705	National Research Foundation [2011-0030040]	National Research Foundation	This work was supported by National Research Foundation 2011-0030040 (http://www.nrf.re.kr) to HK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SW, 2005, J CONTEMP ASIA, V35, P485, DOI 10.1080/00472330580000281; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2012, BIOSCIENCE, V62, P744, DOI 10.1525/bio.2012.62.8.7; Cochard R, 2008, PERSPECT PLANT ECOL, V10, P3, DOI 10.1016/j.ppees.2007.11.001; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Dhakal S, 2010, WIREL TELECOMM SYMP; Dudley N., 2008, GUIDELINES FOR APPLY; Dudley N., 2011, SOLUTIONS, V2, P87; Eggleston S., 2006, IPCC GUIDELINES FOR; ESRI, 2012, ARCGIS DESKTOP RELEA; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Garcia-Nieto AP, 2013, ECOSYST SERV, V4, P126, DOI 10.1016/j.ecoser.2013.03.003; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Gornitz V., 1990, J COASTAL RES, V9, P201, DOI DOI 10.1007/S10661-017-6282-Y; Guerry Anne D., 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P107, DOI 10.1080/21513732.2011.647835; Hong SK, 2010, ENVIRON MANAGE, V45, P1014, DOI 10.1007/s00267-006-0164-3; Hong SY, 2010, DIGITAL SOIL MAPPING; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Hwang SI, 2010, LOW CARBON LAND USE; Ingram J, 2012, APPLYING ECOSYSTEM S, V5; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; KHOA, 2013, CALCULATING DEVATION; Kim J., 2007, ECO, V11, P285; KMA, 2011, ANNUAL CLIMATOLOGICA; Koh CH, 2009, COMP STUDY POLICY MA; Korea Statistics, 2010, CENSUS OF AGRICULTUR; Korea Statistics, 2014, KOREAN STATISTICAL I; Korea Statistics, 2010, UNDERSTANDING STATIS; Korea Statistics, 2013, KOREA STATISTICAL YE; Korea Statistics, 2014, STATISTICAL GEOGRAPH; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Liquete C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067737; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu JG, 2015, SCIENCE, V347, DOI 10.1126/science.1258832; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035420; Liverman D, 1998, PEOPLE AND PIXELS LI; MA, 2005, ECOSYSTEMS AND HUMAN; Ma ZJ, 2014, SCIENCE, V346, P912, DOI 10.1126/science.1257258; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; McLeod K., 2009, ECOSYSTEM BASED MANA; Ministry of Environment, 2014, ENVIRONMENT GEOGRAPH; MLTM, 2013, NATIONAL SPATIAL INF; MLTM, 2011, THE SECOND INTEGRATE; MLTM, 2008, THE MANAGEMENT OF CO; MOF, 2014, THE NATIONAL SURVEY; MOF, 2014, COASTAL MANAGEMENT I; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Petter M, 2013, ECOL SOC, V18, DOI 10.5751/ES-05260-180131; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Potschin M, 2013, COMMON INTERNATIONAL; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; R Core Team, 2021, R LANGUAGE ENV STAT; Rees SE, 2013, FISH RES, V146, P51, DOI 10.1016/j.fishres.2013.04.003; Sachedina H., 2012, INTEGRATING ECOLOGY, DOI [10.1007/978-1-4614-0186-5_12, DOI 10.1007/978-1-4614-0186-5_12]; Sander HA, 2009, LAND USE POLICY, V26, P837, DOI 10.1016/j.landusepol.2008.10.009; SAS Institute Inc, 2008, SAS STAT 9 2 USERS G; Schroth G, 2011, ENVIRON MANAGE, V48, P229, DOI 10.1007/s00267-011-9708-2; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Sharp R, 2014, INVEST USERS GUIDE T; Tallis HT, 2013, THE NATURAL CAPITAL; Tallis HT, 2011, THE NATURAL CAPITAL; TEEB, 2010, THE ECONOMICS OF ECO; UNEP, 2006, MARINE AND COASTAL E; Wang X, 2010, ECOL ECON, V69, P2549, DOI 10.1016/j.ecolecon.2010.07.031; Willemen L, 2013, ECOSYST SERV, V4, P95, DOI 10.1016/j.ecoser.2013.02.004; Yackulic CB, 2011, ECOL SOC, V16, DOI 10.5751/ES-04275-160315; Zhao B, 2004, LAND USE POLICY, V21, P139, DOI 10.1016/j.landusepol.2003.10.003; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	73	27	27	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133856	10.1371/journal.pone.0133856	http://dx.doi.org/10.1371/journal.pone.0133856			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221950	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800072
J	Gimenez-Dejoz, J; Kolar, MH; Ruiz, FX; Crespo, I; Cousido-Siah, A; Podjarny, A; Barski, OA; Fanfrlik, J; Pares, X; Farres, J; Porte, S				Gimenez-Dejoz, Joan; Kolar, Michal H.; Ruiz, Francesc X.; Crespo, Isidro; Cousido-Siah, Alexandra; Podjarny, Alberto; Barski, Oleg A.; Fanfrlik, Jindrich; Pares, Xavier; Farres, Jaume; Porte, Sergio			Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase	PLOS ONE			English	Article							RETINOIC ACID BIOSYNTHESIS; SCORING FUNCTION; AKR1B10; BINDING; SITE; DEHYDROGENASE; PROTEINS; SUPERFAMILY; FLEXIBILITY; METABOLISM	Human aldo-keto reductase 1B15 (AKR1B15) is a newly discovered enzyme which shares 92% amino acid sequence identity with AKR1B10. While AKR1B10 is a well characterized enzyme with high retinaldehyde reductase activity, involved in the development of several cancer types, the enzymatic activity and physiological role of AKR1B15 are still poorly known. Here, the purified recombinant enzyme has been subjected to substrate specificity characterization, kinetic analysis and inhibitor screening, combined with structural modeling. AKR1B15 is active towards a variety of carbonyl substrates, including retinoids, with lower k(cat) and K-m values than AKR1B10. In contrast to AKR1B10, which strongly prefers all-trans-retinaldehyde, AKR1B15 exhibits superior catalytic efficiency with 9-cis-retinaldehyde, the best substrate found for this enzyme. With ketone and dicarbonyl substrates, AKR1B15 also shows higher catalytic activity than AKR1B10. Several typical AKR inhibitors do not significantly affect AKR1B15 activity. Amino acid substitutions clustered in loops A and C result in a smaller, more hydrophobic and more rigid active site in AKR1B15 compared with the AKR1B10 pocket, consistent with distinct substrate specificity and narrower inhibitor selectivity for AKR1B15.	[Gimenez-Dejoz, Joan; Crespo, Isidro; Pares, Xavier; Farres, Jaume; Porte, Sergio] Univ Autonoma Barcelona, Fac Biosci, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Kolar, Michal H.; Fanfrlik, Jindrich] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Kolar, Michal H.] Forschungszentrum Julich, INM 9, D-52425 Julich, Germany; [Kolar, Michal H.] Forschungszentrum Julich, IAS 5, D-52425 Julich, Germany; [Ruiz, Francesc X.; Cousido-Siah, Alexandra; Podjarny, Alberto] UdS, INSERM, CNRS, Dept Integrat Struct Biol,Inst Genet & Biol Mol &, Illkirch Graffenstaden, France; [Barski, Oleg A.] Univ Louisville, Sch Med, Diabet & Obes Ctr, Louisville, KY 40292 USA	Autonomous University of Barcelona; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Louisville	Farres, J (corresponding author), Univ Autonoma Barcelona, Fac Biosci, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain.	jaume.farres@uab.cat; sergio.porte@gmail.com	Ruiz, Francesc Xavier/AAA-1324-2020; Giménez Dejoz, Joan/C-7434-2017; Farrés, Jaume/F-8648-2016; Kolář, Michal H./AFP-3197-2022; Kolar, Michal H/H-3721-2011; Pares, Xavier/K-8228-2017	Ruiz, Francesc Xavier/0000-0002-0457-0030; Giménez Dejoz, Joan/0000-0002-3839-950X; Farrés, Jaume/0000-0001-9069-3987; Kolář, Michal H./0000-0003-0841-944X; Podjarny, Alberto/0000-0002-7685-1077; Pares, Xavier/0000-0002-5071-9465; Fanfrlik, Jindrich/0000-0002-1257-1201; Cousido-Siah, Alexandra/0000-0002-3051-1560; Crespo, Isidro/0000-0001-7698-1720	Spanish Ministerio de Economia y Competitividad [BFU2011-24176]; Generalitat de Catalunya [2009 SGR 795]; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite de Strasbourg; Region Alsace; Hopital Civil de Strasbourg; l Instruct part of the European Strategy Forum of Research Infrastructures; ESFRI; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Fondation pour la Recherche Medicale [SPF20121226275]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg; Region Alsace(Region Grand-Est); Hopital Civil de Strasbourg; l Instruct part of the European Strategy Forum of Research Infrastructures; ESFRI; French Infrastructure for Integrated Structural Biology (FRISBI); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	JGD, IC, XP, JF and SP received support from Spanish Ministerio de Economia y Competitividad [BFU2011-24176] (http://www.mineco.gob.es) and Generalitat de Catalunya [2009 SGR 795] (http://www.gencat.cat/agaur). FXR, ACS and AP received support from Centre National de la Recherche Scientifique (http://www.cnrs.fr); Institut National de la Sante et de la Recherche Medicale (http://www.inserm.fr); Universite de Strasbourg (https://www.unistra.fr); Region Alsace (http://www.region.alsace); Hopital Civil de Strasbourg (http://www.chru-strasbourg.fr/Hopital-civi); l Instruct (part of the European Strategy Forum of Research Infrastructures; ESFRI) (https://www.structuralbiology.eu); and French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01] (http://frisbi.eu). FXR received support from Fondation pour la Recherche Medicale [SPF20121226275] (http://www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Belyaeva OV, 2008, FEBS J, V275, P138, DOI 10.1111/j.1742-4658.2007.06184.x; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Calam E, 2013, CHEM-BIOL INTERACT, V202, P195, DOI 10.1016/j.cbi.2012.12.006; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chatzopoulou M, 2012, EXPERT OPIN THER PAT, V22, P1303, DOI 10.1517/13543776.2012.726615; Constantinescu S, 2014, CHEM RES TOXICOL, V27, P377, DOI 10.1021/tx400427t; Cousido-Siah A, 2014, ACTA CRYSTALLOGR D, V70, P889, DOI 10.1107/S1399004713033452; Crosas B, 2001, J BIOL CHEM, V276, P19132, DOI 10.1074/jbc.M010478200; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Echtay KS, 2007, REDOX REP, V12, P26, DOI 10.1179/135100007X162158; EHRIG T, 1994, BIOCHEMISTRY-US, V33, P7157, DOI 10.1021/bi00189a019; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Endo S, 2010, BIOL PHARM BULL, V33, P886, DOI 10.1248/bpb.33.886; Endo S, 2010, BIOORGAN MED CHEM, V18, P2485, DOI 10.1016/j.bmc.2010.02.050; Endo S, 2009, ARCH BIOCHEM BIOPHYS, V487, P1, DOI 10.1016/j.abb.2009.05.009; Fanfrlik J, 2013, ACS CHEM BIOL, V8, P2484, DOI 10.1021/cb400526n; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kimble-Hill AC, 2014, J MED CHEM, V57, P714, DOI 10.1021/jm401377v; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Kokkinidis M, 2012, ADV PROTEIN CHEM STR, V87, P181, DOI 10.1016/B978-0-12-398312-1.00007-X; KUBISESKI TJ, 1995, J BIOL CHEM, V270, P16911, DOI 10.1074/jbc.270.28.16911; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lepsik M, 2013, CHEMPLUSCHEM, V78, P921, DOI 10.1002/cplu.201300199; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Ma J., 2012, CLIN DEV IMMUNOL, V2012, P1, DOI DOI 10.1109/PESGM.2012.6345243; Matsunaga T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00005; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Palczewski G, 2014, FASEB J, P1, DOI [10.1096/fj.14-0101LTE, DOI 10.1096/FJ.14-0101LTE]; Pastel E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00148; Pathania S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061327; Porte S, 2013, CHEM-BIOL INTERACT, V202, P186, DOI 10.1016/j.cbi.2012.11.014; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Rezac J, 2009, J CHEM THEORY COMPUT, V5, P1749, DOI 10.1021/ct9000922; Ruiz FX, 2011, BIOCHEM J, V440, P335, DOI 10.1042/BJ20111286; Ruiz FX, 2009, CHEM-BIOL INTERACT, V178, P171, DOI 10.1016/j.cbi.2008.10.027; Salabei JK, 2011, CHEM-BIOL INTERACT, V191, P177, DOI 10.1016/j.cbi.2011.01.020; Seeliger D, 2007, STRUCTURE, V15, P1482, DOI 10.1016/j.str.2007.09.017; Shen Y, 2011, CHEM-BIOL INTERACT, V191, P192, DOI 10.1016/j.cbi.2011.02.004; Soda M, 2012, EUR J MED CHEM, V48, P321, DOI 10.1016/j.ejmech.2011.12.034; Sundaram K, 2011, BIOORG MED CHEM LETT, V21, P801, DOI 10.1016/j.bmcl.2010.11.086; Tammali R, 2011, CARCINOGENESIS, V32, P1259, DOI 10.1093/carcin/bgr102; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Urzhumtsev A, 1997, STRUCTURE, V5, P601, DOI 10.1016/S0969-2126(97)00216-5; Verma M, 2008, EUR J PHARMACOL, V584, P213, DOI 10.1016/j.ejphar.2008.01.036; Weber S, 2015, J BIOL CHEM, V290, P6531, DOI 10.1074/jbc.M114.610121; Ruiz FX, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00058; Ruiz FX, 2011, CHEM-BIOL INTERACT, V191, P199, DOI 10.1016/j.cbi.2011.02.007; Ruiz FX, 2013, CHEM-BIOL INTERACT, V202, P178, DOI 10.1016/j.cbi.2012.12.013; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Zhang LP, 2014, CHEMMEDCHEM, V9, P706, DOI 10.1002/cmdc.201300455; Zhang LP, 2013, FEBS LETT, V587, P3681, DOI 10.1016/j.febslet.2013.09.031; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011	71	14	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134506	10.1371/journal.pone.0134506	http://dx.doi.org/10.1371/journal.pone.0134506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222439	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800146
J	Lee, YT; Hu, LY; Shen, CC; Huang, MW; Tsai, SJ; Yang, AC; Hu, CK; Perng, CL; Huang, YS; Hung, JH				Lee, Yao-Tung; Hu, Li-Yu; Shen, Cheng-Che; Huang, Min-Wei; Tsai, Shih-Jen; Yang, Albert C.; Hu, Chang-Kuo; Perng, Chin-Lin; Huang, Yi-Shin; Hung, Jeng-Hsiu			Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							HPA AXIS; DEPRESSION; ANXIETY; SEVERITY; COMORBIDITIES; DYSREGULATION; INFLAMMATION; ASSOCIATION; PREVALENCE; PATIENT	Background Irritable bowel syndrome (IBS) is the most common functional gastrointestinal (GI) disorder observed in patients who visit general practitioners for GI-related complaints. A high prevalence of psychiatric comorbidities, particularly anxiety and depressive disorders, has been reported in patients with IBS. However, a clear temporal relationship between IBS and psychiatric disorders has not been well established. Objective We explored the relationship between IBS and the subsequent development of psychiatric disorders including schizophrenia, bipolar disorder, depressive disorder, anxiety disorder, and sleep disorder. Methods We selected patients who were diagnosed with IBS caused by gastroenteritis, according to the data in the Taiwan National Health Insurance Research Database. A comparison cohort was formed of patients without IBS who were matched according to age and sex. The incidence rate and the hazard ratios (HRs) of subsequent new-onset psychiatric disorders were calculated for both cohorts, based on psychiatrist diagnoses. Results The IBS cohort consisted of 4689 patients, and the comparison cohort comprised 18756 matched control patients without IBS. The risks of depressive disorder (HR = 2.71, 95% confidence interval [CI] = 2.30-3.19), anxiety disorder (HR = 2.89, 95% CI = 2.42-3.46), sleep disorder (HR = 2.47, 95% CI = 2.02-3.02), and bipolar disorder (HR = 2.44, 95% CI = 1.34-4.46) were higher in the IBS cohort than in the comparison cohort. In addition, the incidence of newly diagnosed depressive disorder, anxiety disorder, and sleep disorder remained significantly increased in all of the stratified follow-up durations (0-1, 1-5, >= 5 y). Conclusions IBS may increase the risk of subsequent depressive disorder, anxiety disorder, sleep disorder, and bipolar disorder. The risk ratios are highest for these disorders within 1 year of IBS diagnosis, but the risk remains statistically significant for more than 5 years. Clinicians should pay particular attention to psychiatric comorbidities in IBS patients.	[Hu, Li-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lee, Yao-Tung] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, New Taipei City, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Shen, Cheng-Che] Natl Chung Cheng Univ, Dept Informat Magagement, Chiayi, Taiwan; [Shen, Cheng-Che; Tsai, Shih-Jen; Yang, Albert C.; Perng, Chin-Lin; Huang, Yi-Shin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Min-Wei] Minist Hlth & Welf, Bali Psychiat Ctr, New Taipei, Taiwan; [Tsai, Shih-Jen; Yang, Albert C.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Hu, Chang-Kuo] Taichung Vet Gen Hosp, Chiayi Branch, Dept Surg, Div Neurosurg, Chiayi, Taiwan; [Perng, Chin-Lin; Huang, Yi-Shin] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Hung, Jeng-Hsiu] Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Buddhist Tzu Chi Med Fdn, Taipei, Taiwan; [Hung, Jeng-Hsiu] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Kaohsiung Veterans General Hospital; Taipei Medical University; Taichung Veterans General Hospital; National Chung Cheng University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taichung Veterans General Hospital; Taipei Veterans General Hospital; Tzu Chi University	Hung, JH (corresponding author), Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Buddhist Tzu Chi Med Fdn, Taipei, Taiwan.	11662@s.tmu.edu.tw	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Yang, Albert Chih-Chieh/0000-0003-2794-9649				Aguilera G, 2011, HORM MOL BIOL CLIN I, V7, P327, DOI 10.1515/HMBCI.2011.123; Aizawa E, 2012, GASTROENTEROLOGY, V143, P1188, DOI 10.1053/j.gastro.2012.07.104; Alander T, 2008, DIGEST DIS SCI, V53, P1856, DOI 10.1007/s10620-007-0101-1; Ali T, 2013, WORLD J GASTROENTERO, V19, P9231, DOI 10.3748/wjg.v19.i48.9231; Bercik P, 2012, NEUROGASTROENT MOTIL, V24, P405, DOI 10.1111/j.1365-2982.2012.01906.x; Berman S, 2012, NEUROIMAGE, V63, P1854, DOI 10.1016/j.neuroimage.2012.08.028; Chang L, 2009, NEUROGASTROENT MOTIL, V21, P149, DOI 10.1111/j.1365-2982.2008.01171.x; Cho HS, 2011, GUT LIVER, V5, P29, DOI 10.5009/gnl.2011.5.1.29; Clarke G, 2009, TRENDS MOL MED, V15, P478, DOI 10.1016/j.molmed.2009.08.001; Coss-Adame Enrique, 2014, Curr Gastroenterol Rep, V16, P379, DOI 10.1007/s11894-014-0379-z; Crane C, 2003, PSYCHOSOM MED, V65, P919, DOI 10.1097/01.PSY.0000088590.01737.07; Dinan TG, 2006, GASTROENTEROLOGY, V130, P304, DOI 10.1053/j.gastro.2005.11.033; Doshi JA, 2014, J MANAG CARE SPEC PH, V20, P382, DOI 10.18553/jmcp.2014.20.4.382; Drossman DA, 2011, AM J GASTROENTEROL, V106, P1749, DOI 10.1038/ajg.2011.201; Dunlop SP, 2003, GASTROENTEROLOGY, V125, P1651, DOI 10.1053/j.gastro.2003.09.028; Fitzgerald P, 2008, NEUROGASTROENT MOTIL, V20, P1291, DOI 10.1111/j.1365-2982.2008.01195.x; Folks David G, 2004, Curr Psychiatry Rep, V6, P210, DOI 10.1007/s11920-004-0066-0; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Graff LA, 2013, CLIN GASTROENTEROL H, V11, P1140, DOI 10.1016/j.cgh.2013.03.031; Gupta S, 1997, SCHIZOPHR RES, V23, P265, DOI 10.1016/S0920-9964(96)00099-0; Harrisberger F, 2015, NEUROSCIENCE BIOBEHA; Hausteiner-Wiehle C, 2014, WORLD J GASTROENTERO, V20, P6024, DOI 10.3748/wjg.v20.i20.6024; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Himmerich H, 2008, EUR PSYCHIAT, V23, P421, DOI 10.1016/j.eurpsy.2008.03.013; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Huerta Ivonne, 2002, Rev Gastroenterol Mex, V67, P161; Joo YE, 2013, J NEUROGASTROENTEROL, V19, P109, DOI 10.5056/jnm.2013.19.1.109; Kennedy PJ, 2012, NEUROSCI BIOBEHAV R, V36, P310, DOI 10.1016/j.neubiorev.2011.07.001; Labus JS, 2014, PAIN, V155, P137, DOI 10.1016/j.pain.2013.09.020; Lee YY, 2012, J GASTROEN HEPATOL, V27, P746, DOI 10.1111/j.1440-1746.2011.06943.x; Levy RL, 2006, GASTROENTEROLOGY, V130, P1447, DOI 10.1053/j.gastro.2005.11.057; Liu CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118209; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Marshall JK, 2010, GUT, V59, P605, DOI 10.1136/gut.2009.202234; Mayer EA, 2008, NEW ENGL J MED, V358, P1692, DOI 10.1056/NEJMcp0801447; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Mykletun A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-88; Nordquist N, 2010, UPSALA J MED SCI, V115, P2, DOI 10.3109/03009730903573246; Quan X, 2015, DIGESTIVE DIS SCI; Quigley EMM, 2006, DIGEST LIVER DIS, V38, P717, DOI 10.1016/j.dld.2006.05.009; Quigley EMM, 2006, WORLD J GASTROENTERO, V12, P1; Rana S V, 2012, Trop Gastroenterol, V33, P251; Savas LS, 2009, ALIMENT PHARM THER, V29, P115, DOI 10.1111/j.1365-2036.2008.03847.x; Schmidt FM, 2014, J PSYCHIATR RES, V55, P29, DOI 10.1016/j.jpsychires.2014.04.021; Schwille-Kiuntke J, 2011, NEUROGASTROENT MOTIL, V23, pE479, DOI 10.1111/j.1365-2982.2011.01779.x; Siah KTH, 2014, WORLD J GASTROENTERO, V20, P2492, DOI 10.3748/wjg.v20.i10.2492; Solmaz M, 2003, EUR J MED RES, V8, P549; Stasi C, 2012, J GASTROENTEROL, V47, P1177, DOI 10.1007/s00535-012-0627-7; Sugaya N, 2012, INT J BEHAV MED, V19, P308, DOI 10.1007/s12529-011-9195-0; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Turnbull AV, 1995, BRAIN BEHAV IMMUN, V9, P253, DOI 10.1006/brbi.1995.1026; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; WALKER EA, 1992, AM J MED, V92, pS26, DOI 10.1016/0002-9343(92)90133-V; Wilson Alisa, 2004, Manag Care Interface, V17, P24; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	56	47	49	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133283	10.1371/journal.pone.0133283	http://dx.doi.org/10.1371/journal.pone.0133283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222511	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800047
J	Liu, JL; Wang, TS				Liu, Ji-Long; Wang, Tong-Song			Systematic Analysis of the Molecular Mechanism Underlying Decidualization Using a Text Mining Approach	PLOS ONE			English	Article							ENDOMETRIAL STROMAL CELLS; PROGESTERONE-RECEPTOR; BIOLOGICAL NETWORKS; EMBRYO IMPLANTATION; DEFINED FACTORS; GENE; FIBROBLASTS; EXPRESSION; PROTEINS; DATABASE	Decidualization is a crucial process for successful embryo implantation and pregnancy in humans. Defects in decidualization during early pregnancy are associated with several pregnancy complications, such as pre-eclampsia, intrauterine growth restriction and recurrent pregnancy loss. However, the mechanism underlying decidualization remains poorly understood. In the present study, we performed a systematic analysis of decidualization- related genes using text mining. We identified 286 genes for humans and 287 genes for mice respectively, with an overlap of 111 genes shared by both species. Through enrichment test, we demonstrated that although divergence was observed, the majority of enriched gene ontology terms and pathways were shared by both species, suggesting that functional categories were more conserved than individual genes. We further constructed a decidualization-related protein-protein interaction network consisted of 344 nodes connected via 1,541 edges. We prioritized genes in this network and identified 12 genes that may be key regulators of decidualization. These findings would provide some clues for further research on the mechanism underlying decidualization.	[Liu, Ji-Long] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Tong-Song] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China	South China Agricultural University; Shantou University	Liu, JL (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.	jilongliu@scau.edu.cn		Liu, Ji-Long/0000-0002-6948-2576	National Natural Science Foundation of China [31271602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant (31271602 to JLL) (http://www.nsfc.gov.cn/).	Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrientos G, 2014, HUM REPROD UPDATE, V20, P175, DOI 10.1093/humupd/dmt040; Blois SM, 2011, J REPROD IMMUNOL, V88, P86, DOI 10.1016/j.jri.2010.11.002; Brar AK, 2001, PHYSIOL GENOMICS, V7, P135, DOI 10.1152/physiolgenomics.00061.2001; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Christian Mark, 2002, Reprod Biomed Online, V4 Suppl 3, P24; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Garrido-Gomez T, 2011, J CLIN ENDOCR METAB, V96, P706, DOI 10.1210/jc.2010-1825; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerner M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-85; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; IRWIN JC, 1989, FERTIL STERIL, V52, P761; Kashiwagi A, 2007, ENDOCRINOLOGY, V148, P4173, DOI 10.1210/en.2007-0268; KREHBIEL ROBERT H[ENRY], 1937, PHYSIOL ZOOL, V10, P212; Large MJ, 2012, MOL CELL ENDOCRINOL, V358, P155, DOI 10.1016/j.mce.2011.07.027; LEDFORD BE, 1976, BIOL REPROD, V15, P529, DOI 10.1095/biolreprod15.4.529; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mewes HW, 2008, NUCLEIC ACIDS RES, V36, pD196, DOI 10.1093/nar/gkm980; Paule SG, 2010, J PROTEOME RES, V9, P5739, DOI 10.1021/pr100525a; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Rebholz-Schuhmann D, 2012, NAT REV GENET, V13, P829, DOI 10.1038/nrg3337; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TANG BQ, 1993, ENDOCRINOLOGY, V133, P2197, DOI 10.1210/en.133.5.2197; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Tierney EP, 2003, PHYSIOL GENOMICS, V16, P47, DOI 10.1152/physiolgenomics.00066.2003; VELARDO JT, 1953, AM J ANAT, V93, P273, DOI 10.1002/aja.1000930205; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	54	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134585	10.1371/journal.pone.0134585	http://dx.doi.org/10.1371/journal.pone.0134585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222155	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800154
J	Wang, Y; Li, ZY; Wong, DWC; Zhang, M				Wang, Yan; Li, Zengyong; Wong, Duo Wai-Chi; Zhang, Ming			Effects of Ankle Arthrodesis on Biomechanical Performance of the Entire Foot	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; TERM FOLLOW-UP; TOTAL REPLACEMENT; KINEMATIC CHANGES; GAIT ANALYSIS; TETRAHEDRAL ELEMENT; INITIAL STABILITY; JOINT FUSION; HIND-FOOT; FIXATION	Background/Methodology Ankle arthrodesis is one popular surgical treatment for ankle arthritis, chronic instability, and degenerative deformity. However, complications such as foot pain, joint arthritis, and bone fracture may cause patients to suffer other problems. Understanding the internal biomechanics of the foot is critical for assessing the effectiveness of ankle arthrodesis and provides a baseline for the surgical plan. This study aimed to understand the biomechanical effects of ankle arthrodesis on the entire foot and ankle using finite element analyses. A three-dimensional finite element model of the foot and ankle, involving 28 bones, 103 ligaments, the plantar fascia, major muscle groups, and encapsulated soft tissue, was developed and validated. The biomechanical performances of a normal foot and a foot with ankle arthrodesis were compared at three gait instants, first-peak, mid-stance, and second-peak. Principal Findings/Conclusions Changes in plantar pressure distribution, joint contact pressure and forces, von Mises stress on bone and foot deformation were predicted. Compared with those in the normal foot, the peak plantar pressure was increased and the center of pressure moved anteriorly in the foot with ankle arthrodesis. The talonavicular joint and joints of the first to third rays in the hind-and mid-foot bore the majority of the loading and sustained substantially increased loading after ankle arthrodesis. An average contact pressure of 2.14 MPa was predicted at the talonavicular joint after surgery and the maximum variation was shown to be 80% in joints of the first ray. The contact force and pressure of the subtalar joint decreased after surgery, indicating that arthritis at this joint was not necessarily a consequence of ankle arthrodesis but rather a progression of pre-existing degenerative changes. Von Mises stress in the second and third metatarsal bones at the second-peak instant increased to 52 MPa and 34 MPa, respectively, after surgery. These variations can provide indications for outcome assessment of ankle arthrodesis surgery.	[Wang, Yan; Wong, Duo Wai-Chi; Zhang, Ming] Hong Kong Polytech Univ, Fac Engn, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Wang, Yan; Wong, Duo Wai-Chi; Zhang, Ming] Hong Kong Polytech Univ, Shenzhen Res Inst, Shenzhen, Peoples R China; [Li, Zengyong] Shandong Univ, Sch Mech Engn, Key Lab High Efficiency & Clean Mech Manufacture, Jinan 250100, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Shandong University	Zhang, M (corresponding author), Hong Kong Polytech Univ, Fac Engn, Interdisciplinary Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China.	ming.zhang@polyu.edu.hk	Wang, Yan/AAU-3194-2021; Zhang, Ming/F-8331-2011; Wong, Duo Wai-Chi/B-4127-2015	Wang, Yan/0000-0002-5404-4098; Zhang, Ming/0000-0002-6027-4594; Wong, Duo Wai-Chi/0000-0002-8805-1157	Hong Kong Polytechnic University Research Studentship; Hong Kong Research Grant Council GRF [PolyU152216/14E]; NSFC [11272273, 31371002, 11120101001]	Hong Kong Polytechnic University Research Studentship; Hong Kong Research Grant Council GRF(Hong Kong Research Grants Council); NSFC(National Natural Science Foundation of China (NSFC))	This project was supported by The Hong Kong Polytechnic University Research Studentship, Hong Kong Research Grant Council GRF (PolyU152216/14E) and NSFC (11272273, 31371002, 11120101001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Vazquez A, 2004, FOOT ANKLE INT, V25, P840, DOI 10.1177/107110070402501115; Alonso-Vazquez A, 2004, CLIN BIOMECH, V19, P751, DOI 10.1016/j.clinbiomech.2004.04.014; Athanasiou KA, 1998, CLIN ORTHOP RELAT R, P269; Barton Tristan, 2011, Foot Ankle Surg, V17, P52, DOI 10.1016/j.fas.2011.01.010; BAUMHAUER JF, 1995, AM J SPORT MED, V23, P564, DOI 10.1177/036354659502300508; Bayod J, 2013, J AM PODIAT MED ASSN, V103, P260, DOI 10.7547/1030260; Beyaert C, 2004, GAIT POSTURE, V20, P84, DOI 10.1016/j.gaitpost.2003.07.006; Bonet J, 1998, COMMUN NUMER METH EN, V14, P437, DOI 10.1002/(SICI)1099-0887(199805)14:5<437::AID-CNM162>3.0.CO;2-W; Bonet J, 2001, COMMUN NUMER METH EN, V17, P551, DOI 10.1002/cnm.429; Bonet J, 2001, INT J NUMER METH ENG, V50, P119, DOI 10.1002/1097-0207(20010110)50:1<119::AID-NME24>3.0.CO;2-C; Buchner M, 2003, CLIN ORTHOP RELAT R, P155, DOI 10.1097/01.blo.0000038046.63743.c3; BUCK P, 1987, J BONE JOINT SURG AM, V69A, P1052, DOI 10.2106/00004623-198769070-00014; Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; Chen WM, 2012, J BIOMECH, V45, P1783, DOI 10.1016/j.jbiomech.2012.04.024; Cheung JTM, 2005, J BIOMECH, V38, P1045, DOI 10.1016/j.jbiomech.2004.05.035; Cheung JTM, 2005, ARCH PHYS MED REHAB, V86, P353, DOI 10.1016/j.apmr.2004.03.031; Coester LM, 2001, J BONE JOINT SURG AM, V83A, P219, DOI 10.2106/00004623-200102000-00009; Cook KD, 2009, J FOOT ANKLE SURG, V48, P427, DOI 10.1053/j.jfas.2009.02.009; De Mits S, 2012, J ORTHOP RES, V30, P655, DOI 10.1002/jor.21570; Dul J, 1983, THESIS; Flavin R, 2013, FOOT ANKLE INT, V34, P1340, DOI 10.1177/1071100713490675; Froberg A, 2009, AM J SPORT MED, V37, P1200, DOI 10.1177/0363546508330126; Fuchs S, 2003, J BONE JOINT SURG BR, V85B, P994, DOI 10.1302/0301-620X.85B7.13984; Fuentes-Sanz A, 2012, FOOT ANKLE INT, V33, P819, DOI 10.3113/FAI.2012.0819; Gefen A, 2000, J BIOMECH ENG-T ASME, V122, P630, DOI 10.1115/1.1318904; Gu YD, 2010, SKIN RES TECHNOL, V16, P291, DOI 10.1111/j.1600-0846.2010.00425.x; HEFTI FL, 1980, ARCH ORTHOP TRAUM SU, V96, P187, DOI 10.1007/BF00457782; Hunt AE, 2001, CLIN BIOMECH, V16, P592, DOI 10.1016/S0268-0033(01)00040-7; Kamiya T, 2012, CLIN BIOMECH, V27, P962, DOI 10.1016/j.clinbiomech.2012.06.006; Keyak JH, 2000, J BIOMECH, V33, P209, DOI 10.1016/S0021-9290(99)00152-9; King H A, 1980, Foot Ankle, V1, P44; Kyu-Jung Kim, 2001, Journal of Musculoskeletal Research, V5, P113; Lee JY, 2011, KNEE SURG SPORT TR A, V19, P842, DOI 10.1007/s00167-010-1383-y; Lemmon D, 1997, J BIOMECH, V30, P615, DOI 10.1016/S0021-9290(97)00006-7; Lin SC, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500535; Liu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080236; Lui TH, 2013, KNEE SURG SPORT TR A, V21, P1279, DOI 10.1007/s00167-012-2047-x; Mann RA, 2007, SURGERY OF THE FOOT; Manter JT, 1941, ANAT REC, V80, P397, DOI 10.1002/ar.1090800402; MAZUR JM, 1979, J BONE JOINT SURG AM, V61, P964, DOI 10.2106/00004623-197961070-00002; Michelson JD, 2000, FOOT ANKLE INT, V21, P278, DOI 10.1177/107110070002100402; Muir Dawson C, 2002, Foot Ankle Clin, V7, P703, DOI 10.1016/S1083-7515(02)00048-7; Nakamura S, 1981, Bull Prosthet Res, V10-35, P27; Nihal Aneel, 2008, Foot Ankle Surg, V14, P1, DOI 10.1016/j.fas.2007.08.004; Niu WX, 2013, APPL BIONICS BIOMECH, V10, P189, DOI [10.1155/2013/818414, 10.3233/ABB-140085]; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Ogut T, 2009, FOOT ANKLE INT, V30, P353, DOI 10.3113/FAI.2009.0353; Ozen M, 2013, ACTA BIOENG BIOMECH, V15, P19, DOI 10.5277/abb130303; Ozkan A, 2013, ACTA BIOENG BIOMECH, V15, P67, DOI 10.5277/abb130409; Parr WCH, 2013, J BIOMECH, V46, P200, DOI 10.1016/j.jbiomech.2012.11.011; PERRY J, 1983, CLIN ORTHOP RELAT R, P9; Perry J, 1992, GAIT ANALYSIS NORMAL; Piriou P, 2008, FOOT ANKLE INT, V29, P3, DOI 10.3113/FAI.2008.0003; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079424; Ramlee MH, 2014, MED ENG PHYS, V36, P1322, DOI 10.1016/j.medengphy.2014.05.015; Ramlee MH, 2014, MED ENG PHYS, V36, P1358, DOI 10.1016/j.medengphy.2014.07.001; Schmiegel A, 2008, GAIT POSTURE, V27, P110, DOI 10.1016/j.gaitpost.2007.02.008; Sheridan BD, 2006, J BONE JOINT SURG BR, V88B, P206, DOI 10.1302/0301-620X.88B2.17065; Shin J, 2012, ANN BIOMED ENG, V40, P2519, DOI 10.1007/s10439-012-0607-3; SIEGLER S, 1988, FOOT ANKLE, V8, P234, DOI 10.1177/107110078800800502; Singer S, 2013, J BONE JOINT SURG AM, V95A, P2194, DOI 10.2106/JBJS.L.00465; SooHoo NF, 2007, J BONE JOINT SURG AM, V89A, P2143, DOI 10.2106/JBJS.F.01611; Spyrou LA, 2012, COMPUT METHOD BIOMEC, V15, P925, DOI 10.1080/10255842.2011.566564; Suckel A, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-80; Sun PC, 2012, COMPUT METHOD BIOMEC, V15, P563, DOI 10.1080/10255842.2010.550165; Takakura Y, 1999, CLIN ORTHOP RELAT R, P178; Thomas R, 2006, J BONE JOINT SURG AM, V88A, P526, DOI 10.2106/JBJS.E.00521; Valderrabano V, 2003, FOOT ANKLE INT, V24, P888, DOI 10.1177/107110070302401203; Valderrabano V, 2003, FOOT ANKLE INT, V24, P881, DOI 10.1177/107110070302401202; Valderrabano V, 2003, FOOT ANKLE INT, V24, P897, DOI 10.1177/107110070302401204; Valtola A, 2002, BONE, V30, P238, DOI 10.1016/S8756-3282(01)00649-4; Vazquez AA, 2003, CLIN BIOMECH, V18, P244, DOI 10.1016/S0268-0033(02)00207-3; Wang Y, 2014, MED ENG PHYS, V36, P1394, DOI 10.1016/j.medengphy.2014.03.014; Weatherall JM, 2013, FOOT ANKLE INT, V34, P104, DOI 10.1177/1071100712458961; WRIGHT DG, 1964, J BONE JOINT SURG AM, V46, P482, DOI 10.2106/00004623-196446030-00002; Wu WL, 2000, GAIT POSTURE, V11, P54, DOI 10.1016/S0966-6362(99)00049-1; Yu J, 2013, J BIOMECH, V46, P2067, DOI 10.1016/j.jbiomech.2013.05.009; Zhang M, 1999, PROSTHET ORTHOT INT, V23, P135	79	27	29	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134340	10.1371/journal.pone.0134340	http://dx.doi.org/10.1371/journal.pone.0134340			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222188	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800134
J	Catavitello, G; Ivanenko, YP; Lacquaniti, F				Catavitello, Giovanna; Ivanenko, Yuri P.; Lacquaniti, Francesco			Planar Covariation of Hindlimb and Forelimb Elevation Angles during Terrestrial and Aquatic Locomotion of Dogs	PLOS ONE			English	Article							KINEMATIC ANALYSIS; QUADRUPEDAL LOCOMOTION; HUMAN WALKING; SPINAL-CORD; PATTERN GENERATION; GAIT TRANSITIONS; DECEREBRATE CATS; CANIS-FAMILIARIS; NEURAL NETWORKS; MODULAR CONTROL	The rich repertoire of locomotor behaviors in quadrupedal animals requires flexible inter-limb and inter-segmental coordination. Here we studied the kinematic coordination of different gaits (walk, trot, gallop, and swim) of six dogs (Canis lupus familiaris) and, in particular, the planar covariation of limb segment elevation angles. The results showed significant variations in the relative duration of rearward limb movement, amplitude of angular motion, and inter-limb coordination, with gait patterns ranging from a lateral sequence of footfalls during walking to a diagonal sequence in swimming. Despite these differences, the planar law of inter-segmental coordination was maintained across different gaits in both forelimbs and hindlimbs. Notably, phase relationships and orientation of the covariation plane were highly limb specific, consistent with the functional differences in their neural control. Factor analysis of published muscle activity data also demonstrated differences in the characteristic timing of basic activation patterns of the forelimbs and hindlimbs. Overall, the results demonstrate that the planar covariation of inter-segmental coordination has emerged for both fore-and hindlimbs and all gaits, although in a limb-specific manner.	[Catavitello, Giovanna; Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, I-00133 Rome, Italy; [Catavitello, Giovanna; Ivanenko, Yuri P.; Lacquaniti, Francesco] Santa Lucia Fdn, Lab Neuromotor Physiol, I-00179 Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, I-00133 Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Rome Tor Vergata	Catavitello, G (corresponding author), Univ Roma Tor Vergata, Ctr Space Biomed, I-00133 Rome, Italy.	g.catavitello@hsantalucia.it	Catavitello, Giovanna/AAQ-8737-2020; Lacquaniti, Francesco/J-9842-2016; Ivanenko, Yury/L-1599-2018	Lacquaniti, Francesco/0000-0003-0896-7315; Ivanenko, Yury/0000-0001-9363-9548	Italian University Ministry (PRIN project) [2010MEFNF7_002]; Italian Space Agency (COREA grant); PhD program in Neurosciences of the University of Rome Tor Vergata	Italian University Ministry (PRIN project); Italian Space Agency (COREA grant); PhD program in Neurosciences of the University of Rome Tor Vergata	This work was supported by grants from the Italian University Ministry (PRIN project grant 2010MEFNF7_002) and the Italian Space Agency (COREA grant). GC is supported by the PhD program in Neurosciences of the University of Rome Tor Vergata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFELT Z, 1983, ACTA NEUROBIOL EXP, V43, P235; Alexander R.M., 1982, LOCOMOTION ANIMALS; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; Arshavskii Iu I, 1965, Biofizika, V10, P665; Barliya A, 2009, EXP BRAIN RES, V193, P371, DOI 10.1007/s00221-008-1633-0; Beliez L, 2015, J NEUROSCI, V35, P6117, DOI 10.1523/JNEUROSCI.4145-14.2015; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bertram JEA, 2000, AM J VET RES, V61, P832, DOI 10.2460/ajvr.2000.61.832; Bianchi L, 1998, J NEUROPHYSIOL, V79, P2155, DOI 10.1152/jn.1998.79.4.2155; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Bohn HF, 2012, J COMP PHYSIOL A, V198, P465, DOI 10.1007/s00359-012-0723-4; Borghese NA, 1996, J PHYSIOL-LONDON, V494, P863, DOI 10.1113/jphysiol.1996.sp021539; Bush JWM, 2006, ANNU REV FLUID MECH, V38, P339, DOI 10.1146/annurev.fluid.38.050304.092157; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Carrier DR, 1998, J EXP BIOL, V201, P3185; CAVAGNA GA, 1988, J PHYSIOL-LONDON, V399, P81; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CHARTERIS J, 1979, J ANAT, V128, P803; Cheron G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/375148; Cheron G, 2001, EXP BRAIN RES, V137, P455, DOI 10.1007/s002210000663; Corazza S, 2010, IEEE T BIO-MED ENG, V57, P806, DOI 10.1109/TBME.2008.2002103; Courtine G, 2005, J NEUROPHYSIOL, V93, P3127, DOI 10.1152/jn.01073.2004; Deban SM, 2012, J EXP BIOL, V215, P287, DOI 10.1242/jeb.063230; DeCamp CE, 1997, VET CLIN N AM-SMALL, V27, P825, DOI 10.1016/S0195-5616(97)50082-9; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Dominici N, 2010, J NEUROPHYSIOL, V103, P1673, DOI 10.1152/jn.00945.2009; Dounskaia N, 2010, EXERC SPORT SCI REV, V38, P201, DOI 10.1097/JES.0b013e3181f45194; Drew T, 2008, J PHYSIOL-LONDON, V586, P1239, DOI 10.1113/jphysiol.2007.146605; Feeney LC, 2007, AM J VET RES, V68, P277, DOI 10.2460/ajvr.68.3.277; Fischer M.S., 2011, DOGS MOTION; Fischer MS, 2006, J EXP ZOOL PART A, V305A, P935, DOI 10.1002/jez.a.333; Fish FE, 2014, INTEGR COMP BIOL, V54, pE65; Fisher N.I., 1993, STAT ANAL SPHERICAL; Full R, 2003, CAN SIMPLE NEURAL OS; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gerasimenko Y, 2009, J NEUROSCI, V29, P5681, DOI 10.1523/JNEUROSCI.6058-08.2009; Giszter SF, 2010, EXP BRAIN RES, V200, P283, DOI 10.1007/s00221-009-2016-x; Goldner B, 2015, VET J IN PRESS; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GOSLOW GE, 1981, J EXP BIOL, V94, P15; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Grillner S, 2011, SCIENCE, V334, P912, DOI 10.1126/science.1214778; Guertin PA, 2013, MOVEMENT DISORD, V3, P183, DOI [10.3389/fneur.2012.00183, DOI 10.3389/FNEUR.2012.00183]; Hallemans A, 2009, EXP BRAIN RES, V198, P95, DOI 10.1007/s00221-009-1937-8; Hart CB, 2010, J NEUROSCI, V30, P1322, DOI 10.1523/JNEUROSCI.5894-08.2010; HILDEBRAND M, 1967, AM J PHYS ANTHROPOL, V26, P119, DOI 10.1002/ajpa.1330260203; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; Hsieh ST, 2004, P NATL ACAD SCI USA, V101, P16784, DOI 10.1073/pnas.0405736101; Hudson PE, 2012, J EXP BIOL, V215, P2425, DOI 10.1242/jeb.066720; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Ivanenko YP, 2008, EUR J NEUROSCI, V27, P3351, DOI 10.1111/j.1460-9568.2008.06289.x; Ivanenko YP, 2008, J NEUROPHYSIOL, V99, P1890, DOI 10.1152/jn.01308.2007; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Ivanenko YP, 2006, NEUROSCIENTIST, V12, P339, DOI 10.1177/1073858406287987; JAYES AS, 1978, J ZOOL, V185, P289, DOI 10.1111/j.1469-7998.1978.tb03334.x; Juvin L, 2012, J NEUROSCI, V32, P953, DOI 10.1523/JNEUROSCI.4640-11.2012; KELLY MF, 1990, IEEE T BIO-MED ENG, V37, P221, DOI 10.1109/10.52324; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kim J, 2008, AM J VET RES, V69, P1116, DOI 10.2460/ajvr.69.9.1116; Lacquaniti F, 1999, NEWS PHYSIOL SCI, V14, P168, DOI 10.1152/physiologyonline.1999.14.4.168; Lacquaniti F, 2002, ARCH ITAL BIOL, V140, P263; Lacquaniti F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00061; Lacquaniti F, 2012, J PHYSIOL-LONDON, V590, P2189, DOI 10.1113/jphysiol.2011.215137; Laroche D, 2007, EXP BRAIN RES, V176, P85, DOI 10.1007/s00221-006-0597-1; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DV, 1999, J EXP BIOL, V202, P3565; Leong P, 1998, J NEUROSCI METH, V80, P191, DOI 10.1016/S0165-0270(97)00201-X; Leurs F, 2012, GAIT POSTURE, V35, P647, DOI 10.1016/j.gaitpost.2011.12.017; MacLellan MJ, 2014, J NEUROPHYSIOL, V111, P1541, DOI 10.1152/jn.00437.2013; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; MacLellan MJ, 2010, EXP BRAIN RES, V202, P307, DOI 10.1007/s00221-009-2133-6; Maes L, 2013, J EXP BIOL, V216, P2257, DOI 10.1242/jeb.082149; Maes LD, 2008, J EXP BIOL, V211, P138, DOI 10.1242/jeb.008243; MAH CD, 1994, J MOTOR BEHAV, V26, P83, DOI 10.1080/00222895.1994.9941664; Marsolais GS, 2003, J AM VET MED ASSOC, V222, P739, DOI 10.2460/javma.2003.222.739; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Meyns P, 2013, GAIT POSTURE, V38, P555, DOI 10.1016/j.gaitpost.2013.02.006; MILLER S, 1975, BRAIN RES, V91, P217, DOI 10.1016/0006-8993(75)90544-2; MISIASZEK JE, 1995, J NEUROPHYSIOL, V73, P2499, DOI 10.1152/jn.1995.73.6.2499; Muybridge Eadweard, 1902, ANIMALS MOTION, P20; Neptune RR, 2009, J BIOMECH, V42, P1282, DOI 10.1016/j.jbiomech.2009.03.009; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Noble JW, 2008, EXP BRAIN RES, V189, P249, DOI 10.1007/s00221-008-1464-z; OLREE KS, 1995, BIOL CYBERN, V73, P409, DOI 10.1007/BF00201475; ORLOVSKII G. N., 1965, BIOFIZIKA, V10, P847; ORLOVSKII G. N., 1966, BIOFIZKA, V11, P364; Patla AE, 1988, NEURAL CONTROL RHYTH, P455; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; PRENTICE SD, 1995, MED BIOL ENG COMPUT, V33, P317, DOI 10.1007/BF02510506; Prentice Stephen D, 2006, COMPUTATIONAL INTELL, P172; Prochazka A, 2012, COMPR PHYSIOL, V2, P2615, DOI 10.1002/cphy.c100086; Revzen S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051907; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Schilling N, 2009, J EXP BIOL, V212, P1036, DOI 10.1242/jeb.020255; Sefati S, 2013, P NATL ACAD SCI USA, V110, P18798, DOI 10.1073/pnas.1309300110; Shapiro LJ, 2005, AM J PHYS ANTHROPOL, V126, P205, DOI 10.1002/ajpa.20049; Shen L, 1995, J NEUROPHYSIOL, V74, P2266, DOI 10.1152/jn.1995.74.6.2266; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; SHIK M. L., 1965, BIOFIZIKA, V10, P1037; SRINIVASAN S, 1992, IEEE T BIO-MED ENG, V39, P716, DOI 10.1109/10.142646; Tan U, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00084; Walter RM, 2007, J EXP BIOL, V210, P208, DOI 10.1242/jeb.02645; Wannier T, 2001, EXP BRAIN RES, V141, P375, DOI 10.1007/s002210100875; WOOTTEN ME, 1990, J ORTHOPAED RES, V8, P247, DOI 10.1002/jor.1100080214; YAMAGUCHI T, 1986, BRAIN RES, V379, P125, DOI 10.1016/0006-8993(86)90264-7; Zelenin PV, 2011, J NEUROSCI, V31, P4636, DOI 10.1523/JNEUROSCI.6511-10.2011	110	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133936	10.1371/journal.pone.0133936	http://dx.doi.org/10.1371/journal.pone.0133936			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218076	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900056
J	Chen, HK; Song, SN; Wang, LH; Mayfield, AB; Chen, YJ; Chen, WNU; Chen, CS				Chen, Hung-Kai; Song, Shin-Ni; Wang, Li-Hsueh; Mayfield, Anderson B.; Chen, Yi-Jyun; Chen, Wan-Nan U.; Chen, Chii-Shiarng			A Compartmental Comparison of Major Lipid Species in a Coral-Symbiodinium Endosymbiosis: Evidence that the Coral Host Regulates Lipogenesis of Its Cytosolic Lipid Bodies	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; MAMMALIAN WAX BIOSYNTHESIS; ACYL-COENZYME; SYMBIOTIC ZOOXANTHELLAE; MONTIPORA-DIGITATA; METABOLISM; MEMBRANES; PROTEINS; DROPLETS; CARBON	The lipid body (LB) formation in the host coral gastrodermal cell cytoplasm is a hallmark of the coral-Symbiodinium endosymbiosis, and such lipid-based entities are not found in endosymbiont-free cnidarian cells. Therefore, the elucidation of lipogenesis regulation in LBs and how it is related to the lipid metabolism of the host and endosymbiont could provide direct insight to understand the symbiosis mechanism. Herein, the lipid composition of host cells of the stony coral Euphyllia glabrescens, as well as that of their cytoplasmic LBs and in hospite Symbiodinium populations, was examined by high performance liquid chromatography (HPLC) and gas chromatography/mass spectrometry (GC/MS), and six major lipid species were identified: wax esters, sterol esters, triacylglycerols, cholesterols, free fatty acids, and phospholipids. Their concentrations differed significantly between host coral cells, LBs, and Symbiodinium, suggesting compartmental regulation. WE were only present in the host coral and were particularly highly concentrated in LBs. Amongst the four species of WE, the monoene R = C18:1/R = C16 was found to be LB-specific and was not present in the host gastrodermal cell cytoplasm. Furthermore, the acyl pool profiles of the individual LB lipid species were more similar, but not equal to, those of the host gastrodermal cells in which they were located, indicating partially autonomous lipid metabolism in these LBs. Nevertheless, given the overall similarity in the host gastrodermal cell and LB lipid profiles, these data suggest that a significant portion of the LB lipids may be of host coral origin. Finally, lipid profiles of the in hospite Symbiodinium populations were significantly distinct from those of the cultured Symbiodinium, potentially suggesting a host regulation effect that may be fundamental to lipid metabolism in endosymbiotic associations involving clade C Symbiodinium.	[Chen, Hung-Kai; Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 804, Taiwan; [Song, Shin-Ni; Wang, Li-Hsueh; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung 944, Taiwan; [Wang, Li-Hsueh; Mayfield, Anderson B.; Chen, Yi-Jyun; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Natl Museum Marine Biol & Aquarium, Pingtung 944, Taiwan; [Mayfield, Anderson B.] Living Oceans Fdn, Landover, MD 20785 USA; [Chen, Wan-Nan U.] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung 805, Taiwan	National Sun Yat Sen University; National Dong Hwa University; National Museum of Marine Biology & Aquarium; I Shou University	Chen, WNU (corresponding author), I Shou Univ, Dept Biol Sci & Technol, Kaohsiung 805, Taiwan.	wendyuchen@isu.edu.tw; cchen@nmmba.gov.tw		Mayfield, Anderson/0000-0003-0138-7844	National Science Council of Taiwan [NSC 101-2311-B-291-002-MY3, NSC 102-2923-B-291-001-MY2]; NMMBA; Khaled bin Sultan Living Oceans Foundation	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NMMBA; Khaled bin Sultan Living Oceans Foundation	This work was funded by a grant from the National Science Council of Taiwan (NSC 101-2311-B-291-002-MY3 and NSC 102-2923-B-291-001-MY2 to CSC) as well as intramural funds from NMMBA. ABM was funded by an international postdoctoral research fellowship from the Khaled bin Sultan Living Oceans Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachok Z, 2006, CORAL REEFS, V25, P545, DOI 10.1007/s00338-006-0130-9; BISHOP DG, 1980, LIPIDS, V15, P799, DOI 10.1007/BF02534368; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Christie WW, 1998, PHYTOCHEM ANALYSIS, V9, P53, DOI 10.1002/(SICI)1099-1565(199803/04)9:2&lt;53::AID-PCA391&gt;3.0.CO;2-U; Connor W E, 1988, Prog Clin Biol Res, V282, P275; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; Dewick PM, 1997, MED NATURAL PRODUCTS, P32; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046801; FANG LS, 1989, MAR BIOL, V103, P359, DOI 10.1007/BF00397270; Garrett TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057975; GRUNWALD C, 1971, PLANT PHYSIOL, V48, P653, DOI 10.1104/pp.48.5.653; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hammond EW, 1986, PACKED COLUMN GAS CH, P113; HARLAND AD, 1993, MAR BIOL, V117, P113, DOI 10.1007/BF00346432; Hashimoto N, 2003, LIPIDS, V38, P991, DOI 10.1007/s11745-003-1153-2; Imbs AB, 2010, RUSS J MAR BIOL+, V36, P452, DOI 10.1134/S1063074010060076; Imbs AB, 2007, COMP BIOCHEM PHYS B, V148, P314, DOI 10.1016/j.cbpb.2007.06.009; Imbs AB, 2007, LIPIDS, V42, P1035, DOI 10.1007/s11745-007-3109-6; Imbs AB, 2014, PHYTOCHEMISTRY, V101, P76, DOI 10.1016/j.phytochem.2014.02.012; Imbs AB, 2010, MAR ECOL PROG SER, V409, P65, DOI 10.3354/meps08622; Imbs AB, 2010, FISHERIES SCI, V76, P375, DOI 10.1007/s12562-009-0213-y; Jiang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087416; Khotimchenko SV, 2002, BOT MAR, V45, P17, DOI 10.1515/BOT.2002.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATYSHEV NA, 1991, MAR ECOL PROG SER, V76, P295, DOI 10.3354/meps076295; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Li-Beisson Y, 2010, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0133; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mastro R, 1999, ANAL BIOCHEM, V273, P313, DOI 10.1006/abio.1999.4224; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1994, LIMNOL OCEANOGR, V39, P925; MUSCATINE L, 1958, P NATL ACAD SCI USA, V44, P1259, DOI 10.1073/pnas.44.12.1259; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; Oku H, 2002, FISHERIES SCI, V68, P517, DOI 10.1046/j.1444-2906.2002.00456.x; Papina M, 2007, COMP BIOCHEM PHYS B, V147, P583, DOI 10.1016/j.cbpb.2007.02.011; Papina M, 2003, COMP BIOCHEM PHYS B, V135, P533, DOI 10.1016/S1096-4959(03)00118-0; Pasaribu B, 2014, MAR BIOTECHNOL, V16, P560, DOI 10.1007/s10126-014-9574-z; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; Peng SE, 2008, CORAL REEFS, V27, P133, DOI 10.1007/s00338-007-0300-4; Peng SE, 2012, BIOL LETTERS, V8, P434, DOI 10.1098/rsbl.2011.0893; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Peng SE, 2010, PROTEOMICS, V10, P1002, DOI 10.1002/pmic.200900595; RENKONEN O, 1972, BIOCHIM BIOPHYS ACTA, V255, P66, DOI 10.1016/0005-2736(72)90008-9; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Sturley SL, 1997, CURR OPIN LIPIDOL, V8, P167, DOI 10.1097/00041433-199706000-00007; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Teece MA, 2011, LIMNOL OCEANOGR, V56, P1285, DOI 10.4319/lo.2011.56.4.1285; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072486; WARD S, 1995, CORAL REEFS, V14, P87, DOI 10.1007/BF00303428; Weng LC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05777; Yonge CM, 1931, SCI REP GREAT BARRIE, V1928-29, P135	63	119	120	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132519	10.1371/journal.pone.0132519	http://dx.doi.org/10.1371/journal.pone.0132519			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218797	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900009
J	Wang, SH; Lin, PY; Chiu, YC; Huang, JS; Kuo, YT; Wu, JC; Chen, CC				Wang, Shu-Huei; Lin, Pei-Ya; Chiu, Ya-Chen; Huang, Ju-Sui; Kuo, Yi-Tsen; Wu, Jen-Chine; Chen, Chin-Chuan			Curcumin-Mediated HDAC Inhibition Suppresses the DNA Damage Response and Contributes to Increased DNA Damage Sensitivity	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; HISTONE DEACETYLASE; SACCHAROMYCES-CEREVISIAE; SYNTHETICALLY LETHAL; RAD52 INACTIVATION; REPAIR PATHWAYS; CANCER-CELLS; AUTOPHAGY; CHECKPOINT	Chemo- and radiotherapy cause multiple forms of DNA damage and lead to the death of cancer cells. Inhibitors of the DNA damage response are candidate drugs for use in combination therapies to increase the efficacy of such treatments. In this study, we show that curcumin, a plant polyphenol, sensitizes budding yeast to DNA damage by counteracting the DNA damage response. Following DNA damage, the Mec1-dependent DNA damage checkpoint is inactivated and Rad52 recombinase is degraded by curcumin, which results in deficiencies in double-stand break repair. Additive effects on damage-induced apoptosis and the inhibition of damage-induced autophagy by curcumin were observed. Moreover, rpd3 mutants were found to mimic the curcumin-induced suppression of the DNA damage response. In contrast, hat1 mutants were resistant to DNA damage, and Rad52 degradation was impaired following curcumin treatment. These results indicate that the histone deacetylase inhibitor activity of curcumin is critical to DSB repair and DNA damage sensitivity.	[Wang, Shu-Huei] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Lin, Pei-Ya; Chiu, Ya-Chen; Huang, Ju-Sui; Kuo, Yi-Tsen; Chen, Chin-Chuan] Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan; [Wu, Jen-Chine] Chang Gung Mem Hosp, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Chen, Chin-Chuan] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan	National Taiwan University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, CC (corresponding author), Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan.	chinchuan@mail.cgu.edu.tw	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; WANG, SHU-HUEI/0000-0002-9208-3135	Chang Gung Memorial Hospital, Chang Gung University [CMRPD3C0011-3]; Ministry of Science and Technology of Taiwan [102-2320-B-182-012-MY3]	Chang Gung Memorial Hospital, Chang Gung University(Chang Gung Memorial Hospital); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	Support was provided by Chang Gung Memorial Hospital, Chang Gung University (CMRPD3C0011-3) for CCC, and by the Ministry of Science and Technology (102-2320-B-182-012-MY3) of Taiwan for CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Azad GK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059003; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Biswas J, 2010, HUM EXP TOXICOL, V29, P513, DOI 10.1177/0960327109359020; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Bora-Tatar G, 2009, BIOORGAN MED CHEM, V17, P5219, DOI 10.1016/j.bmc.2009.05.042; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Choy JS, 2002, MOL CELL BIOL, V22, P8215, DOI 10.1128/MCB.22.23.8215-8225.2002; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Dietlein F, 2014, CLIN CANCER RES, V20, P5882, DOI 10.1158/1078-0432.CCR-14-1165; Dietlein F, 2014, TRENDS GENET, V30, P326, DOI 10.1016/j.tig.2014.06.003; DORNFELD KJ, 1991, MOL CELL BIOL, V11, P2013, DOI 10.1128/MCB.11.4.2013; Dubrana K, 2007, J CELL SCI, V120, P4209, DOI 10.1242/jcs.018366; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Hasima N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.467; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Javvadi P, 2010, CANCER RES, V70, P1941, DOI 10.1158/0008-5472.CAN-09-3025; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Ji ZY, 2010, BREAST CANCER-BASIC, V4, P1; Kim PM, 2001, NUCLEIC ACIDS RES, V29, P4352, DOI 10.1093/nar/29.21.4352; Ko JC, 2011, TOXICOL APPL PHARM, V255, P327, DOI 10.1016/j.taap.2011.07.012; Lee SJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-144; Li H, 2008, TOXICOL APPL PHARM, V227, P115, DOI 10.1016/j.taap.2007.10.002; Liou JS, 2014, TOXICOL APPL PHARM, V278, P249, DOI 10.1016/j.taap.2014.04.028; Liu HL, 2005, ACTA PHARMACOL SIN, V26, P603, DOI 10.1111/j.1745-7254.2005.00081.x; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; Lu HF, 2009, NEUROCHEM RES, V34, P1491, DOI 10.1007/s11064-009-9936-5; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Ogiwara H, 2013, CARCINOGENESIS, V34, P2486, DOI 10.1093/carcin/bgt240; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Qin J, 2003, RADIAT RES, V159, P139, DOI 10.1667/0033-7587(2003)159[0139:MAOTDD]2.0.CO;2; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shehzad A, 2013, BIOFACTORS, V39, P27, DOI 10.1002/biof.1065; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shu LM, 2011, AAPS J, V13, P606, DOI 10.1208/s12248-011-9300-y; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Thoms J, 2010, SEMIN RADIAT ONCOL, V20, P217, DOI 10.1016/j.semradonc.2010.06.003; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhou J, 2009, NUCLEIC ACIDS RES, V37, P3699, DOI 10.1093/nar/gkp233	60	34	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134110	10.1371/journal.pone.0134110	http://dx.doi.org/10.1371/journal.pone.0134110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218133	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900079
J	Zhang, JF; Shi, H; Xu, LY; Zhu, XY; Li, XQ				Zhang, Jinfeng; Shi, Hao; Xu, Linyu; Zhu, Xiaoyan; Li, Xiangqian			Site-Directed Mutagenesis of a Hyperthermophilic Endoglucanase Cel12B from Thermotoga maritima Based on Rational Design	PLOS ONE			English	Article							BETA-GLUCOSIDASE; SWISS-MODEL; ACTIVE-SITE; PROTEIN; CELLULOSE; IDENTIFICATION; ENVIRONMENT; CELLULASES; EXPRESSION; CELLOBIOSE	To meet the demand for the application of high activity and thermostable cellulases in the production of new-generation bioethanol from nongrain-cellulose sources, a hyperthermostable beta-1,4-endoglucase Cel12B from Thermotoga maritima was selected for further modification by gene site-directed mutagenesis method in the present study, based on homology modeling and rational design. As a result, two recombinant enzymes showed significant improvement in enzyme activity by 77% and 87%, respectively, higher than the parental enzyme TmCel12B. Furthermore, the two mutants could retain 80% and 90.5% of their initial activity after incubation at 80 degrees C for 8 h, while only 45% for 5 h to TmCel12B. The K-m and V-max of the two recombinant enzymes were 1.97 +/- 0.05 mM, 4.23 +/- 0.15 mu mol.mg(-1).min(-1) of TmCel12B-E225H-K207G-D37V, and 2.97 +/- 0.12 mM, 3.15 +/- 0.21 mu mol.mg(-1).min(-1) of TmCel12B-E225H-K207G, respectively, when using CMC-Na as the substrate. The roles of the mutation sites were also analyzed and evaluated in terms of electron density, hydrophobicity of the modeled protein structures. The recombinant enzymes may be used in the hydrolysis of cellulose at higher temperature in the future. It was concluded that the gene mutagenesis approach of a certain active residues may effectively improve the performance of cellulases for the industrial applications and contribute to the study the thermostable mechanism of thermophilic enzymes.	[Zhang, Jinfeng; Shi, Hao; Xu, Linyu; Zhu, Xiaoyan; Li, Xiangqian] Huaiyin Inst Technol, Jiangsu Prov Engn Lab Biomass Convers & Proc Inte, Huaian 223003, Jiangsu, Peoples R China; [Zhang, Jinfeng; Xu, Linyu; Zhu, Xiaoyan; Li, Xiangqian] Huaiyin Inst Technol, Sch Life Sci & Chem Engn, Huaian 223003, Jiangsu, Peoples R China; [Zhu, Xiaoyan] Huaiyin Normal Univ, Jiangsu Key Lab Biomass Based Energy & Enzyme Tec, Huaian 223300, Jiangsu, Peoples R China	Huaiyin Institute of Technology; Huaiyin Institute of Technology; Huaiyin Normal University	Li, XQ (corresponding author), Huaiyin Inst Technol, Jiangsu Prov Engn Lab Biomass Convers & Proc Inte, Huaian 223003, Jiangsu, Peoples R China.	lixq2002@126.com	zhang, jin/GXV-9154-2022; Dai, Kai/O-5669-2016	Dai, Kai/0000-0003-0056-5653	National Natural Science Foundation of China [20971050]; Opening Fund of the Jiangsu Provincial Engineering Laboratory for Biomass Conversion and Process Integration (Huaiyin Institute of Technology) [JPELBCPL2012001, 20130010]; Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology (Huaiyin Normal University) [JSBEET1304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Fund of the Jiangsu Provincial Engineering Laboratory for Biomass Conversion and Process Integration (Huaiyin Institute of Technology); Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology (Huaiyin Normal University)	The authors gratefully acknowledge the financial support of the National Natural Science Foundation of China (No. 20971050), Opening Fund of the Jiangsu Provincial Engineering Laboratory for Biomass Conversion and Process Integration (Huaiyin Institute of Technology) (No. JPELBCPL2012001, 20130010) and Jiangsu Key Laboratory for Biomass-based Energy and Enzyme Technology (Huaiyin Normal University) (No. JSBEET1304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterbach-Bahl K, 2013, NATURE, V493, P483, DOI 10.1038/nature11853; Carstensen L, 2012, BIOCHEMISTRY-US, V51, P3420, DOI 10.1021/bi300189f; Charoenrat T, 2013, J BIOSCI BIOENG, V116, P193, DOI 10.1016/j.jbiosc.2013.02.020; Cheng YS, 2011, PROTEINS, V79, P1193, DOI 10.1002/prot.22953; Couturier M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-103; Crennell SJ, 2002, J MOL BIOL, V320, P883, DOI 10.1016/S0022-2836(02)00446-1; Forse GJ, 2011, PROTEIN SCI, V20, P168, DOI 10.1002/pro.550; Gao SH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-24; Geng J, 2012, BIOTECHNOL BIOENG, V109, P1508, DOI 10.1002/bit.24419; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jeon SD, 2012, NEW BIOTECHNOL, V29, P365, DOI 10.1016/j.nbt.2011.06.008; Karnaouri AC, 2014, APPL MICROBIOL BIOT, V98, P231, DOI 10.1007/s00253-013-4895-9; Kawai Y, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-45; Kojima M, 2013, APPL MICROBIOL BIOT, V97, P5137, DOI 10.1007/s00253-013-4874-1; Kufner K, 2013, BMC BIOCHEM, V14, DOI 10.1186/1471-2091-14-11; Kumar R, 2014, BIOTECHNOL BIOENG, V111, P1341, DOI 10.1002/bit.25218; Levine SE, 2011, BIOTECHNOL BIOENG, V108, P2561, DOI 10.1002/bit.23249; Li Xiang-qian, 2006, Weishengwu Xuebao, V46, P726; Liebl W, 1996, MICROBIOL-SGM, V142, P2533, DOI 10.1099/00221287-142-9-2533; Liu M, 2013, CHEM COMMUN, V49, P7219, DOI 10.1039/c3cc42485e; Liu WJ, 2010, APPL ENVIRON MICROB, V76, P4914, DOI 10.1128/AEM.00958-10; Liu WJ, 2009, BIOTECHNOL BIOENG, V103, P1087, DOI 10.1002/bit.22340; MACARRON R, 1993, FEBS LETT, V316, P137, DOI 10.1016/0014-5793(93)81202-B; Merceron R, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394114; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakazawa H, 2009, APPL MICROBIOL BIOT, V83, P649, DOI 10.1007/s00253-009-1901-3; Sambrook J., 2001, MOL CLONING LAB MANU; Sandgren M, 2005, PROG BIOPHYS MOL BIO, V89, P246, DOI 10.1016/j.pbiomolbio.2004.11.002; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi H, 2014, BIORESOURCES, V9, P3526; Shi H, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-8; Shi RR, 2013, BIORESOURCE TECHNOL, V142, P338, DOI 10.1016/j.biortech.2013.05.037; Skopec CE, 2003, PROTEIN ENG, V16, P1005, DOI 10.1093/protein/gzg115; Srikrishnan S, 2012, BIOTECHNOL BIOENG, V109, P1595, DOI 10.1002/bit.24414; Tishkov VI, 2013, BIOCHIMIE, V95, P1704, DOI 10.1016/j.biochi.2013.05.018; Worning P, 2000, NUCLEIC ACIDS RES, V28, P706, DOI 10.1093/nar/28.3.706; Ye XH, 2012, MOL BIOSYST, V8, P1815, DOI 10.1039/c2mb05492b; Yennamalli RM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-136; Yi ZL, 2011, BIORESOURCE TECHNOL, V102, P3636, DOI 10.1016/j.biortech.2010.11.043; Zhang F, 2011, BIORESOURCE TECHNOL, V102, P10143, DOI 10.1016/j.biortech.2011.08.019; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	44	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133824	10.1371/journal.pone.0133824	http://dx.doi.org/10.1371/journal.pone.0133824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218520	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900049
J	Lei, Y; Boinapally, V; Zoltowska, A; Adner, M; Hellman, L; Nilsson, G				Lei, Ying; Boinapally, Vamsi; Zoltowska, Anna; Adner, Mikael; Hellman, Lars; Nilsson, Gunnar			Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma	PLOS ONE			English	Article							ALLERGIC INFLAMMATION; MURINE MODEL; IGE; ASSOCIATION; INTERLEUKIN-33; IDENTIFICATION; EXACERBATION; INFECTIONS; PHENOTYPES; CHALLENGE	In several clinical and experimental studies IL-33 and its receptor have been found to play important roles in the development of asthma and allergic airway inflammation. We evaluated the effects of vaccination against IL-33 in a mouse model of airway inflammation induced by house dust mite (HDM) allergen. Balb/c mice received the IL-33 vaccine subcutaneously, followed by intranasal administration of HDM for up to six weeks. Vaccination against IL-33 induced high titers of specific anti-IL-33 IgG antibodies that inhibited HDM-induced airway hyperresponsiveness (AHR) in the conducting airways and tissue damping. The vaccination also attenuated the HDM-induced elevation in the numbers of eosinophils in bronchoalveolar lavage fluid (BALF) and suppressed the accumulation of inflammatory cells in the airways. Furthermore, the levels of IL-17A, IL-25, IL-33 and TSLP in lung tissue homogenates were reduced by vaccination against IL-33. These observations demonstrate that vaccination against IL-33 inhibits HDM-induced development of AHR, airway inflammation and production of inflammatory cytokines. The results also indicate an important role of IL-33 in the regulation of AHR of the distal lung compartments. Thus, administration of such a vaccine is potentially an effective therapeutic tool for treating allergic asthma.	[Lei, Ying; Zoltowska, Anna; Nilsson, Gunnar] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden; [Lei, Ying; Zoltowska, Anna; Nilsson, Gunnar] Karolinska Univ Hosp, Stockholm, Sweden; [Boinapally, Vamsi; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Adner, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Adner, Mikael; Nilsson, Gunnar] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Lei, Ying] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Pharm, Xian 710049, Peoples R China	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; Karolinska Institutet; Xi'an Jiaotong University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	lars.hellman@icm.uu.se; gunnar.p.nilsson@ki.se		Nilsson, Gunnar/0000-0001-6795-5512	Swedish Research Council-Medicine and Health [521-2011-3286, 521-2011-2517]; Heart and Lung Foundation [20120345]; Ollie and Elof Ericsson's foundation; Konsul Th C Bergh's Foundation; Centre for Allergy Research at Karolinska Institutet; National Natural Science Foundation of China [81200001]	Swedish Research Council-Medicine and Health; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Ollie and Elof Ericsson's foundation; Konsul Th C Bergh's Foundation; Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Swedish Research Council-Medicine and Health; 521-2011-3286 (GN), 521-2011-2517 (LH) www.vr.se, the Heart and Lung Foundation; 20120345 (GN), www.hjart-lungfonden.se, the Ollie and Elof Ericsson's foundation; (GN) http://oestiftelse.se/, Konsul Th C Bergh's Foundation; (MA), www.konsulbergh.se, the Centre for Allergy Research at Karolinska Institutet (MA, GN), www.ki.se/cfa, National Natural Science Foundation of China; 81200001 (YL) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besnard AG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004607; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Borges MC, 2013, RESP PHYSIOL NEUROBI, V189, P144, DOI 10.1016/j.resp.2013.07.005; Brode SK, 2015, THORAX, V70, P677, DOI 10.1136/thoraxjnl-2014-206470; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; Ford AC, 2013, AM J GASTROENTEROL, V108, P1268, DOI 10.1038/ajg.2013.138; Fuchs B, 2012, AM J PHYSIOL-LUNG C, V303, pL1027, DOI 10.1152/ajplung.00227.2012; Fux M, 2014, ALLERGY, V69, P216, DOI 10.1111/all.12309; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hellman L, 2008, EXPERT REV VACCINES, V7, P193, DOI 10.1586/14760584.7.2.193; Hellman L, 2007, BIOMED PHARMACOTHER, V61, P34, DOI 10.1016/j.biopha.2006.10.001; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Huijbers EJM, 2012, VACCINE, V30, P225, DOI 10.1016/j.vaccine.2011.11.010; Huijbers EJM, 2010, FASEB J, V24, P4535, DOI 10.1096/fj.10-163022; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Johansson J, 2004, VACCINE, V22, P2873, DOI 10.1016/j.vaccine.2003.12.029; Johansson J, 2007, VACCINE, V25, P1676, DOI 10.1016/j.vaccine.2006.10.055; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kabata H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3675; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kim YH, 2012, J ASTHMA, V49, P738, DOI 10.3109/02770903.2012.702841; Lee HY, 2014, EXP LUNG RES, V40, P66, DOI 10.3109/01902148.2013.870261; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Mizutani N, 2014, J IMMUNOL, V192, P1372, DOI 10.4049/jimmunol.1301538; Mizutani N, 2013, IMMUNOLOGY, V139, P205, DOI 10.1111/imm.12071; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nandakumar KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013511; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Reijmerink NE, 2008, J ALLERGY CLIN IMMUN, V122, P651, DOI 10.1016/j.jaci.2008.06.030; Ringvall M, 2009, VACCINE, V28, P48, DOI 10.1016/j.vaccine.2009.09.122; Saglani S, 2009, AM J RESP CELL MOL, V41, P281, DOI 10.1165/rcmb.2008-0396OC; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Savenije OE, 2014, J ALLERGY CLIN IMMUN, V134, P170, DOI 10.1016/j.jaci.2013.12.1080; Silverpil E, 2012, EXPERT REV RESP MED, V6, P173, DOI [10.1586/ERS.12.12, 10.1586/ers.12.12]; Sjoberg LC, 2015, ALLERGY, V70, P514, DOI 10.1111/all.12590; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678	48	30	31	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133774	10.1371/journal.pone.0133774	http://dx.doi.org/10.1371/journal.pone.0133774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214807	gold, Green Published, Green Submitted			2022-12-27	WOS:000358594300032
J	Lugo, JE; Doti, R; Faubert, J				Lugo, J. E.; Doti, Rafael; Faubert, Jocelyn			Planckian Power Spectral Densities from Human Calves during Posture Maintenance and Controlled Isometric Contractions	PLOS ONE			English	Article							MEDIAN FREQUENCY; MOTOR UNITS; MUSCLE ARCHITECTURE; CONDUCTION-VELOCITY; MYOELECTRIC SIGNAL; ELECTRODE; SIZE; FORCE	Background The relationship between muscle anatomy and physiology and its corresponding electromyography activity (EMGA) is complex and not well understood. EMGA models may be broadly divided in stochastic and motor-unit-based models. For example, these models have successfully described many muscle physiological variables such as the value of the muscle fiber velocity and the linear relationship between median frequency and muscle fiber velocity. However they cannot explain the behavior of many of these variables with changes in intramuscular temperature, or muscle PH acidity, for instance. Here, we propose that the motor unit action potential can be treated as an electromagnetic resonant mode confined at thermal equilibrium inside the muscle. The motor units comprising the muscle form a system of standing waves or modes, where the energy of each mode is proportional to its frequency. Therefore, the power spectral density of the EMGA is well described and fit by Planck's law and from its distribution we developed theoretical relationships that explain the behavior of known physiological variables with changes in intramuscular temperature or muscle PH acidity, for instance. Methods EMGA of the calf muscle was recorded during posture maintenance in seven participants and during controlled isometric contractions in two participants. The power spectral density of the EMGA was then fit with the Planckian distribution. Then, we inferred nine theoretical relationships from the distribution and compared the theoretically derived values with experimentally obtained values. Results The power spectral density of EMGA was fit by Planckian distributions and all the theoretical relationships were validated by experimental results. Conclusions Only by considering the motor unit action potentials as electromagnetic resonant modes confined at thermal equilibrium inside the muscle suffices to predict known or new theoretical relationships for muscle physiological variables that other models have failed to do.	[Lugo, J. E.; Doti, Rafael; Faubert, Jocelyn] Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada	Universite de Montreal	Lugo, JE (corresponding author), Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada.	eduardo.lugo@gmail.com	Faubert, Jocelyn/E-2207-2011		Natural Sciences and Engineering Research Council of Canada operating grant	Natural Sciences and Engineering Research Council of Canada operating grant	This work was supported by a Natural Sciences and Engineering Research Council of Canada operating grant.	Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Basmajian JV, 1985, MUSCLES ALIVE THEIR, VFifth, P10; Bonato P, 2001, IEEE ENG MED BIOL, V20, P29, DOI 10.1109/MEMB.2001.982272; BRODY LR, 1991, J APPL PHYSIOL, V71, P1878, DOI 10.1152/jappl.1991.71.5.1878; Conwit RA, 1999, CLIN NEUROPHYSIOL, V110, P1270, DOI 10.1016/S1388-2457(99)00054-1; De Luca C. J., 2008, PRACTICUM USE SEMG S; DE LUCA CJ, 1979, IEEE T BIO-MED ENG, V26, P313, DOI 10.1109/TBME.1979.326534; Eben JC, 1936, AM J ANAT, V58, P259; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Heymsfield SB, 2002, AM J PHYSIOL-ENDOC M, V282, pE132, DOI 10.1152/ajpendo.2002.282.1.E132; LATEVA ZC, 1993, J ELECTROMYOGR KINES, V3, P195, DOI 10.1016/1050-6411(93)90008-K; Lee C T, 1998, SPUMS J, V28, P125; LINDSTROM LH, 1977, P IEEE, V65, P653, DOI 10.1109/PROC.1977.10544; McGill KC, 2004, MED BIOL ENG COMPUT, V42, P446, DOI 10.1007/BF02350985; MCPHEDRA.AM, 1965, J NEUROPHYSIOL, V28, P71, DOI 10.1152/jn.1965.28.1.71; MERLETTI R, 1984, EUR J APPL PHYSIOL, V52, P258, DOI 10.1007/BF01015206; MONSTER AW, 1977, J NEUROPHYSIOL, V40, P1432, DOI 10.1152/jn.1977.40.6.1432; MORE JJ, 1983, SIAM J SCI STAT COMP, V4, P553, DOI 10.1137/0904038; MORIMOTO S, 1980, JPN J PHYSIOL, V30, P71; Morse CI, 2005, ACTA PHYSIOL SCAND, V183, P291, DOI 10.1111/j.1365-201X.2004.01404.x; Petrofsky J., 2005, BASIC APPL MYOL, V15, P61; ROY SH, 1986, J APPL PHYSIOL, V61, P1510, DOI 10.1152/jappl.1986.61.4.1510; Saitou K, 2000, J Hum Ergol (Tokyo), V29, P35; Santillan M., 1998, European Journal of Physics, V19, P361, DOI 10.1088/0143-0807/19/4/008; Stulen EB, 1981, IEEE T BIOMED ENG, V28, P515; Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WUERKER RB, 1965, J NEUROPHYSIOL, V28, P85, DOI 10.1152/jn.1965.28.1.85; Yamada H, 2000, J Hum Ergol (Tokyo), V29, P7; Yuan Y-x, 1994, C SCI COMP HONG KONG; Zubieta-Calleja G, 2004, NEW HUMAN PHYSL	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0131798	10.1371/journal.pone.0131798	http://dx.doi.org/10.1371/journal.pone.0131798			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214179	Green Published, gold, Green Submitted			2022-12-27	WOS:000358594300007
J	Stewart, EM; Michelutti, N; Shenstone-Harris, S; Grooms, C; Weseloh, C; Kimpe, LE; Blais, JM; Smol, JP				Stewart, Emily M.; Michelutti, Neal; Shenstone-Harris, Sarah; Grooms, Christopher; Weseloh, Chip; Kimpe, Linda E.; Blais, Jules M.; Smol, John P.			Tracking the History and Ecological Changes of Rising Double-Crested Cormorant Populations Using Pond Sediments from Islands in Eastern Lake Ontario	PLOS ONE			English	Article							GREAT-LAKES; STABLE-ISOTOPES; TRENDS; EUTROPHICATION; ACCUMULATION; MANAGEMENT; NUTRIENTS; TRANSPORT; GULLS; BASIN	In the Laurentian Great Lakes region, the double-crested cormorant (Phalacrocorax auritus) has seen a thousand-fold population increase in recent decades. These large colonies of birds now often conflict with socioeconomic interests, particularly due to perceived competition with fisheries and the destruction of terrestrial vegetation in nesting habitats. Here we use dated sediment cores from ponds on islands in eastern Lake Ontario that receive waste inputs from dense colonies of cormorants and ring-billed gulls (Larus delawarensis) to chronicle the population rise of these species and assess their long-term ecological impacts. Modern water chemistry sampling from these sites reveals drastically elevated nutrient and major ion concentrations compared to reference ponds not influenced by waterbirds. Geochemical tracers in dated sediment cores, particularly delta N-15 and chlorophyll-a concentrations, track waterbird influences over time. Fossil diatom assemblages were dominated by species tolerant of hyper-eutrophic and polluted systems, which is in marked contrast to assemblages in reference sites. In addition to establishing long-term ecological impacts, this multi-proxy paleoecological approach can be used to determine whether islands of concern have been long-term nesting sites or were only recently colonized by cormorant or ring-billed gull populations across the Great Lakes, facilitating informed management decisions about controversial culling programs.	[Stewart, Emily M.; Michelutti, Neal; Shenstone-Harris, Sarah; Grooms, Christopher; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Weseloh, Chip] Environm Canada, Canadian Wildlife Serv, Toronto, ON M3H 5T4, Canada; [Kimpe, Linda E.; Blais, Jules M.] Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada	Queens University - Canada; Environment & Climate Change Canada; Canadian Wildlife Service; University of Ottawa	Stewart, EM (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	em.stewart16@gmail.com	Blais, Jules/AAV-2321-2020	Blais, Jules/0000-0002-7188-3598; Smol, John/0000-0002-2499-6696; Stewart, Emily/0000-0003-0243-9407	Natural Sciences and Engineering Research Council of Canada [2360-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors' research was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), grant number: 2360-2009 JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ENVIRONMENT CANADA M, V1; [Anonymous], 1994, ENVIRONMENT CANADA M, V2; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Audubon JJ, 1844, THE BIRDS OF AMERICA, V7; Audubon JJ, 1843, THE BIRDS OF AMERICA, V6; Battarbee R. W., 2001, TRACKING ENV CHANGE, P155, DOI DOI 10.1007/0-306-47668-1_8; Belant JL, 1998, LANDSCAPE URBAN PLAN, V43, P11, DOI 10.1016/S0169-2046(98)00100-5; Blais JM, 2005, SCIENCE, V309, P445, DOI 10.1126/science.1112658; Blais JM, 2007, ENVIRON SCI TECHNOL, V41, P1075, DOI 10.1021/es061314a; Blokpoel H, 1991, TECHNICAL REPORT SER, V117; Boutin C, 2011, RESTOR ECOL, V19, P720, DOI 10.1111/j.1526-100X.2010.00769.x; Caron-Beaudoin E, 2013, CAN J ZOOL, V91, P689, DOI 10.1139/cjz-2013-0008; Cuthbert FJ, 2002, J GREAT LAKES RES, V28, P145, DOI 10.1016/S0380-1330(02)70572-8; Doucette JL, 2011, ECOL APPL, V21, P2987, DOI 10.1890/10-2384.1; Dove A, 2009, AQUAT ECOSYST HEALTH, V12, P281, DOI 10.1080/14634980903136388; EISENREICH SJ, 1989, ENVIRON SCI TECHNOL, V23, P1116, DOI 10.1021/es00067a009; Ellis JC, 2006, J ANIM ECOL, V75, P565, DOI 10.1111/j.1365-2656.2006.01077.x; Glahn JF, 1995, COLON WATERBIRD, V18, P137, DOI 10.2307/1521533; Glew J.R., 1989, J PALEOLIMNOL, V2, P241, DOI [DOI 10.1007/BF00195474, 10.1007/BF00195474]; Glew J.R., 1988, J PALEOLIMNOL, V1, P235, DOI DOI 10.1007/BF00177769; Hodell DA, 1998, LIMNOL OCEANOGR, V43, P200, DOI 10.4319/lo.1998.43.2.0200; Hyatt CV, 2010, THESIS; Kendall C, 1998, ISOTOPE TRACERS IN C; Korosi JB, 2015, DEV PALEOENVIRON RES, V18, P161, DOI 10.1007/978-94-017-9541-8_8; Krammer K., 1986, BACILLARIOPHYCEAE; Krummel EM, 2003, NATURE, V425, P255, DOI 10.1038/425255a; Lantry BF, 2002, J GREAT LAKES RES, V28, P193, DOI 10.1016/S0380-1330(02)70576-5; Ligeza S, 2003, CHEMOSPHERE, V52, P595, DOI 10.1016/S0045-6535(03)00241-8; LUDWIG JP, 1974, AUK, V91, P575, DOI 10.2307/4084477; Michelutti N, 2009, P ROY SOC B-BIOL SCI, V276, P591, DOI 10.1098/rspb.2008.1103; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; Morris RD, 2011, WATERBIRDS, V34, P202, DOI 10.1675/063.034.0209; Robinson SA, 2009, CAN J ZOOL, V87, P740, DOI 10.1139/Z09-062; Rott E, 1998, CAN J FISH AQUAT SCI, V55, P1443, DOI 10.1139/cjfas-55-6-1443; SMOL JP, 1985, HYDROBIOLOGIA, V123, P199, DOI 10.1007/BF00034378; Smol JP, 2010, THE DIATOMS APPLICAT; Spaulding S, 2008, DATABASE DIATOMS OF; Stewart EM, 2014, HYDROBIOLOGIA, V721, P251, DOI 10.1007/s10750-013-1667-6; Van Dam Herman, 1994, Netherlands Journal of Aquatic Ecology, V28, P117; Wait DA, 2005, J ARID ENVIRON, V60, P681, DOI 10.1016/j.jaridenv.2004.07.001; Weir RD, 2008, BIRDS OF THE KINGSTO; Weseloh DVC, 2012, WATERBIRDS, V35, P1; Weseloh DV, 1995, COLON WATERBIRD, V18, P48, DOI 10.2307/1521523; Weseloh DVC, 2002, J GREAT LAKES RES, V28, P125; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273; Wires LR, 2006, WATERBIRDS, V29, P9, DOI 10.1675/1524-4695(2006)29[9:HPOTDC]2.0.CO;2; YAMAMURO M, 1995, LIMNOL OCEANOGR, V40, P1001, DOI 10.4319/lo.1995.40.5.1001	47	16	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134167	10.1371/journal.pone.0134167	http://dx.doi.org/10.1371/journal.pone.0134167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214177	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300056
J	Tamura, H; Goto, R; Akune, Y; Hiratsuka, Y; Hiragi, S; Yamada, M				Tamura, Hiroshi; Goto, Rei; Akune, Yoko; Hiratsuka, Yoshimune; Hiragi, Shusuke; Yamada, Masakazu			The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION SECONDARY; VISUAL IMPAIRMENT; UTILITY ANALYSIS; PHOTODYNAMIC THERAPY; CATARACT-SURGERY; EYE DISEASE; FELLOW EYES; RANIBIZUMAB; PREVALENCE; POPULATION	Objective To investigate the cost-effectiveness of screening and subsequent intervention for age-related macular degeneration (AMD) in Japan. Methods The clinical effectiveness and cost-effectiveness of screening and subsequent intervention for AMD were assessed using a Markov model. The Markov model simulation began at the age of 40 years and concluded at the age of 90 years. The first-eye and second-eye combined model assumed an annual state-transition probability, development of prodromal symptoms, choroidal neovascularization (CNV), and reduction in visual acuity. Anti-vascular-endothelial-growth-factor (anti-VEGF) intravitreal injection therapy and photodynamic therapy (PDT) were performed to treat CNV. Intake of supplements was recommended to patients who had prodromal symptoms and unilateral AMD. Data on prevalence, morbidity, transition probability, utility value of each AMD patient, and treatment costs were obtained from published clinical reports. Results In the base-case analysis, screening for AMD every 5 years, beginning at the age of 50 years, showed a decrease of 41% in the total number of blind patients. The screening program reduced the incidence of blindness more than did the additional intake of supplements. However, the incremental cost-effectiveness ratio (ICER) of screening versus no screening was 27,486,352 Japanese yen (JPY), or 259,942 US dollars (USD) per quality-adjusted life year (QALY). In the sensitivity analysis, prodromal symptom-related factors for AMD had great impacts on the cost-effectiveness of screening. The lowest ICER obtained from the best scenario was 4,913,717 JPY (46,470 USD) per QALY, which was approximately equal to the willingness to pay in Japan. Conclusions Ophthalmologic screening for AMD in adults is highly effective in reducing the number of patients with blindness but not cost-effective as demonstrated by a Markov model based on clinical data from Japan.	[Tamura, Hiroshi; Hiragi, Shusuke] Kyoto Univ Hosp, Div Med Informat Technol & Adm Planning, Sakyo Ku, Kyoto 6068507, Japan; [Tamura, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan; [Goto, Rei] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Goto, Rei] Kyoto Univ, Grad Sch Econ, Sakyo Ku, Kyoto 6068501, Japan; [Akune, Yoko] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Hiratsuka, Yoshimune] Natl Inst Publ Hlth, Dept Hlth & Welf Serv, Wako, Saitama 3510197, Japan; [Yamada, Masakazu] Kyorin Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; National Institute of Public Health - Japan; Kyorin University	Tamura, H (corresponding author), Kyoto Univ Hosp, Div Med Informat Technol & Adm Planning, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	htamura@kuhp.kyoto-u.ac.jp	Hiragi, Shusuke/AAF-4310-2019; TAMURA, Hiroshi/H-1855-2011; HIRAGI, Shusuke/GYA-3171-2022	Hiragi, Shusuke/0000-0003-1629-6195; TAMURA, Hiroshi/0000-0002-7740-2732; 	Japan Society for the Promotion of Science, Tokyo, Japan [24592626]; Japan Ophthalmologists Association, Tokyo, Japan; Japan National Society for the Prevention of Blindness, Tokyo, Japan	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Ophthalmologists Association, Tokyo, Japan; Japan National Society for the Prevention of Blindness, Tokyo, Japan(Japan National Society for the Prevention of Blindness)	This study was supported in part by grants-in-aid for scientific research (Nos. 24592626) from the Japan Society for the Promotion of Science, Tokyo, Japan, http://www.jsps.go.jp/j-grantsinaid/index.html; the Japan Ophthalmologists Association, Tokyo, Japan, http://www.gankaikai.or.jp/; and the Japan National Society for the Prevention of Blindness, Tokyo, Japan, http://www.business1.jp/jnspb/pc/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Arch Ophthalmol, V117, P1329; Antoszyk AN, 2008, AM J OPHTHALMOL, V145, P862, DOI 10.1016/j.ajo.2007.12.029; Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; Bonds DE, 2014, JAMA INTERN MED, V174, P763, DOI 10.1001/jamainternmed.2014.328; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown G C, 1999, Trans Am Ophthalmol Soc, V97, P473; Brown GC, 2007, OPHTHALMOLOGY, V114, P1170, DOI 10.1016/j.ophtha.2006.09.019; Brown GC, 2000, ARCH OPHTHALMOL-CHIC, V118, P47; Brown MM, 2008, OPHTHALMOLOGY, V115, P1039, DOI 10.1016/j.ophtha.2007.08.033; Cheung CSY, 2012, OPHTHALMOLOGY, V119, P1609, DOI 10.1016/j.ophtha.2012.02.014; Chew EY, 2014, OPHTHALMOLOGY, V121, P535, DOI 10.1016/j.ophtha.2013.10.027; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Cohen SY, 2008, GRAEF ARCH CLIN EXP, V246, P1527, DOI 10.1007/s00417-008-0890-8; Fletcher EC, 2008, OPHTHALMOLOGY, V115, P2192, DOI 10.1016/j.ophtha.2008.07.018; Hiratsuka Y, 2014, JPN J OPHTHALMOL, V58, P415, DOI 10.1007/s10384-014-0335-3; Hiratsuka Y, 2013, JPN J OPHTHALMOL, V57, P391, DOI 10.1007/s10384-013-0238-8; Hirneiss C, 2014, CLIN OPHTHALMOL, V8, P1703, DOI 10.2147/OPTH.S64200; Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731; Holz FG, 2015, BRIT J OPHTHALMOL, V99, P220, DOI 10.1136/bjophthalmol-2014-305327; Hurley Susan F, 2008, Cost Eff Resour Alloc, V6, P12, DOI 10.1186/1478-7547-6-12; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Japan Ophthalmologists Association, 2009, SOC BURD VIS DIST JA; Hernandez-Pastor LJ, 2010, GRAEF ARCH CLIN EXP, V248, P467, DOI 10.1007/s00417-009-1156-9; Hernandez-Pastor LJ, 2008, CLIN THER, V30, P2436, DOI 10.1016/j.clinthera.2008.12.025; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Kanagasingam Y, 2014, PROG RETIN EYE RES, V38, P20, DOI 10.1016/j.preteyeres.2013.10.002; Kawasaki R, 2015, OPHTHAL EPIDEMIOL, V22, P4, DOI 10.3109/09286586.2014.988876; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Krishnadev N, 2010, CURR OPIN OPHTHALMOL, V21, P184, DOI 10.1097/ICU.0b013e32833866ee; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Mitchell P, 2011, PHARMACOECONOMICS, V29, P107, DOI 10.2165/11585520-000000000-00000; Miyazaki M, 2003, BRIT J OPHTHALMOL, V87, P469, DOI 10.1136/bjo.87.4.469; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Nakae K MK, 2006, GERIATR MED, V44, P1221; Nakata I, 2013, AM J OPHTHALMOL, V156, P1002, DOI 10.1016/j.ajo.2013.06.007; Neubauer AS, 2010, CLIN THER, V32, P1343, DOI 10.1016/j.clinthera.2010.07.010; Oshima Y, 2001, BRIT J OPHTHALMOL, V85, P1153, DOI 10.1136/bjo.85.10.1153; Pineles SL, 2011, AM J OPHTHALMOL, V152, P133, DOI 10.1016/j.ajo.2011.01.023; Pushpoth S, 2012, BRIT J OPHTHALMOL, V96, P1469, DOI 10.1136/bjophthalmol-2012-302167; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Sharma S, 2001, OPHTHALMOLOGY, V108, P2051, DOI 10.1016/S0161-6420(01)00764-3; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; Takahashi Kanji, 2012, Nippon Ganka Gakkai Zasshi, V116, P1150; Tamura H, 2012, AM J OPHTHALMOL, V154, P542, DOI 10.1016/j.ajo.2012.03.042; Tano Y, 2010, ACTA OPHTHALMOL, V88, P309, DOI 10.1111/j.1755-3768.2009.01843.x; Ueta T, 2008, AM J OPHTHALMOL, V146, P96, DOI 10.1016/j.ajo.2008.03.002; Uyama M, 2000, BRIT J OPHTHALMOL, V84, P1018, DOI 10.1136/bjo.84.9.1018; Wako Rina, 2014, Nippon Ganka Gakkai Zasshi, V118, P495; Wang JJ, 2000, CLIN EXP OPHTHALMOL, V28, P268, DOI 10.1046/j.1442-9071.2000.00315.x; Weih LM, 2000, ARCH OPHTHALMOL-CHIC, V118, P264; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Yanagi Yasuo, 2011, Nippon Ganka Gakkai Zasshi, V115, P825; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017	62	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133628	10.1371/journal.pone.0133628	http://dx.doi.org/10.1371/journal.pone.0133628			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214804	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300025
J	Bengtsen, M; Klepper, K; Gundersen, S; Cuervo, I; Drablos, F; Hovig, E; Sandve, GK; Gabrielsen, OS; Eskeland, R				Bengtsen, Mads; Klepper, Kjetil; Gundersen, Sveinung; Cuervo, Ignacio; Drablos, Finn; Hovig, Eivind; Sandve, Geir Kjetil; Gabrielsen, Odd Stokke; Eskeland, Ragnhild			c-Myb Binding Sites in Haematopoietic Chromatin Landscapes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR-BINDING; CHIP-SEQ DATA; DNA-BINDING; HUMAN GENOME; IN-VIVO; A-MYB; HISTONE METHYLTRANSFERASE; DEVELOPMENTAL REGULATORS; MYELOID PROGENITOR	Strict control of tissue-specific gene expression plays a pivotal role during lineage commitment. The transcription factor c-Myb has an essential role in adult haematopoiesis and functions as an oncogene when rearranged in human cancers. Here we have exploited digital genomic footprinting analysis to obtain a global picture of c-Myb occupancy in the genome of six different haematopoietic cell-types. We have biologically validated several c-Myb footprints using c-Myb knockdown data, reporter assays and DamID analysis. We show that our predicted conserved c-Myb footprints are highly dependent on the haematopoietic cell type, but that there is a group of gene targets common to all cell-types analysed. Furthermore, we find that c-Myb footprints co-localise with active histone mark H3K4me3 and are significantly enriched at exons. We analysed co-localisation of c-Myb footprints with 104 chromatin regulatory factors in K562 cells, and identified nine proteins that are enriched together with c-Myb footprints on genes positively regulated by c-Myb and one protein enriched on negatively regulated genes. Our data suggest that c-Myb is a transcription factor with multifaceted target regulation depending on cell type.	[Bengtsen, Mads; Cuervo, Ignacio; Gabrielsen, Odd Stokke; Eskeland, Ragnhild] Univ Oslo, Dept Biosci, Oslo, Norway; [Klepper, Kjetil; Drablos, Finn] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Gundersen, Sveinung; Hovig, Eivind; Sandve, Geir Kjetil] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Med Informat, Oslo, Norway	University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo	Gabrielsen, OS (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	o.s.gabrielsen@ibv.uio.no; Ragnhild.Eskeland@ibv.uio.no	Eskeland, Ragnhild/AFM-2892-2022; Eskeland, Ragnhild/GSN-9383-2022; Drablos, Finn/L-4970-2019; Gundersen, Sveinung/HCI-0764-2022; Eskeland, Ragnhild/K-7018-2014; Hovig, Eivind/H-2474-2011	Eskeland, Ragnhild/0000-0003-2789-3171; Drablos, Finn/0000-0001-5794-828X; Eskeland, Ragnhild/0000-0003-2789-3171; Hovig, Eivind/0000-0002-9103-1077; Sandve, Geir Kjetil/0000-0002-4959-1409; Gundersen, Sveinung/0000-0001-9888-7954	 [231217/F20];  [3485238-2013];  [419436 107692-PR-2007-0148]	; ; 	Funding provided by (RE) https://www.forskningsradet.no/ (231217/F20)*, (RE) https://kreftforeningen.no (3485238-2013)* and (OSG) https://kreftforeningen.no (419436 107692-PR-2007-0148)*. *The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berge T, 2007, BLOOD CELL MOL DIS, V39, P278, DOI 10.1016/j.bcmd.2007.05.007; Bergholtz S, 2001, NUCLEIC ACIDS RES, V29, P3546, DOI 10.1093/nar/29.17.3546; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Chen XY, 2010, BIOINFORMATICS, V26, pi334, DOI 10.1093/bioinformatics/btq175; Clarke D, 2000, ONCOGENE, V19, P3343, DOI 10.1038/sj.onc.1203661; Dahle O, 2003, EUR J BIOCHEM, V270, P1338, DOI 10.1046/j.1432-1033.2003.03504.x; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; Dekker J, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-25; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Erwin GD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003677; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Garcia P, 2009, EMBO J, V28, P1492, DOI 10.1038/emboj.2009.97; GOLAY J, 1994, ONCOGENE, V9, P2469; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hooper J, 2008, IMMUNOLOGY, V123, P282, DOI 10.1111/j.1365-2567.2007.02697.x; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Klepper K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-9; Kulakovskiy IV, 2010, BIOINFORMATICS, V26, P2622, DOI 10.1093/bioinformatics/btq488; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li LK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005070; Lipsick JS, 1996, ONCOGENE, V13, P223; Lorenzo Petra Isabel, 2011, Genes Cancer, V2, P805, DOI 10.1177/1947601911428224; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Molvaersmyr AK, 2010, NUCLEIC ACIDS RES, V38, P4970, DOI 10.1093/nar/gkq245; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; MYRSET AH, 1993, EMBO J, V12, P4625, DOI 10.1002/j.1460-2075.1993.tb06151.x; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; Nakata Y, 2010, BLOOD, V116, P1280, DOI 10.1182/blood-2009-05-223255; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Oki S, 2014, GENES CELLS, V19, P919, DOI 10.1111/gtc.12190; ORLIC D, 1995, P NATL ACAD SCI USA, V92, P4601, DOI 10.1073/pnas.92.10.4601; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Pinson B, 2001, NUCLEIC ACIDS RES, V29, P527, DOI 10.1093/nar/29.2.527; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Sakamoto Y, 2007, J BIOL CHEM, V282, P16391, DOI 10.1074/jbc.M700011200; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sandve GK, 2013, NUCLEIC ACIDS RES, V41, pW133, DOI 10.1093/nar/gkt342; Sanghvi VR, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005500; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SHAPIRO LH, 1995, J BIOL CHEM, V270, P8763, DOI 10.1074/jbc.270.15.8763; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stenman G, 2010, CELL CYCLE, V9, P2986, DOI 10.4161/cc.9.15.12515; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Sung MH, 2014, MOL CELL, V56, P275, DOI 10.1016/j.molcel.2014.08.016; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tanikawa J, 2004, J BIOL CHEM, V279, P55393, DOI 10.1074/jbc.M411658200; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Tuteja G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003449; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; WESTON K, 1992, NUCLEIC ACIDS RES, V20, P3043, DOI 10.1093/nar/20.12.3043; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Ye P, 2013, LEUKEMIA RES, V37, P595, DOI 10.1016/j.leukres.2013.01.012; Zargarian L, 1999, BIOCHEMISTRY-US, V38, P1921, DOI 10.1021/bi981199j; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218; Zhao L, 2014, ONCOGENE, V33, P4442, DOI 10.1038/onc.2013.419; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024; Zhou Y, 2013, FRONT BIOSCI, V16, P1109	95	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133280	10.1371/journal.pone.0133280	http://dx.doi.org/10.1371/journal.pone.0133280			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208222	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000075
J	Broekman, MMTJ; Roelofs, HMJ; Hoentjen, F; Wiegertjes, R; Stoel, N; Joosten, LA; de Jong, DJ; Wanten, GJA				Broekman, Mark M. T. J.; Roelofs, Hennie M. J.; Hoentjen, Frank; Wiegertjes, Renske; Stoel, Nicole; Joosten, Leo A.; de Jong, Dirk J.; Wanten, Geert J. A.			LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; TNF-ALPHA; LIPOPOLYSACCHARIDE STIMULATION; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISMS; MONONUCLEAR-CELLS; INNATE PRODUCTION; INTERLEUKIN-10; ASSOCIATION	Introduction Crohn's disease (CD) is a chronic inflammatory disease in which cytokines play a pivotal role in the induction and maintenance of inflammation. Innate cytokine production is genetically determined and varies largely between individuals; this might impact the severity of inflammation. We aimed to assess whether ex-vivo endotoxin-stimulated levels of cytokines could be associated with disease phenotype. Methods Patients with quiescent CD (Harvey-Bradshaw Index <= 4 and negative inflammation markers) who were not using immunomodulating drugs or biologicals were eligible. Historical disease characteristics (localization, behavior, number of bowel resections, drug history, extra-intestinal symptoms) were extracted from medical records. We measured cytokine levels (tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 and IL-10) in supernatants of lipopolysaccharide (LPS) -stimulated whole blood cultures and correlated these with disease characteristics and age- and sex-matched healthy controls. In addition, we analyzed whether single nucleotide polymorphisms (SNPs) in the promoter region of the TNF-alpha gene were related to TNF-alpha levels. Results We included 75 patients with CD and 24 healthy controls. Six patients were excluded because of increased inflammation markers resulting in a total of 69 patients. The mean age (SD) of patients with CD was 51.2 (12.3) years with a mean (SD) disease duration of 24.1 (11.5) years. Disease localization, peri-anal involvement and behavior were not related to LPS-stimulated TNF-alpha, IL-1 beta, IL-6 or IL-10 levels. In addition, combination of localization with behavior to differentiate mild from severe disease type showed no significant differences. TNF-alpha levels were higher in patients with CD (428 pg/ml IQR [267-468]) compared to healthy controls (459 pg/ml IQR [364-570], p=0.02). We found no associations between SNPs in the promoter region and TNF-alpha levels. Conclusion In this study, innate cytokine production of TNF-alpha, IL-1 beta, IL-6 and IL-10 was not related to historical disease characteristics or disease severity in patients with quiescent CD. These findings suggest that genetically determined levels of these cytokines obtained from LPS-stimulated whole blood cultures are not linked with disease behavior or severity.	[Broekman, Mark M. T. J.; Roelofs, Hennie M. J.; Hoentjen, Frank; Wiegertjes, Renske; Stoel, Nicole; de Jong, Dirk J.; Wanten, Geert J. A.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [Joosten, Leo A.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Broekman, MMTJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands.	mark.broekman@radboudumc.nl	Stoel, Nicole/V-8803-2018; de Jong, D.J./L-4417-2015; Hoentjen, F./L-4378-2015; Broekman, Mark/P-5697-2015; Joosten, Leo AB/H-3138-2015; Wanten, G.J.A./L-4742-2015; Wiegertjes, Renske/P-1696-2016	Joosten, Leo AB/0000-0001-6166-9830; Hoentjen, Frank/0000-0001-5314-4452				Ai WC, 2013, INT J ENV RES PUB HE, V10, P3834, DOI 10.3390/ijerph10093834; Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Botha-Scheepers S, 2008, ANN RHEUM DIS, V67, P1165, DOI 10.1136/ard.2007.084657; Brazova J, 2005, CLIN IMMUNOL, V115, P210, DOI 10.1016/j.clim.2005.01.013; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Castro-Santos P, 2006, AM J GASTROENTEROL, V101, P1039, DOI 10.1111/j.1572-0241.2006.00501.x; Correa I, 2009, J LEUKOCYTE BIOL, V85, P896, DOI 10.1189/jlb.1108698; Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005; de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; de Jong DJ, 2003, GUT, V52, P547, DOI 10.1136/gut.52.4.547; Leal RF, 2015, GUT, V64, P233, DOI 10.1136/gutjnl-2013-306518; Gerards AH, 2003, RHEUMATOLOGY, V42, P1189, DOI 10.1093/rheumatology/keg323; Gresnigt MS, 2012, J IMMUNOL, V189, P4806, DOI 10.4049/jimmunol.1103551; Hildner K, 1998, ANN NY ACAD SCI, V859, P204, DOI 10.1111/j.1749-6632.1998.tb11129.x; Horton DL, 2010, CLIN VACCINE IMMUNOL, V17, P979, DOI 10.1128/CVI.00404-09; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kayakabe K, 2012, RHEUMATOLOGY, V51, P1639, DOI 10.1093/rheumatology/kes094; Koss K, 2000, GENES IMMUN, V1, P207, DOI 10.1038/sj.gene.6363658; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Larsen MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066262; Louis E, 2011, BEST PRACT RES CL GA, V25, pS2, DOI 10.1016/S1521-6918(11)70003-8; Maranville JC, 2014, J CROHNS COLITIS, V8, P1539, DOI 10.1016/j.crohns.2014.06.013; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Meresse B, 2002, GUT, V50, P25, DOI 10.1136/gut.50.1.25; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470; Ouyang Y, 2000, J ALLERGY CLIN IMMUN, V106, P280, DOI 10.1067/mai.2000.107751; Page TH, 2010, J IMMUNOL, V185, P3694, DOI 10.4049/jimmunol.1000906; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Riyazi N, 2005, ARTHRITIS RHEUM-US, V52, P1443, DOI 10.1002/art.21014; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Schwarzmaier D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062761; Sewell GW, 2012, INFLAMM BOWEL DIS, V18, P2120, DOI 10.1002/ibd.22952; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Somasundaram R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084521; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; van der Linden MW, 1998, J IMMUNOL METHODS, V218, P63, DOI 10.1016/S0022-1759(98)00108-2; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Vermeire S, 2013, GUT, V62, P1511, DOI 10.1136/gutjnl-2012-303958; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; Waschke KA, 2005, AM J GASTROENTEROL, V100, P1126, DOI 10.1111/j.1572-0241.2005.40534.x; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Wouters IM, 2002, TOXICOL IND HEALTH, V18, P15, DOI 10.1191/0748233702th126oa; Yamamoto T, 2004, ALIMENT PHARM THER, V19, P671, DOI 10.1111/j.1365-2036.2004.01899.x; Yaqoob P, 1999, CYTOKINE, V11, P600, DOI 10.1006/cyto.1998.0471	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133932	10.1371/journal.pone.0133932	http://dx.doi.org/10.1371/journal.pone.0133932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208333	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000177
J	Chuzel, T; Sanchez, V; Vandamme, M; Martin, S; Flety, O; Pager, A; Chabanel, C; Magnier, L; Foskolos, M; Petit, O; Rokbi, B; Chereul, E				Chuzel, Thomas; Sanchez, Violette; Vandamme, Marc; Martin, Stephane; Flety, Odile; Pager, Aurelie; Chabanel, Christophe; Magnier, Luc; Foskolos, Marie; Petit, Oceane; Rokbi, Bachra; Chereul, Emmanuel			Impact of Anesthesia Protocols on In Vivo Bioluminescent Bacteria Imaging Results	PLOS ONE			English	Article							INFECTIONS; MICE; HEMODYNAMICS; LUCIFERASE; MODELS	Infectious murine models greatly benefit from optical imaging using bioluminescent bacteria to non-invasively and repeatedly follow in vivo bacterial infection. In this context, one of the most critical parameters is the bioluminescence sensitivity to reliably detect the smallest number of bacteria. Another critical point is the anesthetic approaches that have been demonstrated to impact the bioluminescence flux emission in studies with luciferase-transfected tumor cells. However, this impact has never been assessed on bacteria bioluminescent models. To this end, we investigated the effects of four anesthesia protocols on the bioluminescence flux in a central venous catheter murine model (SKH1-hrhr mice) infected by a bioluminescent S. aureus Xen36 strain. Bioluminescence imaging was performed on mice anesthetized by either ketamine/xylazine (with or without oxygen supplementation), or isoflurane carried with air or oxygen. Total flux emission was determined in vivo daily for 3 days and ex vivo at the end of the study together with a CFU counting of the biofilm in the catheter. Bioluminescence flux differences appear between the different anesthetic protocols. Using a ketamine/xylazine anesthesia (with air), bacteria detection was impossible since the bioluminescence signal remains in the background signal. Mice anesthetized with isoflurane and oxygen led to a signal significantly higher to the background all along the kinetics. The use of isoflurane in air presents a bioluminescence signal similar to the use of ketamine/xylazine with oxygen. These data highlight the importance of oxygen to improve bioluminescence flux by bacteria with isoflurane as well as with ketamine/xylazine anesthetics. As a conclusion, we recommend the use of isoflurane anesthetic with oxygen to increase the bioluminescence sensitivity in this kind of study.	[Chuzel, Thomas; Vandamme, Marc; Martin, Stephane; Pager, Aurelie; Magnier, Luc; Foskolos, Marie; Petit, Oceane; Chereul, Emmanuel] Voxcan, Marcy Letoile, France; [Sanchez, Violette; Flety, Odile; Chabanel, Christophe; Rokbi, Bachra] Sanofi Pasteur, Marcy Letoile, France		Chereul, E (corresponding author), Voxcan, Marcy Letoile, France.	emmanuel.chereul@voxcan.fr			VOXCAN; SANOFI PASTEUR	VOXCAN; SANOFI PASTEUR	The authors received no specific funding for this work. VOXCAN provided support in the form of salaries for authors TC, MV, SM, AP, LM, MF, OP, and EC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. SANOFI PASTEUR provided support in the form of salaries for authors VS, OF, CC, and BR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Chauhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037281; Cui KM, 2008, LUMINESCENCE, V23, P292, DOI 10.1002/bio.1032; Ebert T, 2011, HUM VACCINES, V7, P630, DOI 10.4161/hv.7.6.15407; Fish R, 2011, ANESTHESIA ANALGESIA; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; Guo Y, 2013, ANTIMICROB AGENTS CH, V57, P855, DOI 10.1128/AAC.01003-12; Hildebrandt IJ, 2008, ILAR J NATL RES COUN, P49; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Kadurugamuwa Jagath L., 2008, V431, P225; Keyaerts M, 2012, PLOS ONE, V7, P374, DOI 10.1371/journal.pone.0030061; Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003; Lerondel S., 2013, CURRENT MOL IMAGING, V2, P18, DOI [10.2174/2211555211302010004, DOI 10.2174/2211555211302010004]; Lorenz U, 2008, MICROBES INFECT, V10, P217, DOI 10.1016/j.micinf.2007.11.006; Semprini S, 2012, J AM ASSOC LAB ANIM, V51, P820; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; Zuurbier CJ, 2002, AM J PHYSIOL-HEART C, V282, pH2099, DOI 10.1152/ajpheart.01002.2001	19	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0134048	10.1371/journal.pone.0134048	http://dx.doi.org/10.1371/journal.pone.0134048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208168	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000195
J	Hayes, MA; Cryan, PM; Wunder, MB				Hayes, Mark A.; Cryan, Paul M.; Wunder, Michael B.			Seasonally-Dynamic Presence-Only Species Distribution Models for a Cryptic Migratory Bat Impacted by Wind Energy Development	PLOS ONE			English	Article							HOARY BAT; LASIURUS-CINEREUS; ROOST SELECTION; FATALITIES; THERMOREGULATION; CONSERVATION; POPULATIONS; PREDICTION; SOLITARY; BEHAVIOR	Understanding seasonal distribution and movement patterns of animals that migrate long distances is an essential part of monitoring and conserving their populations. Compared to migratory birds and other more conspicuous migrants, we know very little about the movement patterns of many migratory bats. Hoary bats (Lasiurus cinereus), a cryptic, wide-ranging, long-distance migrant, comprise a substantial proportion of the tens to hundreds of thousands of bat fatalities estimated to occur each year at wind turbines in North America. We created seasonally-dynamic species distribution models (SDMs) from 2,753 museum occurrence records collected over five decades in North America to better understand the seasonal geographic distributions of hoary bats. We used 5 SDM approaches: logistic regression, multivariate adaptive regression splines, boosted regression trees, random forest, and maximum entropy and consolidated outputs to generate ensemble maps. These maps represent the first formal hypotheses for sex-and season-specific hoary bat distributions. Our results suggest that North American hoary bats winter in regions with relatively long growing seasons where temperatures are moderated by proximity to oceans, and then move to the continental interior for the summer. SDMs suggested that hoary bats are most broadly distributed in autumn-the season when they are most susceptible to mortality from wind turbines; this season contains the greatest overlap between potentially suitable habitat and wind energy facilities. Comparing wind-turbine fatality data to model outputs could test many predictions, such as 'risk from turbines is highest in habitats between hoary bat summering and wintering grounds'. Although future field studies are needed to validate the SDMs, this study generated well-justified and testable hypotheses of hoary bat migration patterns and seasonal distribution.	[Hayes, Mark A.; Wunder, Michael B.] Univ Colorado, Dept Integrat Biol, Denver, CO 80204 USA; [Hayes, Mark A.; Cryan, Paul M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA	University of Colorado System; University of Colorado Denver; United States Department of the Interior; United States Geological Survey	Hayes, MA (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80204 USA.	hayesm@usgs.gov		Cryan, Paul/0000-0002-2915-8894	U.S. Geological Survey; University of Colorado Denver	U.S. Geological Survey(United States Geological Survey); University of Colorado Denver	This study was supported by U.S. Geological Survey and University of Colorado Denver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G. M., 1939, BATS BIOL BEHAV FOLK; Altringham John D., 2005, P280; [Anonymous], 2011, ECOLOGICAL NICHES GE; [Anonymous], 2011, MODIS VEGETATION CON; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett Edward B., 2013, P435; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; Barbour R. W., 1969, BATS OF AM; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Berthold P, 2001, AUK, V2nd; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carter TC, 2003, MONITORING TRENDS BA, P41; Cryan P. M., 2011, ENVIRON LAW, V41, P355; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Cryan PM, 2014, P NATL ACAD SCI USA, V111, P15126, DOI 10.1073/pnas.1406672111; Cryan PM, 2014, ECOL APPL, V24, P602, DOI 10.1890/13-0752.1; Cryan PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047586; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan Paul M., 2009, P476; Cryan Paul M., 2007, P153; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Dalquest W. W., 1943, Murrelet Seattle, V24, P21, DOI 10.2307/3534418; Diffendorfer J. E., 2014, US GEOLOGICAL SURVEY; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellison L. E., 2012, 20121110 US GEOL SUR; Findley J. S., 1964, Journal of Mammalogy, V45, P461, DOI 10.2307/1377421; Fink D., 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1.; Fleming TH, 2003, BAT ECOLOGY, P156; Franklin J, 2009, MAPPING SPECIES DIST; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Griffin D.R., 1940, B MUS COMP ZOOL HARV, V86, P217; Grinnell H. W., 1918, U CALIFORNIA PUBLICA, V17, P223; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Illan JG, 2010, GLOBAL ECOL BIOGEOGR, V19, P159, DOI 10.1111/j.1466-8238.2009.00507.x; Hayes MA, 2013, BIOSCIENCE, V63, P975, DOI 10.1525/bio.2013.63.12.10; Hayes MA, 2011, J WILDLIFE MANAGE, V75, P137, DOI 10.1002/jwmg.6; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOFFMEISTER D F, 1970, Southwestern Naturalist, V15, P11, DOI 10.2307/3670197; Jimenez-Valverde A, 2013, GLOBAL ECOL BIOGEOGR, V22, P508, DOI 10.1111/geb.12007; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Klug BJ, 2013, J MAMMAL, V94, P477, DOI 10.1644/12-MAMM-A-178.1; Klug BJ, 2012, CAN J ZOOL, V90, P329, DOI 10.1139/Z11-139; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kunz TH, 2007, J WILDLIFE MANAGE, V71, P2449, DOI 10.2193/2007-270; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Linsley JH, 1842, AM J SCI, V43, P345; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Merriam C.H., 1887, T ROY SOC CAN, V4, P85; Merriam CH, 1884, MAMMALS ADIRONDACK R; Miller J, 2010, GEOGR COMPASS, V4, P490, DOI 10.1111/j.1749-8198.2010.00351.x; Morisette JT, 2013, ECOGRAPHY, V36, P129, DOI 10.1111/j.1600-0587.2012.07815.x; Mumford R. E., 1963, Journal of Mammalogy, V44, P272, DOI 10.2307/1377465; ORR RT, 1950, J MAMMAL, V31, P456; PEARSON RG, 2007, SPECIES DISTRIBUTION; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Rodhouse TJ, 2012, ECOL APPL, V22, P1098, DOI 10.1890/11-1662.1; Ruf T, 2014, BIOL REV, DOI [10.1111/brv.12137:1-38, DOI 10.1111/BRV.12137:1-38]; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Seton Ernest T., 1909, LIFE HIST NO ANIMALS; Shump K.A. Jr, 1982, Mammalian Species, P1; Smallwood KS, 2013, WILDLIFE SOC B, V37, P19, DOI 10.1002/wsb.260; Strelkov P. P., 1969, Acta Zoologica Cracoviensia, V14, P393; Talbert CB, 2014, USER MANUAL SAHM PAC; Talbert MK, 2014, TUTORIAL SOFTWARE AS; Tan B, 2011, IEEE J-STARS, V4, P361, DOI 10.1109/JSTARS.2010.2075916; Vaughan T. A., 1954, Publications of the Museum of Natural History University of Kansas, V7, P513; VAUGHAN TA, 1954, J MAMMAL, V35, P431, DOI 10.2307/1375977; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WHITAKER J O JR, 1972, Proceedings of the Indiana Academy of Science, V81, P376; WHITAKER JO, 1967, J MAMMAL, V48, P663, DOI 10.2307/1377600; Willis CKR, 2005, J MAMMAL, V86, P85, DOI 10.1644/1545-1542(2005)086<0085:PAEAOR>2.0.CO;2; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; ZINN TL, 1979, J MAMMAL, V60, P634, DOI 10.2307/1380110	84	30	32	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132599	10.1371/journal.pone.0132599	http://dx.doi.org/10.1371/journal.pone.0132599			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208098	gold, Green Published			2022-12-27	WOS:000358622000034
J	Kolby, JE; Smith, KM; Ramirez, SD; Rabemananjara, F; Pessier, AP; Brunner, JL; Goldberg, CS; Berger, L; Skerratt, LF				Kolby, Jonathan E.; Smith, Kristine M.; Ramirez, Sara D.; Rabemananjara, Falitiana; Pessier, Allan P.; Brunner, Jesse L.; Goldberg, Caren S.; Berger, Lee; Skerratt, Lee F.			Rapid Response to Evaluate the Presence of Amphibian Chytrid Fungus (Batrachochytrium dendrobatidis) and Ranavirus in Wild Amphibian Populations in Madagascar (vol 10, e0125330, 2015)	PLOS ONE			English	Correction													Kolby, Jonathan/GWZ-3092-2022; Kolby, Jonathan/GWV-5557-2022; Brunner, Jesse L./B-1692-2013	Brunner, Jesse L./0000-0003-4894-8274; Berger, Lee/0000-0001-9227-5439; Skerratt, Lee/0000-0003-3471-7512				Kolby JE, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0125330, DOI 10.1371/J0URNAL.P0NE.0125330]; Kolby JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125330	2	0	0	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134524	10.1371/journal.pone.0134524	http://dx.doi.org/10.1371/journal.pone.0134524			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222617	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800148
J	Mobley, BC; Kwon, M; Kraemer, BR; Hickman, FE; Qiao, JB; Chung, DH; Carter, BD				Mobley, Bret C.; Kwon, Minjae; Kraemer, Bradley R.; Hickman, F. Edward; Qiao, Jingbo; Chung, Dai H.; Carter, Bruce D.			Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis	PLOS ONE			English	Article							CREST STEM-CELLS; N-MYC; IN-VIVO; NEURONAL DIFFERENTIATION; AMPLIFIED NEUROBLASTOMA; SYMPATHETIC NEURONS; GENE-EXPRESSION; NERVOUS-SYSTEM; PROMOTES; DNA	Neuroblastoma is a pediatric malignancy of the sympathetic ganglia and adrenal glands, hypothesized to originate from progenitors of the developing sympathetic nervous system. Amplification of the MYCN oncogene is a genetic marker of risk in this disease. Understanding the impact of oncogene expression on sympathoadrenal progenitor development may improve our knowledge of neuroblastoma initiation and progression. We isolated sympathoadrenal progenitor cells from the postnatal murine adrenal gland by sphere culture and found them to be multipotent, generating differentiated colonies of neurons, Schwann cells, and myofibroblasts. MYCN overexpression in spheres promoted commitment to the neural lineage, evidenced by an increased frequency of neuron-containing colonies. MYCN promoted proliferation of both sympathoadrenal progenitor spheres and differentiated neurons derived from these spheres, but there was also an increase in apoptosis. The proliferation, apoptosis, and neural lineage commitment induced by MYCN are tumor-like characteristics and thereby support the hypothesis that multipotent adrenal medullary progenitor cells are cells of origin for neuroblastoma. We find, however, that MYCN overexpression is not sufficient for these cells to form tumors in nude mice, suggesting that additional transforming mutations are necessary for tumorigenesis.	[Mobley, Bret C.; Kwon, Minjae] Vanderbilt Univ, Med Ctr, Div Neuropathol, Dept Pathol Microbiol & Immunol, Nashville, TN 37240 USA; [Kraemer, Bradley R.; Hickman, F. Edward; Carter, Bruce D.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN USA; [Kraemer, Bradley R.; Hickman, F. Edward; Carter, Bruce D.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN USA; [Qiao, Jingbo; Chung, Dai H.] Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Mobley, BC (corresponding author), Vanderbilt Univ, Med Ctr, Div Neuropathol, Dept Pathol Microbiol & Immunol, Nashville, TN 37240 USA.	bret.mobley@vanderbilt.edu; bruce.carter@vanderbilt.edu		Mobley, Bret/0000-0002-8138-5330	American Cancer Society Institutional Research Grant [IRG-58-009-52]; National Institutes of Health [R01 NS038220, R01 DK061470]; NIH [CA68485, DK20593, DK58404, DK59637, EY08126]; NCI/NIH Cancer Center Support Grant [2P30 CA068485-14]; Vanderbilt Mouse Metabolic Phenotyping Center Grant [5U24DK059637-13]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059637, P30DK058404, P30DK020593, P60DK020593, R01DK061470, U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/NIH Cancer Center Support Grant; Vanderbilt Mouse Metabolic Phenotyping Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the American Cancer Society Institutional Research Grant #IRG-58-009-52 (BCM) and from the National Institutes of Health R01 NS038220 (B.D.C.) and R01 DK061470 (D.H.C.). The VUMC Cell Imaging Shared Resource is supported by NIH grants CA68485, DK20593, DK58404, DK59637 and EY08126. The Translational Pathology Shared Resource is supported by NCI/NIH Cancer Center Support Grant 2P30 CA068485-14 and the Vanderbilt Mouse Metabolic Phenotyping Center Grant 5U24DK059637-13.	Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Cohen LE, 2014, BONE MARROW TRANSPL, V49, P502, DOI 10.1038/bmt.2013.218; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; DELELLIS RA, 2004, STERNBERGS DIAGNOSTI, P622; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; Escobar MA, 2006, J PEDIATR SURG, V41, P377, DOI 10.1016/j.jpedsurg.2005.11.032; Gonsalvez DG, 2013, J NEUROSCI, V33, P5969, DOI 10.1523/JNEUROSCI.4350-12.2013; Guglielmi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.42; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Gutierrez JC, 2007, PEDIATR SURG INT, V23, P637, DOI 10.1007/s00383-007-1933-7; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Henriksen JR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-1; Hoehner JC, 1998, LAB INVEST, V78, P29; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Kang JH, 2007, CANCER LETT, V253, P273, DOI 10.1016/j.canlet.2007.02.007; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kubota M, 2010, J PEDIATR SURG, V45, P673, DOI 10.1016/j.jpedsurg.2009.09.002; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; MATSUMOTO M, 1989, ACTA NEUROPATHOL, V79, P217, DOI 10.1007/BF00294382; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nara K, 2007, INT J ONCOL, V30, P1189; NEGRONI A, 1991, CELL GROWTH DIFFER, V2, P511; Nishino J, 2010, J NEUROSCI, V30, P15228, DOI 10.1523/JNEUROSCI.2286-10.2010; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; ROHRER H, 1987, J NEUROSCI, V7, P3739; Santana MM, 2012, STEM CELL TRANSL MED, V1, P783, DOI 10.5966/sctm.2012-0022; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Saxena S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064454; Schulte JH, 2013, ONCOGENE, V32, P1059, DOI 10.1038/onc.2012.106; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Straub JA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-10; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Watt F, 2007, CANCER GENE THER, V14, P287, DOI 10.1038/sj.cgt.7701012; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wolf E, 1999, J NEUROBIOL, V40, P366, DOI 10.1002/(SICI)1097-4695(19990905)40:3<366::AID-NEU8>3.0.CO;2-B; Yazawa T, 2002, AM J PATHOL, V161, P291, DOI 10.1016/S0002-9440(10)64181-8; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	57	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133897	10.1371/journal.pone.0133897	http://dx.doi.org/10.1371/journal.pone.0133897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222553	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800078
J	Yi, JZ; Warunek, D; Craft, D				Yi, Jizu; Warunek, David; Craft, David			Degradation and Stabilization of Peptide Hormones in Human Blood Specimens	PLOS ONE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; HUMAN PLASMA; MASS-SPECTROMETRY; PROFILING EXPERIMENTS; DIABETES-MELLITUS; FOOD-INTAKE; HUMAN SERUM; LC-MS/MS; GLUCAGON; GLP-1	Plasma hormone peptides, including GLP-1, GIP, Glucagon, and OXM, possess multiple physiological roles and potential therapeutic and diagnostic utility as biomarkers in the research of metabolic disorders. These peptides are subject to proteolytic degradation causing preanalytical variations. Stabilization for accurate quantitation of these active peptides in ex vivo blood specimens is essential for drug and biomarker development. We investigated the protease-driven instability of these peptides in conventional serum, plasma, anticoagulated whole blood, as well as whole blood and plasma stabilized with protease inhibitors. The peptide was monitored by both time-course Matrix-Assisted Laser Desorption Ionization Time-to-Flight Mass Spectrometry (MALDI -TOF MS) and Ab-based assay (ELISA or RIA). MS enabled the identification of proteolytic fragments. In non-stabilized blood samples, the results clearly indicated that dipeptidyl peptidase-IV (DPP-IV) removed the N-terminal two amino acid residues from GLP-1, GIP and OXM(1-37) and not-yet identified peptidase(s) cleave(s) the full-length OXM(1-37) and its fragments. DPP-IV also continued to remove two additional N-terminal residues of processed OXM(3-37) to yield OXM(5-37). Importantly, both DPP-IV and other peptidase(s) activities were inhibited efficiently by the protease inhibitors included in the BD P800* tube. There was preservation of GLP-1, GIP, OXM and glucagon in the P800 plasma samples with half-lives > 96, 96, 72, and 45 hours at room temperature (RT), respectively. In the BD P700* plasma samples, the stabilization of GLP-1 was also achieved with half-life > 96 hours at RT. The stabilization of these variable peptides increased their utility in drug and/or biomarker development. While stability results of GLP-1 obtained with Ab-based assay were consistent with those obtained by MS analysis, the Ab-based results of GIP, Glucagon, and OXM did not reflect the time-dependent degradations revealed by MS analysis. Therefore, we recommended characterizing the degradation of the peptide using the MS-based method when investigating the stability of a specific peptide.	[Yi, Jizu; Warunek, David; Craft, David] BD Diagnost, Franklin Lakes, NJ 07417 USA		Yi, JZ (corresponding author), BD Diagnost, One Becton Dr, Franklin Lakes, NJ 07417 USA.	Jizu_Yi@bd.com; David_Craft@BD.com			BD Diagnostics	BD Diagnostics	The authors received no specific funding for this work. BD Diagnostics provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bhat VK, 2013, BIOCHEM PHARMACOL, V85, P1655, DOI 10.1016/j.bcp.2013.03.009; BLACHE P, 1988, ANAL BIOCHEM, V173, P151, DOI 10.1016/0003-2697(88)90172-8; Bystrom CE, 2010, CLIN CHEM, V56, P1561, DOI 10.1373/clinchem.2010.146449; CarlesBonnet C, 1996, PEPTIDES, V17, P557, DOI 10.1016/0196-9781(96)00001-0; Cohen MA, 2003, J CLIN ENDOCR METAB, V88, P4696, DOI 10.1210/jc.2003-030421; Craft D, 2009, ANAL LETT, V42, P1398, DOI 10.1080/00032710902961073; Deacon CF, 2000, J CLIN ENDOCR METAB, V85, P3575, DOI 10.1210/jc.85.10.3575; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Findeisen P, 2005, CLIN CHEM, V51, P2409, DOI 10.1373/clinchem.2005.054585; Garber Alan J, 2011, Rev Diabet Stud, V8, P307, DOI 10.1900/RDS.2011.8.307; Gautier JF, 2005, DIABETES METAB, V31, P233, DOI 10.1016/S1262-3636(07)70190-8; Greco V, 2014, PROTEOMICS, V14, P1954, DOI 10.1002/pmic.201300565; Halquist MS, 2012, J CHROMATOGR B, V903, P102, DOI 10.1016/j.jchromb.2012.06.047; Hewage CM, 2013, CHEMMEDCHEM, V8, P560, DOI 10.1002/cmdc.201200445; Hinke SA, 2000, J BIOL CHEM, V275, P3827, DOI 10.1074/jbc.275.6.3827; Hoist JJ, 1994, GUT PEPTIDES BIOCH P, P305; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Karsan A, 2005, CLIN CHEM, V51, P1525, DOI 10.1373/clinchem.2005.050708; KERVRAN A, 1990, REGUL PEPTIDES, V31, P41, DOI 10.1016/0167-0115(90)90194-2; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Kolb A, 2009, CANCER BIOL THER, V8, P1527, DOI 10.4161/cbt.8.16.9006; Koomen JM, 2005, J PROTEOME RES, V4, P972, DOI 10.1021/pr050046x; Li YX, 2012, BIOANALYSIS, V4, P685, DOI [10.4155/BIO.12.12, 10.4155/bio.12.12]; Maida A, 2008, ENDOCRINOLOGY, V149, P5670, DOI 10.1210/en.2008-0336; McDonald TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042084; McLerran D, 2008, CLIN CHEM, V54, P44, DOI 10.1373/clinchem.2007.091470; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Mentlein R, 2009, BEST PRACT RES CL EN, V23, P443, DOI 10.1016/j.beem.2009.03.005; Miyachi A, 2013, J PROTEOME RES, V12, P2690, DOI 10.1021/pr400069f; Nauck M, 2009, BEST PRACT RES CL EN, V23, P513, DOI 10.1016/j.beem.2009.03.002; Percy AJ, 2013, BIOANALYSIS, V5, P2837, DOI 10.4155/bio.13.245; Pieragostino D, 2010, J PROTEOMICS, V73, P579, DOI 10.1016/j.jprot.2009.07.014; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Rai AJ, 2006, EXPERT REV PROTEOMIC, V3, P409, DOI 10.1586/14789450.3.4.409; Razavi M, 2012, J PROTEOME RES, V11, P5642, DOI 10.1021/pr300652v; Rogatsky E, 2006, J SEP SCI, V29, P538, DOI 10.1002/jssc.200500474; Santoprete A, 2011, J PEPT SCI, V17, P270, DOI 10.1002/psc.1328; Sharma R, 2013, DRUG METAB DISPOS, V41, P2148, DOI 10.1124/dmd.113.054254; Siskos AP, 2009, J PROTEOME RES, V8, P3487, DOI 10.1021/pr900155h; Skibicka KP, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00181; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; THIM L, 1981, REGUL PEPTIDES, V2, P139, DOI 10.1016/0167-0115(81)90007-0; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Troutt JS, 2011, CLIN CHEM, V57, P849, DOI 10.1373/clinchem.2010.159954; van den Broek I, 2013, J CHROMATOGR B, V929, P161, DOI 10.1016/j.jchromb.2013.04.030; Wettergren A, 1998, REGUL PEPTIDES, V77, P83, DOI 10.1016/S0167-0115(98)00044-5; White CM, 1999, J CLIN PHARMACOL, V39, P442; Yi JZ, 2007, J PROTEOME RES, V6, P1768, DOI 10.1021/pr060550h; Yi JZ, 2011, METHODS MOL BIOL, V728, P161, DOI 10.1007/978-1-61779-068-3_10; Yi JZ, 2011, METHODS MOL BIOL, V728, P137, DOI 10.1007/978-1-61779-068-3_8; Yi JZ, 2008, J PROTEOME RES, V7, P5112, DOI 10.1021/pr800396c; Zhang HW, 2011, RAPID COMMUN MASS SP, V25, P3427, DOI 10.1002/rcm.5241; Zhu L, 2003, J BIOL CHEM, V278, P22418, DOI 10.1074/jbc.M212355200	57	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134427	10.1371/journal.pone.0134427	http://dx.doi.org/10.1371/journal.pone.0134427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222180	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800144
J	Hou, Q; Lin, JY; Huang, WT; Li, MY; Feng, JH; Mao, XM				Hou, Qi; Lin, Jinyan; Huang, Wentao; Li, Maoyin; Feng, Jianhua; Mao, Xiangming			CTRP3 Stimulates Proliferation and Anti-Apoptosis of Prostate Cells through PKC Signaling Pathways	PLOS ONE			English	Article							C1Q/TNF-RELATED PROTEIN-3 CTRP3; PROMOTES PROLIFERATION; ADIPOSE-TISSUE; CTRP3/CARTDUCIN; PARALOG; METABOLISM; EXPRESSION; CARTDUCIN; ADIPOKINE; CORS-26	C1q/TNF-related protein-3 (CTRP3) is a novel adipokine with roles in multiple cellular processes. However, little is known about its function in prostate cells. This study investigated the effects and mechanisms of CTRP3 in prostate cells. We first generated and purified CTRP3 protein in HEK 293T cells. Proliferation of RWPE-1 prostate cells was evaluated by MTT analyses under treatment with different concentrations of CTRP3 for various exposure times. The results revealed maximum enhancement of proliferation with 10 mu g/mL CTRP3 for 72 h. Cell apoptosis and cell cycle were determined by TUNEL staining and flow cytometry analysis. TUNEL assay showed decreased TUNEL-positive cells in RWPE-1 prostate cells treated with CTRP3, and flow cytometry showed significantly decreased apoptotic cells upon CTRP3 treatment (treated cells, 8.34 +/- 1.175 vs. controls, 20.163 +/- 0.35) (P < 0.01). Moreover, flow cytometry analysis also showed a significant decrease of cells in the G1 phase and an increase of cells in the S and G2 phase upon CTRP3 treatment (treated cells, 42.85 +/- 1.40 vs. control, 52.77 +/- 0.90; 28.41 +/- 0.57 vs. 23.49 +/- 1.13; 27.08 +/- 1.97 vs. 22.20 +/- 1.32, respectively) (all P < 0.05). Two-dimensional gel electrophoresis and mass spectrometry identified differentially expressed proteins, including cytokeratin-19, GLRX3 and DDAH1, which were upregulated in CTRP3 treated cells, and cytokeratin-17 and 14-3-3 sigma, which were downregulated. GLRX3, DDAH1 and 14-3-3 sigma were confirmed using western blot analysis. A PKC inhibitor, staurosporine, was used to inhibit PKC activity in CTRP3 treated RWPE-1 cells. Staurosporine completely abolished the CTRP3-induced increased phosphorylation of intracellular PKC substrates and CTRP3-stimulated effect by RWPE-1 cells. Our results provide the first evidence for a physiological role of the novel adipokine, CTRP3, in prostate cells. Our findings suggest that CTRP3 could improve proliferation and anti-apoptosis of prostate cells through protein kinase C signaling pathways.	[Hou, Qi; Feng, Jianhua] Longgang Dist Cent Hosp, Dept Urol, Shenzhen, Peoples R China; [Lin, Jinyan] Southern Med Univ, Nanfang Hosp, Hlth management Ctr, Guangzhou, Guangdong, Peoples R China; [Huang, Wentao; Li, Maoyin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Mao, Xiangming] Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen, Peoples R China	Southern Medical University - China; Sun Yat Sen University; Peking University	Feng, JH (corresponding author), Longgang Dist Cent Hosp, Dept Urol, Shenzhen, Peoples R China.	feng-jianhua@hotmail.com; 13691903635@126.com		Mao, Xiangming/0000-0002-3335-7263; Hou, Qi/0000-0002-4597-7013	Medical Science and Technology Program of Shenzhen Longgang district [201406093001004]	Medical Science and Technology Program of Shenzhen Longgang district	This work was supported by a grant from the Medical Science and Technology Program of Shenzhen Longgang district (No. 201406093001004).	Akiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x; Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Akiyama H, 2009, ONCOL REP, V21, P1477, DOI 10.3892/or_00000377; Cha MK, 2009, CANCER EPIDEMIOL, V33, P281, DOI 10.1016/j.canep.2009.08.006; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Hou M, 2014, INT J MOL MED, V33, P97, DOI 10.3892/ijmm.2013.1550; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Lodygin D, 2004, ONCOGENE, V23, P9034, DOI 10.1038/sj.onc.1208004; Maas R, 2009, PHARMACOL RES, V60, P475, DOI 10.1016/j.phrs.2009.07.012; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Maeda T, 2001, J BIOL CHEM, V276, P3628, DOI 10.1074/jbc.M007898200; Maeda T, 2010, CELL BIOL INT, V34, P261, DOI 10.1042/CBI20090043; Osada H, 2002, ONCOGENE, V21, P2418, DOI 10.1038/sj.onc.1205303; Otani M, 2012, CYTOKINE, V58, P238, DOI 10.1016/j.cyto.2012.01.018; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Qu Y, 2011, J CLIN INVEST, V121, P212, DOI 10.1172/JCI43144; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Schaffler A, 2003, BBA-GENE STRUCT EXPR, V1630, P123, DOI 10.1016/j.bbaexp.2003.08.013; Ummanni R, 2008, CANCER LETT, V266, P171, DOI 10.1016/j.canlet.2008.02.047; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Zhang P, 2011, ARTERIOSCL THROM VAS, V31, P890, DOI 10.1161/ATVBAHA.110.215640	29	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134006	10.1371/journal.pone.0134006	http://dx.doi.org/10.1371/journal.pone.0134006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218761	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900063
J	Huang, XD; Zhang, H; He, MX				Huang, Xian-De; Zhang, Hua; He, Mao-Xian			Comparative and Evolutionary Analysis of the Interleukin 17 Gene Family in Invertebrates	PLOS ONE			English	Article							OYSTER PINCTADA-FUCATA; MESSENGER-RNA; IL-17; EXPRESSION; REPERTOIRE; COMPLEXITY; CYTOKINES; GENOME; RECEPTORS; INTRONS	Interleukin 17 (IL-17) is an important pro-inflammatory cytokine and plays critical roles in the immune response to pathogens and in the pathogenesis of inflammatory and autoimmune diseases. Despite its important functions, the origin and evolution of IL-17 in animal phyla have not been characterized. As determined in this study, the distribution of the IL-17 family among 10 invertebrate species and 7 vertebrate species suggests that the IL-17 gene may have originated from Nematoda but is absent from Saccoglossus kowalevskii (Hemichordata) and Insecta. Moreover, the gene number, protein length and domain number of IL-17 differ widely. A comparison of IL-17-containing domains and conserved motifs indicated somewhat low amino acid sequence similarity but high conservation at the motif level, although some motifs were lost in certain species. The third disulfide bond for the cystine knot fold is formed by two cysteine residues in invertebrates, but these have been replaced by two serine residues in Chordata and vertebrates. One third of invertebrate IL-17 proteins were found to have no predicted signal peptide. Furthermore, an analysis of phylogenetic trees and exon-intron structures indicated that the IL-17 family lacks conservation and displays high divergence. These results suggest that invertebrate IL-17 proteins have undergone complex differentiation and that their members may have developed novel functions during evolution.	[Huang, Xian-De; Zhang, Hua; He, Mao-Xian] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Huang, Xian-De; Zhang, Hua; He, Mao-Xian] Chinese Acad Sci, South China Sea Inst Oceanol, Guangdong Prov Key Lab Appl Marine Biol LAMB, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	He, MX (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	hmx@scsio.ac.cn			National Science and Technology Program of China [2012AA10A410]	National Science and Technology Program of China	This work was supported by grants from the National Science and Technology Program of China (2012AA10A410).	Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; GRUSS P, 1979, P NATL ACAD SCI USA, V76, P4317, DOI 10.1073/pnas.76.9.4317; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kono T, 2011, FISH SHELLFISH IMMUN, V31, P635, DOI 10.1016/j.fsi.2010.11.028; Korenaga H, 2010, FISH SHELLFISH IMMUN, V28, P809, DOI 10.1016/j.fsi.2010.01.016; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lee Y, 2013, BMB REP, V46, P479, DOI 10.5483/BMBRep.2013.46.10.141; Manni ML, 2014, EXPERT REV RESP MED, V8, P25, DOI 10.1586/17476348.2014.854167; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Nehyba J, 2009, MOL BIOL EVOL, V26, P2539, DOI 10.1093/molbev/msp167; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Roberts S, 2008, DEV COMP IMMUNOL, V32, P1099, DOI 10.1016/j.dci.2008.02.006; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Song XY, 2013, CELL SIGNAL, V25, P2335, DOI 10.1016/j.cellsig.2013.07.021; Swinburne IA, 2008, GENE DEV, V22, P2342, DOI 10.1101/gad.1696108; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Walter P, 1995, Harvey Lect, V91, P115; Wu SZ, 2013, FISH SHELLFISH IMMUN, V34, P1050, DOI 10.1016/j.fsi.2013.01.005; Wu SZ, 2013, FISH SHELLFISH IMMUN; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang XP, 2011, PROTEIN CELL, V2, P26, DOI 10.1007/s13238-011-1006-5	41	24	24	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0132802	10.1371/journal.pone.0132802	http://dx.doi.org/10.1371/journal.pone.0132802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218896	Green Submitted, gold, Green Published			2022-12-27	WOS:000358595900010
J	Zhao, WT; Liu, JW; Xu, RX; Zhang, C; Pang, Q; Chen, X; Liu, SF; Hong, LX; Yuan, J; Li, XT; Chen, YX; Li, J; Su, XZ				Zhao, Wenting; Liu, Jianwen; Xu, Ruixue; Zhang, Cui; Pang, Qin; Chen, Xin; Liu, Shengfa; Hong, Lingxian; Yuan, Jing; Li, Xiaotong; Chen, Yixin; Li, Jian; Su, Xin-zhuan			The Gametocytes of Leucocytozoon sabrazesi Infect Chicken Thrombocytes, Not Other Blood Cells	PLOS ONE			English	Article							PLASMODIUM; PREVALENCE; PARASITES; AGGREGATION; MICROSCOPY; BIRDS	Leucocytozoon parasites infect a large number of avian hosts, including domestic chicken, and cause significant economical loss to the poultry industry. Although the transmission stages of the parasites were observed in avian blood cells more than a century ago, the specific host cell type(s) that the gametocytes infect remain uncertain. Because all the avian blood cells, including red blood cells (RBCs), are nucleated, and the developing parasites dramatically change the morphology of the infected host cells, it has been difficult to identify Leucocytozoon infected host cell(s). Here we use cell-type specific antibodies to investigate the identities of the host cells infected by Leucocytozoon sabrazesi gametocytes. Anti-RBC antibodies stained RBCs membrane strongly, but not the parasite-infected cells, ruling out the possibility of RBCs being the infected host cells. Antibodies recognizing various leukocytes including heterophils, monocytes, lymphocytes, and macrophages did not stain the infected cells either. Antisera raised against a peptide of the parasite cytochrome B (CYTB) stained parasite-infected cells and some leukocytes, particularly cells with a single round nucleus as well as clear/pale cytoplasm suggestive of thrombocytes. Finally, a monoclonal antibody known to specifically bind chicken thrombocytes also stained the infected cells, confirming that L. sabrazesi gametocytes develop within chicken thrombocytes. The identification of L. sabrazesi infected host cell solves a long unresolved puzzle and provides important information for studying parasite invasion of host cells and for developing reagents to interrupt parasite transmission.	[Zhao, Wenting; Liu, Jianwen; Xu, Ruixue; Zhang, Cui; Pang, Qin; Chen, Xin; Liu, Shengfa; Hong, Lingxian; Yuan, Jing; Li, Xiaotong; Chen, Yixin; Li, Jian; Su, Xin-zhuan] Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Chen, Yixin] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Publ Hlth, Xiamen 361005, Fujian, Peoples R China; [Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Xiamen University; Xiamen University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Li, J (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Innovat Ctr Cell Signaling Network, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	jianli_204@xmu.edu.cn; xsu@niaid.nih.gov	Li, xiaotong/GYV-4890-2022	Su, Xinzhuan/0000-0003-3246-3248	National Natural Science Foundation of China [81220108019, 81271858, 81201324]; Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China [B06016]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural Science Foundation of China #81220108019, 81271858, and #81201324, by Project 111 of the State Bureau of Foreign Experts and Ministry of Education of China (B06016), and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2014, BLOOD, V123, P959, DOI 10.1182/blood-2013-08-520767; Argilla LS, 2013, PARASITOLOGY, V140, P672, DOI 10.1017/S0031182012002089; AWADHIYA RP, 1980, RES VET SCI, V29, P120, DOI 10.1016/S0034-5288(18)32701-2; BELAMARI.FA, 1966, NATURE, V212, P1579, DOI 10.1038/2121579a0; Bunbury N, 2007, PARASITOLOGY, V134, P797, DOI 10.1017/S0031182006002149; Campbell Terry W., 1994, P176; CARLSON HC, 1968, AVIAN DIS, V12, P700, DOI 10.2307/1588457; Dezfoulian O, 2013, IRAN J PARASITOL, V8, P171; Farfour E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-285; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; Genovese KJ, 2013, DEV COMP IMMUNOL, V41, P334, DOI 10.1016/j.dci.2013.03.021; GRANT RA, 1973, AM J PHYSIOL, V225, P340, DOI 10.1152/ajplegacy.1973.225.2.340; GRECCHI R, 1980, J PATHOL, V130, P23, DOI 10.1002/path.1711300104; HONG L, 1990, Acta Zoologica Sinica, V36, P123; Huff CG, 1942, J INFECT DIS, V71, P18, DOI 10.1093/infdis/71.1.18; Imura T, 2012, VET PARASITOL, V183, P244, DOI 10.1016/j.vetpar.2011.07.027; Ishak HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002304; KUNICKI TJ, 1985, P NATL ACAD SCI USA, V82, P7319, DOI 10.1073/pnas.82.21.7319; Meseguer J, 2002, MICROSC RES TECHNIQ, V57, P491, DOI 10.1002/jemt.10102; Pattaradilokrat S, 2014, GENES IMMUN, V15, P145, DOI 10.1038/gene.2013.74; Peirce MA, 2005, VET REC, V157, DOI 10.1136/vr.157.25.819-a; Seliger C, 2012, VET IMMUNOL IMMUNOP, V145, P86, DOI 10.1016/j.vetimm.2011.10.010; St Paul M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043381; STEELE EJ, 1993, J EUKARYOT MICROBIOL, V40, P384, DOI 10.1111/j.1550-7408.1993.tb04932.x; Steele EJ, 2001, J EUKARYOT MICROBIOL, V48, P118, DOI 10.1111/j.1550-7408.2001.tb00423.x; Swayne D E, 1986, Vet Clin Pathol, V15, P17, DOI 10.1111/j.1939-165X.1986.tb00639.x; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Viertlboeck BC, 2007, VET IMMUNOL IMMUNOP, V119, P137, DOI 10.1016/j.vetimm.2007.06.017; Weng Z, 1998, FUJIAN J ANI HUSB VE, V2, P10; Wingstrand KG, 1947, SOME HAEMATOZOA SWED; Zhao WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094877; Garamszegi LZ, 2010, J PARASITOL, V96, P1197, DOI 10.1645/GE-2531.1	33	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133478	10.1371/journal.pone.0133478	http://dx.doi.org/10.1371/journal.pone.0133478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218846	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900032
J	Hermannsen, L; Tougaard, J; Beedholm, K; Nabe-Nielsen, J; Madsen, PT				Hermannsen, Line; Tougaard, Jakob; Beedholm, Kristian; Nabe-Nielsen, Jacob; Madsen, Peter Teglberg			Characteristics and Propagation of Airgun Pulses in Shallow Water with Implications for Effects on Small Marine Mammals	PLOS ONE			English	Article							PORPOISE PHOCOENA-PHOCOENA; WHALES PHYSETER-MACROCEPHALUS; TEMPORARY THRESHOLD SHIFTS; EQUAL-LOUDNESS CONTOURS; HARBOR PORPOISE; SPERM-WHALES; SEISMIC SURVEYS; NOISE; EXPOSURE; SOUNDS	Airguns used in seismic surveys are among the most prevalent and powerful anthropogenic noise sources in marine habitats. They are designed to produce most energy below 100 Hz, but the pulses have also been reported to contain medium-to-high frequency components with the potential to affect small marine mammals, which have their best hearing sensitivity at higher frequencies. In shallow water environments, inhabited by many of such species, the impact of airgun noise may be particularly challenging to assess due to complex propagation conditions. To alleviate the current lack of knowledge on the characteristics and propagation of airgun pulses in shallow water with implications for effects on small marine mammals, we recorded pulses from a single airgun with three operating volumes (10 in(3), 25 in(3) and 40 in(3)) at six ranges (6, 120, 200, 400, 800 and 1300 m) in a uniform shallow water habitat using two calibrated Reson 4014 hydrophones and four DSG-Ocean acoustic data recorders. We show that airgun pulses in this shallow habitat propagated out to 1300 meters in a way that can be approximated by a 18log(r) geometric transmission loss model, but with a high pass filter effect from the shallow water depth. Source levels were back-calculated to 192 dB re mu Pa(2)s (sound exposure level) and 200 dB re 1 mu Pa dB Leq-fast (rms over 125 ms duration), and the pulses contained substantial energy up to 10 kHz, even at the furthest recording station at 1300 meters. We conclude that the risk of causing hearing damage when using single airguns in shallow waters is small for both pinnipeds and porpoises. However, there is substantial potential for significant behavioral responses out to several km from the airgun, well beyond the commonly used shut-down zone of 500 meters.	[Hermannsen, Line; Tougaard, Jakob; Nabe-Nielsen, Jacob] Aarhus Univ, Dept Biosci, Sect Marine Mammal Res, Roskilde, Denmark; [Hermannsen, Line; Beedholm, Kristian; Madsen, Peter Teglberg] Aarhus Univ, Dept Biosci, Zoophysiol, Roskilde, Denmark; [Madsen, Peter Teglberg] Murdoch Univ, Sch Vet & Life Sci, Cetacean Res Unit, Perth, WA, Australia	Aarhus University; Aarhus University; Murdoch University	Hermannsen, L (corresponding author), Aarhus Univ, Dept Biosci, Sect Marine Mammal Res, Roskilde, Denmark.	line.hermannsen@gmail.com	Madsen, Peter T/K-5832-2013; Nabe-Nielsen, Jacob/A-5891-2010; Tougaard, Jakob/G-4948-2011; Vattenfall, Bioscience/AHA-7236-2022	Madsen, Peter T/0000-0002-5208-5259; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Tougaard, Jakob/0000-0002-4422-7800; 	Danish Research Council; Vattenfall; Forewind; SMart Wind; ENECO Luchterduinen; East Anglia Offshore Wind	Danish Research Council(Det Frie Forskningsrad (DFF)); Vattenfall; Forewind; SMart Wind; ENECO Luchterduinen; East Anglia Offshore Wind	Some of the recording equipment was funded by a grant from the Danish Research Council (www.ufm.dk) to PTM (www.marinebioacoustics.com). This study is part of the DEPONS project (www.depons.au.dk) funded by the offshore wind developers Vattenfall, Forewind, SMart Wind, ENECO Luchterduinen and East Anglia Offshore Wind. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2000, SPR HDB AUD, V12, P1; Blackwell SB, 2004, J ACOUST SOC AM, V115, P2346, DOI 10.1121/1.1701899; Cerchio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086464; DeRuiter SL, 2006, J ACOUST SOC AM, V120, P4100, DOI 10.1121/1.2359705; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Dragoset W.H., 1990, LEAD EDGE, V9, P24, DOI [10.1190/1.1439671, DOI 10.1190/1.1439671]; Finneran JJ, 2011, J ACOUST SOC AM, V130, P3124, DOI 10.1121/1.3641449; Goold JC, 1998, J ACOUST SOC AM, V103, P2177, DOI 10.1121/1.421363; Goold JC, 2006, IWC SC, P1; Gordon J, 2003, MAR TECHNOL SOC J, V37, P16, DOI 10.4031/002533203787536998; Gordon J, 1998, INVESTIGATIONS EFFEC; GREENE CR, 1988, J ACOUST SOC AM, V83, P2246, DOI 10.1121/1.396354; Guerra M, 2011, J ACOUST SOC AM, V130, P3046, DOI 10.1121/1.3628326; Harris RE, 2001, MAR MAMMAL SCI, V17, P795, DOI 10.1111/j.1748-7692.2001.tb01299.x; Hermannsen L, 2014, J ACOUST SOC AM, V136, P1640, DOI 10.1121/1.4893908; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Joint Nature Conservation Committee (JNCC), 2010, JNCC GUID MIN RISK I, P1; Kastak D, 2005, J ACOUST SOC AM, V118, P3154, DOI 10.1121/1.2047128; Kastelein RA, 2002, J ACOUST SOC AM, V112, P334, DOI 10.1121/1.1480835; Kastelein RA, 2014, J ACOUST SOC AM, V136, P412, DOI 10.1121/1.4883596; Kastelein RA, 2013, J ACOUST SOC AM, V134, P13, DOI 10.1121/1.4808078; Kastelein RA, 2012, J ACOUST SOC AM, V132, P3525, DOI 10.1121/1.4757641; Kastelein RA, 2011, J ACOUST SOC AM, V129, P488, DOI 10.1121/1.3518779; Kastelein RA, 2010, J ACOUST SOC AM, V128, P3211, DOI 10.1121/1.3493435; Ketten DR, 2000, SPR HDB AUD, V12, P43; Lucke K, 2009, J ACOUST SOC AM, V125, P4060, DOI 10.1121/1.3117443; Madsen PT, 2006, J ACOUST SOC AM, V120, P2366, DOI 10.1121/1.2229287; Madsen P. T., 2002, Aquatic Mammals, V28, P231; Madsen PT, 2005, J ACOUST SOC AM, V117, P3952, DOI 10.1121/1.1921508; Malakoff D, 2002, SCIENCE, V298, P722, DOI 10.1126/science.298.5594.722; Medwin H., 1998, FUNDAMENTALS ACOUSTI; Miller PJO, 2009, DEEP-SEA RES PT I, V56, P1168, DOI 10.1016/j.dsr.2009.02.008; MOHL B, 1990, NATO ADV SCI I A-LIF, V196, P295; Moore S. E, 1995, MARINE MAMMALS NOISE, P136; National Oceanographic and Atmospheric Administration (NOAA), 2013, GUID ASS EF IN PRESS, P1; National Research Council, 2005, MAR MAMM POP OC NOIS; Nedwell JR, 2007, 534R1231 SUB, P1; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; NRC, 2003, OC NOIS MAR MAMM; Pirotta E, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1090; Reichmuth C, 2013, J COMP PHYSIOL A, V199, P491, DOI 10.1007/s00359-013-0813-y; Richardson WJ, 1995, MARINE MAMMALS NOISE, P241, DOI DOI 10.1016/B978-012588440-2/50009-3; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Romano TA, 2004, CAN J FISH AQUAT SCI, V61, P1124, DOI [10.1139/f04-055, 10.1139/F04-055]; Smoorenburg GF, 1982, NEW PERSPECTIVES NOI, P471; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Stone Carolyn J., 2006, Journal of Cetacean Research and Management, V8, P255; Thompson D, 1998, C7940098 MAS2 EUR CO; Thompson PM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2001; Tougaard J, 2015, MAR POLLUT BULL, V90, P196, DOI 10.1016/j.marpolbul.2014.10.051; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Weilgart L., 2013, CBD EXPERT WORKSHOP, P1; Weir Caroline R., 2008, Aquatic Mammals, V34, P71, DOI 10.1578/AM.34.1.2008.71	54	20	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133436	10.1371/journal.pone.0133436	http://dx.doi.org/10.1371/journal.pone.0133436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214849	Green Published, Green Submitted, gold			2022-12-27	WOS:000358594300019
J	Yokogawa, N; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Yamamoto, M; Iseki, S; Tsuchiya, H				Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Yamamoto, Miyuki; Iseki, Shoichi; Tsuchiya, Hiroyuki			Effects of Radiation on Spinal Dura Mater and Surrounding Tissue in Mice	PLOS ONE			English	Article							CORD COMPRESSION; INDUCED FIBROSIS; RISK-FACTORS; MOUSE; RADIOTHERAPY; PENTOXIFYLLINE; IRRADIATION; METASTASIS; MYELOPATHY; MECHANISMS	Purpose Spinal surgery in a previously irradiated field carries increased risk of perioperative complications, such as delayed wound healing or wound infection. In addition, adhesion around the dura mater is often observed clinically. Therefore, similar to radiation-induced fibrosisa major late-stage radiation injury in other tissue-epidural fibrosis is anticipated to occur after spinal radiation. In this study, we performed histopathologic assessment of postirradiation changes in the spinal dura mater and peridural tissue in mice. Materials and Methods The thoracolumbar transition of ddY mice was irradiated with a single dose of 10 or 20 Gy. After resection of the irradiated spine, occurrence of epidural fibrosis and expression of transforming growth factor beta 1 in the spinal dura mater were evaluated. In addition, microstructures in the spinal dura mater and peridural tissue were assessed using an electron microscope. Results In the 20-Gy irradiated mice, epidural fibrosis first occurred around 12 weeks postirradiation, and was observed in all cases from 16 weeks postirradiation. In contrast, epidural fibrosis was not observed in the nonirradiated mice. Compared with the nonirradiated mice, the 10- and 20-Gy irradiated mice had significantly more overexpression of transforming growth factor beta 1 at 1 week postirradiation and in the late stages after irradiation. In microstructural assessment, the arachnoid barrier cell layer was thinned at 12 and 24 weeks postirradiation compared with that in the nonirradiated mice. Conclusion In mice, spinal epidural fibrosis develops in the late stages after high-dose irradiation, and overexpression of transforming growth factor beta 1 occurs in a manner similar to that seen in radiation-induced fibrosis in other tissue. Additionally, thinning of the arachnoid barrier cell layer was observed in the late stages after irradiation. Thus, consideration should be given to the possibility that these phenomena can occur as radiation-induced injuries of the spine.	[Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan; [Yamamoto, Miyuki; Iseki, Shoichi] Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, Kanazawa, Ishikawa 9208641, Japan	Kanazawa University; Kanazawa University	Yokogawa, N (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	chakkun1981chakkun@yahoo.co.jp	DEMURA, Satoru/X-8589-2019	Kato, Satoshi/0000-0003-4762-5932	JSPS KAKENHI [26462233]; Radiation Effects Association	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Radiation Effects Association	This study was supported by JSPS KAKENHI Grant No. 26462233 to H.M. and N.Y., and a grant-in-aid for research from the Radiation Effects Association to N.Y. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GA, 2012, SPINE J, V12, P121, DOI 10.1016/j.spinee.2012.01.012; Bartels RHMA, 2008, CA-CANCER J CLIN, V58, P245, DOI 10.3322/CA.2007.0016; BATES T, 1992, INT J RADIAT ONCOL, V23, P217, DOI 10.1016/0360-3016(92)90565-Y; BERNARDS CM, 1990, ANESTHESIOLOGY, V73, P1214, DOI 10.1097/00000542-199012000-00020; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CAUCHOIX J, 1978, Spine, V3, P256; COUTURE D, 2003, NEUROSURG FOCUS, V15, P1; De Andres J, 2009, EUR J PAIN SUPP, P55, DOI 10.1016/j.eujps.2009.07.004; Delanian S, 2003, J CLIN ONCOL, V21, P2545, DOI 10.1200/JCO.2003.06.064; Delanian S, 2007, SEMIN RADIAT ONCOL, V17, P99, DOI 10.1016/j.semradonc.2006.11.006; Demura S, 2009, SPINE, V34, P635, DOI 10.1097/BRS.0b013e31819712ca; Devalia HL, 2008, INT WOUND J, V5, P40, DOI 10.1111/j.1742-481X.2007.00351.x; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Dowd S.B., 1999, PRACTICAL RAD PROTEC; Gerszten PC, 2009, SPINE, V34, pS78, DOI 10.1097/BRS.0b013e3181b8b6f5; Ghogawala Z, 2001, SPINE, V26, P818, DOI 10.1097/00007632-200104010-00025; GOLDWEIN JW, 1987, MED PEDIATR ONCOL, V15, P89, DOI 10.1002/mpo.2950150208; Haubner F, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-162; He Y, 1995, SPINE, V1, P20; Janjan NA, 1996, J PAIN SYMPTOM MANAG, V11, P47, DOI 10.1016/0885-3924(95)00137-9; KEY JA, 1948, J BONE JOINT SURG AM, V30-A, P621, DOI 10.2106/00004623-194830030-00009; Lefaix JL, 1999, INT J RADIAT ONCOL, V43, P839, DOI 10.1016/S0360-3016(98)00419-2; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mozes MM, 1999, J IMMUNOL METHODS, V225, P87, DOI 10.1016/S0022-1759(99)00031-9; Nishioka A, 2004, INT J RADIAT ONCOL, V58, P1235, DOI 10.1016/j.ijrobp.2003.11.006; PATIN DJ, 1993, ANESTH ANALG, V76, P535; Rades D, 2010, NAT REV CLIN ONCOL, V7, P590, DOI 10.1038/nrclinonc.2010.137; Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085; RODEMANN HP, 1995, RADIOTHER ONCOL, V35, P83, DOI 10.1016/0167-8140(95)01540-W; Ronnberg K, 2008, EUR SPINE J, V17, P1714, DOI 10.1007/s00586-008-0805-8; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; SCHULTHEISS TE, 1984, INT J RADIAT ONCOL, V10, P1109, DOI 10.1016/0360-3016(84)90184-6; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SHARPLIN J, 1989, RADIAT RES, V119, P15, DOI 10.2307/3577364; SIQUEIRA EB, 1983, SURG NEUROL, V19, P168, DOI 10.1016/0090-3019(83)90418-4; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; TAYLOR JMG, 1992, INT J RADIAT ONCOL, V23, P41, DOI 10.1016/0360-3016(92)90541-O; Vandenabeele F, 1996, J ANAT, V189, P417; Wang Junru, 2006, Hernia, V10, P502, DOI 10.1007/s10029-006-0150-y; Westbury CB, 2012, CLIN ONCOL-UK, V24, P657, DOI 10.1016/j.clon.2012.04.001; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002; Yokogawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098797; ZIDE BM, 1987, J NEUROSURG, V67, P59, DOI 10.3171/jns.1987.67.1.0059	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0133806	10.1371/journal.pone.0133806	http://dx.doi.org/10.1371/journal.pone.0133806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214850	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300033
J	Zhu, LS; Lv, RT; Kong, LC; Cheng, HD; Lan, F; Li, XT				Zhu, Lisha; Lv, Ruitu; Kong, Lingchun; Cheng, Haidong; Lan, Fei; Li, Xiaotian			Genome-Wide Mapping of 5mC and 5hmC Identified Differentially Modified Genomic Regions in Late-Onset Severe Preeclampsia: A Pilot Study	PLOS ONE			English	Article							POLARITY PROTEIN PARD-3; CHRONIC KIDNEY-DISEASE; EMBRYONIC STEM-CELLS; PROMOTER HYPOMETHYLATION; DNA HYPOMETHYLATION; GROWTH-FACTOR; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; PLACENTAS; 5-METHYLCYTOSINE	Preeclampsia (PE) is a leading cause of perinatal morbidity and mortality. However, as a common form of PE, the etiology of late-onset PE is elusive. We analyzed 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) levels in the placentas of late-onset severe PE patients (n = 4) and normal controls (n = 4) using a (hydroxy) methylated DNA immunoprecipitation approach combined with deep sequencing ([h] MeDIP-seq), and the results were verified by (h) MeDIP-qPCR. The most significant differentially methylated regions (DMRs) were verified by MassARRAY EppiTYPER in an enlarged sample size (n = 20). Bioinformatics analysis identified 714 peaks of 5mC that were associated with 403 genes and 119 peaks of 5hmC that were associated with 61 genes, thus showing significant differences between the PE patients and the controls (>2-fold, p<0.05). Further, only one gene, PTPRN2, had both 5mC and 5hmC changes in patients. The ErbB signaling pathway was enriched in those 403 genes that had significantly different5mC level between the groups. This genome-wide mapping of 5mC and 5hmC in late-onset severe PE and normal controls demonstrates that both 5mC and 5hmC play epigenetic roles in the regulation of the disease, but work independently. We reveal the genome-wide mapping of DNA methylation and DNA hydroxymethylation in late-onset PE placentas for the first time, and the identified ErbB signaling pathway and the gene PTPRN2 may be relevant to the epigenetic pathogenesis of late-onset PE.	[Zhu, Lisha; Cheng, Haidong; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Dept Obstet, Shanghai 200011, Peoples R China; [Lv, Ruitu; Kong, Lingchun; Lan, Fei] Fudan Univ, Key Lab Epigenet Shanghai, Minist Educ, Sch Basic Med, Shanghai 200032, Peoples R China; [Lv, Ruitu; Kong, Lingchun; Lan, Fei] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Lan, Fei] Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 201102, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Cheng, HD (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Obstet, Shanghai 200011, Peoples R China.	hdcheng2003@163.com; fei_lan@fudan.edu.cn; xiaotianli555@163.com	Lyu, Ruitu/ABU-6220-2022; Lyu, Ruitu/ABG-1437-2021; Li, Xiaotian/ABI-3309-2020	Lyu, Ruitu/0000-0003-4597-1604; Lyu, Ruitu/0000-0003-4597-1604; Li, Xiaotian/0000-0002-2051-4581	National Science Fund of China [81270712]	National Science Fund of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Science Fund of China, http://www.nsfc.gov.cn/ (81270712). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armant DR, 2006, DEVELOPMENT, V133, P751, DOI 10.1242/dev.02237; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Chen BS, 2010, AM J PHYSIOL-CELL PH, V299, pC968, DOI 10.1152/ajpcell.00154.2010; Chen JH, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/970435; Ching T, 2014, MOL HUM REPROD, V20, P885, DOI 10.1093/molehr/gau046; Choudhury M, 2012, CLIN EXP HYPERTENS, V34, P334, DOI 10.3109/10641963.2011.649931; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Figueroa-Romero C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052672; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gould PS, 2010, HYPERTENSION, V56, P172, DOI 10.1161/HYPERTENSIONAHA.110.152074; Goyal R, 2010, PLACENTA, V31, P568, DOI 10.1016/j.placenta.2010.05.004; Haram K, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/910751; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang HS, 2012, EUR J OBSTET GYN R B, V160, P137, DOI 10.1016/j.ejogrb.2011.10.007; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Johansson A, 2011, EUR J HUM GENET, V19, P796, DOI 10.1038/ejhg.2011.19; Johnson MP, 2013, MOL HUM REPROD, V19, P423, DOI 10.1093/molehr/gat011; Kornacki J, 2014, GINEKOL POL, V85, P504; Kroeze LI, 2015, BBA-REV CANCER, V1855, P144, DOI 10.1016/j.bbcan.2015.01.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liao AH, 2009, AM J REPROD IMMUNOL, V61, P313, DOI 10.1111/j.1600-0897.2009.00697.x; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu Y, 2014, HYPERTENSION, V63, P827, DOI 10.1161/HYPERTENSIONAHA.113.02637; Loewendorf AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096723; Matsukawa R, 2013, AM J HYPERTENS, V26, P51, DOI 10.1093/ajh/hps005; Mbah AK, 2010, BJOG-INT J OBSTET GY, V117, P997, DOI 10.1111/j.1471-0528.2010.02593.x; Mendola P, 2015, EPIDEMIOLOGY, V26, P17, DOI 10.1097/EDE.0000000000000213; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Park SY, 2015, CANCER LETT, V357, P419, DOI 10.1016/j.canlet.2014.12.005; Parry S, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.035; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Schanz A, 2011, EUR J OBSTET GYN R B, V157, P32, DOI 10.1016/j.ejogrb.2011.02.023; Sharp AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087621; Smyth LJ, 2014, EPIGENETICS-US, V9, P366, DOI 10.4161/epi.27161; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt091; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tejera E, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-51; van Dijk Marie, 2013, Frontiers in Genetics, V4, P180, DOI 10.3389/fgene.2013.00180; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yao B, 2014, HUM MOL GENET, V23, P1095, DOI 10.1093/hmg/ddt504; Yazbek SN, 2011, GENOME RES, V21, P1065, DOI 10.1101/gr.120741.111; Yoshida T, 2010, EXP THER MED, V1, P137, DOI 10.3892/etm_00000023; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Yung HW, 2014, J PATHOL, V234, P262, DOI 10.1002/path.4394; Zhao J, 2011, REPROD SCI, V18, P164, DOI 10.1177/1933719110382920; Zhao S, 2011, REPROD SCI, V18, P772, DOI 10.1177/1933719111398145	52	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2015	10	7							e0134119	10.1371/journal.pone.0134119	http://dx.doi.org/10.1371/journal.pone.0134119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7DN	26214307	Green Submitted, Green Published, gold			2022-12-27	WOS:000358594300050
J	Qi, Y; Qi, ZH; Li, ZC; Wong, CK; So, C; Lo, IC; Huang, Y; Yao, XQ; Tsang, SY				Qi, Yan; Qi, Zenghua; Li, Zhichao; Wong, Chun-Kit; So, Chun; Lo, Iek-Chi; Huang, Yu; Yao, Xiaoqiang; Tsang, Suk-Ying			Role of TRPV1 in the Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; POTASSIUM CHANNELS; IDENTIFICATION; CARDIOGENESIS; ANTAGONIST; PATHWAY; MICE	Cytosolic Ca2+ ([Ca2+](i)) is an important signal that regulates cardiomyocyte differentiation during cardiogenesis. TRPV1 is a Ca2+-permeable channel that is expressed in cardiomyocytes. In the present study, we utilized mouse embryonic stem cell-derived cardiomyocytes (mESC-CMs) as a model to investigate the functional role of TRPV1 in cardiomyocyte differentiation. Induction of embryonic stem cells into cardiomyocytes was achieved using embryoid body (EB)-based differentiation method. Quantitative PCRs showed an increased TRPV1 expression during the differentiation process. In [Ca2+](i) measurement study, application of TRPV1 agonists, capsaicin and camphor, elicited a [Ca2+](i) rise in mESC-CMs, the effect of which was abolished by TRPV1-shRNA. In functional study, treatment of EBs with TRPV1 antagonists (capsazepine and SB366791) and TRPV1-shRNA reduced the size of the EBs and decreased the percentage of spontaneously beating EBs. TRPV1 antagonists and TRPV1-shRNA also suppressed the expression of cardiomyocyte marker genes, including cardiac actin, c-TnT, c-TnI, and alpha-MHC. Taken together, this study demonstrated an important functional role of TRPV1 channels in the differentiation of mESCs into cardiomyocytes.	[Qi, Yan; Li, Zhichao; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Qi, Yan; Li, Zhichao; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Qi, Zenghua; Wong, Chun-Kit; So, Chun; Lo, Iek-Chi; Tsang, Suk-Ying] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Tsang, Suk-Ying] Chinese Univ Hong Kong, Partner State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Tsang, Suk-Ying] Chinese Univ Hong Kong, Ctr Novel Biomat, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Yao, XQ (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk; fayetsang@cuhk.edu.hk	So, Chun/AAD-1181-2022; TSANG, Suk/Q-6402-2018; So, Chun/GPG-0333-2022; Huang, Yu/K-2866-2017; Yao, Xiaoqiang/I-5413-2016	So, Chun/0000-0003-3901-7654; TSANG, Suk/0000-0002-9992-5454; Huang, Yu/0000-0002-1277-6784; Yao, Xiaoqiang/0000-0002-0687-8186; Li, Zhichao/0000-0001-6803-6876	Hong Kong RGC [T13-706/11, AoE/M-05/12, CUHK2/CRF/11G, CUHK478710, CUHK478011, CUHK478413, CUHK474711, CUHK474412, CUHK474913]; National Science Foundation of China [31171100]; Innovative Technology Fund of Innovation Technology Commission	Hong Kong RGC(Hong Kong Research Grants Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Technology Fund of Innovation Technology Commission	This work was supported by T13-706/11 (XY), AoE/M-05/12 (XY), CUHK2/CRF/11G (XY), CUHK478710 (XY), CUHK478011 (XY, YH), CUHK478413 (XY), CUHK478413 (XY), CUHK474711 (SYT), CUHK474412 (SYT), and CUHK474913 (SYT) from the Hong Kong RGC; National Science Foundation of China grant 31171100 (XY); Innovative Technology Fund of Innovation Technology Commission: Funding Support to Partner State Key Laboratories in Hong Kong (SYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Fijnvandraat AC, 2003, CARDIOVASC RES, V58, P399, DOI 10.1016/S0008-6363(03)00282-7; Guasch G, 2005, NAT GENET, V37, P1201, DOI 10.1038/ng1667; Gunthorpe MJ, 2004, NEUROPHARMACOLOGY, V46, P133, DOI 10.1016/S0028-3908(03)00305-8; Idris AI, 2010, BONE, V46, P1089, DOI 10.1016/j.bone.2010.01.368; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Law SK, 2013, INT J CARDIOL, V168, P3458, DOI 10.1016/j.ijcard.2013.04.178; Leuner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014716; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Ng SY, 2010, J CELL PHYSIOL, V224, P165, DOI 10.1002/jcp.22113; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Puceat M, 2005, CELL CALCIUM, V38, P383, DOI 10.1016/j.ceca.2005.06.016; Selescu T, 2013, CHEM SENSES, V38, P563, DOI 10.1093/chemse/bjt027; Shin HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010359; Toth BI, 2009, FEBS LETT, V583, P1619, DOI 10.1016/j.febslet.2009.04.031; Tsang SY, 2007, BIOCHEM BIOPH RES CO, V357, P480, DOI 10.1016/j.bbrc.2007.03.187; Wang K, 2005, STEM CELLS, V23, P1526, DOI 10.1634/stemcells.2004-0299; Wei WJ, 2012, J BIOL CHEM, V287, P35599, DOI 10.1074/jbc.M112.392530; Wobus A M, 2002, Methods Mol Biol, V185, P127; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Xia R, 2011, ADV EXP MED BIOL, V704, P637, DOI 10.1007/978-94-007-0265-3_34; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yanagida E, 2004, CELL CALCIUM, V36, P135, DOI 10.1016/j.ceca.2004.01.022; Zhang YM, 2012, J MOL CELL BIOL, V4, P97, DOI 10.1093/jmcb/mjs002; Zhang YM, 2003, AM J PHYSIOL-HEART C, V285, pH2770, DOI 10.1152/ajpheart.01114.2002; Zhong BH, 2009, AM J PHYSIOL-REG I, V297, pR1681, DOI 10.1152/ajpregu.90746.2008	33	7	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133211	10.1371/journal.pone.0133211	http://dx.doi.org/10.1371/journal.pone.0133211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208267	gold, Green Published, Green Submitted			2022-12-27	WOS:000358622000066
J	Sun, CK; Sun, PF; Wang, P				Sun, Changku; Sun, Pengfei; Wang, Peng			An Improvement of Pose Measurement Method Using Global Control Points Calibration	PLOS ONE			English	Article							ALGORITHM; VISION; CIRCLE; SYSTEM; MODEL	During the last decade pose measurement technologies have gained an increasing interest in the computer vision. The vision-based pose measurement method has been widely applied in complex environments. However, the pose measurement error is a problem in the measurement applications. It grows rapidly with increasing measurement range. In order to meet the demand of high accuracy in large measurement range, a measurement error reduction solution to the vision-based pose measurement method, called Global Control Point Calibration (GCPC), is proposed. GCPC is an optimized process of existing visual pose measurement methods. The core of GCPC is to divide the measurement error into two types: the control point error and the control space error. Then by creating the global control points as well as performing error calibration of object pose, the two errors are processed. The control point error can be eliminated and the control space error is minimized. GCPC is experimented on the moving target in the camera's field of view. The results show that the RMS error is 0.175 degrees in yaw angle, 0.189 degrees in pitch angle, and 0.159 degrees in roll angle, which demonstrate that GCPC works effectively and stably.	[Sun, Changku; Sun, Pengfei; Wang, Peng] Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin 300072, Peoples R China; [Wang, Peng] Luoyang Inst Electroopt Equipment, Sci & Technol Electroopt Control Lab, Luoyang, Peoples R China	Tianjin University	Wang, P (corresponding author), Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin 300072, Peoples R China.	wang_peng@tju.edu.cn	SUN, CHANG/GXM-3680-2022		National Natural Science Foundation of China [51375339]; Science and Technology on Electro-optic Control Laboratory and Aeronautics Science Foundation of China [20135148004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology on Electro-optic Control Laboratory and Aeronautics Science Foundation of China	This work is supported by the National Natural Science Foundation of China (No. 51375339). URL: http://www.nsfc.gov.cn/publish/portal0/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is also supported by the Science and Technology on Electro-optic Control Laboratory and Aeronautics Science Foundation of China (No. 20135148004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2001, PATTERN RECOGN, V34, P2283, DOI 10.1016/S0031-3203(00)00152-7; Al-Sharadqah A, 2009, ELECTRON J STAT, V3, P886, DOI 10.1214/09-EJS419; David P, 2004, INT J COMPUT VISION, V59, P259, DOI 10.1023/B:VISI.0000025800.10423.1f; DEMENTHON DF, 1995, INT J COMPUT VISION, V15, P123, DOI 10.1007/BF01450852; Fan BJ, 2013, IET COMPUT VIS, V7, P382, DOI 10.1049/iet-cvi.2012.0258; Gramegna T, 2004, ROBOT AUTON SYST, V48, P145, DOI 10.1016/j.robot.2004.05.001; Grossberg MD, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P108, DOI 10.1109/ICCV.2001.937611; Hesch JA, 2011, IEEE I CONF COMP VIS, P383, DOI 10.1109/ICCV.2011.6126266; Hmam H, 2010, IMAGE VISION COMPUT, V28, P1515, DOI 10.1016/j.imavis.2010.03.005; Kim SJ, 2013, IEEE T IND ELECTRON, V60, P4562, DOI 10.1109/TIE.2012.2216235; Lepetit Vincent, 2005, Foundations and Trends in Computer Graphics and Vision, V1, P1, DOI 10.1561/0600000001; Li Y, 2012, PROCEEDINGS OF 2012 2ND INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND NETWORK TECHNOLOGY (ICCSNT 2012), P1413, DOI 10.1109/ICCSNT.2012.6526185; Lukacs G, 1998, COMPUTER VISION ECCV; Mao W, 2008, NONLINEAR DYN SYST T, V8, P375; Murphy-Chutorian E, 2009, IEEE T PATTERN ANAL, V31, P607, DOI 10.1109/TPAMI.2008.106; Ons B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021091; Pan H, 2014, APPL MECH MAT; Pan H, 2014, OPTIK, V125, P3127, DOI 10.1016/j.ijleo.2013.12.020; Schall G, 2009, INT SYM MIX AUGMENT, P153, DOI 10.1109/ISMAR.2009.5336489; Schwartz G, 2008, PUBLIC INVESTMENT AND PUBLIC-PRIVATE PARTNERSHIPS: ADDRESSING INFRASTRUCTURE CHALLENGES AND MANAGING FISCAL RISKS, P1; Tang JL, 2008, APPL MATH COMPUT, V205, P628, DOI 10.1016/j.amc.2008.05.037; Tsai RY, 1986, CVPR 1986 P IEEE C C; Valasek J, 2005, J GUID CONTROL DYNAM, V28, P979, DOI 10.2514/1.11934; Valenti R, 2012, IEEE T IMAGE PROCESS, V21, P802, DOI 10.1109/TIP.2011.2162740; Wang J, 2008, PATTERN RECOGN, V41, P607, DOI 10.1016/j.patcog.2007.06.012; Wu YH, 2006, J MATH IMAGING VIS, V24, P131, DOI 10.1007/s10851-005-3617-z; Xiaopeng Chen, 2010, 2010 IEEE International Conference on Mechatronics and Automation (ICMA), P1314, DOI 10.1109/ICMA.2010.5588089	27	5	9	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133905	10.1371/journal.pone.0133905	http://dx.doi.org/10.1371/journal.pone.0133905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207825	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000171
J	Tsai, VWW; Macia, L; Feinle-Bisset, C; Manandhar, R; Astrup, A; Raben, A; Lorenzen, JK; Schmidt, PT; Wiklund, F; Pedersen, NL; Campbell, L; Kriketos, A; Xu, AM; Zhou, PC; Jia, WP; Curmi, PMG; Angstmann, CN; Lee-Ng, KKM; Zhang, HP; Marquis, CP; Husaini, Y; Beglinger, C; Lin, S; Herzog, H; Brown, DA; Sainsbury, A; Breit, SN				Tsai, Vicky Wang-Wei; Macia, Laurence; Feinle-Bisset, Christine; Manandhar, Rakesh; Astrup, Arne; Raben, Anne; Lorenzen, Janne Kunchel; Schmidt, Peter T.; Wiklund, Fredrik; Pedersen, Nancy L.; Campbell, Lesley; Kriketos, Adamandia; Xu, Aimin; Zhou Pengcheng; Jia, Weiping; Curmi, Paul M. G.; Angstmann, Christopher N.; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Marquis, Christopher P.; Husaini, Yasmin; Beglinger, Christoph; Lin, Shu; Herzog, Herbert; Brown, David A.; Sainsbury, Amanda; Breit, Samuel N.			Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; RHEUMATOID-ARTHRITIS; COGNITIVE-ABILITIES; FATTY-ACIDS; MIC-1; APPETITE; LEPTIN; MARKER; HORMONE; PLASMA	The TGF-b superfamily cytokine MIC-1/GDF15 circulates in the blood of healthy humans. Its levels rise substantially in cancer and other diseases and this may sometimes lead to development of an anorexia/cachexia syndrome. This is mediated by a direct action of MIC1/GDF15 on feeding centres in the hypothalamus and brainstem. More recent studies in germline gene deleted mice also suggest that this cytokine may play a role in physiological regulation of energy homeostasis. To further characterize the role of MIC-1/GDF15 in physiological regulation of energy homeostasis in man, we have examined diurnal and food associated variation in serum levels and whether variation in circulating levels relate to BMI in human monozygotic twin pairs. We found that the within twin pair differences in serum MIC-1/GDF15 levels were significantly correlated with within twin pair differences in BMI, suggesting a role for MIC-1/GDF15 in the regulation of energy balance in man. MIC-1/GDF15 serum levels altered slightly in response to a meal, but comparison with variation its serum levels over a 24hour period suggested that these changes are likely to be due to bimodal diurnal variation which can alter serum MIC-1/GDF15 levels by about plus or minus 10% from the mesor. The lack of a rapid and substantial postprandial increase in MIC-1/GDF15 serum levels suggests that MIC1/GDF15 is unlikely to act as a satiety factor. Taken together, our findings suggest that MIC-1/GDF15 may be a physiological regulator of energy homeostasis in man, most probably due to actions on long-term regulation of energy homeostasis.	[Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Lee-Ng, Ka Ki Michelle; Zhang, Hong Ping; Husaini, Yasmin; Brown, David A.; Breit, Samuel N.] Univ New S Wales, Sydney, NSW, Australia; [Macia, Laurence] Monash Univ, Sch Biomed Sci, Ctr Immunol & Inflammat, Clayton, Vic, Australia; [Feinle-Bisset, Christine] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Astrup, Arne; Raben, Anne; Lorenzen, Janne Kunchel] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Schmidt, Peter T.] Karolinska Univ Hosp, Dept Med, Unit Gastroenterol & Hepatol, Stockholm, Sweden; [Wiklund, Fredrik; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Campbell, Lesley; Kriketos, Adamandia] Garvan Inst Med Res, Diabet & Metab Div, Sydney, NSW, Australia; [Xu, Aimin; Zhou Pengcheng] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin; Zhou Pengcheng] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW, Australia; [Angstmann, Christopher N.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia; [Marquis, Christopher P.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Beglinger, Christoph] Univ Basel Hosp, Dept Biomed, Clin Res Ctr, CH-4031 Basel, Switzerland; [Lin, Shu; Herzog, Herbert] Garvan Inst Med Res, Div Neurosci, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ Sydney, Sydney Med Sch, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; Monash University; University of Adelaide; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Garvan Institute of Medical Research; University of Hong Kong; University of Hong Kong; Shanghai Jiao Tong University; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Basel; Garvan Institute of Medical Research; University of Sydney	Breit, SN (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia.	s.breit@amr.org.au	Salis, Amanda/A-3187-2011; Macia, laurence/D-5983-2016; Angstmann, Christopher N/G-1990-2015; Curmi, Paul/G-7185-2011; Marquis, Christopher/E-3847-2013; Raben, Anne/B-6978-2015; Astrup, Arne/B-1407-2015	Salis, Amanda/0000-0001-9176-1574; Macia, laurence/0000-0003-0835-851X; Angstmann, Christopher N/0000-0002-6688-9346; Curmi, Paul/0000-0001-5762-7638; Marquis, Christopher/0000-0003-1656-7215; Raben, Anne/0000-0001-5229-4491; , Herbert/0000-0002-1713-1029; Brown, David/0000-0003-1382-9419; lin, shu/0000-0002-4239-2028; Astrup, Arne/0000-0001-8968-8996	National Health and Medical Research Council of Australia (NHMRC); NHMRC	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC). SNB, AS, DAB, CF-B and HH are all recipients of NHMRC Fellowships. The funder had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Beglinger C, 2001, AM J PHYSIOL-REG I, V280, pR1149, DOI 10.1152/ajpregu.2001.280.4.R1149; Bertani S, 2010, IN VIVO, V24, P827; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2012, NEPHROL DIAL TRANSPL, V27, P70, DOI 10.1093/ndt/gfr575; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brennan IM, 2005, AM J PHYSIOL-REG I, V288, pR1477, DOI 10.1152/ajpregu.00732.2004; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Brown DA, 2007, ARTHRITIS RHEUM, V56, P753, DOI 10.1002/art.22410; Cegla J, 2010, CURR OPIN CLIN NUTR, V13, P588, DOI 10.1097/MCO.0b013e32833b64a3; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Finkel D, 2004, AGING NEUROPSYCHOL C, V11, P325, DOI 10.1080/13825580490511152; Fuchs T, 2013, AGING CELL, V12, P882, DOI 10.1111/acel.12116; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Heptulla R, 2001, J CLIN ENDOCR METAB, V86, P90, DOI 10.1210/jc.86.1.90; Horwich TB, 2007, SEMIN DIALYSIS, V20, P549, DOI 10.1111/j.1525-139X.2007.00346.x; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Joshi JP, 2011, BIOCHEM PHARMACOL, V82, P1090, DOI 10.1016/j.bcp.2011.07.082; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Kuiper N. H., 1960, P KONINKLIJKE NEDE A, V63, P38, DOI [10.1016/S1385-7258(60)50006-0, DOI 10.1016/S1385-7258(60)50006-0]; Little TJ, 2005, OBES REV, V6, P297, DOI 10.1111/j.1467-789X.2005.00212.x; Lorenzen JK, 2007, AM J CLIN NUTR, V85, P678, DOI 10.1093/ajcn/85.3.678; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Suzuki K, 2011, J OBES, V2011, DOI 10.1155/2011/528401; Tsai VWW, 2012, J CACHEXIA SARCOPENI, V3, P239, DOI 10.1007/s13539-012-0082-6; Tsai VWW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100370; Tsai VWW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055174; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Witte AB, 2009, REGUL PEPTIDES, V158, P57, DOI 10.1016/j.regpep.2009.07.013; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Zac-Varghese S, 2010, DISCOV MED, V10, P543	43	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133362	10.1371/journal.pone.0133362	http://dx.doi.org/10.1371/journal.pone.0133362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207898	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000082
J	Wortham, JM; Gray, J; Verani, J; Contreras, CL; Bernart, C; Moscoso, F; Moir, JC; Marroquin, ELR; Castellan, R; Arvelo, W; Lindblade, K; McCracken, JP				Wortham, Jonathan M.; Gray, Jennifer; Verani, Jennifer; Lucia Contreras, Carmen; Bernart, Chris; Moscoso, Fabiola; Carlos Moir, Juan; Reyes Marroquin, Emma Lissette; Castellan, Rigoberto; Arvelo, Wences; Lindblade, Kim; McCracken, John P.			Using Standardized Interpretation of Chest Radiographs to Identify Adults with Bacterial Pneumonia-Guatemala, 2007-2012	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD PNEUMONIA; CHILDREN YOUNGER; HERD-IMMUNITY; DIAGNOSIS; ETIOLOGY; ANTIGEN; EPIDEMIOLOGY	Background Bacterial pneumonia is a leading cause of illness and death worldwide, but quantifying its burden is difficult due to insensitive diagnostics. Although World Health Organization (WHO) protocol standardizes pediatric chest radiograph (CXR) interpretation for epidemiologic studies of bacterial pneumonia, its validity in adults is unknown. Methods Patients (age >= 15 years) admitted with respiratory infections to two Guatemalan hospitals between November 2007 and March 2012 had urine and nasopharyngeal/oropharyngeal (NP/OP) swabs collected; blood cultures and CXR were also performed at physician clinical discretion. 'Any bacterial infection' was defined as a positive urine pneumococcal antigen test, isolation of a bacterial pneumonia pathogen from blood culture, or detection of an atypical bacterial pathogen by polymerase chain reaction (PCR) of nasopharyngeal/oropharyngeal (NP/OP) specimens. 'Viral infection' was defined as detection of viral pathogens by PCR of NP/OP specimens. CXRs were interpreted according to the WHO protocol as having 'endpoint consolidation', 'other infiltrate', or 'normal' findings. We examined associations between bacterial and viral infections and endpoint consolidation. Findings Urine antigen and/or blood culture results were available for 721 patients with CXR interpretations; of these, 385 (53%) had endpoint consolidation and 253 (35%) had other infiltrate. Any bacterial infection was detected in 119 (17%) patients, including 106 (89%) pneumococcal infections. Any bacterial infection (Diagnostic Odds Ratio [DOR] = 2.9; 95% confidence Interval (CI): 1.3-7.9) and pneumococcal infection (DOR = 3.4; 95% CI: 1.5-10.0) were associated with 'endpoint consolidation', but not 'other infiltrate' (DOR = 1.7; 95% CI: 0.7-4.9, and 1.7; 95% CI: 0.7-4.9 respectively). Viral infection was not significantly associated with 'endpoint consolidation', 'other infiltrate,' or 'normal' findings. Interpretation 'Endpoint consolidation' was associated with 'any bacterial infection,' specifically pneumococcal infection. Therefore, endpoint consolidation may be a useful surrogate for studies measuring the impact of interventions, such as conjugate vaccines, against bacterial pneumonia.	[Wortham, Jonathan M.; Verani, Jennifer; Arvelo, Wences; Lindblade, Kim] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Gray, Jennifer; Lucia Contreras, Carmen; Bernart, Chris; Moscoso, Fabiola; Castellan, Rigoberto; McCracken, John P.] Univ Valle Guatemala, Guatemala City, Guatemala; [Carlos Moir, Juan; Reyes Marroquin, Emma Lissette] Minist Salud Publ & Asistencia Social, Guatemala City, Guatemala	Centers for Disease Control & Prevention - USA; Universidad del Valle de Guatemala	Wortham, JM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	vij5@cdc.gov		Lindblade, Kim/0000-0002-5593-0470	U.S Centers for Disease Control and Prevention (CDC) [UO1 GH000028-02]	U.S Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported in part by Cooperative Agreement Number UO1 GH000028-02 from the U.S Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Albaum MN, 1996, CHEST, V110, P343, DOI 10.1378/chest.110.2.343; Baqui AH, 2007, PEDIATR INFECT DIS J, V26, P565, DOI 10.1097/INF.0b013e31806166a0; Butler JC, 2003, J INFECT DIS, V187, P1416, DOI 10.1086/374623; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Corbo J, 2004, EMERG MED J, V21, P446, DOI 10.1136/emj.2003.005306; de la Hoz F, 2004, VACCINE, V23, P36, DOI 10.1016/j.vaccine.2004.05.017; Elberse KEM, 2012, VACCINE, V30, P7644, DOI 10.1016/j.vaccine.2012.04.021; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Ewig S, 2002, CHEST, V121, P1486, DOI 10.1378/chest.121.5.1486; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Haber M, 2007, VACCINE, V25, P5390, DOI 10.1016/j.vaccine.2007.04.088; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Heiskanen-Kosma T, 1998, PEDIATR INFECT DIS J, V17, P986, DOI 10.1097/00006454-199811000-00004; Javadi M, 2006, INT J INFECT DIS, V10, P129, DOI 10.1016/j.ijid.2005.01.007; Lynch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011989; Mendoza-Paredes A, 2013, CLIN MED INSIGHTS-PE, V7, P1, DOI 10.4137/CMPed.S8051; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; MIMICA I, 1971, AM J DIS CHILD, V122, P278, DOI 10.1001/archpedi.1971.02110040062002; Myers AL, 2013, PEDIAT INFECT DIS J; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro SK, 2006, LANCET INFECT DIS, V6, P150, DOI 10.1016/S1473-3099(06)70411-X; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; SILVERMAN M, 1977, ARCH DIS CHILD, V52, P925, DOI 10.1136/adc.52.12.925; Sinclair A, 2013, J CLIN MICROBIOL, V51, P2303, DOI 10.1128/JCM.00137-13; Verani JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083600; Wang SA, 2013, MMWR-MORBID MORTAL W, V62, P308; Watt JP, 2010, EPIDEMIOL INFECT, V138, P1146, DOI 10.1017/S0950268809991464; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wiemken TL, 2012, SEMIN RESP CRIT CARE, V33, P213, DOI 10.1055/s-0032-1315633; World Health Organization, 2001, STAND INT CHEST RAD	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133257	10.1371/journal.pone.0133257	http://dx.doi.org/10.1371/journal.pone.0133257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207918	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000072
J	Zhu, Y; Wang, JL; He, ZY; Jin, F; Tang, L				Zhu, Ying; Wang, Jia-Lu; He, Zhi-Yi; Jin, Feng; Tang, Ling			Association of Altered Serum MicroRNAs with Perihematomal Edema after Acute Intracerebral Hemorrhage	PLOS ONE			English	Article							BRAIN EDEMA; INFLAMMATION; STROKE; EXPRESSION; PREDICTOR; MORTALITY; TARGETS; GROWTH; INJURY; VOLUME	Background and Purpose Perihematomal edema (PHE) contributes to secondary brain damage and aggravates patient outcomes after intracerebral hemorrhage (ICH). MicroRNAs (miRNAs) are stable in circulation, and their unique expression profiles have fundamental roles in modulating vascular disease. The objective of this study was to test the hypothesis that altered miRNA levels are associated with PHE in ICH patients. Methods Hematoma and PHE volumes of ICH patients were measured on admission and in follow-up computed tomography scans. Whole-genome miRNA profiles of ICH patients and healthy controls were determined using the Exiqon miRCURY LNA Array, and validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Bioinformatics analysis investigated dysregulated miRNA target genes and the signaling pathways involved. Results We identified 55 miRNAs that were differentially expressed in ICH patients compared with normal controls, of which 54 were down-regulated and one was up-regulated. qRT-PCR confirmation showed decreases in miR-126 (0.63-fold), miR-146a (0.64-fold), miR-let-7a (0.50-fold), and miR-26a (0.54-fold) in ICH patients relative to controls. Serum miR-126, but not miR-146a, miR-let-7a or miR-26a, levels were significantly correlated with relative PHE volume on days 3-4 (r = -0.714; P<0.001) in patients with ICH. Conclusions ICH patients appear to have a specific miRNA expression profile. Low expression of miR-126 was positively correlated with the extent of PHE, suggesting it may have a pathogenic role in the development of PHE after ICH.	[Zhu, Ying; Wang, Jia-Lu; He, Zhi-Yi; Jin, Feng; Tang, Ling] China Med Univ, Dept Neurol, Hosp 1, Shenyang, Peoples R China	China Medical University	He, ZY (corresponding author), China Med Univ, Dept Neurol, Hosp 1, Shenyang, Peoples R China.	he-zy@outlook.com			National Natural Science Foundation of China [81271291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81271291).	Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Bai YY, 2011, MED HYPOTHESES, V77, P488, DOI 10.1016/j.mehy.2011.06.017; Bao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106540; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; BRODERICK J, 1994, NEUROSURGERY, V34, P882, DOI 10.1227/00006123-199405000-00015; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; Guo D, 2013, STROKE, V44, P1739, DOI 10.1161/STROKEAHA.111.000835; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hu JZ, 2015, BRAIN RES, V1608, P191, DOI 10.1016/j.brainres.2015.02.036; Kim JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097946; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; McColl BW, 2007, BIOCHEM SOC T, V35, P1163, DOI 10.1042/BST0351163; Nikolic Iva, 2010, J Angiogenes Res, V2, P9, DOI 10.1186/2040-2384-2-9; Pogue AI, 2009, J INORG BIOCHEM, V103, P1591, DOI 10.1016/j.jinorgbio.2009.05.012; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan JR, 2011, CURR MOL MED, V11, P76; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wasserman JK, 2007, BRAIN RES, V1180, P140, DOI 10.1016/j.brainres.2007.08.058; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2002, NEUROSURG CLIN N AM, V13, P371, DOI 10.1016/S1042-3680(02)00007-4; Zheng HW, 2012, CNS NEUROSCI THER, V18, P1003, DOI 10.1111/cns.12019; Zhou QB, 2014, INFLAMMATION, V37, P107, DOI 10.1007/s10753-013-9717-9	33	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133783	10.1371/journal.pone.0133783	http://dx.doi.org/10.1371/journal.pone.0133783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207814	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000141
J	Allen, K; Corre, MD; Tjoa, A; Veldkamp, E				Allen, Kara; Corre, Marife D.; Tjoa, Aiyen; Veldkamp, Edzo			Soil Nitrogen-Cycling Responses to Conversion of Lowland Forests to Oil Palm and Rubber Plantations in Sumatra, Indonesia	PLOS ONE			English	Article							MICROBIAL BIOMASS NITROGEN; OLD-GROWTH LOWLAND; LAND-USE SYSTEMS; CENTRAL SULAWESI; RETENTION PROCESSES; DIRECT EXTRACTION; PRODUCTIVITY; EMISSIONS; AMAZONIA; DYNAMICS	Rapid deforestation in Sumatra, Indonesia is presently occurring due to the expansion of palm oil and rubber production, fueled by an increasing global demand. Our study aimed to assess changes in soil-N cycling rates with conversion of forest to oil palm (Elaeis guineensis) and rubber (Hevea brasiliensis) plantations. In Jambi Province, Sumatra, Indonesia, we selected two soil landscapes - loam and clay Acrisol soils - each with four land-use types: lowland forest and forest with regenerating rubber (hereafter, "jungle rubber") as reference land uses, and rubber and oil palm as converted land uses. Gross soil-N cycling rates were measured using the N-15 pool dilution technique with in-situ incubation of soil cores. In the loam Acrisol soil, where fertility was low, microbial biomass, gross N mineralization and NH4+ immobilization were also low and no significant changes were detected with land-use conversion. The clay Acrisol soil which had higher initial fertility based on the reference land uses (i.e. higher pH, organic C, total N, effective cation exchange capacity (ECEC) and base saturation) (P <= 0.05-0.09) had larger microbial biomass and NH4+ transformation rates (P <= 0.05) compared to the loam Acrisol soil. Conversion of forest and jungle rubber to rubber and oil palm in the clay Acrisol soil decreased soil fertility which, in turn, reduced microbial biomass and consequently decreased NH4+ transformation rates (P <= 0.05-0.09). This was further attested by the correlation of gross N mineralization and microbial biomass N with ECEC, organic C, total N (R=0.51-0.76; P <= 0.05) and C: N ratio (R=-0.71 - -0.75, P <= 0.05). Our findings suggest that the larger the initial soil fertility and N availability, the larger the reductions upon land-use conversion. Because soil N availability was dependent on microbial biomass, management practices in converted oil palm and rubber plantations should focus on enriching microbial biomass.	[Allen, Kara; Corre, Marife D.; Veldkamp, Edzo] Univ Gottingen, Soil Sci Trop & Subtrop Ecosyst, Busgen Inst, D-37073 Gottingen, Germany; [Tjoa, Aiyen] Univ Tadulako, Fak Pertanian, Agroforestry Ctr, Palu, Sulawesi, Indonesia	University of Gottingen; Universitas Tadulako	Allen, K (corresponding author), Univ Gottingen, Soil Sci Trop & Subtrop Ecosyst, Busgen Inst, D-37073 Gottingen, Germany.	Kara.Allen@forst.uni-goettingen.de	Veldkamp, Edzo/A-6660-2008; Tjoa, A Min/AAL-5676-2020	Veldkamp, Edzo/0000-0002-8318-8349; Tjoa, A Min/0000-0002-8295-9252	Deutsche Forschungsgemeinschaft (DFG), German-Indonesian Collaborative Research Center [990]	Deutsche Forschungsgemeinschaft (DFG), German-Indonesian Collaborative Research Center(German Research Foundation (DFG))	The study was financed by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de) as part of the project A05 in the framework of the German-Indonesian Collaborative Research Center 990 entitled "Ecological and Socioeconomic Function of Tropical Lowland Rainforest Transformation Systems" (EEFForTs) (https://www.uni-goettingen.de/en/310995.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Arnold J, 2009, FOREST ECOL MANAG, V257, P2079, DOI 10.1016/j.foreco.2009.02.014; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Carlson KM, 2012, NAT CLIM CHANG; Corre MD, 2007, GLOBAL CHANGE BIOL, V13, P1509, DOI 10.1111/j.1365-2486.2007.01371.x; Corre MD, 2010, ECOLOGY, V91, P1715, DOI 10.1890/09-0274.1; Corre MD, 2006, SOIL SCI SOC AM J, V70, P359, DOI 10.2136/sssaj2005.0061; Corre MD, 2003, ECOL APPL, V13, P287, DOI 10.1890/1051-0761(2003)013[0287:SNCIHN]2.0.CO;2; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; DAVIDSON EA, 1991, J SOIL SCI, V42, P335, DOI 10.1111/j.1365-2389.1991.tb00413.x; DAVIDSON EA, 1989, SOIL BIOL BIOCHEM, V21, P773, DOI 10.1016/0038-0717(89)90169-7; DAVIDSON EA, 1993, ECOLOGY, V74, P130, DOI 10.2307/1939508; de Blecourt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069357; Dechert G, 2005, NUTR CYCL AGROECOSYS, V72, P201, DOI 10.1007/s10705-005-1546-2; Dechert G, 2004, PLANT SOIL, V265, P197, DOI 10.1007/s11104-005-0885-8; FAO/IIASA/ISRIC/ISSCAS/JRC, HARM WORLD SOIL DAT; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; GOUYON A, 1993, AGROFOREST SYST, V22, P181, DOI 10.1007/BF00705233; Hall SJ, 2003, ECOL MONOGR, V73, P107, DOI 10.1890/0012-9615(2003)073[0107:NSOTRF]2.0.CO;2; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Jarvis A., HOLE FILLED SRTM GLO; Klinge R, 2004, BIOGEOCHEMISTRY, V69, P63, DOI 10.1023/B:BIOG.0000031040.38388.9b; Kotowska MM, 2015, GLOBAL CHANGE BIOL, V21, P3620, DOI 10.1111/gcb.12979; Laumonier Y, 2010, BIODIVERS CONSERV, V19, P1153, DOI 10.1007/s10531-010-9784-2; Margono BA, 2014, NAT CLIM CHANG; Markewitz D, 2001, NATURE, V410, P802, DOI 10.1038/35071052; Ngoze S, 2008, GLOBAL CHANGE BIOL, V14, P2810, DOI 10.1111/j.1365-2486.2008.01698.x; R Core Team, R LANG ENV STAT COMP; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; Silver WL, 2001, ECOLOGY, V82, P2410, DOI 10.1890/0012-9658(2001)082[2410:DNRTAI]2.0.CO;2; Silver WL, 2000, ECOSYSTEMS, V3, P193, DOI 10.1007/s100210000019; Silver WL, 2005, ECOL APPL, V15, P1604, DOI 10.1890/04-1322; Sotta ED, 2008, SOIL BIOL BIOCHEM, V40, P740, DOI 10.1016/j.soilbio.2007.10.009; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Templer PH, 2008, ECOLOGY, V89, P3030, DOI 10.1890/07-1631.1; VANBREEMEN N, 1983, PLANT SOIL, V75, P283, DOI 10.1007/BF02369968; Veldkamp E, 2008, J GEOPHYS RES; Wang YF, 2007, GLOBAL CHANGE BIOL, V13, P2270, DOI 10.1111/j.1365-2486.2007.01441.x; WHITE CS, 1991, BIOGEOCHEMISTRY, V12, P43, DOI 10.1007/BF00002625	42	84	88	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133325	10.1371/journal.pone.0133325	http://dx.doi.org/10.1371/journal.pone.0133325			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222690	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800049
J	Chen, VCH; Kuo, CJ; Wang, TN; Lee, WC; Chen, WJ; Ferri, CP; Tsai, D; Lai, TJ; Huang, MC; Stewart, R; Ko, YC				Chen, Vincent Chin-Hung; Kuo, Chian-Jue; Wang, Tsu-Nai; Lee, Wen-Chung; Chen, Wei J.; Ferri, Cleusa P.; Tsai, Duujian; Lai, Te-Jen; Huang, Meng-Chuan; Stewart, Robert; Ko, Ying-Chin			Suicide and Other-Cause Mortality after Early Exposure to Smoking and Second Hand Smoking: A 12-Year Population-Based Follow-Up Study	PLOS ONE			English	Article							CIGARETTE-SMOKING; SECONDHAND SMOKE; COMPLETED SUICIDE; MENTAL-HEALTH; RISK; ASSOCIATION; ASTHMA; PREVALENCE; DEPRESSION; BEHAVIOR	Background The association between smoking and suicide is still controversial, particular for early life cigarette smoking exposure. Few studies have investigated this association in adolescents using population-based cohorts, and the relationship with second hand smoking (SHS) exposure has not been addressed. Methods and Findings In this study, we followed a large population-based sample of younger people to investigate the association between smoking, SHS exposure and suicide mortality. Between October 1995 and June 1996, 162,682 junior high school students ages 11 to 16 years old living in a geographic catchment area in Taiwan were enrolled and then followed till December 2007 (1,948,432 person-years) through linkage to the National Death Certification System. Participants who were currently smoking at baseline had a greater than six-fold higher suicide mortality than those who did not smoke (29.5 vs. 4.8 per 100,000 person-years, p<0.001) as well as higher natural mortality (33.7 vs. 10.3 per 100,000 person-years, p<0.001). After controlling for gender, age, parental education, asthma, allergic rhinitis, and alcohol consumption, the adjusted hazard ratios for suicide were 3.69 (95% CI 1.85-7.39) in current smokers, and 1.47 (95% CI 0.94-2.30) and 2.83 (95% CI 1.54-5.20) respectively in adolescents exposed to SHS of 1-20 cigarettes and >20 cigarettes/per day. The estimated depression-adjusted odds ratio did not change substantially. The population attributable fractions for suicide associated with smoking and heavy SHS exposure (>20 cigarettes/per day) were 9.6% and 10.6%, respectively. Conclusions This study showed evidence of excess suicide mortality among young adults exposed to active or passive early life cigarette smoking.	[Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Chang Gung Med Fdn, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Chiayi, Taiwan; [Chen, Vincent Chin-Hung; Lai, Te-Jen] Chung San Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Chen, Vincent Chin-Hung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Kuo, Chian-Jue] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Kuo, Chian-Jue] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Wang, Tsu-Nai] Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan; [Lee, Wen-Chung; Chen, Wei J.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Ferri, Cleusa P.] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Tsai, Duujian] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Lai, Te-Jen] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Huang, Meng-Chuan] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Publ Hlth & Environm Med, Kaohsiung, Taiwan; [Huang, Meng-Chuan] Kaohsiung Med Univ Hosp, Dept Nutr & Dietet, Kaohsiung, Taiwan; [Stewart, Robert] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Ko, Ying-Chin] China Med Univ Hosp, Environm Om Dis Res Ctr, Taichung, Taiwan; [Ko, Ying-Chin] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Taipei City Hospital; Taipei Medical University; Kaohsiung Medical University; National Taiwan University; Universidade Federal de Sao Paulo (UNIFESP); Taipei Medical University; Chung Shan Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of London; King's College London; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wang, TN (corresponding author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Publ Hlth, Kaohsiung, Taiwan.	wangtn@kmu.eud.tw; ycko0406@gmail.com	Ferri, Cleusa Pinheiro/B-2922-2010; Stewart, Robert/B-1667-2010	Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Stewart, Robert/0000-0002-4435-6397; Wang, Tsu-Nai/0000-0002-0278-289X	National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; Taiwan Ministry of Health Welfare [MOHW 103-TD-B-111-03]; China Medical University Hospital (Taichung, Taiwan) [DMR-103-118]; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan) [MOHW104-TDU-B-212-124-002]; Environmental Protective Administration (Taiwan) [EPA85-1601-08-05]; Ministry of Science and Technology (Taiwan) [MOST 103-2314-B-037-018-MY3, 102-2314-B-182A-122-MY3, 99-2314-B-040-021-MY3]; Taipei City Hospital [97001-62-001]; NIH [P20 MH071897]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH071897] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London; Taiwan Ministry of Health Welfare; China Medical University Hospital (Taichung, Taiwan); Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan); Environmental Protective Administration (Taiwan); Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Taipei City Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	RS is partially funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. Other funding was provided by grant MOHW 103-TD-B-111-03 from Taiwan Ministry of Health Welfare, DMR-103-118 from China Medical University Hospital (Taichung, Taiwan), grant MOHW104-TDU-B-212-124-002 from Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan), grant EPA85-1601-08-05 from the Environmental Protective Administration (Taiwan); grant MOST 103-2314-B-037-018-MY3, 102-2314-B-182A-122-MY3 and 99-2314-B-040-021-MY3 from Ministry of Science and Technology (Taiwan), grant 97001-62-001 from Taipei City Hospital, and NIH grant P20 MH071897. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandiera FC, 2011, ARCH PEDIAT ADOL MED, V165, P332, DOI 10.1001/archpediatrics.2011.30; Boden JM, 2008, PSYCHOL MED, V38, P433, DOI 10.1017/S0033291707001547; Breslau N, 2005, ARCH GEN PSYCHIAT, V62, P328, DOI 10.1001/archpsyc.62.3.328; Bubak ME, 2008, S DAKOTA MED J S DAK, P13; Chang SS, 2010, SOC PSYCH PSYCH EPID, V45, P143, DOI 10.1007/s00127-009-0049-x; Crump C, 2014, PSYCHOL MED, V44, P279, DOI 10.1017/S0033291713000810; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Edition t, 1999, KAPLAN SADOCKS COMPR; General S, 2012, PREVENTING TOBACCO U, P12; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Greenland S, 2008, MODERN EPIDEMIOLOGY, V3rd; Hallfors DD, 2004, AM J PREV MED, V27, P224, DOI 10.1016/j.amepre.2004.06.001; Hamer M, 2010, ARCH GEN PSYCHIAT, V67, P850, DOI 10.1001/archgenpsychiatry.2010.76; Hemmingsson T, 2003, INT J EPIDEMIOL, V32, P1000, DOI 10.1093/ije/dyg203; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Iwasaki M, 2005, ANN EPIDEMIOL, V15, P286, DOI 10.1016/j.annepidem.2004.08.011; Jha P, 2002, AM J PUBLIC HEALTH, V92, P1002, DOI 10.2105/AJPH.92.6.1002; KLATSKY AL, 1993, ALCOHOL CLIN EXP RES, V17, P1156, DOI 10.1111/j.1530-0277.1993.tb05221.x; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kuo CJ, 2010, AM J PSYCHIAT, V167, P1092, DOI 10.1176/appi.ajp.2010.09101455; Lai HK, 2009, PEDIATRICS, V124, P1306, DOI 10.1542/peds.2009-0669; Lewitzka U, 2008, ACTA PSYCHIAT SCAND, V117, P41, DOI 10.1111/j.1600-0447.2007.01121.x; Li DJ, 2012, J PSYCHIATR RES, V46, P1257, DOI 10.1016/j.jpsychires.2012.03.013; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Malone KM, 2003, AM J PSYCHIAT; Markou A, 2002, NEUROTOX RES, V4, P297, DOI 10.1080/10298420290023963; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; Miller M, 2000, AM J EPIDEMIOL, V151, P1060, DOI 10.1093/oxfordjournals.aje.a010148; Olausson P, 2002, PHARMACOL BIOCHEM BE, V71, P757, DOI 10.1016/S0091-3057(01)00673-6; Padron A, 2014, TOB CONTROL, V23, P302, DOI 10.1136/tobaccocontrol-2012-050548; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Polanska K, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320600886562; Riala K, 2007, J CLIN PSYCHIAT, V68, P775, DOI 10.4088/JCP.v68n0518; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; SHAW RA, 1992, MED J AUSTRALIA, V157, P311, DOI 10.5694/j.1326-5377.1992.tb137182.x; Wang TN, 1999, ENVIRON RES, V81, P239, DOI 10.1006/enrs.1999.3985; Wen CP, 2005, TOB CONTROL, V14, pI28, DOI 10.1136/tc.2003.005629; Wipfli H, 2009, CLIN PHARMACOL THER, V86, P272, DOI 10.1038/clpt.2009.94	39	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0130044	10.1371/journal.pone.0130044	http://dx.doi.org/10.1371/journal.pone.0130044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222448	Green Published, gold			2022-12-27	WOS:000358836800006
J	Heinze, J; Buschinger, A; Poettinger, T; Suefuji, M				Heinze, Juegen; Buschinger, Alfred; Poettinger, Theo; Suefuji, Masaki			Multiple Convergent Origins of Workerlessness and Inbreeding in the Socially Parasitic Ant Genus Myrmoxenus	PLOS ONE			English	Article							SYMPATRIC SPECIATION; EPIMYRMA HYMENOPTERA; EVOLUTION; MORPHOLOGY; RAVOUXI	The socially parasitic ant genus Myrmoxenus varies strongly in fundamental life history traits, such as queen-worker ratio, the timing of sexual production, and mating behavior. Myrmoxenus queens generally take over nests of Temnothorax ants, kill the resident queen by throttling, and force the workers to take care of the social parasite's brood. Young queens of M. ravouxi and other species produce large numbers of workers, which during "slaveraids" pillage host pupae from neighboring Temnothorax colonies to increase the workforce in their own nests. Other species, such as M. corsicus, have lost caste polyphenism and rear only male and female sexual offspring. Using sequences of the genes CO I / CO II and wingless we reconstruct the phylogeny of Myrmoxenus and document that the worker caste was lost convergently at least three times. Furthermore, mating in the nest and inbreeding obviously also evolved in parallel from ancestors whose sexuals presumably mated during nuptial flights. Myrmoxenus might thus provide a suitable model to investigate caste differentiation and the plasticity of mating behavior in Hymenoptera.	[Heinze, Juegen; Poettinger, Theo; Suefuji, Masaki] Univ Regensburg, Zool Evolutionary Biol, D-93053 Regensburg, Germany; [Buschinger, Alfred] Tech Univ Darmstadt, Reinheim, Germany	University of Regensburg; Technical University of Darmstadt	Heinze, J (corresponding author), Univ Regensburg, Zool Evolutionary Biol, D-93053 Regensburg, Germany.	juergen.heinze@ur.de	Poettinger, Theodor/A-8141-2015	Poettinger, Theodor/0000-0001-7274-615X	 [15623/24]		Funding was provided by He 15623/24, www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beibl J, 2007, INSECT SOC, V54, P174, DOI 10.1007/s00040-007-0929-6; Beibl J, 2005, INSECT SOC, V52, P291, DOI 10.1007/s00040-005-0808-y; Bolton B., 1994, IDENTIFICATION GUIDE; BOURKE AFG, 1991, BIOL J LINN SOC, V43, P157, DOI 10.1111/j.1095-8312.1991.tb00591.x; Buschinger A., 1983, Psyche (Cambridge), V90, P335, DOI 10.1155/1983/48717; BUSCHINGER A, 1986, Psyche (Cambridge), V93, P253, DOI 10.1155/1986/43540; BUSCHINGER A, 1989, Psyche (Cambridge), V96, P69, DOI 10.1155/1989/19504; BUSCHINGER A, 1985, ENTOMOL GEN, V10, P65; BUSCHINGER A, 1980, Z TIERPSYCHOL, V53, P245; BUSCHINGER A, 1983, ENTOMOL GEN, V8, P251; BUSCHINGER A, 1989, J EVOLUTION BIOL, V2, P265, DOI 10.1046/j.1420-9101.1989.2040265.x; BUSCHINGER A, 1990, Z ZOOL SYST EVOL, V28, P241; Buschinger Alfred, 2001, Myrmecologische Nachrichten, V4, P25; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; Cardoso DC, 2014, MOL PHYLOGENET EVOL, V70, P378, DOI 10.1016/j.ympev.2013.10.012; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DOUWES P, 1988, ENTOMOL SCAND, V19, P239; Gratiashvili N, 2014, ORG DIVERS EVOL, V14, P259, DOI 10.1007/s13127-014-0174-6; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heinze J, 2000, TRENDS ECOL EVOL, V15, P508, DOI 10.1016/S0169-5347(00)01995-9; Horandl E, 2010, TAXON, V59, P1641, DOI 10.1002/tax.596001; Holldobler B., 1990, pi; Holldobler B., 2008, SUPERORGANISM BEAUTY; JESSEN K, 1990, INSECT SOC, V37, P273, DOI 10.1007/BF02225993; Oster G.F., 1978, Monographs in Population Biology, pi; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; PEETERS C, 1991, BIOL J LINN SOC, V44, P141, DOI 10.1111/j.1095-8312.1991.tb00612.x; Peeters C, 2012, MYRMECOL NEWS, V16, P75; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sambrook J., 2001, MOL CLONING; Schrempf A, 2006, HEREDITY, V97, P75, DOI 10.1038/sj.hdy.6800846; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schulz Andreas, 2002, Entomofauna, V23, P157; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; SEIFERT B, 2007, AMEISEN MITTEL NORDE; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suefuji M, 2015, INTEGR ZOOL, V10, P182, DOI 10.1111/1749-4877.12120; Suefuji M, 2014, CONSERV GENET, V15, P201, DOI 10.1007/s10592-013-0531-6; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Ward PS, 2015, SYST ENTOMOL, V40, P61, DOI 10.1111/syen.12090; WHEELER WILLIAM MORTON, 1931, BULL MUS COMP ZOOL HARVARD COLLEGE, V72, P1; Wheeler WM, 1913, B MUS COMP ZOOL HARV, V54, P477; WILSON EO, 1963, EVOLUTION, V17, P249, DOI 10.2307/2406469	44	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131023	10.1371/journal.pone.0131023	http://dx.doi.org/10.1371/journal.pone.0131023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221735	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800011
J	Igawa, T; Watanabe, A; Suzuki, A; Kashiwagi, A; Kashiwagi, K; Noble, A; Guille, M; Simpson, DE; Horb, ME; Fujii, T; Sumida, M				Igawa, Takeshi; Watanabe, Ai; Suzuki, Atsushi; Kashiwagi, Akihiko; Kashiwagi, Keiko; Noble, Anna; Guille, Matt; Simpson, David E.; Horb, Marko E.; Fujii, Tamotsu; Sumida, Masayuki			Inbreeding Ratio and Genetic Relationships among Strains of the Western Clawed Frog, Xenopus tropicalis	PLOS ONE			English	Article							GENOME; ACCURACY; MUTANTS; LAEVIS; TREES; TOOL; MAP	The Western clawed frog, Xenopus tropicalis, is a highly promising model amphibian, especially in developmental and physiological research, and as a tool for understanding disease. It was originally found in the West African rainforest belt, and was introduced to the research community in the 1990s. The major strains thus far known include the Nigerian and Ivory Coast strains. However, due to its short history as an experimental animal, the genetic relationship among the various strains has not yet been clarified, and establishment of inbred strains has not yet been achieved. Since 2003 the Institute for Amphibian Biology (IAB), Hiroshima University has maintained stocks of multiple X. tropicalis strains and conducted consecutive breeding as part of the National BioResource Project. In the present study we investigated the inbreeding ratio and genetic relationship of four inbred strains at IAB, as well as stocks from other institutions, using highly polymorphic microsatellite markers and mitochondrial haplotypes. Our results show successive reduction of heterozygosity in the genome of the IAB inbred strains. The Ivory Coast strains clearly differed from the Nigerian strains genetically, and three subgroups were identified within both the Nigerian and Ivory Coast strains. It is noteworthy that the Ivory Coast strains have an evolutionary divergent genetic background. Our results serve as a guide for the most effective use of X. tropicalis strains, and the long-term maintenance of multiple strains will contribute to further research efforts.	[Igawa, Takeshi; Watanabe, Ai; Suzuki, Atsushi; Kashiwagi, Akihiko; Kashiwagi, Keiko; Sumida, Masayuki] Hiroshima Univ, Grad Sch Sci, Inst Amphibian Biol, Higashihiroshima, Hiroshima 724, Japan; [Noble, Anna; Guille, Matt] Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Portsmouth, Hants, England; [Simpson, David E.] Univ Cambridge, Henry Wellcome Bldg Canc & Dev Biol, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge, England; [Horb, Marko E.] Marine Biol Lab, Bell Ctr Regenerat Biol & Tissue Engn, Woods Hole, MA 02543 USA; [Horb, Marko E.] Marine Biol Lab, Natl Xenopus Resource, Woods Hole, MA 02543 USA; [Fujii, Tamotsu] Prefectural Univ Hiroshima, Fac Human Culture & Sci, Dept Hlth Sci, Hiroshima, Japan	Hiroshima University; University of Portsmouth; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole	Igawa, T (corresponding author), Hiroshima Univ, Grad Sch Int Dev & Cooperat, Div Dev Sci, Higashihiroshima, Hiroshima 724, Japan.	tigawa@hiroshima-u.ac.jp	Igawa, Takeshi/E-2881-2014	Igawa, Takeshi/0000-0001-6880-6180; Horb, Marko/0000-0002-5067-0518; Guille, Matthew/0000-0001-6865-4519	Wellcome Trust [101480/Z/13/Z]; Biotechnology and Biological Sciences Research Council [BB/K019988/1]; Ministry of Education, Culture, Sports, Science and Technology, Japan [23710282, 20510216]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010997] Funding Source: NIH RePORTER; BBSRC [BB/K019988/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (101480/Z/13/Z, http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_publishing_group/documents/web_document/wts058331.pdf) and Biotechnology and Biological Sciences Research Council (BB/K019988/1, http://www.bbsrc.ac.uk/pa/grants/AwardDetails.aspx? FundingReference=BB/K019988/1) to the European Xenopus Resource Centre. This work was also supported by a Grant-in-Aid for Young Scientists (B) (No. 23710282, http://kaken.nii.ac.jp/d/p/23710282.en.html) to TI from the Ministry of Education, Culture, Sports, Science and Technology, Japan and a Grant-in-Aid for Scientific Research (B) (No. 20510216, http://kaken.nii.ac.jp/d/p/24310173.en.html) to MS from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Castresana J, 2002, GBLOCKS SELECTION OF; Coe TS, 2009, ECOTOXICOLOGY, V18, P144, DOI 10.1007/s10646-008-0267-0; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gao Z, 2014, EVOLUTION NY, V62, P431, DOI [10.1111/evo.12567, DOI 10.1111/EV0.12567]; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grainger Robert M, 2012, Methods Mol Biol, V917, P3, DOI 10.1007/978-1-61779-992-1_1; Grammer TC, 2005, MECH DEVELOP, V122, P263, DOI 10.1016/j.mod.2004.11.003; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Ishibashi S, 2012, BIOL OPEN, V1, P1273, DOI 10.1242/bio.20123228; Johnson SL, 1999, METHOD CELL BIOL, V60, P357; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; KROTOSKI DM, 1985, J EXP ZOOL, V233, P443, DOI 10.1002/jez.1402330313; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Milligan BG, 2003, GENETICS, V163, P1153; Nakajima K, 2012, DEV GROWTH DIFFER, V54, P777, DOI 10.1111/dgd.12006; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nowell RW, 2011, GENET RES, V93, P255, DOI 10.1017/S0016672311000206; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Sater AK, 2012, GENOME MAPPING GENOM, P183, DOI 10.1007/978-3-642-31316-5; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seifertova E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-357; Showell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022392; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMPKINS R, 1991, METHOD CELL BIOL, V36, P35; TYMOWSKA J, 1973, CHROMOSOMA, V44, P335, DOI 10.1007/BF00291027; Uno Y, 2013, HEREDITY, V111, P430, DOI 10.1038/hdy.2013.65; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; van Oppen MJH, 2000, MOL BIOL EVOL, V17, P489, DOI 10.1093/oxfordjournals.molbev.a026329; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wells DE, 2011, DEV BIOL, V354, P1, DOI 10.1016/j.ydbio.2011.03.022; Xu ZK, 2008, BIOINFORM BIOL INSIG, V2, P157; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108	42	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133963	10.1371/journal.pone.0133963	http://dx.doi.org/10.1371/journal.pone.0133963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222540	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800087
J	Lange, N; Unger, FT; Schoppler, M; Pursche, K; Juhl, H; David, KA				Lange, Nicole; Unger, Florian T.; Schoeppler, Monika; Pursche, Katja; Juhl, Hartmut; David, Kerstin A.			Identification and Validation of a Potential Marker of Tissue Quality Using Gene Expression Analysis of Human Colorectal Tissue	PLOS ONE			English	Article							REAL-TIME PCR; CELL CARCINOMA; ISCHEMIA; PROTEIN; IMPACT; TUMOR; MODEL	Correlative studies have identified numerous biomarkers that are individualizing therapy across many medical specialties, including oncology. Accurate interpretation of these studies requires the collection of tissue samples of sufficient quality. Tissue quality can be measured by changes in levels of gene expression and can be influenced by many factors including pre-analytical conditions, ischemic effects and the surgical collection procedure itself. However, as yet there are no reliable biomarkers of tissue quality at researchers' disposal. The aim of the current study was to identify genes with expression patterns that fluctuated reproducibly in response to typical post-surgical stress (ischemia) in order to identify a specific marker of tissue quality. All tissue samples were obtained from patients with primary colorectal carcinoma (CRC) (N = 40) either via colonoscopy prior to surgery, or by surgical resection. Surgically resected tissue samples were divided into three groups and subjected to cold ischemia for 10, 20 or 45 minutes. Normal colorectal tissue and CRC tissue was analyzed using microarray and quantitative real-time PCR (qPCR). Comparing changes in gene expression between pre-and post-surgical tissue using microarray analysis identified a list of potential tissue quality biomarkers and this list was validated using qPCR. Results revealed that postoperative ischemia significantly alters gene expression in normal and CRC tissue samples. Both microarray analysis and qPCR revealed regulator of G-protein signaling 1 (RGS1) as a potential marker of CRC tissue quality and eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) as a potential reference gene of post-operative tissue quality. Larger studies with additional time points and endpoints will be needed to confirm these results.	[Lange, Nicole; Unger, Florian T.; Schoeppler, Monika; Pursche, Katja; Juhl, Hartmut; David, Kerstin A.] Indivumed GmbH, Hamburg, Germany		David, KA (corresponding author), Indivumed GmbH, Hamburg, Germany.	David@indivumed.com			Indivumed GmbH; Federal funds from the National Cancer Institute, National Institutes of Health [HHSN261200800001E]	Indivumed GmbH; Federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded in part by Indivumed GmbH and with Federal funds from the National Cancer Institute, National Institutes of Health (http://www.cancer.gov/), under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. National Cancer Institute, National Institutes of Health had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Indivumed GmbH provided support in the form of salaries for all authors (Nicole Lange, Florian T. Unger, Monika Schoppler, Katja Pursche, Hartmut Juhl and Kerstin A. David), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cervia D, 2008, J NEUROCHEM, V106, P2224, DOI 10.1111/j.1471-4159.2008.05556.x; David KA, 2014, ONCOTARGET, V5, P11017, DOI 10.18632/oncotarget.2669; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gourdin M, 2013, IMPACT ISCHEMIA CELL; Huang J, 2001, J SURG RES, V99, P222, DOI 10.1006/jsre.2001.6195; Hwang IY, 2010, GENES IMMUN, V11, P384, DOI 10.1038/gene.2010.27; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Liu NW, 2013, CLIN CANCER RES, V19, P42, DOI 10.1158/1078-0432.CCR-12-2606; Moratz C, 2004, MOL CELL BIOL, V24, P5767, DOI 10.1128/MCB.24.13.5767-5775.2004; Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17; Piepoli A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-11; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Piovan E, 2007, CANCER RES, V67, P8605, DOI 10.1158/0008-5472.CAN-06-4722; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Sinicropi D, 2007, BIOMEMS BIOMEDICAL N, VII, P23, DOI DOI 10.1007/B136238/PAGE/1]; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Wierenga ATJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093494; Yamagishi A, 2014, ONCOL REP, V31, P1531, DOI 10.3892/or.2014.3053; Zhan C, 2014, ACTA BIOCH BIOPH SIN, V46, P330, DOI 10.1093/abbs/gmt153	23	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133987	10.1371/journal.pone.0133987	http://dx.doi.org/10.1371/journal.pone.0133987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222051	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800093
J	Rueckert, IM; Baumert, J; Schunk, M; Holle, R; Schipf, S; Voelzke, H; Kluttig, A; Greiser, KH; Tamayo, T; Rathmann, W; Meisinger, C				Ruckert, Ina-Maria; Baumert, Jens; Schunk, Michaela; Holle, Rolf; Schipf, Sabine; Volzke, Henry; Kluttig, Alexander; Greiser, Karin-Halina; Tamayo, Teresa; Rathmann, Wolfgang; Meisinger, Christa			Blood Pressure Control Has Improved in People with and without Type 2 Diabetes but Remains Suboptimal: A Longitudinal Study Based on the German DIAB-CORE Consortium	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PULSE PRESSURE; HYPERTENSION; RISK; POPULATION; PREVALENCE; MANAGEMENT; HEALTH; IMPACT	Background Hypertension is a very common comorbidity and major risk factor for cardiovascular complications, especially in people with Type 2 Diabetes (T2D). Nevertheless, studies in the past have shown that blood pressure is often insufficiently controlled in medical practice. For the DIAB-CARE study, we used longitudinal data based on the German DIAB-CORE Consortium to assess whether health care regarding hypertension has improved during the last decade in our participants. Methods Data of the three regional population-based studies CARLA (baseline 2002-2006 and follow-up 2007-2010), KORA (baseline 1999-2001 and follow-up 2006-2008) and SHIP (baseline 1997-2001 and follow-up 2002-2006) were pooled. Stratified by T2D status we analysed changes in frequencies, degrees of awareness, treatment and control. Linear mixed models were conducted to assess the influence of sex, age, study, and T2D status on changes of systolic blood pressure between the baseline and follow-up examinations (mean observation time 5.7 years). We included 4,683 participants aged 45 to 74 years with complete data and accounted for 1,256 participants who were lost to follow-up by inverse probability weighting. Results Mean systolic blood pressure decreased in all groups from baseline to follow-up (e. g. -8.5 mmHg in those with incident T2D). Pulse pressure (PP) was markedly higher in persons with T2D than in persons without T2D (64.14 mmHg in prevalent T2D compared to 52.87 mmHg in non-T2D at baseline) and did not change much between the two examinations. Awareness, treatment and control increased considerably in all subgroups however, the percentage of those with insufficiently controlled hypertension remained high (at about 50% of those with hypertension) especially in prevalent T2D. Particularly elderly people with T2D often had both, high blood pressure >= 140/90 mmHg and a PP of >= 60 mmHg. Blood pressure in men had improved more than in women at follow-up, however, men still had higher mean SBP than women at follow-up. Conclusion Blood pressure management has developed positively during past years in Germany. While hypertension prevalence, awareness and treatment were substantially higher in participants with T2D than in those without T2D at follow-up, hypertension control was achieved only in about half the number of people in each T2D group leaving much room for further improvement.	[Ruckert, Ina-Maria; Baumert, Jens; Meisinger, Christa] Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Ruckert, Ina-Maria; Baumert, Jens; Schunk, Michaela; Holle, Rolf; Meisinger, Christa] German Ctr Diabet Res DZD EV, D-85764 Neuherberg, Germany; [Schunk, Michaela; Holle, Rolf] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Schipf, Sabine; Volzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Volzke, Henry] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Kluttig, Alexander; Greiser, Karin-Halina] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, D-06108 Halle, Saale, Germany; [Greiser, Karin-Halina] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Tamayo, Teresa; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; German Centre for Cardiovascular Research; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Rueckert, IM (corresponding author), Helmholtz Zentrum Munchen, Inst Epidemiol 2, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany.	ina-maria.rueckert@helmholtz-muenchen.de	Holle, Rolf/D-9333-2013; Meisinger, Christine/B-5358-2014	Holle, Rolf/0000-0001-5395-2695; Schunk, Michaela/0000-0002-1200-1903; Meisinger, Christa/0000-0002-9026-6544	'Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)' - Federal Ministry of Education and Research [FKZ 01GI0814-0816/-0855-0858]; Deutsche Forschungsgemeinschaft [Collaborative Research Center 598]; Wilhelm-Roux Programme of the Martin-Luther University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office; Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; German Federal Ministry of Education and Research (BMBF) [01ZZ0403]; Ministry for Education, Research and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania	'Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)' - Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Roux Programme of the Martin-Luther University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office; Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Research and Cultural Affairs; Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania	This work was supported by 'Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus)' funded by the Federal Ministry of Education and Research (FKZ 01GI0814-0816/-0855-0858). The CARLA study was funded by a grant from the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 598 'Heart failure in the elderly - cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther University Halle-Wittenberg, by a grant from the Wilhelm-Roux Programme of the Martin-Luther University Halle-Wittenberg, by the Ministry of Education and Cultural Affairs of Saxony-Anhalt and by the Federal Employment Office. The KORA research platform (KORA, Cooperative Health Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. SHIP is part of the Community Medicine Research net (http://www.community-medicine.de) at the University of Greifswald, Germany. Funding was provided by grants from the German Federal Ministry of Education and Research (BMBF, grant 01ZZ0403), the Ministry for Education, Research and Cultural Affairs and the Ministry for Social Affairs of the Federal State of Mecklenburg-West Pomerania.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anthony H, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-24; Assmann G, 2005, EUR HEART J, V26, P2120, DOI 10.1093/eurheartj/ehi467; Avanzini F, 2006, J HYPERTENS, V24, P2377, DOI 10.1097/01.hjh.0000251897.40002.bf; Bundesarztek&auml;mmer, 2002, NATIONALES PROGRAMM; Bundesarztekammer. Programm fur Nationale Versorgungsleitlinien, 2013, PROGRAMM FUR NATIONA; Dao HH, 2005, CARDIOVASC RES, V66, P307, DOI 10.1016/j.cardiores.2005.01.012; de Burgos-Lunar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086713; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Furthauer J, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-47; Greiser Karin H, 2005, BMC Cardiovasc Disord, V5, P33, DOI 10.1186/1471-2261-5-33; Greving JP, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-25; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Janhsen K, 2008, HYPERTONIE; Kengne AP, 2009, HYPERTENSION, V54, P399, DOI 10.1161/HYPERTENSIONAHA.109.133041; Kshirsagar AV, 2006, AM J MED, V119, P133, DOI 10.1016/j.amjmed.2005.08.023; Labeit AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052229; Lawes CMM, 2006, J HYPERTENS, V24, P413, DOI 10.1097/01.hjh.0000199801.72563.6f; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; MARMOT MG, 1984, BRIT MED BULL, V40, P380, DOI 10.1093/oxfordjournals.bmb.a072008; Neuhauser HK, 2015, J HUM HYPERTENS, V29, P247, DOI 10.1038/jhh.2014.82; Niiranen TJ, 2006, J HYPERTENS, V24, P463, DOI 10.1097/01.hjh.0000209982.21112.bc; Nilsson PM, 2009, DIABETES METAB, V35, P439, DOI 10.1016/j.diabet.2009.04.010; Ott P, 2009, DEUT MED WOCHENSCHR, V134, P291, DOI 10.1055/s-0028-1123994; PAGE LB, 1974, CIRCULATION, V49, P1132, DOI 10.1161/01.CIR.49.6.1132; Prugger C, 2006, HERZ, V31, P287, DOI 10.1007/s00059-006-2818-6; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; Ruckert IM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-120; Ruckert IM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-50; Schunk M, 2011, BUNDESGESUNDHEITSBLA, V54, P1187, DOI 10.1007/s00103-011-1364-4; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Stark RG, 2011, DIABETES-METAB RES, V27, P383, DOI 10.1002/dmrr.1186; Strandberg TE, 2003, CURR OPIN NEPHROL HY, V12, P293, DOI 10.1097/00041552-200305000-00011; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Williams B, 2008, DIABETIC MED, V25, P13, DOI 10.1111/j.1464-5491.2008.02506.x; Zhao D, 2011, NAT REV CARDIOL, V8, P456, DOI 10.1038/nrcardio.2011.75; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061779	40	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133493	10.1371/journal.pone.0133493	http://dx.doi.org/10.1371/journal.pone.0133493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221962	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800052
J	Wong, ESY; Shekar, S; Chan, CHT; Hong, LZ; Poon, SY; Silla, T; Lin, C; Kumar, V; Davila, S; Voorhoeve, M; Thike, AA; Ho, GH; Yap, YS; Tan, PH; Tan, MH; Ang, P; Lee, ASG				Wong, Edward S. Y.; Shekar, Sandhya; Chan, Claire H. T.; Hong, Lewis Z.; Poon, Suk-Yean; Silla, Toomas; Lin, Clarabelle; Kumar, Vikrant; Davila, Sonia; Voorhoeve, Mathijs; Thike, Aye Aye; Ho, Gay Hui; Yap, Yoon Sim; Tan, Puay Hoon; Tan, Min-Han; Ang, Peter; Lee, Ann S. G.			Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; ESTROGEN-RECEPTOR STATUS; GERMLINE MUTATIONS; OVARIAN-CANCER; WOMEN; GRADE; PREVALENCE; CARCINOMA; PLATFORM; RISK	Purpose The National Comprehensive Cancer Network (NCCN) has proposed guidelines for the genetic testing of the BRCA1 and BRCA2 genes, based on studies in western populations. This current study assessed potential predictive factors for BRCA mutation probability, in an Asian population. Methods A total of 359 breast cancer patients, who presented with either a family history (FH) of breast and/or ovarian cancer or early onset breast cancer, were accrued at the National Cancer Center Singapore (NCCS). The relationships between clinico-pathological features and mutational status were calculated using the Chi-squared test and binary logistic regression analysis. Results Of 359 patients, 45 (12.5%) had deleterious or damaging missense mutations in BRCA1 and/or BRCA2. BRCA1 mutations were more likely to be found in ER-negative than ER-positive breast cancer patients (P=0.01). Moreover, ER-negative patients with BRCA mutations were diagnosed at an earlier age (40 vs. 48 years, P=0.008). Similarly, triple-negative breast cancer (TNBC) patients were more likely to have BRCA1 mutations (P=0.001) and that these patients were diagnosed at a relatively younger age than non-TNBC patients (38 vs. 46 years, P=0.028). Our analysis has confirmed that ER-negative status, TNBC status and a FH of hereditary breast and ovarian cancer (HBOC) are strong factors predicting the likelihood of having BRCA mutations. Conclusions Our study provides evidence that TNBC or ER-negative patients may benefit from BRCA genetic testing, particularly younger patients (<40 years) or those with a strong FH of HBOC, in Asian patients.	[Wong, Edward S. Y.; Shekar, Sandhya; Chan, Claire H. T.; Lee, Ann S. G.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Med Sci, Singapore, Singapore; [Hong, Lewis Z.; Poon, Suk-Yean] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Silla, Toomas; Voorhoeve, Mathijs] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Lin, Clarabelle; Kumar, Vikrant; Davila, Sonia] Genome Inst Singapore, Human Genet, Singapore, Singapore; [Thike, Aye Aye; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Ho, Gay Hui] Natl Canc Ctr, Dept Surg Oncol, Singapore, Singapore; [Yap, Yoon Sim; Tan, Min-Han; Ang, Peter] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Ang, Peter] Mt Elizabeth Novena Specialist Ctr, OncoCare Canc Ctr, Singapore, Singapore; [Lee, Ann S. G.] Natl Univ Singapore, Yong Yoo Lin Sch Med, Dept Physiol, Singapore 117548, Singapore; [Lee, Ann S. G.] Duke NUS Grad Med Sch, Off Clin & Acad Fac Affairs, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Singapore General Hospital; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore	Lee, ASG (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Med Sci, Singapore, Singapore.	dmslsg@nccs.com.sg	Lin, Clarabelle/AAK-4409-2020; Tan, Min/GQQ-2702-2022	Ang, Peter/0000-0002-0482-3069; Yap, Yoon-Sim/0000-0002-0347-5066	National Medical Research Council of Singapore [NMRC/CBRG/0034/2013]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by the National Medical Research Council of Singapore (NMRC/CBRG/0034/2013).	Ahmed SS, 2011, J CLIN PATHOL, V64, P120, DOI 10.1136/jcp.2010.085423; Ang P, 2007, CANCER EPIDEM BIOMAR, V16, P2276, DOI 10.1158/1055-9965.EPI-07-0403; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Bayraktar S, 2011, BREAST CANCER RES TR, V130, P145, DOI 10.1007/s10549-011-1711-z; Castera L, 2014, NEXT GENERATION SEQU; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan M, 2012, J MOL DIAGN, V14, P602, DOI 10.1016/j.jmoldx.2012.06.003; Claes K, 1999, Hum Mutat, V13, P256, DOI 10.1002/(SICI)1098-1004(1999)13:3<256::AID-HUMU12>3.0.CO;2-M; Comen E, 2011, BREAST CANCER RES TR, V129, P185, DOI 10.1007/s10549-011-1433-2; Eisinger F, 1996, CANCER RES, V56, P471; Evans DG, 2011, J MED GENET, V48, P520, DOI 10.1136/jmedgenet-2011-100006; Feliubadalo L, 2013, EUR J HUM GENET, V21, P864, DOI 10.1038/ejhg.2012.270; Fostira F, 2012, BREAST CANCER RES TR, V134, P353, DOI 10.1007/s10549-012-2021-9; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Ho GH, 2000, CANCER-AM CANCER SOC, V89, P811, DOI 10.1002/1097-0142(20000815)89:4<811::AID-CNCR13>3.0.CO;2-R; Iqbal J, 2012, HISTOPATHOLOGY, V61, P652, DOI 10.1111/j.1365-2559.2012.04255.x; Janavicius R, 2010, EPMA J, V1, P397, DOI 10.1007/s13167-010-0037-y; Kang PCE, 2014, BREAST CANCER RES TR, V144, P635, DOI 10.1007/s10549-014-2894-x; Karp SE, 1997, CANCER-AM CANCER SOC, V80, P435, DOI 10.1002/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; Loman N, 1998, CANCER, V83, P310, DOI 10.1002/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038361, DOI 10.1371/J0URNAL.P0NE.0038361]; National Comprehensive Cancer Network I, 2014, NCCN GUID GEN FAM HI; Peshkin Beth N, 2010, Breast Dis, V32, P25, DOI 10.3233/BD-2010-0306; Phuah SY, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3347; Robson M, 1998, J CLIN ONCOL, V16, P1642, DOI 10.1200/JCO.1998.16.5.1642; Seong MW, 2014, BREAST CANCER RES TR, V146, P63, DOI 10.1007/s10549-014-3006-7; Snape K, 2012, BREAST CANCER RES TR, V134, P429, DOI 10.1007/s10549-012-2057-x; Teng YHF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2857; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Yeo ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-516	35	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134408	10.1371/journal.pone.0134408	http://dx.doi.org/10.1371/journal.pone.0134408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26221963	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800142
J	Dynnik, VV; Kononov, AV; Sergeev, AI; Teplov, IY; Tankanag, AV; Zinchenko, VP				Dynnik, Vladimir V.; Kononov, Alexey V.; Sergeev, Alexander I.; Teplov, Iliya Y.; Tankanag, Arina V.; Zinchenko, Valery P.			To Break or to Brake Neuronal Network Accelerated by Ammonium Ions?	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; HEPATIC-ENCEPHALOPATHY; NMDA RECEPTORS; SPINAL-CORD; N-ACETYLASPARTYLGLUTAMATE; PRIMARY CULTURES; LIVER-FAILURE; L-CARNITINE; IN-VITRO; RAT	Purpose The aim of present study was to investigate the effects of ammonium ions on in vitro neuronal network activity and to search alternative methods of acute ammonia neurotoxicity prevention. Methods Rat hippocampal neuronal and astrocytes co-cultures in vitro, fluorescent microscopy and perforated patch clamp were used to monitor the changes in intracellular Ca2+- and membrane potential produced by ammonium ions and various modulators in the cells implicated in neural networks. Results Low concentrations of NH4Cl (0.1-4 mM) produce short temporal effects on network activity. Application of 5-8 mM NH4Cl: invariably transforms diverse network firing regimen to identical burst patterns, characterized by substantial neuronal membrane depolarization at plateau phase of potential and high-amplitude Ca2+-oscillations; raises frequency and average for period of oscillations Ca2+-level in all cells implicated in network; results in the appearance of group of "run out" cells with high intracellular Ca2+ and steadily diminished amplitudes of oscillations; increases astrocyte Ca2+-signalling, characterized by the appearance of groups of cells with increased intracellular Ca2+-level and/or chaotic Ca2+-oscillations. Accelerated network activity may be suppressed by the blockade of NMDA or AMPA/kainate-receptors or by overactivation of AMPA/kainite-receptors. Ammonia still activate neuronal firing in the presence of GABA(A) receptors antagonist bicuculline, indicating that "disinhibition phenomenon" is not implicated in the mechanisms of networks acceleration. Network activity may also be slowed down by glycine, agonists of metabotropic inhibitory receptors, betaine, L-carnitine, L-arginine, etc. Conclusions Obtained results demonstrate that ammonium ions accelerate neuronal networks firing, implicating ionotropic glutamate receptors, having preserved the activities of group of inhibitory ionotropic and metabotropic receptors. This may mean, that ammonia neurotoxicity might be prevented by the activation of various inhibitory receptors (i.e. by the reinforcement of negative feedback control), instead of application of various enzyme inhibitors and receptor antagonists (breaking of neural, metabolic and signaling systems).	[Dynnik, Vladimir V.; Kononov, Alexey V.; Sergeev, Alexander I.; Teplov, Iliya Y.; Tankanag, Arina V.; Zinchenko, Valery P.] Russian Acad Sci, Inst Cell Biophys, Lab Intracellular Signaling, Pushchino 142292, Russia; [Dynnik, Vladimir V.] Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Bioenerget, Pushchino 142292, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Dynnik, VV (corresponding author), Russian Acad Sci, Inst Cell Biophys, Lab Intracellular Signaling, Pushchino 142292, Russia.	dynnik@rambler.ru	Tankanag, Arina/D-7222-2012; Teplov, Ilia Y./C-7050-2015	Tankanag, Arina/0000-0002-9538-1939; Teplov, Ilia Y./0000-0001-8333-2294	Russian Foundation of Basic Research [14-04-01597, 14-0401695]; Russian Science Foundation [14-14-00989]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Foundation of Basic Research (http://www.rfbr.ru/rffi/ru/) (projects No 14-04-01597, 14-0401695) and the Russian Science Foundation (http://www.rscf.ru/) (projects No 14-14-00989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahboucha S, 2012, NEUROCHEM INT, V60, P707, DOI 10.1016/j.neuint.2011.10.003; Al Sibae Mohamad Rasm, 2009, Ther Clin Risk Manag, V5, P617; Arnsten Amy F. T., 2012, Yale Journal of Biology and Medicine, V85, P45; BASILE AS, 1991, PHARMACOL REV, V43, P27; Bergeron R, 2005, NEUROPSYCHOPHARMACOL, V30, P7, DOI 10.1038/sj.npp.1300559; Bosoi CR, 2014, J HEPATOL, V60, P554, DOI 10.1016/j.jhep.2013.10.011; Braissant O, 2013, J INHERIT METAB DIS, V36, P595, DOI 10.1007/s10545-012-9546-2; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; BRUSILOW SW, 1986, NEW ENGL J MED, V314, P786; Butterworth RF, 2002, METAB BRAIN DIS, V17, P221, DOI 10.1023/A:1021989230535; Butterworth RF, 2010, NEUROCHEM INT, V57, P383, DOI 10.1016/j.neuint.2010.03.012; Calligaris L, 2013, PEDIATR ANESTH, V23, P202, DOI 10.1111/pan.12088; Cauli O, 2014, NEUROMOL MED, V16, P360, DOI 10.1007/s12017-013-8283-5; Cauli O, 2009, METAB BRAIN DIS, V24, P69, DOI 10.1007/s11011-008-9115-4; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; Chu CJ, 2006, J GASTROEN HEPATOL, V21, P1194, DOI 10.1111/j.1440-1746.2006.04310.x; COLOMBO JP, 1971, MONOGR PAEDIATRICA, V1, P1; Darbon P, 2002, J NEUROPHYSIOL, V88, P1461, DOI 10.1152/jn.2002.88.3.1461; Darbon P, 2002, EUR J NEUROSCI, V15, P671, DOI 10.1046/j.1460-9568.2002.01904.x; Eck NV, 1877, VOEN MED J, V130, P1; FALCHETTO S, 1971, CAN J PHYSIOL PHARM, V49, P1, DOI 10.1139/y71-001; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Fisher SK, 2010, J PHYSIOL-LONDON, V588, P3355, DOI 10.1113/jphysiol.2010.190777; Fricker AC, 2009, NEUROPHARMACOLOGY, V56, P1060, DOI 10.1016/j.neuropharm.2009.03.002; Gerova A, 2004, PHYSIOL RES, V53, P357; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Gonzalez-Usano A, 2013, J NEUROCHEM, V125, P133, DOI 10.1111/jnc.12119; Granata AR, 2001, NEUROSCI LETT, V300, P49, DOI 10.1016/S0304-3940(00)01673-6; Haack N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105832; Haussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829; Hahn M, 1893, ARCH EXP PATHOL PH, V32, P161; HAWKINS RA, 1973, BIOCHEM J, V134, P1001, DOI 10.1042/bj1341001; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Hertz L, 2015, NEUROCHEM RES, V40, P241, DOI 10.1007/s11064-014-1352-9; HINDFELT B, 1971, SCAND J CLIN LAB INV, V28, P365, DOI 10.3109/00365517109095711; ILES JF, 1980, BRAIN, V103, P555, DOI 10.1093/brain/103.3.555; Imre G, 2007, CNS DRUG REV, V13, P444; Izumi Y, 2013, NEUROSCIENCE, V233, P166, DOI 10.1016/j.neuroscience.2012.12.035; JANIRI L, 1991, J NEURAL TRANSM-GEN, V86, P135, DOI 10.1007/BF01250574; Jayakumar AR, 2014, J NEUROCHEM, V128, P890, DOI 10.1111/jnc.12516; Jayakumar AR, 2009, J NEUROCHEM, V109, P252, DOI 10.1111/j.1471-4159.2009.05842.x; Kelly T, 2005, PFLUG ARCH EUR J PHY, V451, P418, DOI 10.1007/s00424-005-1483-6; Kelly T, 2006, J NEUROPHYSIOL, V96, P2342, DOI 10.1152/jn.01269.2005; Kelly T, 2009, GLIA, V57, P921, DOI 10.1002/glia.20817; Kircheis G, 2002, METAB BRAIN DIS, V17, P453, DOI 10.1023/A:1021934607762; Kleiman-Weiner M, 2009, J NEUROPHYSIOL, V102, P203, DOI 10.1152/jn.91158.2008; KLOIBER O, 1988, TOXICOLOGY, V49, P83, DOI 10.1016/0300-483X(88)90178-3; Kononov AV, 2013, RECEPTORS INTRACELLU, P275; KOSENKO E, 1995, NEUROCHEM RES, V20, P451, DOI 10.1007/BF00973101; Kosenko EA, 1995, B EXP BIOL MED+, V120, P1111, DOI 10.1007/BF02445478; Langer SZ, 2008, NEUROCHEM INT, V52, P26, DOI 10.1016/j.neuint.2007.04.031; Lee CR, 2007, J NEUROSCI, V27, P6531, DOI 10.1523/JNEUROSCI.1678-07.2007; Legrand JC, 2004, EUR J NEUROSCI, V19, P521, DOI 10.1111/j.0953-816X.2003.03143.x; Lin BJ, 2007, J PHYSIOL-LONDON, V582, P163, DOI 10.1113/jphysiol.2006.125963; LUX HD, 1971, SCIENCE, V173, P555, DOI 10.1126/science.173.3996.555; MANZONI OJ, 1995, NEUROPHARMACOLOGY, V34, P965, DOI 10.1016/0028-3908(95)00060-J; MARCAIDA G, 1992, FEBS LETT, V296, P67, DOI 10.1016/0014-5793(92)80404-5; Marchetti C, 2002, EUR J NEUROSCI, V15, P975, DOI 10.1046/j.1460-9568.2002.01927.x; Masuda A, 1998, BRAIN RES, V807, P70, DOI 10.1016/S0006-8993(98)00737-9; McDERMOTT W V Jr, 1958, Bull N Y Acad Med, V34, P357; Minana MD, 1996, J PHARMACOL EXP THER, V279, P194; Mitchell VA, 2011, NEUROPSYCHOPHARMACOL, V36, P1801, DOI 10.1038/npp.2011.59; Neale SA, 2006, J PHYSIOL-LONDON, V577, P659, DOI 10.1113/jphysiol.2006.119073; Nencki M, 1896, ARCH EXP PATHOL PH, V37, P26; Nencki M, 1895, ARCH EXP PATHOL PHAR, V36, P385; Nguyen JH, 2012, NEUROCHEM INT, V60, P676, DOI 10.1016/j.neuint.2011.10.012; NICOLL RA, 1978, J PHYSIOL-LONDON, V283, P121, DOI 10.1113/jphysiol.1978.sp012491; OCONNOR JE, 1990, ADV EXP MED BIOL, V272, P183; OCONNOR JE, 1984, FEBS LETT, V166, P331, DOI 10.1016/0014-5793(84)80106-4; Onativia J, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046017; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Pflieger JF, 2002, BRAIN RES, V935, P81, DOI 10.1016/S0006-8993(02)02469-1; RAABE W, 1975, J NEUROPHYSIOL, V38, P347, DOI 10.1152/jn.1975.38.2.347; Rose C, 2005, J BIOL CHEM, V280, P20937, DOI 10.1074/jbc.M412448200; Rose CF, 2012, CLIN PHARMACOL THER, V92, P321, DOI 10.1038/clpt.2012.112; Sanchez-Blazquez P, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00169; Schwarz CS, 2012, EXP NEUROL, V235, P368, DOI 10.1016/j.expneurol.2012.02.019; SHERLOCK S, 1961, GASTROENTEROLOGY, V41, P1; Smith MD, 2008, EPILEPSY RES, V79, P6, DOI 10.1016/j.eplepsyres.2007.12.009; SNODGRASS SR, 1990, FASEB J, V4, P2755; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Stauffer VL, 2014, J CLIN PSYCHOPHARM, V34, P552, DOI 10.1097/JCP.0000000000000187; Sturgeon JP, 2014, EXPERT REV GASTROENT, V8, P83, DOI 10.1586/17474124.2014.858598; Tankanag A.V., 2013, MED PHYS, P85; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Turovskaya MV, 2012, NEUROSCI LETT, V516, P151, DOI 10.1016/j.neulet.2012.03.084; Turovsky EA, 2012, BIOCHEM MOSC SUPPL S, V6, P35, DOI 10.1134/S1990747811060158; Turovsky EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063483; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Walder KK, 2013, EUR J NEUROSCI, V37, P118, DOI 10.1111/ejn.12027; Wang F, 2015, ACTA PHYSIOL, V214, P261, DOI 10.1111/apha.12500; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; WARREN KS, 1964, J LAB CLIN MED, V64, P442; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Xu TL, 2010, PROG NEUROBIOL, V91, P349, DOI 10.1016/j.pneurobio.2010.04.008; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Zuidema G D, 1964, Major Probl Clin Surg, V1, P102	99	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134145	10.1371/journal.pone.0134145	http://dx.doi.org/10.1371/journal.pone.0134145			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26217943	Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900088
J	Hansen, R; Scott, KP; Khan, S; Martin, JC; Berry, SH; Stevenson, M; Okpapi, A; Munro, MJ; Hold, GL				Hansen, Richard; Scott, Karen P.; Khan, Shoaib; Martin, Jenny C.; Berry, Susan H.; Stevenson, Matthew; Okpapi, Augusta; Munro, Michael J.; Hold, Georgina L.			First-Pass Meconium Samples from Healthy Term Vaginally-Delivered Neonates: An Analysis of the Microbiota	PLOS ONE			English	Article							BACTERIA; BIFIDOBACTERIUM; PRETERM; MILK	Background Considerable effort has been made to categorise the bacterial composition of the human gut and correlate findings with gastrointestinal disease. The infant gut has long been considered sterile at birth followed by rapid colonisation; however, this view has recently been challenged. We examined first-pass meconium from healthy term infants to confirm or refute sterility. Methods Healthy mothers were approached following vaginal delivery. First-pass meconium stools within 24 hours of delivery were obtained from healthy, breastfed infants with tight inclusion/exclusion criteria including rejecting any known antibiotic exposure-mother within 7 days preceding delivery or infant after birth. Stools were processed in triplicate for fluorescent insitu hybridisation (FISH) with 16S rRNA-targeted probes including Bifidobacterium; Bacteroides- Prevotella; Lactobacillaceae/Enterococcaceae; Enterobacteriaceae; Streptococcaceae; Staphylococcaceae and Enterococcaceae. Absolute counts of all bacteria and proportional identification of each bacterial group were calculated. Confirmation of bacterial presence by PCR was undertaken on FISH-positive samples. Results The mothers of 31 newborn infants were recruited, 15 met inclusion/exclusion criteria and provided a sample within 24 hours of birth, processed in the lab within 4 hours. All babies were 37-40 weeks gestation. 8/15 were male, mean birth weight was 3.4kg and mean maternal age was 32 years. Meconium samples from 10/15 (66%) infants had evidence of bacteria based on FISH analysis. Of these, PCR was positive in only 1. Positive FISH counts ranged from 2.2-41.8 x 10(4) cells/g with a mean of 15.4 x 10(4) cells/g. (The limit of detection for automated counting is 106 cells/g). Cell counts were too low to allow formal diversity analysis. Amplification by PCR was not possible despite positive spiked samples demonstrating the feasibility of reaction. One baby was dominated by Enterobacteriaceae. The others contained 2-5 genera, with Bifidobacterium, Enterobacteriaceae, Enterococcaceae and Bacteroides-Prevotella the most prevalent. There was no association between bacterial counts and rupture of membrane duration, time to passage of meconium or time to lab. Conclusion This study provides evidence that low numbers of bacteria are present in first-pass meconium samples from healthy, vaginally-delivered, breastfed term infants. Only two-thirds of meconium samples had detectable bacteria, though at levels too low for automated counting or for reliable confirmation by PCR. This study suggests that gut bacterial colonisation is extremely limited at birth and occurs rapidly thereafter.	[Hansen, Richard; Khan, Shoaib; Okpapi, Augusta; Munro, Michael J.] Aberdeen Matern Hosp, Dept Neonatol, Aberdeen, Scotland; [Hansen, Richard; Berry, Susan H.; Stevenson, Matthew; Hold, Georgina L.] Univ Aberdeen, Gastrointestinal Res Grp, Aberdeen, Scotland; [Scott, Karen P.; Martin, Jenny C.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen	Hold, GL (corresponding author), Univ Aberdeen, Gastrointestinal Res Grp, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Scott, Karen/ABD-5484-2021; Hold, Georgina Louise/AAG-9923-2020	Scott, Karen/0000-0002-4608-0013; Hold, Georgina Louise/0000-0001-7573-3397; Hansen, Richard/0000-0002-3944-6646	NHS Grampian Neonatal Endowments; Rural and Environmental Science and Analytical Services programme of the Scottish Government	NHS Grampian Neonatal Endowments; Rural and Environmental Science and Analytical Services programme of the Scottish Government	This work was funded from NHS Grampian Neonatal Endowments. The Rowett Institute receives funding from the Rural and Environmental Science and Analytical Services programme of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Bekkali N, 2008, ARCH DIS CHILD-FETAL, V93, pF376, DOI 10.1136/adc.2008.138024; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Gey A, 2013, J VET DIAGN INVEST, V25, P386, DOI 10.1177/1040638713486113; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078257; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Steel JH, 2005, PEDIATR RES, V57, P404, DOI 10.1203/01.PDR.0000153869.96337.90; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005	22	98	108	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133320	10.1371/journal.pone.0133320	http://dx.doi.org/10.1371/journal.pone.0133320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218283	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000358595900026
J	Jung, YS; Lim, J; Jung, KW; Ryu, J; Won, YJ				Jung, Yuh-S; Lim, Jiwon; Jung, Kyu-Won; Ryu, Junsun; Won, Young-Joo			Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010)	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; PRIMARY TUMORS; UNITED-STATES; RISK-FACTORS; TRENDS; ASSOCIATION; PREVALENCE	Second primary malignancy (SPM) is the major long-term cause of patient mortality with head and neck squamous cell carcinoma (HNSCC). As the incidence of high-risk human papillomavirus (HPV)-related HNSCC is increasing globally, we analyzed the patterns of SPM occurrence, the effect of the index tumor site along with attributes to HPV, and the effect of SPM on survival in South Korean patients with head and neck cancer (HNC). Data were retrieved from the Korea Central Cancer Registry, a nationwide population-based cancer registry, from 1993 to 2010. Standardized incidence ratios were analyzed and compared between index tumor sites, particularly oropharyngeal vs. non-oropharyngeal sites. After adjustment for competing risks, 3- and 5-year SPM rates were calculated using the cumulative incidence function. The effects of SPM occurrence on overall survival (OS) were then analyzed. SPM rates were significantly lower for HPV-attributable oropharyngeal sites than for non-oropharyngeal sites, such as the larynx and hypopharynx (p<0.001). SPM rates were also lower for oral cavity first primary sites than for non-oropharyngeal first primary sites (p<0.001). SPMs typically occurred in the esophagus, lungs and the head and neck. Uterine cervical cancers occurred significantly more frequently after index oropharyngeal cancer in women. The 5-year and 10-year OS rates were 57.8 and 45.7% in all HNC patients, respectively. The OS after SPM occurrence was poor (5-year, 31.8%; 10-year, 20.8%) compared to after index HNC occurrence (5-year, 68.4%; 10-year, 41.2%). SPM occurrence in the esophagus and lung/bronchus showed a worse OS than SPM localized to the head and neck. South Korean HNC patient, the first primary cancer site affected SPM risk and distribution. The 5- and 10-year OS rates deteriorated after SPM occurrence, particularly in the esophagus and lungs. Further optimization of follow-up strategies for effective surveillance of SPM, particularly in the esophagus and lungs, is warranted.	[Jung, Yuh-S; Ryu, Junsun] Natl Canc Ctr, Res Inst & Hosp, Ctr Thyroid Canc, Specif Organs Canc Branch,Dept Otolaryngol, Goyang, South Korea; [Lim, Jiwon; Jung, Kyu-Won; Won, Young-Joo] Natl Canc Ctr, Canc Registrat & Stat Branch, Div Canc Registrat & Surveillance, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Won, YJ (corresponding author), Natl Canc Ctr, Canc Registrat & Stat Branch, Div Canc Registrat & Surveillance, Goyang, South Korea.	astra67@ncc.re.kr		Lim, Jiwon/0000-0002-3322-7792; Ryu, Junsun/0000-0002-6730-6755	National Cancer Center Grant [NCC-1310220]	National Cancer Center Grant	This work was supported by the National Cancer Center Grant (NCC-1310220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2012, CANCER-AM CANCER SOC, V118, P5783, DOI 10.1002/cncr.27609; Biron VL, 2011, J OTOLARYNGOL-HEAD N, V40, pS65, DOI 10.2310/7070.2010.100093; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Erkal HS, 2001, J CLIN ONCOL, V19, P1358, DOI 10.1200/JCO.2001.19.5.1358; Fritz AG, 2000, INTERNATIONAL CLASSI; Gan SJ, 2013, CANCER-AM CANCER SOC, V119, P2593, DOI 10.1002/cncr.28107; Garavello W, 2006, ARCH OTOLARYNGOL, V132, P762, DOI 10.1001/archotol.132.7.762; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Jain KS, 2013, CANCER-AM CANCER SOC, V119, P1832, DOI 10.1002/cncr.27988; Johnson-Obaseki S, 2012, OTOLARYNG HEAD NECK, V147, P74, DOI 10.1177/0194599812437332; JONES AS, 1995, CANCER, V75, P1343, DOI 10.1002/1097-0142(19950315)75:6<1343::AID-CNCR2820750617>3.0.CO;2-T; Joseph AW, 2013, ORAL ONCOL, V49, P244, DOI 10.1016/j.oraloncology.2012.09.009; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Leon X, 1999, HEAD NECK-J SCI SPEC, V21, P204, DOI 10.1002/(SICI)1097-0347(199905)21:3<204::AID-HED4>3.0.CO;2-7; Lozza V, 2014, ARCH GYNECOL OBSTET, V290, P375, DOI 10.1007/s00404-014-3187-7; Meyer MF, 2014, ORAL ONCOL, V50, P27, DOI 10.1016/j.oraloncology.2013.10.009; Morris LGT, 2011, J CLIN ONCOL, V29, P739, DOI 10.1200/JCO.2010.31.8311; PANOSETTI E, 1989, LARYNGOSCOPE, V99, P1267; Park WS, 2012, HEAD NECK-J SCI SPEC, V34, P1408, DOI 10.1002/hed.21939; Peck BW, 2013, HEAD NECK-J SCI SPEC, V35, P794, DOI 10.1002/hed.23033; Roeser MM, 2010, LARYNGOSCOPE, V120, pS181, DOI 10.1002/lary.21645; SCHWARTZ LH, 1994, CANCER, V74, P1933, DOI 10.1002/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X; Shin A, 2013, LARYNGOSCOPE, V123, pE30, DOI 10.1002/lary.24243; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Singhi AD, 2012, HEAD NECK-J SCI SPEC, V34, P213, DOI 10.1002/hed.21714; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; STURGIS EM, 1995, ANN OTO RHINOL LARYN, V104, P946, DOI 10.1177/000348949510401206; Tiwana MS, 2014, LARYNGOSCOPE, V124, P2287, DOI 10.1002/lary.24719; VIKRAM B, 1984, ARCH OTOLARYNGOL, V110, P564	30	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134160	10.1371/journal.pone.0134160	http://dx.doi.org/10.1371/journal.pone.0134160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218068	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900089
J	Mpimbaza, A; Sears, D; Sserwanga, A; Kigozi, R; Rubahika, D; Nadler, A; Yeka, A; Dorsey, G				Mpimbaza, Arthur; Sears, David; Sserwanga, Asadu; Kigozi, Ruth; Rubahika, Denis; Nadler, Adam; Yeka, Adoke; Dorsey, Grant			Admission Risk Score to Predict Inpatient Pediatric Mortality at Four Public Hospitals in Uganda	PLOS ONE			English	Article							EMERGENCY TRIAGE ASSESSMENT; DEVELOPING-COUNTRIES; CHILDREN; CARE; GUIDELINES; SEVERITY; SERVICES; MALARIA; ILLNESS; TOOL	Mortality rates among hospitalized children in many government hospitals in sub-Saharan Africa are high. Pediatric emergency services in these hospitals are often sub-optimal. Timely recognition of critically ill children on arrival is key to improving service delivery. We present a simple risk score to predict inpatient mortality among hospitalized children. Between April 2010 and June 2011, the Uganda Malaria Surveillance Project (UMSP), in collaboration with the National Malaria Control Program (NMCP), set up an enhanced sentinel site malaria surveillance program for children hospitalized at four public hospitals in different districts: Tororo, Apac, Jinja and Mubende. Clinical data collected through March 2013, representing 50249 admissions were used to develop a mortality risk score (derivation data set). One year of data collected subsequently from the same hospitals, representing 20406 admissions, were used to prospectively validate the performance of the risk score (validation data set). Using a backward selection approach, 13 out of 25 clinical parameters recognizable on initial presentation, were selected for inclusion in a final logistic regression prediction model. The presence of individual parameters was awarded a score of either 1 or 2 based on regression coefficients. For each individual patient, a composite risk score was generated. The risk score was further categorized into three categories; low, medium, and high. Patient characteristics were comparable in both data sets. Measures of performance for the risk score included the receiver operating characteristics curves and the area under the curve (AUC), both demonstrating good and comparable ability to predict deathusing both the derivation (AUC = 0.76) and validation dataset (AUC = 0.74). Using the derivation and validation datasets, the mortality rates in each risk category were as follows: low risk (0.8% vs. 0.7%), moderate risk (3.5% vs. 3.2%), and high risk (16.5% vs. 12.6%), respectively. Our analysis resulted in development of a risk score that ably predicted mortality risk among hospitalized children. While validation studies are needed, this approach could be used to improve existing triage systems.	[Mpimbaza, Arthur] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Mpimbaza, Arthur; Sserwanga, Asadu; Kigozi, Ruth; Yeka, Adoke] Infect Dis Res Collaborat, Kampala, Uganda; [Sears, David; Nadler, Adam; Dorsey, Grant] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA; [Rubahika, Denis] Minist Hlth Uganda, Natl Malaria Control Program, Kampala, Uganda; [Yeka, Adoke] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	Makerere University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University	Mpimbaza, A (corresponding author), Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda.	arthurwakg@yahoo.com		Sears, David/0000-0003-3854-6482	President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development; Centers for Disease Control and Prevention; FOGARTY INTERNATIONAL CENTER [R25TW009343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674, T32AI007641] Funding Source: NIH RePORTER	President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was made possible through support provided by the President's Malaria Initiative via the Office of Health, Infectious Diseases, and Nutrition, Bureau for Global Health, U.S. Agency for International Development, under the terms of an Interagency Agreement with the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed herein are those of the author(s)	Afolabi BM, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-39; Bachou H, 2006, BMC PEDIATR, V6, p[6, 7]; Baker T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-140; Barasa EW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001238; Buys H, 2013, SAMJ S AFR MED J, V103, P161, DOI [10.7196/samj.6020, 10.7196/SAMJ.6020]; Campbell D, 2004, J TROP PEDIATRICS, V50, P158, DOI 10.1093/tropej/50.3.158; Clark M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041458; Einterz EM, 2011, RURAL REMOTE HEALTH, V11; Gordon DM, 2013, J TROP PEDIATRICS, V59, P350, DOI 10.1093/tropej/fmt031; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; Hargrove J, 2005, CRIT CARE, V9, P376, DOI 10.1186/cc3518; Helbok R, 2003, AM J TROP MED HYG, V68, P372, DOI 10.4269/ajtmh.2003.68.372; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Irimu GW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-59; Irimu GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039964; Lidal IB, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-28; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Molyneux EM, 2013, SAMJ S AFR MED J, V103, P158, DOI [10.7196/SAMJ.6531, 10.7196/samj.6531]; Molyneux EM, 2010, ANN TROP PAEDIATR, V30, P165, DOI 10.1179/146532810X12703902516482; MOLYNEUX ME, 1989, Q J MED, V71, P441; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Olson D, 2013, TROP MED INT HEALTH, V18, P871, DOI 10.1111/tmi.12137; Peterson S, 2004, LANCET, V363, P1955, DOI 10.1016/S0140-6736(04)16411-8; Pollock L, 2013, LANCET, V381, P1357, DOI 10.1016/S0140-6736(13)60879-X; Qureshi N. A., 2010, Eastern Mediterranean Health Journal, V16, P690; Robertson MA, 2001, ARCH DIS CHILD, V85, P208, DOI 10.1136/adc.85.3.208; Robison JA, 2012, PEDIATRICS, V130, pE676, DOI 10.1542/peds.2012-0026; Tamburlini G, 1999, ARCH DIS CHILD, V81, P478, DOI 10.1136/adc.81.6.478; Twomey M, 2013, SAMJ S AFR MED J, V103, P304, DOI 10.7196/SAMJ.6877; Veirum JE, 2007, ACTA PAEDIATR, V96, P1526, DOI 10.1111/j.1651-2227.2007.00467.x	32	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133950	10.1371/journal.pone.0133950	http://dx.doi.org/10.1371/journal.pone.0133950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218274	gold, Green Published, Green Submitted			2022-12-27	WOS:000358595900058
J	Robles-Rubio, CA; Bertolizio, G; Brown, KA; Kearney, RE				Robles-Rubio, Carlos Alejandro; Bertolizio, Gianluca; Brown, Karen A.; Kearney, Robert E.			Scoring Tools for the Analysis of Infant Respiratory Inductive Plethysmography Signals	PLOS ONE			English	Article							QUALITATIVE DIAGNOSTIC CALIBRATION; FORMER PRETERM INFANTS; POSTOPERATIVE APNEA; GENERAL-ANESTHESIA; PREMATURE-INFANTS; SLEEP; OBSTRUCTION; AGREEMENT; EVENTS; RISK	Infants recovering from anesthesia are at risk of life threatening Postoperative Apnea (POA). POA events are rare, and so the study of POA requires the analysis of long cardiorespiratory records. Manual scoring is the preferred method of analysis for these data, but it is limited by low intra-and inter-scorer repeatability. Furthermore, recommended scoring rules do not provide a comprehensive description of the respiratory patterns. This work describes a set of manual scoring tools that address these limitations. These tools include: (i) a set of definitions and scoring rules for 6 mutually exclusive, unique patterns that fully characterize infant respiratory inductive plethysmography (RIP) signals; (ii) RIPScore, a graphical, manual scoring software to apply these rules to infant data; (iii) a library of data segments representing each of the 6 patterns; (iv) a fully automated, interactive formal training protocol to standardize the analysis and establish intra-and inter-scorer repeatability; and (v) a quality control method to monitor scorer ongoing performance over time. To evaluate these tools, three scorers from varied backgrounds were recruited and trained to reach a performance level similar to that of an expert. These scorers used RIPScore to analyze data from infants at risk of POA in two separate, independent instances. Scorers performed with high accuracy and consistency, analyzed data efficiently, had very good intra-and inter-scorer repeatability, and exhibited only minor confusion between patterns. These results indicate that our tools represent an excellent method for the analysis of respiratory patterns in long data records. Although the tools were developed for the study of POA, their use extends to any study of respiratory patterns using RIP (e.g., sleep apnea, extubation readiness). Moreover, by establishing and monitoring scorer repeatability, our tools enable the analysis of large data sets by multiple scorers, which is essential for longitudinal and multicenter studies.	[Robles-Rubio, Carlos Alejandro; Kearney, Robert E.] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Bertolizio, Gianluca; Brown, Karen A.] McGill Univ, Ctr Hlth, Dept Anesthesia, Montreal, PQ, Canada	McGill University; McGill University	Robles-Rubio, CA (corresponding author), McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.	carlos.roblesrubio@mail.mcgill.ca	Brown, Karen/AAE-1816-2020; Bertolizio, Gianluca/AAM-7595-2020	Kearney, Robert/0000-0002-5107-6190	Natural Sciences and Engineering Research Council of Canada [NSERC RGPIN 1051-13]; Queen Elizabeth Hospital of Montreal Foundation Chair in Pediatric Anesthesia, McGill University Faculty of Medicine; Mexican National Council for Science and Technology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen Elizabeth Hospital of Montreal Foundation Chair in Pediatric Anesthesia, McGill University Faculty of Medicine; Mexican National Council for Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca, grant NSERC RGPIN 1051-13), and in part by the Queen Elizabeth Hospital of Montreal Foundation Chair in Pediatric Anesthesia, McGill University Faculty of Medicine (www.mcgill.ca/medicine/faculty-medicine). CARR was supported in part by a scholarship for graduate studies from the Mexican National Council for Science and Technology (www.conacyt.gob.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JL, 1991, PEDIATR PULM, V11, P37, DOI 10.1002/ppul.1950110107; ALLEN JL, 1990, AM REV RESPIR DIS, V141, P337, DOI 10.1164/ajrccm/141.2.337; American Academy of Sleep M, 2001, INT CLASS SLEEP DIS; Aoude A, 2006, BIOMEDICAL ENG; Aoude A A, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4631; Aoude AA, 2011, IEEE T BIO-MED ENG, V58, P1724, DOI 10.1109/TBME.2011.2112657; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P133; BROUILLETTE RT, 1987, J PEDIATR-US, V111, P377, DOI 10.1016/S0022-3476(87)80457-2; Brown K, 1998, EUR RESPIR J, V12, P935, DOI 10.1183/09031936.98.12040935; Brown KA, 2008, CAN J ANAESTH, V55, P739, DOI 10.1007/BF03016346; Caples SM, 2007, J CLIN SLEEP MED, V3, P147; Cardillo G., 2007, FLEISSES KAPPA COMPU; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collop NA, 2002, SLEEP MED, V3, P43, DOI 10.1016/S1389-9457(01)00115-0; COTE CJ, 1995, ANESTHESIOLOGY, V82, P809, DOI 10.1097/00000542-199504000-00002; COTE CJ, 1990, ANESTHESIOLOGY, V72, P559, DOI 10.1097/00000542-199003000-00027; DallAva-Santucci J, 1991, PULMONARY FUNCTION M, P121; Davidson AJ, 2015, ANESTHESIOLOGY; De Groote A, 2001, J APPL PHYSIOL, V90, P1025, DOI 10.1152/jappl.2001.90.3.1025; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP; Grigg-Damberger M, 2007, J CLIN SLEEP MED, V3, P201; Hrynaszkiewicz I, 2010, BMJ, V340; Iber C, 2007, J CLIN SLEEP MED, V3, P107; KONNO K, 1967, J APPL PHYSIOL, V22, P407, DOI 10.1152/jappl.1967.22.3.407; KRANE EJ, 1995, ANESTH ANALG, V80, P7, DOI 10.1097/00000539-199501000-00003; KURTH CD, 1987, ANESTHESIOLOGY, V66, P483, DOI 10.1097/00000542-198704000-00006; KURTH CD, 1991, ANESTHESIOLOGY, V75, P22, DOI 10.1097/00000542-199107000-00005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Penzel T, 2007, J CLIN SLEEP MED, V3, P109; Precup D, 2012, IEEE ENG MED BIO, P5630, DOI 10.1109/EMBC.2012.6347271; Ramanathan R, 2001, JAMA-J AM MED ASSOC, V285, P2199, DOI 10.1001/jama.285.17.2199; Redline S, 2007, J CLIN SLEEP MED, V3, P169; Robles-Rubio CA, 2015, PEDIATR PULM, V50, P479, DOI 10.1002/ppul.23151; Robles-Rubio CA, 2011, 12 INT S SLEEP BREAT; Robles-Rubio CA, 2013, 13 INT S SLEEP BREAT; Robles-Rubio CA, 2013, IEEE ENG MED BIO, P2295, DOI 10.1109/EMBC.2013.6609996; Robles-Rubio CA, 2012, IEEE ENG MED BIO, P6333, DOI 10.1109/EMBC.2012.6347442; Robles-Rubio CA, 2011, IEEE ENG MED BIO, P3201, DOI 10.1109/IEMBS.2011.6090871; Semienchuk SM, 2005, P ANN INT IEEE EMBS, P4420, DOI 10.1109/IEMBS.2005.1615446; Silber MH, 2007, J CLIN SLEEP MED, V3, P22, DOI DOI 10.5664/jcsm.26814; STEWARD DJ, 1982, ANESTHESIOLOGY, V56, P304, DOI 10.1097/00000542-198204000-00013; Walters AS, 2007, J CLIN SLEEP MED, V3, P155; WELBORN LG, 1990, ANESTHESIOLOGY, V72, P838, DOI 10.1097/00000542-199005000-00012; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	47	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134182	10.1371/journal.pone.0134182	http://dx.doi.org/10.1371/journal.pone.0134182			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218351	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900092
J	Supper, E; Tahir, S; Imai, T; Inoue, J; Minato, N				Supper, Emmanuelle; Tahir, Suhail; Imai, Takahiko; Inoue, Joe; Minato, Nagahiro			Modification of Gene Expression, Proliferation, and Function of OP9 Stroma Cells by Bcr-Abl-Expressing Leukemia Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; ACUTE MYELOID-LEUKEMIA; NICHE; PROGENITORS; CANCER; INFLAMMATION; PATHWAYS; RAP1	Expression of the Bcr-Abl fusion gene in hematopoietic progenitor cells (HPCs) results in the development of chronic myelogenous leukemia (CML), for which hematopoietic microenvironment plays an important role. We investigated the specific effects of an HPC line transduced with Bcr-Abl, KOBA, on BM-derived OP9 stroma cells. DNA microarray analysis revealed that OP9 cells co-cultured with KOBA cells (OP9/L) show diverse changes in the gene expression. OP9/L cells showed significant down-regulation of Cdkn genes and up-regulation of Icam1, leading to the increased proliferation capacity of OP9 cells and enhanced transmigration of leukemia cells through them. The effects were attributed to direct Notch activation of OP9 cells by KOBA cells. OP9/L cells also showed a markedly altered cytokine gene expression pattern, including a robust increase in a variety of proinflammatory genes and a decrease in hematopoietic cytokines such as Cxcl12, Scf, and Angpt1. Consequently, OP9/L cells promoted the proliferation of KOBA cells more efficiently than parental OP9 cells, whereas the activity supporting normal myelopoiesis was attenuated. In mice bearing KOBA leukemia, the characteristic genetic changes observed in OP9/L cells were reflected differentially in the endothelial cells (ECs) and mesenchymal stroma cells (MCs) of the BM. The ECs were markedly increased with Notch-target gene activation and decreased Cdkn expression, whereas the MCs showed a marked increase in proinflammatory gene expression and a profound decrease in hematopoietic genes. Human CML cell lines also induced essentially similar genetic changes in OP9 cells. Our results suggest that CML cells remodel the hematopoietic microenvironment by changing the gene expression patterns differentially in ECs and MCs of BM.	[Supper, Emmanuelle; Tahir, Suhail; Imai, Takahiko; Inoue, Joe; Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Kyoto University	Minato, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan.	minato@imm.med.kyoto-u.ac.jp			Ministry of Education, Culture, Science, Sports and Technology, Special Coordination Funds for Promoting Science and Technology of the Japanese Government [24111008]	Ministry of Education, Culture, Science, Sports and Technology, Special Coordination Funds for Promoting Science and Technology of the Japanese Government	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (24111008) (http://www.jsps.go.jp/j-grantsinaid/34_new_scientific/) and a grant-in-aid from the Ministry of Education, Culture, Science, Sports and Technology, Special Coordination Funds for Promoting Science and Technology of the Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony BA, 2014, TRENDS IMMUNOL, V35, P32, DOI 10.1016/j.it.2013.10.002; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Bruns I, 2009, LEUKEMIA, V23, P892, DOI 10.1038/leu.2008.392; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Copland I, 2008, EXPER HEMATOL, V36, P93103; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fischer LJ, 2009, J SURG RES, V152, P157, DOI 10.1016/j.jss.2008.06.029; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Gao JA, 2010, J GENET GENOMICS, V37, P475, DOI 10.1016/S1673-8527(09)60067-9; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Guichet PO, 2015, STEM CELLS, V33, P21, DOI 10.1002/stem.1767; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Jamieson Catriona H, 2008, Hematology Am Soc Hematol Educ Program, P436, DOI 10.1182/asheducation-2008.1.436; Jin A, 2006, ONCOGENE, V25, P4332, DOI 10.1038/sj.onc.1209459; JUNEJA HS, 1993, EXP HEMATOL, V21, P444; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kometani K, 2006, CANCER RES, V66, P9967, DOI 10.1158/0008-5472.CAN-06-1346; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Mahadevan KK, 2014, J CLIN DIAGN RES, V8, pFC4, DOI 10.7860/JCDR/2014/7994.4405; Minato N, 2013, EXP CELL RES, V319, P2323, DOI 10.1016/j.yexcr.2013.04.009; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Priestley GV, 2006, BLOOD, V107, P2959, DOI 10.1182/blood-2005-07-2670; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; Zalc A, 2014, DEVELOPMENT, V141, P2780, DOI 10.1242/dev.110155; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018	39	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0134026	10.1371/journal.pone.0134026	http://dx.doi.org/10.1371/journal.pone.0134026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218064	gold, Green Submitted, Green Published			2022-12-27	WOS:000358595900067
J	Yamamoto, N; Hamaguchi, S; Akeda, Y; Santanirand, P; Kerdsin, A; Seki, M; Ishii, Y; Paveenkittiporn, W; Bonomo, RA; Oishi, K; Malathum, K; Tomono, K				Yamamoto, Norihisa; Hamaguchi, Shigeto; Akeda, Yukihiro; Santanirand, Pitak; Kerdsin, Anusak; Seki, Masafumi; Ishii, Yoshikazu; Paveenkittiporn, Wantana; Bonomo, Robert A.; Oishi, Kazunori; Malathum, Kumthorn; Tomono, Kazunori			Clinical Specimen-Direct LAMP: A Useful Tool for the Surveillance of bla(OXA-23)-Positive Carbapenem-Resistant Acinetobacter baumannii	PLOS ONE			English	Article							BETA-LACTAMASES; IDENTIFICATION; EMERGENCE; INFECTION	Healthcare-associated infections are a leading cause of morbidity and mortality worldwide. Treatment is increasingly complicated by the escalating incidence of antimicrobial resistance. Among drug-resistant pathogens, carbapenem-resistant Acinetobacter baumannii (CRAb) is of increasing concern because of the limited applicable therapies and its expanding global distribution in developed countries and newly industrialized countries. Therefore, a rapid detection method that can be used even in resource-poor countries is urgently required to control this global public health threat. Conventional techniques, such as bacterial culture and polymerase chain reaction (PCR), are insufficient to combat this threat because they are time-consuming and laborious. In this study, we developed a loop-mediated isothermal amplification (LAMP) method for detecting bla(OXA-23)-positive CRAb, the most prevalent form of CRAb in Asia, especially in Thailand, and confirmed its efficacy as a surveillance tool in a clinical setting. Clinical samples of sputum and rectal swabs were collected from patients in a hospital in Bangkok and used for LAMP assays. After boiling and centrifugation, the supernatants were used directly in the assay. In parallel, a culture method was used for comparison purposes to evaluate the specificity and sensitivity of LAMP. As a first step, a total of 120 sputum samples were collected. The sensitivity of LAMP was 88.6% (39/44), and its specificity was 92.1% (70/76) using the culture method as the "gold standard". When surveillance samples including sputum and rectal swabs were analyzed with the LAMP assay, its sensitivity was 100.0%. This method enables the direct analysis of clinical specimens and provides results within 40 minutes of sample collection, making it a useful tool for surveillance even in resource-poor countries.	[Yamamoto, Norihisa; Hamaguchi, Shigeto; Akeda, Yukihiro; Seki, Masafumi; Tomono, Kazunori] Osaka Univ, Grad Sch Med, Div Infect Control & Prevent, Osaka, Japan; [Yamamoto, Norihisa; Hamaguchi, Shigeto; Akeda, Yukihiro; Oishi, Kazunori] Osaka Univ, Microbial Dis Res Inst, Lab Clin Res Infect Dis, Osaka, Japan; [Santanirand, Pitak; Malathum, Kumthorn] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Kerdsin, Anusak; Paveenkittiporn, Wantana] Natl Inst Hlth, Dept Med Sci, Minist Publ Hlth, Gen Bacteriol Sect, Bangkok, Thailand; [Ishii, Yoshikazu] Toho Univ, Fac Med, Sch Med, Dept Microbiol & Infect Dis, Tokyo, Japan; [Bonomo, Robert A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Osaka University; Osaka University; Mahidol University; Ministry of Public Health - Thailand; Toho University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; National Institute of Infectious Diseases (NIID)	Tomono, K (corresponding author), Osaka Univ, Grad Sch Med, Div Infect Control & Prevent, Osaka, Japan.	tomono@hp-infect.med.osaka-u.ac.jp	はまぐち しげと, 濱口 重人/GQZ-8515-2022; Kerdsin, Anusak/H-5360-2019; Malathum, Kumthorn/AAD-7189-2020	Kerdsin, Anusak/0000-0003-1055-3656; Hamaguchi, Shigeto/0000-0003-2560-9982; Santanirand, Pitak/0000-0002-3914-1367	JSPS KAKENHI [24406022]; Grants-in-Aid for Scientific Research [25461524] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24406022 for KT [http://www.jsps.go.jp/english/e-grants/index.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Afzal-Shah M, 2001, ANTIMICROB AGENTS CH, V45, P583, DOI 10.1128/AAC.45.2.583-588.2001; Alvarez-Buylla A, 2012, INFECT GENET EVOL, V12, P345, DOI 10.1016/j.meegid.2012.01.002; Baraibar J, 1997, CHEST, V112, P1050, DOI 10.1378/chest.112.4.1050; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; De Luca F, 2011, P NATL ACAD SCI USA, V108, P18424, DOI 10.1073/pnas.1110530108; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Erbay A, 2009, INT J ANTIMICROB AG, V34, P575, DOI 10.1016/j.ijantimicag.2009.07.006; Evans BA, 2008, CLIN MICROBIOL INFEC, V14, P268, DOI 10.1111/j.1469-0691.2007.01919.x; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Hall AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073845; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kouyama Y, 2012, J INFECT CHEMOTHER, V18, P522, DOI 10.1007/s10156-012-0374-y; Latibeaudiere R, 2014, CLIN INFECT IN PRESS; Lemos EV, 2014, CLIN MICROBIOL INFEC, V20, P416, DOI 10.1111/1469-0691.12363; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Marchaim D, 2007, INFECT CONT HOSP EP, V28, P945, DOI 10.1086/518970; Marti S, 2008, ANTIMICROB AGENTS CH, V52, P2955, DOI 10.1128/AAC.00072-08; Mitsuda T, 1999, J CLIN MICROBIOL, V37, P2548, DOI 10.1128/JCM.37.8.2548-2552.1999; Mongkolrattanothai K, 2004, ANTIMICROB AGENTS CH, V48, P1823, DOI 10.1128/AAC.48.5.1823-1836.2004; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Mori Y, 2013, J INFECT CHEMOTHER, V19, P404, DOI 10.1007/s10156-013-0590-0; Niumsup PR, 2009, JPN J INFECT DIS, V62, P152; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Okada K, 2010, DIAGN MICR INFEC DIS, V66, P135, DOI 10.1016/j.diagmicrobio.2009.09.004; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2006, INFECT CONT HOSP EP, V27, P759, DOI 10.1086/507012; Romero-Steiner S, 2001, CLIN DIAGN LAB IMMUN, V8, P1115, DOI 10.1128/CDLI.8.6.1115-1119.2001; Soo PC, 2013, J MICROBIOL METH, V92, P197, DOI 10.1016/j.mimet.2012.11.020; Thapa B, 2009, THESIS U MAHIDOL BAN; Thapa B, 2010, SE ASIAN J TROP MED, V41, P625; Vergara A, 2014, ANTIMICROB AGENTS CH, V58, P7538, DOI 10.1128/AAC.03870-14; Wang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066406	36	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133204	10.1371/journal.pone.0133204	http://dx.doi.org/10.1371/journal.pone.0133204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218925	Green Submitted, Green Published, gold			2022-12-27	WOS:000358595900021
J	Yoshina, S; Mitani, S				Yoshina, Sawako; Mitani, Shohei			Loss of C. elegans GON-1, an ADAMTS9 Homolog, Decreases Secretion Resulting in Altered Lifespan and Dauer Formation	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; INSULIN-RESISTANCE; GENE-EXPRESSION; MUTANTS; DAF-16; LOCI; LONGEVITY; MEMBER; GLYCOSYLATION; MUTATIONS	ADAMTS9 is a metalloprotease that cleaves components of the extracellular matrix and is also implicated in transport from the endoplasmic reticulum (ER) to the Golgi. It has been reported that an ADAMTS9 gene variant is associated with type 2 diabetes. The underlying pathology of type 2 diabetes is insulin resistance and beta-cell dysfunction. However, the molecular mechanisms underlying ADAMTS9 function in beta cells and peripheral tissues are unknown. We show that loss of C. elegans GON-1, an ADAMTS9 homolog, alters lifespan and dauer formation. GON-1 loss impairs secretion of proteins such as insulin orthologs and TGF-beta, and additionally impacts insulin/IGF-1 signaling in peripheral tissues. The function of the GON domain, but not the protease domain, is essential for normal lifespan and dauer formation in these scenarios. We conclude that the GON domain is critical for ADAMTS9/GON-1 function across species, which should help the understanding of type 2 diabetes in humans.	[Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Mitani, Shohei] Tokyo Womens Med Univ, Inst Integrated Med Sci TIIMS, Tokyo 1628666, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Mitani, S (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan.	mitani.shohei@twmu.ac.jp			Program for Promoting the Establishment of Strategic Research Centers; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology (Japan); Uehara Memorial Foundation; Japan Society for the promotion of Science	Program for Promoting the Establishment of Strategic Research Centers; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported partly by the Program for Promoting the Establishment of Strategic Research Centers; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology (Japan) (to S.M.), a grant from the Uehara Memorial Foundation (to S.M.), and grant-in-Aid for young scientists from Japan Society for the promotion of Science (to S.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailion M, 2003, GENETICS, V165, P127; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; BRENNER S, 1974, GENETICS, V77, P71; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; Fares H, 2001, GENETICS, V159, P133; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Inoue T, 2000, GENETICS, V156, P1035; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitaoka S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068475; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; MALONE EA, 1994, GENETICS, V136, P879; Matsunaga Y, 2012, BIOCHEM BIOPH RES CO, V423, P478, DOI 10.1016/j.bbrc.2012.05.145; Maures TJ, 2014, SCIENCE, V343, P541, DOI 10.1126/science.1244160; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Trombetta M, 2013, ACTA DIABETOL, V50, P401, DOI 10.1007/s00592-012-0443-9; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Yoshina S, 2012, MOL BIOL CELL, V23, P1728, DOI 10.1091/mbc.E11-10-0857; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	41	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2015	10	7							e0133966	10.1371/journal.pone.0133966	http://dx.doi.org/10.1371/journal.pone.0133966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7ED	26218657	Green Published, gold, Green Submitted			2022-12-27	WOS:000358595900062
J	Bennett, JA; Singh, KP; Unnisa, Z; Welle, SL; Gasiewicz, TA				Bennett, John A.; Singh, Kameshwar P.; Unnisa, Zeenath; Welle, Stephen L.; Gasiewicz, Thomas A.			Deficiency in Aryl Hydrocarbon Receptor (AHR) Expression throughout Aging Alters Gene Expression Profiles in Murine Long-Term Hematopoietic Stem Cells	PLOS ONE			English	Article							GROWTH; QUIESCENCE; PATHWAY; PROLIFERATION; MAINTENANCE; ACTIVATION; LYMPHOMA; EXPOSURE; AGONIST; CANCER	Dysregulation of hematopoietic stem cell (HSC) signaling can contribute to the development of diseases of the blood system. Lack of aryl hydrocarbon receptor (AhR) has been associated with alterations in gene expression related to HSC function and the subsequent development of a myeloproliferative disorder in aging female mice. We sorted the most primitive population of HSCs with the highest stem cell potential (Long-term, or LT-HSCs) from 18-month-old AhR-null-allele (AhR-KO) and WT mice and analyzed gene expression using microarray to determine alterations in gene expression and cell signaling networks in HSCs that could potentially contribute to the aging phenotype of AhR-KO mice. Comparisons with previous array data from 8-week old mice indicated that aging alone is sufficient to alter gene expression. In addition, a significant number of gene expression differences were observed in aged LT-HSCs that are dependent on both aging and lack of AhR. Pathway analysis of these genes revealed networks related to hematopoietic stem cell activity or function. qPCR was used to confirm the differential expression of a subset of these genes, focusing on genes that may represent novel AhR targets due to the presence of a putative AhR binding site in their upstream regulatory region. We verified differential expression of PDGF-D, Smo, Wdfy1, Zbtb37 and Zfp382. Pathway analysis of this subset of genes revealed overlap between cellular functions of the novel AhR targets and AhR itself. Lentiviral-mediated knockdown of AhR in lineage-negative hematopoietic cells was sufficient to induce changes in all five of the candidate AhR targets identified. Taken together, these data suggest a role for AhR in HSC functional regulation, and identify novel HSC AhR target genes that may contribute to the phenotypes observed in AhR-KO mice.	[Bennett, John A.; Singh, Kameshwar P.; Unnisa, Zeenath; Gasiewicz, Thomas A.] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Welle, Stephen L.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Gasiewicz, TA (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA.	tom_gasiewicz@urmc.rochester.edu			National Institutes of Health [T32ES07026, ES004862, ES023068]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004862, R01ES023068, T32ES007026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by National Institutes of Health grants T32ES07026, ES004862 and ES023068. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 2012, VITAM HORM, V88, P25, DOI 10.1016/B978-0-12-394622-5.00002-X; Ahrenhoerster LS, 2015, TOXICOL APPL PHARM, V283, P99, DOI 10.1016/j.taap.2014.12.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Bertazzi PA, 2001, AM J EPIDEMIOL, V153, P1031, DOI 10.1093/aje/153.11.1031; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bock KW, 2014, BIOCHEM PHARMACOL, V90, P1, DOI 10.1016/j.bcp.2014.04.009; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Boyd AL, 2013, EXP HEMATOL, V41, P858, DOI 10.1016/j.exphem.2013.05.287; Casado FL, 2011, MOL PHARMACOL, V80, P673, DOI 10.1124/mol.111.071381; Chaklader M, 2012, ARH HIG RADA TOKSIKO, V63, P271, DOI 10.2478/10004-1254-63-2012-2255; Charbord P, 2014, CELL STEM CELL, V15, P376, DOI 10.1016/j.stem.2014.06.005; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cooper CL, 2012, BLOOD, V119, P5438, DOI 10.1182/blood-2011-12-397976; Dorshkind K, 2009, CURR OPIN IMMUNOL, V21, P404, DOI 10.1016/j.coi.2009.07.001; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Faust D, 2013, TOXICOL LETT, V223, P73, DOI 10.1016/j.toxlet.2013.08.022; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Garrett RW, 2006, MOL PHARMACOL, V69, P2076, DOI 10.1124/mol.105.021006; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Hayes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106955; Hecht E, 2014, TOXICOL APPL PHARM, V280, P511, DOI 10.1016/j.taap.2014.08.023; Hilpert M, 2014, STEM CELL REP, V3, P1085, DOI 10.1016/j.stemcr.2014.10.005; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Kim YR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-124; Kramer S, 2012, ENVIRON HEALTH PERSP, V120, P1067, DOI 10.1289/ehp.1104652; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Mar BG, 2011, LEUKEMIA, V25, P1665, DOI 10.1038/leu.2011.143; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Migasa AA, 2014, LEUKEMIA RES, V38, P1102, DOI 10.1016/j.leukres.2014.06.002; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; POLAND A, 1976, J BIOL CHEM, V251, P4936; Rimmele P, 2014, STEM CELL R IN PRESS, V3, P1, DOI DOI 10.1016/J.STEMCR.2014.04.015; Santos PM, 2014, J IMMUNOL, V192, P160, DOI 10.4049/jimmunol.1302502; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Singh KP, 2014, STEM CELLS DEV, V23, P95, DOI 10.1089/scd.2013.0346; Singh KP, 2011, STEM CELLS DEV, V20, P769, DOI 10.1089/scd.2010.0333; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Tonks A, 2007, LEUKEMIA, V21, P2495, DOI 10.1038/sj.leu.2404961; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Vogel CFA, 2007, AM J PATHOL, V171, P1538, DOI 10.2353/ajpath.2007.070406; Ward A, 2015, LEUKEMIA LYMPHOMA, V56, P2123, DOI 10.3109/10428194.2014.971407	49	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133791	10.1371/journal.pone.0133791	http://dx.doi.org/10.1371/journal.pone.0133791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208102	gold, Green Submitted, Green Published			2022-12-27	WOS:000358622000144
J	Bommele, J; Kleinjan, M; Schoenmakers, TM; Burk, WJ; van den Eijnden, R; van de Mheen, D				Bommele, Jeroen; Kleinjan, Marloes; Schoenmakers, Tim M.; Burk, William J.; van den Eijnden, Regina; van de Mheen, Dike			Identifying Subgroups among Hardcore Smokers: a Latent Profile Approach	PLOS ONE			English	Article							INCREASE FUTURE CESSATION; NICOTINE DEPENDENCE; SMOKING-CESSATION; INTEGRATIVE MODEL; CLUSTER SUBTYPES; FAGERSTROM TEST; CORE SMOKERS; SAMPLE; REDUCTION; BELIEFS	Introduction Hardcore smokers are smokers who have little to no intention to quit. Previous research suggests that there are distinct subgroups among hardcore smokers and that these subgroups vary in the perceived pros and cons of smoking and quitting. Identifying these subgroups could help to develop individualized messages for the group of hardcore smokers. In this study we therefore used the perceived pros and cons of smoking and quitting to identify profiles among hardcore smokers. Methods A sample of 510 hardcore smokers completed an online survey on the perceived pros and cons of smoking and quitting. We used these perceived pros and cons in a latent profile analysis to identify possible subgroups among hardcore smokers. To validate the profiles identified among hardcore smokers, we analysed data from a sample of 338 non-hardcore smokers in a similar way. Results We found three profiles among hardcore smokers. 'Receptive' hardcore smokers (36%) perceived many cons of smoking and many pros of quitting. 'Ambivalent' hardcore smokers (59%) were rather undecided towards quitting. 'Resistant' hardcore smokers (5%) saw few cons of smoking and few pros of quitting. Among non-hardcore smokers, we found similar groups of 'receptive' smokers (30%) and 'ambivalent' smokers (54%). However, a third group consisted of 'disengaged' smokers (16%), who saw few pros and cons of both smoking and quitting. Discussion Among hardcore smokers, we found three distinct profiles based on perceived pros and cons of smoking. This indicates that hardcore smokers are not a homogenous group. Each profile might require a different tobacco control approach. Our findings may help to develop individualized tobacco control messages for the particularly hard-to-reach group of hardcore smokers.	[Bommele, Jeroen; Schoenmakers, Tim M.; van de Mheen, Dike] IVO Addict Res Inst, Rotterdam, Netherlands; [Bommele, Jeroen; Schoenmakers, Tim M.; van de Mheen, Dike] Erasmus MC, Rotterdam, Netherlands; [Kleinjan, Marloes] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands; [Burk, William J.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van den Eijnden, Regina] Univ Utrecht, Fac Social Sci, Utrecht, Netherlands; [van de Mheen, Dike] Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Trimbos Institute; Radboud University Nijmegen; Utrecht University; Maastricht University	Bommele, J (corresponding author), IVO Addict Res Inst, Rotterdam, Netherlands.	bommele@ivo.nl	Schoenmakers, Tim M/H-9976-2018; van den Eijnden, Regina/P-5510-2019; Kleinjan, Marloes/AAF-1128-2019; Schoenmakers, Tim M./A-7847-2017; Burk, William/AGK-4576-2022	Schoenmakers, Tim M./0000-0003-1314-9464; Kleinjan, Marloes/0000-0002-4545-5549	Netherlands Organisation for Health Research and Development [200120001]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organisation for Health Research and Development (www.zonmw.nl; 200120001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldridge AA, 2008, J ADOLESCENCE, V31, P499, DOI 10.1016/j.adolescence.2007.08.005; Anatchkova MD, 2006, ADDICT BEHAV, V31, P1101, DOI 10.1016/j.addbeh.2005.08.002; Augustson EM, 2004, NICOTINE TOB RES, V6, P621, DOI 10.1080/14622200410001727876; Bommele J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-175; Carpenter MJ, 2004, J CONSULT CLIN PSYCH, V72, P371, DOI 10.1037/0022-006X.72.3.371; CHAPMAN S, 1993, AM J PUBLIC HEALTH, V83, P215, DOI 10.2105/AJPH.83.2.215; Costa ML, 2010, NICOTINE TOB RES, V12, P860, DOI 10.1093/ntr/ntq103; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; Dijkstra A, 2000, PSYCHOL HEALTH, V15, P501, DOI 10.1080/08870440008402009; Dijkstra A, 2000, ADDICT BEHAV, V25, P373, DOI 10.1016/S0306-4603(99)00073-8; Dijkstra A, 2000, HEALTH EDUC RES, V15, P423, DOI 10.1093/her/15.4.423; Eisenberg MJ, 2008, CAN MED ASSOC J, V179, P135, DOI 10.1503/cmaj.070256; Emery S, 2000, AM J PUBLIC HEALTH, V90, P387, DOI 10.2105/AJPH.90.3.387; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hughes JR, 2006, NICOTINE TOB RES, V8, P739, DOI 10.1080/14622200600789726; Jarvis MJ, 2003, BMJ-BRIT MED J, V326, P1061, DOI 10.1136/bmj.326.7398.1061; Klein WMP, 2011, J EXP SOC PSYCHOL, V47, P1237, DOI 10.1016/j.jesp.2011.05.005; Kleinjan M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-196; Kleinjan M, 2009, ADDICT BEHAV, V34, P440, DOI 10.1016/j.addbeh.2008.12.010; Lai DTC, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006936.pub2, 10.1002/14651858.CD006936.pub3]; Lustria MLA, 2009, PATIENT EDUC COUNS, V74, P156, DOI 10.1016/j.pec.2008.08.023; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; MCLACHLAN GJ, 1987, J R STAT SOC C-APPL, V36, P318; MILLER WR, 1983, BEHAV PSYCHOTHER, V11, P147, DOI 10.1017/S0141347300006583; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Muthen L.K., 2010, MPLUS USERS GUIDE; Norman GJ, 2000, ADDICT BEHAV, V25, P183, DOI 10.1016/S0306-4603(99)00054-4; Pomerleau C S, 2000, Nicotine Tob Res, V2, P275; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437; Riemerth A, 2009, WIEN MED WOCHENSCHR, V159, P47, DOI 10.1007/s10354-008-0640-x; Schmitz N, 2003, AM J PSYCHIAT, V160, P1670, DOI 10.1176/appi.ajp.160.9.1670; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seybert H, 2012, EUROSTAT STAT FOCUS, P1; Sorg A, 2011, TOB CONTROL, V20, P388, DOI 10.1136/tc.2010.039743; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Vangeli E, 2011, ADDICTION, V106, P2110, DOI 10.1111/j.1360-0443.2011.03565.x; Velicer WF, 2007, ADDICT BEHAV, V32, P228, DOI 10.1016/j.addbeh.2006.03.041; Vink JM, 2005, ADDICT BEHAV, V30, P575, DOI 10.1016/j.addbeh.2004.05.023; Warner KE, 2003, NICOTINE TOB RES, V5, P37, DOI 10.1080/1462220021000060428; World Health Organization, 2009, WHO REPORT ON THE GL	42	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133570	10.1371/journal.pone.0133570	http://dx.doi.org/10.1371/journal.pone.0133570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26207829	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000101
J	Collet, AC; Fize, D; VanRullen, R				Collet, Anne-Claire; Fize, Denis; VanRullen, Rufin			Contextual Congruency Effect in Natural Scene Categorization: Different Strategies in Humans and Monkeys (Macaca mulatta)	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; OBJECT RECOGNITION; NONHUMAN-PRIMATES; VISUAL-SEARCH; CEBUS-APELLA; PIGEONS; STIMULI; REPRESENTATIONS; DISCRIMINATION; ORGANIZATION	Rapid visual categorization is a crucial ability for survival of many animal species, including monkeys and humans. In real conditions, objects (either animate or inanimate) are never isolated but embedded in a complex background made of multiple elements. It has been shown in humans and monkeys that the contextual background can either enhance or impair object categorization, depending on context/object congruency (for example, an animal in a natural vs. man-made environment). Moreover, a scene is not only a collection of objects; it also has global physical features (i.e phase and amplitude of Fourier spatial frequencies) which help define its gist. In our experiment, we aimed to explore and compare the contribution of the amplitude spectrum of scenes in the context-object congruency effect in monkeys and humans. We designed a rapid visual categorization task, Animal versus Non-Animal, using as contexts both real scenes photographs and noisy backgrounds built from the amplitude spectrum of real scenes but with randomized phase spectrum. We showed that even if the contextual congruency effect was comparable in both species when the context was a real scene, it differed when the foreground object was surrounded by a noisy background: in monkeys we found a similar congruency effect in both conditions, but in humans the congruency effect was absent (or even reversed) when the context was a noisy background.	[Collet, Anne-Claire; Fize, Denis; VanRullen, Rufin] Univ Toulouse, Ctr Rech Cerveau & Cognit, UPS, Toulouse, France; [Collet, Anne-Claire; Fize, Denis; VanRullen, Rufin] CNRS, CerCo, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Collet, AC (corresponding author), Univ Toulouse, Ctr Rech Cerveau & Cognit, UPS, Toulouse, France.	collet@cerco.ups-tlse.fr	Fize, Denis/F-4525-2011; VanRullen, Rufin/B-2150-2008	VanRullen, Rufin/0000-0002-3611-7716				ASTLEY SL, 1992, J EXP PSYCHOL ANIM B, V18, P193, DOI 10.1037/0097-7403.18.2.193; Aust U, 2001, ANIM LEARN BEHAV, V29, P107, DOI 10.3758/BF03192820; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; CERELLA J, 1980, PATTERN RECOGN, V12, P1, DOI 10.1016/0031-3203(80)90048-5; DAMATO MR, 1988, J EXP PSYCHOL ANIM B, V14, P43, DOI 10.1037/0097-7403.14.1.43; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; EDWARDS CA, 1987, LEARN MOTIV, V18, P235, DOI 10.1016/0023-9690(87)90013-0; Fabre-Thorpe M, 1998, NEUROREPORT, V9, P303, DOI 10.1097/00001756-199801260-00023; Fagot J, 2000, PICTURE PERCEPTION A; Fagot J, 2010, P NATL ACAD SCI USA, V107, P519, DOI 10.1073/pnas.0913577107; Fize D, 2011, P NATL ACAD SCI USA, V108, P7635, DOI 10.1073/pnas.1016213108; GAFFAN D, 1993, J COGNITIVE NEUROSCI, V5, P118, DOI 10.1162/jocn.1993.5.1.118; Gronau N, 2008, J COGNITIVE NEUROSCI, V20, P371, DOI 10.1162/jocn.2008.20.3.371; Guyader N, 2004, CR BIOL, V327, P313, DOI 10.1016/j.crvi.2004.02.006; HERRNSTEIN RJ, 1964, SCIENCE, V146, P549, DOI 10.1126/science.146.3643.549; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Joubert OR, 2008, J VISION, V8, DOI 10.1167/8.13.11; Joubert OR, 2009, J VISION, V9, DOI 10.1167/9.1.2; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; KirkpatrickSteger K, 1996, J EXP ANAL BEHAV, V65, P465, DOI 10.1901/jeab.1996.65-465; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; Loschky LC, 2007, J EXP PSYCHOL HUMAN, V33, P1431, DOI 10.1037/0096-1523.33.6.1431; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; Miller MB, 1998, NEUROPSYCHOLOGIA, V36, P513, DOI 10.1016/S0028-3932(97)00148-6; Neider MB, 2006, VISION RES, V46, P2217, DOI 10.1016/j.visres.2006.01.006; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Parron C, 2008, BEHAV PROCESS, V78, P351, DOI 10.1016/j.beproc.2008.01.019; Pokorny JJ, 2009, P NATL ACAD SCI USA, V106, P21539, DOI 10.1073/pnas.0912174106; ROBERTS WA, 1988, J EXP PSYCHOL ANIM B, V14, P247, DOI 10.1037/0097-7403.14.3.247; Rousselet GA, 2005, VIS COGN, V12, P852, DOI 10.1080/13506280444000553; SANDS SF, 1982, J EXP PSYCHOL GEN, V111, P369, DOI 10.1037/0096-3445.111.4.369; SCHRIER AM, 1984, J EXP PSYCHOL ANIM B, V10, P564, DOI 10.1037/0097-7403.10.4.564; SCHRIER AM, 1987, J EXP PSYCHOL ANIM B, V13, P136; SIEGEL S., 1956, NONPARAMETRIC STAT B; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Truppa V, 2009, BEHAV PROCESS, V82, P140, DOI 10.1016/j.beproc.2009.05.004; WASSERMAN EA, 1993, PSYCHOL SCI, V4, P336, DOI 10.1111/j.1467-9280.1993.tb00575.x; Wasserman EA, 1996, J EXP PSYCHOL ANIM B, V22, P205, DOI 10.1037/0097-7403.22.2.205; Wolfe JM, 2002, VISION RES, V42, P2985, DOI 10.1016/S0042-6989(02)00388-7	42	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133721	10.1371/journal.pone.0133721	http://dx.doi.org/10.1371/journal.pone.0133721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207915	Green Published, gold			2022-12-27	WOS:000358622000122
J	Deng, XQ; Li, YY; Zhou, L; Liu, CY; Liu, M; Ding, NC; Shao, JY				Deng, Xingqi; Li, Yanyan; Zhou, Ling; Liu, Chunyan; Liu, Mei; Ding, Nianchang; Shao, Jinyan			Gender Differences in the Symptoms, Signs, Disease History, Lesion Position and Pathophysiology in Patients with Pulmonary Embolism	PLOS ONE			English	Article							EUROPEAN-SOCIETY; CARDIOLOGY ESC; TASK-FORCE; MANAGEMENT; DIAGNOSIS; THROMBOEMBOLISM; GUIDELINES; THROMBOSIS	Advances in research relating to pulmonary embolisms (PE) can assist physicians in selecting the best management strategies for PE patients. However, the symptoms, signs, disease history, lesion position and pathophysiology linked to different genders in patients with PE have rarely been evaluated. One hundred and forty-nine PE patients (73 males and 76 females) were sequentially recruited to this study over the last five years whilst attending our Emergency Department. Data relating to the symptoms, signs, disease history, biochemical testing, cardiac electrophysiology, imaging detection, treatment and outcome were collected and the gender differences were analyzed. We found that embolisms occurred significantly more frequently in the right lung (89.7%) than in the left lung (42.6%). The presence of dyspnea, the number of patients presenting with tumors, the number of patients with chronic pulmonary disease, those with emboli in the right pulmonary artery and emboli in the right lung, as well as the average systolic and diastolic blood pressure were: 78.1%, 15.1%, 31.5%, 32.9%, 94.5%, 129.9+20.0 and 75.0+11.2 in the male patients and 59.2%, 1.3%, 14.5%, 17.1%, 69.7%, 125.1+14.6 and 69.3+11.0 in the female patients. These indicators were found to be significantly higher in male patients. In contrast, the rate of V1-V4 T-wave inversion and level of D-dimer in the blood were significantly lower in males than in females. No significant difference was observed in the remaining observational indicators. Gender differences regarding the symptoms, signs, disease history, lesion position and pathophysiology exist in patients with PE and should be considered in clinical practice.	[Deng, Xingqi] Fudan Univ, Dept Emergency Med, Shanghai 200433, Peoples R China; Fudan Univ, Ctr Hosp Minhang Dist, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Deng, XQ (corresponding author), Fudan Univ, Dept Emergency Med, Shanghai 200433, Peoples R China.	dengchengsheng@sina.com			Program for Development of Key Disciplines of Shanghai [ZK2012A23]	Program for Development of Key Disciplines of Shanghai	This work was supported by the Program for Development of Key Disciplines of Shanghai (grant number: ZK2012A23). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Borrero S, 2007, J WOMENS HEALTH, V16, P1165, DOI 10.1089/jwh.2006.0236; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jenab Y, 2013, J ULTRAS MED, V32, P1997, DOI 10.7863/ultra.32.11.1997; Keller K, 2014, DEUT MED WOCHENSCHR, V139, P2329, DOI 10.1055/s-0034-1387367; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Lapner ST, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f757; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Manfreda J, 2004, CHEST, V125, P1657, DOI 10.1378/chest.125.5.1657; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Siddique RM, 1998, AM J PUBLIC HEALTH, V88, P1476, DOI 10.2105/AJPH.88.10.1476; Silverman EK, 2000, AM J RESP CRIT CARE, V162, P2152, DOI 10.1164/ajrccm.162.6.2003112; Stein PD, 2004, AM J CARDIOL, V93, P1197, DOI 10.1016/j.amjcard.2004.01.058; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Tang YY, 2011, CIRCULATION, V123, P2219, DOI 10.1161/CIRCULATIONAHA.110.976134; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Yu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113076	20	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133993	10.1371/journal.pone.0133993	http://dx.doi.org/10.1371/journal.pone.0133993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208352	Green Submitted, Green Published, gold			2022-12-27	WOS:000358622000187
J	Ho, YJ; Wang, YM; Lu, JW; Wu, TY; Lin, LI; Kuo, SC; Lin, CC				Ho, Yi-Jung; Wang, Yu-Ming; Lu, Jeng-wei; Wu, Tzong-Yuan; Lin, Liang-In; Kuo, Szu-Cheng; Lin, Chang-Chi			Suramin Inhibits Chikungunya Virus Entry and Transmission	PLOS ONE			English	Article							CELL-TO-CELL; E2 GLYCOPROTEIN; MEMBRANE-FUSION; DENGUE VIRUS; INFECTION; PROTEIN; BINDING; EXPRESSION; GLYCOSAMINOGLYCAN; IDENTIFICATION	The mosquito-borne Chikungunya virus (CHIKV) is a profound global threat due to its high rate of contagion and the lack of vaccine or effective treatment. Suramin is a symmetric polyanionic naphthylurea that is widely used in the clinical treatment of parasite infections. Numerous studies have reported the broad antiviral activities of suramin; however, inhibition effects against CHIKV have not yet been demonstrated. The aim of this study was thus to investigate the antiviral effect of suramin on CHIKV infection and to elucidate the molecular mechanism underlying inhibition using plaque reduction assay, RT-qPCR, western blot analysis, and plaque assay. Microneutralization assay was used to determine the EC50 of suramin in the CHIKV-S27 strain as well as in three other clinical strains (0611aTw, 0810bTw and 0706aTw). Time-of-addition was used to reveal the anti-CHIKV mechanism of suramin. We also evaluated anti-CHIKV activity with regard to viral entry, virus release, and cell-to-cell transmission. Cytopathic effect, viral RNA, viral protein, and the virus yield of CHIKV infection were shown to diminish in the presence of suramin in a dose-dependent manner. Suramin was also shown the inhibitory activities of the three clinical isolates. Suramin inhibited the early progression of CHIKV infection, due perhaps to interference with virus fusion and binding, which subsequently prevented viral entry. Results of a molecular docking simulation indicate that suramin may embed within the cavity of the E1/E2 heterodimer to interfere with their function. Suramin was also shown to reduce viral release and cell-to-cell transmission of CHIKV. In conclusion, Suramin shows considerable potential as a novel anti-CHIKV agent targeting viral entry, extracellular transmission, and cell-to-cell transmission.	[Ho, Yi-Jung; Wang, Yu-Ming; Kuo, Szu-Cheng; Lin, Chang-Chi] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Ho, Yi-Jung; Kuo, Szu-Cheng; Lin, Chang-Chi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Chang-Chi] Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, Taipei, Taiwan; [Kuo, Szu-Cheng] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Kuo, Szu-Cheng] Natl Def Med Ctr, Grad Inst Pathol & Parasitol, Taipei, Taiwan; [Lu, Jeng-wei; Lin, Liang-In] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Lu, Jeng-wei; Lin, Liang-In] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Lin, Liang-In] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Kuo, SC (corresponding author), Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan.	szucheng1234@gmail.com; chalin3@ndmctsgh.edu.tw	Lin, Liang-In/K-4600-2019	Lu, Jeng-Wei/0000-0003-2128-2046; LIN, LIANG-IN/0000-0002-3561-1093	Institute of Preventive Medicine, National Defense Medical Center [104-9-B19, 103-A8, 103-B14, 103-B22, 103-B23]	Institute of Preventive Medicine, National Defense Medical Center	This study was supported by grants (104-9-B19, 103-A8, 103-B14, 103-B22 and 103-B23) from the Institute of Preventive Medicine, National Defense Medical Center.	Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723; Al Olaby RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111333; Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113; Basu A, 2004, J VIROL, V78, P4478, DOI 10.1128/JVI.78.9.4478-4486.2004; Brindley MA, 2015, J VIROL, V89, P1230, DOI 10.1128/JVI.02754-14; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Chijioke CP, 1998, EUR J CLIN PHARMACOL, V54, P249, DOI 10.1007/s002280050454; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Croci R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091765; Cruz DJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002471; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Ellenbecker M, 2014, ANTIMICROB AGENTS CH; Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500; Gardner CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002719; Garoff H, 2004, VIRUS RES, V106, P103, DOI 10.1016/j.virusres.2004.08.008; Garson JA, 1999, J MED VIROL, V57, P238; HAHON N, 1970, APPL MICROBIOL, V19, P389, DOI 10.1128/AEM.19.2.389-391.1970; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Higgs S, 2006, VECTOR-BORNE ZOONOT, V6, P115, DOI 10.1089/vbz.2006.6.115; Huang JH, 2009, EMERG INFECT DIS, V15, P1854, DOI 10.3201/eid1511.090398; Jiao LY, 2013, J VIROL, V87, P6829, DOI 10.1128/JVI.00672-13; Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12; KESSLER HA, 1986, AIDS RES HUM RETROV, V2, P63, DOI 10.1089/aid.1.1986.2.63; Khan K., 2014, PLOS CURR, V6, DOI [10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5, DOI 10.1371/CURRENTS.OUTBREAKS.2134A0A7BF37FD8D388181539FEA2DA5]; Kuo SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-44; Kuo SC, 2011, J VIROL METHODS, V175, P206, DOI 10.1016/j.jviromet.2011.05.015; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Lee CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002390; Madsen C, 2014, ANTIVIR RES, V112, P26, DOI 10.1016/j.antiviral.2014.10.002; Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038; Mastrangelo E, 2014, CHEMMEDCHEM, V9, P933, DOI 10.1002/cmdc.201300563; MITSUYA H, 1984, SCIENCE, V226, P172, DOI 10.1126/science.6091268; Moghaddam E, 2014, SCI REP-UK, V4, DOI 10.1038/srep05452; Monel B, 2012, J VIROL, V86, P3924, DOI 10.1128/JVI.06478-11; Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14; Noret M, 2012, J INFECT DIS, V206, P455, DOI 10.1093/infdis/jis368; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Rashad AA, 2014, J MED CHEM, V57, P1147, DOI 10.1021/jm400460d; Rashad AA, 2013, J MOL GRAPH MODEL, V44, P241, DOI 10.1016/j.jmgm.2013.07.001; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Shih SR, 2010, J ANTIMICROB CHEMOTH, V65, P63, DOI 10.1093/jac/dkp393; Silva LA, 2014, J VIROL, V88, P2385, DOI 10.1128/JVI.03116-13; Sjoberg M, 2003, J VIROL, V77, P3441, DOI 10.1128/JVI.77.6.3441-3450.2003; Soonsawad P, 2010, J VIROL, V84, P11145, DOI 10.1128/JVI.00036-10; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Wang YX, 2014, ANTIVIR RES, V103, P1, DOI 10.1016/j.antiviral.2013.12.008; Xu Keshu, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P375; YAHI N, 1994, J BIOL CHEM, V269, P24349	53	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133511	10.1371/journal.pone.0133511	http://dx.doi.org/10.1371/journal.pone.0133511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208101	Green Submitted, gold, Green Published			2022-12-27	WOS:000358622000094
J	Huang, LL; Damle, SS; Booten, S; Singh, P; Sabripour, M; Hsu, J; Jo, MJ; Katz, M; Watt, A; Hart, CE; Freier, SM; Monia, BP; Guo, SL				Huang, Lulu; Damle, Sagar S.; Booten, Sheri; Singh, Priyam; Sabripour, Mahyar; Hsu, Jeff; Jo, Minji; Katz, Melanie; Watt, Andy; Hart, Christopher E.; Freier, Susan M.; Monia, Brett P.; Guo, Shuling			Partial Hepatectomy Induced Long Noncoding RNA Inhibits Hepatocyte Proliferation during Liver Regeneration	PLOS ONE			English	Article							EXPRESSION PROFILES; CANCER; MALAT1; MOUSE; MECHANISMS; PROTEINS; GENOME; CELLS; GENE; IDENTIFICATION	Liver regeneration after partial hepatectomy (PHx) is a complex and well-orchestrated biological process in which synchronized cell proliferation is induced in response to the loss of liver mass. To define long noncoding RNAs (lncRNAs) that participate in the regulation of liver regeneration, we performed microarray analysis and identified more than 400 lncRNAs exhibiting significantly altered expression. Of these, one lncRNA, LncPHx2 (Long noncoding RNA induced by PHx 2), was highly upregulated during liver regeneration. Depletion of LncPHx2 during liver regeneration using antisense oligonucleotides led to a transient increase in hepatocyte proliferation and more rapid liver regeneration. Gene expression analysis showed that LncPHx2 depletion resulted in upregulation of mRNAs encoding proteins known to promote cell proliferation, including MCM components, DNA polymerases, histone proteins, and transcription factors. LncPHx2 interacts with the mRNAs of MCM components, making it a candidate to regulate the expression of MCMs and other genes post-transcriptionally. Collectively, our data demonstrate that LncPHx2 is a key lncRNA that participates in a negative feedback loop modulating hepatocyte proliferation through RNA-RNA interactions.	[Huang, Lulu; Damle, Sagar S.; Booten, Sheri; Singh, Priyam; Sabripour, Mahyar; Hsu, Jeff; Jo, Minji; Katz, Melanie; Watt, Andy; Hart, Christopher E.; Freier, Susan M.; Monia, Brett P.; Guo, Shuling] Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Carlsbad, CA 92010 USA	Isis Pharmaceuticals Inc	Guo, SL (corresponding author), Isis Pharmaceut Inc, Dept Antisense Drug Discovery, Carlsbad, CA 92010 USA.	sguo@isisph.com	Singh, Priyam/P-3985-2019; Singh, Priyam/AAA-8574-2019		Isis Pharmaceuticals	Isis Pharmaceuticals	The work was supported by Isis Pharmaceuticals in the form of salaries for authors LH, SSD, SB, PS, MS, JH, MJ, MK, ATW, CEH, SMF, BPM and SG, but the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Hortelano S, 2007, FRONT BIOSCI-LANDMRK, V12, P13, DOI 10.2741/2045; Hu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107016; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kambara H, 2014, NUCLEIC ACIDS RES, V42, P10668, DOI 10.1093/nar/gku713; Kitagawa M, 2013, CELL MOL LIFE SCI, V70, P4785, DOI 10.1007/s00018-013-1423-0; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kurinna S, 2011, INT J BIOCHEM CELL B, V43, P189, DOI 10.1016/j.biocel.2010.03.013; Lalith S., 2013, INCRNA PROTEIN INTER; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu XF, 2012, EMBO J, V31, P4415, DOI 10.1038/emboj.2012.292; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sanchez Y, 2013, NUCLEIC ACID THER, V23, P15, DOI 10.1089/nat.2012.0414; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zong Xingying H L, 2015, KNOCKDOWN NUCL RETAI	51	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132798	10.1371/journal.pone.0132798	http://dx.doi.org/10.1371/journal.pone.0132798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26207833	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000041
J	Ng, CS; Wei, W; Bankson, JA; Ravoori, MK; Han, L; Brammer, DW; Klumpp, S; Waterton, JC; Jackson, EF				Ng, Chaan S.; Wei, Wei; Bankson, James A.; Ravoori, Murali K.; Han, Lin; Brammer, David W.; Klumpp, Sherry; Waterton, John C.; Jackson, Edward F.			Dependence of DCE-MRI biomarker values on analysis algorithm	PLOS ONE			English	Article							CONTRAST-ENHANCED-MRI; ARTERIAL INPUT FUNCTION; CLINICAL-TRIALS; DYNAMIC MRI; TUMORS; AGENT; INHIBITOR; CANCER; MODEL; AZD2171	Background Dynamic contrast-enhanced MRI (DCE-MRI) biomarkers have proven utility in tumors in evaluating microvascular perfusion and permeability, but it is unclear whether measurements made in different centers are comparable due to methodological differences. Purpose To evaluate how commonly utilized analytical methods for DCE-MRI biomarkers affect both the absolute parameter values and repeatability. Materials and Methods DCE-MRI was performed on three consecutive days in twelve rats bearing C6 xenografts. Endothelial transfer constant (K-trans), extracellular extravascular space volume fraction (v(e)), and contrast agent reflux rate constant (k(ep)) measures were computed using: 2-parameter ("Tofts" or "standard Kety") vs. 3-parameter ("General Kinetic" or "extended Kety") compartmental models (including blood plasma volume fraction (v(p)) with 3-parameter models); individual-vs. population-based vascular input functions (VIFs); and pixel-by-pixel vs. whole tumor-ROI. Variability was evaluated by within-subject coefficient of variation (wCV) and variance components analyses. Results DCE-MRI absolute parameter values and wCVs varied widely by analytical method. Absolute parameter values ranged, as follows, median K-trans, 0.09-0.18 min(-1); k(ep), 0.51-0.92 min(-1); v(e), 0.17-0.23; and v(p), 0.02-0.04. wCVs also varied widely by analytical method, as follows: mean K-trans, 32.9-61.9%; k(ep), 11.6- 41.9%; v(e), 16.1-54.9%; and v(p), 53.9-77.2%. K-trans and k(ep) values were lower with 3-than 2-parameter modeling (p<0.0001); k(ep) and v(p) were lower with pixel-than whole-ROI analyses (p<0.0006). wCVs were significantly smaller for v(e), and larger for k(ep), with individual-than population-based VIFs. Conclusions DCE-MRI parameter values and repeatability can vary widely by analytical methodology. Absolute values of DCE-MRI biomarkers are unlikely to be comparable between different studies unless analyses are carefully standardized.	[Ng, Chaan S.; Ravoori, Murali K.; Han, Lin] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA; [Wei, Wei] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Bankson, James A.] Univ Texas MD Anderson Canc Ctr, Dept Biostat Imaging Phys, Houston, TX 77030 USA; [Brammer, David W.; Klumpp, Sherry] Univ Texas MD Anderson Canc Ctr, Dept Biostat Vet Med & Surg, Houston, TX 77030 USA; [Waterton, John C.] AstraZeneca, Personalised Healthcare & Biomarkers, Alderley Pk, Cheshire, England; [Jackson, Edward F.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; AstraZeneca; University of Wisconsin System; University of Wisconsin Madison	Ng, CS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA.	cng@mdanderson.org	Jackson, Edward F/L-5159-2013; Bankson, James A./J-9798-2014; Waterton, John Charles/A-8565-2008	Bankson, James A./0000-0002-8574-154X; Waterton, John Charles/0000-0002-7734-2290; Jackson, Edward/0000-0002-5958-0076; Wei, Wei/0000-0002-0960-7269	MDACC - AstraZeneca Research Collaboration Alliance; Cancer Center Support Grant [P30-CA016672]; John S. Dunn Sr. Distinguished Chair in Diagnostic Imaging; AstraZeneca; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	MDACC - AstraZeneca Research Collaboration Alliance; Cancer Center Support Grant; John S. Dunn Sr. Distinguished Chair in Diagnostic Imaging; AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MDACC - AstraZeneca Research Collaboration Alliance; Cancer Center Support Grant (P30-CA016672); John S. Dunn Sr. Distinguished Chair in Diagnostic Imaging. AstraZeneca provided support in the form of salary for author JCW.	Ashton EA, 2007, P 15 ANN M ISMRM BER; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bland M, 2003, INTRO MED STAT, P268; Bradley DP, 2008, NMR BIOMED, V21, P42, DOI 10.1002/nbm.1161; Bradley DP, 2009, MAGN RESON IMAGING, V27, P377, DOI 10.1016/j.mri.2008.07.021; Checkley D, 2003, BRIT J CANCER, V89, P1889, DOI 10.1038/sj.bjc.6601386; Evelhoch JL, 2004, CLIN CANCER RES, V10, P3650, DOI 10.1158/1078-0432.CCR-03-0417; Galbraith SM, 2002, NMR BIOMED, V15, P132, DOI 10.1002/nbm.731; KETY SS, 1951, PHARMACOL REV, V3, P1; Laking GR, 2006, CRIT REV ONCOL HEMAT, V58, P95, DOI 10.1016/j.critrevonc.2005.10.006; Lankester KJ, 2007, J MAGN RESON IMAGING, V25, P796, DOI 10.1002/jmri.20881; Lankester KJ, 2005, BRIT J CANCER, V93, P979, DOI 10.1038/sj.bjc.6602814; LARSSON HBW, 1990, MAGNET RESON MED, V16, P117, DOI 10.1002/mrm.1910160111; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Liu G, 2005, J CLIN ONCOL, V23, P5464, DOI 10.1200/JCO.2005.04.143; Loveless ME, 2012, MAGN RESON MED, V67, P226, DOI 10.1002/mrm.22988; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; Morgan B, 2003, J CLIN ONCOL, V21, P3955, DOI 10.1200/JCO.2003.08.092; Ng CS, 2012, TECHNOL CANCER RES T, V11, P279, DOI 10.7785/tcrt.2012.500296; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Pickup S, 2003, ACAD RADIOL, V10, P963, DOI 10.1016/s1076-6332(03)00291-5; Ragan DK, 2011, NMR BIOMED, V24, P373, DOI 10.1002/nbm.1601; Ragan DK, 2011, J MAGN RESON IMAGING, V33, P1256, DOI 10.1002/jmri.22523; Rijpkema M, 2001, J MAGN RESON IMAGING, V14, P457, DOI 10.1002/jmri.1207; Roberts C, 2006, J MAGN RESON IMAGING, V23, P554, DOI 10.1002/jmri.20529; Stevenson JP, 2003, J CLIN ONCOL, V21, P4428, DOI 10.1200/JCO.2003.12.986; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Waterton JC, 2013, NEW DEV NMR, P333, DOI 10.1039/9781849737661-00333; WEINMANN HJ, 1984, PHYSIOL CHEM PHYS ME, V16, P167; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988	33	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0130168	10.1371/journal.pone.0130168	http://dx.doi.org/10.1371/journal.pone.0130168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208254	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000006
J	Regidor, E; Reques, L; Giraldez-Garcia, C; Miqueleiz, E; Santos, JM; Martinez, D; de la Fuente, L				Regidor, Enrique; Reques, Laura; Giraldez-Garcia, Carolina; Miqueleiz, Estrella; Santos, Juana M.; Martinez, David; de la Fuente, Luis			The Association of Geographic Coordinates with Mortality in People with Lower and Higher Education and with Mortality Inequalities in Spain	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; CANCER INCIDENCE; HIGHER ALTITUDES; PATTERNS; AREAS; DETERMINANTS; NORTHERN; STROKE; TRENDS; INDEX	Objective Geographic patterns in total mortality and in mortality by cause of death are widely known to exist in many countries. However, the geographic pattern of inequalities in mortality within these countries is unknown. This study shows mathematically and graphically the geographic pattern of mortality inequalities by education in Spain. Methods Data are from a nation-wide prospective study covering all persons living in Spain's 50 provinces in 2001. Individuals were classified in a cohort of subjects with low education and in another cohort of subjects with high education. Age- and sex-adjusted mortality rate from all causes and from leading causes of death in each cohort and mortality rate ratios in the low versus high education cohort were estimated by geographic coordinates and province. Results Latitude but not longitude was related to mortality. In subjects with low education, latitude had a U-shaped relation to mortality. In those with high education, mortality from all causes, and from cardiovascular, respiratory and digestive diseases decreased with increasing latitude, whereas cancer mortality increased. The mortality-rate ratio for all-cause death was 1.27 in the southern latitudes, 1.14 in the intermediate latitudes, and 1.20 in the northern latitudes. The mortality rate ratios for the leading causes of death were also higher in the lower and upper latitudes than in the intermediate latitudes. The geographic pattern of the mortality rate ratios is similar to that of the mortality rate in the low-education cohort: the highest magnitude is observed in the southern provinces, intermediate magnitudes in the provinces of the north and those of the Mediterranean east coast, and the lowest magnitude in the central provinces and those in the south of the Western Pyrenees. Conclusion Mortality inequalities by education in Spain are higher in the south and north of the country and lower in the large region making up the central plateau. This geographic pattern is similar to that observed in mortality in the low-education cohort.	[Regidor, Enrique; Giraldez-Garcia, Carolina; Santos, Juana M.; Martinez, David] Univ Complutense Madrid, Fac Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Regidor, Enrique; Giraldez-Garcia, Carolina; Santos, Juana M.; Martinez, David] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain; [Regidor, Enrique; de la Fuente, Luis] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Reques, Laura] Inst Salud Carlos III, Natl Sch Publ Hlth, Madrid, Spain; [Miqueleiz, Estrella] Univ Publ Navarra, Dept Sociol, Pamplona, Spain; [de la Fuente, Luis] Inst Salud Carlos III, Natl Epidemiol Ctr, Madrid, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Universidad Publica de Navarra; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Regidor, E (corresponding author), Univ Complutense Madrid, Fac Med, Dept Prevent Med & Publ Hlth, Madrid, Spain.	enriqueregidor@hotmail.com		Giraldez-Garcia, Carolina/0000-0002-1938-0280; Regidor, Enrique/0000-0002-2374-9861; De la Fuente, Luis/0000-0003-4527-1608	UCM-Banco de Santander [GR3/14]	UCM-Banco de Santander	This study was funded by UCM-Banco de Santander (GR3/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ATLAS US MORTALITY; Artalejo FR, 1996, INT J EPIDEMIOL, V25, P1196, DOI 10.1093/ije/25.6.1196; Ashouri K., 1994, Ethnicity and Disease, V4, P82; Benach J, 2004, OCCUP ENVIRON MED, V61, P280, DOI 10.1136/oem.2002.001933; Benach J, 1999, J EPIDEMIOL COMMUN H, V53, P423, DOI 10.1136/jech.53.7.423; Benach J, 2013, ATLAS MORTALITY SPAN; Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264; BUECHLEY RW, 1979, AM J EPIDEMIOL, V109, P663, DOI 10.1093/oxfordjournals.aje.a112729; Burtscher M, 2014, AGING DIS, V5, P274, DOI 10.14336/AD.2014.0500274; Coulsen M.R.C., 1987, CARTOGRAPHICA, V24, P16, DOI DOI 10.3138/U7X0-1836-5715-3546; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; Divino F, 2009, DEMOGR RES, V20, P435, DOI 10.4054/DemRes.2009.20.18; Eurostat, 2009, HLTH STAT ATL MORT E; Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938; FABSITZ R, 1980, AM J EPIDEMIOL, V111, P315, DOI 10.1093/oxfordjournals.aje.a112903; Faeh D, 2009, CIRCULATION, V120, P495, DOI 10.1161/CIRCULATIONAHA.108.819250; Federico B, 2013, J EPIDEMIOL COMMUN H, V67, P603, DOI 10.1136/jech-2012-201716; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Grant WB, 2007, INT J CANCER, V120, P1123, DOI 10.1002/ijc.22386; Grant WB, 2010, DERM-ENDOCRINOL, V2, P62, DOI 10.4161/derm.2.2.13624; Grant WB, 2009, ANN EPIDEMIOL, V19, P446, DOI 10.1016/j.annepidem.2008.12.014; Guallar-Castillon P, 2014, REV ESP CARDIOL, V67, P367, DOI [10.1016/j.rec.2013.08.014, 10.1016/j.recesp.2013.08.014]; Gutierrez-Fisac JL, 1999, INT J OBESITY, V23, P342, DOI 10.1038/sj.ijo.0800823; Hacking JM, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d508; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; MACKENBACH JP, 1991, J EPIDEMIOL COMMUN H, V45, P231, DOI 10.1136/jech.45.3.231; Mazuy M, 2013, POPULATION, V68, P385, DOI 10.3917/popu.1303.0385; Montez JK, 2014, AM J PUBLIC HEALTH, V104, pE82, DOI 10.2105/AJPH.2013.301526; MORTIMER EA, 1977, NEW ENGL J MED, V296, P581, DOI 10.1056/NEJM197703172961101; National Statistical Institute, SOC IND; National Statistical Institute, 2001, POP HOUS CENS; Ocana-Riola R, 2006, SOC SCI MED, V63, P1352, DOI 10.1016/j.socscimed.2006.03.016; Rodriguez-Artalejo F, 2000, EUR HEART J, V21, P1841, DOI 10.1053/euhj.2000.2320; VOORS AW, 1979, J CHRON DIS, V32, P157, DOI 10.1016/0021-9681(79)90044-4	35	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133765	10.1371/journal.pone.0133765	http://dx.doi.org/10.1371/journal.pone.0133765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN7NT	26208113	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000134
J	Takahashi, Y; Nagata, N; Shimbo, T; Nishijima, T; Watanabe, K; Aoki, T; Sekine, K; Okubo, H; Watanabe, K; Sakurai, T; Yokoi, C; Kobayakawa, M; Yazaki, H; Teruya, K; Gatanaga, H; Kikuchi, Y; Mine, S; Igari, T; Takahashi, Y; Mimori, A; Oka, S; Akiyama, J; Uemura, N				Takahashi, Yuta; Nagata, Naoyoshi; Shimbo, Takuro; Nishijima, Takeshi; Watanabe, Koji; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Watanabe, Kazuhiro; Sakurai, Toshiyuki; Yokoi, Chizu; Kobayakawa, Masao; Yazaki, Hirohisa; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Mine, Sohtaro; Igari, Toru; Takahashi, Yuko; Mimori, Akio; Oka, Shinichi; Akiyama, Junichi; Uemura, Naomi			Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients	PLOS ONE			English	Article							PNEUMOCYSTIS-CARINII-PNEUMONIA; HELICOBACTER-PYLORI INFECTION; ANTIRETROVIRAL THERAPY; DEFENSE-MECHANISMS; DIAGNOSIS; ALBICANS; DISEASE; ERA	Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Methods Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immuno-suppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. Results CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/mu L (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). Conclusions This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.	[Takahashi, Yuta; Nagata, Naoyoshi; Aoki, Tomonori; Sekine, Katsunori; Okubo, Hidetaka; Sakurai, Toshiyuki; Yokoi, Chizu; Kobayakawa, Masao; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Fukushima, Japan; [Nishijima, Takeshi; Watanabe, Koji; Watanabe, Kazuhiro; Yazaki, Hirohisa; Teruya, Katsuji; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, Div AIDS Clin Ctr ACC, Tokyo, Japan; [Mine, Sohtaro; Igari, Toru] Natl Ctr Global Hlth & Med, Dept Pathol, Tokyo, Japan; [Takahashi, Yuko; Mimori, Akio] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp	宗太郎, 峰/ABB-7890-2020; 小早川, 雅男/HII-5007-2022	宗太郎, 峰/0000-0002-4912-4077; Takahashi, Yuta/0000-0002-6996-3505	Ministry of Health, Labour and Welfare of Japan [H26-003]; National Center for Global Health and Medicine [26A-201]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported in part by a Grant-in Aid for AIDS research from the Ministry of Health, Labour and Welfare of Japan (H26-003 http://www.mhlw.go.jp/english/), and a Grants-in-Aid for Research from the National Center for Global Health and Medicine (26A-201 http://www.ncgm.go.jp/eng/). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTINORI A, 1995, ENDOSCOPY, V27, P371, DOI 10.1055/s-2007-1005716; Asare K, 2007, PHARMACOTHERAPY, V27, P1512, DOI 10.1592/phco.27.11.1512; Asayama N, 2014, DIS ESOPHAGUS, V27, P214, DOI 10.1111/dote.12102; BAEHR PH, 1994, GASTROENTEROLOGY, V106, P509, DOI 10.1016/0016-5085(94)90613-0; BALISH E, 1990, INFECT IMMUN, V58, P107, DOI 10.1128/IAI.58.1.107-113.1990; BONACINI M, 1991, ARCH INTERN MED, V151, P1567, DOI 10.1001/archinte.151.8.1567; Choi JH, 2013, YONSEI MED J, V54, P160, DOI 10.3349/ymj.2013.54.1.160; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; GIANNELLA RA, 1973, ANN INTERN MED, V78, P271, DOI 10.7326/0003-4819-78-2-271; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Hamada Y, 2014, JAIDS-J ACQ IMM DEF, V65, P312, DOI 10.1097/QAI.0000000000000016; HEIDENREICH S, 1994, CELL IMMUNOL, V157, P320, DOI 10.1006/cimm.1994.1230; KODSI BE, 1976, GASTROENTEROLOGY, V71, P715; Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Martinez AC, 2000, EUR J CLIN MICROBIOL, V19, P96; Mocroft A, 2005, AM J GASTROENTEROL, V100, P1446, DOI 10.1111/j.1572-0241.2005.41949.x; Monkemuller KE, 2000, AM J GASTROENTEROL, V95, P457, DOI 10.1111/j.1572-0241.2000.01768.x; Nagata N, 2014, J GASTROENTEROL HEPA; Naito Y, 1988, Gastroenterol Jpn, V23, P363; Negata N, 2012, EMERG INFECT DIS, V18, P717, DOI 10.3201/eid1805.111275; Nishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058217; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; PORGES AJ, 1992, J RHEUMATOL, V19, P1191; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Underwood JA, 2003, DIS ESOPHAGUS, V16, P66, DOI 10.1046/j.1442-2050.2003.00305.x; Weerasuriya N, 2006, DIS ESOPHAGUS, V19, P189, DOI 10.1111/j.1442-2050.2006.00563.x; WHEELER RR, 1987, REV INFECT DIS, V9, P88; Willemot Patrick, 2004, Expert Rev Anti Infect Ther, V2, P521, DOI 10.1586/14787210.2.4.521; Yakoob A, 2003, WORLD J GASTROENTERO, V9, P2328; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5; YEH CK, 1988, J ACQ IMMUN DEF SYND, V1, P361	34	31	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133589	10.1371/journal.pone.0133589	http://dx.doi.org/10.1371/journal.pone.0133589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208220	Green Published, gold, Green Submitted			2022-12-27	WOS:000358622000105
J	Xie, FY; Feng, YL; Wang, HH; Ma, YF; Yang, Y; Wang, YC; Shen, W; Pan, QJ; Yin, S; Sun, YJ; Ma, JY				Xie, Feng-Yun; Feng, Yu-Long; Wang, Hong-Hui; Ma, Yun-Feng; Yang, Yang; Wang, Yin-Chao; Shen, Wei; Pan, Qing-Jie; Yin, Shen; Sun, Yu-Jiang; Ma, Jun-Yu			De Novo Assembly of the Donkey White Blood Cell Transcriptome and a Comparative Analysis of Phenotype-Associated Genes between Donkeys and Horses	PLOS ONE			English	Article							PACT; INTEGRATION	Prior to the mechanization of agriculture and labor-intensive tasks, humans used donkeys (Equus africanus asinus) for farm work and packing. However, as mechanization increased, donkeys have been increasingly raised for meat, milk, and fur in China. To maintain the development of the donkey industry, breeding programs should focus on traits related to these new uses. Compared to conventional marker-assisted breeding plans, genome- and transcriptome-based selection methods are more efficient and effective. To analyze the coding genes of the donkey genome, we assembled the transcriptome of donkey white blood cells de novo. Using transcriptomic deep-sequencing data, we identified 264,714 distinct donkey unigenes and predicted 38,949 protein fragments. We annotated the donkey unigenes by BLAST searches against the non-redundant (NR) protein database. We also compared the donkey protein sequences with those of the horse (E. caballus) and wild horse (E. przewalskii), and linked the donkey protein fragments with mammalian phenotypes. As the outer ear size of donkeys and horses are obviously different, we compared the outer ear size-associated proteins in donkeys and horses. We identified three ear size-associated proteins, HIC1, PRKRA, and KMT2A, with sequence differences among the donkey, horse, and wild horse loci. Since the donkey genome sequence has not been released, the de novo assembled donkey transcriptome is helpful for preliminary investigations of donkey cultivars and for genetic improvement.	[Xie, Feng-Yun; Wang, Hong-Hui; Shen, Wei; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Inst Reprod Sci, Qingdao 266109, Shandong, Peoples R China; [Xie, Feng-Yun; Wang, Hong-Hui; Shen, Wei; Pan, Qing-Jie; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao 266109, Shandong, Peoples R China; [Xie, Feng-Yun; Feng, Yu-Long; Wang, Hong-Hui; Ma, Yun-Feng; Yang, Yang; Shen, Wei; Pan, Qing-Jie; Yin, Shen; Sun, Yu-Jiang; Ma, Jun-Yu] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao 266109, Shandong, Peoples R China; [Feng, Yu-Long; Ma, Yun-Feng; Wang, Yin-Chao] Shandong Dongeejiao Co Ltd, Black Donkey Res Inst, Liaocheng 252000, Shandong, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University	Ma, JY (corresponding author), Qingdao Agr Univ, Inst Reprod Sci, Qingdao 266109, Shandong, Peoples R China.	jun_yu_ma@aliyun.com			Shandong Province	Shandong Province	Funding was provided to Yu-Jiang Sun from Breeding Projects in Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Denis Fielding PS, 1997, PEOPLE AND DEVELOPME; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hancock JM, 2007, MAMM GENOME, V18, P157, DOI 10.1007/s00335-007-9004-x; Hoehenwarter W, 2008, PROTEOMICS, V8, P4214, DOI 10.1002/pmic.200701047; Huang JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04958; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; Peters GA, 2006, J BIOL CHEM, V281, P35129, DOI 10.1074/jbc.M607714200; Resources CNCoAG, 2011, RESOURCES CNCOAG ANI; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stock KF, 2013, REPROD DOMEST ANIM, V48, P2, DOI 10.1111/rda.12201; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Waltraud Kugler H-PG, 2008, CONSERVATION REPORT	21	1	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0133258	10.1371/journal.pone.0133258	http://dx.doi.org/10.1371/journal.pone.0133258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	26208029	Green Published, Green Submitted, gold			2022-12-27	WOS:000358622000073
